data_2jtc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jtc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.752 HG13 ' HA2' ' A' ' 201' ' ' GLY . 36.7 t . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.181 0.515 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -75.23 172.89 11.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.597 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.9 t -76.9 108.13 9.73 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.488 -0.757 . . . . 0.0 110.807 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.66 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 41.0 mt -58.54 -50.4 73.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 8' ' ' LEU . 13.5 mt -55.54 -40.81 72.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.879 -1.138 . . . . 0.0 108.503 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 14.6 m-20 -67.84 -42.8 80.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.292 -0.88 . . . . 0.0 109.149 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -57.98 -15.09 7.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 108.932 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 5.8 mtpp -116.54 20.39 14.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.34 37.01 4.5 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 59.2 mt -88.54 110.1 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 122.351 1.072 . . . . 0.0 110.385 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' PRO . 77.4 m80 -133.53 97.96 4.08 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' HD13 ' A' ' 116' ' ' ILE . 4.2 m-30 -103.16 174.31 5.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.157 0.98 . . . . 0.0 111.823 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -146.83 -171.26 3.72 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.9 mt-30 -124.2 -11.19 7.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.919 -1.113 . . . . 0.0 109.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.73 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.17 -39.75 0.86 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.982 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -140.75 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.511 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.253 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.4 Cg_endo -73.85 2.3 6.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 122.523 1.937 . . . . 0.0 109.0 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 19' ' ' ASN . 46.9 m-85 -72.76 -37.48 67.66 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.704 -0.622 . . . . 0.0 109.59 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 38.3 p-10 -96.15 21.24 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.564 -1.335 . . . . 0.0 110.087 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.75 4.44 6.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.315 -0.865 . . . . 0.0 109.622 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 118' ' ' GLU . 15.0 mt -136.29 -1.81 2.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.936 -1.103 . . . . 0.0 110.467 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 43' ' ' ALA . 23.3 p -61.56 161.77 18.44 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 86' ' ' LEU . 20.0 Cg_endo -69.85 137.51 35.38 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.697 1.598 . . . . 0.0 110.597 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.92 142.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.792 0.806 . . . . 0.0 110.82 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.674 HD13 ' HD3' ' A' ' 133' ' ' PRO . 18.5 mt -76.9 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.415 0.626 . . . . 0.0 109.833 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 39' ' ' VAL . 64.0 mt-10 -126.22 -19.31 4.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.804 . . . . 0.0 111.398 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' TYR . 34.0 mtpt -123.11 171.77 9.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.729 -1.232 . . . . 0.0 110.58 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.742 0.782 . . . . 0.0 110.963 -179.291 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.612 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.2 m-85 -124.07 18.97 9.2 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.853 -1.154 . . . . 0.0 110.23 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 28' ' ' ILE . 45.1 t -67.88 140.36 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.556 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.39 -2.26 72.61 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 13.2 mt-30 -83.4 136.52 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.33 -1.1 . . . . 0.0 109.824 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -73.2 108.58 6.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.2 168.79 0.09 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.721 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -90.24 173.36 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.005 . . . . 0.0 110.066 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 129' ' ' MET . 31.3 p -83.15 -37.68 23.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.229 -0.919 . . . . 0.0 108.603 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 135' ' ' SER . . . 105.05 136.44 8.69 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' VAL . 2.8 p -54.57 -54.04 46.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -1.231 . . . . 0.0 108.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 137' ' ' SER . 38.2 t -46.38 -52.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . . . -59.26 -52.28 66.35 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.865 0.84 . . . . 0.0 109.791 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -63.27 -32.61 74.07 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.186 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -66.85 -41.86 86.69 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.222 -1.391 . . . . 0.0 108.135 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 143' ' ' VAL . 83.9 m -73.52 -53.05 11.49 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.754 0.788 . . . . 0.0 109.651 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.608 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.39 -42.64 64.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.805 -0.56 . . . . 0.0 110.193 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.1 mt-30 -56.66 -48.75 76.9 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 198' ' ' VAL . 32.5 mt -66.27 -26.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.587 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 29.7 mtp -70.31 -35.88 73.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 23.7 tptt -72.58 -42.05 65.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.66 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.1 t80 -53.9 -31.61 50.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 71.9 m-70 -107.86 -22.35 12.48 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.649 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.68 51.43 3.03 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.547 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.5 t80 -70.02 -74.34 0.16 Allowed Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 61' ' ' TYR . 33.9 Cg_endo -68.97 107.59 1.74 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 CA-C-N 119.044 0.694 . . . . 0.0 112.158 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -70.32 -21.95 62.87 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.2 tttm -134.27 148.06 50.75 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 144.9 42.42 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.238 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.566 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.435 -1.038 . . . . 0.0 111.579 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' ' OD1' ' A' ' 150' ' ' ASN . 51.7 tttt -151.51 137.24 17.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.093 -1.629 . . . . 0.0 111.229 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' HB3' ' A' ' 91' ' ' SER . 75.6 m-20 -59.42 152.76 20.71 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -126.85 172.81 10.08 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.62 -1.3 . . . . 0.0 107.986 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.7 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 10.9 t -167.87 134.74 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.01 173.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.61 ' CD2' ' OH ' ' A' ' 69' ' ' TYR . 3.3 p90 -148.67 146.47 28.18 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.258 -0.901 . . . . 0.0 109.112 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.8 m -93.43 135.15 34.95 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 77' ' ' ASN . 10.2 tp -52.14 144.58 12.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.86 0.838 . . . . 0.0 111.428 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.93 145.08 53.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.364 0.602 . . . . 0.0 110.453 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -0.15 11.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.92 . . . . 0.0 109.756 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.49 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -96.28 -10.36 28.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.204 -0.935 . . . . 0.0 108.874 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 29.0 t-20 -69.79 111.0 7.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.713 -0.617 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.1 Cg_endo -88.95 17.5 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.82 2.346 . . . . 0.0 109.193 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.601 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 89.6 m-85 -107.1 -15.27 14.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.575 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -135.52 167.21 21.51 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.584 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 19.3 m-80 -48.7 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.12 -48.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 111.302 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -75.66 60.54 5.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 N-CA-C 106.955 -1.979 . . . . 0.0 106.955 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.537 ' HG3' HD12 ' A' ' 86' ' ' LEU . 2.0 tptt -104.5 119.78 39.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.424 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -100.88 119.28 38.46 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.406 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.603 HD23 ' HG3' ' A' ' 26' ' ' PRO . 2.7 mp -94.88 143.57 26.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.51 ' HA ' ' CE1' ' A' ' 69' ' ' TYR . 18.2 t80 -139.03 130.75 27.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 110.726 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -110.22 119.4 39.13 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.7 45.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.696 -1.252 . . . . 0.0 107.834 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.685 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 15.4 mt -52.32 -56.56 6.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 O-C-N 121.578 -0.701 . . . . 0.0 109.999 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.535 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -44.56 -26.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 108.987 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -111.47 34.72 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 108.916 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.685 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 38.1 mmt-85 -93.35 155.81 17.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 110.868 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.73 88.77 2.98 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' ASN . 3.2 m-85 -80.76 86.38 5.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.208 -0.932 . . . . 0.0 110.416 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 30.3 t30 -79.38 90.96 5.03 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.649 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 77.5 m95 -61.36 -6.23 2.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.438 -0.789 . . . . 0.0 110.46 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 53.4 t-20 -89.88 -19.26 24.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 12.9 m-20 -99.67 -28.72 13.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.641 HD12 ' CE3' ' A' ' 97' ' ' TRP . 41.8 mt -74.34 66.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 9.4 mt -46.32 148.66 1.53 Allowed Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 121.662 -0.649 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.5 Cg_endo -78.79 -19.5 11.09 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.92 2.414 . . . . 0.0 110.432 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -142.78 121.58 12.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.113 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.465 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 64.4 m-85 -109.28 138.54 45.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.932 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -101.11 -3.84 28.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.0 108.973 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.28 87.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -115.06 -1.03 13.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -1.231 . . . . 0.0 109.606 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -67.08 170.83 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.717 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.455 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.7 OUTLIER -65.9 174.27 2.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -77.26 -34.34 55.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.56 -59.72 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 109.576 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.455 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 1.3 mp0 -62.8 -34.15 76.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.132 -0.98 . . . . 0.0 109.158 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.511 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 85.4 mttt -66.01 -42.72 89.34 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.464 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 35.8 ttm -59.34 -35.63 74.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.433 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.21 -68.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.726 -0.609 . . . . 0.0 110.592 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.576 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.7 tp -60.14 -41.69 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.528 ' N ' HG23 ' A' ' 116' ' ' ILE . 11.5 p -53.73 -43.24 68.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.853 -1.154 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.587 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 9.2 tt0 -69.36 -42.14 75.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.999 -1.063 . . . . 0.0 108.78 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.05 -53.69 49.57 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.608 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -57.07 -43.06 81.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -66.18 -39.66 89.88 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 15.6 m-20 -68.47 -46.48 69.63 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 49' ' ' ALA . 43.6 t -67.01 -63.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.545 ' CA ' ' HB3' ' A' ' 49' ' ' ALA . . . -46.22 -38.82 9.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.849 HG22 ' CE1' ' A' ' 69' ' ' TYR . 2.9 mt -69.84 -60.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.306 -1.114 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.457 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 2.2 p -46.47 -25.74 0.73 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.851 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.1 m -104.26 33.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 109.792 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' VAL . 2.2 m-20 41.75 40.96 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 109.8 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 35.4 tpp -56.42 134.05 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 111.589 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 34.4 m-20 -78.09 122.41 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 40.3 m-85 -103.9 106.24 16.68 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.474 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -141.2 -162.09 8.98 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 104.332 -3.507 . . . . 0.0 104.332 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.674 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.74 -30.96 78.73 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 106.007 -2.343 . . . . 0.0 106.007 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.93 139.15 45.34 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 73.8 m -114.14 112.72 23.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 119.934 -1.729 . . . . 0.0 110.721 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.67 130.52 10.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.624 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -117.23 -168.16 1.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.056 -1.261 . . . . 0.0 108.3 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.624 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.15 -50.85 5.76 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.52 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 124.01 -129.08 7.09 Favored Glycine 0 N--CA 1.481 1.684 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.257 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.544 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 4.2 m -48.23 -59.71 3.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.962 -0.728 . . . . 0.0 112.019 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 140' ' ' SER . 40.1 p -46.97 -35.35 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.789 -1.194 . . . . 0.0 108.622 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 74.9 mmt-85 -80.62 -48.51 12.56 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.91 0.862 . . . . 0.0 109.192 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 185' ' ' TYR . 89.0 t -66.66 -59.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.5 -33.21 65.79 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 108.58 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.8 ttm180 -76.79 -53.91 7.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.007 -1.058 . . . . 0.0 109.48 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -64.33 -38.21 90.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.105 -0.997 . . . . 0.0 109.575 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD1' HG11 ' A' ' 143' ' ' VAL . 17.1 mt -51.05 -48.6 61.52 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.665 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.541 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 55.2 mtmt -88.17 -31.2 19.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 111.285 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 19.8 mt-10 -74.29 -65.51 0.84 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.718 -1.239 . . . . 0.0 112.732 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.589 ' OD1' ' CG2' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.98 -32.17 30.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.633 -1.292 . . . . 0.0 111.966 -177.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 32.8 m-85 -103.55 -10.26 18.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.512 -1.367 . . . . 0.0 110.768 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.566 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 58.6 39.15 92.93 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.097 -1.002 . . . . 0.0 112.531 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.2 m-85 -63.3 162.01 12.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.202 -1.764 . . . . 0.0 107.641 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 50.4 t-20 -47.1 147.9 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.826 -1.171 . . . . 0.0 109.923 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -53.86 -17.97 2.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.529 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 26.4 p -57.37 -11.95 2.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 110.051 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.541 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 16.0 t -70.92 121.44 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.798 -1.189 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.644 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 7.6 p-80 -148.65 179.79 7.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.544 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 4.5 tt0 -123.8 138.41 54.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.578 HG13 ' CH2' ' A' ' 170' ' ' TRP . 14.8 pt -122.96 152.37 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 8.5 m-80 -109.89 103.23 11.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.109 . . . . 0.0 111.027 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.597 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 13.2 tpt180 -47.83 -36.48 11.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.043 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.6 67.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 4.74 35.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.922 -1.34 . . . . 0.0 111.668 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -118.17 161.19 20.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.569 -1.332 . . . . 0.0 110.143 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 5.2 p -87.06 131.71 34.03 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.3 ttpt -32.78 -44.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.83 -0.543 . . . . 0.0 110.906 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -63.59 -63.73 1.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.953 -1.092 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -62.42 -17.34 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.741 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 162' ' ' ARG . 76.4 t-105 -76.31 -47.86 22.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.087 -1.008 . . . . 0.0 109.172 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 59.5 mt-10 -67.71 -22.73 65.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.98 97.14 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -60.94 -36.2 78.71 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 208' ' ' TYR . 18.5 mt -73.78 -66.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.385 -0.822 . . . . 0.0 110.575 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -48.27 -41.72 28.61 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 109.446 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.452 ' O ' ' OG ' ' A' ' 179' ' ' SER . 10.0 tttt -52.29 -47.47 65.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.0 mm-40 -61.06 -45.21 95.69 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.532 HD12 ' CG2' ' A' ' 199' ' ' ILE . 27.8 mt -68.29 -30.34 69.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.665 -0.647 . . . . 0.0 110.425 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' ASP . 62.7 p -52.55 -35.94 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.069 -1.019 . . . . 0.0 108.799 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 17.7 mt-30 -101.17 28.78 5.1 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.527 ' CB ' HD21 ' A' ' 7' ' ' LEU . 96.3 m-20 49.26 50.72 17.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 21.4 mt-30 -123.67 110.95 29.7 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.504 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.8 Cg_endo -64.21 166.16 17.64 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.567 1.511 . . . . 0.0 112.087 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 35.8 t -123.7 136.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.266 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.689 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -85.38 118.34 24.85 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 175.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 6.5 t80 -122.45 158.18 30.31 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.793 -1.192 . . . . 0.0 109.399 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 187' ' ' GLN . 3.5 pt20 -167.38 136.73 2.74 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.538 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.68 108.91 2.97 Favored Glycine 0 C--N 1.288 -2.108 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.57 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 19.3 t -78.56 160.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.241 -1.152 . . . . 0.0 112.159 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.12 -56.12 3.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -1.212 . . . . 0.0 110.507 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 193' ' ' GLY . 2.9 m -59.04 -23.86 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.271 -0.893 . . . . 0.0 111.416 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 192' ' ' VAL . . . 138.53 -167.54 24.98 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.62 106.25 3.01 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 121.062 -1.257 . . . . 0.0 111.496 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 6.5 t-80 -72.09 125.33 26.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 186' ' ' TYR . . . -117.34 163.93 15.6 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.081 -1.448 . . . . 0.0 113.199 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 186' ' ' TYR . 32.2 p90 -159.48 170.16 22.31 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 55' ' ' ILE . 85.5 t -114.67 135.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.515 -1.365 . . . . 0.0 112.45 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 11.8 mt -97.72 127.56 49.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.1 p30 -140.28 33.64 1.89 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.611 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.752 ' HA2' HG13 ' A' ' 4' ' ' VAL . . . 172.71 -175.51 45.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.442 -1.837 . . . . 0.0 111.003 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.658 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -161.3 152.2 18.31 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.424 -1.045 . . . . 0.0 109.092 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -113.81 14.62 18.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.775 -1.203 . . . . 0.0 111.338 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.87 -4.99 85.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.706 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 207' ' ' PHE . 4.5 mtp180 -128.2 70.83 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.802 -1.41 . . . . 0.0 110.59 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 205' ' ' ARG . 64.2 m-20 39.33 28.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 109.919 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 205' ' ' ARG . 1.9 m-85 -121.08 128.43 52.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.299 -0.876 . . . . 0.0 109.046 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.577 ' HB3' HG21 ' A' ' 199' ' ' ILE . 73.9 m-85 -109.05 170.33 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.597 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 53.3 t-80 -91.55 115.34 27.96 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.585 HG13 ' CD2' ' A' ' 197' ' ' PHE . 11.5 t -112.85 142.84 23.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 122.256 1.027 . . . . 0.0 112.277 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.504 ' N ' HG11 ' A' ' 210' ' ' VAL . 21.8 t-20 -110.6 78.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.506 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 68.9 m95 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.149 -0.969 . . . . 0.0 110.109 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' A' ' 162' ' ' ARG . 12.0 tt0 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.3 p -151.62 169.95 20.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.059 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -140.92 146.34 37.28 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.186 0.993 . . . . 0.0 110.934 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.8 t -105.13 118.81 53.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 33.3 m -125.88 145.71 32.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.86 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.09 52.21 2.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.632 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 50.6 mt -97.44 88.94 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -1.083 . . . . 0.0 109.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.21 152.32 12.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.547 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.342 2.028 . . . . 0.0 110.402 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 178' ' ' LEU . 85.4 t . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.508 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -74.43 -173.63 1.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.069 -1.02 . . . . 0.0 109.012 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.591 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 69.8 m -77.44 100.35 5.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.808 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 18.2 mt -58.83 -48.25 81.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.185 -0.947 . . . . 0.0 108.485 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.468 HD11 HG11 ' A' ' 198' ' ' VAL . 9.5 mt -55.91 -41.45 74.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 33.8 t0 -67.0 -38.73 86.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -15.9 11.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 108.558 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 16.0 mtpp -120.07 14.8 12.34 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.95 43.67 8.52 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.8 mt -93.1 110.28 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.493 -1.004 . . . . 0.0 110.574 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 51.6 m80 -135.13 100.02 4.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . 14.6 m-30 -102.4 175.9 5.36 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.891 -1.131 . . . . 0.0 110.843 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 5.1 t-20 -146.54 -171.27 3.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 58.4 mt-30 -124.97 -3.56 7.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.829 -1.17 . . . . 0.0 110.676 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.03 -60.61 0.34 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.147 -1.501 . . . . 0.0 112.737 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.745 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -44.78 -123.72 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.424 0 CA-C-O 117.369 -1.3 . . . . 0.0 112.371 -176.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.745 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 42.7 Cg_endo -81.41 10.54 3.4 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 123.452 2.269 . . . . 0.0 109.596 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.815 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 92.6 m-85 -83.03 -38.64 22.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 110.663 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 44.4 p30 -103.55 35.39 2.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.622 -1.299 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 4.7 mt -78.11 -3.96 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.873 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.551 HD13 ' N ' ' A' ' 118' ' ' GLU . 21.3 mt -129.4 10.82 5.77 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.923 -1.11 . . . . 0.0 109.391 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.3 p -81.39 163.21 55.7 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.4 Cg_endo -69.82 128.59 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.131 1.887 . . . . 0.0 111.82 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.541 HG22 ' CE1' ' A' ' 42' ' ' HIS . 10.8 t -74.43 150.67 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.655 HD13 ' HD3' ' A' ' 133' ' ' PRO . 18.2 mt -77.67 148.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.467 -0.771 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.55 -21.75 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.721 -0.612 . . . . 0.0 110.404 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.3 mtpp -122.29 171.96 8.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 110.071 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 37' ' ' SER . 84.0 t . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.394 -0.816 . . . . 0.0 111.113 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.459 ' HA ' HG13 ' A' ' 31' ' ' VAL . 1.9 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.069 0.462 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.63 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.4 m-85 -123.78 19.05 9.43 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 28' ' ' ILE . 66.9 t -66.8 144.5 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.73 -4.01 66.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 28.5 mt-30 -86.65 128.77 35.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -1.174 . . . . 0.0 109.564 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.541 ' CE1' HG22 ' A' ' 27' ' ' VAL . 1.1 m-70 -73.23 113.79 10.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.81 158.07 1.47 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.77 -1.172 . . . . 0.0 108.933 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.47 170.09 17.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.391 0.615 . . . . 0.0 109.973 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 129' ' ' MET . 10.3 p -77.63 -31.58 52.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 103.6 138.08 9.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 p -54.51 -53.65 51.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -1.068 . . . . 0.0 108.408 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG12 HG22 ' A' ' 127' ' ' VAL . 4.9 t -47.01 -52.27 4.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.61 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.29 -50.12 74.89 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.947 0.879 . . . . 0.0 110.068 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -63.36 -33.88 76.5 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -178.248 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.56 87.66 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.217 -1.393 . . . . 0.0 107.43 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.7 m -74.42 -53.54 9.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 108.852 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -53.32 -37.94 62.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.813 -0.554 . . . . 0.0 110.77 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 27.1 mt-30 -67.34 -52.85 35.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.581 -1.324 . . . . 0.0 108.108 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 198' ' ' VAL . 31.9 mt -65.0 -18.8 24.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.588 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 34.4 mtp -73.84 -45.25 52.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 18.4 tptt -67.12 -36.02 81.0 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 65.9 t80 -54.06 -31.93 53.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.431 -0.793 . . . . 0.0 109.297 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 70.9 m-70 -106.92 -22.04 12.82 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.603 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 98.4 m-20 45.61 56.12 6.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 4.3 t80 -79.82 -74.54 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -68.11 103.15 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-N 119.104 0.716 . . . . 0.0 111.888 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 95' ' ' TYR . 28.7 m120 -70.56 -22.79 62.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.41 140.8 45.22 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.59 151.13 33.37 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.752 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -88.84 -44.29 10.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.506 -0.997 . . . . 0.0 109.97 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 13.9 tttp -152.57 142.35 21.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.103 -0.998 . . . . 0.0 109.855 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' A' ' 89' ' ' ALA . 1.5 m-20 -65.24 164.49 13.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.673 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 70' ' ' THR . 7.6 t80 -143.78 147.19 33.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.431 -0.793 . . . . 0.0 109.272 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.629 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t -150.2 166.11 30.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 26.1 p90 -171.68 157.03 4.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 86.9 m -93.13 131.37 38.25 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 77' ' ' ASN . 8.7 tp -44.94 150.13 0.4 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 111.403 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 p -61.56 139.46 58.25 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -4.83 11.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.543 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -97.59 -7.41 31.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.588 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 25.9 t-20 -70.01 108.59 3.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 109.73 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.1 Cg_endo -89.36 15.73 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.997 2.465 . . . . 0.0 110.533 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 85.0 m-85 -106.42 -24.43 12.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.0 110.866 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' A' ' 81' ' ' ASN . 72.8 m-85 -117.71 163.85 15.86 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.7 m-80 -48.19 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.4 OUTLIER 175.04 -47.56 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 111.307 175.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.47 55.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.0 tptt -106.0 104.94 14.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.253 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.14 140.99 33.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.124 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.635 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -115.23 145.88 41.99 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -136.83 128.42 28.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.32 111.84 23.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.408 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . . . -72.81 53.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.577 -1.327 . . . . 0.0 107.909 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.649 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 10.5 mt -52.62 -54.17 16.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.033 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -45.36 -26.14 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.751 -1.218 . . . . 0.0 109.073 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -110.86 32.34 5.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 108.892 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.649 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 35.0 mmt-85 -92.48 154.22 18.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.432 ' CA ' ' NE2' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -117.32 90.98 3.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.563 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.5 m-85 -80.84 85.04 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 110.664 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.481 ' O ' HG13 ' A' ' 100' ' ' ILE . 4.9 t30 -78.88 89.33 4.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.616 ' CE3' HD12 ' A' ' 100' ' ' ILE . 77.7 m95 -61.36 -5.1 1.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.525 -0.734 . . . . 0.0 110.939 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.25 -15.58 33.24 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.728 -1.233 . . . . 0.0 107.684 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -99.65 -30.75 11.93 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.616 HD12 ' CE3' ' A' ' 97' ' ' TRP . 22.3 mt -73.64 67.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.653 0.74 . . . . 0.0 109.307 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 16.0 mt -47.47 148.78 2.23 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.597 -0.689 . . . . 0.0 109.528 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 31.4 Cg_endo -79.39 -17.38 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.648 2.232 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.27 123.08 9.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.044 . . . . 0.0 109.478 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 90.8 m-85 -110.79 144.03 40.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -100.53 2.68 42.18 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.325 -0.86 . . . . 0.0 108.816 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 81.67 0.73 89.67 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 2.84 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 104' ' ' TYR . 1.3 mp0 -67.11 169.02 9.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -64.9 177.46 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.278 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.438 ' N ' ' OG ' ' A' ' 109' ' ' SER . 1.2 m-20 -82.11 -36.49 27.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.854 . . . . 0.0 109.632 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.06 -57.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -38.08 89.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.14 -0.975 . . . . 0.0 108.84 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 81.0 mttt -63.78 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.45 -0.781 . . . . 0.0 109.011 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.485 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.0 ttm -58.78 -40.83 85.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 0.0 109.182 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -57.79 -54.58 45.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 117' ' ' SER . 1.8 tp -68.36 -38.51 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.538 -1.352 . . . . 0.0 109.743 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 116' ' ' ILE . 9.4 p -56.71 -43.65 80.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.102 -0.999 . . . . 0.0 109.887 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' N ' HD13 ' A' ' 24' ' ' LEU . 35.2 tt0 -69.99 -37.02 75.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 53' ' ' ALA . 8.4 tp -62.97 -52.01 64.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.815 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -60.68 -48.05 83.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.559 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.72 90.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 0.0 108.821 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 126' ' ' SER . 88.3 m-20 -63.95 -41.44 97.6 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -71.44 -59.16 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.391 0.615 . . . . 0.0 109.46 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.504 ' CA ' ' HB3' ' A' ' 49' ' ' ALA . . . -45.99 -47.43 14.68 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 88' ' ' ALA . 2.3 mt -63.7 -56.15 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.316 -1.108 . . . . 0.0 108.217 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 2.2 p -45.96 -29.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.298 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 48' ' ' VAL . 17.6 m -105.95 38.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 9.1 p-10 36.94 50.76 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.515 0.674 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.536 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 49.8 tpp -59.76 128.14 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.55 -0.718 . . . . 0.0 110.74 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 135' ' ' SER . 33.8 t70 -75.36 123.8 26.0 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 64.9 m-85 -103.33 114.09 28.1 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.539 1.161 . . . . 0.0 113.144 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.498 ' CA ' HD13 ' A' ' 28' ' ' ILE . . . -150.3 -164.24 11.74 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 0.0 104.426 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.655 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.35 -29.38 79.49 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 N-CA-C 105.952 -2.365 . . . . 0.0 105.952 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.75 139.5 44.73 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.512 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 54.8 m -119.42 109.19 15.47 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.898 -1.751 . . . . 0.0 109.948 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 130' ' ' ASP . . . -108.08 142.91 16.02 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.826 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 4.7 t -116.43 -162.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.59 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.96 -47.55 7.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.52 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 132.41 -139.55 11.04 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.029 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.459 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 9.0 m -50.32 -53.01 31.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.795 -0.826 . . . . 0.0 112.329 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 145' ' ' ARG . 1.5 p -47.42 -33.84 6.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.708 -1.245 . . . . 0.0 108.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 3.1 mmp_? -80.51 -48.22 13.1 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.949 0.88 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.727 HG21 ' CE2' ' A' ' 185' ' ' TYR . 70.4 t -67.24 -56.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.914 -0.491 . . . . 0.0 110.966 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.492 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.9 pp0? -56.12 -33.54 65.24 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -77.37 -48.1 18.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.35 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -68.94 -36.15 77.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.157 -0.964 . . . . 0.0 110.274 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.526 ' CD1' HG11 ' A' ' 143' ' ' VAL . 41.7 mt -57.13 -46.26 82.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.825 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.55 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 51.8 mtmt -87.18 -44.02 11.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.995 -1.066 . . . . 0.0 111.18 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.0 mt-10 -69.34 -50.5 45.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.399 -1.438 . . . . 0.0 111.446 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 18.1 m120 -88.63 -45.52 9.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 0.0 111.636 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.588 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.5 m-85 -102.2 18.28 21.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 31.63 41.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.648 -0.658 . . . . 0.0 112.985 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.1 m-85 -63.41 164.32 9.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.268 -1.725 . . . . 0.0 108.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.51 145.86 2.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.928 -1.108 . . . . 0.0 109.529 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -53.8 -18.96 3.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.056 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.576 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 84.6 p -55.3 -15.0 2.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 16.5 t -67.61 121.57 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.781 -1.199 . . . . 0.0 109.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.613 ' CD2' HG22 ' A' ' 249' ' ' VAL . 1.2 p-80 -147.84 175.61 10.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 109.449 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 144' ' ' GLN . 3.7 tt0 -120.86 138.45 54.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.721 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.531 HG13 ' CH2' ' A' ' 170' ' ' TRP . 12.7 pt -125.75 158.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.6 m-80 -114.56 101.22 8.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.871 -1.143 . . . . 0.0 110.71 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.2 tpt180 -45.71 -36.82 5.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 109.072 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.59 -27.77 66.67 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.88 6.92 36.77 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.984 -1.303 . . . . 0.0 111.917 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -118.12 171.24 8.24 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.392 -1.443 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 95.0 p -95.23 134.34 38.1 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 9.4 ttpp -35.36 -48.98 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.717 -0.615 . . . . 0.0 110.781 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -57.74 8.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.996 -1.065 . . . . 0.0 110.294 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.2 -20.56 65.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 76.7 t-105 -75.26 -43.96 48.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.397 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 90.3 mt-10 -68.97 -31.28 70.03 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.948 -1.095 . . . . 0.0 108.311 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.25 73.95 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 12.0 mm100 -61.14 -41.63 97.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 108.975 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.555 HG23 ' CD1' ' A' ' 199' ' ' ILE . 10.4 mt -75.38 -57.35 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 110.56 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -49.42 -42.61 43.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.069 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -54.17 -46.03 72.23 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.534 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 45.7 mm-40 -58.55 -50.46 73.72 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 4' ' ' VAL . 16.0 mt -65.8 -29.27 69.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.371 -0.83 . . . . 0.0 109.626 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 5.8 p -50.03 -42.98 50.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 108.729 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 14.7 mt-30 -95.83 30.76 2.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 178' ' ' LEU . 66.7 m-80 49.36 51.37 16.46 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 22.1 mt-30 -123.14 111.96 30.29 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.581 ' HD3' HD12 ' A' ' 7' ' ' LEU . 13.8 Cg_endo -62.88 173.64 3.65 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.223 1.949 . . . . 0.0 112.539 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.546 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 93.7 t -133.45 142.16 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.36 1.076 . . . . 0.0 112.803 -176.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.727 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -90.85 117.7 29.67 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 175.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 10.0 t80 -122.51 161.57 23.37 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.129 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.2 pt20 -167.29 138.73 3.15 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 118.171 -1.412 . . . . 0.0 110.791 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.48 108.33 2.31 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.484 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 21.9 t -66.85 163.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 111.174 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -167.87 -136.59 2.07 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -32.49 18.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 111.253 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.78 -18.7 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.874 -1.141 . . . . 0.0 111.504 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.88 -170.43 23.47 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -78.11 100.15 1.61 Allowed Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.83 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.618 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.1 t-80 -72.26 126.69 30.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 186' ' ' TYR . . . -119.13 165.86 13.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.053 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 40.7 p90 -156.89 -159.91 0.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.639 HG22 HG13 ' A' ' 55' ' ' ILE . 11.5 t -139.74 138.77 38.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.693 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.555 ' CD1' HG23 ' A' ' 174' ' ' ILE . 90.7 mt -107.08 111.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' LYS . 15.1 p-10 -123.7 34.21 5.14 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.285 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 174.62 160.1 22.09 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.354 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.67 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -138.42 168.38 19.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -126.76 -11.17 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.958 -1.089 . . . . 0.0 110.209 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.59 -35.85 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 4.8 mtt180 -88.73 35.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.253 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 70.43 31.67 2.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 109.648 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 48.5 m-85 -122.26 133.78 54.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.17 -0.956 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 33.9 m-85 -124.07 160.47 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.311 -0.868 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.591 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 40.3 t-80 -92.13 134.6 34.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 198' ' ' VAL . 21.4 t -131.58 146.19 33.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.337 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 42.6 t-20 -114.45 81.92 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 91.4 m95 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.721 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -149.58 166.16 30.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.045 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.508 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -141.26 152.23 44.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.278 1.037 . . . . 0.0 110.925 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 68.9 t -111.02 117.56 55.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.613 HG22 ' CD2' ' A' ' 158' ' ' HIS . 25.0 m -123.12 145.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.066 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 87.74 56.44 2.1 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 63.2 mt -100.32 74.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.565 -0.962 . . . . 0.0 110.674 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -152.4 156.76 33.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.086 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.295 1.997 . . . . 0.0 110.476 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.535 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 200' ' ' ASP . 35.4 mmtt -76.77 179.57 6.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.477 ' CA ' ' OD2' ' A' ' 200' ' ' ASP . 4.2 m -77.67 104.93 8.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.014 -1.054 . . . . 0.0 109.363 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.645 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.6 mt -57.95 -56.17 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 198' ' ' VAL . 18.2 mt -55.14 -36.88 66.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.41 -1.431 . . . . 0.0 108.294 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 22.4 t0 -68.52 -42.1 79.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.126 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -58.55 -14.98 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.05 -1.031 . . . . 0.0 109.045 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' HG13 ' A' ' 13' ' ' ILE . 15.5 mtpt -120.56 20.27 11.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.42 37.6 4.86 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 60.6 mt -85.31 106.92 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.386 1.089 . . . . 0.0 110.551 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 102' ' ' PRO . 17.7 m-70 -134.81 95.43 3.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.573 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 9.3 m-30 -98.95 179.13 4.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 111.064 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.525 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 26.1 t-20 -145.96 -177.44 5.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.531 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 39.0 mt-30 -116.64 -18.0 10.42 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.923 -1.111 . . . . 0.0 110.164 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.72 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.95 -38.22 0.9 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.337 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.764 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.01 -142.5 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.458 -177.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -73.78 2.99 5.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 122.411 1.897 . . . . 0.0 109.441 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.57 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 11.2 m-85 -79.29 -28.01 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.122 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 14.7 p-10 -96.51 23.38 6.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.593 -1.317 . . . . 0.0 109.783 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 8.7 mt -76.79 -5.64 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.566 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 118' ' ' GLU . 6.8 mt -125.57 9.46 7.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.602 -1.311 . . . . 0.0 109.428 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 40.9 p -82.06 160.87 62.14 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.604 ' HD2' ' CD1' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -68.82 126.18 13.61 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.14 1.894 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 44.4 t -74.65 151.45 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.423 0.63 . . . . 0.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.657 HD13 ' HD3' ' A' ' 133' ' ' PRO . 22.2 mt -77.69 147.23 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 110.899 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -126.31 -20.74 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.745 -0.597 . . . . 0.0 110.535 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 48.0 mtpt -120.12 172.9 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.005 -1.059 . . . . 0.0 110.158 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 37' ' ' SER . 79.7 t . . . . . 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 111.05 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 31' ' ' VAL . 1.5 t . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.157 0.503 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 75.5 m-85 -124.18 23.92 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.107 -0.996 . . . . 0.0 109.367 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.99 146.49 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.809 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.05 1.84 86.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mt-30 -93.06 126.8 38.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -1.131 . . . . 0.0 109.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 1.7 m-70 -72.83 111.55 8.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.32 157.69 1.37 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.997 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.07 166.04 23.81 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.628 0.727 . . . . 0.0 109.946 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 120' ' ' MET . 19.1 p -77.11 -33.66 56.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 106.18 136.57 8.44 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.487 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 5.3 p -54.85 -50.12 69.45 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.292 -1.122 . . . . 0.0 108.275 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 127' ' ' VAL . 9.5 t -47.52 -53.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.53 -48.65 80.85 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.046 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.62 ' CG2' ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -62.79 -33.6 75.53 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.966 -177.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -65.73 -41.93 91.62 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.882 -1.527 . . . . 0.0 108.036 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.578 ' OG1' HG23 ' A' ' 143' ' ' VAL . 31.3 m -75.46 -50.68 15.03 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.426 0.631 . . . . 0.0 110.003 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.32 -35.57 38.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 mt-30 -68.47 -44.88 73.85 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 198' ' ' VAL . 53.0 mt -69.92 -22.9 25.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.582 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 16.8 mtp -73.76 -34.58 64.77 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.573 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 33.7 tptt -74.9 -43.39 54.59 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.645 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.8 t80 -54.06 -25.46 21.71 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.351 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 32.1 m-70 -108.31 -27.81 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 110.674 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 67.6 m-20 45.11 61.36 2.57 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.3 t80 -84.98 -77.56 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.6 Cg_endo -70.66 106.47 1.83 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 119.467 0.845 . . . . 0.0 113.83 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -67.51 -24.79 65.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -131.83 127.04 35.76 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 176.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.73 166.08 4.84 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 118.566 -1.778 . . . . 0.0 110.877 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.557 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -95.95 -35.29 11.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.469 -1.018 . . . . 0.0 111.44 -178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 27.0 tttp -152.76 130.54 11.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.534 -1.354 . . . . 0.0 110.887 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 3.4 m-20 -62.25 171.35 1.88 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.08 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 47.4 t80 -149.11 141.8 24.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.578 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t -144.65 148.37 34.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 27.5 p90 -160.47 155.2 24.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 85' ' ' ASN . 29.1 m -93.01 131.71 37.76 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 86' ' ' LEU . 9.9 tp -45.13 147.72 0.68 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.845 . . . . 0.0 110.727 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 1.5 t -61.79 146.75 48.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.941 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 0.99 9.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.109 -0.994 . . . . 0.0 109.745 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -99.47 -7.99 25.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.448 ' CG ' HD21 ' A' ' 73' ' ' LEU . 17.6 t-20 -70.32 109.41 4.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.751 -0.593 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.623 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.2 Cg_endo -89.26 15.68 1.95 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 73.9 m-85 -110.78 -23.65 10.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 111.167 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 80.4 m-85 -118.14 160.69 21.11 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 15.4 m-80 -48.22 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 174.76 -45.75 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.387 -0.821 . . . . 0.0 111.311 175.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.0 Cg_endo -75.76 55.32 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 N-CA-C 107.86 -1.631 . . . . 0.0 107.86 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 5.4 tptt -106.75 106.81 17.51 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.237 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.415 ' OD1' ' OG1' ' A' ' 72' ' ' THR . 67.7 m-80 -100.1 141.54 32.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.64 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 mp -118.26 125.41 50.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 12.1 t80 -120.16 127.71 52.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.956 . . . . 0.0 110.133 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.34 111.9 24.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' CB ' HG21 ' A' ' 92' ' ' THR . . . -72.94 53.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.739 -1.226 . . . . 0.0 108.352 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.638 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.7 mt -53.24 -58.3 3.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.746 -0.596 . . . . 0.0 111.195 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.0 p -43.56 -29.44 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.815 -1.178 . . . . 0.0 109.257 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.546 HG21 ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.29 30.14 7.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.46 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.638 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 27.7 mmt-85 -79.22 156.06 28.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.537 -1.352 . . . . 0.0 109.4 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -116.46 83.78 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 122' ' ' ASP . 9.1 m-85 -80.71 97.83 7.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.611 -0.681 . . . . 0.0 110.132 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.491 ' O ' HG13 ' A' ' 100' ' ' ILE . 29.5 t-20 -79.02 89.88 4.79 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 45.5 m95 -60.54 -8.89 3.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.68 -21.68 21.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.2 m-20 -100.07 -24.76 14.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.593 HD12 ' CE3' ' A' ' 97' ' ' TRP . 36.3 mt -73.49 64.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.575 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 37.7 mt -46.4 149.23 1.4 Allowed Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.6 Cg_endo -77.58 -25.17 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.579 2.186 . . . . 0.0 110.522 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER -142.13 125.37 16.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 109.516 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.648 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 76.5 m-85 -112.78 145.14 41.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -99.56 -4.36 31.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 82.49 7.64 87.26 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -118.5 9.12 12.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -1.068 . . . . 0.0 108.724 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -72.76 -177.84 2.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.464 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -73.92 172.94 10.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -74.81 -36.18 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.634 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.3 t -51.81 -60.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.464 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 5.2 mp0 -62.54 -36.24 82.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.974 -1.079 . . . . 0.0 108.989 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.507 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 72.9 mttt -64.5 -42.67 95.7 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.481 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.5 ttm -60.03 -38.73 83.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -69.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.485 -0.76 . . . . 0.0 110.476 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 3.0 tp -57.92 -43.6 84.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 110.227 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.3 p -50.51 -40.52 51.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.493 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.509 ' HA ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.62 -48.96 58.23 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 53' ' ' ALA . 5.4 tp -49.19 -48.76 45.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.62 ' HE1' ' CG2' ' A' ' 50' ' ' THR . 1.7 mmt -58.82 -55.28 37.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.577 -0.702 . . . . 0.0 110.583 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.42 -33.43 75.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 126' ' ' SER . 21.6 m-20 -64.37 -47.12 80.48 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 49' ' ' ALA . 62.1 t -71.35 -55.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.499 -0.75 . . . . 0.0 109.264 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.26 -50.53 12.94 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.0 mt -63.69 -55.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.255 -1.144 . . . . 0.0 108.046 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 6.9 p -46.93 -32.05 3.57 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.296 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.747 HG13 HG22 ' A' ' 143' ' ' VAL . 14.1 m -100.66 34.32 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.9 m-20 38.6 53.69 1.88 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.611 0.719 . . . . 0.0 109.509 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.549 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 57.3 tpp -65.87 129.56 40.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 111.629 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -76.61 121.83 23.78 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.604 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 75.6 m-85 -103.38 117.46 34.53 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.705 1.24 . . . . 0.0 113.432 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.517 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.54 -162.46 10.6 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 104.12 -3.592 . . . . 0.0 104.12 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.657 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.53 -30.48 79.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 106.049 -2.327 . . . . 0.0 106.049 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.94 143.06 40.42 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.502 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.0 m -124.59 112.55 16.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.975 -1.703 . . . . 0.0 110.092 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 146.28 16.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.532 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 33.5 t -120.0 -164.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.89 -52.31 4.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.588 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.15 -143.33 14.75 Favored Glycine 0 N--CA 1.48 1.592 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.978 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.526 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 74.6 m -48.37 -51.18 27.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.755 -0.85 . . . . 0.0 111.846 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.49 -39.17 10.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.789 -1.195 . . . . 0.0 108.761 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.566 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 10.5 mmt180 -81.77 -44.3 17.18 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.203 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 127' ' ' VAL . 41.2 t -69.07 -51.28 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 110.584 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.4 pp0? -56.95 -35.73 69.44 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.001 -1.062 . . . . 0.0 108.691 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 30.6 ttm180 -77.27 -47.0 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.965 . . . . 0.0 110.147 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 126' ' ' SER . . . -64.09 -36.55 84.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.125 -0.984 . . . . 0.0 110.353 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -59.7 -46.35 89.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.751 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 33.2 mtmt -85.0 -47.72 9.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 110.758 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 18.8 mt-10 -70.63 -47.07 61.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.911 -1.118 . . . . 0.0 112.273 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.406 ' HB3' HD13 ' A' ' 90' ' ' ILE . 18.6 m120 -89.57 -53.27 4.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.575 -1.328 . . . . 0.0 112.126 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.582 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 46.6 m-85 -90.06 -13.75 35.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 110.448 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.557 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 65.52 36.55 92.65 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.054 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 154' ' ' ASN . 7.9 m-85 -63.43 172.63 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.374 -1.662 . . . . 0.0 107.808 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 33.5 t-20 -47.86 134.74 12.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.725 -1.234 . . . . 0.0 109.235 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 30.1 mm-40 -53.31 -21.67 5.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.958 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 154' ' ' ASN . 52.6 p -54.49 -16.72 2.51 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.369 -0.832 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 39.4 t -57.19 123.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.032 -1.043 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.593 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 15.2 p-80 -143.46 161.35 38.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 6.4 tt0 -102.27 154.65 18.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 0.0 110.274 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 247' ' ' ALA . 14.7 pt -137.64 134.92 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.5 m-80 -102.73 107.36 18.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.838 -1.163 . . . . 0.0 111.069 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.653 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -47.38 -44.46 24.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.85 -21.58 55.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 18.1 m-20 -104.9 2.24 29.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.953 -1.322 . . . . 0.0 112.162 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -117.65 175.05 5.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.302 -1.498 . . . . 0.0 110.314 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.509 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.1 p -100.41 131.63 46.22 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.509 ' C ' ' O ' ' A' ' 166' ' ' SER . 28.3 ttmt -30.09 -49.35 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.204 0.526 . . . . 0.0 111.002 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -62.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.96 -1.087 . . . . 0.0 110.188 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.39 -16.12 52.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.004 -1.06 . . . . 0.0 109.28 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 57.6 t-105 -72.71 -51.14 20.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.466 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 30.0 mt-10 -68.88 -37.12 78.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.08 -1.012 . . . . 0.0 108.319 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.61 -42.16 15.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -61.01 -42.81 99.17 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.517 ' CG2' HD11 ' A' ' 199' ' ' ILE . 6.9 mt -70.34 -53.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.729 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.471 ' OD1' ' CE2' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -49.84 -55.92 12.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.634 -178.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 179' ' ' SER . 22.1 tttt -50.91 -41.32 58.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.837 -1.165 . . . . 0.0 108.517 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.581 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.7 mm-40 -61.26 -49.79 75.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.556 HD12 ' CG2' ' A' ' 199' ' ' ILE . 46.9 mt -68.53 -24.67 64.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.247 -0.908 . . . . 0.0 110.257 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.426 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 53.3 p -52.05 -37.12 52.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.464 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 mt-30 -102.71 34.11 2.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 7' ' ' LEU . 30.5 m-20 44.21 51.71 7.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.15 -0.969 . . . . 0.0 108.893 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mt-30 -123.79 107.44 31.25 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.49 ' HD3' HD12 ' A' ' 7' ' ' LEU . 14.7 Cg_endo -62.63 165.74 15.13 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.708 1.605 . . . . 0.0 112.681 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 18.7 t -120.04 134.88 62.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.207 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.588 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.9 OUTLIER -82.81 115.3 21.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.12 158.59 28.96 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.914 -1.117 . . . . 0.0 108.798 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 196' ' ' ALA . 2.0 pt20 -167.77 128.37 1.41 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.006 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' HIS . . . -91.1 124.44 7.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 106.154 -2.778 . . . . 0.0 106.154 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 1.9 t -101.86 164.51 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.727 -1.455 . . . . 0.0 112.957 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.07 -136.61 2.06 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -25.28 22.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.817 -1.402 . . . . 0.0 110.777 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.46 -22.43 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.003 -1.061 . . . . 0.0 111.659 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' C ' HG11 ' A' ' 189' ' ' VAL . . . 138.31 176.8 14.76 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -76.87 113.19 3.72 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.57 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 33.5 t-80 -71.27 95.32 1.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 186' ' ' TYR . . . -86.12 155.67 20.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.719 1.247 . . . . 0.0 113.793 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 35.0 p90 -154.04 177.06 11.48 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.505 HG22 HG13 ' A' ' 55' ' ' ILE . 97.9 t -123.26 136.66 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.496 -1.377 . . . . 0.0 112.418 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.556 ' CG2' HD12 ' A' ' 178' ' ' LEU . 64.9 mt -97.11 124.13 49.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 7.4 p-10 -137.15 29.65 2.76 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.989 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -168.87 174.36 43.44 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.506 -2.283 . . . . 0.0 112.169 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.535 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.87 147.79 5.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -120.33 34.41 5.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.654 -1.279 . . . . 0.0 109.686 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 53.88 18.62 8.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 3.2 mtt85 -136.63 32.58 2.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -1.178 . . . . 0.0 109.225 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 1.3 m120 64.75 22.79 12.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 10.0 m-85 -110.73 100.26 9.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 11.1 m-85 -96.56 156.28 16.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.444 -0.785 . . . . 0.0 110.292 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.2 t-80 -93.17 123.32 36.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 197' ' ' PHE . 9.1 t -112.76 135.31 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.821 1.296 . . . . 0.0 111.825 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 212' ' ' TRP . 3.8 t30 -112.95 99.55 7.95 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.89 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 43.9 m95 . . . . . 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.749 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 5.4 tt0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 25.6 p -150.57 164.56 35.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 110.617 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' ILE . . . -140.41 163.47 32.72 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.846 0.832 . . . . 0.0 109.703 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 8.4 t -117.28 128.42 74.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.593 ' CG2' ' NE2' ' A' ' 158' ' ' HIS . 32.7 m -127.05 144.96 35.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.796 -1.19 . . . . 0.0 111.072 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.18 51.45 2.97 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.611 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 8.2 mt -102.43 97.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.575 -0.956 . . . . 0.0 109.824 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.6 150.78 10.58 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.095 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.6 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.178 1.918 . . . . 0.0 110.359 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 178' ' ' LEU . 13.7 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.0 mmtt -74.82 -169.28 0.86 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.061 -1.024 . . . . 0.0 108.291 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.587 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 72.7 m -80.86 101.58 9.5 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.155 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 200' ' ' ASP . 45.0 mt -58.15 -49.18 77.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.999 -1.063 . . . . 0.0 108.737 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.74 -38.82 82.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.073 -1.017 . . . . 0.0 109.157 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 8.0 t0 -67.26 -37.75 84.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 109.152 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 p -57.88 -15.73 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.005 . . . . 0.0 108.575 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HB2' HG13 ' A' ' 13' ' ' ILE . 3.1 mtpt -120.84 18.16 11.82 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 47.1 41.25 14.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 8.3 mt -89.63 102.0 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -1.039 . . . . 0.0 110.29 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' PRO . 27.1 m80 -128.1 77.7 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.596 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 11.4 m-30 -81.61 -179.79 7.52 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.102 0.953 . . . . 0.0 111.182 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.98 -164.04 1.93 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 20.7 mt-30 -125.16 -19.64 5.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.061 -1.025 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.83 -35.44 1.26 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.617 -1.277 . . . . 0.0 111.424 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.759 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.77 -140.17 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 118.469 -0.776 . . . . 0.0 110.981 -178.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.759 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.3 Cg_endo -74.16 3.54 5.06 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 122.46 1.914 . . . . 0.0 109.616 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.561 ' CD2' ' HE2' ' A' ' 120' ' ' MET . 7.5 m-85 -79.93 -31.13 40.07 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.231 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.0 p-10 -93.46 17.88 10.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.484 -1.385 . . . . 0.0 109.944 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.5 4.92 5.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.862 . . . . 0.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 118' ' ' GLU . 13.3 mt -133.39 -4.45 2.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.721 -1.237 . . . . 0.0 110.368 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.6 p -61.99 164.62 10.02 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.9 Cg_endo -71.7 132.96 21.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.648 1.565 . . . . 0.0 110.573 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.93 145.38 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 110.229 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD13 ' HD3' ' A' ' 133' ' ' PRO . 8.9 mt -77.01 149.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.592 -0.692 . . . . 0.0 110.565 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 39' ' ' VAL . 6.2 mt-10 -125.39 -23.84 4.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.703 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 79' ' ' TYR . 25.8 mtpp -114.74 174.48 5.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.958 -1.089 . . . . 0.0 109.98 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.47 HG23 ' CB ' ' A' ' 37' ' ' SER . 98.3 t . . . . . 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.887 . . . . 0.0 111.008 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.47 ' CB ' HG23 ' A' ' 31' ' ' VAL . 32.0 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.014 0.435 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.718 ' CD2' ' CG ' ' A' ' 133' ' ' PRO . 17.3 m-30 -111.78 11.69 20.93 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 109.275 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 29' ' ' GLU . 20.3 t -61.54 119.15 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.841 -1.162 . . . . 0.0 108.617 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.04 52.34 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 21.8 mt-30 -74.53 135.81 42.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.947 . . . . 0.0 109.255 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.48 116.14 13.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.92 156.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.326 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' CB ' ' OG ' ' A' ' 135' ' ' SER . . . -80.57 167.12 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.559 HG22 ' SD ' ' A' ' 120' ' ' MET . 31.0 p -81.96 -37.61 26.44 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.567 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 105.14 139.3 9.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' VAL . 1.2 p -55.11 -50.26 69.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -1.161 . . . . 0.0 108.158 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.52 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.7 t -46.32 -53.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -63.57 -48.04 79.04 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.468 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 53.2 m -62.51 -31.87 72.7 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.734 -0.604 . . . . 0.0 109.439 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.37 76.24 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.69 -1.256 . . . . 0.0 108.756 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.576 HG22 ' HG3' ' A' ' 56' ' ' MET . 28.2 m -74.75 -51.71 13.47 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.567 0.698 . . . . 0.0 109.729 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.556 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -50.94 -36.69 40.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.684 -0.635 . . . . 0.0 109.567 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.596 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 23.1 mt-30 -69.69 -58.91 3.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.665 -1.272 . . . . 0.0 107.969 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.679 HG13 HG22 ' A' ' 198' ' ' VAL . 78.0 mt -57.68 -20.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.585 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 24.7 mtp -73.91 -35.82 64.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 28.9 tptt -77.49 -41.04 40.85 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.188 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 46.3 t80 -53.19 -26.76 18.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 108.813 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 65.2 m-70 -107.85 -26.66 10.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 110.426 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.602 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 85.7 m-20 47.97 58.39 5.12 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.582 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.5 t80 -83.91 -73.88 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 113.087 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.8 Cg_endo -68.23 101.61 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.026 0.688 . . . . 0.0 111.6 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.407 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 4.2 m120 -70.32 -20.51 63.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 51.5 tttt -134.74 142.25 46.7 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.89 147.47 37.3 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.52 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -86.81 -50.57 6.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.989 . . . . 0.0 109.992 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 44.9 tttt -148.49 152.73 37.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.943 . . . . 0.0 109.594 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 89' ' ' ALA . 12.9 m-20 -73.01 178.01 4.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 70' ' ' THR . 24.5 t80 -154.26 153.82 32.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.373 -0.83 . . . . 0.0 109.581 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.616 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -158.0 154.12 27.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.611 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 30.8 p90 -161.66 162.73 30.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 56.6 m -93.83 131.67 38.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.504 HD21 ' CG ' ' A' ' 77' ' ' ASN . 9.7 tp -47.13 148.43 1.19 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 111.11 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.67 143.43 56.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.689 -0.632 . . . . 0.0 110.041 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 t -69.61 -2.76 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 110.087 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 m-20 -99.39 -3.72 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.026 -1.046 . . . . 0.0 109.39 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.574 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 19.6 t-20 -70.65 110.67 7.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.536 -0.728 . . . . 0.0 110.11 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -90.91 20.19 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 123.101 2.534 . . . . 0.0 108.559 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 45.2 m-85 -114.11 -28.34 7.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 111.879 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.487 ' CD1' HD23 ' A' ' 73' ' ' LEU . 49.3 m-85 -118.06 164.83 14.52 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.3 m-80 -46.99 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.95 -47.48 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 111.044 175.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -77.38 54.31 4.65 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 N-CA-C 107.216 -1.879 . . . . 0.0 107.216 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HE3' ' HG ' ' A' ' 86' ' ' LEU . 13.3 tptt -106.68 107.08 17.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.812 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -100.93 140.17 35.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 108.983 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.7 mp -111.32 149.41 31.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -137.17 123.19 20.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.994 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.12 112.85 25.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -74.72 50.98 0.46 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.795 -1.191 . . . . 0.0 108.4 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.628 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 92.9 mt -52.6 -45.4 47.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.9 p -45.23 -26.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.738 -1.226 . . . . 0.0 109.047 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -111.38 37.76 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 108.929 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 11.9 mmt-85 -95.48 154.93 16.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.493 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.48 91.95 3.71 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.566 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.7 m-85 -81.19 90.26 6.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 110.573 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -78.92 92.18 4.88 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 67.0 m95 -60.72 -9.17 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.408 -0.808 . . . . 0.0 110.164 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -90.75 -20.39 22.46 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 30.9 m-20 -92.08 -34.62 14.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.578 HD12 ' CE3' ' A' ' 97' ' ' TRP . 25.9 mt -73.83 94.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.0 mt -71.47 153.03 93.94 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.496 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.4 Cg_endo -80.05 -30.31 2.25 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.808 2.339 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 t -136.7 128.15 28.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.589 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 68.1 m-85 -112.52 138.01 49.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.7 p -99.95 2.02 43.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 108.707 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.72 0.12 89.87 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -120.1 13.23 12.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 0.0 109.461 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 3.7 mp0 -72.5 170.25 14.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.9 173.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.125 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -79.72 -44.12 21.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.98 -47.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.21 -43.54 97.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.094 -1.004 . . . . 0.0 109.207 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 116' ' ' ILE . 52.1 mttt -60.52 -36.22 77.86 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.412 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 6.2 ttm -60.07 -46.74 88.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.4 73.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.187 -0.945 . . . . 0.0 110.727 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.589 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 2.3 tp -69.55 -46.96 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.612 -1.305 . . . . 0.0 109.734 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.2 p -53.71 -40.26 65.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.003 . . . . 0.0 109.156 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.581 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 1.1 tp10 -69.81 -45.42 67.94 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 53' ' ' ALA . 10.0 tp -51.42 -50.25 60.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.561 ' HE2' ' CD2' ' A' ' 21' ' ' TYR . 1.1 mmt -60.87 -46.8 89.19 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.768 -0.582 . . . . 0.0 109.816 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.67 -39.66 94.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.467 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -64.53 -46.12 84.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 49' ' ' ALA . 89.1 t -71.4 -58.92 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.53 0.681 . . . . 0.0 109.822 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -45.79 -48.25 13.36 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.9 mt -63.5 -58.05 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.3 p -47.58 -29.22 2.72 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.986 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 143' ' ' VAL . 19.8 m -100.68 37.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 127' ' ' VAL . 91.1 m-20 37.1 50.19 0.91 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.679 0.752 . . . . 0.0 109.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.52 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 54.9 tpp -65.75 130.55 43.68 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.539 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 38.6 t0 -76.57 118.69 19.48 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 104.014 -2.588 . . . . 0.0 104.014 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.565 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 39.8 m-85 -101.19 110.6 22.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.62 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -150.14 -170.34 17.32 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 103.722 -3.751 . . . . 0.0 103.722 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.756 ' HD3' HD13 ' A' ' 28' ' ' ILE . 13.9 Cg_endo -62.54 -20.61 71.19 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 106.923 -1.991 . . . . 0.0 106.923 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -110.86 135.21 51.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.531 ' OG ' ' CB ' ' A' ' 44' ' ' ALA . 69.1 m -123.6 111.05 15.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 119.817 -1.802 . . . . 0.0 110.97 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.57 130.91 10.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 5.5 t -110.1 -163.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.879 -1.365 . . . . 0.0 107.433 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.576 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -89.8 -55.92 3.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.602 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 142.92 -136.2 6.95 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.051 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.527 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 13.8 m -56.62 -45.16 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.858 -0.789 . . . . 0.0 112.108 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 140' ' ' SER . 14.7 p -46.11 -43.35 14.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.946 -1.096 . . . . 0.0 109.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.621 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.8 mmt180 -82.34 -40.25 21.67 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 127' ' ' VAL . 55.3 t -68.33 -54.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.7 pp0? -56.73 -33.95 67.02 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.268 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.1 ttp180 -77.15 -48.52 17.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -63.1 -34.95 78.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.959 . . . . 0.0 110.043 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' HB2' HG13 ' A' ' 157' ' ' VAL . 50.7 mt -58.77 -47.93 83.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.088 -1.008 . . . . 0.0 109.475 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 14.0 mtmt -87.17 -35.65 18.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.859 -1.15 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 43.2 mt-10 -77.68 -55.28 5.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.406 -1.434 . . . . 0.0 111.823 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 34.2 m120 -84.35 -40.39 17.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.966 -1.084 . . . . 0.0 111.578 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.585 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.6 m-85 -102.51 -2.25 28.97 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.767 -1.208 . . . . 0.0 110.665 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 52.0 36.65 43.49 Favored Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.163 -0.961 . . . . 0.0 112.011 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.3 m-85 -62.01 163.85 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.242 -1.74 . . . . 0.0 107.993 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.468 ' HB3' ' OG ' ' A' ' 156' ' ' SER . 55.9 t30 -47.3 147.01 1.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.452 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.37 4.71 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.23 -0.918 . . . . 0.0 108.698 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.536 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 16.7 p -54.08 -16.21 1.86 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.417 -0.802 . . . . 0.0 109.955 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.526 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 4.7 t -65.3 120.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.787 -1.195 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CD2' HG22 ' A' ' 249' ' ' VAL . 2.9 p-80 -147.21 157.57 43.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.027 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.527 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 6.7 tt0 -101.93 155.81 17.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 246' ' ' SER . 2.6 pt -138.57 154.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.88 97.59 7.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 110.569 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.594 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 5.3 tpt180 -47.77 -31.58 5.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.25 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.52 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -63.7 -23.64 67.32 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -103.64 2.03 32.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.124 -1.221 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -117.92 140.57 49.54 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.63 -1.294 . . . . 0.0 109.81 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -67.98 139.97 56.37 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' HA ' ' NH1' ' A' ' 162' ' ' ARG . 59.2 tttt -38.04 -46.78 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -56.83 12.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 169' ' ' ASP . 1.7 m-20 -63.43 -23.38 67.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 109.268 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.594 ' CE3' ' HA ' ' A' ' 162' ' ' ARG . 66.8 t-105 -72.53 -43.63 63.28 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 175' ' ' ASP . 34.3 mt-10 -62.71 -26.62 68.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.34 81.94 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -61.22 -42.4 98.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -0.851 . . . . 0.0 108.881 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.552 HG23 ' CD1' ' A' ' 199' ' ' ILE . 28.7 mt -75.99 -61.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.713 . . . . 0.0 110.889 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.4 OUTLIER -49.29 -51.58 33.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.967 -1.083 . . . . 0.0 109.601 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.44 ' O ' ' OG ' ' A' ' 179' ' ' SER . 12.8 tttt -52.1 -40.69 61.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.882 -1.136 . . . . 0.0 107.988 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.577 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 5.0 mm-40 -60.88 -53.96 50.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.603 -0.686 . . . . 0.0 109.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.515 ' HB3' HG11 ' A' ' 4' ' ' VAL . 5.8 mt -65.69 -24.68 67.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 176' ' ' LYS . 24.8 p -52.31 -45.17 65.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.974 -1.079 . . . . 0.0 108.193 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 19.9 mt-30 -94.29 39.09 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.476 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.3 m-20 42.52 51.2 4.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 10.2 mt-30 -123.94 105.14 32.32 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.541 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.1 Cg_endo -63.93 173.58 4.69 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.103 1.869 . . . . 0.0 112.653 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 63.9 t -129.84 142.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.242 1.02 . . . . 0.0 112.236 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.602 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.6 OUTLIER -93.29 121.17 34.39 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.675 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 14.0 t80 -122.69 159.42 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.549 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -152.52 119.86 5.94 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.594 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 195' ' ' HIS . . . -91.97 106.03 3.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.477 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 10.1 t -67.11 160.76 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.25 -1.147 . . . . 0.0 110.644 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -172.34 -145.65 5.04 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -30.45 20.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.292 . . . . 0.0 110.229 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.51 -22.2 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.3 -169.61 23.94 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -77.38 112.55 3.53 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.176 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.5 t-80 -77.44 113.73 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -105.98 164.34 12.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.782 1.277 . . . . 0.0 114.036 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' ' 186' ' ' TYR . 43.5 p90 -162.64 -160.68 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 55' ' ' ILE . 5.7 t -139.61 139.35 38.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.206 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 174' ' ' ILE . 40.0 mt -105.66 108.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 10.2 p-10 -120.87 32.43 5.97 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.428 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.485 ' HA2' ' HB ' ' A' ' 4' ' ' VAL . . . 178.17 166.16 34.11 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.267 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -145.77 164.26 32.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.65 2.15 3.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.369 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.8 -31.06 4.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 10.0 mtt-85 -87.49 39.19 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.033 -1.275 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 17.0 m120 61.71 16.18 7.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 110.094 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -114.43 138.2 50.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 9.2 m-85 -123.17 162.48 22.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.337 -0.852 . . . . 0.0 110.285 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 59.2 t-80 -92.11 139.63 30.44 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.638 ' CG1' ' CE2' ' A' ' 212' ' ' TRP . 2.7 t -140.23 157.96 25.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.867 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 43.9 t-20 -117.95 85.23 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.638 ' CE2' ' CG1' ' A' ' 210' ' ' VAL . 19.7 m95 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.146 -0.972 . . . . 0.0 112.019 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 13.5 p -167.53 149.88 5.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 110.085 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.543 ' HB1' ' CH2' ' A' ' 170' ' ' TRP . . . -129.98 169.15 15.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.249 1.024 . . . . 0.0 109.751 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 11.4 t -117.95 119.9 62.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 158' ' ' HIS . 30.1 m -119.17 150.23 21.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.286 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 84.82 33.2 19.33 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.626 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 46.8 mt -79.18 90.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.341 -1.093 . . . . 0.0 109.974 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.76 152.04 12.87 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.582 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.316 2.011 . . . . 0.0 110.447 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.9 t . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 200' ' ' ASP . 49.2 mmtt -75.07 178.52 5.61 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.032 -1.043 . . . . 0.0 108.441 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.586 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 1.6 t -77.6 103.82 7.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.099 -1.001 . . . . 0.0 109.208 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.7 mt -57.15 -49.0 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.871 . . . . 0.0 108.923 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' H ' ' CB ' ' A' ' 200' ' ' ASP . 12.6 mt -56.5 -42.18 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.739 -1.226 . . . . 0.0 108.826 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.477 ' CB ' ' OG ' ' A' ' 6' ' ' SER . 54.8 t0 -67.48 -36.31 80.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.151 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -16.79 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.034 -1.042 . . . . 0.0 108.266 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.8 mtpt -122.32 18.32 10.63 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.25 43.12 7.24 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 57.6 mt -87.72 107.37 17.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.255 1.026 . . . . 0.0 110.23 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.8 m80 -135.02 86.97 2.29 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.593 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.7 m-30 -92.95 -179.9 5.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 110.768 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.17 -163.81 1.85 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.0 mt-30 -124.88 -20.8 4.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.929 -1.107 . . . . 0.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.38 -35.62 1.29 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.43 -1.367 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.773 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -142.74 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.529 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.132 -177.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.773 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.6 Cg_endo -72.98 1.83 6.11 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 CA-C-N 122.363 1.88 . . . . 0.0 109.559 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.559 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 10.4 m-85 -76.46 -31.12 57.63 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.953 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 10.8 p-10 -94.09 17.33 12.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.596 -1.315 . . . . 0.0 109.566 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.519 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 26.7 mt -72.28 -3.03 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.978 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 118' ' ' GLU . 6.0 mt -127.13 -7.56 5.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.5 p -61.9 164.93 8.91 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.674 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.6 Cg_endo -71.43 138.89 33.58 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.435 2.09 . . . . 0.0 112.11 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 ' CE1' ' A' ' 42' ' ' HIS . 28.8 t -81.11 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.646 -0.659 . . . . 0.0 110.287 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 ' HD3' ' A' ' 133' ' ' PRO . 17.1 mt -78.11 148.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.499 -0.751 . . . . 0.0 110.523 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.428 ' HA ' HG11 ' A' ' 39' ' ' VAL . 3.8 mt-10 -125.73 -22.12 4.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.759 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.3 mtpp -121.19 173.34 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.992 -1.068 . . . . 0.0 109.893 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG13 ' HA ' ' A' ' 37' ' ' SER . 98.7 t . . . . . 0 N--CA 1.487 1.417 0 O-C-N 121.401 -0.812 . . . . 0.0 110.676 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.455 ' HA ' HG13 ' A' ' 31' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.022 0.439 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.625 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.3 m-85 -124.45 16.93 8.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.084 -1.01 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 29' ' ' GLU . 47.2 t -63.26 143.59 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.041 -1.037 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 39' ' ' VAL . . . 80.07 -4.23 67.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.0 mt-30 -85.46 129.43 34.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -1.201 . . . . 0.0 109.595 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.445 ' CE1' HG22 ' A' ' 27' ' ' VAL . 1.8 m-70 -73.11 113.39 10.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.76 160.0 1.0 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.097 -1.041 . . . . 0.0 109.538 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.48 170.19 17.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.697 0.761 . . . . 0.0 109.793 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.55 HG22 ' SD ' ' A' ' 120' ' ' MET . 29.8 p -81.62 -34.98 30.57 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 104.28 136.65 8.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.9 p -55.18 -51.01 67.89 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.393 -1.063 . . . . 0.0 108.501 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.529 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 51.1 t -47.48 -52.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.38 -50.67 72.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.11 0.957 . . . . 0.0 109.437 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 99.1 m -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.931 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.21 -41.91 84.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.734 -1.229 . . . . 0.0 108.119 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 56' ' ' MET . 43.8 m -74.64 -53.25 9.69 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.447 0.641 . . . . 0.0 110.405 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.0 -37.71 46.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.572 -0.705 . . . . 0.0 109.585 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.593 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 32.0 mt-30 -63.05 -45.67 91.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 198' ' ' VAL . 53.1 mt -70.12 -28.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.586 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 22.3 mtp -66.97 -40.78 87.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.551 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 29.9 tptt -70.33 -41.35 73.34 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 49.0 t80 -54.05 -30.4 47.76 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 43.4 m-70 -107.39 -24.03 11.99 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.05 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.633 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 79.2 m-20 44.3 54.17 6.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.9 t80 -78.75 -70.65 0.19 Allowed Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.308 -175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.9 Cg_endo -70.23 100.81 0.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 CA-C-N 118.929 0.653 . . . . 0.0 111.609 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -68.97 -20.58 64.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -134.33 141.87 47.06 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.19 151.84 26.22 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.098 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.514 HD12 ' CA ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -89.14 -60.97 1.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -1.043 . . . . 0.0 110.186 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 49.0 tttt -135.95 134.46 38.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 109.598 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 4.5 m-20 -58.2 159.79 5.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.454 -0.779 . . . . 0.0 109.605 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.461 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 31.9 t80 -144.43 139.65 28.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -143.19 153.82 43.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.084 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.657 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 26.6 p90 -154.46 155.41 34.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.886 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 98.4 m -92.83 130.07 38.55 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 77' ' ' ASN . 9.7 tp -45.18 148.91 0.54 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.935 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 t -61.6 142.31 57.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.818 -0.551 . . . . 0.0 109.835 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -68.65 -3.38 11.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.038 -1.039 . . . . 0.0 109.75 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -98.7 -7.69 27.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 30.2 t-20 -70.49 110.1 6.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.591 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -89.26 16.28 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.968 2.445 . . . . 0.0 110.483 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 90.9 m-85 -106.01 -22.65 12.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.132 -0.98 . . . . 0.0 111.315 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 4.8 m-85 -122.34 162.56 21.32 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.561 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.4 m-80 -46.02 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.45 -46.04 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.451 175.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.3 56.48 5.01 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 N-CA-C 107.51 -1.765 . . . . 0.0 107.51 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.98 102.97 12.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.116 -178.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.14 134.9 43.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.656 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.657 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -108.15 144.56 35.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 17.7 t80 -134.0 130.23 37.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.007 -1.058 . . . . 0.0 110.365 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.68 113.82 27.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 53.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.642 -1.286 . . . . 0.0 108.458 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 9.8 mt -52.89 -52.73 25.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 4.1 p -45.55 -26.6 0.61 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.342 -1.473 . . . . 0.0 109.219 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -111.78 19.78 17.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 109.534 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.654 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 13.5 mmt-85 -76.83 147.55 37.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 110.378 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 90.34 3.31 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-85 -81.02 96.95 7.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.548 -0.72 . . . . 0.0 110.617 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.6 t-20 -80.53 88.69 5.65 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 39.1 m95 -61.03 -8.98 3.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.446 -0.784 . . . . 0.0 110.411 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -19.17 23.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.24 -26.29 13.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.601 HD12 ' CE3' ' A' ' 97' ' ' TRP . 66.6 mt -73.88 67.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.7 mt -46.83 150.12 1.37 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.546 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.4 Cg_endo -78.84 -21.2 9.86 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.759 2.306 . . . . 0.0 110.587 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 134.47 26.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.007 -1.058 . . . . 0.0 109.684 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.63 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 89.3 m-85 -124.49 137.9 54.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.923 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.9 p -99.04 -0.09 42.65 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 81.45 10.02 85.07 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.17 5.9 10.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.395 -1.062 . . . . 0.0 108.956 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.14 167.72 19.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.694 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -57.79 171.71 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.195 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -76.9 -33.97 57.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -51.99 -60.42 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.435 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 2.1 mp0 -62.45 -35.16 78.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 0.0 109.376 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 109' ' ' SER . 26.7 mttt -63.8 -43.47 96.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 108.291 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.467 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 28.7 ttm -59.93 -38.24 81.8 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.535 -0.728 . . . . 0.0 110.403 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.63 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 3.6 tp -59.9 -39.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.471 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 25.2 p -53.61 -43.74 68.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.956 -1.09 . . . . 0.0 109.635 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 4.4 tt0 -69.88 -42.49 73.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 108.518 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 53' ' ' ALA . 7.7 tp -52.15 -51.6 56.98 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.559 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.5 mmt -59.7 -45.7 91.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.635 -0.666 . . . . 0.0 109.489 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.75 -38.35 90.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 126' ' ' SER . 6.6 m-20 -68.67 -48.43 63.97 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 49' ' ' ALA . 55.9 t -67.12 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.41 -42.39 13.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.9 mt -69.72 -57.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.346 -1.091 . . . . 0.0 108.325 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.508 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 2.1 p -45.47 -27.64 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.429 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.6 m -105.0 32.76 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.139 -0.976 . . . . 0.0 109.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 142' ' ' ARG . 43.1 m-20 40.71 44.99 1.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.343 -0.848 . . . . 0.0 109.651 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 41.1 tpp -56.86 133.09 54.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 111.145 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 18.6 t0 -79.56 122.66 26.76 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.82 117.79 35.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.312 1.053 . . . . 0.0 113.064 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -150.6 -164.56 12.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 104.261 -3.536 . . . . 0.0 104.261 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -61.96 -31.5 84.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 105.582 -2.507 . . . . 0.0 105.582 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.0 m -109.7 141.54 42.14 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 47.5 m -119.2 109.84 16.33 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 119.966 -1.709 . . . . 0.0 109.919 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.83 136.12 13.24 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 13.1 t -117.87 -162.59 0.89 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.234 -1.156 . . . . 0.0 108.335 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.02 -57.21 2.8 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.532 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 131.46 -131.05 6.21 Favored Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.393 -1.384 . . . . 0.0 112.042 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.553 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 36.8 m -47.83 -58.62 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.891 -0.77 . . . . 0.0 111.786 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' SER . 11.1 p -46.75 -36.81 7.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 0.0 108.95 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 53.9 mmt-85 -80.37 -47.88 13.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.01 0.909 . . . . 0.0 108.92 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.659 HG21 ' CE2' ' A' ' 185' ' ' TYR . 93.9 t -67.85 -56.57 12.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.7 pp0? -56.48 -33.73 66.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.171 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.512 ' NE ' ' OE2' ' A' ' 149' ' ' GLU . 12.1 ttt85 -77.1 -52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 126' ' ' SER . . . -63.56 -35.95 82.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.086 -1.009 . . . . 0.0 110.047 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.438 ' CD1' HG11 ' A' ' 143' ' ' VAL . 40.5 mt -56.41 -48.44 76.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.516 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.6 mtmt -86.45 -39.13 16.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.133 -0.979 . . . . 0.0 110.407 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.512 ' OE2' ' NE ' ' A' ' 145' ' ' ARG . 54.1 mt-10 -67.97 -54.46 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 112.007 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.478 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 20.7 m120 -92.75 -40.87 10.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.703 -1.248 . . . . 0.0 111.746 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.586 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 29.2 m-85 -99.56 10.59 41.08 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.715 -1.241 . . . . 0.0 110.514 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 36.04 39.12 0.27 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.55 -0.719 . . . . 0.0 112.875 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.5 m-85 -61.92 162.88 8.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.142 -1.799 . . . . 0.0 107.364 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.1 t-20 -47.48 139.02 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.87 -1.144 . . . . 0.0 109.414 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -53.72 -18.97 3.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 58.7 p -53.07 -18.23 1.99 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 251' ' ' ILE . 39.8 t -58.33 123.7 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 109.158 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.564 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 8.7 p-80 -143.87 154.82 43.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.086 -1.009 . . . . 0.0 109.404 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.553 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.0 tt0 -100.73 154.2 18.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.36 -0.838 . . . . 0.0 110.509 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.489 ' N ' ' HG2' ' A' ' 159' ' ' GLN . 10.5 pt -135.96 142.37 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.9 m-80 -107.25 100.49 9.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.873 -1.142 . . . . 0.0 111.065 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.9 tpt180 -44.01 -41.22 5.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.154 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.09 -23.17 59.21 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ASN . 0.8 OUTLIER -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.063 -1.257 . . . . 0.0 111.576 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.92 174.94 5.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.516 -1.365 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -103.91 134.28 47.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 166' ' ' SER . 18.3 ttmt -31.91 -45.62 0.1 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.101 0.477 . . . . 0.0 110.869 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -64.17 -63.69 1.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.927 -1.108 . . . . 0.0 109.823 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.22 -15.67 57.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.359 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.9 t-105 -74.85 -46.95 33.0 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.177 -0.952 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.417 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 43.4 mt-10 -69.53 -30.48 68.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.091 -1.006 . . . . 0.0 108.606 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.66 -45.43 73.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 108.751 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -61.13 -40.28 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 108.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.553 HG23 ' CD1' ' A' ' 199' ' ' ILE . 13.7 mt -76.13 -60.94 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.557 -0.714 . . . . 0.0 111.119 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.03 -46.67 44.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 109.24 -178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.578 ' NZ ' ' HB3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -51.35 -48.67 62.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.597 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.4 mm-40 -54.87 -51.07 67.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 4' ' ' VAL . 17.6 mt -68.2 -33.51 74.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.205 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 175' ' ' ASP . 53.4 p -51.99 -30.78 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.458 HE21 ' CD ' ' A' ' 176' ' ' LYS . 1.2 mt-30 -102.41 33.65 3.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.473 ' HA ' HD21 ' A' ' 7' ' ' LEU . 11.6 m120 40.67 46.68 2.27 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.816 0.817 . . . . 0.0 108.918 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 14.7 mt-30 -123.69 111.8 29.35 Favored Pre-proline 0 C--N 1.294 -1.815 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.517 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -65.09 169.66 11.7 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.803 1.668 . . . . 0.0 112.653 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 45.9 t -121.12 132.79 69.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.58 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.659 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -81.57 116.39 21.31 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 175.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 6.5 t80 -121.97 157.27 31.65 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.809 -1.182 . . . . 0.0 110.192 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 4.8 pt20 -167.06 136.05 2.76 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.6 1.66 Allowed Glycine 0 C--N 1.289 -2.031 0 N-CA-C 107.675 -2.17 . . . . 0.0 107.675 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.537 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 6.8 t -69.93 166.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -1.117 . . . . 0.0 111.419 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -170.53 -129.11 1.08 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -88.11 -36.96 16.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.251 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.0 m -79.92 -15.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.974 -1.079 . . . . 0.0 111.284 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.432 ' C ' HG11 ' A' ' 189' ' ' VAL . . . 130.88 -167.63 22.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -83.47 101.51 2.36 Favored Glycine 0 N--CA 1.485 1.929 0 O-C-N 121.049 -1.265 . . . . 0.0 110.781 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 17.3 t-80 -71.27 121.11 17.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -113.08 160.67 17.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.517 -1.273 . . . . 0.0 113.361 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 33.0 p90 -156.91 175.19 14.41 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.534 HG22 HG13 ' A' ' 55' ' ' ILE . 92.8 t -121.14 135.69 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.575 -1.328 . . . . 0.0 112.094 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 73.6 mt -99.9 123.13 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -134.17 32.76 3.41 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.131 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 178' ' ' LEU . . . -171.69 167.68 40.75 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 117.709 -2.186 . . . . 0.0 112.345 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.53 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.17 148.0 27.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ARG . 0.5 OUTLIER -121.61 24.26 9.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.755 -1.216 . . . . 0.0 110.357 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 43.05 26.45 0.49 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 14.3 mtt-85 -142.43 21.44 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -1.118 . . . . 0.0 109.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 9.4 t30 80.6 20.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.563 -0.711 . . . . 0.0 109.65 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.27 128.26 49.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.426 ' HD2' ' CD1' ' A' ' 178' ' ' LEU . 25.7 m-85 -120.7 163.51 17.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.0 . . . . 0.0 109.557 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 37.1 t-80 -93.39 116.11 28.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 197' ' ' PHE . 20.7 t -114.51 140.02 37.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.105 -0.997 . . . . 0.0 111.165 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 28.2 t-20 -108.64 92.32 4.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.476 ' O ' ' O ' ' A' ' 211' ' ' ASN . 3.1 m95 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 0.0 110.404 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 3.9 mt-30 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 56.4 p -159.15 157.39 30.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.029 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.14 166.47 24.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.4 -0.812 . . . . 0.0 110.021 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 46.9 t -119.29 114.59 45.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.597 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 16.6 m -114.69 147.85 17.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 O-C-N 121.282 -0.886 . . . . 0.0 110.402 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 96.12 47.14 2.48 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.042 -1.551 . . . . 0.0 109.881 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.602 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.9 mt -103.22 96.11 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -1.185 . . . . 0.0 110.173 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.39 146.77 8.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.602 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.1 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.206 1.937 . . . . 0.0 110.452 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.594 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 12.0 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.212 0.53 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 200' ' ' ASP . 58.3 mmtt -77.01 -179.51 5.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 34.7 t -77.79 102.42 7.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.666 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 35.7 mt -57.63 -49.65 75.75 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.8 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 8' ' ' LEU . 11.9 mt -56.02 -42.46 76.52 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.776 -1.202 . . . . 0.0 108.641 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -68.34 -36.19 78.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.058 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -58.08 -15.36 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.102 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' CB ' HG13 ' A' ' 13' ' ' ILE . 9.1 mtpt -121.95 23.54 9.97 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.97 39.89 5.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.488 HG13 ' CB ' ' A' ' 11' ' ' LYS . 40.2 mt -86.03 110.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.355 1.074 . . . . 0.0 110.408 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 6.7 m-70 -133.45 99.44 4.51 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.606 ' CE2' HD13 ' A' ' 116' ' ' ILE . 6.4 m-30 -103.66 176.0 5.29 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.012 . . . . 0.0 111.513 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.562 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -146.98 -175.17 4.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mt-30 -118.37 -20.96 8.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.943 -1.098 . . . . 0.0 109.977 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.42 -34.13 1.49 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.94 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.778 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.0 -140.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.021 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.32 3.22 5.42 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 CA-C-N 122.55 1.947 . . . . 0.0 109.325 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.1 m-85 -78.63 -30.66 46.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.478 -0.764 . . . . 0.0 109.068 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 20.6 p-10 -96.12 12.86 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.545 -1.347 . . . . 0.0 109.341 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' CD1' ' HD3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -67.79 -8.61 37.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.918 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' A' ' 114' ' ' MET . 8.7 mt -126.68 -6.23 6.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 0.0 109.703 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.8 p -61.14 165.95 5.7 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -71.1 136.81 30.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.013 1.809 . . . . 0.0 111.609 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 28' ' ' ILE . 41.9 t -81.16 149.97 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.614 0.721 . . . . 0.0 110.136 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.642 HD13 ' HD3' ' A' ' 133' ' ' PRO . 16.8 mt -77.77 148.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.565 -0.709 . . . . 0.0 110.544 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -125.67 -20.82 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.705 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 79' ' ' TYR . 44.7 mtpt -123.72 172.01 9.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.89 -1.131 . . . . 0.0 109.949 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.0 t . . . . . 0 C--N 1.304 -1.392 0 O-C-N 121.397 -0.814 . . . . 0.0 110.94 -179.206 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -123.81 19.52 9.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.084 -1.01 . . . . 0.0 109.798 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 40' ' ' GLY . 59.6 t -67.74 145.08 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.557 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.491 ' N ' HG11 ' A' ' 39' ' ' VAL . . . 79.15 -1.9 73.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.1 mt-30 -88.03 130.3 35.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 109.813 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -73.06 112.34 9.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.77 158.28 1.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.847 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -71.59 166.38 21.97 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.522 HG22 ' SD ' ' A' ' 120' ' ' MET . 41.1 p -80.45 -29.15 37.54 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.515 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 99.08 136.85 9.53 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.6 p -54.67 -52.94 60.79 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.217 -1.167 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.563 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 54.7 t -46.91 -52.53 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.46 -51.29 70.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.969 0.89 . . . . 0.0 109.861 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.615 ' CG2' ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -64.21 -32.31 73.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.664 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -66.57 -39.44 88.48 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.648 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.504 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.3 m -74.59 -53.63 9.01 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.701 0.762 . . . . 0.0 110.05 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.22 -38.43 52.41 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.702 -0.624 . . . . 0.0 109.837 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.537 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -63.91 -46.88 82.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.13 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 HG22 ' A' ' 198' ' ' VAL . 37.7 mt -67.87 -24.49 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.601 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 31.6 mtp -73.57 -32.26 64.06 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.57 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 26.0 tptt -75.82 -44.34 41.6 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 33.8 t80 -53.61 -27.78 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.75 -0.594 . . . . 0.0 110.023 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 35.0 m-70 -107.5 -26.09 11.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.288 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.623 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 90.2 m-20 44.54 59.2 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.0 t80 -84.88 -72.22 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 37.2 Cg_endo -69.77 105.76 1.54 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 CA-C-N 118.955 0.663 . . . . 0.0 111.952 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 95' ' ' TYR . 8.0 m120 -72.14 -23.59 61.32 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -135.89 137.33 41.32 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -58.67 152.06 31.8 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.421 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.634 HD12 ' HA3' ' A' ' 152' ' ' GLY . 2.6 mt -92.31 -42.01 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.406 -1.055 . . . . 0.0 109.961 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 11.7 ttpp -152.29 136.41 16.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.934 -1.104 . . . . 0.0 110.334 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -59.41 164.66 3.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.629 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 70' ' ' THR . 20.6 t80 -141.78 152.05 43.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 3.4 t -151.22 166.06 32.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.927 -1.108 . . . . 0.0 110.192 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 25.6 p90 -169.12 154.03 5.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.443 -0.786 . . . . 0.0 109.32 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.9 m -92.81 136.06 33.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.512 HD21 ' CG ' ' A' ' 77' ' ' ASN . 10.5 tp -52.34 153.17 3.03 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.335 -0.853 . . . . 0.0 111.335 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -61.33 137.0 58.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.33 0.586 . . . . 0.0 110.016 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 p -64.58 -7.74 11.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.7 t-20 -99.66 -4.21 31.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.029 -1.045 . . . . 0.0 109.717 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 36.4 t-20 -69.9 109.97 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.774 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.624 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.6 15.55 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.83 2.353 . . . . 0.0 109.991 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 75.0 m-85 -105.71 -27.26 11.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' ASN . 19.2 m-85 -118.91 164.43 15.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.636 -1.29 . . . . 0.0 107.774 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.9 m-80 -47.39 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.64 -48.2 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 175.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.9 56.71 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 N-CA-C 106.958 -1.978 . . . . 0.0 106.958 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.46 104.1 13.76 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.13 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.96 130.65 46.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.824 . . . . 0.0 109.441 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -102.47 137.73 40.33 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -124.96 129.08 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.375 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.18 114.12 27.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 50.03 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.665 -1.272 . . . . 0.0 108.569 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.8 mt -52.48 -51.49 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.325 -0.859 . . . . 0.0 109.085 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.92 -29.24 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.065 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.15 30.21 7.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.654 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 6.4 mmt-85 -85.5 150.44 24.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' ' 94' ' ' GLN . 1.9 mm100 -116.9 91.09 3.48 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.3 m-85 -81.08 91.31 6.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.472 -0.767 . . . . 0.0 111.134 -176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.466 ' O ' HG13 ' A' ' 100' ' ' ILE . 38.2 t-20 -79.76 87.14 5.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 63.2 m95 -61.23 -8.32 3.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.36 -17.73 26.79 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -99.6 -27.72 13.55 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.618 HD12 ' CE3' ' A' ' 97' ' ' TRP . 58.0 mt -74.41 66.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 24.3 mt -46.71 149.25 1.52 Allowed Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.854 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.514 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.7 Cg_endo -78.67 -23.97 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.74 2.293 . . . . 0.0 110.409 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.19 126.69 23.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 108.994 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.515 ' CE2' ' CG2' ' A' ' 116' ' ' ILE . 54.8 m-85 -113.51 148.82 35.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' OE1' ' A' ' 108' ' ' GLU . 36.1 p -103.5 -9.83 19.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.56 -0.11 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -120.11 1.06 10.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -1.171 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' OE1' ' OG ' ' A' ' 105' ' ' SER . 0.1 OUTLIER -64.86 165.29 10.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.808 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.38 166.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -72.37 -34.45 67.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.36 -58.97 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.435 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.63 -36.28 80.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 0.0 108.897 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.539 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 21.4 mttt -65.71 -44.19 86.85 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.463 ' HG3' HD13 ' A' ' 24' ' ' LEU . 4.8 ttm -59.28 -35.72 74.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 100' ' ' ILE . . . -57.09 -66.63 0.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.61 -0.681 . . . . 0.0 109.619 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.606 HD13 ' CE2' ' A' ' 15' ' ' TYR . 2.4 tp -65.74 -40.15 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.815 . . . . 0.0 109.552 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.555 ' N ' HG23 ' A' ' 116' ' ' ILE . 11.2 p -57.21 -41.89 80.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.222 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.589 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 22.9 tt0 -69.72 -40.59 76.13 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.498 HD22 ' CD1' ' A' ' 116' ' ' ILE . 10.3 tp -54.84 -52.32 63.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.615 ' HE1' ' CG2' ' A' ' 50' ' ' THR . 1.6 mmt -58.51 -44.84 89.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.46 -38.84 92.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.514 ' OD2' ' NE ' ' A' ' 93' ' ' ARG . 5.9 m-20 -69.22 -43.02 74.91 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 49' ' ' ALA . 55.3 t -71.21 -62.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.609 -0.682 . . . . 0.0 109.774 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.31 -45.77 16.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.8 mt -65.03 -57.62 10.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 108.664 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.566 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 5.2 p -46.32 -31.08 2.36 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.771 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.0 m -101.46 37.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 109.626 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.8 m-20 39.36 42.14 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.482 -0.761 . . . . 0.0 109.782 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.557 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 45.9 tpp -55.59 128.23 33.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.405 -0.809 . . . . 0.0 111.446 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 21.6 t0 -77.71 126.07 30.31 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.0 m-85 -108.18 120.72 43.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.759 -1.177 . . . . 0.0 113.51 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.9 -164.0 11.71 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 103.834 -3.706 . . . . 0.0 103.834 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.642 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -61.38 -30.26 86.99 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 N-CA-C 105.445 -2.56 . . . . 0.0 105.445 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.54 46.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -115.71 112.83 22.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.853 -1.779 . . . . 0.0 109.851 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.29 133.72 11.81 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.557 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 16.0 t -118.27 -162.11 0.87 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -1.182 . . . . 0.0 108.761 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.542 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.21 -60.51 1.83 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.544 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 136.29 -133.71 6.74 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.888 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.543 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -48.11 -57.83 5.31 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.797 -0.825 . . . . 0.0 111.911 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 1.7 p -47.31 -36.72 9.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.752 -1.217 . . . . 0.0 109.015 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 25.8 mmt180 -79.84 -46.69 16.41 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.064 0.935 . . . . 0.0 108.797 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.616 HG21 ' CE2' ' A' ' 185' ' ' TYR . 79.5 t -68.09 -56.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.275 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.53 -34.53 67.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 109.357 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' CG ' ' OE2' ' A' ' 149' ' ' GLU . 34.1 ttm-85 -77.36 -42.89 34.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.944 -1.098 . . . . 0.0 109.836 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -69.85 -32.68 71.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.85 -48.44 81.78 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.505 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.8 mtmt -86.55 -44.25 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.07 -1.019 . . . . 0.0 110.583 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.504 ' OE2' ' CG ' ' A' ' 145' ' ' ARG . 82.1 mt-10 -67.4 -47.93 68.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.879 -1.138 . . . . 0.0 111.498 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -94.37 -44.19 8.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 111.671 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 31.1 m-85 -101.6 16.6 25.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 110.618 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 33.32 39.86 0.1 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 121.594 -0.691 . . . . 0.0 113.16 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.4 m-85 -62.04 159.81 13.72 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 120.529 2.165 . . . . 0.0 107.154 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 51.4 t-20 -47.06 143.8 2.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.737 -1.227 . . . . 0.0 109.372 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 32.9 tp60 -53.64 -17.86 2.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.398 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.495 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 18.9 p -53.29 -17.08 1.55 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 109.876 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 251' ' ' ILE . 38.8 t -64.59 127.88 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.75 -1.219 . . . . 0.0 109.438 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.598 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 8.2 p-80 -147.37 149.58 33.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.543 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -100.69 139.92 35.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.641 ' CD1' ' CZ3' ' A' ' 170' ' ' TRP . 16.4 pt -122.5 158.04 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m-80 -116.88 103.65 10.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.183 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 8.2 tpt180 -47.46 -28.65 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.602 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.3 75.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -103.96 16.17 26.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.013 -1.287 . . . . 0.0 111.675 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -121.45 155.86 33.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.57 -1.331 . . . . 0.0 109.89 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -84.86 139.62 31.76 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.8 ttmm -36.79 -47.98 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.559 -0.713 . . . . 0.0 110.704 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.93 -56.74 13.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 110.356 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.54 -21.5 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 110.123 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.641 ' CZ3' ' CD1' ' A' ' 160' ' ' ILE . 76.4 t-105 -76.66 -40.49 48.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.915 -1.116 . . . . 0.0 109.333 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.48 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 43.3 mt-10 -73.87 -48.38 31.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -48.27 -40.62 25.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 11.2 mm100 -61.14 -48.14 82.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.507 HG23 HD11 ' A' ' 199' ' ' ILE . 22.8 mt -73.21 -49.99 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.656 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 179' ' ' SER . 1.5 m-20 -52.57 -42.9 64.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.2 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -52.18 -46.26 65.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.698 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 65.6 mm-40 -56.19 -51.7 67.07 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -68.69 -24.13 64.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 175' ' ' ASP . 32.1 p -52.58 -38.2 59.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.754 -1.217 . . . . 0.0 107.802 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 28.8 mt-30 -102.21 31.76 3.83 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.471 ' HA ' HD21 ' A' ' 7' ' ' LEU . 17.6 m-80 48.2 51.22 15.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 109.148 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 27.2 mt-30 -124.08 116.09 27.41 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.561 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.9 Cg_endo -64.76 166.59 17.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.07 1.847 . . . . 0.0 112.497 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 77.0 t -125.55 140.73 47.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.102 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.616 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -86.02 120.17 27.12 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 4.2 t80 -123.63 161.41 25.09 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.061 -1.024 . . . . 0.0 109.5 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.7 pt20 -167.63 130.29 1.62 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 117.591 -1.644 . . . . 0.0 112.007 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.431 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -94.11 114.06 4.68 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 21.5 t -71.89 167.69 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.902 -1.351 . . . . 0.0 110.647 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -174.87 -141.18 3.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -37.53 16.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.026 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.1 m -80.75 1.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.94 -1.1 . . . . 0.0 111.153 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 118.86 -162.21 13.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -89.84 106.01 3.28 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.721 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.75 125.4 27.05 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -114.1 160.46 18.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.612 -1.235 . . . . 0.0 112.923 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 29.9 p90 -156.66 168.76 26.42 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 55' ' ' ILE . 71.5 t -114.18 136.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.755 -1.216 . . . . 0.0 112.158 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 39.5 mt -100.05 114.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.4 p30 -130.44 37.59 3.84 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.304 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -177.13 169.73 42.13 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.09 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.594 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -153.25 136.59 15.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 0.14 48.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.465 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 88.67 -26.94 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -100.18 51.08 0.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -1.136 . . . . 0.0 109.854 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.48 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 7.5 m120 60.9 20.79 11.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 3.2 m-85 -111.73 137.94 48.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.083 -1.011 . . . . 0.0 109.406 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.6 m-85 -122.87 164.3 18.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 110.097 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.9 t-80 -92.45 120.28 32.79 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.584 HG13 ' CD1' ' A' ' 197' ' ' PHE . 26.7 t -114.73 145.08 20.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.112 -0.992 . . . . 0.0 111.802 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.485 ' N ' HG11 ' A' ' 210' ' ' VAL . 16.4 t-20 -112.34 79.18 1.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.581 ' CD2' HG12 ' A' ' 210' ' ' VAL . 32.9 m95 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 120.903 -1.123 . . . . 0.0 109.572 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 80.4 mt-30 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 79.8 p -161.71 161.67 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.64 144.79 35.93 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.47 0.652 . . . . 0.0 109.57 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 16.8 t -105.2 116.46 49.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.698 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 4.1 m -117.05 139.12 45.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.318 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 90.7 47.17 3.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.619 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 mt -94.5 98.25 7.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.16 149.34 10.05 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.603 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.283 1.989 . . . . 0.0 110.358 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' ' 178' ' ' LEU . 86.8 t . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 20.3 mmtp -76.4 -179.77 5.36 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 108.545 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 9' ' ' ASP . 27.6 t -77.82 105.65 9.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.652 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.684 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 34.3 mt -58.53 -50.44 73.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -0.86 . . . . 0.0 108.824 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.46 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 14.1 mt -54.6 -39.2 67.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 0.0 108.516 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 6.0 t0 -67.85 -42.21 81.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 109.801 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 44.0 p -58.04 -14.91 7.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.156 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -117.74 19.67 13.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.69 35.72 4.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 42.8 mt -85.52 110.45 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.328 -1.101 . . . . 0.0 110.287 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.6 m-70 -134.01 81.9 1.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CE2' HD13 ' A' ' 116' ' ' ILE . 11.4 m-30 -92.18 170.54 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.229 1.014 . . . . 0.0 111.475 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -147.98 -167.65 2.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.497 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 16.6 mt-30 -125.45 -2.81 7.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.798 -1.189 . . . . 0.0 110.471 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.665 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.37 -54.81 0.33 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.465 -1.35 . . . . 0.0 112.31 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.703 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -129.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.579 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.938 -176.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -77.38 6.25 4.53 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 123.435 2.263 . . . . 0.0 109.062 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.736 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 85.8 m-85 -77.19 -35.92 55.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.85 -0.531 . . . . 0.0 110.077 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 47.2 p30 -98.85 20.33 13.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.773 -1.205 . . . . 0.0 109.043 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 23' ' ' LEU . 6.9 mt -71.43 -6.11 37.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 111.079 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 118' ' ' GLU . 7.6 mt -131.91 0.59 3.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.687 -1.258 . . . . 0.0 109.789 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -67.31 167.04 16.54 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -70.58 142.85 45.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.747 1.632 . . . . 0.0 111.509 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.24 150.08 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.592 0.711 . . . . 0.0 110.37 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.796 HG21 ' HB3' ' A' ' 79' ' ' TYR . 34.1 mt -77.64 147.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.552 0.692 . . . . 0.0 110.165 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 28' ' ' ILE . 1.9 mm-40 -124.49 -22.7 4.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.212 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 79' ' ' TYR . 3.8 mtpt -122.68 168.76 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.371 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 37' ' ' SER . 42.5 t . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.78 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.082 0.468 . . . . 0.0 109.741 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.594 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.4 m-85 -123.72 27.34 7.36 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.036 -1.04 . . . . 0.0 109.344 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 31' ' ' VAL . 49.2 t -73.58 142.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.484 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HG11 ' A' ' 39' ' ' VAL . . . 79.46 -2.38 72.45 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.2 mt-30 -82.58 133.98 35.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.317 -1.108 . . . . 0.0 109.827 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -73.23 109.07 6.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.49 159.08 1.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.215 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -79.12 165.55 23.21 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.726 0.775 . . . . 0.0 109.857 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 120' ' ' MET . 5.8 p -81.06 -34.14 32.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 108.588 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.96 137.11 8.16 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.0 p -55.29 -48.98 73.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 37.7 t -47.02 -53.72 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.557 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.28 -50.87 72.33 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.64 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 86.6 m -64.19 -31.48 72.7 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.852 -0.53 . . . . 0.0 109.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.13 -43.09 83.27 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.055 -1.458 . . . . 0.0 107.292 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' HG23 ' A' ' 143' ' ' VAL . 21.7 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.595 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.65 -39.19 57.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 109.785 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.601 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.9 mt-30 -60.05 -51.15 70.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.695 -1.253 . . . . 0.0 107.647 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 198' ' ' VAL . 35.0 mt -63.41 -24.21 35.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.618 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 21.9 mtp -73.0 -38.46 66.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 44.7 tptt -69.17 -40.58 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.684 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 50.2 t80 -53.53 -30.5 41.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.058 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.0 m-70 -107.86 -23.08 12.2 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.214 -0.929 . . . . 0.0 110.763 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.602 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 54.4 m-20 44.44 54.8 6.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.606 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -76.79 -75.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 119.443 -0.903 . . . . 0.0 113.406 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.549 ' CD ' ' CB ' ' A' ' 61' ' ' TYR . 34.0 Cg_endo -67.09 104.19 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 120.3 0.667 . . . . 0.0 112.107 -176.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.4 -20.32 62.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.4 OUTLIER -133.96 143.68 48.32 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.8 34.96 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.226 -1.464 . . . . 0.0 109.847 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.534 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -90.14 -64.88 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.379 -1.071 . . . . 0.0 109.645 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 5.9 tttt -131.9 148.82 52.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 m-20 -73.9 179.58 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 70' ' ' THR . 14.2 t80 -153.9 151.32 29.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.307 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 t -155.03 152.42 29.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.096 -1.002 . . . . 0.0 109.656 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 21.3 p90 -161.66 155.01 21.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 109.61 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 97.0 m -93.33 139.37 30.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' CG ' ' A' ' 77' ' ' ASN . 9.9 tp -56.55 147.78 21.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 111.221 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -61.95 143.79 55.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.35 0.595 . . . . 0.0 109.749 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -70.13 -2.14 12.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.0 m120 -97.47 -8.94 28.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 29.8 t-20 -70.44 109.51 5.11 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.747 -0.596 . . . . 0.0 109.88 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -89.16 15.82 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.959 2.439 . . . . 0.0 110.193 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.796 ' HB3' HG21 ' A' ' 28' ' ' ILE . 78.7 m-85 -105.92 -25.86 11.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.718 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' C ' ' A' ' 81' ' ' ASN . 8.7 m-85 -119.21 163.0 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.5 m-80 -46.58 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.06 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 111.041 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.17 56.63 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 N-CA-C 107.24 -1.869 . . . . 0.0 107.24 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.92 106.73 17.37 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.408 -178.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 134.29 43.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.641 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.91 125.03 51.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.51 124.93 46.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.147 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.451 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.21 108.47 19.91 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.9 54.19 0.36 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.799 -1.188 . . . . 0.0 108.428 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.644 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 46.6 mt -52.43 -45.75 46.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 O-C-N 121.405 -0.809 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 p -45.42 -26.46 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.799 -1.188 . . . . 0.0 109.286 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 26.75 10.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.45 154.13 22.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.111 -0.993 . . . . 0.0 110.375 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.27 95.03 4.79 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 7.0 m-85 -81.82 88.96 6.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 110.857 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.479 ' O ' HG13 ' A' ' 100' ' ' ILE . 11.7 t30 -79.94 91.13 5.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.603 ' CE3' HD12 ' A' ' 100' ' ' ILE . 61.7 m95 -61.29 -6.25 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.423 -0.798 . . . . 0.0 110.805 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -90.33 -18.86 24.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.779 -1.201 . . . . 0.0 107.876 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.3 m-20 -99.59 -29.11 12.88 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.603 HD12 ' CE3' ' A' ' 97' ' ' TRP . 31.0 mt -73.83 63.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.522 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 61.0 mt -46.27 148.64 1.51 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.544 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.5 Cg_endo -77.75 -29.07 4.73 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.598 2.199 . . . . 0.0 110.455 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 14' ' ' HIS . 7.6 t -134.68 124.5 25.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.122 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.0 m-85 -109.42 138.92 45.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.6 p -100.09 1.65 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.79 89.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -120.13 9.66 11.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.196 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -74.73 -178.95 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -76.38 174.98 9.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 1.2 m120 -78.48 -36.76 44.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.658 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.9 t -53.47 -59.42 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.801 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -33.15 73.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 108.94 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.539 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 32.1 mttt -67.81 -44.22 77.8 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -33.18 70.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.437 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.09 -67.84 0.28 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.71 -0.619 . . . . 0.0 109.579 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.632 HD13 ' CE2' ' A' ' 15' ' ' TYR . 2.9 tp -61.96 -41.34 90.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.193 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.552 ' N ' HG23 ' A' ' 116' ' ' ILE . 4.5 p -57.15 -40.02 76.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 109.164 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 31.3 tt0 -69.99 -43.26 71.8 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.473 HD22 ' CD1' ' A' ' 116' ' ' ILE . 6.8 tp -57.41 -48.41 79.16 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.736 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -56.61 -47.6 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.476 178.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.71 -39.22 93.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 126' ' ' SER . 13.0 m-20 -65.3 -53.87 37.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 49' ' ' ALA . 89.1 t -65.31 -54.99 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.296 -0.878 . . . . 0.0 109.454 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -47.22 -53.07 11.9 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.1 mt -65.99 -53.16 40.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -1.093 . . . . 0.0 108.516 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.49 ' OG ' ' HA ' ' A' ' 123' ' ' VAL . 60.3 p -45.53 -33.53 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.067 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.7 m -100.86 38.69 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.713 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' VAL . 22.4 m-20 37.15 52.04 1.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.517 -0.74 . . . . 0.0 109.624 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 45' ' ' THR . 44.2 tpp -66.63 130.55 43.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.57 -0.707 . . . . 0.0 111.774 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 135' ' ' SER . 8.0 t70 -76.92 122.01 24.26 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.629 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.59 120.31 40.63 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.479 1.133 . . . . 0.0 113.029 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -152.09 -163.21 11.37 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 104.485 -3.446 . . . . 0.0 104.485 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -62.26 -31.54 82.16 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 N-CA-C 105.551 -2.519 . . . . 0.0 105.551 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.2 m -109.36 142.21 40.62 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 30.7 m -124.64 109.8 13.61 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 119.961 -1.712 . . . . 0.0 110.104 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.3 137.41 14.08 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 3.5 t -117.35 -162.22 0.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.69 -50.65 5.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.524 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 121.37 -126.24 6.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.488 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 10.4 m -47.08 -60.55 2.39 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.712 -0.875 . . . . 0.0 112.279 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.4 p -47.18 -41.45 18.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 0.0 109.253 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 3.5 mmp_? -79.9 -41.14 26.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.432 1.111 . . . . 0.0 109.142 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.593 HG21 ' CZ ' ' A' ' 185' ' ' TYR . 55.1 t -67.71 -60.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.16 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.46 ' HB3' HG23 ' A' ' 248' ' ' VAL . 1.9 pp0? -56.2 -34.78 66.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.755 -1.216 . . . . 0.0 108.651 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -70.66 -44.8 66.31 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.315 -0.866 . . . . 0.0 109.329 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -67.76 -36.91 81.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.182 -0.949 . . . . 0.0 110.662 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.575 HD13 HG12 ' A' ' 251' ' ' ILE . 76.6 mt -55.67 -54.73 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 109.921 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.546 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 11.1 mtmt -81.07 -33.87 33.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 111.597 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 84.9 mt-10 -74.09 -66.97 0.65 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.48 -1.388 . . . . 0.0 112.628 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -81.63 -31.78 32.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.923 -1.111 . . . . 0.0 111.727 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.618 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 22.4 m-85 -102.57 -8.17 21.22 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.64 -1.287 . . . . 0.0 110.382 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.534 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 53.74 38.45 59.29 Favored Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.137 -0.977 . . . . 0.0 112.212 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.24 162.8 9.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.3 -1.706 . . . . 0.0 107.677 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 35.8 t-20 -47.11 143.87 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 109.586 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 155' ' ' GLN . 11.3 mm-40 -53.58 -19.97 4.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.492 -0.755 . . . . 0.0 109.009 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 154' ' ' ASN . 3.7 p -53.99 -16.63 2.01 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.812 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.546 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 41.0 t -61.34 127.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.911 -1.118 . . . . 0.0 109.552 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.585 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 18.7 p-80 -149.08 158.76 44.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.375 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 3.8 tt0 -102.78 149.22 24.69 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.583 HD11 ' CH2' ' A' ' 170' ' ' TRP . 14.8 pt -127.87 146.79 32.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.8 m-80 -112.36 102.98 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.131 . . . . 0.0 111.125 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.21 -28.41 3.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.83 . . . . 0.0 109.049 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.523 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.54 -27.69 73.31 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -103.85 4.72 35.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.1 -1.235 . . . . 0.0 111.6 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.08 171.04 8.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.404 -1.435 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 167' ' ' LYS . 84.1 p -103.94 134.56 47.02 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 166' ' ' SER . 54.7 tttt -30.57 -45.08 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.923 -0.485 . . . . 0.0 111.077 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -63.3 -66.04 0.6 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.185 . . . . 0.0 109.851 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -16.01 58.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 109.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.657 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 45.8 t-105 -72.18 -49.34 36.39 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.153 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 175' ' ' ASP . 18.8 mt-10 -67.6 -33.7 75.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.7 -48.01 20.32 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -61.01 -38.47 86.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.555 HG23 ' CD1' ' A' ' 199' ' ' ILE . 53.3 mt -75.92 -63.86 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 110.425 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -49.28 -53.89 19.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -51.92 -40.2 60.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 108.112 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.552 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.0 mm-40 -61.11 -50.26 73.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.535 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.2 mt -68.61 -25.78 65.03 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.484 -0.76 . . . . 0.0 109.7 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 37.0 p -51.85 -38.0 54.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 108.26 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 23.4 mt-30 -101.09 33.87 2.71 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.526 ' CB ' HD21 ' A' ' 7' ' ' LEU . 2.0 m-80 45.97 50.66 11.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 15.0 mt-30 -124.07 107.14 30.7 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.49 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -64.19 170.06 9.79 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.145 1.897 . . . . 0.0 112.667 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 51.6 t -123.67 135.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.614 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.593 ' CZ ' HG21 ' A' ' 143' ' ' VAL . 1.2 t80 -83.42 117.95 23.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 4.1 t80 -123.19 153.41 40.12 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 120.845 -1.16 . . . . 0.0 109.705 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.609 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.9 pt20 -164.81 135.5 4.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.328 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.92 114.98 4.66 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 107.239 -2.345 . . . . 0.0 107.239 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 41.5 t -80.96 145.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.255 . . . . 0.0 111.349 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 189' ' ' VAL . . . -145.9 -145.75 4.3 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -87.95 -29.77 20.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -1.162 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.2 m -82.9 -13.07 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.8 -166.13 25.18 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -97.91 110.89 4.12 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 119.038 -1.553 . . . . 0.0 110.735 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.33 117.37 12.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.551 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.99 160.92 15.41 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.373 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 46.7 p90 -159.09 166.5 31.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 55' ' ' ILE . 94.8 t -114.11 136.11 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.696 -1.253 . . . . 0.0 112.036 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 7.4 mt -98.71 125.79 52.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.596 ' OD2' ' CD2' ' A' ' 209' ' ' HIS . 1.5 p30 -139.92 32.33 1.99 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.716 -1.594 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -167.03 173.45 42.29 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 117.862 -2.113 . . . . 0.0 111.719 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.497 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -160.92 149.28 16.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -122.46 31.66 6.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.711 -1.243 . . . . 0.0 110.45 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 44.33 25.38 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 2.2 mtt180 -142.26 21.79 2.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.227 -1.16 . . . . 0.0 108.95 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.9 OUTLIER 77.88 23.51 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.221 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 29.7 m-85 -122.72 128.45 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.928 . . . . 0.0 109.356 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.3 m-85 -122.94 171.6 9.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.299 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.596 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.4 t60 -93.64 136.39 33.96 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 212' ' ' TRP . 51.2 t -128.62 137.32 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.052 -1.03 . . . . 0.0 110.414 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.5 t-20 -111.85 73.13 0.8 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.578 ' CE2' HG12 ' A' ' 210' ' ' VAL . 82.3 m95 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.459 -0.776 . . . . 0.0 110.179 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 1.4 pt20 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.511 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 15.1 p -166.1 163.21 18.11 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -142.08 167.15 22.81 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.942 0.877 . . . . 0.0 109.925 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.588 HG21 HG12 ' A' ' 143' ' ' VAL . 15.5 t -118.0 120.77 65.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.585 ' CG2' ' NE2' ' A' ' 158' ' ' HIS . 33.4 m -120.69 149.75 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.95 -1.094 . . . . 0.0 111.282 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 86.03 46.92 5.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.616 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.1 mt -93.57 93.98 4.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.406 -1.055 . . . . 0.0 109.761 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.07 148.67 9.71 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.44 -0.788 . . . . 0.0 108.946 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.606 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.389 2.06 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.8 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -76.14 -166.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 108.908 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.572 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 2.7 t -87.89 106.11 17.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.873 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.672 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 46.6 mt -58.49 -50.11 74.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 108.906 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.93 -38.02 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.66 -1.275 . . . . 0.0 108.858 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 43.9 m-20 -67.25 -43.48 81.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.796 . . . . 0.0 109.774 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 3.7 p -58.24 -14.44 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.048 . . . . 0.0 109.317 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.5 mtpm? -117.15 17.9 14.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.793 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.26 41.44 6.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.509 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 48.2 mt -91.11 108.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 122.247 1.022 . . . . 0.0 110.526 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 8.5 m-70 -134.83 81.25 1.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 116' ' ' ILE . 9.6 m-30 -87.11 179.99 6.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 111.152 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.74 -162.61 1.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 17.5 mt-30 -125.36 -21.93 4.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.721 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.06 -33.87 1.59 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.604 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.6 -139.68 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.512 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.064 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -74.24 2.99 5.58 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 CA-C-N 122.554 1.948 . . . . 0.0 109.269 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.7 m-85 -77.91 -31.59 51.25 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.404 -0.81 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 23.8 p-10 -93.88 14.35 19.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.632 -1.293 . . . . 0.0 109.746 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.4 -7.83 46.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.738 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 118' ' ' GLU . 11.3 mt -123.74 -9.35 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.092 -1.005 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.0 p -60.85 165.31 6.1 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.2 Cg_endo -70.48 143.02 46.2 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.357 2.038 . . . . 0.0 112.184 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.23 148.12 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.559 0.695 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.668 HD13 ' HD3' ' A' ' 133' ' ' PRO . 23.9 mt -78.51 148.05 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 111.173 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 39' ' ' VAL . 3.9 mt-10 -126.4 -21.5 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.732 -0.605 . . . . 0.0 110.659 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' PRO . 9.0 mtpm? -118.82 168.39 10.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.859 -1.15 . . . . 0.0 110.284 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 37' ' ' SER . 74.9 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.557 -0.715 . . . . 0.0 110.69 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.442 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 82.5 m-85 -123.61 14.71 9.47 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.899 -1.126 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 28' ' ' ILE . 61.0 t -62.99 141.89 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.189 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 1.38 87.39 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -91.97 132.14 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -1.096 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -73.2 111.89 8.74 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.21 160.61 0.75 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 109.003 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.76 166.93 22.34 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.616 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.547 HG22 ' SD ' ' A' ' 120' ' ' MET . 29.5 p -79.67 -35.56 39.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.6 139.02 9.53 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 51' ' ' ALA . 5.6 p -55.17 -49.75 71.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 127' ' ' VAL . 3.9 t -47.02 -52.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -64.77 -47.38 78.39 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.847 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 96.1 m -62.6 -30.2 71.17 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.97 -47.22 69.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.968 -1.083 . . . . 0.0 108.822 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.577 ' OG1' HG23 ' A' ' 143' ' ' VAL . 30.8 m -75.6 -49.82 17.39 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.409 0.623 . . . . 0.0 110.277 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.6 -34.55 37.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 109.078 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.593 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -67.71 -48.93 65.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 198' ' ' VAL . 36.0 mt -66.79 -28.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.601 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 19.3 mtp -67.13 -39.58 86.62 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.563 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -71.89 -39.48 69.56 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.672 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 56.9 t80 -53.44 -34.43 57.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.493 -0.754 . . . . 0.0 109.346 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 83.8 m-70 -107.75 -20.45 13.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.36 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.641 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.55 54.63 1.89 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -74.64 -70.7 0.23 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.0 Cg_endo -69.67 103.81 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 122.269 0.615 . . . . 0.0 111.806 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' TYR . 7.6 m120 -70.09 -21.57 63.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -134.78 140.13 45.65 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.84 34.9 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.664 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.447 HD13 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -89.01 -44.3 10.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.62 -0.929 . . . . 0.0 110.387 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.4 tttt -151.61 137.86 18.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 164.94 7.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.0 110.219 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 26.1 t80 -148.94 141.35 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.264 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t -146.99 161.12 41.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.932 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.673 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 28.6 p90 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.656 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 85' ' ' ASN . 27.4 m -93.19 129.82 39.08 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' CB ' ' A' ' 77' ' ' ASN . 10.2 tp -47.67 150.58 0.99 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 111.28 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 t -62.15 140.67 58.42 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -3.82 11.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 0.0 109.868 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 52.6 t30 -99.28 -7.75 25.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.513 ' CB ' HD21 ' A' ' 73' ' ' LEU . 39.6 t-20 -70.37 111.58 9.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 109.971 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.623 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.3 Cg_endo -88.54 13.11 2.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.982 2.454 . . . . 0.0 110.094 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.4 m-85 -104.94 -5.0 21.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 111.139 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 5.5 m-85 -142.22 162.0 36.58 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.564 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 4.8 m120 -46.67 -79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.79 -46.8 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 111.047 175.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.88 57.34 5.67 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 N-CA-C 107.012 -1.957 . . . . 0.0 107.012 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.51 101.59 11.11 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.294 -178.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' OG1' ' A' ' 72' ' ' THR . 37.3 m-80 -100.11 128.87 46.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.756 . . . . 0.0 109.466 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -100.75 134.5 43.63 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.77 129.63 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.81 111.37 23.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 51.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 108.304 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.4 mt -52.77 -54.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.384 -0.822 . . . . 0.0 110.027 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.1 p -44.59 -27.61 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.242 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -111.97 34.36 4.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -0.83 . . . . 0.0 109.177 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.643 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.05 90.31 3.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.4 m-85 -81.31 88.08 6.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 47.3 t-20 -79.4 87.79 5.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.641 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.0 m95 -60.98 -7.04 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -89.43 -18.76 26.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -100.08 -26.48 13.94 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.641 HD12 ' CE3' ' A' ' 97' ' ' TRP . 51.9 mt -76.53 67.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 108.903 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 18.9 mt -46.84 149.42 1.53 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.775 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.522 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.7 Cg_endo -78.99 -18.11 11.63 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.903 2.402 . . . . 0.0 110.725 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 133.3 25.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.995 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.565 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 62.1 m-85 -121.49 136.75 54.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.258 -0.901 . . . . 0.0 109.845 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -99.94 0.91 42.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA2' ' NZ ' ' A' ' 113' ' ' LYS . . . 81.15 -1.76 83.81 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.533 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -110.46 -6.88 14.83 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.423 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.86 164.66 9.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 109.755 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -62.1 172.74 1.31 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 17.3 m-20 -77.03 -31.26 56.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.623 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.2 -60.17 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.467 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 5.2 mp0 -62.76 -35.04 78.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.785 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 33.6 mttt -65.27 -42.34 93.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.469 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 12.2 ttm -59.15 -37.81 78.2 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.33 -68.1 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.672 -0.643 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.617 HD13 ' CE2' ' A' ' 15' ' ' TYR . 3.1 tp -62.37 -37.48 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.633 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.527 ' N ' HG23 ' A' ' 116' ' ' ILE . 14.2 p -57.18 -40.44 77.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.921 -1.112 . . . . 0.0 109.95 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 35.3 tt0 -69.4 -41.57 76.26 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.479 HD22 ' CD1' ' A' ' 116' ' ' ILE . 9.3 tp -54.65 -52.69 61.52 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.553 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.3 mmt -58.68 -43.93 90.1 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.5 -0.75 . . . . 0.0 109.292 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.48 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.09 -36.69 84.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 93' ' ' ARG . 27.8 m-20 -69.6 -54.61 13.2 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 49' ' ' ALA . 48.4 t -63.38 -57.78 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.19 -49.84 13.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.0 mt -63.9 -58.8 5.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 108.276 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.25 -29.23 1.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.517 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.8 HG13 HG22 ' A' ' 143' ' ' VAL . 20.9 m -101.42 36.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.895 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 127' ' ' VAL . 3.3 m-20 37.81 51.93 1.39 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.466 -0.771 . . . . 0.0 109.407 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.7 tpp -66.04 126.92 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.53 -0.731 . . . . 0.0 111.741 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -75.77 120.66 21.44 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 57.3 m-85 -102.83 115.67 31.05 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.279 1.038 . . . . 0.0 112.719 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.513 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.92 -162.88 10.95 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 104.869 -3.292 . . . . 0.0 104.869 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.668 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.39 -30.56 80.72 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 N-CA-C 105.802 -2.422 . . . . 0.0 105.802 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.99 140.76 43.65 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.527 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 32.7 m -124.26 109.66 13.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.843 -1.786 . . . . 0.0 110.286 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -108.88 144.72 16.42 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.648 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.54 -163.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -1.219 . . . . 0.0 107.765 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.566 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.75 -53.97 4.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.533 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 134.18 -139.02 10.51 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 119.145 -1.502 . . . . 0.0 111.981 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.463 ' HB2' ' CD ' ' A' ' 159' ' ' GLN . 0.7 OUTLIER -48.06 -54.37 13.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.139 -0.624 . . . . 0.0 112.237 -177.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 p -46.53 -41.25 13.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.926 -1.109 . . . . 0.0 109.7 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.587 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.3 mmt180 -81.15 -42.63 20.58 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 109.585 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.8 HG22 HG13 ' A' ' 127' ' ' VAL . 44.3 t -68.14 -52.79 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 110.463 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.452 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.8 pp0? -56.9 -34.36 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.554 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 2.4 ttm180 -77.35 -51.8 10.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 109.197 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -61.2 -34.75 75.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 143' ' ' VAL . 46.0 mt -56.92 -50.57 72.17 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.099 -1.0 . . . . 0.0 109.652 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.557 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 4.5 mtmp? -87.65 -41.12 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.017 -1.052 . . . . 0.0 110.589 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 85.1 mt-10 -68.08 -49.1 63.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.919 -1.113 . . . . 0.0 111.727 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -93.94 -43.19 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.907 -1.121 . . . . 0.0 111.652 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.5 m-85 -102.27 15.49 28.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.658 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 35.08 40.22 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.626 -0.671 . . . . 0.0 112.581 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.2 m-85 -62.53 164.06 8.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.062 -1.846 . . . . 0.0 107.853 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.5 t-20 -47.37 145.1 2.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.174 . . . . 0.0 109.617 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -53.43 -19.96 4.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.909 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.537 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 7.8 p -55.72 -14.5 2.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.331 -0.856 . . . . 0.0 109.739 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 4.1 t -66.4 119.85 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.938 -1.101 . . . . 0.0 109.65 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' HG22 ' A' ' 249' ' ' VAL . 3.6 p-80 -148.55 163.17 38.02 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.463 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 2.0 tt0 -104.07 146.36 28.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.617 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.58 ' CG1' ' HB1' ' A' ' 247' ' ' ALA . 4.3 pt -121.93 155.17 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.2 m-80 -123.29 105.73 10.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.814 -1.179 . . . . 0.0 111.041 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 44.4 tpt85 -48.14 -38.9 19.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 109.012 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.54 -25.83 63.69 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.03 -1.03 28.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.064 -1.256 . . . . 0.0 111.273 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.04 173.92 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.785 -1.197 . . . . 0.0 110.027 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 167' ' ' LYS . 83.8 p -98.53 138.71 35.34 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 166' ' ' SER . 35.5 tttt -35.22 -48.43 0.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.766 -0.584 . . . . 0.0 110.361 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.404 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 7.5 mp0 -65.4 -59.23 4.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.049 -1.032 . . . . 0.0 109.854 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.52 -15.59 58.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.988 . . . . 0.0 109.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CH2' ' N ' ' A' ' 162' ' ' ARG . 61.0 t-105 -73.66 -47.78 37.26 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.492 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 29.2 mt-10 -70.76 -30.98 67.63 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.24 65.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 15.8 mm100 -61.26 -41.19 96.49 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.538 ' CG2' HG23 ' A' ' 184' ' ' VAL . 22.3 mt -74.03 -51.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.553 -0.717 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.455 ' OD2' ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -55.97 -41.98 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 108.626 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -51.97 -43.29 63.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.583 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 51.9 mm-40 -59.72 -51.94 67.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.548 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.94 -25.61 64.65 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.828 . . . . 0.0 110.044 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.5 p -52.05 -38.12 55.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.468 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 25.0 mt-30 -101.55 29.52 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.45 ' C ' HD11 ' A' ' 7' ' ' LEU . 8.1 m-20 51.15 49.18 21.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.72 0.771 . . . . 0.0 109.165 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 27.8 mt-30 -124.34 117.08 26.77 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.554 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.8 Cg_endo -65.67 171.4 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.21 1.94 . . . . 0.0 112.328 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.538 HG23 ' CG2' ' A' ' 174' ' ' ILE . 23.4 t -125.98 115.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.367 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.558 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -66.27 113.27 4.46 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.9 t80 -123.77 157.39 34.13 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 120.891 -1.13 . . . . 0.0 109.658 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.1 pt20 -158.93 129.84 6.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 117.927 -1.509 . . . . 0.0 111.804 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.466 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.17 109.71 3.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 3.6 t -66.8 166.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -1.179 . . . . 0.0 111.099 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.594 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -175.21 -136.78 2.35 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -87.81 -55.85 3.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.24 . . . . 0.0 111.357 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.15 -8.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.057 -1.027 . . . . 0.0 111.47 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.45 21.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -91.25 107.57 3.5 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.0 t-80 -71.66 126.19 29.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.539 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -118.92 159.07 24.47 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.533 1.159 . . . . 0.0 112.723 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 43.2 p90 -153.58 -161.05 1.19 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 55' ' ' ILE . 85.9 t -139.34 133.27 38.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 120.362 -1.461 . . . . 0.0 111.377 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 82.8 mt -99.14 120.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 3.1 p30 -133.24 33.47 3.61 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.439 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.23 163.92 35.62 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 117.706 -2.188 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.527 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.28 140.9 29.47 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -111.31 11.18 21.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.103 . . . . 0.0 110.567 -178.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.64 4.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -80.57 53.54 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 109.884 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.476 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 2.0 m120 53.09 38.54 27.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.783 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.503 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 1.2 m-85 -121.92 133.92 54.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 12.9 m-85 -122.91 159.77 27.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.07 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.572 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 39.4 t-80 -93.22 117.78 30.48 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.489 HG11 ' N ' ' A' ' 211' ' ' ASN . 29.1 t -114.55 138.64 43.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 111.447 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.51 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 19.4 t-20 -104.62 80.56 1.68 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 23.0 m95 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -178.876 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 1.5 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 72.6 p -136.05 164.82 27.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.712 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.91 161.7 37.2 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.552 ' CG2' ' CD1' ' A' ' 185' ' ' TYR . 39.1 t -116.15 113.67 43.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 158' ' ' HIS . 13.9 m -112.55 142.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.941 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.42 ' N ' ' OE1' ' A' ' 177' ' ' GLU . . . 90.65 54.77 2.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.616 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 38.5 mt -102.75 89.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 110.225 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 2.2 pptp? -162.89 151.76 12.41 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 0.0 109.03 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.593 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.335 2.023 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.7 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -76.19 -178.6 4.56 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.496 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 17.5 t -78.13 106.2 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.896 -1.128 . . . . 0.0 109.312 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.677 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.8 mt -56.69 -48.44 77.64 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 13.7 mt -55.01 -42.25 72.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 108.386 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 2.1 t0 -67.19 -40.87 86.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.133 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 p -58.11 -15.7 10.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.998 -1.064 . . . . 0.0 108.772 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 2.0 mtpp -116.9 16.96 15.15 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 46.85 39.22 10.9 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.505 HG13 ' HB2' ' A' ' 11' ' ' LYS . 27.8 mt -91.34 110.67 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -1.037 . . . . 0.0 110.519 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.0 m80 -134.7 83.05 2.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.608 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.2 m-30 -89.49 179.28 6.09 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.141 0.972 . . . . 0.0 110.991 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -147.89 -163.24 1.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.486 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 37.3 mt-30 -124.95 -21.21 4.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.978 -1.076 . . . . 0.0 110.572 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.31 -35.09 1.36 Allowed Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.522 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -138.06 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.527 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.202 -178.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.1 Cg_endo -75.08 4.46 4.75 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 CA-C-N 122.688 1.996 . . . . 0.0 109.589 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 8.9 m-85 -80.42 -34.1 36.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 29.9 p-10 -88.79 15.65 8.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.536 -1.352 . . . . 0.0 109.177 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 20' ' ' PRO . 6.1 mt -70.17 -5.96 30.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.104 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.523 HD13 ' CA ' ' A' ' 118' ' ' GLU . 14.1 mt -128.57 -5.81 5.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 109.934 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -61.24 164.57 8.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.614 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.1 Cg_endo -69.59 136.36 33.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.231 1.954 . . . . 0.0 112.251 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 ' CG1' ' HA2' ' A' ' 40' ' ' GLY . 38.8 t -76.01 148.19 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.538 0.685 . . . . 0.0 109.924 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.656 HD13 ' HD3' ' A' ' 133' ' ' PRO . 13.7 mt -78.19 150.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.836 0.827 . . . . 0.0 111.122 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 39' ' ' VAL . 3.3 mt-10 -125.06 -23.15 4.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.704 -0.623 . . . . 0.0 110.152 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.0 mtpt -120.75 165.91 14.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 37' ' ' SER . 86.0 t . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 110.588 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.497 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 74.4 m-85 -118.52 12.93 13.36 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.995 -1.066 . . . . 0.0 109.156 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 28' ' ' ILE . 78.0 t -62.86 138.94 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.445 ' HA2' ' CG1' ' A' ' 27' ' ' VAL . . . 79.89 1.62 87.53 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 11.8 mt-30 -89.39 134.06 34.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.33 111.18 8.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.29 161.08 0.69 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.974 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.68 167.23 21.91 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.661 -0.649 . . . . 0.0 109.515 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.556 HG22 ' SD ' ' A' ' 120' ' ' MET . 30.5 p -80.48 -33.77 36.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.112 -0.993 . . . . 0.0 108.495 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 102.86 138.22 9.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.0 p -55.21 -48.66 73.55 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 127' ' ' VAL . 3.7 t -47.11 -52.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -64.41 -47.86 77.56 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.088 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.498 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 54.8 m -62.86 -29.47 70.78 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.569 -0.707 . . . . 0.0 109.157 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.91 -47.09 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.751 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.54 ' OG1' HG23 ' A' ' 143' ' ' VAL . 35.4 m -75.72 -48.88 20.05 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.441 0.639 . . . . 0.0 110.255 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.65 -33.96 35.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.513 -0.742 . . . . 0.0 109.085 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.608 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 28.7 mt-30 -68.31 -50.38 53.91 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 HG13 HG22 ' A' ' 198' ' ' VAL . 33.7 mt -65.0 -23.99 34.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.526 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 18.1 mtp -72.56 -36.23 68.17 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.551 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 42.4 tptt -71.5 -44.42 64.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.677 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.9 t80 -53.38 -30.58 40.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.24 0.543 . . . . 0.0 109.739 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 61.0 m-70 -107.81 -23.62 12.0 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.625 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.662 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.23 58.92 1.81 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -77.96 -76.82 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.375 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.3 Cg_endo -71.19 108.59 2.37 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 CA-C-N 119.41 0.825 . . . . 0.0 113.225 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.76 -26.99 67.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 103.819 -2.659 . . . . 0.0 103.819 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 18.9 tttt -129.58 130.35 45.58 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.93 167.46 4.35 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.396 -1.859 . . . . 0.0 110.904 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.541 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.11 -38.64 10.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.537 -0.978 . . . . 0.0 111.301 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 73.4 tttt -152.67 132.49 13.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.677 -1.265 . . . . 0.0 110.7 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 3.0 m-20 -60.42 168.29 2.17 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.368 -0.832 . . . . 0.0 109.495 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 35.8 t80 -151.97 141.81 21.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 109.724 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.0 t -144.39 153.51 42.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 109.271 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.683 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 28.1 p90 -152.88 156.7 39.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.44 HG23 ' CG ' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -92.9 127.19 38.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 77' ' ' ASN . 10.5 tp -44.81 150.36 0.37 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 111.205 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -61.99 142.89 57.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.862 -0.524 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 p -70.06 -2.1 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.013 -1.054 . . . . 0.0 109.816 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 16.0 t-20 -99.83 -8.18 24.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.146 -0.971 . . . . 0.0 109.666 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.501 ' CB ' HD21 ' A' ' 73' ' ' LEU . 37.8 t-20 -70.23 112.09 11.51 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.592 -0.693 . . . . 0.0 110.021 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.0 Cg_endo -86.94 9.03 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.042 2.494 . . . . 0.0 110.589 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 58.2 m-85 -104.83 -14.04 15.65 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.106 -0.997 . . . . 0.0 111.5 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 53.2 m-85 -128.18 159.57 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.7 m-80 -46.9 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.47 -48.31 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.966 175.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.58 57.72 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.91 104.98 14.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.487 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.44 ' CG ' HG23 ' A' ' 72' ' ' THR . 2.4 m-80 -100.42 132.23 45.92 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.337 -0.852 . . . . 0.0 109.882 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.683 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -105.86 143.26 34.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -130.91 128.84 41.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.923 -1.11 . . . . 0.0 110.537 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -111.12 112.16 23.76 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.89 53.84 0.48 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.673 -1.267 . . . . 0.0 108.102 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.637 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.3 mt -52.98 -56.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.726 -0.609 . . . . 0.0 111.332 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -43.83 -29.73 0.58 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.703 -1.248 . . . . 0.0 109.456 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -112.93 33.04 5.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.391 179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.637 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 32.7 mmt-85 -82.29 158.12 23.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.736 -1.228 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -116.1 81.73 1.66 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.3 m-85 -81.49 89.9 6.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.581 -0.699 . . . . 0.0 110.198 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.5 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.5 t30 -78.76 90.83 4.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.662 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 63.8 m95 -60.09 -8.16 2.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.75 -18.12 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 46.1 m-20 -99.72 -31.27 11.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' CE3' ' A' ' 97' ' ' TRP . 24.0 mt -73.83 66.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.538 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 24.9 mt -45.79 149.16 1.18 Allowed Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.546 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -78.24 -23.04 9.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.635 2.223 . . . . 0.0 110.441 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -137.57 130.3 30.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.02 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 86.3 m-85 -116.82 144.29 44.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.042 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.2 p -100.53 -16.62 17.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.49 -2.72 57.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -120.19 7.22 10.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -1.227 . . . . 0.0 109.523 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.23 177.31 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.905 . . . . 0.0 109.486 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.452 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 1.3 p -69.33 170.85 9.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.77 -38.53 53.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.9 t -51.44 -56.75 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.452 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -62.46 -40.48 96.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.082 -1.012 . . . . 0.0 109.214 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.506 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.6 mttt -62.53 -39.03 92.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.455 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.0 ttm -59.91 -43.37 94.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.475 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -58.58 -52.05 67.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.619 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.6 tp -69.45 -39.2 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.391 -1.443 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.7 p -57.55 -41.74 81.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.079 -1.013 . . . . 0.0 110.454 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.523 ' CA ' HD13 ' A' ' 24' ' ' LEU . 20.6 tt0 -68.76 -38.9 80.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.991 -1.068 . . . . 0.0 108.18 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 53' ' ' ALA . 6.0 tp -56.41 -51.04 69.85 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.556 ' SD ' HG22 ' A' ' 45' ' ' THR . 1.6 mmt -59.69 -44.95 93.44 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 108.999 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.48 -36.28 83.66 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.537 ' OD2' ' CD ' ' A' ' 93' ' ' ARG . 18.5 m-20 -69.41 -52.43 27.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 49' ' ' ALA . 58.6 t -65.89 -57.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.146 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.16 -49.09 14.7 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.01 -58.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.287 -1.125 . . . . 0.0 108.264 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -47.1 -30.2 2.64 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.571 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.831 HG13 HG22 ' A' ' 143' ' ' VAL . 19.2 m -101.08 37.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 0.0 109.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.1 m-20 37.48 51.44 1.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.476 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 57.8 tpp -65.64 125.61 25.79 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 111.545 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.9 t0 -75.86 121.27 22.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.614 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.0 117.68 35.14 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.519 1.152 . . . . 0.0 113.206 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.512 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.64 -164.2 12.01 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 104.659 -3.377 . . . . 0.0 104.659 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.656 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.24 -29.09 79.8 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.44 141.81 43.02 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.519 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 43.4 m -125.33 110.94 14.6 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 119.882 -1.761 . . . . 0.0 110.533 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.92 144.42 16.4 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.7 t -118.17 -163.99 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.111 -1.229 . . . . 0.0 107.719 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.58 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.09 -55.99 3.33 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 135.0 -137.68 9.43 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 119.313 -1.422 . . . . 0.0 111.623 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 2.8 m -48.7 -50.22 34.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.812 -0.816 . . . . 0.0 112.408 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' SER . 57.2 p -45.36 -47.28 13.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 0.0 109.842 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.604 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 17.3 mmt180 -81.41 -38.27 26.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 110.195 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 127' ' ' VAL . 54.1 t -67.67 -53.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.017 . . . . 0.0 110.503 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.477 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.7 pp0? -56.95 -34.82 68.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.896 -1.127 . . . . 0.0 108.389 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -77.38 -52.73 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.581 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -58.52 -34.29 70.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.44 ' HB2' HG13 ' A' ' 157' ' ' VAL . 57.2 mt -59.85 -49.45 77.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.274 -0.891 . . . . 0.0 109.742 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 6.0 mtmt -87.34 -42.74 12.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.891 -1.13 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 32.8 mt-10 -69.31 -51.98 31.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.898 -1.126 . . . . 0.0 112.436 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 21.9 m120 -88.17 -50.47 6.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.725 -1.234 . . . . 0.0 111.986 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 49.9 m-85 -90.04 -16.47 29.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.748 -1.22 . . . . 0.0 110.489 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 68.1 37.8 87.57 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.916 -1.115 . . . . 0.0 111.791 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.9 m-85 -63.04 165.92 6.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.335 -1.686 . . . . 0.0 107.757 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 37.6 t-20 -47.15 143.82 2.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.803 -1.186 . . . . 0.0 109.104 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 11.4 mm100 -53.15 -20.05 3.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 108.983 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.506 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.6 p -55.04 -15.04 1.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 4.1 t -63.57 120.23 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.864 -1.147 . . . . 0.0 109.45 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.644 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 12.0 p-80 -148.12 160.22 43.12 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.1 tt0 -102.48 152.33 21.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.643 ' CD1' ' CH2' ' A' ' 170' ' ' TRP . 3.3 pt -131.48 138.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m-80 -106.18 103.32 12.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.591 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 1.8 tpt180 -47.66 -29.77 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 108.978 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.92 -22.8 65.01 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.68 -2.87 25.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.241 . . . . 0.0 111.402 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -117.84 177.67 4.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.558 -1.339 . . . . 0.0 110.27 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 170' ' ' TRP . 42.3 p -109.06 147.38 32.47 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' SER . 5.1 ttmm -40.44 -44.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 110.136 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.844 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.37 -15.92 63.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.643 ' CH2' ' CD1' ' A' ' 160' ' ' ILE . 40.5 t-105 -75.11 -38.71 61.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.457 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 42.3 mt-10 -71.24 -34.69 71.0 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.24 -0.912 . . . . 0.0 108.769 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 176' ' ' LYS . . . -55.22 -47.3 75.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.86 . . . . 0.0 109.061 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 25.8 mm100 -61.25 -43.5 98.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.045 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.488 HG21 HG23 ' A' ' 184' ' ' VAL . 12.0 mt -75.39 -60.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 111.435 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -49.5 -43.4 45.4 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.496 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 172' ' ' ALA . 9.6 tttt -52.21 -44.67 64.88 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.578 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 42.6 mm-40 -58.93 -54.55 45.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.544 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.9 mt -66.25 -26.37 67.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' ASP . 45.0 p -51.9 -43.83 63.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.476 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 25.2 mt-30 -94.89 32.05 1.73 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.446 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 19.6 m-20 49.65 50.59 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 12.6 mt-30 -124.16 114.5 27.73 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.545 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.1 Cg_endo -66.25 171.13 10.79 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.136 1.89 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 21.2 t -126.91 115.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.775 -0.578 . . . . 0.0 111.007 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.551 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -65.11 112.11 3.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 176.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 5.2 t80 -123.46 155.77 36.83 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.013 -1.054 . . . . 0.0 109.449 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.36 128.66 3.56 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.21 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 245' ' ' GLN . . . -92.19 101.01 2.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 50.8 t -67.13 164.13 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 110.988 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.539 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -167.44 -130.54 1.18 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -87.72 -51.64 5.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -1.214 . . . . 0.0 111.103 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 193' ' ' GLY . 3.8 m -65.35 -18.19 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 111.776 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 192' ' ' VAL . . . 138.09 -158.9 24.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -87.6 106.82 3.23 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.916 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 9.3 t-80 -71.83 119.37 15.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -112.94 160.14 18.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.492 -1.283 . . . . 0.0 112.837 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.642 ' CD1' ' CZ3' ' A' ' 212' ' ' TRP . 54.3 p90 -161.54 173.46 14.77 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 55' ' ' ILE . 94.8 t -116.59 134.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.558 -1.339 . . . . 0.0 111.582 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 96.7 mt -102.7 109.1 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -124.0 33.28 5.33 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.306 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.22 164.92 37.97 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 117.512 -2.28 . . . . 0.0 112.675 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.514 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.91 147.63 34.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -112.45 7.46 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.833 -1.167 . . . . 0.0 110.146 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.87 -46.23 3.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -85.55 44.88 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -1.179 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER 65.34 31.06 10.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.128 -0.982 . . . . 0.0 109.982 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.538 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 3.6 m-85 -117.93 135.26 54.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.087 -1.008 . . . . 0.0 109.126 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 38.8 m-85 -123.41 162.96 21.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.8 t60 -91.97 137.54 32.28 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.598 HG13 ' CD2' ' A' ' 197' ' ' PHE . 23.9 t -129.46 138.18 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.626 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -109.25 72.59 0.81 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.642 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 81.4 m95 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 110.26 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.497 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 13.3 pt20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.513 0.673 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 60.1 p -145.72 170.92 15.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.25 161.92 34.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.672 0.749 . . . . 0.0 109.102 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.545 ' CG2' ' CD1' ' A' ' 185' ' ' TYR . 22.8 t -116.3 112.36 39.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 13.6 m -110.64 143.63 20.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.036 -175.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 88.06 46.35 4.79 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 29.3 mt -92.7 94.01 4.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.392 -1.064 . . . . 0.0 109.812 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 9.0 ptmt -160.87 149.08 12.86 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.594 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.6 Cg_endo . . . . . 0 C--N 1.308 -1.553 0 C-N-CA 122.257 1.971 . . . . 0.0 110.452 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.517 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 44.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -76.39 -176.64 3.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.147 -0.971 . . . . 0.0 108.568 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.52 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 3.0 t -77.45 104.82 8.19 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.467 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.653 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 39.4 mt -57.76 -48.16 80.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 108.894 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 11.9 mt -55.63 -42.04 74.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 108.496 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 5.2 m-20 -67.65 -41.41 83.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.068 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -58.32 -14.66 7.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.9 mtpp -118.86 23.43 11.43 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 43.69 38.55 4.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 30.5 mt -90.07 109.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.412 1.101 . . . . 0.0 110.436 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 102' ' ' PRO . 8.7 m-70 -133.59 97.73 4.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CE2' HD13 ' A' ' 116' ' ' ILE . 3.8 m-30 -102.83 174.49 5.85 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.245 1.022 . . . . 0.0 111.614 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -147.01 -172.92 4.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 10.1 mt-30 -124.12 -8.94 7.66 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.828 -1.17 . . . . 0.0 110.036 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.713 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.16 -42.9 0.68 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.788 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.1 -139.98 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.563 0 CA-C-O 118.387 -0.816 . . . . 0.0 111.381 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.788 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.6 Cg_endo -73.75 2.31 6.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 122.545 1.945 . . . . 0.0 109.249 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 48.4 m-85 -73.28 -35.87 66.22 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 34.6 p-10 -98.88 20.53 13.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.617 -1.302 . . . . 0.0 109.797 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -73.52 -2.1 21.31 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.924 . . . . 0.0 109.367 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -128.68 -5.78 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.925 . . . . 0.0 109.726 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 24.6 p -65.25 165.09 18.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.616 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.4 Cg_endo -70.61 139.24 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.108 1.872 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG11 ' N ' ' A' ' 28' ' ' ILE . 10.6 t -84.24 149.55 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.73 . . . . 0.0 110.039 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 79' ' ' TYR . 42.9 mt -78.02 144.2 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 110.351 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 28' ' ' ILE . 80.6 mt-10 -123.56 -23.2 4.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 110.115 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.2 mtpm? -118.83 164.01 16.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 37' ' ' SER . 42.2 t . . . . . 0 N--CA 1.487 1.415 0 O-C-N 121.216 -0.928 . . . . 0.0 111.27 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.114 0.483 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.578 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 70.8 m-85 -120.47 18.68 12.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.92 . . . . 0.0 108.92 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 31' ' ' VAL . 45.3 t -68.77 150.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.14 81.39 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mm-40 -91.43 129.24 37.44 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.339 -1.095 . . . . 0.0 109.738 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.29 112.7 9.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.27 157.4 1.42 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.176 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -76.6 171.63 14.33 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.398 0.618 . . . . 0.0 109.829 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HE2' ' A' ' 129' ' ' MET . 24.5 p -80.34 -36.14 34.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.112 -0.993 . . . . 0.0 108.353 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 107.11 135.63 7.92 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -54.1 -52.77 59.95 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -1.149 . . . . 0.0 108.002 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 64.4 t -45.96 -53.84 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.52 -51.88 67.56 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -63.3 -32.24 73.6 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.154 -178.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.3 -41.31 85.6 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.277 -1.369 . . . . 0.0 108.228 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' HG13 ' A' ' 143' ' ' VAL . 44.1 m -73.8 -54.26 8.43 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.004 0.907 . . . . 0.0 109.887 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -51.68 -39.27 57.95 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-30 -60.42 -48.75 80.39 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 HG22 ' A' ' 198' ' ' VAL . 39.1 mt -65.47 -24.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.604 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 36.6 mtp -73.42 -39.51 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 26.7 tptt -68.24 -41.82 80.63 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.69 -34.21 58.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.812 -0.555 . . . . 0.0 109.966 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.8 m-70 -106.92 -20.6 13.28 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.634 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.21 52.59 1.64 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -72.29 -69.01 0.37 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.546 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -70.25 105.79 1.63 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 120.328 0.686 . . . . 0.0 112.17 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -70.35 -22.05 62.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 13.1 tttp -134.19 144.07 48.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.84 141.62 44.73 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.43 -41.95 19.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 0.0 109.967 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 2.6 tttt -152.74 134.55 14.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.916 -1.115 . . . . 0.0 110.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.465 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.18 166.29 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.46 -0.775 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.504 ' CG ' ' HA ' ' A' ' 126' ' ' SER . 43.1 t80 -143.93 146.44 32.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 t -146.41 152.15 38.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.638 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 25.1 p90 -160.24 155.42 24.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.843 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 94.9 m -93.15 137.16 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 77' ' ' ASN . 10.1 tp -53.8 151.12 6.68 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 111.306 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -65.6 -6.51 11.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.038 -1.039 . . . . 0.0 109.727 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.516 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -95.56 -8.24 35.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.506 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 36.9 t-20 -69.74 109.82 5.37 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -88.52 15.51 2.06 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.929 2.419 . . . . 0.0 110.227 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.806 ' HB3' HG21 ' A' ' 28' ' ' ILE . 78.9 m-85 -108.14 -18.29 13.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.696 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.475 ' HB2' HD22 ' A' ' 73' ' ' LEU . 63.5 m-85 -123.69 161.28 25.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 16.7 m-80 -47.51 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 175.07 -47.13 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.337 -0.852 . . . . 0.0 110.947 174.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -77.15 56.25 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.74 104.73 14.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.506 -177.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.95 134.3 44.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 109.405 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.638 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.25 129.71 55.19 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.78 125.71 47.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.04 112.68 25.74 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 68' ' ' ASP . . . -73.67 51.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.053 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 37.0 mt -52.88 -49.86 46.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -44.97 -28.07 0.62 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.765 -1.209 . . . . 0.0 108.957 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 35.9 3.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 109.374 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.646 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -93.81 154.87 17.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.013 -1.054 . . . . 0.0 110.602 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.11 93.39 4.16 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-85 -81.56 91.37 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.692 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -79.8 87.31 5.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 61.2 m95 -61.67 -6.76 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.63 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.83 -21.22 22.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.751 -1.218 . . . . 0.0 108.032 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 21.8 m-20 -100.12 -26.85 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.619 HD12 ' CE3' ' A' ' 97' ' ' TRP . 64.1 mt -73.17 67.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 15.1 mt -46.85 149.2 1.58 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.8 -0.563 . . . . 0.0 110.19 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.529 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.3 Cg_endo -78.49 -17.9 12.55 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.965 2.443 . . . . 0.0 110.581 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 1.6 t -146.42 122.45 10.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 108.81 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.452 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 66.3 m-85 -109.48 140.37 43.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.135 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 p -102.81 -1.28 30.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.465 -0.772 . . . . 0.0 108.951 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.59 9.01 86.25 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.67 -10.35 9.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.336 -1.096 . . . . 0.0 109.428 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -64.03 161.0 16.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 171.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.418 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.442 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -74.41 -29.58 61.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.44 -61.38 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -62.5 -33.55 75.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 108.975 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 79.4 mttt -65.1 -44.18 89.66 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.468 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 34.9 ttm -59.41 -36.6 76.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -69.36 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.716 -0.615 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.592 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.4 tp -59.11 -40.37 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.867 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.534 ' N ' HG23 ' A' ' 116' ' ' ILE . 23.0 p -56.83 -41.76 78.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 0.0 110.423 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.525 ' N ' HD11 ' A' ' 24' ' ' LEU . 28.0 tt0 -69.37 -38.51 78.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.279 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tp -59.38 -55.46 34.45 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.604 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.4 mmt -57.45 -40.51 78.62 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.89 -41.52 91.42 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -65.25 -49.68 68.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' ALA . 76.3 t -65.95 -58.12 7.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.518 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.82 -50.5 14.83 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.9 mt -65.36 -54.47 28.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.219 -1.165 . . . . 0.0 108.256 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.504 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 65.0 p -46.48 -31.08 2.5 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.065 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.48 40.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.989 -1.069 . . . . 0.0 110.089 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 127' ' ' VAL . 0.7 OUTLIER 37.26 49.23 0.88 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.597 0.713 . . . . 0.0 109.745 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.547 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 46.7 tpp -66.02 129.02 38.35 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.532 -0.73 . . . . 0.0 111.564 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.2 t0 -76.9 123.14 25.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.616 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.8 m-85 -104.29 118.17 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.405 1.098 . . . . 0.0 113.113 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.524 ' CA ' HD13 ' A' ' 28' ' ' ILE . . . -150.94 -162.87 10.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 104.498 -3.441 . . . . 0.0 104.498 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.661 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.7 Cg_endo -62.31 -29.88 80.38 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 N-CA-C 105.755 -2.44 . . . . 0.0 105.755 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -110.14 137.78 47.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 59.8 m -116.79 107.62 14.86 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.015 -1.678 . . . . 0.0 109.702 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.73 137.08 13.84 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.562 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.8 t -117.33 -161.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.41 -55.46 3.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.564 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 131.83 -127.57 5.03 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.603 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.466 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 3.8 m -51.13 -56.74 11.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.681 -0.894 . . . . 0.0 111.692 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 24.5 p -47.64 -39.89 18.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.045 -1.035 . . . . 0.0 109.865 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.569 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 33.7 mmt-85 -79.05 -43.54 24.01 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.653 HG21 ' CE2' ' A' ' 185' ' ' TYR . 78.4 t -68.82 -55.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.415 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 140' ' ' SER . 2.6 pp0? -56.12 -31.75 63.59 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.084 -1.047 . . . . 0.0 108.577 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp85 -77.14 -49.64 14.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 126' ' ' SER . . . -63.51 -34.8 78.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.146 -0.971 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD12 HG11 ' A' ' 157' ' ' VAL . 51.5 mt -61.06 -48.19 82.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 110.46 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.495 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 47.7 mtmt -86.77 -43.67 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 111.222 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.8 mt-10 -76.21 -41.51 49.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 112.224 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 32.0 m120 -93.91 -44.27 8.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.584 -1.323 . . . . 0.0 111.66 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.604 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 39.4 m-85 -100.33 -2.45 33.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.79 -1.194 . . . . 0.0 110.476 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 52.94 37.72 53.8 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.286 -0.884 . . . . 0.0 112.449 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.426 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.4 m-85 -62.6 167.48 4.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.182 -1.775 . . . . 0.0 107.188 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.8 t-20 -47.82 140.14 6.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.628 -1.295 . . . . 0.0 109.089 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -53.2 -19.68 3.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.313 -0.867 . . . . 0.0 108.906 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.533 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 73.2 p -53.42 -17.2 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.302 -0.874 . . . . 0.0 109.829 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 42.7 t -62.92 122.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.705 -1.247 . . . . 0.0 108.947 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CD2' HG22 ' A' ' 249' ' ' VAL . 2.0 p-80 -146.75 153.38 40.16 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.119 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.466 ' OE1' ' HB2' ' A' ' 140' ' ' SER . 2.8 tt0 -101.32 148.29 25.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.57 HD11 ' CH2' ' A' ' 170' ' ' TRP . 6.5 pt -130.96 159.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -112.37 95.81 5.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.865 -1.147 . . . . 0.0 110.688 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.622 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 39.3 tpt85 -42.81 -27.97 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.395 -0.815 . . . . 0.0 109.083 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -62.39 -36.88 93.73 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.27 38.5 1.85 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.051 -1.264 . . . . 0.0 111.691 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.53 169.14 18.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.542 -1.349 . . . . 0.0 110.05 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -100.63 140.63 34.63 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 166' ' ' SER . 6.4 tttt -40.3 -46.25 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -63.54 -53.26 54.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 110.055 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.0 -26.25 68.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.622 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 69.4 t-105 -74.47 -35.72 63.3 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.132 -0.98 . . . . 0.0 109.911 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.455 ' OE2' ' OD1' ' A' ' 206' ' ' ASN . 45.8 mt-10 -72.22 -32.16 66.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.104 -0.998 . . . . 0.0 109.232 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.59 88.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.31 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.438 ' NE2' HG23 ' A' ' 249' ' ' VAL . 16.1 mm100 -64.78 -50.01 68.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.37 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.528 ' HA ' HG23 ' A' ' 184' ' ' VAL . 64.3 mt -71.84 -52.51 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 111.174 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -53.38 -43.06 67.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.108 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.422 ' HE2' ' NE2' ' A' ' 180' ' ' GLN . 7.4 tttt -51.97 -47.21 64.94 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.603 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 38.9 mm-40 -59.24 -52.67 64.67 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.505 ' HB3' HG11 ' A' ' 4' ' ' VAL . 20.7 mt -65.59 -28.3 69.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.445 -0.784 . . . . 0.0 110.149 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -52.51 -43.23 64.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 108.757 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.519 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 26.7 mt-30 -99.34 42.95 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.481 ' HB3' HD21 ' A' ' 7' ' ' LEU . 14.5 m-20 42.33 51.09 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.77 0.795 . . . . 0.0 108.913 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.519 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 5.1 mt-30 -124.15 109.52 29.37 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.527 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.1 Cg_endo -64.89 169.6 11.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.886 1.724 . . . . 0.0 111.944 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 62.1 t -127.03 131.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.804 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.653 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -80.97 121.34 25.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 177.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.595 ' CD2' HD13 ' A' ' 199' ' ' ILE . 4.7 t80 -123.29 164.68 18.31 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.962 -1.086 . . . . 0.0 109.673 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -165.63 124.5 1.65 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.19 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.16 108.06 3.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.512 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 40.0 t -71.1 164.38 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.313 . . . . 0.0 111.457 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -161.42 -142.67 3.45 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.411 -1.875 . . . . 0.0 108.411 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.64 -29.66 21.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -1.199 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 m -83.43 -11.74 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.042 -1.036 . . . . 0.0 111.381 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 -168.36 23.21 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -78.76 109.98 2.95 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.362 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.653 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -72.06 130.87 41.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.69 160.32 24.73 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.363 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.608 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 29.1 p90 -163.04 168.53 20.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 55' ' ' ILE . 71.6 t -113.88 137.91 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.753 -1.217 . . . . 0.0 111.888 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.728 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 77.6 mt -104.07 110.42 30.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 209' ' ' HIS . 1.6 p30 -124.8 34.32 5.02 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.372 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.58 161.56 33.85 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 117.073 -2.489 . . . . 0.0 113.202 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.517 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.52 141.27 29.41 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -112.6 11.53 19.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.777 -1.202 . . . . 0.0 110.442 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.45 -50.23 3.99 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -79.46 53.83 1.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 0.0 109.64 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.455 ' OD1' ' OE2' ' A' ' 171' ' ' GLU . 0.7 OUTLIER 50.73 38.16 18.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 0.3 OUTLIER -121.02 132.73 55.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.095 -1.003 . . . . 0.0 109.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 26.2 m-85 -123.6 160.71 26.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.974 . . . . 0.0 110.039 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.8 t60 -92.73 146.56 23.56 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.58 HG13 ' CD1' ' A' ' 197' ' ' PHE . 23.8 t -139.25 139.03 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 25.9 t-20 -108.95 70.38 0.74 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.608 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 89.7 m95 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.456 -0.777 . . . . 0.0 110.193 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 2.4 pt20 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 4.9 p -149.43 167.04 27.29 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.74 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -140.99 145.58 36.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.575 0.703 . . . . 0.0 109.536 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 22.0 t -107.94 114.42 46.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 158' ' ' HIS . 12.3 m -119.52 138.95 48.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.252 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 97.95 53.84 1.25 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.608 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.4 mt -103.65 96.36 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -1.152 . . . . 0.0 110.102 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.48 147.42 8.54 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.646 0 C-N-CA 122.227 1.951 . . . . 0.0 110.288 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 178' ' ' LEU . 94.7 t . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -76.36 178.44 6.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.469 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 1.8 t -77.9 106.35 9.69 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.024 -1.048 . . . . 0.0 109.241 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.679 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 38.3 mt -57.4 -50.72 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.879 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.455 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 12.1 mt -55.49 -41.84 73.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.784 -1.198 . . . . 0.0 109.224 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 29.8 t0 -67.75 -40.47 84.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.581 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.6 p -58.53 -14.16 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.1 -1.0 . . . . 0.0 109.293 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 13' ' ' ILE . 17.7 mtpt -117.75 22.12 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 0.0 108.802 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.0 37.85 4.42 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 48.1 mt -88.63 109.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 122.427 1.108 . . . . 0.0 110.219 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 102' ' ' PRO . 28.0 m80 -133.78 98.0 4.06 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.574 ' CE2' HD13 ' A' ' 116' ' ' ILE . 4.6 m-30 -103.61 171.66 7.24 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.216 1.008 . . . . 0.0 112.064 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.3 t30 -147.19 -173.21 4.19 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 30.3 mt-30 -124.11 -3.7 8.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.64 -56.17 0.35 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.158 -1.496 . . . . 0.0 112.152 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.752 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.65 -125.14 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-O 117.531 -1.224 . . . . 0.0 112.257 -176.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.752 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -80.54 9.21 3.8 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 123.381 2.243 . . . . 0.0 110.212 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 15' ' ' TYR . 71.0 m-85 -83.94 -33.92 24.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 109.818 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.515 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.2 p30 -102.51 21.87 14.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.748 -1.22 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 6.4 mt -69.37 -4.4 18.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.94 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 118' ' ' GLU . 63.6 mt -131.67 -5.67 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.878 -1.139 . . . . 0.0 110.275 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 21.2 p -61.38 165.83 6.32 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 0.0 108.392 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.2 Cg_endo -69.57 131.31 21.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.069 1.846 . . . . 0.0 111.675 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG22 ' ND1' ' A' ' 42' ' ' HIS . 76.6 t -77.34 151.31 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.605 -0.684 . . . . 0.0 109.601 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.667 HD13 ' HD3' ' A' ' 133' ' ' PRO . 12.7 mt -77.54 150.28 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -125.13 -23.37 4.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.434 -0.791 . . . . 0.0 111.15 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' TYR . 16.1 mtpt -121.54 176.35 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.845 -1.159 . . . . 0.0 109.927 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.486 1.337 0 O-C-N 121.241 -0.912 . . . . 0.0 110.772 -179.257 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 15.74 11.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.918 -1.114 . . . . 0.0 109.571 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.1 143.49 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.91 67.16 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.9 mt-30 -83.92 127.08 33.6 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.192 -1.181 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.482 ' ND1' HG22 ' A' ' 27' ' ' VAL . 3.4 m-70 -72.86 110.28 7.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.23 158.44 1.15 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.599 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -75.75 169.2 18.59 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 109.363 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.476 ' O ' ' HE2' ' A' ' 129' ' ' MET . 8.7 p -80.7 -34.5 34.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.113 . . . . 0.0 108.051 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.06 135.29 7.83 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.422 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.1 p -54.49 -49.19 70.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -1.215 . . . . 0.0 107.93 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.618 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 20.3 t -46.38 -56.41 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -58.7 -50.13 75.03 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.667 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.77 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -66.66 -38.3 86.57 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.071 -1.452 . . . . 0.0 107.632 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.611 ' OG1' HG22 ' A' ' 143' ' ' VAL . 61.8 m -74.55 -53.98 8.38 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.26 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -55.13 -41.37 71.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 110.323 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.4 mt-30 -57.61 -47.5 82.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.491 -1.38 . . . . 0.0 107.331 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.512 HG13 HG22 ' A' ' 198' ' ' VAL . 59.3 mt -65.74 -24.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.6 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 27.7 mtp -73.75 -37.68 64.97 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 22.3 tptt -71.2 -39.04 72.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.679 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.2 t80 -53.53 -34.49 58.38 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 109.528 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 75.5 m-70 -107.62 -20.08 13.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.645 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.02 54.33 1.64 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 1.4 t80 -72.38 -73.84 0.16 Allowed Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 34.4 Cg_endo -68.58 103.4 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.342 0.654 . . . . 0.0 112.057 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.442 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t-20 -70.84 -18.83 62.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 8.0 tttp -134.11 141.73 47.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.25 148.6 36.72 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.42 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -87.89 -59.04 2.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -1.02 . . . . 0.0 109.316 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 68' ' ' ASP . 15.6 tttt -139.03 150.42 45.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-20 -74.58 179.99 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 70' ' ' THR . 61.9 t80 -147.73 167.5 24.5 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.374 -0.829 . . . . 0.0 109.605 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 6.8 t -166.22 147.87 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.617 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 19.1 p90 -163.35 152.67 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 21.1 m -93.09 138.14 31.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 77' ' ' ASN . 9.5 tp -52.54 150.03 5.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 111.331 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -61.95 144.07 55.58 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.54 . . . . 0.0 109.715 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -1.91 11.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.82 -8.95 23.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 109.732 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.557 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 31.2 t-20 -70.24 109.4 4.81 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.765 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.594 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.0 Cg_endo -89.3 16.07 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.0 2.467 . . . . 0.0 110.279 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 91.2 m-85 -104.45 -23.53 13.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.746 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 2.4 m-85 -122.56 161.38 23.79 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.573 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 21.7 m-80 -46.1 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.18 -47.1 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 175.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.64 57.55 4.99 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 N-CA-C 107.39 -1.812 . . . . 0.0 107.39 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -105.67 107.25 18.15 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.247 -178.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -100.49 139.12 36.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.617 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.3 mp -115.97 123.14 47.29 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.27 125.25 47.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.079 -1.013 . . . . 0.0 110.059 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.04 113.79 27.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.61 53.0 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.874 -1.141 . . . . 0.0 108.557 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.625 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 48.7 mt -52.37 -46.66 46.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 121.264 -0.897 . . . . 0.0 109.76 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.4 p -45.22 -26.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.162 . . . . 0.0 108.936 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.0 p -111.51 33.19 4.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 0.0 109.203 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -89.37 153.75 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.12 91.24 3.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.23 87.07 6.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.469 -0.769 . . . . 0.0 110.84 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.489 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.3 t30 -79.23 88.58 4.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.645 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 72.3 m95 -61.6 -5.69 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 110.737 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.87 -19.46 24.57 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.15 -27.47 13.51 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' CE3' ' A' ' 97' ' ' TRP . 48.0 mt -74.14 70.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 38.1 mt -48.8 148.84 3.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.728 -0.607 . . . . 0.0 109.961 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.532 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.1 Cg_endo -79.08 -22.81 8.27 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.758 2.305 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 14' ' ' HIS . 7.6 t -139.51 121.88 16.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 108.878 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 58.2 m-85 -109.43 140.41 43.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -0.947 . . . . 0.0 109.911 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.9 p -99.9 -0.69 39.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.046 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 82.07 -0.74 88.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -118.07 1.94 12.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -1.194 . . . . 0.0 109.561 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.68 164.88 15.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.545 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.429 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -60.16 171.55 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.202 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 63.2 m-20 -75.51 -31.48 60.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.89 . . . . 0.0 109.764 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.31 -63.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.87 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 1.1 mp0 -62.46 -31.52 72.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.494 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.2 mttt -66.21 -44.29 84.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.48 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 11.0 ttm -59.11 -34.53 72.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.69 -68.99 0.19 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.697 -0.627 . . . . 0.0 110.539 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.574 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.8 tp -59.85 -40.9 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 110.209 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.542 ' N ' HG23 ' A' ' 116' ' ' ILE . 14.7 p -56.9 -40.22 75.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.767 -1.208 . . . . 0.0 109.764 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 37.2 tt0 -69.84 -39.19 76.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 108.682 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.44 -60.39 3.89 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.591 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -51.24 -39.22 56.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.628 -0.67 . . . . 0.0 109.679 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.62 -41.26 92.92 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 126' ' ' SER . 8.7 m-20 -65.39 -54.59 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 49' ' ' ALA . 87.0 t -63.08 -52.06 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.314 -0.867 . . . . 0.0 108.799 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -51.42 -51.55 36.71 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.3 mt -66.5 -54.39 26.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.076 -1.249 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.478 ' HB2' ' HB1' ' A' ' 146' ' ' ALA . 33.1 p -46.22 -28.13 1.18 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.644 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.8 m -101.28 30.95 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.864 -1.148 . . . . 0.0 109.674 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 4.1 m-20 42.51 38.88 1.37 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.247 -0.908 . . . . 0.0 108.944 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.512 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 37.6 tpp -53.33 132.21 38.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.574 -0.704 . . . . 0.0 111.583 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 15.5 t0 -76.69 120.73 22.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.62 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.65 120.17 40.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.3 1.048 . . . . 0.0 112.96 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -151.11 -164.25 11.93 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.667 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.4 Cg_endo -62.0 -30.94 83.88 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 105.687 -2.466 . . . . 0.0 105.687 175.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 m -109.97 142.46 41.31 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 44.3 m -119.54 110.42 16.86 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 119.849 -1.782 . . . . 0.0 109.972 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.17 133.28 11.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -118.44 -169.0 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -1.115 . . . . 0.0 108.602 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.29 -57.33 2.88 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.572 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 129.94 -122.5 3.73 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.551 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 3.1 m -47.99 -60.58 2.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 24.7 p -46.88 -41.18 15.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.78 -1.2 . . . . 0.0 109.238 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.4 mmp_? -80.33 -42.62 22.64 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.611 HG22 ' OG1' ' A' ' 52' ' ' THR . 84.7 t -68.65 -59.38 3.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.722 -0.612 . . . . 0.0 111.149 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.44 -32.88 65.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.16 -0.963 . . . . 0.0 109.175 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 14.2 ttm180 -75.89 -44.15 41.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.099 -1.0 . . . . 0.0 109.375 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -70.49 -32.11 69.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 109.908 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 151' ' ' PHE . 51.8 mt -60.31 -47.89 84.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.369 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.513 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 24.6 mtmt -87.73 -29.47 21.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.729 -1.232 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 88.4 mt-10 -74.3 -67.46 0.62 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 112.333 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 68' ' ' ASP . 36.1 m120 -82.1 -31.04 30.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.851 -1.156 . . . . 0.0 111.652 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.6 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 19.6 m-85 -102.53 -6.15 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.662 -1.274 . . . . 0.0 110.36 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 48.95 40.45 27.38 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.224 -0.923 . . . . 0.0 112.244 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.6 m-85 -62.76 160.24 14.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.408 -1.643 . . . . 0.0 107.999 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 49.6 t30 -47.64 155.42 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 109.486 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -55.85 -17.57 6.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.895 . . . . 0.0 108.837 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.544 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 21.4 p -53.69 -15.72 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 12.8 t -72.25 119.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.68 -1.262 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.583 ' CD2' HG22 ' A' ' 249' ' ' VAL . 3.1 p-80 -146.77 155.29 42.26 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 2.1 tt0 -102.15 143.78 31.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.672 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' CA ' ' A' ' 246' ' ' SER . 4.1 pt -128.33 154.16 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -109.62 94.93 5.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.991 -1.068 . . . . 0.0 110.542 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.574 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 1.2 tpt85 -46.39 -27.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 108.99 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.82 -23.56 72.57 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -103.64 4.29 35.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.072 -1.252 . . . . 0.0 111.17 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -118.11 167.98 10.98 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.554 -1.341 . . . . 0.0 109.836 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 167' ' ' LYS . 32.0 p -98.94 136.86 38.32 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 166' ' ' SER . 29.3 tttm -34.42 -45.66 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.76 -0.587 . . . . 0.0 110.721 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -63.55 -62.22 1.81 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.958 -1.089 . . . . 0.0 109.733 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.45 -19.88 65.09 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 109.069 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.574 ' CE3' ' HA ' ' A' ' 162' ' ' ARG . 67.3 t-105 -75.44 -44.25 45.38 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.981 -1.074 . . . . 0.0 108.842 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 208' ' ' TYR . 12.3 mt-10 -61.68 -31.51 71.65 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.97 80.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.826 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -61.32 -45.38 94.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 109.249 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.509 ' HA ' HG23 ' A' ' 184' ' ' VAL . 9.8 mt -76.01 -48.21 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 111.091 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.468 ' OD2' ' OH ' ' A' ' 208' ' ' TYR . 0.3 OUTLIER -58.33 -53.76 54.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.014 -1.054 . . . . 0.0 109.67 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -51.28 -38.0 50.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.558 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.2 mm-40 -61.0 -51.32 69.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.554 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.8 mt -69.09 -24.95 64.2 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.489 -0.757 . . . . 0.0 109.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.425 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.7 p -52.21 -38.16 57.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.95 -1.094 . . . . 0.0 108.096 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 24.2 mt-30 -101.32 33.5 2.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.487 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.7 m-20 47.11 51.15 13.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.1 mt-30 -123.75 106.0 32.27 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.4 Cg_endo -63.59 168.77 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.908 1.738 . . . . 0.0 112.497 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 42.3 t -121.86 135.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.454 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.572 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 3.3 t80 -85.07 118.31 24.55 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.649 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 8.8 t80 -122.29 150.93 41.67 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.808 -1.183 . . . . 0.0 109.774 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.572 ' OE1' ' HA3' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -152.54 121.92 6.77 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.705 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -90.98 112.38 4.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.6 t -66.37 164.82 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -1.178 . . . . 0.0 110.794 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -175.65 -143.22 4.51 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -35.68 18.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.235 . . . . 0.0 110.213 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.59 -9.31 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.12 -162.03 18.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.52 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.93 111.53 3.27 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.584 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.6 t-80 -71.57 101.23 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.618 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -86.24 153.1 22.25 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.822 1.296 . . . . 0.0 114.216 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.676 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 21.5 p90 -163.58 164.77 24.06 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 55' ' ' ILE . 70.6 t -113.74 139.06 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.705 -1.247 . . . . 0.0 112.011 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 51.9 mt -103.38 111.68 34.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.577 ' OD1' ' CD2' ' A' ' 209' ' ' HIS . 1.6 p30 -125.22 31.33 5.62 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.395 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.08 41.59 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.271 -2.395 . . . . 0.0 112.883 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.439 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -156.48 149.7 24.27 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 207' ' ' PHE . 18.2 p-10 -128.56 29.81 5.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.578 -1.326 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 48.0 22.24 2.04 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 22.7 mtm180 -135.04 25.25 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -1.211 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 1.9 m-80 72.58 18.66 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.465 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 9.7 m-85 -120.15 113.73 20.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.901 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.552 ' CZ ' ' HG2' ' A' ' 171' ' ' GLU . 3.5 m-85 -102.67 167.35 9.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 108.919 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.4 t60 -92.18 139.48 30.58 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.565 HG13 ' CD1' ' A' ' 197' ' ' PHE . 42.4 t -130.89 136.18 58.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.533 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.45 ' N ' HG11 ' A' ' 210' ' ' VAL . 23.3 t-20 -108.62 73.67 0.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.676 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 73.5 m95 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 110.269 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 4.4 pt20 . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.503 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 14.2 p -155.96 152.4 28.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 109.89 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.479 ' HB1' ' CH2' ' A' ' 170' ' ' TRP . . . -132.12 167.76 19.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.119 0.961 . . . . 0.0 109.854 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 8.7 t -117.42 116.25 51.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 158' ' ' HIS . 29.4 m -117.64 145.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.734 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.89 49.12 3.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.611 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.3 mt -98.98 89.05 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.774 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -160.34 150.71 15.08 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.451 -0.781 . . . . 0.0 109.117 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 33.9 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.447 2.098 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 178' ' ' LEU . 70.1 t . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 200' ' ' ASP . 7.4 mmtp -76.23 -177.46 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -0.947 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 32.8 t -78.06 104.35 8.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 109.911 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.4 mt -57.84 -52.87 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.528 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' HB2' ' OD2' ' A' ' 200' ' ' ASP . 16.3 mt -54.44 -40.08 68.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.768 -1.207 . . . . 0.0 108.748 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -68.06 -42.57 80.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.912 . . . . 0.0 109.286 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 p -58.49 -14.78 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.086 -1.009 . . . . 0.0 109.218 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -116.37 22.54 12.76 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.07 33.5 2.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 11' ' ' LYS . 31.5 mt -85.85 109.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.498 -1.001 . . . . 0.0 110.261 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' PRO . 40.1 m80 -134.8 77.46 1.69 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.0 m-30 -85.13 177.08 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.148 0.975 . . . . 0.0 111.197 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -147.68 -164.26 1.96 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 25.8 mt-30 -124.85 -20.57 4.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.856 -1.153 . . . . 0.0 110.583 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.43 -34.56 1.42 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.469 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.755 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 -140.22 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.466 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.846 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.8 Cg_endo -74.2 3.44 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 CA-C-N 122.511 1.933 . . . . 0.0 109.559 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.558 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 9.1 m-85 -78.87 -31.37 45.53 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.478 -0.764 . . . . 0.0 108.962 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 28.1 p-10 -93.9 19.84 8.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.556 -1.34 . . . . 0.0 109.617 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD1' ' HD3' ' A' ' 113' ' ' LYS . 11.3 mt -74.49 -3.05 28.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD13 ' HG3' ' A' ' 114' ' ' MET . 6.3 mt -129.24 -0.98 5.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 0.0 109.485 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -66.12 166.01 18.91 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.7 Cg_endo -71.32 141.36 38.87 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.368 2.045 . . . . 0.0 112.223 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 35.8 t -80.01 147.05 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.658 HD13 ' HD3' ' A' ' 133' ' ' PRO . 21.6 mt -77.88 148.47 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.704 0.764 . . . . 0.0 110.853 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.6 mm-40 -125.73 -21.54 4.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.621 -0.675 . . . . 0.0 110.432 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 80' ' ' PHE . 13.8 mtpp -122.76 166.97 14.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 37' ' ' SER . 91.8 t . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.558 -0.714 . . . . 0.0 110.577 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.608 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 76.0 m-85 -123.62 15.89 9.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.931 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' HG22 ' A' ' 28' ' ' ILE . 94.1 t -63.3 136.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.51 -3.12 83.58 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.441 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.5 mt-30 -83.76 132.92 34.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.293 -1.122 . . . . 0.0 109.605 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -73.64 110.31 7.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.48 159.39 1.03 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.8 171.78 14.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.455 0.645 . . . . 0.0 109.701 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.558 HG22 ' SD ' ' A' ' 120' ' ' MET . 24.6 p -80.81 -34.62 33.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 108.708 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.34 137.29 8.92 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -48.03 74.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.326 -1.103 . . . . 0.0 108.313 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 127' ' ' VAL . 3.3 t -46.93 -53.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -63.47 -47.94 79.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.888 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 70.9 m -62.91 -30.47 71.57 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.642 -0.661 . . . . 0.0 109.499 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.7 72.14 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.808 -1.157 . . . . 0.0 108.439 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.561 ' OG1' HG23 ' A' ' 143' ' ' VAL . 40.3 m -76.2 -49.5 17.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.293 0.568 . . . . 0.0 110.752 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.02 -34.28 28.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.177 -0.952 . . . . 0.0 108.742 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.609 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-30 -68.26 -48.95 63.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 198' ' ' VAL . 55.2 mt -65.58 -23.1 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' THR . 22.8 mtp -73.92 -34.23 64.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 100' ' ' ILE . 42.8 tptt -72.34 -45.46 59.82 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.67 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.4 t80 -52.42 -30.83 31.36 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.265 0.555 . . . . 0.0 109.815 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.638 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 59.3 m-70 -108.35 -24.09 11.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 111.151 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.633 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.23 57.15 2.5 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -79.33 -71.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.0 Cg_endo -68.34 103.43 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 122.26 0.611 . . . . 0.0 111.838 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -21.88 63.48 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 4.9 ttpt -134.8 141.25 46.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.08 146.6 39.29 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.351 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -82.91 -45.15 14.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -1.027 . . . . 0.0 110.206 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.2 ttpp -152.16 135.29 15.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.035 -1.041 . . . . 0.0 110.069 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.5 OUTLIER -60.65 164.39 4.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.043 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.459 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 45.2 t80 -143.37 154.37 43.66 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t -154.52 150.43 27.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.661 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 14.7 p90 -155.3 152.3 29.04 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.466 ' OG1' ' OD1' ' A' ' 85' ' ' ASN . 46.5 m -92.75 140.25 29.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.495 HD21 ' CG ' ' A' ' 77' ' ' ASN . 8.7 tp -55.5 148.57 15.26 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 111.467 -178.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.444 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 3.5 p -61.69 141.87 57.57 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.301 0.572 . . . . 0.0 110.122 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.7 m -67.32 -5.41 14.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.9 m120 -99.45 -3.64 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 28.1 t-20 -70.68 111.78 10.82 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.552 -0.717 . . . . 0.0 109.878 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.644 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.1 Cg_endo -88.5 13.64 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.975 2.45 . . . . 0.0 109.792 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.644 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 59.2 m-85 -112.73 -4.07 14.12 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.283 -0.885 . . . . 0.0 111.641 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.488 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 69.1 m-85 -140.62 161.0 38.79 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 44.5 m-80 -47.77 -81.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 1.1 m-70 174.95 -46.84 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.506 -0.746 . . . . 0.0 110.929 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.2 Cg_endo -76.95 54.6 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 N-CA-C 107.419 -1.8 . . . . 0.0 107.419 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 4.8 tptt -105.67 105.71 15.87 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.068 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' OG1' ' A' ' 72' ' ' THR . 11.6 m-80 -100.3 140.06 35.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.661 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -113.93 128.38 56.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -120.31 129.68 54.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.094 -1.003 . . . . 0.0 110.235 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.64 111.13 23.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.56 52.44 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.733 -1.23 . . . . 0.0 108.372 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.644 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.7 mt -52.43 -52.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.565 -0.709 . . . . 0.0 109.417 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -45.51 -26.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.096 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -112.26 19.85 17.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.5 mmt-85 -76.59 152.84 35.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 89.11 3.04 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.0 89.9 5.95 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 110.508 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 15.9 t-20 -80.05 92.32 5.6 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.4 m95 -61.14 -8.82 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 110.026 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -90.79 -15.94 29.22 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 27.2 m-20 -99.26 -33.59 10.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.602 HD12 ' CE3' ' A' ' 97' ' ' TRP . 30.6 mt -73.46 93.71 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 30.1 mt -71.05 151.33 94.9 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -78.87 -28.15 4.23 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.132 . . . . 0.0 110.223 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.93 127.65 27.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.902 . . . . 0.0 109.31 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.588 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 82.6 m-85 -112.0 145.33 39.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 109.874 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 p -100.11 -12.79 19.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.98 -3.4 62.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -118.68 15.32 13.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.153 . . . . 0.0 109.287 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.02 -172.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.2 p -87.32 179.82 6.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.433 -0.792 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -78.01 -38.61 44.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.54 -58.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.71 -35.27 79.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.289 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.527 ' HD3' ' CD1' ' A' ' 23' ' ' LEU . 14.6 mttm -64.02 -43.06 96.75 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.469 ' HG3' HD13 ' A' ' 24' ' ' LEU . 23.1 ttm -60.0 -38.29 82.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.55 -68.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.704 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.588 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.3 tp -66.0 -48.64 81.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.386 -0.821 . . . . 0.0 109.68 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 51.3 p -47.48 -44.84 25.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.938 -1.101 . . . . 0.0 108.378 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.585 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 4.2 tt0 -70.26 -47.47 61.13 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 53' ' ' ALA . 7.2 tp -48.62 -51.66 26.97 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 45' ' ' THR . 1.3 mmt -60.26 -46.55 89.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.688 -0.632 . . . . 0.0 109.755 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.58 -35.64 81.17 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 126' ' ' SER . 4.9 m-20 -68.09 -55.47 12.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 49' ' ' ALA . 44.8 t -62.93 -58.32 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.0 109.185 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -45.55 -50.13 11.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.2 mt -63.68 -58.98 5.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.185 -1.186 . . . . 0.0 108.216 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.9 OUTLIER -46.4 -28.59 1.4 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.39 -177.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.783 HG13 HG22 ' A' ' 143' ' ' VAL . 24.2 m -101.24 34.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.592 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.2 m-20 38.74 53.05 1.93 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.321 -0.862 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.549 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.4 tpp -65.69 127.01 30.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 111.726 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -75.92 121.64 22.98 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 52.5 m-85 -103.31 117.69 35.08 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.545 1.164 . . . . 0.0 113.316 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.52 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.02 -162.55 10.75 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 104.617 -3.393 . . . . 0.0 104.617 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.658 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.45 -30.89 80.66 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 105.812 -2.418 . . . . 0.0 105.812 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.86 140.75 43.45 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 173.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.521 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.4 m -121.09 109.69 15.33 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 119.913 -1.742 . . . . 0.0 110.076 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.9 136.76 13.66 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.444 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 11.2 t -111.66 -161.69 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.569 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.89 -57.1 2.93 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.581 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.55 -134.57 7.2 Favored Glycine 0 N--CA 1.479 1.54 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.504 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.542 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -52.85 -53.26 51.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.804 -0.821 . . . . 0.0 111.89 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 140' ' ' SER . 5.2 p -45.89 -41.85 11.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.003 . . . . 0.0 109.07 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 26.3 mmt180 -81.35 -43.15 19.45 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.783 HG22 HG13 ' A' ' 127' ' ' VAL . 41.5 t -68.38 -53.88 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.634 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.1 pp0? -56.71 -34.21 67.24 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.256 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -77.82 -51.19 10.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.973 178.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -60.44 -37.1 79.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.113 -0.992 . . . . 0.0 110.049 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.4 mt -58.04 -51.55 69.21 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.482 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 29.3 mtmt -80.27 -45.78 17.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 110.182 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.437 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 86.2 mt-10 -68.32 -52.03 38.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.048 -1.033 . . . . 0.0 111.905 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -90.43 -46.55 8.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.798 -1.189 . . . . 0.0 111.935 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.476 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 29.9 m-85 -99.38 13.68 32.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.648 -1.282 . . . . 0.0 110.938 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 34.34 41.46 0.22 Allowed Glycine 0 N--CA 1.496 2.679 0 O-C-N 121.512 -0.742 . . . . 0.0 112.815 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.5 m-85 -63.14 169.94 3.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.126 -1.808 . . . . 0.0 107.883 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 30.3 t30 -47.6 136.57 10.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.72 -1.238 . . . . 0.0 109.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.16 -21.01 4.4 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.201 -0.937 . . . . 0.0 108.79 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.502 ' HB3' ' ND2' ' A' ' 154' ' ' ASN . 84.4 p -53.6 -17.44 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 109.787 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.5 t -58.42 125.17 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.969 -1.082 . . . . 0.0 109.121 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.594 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 9.3 p-80 -146.42 156.7 43.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.6 tt0 -101.74 150.35 23.22 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.872 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 246' ' ' SER . 20.3 pt -130.77 154.22 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.6 m-80 -119.2 106.16 12.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.163 . . . . 0.0 110.906 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 tpt85 -48.03 -45.03 31.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.461 -0.775 . . . . 0.0 109.765 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.92 -22.75 58.13 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 6.7 m-20 -104.75 2.03 29.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.198 -1.177 . . . . 0.0 111.7 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -117.67 175.03 5.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.498 -1.376 . . . . 0.0 110.665 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.474 ' O ' ' C ' ' A' ' 167' ' ' LYS . 1.1 p -100.46 138.19 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.3 ttmm -35.39 -49.61 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.688 -0.632 . . . . 0.0 110.629 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.418 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 38.3 mm-40 -64.15 -58.3 7.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.004 -1.06 . . . . 0.0 109.777 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.86 -20.77 65.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.455 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 68.6 t-105 -76.15 -44.69 37.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.469 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 83.1 mt-10 -73.52 -36.91 65.78 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.172 -0.955 . . . . 0.0 108.497 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.8 -44.3 49.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -61.58 -42.08 98.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 109.028 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.55 HG23 ' CD1' ' A' ' 199' ' ' ILE . 11.5 mt -75.83 -58.08 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 111.051 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.78 -54.05 21.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 0.0 109.665 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -51.03 -41.27 59.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.57 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 6.0 mm-40 -59.13 -50.53 73.7 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' A' ' 4' ' ' VAL . 15.2 mt -68.32 -25.92 65.36 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 110.099 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 10.5 p -52.43 -40.19 61.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.95 -1.094 . . . . 0.0 108.427 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 31.1 mt-30 -97.7 31.61 2.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.478 ' HB3' HD21 ' A' ' 7' ' ' LEU . 86.9 m-20 48.61 49.2 18.89 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 26.6 mt-30 -123.7 107.38 31.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.516 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.2 Cg_endo -64.05 168.9 11.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.125 1.883 . . . . 0.0 112.791 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 50.6 t -120.9 134.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.551 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.581 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.5 OUTLIER -82.56 116.02 21.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 5.7 t80 -122.25 158.16 30.09 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 120.954 -1.091 . . . . 0.0 109.355 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -167.2 128.45 1.58 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 117.881 -1.528 . . . . 0.0 111.549 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.01 115.79 4.87 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 5.3 t -80.6 169.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -173.99 -142.91 4.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.6 -28.86 21.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.157 -1.202 . . . . 0.0 110.739 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.0 -14.1 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.931 -1.106 . . . . 0.0 110.973 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.02 -171.06 21.11 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -82.8 105.82 2.69 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.878 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 15.2 t-80 -70.93 127.58 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.44 161.62 20.93 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.426 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 33.0 p90 -157.56 -171.35 3.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 55' ' ' ILE . 75.3 t -134.0 134.94 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.617 -1.302 . . . . 0.0 111.218 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.55 ' CD1' HG23 ' A' ' 174' ' ' ILE . 56.1 mt -97.66 119.25 45.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 33.9 p30 -130.62 31.9 4.48 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.564 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.65 161.72 32.39 Favored Glycine 0 N--CA 1.484 1.839 0 C-N-CA 117.254 -2.403 . . . . 0.0 112.457 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.46 145.3 32.49 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -116.57 17.69 15.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.863 -1.148 . . . . 0.0 110.328 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.33 -51.26 3.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -79.7 50.69 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.067 -1.255 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 51.04 35.25 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' ASP . 0.2 OUTLIER -115.37 130.08 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.063 -1.023 . . . . 0.0 108.96 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 6.8 m-85 -122.97 156.72 34.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.476 ' HB3' ' OD1' ' A' ' 200' ' ' ASP . 61.0 t-80 -93.29 114.78 27.32 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.592 HG13 ' CD1' ' A' ' 197' ' ' PHE . 14.3 t -113.89 142.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.077 . . . . 0.0 111.797 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 30.1 t-20 -101.32 77.7 1.81 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.462 ' CD2' HG12 ' A' ' 210' ' ' VAL . 45.1 m95 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.683 0.754 . . . . 0.0 110.991 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 6.4 tt0 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -166.75 163.29 16.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.763 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.39 165.35 27.66 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.293 1.044 . . . . 0.0 109.749 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 6.6 t -118.32 114.9 46.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.594 ' CG2' ' NE2' ' A' ' 158' ' ' HIS . 27.1 m -115.25 144.95 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 120.942 -1.099 . . . . 0.0 111.092 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 88.69 51.73 2.99 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.638 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.54 95.36 3.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -1.049 . . . . 0.0 109.971 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.65 153.92 13.28 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 108.899 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.8 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.211 1.941 . . . . 0.0 110.509 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 63.8 t . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -76.64 172.94 12.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 108.571 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 47.2 t -77.52 103.32 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.119 -0.988 . . . . 0.0 109.158 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.663 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 30.5 mt -58.62 -50.61 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.552 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 200' ' ' ASP . 11.5 mt -55.41 -37.08 67.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.599 -1.313 . . . . 0.0 108.861 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.5 OUTLIER -67.49 -41.44 84.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 p -58.14 -14.65 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 109.278 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CB ' HG13 ' A' ' 13' ' ' ILE . 1.1 mtpt -121.51 16.4 11.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.82 42.48 6.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 43.1 mt -87.99 110.83 21.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.196 0.998 . . . . 0.0 110.504 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 102' ' ' PRO . 55.3 m80 -134.7 97.71 3.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.5 m-30 -104.0 178.46 4.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.984 -1.073 . . . . 0.0 110.938 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 -165.43 2.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 13.9 mt-30 -124.57 -16.61 6.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.004 -1.06 . . . . 0.0 110.221 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.723 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.77 -37.25 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.305 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.771 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.53 -139.57 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.124 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.771 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.39 3.35 5.35 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 CA-C-N 122.625 1.973 . . . . 0.0 109.161 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.3 m-85 -77.79 -32.29 52.36 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.533 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 37.9 p-10 -94.46 17.8 12.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 12.2 mt -74.18 4.88 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 110.401 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD13 ' HG3' ' A' ' 114' ' ' MET . 9.2 mt -139.45 2.5 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.68 -1.262 . . . . 0.0 110.389 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.6 p -63.4 164.33 15.39 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.5 Cg_endo -70.07 137.16 33.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.731 1.621 . . . . 0.0 110.73 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 145.58 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.649 0.738 . . . . 0.0 110.085 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.759 HD13 ' HD3' ' A' ' 133' ' ' PRO . 6.5 mt -77.43 151.36 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.476 0.655 . . . . 0.0 110.354 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 39' ' ' VAL . 25.5 mt-10 -124.77 -25.44 3.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.468 -0.77 . . . . 0.0 110.779 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.6 mtpm? -117.38 177.22 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.918 -1.114 . . . . 0.0 109.917 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG23 ' CB ' ' A' ' 37' ' ' SER . 97.3 t . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.893 . . . . 0.0 111.536 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.486 ' CB ' HG23 ' A' ' 31' ' ' VAL . 32.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.094 0.473 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.719 ' CD2' ' CG ' ' A' ' 133' ' ' PRO . 18.7 m-30 -111.77 10.97 20.91 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.046 -1.034 . . . . 0.0 109.33 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' GLU . 17.6 t -61.22 119.26 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.749 -1.219 . . . . 0.0 108.726 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.9 -11.23 57.47 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 20.8 mt-30 -76.5 134.41 39.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.569 -0.959 . . . . 0.0 109.305 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.19 112.71 9.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 25' ' ' THR . . . -52.83 163.76 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -87.57 170.18 11.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.863 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.518 HG22 ' SD ' ' A' ' 120' ' ' MET . 30.3 p -82.73 -36.58 25.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 102.82 136.36 9.1 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.504 ' N ' ' NE2' ' A' ' 17' ' ' GLN . 2.1 p -54.58 -50.44 68.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.138 -1.213 . . . . 0.0 108.02 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.637 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 40.6 t -46.44 -54.86 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.15 -51.31 70.57 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.034 0.921 . . . . 0.0 109.625 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.51 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 48.0 m -62.92 -34.5 77.58 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.813 -0.554 . . . . 0.0 110.232 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.24 -39.95 86.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.575 -1.328 . . . . 0.0 108.331 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.492 ' OG1' HG23 ' A' ' 143' ' ' VAL . 61.8 m -74.41 -52.04 13.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.608 0.718 . . . . 0.0 109.993 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.06 -39.35 59.52 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.624 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.7 mt-30 -59.57 -53.1 61.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.726 -1.233 . . . . 0.0 107.86 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 198' ' ' VAL . 26.1 mt -63.24 -29.63 47.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.514 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 26.2 mtp -66.23 -42.61 88.41 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.558 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.5 tptt -67.51 -39.43 85.13 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.3 t80 -53.7 -32.5 52.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.644 -0.66 . . . . 0.0 110.245 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 80.6 m-70 -107.03 -21.26 13.06 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.261 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.599 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 81.4 m-20 44.37 53.39 6.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.2 t80 -74.11 -76.62 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.7 -0.8 . . . . 0.0 113.082 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.93 105.1 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 CA-C-N 119.071 0.704 . . . . 0.0 112.084 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.2 m-80 -69.9 -21.51 63.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.04 141.73 49.32 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.37 147.99 34.51 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.601 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.61 -48.77 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.585 -0.95 . . . . 0.0 109.94 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 28.3 tttp -151.59 140.07 20.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 109.626 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 39.1 m-20 -59.35 172.7 0.6 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.471 -0.768 . . . . 0.0 109.767 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CD1' ' OD1' ' A' ' 150' ' ' ASN . 40.7 t80 -148.0 161.03 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.446 -0.784 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.418 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 14.8 t -159.7 149.69 18.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.624 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 24.5 p90 -160.03 155.63 25.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.097 -1.002 . . . . 0.0 109.829 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 82.7 m -92.77 132.71 36.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.572 HD23 ' CD1' ' A' ' 80' ' ' PHE . 10.0 tp -44.45 147.76 0.54 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.264 -0.898 . . . . 0.0 110.77 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t -61.27 143.63 55.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.434 0.635 . . . . 0.0 110.263 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 p -68.58 -3.93 13.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.56 -2.55 35.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.538 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 19.5 t-20 -71.27 110.89 8.3 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.763 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.8 Cg_endo -91.09 20.26 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.089 2.526 . . . . 0.0 108.886 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 38' ' ' PHE . 53.7 m-85 -114.93 -22.97 9.33 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.306 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -123.54 165.47 17.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.8 m-80 -47.94 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.8 -47.16 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 111.202 175.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.72 57.63 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.394 -1.81 . . . . 0.0 107.394 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.4 tptt -110.86 108.2 17.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.536 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.553 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.81 145.16 28.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.624 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 6.0 mp -116.98 156.99 26.52 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 32.8 t80 -143.26 128.37 18.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.978 -1.076 . . . . 0.0 110.424 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.83 115.38 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.04 53.3 0.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.653 -1.279 . . . . 0.0 108.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.8 mt -52.9 -55.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.451 -0.781 . . . . 0.0 110.339 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -45.7 -26.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.475 -1.39 . . . . 0.0 109.207 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -111.25 22.4 15.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.65 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 42.8 mmt-85 -82.45 152.7 26.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.983 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.471 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.02 91.27 3.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.09 90.22 6.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 110.425 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 35.3 t-20 -80.03 90.27 5.39 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.642 ' CE3' HD12 ' A' ' 100' ' ' ILE . 51.9 m95 -61.16 -7.53 2.78 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.585 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -90.14 -18.52 25.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.6 m-20 -98.88 -30.06 12.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.642 HD12 ' CE3' ' A' ' 97' ' ' TRP . 44.1 mt -73.84 69.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 24.6 mt -47.45 150.26 1.71 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.805 -0.559 . . . . 0.0 110.108 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.52 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -80.16 -28.13 3.26 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.824 2.349 . . . . 0.0 110.735 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -135.29 121.89 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 63.0 m-85 -109.53 139.9 43.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 109.899 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 p -100.19 -7.97 24.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 -0.01 73.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -118.37 7.31 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -1.123 . . . . 0.0 109.384 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.485 ' O ' ' NZ ' ' A' ' 113' ' ' LYS . 0.5 OUTLIER -72.41 168.76 17.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.1 p -64.18 165.27 9.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.7 m-20 -71.72 -32.03 67.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -52.41 -61.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -62.31 -33.65 75.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.495 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 17.0 mttt -65.88 -44.06 86.46 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.473 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -58.74 -36.53 74.47 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.465 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.19 -67.86 0.28 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.647 -0.658 . . . . 0.0 109.584 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.624 HD13 ' CE2' ' A' ' 15' ' ' TYR . 2.2 tp -63.74 -40.7 90.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.557 ' N ' HG23 ' A' ' 116' ' ' ILE . 10.5 p -58.13 -43.38 87.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.92 -1.112 . . . . 0.0 108.841 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' OE2' ' CD ' ' A' ' 93' ' ' ARG . 50.3 tt0 -69.29 -38.0 78.1 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.556 HD22 ' CD1' ' A' ' 116' ' ' ILE . 24.6 tp -56.83 -52.37 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.581 ' HE2' ' CD2' ' A' ' 21' ' ' TYR . 1.1 mmt -57.78 -43.06 85.3 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.87 -38.61 91.56 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 6.1 m-20 -69.41 -54.85 12.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 49' ' ' ALA . 49.0 t -58.84 -62.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.37 -46.74 16.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.484 HD13 ' HB2' ' A' ' 88' ' ' ALA . 3.0 mt -63.63 -57.45 11.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 107.979 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.43 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 1.7 p -46.55 -27.33 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.81 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.521 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -104.5 31.53 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 45.7 m-20 41.75 43.52 2.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.158 -0.964 . . . . 0.0 109.747 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.517 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 35.2 tpp -60.37 134.2 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -0.778 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -76.96 123.16 25.91 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' C ' ' HB3' ' A' ' 43' ' ' ALA . 34.3 m-85 -103.47 103.92 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -142.04 -170.03 12.36 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.759 ' HD3' HD13 ' A' ' 28' ' ' ILE . 13.6 Cg_endo -62.55 -20.91 72.08 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.633 -2.103 . . . . 0.0 106.633 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.64 130.31 55.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 72.6 m -113.87 113.83 25.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 119.753 -1.842 . . . . 0.0 110.339 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.67 126.48 8.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -118.06 -170.7 1.93 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.149 -1.207 . . . . 0.0 107.8 178.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.585 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.45 -49.95 6.23 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.545 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 116.76 -111.19 2.26 Favored Glycine 0 N--CA 1.481 1.657 0 C-N-CA 119.955 -1.117 . . . . 0.0 111.751 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.502 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 6.1 m -48.46 -72.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.862 . . . . 0.0 112.317 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 11.4 p -46.61 -32.86 3.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 110.276 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.523 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 24.4 mmt180 -80.41 -49.92 10.8 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.972 -1.08 . . . . 0.0 109.787 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.676 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.9 t -68.37 -58.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.7 -0.625 . . . . 0.0 111.049 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 3.1 pp0? -56.55 -31.88 64.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.016 -1.052 . . . . 0.0 108.608 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.48 ' CB ' ' O ' ' A' ' 141' ' ' SER . 1.9 ttm-85 -77.31 -52.84 8.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.002 -1.061 . . . . 0.0 109.61 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -63.95 -37.81 88.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.0 110.053 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.51 HD13 HG11 ' A' ' 143' ' ' VAL . 34.3 mt -55.21 -47.31 75.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.549 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 50.5 mtmt -87.38 -45.17 10.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.063 -1.023 . . . . 0.0 110.887 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.96 -48.99 69.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.999 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.56 ' OD1' ' CD1' ' A' ' 69' ' ' TYR . 10.5 m120 -94.36 -45.43 7.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.676 -1.265 . . . . 0.0 111.645 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.514 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 27.4 m-85 -99.97 18.67 17.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.763 -1.21 . . . . 0.0 110.716 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 30.16 43.55 0.07 OUTLIER Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.777 -0.577 . . . . 0.0 112.857 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 7.0 m-85 -64.17 164.16 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.267 -1.725 . . . . 0.0 108.013 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 27.3 t-20 -47.99 151.4 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.843 -1.161 . . . . 0.0 109.626 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 9.0 mm100 -56.16 -17.14 6.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.066 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.593 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 22.3 p -55.17 -14.84 1.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.84 . . . . 0.0 109.852 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.549 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 39.8 t -72.66 119.61 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 156' ' ' SER . 1.0 OUTLIER -149.56 -177.7 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.596 178.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.502 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.7 tt0 -123.42 139.1 54.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.902 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 246' ' ' SER . 7.7 pt -123.91 176.2 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 1.2 m-80 -128.55 97.54 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.793 -1.192 . . . . 0.0 110.558 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.636 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.2 tpt180 -46.91 -41.15 15.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.047 -1.033 . . . . 0.0 109.327 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.72 -21.04 54.29 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 64.3 m-20 -104.04 0.25 29.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -1.228 . . . . 0.0 111.677 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.18 173.49 6.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.444 -1.41 . . . . 0.0 110.491 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 167' ' ' LYS . 18.6 p -101.33 136.51 41.05 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 166' ' ' SER . 15.0 ttpp -31.48 -51.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.912 -0.492 . . . . 0.0 111.228 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.65 -58.77 5.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.449 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 15.2 m-20 -62.6 -19.67 63.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.0 108.513 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.636 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 71.4 t-105 -74.95 -47.55 28.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 19.8 mt-10 -64.15 -23.98 67.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 169' ' ' ASP . . . -61.28 -43.44 98.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -60.5 -44.07 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 108.687 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.539 HG21 ' CG2' ' A' ' 184' ' ' VAL . 4.9 mt -74.24 -41.52 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 108.644 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -50.74 -51.87 45.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 109.08 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 179' ' ' SER . 13.1 tttt -51.96 -50.73 60.64 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 53.7 mm-40 -56.64 -61.25 2.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' A' ' 208' ' ' TYR . 13.1 mt -55.72 -32.36 63.27 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.183 0.516 . . . . 0.0 110.263 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.5 p -52.32 -53.23 47.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 25.5 mt-30 -88.75 44.13 1.19 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.468 ' HB3' HD21 ' A' ' 7' ' ' LEU . 2.0 m120 41.97 52.45 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 4.7 mt-30 -124.49 113.56 27.45 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.574 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.2 Cg_endo -66.34 169.14 14.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 121.743 1.629 . . . . 0.0 111.591 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 55.4 t -125.1 134.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.811 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.676 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.48 122.5 30.51 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 175.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.8 t80 -123.3 163.35 20.89 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.799 -1.188 . . . . 0.0 109.826 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -166.17 123.6 1.41 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.281 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 245' ' ' GLN . . . -93.2 124.26 7.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 177.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 60.5 t -82.03 158.4 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.81 -1.406 . . . . 0.0 111.212 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.56 -137.8 2.28 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -36.33 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.65 -6.78 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.943 -1.098 . . . . 0.0 111.077 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.71 -159.78 19.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.48 114.29 4.04 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.849 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 32.3 t-80 -70.3 145.48 51.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.56 154.72 38.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 117.852 -1.539 . . . . 0.0 113.908 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.596 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 10.4 p90 -163.4 163.56 24.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 55' ' ' ILE . 81.7 t -112.51 137.51 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.869 -1.145 . . . . 0.0 112.171 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.645 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 50.5 mt -103.74 121.03 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 19.1 p30 -126.3 16.17 7.75 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.493 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 178' ' ' LEU . . . -160.98 172.31 37.23 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 116.613 -2.708 . . . . 0.0 114.721 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.745 ' CB ' ' CE1' ' A' ' 208' ' ' TYR . . . -159.06 152.07 22.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.97 28.82 5.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.416 -1.428 . . . . 0.0 109.494 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 59.0 14.76 25.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -142.4 47.28 1.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -1.157 . . . . 0.0 108.972 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.99 19.87 2.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 108.967 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -102.06 92.38 4.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.745 ' CE1' ' CB ' ' A' ' 202' ' ' ALA . 3.3 m-30 -102.86 155.97 17.97 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.068 -1.02 . . . . 0.0 111.232 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.574 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.0 t60 -90.96 139.21 30.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.008 -1.682 . . . . 0.0 107.331 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 197' ' ' PHE . 19.4 t -131.09 139.62 50.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.516 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 39.3 t-20 -114.04 84.17 1.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.596 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 94.8 m95 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.577 ' NE2' ' CG ' ' A' ' 162' ' ' ARG . 7.3 tt0 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -148.83 166.76 27.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -140.64 151.99 45.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.116 0.96 . . . . 0.0 110.057 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 84.7 t -109.15 118.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.591 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 33.5 m -127.1 144.03 38.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.164 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 91.87 55.71 1.72 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.615 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 36.4 mt -102.44 81.62 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.35 -1.088 . . . . 0.0 110.148 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -156.89 148.91 17.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.185 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.586 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.975 . . . . 0.0 110.573 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.8 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 200' ' ' ASP . 4.9 mmtp -75.91 -178.11 4.17 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.518 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 1.9 t -77.72 105.68 9.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.011 -1.056 . . . . 0.0 109.408 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.654 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 45.7 mt -57.4 -49.37 76.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 108.986 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 198' ' ' VAL . 10.4 mt -55.66 -41.57 73.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.807 -1.183 . . . . 0.0 108.781 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 24.5 t70 -67.4 -39.09 85.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.159 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -58.58 -14.38 8.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' CB ' HG13 ' A' ' 13' ' ' ILE . 4.1 mtpp -121.01 21.74 11.24 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.28 -0.888 . . . . 0.0 108.707 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.78 38.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 48.8 mt -86.61 109.62 19.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 122.283 1.039 . . . . 0.0 110.355 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 102' ' ' PRO . 20.1 m-70 -134.5 88.37 2.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.1 m-30 -95.0 -179.65 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.885 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.449 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 1.4 t-20 -148.54 -163.93 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.512 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 43.9 mt-30 -124.6 -23.37 4.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.076 -1.015 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.716 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -114.92 -34.67 1.47 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.308 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.771 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.21 -140.36 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.242 -178.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.771 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -74.37 3.77 4.98 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 CA-C-N 122.545 1.945 . . . . 0.0 109.694 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.543 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 8.8 m-85 -80.41 -31.46 37.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.435 -0.791 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 17.4 p-10 -92.13 15.26 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.604 -1.31 . . . . 0.0 109.103 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -69.55 -6.97 34.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.852 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.517 HD11 ' N ' ' A' ' 118' ' ' GLU . 15.9 mt -125.92 -9.24 6.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.007 . . . . 0.0 109.761 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -60.88 166.64 4.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.4 Cg_endo -70.06 145.88 56.72 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.014 1.81 . . . . 0.0 112.367 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -85.74 148.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.554 0.692 . . . . 0.0 109.808 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.65 HD13 ' HD3' ' A' ' 133' ' ' PRO . 25.4 mt -78.21 149.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.448 -0.782 . . . . 0.0 111.295 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' VAL . 92.9 mt-10 -126.17 -22.16 4.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.596 . . . . 0.0 110.468 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 30.3 mtpt -120.26 169.47 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.858 -1.151 . . . . 0.0 110.258 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 37' ' ' SER . 88.0 t . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 31' ' ' VAL . 1.3 t . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 13.92 11.49 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.903 -1.123 . . . . 0.0 109.763 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 28' ' ' ILE . 58.7 t -62.99 141.07 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 109.436 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 39' ' ' VAL . . . 80.79 -2.27 80.36 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.6 mt-30 -86.92 132.84 33.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -1.188 . . . . 0.0 109.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -73.34 111.14 8.19 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.22 161.21 0.66 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.106 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.38 169.51 18.13 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.405 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.565 ' O ' ' CE ' ' A' ' 129' ' ' MET . 24.0 p -80.66 -33.84 35.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 108.469 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.05 135.87 8.01 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.414 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 14.1 p -53.69 -47.89 70.05 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 29.9 t -47.8 -57.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.372 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.78 -45.16 93.14 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 110.555 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 76.2 m -62.5 -39.24 92.86 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.64 -0.662 . . . . 0.0 110.244 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.62 80.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.489 -1.382 . . . . 0.0 108.778 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.569 ' OG1' HG22 ' A' ' 143' ' ' VAL . 60.7 m -74.71 -55.19 6.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.3 -34.91 48.88 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.643 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.4 mt-30 -63.5 -53.83 45.82 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 HG13 HG23 ' A' ' 198' ' ' VAL . 63.2 mt -63.1 -22.29 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.597 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 24.7 mtp -73.36 -37.36 66.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.568 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.4 tptt -71.19 -40.07 71.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 40.9 t80 -53.65 -31.46 47.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.653 -0.654 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.1 m-70 -107.93 -22.4 12.45 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.287 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.639 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.13 57.3 2.0 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -178.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -77.54 -71.59 0.18 Allowed Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -69.17 105.65 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 120.272 0.648 . . . . 0.0 112.171 -176.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.04 -20.35 61.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 34.0 tttt -134.28 139.8 45.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 148.4 37.4 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.411 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.526 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.79 -46.79 8.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.989 . . . . 0.0 109.822 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 38.3 tttt -151.92 140.51 20.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' SER . 10.7 m-20 -67.62 174.71 3.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.453 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 36.9 t80 -152.16 150.16 29.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.13 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.451 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.61 164.47 35.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 30.0 p90 -169.3 155.79 6.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 91.3 m -93.04 130.29 38.69 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.503 HD13 HD11 ' A' ' 86' ' ' LEU . 9.9 tp -45.37 149.97 0.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 111.057 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.421 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -61.42 137.37 58.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.694 -0.629 . . . . 0.0 109.568 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -64.44 -7.24 9.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 109.875 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 m120 -96.73 -6.03 37.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 35.2 t-20 -71.04 111.8 11.19 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 53.3 Cg_endo -88.48 12.3 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.887 2.391 . . . . 0.0 109.8 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 70.9 m-85 -107.04 -1.99 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 111.461 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 34.0 m-85 -142.35 161.91 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.572 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.3 m-80 -47.54 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 174.62 -46.47 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 111.008 174.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.94 55.98 5.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.83 103.46 12.97 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.649 -178.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -100.85 132.75 46.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.621 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -105.25 137.92 42.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 20.9 t80 -125.13 125.34 43.58 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.151 -0.968 . . . . 0.0 110.395 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.87 105.7 15.63 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.01 54.79 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 108.67 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 70.5 mt -52.71 -52.87 23.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.543 -0.723 . . . . 0.0 110.433 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 p -44.4 -25.47 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -110.56 35.75 3.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 108.565 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 23.5 mmt-85 -95.75 155.65 16.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.843 . . . . 0.0 110.735 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -118.69 91.41 3.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -81.66 88.18 6.25 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 110.951 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.501 ' O ' HG13 ' A' ' 100' ' ' ILE . 42.8 t-20 -79.66 89.63 5.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.639 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 79.1 m95 -61.27 -6.62 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.85 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 -16.14 31.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -99.9 -30.84 11.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' CE3' ' A' ' 97' ' ' TRP . 27.7 mt -73.42 67.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.492 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 12.9 mt -46.32 150.71 1.08 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.542 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.9 Cg_endo -77.45 -26.67 7.05 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.607 2.205 . . . . 0.0 110.946 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.426 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 2.1 t -138.2 125.23 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.616 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 87.2 m-85 -109.62 139.45 44.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.91 4.51 45.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 108.991 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.72 -6.86 63.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -113.52 15.94 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -1.148 . . . . 0.0 109.395 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -75.8 167.53 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.8 OUTLIER -63.18 -179.69 0.33 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -82.68 -43.94 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.54 -51.88 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.787 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.433 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -62.56 -44.43 96.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.032 -1.043 . . . . 0.0 109.084 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.8 mttt -61.93 -36.56 81.75 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.257 -0.902 . . . . 0.0 108.835 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.446 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 14.8 ttm -60.35 -45.32 93.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -58.13 -51.6 69.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 111.098 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.616 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 tp -69.35 -39.11 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.601 -1.312 . . . . 0.0 110.04 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.466 ' OG ' HD11 ' A' ' 24' ' ' LEU . 5.7 p -58.04 -41.49 83.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.098 -1.001 . . . . 0.0 110.44 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 93' ' ' ARG . 22.6 tt0 -68.86 -37.39 79.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.954 -1.091 . . . . 0.0 108.218 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 53' ' ' ALA . 6.0 tp -57.95 -51.8 68.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.554 ' SD ' HG22 ' A' ' 45' ' ' THR . 1.4 mmt -59.37 -40.62 87.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.524 -0.735 . . . . 0.0 109.465 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.23 -37.93 88.81 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -69.07 -57.43 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' ALA . 22.6 t -61.73 -48.48 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.048 -1.033 . . . . 0.0 108.835 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -54.64 -54.03 35.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.4 mt -65.91 -53.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.009 -1.289 . . . . 0.0 108.321 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 59.8 p -45.99 -32.11 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.577 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.637 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.5 m -101.39 39.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.3 m-20 37.41 50.97 1.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.565 ' CE ' ' O ' ' A' ' 45' ' ' THR . 51.2 tpp -65.98 127.45 32.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.427 -0.795 . . . . 0.0 111.602 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.6 OUTLIER -76.26 123.05 25.29 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.632 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.4 m-85 -103.94 118.77 37.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.326 1.06 . . . . 0.0 113.578 -175.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.525 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.07 -163.8 11.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 104.598 -3.401 . . . . 0.0 104.598 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.65 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.29 -30.86 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.573 -2.51 . . . . 0.0 105.573 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.88 142.03 41.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 46.4 m -122.25 113.22 19.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 119.855 -1.778 . . . . 0.0 110.157 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.47 132.49 11.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -117.84 -164.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -1.112 . . . . 0.0 108.12 178.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.613 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.86 -64.37 1.12 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.807 -1.183 . . . . 0.0 108.125 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.568 ' HA2' HG13 ' A' ' 48' ' ' VAL . . . 132.31 -130.56 5.92 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.837 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 144' ' ' GLN . 1.4 m -47.36 -55.59 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.745 -0.856 . . . . 0.0 111.531 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -45.69 21.22 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.867 -1.146 . . . . 0.0 109.269 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.637 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.6 mmp_? -80.63 -38.79 28.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.61 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.569 HG22 ' OG1' ' A' ' 52' ' ' THR . 76.2 t -67.77 -57.29 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 140' ' ' SER . 0.8 OUTLIER -56.7 -33.09 66.12 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.103 -1.039 . . . . 0.0 108.674 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 141' ' ' SER . 2.6 ttp85 -77.8 -46.45 21.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -67.14 -33.8 76.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.699 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 143' ' ' VAL . 59.1 mt -60.58 -46.5 90.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.697 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.568 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 43.5 mtmt -88.08 -38.87 15.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.784 -1.197 . . . . 0.0 110.722 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 48.3 mt-10 -72.87 -51.66 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.85 -1.156 . . . . 0.0 111.753 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.3 m120 -89.56 -41.38 12.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.884 -1.135 . . . . 0.0 111.587 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.597 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.4 m-85 -102.83 8.25 39.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.756 -1.215 . . . . 0.0 110.834 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.526 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 39.38 40.92 1.44 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 121.172 -0.955 . . . . 0.0 112.122 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.13 168.9 3.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.385 -1.656 . . . . 0.0 108.318 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.4 t30 -47.82 142.39 4.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.097 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.43 -20.91 5.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.923 . . . . 0.0 108.956 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.494 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 79.0 p -56.49 -14.46 3.09 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 109.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 7.0 t -61.82 122.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 0.0 109.586 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 12.1 p-80 -148.55 159.19 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.709 -0.797 . . . . 0.0 109.202 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 144' ' ' GLN . 2.3 tt0 -102.79 145.38 29.84 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.635 ' CD1' ' CH2' ' A' ' 170' ' ' TRP . 3.4 pt -121.77 154.4 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -121.53 99.51 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.874 -1.141 . . . . 0.0 110.646 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.629 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 1.1 tpt180 -46.29 -38.86 9.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.35 -24.26 61.16 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -104.52 1.54 29.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.243 . . . . 0.0 111.857 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -117.77 179.7 4.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.4 -1.437 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 167' ' ' LYS . 60.6 p -104.85 136.64 43.97 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.487 ' HD2' ' NE2' ' A' ' 168' ' ' GLN . 21.7 ttmt -34.35 -47.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.74 -0.6 . . . . 0.0 110.825 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.487 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 49.1 mm-40 -64.97 -59.5 4.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.117 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.51 -16.25 60.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.28 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 160' ' ' ILE . 50.8 t-105 -71.01 -47.97 55.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.486 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 33.8 mt-10 -67.1 -38.01 84.92 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -44.67 -49.59 10.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 23.4 mm100 -61.1 -42.02 97.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 108.725 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 199' ' ' ILE . 96.6 mt -71.71 -63.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 0.0 111.381 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.5 OUTLIER -48.11 -43.3 30.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 -177.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 179' ' ' SER . 12.4 tmtt? -51.84 -43.46 63.19 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.553 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 48.8 mm-40 -59.8 -53.51 57.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.53 ' HB3' HG11 ' A' ' 4' ' ' VAL . 11.4 mt -68.38 -25.06 64.88 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.911 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 175' ' ' ASP . 28.4 p -52.24 -40.12 61.23 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.481 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 25.7 mt-30 -99.94 33.54 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 7' ' ' LEU . 12.9 m120 49.22 48.99 20.38 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 10.6 mt-30 -124.15 114.78 27.67 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.566 ' HD3' HD12 ' A' ' 7' ' ' LEU . 19.7 Cg_endo -66.67 172.14 9.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.03 1.82 . . . . 0.0 112.187 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 18.9 t -125.87 118.04 50.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 26.4 t80 -67.78 111.95 4.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.629 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 6.5 t80 -123.21 156.64 34.72 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.17 -0.956 . . . . 0.0 109.465 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -164.65 128.73 2.52 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.813 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.474 ' HA2' ' CG ' ' A' ' 245' ' ' GLN . . . -91.63 109.08 3.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.556 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.0 t -71.7 160.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.459 -1.024 . . . . 0.0 111.382 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.57 -137.8 2.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -43.32 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.05 -1.265 . . . . 0.0 111.13 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.96 -13.56 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.96 -1.087 . . . . 0.0 111.457 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.99 -165.35 24.9 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.5 108.42 3.21 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.798 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -71.48 118.34 14.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.4 160.52 15.58 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.773 1.273 . . . . 0.0 113.072 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.629 ' CE1' ' HB3' ' A' ' 186' ' ' TYR . 20.5 p90 -162.36 170.2 19.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.579 ' HB ' HD11 ' A' ' 8' ' ' LEU . 47.4 t -114.37 136.07 52.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 120.673 -1.267 . . . . 0.0 112.234 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 174' ' ' ILE . 65.7 mt -100.56 108.73 23.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.0 p30 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.68 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -172.5 161.86 33.52 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 117.142 -2.456 . . . . 0.0 112.878 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.519 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -142.73 144.54 32.71 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 207' ' ' PHE . 1.8 t0 -114.11 11.45 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.751 -1.218 . . . . 0.0 110.61 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.77 -47.28 3.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -79.33 50.42 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 109.751 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 53.01 31.67 11.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 110.096 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.1 m-85 -121.06 135.89 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 109.769 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 5.7 m-85 -123.39 164.71 18.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.599 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 0.7 OUTLIER -92.73 148.46 22.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.588 ' N ' ' CD2' ' A' ' 209' ' ' HIS . 22.4 t -139.59 137.82 39.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.547 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 32.7 t-20 -102.02 80.58 2.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.459 ' CE3' ' HA ' ' A' ' 212' ' ' TRP . 1.6 m95 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 109.773 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 4.7 mt-30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 34.5 p -131.1 155.53 46.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.381 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -141.11 162.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.831 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 16.3 t -116.16 110.32 31.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 15.4 m -107.75 146.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 121.379 -0.826 . . . . 0.0 110.943 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 84.42 42.42 7.42 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 54.0 mt -89.58 86.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.536 -0.979 . . . . 0.0 110.362 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.51 156.37 17.89 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.604 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.378 2.052 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 178' ' ' LEU . 78.0 t . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 200' ' ' ASP . 11.4 mmtp -75.8 -177.18 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 108.947 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 209' ' ' HIS . 66.3 m -77.72 103.08 7.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.647 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.696 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 36.3 mt -57.97 -51.62 68.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 109.483 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 200' ' ' ASP . 9.0 mt -55.55 -39.32 70.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.746 -1.221 . . . . 0.0 109.021 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -67.33 -37.63 83.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -58.43 -14.49 7.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mtpt -121.08 18.93 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 108.846 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.95 39.74 5.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' CG ' ' A' ' 57' ' ' LYS . 18.7 mt -86.14 111.42 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.423 -1.045 . . . . 0.0 110.36 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 42.4 m80 -135.23 87.48 2.33 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.619 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.2 m-30 -88.29 178.23 6.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.977 0.894 . . . . 0.0 110.781 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.73 -163.77 1.85 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.474 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 53.5 mt-30 -125.01 -20.97 4.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.963 -1.086 . . . . 0.0 111.061 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.14 -36.28 1.24 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.22 -1.467 . . . . 0.0 111.666 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.777 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.35 -140.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.492 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.016 -177.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.777 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.2 Cg_endo -73.85 2.84 5.52 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 CA-C-N 122.538 1.942 . . . . 0.0 109.753 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.566 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 9.1 m-85 -78.26 -31.52 49.13 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.024 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 24.6 p-10 -92.36 15.71 13.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.584 -1.323 . . . . 0.0 109.463 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 113' ' ' LYS . 11.4 mt -70.38 -3.72 18.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 HD13 ' CA ' ' A' ' 118' ' ' GLU . 14.7 mt -129.27 -6.36 4.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 109.988 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.9 p -61.58 165.47 7.28 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.617 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.1 Cg_endo -69.16 145.65 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.058 1.839 . . . . 0.0 112.041 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.25 147.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.73 0.776 . . . . 0.0 110.396 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.653 HD13 ' HD3' ' A' ' 133' ' ' PRO . 22.6 mt -78.02 149.68 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.683 0.754 . . . . 0.0 111.396 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 39' ' ' VAL . 2.2 mt-10 -126.06 -20.83 4.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 110.573 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -121.25 168.13 11.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 110.15 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 37' ' ' SER . 84.9 t . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 111.119 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.469 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.561 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 74.7 m-85 -118.54 13.07 13.37 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.451 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 28' ' ' ILE . 77.2 t -63.35 142.52 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 109.367 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 39' ' ' VAL . . . 79.43 -1.26 77.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.455 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 3.0 mt-30 -87.92 131.72 34.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 25' ' ' THR . 4.5 m-70 -73.55 111.69 8.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -51.93 161.42 0.57 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.08 -1.013 . . . . 0.0 109.329 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.53 170.88 15.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.564 0.697 . . . . 0.0 109.866 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.555 HG22 ' SD ' ' A' ' 120' ' ' MET . 28.2 p -81.2 -34.31 32.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 108.646 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 103.75 137.82 9.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 51' ' ' ALA . 4.3 p -55.14 -52.56 62.89 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -1.086 . . . . 0.0 108.172 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.55 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 55.3 t -46.8 -51.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -61.43 -51.53 68.35 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.501 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 m -63.19 -30.96 72.01 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.705 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.53 -42.23 83.07 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.733 -1.23 . . . . 0.0 107.836 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 56' ' ' MET . 55.8 m -74.76 -53.03 9.94 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.494 0.664 . . . . 0.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.29 -35.4 37.42 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.501 -0.749 . . . . 0.0 109.646 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.587 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.5 mt-30 -64.32 -53.99 40.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.514 HG13 HG22 ' A' ' 198' ' ' VAL . 36.7 mt -60.88 -24.45 32.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.581 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 29.7 mtp -72.72 -31.68 65.15 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CG ' HG12 ' A' ' 13' ' ' ILE . 41.3 tptt -73.69 -47.07 42.39 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 41.8 t80 -52.95 -29.98 32.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.727 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 50.4 m-70 -107.32 -24.44 11.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.755 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.609 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 86.1 m-20 44.83 56.17 5.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.8 t80 -79.77 -76.08 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.8 Cg_endo -70.24 105.16 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 119.258 0.771 . . . . 0.0 111.837 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.6 OUTLIER -72.0 -20.75 61.67 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.0 tttt -133.95 138.6 45.57 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.82 152.71 26.89 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.164 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.643 HD12 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mt -94.95 -59.84 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.431 -1.041 . . . . 0.0 110.492 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 14.1 tttm -134.11 151.36 51.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 21.6 m-20 -74.45 172.56 11.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.829 . . . . 0.0 109.499 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 70' ' ' THR . 28.9 t80 -147.48 153.82 40.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.582 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -157.37 149.68 22.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.095 -1.003 . . . . 0.0 110.097 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.656 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 26.9 p90 -156.44 157.05 34.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.583 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.3 m -93.35 134.95 35.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.516 HD21 ' CG ' ' A' ' 77' ' ' ASN . 9.9 tp -52.78 149.99 5.71 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 111.136 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.78 138.26 58.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.729 -0.607 . . . . 0.0 109.596 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -6.08 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 6.8 m-20 -96.2 -7.26 36.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.164 -0.96 . . . . 0.0 109.575 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 32.3 t-20 -70.25 111.54 9.67 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 109.82 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.641 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 50.3 Cg_endo -88.19 12.68 2.77 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.973 2.449 . . . . 0.0 109.996 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.641 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.0 m-85 -105.18 -11.86 16.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.69 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 4.3 m-85 -134.76 163.19 30.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.3 m120 -47.48 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.25 -46.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 111.039 175.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.5 Cg_endo -76.69 56.72 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.99 102.51 11.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.63 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.86 128.85 46.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.656 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -102.06 129.1 48.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 11.2 t80 -121.78 126.91 49.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.92 . . . . 0.0 110.047 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.55 116.05 31.24 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.86 51.26 0.62 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.854 -1.154 . . . . 0.0 108.314 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 25.8 mt -52.09 -44.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 O-C-N 121.259 -0.901 . . . . 0.0 109.579 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 4.7 p -45.62 -26.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.649 -1.282 . . . . 0.0 108.76 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -112.51 34.51 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.411 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.646 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 2.2 mmt-85 -93.0 151.5 19.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 110.336 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.462 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.2 94.51 4.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.7 m-85 -81.55 93.04 6.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.472 -0.768 . . . . 0.0 110.408 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 30.7 t-20 -79.81 90.15 5.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.609 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 65.0 m95 -61.22 -9.29 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -90.53 -15.59 30.41 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 22.9 m-20 -98.69 -34.27 10.61 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.599 HD12 ' CE3' ' A' ' 97' ' ' TRP . 34.2 mt -73.1 91.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 14.8 mt -71.06 151.62 94.85 Favored Pre-proline 0 C--N 1.29 -1.99 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.2 Cg_endo -76.58 -20.7 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.462 2.108 . . . . 0.0 110.783 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 140.4 32.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.281 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.578 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 82.8 m-85 -126.61 135.45 51.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.409 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.6 p -99.52 1.87 44.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 108.962 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.44 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -118.29 11.41 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.331 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -73.11 172.59 10.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.669 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.44 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.9 OUTLIER -66.83 177.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.331 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -80.85 -42.1 22.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.97 -51.76 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.44 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.458 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 20' ' ' PRO . 15.8 mttt -61.18 -37.46 83.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.12 -0.987 . . . . 0.0 109.118 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.437 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.2 ttm -59.62 -45.24 92.56 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.373 -0.829 . . . . 0.0 110.028 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.31 70.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.857 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 3.6 tp -69.78 -43.5 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.549 -1.344 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.467 ' OG ' HD11 ' A' ' 24' ' ' LEU . 4.7 p -54.33 -40.36 67.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CA ' HD13 ' A' ' 24' ' ' LEU . 19.6 tt0 -70.46 -43.28 70.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 53' ' ' ALA . 7.1 tp -54.04 -51.48 63.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.566 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.7 mmt -60.16 -44.22 95.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.598 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.57 -41.82 96.03 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -65.37 -52.54 52.93 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' ALA . 78.6 t -61.18 -61.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.74 -50.99 13.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.8 mt -63.65 -55.45 22.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.319 . . . . 0.0 108.418 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 3.4 p -46.19 -31.3 2.36 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.515 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.592 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.2 m -102.28 40.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.156 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER 39.38 38.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.339 -0.851 . . . . 0.0 110.253 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.54 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 48.2 tpp -52.56 128.34 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 111.314 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 25.4 t0 -78.33 123.2 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.617 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 68.7 m-85 -104.5 115.81 31.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 113.579 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.509 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.73 -163.82 11.55 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 104.482 -3.447 . . . . 0.0 104.482 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.653 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.34 -29.47 79.71 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 105.589 -2.504 . . . . 0.0 105.589 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -110.47 137.7 47.82 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 50.5 m -116.64 108.7 16.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 119.872 -1.768 . . . . 0.0 109.977 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.1 136.22 13.24 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.54 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 14.6 t -118.56 -163.41 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 108.8 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.29 -55.55 3.38 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.543 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 126.99 -123.78 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.758 -1.21 . . . . 0.0 111.934 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 10.7 m -48.38 -65.39 0.57 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.817 -0.814 . . . . 0.0 112.458 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -46.52 -34.27 4.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.931 -1.106 . . . . 0.0 109.402 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 29.6 mmt180 -80.12 -49.74 11.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.876 0.846 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 185' ' ' TYR . 92.9 t -68.31 -54.82 19.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.867 -0.521 . . . . 0.0 111.19 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.466 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.3 pp0? -56.68 -34.11 67.06 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.958 -1.089 . . . . 0.0 108.741 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -77.24 -47.85 19.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -66.29 -34.48 78.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 109.927 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 143' ' ' VAL . 66.0 mt -57.13 -49.0 77.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 109.607 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.557 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 58.3 mtmt -87.39 -33.69 19.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 111.116 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 69.6 mt-10 -72.23 -63.94 1.04 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.432 -1.417 . . . . 0.0 112.182 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 10.6 m120 -82.89 -37.22 24.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.581 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 22.4 m-85 -100.76 1.53 40.42 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.752 -1.217 . . . . 0.0 110.471 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.643 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 42.94 41.41 4.57 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.344 -0.848 . . . . 0.0 112.445 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.4 m-85 -61.99 164.75 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.162 -1.787 . . . . 0.0 107.598 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.0 t-20 -47.23 144.7 2.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.683 -1.261 . . . . 0.0 109.014 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 148' ' ' LYS . 7.8 tp-100 -53.02 -19.75 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.004 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.1 p -54.85 -15.17 1.75 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.301 -0.874 . . . . 0.0 110.08 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 5.5 t -65.02 121.36 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.46 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.638 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 8.9 p-80 -147.86 159.9 43.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.748 . . . . 0.0 109.164 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.3 tt0 -101.81 155.73 17.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 109.925 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.542 ' CG1' ' HB1' ' A' ' 247' ' ' ALA . 7.1 pt -135.43 143.23 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.2 m-80 -107.91 104.63 14.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.886 -1.134 . . . . 0.0 111.027 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 10.0 tpt180 -47.52 -37.15 11.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 108.857 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -64.44 -20.48 65.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 161' ' ' ASN . 6.4 m-20 -103.63 -4.09 24.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -1.231 . . . . 0.0 110.89 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -118.03 168.18 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.239 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 167' ' ' LYS . 43.4 p -97.19 136.49 37.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 166' ' ' SER . 2.1 tttt -32.69 -45.63 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.152 0.501 . . . . 0.0 110.642 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -64.47 -63.89 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.087 -1.008 . . . . 0.0 109.832 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -63.4 -14.37 49.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.29 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.2 t-105 -75.95 -47.67 24.19 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 76.9 mt-10 -70.93 -30.73 67.13 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.53 -44.27 76.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.853 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -61.25 -40.2 93.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.296 -0.877 . . . . 0.0 108.731 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.603 HG23 ' CD1' ' A' ' 199' ' ' ILE . 21.2 mt -73.35 -57.9 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.441 -0.787 . . . . 0.0 110.447 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.43 -43.5 44.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.004 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -51.65 -44.19 62.91 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.577 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.3 mm-40 -60.98 -49.0 79.22 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.555 ' HB3' HG11 ' A' ' 4' ' ' VAL . 30.1 mt -67.4 -28.48 67.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.677 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 175' ' ' ASP . 9.9 p -51.33 -42.59 61.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 108.573 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.8 mt-30 -97.37 32.67 2.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.467 ' HA ' HD21 ' A' ' 7' ' ' LEU . 81.5 m-20 48.71 49.96 18.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.3 mt-30 -123.88 116.29 27.63 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.567 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.5 Cg_endo -66.35 169.76 13.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.143 1.896 . . . . 0.0 112.461 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 57.5 t -126.53 130.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.479 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -79.39 120.18 23.46 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 176.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 7.1 t80 -123.1 159.33 28.74 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.995 -1.066 . . . . 0.0 109.766 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -166.78 125.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.776 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 245' ' ' GLN . . . -93.85 104.43 3.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 46.6 t -68.32 164.07 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 110.925 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.559 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -165.12 -141.46 3.14 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.526 -1.829 . . . . 0.0 108.526 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -30.9 20.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.076 -1.249 . . . . 0.0 110.237 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.47 -22.49 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.022 -1.049 . . . . 0.0 110.495 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.11 -169.48 24.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.561 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.91 102.34 1.9 Allowed Glycine 0 N--CA 1.482 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 111.138 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.604 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.0 t-80 -71.29 128.14 34.9 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.55 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -118.82 161.79 19.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.295 -1.362 . . . . 0.0 113.195 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.703 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 13.6 p90 -159.29 167.8 28.03 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.514 HG22 HG13 ' A' ' 55' ' ' ILE . 83.5 t -114.69 136.92 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.756 -1.215 . . . . 0.0 112.236 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.603 ' CD1' HG23 ' A' ' 174' ' ' ILE . 70.7 mt -99.63 125.04 53.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 20.1 p-10 -135.05 30.0 3.36 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.458 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -176.52 165.82 36.36 Favored Glycine 0 N--CA 1.483 1.79 0 C-N-CA 117.369 -2.348 . . . . 0.0 112.226 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 207' ' ' PHE . . . -148.86 146.6 28.02 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.98 2.61 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 110.071 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 86.07 -35.84 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.098 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER -88.46 32.04 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -1.23 . . . . 0.0 110.192 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.1 OUTLIER 76.28 27.44 0.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 7.2 m-85 -118.88 133.27 55.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.186 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 48.0 m-85 -122.96 165.24 17.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.375 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 6' ' ' SER . 29.1 t-80 -92.89 145.53 24.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.541 HG12 ' CE2' ' A' ' 212' ' ' TRP . 97.6 t -135.05 137.83 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.917 -1.114 . . . . 0.0 111.558 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 30.4 t-20 -111.22 68.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 98.2 m95 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.808 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.464 ' OE1' ' HA2' ' A' ' 188' ' ' GLY . 25.1 tt0 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.506 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 2.5 p -155.41 169.38 24.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.427 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.542 ' HB1' ' CG1' ' A' ' 160' ' ' ILE . . . -141.19 162.55 35.22 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.774 0.797 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 18.3 t -116.51 124.06 72.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 9.2 m -123.2 139.96 48.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.85 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.45 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 92.98 51.39 2.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 37.2 mt -98.41 91.09 2.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.319 -1.107 . . . . 0.0 109.567 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.4 148.31 9.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 109.095 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.566 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.264 1.976 . . . . 0.0 110.465 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.0 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 200' ' ' ASP . 59.8 mmtt -75.51 -177.14 3.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.071 -1.018 . . . . 0.0 108.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.592 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 4.5 t -77.53 104.25 7.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.679 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.8 mt -56.99 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.028 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 8' ' ' LEU . 14.2 mt -54.47 -43.79 72.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 108.595 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -67.55 -37.03 82.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -15.67 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 108.856 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 13' ' ' ILE . 11.8 mtpp -121.12 22.17 11.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.2 38.59 6.5 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 32.3 mt -90.86 109.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.332 -1.099 . . . . 0.0 110.138 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 102' ' ' PRO . 79.6 m80 -134.08 85.85 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.635 ' CZ ' HD13 ' A' ' 116' ' ' ILE . 9.0 m-30 -93.59 174.21 7.3 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.252 1.025 . . . . 0.0 111.614 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 25.5 t30 -148.38 -172.42 4.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.475 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 1.3 mt-30 -125.4 -0.98 7.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.867 -1.146 . . . . 0.0 110.238 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.51 -56.31 0.35 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.252 -1.452 . . . . 0.0 112.145 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.725 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.07 -126.07 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.966 -176.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.725 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 41.0 Cg_endo -79.11 6.69 4.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 CA-C-N 123.56 2.307 . . . . 0.0 109.713 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 16' ' ' ASN . 57.8 m-85 -78.18 -35.3 48.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.641 -0.662 . . . . 0.0 109.535 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 47.8 p30 -96.78 20.29 11.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.831 -1.168 . . . . 0.0 109.098 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 20' ' ' PRO . 4.9 mt -74.39 1.74 11.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 110.106 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD13 ' CA ' ' A' ' 118' ' ' GLU . 16.6 mt -134.68 0.9 3.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.829 -1.17 . . . . 0.0 110.265 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 43' ' ' ALA . 29.6 p -66.72 164.4 33.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.57 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 18.6 Cg_endo -71.8 131.08 17.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.701 1.601 . . . . 0.0 110.297 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.44 145.63 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.77 0.795 . . . . 0.0 110.429 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.754 HD13 ' HD3' ' A' ' 133' ' ' PRO . 10.3 mt -77.65 148.92 6.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.624 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.24 -22.28 4.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.104 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' TYR . 17.4 mtpp -119.39 172.85 7.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 37' ' ' SER . 88.2 t . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.376 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.488 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 13.2 m-85 -116.3 9.81 14.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.796 -1.19 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' GLU . 34.1 t -60.72 117.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.728 -1.232 . . . . 0.0 108.521 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.38 -11.23 50.93 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.475 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 22.9 mt-30 -76.18 133.25 40.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.447 -1.031 . . . . 0.0 109.168 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.83 114.7 11.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -53.24 145.81 13.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -69.97 167.35 17.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.871 -1.143 . . . . 0.0 109.697 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 120' ' ' MET . 23.4 p -82.14 -33.03 29.79 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 108.511 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.71 138.62 9.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 p -55.17 -51.45 66.48 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.236 -1.155 . . . . 0.0 107.94 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 127' ' ' VAL . 23.4 t -45.11 -53.99 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.786 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.13 -55.76 30.87 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.44 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 59.3 m -63.47 -28.43 69.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.572 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -66.5 -47.99 71.25 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.219 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.554 ' OG1' HG23 ' A' ' 143' ' ' VAL . 85.8 m -75.38 -48.97 20.51 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.842 0.83 . . . . 0.0 109.864 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.83 -33.76 37.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.426 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.614 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.9 mt-30 -68.34 -50.1 55.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 251' ' ' ILE . 40.2 mt -62.95 -23.37 33.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.494 ' HG3' HG22 ' A' ' 52' ' ' THR . 20.0 mtp -73.55 -40.89 63.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 43.6 tptt -65.91 -44.48 85.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.679 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 34.8 t80 -53.39 -28.4 29.22 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 41.0 m-70 -107.65 -25.26 11.4 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.094 -1.004 . . . . 0.0 110.866 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.615 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 94.9 m-20 43.76 59.69 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.7 t80 -83.09 -78.76 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.572 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.37 108.68 2.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 CA-C-N 119.6 0.893 . . . . 0.0 112.996 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.9 -26.22 66.77 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 2.7 ttpt -130.52 130.76 44.55 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.96 164.97 5.68 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 118.487 -1.816 . . . . 0.0 110.682 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.13 -35.84 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.986 . . . . 0.0 111.188 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 8.6 tttm -152.42 131.71 12.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.73 -1.231 . . . . 0.0 110.489 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.567 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 36.5 m-20 -60.23 170.68 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.368 -0.832 . . . . 0.0 108.962 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.506 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 43.4 t80 -145.8 142.1 28.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 152.34 41.97 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.208 -0.932 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 28.7 p90 -160.05 158.09 29.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -92.6 126.3 37.63 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 86' ' ' LEU . 12.1 tp -43.99 147.53 0.49 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.664 0.745 . . . . 0.0 110.509 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 142.79 54.93 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.527 0.68 . . . . 0.0 110.632 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.7 t -69.49 -2.97 12.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.732 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.8 m-80 -97.57 -2.17 42.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.222 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 18.9 t-20 -70.04 109.6 5.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.9 Cg_endo -90.57 19.63 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.95 2.433 . . . . 0.0 108.827 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 44.7 m-85 -117.66 -25.83 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.835 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' ASN . 88.4 m-85 -117.35 170.76 8.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.676 -1.265 . . . . 0.0 108.102 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.5 m-80 -53.96 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.47 -49.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.289 -0.882 . . . . 0.0 111.426 174.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 32.0 Cg_endo -75.92 58.51 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.328 -1.836 . . . . 0.0 107.328 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.575 ' HG3' HD12 ' A' ' 86' ' ' LEU . 18.7 tptt -105.52 121.88 44.87 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.663 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.45 116.65 33.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 0.0 110.225 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.4 mp -96.17 134.01 39.77 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 26.0 t80 -132.36 131.38 41.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.776 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -111.77 118.21 34.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.7 53.01 0.42 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.724 -1.235 . . . . 0.0 108.273 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.655 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 mt -52.88 -58.1 3.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 0.0 111.23 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.3 p -44.52 -27.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.874 -1.141 . . . . 0.0 108.84 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -112.56 30.48 7.08 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.655 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 31.0 mmt-85 -81.17 157.36 25.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.514 -1.366 . . . . 0.0 109.542 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -116.32 81.47 1.62 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 12.1 m-85 -80.96 88.3 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.485 -0.759 . . . . 0.0 110.082 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.2 t-20 -79.17 91.84 5.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.622 ' CE3' HD12 ' A' ' 100' ' ' ILE . 60.0 m95 -60.59 -7.75 2.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.823 . . . . 0.0 110.381 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 9.1 m-20 -89.37 -18.83 26.08 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 24.3 m-20 -100.35 -31.2 11.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.622 HD12 ' CE3' ' A' ' 97' ' ' TRP . 24.1 mt -74.03 65.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.532 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 47.9 mt -45.65 149.16 1.13 Allowed Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.6 Cg_endo -77.23 -20.27 12.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.013 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.7 t -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.945 -1.097 . . . . 0.0 109.414 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.54 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 96.8 m-85 -109.26 144.01 37.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.971 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -99.16 -3.4 34.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' HA3' ' ND2' ' A' ' 19' ' ' ASN . . . 81.84 3.65 90.53 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -119.22 6.69 11.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.44 -1.035 . . . . 0.0 108.836 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -174.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.451 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 3.0 p -72.27 173.57 8.47 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.229 -0.92 . . . . 0.0 108.778 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.0 m120 -78.74 -34.57 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.136 -0.977 . . . . 0.0 109.446 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.24 -61.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.818 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.451 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -62.2 -34.21 76.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.996 -1.065 . . . . 0.0 109.038 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 73.6 mttt -66.1 -44.27 84.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.421 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 40.2 ttm -59.53 -34.93 73.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.491 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.73 -67.89 0.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.83 -0.544 . . . . 0.0 110.752 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.635 HD13 ' CZ ' ' A' ' 15' ' ' TYR . 4.0 tp -59.43 -42.35 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.52 ' N ' HG23 ' A' ' 116' ' ' ILE . 5.7 p -53.47 -41.71 66.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.92 -1.112 . . . . 0.0 109.908 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.529 ' CA ' HD13 ' A' ' 24' ' ' LEU . 8.5 tt0 -69.31 -45.36 69.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 53' ' ' ALA . 4.6 tp -55.42 -50.03 70.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.597 ' HE1' ' CD2' ' A' ' 15' ' ' TYR . 22.7 mmt -58.26 -46.12 86.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.42 -38.46 89.97 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.529 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 20.8 m-20 -64.77 -55.68 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 49' ' ' ALA . 51.4 t -61.8 -51.36 73.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' A' ' 49' ' ' ALA . . . -50.86 -49.15 42.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 88' ' ' ALA . 2.2 mt -64.95 -60.42 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -1.103 . . . . 0.0 108.489 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.485 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -45.98 -30.5 1.83 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.494 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.731 HG13 HG22 ' A' ' 143' ' ' VAL . 32.9 m -101.26 38.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.152 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.6 m-20 35.82 54.06 0.89 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.577 0.703 . . . . 0.0 109.619 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.547 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 40.1 tpp -66.3 130.56 43.62 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 112.144 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' SER . 7.4 t0 -75.87 119.8 20.34 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.539 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 29.5 m-85 -102.34 108.82 20.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -174.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -149.76 -169.35 15.97 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 103.956 -3.658 . . . . 0.0 103.956 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.754 ' HD3' HD13 ' A' ' 28' ' ' ILE . 14.2 Cg_endo -62.5 -21.28 72.6 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 N-CA-C 106.887 -2.005 . . . . 0.0 106.887 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.42 131.04 55.4 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.519 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 68.0 m -117.3 105.48 12.23 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 119.96 -1.713 . . . . 0.0 110.127 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -109.01 134.41 12.23 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.89 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.603 ' OG ' ' NE ' ' A' ' 142' ' ' ARG . 24.9 t -117.42 -160.86 0.79 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -1.214 . . . . 0.0 108.221 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.514 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.7 -49.82 6.26 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.695 ' O ' ' NH2' ' A' ' 142' ' ' ARG . . . 122.87 -111.72 1.79 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.448 ' HB3' ' CD ' ' A' ' 159' ' ' GLN . 0.4 OUTLIER -59.1 -54.14 50.35 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 119.22 -2.341 . . . . 0.0 114.759 -175.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 p -47.12 -32.24 4.08 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.674 -1.266 . . . . 0.0 114.091 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.78 ' CZ ' ' HB2' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -92.93 -36.28 12.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.977 -1.702 . . . . 0.0 110.58 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.731 HG22 HG13 ' A' ' 127' ' ' VAL . 84.0 t -65.32 -42.69 94.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 109.534 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.439 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 3.6 pp0? -69.27 -37.18 77.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp180 -75.31 -51.6 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 109.689 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -62.7 -38.69 91.39 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 110.322 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' HB2' HG13 ' A' ' 157' ' ' VAL . 27.6 mt -56.68 -45.05 81.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.941 -1.1 . . . . 0.0 109.203 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.563 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 32.5 mtmt -87.97 -39.0 15.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.993 -1.067 . . . . 0.0 110.791 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 71.5 mt-10 -71.61 -60.69 2.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.723 -1.235 . . . . 0.0 112.535 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.7 m120 -82.28 -44.92 15.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.73 -1.231 . . . . 0.0 111.937 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 36.4 m-85 -90.84 -14.13 32.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.656 -1.278 . . . . 0.0 110.553 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 66.63 33.25 83.88 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.208 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 10.1 m-85 -63.61 156.71 25.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.22 -1.753 . . . . 0.0 108.014 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.21 153.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.948 -1.095 . . . . 0.0 109.718 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -55.41 -16.77 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.607 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 0.7 OUTLIER -52.99 -17.56 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.185 -0.947 . . . . 0.0 109.617 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.563 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 21.8 t -70.66 121.42 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.911 -1.118 . . . . 0.0 109.405 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 156' ' ' SER . 1.5 p-80 -148.11 170.42 17.85 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.069 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.448 ' CD ' ' HB3' ' A' ' 140' ' ' SER . 3.9 tt0 -111.24 147.29 35.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.694 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 246' ' ' SER . 10.2 pt -141.51 141.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.5 m-80 -104.81 107.86 19.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.059 -1.025 . . . . 0.0 110.377 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.4 -28.94 3.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.057 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.04 -13.53 79.26 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 161' ' ' ASN . 0.7 OUTLIER -103.65 -4.63 23.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -1.134 . . . . 0.0 110.192 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -118.66 179.76 4.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.915 -1.116 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.47 ' OG ' ' OD2' ' A' ' 169' ' ' ASP . 1.8 p -107.18 141.88 37.76 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 41.2 tttp -35.39 -49.3 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.702 -0.623 . . . . 0.0 110.818 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -64.18 -57.76 8.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.946 -1.097 . . . . 0.0 110.18 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.47 ' OD2' ' OG ' ' A' ' 166' ' ' SER . 59.1 m-20 -64.03 -19.69 65.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.02 . . . . 0.0 109.463 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 63.9 t-105 -73.18 -43.11 61.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 208' ' ' TYR . 30.1 mt-10 -64.33 -33.68 76.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 108.706 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.76 81.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.426 -0.796 . . . . 0.0 109.392 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -61.03 -47.13 87.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.166 -0.959 . . . . 0.0 109.162 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.529 HG21 ' CG2' ' A' ' 184' ' ' VAL . 16.8 mt -76.06 -50.67 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.099 -1.0 . . . . 0.0 110.706 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -55.28 -53.36 57.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.129 -0.982 . . . . 0.0 108.984 -178.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -51.45 -40.29 59.14 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.597 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.9 mm-40 -61.15 -52.7 63.76 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.75 -24.31 64.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 175' ' ' ASP . 33.5 p -52.74 -38.82 61.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 181' ' ' ASN . 28.5 mt-30 -101.33 38.09 1.65 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.488 ' HB3' HD21 ' A' ' 7' ' ' LEU . 16.3 m-20 42.61 50.73 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.745 0.784 . . . . 0.0 108.938 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 7.5 mt-30 -123.51 106.43 32.59 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 7' ' ' LEU . 14.9 Cg_endo -63.22 169.36 9.46 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.237 1.958 . . . . 0.0 113.086 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 40.8 t -122.8 135.15 63.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.273 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.65 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.2 OUTLIER -86.73 114.35 23.34 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.619 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 4.2 t80 -121.36 162.52 20.2 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.2 pt20 -167.35 132.95 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.952 -1.499 . . . . 0.0 111.624 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.42 110.75 4.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.612 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 94.2 t -78.2 162.59 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.334 . . . . 0.0 111.496 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.492 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -164.68 -139.77 2.72 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -87.86 -38.4 15.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -1.23 . . . . 0.0 110.985 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 m -76.66 -12.18 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.988 -1.07 . . . . 0.0 111.076 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.59 -172.57 21.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.14 107.95 3.22 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.516 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 8.7 t-80 -72.76 125.12 26.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -119.58 164.38 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.123 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 37.7 p90 -156.59 -158.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 55' ' ' ILE . 70.5 t -139.39 136.53 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.496 -1.377 . . . . 0.0 111.204 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 51.3 mt -102.94 112.51 36.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 23.4 p-10 -124.5 35.06 4.88 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.335 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.1 167.04 39.36 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 117.837 -2.125 . . . . 0.0 112.272 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.52 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -148.43 148.22 30.06 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.38 22.53 12.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 109.686 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.61 21.89 3.62 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.5 mtp180 -138.66 29.74 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -1.188 . . . . 0.0 109.108 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 11.7 m120 74.36 11.62 4.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 109.503 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.73 138.06 51.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.519 ' OH ' ' CG ' ' A' ' 171' ' ' GLU . 5.8 m-85 -123.07 168.13 12.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.054 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.592 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 51.2 t-80 -93.33 115.76 28.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.9 t -113.67 138.15 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.98 -1.075 . . . . 0.0 111.457 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 14.9 t-20 -100.28 80.92 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.557 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 3.4 m95 . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.498 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 3.2 pt20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 96.9 p -167.45 161.93 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -138.92 169.07 18.46 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.694 1.235 . . . . 0.0 110.4 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 40.6 t -117.12 119.2 61.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 158' ' ' HIS . 19.7 m -125.24 145.16 33.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 156' ' ' SER . . . 101.11 52.42 1.08 Allowed Glycine 0 N--CA 1.486 1.997 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.051 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.4 mt -103.94 93.63 2.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.273 . . . . 0.0 110.421 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.2 OUTLIER -162.41 141.99 7.25 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 178.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.579 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.354 2.036 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 201' ' ' GLY . 58.7 t . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 121.209 0.528 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 200' ' ' ASP . 18.4 mmtt -75.37 177.84 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 108.945 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.604 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.1 OUTLIER -77.49 103.04 7.19 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.607 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.669 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 23.8 mt -58.27 -52.97 63.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 108.89 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 ' HB ' ' A' ' 198' ' ' VAL . 11.3 mt -54.96 -41.3 70.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.698 -1.251 . . . . 0.0 108.893 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.5 t70 -68.92 -41.8 77.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.063 . . . . 0.0 108.903 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 p -58.48 -15.03 9.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 108.992 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 58' ' ' TYR . 9.4 mtpp -117.08 22.0 12.84 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.39 34.01 3.3 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 25.4 mt -87.35 108.3 18.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.379 -1.071 . . . . 0.0 110.06 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' CD2' ' HB ' ' A' ' 103' ' ' THR . 23.0 m-70 -134.82 83.62 2.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.625 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -90.4 176.17 6.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.84 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.415 ' O ' HG21 ' A' ' 50' ' ' THR . 6.1 t-20 -147.22 -164.66 2.05 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.6 mt-30 -124.52 -17.7 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.337 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.734 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.31 -36.98 1.05 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.632 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.755 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.02 -142.02 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.55 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.341 -177.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -74.13 3.72 4.9 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 CA-C-N 122.394 1.891 . . . . 0.0 109.417 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 11.1 m-85 -78.86 -32.26 45.95 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.1 p-10 -92.79 23.63 4.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.595 -1.316 . . . . 0.0 109.635 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mt -77.05 -1.33 28.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.169 -0.957 . . . . 0.0 110.362 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD13 ' HG3' ' A' ' 114' ' ' MET . 10.8 mt -134.14 14.09 3.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.717 -1.239 . . . . 0.0 109.359 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 22.3 p -82.68 163.88 49.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.65 134.63 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.002 1.801 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' CE2' ' A' ' 80' ' ' PHE . 20.7 t -78.89 149.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.502 0.668 . . . . 0.0 109.738 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.67 HD13 ' HD3' ' A' ' 133' ' ' PRO . 22.1 mt -78.3 148.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.804 0.811 . . . . 0.0 111.169 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' VAL . 9.0 mm-40 -126.04 -21.2 4.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.782 -0.574 . . . . 0.0 110.235 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.428 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 10.0 mtpt -121.28 164.51 16.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.148 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 37' ' ' SER . 80.9 t . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 110.625 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.496 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 64.7 m-85 -119.94 15.52 12.52 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.922 -1.111 . . . . 0.0 109.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 28' ' ' ILE . 62.3 t -63.83 137.44 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.599 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.19 -7.36 67.72 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.442 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.7 mt-30 -77.72 130.84 37.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -1.113 . . . . 0.0 109.651 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -73.15 110.0 7.1 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.15 159.9 0.85 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.141 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.61 168.3 19.97 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.599 0.714 . . . . 0.0 110.043 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.526 HG22 ' SD ' ' A' ' 120' ' ' MET . 18.0 p -78.85 -35.19 44.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 109.69 134.51 6.94 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 p -54.02 -50.49 66.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.55 HG13 ' HA2' ' A' ' 139' ' ' GLY . 47.0 t -47.05 -55.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.68 -48.15 82.81 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.911 0.862 . . . . 0.0 110.351 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.1 m -61.28 -38.92 88.51 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.49 -37.36 80.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.642 -1.286 . . . . 0.0 108.334 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 56' ' ' MET . 97.6 m -70.44 -56.68 6.04 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.36 -34.98 50.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.52 -0.737 . . . . 0.0 109.199 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.625 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 24.9 mt-30 -63.49 -61.95 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.493 HG13 HG23 ' A' ' 198' ' ' VAL . 46.4 mt -57.23 -30.19 34.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.515 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 25.8 mtp -63.36 -32.41 73.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.558 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 49.2 tptt -74.65 -43.38 55.62 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.669 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 39.2 t80 -51.8 -33.12 34.2 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.69 -0.631 . . . . 0.0 109.789 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 93.4 m-70 -108.71 -22.18 12.35 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 111.05 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.619 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 41.08 55.25 3.22 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -177.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -76.39 -68.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.7 Cg_endo -68.2 96.82 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.31 0.673 . . . . 0.0 111.962 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.06 -20.23 64.94 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -135.44 138.05 42.82 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 177.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.71 149.16 33.74 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.365 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.452 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -88.96 -54.35 4.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.951 . . . . 0.0 110.326 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.9 tttt -140.71 134.52 30.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.088 -1.008 . . . . 0.0 110.245 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -62.2 166.25 5.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.518 -0.738 . . . . 0.0 109.942 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 36.2 t80 -150.04 143.81 25.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.202 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.14 171.63 16.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.16 -0.963 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.617 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 27.3 p90 -173.06 158.57 3.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 109.92 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 89.0 m -93.66 137.89 32.46 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 HD11 ' A' ' 86' ' ' LEU . 9.3 tp -53.26 149.74 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.035 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 141.32 57.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.767 -0.583 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -69.08 -3.01 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t30 -99.53 -6.01 28.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.467 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 22.0 t-20 -70.12 110.87 7.54 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.867 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.4 Cg_endo -87.46 10.86 3.37 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.973 2.449 . . . . 0.0 110.216 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.642 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 56.6 m-85 -108.8 -1.71 19.06 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 111.415 -176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASN . 74.7 m-85 -141.57 160.93 39.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 9.2 m-80 -48.37 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER 174.42 -46.32 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.385 -0.822 . . . . 0.0 111.284 174.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.41 55.81 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 107.549 -1.75 . . . . 0.0 107.549 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 3.3 tptt -105.8 103.69 13.25 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.77 133.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 109.558 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.617 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -106.31 154.19 21.12 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 7.0 t80 -144.41 139.43 28.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.101 -178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.53 111.02 18.07 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.62 50.68 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.694 -1.254 . . . . 0.0 108.19 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.602 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 4.3 mt -52.81 -51.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.401 -0.812 . . . . 0.0 109.516 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.6 p -44.21 -29.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.674 -1.266 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -112.88 33.73 4.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 108.774 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.594 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.48 153.3 23.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.993 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -122.49 85.58 2.44 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-85 -80.9 95.47 6.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.272 -0.892 . . . . 0.0 109.896 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.1 m120 -78.69 92.11 4.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.619 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 50.2 m95 -60.95 -8.81 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.354 -0.841 . . . . 0.0 109.932 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -90.48 -23.51 20.95 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 8.3 m-20 -97.99 -26.62 14.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.558 ' O ' ' CE ' ' A' ' 57' ' ' LYS . 51.7 mt -74.05 64.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 59.4 mt -46.28 150.7 1.07 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.639 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.534 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -79.01 -27.12 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.496 2.131 . . . . 0.0 110.364 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.519 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -139.31 133.05 30.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.98 . . . . 0.0 109.132 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.648 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 76.9 m-85 -115.97 142.82 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.155 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.82 -4.39 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.96 10.11 84.43 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.93 -6.14 10.05 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.465 -1.02 . . . . 0.0 109.424 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HA ' ' NE ' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -63.97 169.54 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -71.07 -176.82 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.693 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 2.8 m120 -80.55 -33.84 35.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.78 -61.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -35.03 78.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.151 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.493 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.0 mttt -64.45 -43.25 94.85 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.058 -1.026 . . . . 0.0 108.308 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -59.91 -37.95 80.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 108.709 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.99 -68.26 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.501 -0.749 . . . . 0.0 109.762 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 2.2 tp -64.17 -43.72 97.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.559 -0.713 . . . . 0.0 109.679 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 24.1 p -56.63 -40.31 75.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 108.588 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.493 ' OE2' ' CZ ' ' A' ' 93' ' ' ARG . 6.3 tt0 -70.65 -40.79 72.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.553 HD22 ' CD1' ' A' ' 116' ' ' ILE . 24.2 tp -55.48 -50.54 69.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.546 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.2 mmt -60.01 -52.11 66.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.898 -0.501 . . . . 0.0 111.531 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.65 95.33 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 118' ' ' GLU . 6.8 m-20 -65.62 -49.43 68.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 49' ' ' ALA . 48.5 t -61.1 -60.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 108.953 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 127' ' ' VAL . . . -46.6 -44.37 16.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.44 -53.39 32.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.023 -1.281 . . . . 0.0 107.676 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 p -47.43 -32.44 5.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.39 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.6 m -101.49 36.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.005 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 127' ' ' VAL . 11.1 m-20 40.1 53.27 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.398 -0.814 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.539 ' HE3' ' CB ' ' A' ' 137' ' ' SER . 48.6 tpp -67.59 137.68 55.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 111.899 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 5.9 t0 -87.32 123.82 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.612 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 83.8 m-85 -104.7 120.57 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.482 1.134 . . . . 0.0 113.824 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.95 -162.44 10.82 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 104.69 -3.364 . . . . 0.0 104.69 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.67 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.16 -31.59 82.87 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 N-CA-C 105.648 -2.482 . . . . 0.0 105.648 175.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.9 m -110.23 143.04 40.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 173.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.509 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.8 m -121.33 110.92 16.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 119.87 -1.769 . . . . 0.0 110.087 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.86 137.94 14.32 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.455 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -117.26 -163.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 107.954 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.631 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.92 -56.22 3.26 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.567 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 125.88 -123.53 4.89 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.499 -1.334 . . . . 0.0 112.009 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.2 m -48.55 -65.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.797 -0.825 . . . . 0.0 112.602 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.48 -32.03 3.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.789 -1.194 . . . . 0.0 109.293 -178.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 53.2 mmt-85 -80.86 -51.25 8.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.973 0.892 . . . . 0.0 109.212 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' A' ' 185' ' ' TYR . 82.7 t -66.9 -54.84 21.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.809 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 2.4 pp0? -57.34 -34.35 68.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.955 -1.091 . . . . 0.0 108.749 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.523 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 6.0 ttm180 -78.4 -53.56 7.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.012 -1.055 . . . . 0.0 109.433 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -61.1 -37.27 82.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.21 -0.931 . . . . 0.0 110.223 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 143' ' ' VAL . 38.1 mt -58.47 -46.09 87.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.952 -1.092 . . . . 0.0 109.377 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.552 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 59.5 mtmt -87.72 -49.24 7.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.104 . . . . 0.0 110.981 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.523 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 34.2 mt-10 -67.07 -43.01 83.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.679 -1.263 . . . . 0.0 111.566 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 31.9 m120 -94.4 -49.7 5.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.681 -1.262 . . . . 0.0 111.485 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.515 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 29.6 m-85 -99.42 20.33 13.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.874 -1.141 . . . . 0.0 110.598 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 30.66 40.64 0.05 OUTLIER Glycine 0 N--CA 1.497 2.767 0 O-C-N 121.862 -0.524 . . . . 0.0 112.62 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.9 m-85 -62.88 158.84 18.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.142 -1.799 . . . . 0.0 107.564 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 61.7 t30 -47.17 154.35 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.741 -1.224 . . . . 0.0 109.533 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -56.05 -16.52 5.1 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.6 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 3.6 p -53.02 -17.35 1.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 40.5 t -72.67 119.61 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.866 -1.146 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.605 ' CD2' HG22 ' A' ' 249' ' ' VAL . 0.6 OUTLIER -148.19 166.81 26.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.191 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.533 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -112.68 137.03 51.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.953 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.578 HG13 ' CH2' ' A' ' 170' ' ' TRP . 14.7 pt -122.62 170.34 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 1.3 m-80 -127.53 103.46 7.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.683 -1.261 . . . . 0.0 110.509 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.6 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.44 -39.45 15.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.86 . . . . 0.0 109.226 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.08 -26.91 64.1 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -104.8 4.57 32.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.057 -1.26 . . . . 0.0 112.274 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.47 163.81 15.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.2 -1.562 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.7 ttpt -29.36 -51.49 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.21 -60.67 2.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.895 -1.128 . . . . 0.0 110.775 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.47 -18.24 58.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 109.571 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.6 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 71.3 t-105 -74.73 -50.89 15.8 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 46.1 mt-10 -69.99 -36.1 74.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -45.75 -41.65 10.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.62 -43.65 97.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 199' ' ' ILE . 14.7 mt -68.6 -53.91 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.27 -49.17 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.138 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' A' ' 179' ' ' SER . 6.3 tttt -51.52 -45.26 62.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.912 -1.118 . . . . 0.0 108.611 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.559 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 19.9 mm-40 -60.53 -52.32 65.68 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.902 . . . . 0.0 108.946 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 199' ' ' ILE . 93.5 mt -65.15 -26.76 68.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.779 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.475 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 22.3 p -51.89 -39.99 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.505 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.499 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 19.6 mt-30 -102.32 35.08 2.52 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 7' ' ' LEU . 16.2 m120 47.82 50.43 15.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 16.7 mt-30 -123.04 105.04 34.92 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 199' ' ' ILE . 18.7 Cg_endo -62.62 168.85 9.32 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 121.602 1.535 . . . . 0.0 111.869 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.553 HG12 HD12 ' A' ' 199' ' ' ILE . 2.4 t -129.84 138.18 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.097 0.951 . . . . 0.0 110.79 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.687 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.1 OUTLIER -86.83 123.34 31.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -123.73 161.45 25.14 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -166.45 129.54 1.95 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 117.666 -1.614 . . . . 0.0 111.115 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.19 122.37 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.527 HG22 ' NE2' ' A' ' 187' ' ' GLN . 5.1 t -85.73 168.84 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.152 -1.205 . . . . 0.0 111.117 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -176.41 -142.82 4.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -87.73 -36.49 17.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.07 -1.253 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.4 m -75.03 -17.76 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.153 -0.967 . . . . 0.0 110.928 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.17 -170.17 22.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.55 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -89.85 107.38 3.42 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.753 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.2 t-80 -72.46 134.92 45.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.64 162.71 20.22 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.609 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 18.3 p90 -157.13 172.3 18.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.603 ' HB ' HD11 ' A' ' 8' ' ' LEU . 87.5 t -113.29 140.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.736 -1.228 . . . . 0.0 112.752 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 209' ' ' HIS . 36.2 mt -98.16 130.44 46.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 7.5 p-10 -150.81 37.45 0.65 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.926 -1.51 . . . . 0.0 111.494 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 4' ' ' VAL . . . 174.92 -179.46 46.2 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 120.267 -1.52 . . . . 0.0 110.464 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.638 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.4 150.9 7.72 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -1.209 . . . . 0.0 109.661 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -111.28 27.52 9.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.07 . . . . 0.0 109.897 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.94 22.34 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.68 44.6 2.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -1.193 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.67 22.36 13.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 5.2 m-85 -121.59 136.69 54.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.509 ' HB3' HG21 ' A' ' 199' ' ' ILE . 28.2 m-85 -121.29 167.64 12.51 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 2.1 t60 -91.55 135.52 33.8 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.089 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 197' ' ' PHE . 49.9 t -123.62 136.18 60.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.204 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.515 ' ND2' HD13 ' A' ' 8' ' ' LEU . 19.6 t-20 -112.91 78.87 1.17 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.574 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 84.5 m95 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 77.2 p -148.72 158.72 44.34 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.207 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.442 ' HB3' ' CH2' ' A' ' 170' ' ' TRP . . . -131.11 151.11 51.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.886 0.851 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 75.8 t -116.54 116.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.605 HG22 ' CD2' ' A' ' 158' ' ' HIS . 18.7 m -124.15 143.05 38.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.741 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.81 56.89 1.57 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.627 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.68 79.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 110.565 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 13.8 pttm -159.58 155.96 24.05 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.9 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.274 1.982 . . . . 0.0 110.439 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.758 HG13 ' HA2' ' A' ' 201' ' ' GLY . 29.0 t . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.282 0.563 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -77.03 175.72 9.33 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.581 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 11.2 t -77.12 111.28 12.56 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.971 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 52.5 mt -58.41 -50.77 72.48 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 13' ' ' ILE . 10.0 mt -56.3 -34.32 66.38 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.964 -1.085 . . . . 0.0 108.339 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 26.5 t0 -66.87 -41.16 87.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 0.0 109.274 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 82.8 p -58.1 -16.06 11.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.095 . . . . 0.0 108.593 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 13' ' ' ILE . 16.7 mtpt -122.41 19.75 10.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 41.84 42.5 3.88 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 11.6 mt -86.8 100.69 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.293 -1.122 . . . . 0.0 110.677 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.5 m-70 -128.05 75.32 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 13.5 m-30 -81.18 170.01 16.66 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.283 1.04 . . . . 0.0 111.851 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.77 -174.91 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 47' ' ' SER . 6.3 mt-30 -125.08 18.36 8.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.816 -1.178 . . . . 0.0 110.056 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 22' ' ' ASN . . . -116.74 -87.14 1.28 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.319 -1.419 . . . . 0.0 113.474 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.848 ' ND2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -46.38 -103.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 116.658 -1.639 . . . . 0.0 113.945 -175.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.848 ' HD2' ' ND2' ' A' ' 19' ' ' ASN . 51.9 Cg_endo -83.95 5.58 6.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 123.332 2.226 . . . . 0.0 112.486 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.447 ' CD1' HG12 ' A' ' 116' ' ' ILE . 83.1 m-85 -87.05 -31.97 20.24 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 120.94 -1.1 . . . . 0.0 110.118 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 38.2 p-10 -101.66 27.95 5.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 109.725 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 9.0 mt -76.03 -4.49 41.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD21 ' HA ' ' A' ' 24' ' ' LEU . 12.2 mt -131.19 21.7 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.8 -1.188 . . . . 0.0 109.264 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.538 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.3 p -89.68 164.31 29.62 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.97 136.46 35.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.248 1.965 . . . . 0.0 112.048 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.08 148.7 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.663 0.744 . . . . 0.0 110.123 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD13 ' HD3' ' A' ' 133' ' ' PRO . 23.8 mt -78.78 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.646 0.736 . . . . 0.0 111.392 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' VAL . 2.6 mt-10 -126.54 -20.38 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.776 -0.578 . . . . 0.0 110.458 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HB2' ' CA ' ' A' ' 79' ' ' TYR . 12.4 mtpp -117.65 168.07 10.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.93 -1.106 . . . . 0.0 110.663 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.595 -0.691 . . . . 0.0 110.335 -179.556 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.9 m-85 -122.4 16.0 10.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.012 -1.055 . . . . 0.0 109.45 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 28' ' ' ILE . 60.5 t -64.03 139.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.932 . . . . 0.0 109.554 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 2.18 89.3 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 21.8 mt-30 -89.02 130.29 35.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -1.165 . . . . 0.0 109.511 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.01 110.14 7.07 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.17 159.01 1.0 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.031 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' OG ' ' A' ' 135' ' ' SER . . . -77.52 166.27 23.28 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.498 0.666 . . . . 0.0 110.085 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.542 ' O ' ' CE ' ' A' ' 129' ' ' MET . 13.2 p -78.89 -30.15 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 100.96 137.19 9.67 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.522 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 7.8 p -55.58 -48.53 74.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.317 -1.107 . . . . 0.0 108.188 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 127' ' ' VAL . 3.3 t -46.43 -52.84 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . . . -61.52 -50.73 71.54 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.685 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 16.9 m -64.83 -28.43 69.55 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.487 -0.758 . . . . 0.0 109.811 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -66.41 -45.15 80.91 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.127 -1.429 . . . . 0.0 107.791 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.569 ' OG1' HG23 ' A' ' 143' ' ' VAL . 33.3 m -76.13 -49.74 16.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.683 0.754 . . . . 0.0 110.281 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.13 -34.49 31.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.391 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.5 mt-30 -67.18 -52.54 40.13 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' CG2' HD13 ' A' ' 251' ' ' ILE . 29.9 mt -61.24 -25.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.577 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 15.1 mtp -70.5 -36.02 73.57 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.575 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.1 tptt -76.11 -40.87 51.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.63 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 52.7 t80 -53.93 -25.56 21.05 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.015 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.1 m-70 -108.09 -28.0 9.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 110.529 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.616 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.5 m-20 47.88 61.75 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -84.67 -78.9 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.0 Cg_endo -71.49 107.47 2.17 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.815 0.97 . . . . 0.0 113.25 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 -24.85 65.65 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 3.5 ttpt -130.12 128.34 41.62 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.56 164.05 5.71 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.463 -1.827 . . . . 0.0 110.397 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.564 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -96.59 -35.36 11.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -1.063 . . . . 0.0 111.285 -179.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.1 tttt -152.67 134.14 14.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.607 -1.308 . . . . 0.0 110.402 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 7.7 m-20 -64.08 172.98 2.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.434 -0.791 . . . . 0.0 109.424 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 27.6 t80 -153.94 147.2 24.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -150.32 169.75 20.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.778 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 28.0 p90 -169.59 157.13 6.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 m -93.01 133.88 35.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 HD21 ' CG ' ' A' ' 77' ' ' ASN . 8.9 tp -50.57 149.56 3.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 111.21 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.43 140.65 58.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.932 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.84 -4.15 11.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.954 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 t30 -99.13 -5.88 29.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.021 -1.049 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 23.5 t-20 -70.17 110.33 6.55 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.733 -0.605 . . . . 0.0 110.208 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.648 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 48.7 Cg_endo -88.61 13.59 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.81 2.34 . . . . 0.0 109.619 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.648 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.1 m-85 -107.89 -4.8 17.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 111.363 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 81' ' ' ASN . 35.3 m-85 -142.24 164.15 30.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.6 m120 -49.23 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 173.74 -47.18 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.976 175.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.62 56.31 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 6.4 tptt -106.06 105.8 16.01 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.342 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.05 139.35 35.84 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -112.07 137.53 49.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 61.5 t80 -125.13 132.24 53.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.593 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -112.75 114.13 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 92' ' ' THR . . . -73.62 50.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.85 -1.156 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.638 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.9 mt -53.47 -57.33 5.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.551 -0.718 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.2 p -43.81 -29.5 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.763 -1.211 . . . . 0.0 109.103 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.58 34.11 4.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.604 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.638 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 8.6 mmt180 -84.31 157.85 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.446 -1.409 . . . . 0.0 109.365 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.14 85.74 2.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.8 m-85 -81.13 93.8 6.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.463 -0.773 . . . . 0.0 110.154 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -77.94 93.27 4.4 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.616 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 56.8 m95 -60.81 -8.35 2.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.518 -0.739 . . . . 0.0 110.458 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -91.02 -21.45 21.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.85 -1.157 . . . . 0.0 108.298 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 26.2 m-20 -99.74 -25.63 14.32 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.608 HD12 ' CE3' ' A' ' 97' ' ' TRP . 68.9 mt -73.69 70.97 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 36.7 mt -52.84 150.43 9.9 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.564 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.8 Cg_endo -79.23 -23.09 7.86 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.964 2.442 . . . . 0.0 110.192 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -144.24 123.93 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.859 -1.151 . . . . 0.0 109.975 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 35.2 m-85 -110.62 138.47 46.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.15 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -99.74 -4.56 30.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.27 7.5 60.7 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -120.28 -1.32 10.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -1.118 . . . . 0.0 109.427 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.33 167.11 7.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.35 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -69.55 170.63 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.339 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.58 -35.19 70.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.01 -61.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.763 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.39 -32.15 72.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.356 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 10.4 mttt -66.5 -44.03 83.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.18 -0.95 . . . . 0.0 108.488 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.434 ' CG ' HD13 ' A' ' 24' ' ' LEU . 4.7 ttm -59.13 -34.49 72.1 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 100' ' ' ILE . . . -56.9 -68.05 0.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.529 -0.732 . . . . 0.0 109.437 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.619 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.5 tp -63.28 -52.13 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.123 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 23' ' ' LEU . 4.2 p -45.6 -41.0 9.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 34.7 tt0 -70.61 -54.4 12.16 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.549 HD22 ' HB3' ' A' ' 53' ' ' ALA . 8.8 tp -46.9 -48.14 21.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.578 ' HE1' ' CD2' ' A' ' 15' ' ' TYR . 24.1 mmt -59.44 -53.99 51.75 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.842 -0.536 . . . . 0.0 111.047 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.22 75.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.939 -1.101 . . . . 0.0 108.564 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.485 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 9.5 m-20 -64.2 -47.3 80.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 49' ' ' ALA . 63.0 t -71.54 -51.65 31.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.126 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.86 -51.7 12.82 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 88' ' ' ALA . 2.9 mt -62.57 -57.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.177 -1.19 . . . . 0.0 108.258 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.512 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.67 -29.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.396 -178.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.764 HG13 HG22 ' A' ' 143' ' ' VAL . 28.5 m -101.08 34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.428 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 127' ' ' VAL . 95.4 m-20 40.83 51.19 3.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 109.246 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.5 tpp -66.04 126.16 27.72 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 111.698 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 135' ' ' SER . 4.5 t0 -76.53 122.57 24.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.593 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.0 m-85 -103.42 116.79 33.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.248 1.023 . . . . 0.0 113.141 -175.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.514 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.28 -162.48 10.74 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.686 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -62.64 -29.47 77.86 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 105.818 -2.416 . . . . 0.0 105.818 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 139.54 45.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 44' ' ' ALA . 50.4 m -121.11 107.88 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.067 -1.646 . . . . 0.0 110.008 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.76 143.73 16.28 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.002 -1.095 . . . . 0.0 110.606 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.5 -163.47 0.93 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.61 -60.1 2.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.602 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 139.43 -134.5 6.71 Favored Glycine 0 N--CA 1.48 1.573 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.627 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.507 ' OG ' HG23 ' A' ' 248' ' ' VAL . 71.7 m -51.42 -49.41 61.68 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.677 -0.896 . . . . 0.0 112.298 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -45.84 -47.47 15.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 110.005 -177.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.6 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.1 mmt180 -81.25 -37.01 29.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.98 -1.075 . . . . 0.0 110.322 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.764 HG22 HG13 ' A' ' 127' ' ' VAL . 48.2 t -66.24 -61.27 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.739 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.38 -31.52 63.91 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.925 -1.109 . . . . 0.0 108.217 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.495 ' NH1' ' OE2' ' A' ' 149' ' ' GLU . 1.6 ttm-85 -76.12 -48.95 18.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 109.28 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -66.56 -36.16 81.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.159 -0.963 . . . . 0.0 110.097 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.494 HD13 HG11 ' A' ' 143' ' ' VAL . 35.8 mt -56.47 -46.4 80.43 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 56.1 mtmt -87.47 -40.75 14.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.903 -1.123 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.495 ' OE2' ' NH1' ' A' ' 145' ' ' ARG . 29.8 mt-10 -68.65 -58.56 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.836 -1.165 . . . . 0.0 112.316 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 90' ' ' ILE . 23.4 m120 -85.07 -46.59 11.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.832 -1.168 . . . . 0.0 112.387 -177.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 44.3 m-85 -89.9 -12.53 38.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.619 -1.3 . . . . 0.0 110.343 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.564 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 66.16 32.15 81.4 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.482 177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 15.2 m-85 -63.35 153.7 34.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.264 -1.727 . . . . 0.0 107.663 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.5 t-20 -46.71 155.71 0.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.786 -1.196 . . . . 0.0 109.971 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 76.7 mm-40 -55.98 -15.99 4.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.379 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.606 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 70.8 p -53.1 -17.61 1.67 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.169 -0.957 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 19.7 t -71.47 122.2 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.926 -1.108 . . . . 0.0 109.495 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CE1' ' O ' ' A' ' 156' ' ' SER . 1.5 p-80 -146.99 -178.26 6.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.119 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 4.2 tt0 -124.91 152.51 43.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 110.472 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.515 ' O ' ' CA ' ' A' ' 246' ' ' SER . 11.0 pt -133.07 145.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -110.56 103.68 12.3 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.034 -1.041 . . . . 0.0 110.895 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.616 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.54 -40.21 18.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.21 -0.931 . . . . 0.0 109.353 179.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.02 -23.57 59.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.23 -0.83 27.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.093 -1.239 . . . . 0.0 111.56 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -117.48 169.04 9.84 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.467 -1.396 . . . . 0.0 109.94 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 167' ' ' LYS . 6.9 p -94.7 132.5 39.38 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 166' ' ' SER . 37.2 tttp -32.73 -44.02 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -64.3 -65.35 0.69 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.55 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 4.0 m-20 -62.36 -14.33 38.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.134 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.616 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 62.2 t-105 -72.76 -52.5 14.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.043 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.477 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 30.8 mt-10 -67.77 -21.99 65.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 169' ' ' ASP . . . -56.54 -45.33 81.25 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.05 -35.93 78.24 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 199' ' ' ILE . 15.5 mt -74.57 -61.81 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.231 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.85 -51.59 39.02 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.373 -0.829 . . . . 0.0 109.767 -178.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -51.15 -44.14 61.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.572 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 4.0 mm-40 -61.1 -46.73 89.44 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.571 HD12 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -67.84 -28.15 67.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.536 -0.728 . . . . 0.0 109.916 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 175' ' ' ASP . 22.5 p -52.45 -40.3 62.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.958 -1.089 . . . . 0.0 108.638 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.442 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 11.4 mt-30 -99.57 33.61 2.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.558 ' HA ' HD21 ' A' ' 7' ' ' LEU . 75.5 m-20 43.73 53.46 6.02 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.892 0.853 . . . . 0.0 108.985 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.53 ' CB ' ' OE1' ' A' ' 177' ' ' GLU . 6.5 mt-30 -124.36 110.68 28.47 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.502 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.7 Cg_endo -64.84 165.48 21.02 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.765 1.643 . . . . 0.0 112.658 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 25.0 t -121.03 132.97 69.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.043 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.2 OUTLIER -83.93 116.57 22.86 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 176.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.686 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 7.3 t80 -122.08 157.44 31.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.957 -1.09 . . . . 0.0 110.153 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.59 131.74 4.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.998 -1.481 . . . . 0.0 111.682 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.83 132.79 11.44 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.504 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 2.9 t -88.99 172.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.916 -1.343 . . . . 0.0 110.964 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -176.28 -148.96 7.27 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -30.04 20.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.1 -1.235 . . . . 0.0 110.716 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -83.39 -16.17 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.91 -1.118 . . . . 0.0 111.034 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.19 -164.18 25.32 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.526 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -95.15 112.34 4.37 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.964 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.4 t-80 -71.94 134.05 45.75 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -120.35 162.92 18.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.058 -1.457 . . . . 0.0 112.777 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.686 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 44.0 p90 -162.44 166.67 24.71 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 55' ' ' ILE . 81.7 t -114.24 137.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.89 -1.131 . . . . 0.0 112.699 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.571 ' CG2' HD12 ' A' ' 178' ' ' LEU . 54.0 mt -98.09 131.32 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.9 p30 -143.43 30.09 1.39 Allowed 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.232 -1.387 . . . . 0.0 110.386 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.758 ' HA2' HG13 ' A' ' 4' ' ' VAL . . . 177.36 -174.25 46.83 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 117.794 -2.145 . . . . 0.0 111.93 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.655 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.2 154.94 11.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.662 -0.905 . . . . 0.0 108.794 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.57 5.96 12.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.757 -1.214 . . . . 0.0 110.314 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.51 -32.79 5.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -84.9 45.67 1.18 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.259 -1.142 . . . . 0.0 109.884 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.29 16.76 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 8.9 m-85 -104.11 145.11 30.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.014 -1.054 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.558 ' HB3' HG21 ' A' ' 199' ' ' ILE . 54.4 m-85 -123.44 161.76 24.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.581 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 30.1 t-80 -91.75 123.02 34.82 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.581 HG12 ' CE2' ' A' ' 212' ' ' TRP . 33.1 t -115.3 150.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.49 -177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.2 t-20 -120.38 70.22 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.581 ' CE2' HG12 ' A' ' 210' ' ' VAL . 18.4 m95 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 111.316 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 22.2 mt-30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.515 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 19.6 p -159.17 159.73 34.69 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.145 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.6 163.86 29.15 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.146 0.974 . . . . 0.0 109.714 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 95.3 t -117.25 126.73 74.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.6 ' CG2' ' CD2' ' A' ' 158' ' ' HIS . 22.8 m -132.49 149.08 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 157' ' ' VAL . . . 98.05 55.06 1.15 Allowed Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.942 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.606 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.2 mt -104.0 94.9 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.165 -1.197 . . . . 0.0 110.447 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 18.0 pttt -163.67 144.9 7.19 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.13 -0.981 . . . . 0.0 109.136 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.594 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.233 1.955 . . . . 0.0 110.387 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 178' ' ' LEU . 98.2 t . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -74.17 -178.34 3.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.984 -1.072 . . . . 0.0 108.359 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -77.53 104.0 7.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.054 -1.029 . . . . 0.0 110.36 -178.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.655 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 33.4 mt -58.06 -45.54 86.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 7.7 mt -61.2 -41.16 96.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.842 -1.161 . . . . 0.0 109.035 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.1 t70 -66.14 -37.52 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -57.64 -16.36 10.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 13' ' ' ILE . 1.7 mtpt -122.39 17.45 10.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.41 45.73 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.9 mt -90.55 107.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -1.021 . . . . 0.0 111.084 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 102' ' ' PRO . 31.5 m80 -131.43 95.58 3.79 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 9.7 m-30 -97.35 179.93 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.93 0.872 . . . . 0.0 111.274 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.42 -164.81 2.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 33.9 mt-30 -124.49 -23.56 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.064 -1.022 . . . . 0.0 110.053 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.68 -33.17 1.61 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.231 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.768 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.63 -142.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.518 0 CA-C-N 117.693 0.746 . . . . 0.0 111.093 -178.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.768 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -73.68 3.24 5.05 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 CA-C-N 122.229 1.832 . . . . 0.0 109.606 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.567 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 7.3 m-85 -80.37 -27.89 38.11 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.002 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.8 p-10 -97.83 16.48 20.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.461 -1.399 . . . . 0.0 109.743 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 5.8 mt -70.84 -3.44 19.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 110.003 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD13 ' CA ' ' A' ' 118' ' ' GLU . 15.7 mt -129.61 -6.37 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.064 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -60.82 164.47 7.52 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.9 Cg_endo -70.22 136.36 31.57 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.017 1.811 . . . . 0.0 111.625 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 42' ' ' HIS . 35.6 t -82.39 149.86 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.557 0.694 . . . . 0.0 109.953 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 ' HD3' ' A' ' 133' ' ' PRO . 9.8 mt -77.75 151.03 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.62 0.724 . . . . 0.0 110.75 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -125.54 -21.96 4.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.683 -0.636 . . . . 0.0 110.417 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' TYR . 48.5 mtpt -124.0 171.1 10.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 110.068 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 37' ' ' SER . 77.1 t . . . . . 0 N--CA 1.487 1.376 0 O-C-N 121.341 -0.849 . . . . 0.0 110.812 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.596 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 73.9 m-85 -124.0 21.79 8.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.898 -1.126 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 28' ' ' ILE . 70.7 t -68.24 139.13 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.776 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.35 1.37 85.92 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 29.0 mt-30 -86.1 129.82 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.542 ' CE1' HG21 ' A' ' 27' ' ' VAL . 1.3 m-70 -73.36 111.38 8.43 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.56 158.08 1.37 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.861 -177.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -74.51 169.36 17.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.429 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 HG22 ' SD ' ' A' ' 120' ' ' MET . 31.7 p -80.76 -34.66 34.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 108.675 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.515 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 103.34 134.47 8.3 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.8 p -54.49 -50.86 66.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.135 -1.214 . . . . 0.0 108.362 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 55.6 t -46.6 -53.87 2.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.599 -0.84 . . . . 0.0 108.754 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -58.49 -52.03 67.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.46 -0.775 . . . . 0.0 110.206 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.496 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 17.4 m -63.48 -34.33 77.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.15 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -63.42 -41.42 98.7 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.299 -1.361 . . . . 0.0 107.865 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' HG13 ' A' ' 143' ' ' VAL . 34.0 m -74.68 -49.0 22.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.42 0.629 . . . . 0.0 109.623 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -52.65 -41.83 64.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.822 . . . . 0.0 109.883 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.631 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 31.0 mt-30 -60.16 -51.64 68.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.759 -1.213 . . . . 0.0 107.941 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.508 HG13 HG22 ' A' ' 198' ' ' VAL . 34.1 mt -63.79 -28.1 44.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.535 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 18.5 mtp -67.93 -36.18 79.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -76.38 -42.55 44.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.3 t80 -53.34 -29.66 35.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 109.312 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 36.7 m-70 -105.5 -25.93 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 110.163 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.612 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.4 m-20 45.0 59.14 3.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -84.34 -70.16 0.13 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.024 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.4 Cg_endo -67.37 96.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.398 0.732 . . . . 0.0 111.623 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.15 -20.39 64.88 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 91' ' ' SER . 4.1 tttp -135.68 140.08 44.18 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.93 144.51 41.62 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.124 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -83.11 -53.85 5.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.951 . . . . 0.0 110.176 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 9.9 ttpp -145.25 142.5 29.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.29 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 9.7 m-20 -66.69 171.51 5.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -0.852 . . . . 0.0 109.884 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 70' ' ' THR . 51.1 t80 -148.62 164.39 34.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.58 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 14.5 t -166.11 162.53 17.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.65 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 24.9 p90 -166.62 154.65 9.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -92.97 136.97 32.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.531 HD21 ' CG ' ' A' ' 77' ' ' ASN . 10.2 tp -54.18 150.77 7.92 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.193 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.74 141.53 57.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.349 0.595 . . . . 0.0 110.076 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -3.26 13.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.082 -1.011 . . . . 0.0 109.71 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.4 m-20 -99.74 -7.27 25.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 33.8 t-20 -69.92 109.84 5.49 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.709 -0.62 . . . . 0.0 109.785 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.635 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.89 16.19 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.867 2.378 . . . . 0.0 110.126 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.635 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.9 m-85 -106.57 -26.25 11.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 111.033 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 3.7 m-85 -118.64 162.74 17.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.1 m-80 -46.36 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.15 -47.88 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.164 -0.96 . . . . 0.0 111.178 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.1 Cg_endo -76.75 57.21 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 106.877 -2.009 . . . . 0.0 106.877 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.66 104.46 14.18 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.394 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -100.53 134.11 43.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.339 -0.85 . . . . 0.0 109.679 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.65 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -106.3 137.32 44.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 27.1 t80 -128.54 131.55 48.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.06 -1.025 . . . . 0.0 110.261 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.01 114.75 28.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.48 51.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.728 -1.232 . . . . 0.0 108.312 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.61 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 6.7 mt -52.55 -54.32 16.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.492 -0.755 . . . . 0.0 109.593 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 90' ' ' ILE . 3.6 p -45.41 -26.62 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.497 -1.377 . . . . 0.0 109.154 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -111.38 28.48 8.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.606 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.52 150.72 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.872 0.844 . . . . 0.0 110.822 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 86.9 2.6 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.5 m-85 -80.8 91.41 5.93 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.339 -0.851 . . . . 0.0 110.19 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 24.2 t-20 -79.58 90.6 5.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 58.0 m95 -61.07 -9.06 3.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.229 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.39 -14.7 32.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 53.3 m-20 -100.13 -32.92 10.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.595 HD12 ' CE3' ' A' ' 97' ' ' TRP . 23.4 mt -73.35 95.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.35 1.071 . . . . 0.0 108.566 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 11.8 mt -72.46 153.13 91.97 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.314 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.1 Cg_endo -79.14 -31.84 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.831 2.354 . . . . 0.0 110.344 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -136.8 136.03 38.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.581 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 74.9 m-85 -120.12 140.63 50.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 p -102.18 -1.06 32.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.15 88.62 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.513 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -118.74 -2.46 10.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.476 -1.014 . . . . 0.0 109.264 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.416 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 14.0 mp0 -64.03 167.79 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.3 p -65.05 179.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -82.97 -40.48 19.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.8 t -52.05 -52.36 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.15 98.75 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 108.988 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.473 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 24.1 mttt -61.21 -36.83 80.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.422 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 50.4 ttm -59.26 -46.03 89.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.5 -0.75 . . . . 0.0 109.666 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.403 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -58.1 -51.88 67.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.581 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 4.9 tp -68.86 -44.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.49 -1.381 . . . . 0.0 109.468 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.8 p -52.9 -41.45 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.024 -1.047 . . . . 0.0 108.649 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.538 ' CA ' HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -70.01 -45.59 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 53' ' ' ALA . 13.2 tp -50.86 -54.41 24.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.567 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -59.84 -43.92 94.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.685 . . . . 0.0 109.521 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.85 -39.86 94.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 126' ' ' SER . 24.8 m-20 -68.69 -43.37 76.24 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 49' ' ' ALA . 79.8 t -70.75 -62.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.726 -0.609 . . . . 0.0 109.849 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.532 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.65 -45.32 17.8 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.81 -57.49 11.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.07 -1.253 . . . . 0.0 108.106 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 9.4 p -46.06 -29.62 1.56 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.61 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.04 37.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.019 -1.051 . . . . 0.0 110.093 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HB2' ' NE ' ' A' ' 142' ' ' ARG . 2.9 m-20 40.31 38.5 0.55 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.369 -0.832 . . . . 0.0 109.656 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.521 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 45.9 tpp -52.97 129.11 29.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.822 . . . . 0.0 111.192 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.9 t0 -78.72 122.78 26.43 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 66.3 m-85 -105.2 119.39 38.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.995 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.506 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -149.99 -163.29 11.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 103.753 -3.739 . . . . 0.0 103.753 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -61.58 -31.0 86.85 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 105.438 -2.562 . . . . 0.0 105.438 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.75 138.26 47.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -114.44 110.5 19.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.853 -1.779 . . . . 0.0 109.577 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -106.81 135.45 12.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 14.9 t -118.18 -163.79 0.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.127 -1.22 . . . . 0.0 108.672 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.533 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.07 -56.05 3.22 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.54 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 128.16 -119.89 3.24 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.796 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.549 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.6 m -51.32 -66.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.85 -0.794 . . . . 0.0 112.871 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -46.89 -35.1 6.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.89 -1.131 . . . . 0.0 109.871 -177.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.567 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 48.0 mmt-85 -79.54 -47.86 14.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.299 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.677 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.7 t -67.29 -60.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.483 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -55.9 -30.18 61.17 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.362 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 3.5 ttt180 -77.35 -41.53 40.06 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.252 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -70.23 -37.44 75.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 110.31 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 251' ' ' ILE . 58.8 mt -58.11 -53.5 57.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.651 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.579 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 53.6 mtmt -77.46 -52.57 8.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.715 . . . . 0.0 112.097 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 9.2 mt-10 -66.23 -45.56 80.26 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.49 -1.381 . . . . 0.0 112.383 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.02 -45.26 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.559 -1.338 . . . . 0.0 111.506 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.535 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 34.2 m-85 -100.02 19.99 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 30.66 39.6 0.04 OUTLIER Glycine 0 N--CA 1.496 2.668 0 O-C-N 121.905 -0.497 . . . . 0.0 112.992 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 9.8 m-85 -63.36 161.08 14.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.212 -1.758 . . . . 0.0 107.478 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.0 t-20 -47.44 147.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.765 -1.209 . . . . 0.0 109.612 -178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -54.81 -17.11 3.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.254 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.585 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 4.4 p -53.54 -15.87 1.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.579 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 67.0 t -68.81 129.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.638 -1.289 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.613 ' CD2' HG22 ' A' ' 249' ' ' VAL . 1.1 p-80 -149.46 172.67 14.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.24 -0.912 . . . . 0.0 109.796 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.549 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -117.49 136.36 53.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 246' ' ' SER . 8.8 pt -123.19 170.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.3 m-80 -123.87 102.66 7.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 110.485 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 2.6 tpt180 -47.22 -39.2 13.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 109.084 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.51 69.74 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -104.91 34.35 3.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.995 -1.297 . . . . 0.0 112.258 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.59 170.94 14.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.306 -1.496 . . . . 0.0 110.217 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.0 p -96.43 135.8 37.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 6.7 ttpt -34.78 -51.49 0.5 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.813 -0.554 . . . . 0.0 110.978 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -56.09 17.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.403 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.404 ' HB2' ' OG ' ' A' ' 166' ' ' SER . 1.5 m-20 -63.09 -22.32 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.124 -0.985 . . . . 0.0 109.612 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 70.0 t-105 -71.87 -45.73 60.32 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.133 -0.979 . . . . 0.0 109.169 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.451 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 69.3 mt-10 -70.87 -26.37 63.22 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.078 -1.014 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.05 83.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.14 -40.45 93.87 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.588 HG23 ' CD1' ' A' ' 199' ' ' ILE . 12.5 mt -75.72 -56.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.422 -0.799 . . . . 0.0 110.486 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.1 OUTLIER -49.87 -46.09 51.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.979 -1.076 . . . . 0.0 109.022 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.439 ' O ' ' OG ' ' A' ' 179' ' ' SER . 6.6 tttt -52.15 -45.26 64.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 108.215 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 31.0 mm-40 -59.71 -48.36 81.98 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.511 ' HB3' HG11 ' A' ' 4' ' ' VAL . 22.6 mt -67.63 -27.63 67.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 176' ' ' LYS . 20.7 p -51.36 -42.78 61.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 108.716 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 181' ' ' ASN . 19.3 mt-30 -98.67 38.58 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.49 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 90.5 m-20 43.3 49.97 5.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 5.3 mt-30 -123.64 114.49 28.52 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.543 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.3 Cg_endo -65.72 169.6 12.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.421 2.08 . . . . 0.0 112.807 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.7 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 58.5 t -125.61 131.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.81 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.677 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -82.93 120.14 25.31 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.98 161.93 23.3 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.894 -1.129 . . . . 0.0 109.546 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -166.74 129.01 1.78 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.466 -1.693 . . . . 0.0 112.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -93.19 124.8 7.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 5.6 t -83.19 170.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.305 . . . . 0.0 111.12 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -175.33 -145.24 5.34 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -87.66 -29.48 21.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.021 -1.282 . . . . 0.0 110.678 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 m -81.82 -14.82 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.959 -1.088 . . . . 0.0 110.893 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.66 -164.41 24.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.539 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -87.93 106.45 3.21 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 121.089 -1.242 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 11.4 t-80 -71.43 132.75 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.71 165.05 15.62 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.102 -1.439 . . . . 0.0 113.006 -177.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.604 ' HB3' ' CE3' ' A' ' 212' ' ' TRP . 17.5 p90 -162.64 168.91 20.97 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.508 HG22 HG13 ' A' ' 55' ' ' ILE . 75.7 t -114.22 136.75 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.638 -1.289 . . . . 0.0 112.376 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.7 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 81.7 mt -101.71 125.64 55.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.61 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 3.9 p30 -134.86 30.23 3.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.842 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 177.42 163.49 29.44 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 117.614 -2.232 . . . . 0.0 112.671 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -144.24 157.06 44.5 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 207' ' ' PHE . 9.5 p-10 -120.86 -0.5 10.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.698 -1.251 . . . . 0.0 110.576 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.0 -27.67 8.81 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 36.4 mtt180 -89.22 30.08 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -1.187 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.6 OUTLIER 71.46 20.48 4.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.691 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.435 ' HB2' ' CG ' ' A' ' 203' ' ' ASP . 16.3 m-85 -116.73 135.12 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.103 -0.998 . . . . 0.0 109.468 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 16.3 m-85 -121.11 168.4 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.367 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.61 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.1 t60 -91.51 147.02 23.32 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.4 t -138.79 137.51 42.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -105.88 78.81 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 197' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.716 . . . . 0.0 110.238 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.505 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 28.7 mt-30 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.323 0.582 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 40.5 p -155.21 162.03 41.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.642 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.465 ' HB3' ' CH2' ' A' ' 170' ' ' TRP . . . -136.93 148.16 46.82 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.204 1.002 . . . . 0.0 110.085 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.9 t -110.49 121.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.613 HG22 ' CD2' ' A' ' 158' ' ' HIS . 24.7 m -132.96 146.45 32.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.675 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 157' ' ' VAL . . . 94.53 54.54 1.55 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.595 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 mt -101.14 97.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.308 -1.113 . . . . 0.0 110.004 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 7.9 pttm -162.85 144.38 7.82 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.17 1.913 . . . . 0.0 110.4 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.541 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 22.6 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 200' ' ' ASP . 63.7 mmtt -76.43 -172.95 2.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.086 -1.009 . . . . 0.0 108.517 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 4.2 t -79.27 101.8 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.4 mt -56.89 -50.23 73.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 108.818 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 200' ' ' ASP . 12.8 mt -55.04 -44.08 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.857 -1.152 . . . . 0.0 108.702 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 97.9 m-20 -67.83 -38.71 83.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.183 -0.948 . . . . 0.0 108.548 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.6 p -58.32 -14.87 8.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 9.4 mtpp -119.13 23.33 11.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.47 35.69 5.54 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 58' ' ' TYR . 17.5 mt -88.91 109.39 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.409 1.1 . . . . 0.0 110.432 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PRO . 63.1 m80 -133.4 98.82 4.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' HD13 ' A' ' 116' ' ' ILE . 4.1 m-30 -103.76 176.81 5.03 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.273 1.035 . . . . 0.0 112.299 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.582 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 t-20 -147.2 -172.74 4.08 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.545 ' CG ' ' OG1' ' A' ' 50' ' ' THR . 4.6 mt-30 -124.23 -14.94 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.917 -1.115 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.711 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.18 -39.11 0.97 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.799 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.781 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.2 -138.96 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.489 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.108 -178.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.2 Cg_endo -74.62 4.02 4.9 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 122.667 1.988 . . . . 0.0 109.185 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 64.1 m-85 -75.79 -35.21 60.15 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.632 -0.667 . . . . 0.0 109.903 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.7 p30 -97.95 21.78 10.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.494 -1.379 . . . . 0.0 109.998 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.7 -2.39 20.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.48 HD11 ' OG ' ' A' ' 117' ' ' SER . 12.3 mt -129.03 -6.3 4.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.988 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 43' ' ' ALA . 23.2 p -62.07 162.62 16.93 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.628 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -70.69 130.37 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.14 1.893 . . . . 0.0 111.841 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG22 ' ND1' ' A' ' 42' ' ' HIS . 71.3 t -76.44 149.15 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.551 0.691 . . . . 0.0 110.168 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.828 HG21 ' HB3' ' A' ' 79' ' ' TYR . 33.7 mt -77.8 144.66 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.558 0.694 . . . . 0.0 110.689 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' N ' HG22 ' A' ' 28' ' ' ILE . 20.5 mt-10 -123.6 -23.51 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.512 -0.742 . . . . 0.0 110.052 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.9 mtpp -118.94 162.5 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.264 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 37' ' ' SER . 42.4 t . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.568 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 87.0 m-85 -123.29 25.03 8.54 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.055 -1.028 . . . . 0.0 109.634 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 HG21 ' A' ' 31' ' ' VAL . 77.1 t -73.74 148.3 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.192 -0.942 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.21 -1.87 73.47 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 5.1 mm-40 -88.27 131.02 34.95 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.423 -1.045 . . . . 0.0 109.668 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.416 ' ND1' HG22 ' A' ' 27' ' ' VAL . 6.6 m-70 -73.13 112.66 9.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.59 157.12 1.64 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.913 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.81 169.43 18.3 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.332 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.532 ' O ' ' HE2' ' A' ' 129' ' ' MET . 31.4 p -77.81 -34.11 52.18 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.979 -1.076 . . . . 0.0 108.385 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 101.64 136.88 9.46 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -54.3 -51.33 64.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.235 -1.156 . . . . 0.0 108.891 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.8 t -46.7 -53.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . . . -60.19 -50.6 73.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.25 -0.907 . . . . 0.0 110.329 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -63.62 -31.72 72.98 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.654 -0.653 . . . . 0.0 110.714 -178.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.08 -41.94 85.49 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.261 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 143' ' ' VAL . 53.8 m -73.51 -54.2 8.78 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.874 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.88 -39.59 62.79 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.809 -0.557 . . . . 0.0 110.316 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.1 mt-30 -61.09 -44.48 97.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.742 -1.224 . . . . 0.0 107.733 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 198' ' ' VAL . 44.1 mt -68.35 -24.53 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.587 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 29.2 mtp -73.36 -38.63 65.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 33.6 tptt -68.46 -43.54 76.8 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.03 -32.66 48.0 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.679 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 53.6 m-70 -107.52 -22.21 12.62 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.521 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.596 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.64 55.54 1.91 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.2 t80 -77.0 -70.52 0.21 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.8 Cg_endo -70.51 104.2 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 120.399 0.733 . . . . 0.0 111.942 -176.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.4 m-80 -69.55 -22.61 63.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 3.6 ttpm? -134.55 141.72 46.76 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.94 153.06 26.65 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.507 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -94.35 -38.65 10.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -1.019 . . . . 0.0 109.984 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 46.3 tttt -152.16 139.45 19.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 91' ' ' SER . 77.7 m-20 -63.87 170.3 3.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 22.8 t80 -153.03 135.66 15.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.069 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.8 t -142.57 152.83 42.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 109.759 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 19.9 p90 -156.44 152.98 28.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.844 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.469 HG23 ' ND2' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -92.74 126.58 37.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.479 HD21 ' CG ' ' A' ' 77' ' ' ASN . 11.5 tp -44.03 147.29 0.52 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.77 0.795 . . . . 0.0 110.947 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 146.55 48.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.716 -0.615 . . . . 0.0 110.187 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.41 1.63 9.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.856 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 10.0 m-20 -98.65 -9.4 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.333 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 28.7 t-20 -69.73 109.35 4.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.782 -0.574 . . . . 0.0 110.35 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.3 Cg_endo -88.72 14.54 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.79 2.327 . . . . 0.0 110.386 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.828 ' HB3' HG21 ' A' ' 28' ' ' ILE . 80.1 m-85 -107.92 -22.6 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 110.66 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' ASN . 87.7 m-85 -118.48 163.35 16.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 7.7 m-80 -49.14 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 175.39 -48.38 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.508 175.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -75.85 58.88 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 N-CA-C 107.01 -1.958 . . . . 0.0 107.01 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.538 ' HG3' HD12 ' A' ' 86' ' ' LEU . 12.1 tptt -105.49 121.86 44.81 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.784 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' HG23 ' A' ' 72' ' ' THR . 2.5 m-80 -105.83 115.98 31.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.0 mp -95.49 128.85 42.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -129.81 141.06 50.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -117.28 113.26 21.91 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -73.24 52.81 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 108.118 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 mt -52.77 -53.63 20.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.555 -0.716 . . . . 0.0 110.205 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 p -45.65 -25.6 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.637 -1.289 . . . . 0.0 109.147 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -111.28 19.78 17.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.352 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.634 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.9 mmt-85 -79.43 151.49 30.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.443 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -117.36 90.99 3.45 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.21 94.66 6.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 110.828 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.7 t30 -82.64 89.39 6.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.621 ' CE3' HD12 ' A' ' 100' ' ' ILE . 68.1 m95 -61.39 -7.13 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 -178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -89.87 -19.8 24.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 6.0 m-20 -99.71 -28.0 13.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.621 HD12 ' CE3' ' A' ' 97' ' ' TRP . 44.9 mt -73.77 65.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 21.2 mt -45.89 148.62 1.35 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.723 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.549 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.0 Cg_endo -78.0 -17.96 13.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.641 2.228 . . . . 0.0 110.446 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 14' ' ' HIS . 9.0 t -144.92 122.5 11.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.2 -0.938 . . . . 0.0 109.082 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.571 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 81.7 m-85 -109.5 141.75 41.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -99.93 -5.95 27.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.452 -0.78 . . . . 0.0 109.086 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -3.78 83.28 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -116.48 0.66 12.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -1.179 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.48 160.82 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 167.47 0.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.176 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 6.1 m-80 -72.79 -29.41 63.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.1 t -51.9 -63.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.519 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.464 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 3.2 mp0 -62.46 -32.42 73.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.271 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 24.6 mttt -66.54 -43.7 84.4 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.486 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.8 ttm -59.6 -35.52 74.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -68.71 0.21 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.676 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.576 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.3 tp -59.84 -37.6 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.295 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.527 ' N ' HG23 ' A' ' 116' ' ' ILE . 13.8 p -57.39 -43.39 83.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.895 -1.128 . . . . 0.0 110.755 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.535 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 0.7 OUTLIER -69.23 -37.18 77.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 108.95 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 53' ' ' ALA . 3.6 tp -59.48 -59.52 5.31 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.612 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.0 mmt -49.87 -40.59 43.11 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.211 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -70.38 -41.04 73.59 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 36.7 m-20 -64.63 -47.14 79.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 49' ' ' ALA . 54.5 t -70.08 -49.7 53.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -60.18 -33.05 78.31 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 88' ' ' ALA . 1.2 mt -75.22 -57.0 7.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.494 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 1.4 p -47.79 -26.92 1.78 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 143' ' ' VAL . 32.9 m -100.44 28.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.358 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 4.4 m-20 39.46 48.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 53.5 tpp -59.66 131.79 52.0 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.1 t0 -76.89 120.66 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.628 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.7 m-85 -103.05 115.69 31.07 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.572 1.177 . . . . 0.0 113.245 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -151.1 -163.7 11.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 104.747 -3.341 . . . . 0.0 104.747 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.657 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.31 -31.44 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 N-CA-C 105.87 -2.396 . . . . 0.0 105.87 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.3 m -109.22 144.35 37.45 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 46.2 m -123.7 110.66 15.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 119.859 -1.776 . . . . 0.0 110.451 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.99 141.55 15.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.529 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 29.4 t -118.22 -162.48 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -1.182 . . . . 0.0 108.998 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.78 -61.45 1.63 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.576 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 138.57 -137.31 8.63 Favored Glycine 0 N--CA 1.481 1.649 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.996 176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.3 m -48.34 -50.06 31.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.882 -0.775 . . . . 0.0 112.422 -178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 p -45.95 -48.45 16.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 110.407 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.638 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 7.0 mmt180 -80.7 -36.17 32.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.821 -1.174 . . . . 0.0 110.069 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 127' ' ' VAL . 87.8 t -67.2 -58.45 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.359 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.3 pp0? -56.03 -31.61 63.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.308 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.4 ttt180 -77.72 -47.67 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.419 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -66.41 -35.06 79.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.544 ' CD1' HG12 ' A' ' 143' ' ' VAL . 39.4 mt -60.13 -46.25 90.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 110.016 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.522 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 28.1 mtmt -87.38 -45.25 10.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 60.2 mt-10 -70.73 -43.54 68.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.875 -1.14 . . . . 0.0 111.792 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.46 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 24.2 m120 -94.42 -44.66 7.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 111.608 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 32.3 m-85 -102.26 15.86 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 110.673 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 33.74 38.93 0.1 OUTLIER Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.639 -0.663 . . . . 0.0 112.75 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.6 m-85 -61.97 164.67 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.189 -1.771 . . . . 0.0 107.666 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 45.5 t30 -47.76 143.12 4.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.893 -1.129 . . . . 0.0 109.084 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -53.51 -18.69 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 109.079 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.519 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 78.0 p -53.36 -16.34 1.33 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -0.856 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.5 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 56.0 t -66.29 118.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.83 -1.168 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 249' ' ' VAL . 9.1 p-80 -142.2 155.57 45.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.378 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -101.15 163.24 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.539 HG13 ' CH2' ' A' ' 170' ' ' TRP . 17.4 pt -145.56 165.77 10.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 162' ' ' ARG . 3.5 m-80 -125.13 100.08 6.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 110.086 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.615 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 45.1 tpt85 -45.34 -35.22 3.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.142 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.34 -28.04 70.31 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -103.89 6.26 36.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.899 -1.353 . . . . 0.0 111.876 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -118.1 177.27 4.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.388 -1.445 . . . . 0.0 110.407 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 88.4 p -103.95 132.65 49.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 20.5 ttmt -33.21 -46.27 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.848 -0.533 . . . . 0.0 110.885 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -64.21 -62.39 1.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.861 -1.15 . . . . 0.0 109.878 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -17.19 61.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.615 ' CH2' ' N ' ' A' ' 162' ' ' ARG . 75.7 t-105 -75.81 -47.01 27.48 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.197 -0.94 . . . . 0.0 109.162 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.469 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 55.5 mt-10 -69.84 -38.19 76.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.168 -0.957 . . . . 0.0 108.549 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.19 50.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.446 ' NE2' HG23 ' A' ' 249' ' ' VAL . 10.9 mm100 -61.07 -41.47 96.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.592 HG23 ' CD1' ' A' ' 199' ' ' ILE . 13.2 mt -75.66 -58.24 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.39 -0.819 . . . . 0.0 110.575 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -49.46 -45.32 46.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.725 -1.235 . . . . 0.0 108.888 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -51.61 -43.03 62.41 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.617 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 44.6 mm-40 -60.18 -50.99 71.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.8 mt -68.27 -26.48 65.69 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.8 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.7 p -52.17 -39.29 59.85 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.4 mt-30 -100.93 35.41 2.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.452 ' HA ' HD21 ' A' ' 7' ' ' LEU . 15.0 m-80 47.18 51.06 13.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 12.6 mt-30 -123.31 113.0 29.56 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.546 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.1 Cg_endo -64.95 169.85 11.2 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.742 1.628 . . . . 0.0 111.792 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.633 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 96.5 t -126.61 130.78 71.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.722 -176.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.576 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -82.86 116.91 22.38 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 176.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -122.48 159.19 28.17 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.92 -1.113 . . . . 0.0 109.35 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.3 pt20 -167.06 130.87 1.88 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.511 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.466 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.43 125.93 8.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.597 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 53.9 t -91.33 162.73 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.147 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.53 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -170.6 -133.27 1.58 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.459 ' HB3' ' NZ ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -87.76 -47.83 8.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.72 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.97 -11.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.175 -0.953 . . . . 0.0 111.205 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.33 -160.18 20.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -95.09 110.59 4.04 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.258 -1.448 . . . . 0.0 111.125 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.617 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.7 t-80 -72.4 132.23 43.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.74 163.92 16.71 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.059 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 15.9 p90 -161.8 168.05 23.82 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.534 HG22 HG13 ' A' ' 55' ' ' ILE . 84.5 t -114.71 135.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.59 -1.319 . . . . 0.0 112.185 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.633 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 76.1 mt -97.62 124.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 8.3 p-10 -137.1 33.05 2.61 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.992 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 178' ' ' LEU . . . -173.73 167.9 40.62 Favored Glycine 0 N--CA 1.484 1.887 0 C-N-CA 117.757 -2.163 . . . . 0.0 112.356 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.541 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.34 149.37 28.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.99 29.07 8.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 110.258 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.5 22.63 3.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -140.74 25.95 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -1.068 . . . . 0.0 108.91 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 75.23 7.77 4.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.401 -0.812 . . . . 0.0 109.719 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 25.9 m-85 -103.33 136.54 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 49.8 m-85 -123.65 163.07 21.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 111.119 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 40.4 t-80 -93.68 123.01 36.73 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 197' ' ' PHE . 54.1 t -117.42 141.67 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 111.619 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 18.2 t-20 -110.1 76.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.516 ' CD2' HG12 ' A' ' 210' ' ' VAL . 65.1 m95 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 162' ' ' ARG . 7.1 mt-30 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 30.6 p -133.41 165.34 25.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.473 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 159' ' ' GLN . . . -141.23 152.68 44.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.725 0.774 . . . . 0.0 110.247 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.57 ' CG2' ' CD1' ' A' ' 185' ' ' TYR . 16.5 t -112.84 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.617 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 4.6 m -109.97 139.72 32.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.318 0.58 . . . . 0.0 110.174 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.434 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 100.5 48.58 1.52 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.211 -1.471 . . . . 0.0 109.659 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 9.0 mt -104.61 94.67 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.245 -1.15 . . . . 0.0 111.131 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 252' ' ' LYS . 0.0 OUTLIER -163.43 146.03 7.94 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.153 1.902 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.482 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 30.5 tt0 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.4 Cg_endo -77.59 151.99 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.192 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 204' ' ' GLY . 9.4 t -89.55 145.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.326 -0.858 . . . . 0.0 109.746 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.752 HG13 ' HA2' ' A' ' 201' ' ' GLY . 36.7 t -137.02 132.82 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 110.095 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -75.23 172.89 11.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.597 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.9 t -76.9 108.13 9.73 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.488 -0.757 . . . . 0.0 110.807 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.66 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 41.0 mt -58.54 -50.4 73.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 8' ' ' LEU . 13.5 mt -55.54 -40.81 72.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.879 -1.138 . . . . 0.0 108.503 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 14.6 m-20 -67.84 -42.8 80.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.292 -0.88 . . . . 0.0 109.149 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -57.98 -15.09 7.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 108.932 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 5.8 mtpp -116.54 20.39 14.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.34 37.01 4.5 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 59.2 mt -88.54 110.1 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 122.351 1.072 . . . . 0.0 110.385 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 102' ' ' PRO . 77.4 m80 -133.53 97.96 4.08 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' HD13 ' A' ' 116' ' ' ILE . 4.2 m-30 -103.16 174.31 5.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.157 0.98 . . . . 0.0 111.823 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -146.83 -171.26 3.72 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.9 mt-30 -124.2 -11.19 7.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.919 -1.113 . . . . 0.0 109.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.73 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.17 -39.75 0.86 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.982 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -140.75 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.511 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.253 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.4 Cg_endo -73.85 2.3 6.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 122.523 1.937 . . . . 0.0 109.0 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 19' ' ' ASN . 46.9 m-85 -72.76 -37.48 67.66 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.704 -0.622 . . . . 0.0 109.59 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 38.3 p-10 -96.15 21.24 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.564 -1.335 . . . . 0.0 110.087 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.75 4.44 6.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.315 -0.865 . . . . 0.0 109.622 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 118' ' ' GLU . 15.0 mt -136.29 -1.81 2.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.936 -1.103 . . . . 0.0 110.467 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 43' ' ' ALA . 23.3 p -61.56 161.77 18.44 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 86' ' ' LEU . 20.0 Cg_endo -69.85 137.51 35.38 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.697 1.598 . . . . 0.0 110.597 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.92 142.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.792 0.806 . . . . 0.0 110.82 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.674 HD13 ' HD3' ' A' ' 133' ' ' PRO . 18.5 mt -76.9 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.415 0.626 . . . . 0.0 109.833 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 39' ' ' VAL . 64.0 mt-10 -126.22 -19.31 4.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.804 . . . . 0.0 111.398 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' TYR . 34.0 mtpt -123.11 171.77 9.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.729 -1.232 . . . . 0.0 110.58 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.44 148.61 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.742 0.782 . . . . 0.0 110.963 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -89.7 129.04 48.21 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.416 1.411 . . . . 0.0 109.951 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.42 18.28 13.52 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.77 -179.98 7.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.597 -0.943 . . . . 0.0 109.232 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -82.07 174.68 11.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 109.633 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 t -81.37 135.81 35.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.612 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.2 m-85 -124.07 18.97 9.2 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.853 -1.154 . . . . 0.0 110.23 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 28' ' ' ILE . 45.1 t -67.88 140.36 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.556 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.39 -2.26 72.61 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 13.2 mt-30 -83.4 136.52 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.33 -1.1 . . . . 0.0 109.824 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -73.2 108.58 6.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.2 168.79 0.09 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.721 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -90.24 173.36 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.005 . . . . 0.0 110.066 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 129' ' ' MET . 31.3 p -83.15 -37.68 23.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.229 -0.919 . . . . 0.0 108.603 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 135' ' ' SER . . . 105.05 136.44 8.69 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' VAL . 2.8 p -54.57 -54.04 46.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -1.231 . . . . 0.0 108.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 137' ' ' SER . 38.2 t -46.38 -52.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HB3' ' CA ' ' A' ' 124' ' ' GLY . . . -59.26 -52.28 66.35 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.865 0.84 . . . . 0.0 109.791 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -63.27 -32.61 74.07 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.186 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -66.85 -41.86 86.69 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.222 -1.391 . . . . 0.0 108.135 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 143' ' ' VAL . 83.9 m -73.52 -53.05 11.49 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.754 0.788 . . . . 0.0 109.651 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.608 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.39 -42.64 64.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.805 -0.56 . . . . 0.0 110.193 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.1 mt-30 -56.66 -48.75 76.9 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 198' ' ' VAL . 32.5 mt -66.27 -26.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.587 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 29.7 mtp -70.31 -35.88 73.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 23.7 tptt -72.58 -42.05 65.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.66 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.1 t80 -53.9 -31.61 50.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 71.9 m-70 -107.86 -22.35 12.48 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.649 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.68 51.43 3.03 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.547 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.5 t80 -70.02 -74.34 0.16 Allowed Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 61' ' ' TYR . 33.9 Cg_endo -68.97 107.59 1.74 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 CA-C-N 119.044 0.694 . . . . 0.0 112.158 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -70.32 -21.95 62.87 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.2 tttm -134.27 148.06 50.75 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 144.9 42.42 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.238 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.566 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.435 -1.038 . . . . 0.0 111.579 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' ' OD1' ' A' ' 150' ' ' ASN . 51.7 tttt -151.51 137.24 17.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.093 -1.629 . . . . 0.0 111.229 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' HB3' ' A' ' 91' ' ' SER . 75.6 m-20 -59.42 152.76 20.71 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -126.85 172.81 10.08 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.62 -1.3 . . . . 0.0 107.986 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.7 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 10.9 t -167.87 134.74 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.01 173.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.61 ' CD2' ' OH ' ' A' ' 69' ' ' TYR . 3.3 p90 -148.67 146.47 28.18 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.258 -0.901 . . . . 0.0 109.112 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.8 m -93.43 135.15 34.95 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 77' ' ' ASN . 10.2 tp -52.14 144.58 12.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.86 0.838 . . . . 0.0 111.428 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.93 145.08 53.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.364 0.602 . . . . 0.0 110.453 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -0.15 11.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.92 . . . . 0.0 109.756 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.49 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -96.28 -10.36 28.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.204 -0.935 . . . . 0.0 108.874 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 29.0 t-20 -69.79 111.0 7.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.713 -0.617 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.1 Cg_endo -88.95 17.5 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.82 2.346 . . . . 0.0 109.193 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.601 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 89.6 m-85 -107.1 -15.27 14.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.575 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -135.52 167.21 21.51 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.584 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 19.3 m-80 -48.7 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.12 -48.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 111.302 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -75.66 60.54 5.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 N-CA-C 106.955 -1.979 . . . . 0.0 106.955 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.537 ' HG3' HD12 ' A' ' 86' ' ' LEU . 2.0 tptt -104.5 119.78 39.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.424 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -100.88 119.28 38.46 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.406 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.603 HD23 ' HG3' ' A' ' 26' ' ' PRO . 2.7 mp -94.88 143.57 26.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.51 ' HA ' ' CE1' ' A' ' 69' ' ' TYR . 18.2 t80 -139.03 130.75 27.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 110.726 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -110.22 119.4 39.13 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.7 45.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.696 -1.252 . . . . 0.0 107.834 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.685 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 15.4 mt -52.32 -56.56 6.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 O-C-N 121.578 -0.701 . . . . 0.0 109.999 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.535 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -44.56 -26.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 108.987 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -111.47 34.72 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 108.916 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.685 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 38.1 mmt-85 -93.35 155.81 17.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 110.868 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.73 88.77 2.98 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' ASN . 3.2 m-85 -80.76 86.38 5.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.208 -0.932 . . . . 0.0 110.416 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 30.3 t30 -79.38 90.96 5.03 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.649 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 77.5 m95 -61.36 -6.23 2.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.438 -0.789 . . . . 0.0 110.46 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 53.4 t-20 -89.88 -19.26 24.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 12.9 m-20 -99.67 -28.72 13.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.641 HD12 ' CE3' ' A' ' 97' ' ' TRP . 41.8 mt -74.34 66.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 9.4 mt -46.32 148.66 1.53 Allowed Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 121.662 -0.649 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.5 Cg_endo -78.79 -19.5 11.09 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.92 2.414 . . . . 0.0 110.432 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -142.78 121.58 12.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.113 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.465 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 64.4 m-85 -109.28 138.54 45.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.932 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -101.11 -3.84 28.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.0 108.973 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.28 87.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -115.06 -1.03 13.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -1.231 . . . . 0.0 109.606 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -67.08 170.83 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.717 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.455 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.7 OUTLIER -65.9 174.27 2.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -77.26 -34.34 55.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.56 -59.72 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 109.576 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.455 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 1.3 mp0 -62.8 -34.15 76.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.132 -0.98 . . . . 0.0 109.158 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.511 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 85.4 mttt -66.01 -42.72 89.34 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.464 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 35.8 ttm -59.34 -35.63 74.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.433 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.21 -68.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.726 -0.609 . . . . 0.0 110.592 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.576 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.7 tp -60.14 -41.69 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.528 ' N ' HG23 ' A' ' 116' ' ' ILE . 11.5 p -53.73 -43.24 68.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.853 -1.154 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.587 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 9.2 tt0 -69.36 -42.14 75.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.999 -1.063 . . . . 0.0 108.78 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.05 -53.69 49.57 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.608 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -57.07 -43.06 81.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -66.18 -39.66 89.88 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 15.6 m-20 -68.47 -46.48 69.63 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 49' ' ' ALA . 43.6 t -67.01 -63.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.545 ' CA ' ' HB3' ' A' ' 49' ' ' ALA . . . -46.22 -38.82 9.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.849 HG22 ' CE1' ' A' ' 69' ' ' TYR . 2.9 mt -69.84 -60.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.306 -1.114 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.457 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 2.2 p -46.47 -25.74 0.73 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.851 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.1 m -104.26 33.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 109.792 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' VAL . 2.2 m-20 41.75 40.96 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 109.8 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 35.4 tpp -56.42 134.05 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 111.589 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 34.4 m-20 -78.09 122.41 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 40.3 m-85 -103.9 106.24 16.68 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.474 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -141.2 -162.09 8.98 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 104.332 -3.507 . . . . 0.0 104.332 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.674 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.74 -30.96 78.73 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 106.007 -2.343 . . . . 0.0 106.007 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.93 139.15 45.34 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 73.8 m -114.14 112.72 23.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 119.934 -1.729 . . . . 0.0 110.721 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.67 130.52 10.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.624 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -117.23 -168.16 1.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.056 -1.261 . . . . 0.0 108.3 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.624 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.15 -50.85 5.76 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.52 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 124.01 -129.08 7.09 Favored Glycine 0 N--CA 1.481 1.684 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.257 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.544 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 4.2 m -48.23 -59.71 3.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.962 -0.728 . . . . 0.0 112.019 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 140' ' ' SER . 40.1 p -46.97 -35.35 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.789 -1.194 . . . . 0.0 108.622 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 74.9 mmt-85 -80.62 -48.51 12.56 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.91 0.862 . . . . 0.0 109.192 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 185' ' ' TYR . 89.0 t -66.66 -59.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.5 -33.21 65.79 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 108.58 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.8 ttm180 -76.79 -53.91 7.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.007 -1.058 . . . . 0.0 109.48 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -64.33 -38.21 90.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.105 -0.997 . . . . 0.0 109.575 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD1' HG11 ' A' ' 143' ' ' VAL . 17.1 mt -51.05 -48.6 61.52 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.665 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.541 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 55.2 mtmt -88.17 -31.2 19.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 111.285 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 19.8 mt-10 -74.29 -65.51 0.84 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.718 -1.239 . . . . 0.0 112.732 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.589 ' OD1' ' CG2' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.98 -32.17 30.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.633 -1.292 . . . . 0.0 111.966 -177.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 32.8 m-85 -103.55 -10.26 18.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.512 -1.367 . . . . 0.0 110.768 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.566 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 58.6 39.15 92.93 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.097 -1.002 . . . . 0.0 112.531 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.2 m-85 -63.3 162.01 12.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.202 -1.764 . . . . 0.0 107.641 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 50.4 t-20 -47.1 147.9 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.826 -1.171 . . . . 0.0 109.923 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -53.86 -17.97 2.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.529 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 26.4 p -57.37 -11.95 2.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 110.051 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.541 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 16.0 t -70.92 121.44 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.798 -1.189 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.644 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 7.6 p-80 -148.65 179.79 7.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.544 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 4.5 tt0 -123.8 138.41 54.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.578 HG13 ' CH2' ' A' ' 170' ' ' TRP . 14.8 pt -122.96 152.37 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 8.5 m-80 -109.89 103.23 11.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.109 . . . . 0.0 111.027 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.597 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 13.2 tpt180 -47.83 -36.48 11.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.043 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.6 67.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 4.74 35.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.922 -1.34 . . . . 0.0 111.668 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -118.17 161.19 20.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.569 -1.332 . . . . 0.0 110.143 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 5.2 p -87.06 131.71 34.03 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.3 ttpt -32.78 -44.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.83 -0.543 . . . . 0.0 110.906 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -63.59 -63.73 1.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.953 -1.092 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -62.42 -17.34 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.741 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 162' ' ' ARG . 76.4 t-105 -76.31 -47.86 22.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.087 -1.008 . . . . 0.0 109.172 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 59.5 mt-10 -67.71 -22.73 65.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.98 97.14 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -60.94 -36.2 78.71 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 208' ' ' TYR . 18.5 mt -73.78 -66.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.385 -0.822 . . . . 0.0 110.575 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -48.27 -41.72 28.61 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 109.446 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.452 ' O ' ' OG ' ' A' ' 179' ' ' SER . 10.0 tttt -52.29 -47.47 65.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.0 mm-40 -61.06 -45.21 95.69 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.532 HD12 ' CG2' ' A' ' 199' ' ' ILE . 27.8 mt -68.29 -30.34 69.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.665 -0.647 . . . . 0.0 110.425 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' ASP . 62.7 p -52.55 -35.94 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.069 -1.019 . . . . 0.0 108.799 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 17.7 mt-30 -101.17 28.78 5.1 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.527 ' CB ' HD21 ' A' ' 7' ' ' LEU . 96.3 m-20 49.26 50.72 17.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 21.4 mt-30 -123.67 110.95 29.7 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.504 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.8 Cg_endo -64.21 166.16 17.64 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.567 1.511 . . . . 0.0 112.087 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 35.8 t -123.7 136.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.266 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.689 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -85.38 118.34 24.85 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 175.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 6.5 t80 -122.45 158.18 30.31 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.793 -1.192 . . . . 0.0 109.399 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 187' ' ' GLN . 3.5 pt20 -167.38 136.73 2.74 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.538 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.68 108.91 2.97 Favored Glycine 0 C--N 1.288 -2.108 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.57 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 19.3 t -78.56 160.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.241 -1.152 . . . . 0.0 112.159 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 237' ' ' GLY . 0.7 OUTLIER -88.12 -56.12 3.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -1.212 . . . . 0.0 110.507 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 193' ' ' GLY . 2.9 m -59.04 -23.86 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.271 -0.893 . . . . 0.0 111.416 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 192' ' ' VAL . . . 138.53 -167.54 24.98 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.62 106.25 3.01 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 121.062 -1.257 . . . . 0.0 111.496 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 6.5 t-80 -72.09 125.33 26.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 186' ' ' TYR . . . -117.34 163.93 15.6 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.081 -1.448 . . . . 0.0 113.199 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 186' ' ' TYR . 32.2 p90 -159.48 170.16 22.31 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 55' ' ' ILE . 85.5 t -114.67 135.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.515 -1.365 . . . . 0.0 112.45 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 11.8 mt -97.72 127.56 49.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.1 p30 -140.28 33.64 1.89 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.611 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.752 ' HA2' HG13 ' A' ' 4' ' ' VAL . . . 172.71 -175.51 45.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.442 -1.837 . . . . 0.0 111.003 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.658 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -161.3 152.2 18.31 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.424 -1.045 . . . . 0.0 109.092 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.471 ' C ' HG21 ' A' ' 3' ' ' VAL . 6.7 t0 -113.81 14.62 18.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.775 -1.203 . . . . 0.0 111.338 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.557 ' N ' HG21 ' A' ' 3' ' ' VAL . . . 85.87 -4.99 85.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.706 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 207' ' ' PHE . 4.5 mtp180 -128.2 70.83 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.802 -1.41 . . . . 0.0 110.59 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 64.2 m-20 39.33 28.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 109.919 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 205' ' ' ARG . 1.9 m-85 -121.08 128.43 52.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.299 -0.876 . . . . 0.0 109.046 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.577 ' HB3' HG21 ' A' ' 199' ' ' ILE . 73.9 m-85 -109.05 170.33 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.597 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 53.3 t-80 -91.55 115.34 27.96 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.585 HG13 ' CD2' ' A' ' 197' ' ' PHE . 11.5 t -112.85 142.84 23.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 122.256 1.027 . . . . 0.0 112.277 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.504 ' N ' HG11 ' A' ' 210' ' ' VAL . 21.8 t-20 -110.6 78.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.506 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 68.9 m95 -46.75 167.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.149 -0.969 . . . . 0.0 110.109 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.86 27.54 7.23 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.412 ' CB ' HG12 ' A' ' 217' ' ' VAL . 88.2 m95 -119.18 -169.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -1.141 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -77.68 -95.6 0.22 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.25 64.34 0.6 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.542 ' CG2' ' N ' ' A' ' 218' ' ' SER . 1.7 p -95.12 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -1.165 . . . . 0.0 109.516 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.542 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 21.5 m -90.39 19.07 5.47 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.75 126.96 23.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.18 -91.59 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 25.5 p90 -102.1 163.24 12.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.7 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.0 OUTLIER -91.62 176.62 6.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.111 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.55 ' O ' ' CE2' ' A' ' 222' ' ' PHE . 0.0 OUTLIER -114.64 153.39 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 0.2 OUTLIER -116.67 -22.39 8.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.299 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.11 -25.64 7.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.08 86.39 2.57 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.111 0.957 . . . . 0.0 109.197 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.539 HD11 ' CE1' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -91.77 48.93 1.5 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-O 121.383 0.611 . . . . 0.0 109.557 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.434 ' HB3' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER -115.94 163.34 21.6 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.251 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.547 ' HB3' ' CE1' ' A' ' 195' ' ' HIS . 35.8 Cg_endo -78.24 128.3 8.87 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.623 2.215 . . . . 0.0 110.468 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.411 ' CB ' HG23 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -57.8 -45.56 85.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.98 88.25 6.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.67 -171.26 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.2 62.11 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.14 -86.99 0.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -1.165 . . . . 0.0 109.685 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -98.36 -123.78 4.88 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.92 15.92 7.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 191' ' ' LYS . . . -112.3 24.95 13.12 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -50.21 169.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 240' ' ' GLY . . . 84.88 140.41 4.99 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 239' ' ' GLY . . . 44.53 91.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -108.38 30.88 6.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -1.176 . . . . 0.0 109.848 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 245' ' ' GLN . 1.4 t-20 -136.2 58.81 1.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.967 -1.083 . . . . 0.0 109.991 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . . . -84.84 -41.99 7.41 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.549 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -135.75 94.05 3.03 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.69 -0.888 . . . . 0.0 109.085 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.457 ' HB2' ' ND2' ' A' ' 242' ' ' ASN . 12.0 tt0 -91.6 126.52 36.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.83 -1.169 . . . . 0.0 108.738 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.3 p -151.62 169.95 20.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.059 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -140.92 146.34 37.28 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.186 0.993 . . . . 0.0 110.934 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.8 t -105.13 118.81 53.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 33.3 m -125.88 145.71 32.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.86 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.09 52.21 2.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.632 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 50.6 mt -97.44 88.94 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -1.083 . . . . 0.0 109.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.21 152.32 12.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.547 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.342 2.028 . . . . 0.0 110.402 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.428 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 51.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.9 Cg_endo -78.28 174.67 12.08 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.515 2.143 . . . . 0.0 110.169 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 4' ' ' VAL . 54.8 t -123.47 136.58 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 178' ' ' LEU . 85.4 t -131.85 130.82 61.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.508 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -74.43 -173.63 1.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.069 -1.02 . . . . 0.0 109.012 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.591 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 69.8 m -77.44 100.35 5.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.808 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 18.2 mt -58.83 -48.25 81.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.185 -0.947 . . . . 0.0 108.485 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.468 HD11 HG11 ' A' ' 198' ' ' VAL . 9.5 mt -55.91 -41.45 74.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 33.8 t0 -67.0 -38.73 86.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -15.9 11.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 108.558 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 16.0 mtpp -120.07 14.8 12.34 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.95 43.67 8.52 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.8 mt -93.1 110.28 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.493 -1.004 . . . . 0.0 110.574 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 51.6 m80 -135.13 100.02 4.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . 14.6 m-30 -102.4 175.9 5.36 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.891 -1.131 . . . . 0.0 110.843 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 5.1 t-20 -146.54 -171.27 3.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 58.4 mt-30 -124.97 -3.56 7.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.829 -1.17 . . . . 0.0 110.676 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.03 -60.61 0.34 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.147 -1.501 . . . . 0.0 112.737 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.745 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -44.78 -123.72 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.424 0 CA-C-O 117.369 -1.3 . . . . 0.0 112.371 -176.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.745 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 42.7 Cg_endo -81.41 10.54 3.4 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 123.452 2.269 . . . . 0.0 109.596 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.815 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 92.6 m-85 -83.03 -38.64 22.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 110.663 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 44.4 p30 -103.55 35.39 2.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.622 -1.299 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 4.7 mt -78.11 -3.96 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.873 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.551 HD13 ' N ' ' A' ' 118' ' ' GLU . 21.3 mt -129.4 10.82 5.77 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.923 -1.11 . . . . 0.0 109.391 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.3 p -81.39 163.21 55.7 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.4 Cg_endo -69.82 128.59 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.131 1.887 . . . . 0.0 111.82 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.541 HG22 ' CE1' ' A' ' 42' ' ' HIS . 10.8 t -74.43 150.67 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.655 HD13 ' HD3' ' A' ' 133' ' ' PRO . 18.2 mt -77.67 148.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.467 -0.771 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.55 -21.75 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.721 -0.612 . . . . 0.0 110.404 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.3 mtpp -122.29 171.96 8.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 110.071 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 37' ' ' SER . 84.0 t -114.36 148.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.394 -0.816 . . . . 0.0 111.113 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -87.84 130.05 48.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -70.31 125.3 11.71 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.57 1.513 . . . . 0.0 110.42 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.92 9.62 34.25 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -146.84 -177.37 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -1.062 . . . . 0.0 109.157 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -80.68 -176.21 5.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.459 ' HA ' HG13 ' A' ' 31' ' ' VAL . 1.9 t -86.4 138.36 31.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.63 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.4 m-85 -123.78 19.05 9.43 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 28' ' ' ILE . 66.9 t -66.8 144.5 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.73 -4.01 66.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 28.5 mt-30 -86.65 128.77 35.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -1.174 . . . . 0.0 109.564 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.541 ' CE1' HG22 ' A' ' 27' ' ' VAL . 1.1 m-70 -73.23 113.79 10.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.81 158.07 1.47 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.77 -1.172 . . . . 0.0 108.933 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.47 170.09 17.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.391 0.615 . . . . 0.0 109.973 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 129' ' ' MET . 10.3 p -77.63 -31.58 52.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 103.6 138.08 9.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 p -54.51 -53.65 51.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -1.068 . . . . 0.0 108.408 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG12 HG22 ' A' ' 127' ' ' VAL . 4.9 t -47.01 -52.27 4.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.61 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.29 -50.12 74.89 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.947 0.879 . . . . 0.0 110.068 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -63.36 -33.88 76.5 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -178.248 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.56 87.66 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.217 -1.393 . . . . 0.0 107.43 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.7 m -74.42 -53.54 9.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 108.852 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -53.32 -37.94 62.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.813 -0.554 . . . . 0.0 110.77 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 27.1 mt-30 -67.34 -52.85 35.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.581 -1.324 . . . . 0.0 108.108 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 198' ' ' VAL . 31.9 mt -65.0 -18.8 24.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.588 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 34.4 mtp -73.84 -45.25 52.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 18.4 tptt -67.12 -36.02 81.0 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 65.9 t80 -54.06 -31.93 53.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.431 -0.793 . . . . 0.0 109.297 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 70.9 m-70 -106.92 -22.04 12.82 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.603 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 98.4 m-20 45.61 56.12 6.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 4.3 t80 -79.82 -74.54 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -68.11 103.15 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-N 119.104 0.716 . . . . 0.0 111.888 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 95' ' ' TYR . 28.7 m120 -70.56 -22.79 62.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.41 140.8 45.22 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.59 151.13 33.37 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.752 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -88.84 -44.29 10.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.506 -0.997 . . . . 0.0 109.97 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 13.9 tttp -152.57 142.35 21.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.103 -0.998 . . . . 0.0 109.855 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' A' ' 89' ' ' ALA . 1.5 m-20 -65.24 164.49 13.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.673 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 70' ' ' THR . 7.6 t80 -143.78 147.19 33.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.431 -0.793 . . . . 0.0 109.272 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.629 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t -150.2 166.11 30.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 26.1 p90 -171.68 157.03 4.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 86.9 m -93.13 131.37 38.25 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 77' ' ' ASN . 8.7 tp -44.94 150.13 0.4 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 111.403 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 p -61.56 139.46 58.25 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -4.83 11.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.543 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -97.59 -7.41 31.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.588 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 25.9 t-20 -70.01 108.59 3.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 109.73 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.1 Cg_endo -89.36 15.73 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.997 2.465 . . . . 0.0 110.533 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 85.0 m-85 -106.42 -24.43 12.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.0 110.866 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' A' ' 81' ' ' ASN . 72.8 m-85 -117.71 163.85 15.86 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.7 m-80 -48.19 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.4 OUTLIER 175.04 -47.56 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 111.307 175.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.47 55.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.0 tptt -106.0 104.94 14.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.253 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.14 140.99 33.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.124 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.635 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -115.23 145.88 41.99 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -136.83 128.42 28.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.32 111.84 23.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.408 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . . . -72.81 53.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.577 -1.327 . . . . 0.0 107.909 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.649 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 10.5 mt -52.62 -54.17 16.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.033 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -45.36 -26.14 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.751 -1.218 . . . . 0.0 109.073 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -110.86 32.34 5.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 108.892 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.649 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 35.0 mmt-85 -92.48 154.22 18.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' CA ' ' NE2' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -117.32 90.98 3.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.563 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.5 m-85 -80.84 85.04 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 110.664 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.481 ' O ' HG13 ' A' ' 100' ' ' ILE . 4.9 t30 -78.88 89.33 4.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.616 ' CE3' HD12 ' A' ' 100' ' ' ILE . 77.7 m95 -61.36 -5.1 1.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.525 -0.734 . . . . 0.0 110.939 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.25 -15.58 33.24 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.728 -1.233 . . . . 0.0 107.684 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -99.65 -30.75 11.93 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.616 HD12 ' CE3' ' A' ' 97' ' ' TRP . 22.3 mt -73.64 67.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.653 0.74 . . . . 0.0 109.307 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 16.0 mt -47.47 148.78 2.23 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.597 -0.689 . . . . 0.0 109.528 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 31.4 Cg_endo -79.39 -17.38 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.648 2.232 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.27 123.08 9.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.044 . . . . 0.0 109.478 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 90.8 m-85 -110.79 144.03 40.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -100.53 2.68 42.18 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.325 -0.86 . . . . 0.0 108.816 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 81.67 0.73 89.67 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 2.84 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 104' ' ' TYR . 1.3 mp0 -67.11 169.02 9.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -64.9 177.46 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.278 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.438 ' N ' ' OG ' ' A' ' 109' ' ' SER . 1.2 m-20 -82.11 -36.49 27.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.854 . . . . 0.0 109.632 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.06 -57.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -38.08 89.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.14 -0.975 . . . . 0.0 108.84 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 81.0 mttt -63.78 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.45 -0.781 . . . . 0.0 109.011 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.485 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.0 ttm -58.78 -40.83 85.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 0.0 109.182 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -57.79 -54.58 45.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 117' ' ' SER . 1.8 tp -68.36 -38.51 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.538 -1.352 . . . . 0.0 109.743 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 116' ' ' ILE . 9.4 p -56.71 -43.65 80.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.102 -0.999 . . . . 0.0 109.887 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' N ' HD13 ' A' ' 24' ' ' LEU . 35.2 tt0 -69.99 -37.02 75.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 53' ' ' ALA . 8.4 tp -62.97 -52.01 64.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.815 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -60.68 -48.05 83.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.559 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.72 90.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 0.0 108.821 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 126' ' ' SER . 88.3 m-20 -63.95 -41.44 97.6 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -71.44 -59.16 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.391 0.615 . . . . 0.0 109.46 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.504 ' CA ' ' HB3' ' A' ' 49' ' ' ALA . . . -45.99 -47.43 14.68 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 88' ' ' ALA . 2.3 mt -63.7 -56.15 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.316 -1.108 . . . . 0.0 108.217 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 2.2 p -45.96 -29.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.298 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 48' ' ' VAL . 17.6 m -105.95 38.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 9.1 p-10 36.94 50.76 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.515 0.674 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.536 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 49.8 tpp -59.76 128.14 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.55 -0.718 . . . . 0.0 110.74 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 135' ' ' SER . 33.8 t70 -75.36 123.8 26.0 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 64.9 m-85 -103.33 114.09 28.1 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.539 1.161 . . . . 0.0 113.144 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.498 ' CA ' HD13 ' A' ' 28' ' ' ILE . . . -150.3 -164.24 11.74 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 0.0 104.426 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.655 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.35 -29.38 79.49 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 N-CA-C 105.952 -2.365 . . . . 0.0 105.952 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.75 139.5 44.73 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.512 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 54.8 m -119.42 109.19 15.47 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.898 -1.751 . . . . 0.0 109.948 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 130' ' ' ASP . . . -108.08 142.91 16.02 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.826 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 4.7 t -116.43 -162.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.59 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.96 -47.55 7.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.52 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 132.41 -139.55 11.04 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.029 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.459 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 9.0 m -50.32 -53.01 31.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.795 -0.826 . . . . 0.0 112.329 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 145' ' ' ARG . 1.5 p -47.42 -33.84 6.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.708 -1.245 . . . . 0.0 108.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 3.1 mmp_? -80.51 -48.22 13.1 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.949 0.88 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.727 HG21 ' CE2' ' A' ' 185' ' ' TYR . 70.4 t -67.24 -56.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.914 -0.491 . . . . 0.0 110.966 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.492 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.9 pp0? -56.12 -33.54 65.24 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -77.37 -48.1 18.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.35 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -68.94 -36.15 77.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.157 -0.964 . . . . 0.0 110.274 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.526 ' CD1' HG11 ' A' ' 143' ' ' VAL . 41.7 mt -57.13 -46.26 82.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.825 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.55 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 51.8 mtmt -87.18 -44.02 11.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.995 -1.066 . . . . 0.0 111.18 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.0 mt-10 -69.34 -50.5 45.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.399 -1.438 . . . . 0.0 111.446 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 18.1 m120 -88.63 -45.52 9.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 0.0 111.636 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.588 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.5 m-85 -102.2 18.28 21.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 31.63 41.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.648 -0.658 . . . . 0.0 112.985 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.1 m-85 -63.41 164.32 9.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.268 -1.725 . . . . 0.0 108.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.51 145.86 2.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.928 -1.108 . . . . 0.0 109.529 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -53.8 -18.96 3.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.056 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.576 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 84.6 p -55.3 -15.0 2.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 16.5 t -67.61 121.57 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.781 -1.199 . . . . 0.0 109.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.613 ' CD2' HG22 ' A' ' 249' ' ' VAL . 1.2 p-80 -147.84 175.61 10.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 109.449 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 144' ' ' GLN . 3.7 tt0 -120.86 138.45 54.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.721 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.531 HG13 ' CH2' ' A' ' 170' ' ' TRP . 12.7 pt -125.75 158.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.6 m-80 -114.56 101.22 8.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.871 -1.143 . . . . 0.0 110.71 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.2 tpt180 -45.71 -36.82 5.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 109.072 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.59 -27.77 66.67 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.88 6.92 36.77 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.984 -1.303 . . . . 0.0 111.917 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -118.12 171.24 8.24 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.392 -1.443 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 95.0 p -95.23 134.34 38.1 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 9.4 ttpp -35.36 -48.98 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.717 -0.615 . . . . 0.0 110.781 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -57.74 8.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.996 -1.065 . . . . 0.0 110.294 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.2 -20.56 65.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 76.7 t-105 -75.26 -43.96 48.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.397 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 90.3 mt-10 -68.97 -31.28 70.03 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.948 -1.095 . . . . 0.0 108.311 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.25 73.95 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 12.0 mm100 -61.14 -41.63 97.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 108.975 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.555 HG23 ' CD1' ' A' ' 199' ' ' ILE . 10.4 mt -75.38 -57.35 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 110.56 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -49.42 -42.61 43.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.069 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -54.17 -46.03 72.23 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.534 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 45.7 mm-40 -58.55 -50.46 73.72 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 4' ' ' VAL . 16.0 mt -65.8 -29.27 69.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.371 -0.83 . . . . 0.0 109.626 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 5.8 p -50.03 -42.98 50.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 108.729 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 14.7 mt-30 -95.83 30.76 2.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 178' ' ' LEU . 66.7 m-80 49.36 51.37 16.46 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 22.1 mt-30 -123.14 111.96 30.29 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.581 ' HD3' HD12 ' A' ' 7' ' ' LEU . 13.8 Cg_endo -62.88 173.64 3.65 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.223 1.949 . . . . 0.0 112.539 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.546 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 93.7 t -133.45 142.16 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.36 1.076 . . . . 0.0 112.803 -176.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.727 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -90.85 117.7 29.67 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 175.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 10.0 t80 -122.51 161.57 23.37 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.129 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.2 pt20 -167.29 138.73 3.15 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 118.171 -1.412 . . . . 0.0 110.791 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.48 108.33 2.31 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 244' ' ' TYR . 21.9 t -66.85 163.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 111.174 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.454 ' HA2' ' CD1' ' A' ' 241' ' ' PHE . . . -167.87 -136.59 2.07 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -88.17 -32.49 18.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 111.253 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.78 -18.7 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.874 -1.141 . . . . 0.0 111.504 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.88 -170.43 23.47 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -78.11 100.15 1.61 Allowed Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.83 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.618 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.1 t-80 -72.26 126.69 30.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 186' ' ' TYR . . . -119.13 165.86 13.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.053 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 40.7 p90 -156.89 -159.91 0.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.639 HG22 HG13 ' A' ' 55' ' ' ILE . 11.5 t -139.74 138.77 38.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.693 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.555 ' CD1' HG23 ' A' ' 174' ' ' ILE . 90.7 mt -107.08 111.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' LYS . 15.1 p-10 -123.7 34.21 5.14 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.285 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 174.62 160.1 22.09 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.354 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.67 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -138.42 168.38 19.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -126.76 -11.17 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.958 -1.089 . . . . 0.0 110.209 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.59 -35.85 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 4.8 mtt180 -88.73 35.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.253 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 70.43 31.67 2.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 109.648 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 48.5 m-85 -122.26 133.78 54.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.17 -0.956 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 33.9 m-85 -124.07 160.47 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.311 -0.868 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.591 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 40.3 t-80 -92.13 134.6 34.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 198' ' ' VAL . 21.4 t -131.58 146.19 33.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.337 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 42.6 t-20 -114.45 81.92 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 91.4 m95 -57.21 163.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.721 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.24 17.4 47.74 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.551 ' NE1' ' CE1' ' A' ' 195' ' ' HIS . 75.1 m95 -107.19 -169.61 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.41 -1.053 . . . . 0.0 108.92 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -76.45 -90.47 0.25 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.65 68.96 0.54 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.583 ' CG2' ' N ' ' A' ' 218' ' ' SER . 0.7 OUTLIER -101.2 -92.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.875 -1.367 . . . . 0.0 110.166 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.583 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 19.1 m -88.29 11.38 16.77 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.21 124.22 13.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.073 . . . . 0.0 109.016 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 209' ' ' HIS . . . 145.48 -97.41 0.19 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.352 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 98.9 m-85 -110.19 174.08 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.246 . . . . 0.0 110.473 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.558 ' CZ ' ' OD1' ' A' ' 228' ' ' ASN . 0.1 OUTLIER -78.42 156.49 29.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 109.669 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.404 ' O ' HD12 ' A' ' 224' ' ' LEU . 5.1 mmt180 -111.3 141.85 44.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 2.2 mm? -120.79 39.34 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.003 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.6 OUTLIER -95.57 -77.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.88 -92.91 0.52 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.291 -0.88 . . . . 0.0 109.261 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.456 HD12 ' HD2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -90.94 -163.09 0.98 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.279 -0.888 . . . . 0.0 108.651 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.584 ' O ' ' CH2' ' A' ' 212' ' ' TRP . 2.5 m-80 -91.29 -52.19 0.3 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 111.878 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 228' ' ' ASN . 33.4 Cg_endo -74.65 149.0 37.8 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.487 2.125 . . . . 0.0 110.64 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.1 t -122.15 -0.34 9.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.62 122.47 40.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 239' ' ' GLY . 0.1 OUTLIER -90.34 34.15 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.573 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 93.29 120.8 3.03 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 30.1 p -86.49 -26.25 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -1.129 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -96.17 -73.66 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -89.64 -137.54 6.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 166.08 98.31 0.12 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -105.61 -14.7 15.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -1.143 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 232' ' ' LEU . . . 132.13 -98.55 0.37 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 96.03 58.93 1.07 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.454 ' CD1' ' HA2' ' A' ' 190' ' ' GLY . 0.8 OUTLIER -81.67 -178.92 7.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -1.179 . . . . 0.0 109.137 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.517 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.6 t-20 -99.07 84.27 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -82.27 -66.1 1.59 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.543 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 9.6 m-85 -135.25 110.68 9.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -1.052 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 -92.5 140.0 30.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 108.751 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -149.58 166.16 30.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.045 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.508 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -141.26 152.23 44.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.278 1.037 . . . . 0.0 110.925 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 68.9 t -111.02 117.56 55.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.613 HG22 ' CD2' ' A' ' 158' ' ' HIS . 25.0 m -123.12 145.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.066 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 87.74 56.44 2.1 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 63.2 mt -100.32 74.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.565 -0.962 . . . . 0.0 110.674 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -152.4 156.76 33.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.086 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.295 1.997 . . . . 0.0 110.476 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.503 ' OE1' ' CA ' ' A' ' 204' ' ' GLY . 12.5 tt0 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.405 ' HD2' ' HG2' ' A' ' 1' ' ' GLN . 35.9 Cg_endo -78.95 169.93 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.494 2.13 . . . . 0.0 110.24 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.11 134.38 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.452 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.535 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 6.7 t -124.49 130.47 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 200' ' ' ASP . 35.4 mmtt -76.77 179.57 6.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.477 ' CA ' ' OD2' ' A' ' 200' ' ' ASP . 4.2 m -77.67 104.93 8.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.014 -1.054 . . . . 0.0 109.363 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.645 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.6 mt -57.95 -56.17 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 198' ' ' VAL . 18.2 mt -55.14 -36.88 66.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.41 -1.431 . . . . 0.0 108.294 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 22.4 t0 -68.52 -42.1 79.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.126 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -58.55 -14.98 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.05 -1.031 . . . . 0.0 109.045 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' HG13 ' A' ' 13' ' ' ILE . 15.5 mtpt -120.56 20.27 11.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.42 37.6 4.86 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 60.6 mt -85.31 106.92 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.386 1.089 . . . . 0.0 110.551 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 102' ' ' PRO . 17.7 m-70 -134.81 95.43 3.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.573 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 9.3 m-30 -98.95 179.13 4.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 111.064 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 26.1 t-20 -145.96 -177.44 5.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.531 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 39.0 mt-30 -116.64 -18.0 10.42 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.923 -1.111 . . . . 0.0 110.164 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.72 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.95 -38.22 0.9 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.337 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.764 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.01 -142.5 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.458 -177.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -73.78 2.99 5.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 122.411 1.897 . . . . 0.0 109.441 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.57 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 11.2 m-85 -79.29 -28.01 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.122 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 14.7 p-10 -96.51 23.38 6.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.593 -1.317 . . . . 0.0 109.783 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 8.7 mt -76.79 -5.64 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.566 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 118' ' ' GLU . 6.8 mt -125.57 9.46 7.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.602 -1.311 . . . . 0.0 109.428 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 40.9 p -82.06 160.87 62.14 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.604 ' HD2' ' CD1' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -68.82 126.18 13.61 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.14 1.894 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 44.4 t -74.65 151.45 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.423 0.63 . . . . 0.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.657 HD13 ' HD3' ' A' ' 133' ' ' PRO . 22.2 mt -77.69 147.23 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 110.899 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -126.31 -20.74 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.745 -0.597 . . . . 0.0 110.535 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 48.0 mtpt -120.12 172.9 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.005 -1.059 . . . . 0.0 110.158 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 37' ' ' SER . 79.7 t -114.4 143.04 24.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 111.05 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HD3' ' OE1' ' A' ' 35' ' ' GLU . 19.3 tttt -76.83 128.72 80.91 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.54 118.61 5.78 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.319 1.346 . . . . 0.0 110.286 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.03 17.05 14.87 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 32' ' ' LYS . 32.3 tt0 -152.79 173.81 14.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.433 -1.039 . . . . 0.0 109.56 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -179.32 2.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 109.996 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 31' ' ' VAL . 1.5 t -87.5 139.2 30.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.363 -0.836 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 75.5 m-85 -124.18 23.92 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.107 -0.996 . . . . 0.0 109.367 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.99 146.49 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.809 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.05 1.84 86.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mt-30 -93.06 126.8 38.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -1.131 . . . . 0.0 109.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 1.7 m-70 -72.83 111.55 8.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.32 157.69 1.37 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.997 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.07 166.04 23.81 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.628 0.727 . . . . 0.0 109.946 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 120' ' ' MET . 19.1 p -77.11 -33.66 56.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 106.18 136.57 8.44 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.487 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 5.3 p -54.85 -50.12 69.45 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.292 -1.122 . . . . 0.0 108.275 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 127' ' ' VAL . 9.5 t -47.52 -53.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.53 -48.65 80.85 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.046 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.62 ' CG2' ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -62.79 -33.6 75.53 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.966 -177.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -65.73 -41.93 91.62 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.882 -1.527 . . . . 0.0 108.036 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.578 ' OG1' HG23 ' A' ' 143' ' ' VAL . 31.3 m -75.46 -50.68 15.03 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.426 0.631 . . . . 0.0 110.003 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.32 -35.57 38.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 mt-30 -68.47 -44.88 73.85 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 198' ' ' VAL . 53.0 mt -69.92 -22.9 25.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.582 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 16.8 mtp -73.76 -34.58 64.77 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.573 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 33.7 tptt -74.9 -43.39 54.59 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.645 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.8 t80 -54.06 -25.46 21.71 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.351 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 32.1 m-70 -108.31 -27.81 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 110.674 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 67.6 m-20 45.11 61.36 2.57 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.3 t80 -84.98 -77.56 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.6 Cg_endo -70.66 106.47 1.83 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 119.467 0.845 . . . . 0.0 113.83 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -67.51 -24.79 65.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -131.83 127.04 35.76 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 176.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.73 166.08 4.84 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 118.566 -1.778 . . . . 0.0 110.877 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.557 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -95.95 -35.29 11.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.469 -1.018 . . . . 0.0 111.44 -178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 27.0 tttp -152.76 130.54 11.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.534 -1.354 . . . . 0.0 110.887 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 3.4 m-20 -62.25 171.35 1.88 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.08 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 47.4 t80 -149.11 141.8 24.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.578 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t -144.65 148.37 34.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 27.5 p90 -160.47 155.2 24.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 85' ' ' ASN . 29.1 m -93.01 131.71 37.76 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 86' ' ' LEU . 9.9 tp -45.13 147.72 0.68 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.845 . . . . 0.0 110.727 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 1.5 t -61.79 146.75 48.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.941 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 0.99 9.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.109 -0.994 . . . . 0.0 109.745 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -99.47 -7.99 25.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' CG ' HD21 ' A' ' 73' ' ' LEU . 17.6 t-20 -70.32 109.41 4.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.751 -0.593 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.623 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.2 Cg_endo -89.26 15.68 1.95 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 73.9 m-85 -110.78 -23.65 10.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 111.167 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 80.4 m-85 -118.14 160.69 21.11 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 15.4 m-80 -48.22 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 174.76 -45.75 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.387 -0.821 . . . . 0.0 111.311 175.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.0 Cg_endo -75.76 55.32 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 N-CA-C 107.86 -1.631 . . . . 0.0 107.86 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 5.4 tptt -106.75 106.81 17.51 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.237 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' OD1' ' OG1' ' A' ' 72' ' ' THR . 67.7 m-80 -100.1 141.54 32.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.64 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 mp -118.26 125.41 50.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 12.1 t80 -120.16 127.71 52.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.956 . . . . 0.0 110.133 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.34 111.9 24.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' CB ' HG21 ' A' ' 92' ' ' THR . . . -72.94 53.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.739 -1.226 . . . . 0.0 108.352 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.638 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.7 mt -53.24 -58.3 3.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.746 -0.596 . . . . 0.0 111.195 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.0 p -43.56 -29.44 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.815 -1.178 . . . . 0.0 109.257 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.546 HG21 ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.29 30.14 7.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.46 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.638 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 27.7 mmt-85 -79.22 156.06 28.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.537 -1.352 . . . . 0.0 109.4 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -116.46 83.78 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 122' ' ' ASP . 9.1 m-85 -80.71 97.83 7.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.611 -0.681 . . . . 0.0 110.132 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.491 ' O ' HG13 ' A' ' 100' ' ' ILE . 29.5 t-20 -79.02 89.88 4.79 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 45.5 m95 -60.54 -8.89 3.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.68 -21.68 21.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.2 m-20 -100.07 -24.76 14.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.593 HD12 ' CE3' ' A' ' 97' ' ' TRP . 36.3 mt -73.49 64.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.575 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 37.7 mt -46.4 149.23 1.4 Allowed Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.6 Cg_endo -77.58 -25.17 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.579 2.186 . . . . 0.0 110.522 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER -142.13 125.37 16.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 109.516 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.648 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 76.5 m-85 -112.78 145.14 41.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -99.56 -4.36 31.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 82.49 7.64 87.26 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -118.5 9.12 12.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -1.068 . . . . 0.0 108.724 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -72.76 -177.84 2.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.464 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -73.92 172.94 10.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -74.81 -36.18 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.634 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.3 t -51.81 -60.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.464 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 5.2 mp0 -62.54 -36.24 82.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.974 -1.079 . . . . 0.0 108.989 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.507 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 72.9 mttt -64.5 -42.67 95.7 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.481 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.5 ttm -60.03 -38.73 83.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -69.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.485 -0.76 . . . . 0.0 110.476 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 3.0 tp -57.92 -43.6 84.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 110.227 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.3 p -50.51 -40.52 51.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.493 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.509 ' HA ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.62 -48.96 58.23 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 53' ' ' ALA . 5.4 tp -49.19 -48.76 45.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.62 ' HE1' ' CG2' ' A' ' 50' ' ' THR . 1.7 mmt -58.82 -55.28 37.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.577 -0.702 . . . . 0.0 110.583 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.42 -33.43 75.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 126' ' ' SER . 21.6 m-20 -64.37 -47.12 80.48 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 49' ' ' ALA . 62.1 t -71.35 -55.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.499 -0.75 . . . . 0.0 109.264 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.26 -50.53 12.94 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.0 mt -63.69 -55.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.255 -1.144 . . . . 0.0 108.046 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 6.9 p -46.93 -32.05 3.57 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.296 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.747 HG13 HG22 ' A' ' 143' ' ' VAL . 14.1 m -100.66 34.32 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.9 m-20 38.6 53.69 1.88 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.611 0.719 . . . . 0.0 109.509 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.549 ' HB3' ' CE2' ' A' ' 131' ' ' TYR . 57.3 tpp -65.87 129.56 40.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 111.629 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -76.61 121.83 23.78 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 75.6 m-85 -103.38 117.46 34.53 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.705 1.24 . . . . 0.0 113.432 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.517 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.54 -162.46 10.6 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 104.12 -3.592 . . . . 0.0 104.12 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.657 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.53 -30.48 79.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 106.049 -2.327 . . . . 0.0 106.049 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.94 143.06 40.42 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.502 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.0 m -124.59 112.55 16.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.975 -1.703 . . . . 0.0 110.092 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 146.28 16.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.532 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 33.5 t -120.0 -164.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.89 -52.31 4.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.588 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.15 -143.33 14.75 Favored Glycine 0 N--CA 1.48 1.592 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.978 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.526 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 74.6 m -48.37 -51.18 27.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.755 -0.85 . . . . 0.0 111.846 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.49 -39.17 10.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.789 -1.195 . . . . 0.0 108.761 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.566 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 10.5 mmt180 -81.77 -44.3 17.18 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.203 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 127' ' ' VAL . 41.2 t -69.07 -51.28 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 110.584 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.4 pp0? -56.95 -35.73 69.44 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.001 -1.062 . . . . 0.0 108.691 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 30.6 ttm180 -77.27 -47.0 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.965 . . . . 0.0 110.147 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 126' ' ' SER . . . -64.09 -36.55 84.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.125 -0.984 . . . . 0.0 110.353 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -59.7 -46.35 89.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.751 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 33.2 mtmt -85.0 -47.72 9.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 110.758 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 18.8 mt-10 -70.63 -47.07 61.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.911 -1.118 . . . . 0.0 112.273 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.406 ' HB3' HD13 ' A' ' 90' ' ' ILE . 18.6 m120 -89.57 -53.27 4.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.575 -1.328 . . . . 0.0 112.126 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.582 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 46.6 m-85 -90.06 -13.75 35.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 110.448 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.557 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 65.52 36.55 92.65 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.054 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 154' ' ' ASN . 7.9 m-85 -63.43 172.63 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.374 -1.662 . . . . 0.0 107.808 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 33.5 t-20 -47.86 134.74 12.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.725 -1.234 . . . . 0.0 109.235 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 30.1 mm-40 -53.31 -21.67 5.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.958 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 154' ' ' ASN . 52.6 p -54.49 -16.72 2.51 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.369 -0.832 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 39.4 t -57.19 123.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.032 -1.043 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.593 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 15.2 p-80 -143.46 161.35 38.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 6.4 tt0 -102.27 154.65 18.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 0.0 110.274 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 247' ' ' ALA . 14.7 pt -137.64 134.92 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.5 m-80 -102.73 107.36 18.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.838 -1.163 . . . . 0.0 111.069 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.653 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -47.38 -44.46 24.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.85 -21.58 55.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 18.1 m-20 -104.9 2.24 29.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.953 -1.322 . . . . 0.0 112.162 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -117.65 175.05 5.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.302 -1.498 . . . . 0.0 110.314 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.509 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.1 p -100.41 131.63 46.22 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.509 ' C ' ' O ' ' A' ' 166' ' ' SER . 28.3 ttmt -30.09 -49.35 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.204 0.526 . . . . 0.0 111.002 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -62.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.96 -1.087 . . . . 0.0 110.188 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.39 -16.12 52.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.004 -1.06 . . . . 0.0 109.28 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 57.6 t-105 -72.71 -51.14 20.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.466 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 30.0 mt-10 -68.88 -37.12 78.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.08 -1.012 . . . . 0.0 108.319 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.61 -42.16 15.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -61.01 -42.81 99.17 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.517 ' CG2' HD11 ' A' ' 199' ' ' ILE . 6.9 mt -70.34 -53.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.729 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.471 ' OD1' ' CE2' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -49.84 -55.92 12.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.634 -178.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 179' ' ' SER . 22.1 tttt -50.91 -41.32 58.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.837 -1.165 . . . . 0.0 108.517 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.581 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.7 mm-40 -61.26 -49.79 75.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.556 HD12 ' CG2' ' A' ' 199' ' ' ILE . 46.9 mt -68.53 -24.67 64.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.247 -0.908 . . . . 0.0 110.257 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.426 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 53.3 p -52.05 -37.12 52.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.464 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 mt-30 -102.71 34.11 2.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 7' ' ' LEU . 30.5 m-20 44.21 51.71 7.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.15 -0.969 . . . . 0.0 108.893 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 9.5 mt-30 -123.79 107.44 31.25 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.49 ' HD3' HD12 ' A' ' 7' ' ' LEU . 14.7 Cg_endo -62.63 165.74 15.13 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.708 1.605 . . . . 0.0 112.681 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 18.7 t -120.04 134.88 62.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.207 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.588 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.9 OUTLIER -82.81 115.3 21.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.12 158.59 28.96 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.914 -1.117 . . . . 0.0 108.798 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 196' ' ' ALA . 2.0 pt20 -167.77 128.37 1.41 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.006 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' HIS . . . -91.1 124.44 7.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 106.154 -2.778 . . . . 0.0 106.154 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 1.9 t -101.86 164.51 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.727 -1.455 . . . . 0.0 112.957 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.07 -136.61 2.06 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -25.28 22.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.817 -1.402 . . . . 0.0 110.777 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.451 ' CG1' ' HA3' ' A' ' 237' ' ' GLY . 15.8 m -83.46 -22.43 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.003 -1.061 . . . . 0.0 111.659 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' C ' HG11 ' A' ' 189' ' ' VAL . . . 138.31 176.8 14.76 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -76.87 113.19 3.72 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.57 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 33.5 t-80 -71.27 95.32 1.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 186' ' ' TYR . . . -86.12 155.67 20.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.719 1.247 . . . . 0.0 113.793 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 35.0 p90 -154.04 177.06 11.48 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.505 HG22 HG13 ' A' ' 55' ' ' ILE . 97.9 t -123.26 136.66 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.496 -1.377 . . . . 0.0 112.418 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.556 ' CG2' HD12 ' A' ' 178' ' ' LEU . 64.9 mt -97.11 124.13 49.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 7.4 p-10 -137.15 29.65 2.76 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.989 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -168.87 174.36 43.44 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.506 -2.283 . . . . 0.0 112.169 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.535 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.87 147.79 5.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -120.33 34.41 5.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.654 -1.279 . . . . 0.0 109.686 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.503 ' CA ' ' OE1' ' A' ' 1' ' ' GLN . . . 53.88 18.62 8.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 3.2 mtt85 -136.63 32.58 2.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -1.178 . . . . 0.0 109.225 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 1.3 m120 64.75 22.79 12.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 10.0 m-85 -110.73 100.26 9.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.531 ' H ' ' CB ' ' A' ' 222' ' ' PHE . 11.1 m-85 -96.56 156.28 16.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.444 -0.785 . . . . 0.0 110.292 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.597 ' CD2' ' HA3' ' A' ' 220' ' ' GLY . 56.2 t-80 -93.17 123.32 36.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 9.1 t -112.76 135.31 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.821 1.296 . . . . 0.0 111.825 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 212' ' ' TRP . 3.8 t30 -112.95 99.55 7.95 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.89 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.551 ' CD1' HG22 ' A' ' 217' ' ' VAL . 43.9 m95 -49.0 178.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.749 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 17' ' ' GLN . . . -86.64 15.45 51.49 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.551 ' CB ' HG13 ' A' ' 217' ' ' VAL . 65.9 m95 -109.52 -167.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.291 . . . . 0.0 109.575 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 15' ' ' TYR . . . -117.87 -28.5 2.24 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.595 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.58 -24.09 9.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.551 HG13 ' CB ' ' A' ' 214' ' ' TRP . 0.9 OUTLIER -85.58 -37.93 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.848 -0.795 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 217' ' ' VAL . 0.2 OUTLIER -41.51 93.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 217' ' ' VAL . 1.9 t70 -98.7 -77.0 0.52 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.025 0.917 . . . . 0.0 112.13 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 144.18 59.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.511 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 1.2 m-85 -120.94 120.12 34.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.126 -1.22 . . . . 0.0 110.975 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' A' ' 222' ' ' PHE . 0.3 OUTLIER -77.11 15.8 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.763 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.481 ' O ' HD11 ' A' ' 224' ' ' LEU . 3.3 mtp180 -85.6 119.25 25.73 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.3 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 197' ' ' PHE . 2.4 mm? -120.78 21.36 11.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.313 -0.867 . . . . 0.0 109.957 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -34.26 31.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 109.051 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.66 97.89 5.49 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 69.49 8.32 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 121.585 0.707 . . . . 0.0 109.657 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -116.56 102.52 53.3 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 232' ' ' LEU . 34.7 Cg_endo -76.34 159.16 36.66 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 110.726 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.6 m -87.41 -35.14 18.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.549 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 214' ' ' TRP . . . -93.26 45.57 1.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.456 HD12 ' HG2' ' A' ' 229' ' ' PRO . 27.0 tp -79.17 -34.63 42.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.66 151.38 1.92 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.37 59.54 1.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -84.71 172.2 48.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -70.55 88.03 0.35 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.451 ' HA3' ' CG1' ' A' ' 192' ' ' VAL . . . -173.77 -167.68 33.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -106.74 163.31 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -1.14 . . . . 0.0 109.399 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.78 -43.89 8.07 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.91 72.21 0.42 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -110.07 127.74 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.141 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 4.3 t-20 -108.35 70.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.962 . . . . 0.0 109.779 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -77.04 -47.0 9.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' VAL . 3.1 m-85 -135.43 148.14 49.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -1.07 . . . . 0.0 109.079 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 5.4 tt0 -151.63 122.43 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 25.6 p -150.57 164.56 35.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 110.617 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' ILE . . . -140.41 163.47 32.72 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.846 0.832 . . . . 0.0 109.703 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 8.4 t -117.28 128.42 74.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.593 ' CG2' ' NE2' ' A' ' 158' ' ' HIS . 32.7 m -127.05 144.96 35.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.796 -1.19 . . . . 0.0 111.072 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.18 51.45 2.97 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.611 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 8.2 mt -102.43 97.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.575 -0.956 . . . . 0.0 109.824 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.6 150.78 10.58 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.095 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.6 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.178 1.918 . . . . 0.0 110.359 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.464 ' NE2' ' CZ ' ' A' ' 208' ' ' TYR . 55.1 tt0 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.33 -170.95 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.403 2.069 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 4' ' ' VAL . 25.1 t -133.45 138.48 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.158 -0.964 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 178' ' ' LEU . 13.7 t -130.92 131.15 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.0 mmtt -74.82 -169.28 0.86 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.061 -1.024 . . . . 0.0 108.291 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.587 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 72.7 m -80.86 101.58 9.5 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.155 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 200' ' ' ASP . 45.0 mt -58.15 -49.18 77.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.999 -1.063 . . . . 0.0 108.737 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.74 -38.82 82.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.073 -1.017 . . . . 0.0 109.157 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 8.0 t0 -67.26 -37.75 84.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 109.152 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 p -57.88 -15.73 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.005 . . . . 0.0 108.575 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HB2' HG13 ' A' ' 13' ' ' ILE . 3.1 mtpt -120.84 18.16 11.82 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 47.1 41.25 14.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 8.3 mt -89.63 102.0 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -1.039 . . . . 0.0 110.29 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' PRO . 27.1 m80 -128.1 77.7 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.596 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 11.4 m-30 -81.61 -179.79 7.52 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.102 0.953 . . . . 0.0 111.182 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.98 -164.04 1.93 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 20.7 mt-30 -125.16 -19.64 5.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.061 -1.025 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.83 -35.44 1.26 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.617 -1.277 . . . . 0.0 111.424 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.759 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.77 -140.17 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 118.469 -0.776 . . . . 0.0 110.981 -178.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.759 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.3 Cg_endo -74.16 3.54 5.06 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 122.46 1.914 . . . . 0.0 109.616 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.561 ' CD2' ' HE2' ' A' ' 120' ' ' MET . 7.5 m-85 -79.93 -31.13 40.07 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.231 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.0 p-10 -93.46 17.88 10.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.484 -1.385 . . . . 0.0 109.944 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.5 4.92 5.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.862 . . . . 0.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 118' ' ' GLU . 13.3 mt -133.39 -4.45 2.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.721 -1.237 . . . . 0.0 110.368 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.6 p -61.99 164.62 10.02 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.9 Cg_endo -71.7 132.96 21.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.648 1.565 . . . . 0.0 110.573 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.93 145.38 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 110.229 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD13 ' HD3' ' A' ' 133' ' ' PRO . 8.9 mt -77.01 149.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.592 -0.692 . . . . 0.0 110.565 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 39' ' ' VAL . 6.2 mt-10 -125.39 -23.84 4.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.703 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 79' ' ' TYR . 25.8 mtpp -114.74 174.48 5.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.958 -1.089 . . . . 0.0 109.98 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.47 HG23 ' CB ' ' A' ' 37' ' ' SER . 98.3 t -114.32 146.48 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.887 . . . . 0.0 111.008 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' N ' HG11 ' A' ' 31' ' ' VAL . 58.3 tttt -86.6 130.76 47.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.65 123.91 10.6 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.466 1.444 . . . . 0.0 110.182 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 11.43 29.86 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.7 tt0 -151.25 168.09 25.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -1.082 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.3 -175.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 108.62 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.47 ' CB ' HG23 ' A' ' 31' ' ' VAL . 32.0 t -87.76 139.1 30.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 110.275 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.718 ' CD2' ' CG ' ' A' ' 133' ' ' PRO . 17.3 m-30 -111.78 11.69 20.93 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 109.275 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 29' ' ' GLU . 20.3 t -61.54 119.15 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.841 -1.162 . . . . 0.0 108.617 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.04 52.34 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 21.8 mt-30 -74.53 135.81 42.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.947 . . . . 0.0 109.255 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.48 116.14 13.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.92 156.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.326 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' CB ' ' OG ' ' A' ' 135' ' ' SER . . . -80.57 167.12 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.559 HG22 ' SD ' ' A' ' 120' ' ' MET . 31.0 p -81.96 -37.61 26.44 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.567 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 105.14 139.3 9.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' VAL . 1.2 p -55.11 -50.26 69.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -1.161 . . . . 0.0 108.158 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.52 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.7 t -46.32 -53.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -63.57 -48.04 79.04 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.468 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 53.2 m -62.51 -31.87 72.7 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.734 -0.604 . . . . 0.0 109.439 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.37 76.24 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.69 -1.256 . . . . 0.0 108.756 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.576 HG22 ' HG3' ' A' ' 56' ' ' MET . 28.2 m -74.75 -51.71 13.47 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.567 0.698 . . . . 0.0 109.729 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.556 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -50.94 -36.69 40.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.684 -0.635 . . . . 0.0 109.567 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.596 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 23.1 mt-30 -69.69 -58.91 3.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.665 -1.272 . . . . 0.0 107.969 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.679 HG13 HG22 ' A' ' 198' ' ' VAL . 78.0 mt -57.68 -20.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.585 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 24.7 mtp -73.91 -35.82 64.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 28.9 tptt -77.49 -41.04 40.85 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.188 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 46.3 t80 -53.19 -26.76 18.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 108.813 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 65.2 m-70 -107.85 -26.66 10.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 110.426 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.602 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 85.7 m-20 47.97 58.39 5.12 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.582 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.5 t80 -83.91 -73.88 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 113.087 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.8 Cg_endo -68.23 101.61 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.026 0.688 . . . . 0.0 111.6 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.407 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 4.2 m120 -70.32 -20.51 63.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 51.5 tttt -134.74 142.25 46.7 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.89 147.47 37.3 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.52 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -86.81 -50.57 6.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.989 . . . . 0.0 109.992 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 44.9 tttt -148.49 152.73 37.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.943 . . . . 0.0 109.594 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 89' ' ' ALA . 12.9 m-20 -73.01 178.01 4.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 70' ' ' THR . 24.5 t80 -154.26 153.82 32.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.373 -0.83 . . . . 0.0 109.581 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.616 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -158.0 154.12 27.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.611 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 30.8 p90 -161.66 162.73 30.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 56.6 m -93.83 131.67 38.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.504 HD21 ' CG ' ' A' ' 77' ' ' ASN . 9.7 tp -47.13 148.43 1.19 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 111.11 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.67 143.43 56.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.689 -0.632 . . . . 0.0 110.041 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 t -69.61 -2.76 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 110.087 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 m-20 -99.39 -3.72 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.026 -1.046 . . . . 0.0 109.39 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.574 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 19.6 t-20 -70.65 110.67 7.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.536 -0.728 . . . . 0.0 110.11 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -90.91 20.19 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 123.101 2.534 . . . . 0.0 108.559 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 45.2 m-85 -114.11 -28.34 7.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 111.879 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.487 ' CD1' HD23 ' A' ' 73' ' ' LEU . 49.3 m-85 -118.06 164.83 14.52 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.3 m-80 -46.99 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.95 -47.48 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 111.044 175.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -77.38 54.31 4.65 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 N-CA-C 107.216 -1.879 . . . . 0.0 107.216 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HE3' ' HG ' ' A' ' 86' ' ' LEU . 13.3 tptt -106.68 107.08 17.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.812 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -100.93 140.17 35.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 108.983 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.7 mp -111.32 149.41 31.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -137.17 123.19 20.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.994 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.12 112.85 25.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -74.72 50.98 0.46 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.795 -1.191 . . . . 0.0 108.4 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.628 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 92.9 mt -52.6 -45.4 47.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.9 p -45.23 -26.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.738 -1.226 . . . . 0.0 109.047 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -111.38 37.76 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 108.929 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 11.9 mmt-85 -95.48 154.93 16.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.493 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.48 91.95 3.71 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.566 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.7 m-85 -81.19 90.26 6.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 110.573 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -78.92 92.18 4.88 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 67.0 m95 -60.72 -9.17 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.408 -0.808 . . . . 0.0 110.164 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -90.75 -20.39 22.46 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 30.9 m-20 -92.08 -34.62 14.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.578 HD12 ' CE3' ' A' ' 97' ' ' TRP . 25.9 mt -73.83 94.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.0 mt -71.47 153.03 93.94 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.496 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.4 Cg_endo -80.05 -30.31 2.25 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.808 2.339 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 t -136.7 128.15 28.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.589 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 68.1 m-85 -112.52 138.01 49.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.7 p -99.95 2.02 43.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 108.707 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.72 0.12 89.87 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -120.1 13.23 12.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 0.0 109.461 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 3.7 mp0 -72.5 170.25 14.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.9 173.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.125 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -79.72 -44.12 21.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.98 -47.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.21 -43.54 97.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.094 -1.004 . . . . 0.0 109.207 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 116' ' ' ILE . 52.1 mttt -60.52 -36.22 77.86 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.412 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 6.2 ttm -60.07 -46.74 88.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.4 73.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.187 -0.945 . . . . 0.0 110.727 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.589 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 2.3 tp -69.55 -46.96 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.612 -1.305 . . . . 0.0 109.734 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.2 p -53.71 -40.26 65.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.003 . . . . 0.0 109.156 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.581 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 1.1 tp10 -69.81 -45.42 67.94 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 53' ' ' ALA . 10.0 tp -51.42 -50.25 60.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.561 ' HE2' ' CD2' ' A' ' 21' ' ' TYR . 1.1 mmt -60.87 -46.8 89.19 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.768 -0.582 . . . . 0.0 109.816 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.67 -39.66 94.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.467 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -64.53 -46.12 84.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 49' ' ' ALA . 89.1 t -71.4 -58.92 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.53 0.681 . . . . 0.0 109.822 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -45.79 -48.25 13.36 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.9 mt -63.5 -58.05 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.564 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.3 p -47.58 -29.22 2.72 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.986 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 143' ' ' VAL . 19.8 m -100.68 37.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 127' ' ' VAL . 91.1 m-20 37.1 50.19 0.91 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.679 0.752 . . . . 0.0 109.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.52 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 54.9 tpp -65.75 130.55 43.68 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.539 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 38.6 t0 -76.57 118.69 19.48 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 104.014 -2.588 . . . . 0.0 104.014 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.565 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 39.8 m-85 -101.19 110.6 22.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.62 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -150.14 -170.34 17.32 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 103.722 -3.751 . . . . 0.0 103.722 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.756 ' HD3' HD13 ' A' ' 28' ' ' ILE . 13.9 Cg_endo -62.54 -20.61 71.19 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 106.923 -1.991 . . . . 0.0 106.923 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -110.86 135.21 51.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.531 ' OG ' ' CB ' ' A' ' 44' ' ' ALA . 69.1 m -123.6 111.05 15.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 119.817 -1.802 . . . . 0.0 110.97 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.57 130.91 10.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 5.5 t -110.1 -163.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.879 -1.365 . . . . 0.0 107.433 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.576 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -89.8 -55.92 3.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.602 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 142.92 -136.2 6.95 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.051 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.527 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 13.8 m -56.62 -45.16 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.858 -0.789 . . . . 0.0 112.108 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 140' ' ' SER . 14.7 p -46.11 -43.35 14.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.946 -1.096 . . . . 0.0 109.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.621 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.8 mmt180 -82.34 -40.25 21.67 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 127' ' ' VAL . 55.3 t -68.33 -54.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.7 pp0? -56.73 -33.95 67.02 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.268 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.1 ttp180 -77.15 -48.52 17.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -63.1 -34.95 78.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.959 . . . . 0.0 110.043 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' HB2' HG13 ' A' ' 157' ' ' VAL . 50.7 mt -58.77 -47.93 83.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.088 -1.008 . . . . 0.0 109.475 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.534 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 14.0 mtmt -87.17 -35.65 18.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.859 -1.15 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 43.2 mt-10 -77.68 -55.28 5.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.406 -1.434 . . . . 0.0 111.823 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 34.2 m120 -84.35 -40.39 17.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.966 -1.084 . . . . 0.0 111.578 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.585 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.6 m-85 -102.51 -2.25 28.97 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.767 -1.208 . . . . 0.0 110.665 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 52.0 36.65 43.49 Favored Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.163 -0.961 . . . . 0.0 112.011 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.3 m-85 -62.01 163.85 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.242 -1.74 . . . . 0.0 107.993 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.468 ' HB3' ' OG ' ' A' ' 156' ' ' SER . 55.9 t30 -47.3 147.01 1.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.452 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.37 4.71 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.23 -0.918 . . . . 0.0 108.698 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.536 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 16.7 p -54.08 -16.21 1.86 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.417 -0.802 . . . . 0.0 109.955 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.526 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 4.7 t -65.3 120.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.787 -1.195 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.584 ' CD2' HG22 ' A' ' 249' ' ' VAL . 2.9 p-80 -147.21 157.57 43.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.027 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.527 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 6.7 tt0 -101.93 155.81 17.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 246' ' ' SER . 2.6 pt -138.57 154.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.88 97.59 7.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 110.569 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.594 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 5.3 tpt180 -47.77 -31.58 5.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.25 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.52 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -63.7 -23.64 67.32 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -103.64 2.03 32.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.124 -1.221 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -117.92 140.57 49.54 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.63 -1.294 . . . . 0.0 109.81 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -67.98 139.97 56.37 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' HA ' ' NH1' ' A' ' 162' ' ' ARG . 59.2 tttt -38.04 -46.78 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -56.83 12.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 169' ' ' ASP . 1.7 m-20 -63.43 -23.38 67.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 109.268 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.594 ' CE3' ' HA ' ' A' ' 162' ' ' ARG . 66.8 t-105 -72.53 -43.63 63.28 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 175' ' ' ASP . 34.3 mt-10 -62.71 -26.62 68.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.34 81.94 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -61.22 -42.4 98.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -0.851 . . . . 0.0 108.881 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.552 HG23 ' CD1' ' A' ' 199' ' ' ILE . 28.7 mt -75.99 -61.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.713 . . . . 0.0 110.889 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.4 OUTLIER -49.29 -51.58 33.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.967 -1.083 . . . . 0.0 109.601 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.44 ' O ' ' OG ' ' A' ' 179' ' ' SER . 12.8 tttt -52.1 -40.69 61.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.882 -1.136 . . . . 0.0 107.988 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.577 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 5.0 mm-40 -60.88 -53.96 50.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.603 -0.686 . . . . 0.0 109.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.515 ' HB3' HG11 ' A' ' 4' ' ' VAL . 5.8 mt -65.69 -24.68 67.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 176' ' ' LYS . 24.8 p -52.31 -45.17 65.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.974 -1.079 . . . . 0.0 108.193 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 19.9 mt-30 -94.29 39.09 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.476 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.3 m-20 42.52 51.2 4.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 10.2 mt-30 -123.94 105.14 32.32 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.541 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.1 Cg_endo -63.93 173.58 4.69 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.103 1.869 . . . . 0.0 112.653 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 63.9 t -129.84 142.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.242 1.02 . . . . 0.0 112.236 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.602 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.6 OUTLIER -93.29 121.17 34.39 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.675 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 14.0 t80 -122.69 159.42 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.549 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -152.52 119.86 5.94 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.594 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 195' ' ' HIS . . . -91.97 106.03 3.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 244' ' ' TYR . 10.1 t -67.11 160.76 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.25 -1.147 . . . . 0.0 110.644 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -172.34 -145.65 5.04 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -30.45 20.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.292 . . . . 0.0 110.229 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 238' ' ' ALA . 5.5 m -83.51 -22.2 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.3 -169.61 23.94 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -77.38 112.55 3.53 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.176 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.5 t-80 -77.44 113.73 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -105.98 164.34 12.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.782 1.277 . . . . 0.0 114.036 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' ' 186' ' ' TYR . 43.5 p90 -162.64 -160.68 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 55' ' ' ILE . 5.7 t -139.61 139.35 38.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.206 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 174' ' ' ILE . 40.0 mt -105.66 108.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 10.2 p-10 -120.87 32.43 5.97 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.428 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.485 ' HA2' ' HB ' ' A' ' 4' ' ' VAL . . . 178.17 166.16 34.11 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.267 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -145.77 164.26 32.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.425 ' C ' HG21 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -133.65 2.15 3.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.369 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.8 -31.06 4.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 10.0 mtt-85 -87.49 39.19 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.033 -1.275 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 17.0 m120 61.71 16.18 7.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 110.094 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -114.43 138.2 50.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 9.2 m-85 -123.17 162.48 22.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.337 -0.852 . . . . 0.0 110.285 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 59.2 t-80 -92.11 139.63 30.44 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.638 ' CG1' ' CE2' ' A' ' 212' ' ' TRP . 2.7 t -140.23 157.96 25.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.867 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 43.9 t-20 -117.95 85.23 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.638 ' CE2' ' CG1' ' A' ' 210' ' ' VAL . 19.7 m95 -70.52 176.4 4.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.146 -0.972 . . . . 0.0 112.019 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.519 ' HA3' ' NE2' ' A' ' 17' ' ' GLN . . . -94.03 33.85 5.0 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.564 ' CH2' ' N ' ' A' ' 233' ' ' GLY . 40.2 m95 -114.85 -162.6 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -1.134 . . . . 0.0 109.716 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -100.97 -53.58 1.02 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.846 -1.168 . . . . 0.0 111.498 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -108.54 -23.09 6.73 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.69 -1.476 . . . . 0.0 110.03 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 218' ' ' SER . 0.9 OUTLIER -73.91 -28.32 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.369 -1.077 . . . . 0.0 108.821 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 217' ' ' VAL . 1.2 t -43.54 -48.53 7.48 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.179 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.14 93.38 6.91 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.494 -1.379 . . . . 0.0 110.095 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -156.19 150.99 22.48 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -100.01 85.07 2.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -1.212 . . . . 0.0 109.327 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -138.65 -177.65 4.96 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.491 0.662 . . . . 0.0 110.176 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.463 ' O ' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -129.72 122.12 28.26 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.588 ' HB2' ' CH2' ' A' ' 212' ' ' TRP . 4.1 mm? -119.66 36.49 4.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.289 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.487 ' OD2' ' NE1' ' A' ' 170' ' ' TRP . 14.3 m-20 -80.07 4.38 17.36 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 242' ' ' ASN . . . -114.96 -65.46 1.19 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 109.68 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.1 -155.62 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 109.942 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.532 ' CB ' ' HD2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -100.7 176.97 1.66 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.844 . . . . 0.0 109.394 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 228' ' ' ASN . 35.8 Cg_endo -78.34 -157.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.813 2.342 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.6 t -117.54 22.49 12.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.068 -1.02 . . . . 0.0 109.767 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.556 ' HB1' ' CD2' ' A' ' 214' ' ' TRP . . . -114.79 126.21 54.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 mt -122.46 18.17 10.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' N ' ' CH2' ' A' ' 214' ' ' TRP . . . 58.55 -176.05 2.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 26.9 m -95.12 -75.79 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -1.191 . . . . 0.0 109.422 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.405 ' O ' ' OE2' ' A' ' 35' ' ' GLU . . . -94.47 31.28 6.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -65.34 -139.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -137.76 -97.25 0.43 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 192' ' ' VAL . . . -132.18 130.9 41.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.429 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -52.01 -74.98 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 241' ' ' PHE . . . 128.95 111.64 1.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -51.72 -177.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -1.133 . . . . 0.0 109.493 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.532 ' ND2' ' NE2' ' A' ' 245' ' ' GLN . 1.2 t-20 -104.77 77.7 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.442 ' HA3' ' CZ ' ' A' ' 241' ' ' PHE . . . -73.06 -55.82 6.11 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 189' ' ' VAL . 74.3 m-85 -135.4 162.36 32.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.558 -0.966 . . . . 0.0 108.587 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' NE2' ' ND2' ' A' ' 242' ' ' ASN . 0.0 OUTLIER -149.52 155.88 41.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.917 . . . . 0.0 108.804 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 13.5 p -167.53 149.88 5.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 110.085 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.543 ' HB1' ' CH2' ' A' ' 170' ' ' TRP . . . -129.98 169.15 15.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.249 1.024 . . . . 0.0 109.751 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 11.4 t -117.95 119.9 62.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 158' ' ' HIS . 30.1 m -119.17 150.23 21.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.286 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 84.82 33.2 19.33 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.626 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 46.8 mt -79.18 90.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.341 -1.093 . . . . 0.0 109.974 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.76 152.04 12.87 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.582 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.316 2.011 . . . . 0.0 110.447 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.543 ' NE2' ' CZ ' ' A' ' 208' ' ' TYR . 31.7 tt0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.1 -174.49 2.26 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.48 2.12 . . . . 0.0 110.038 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 4' ' ' VAL . 47.7 t -116.82 141.86 33.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.119 -0.988 . . . . 0.0 109.986 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.9 t -138.03 132.41 43.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 200' ' ' ASP . 49.2 mmtt -75.07 178.52 5.61 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.032 -1.043 . . . . 0.0 108.441 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.586 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 1.6 t -77.6 103.82 7.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.099 -1.001 . . . . 0.0 109.208 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.7 mt -57.15 -49.0 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.871 . . . . 0.0 108.923 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' H ' ' CB ' ' A' ' 200' ' ' ASP . 12.6 mt -56.5 -42.18 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.739 -1.226 . . . . 0.0 108.826 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.477 ' CB ' ' OG ' ' A' ' 6' ' ' SER . 54.8 t0 -67.48 -36.31 80.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.151 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -16.79 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.034 -1.042 . . . . 0.0 108.266 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.8 mtpt -122.32 18.32 10.63 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.25 43.12 7.24 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 57.6 mt -87.72 107.37 17.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.255 1.026 . . . . 0.0 110.23 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.8 m80 -135.02 86.97 2.29 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.593 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.7 m-30 -92.95 -179.9 5.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 110.768 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.17 -163.81 1.85 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.0 mt-30 -124.88 -20.8 4.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.929 -1.107 . . . . 0.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.38 -35.62 1.29 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.43 -1.367 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.773 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -142.74 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.529 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.132 -177.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.773 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.6 Cg_endo -72.98 1.83 6.11 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 CA-C-N 122.363 1.88 . . . . 0.0 109.559 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.559 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 10.4 m-85 -76.46 -31.12 57.63 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.953 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 10.8 p-10 -94.09 17.33 12.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.596 -1.315 . . . . 0.0 109.566 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.519 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 26.7 mt -72.28 -3.03 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.978 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 118' ' ' GLU . 6.0 mt -127.13 -7.56 5.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.5 p -61.9 164.93 8.91 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.674 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.6 Cg_endo -71.43 138.89 33.58 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.435 2.09 . . . . 0.0 112.11 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 ' CE1' ' A' ' 42' ' ' HIS . 28.8 t -81.11 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.646 -0.659 . . . . 0.0 110.287 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 ' HD3' ' A' ' 133' ' ' PRO . 17.1 mt -78.11 148.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.499 -0.751 . . . . 0.0 110.523 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' HA ' HG11 ' A' ' 39' ' ' VAL . 3.8 mt-10 -125.73 -22.12 4.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.759 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.3 mtpp -121.19 173.34 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.992 -1.068 . . . . 0.0 109.893 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG13 ' HA ' ' A' ' 37' ' ' SER . 98.7 t -114.04 139.52 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.401 -0.812 . . . . 0.0 110.676 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 11.3 tttt -78.71 130.48 70.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.87 124.51 11.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.396 1.398 . . . . 0.0 110.054 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.99 10.91 31.26 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 6.7 tt0 -148.73 -179.65 7.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -1.038 . . . . 0.0 109.273 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -78.89 -174.99 4.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.195 -0.941 . . . . 0.0 109.865 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.455 ' HA ' HG13 ' A' ' 31' ' ' VAL . 1.4 t -87.11 137.93 31.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 109.929 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.625 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.3 m-85 -124.45 16.93 8.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.084 -1.01 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 29' ' ' GLU . 47.2 t -63.26 143.59 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.041 -1.037 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 39' ' ' VAL . . . 80.07 -4.23 67.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.0 mt-30 -85.46 129.43 34.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -1.201 . . . . 0.0 109.595 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.445 ' CE1' HG22 ' A' ' 27' ' ' VAL . 1.8 m-70 -73.11 113.39 10.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.76 160.0 1.0 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.097 -1.041 . . . . 0.0 109.538 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.48 170.19 17.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.697 0.761 . . . . 0.0 109.793 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.55 HG22 ' SD ' ' A' ' 120' ' ' MET . 29.8 p -81.62 -34.98 30.57 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 104.28 136.65 8.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.9 p -55.18 -51.01 67.89 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.393 -1.063 . . . . 0.0 108.501 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.529 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 51.1 t -47.48 -52.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.38 -50.67 72.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.11 0.957 . . . . 0.0 109.437 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 99.1 m -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.931 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.21 -41.91 84.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.734 -1.229 . . . . 0.0 108.119 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 56' ' ' MET . 43.8 m -74.64 -53.25 9.69 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.447 0.641 . . . . 0.0 110.405 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.0 -37.71 46.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.572 -0.705 . . . . 0.0 109.585 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.593 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 32.0 mt-30 -63.05 -45.67 91.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 198' ' ' VAL . 53.1 mt -70.12 -28.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.586 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 22.3 mtp -66.97 -40.78 87.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.551 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 29.9 tptt -70.33 -41.35 73.34 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 49.0 t80 -54.05 -30.4 47.76 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 43.4 m-70 -107.39 -24.03 11.99 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.05 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 79.2 m-20 44.3 54.17 6.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.9 t80 -78.75 -70.65 0.19 Allowed Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.308 -175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.9 Cg_endo -70.23 100.81 0.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 CA-C-N 118.929 0.653 . . . . 0.0 111.609 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -68.97 -20.58 64.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -134.33 141.87 47.06 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.19 151.84 26.22 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.098 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.514 HD12 ' CA ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -89.14 -60.97 1.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -1.043 . . . . 0.0 110.186 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 49.0 tttt -135.95 134.46 38.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 109.598 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 4.5 m-20 -58.2 159.79 5.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.454 -0.779 . . . . 0.0 109.605 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.461 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 31.9 t80 -144.43 139.65 28.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -143.19 153.82 43.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.084 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.657 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 26.6 p90 -154.46 155.41 34.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.886 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 98.4 m -92.83 130.07 38.55 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 77' ' ' ASN . 9.7 tp -45.18 148.91 0.54 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.935 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 t -61.6 142.31 57.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.818 -0.551 . . . . 0.0 109.835 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -68.65 -3.38 11.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.038 -1.039 . . . . 0.0 109.75 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -98.7 -7.69 27.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 30.2 t-20 -70.49 110.1 6.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.591 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -89.26 16.28 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.968 2.445 . . . . 0.0 110.483 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 90.9 m-85 -106.01 -22.65 12.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.132 -0.98 . . . . 0.0 111.315 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 4.8 m-85 -122.34 162.56 21.32 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.561 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.4 m-80 -46.02 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.45 -46.04 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.451 175.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.3 56.48 5.01 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 N-CA-C 107.51 -1.765 . . . . 0.0 107.51 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.98 102.97 12.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.116 -178.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.14 134.9 43.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.656 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.657 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -108.15 144.56 35.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 17.7 t80 -134.0 130.23 37.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.007 -1.058 . . . . 0.0 110.365 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.68 113.82 27.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 53.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.642 -1.286 . . . . 0.0 108.458 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 9.8 mt -52.89 -52.73 25.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 4.1 p -45.55 -26.6 0.61 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.342 -1.473 . . . . 0.0 109.219 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -111.78 19.78 17.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 109.534 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.654 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 13.5 mmt-85 -76.83 147.55 37.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 110.378 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 90.34 3.31 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-85 -81.02 96.95 7.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.548 -0.72 . . . . 0.0 110.617 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.6 t-20 -80.53 88.69 5.65 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 39.1 m95 -61.03 -8.98 3.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.446 -0.784 . . . . 0.0 110.411 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -19.17 23.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.24 -26.29 13.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.601 HD12 ' CE3' ' A' ' 97' ' ' TRP . 66.6 mt -73.88 67.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.7 mt -46.83 150.12 1.37 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.546 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.4 Cg_endo -78.84 -21.2 9.86 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.759 2.306 . . . . 0.0 110.587 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 134.47 26.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.007 -1.058 . . . . 0.0 109.684 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.63 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 89.3 m-85 -124.49 137.9 54.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.923 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.9 p -99.04 -0.09 42.65 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 81.45 10.02 85.07 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.17 5.9 10.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.395 -1.062 . . . . 0.0 108.956 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.14 167.72 19.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.694 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -57.79 171.71 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.195 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -76.9 -33.97 57.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -51.99 -60.42 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.435 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 2.1 mp0 -62.45 -35.16 78.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 0.0 109.376 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 109' ' ' SER . 26.7 mttt -63.8 -43.47 96.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 108.291 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.467 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 28.7 ttm -59.93 -38.24 81.8 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.535 -0.728 . . . . 0.0 110.403 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.63 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 3.6 tp -59.9 -39.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.471 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 25.2 p -53.61 -43.74 68.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.956 -1.09 . . . . 0.0 109.635 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 4.4 tt0 -69.88 -42.49 73.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 108.518 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 53' ' ' ALA . 7.7 tp -52.15 -51.6 56.98 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.559 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.5 mmt -59.7 -45.7 91.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.635 -0.666 . . . . 0.0 109.489 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.75 -38.35 90.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 126' ' ' SER . 6.6 m-20 -68.67 -48.43 63.97 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 49' ' ' ALA . 55.9 t -67.12 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.41 -42.39 13.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.9 mt -69.72 -57.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.346 -1.091 . . . . 0.0 108.325 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.508 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 2.1 p -45.47 -27.64 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.429 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.6 m -105.0 32.76 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.139 -0.976 . . . . 0.0 109.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 142' ' ' ARG . 43.1 m-20 40.71 44.99 1.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.343 -0.848 . . . . 0.0 109.651 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 41.1 tpp -56.86 133.09 54.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 111.145 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 18.6 t0 -79.56 122.66 26.76 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.82 117.79 35.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.312 1.053 . . . . 0.0 113.064 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -150.6 -164.56 12.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 104.261 -3.536 . . . . 0.0 104.261 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -61.96 -31.5 84.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 105.582 -2.507 . . . . 0.0 105.582 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.0 m -109.7 141.54 42.14 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 47.5 m -119.2 109.84 16.33 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 119.966 -1.709 . . . . 0.0 109.919 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.83 136.12 13.24 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 13.1 t -117.87 -162.59 0.89 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.234 -1.156 . . . . 0.0 108.335 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.02 -57.21 2.8 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.532 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 131.46 -131.05 6.21 Favored Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.393 -1.384 . . . . 0.0 112.042 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.553 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 36.8 m -47.83 -58.62 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.891 -0.77 . . . . 0.0 111.786 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' SER . 11.1 p -46.75 -36.81 7.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 0.0 108.95 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 53.9 mmt-85 -80.37 -47.88 13.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.01 0.909 . . . . 0.0 108.92 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.659 HG21 ' CE2' ' A' ' 185' ' ' TYR . 93.9 t -67.85 -56.57 12.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.7 pp0? -56.48 -33.73 66.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.171 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' NE ' ' OE2' ' A' ' 149' ' ' GLU . 12.1 ttt85 -77.1 -52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 126' ' ' SER . . . -63.56 -35.95 82.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.086 -1.009 . . . . 0.0 110.047 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.438 ' CD1' HG11 ' A' ' 143' ' ' VAL . 40.5 mt -56.41 -48.44 76.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.516 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.6 mtmt -86.45 -39.13 16.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.133 -0.979 . . . . 0.0 110.407 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.512 ' OE2' ' NE ' ' A' ' 145' ' ' ARG . 54.1 mt-10 -67.97 -54.46 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 112.007 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.478 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 20.7 m120 -92.75 -40.87 10.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.703 -1.248 . . . . 0.0 111.746 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.586 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 29.2 m-85 -99.56 10.59 41.08 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.715 -1.241 . . . . 0.0 110.514 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 36.04 39.12 0.27 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.55 -0.719 . . . . 0.0 112.875 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.5 m-85 -61.92 162.88 8.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.142 -1.799 . . . . 0.0 107.364 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.1 t-20 -47.48 139.02 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.87 -1.144 . . . . 0.0 109.414 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -53.72 -18.97 3.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 58.7 p -53.07 -18.23 1.99 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 251' ' ' ILE . 39.8 t -58.33 123.7 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 109.158 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.564 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 8.7 p-80 -143.87 154.82 43.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.086 -1.009 . . . . 0.0 109.404 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.553 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.0 tt0 -100.73 154.2 18.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.36 -0.838 . . . . 0.0 110.509 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.489 ' N ' ' HG2' ' A' ' 159' ' ' GLN . 10.5 pt -135.96 142.37 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.9 m-80 -107.25 100.49 9.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.873 -1.142 . . . . 0.0 111.065 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.9 tpt180 -44.01 -41.22 5.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.154 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.09 -23.17 59.21 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ASN . 0.8 OUTLIER -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.063 -1.257 . . . . 0.0 111.576 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.92 174.94 5.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.516 -1.365 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -103.91 134.28 47.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 166' ' ' SER . 18.3 ttmt -31.91 -45.62 0.1 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.101 0.477 . . . . 0.0 110.869 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -64.17 -63.69 1.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.927 -1.108 . . . . 0.0 109.823 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.22 -15.67 57.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.359 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.9 t-105 -74.85 -46.95 33.0 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.177 -0.952 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.417 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 43.4 mt-10 -69.53 -30.48 68.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.091 -1.006 . . . . 0.0 108.606 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.66 -45.43 73.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 108.751 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -61.13 -40.28 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 108.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.553 HG23 ' CD1' ' A' ' 199' ' ' ILE . 13.7 mt -76.13 -60.94 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.557 -0.714 . . . . 0.0 111.119 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -49.03 -46.67 44.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 109.24 -178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.578 ' NZ ' ' HB3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -51.35 -48.67 62.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.597 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.4 mm-40 -54.87 -51.07 67.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 4' ' ' VAL . 17.6 mt -68.2 -33.51 74.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.205 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 175' ' ' ASP . 53.4 p -51.99 -30.78 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.458 HE21 ' CD ' ' A' ' 176' ' ' LYS . 1.2 mt-30 -102.41 33.65 3.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.473 ' HA ' HD21 ' A' ' 7' ' ' LEU . 11.6 m120 40.67 46.68 2.27 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.816 0.817 . . . . 0.0 108.918 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 14.7 mt-30 -123.69 111.8 29.35 Favored Pre-proline 0 C--N 1.294 -1.815 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.517 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -65.09 169.66 11.7 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.803 1.668 . . . . 0.0 112.653 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 45.9 t -121.12 132.79 69.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.58 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.659 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -81.57 116.39 21.31 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 175.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 6.5 t80 -121.97 157.27 31.65 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.809 -1.182 . . . . 0.0 110.192 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 4.8 pt20 -167.06 136.05 2.76 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.6 1.66 Allowed Glycine 0 C--N 1.289 -2.031 0 N-CA-C 107.675 -2.17 . . . . 0.0 107.675 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 244' ' ' TYR . 6.8 t -69.93 166.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -1.117 . . . . 0.0 111.419 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -170.53 -129.11 1.08 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -88.11 -36.96 16.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.251 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 236' ' ' GLY . 3.0 m -79.92 -15.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.974 -1.079 . . . . 0.0 111.284 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.432 ' C ' HG11 ' A' ' 189' ' ' VAL . . . 130.88 -167.63 22.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -83.47 101.51 2.36 Favored Glycine 0 N--CA 1.485 1.929 0 O-C-N 121.049 -1.265 . . . . 0.0 110.781 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 17.3 t-80 -71.27 121.11 17.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -113.08 160.67 17.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.517 -1.273 . . . . 0.0 113.361 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 33.0 p90 -156.91 175.19 14.41 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.534 HG22 HG13 ' A' ' 55' ' ' ILE . 92.8 t -121.14 135.69 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.575 -1.328 . . . . 0.0 112.094 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 73.6 mt -99.9 123.13 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -134.17 32.76 3.41 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.131 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 178' ' ' LEU . . . -171.69 167.68 40.75 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 117.709 -2.186 . . . . 0.0 112.345 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.53 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.17 148.0 27.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ARG . 0.5 OUTLIER -121.61 24.26 9.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.755 -1.216 . . . . 0.0 110.357 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 1' ' ' GLN . . . 43.05 26.45 0.49 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 14.3 mtt-85 -142.43 21.44 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -1.118 . . . . 0.0 109.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 9.4 t30 80.6 20.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.563 -0.711 . . . . 0.0 109.65 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.27 128.26 49.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.543 ' CZ ' ' NE2' ' A' ' 1' ' ' GLN . 25.7 m-85 -120.7 163.51 17.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.0 . . . . 0.0 109.557 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 37.1 t-80 -93.39 116.11 28.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 197' ' ' PHE . 20.7 t -114.51 140.02 37.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.105 -0.997 . . . . 0.0 111.165 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.517 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 28.2 t-20 -108.64 92.32 4.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.521 ' CH2' HD13 ' A' ' 227' ' ' LEU . 3.1 m95 -46.54 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 0.0 110.404 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.16 -10.06 58.62 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.481 ' HB2' HG12 ' A' ' 217' ' ' VAL . 49.1 m95 -107.72 168.52 9.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -1.019 . . . . 0.0 109.015 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.01 3.66 12.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.22 5.18 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 218' ' ' SER . 1.9 p -96.11 -153.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.274 -1.133 . . . . 0.0 109.622 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 217' ' ' VAL . 14.4 m -68.68 58.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.99 -1.068 . . . . 0.0 110.399 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.7 OUTLIER -86.84 120.36 28.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.047 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 172.77 -148.78 10.79 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.92 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 94.2 m-85 -75.15 119.86 19.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -1.089 . . . . 0.0 109.785 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.64 -173.16 3.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 109.044 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.425 ' C ' HD13 ' A' ' 224' ' ' LEU . 11.5 mtp180 -109.95 167.35 10.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -108.86 1.9 21.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.155 -0.966 . . . . 0.0 109.935 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.462 ' OD1' ' NH2' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -95.96 -30.77 13.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.205 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.19 88.22 2.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 109.089 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.564 HD11 ' CZ ' ' A' ' 197' ' ' PHE . 4.2 mm? -91.39 93.12 8.88 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-O 121.485 0.66 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -116.83 117.72 37.22 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.213 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.69 154.7 30.82 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.399 2.066 . . . . 0.0 110.75 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -98.53 -39.23 8.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.25 71.67 9.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.494 HD13 ' CD2' ' A' ' 241' ' ' PHE . 17.3 tp -99.84 -27.04 13.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 68.93 157.55 1.27 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 57.5 m -101.69 33.65 2.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -1.142 . . . . 0.0 109.507 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -105.51 -98.98 2.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.431 ' O ' HG11 ' A' ' 192' ' ' VAL . . . -79.63 4.6 63.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -89.45 129.41 9.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.15 159.54 15.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.405 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -49.84 -87.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -51.93 127.85 32.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 195' ' ' HIS . 1.0 OUTLIER -122.14 42.38 3.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -1.117 . . . . 0.0 109.695 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.531 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.2 t-20 -135.29 70.63 1.43 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 110.05 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 189' ' ' VAL . . . -80.17 -62.02 2.15 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.542 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 57.6 m-85 -136.0 109.25 7.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -1.034 . . . . 0.0 108.863 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 3.9 mt-30 -91.97 133.83 35.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.828 -1.17 . . . . 0.0 109.359 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 56.4 p -159.15 157.39 30.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.029 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.14 166.47 24.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.4 -0.812 . . . . 0.0 110.021 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 46.9 t -119.29 114.59 45.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.597 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 16.6 m -114.69 147.85 17.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 O-C-N 121.282 -0.886 . . . . 0.0 110.402 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 96.12 47.14 2.48 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.042 -1.551 . . . . 0.0 109.881 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.602 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.9 mt -103.22 96.11 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -1.185 . . . . 0.0 110.173 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.39 146.77 8.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.602 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.1 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.206 1.937 . . . . 0.0 110.452 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.446 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 34.5 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.9 156.73 27.12 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.297 1.998 . . . . 0.0 109.759 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 4' ' ' VAL . 17.3 t -90.97 143.6 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.06 -1.025 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.594 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 12.0 t -131.22 131.88 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 200' ' ' ASP . 58.3 mmtt -77.01 -179.51 5.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 34.7 t -77.79 102.42 7.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.666 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 35.7 mt -57.63 -49.65 75.75 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.8 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 8' ' ' LEU . 11.9 mt -56.02 -42.46 76.52 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.776 -1.202 . . . . 0.0 108.641 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -68.34 -36.19 78.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.058 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -58.08 -15.36 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.102 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' CB ' HG13 ' A' ' 13' ' ' ILE . 9.1 mtpt -121.95 23.54 9.97 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.97 39.89 5.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.488 HG13 ' CB ' ' A' ' 11' ' ' LYS . 40.2 mt -86.03 110.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.355 1.074 . . . . 0.0 110.408 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 6.7 m-70 -133.45 99.44 4.51 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.606 ' CE2' HD13 ' A' ' 116' ' ' ILE . 6.4 m-30 -103.66 176.0 5.29 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.012 . . . . 0.0 111.513 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.562 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -146.98 -175.17 4.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mt-30 -118.37 -20.96 8.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.943 -1.098 . . . . 0.0 109.977 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.42 -34.13 1.49 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.94 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.778 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.0 -140.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.021 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.32 3.22 5.42 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 CA-C-N 122.55 1.947 . . . . 0.0 109.325 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.1 m-85 -78.63 -30.66 46.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.478 -0.764 . . . . 0.0 109.068 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 20.6 p-10 -96.12 12.86 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.545 -1.347 . . . . 0.0 109.341 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' CD1' ' HD3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -67.79 -8.61 37.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.918 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' A' ' 114' ' ' MET . 8.7 mt -126.68 -6.23 6.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 0.0 109.703 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.8 p -61.14 165.95 5.7 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -71.1 136.81 30.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.013 1.809 . . . . 0.0 111.609 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 28' ' ' ILE . 41.9 t -81.16 149.97 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.614 0.721 . . . . 0.0 110.136 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.642 HD13 ' HD3' ' A' ' 133' ' ' PRO . 16.8 mt -77.77 148.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.565 -0.709 . . . . 0.0 110.544 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -125.67 -20.82 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.705 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 79' ' ' TYR . 44.7 mtpt -123.72 172.01 9.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.89 -1.131 . . . . 0.0 109.949 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.0 t -114.44 147.41 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.397 -0.814 . . . . 0.0 110.94 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 9.9 tttt -86.19 129.39 53.93 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.42 124.18 10.57 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.424 1.416 . . . . 0.0 110.369 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.67 11.96 29.48 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 tt0 -147.83 -176.85 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -1.11 . . . . 0.0 109.481 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -80.52 -177.3 6.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -87.47 137.64 32.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -123.81 19.52 9.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.084 -1.01 . . . . 0.0 109.798 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 40' ' ' GLY . 59.6 t -67.74 145.08 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.557 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.491 ' N ' HG11 ' A' ' 39' ' ' VAL . . . 79.15 -1.9 73.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.1 mt-30 -88.03 130.3 35.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 109.813 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -73.06 112.34 9.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.77 158.28 1.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.847 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -71.59 166.38 21.97 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.522 HG22 ' SD ' ' A' ' 120' ' ' MET . 41.1 p -80.45 -29.15 37.54 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.515 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 99.08 136.85 9.53 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.6 p -54.67 -52.94 60.79 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.217 -1.167 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.563 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 54.7 t -46.91 -52.53 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.46 -51.29 70.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.969 0.89 . . . . 0.0 109.861 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.615 ' CG2' ' HE1' ' A' ' 120' ' ' MET . 0.2 OUTLIER -64.21 -32.31 73.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.664 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -66.57 -39.44 88.48 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.648 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.504 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.3 m -74.59 -53.63 9.01 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.701 0.762 . . . . 0.0 110.05 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.22 -38.43 52.41 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.702 -0.624 . . . . 0.0 109.837 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.537 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -63.91 -46.88 82.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.13 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 HG22 ' A' ' 198' ' ' VAL . 37.7 mt -67.87 -24.49 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.601 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 31.6 mtp -73.57 -32.26 64.06 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.57 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 26.0 tptt -75.82 -44.34 41.6 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 33.8 t80 -53.61 -27.78 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.75 -0.594 . . . . 0.0 110.023 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 35.0 m-70 -107.5 -26.09 11.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.288 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.623 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 90.2 m-20 44.54 59.2 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.0 t80 -84.88 -72.22 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 37.2 Cg_endo -69.77 105.76 1.54 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 CA-C-N 118.955 0.663 . . . . 0.0 111.952 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 95' ' ' TYR . 8.0 m120 -72.14 -23.59 61.32 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -135.89 137.33 41.32 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -58.67 152.06 31.8 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.421 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.634 HD12 ' HA3' ' A' ' 152' ' ' GLY . 2.6 mt -92.31 -42.01 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.406 -1.055 . . . . 0.0 109.961 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 11.7 ttpp -152.29 136.41 16.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.934 -1.104 . . . . 0.0 110.334 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -59.41 164.66 3.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.629 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 70' ' ' THR . 20.6 t80 -141.78 152.05 43.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 3.4 t -151.22 166.06 32.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.927 -1.108 . . . . 0.0 110.192 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 25.6 p90 -169.12 154.03 5.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.443 -0.786 . . . . 0.0 109.32 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.9 m -92.81 136.06 33.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.512 HD21 ' CG ' ' A' ' 77' ' ' ASN . 10.5 tp -52.34 153.17 3.03 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.335 -0.853 . . . . 0.0 111.335 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -61.33 137.0 58.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.33 0.586 . . . . 0.0 110.016 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 p -64.58 -7.74 11.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.7 t-20 -99.66 -4.21 31.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.029 -1.045 . . . . 0.0 109.717 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 36.4 t-20 -69.9 109.97 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.774 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.624 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.6 15.55 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.83 2.353 . . . . 0.0 109.991 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 75.0 m-85 -105.71 -27.26 11.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' ASN . 19.2 m-85 -118.91 164.43 15.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.636 -1.29 . . . . 0.0 107.774 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.9 m-80 -47.39 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.64 -48.2 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 175.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.9 56.71 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 N-CA-C 106.958 -1.978 . . . . 0.0 106.958 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.46 104.1 13.76 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.13 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.96 130.65 46.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.824 . . . . 0.0 109.441 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -102.47 137.73 40.33 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -124.96 129.08 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.375 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.18 114.12 27.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 50.03 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.665 -1.272 . . . . 0.0 108.569 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.8 mt -52.48 -51.49 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.325 -0.859 . . . . 0.0 109.085 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.92 -29.24 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.065 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.15 30.21 7.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.654 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 6.4 mmt-85 -85.5 150.44 24.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' ' 94' ' ' GLN . 1.9 mm100 -116.9 91.09 3.48 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.3 m-85 -81.08 91.31 6.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.472 -0.767 . . . . 0.0 111.134 -176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.466 ' O ' HG13 ' A' ' 100' ' ' ILE . 38.2 t-20 -79.76 87.14 5.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 63.2 m95 -61.23 -8.32 3.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.36 -17.73 26.79 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -99.6 -27.72 13.55 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.618 HD12 ' CE3' ' A' ' 97' ' ' TRP . 58.0 mt -74.41 66.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 24.3 mt -46.71 149.25 1.52 Allowed Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.854 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.514 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.7 Cg_endo -78.67 -23.97 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.74 2.293 . . . . 0.0 110.409 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.19 126.69 23.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 108.994 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.515 ' CE2' ' CG2' ' A' ' 116' ' ' ILE . 54.8 m-85 -113.51 148.82 35.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' OE1' ' A' ' 108' ' ' GLU . 36.1 p -103.5 -9.83 19.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.56 -0.11 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -120.11 1.06 10.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -1.171 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' OE1' ' OG ' ' A' ' 105' ' ' SER . 0.1 OUTLIER -64.86 165.29 10.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.808 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.38 166.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -72.37 -34.45 67.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.36 -58.97 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.435 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.63 -36.28 80.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 0.0 108.897 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.539 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 21.4 mttt -65.71 -44.19 86.85 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.463 ' HG3' HD13 ' A' ' 24' ' ' LEU . 4.8 ttm -59.28 -35.72 74.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 100' ' ' ILE . . . -57.09 -66.63 0.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.61 -0.681 . . . . 0.0 109.619 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.606 HD13 ' CE2' ' A' ' 15' ' ' TYR . 2.4 tp -65.74 -40.15 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.815 . . . . 0.0 109.552 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.555 ' N ' HG23 ' A' ' 116' ' ' ILE . 11.2 p -57.21 -41.89 80.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.222 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.589 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 22.9 tt0 -69.72 -40.59 76.13 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.498 HD22 ' CD1' ' A' ' 116' ' ' ILE . 10.3 tp -54.84 -52.32 63.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.615 ' HE1' ' CG2' ' A' ' 50' ' ' THR . 1.6 mmt -58.51 -44.84 89.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.46 -38.84 92.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.514 ' OD2' ' NE ' ' A' ' 93' ' ' ARG . 5.9 m-20 -69.22 -43.02 74.91 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 49' ' ' ALA . 55.3 t -71.21 -62.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.609 -0.682 . . . . 0.0 109.774 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.31 -45.77 16.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.8 mt -65.03 -57.62 10.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 108.664 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.566 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 5.2 p -46.32 -31.08 2.36 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.771 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.0 m -101.46 37.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 109.626 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.8 m-20 39.36 42.14 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.482 -0.761 . . . . 0.0 109.782 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.557 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 45.9 tpp -55.59 128.23 33.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.405 -0.809 . . . . 0.0 111.446 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 21.6 t0 -77.71 126.07 30.31 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.0 m-85 -108.18 120.72 43.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.759 -1.177 . . . . 0.0 113.51 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.9 -164.0 11.71 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 103.834 -3.706 . . . . 0.0 103.834 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.642 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -61.38 -30.26 86.99 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 N-CA-C 105.445 -2.56 . . . . 0.0 105.445 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.54 46.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.494 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -115.71 112.83 22.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.853 -1.779 . . . . 0.0 109.851 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.29 133.72 11.81 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.557 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 16.0 t -118.27 -162.11 0.87 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -1.182 . . . . 0.0 108.761 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.542 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.21 -60.51 1.83 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.544 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 136.29 -133.71 6.74 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.888 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.543 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -48.11 -57.83 5.31 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.797 -0.825 . . . . 0.0 111.911 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 1.7 p -47.31 -36.72 9.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.752 -1.217 . . . . 0.0 109.015 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 25.8 mmt180 -79.84 -46.69 16.41 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.064 0.935 . . . . 0.0 108.797 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.616 HG21 ' CE2' ' A' ' 185' ' ' TYR . 79.5 t -68.09 -56.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.275 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.53 -34.53 67.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 109.357 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' CG ' ' OE2' ' A' ' 149' ' ' GLU . 34.1 ttm-85 -77.36 -42.89 34.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.944 -1.098 . . . . 0.0 109.836 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -69.85 -32.68 71.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.85 -48.44 81.78 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.505 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.8 mtmt -86.55 -44.25 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.07 -1.019 . . . . 0.0 110.583 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.504 ' OE2' ' CG ' ' A' ' 145' ' ' ARG . 82.1 mt-10 -67.4 -47.93 68.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.879 -1.138 . . . . 0.0 111.498 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -94.37 -44.19 8.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 111.671 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 31.1 m-85 -101.6 16.6 25.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 110.618 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 33.32 39.86 0.1 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 121.594 -0.691 . . . . 0.0 113.16 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.4 m-85 -62.04 159.81 13.72 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 120.529 2.165 . . . . 0.0 107.154 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 51.4 t-20 -47.06 143.8 2.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.737 -1.227 . . . . 0.0 109.372 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 155' ' ' GLN . 32.9 tp60 -53.64 -17.86 2.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.398 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.495 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 18.9 p -53.29 -17.08 1.55 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 109.876 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 251' ' ' ILE . 38.8 t -64.59 127.88 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.75 -1.219 . . . . 0.0 109.438 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.598 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 8.2 p-80 -147.37 149.58 33.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.543 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -100.69 139.92 35.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.641 ' CD1' ' CZ3' ' A' ' 170' ' ' TRP . 16.4 pt -122.5 158.04 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m-80 -116.88 103.65 10.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.183 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 8.2 tpt180 -47.46 -28.65 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.602 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.3 75.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -103.96 16.17 26.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.013 -1.287 . . . . 0.0 111.675 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -121.45 155.86 33.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.57 -1.331 . . . . 0.0 109.89 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -84.86 139.62 31.76 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.8 ttmm -36.79 -47.98 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.559 -0.713 . . . . 0.0 110.704 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.93 -56.74 13.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 110.356 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.54 -21.5 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 110.123 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.641 ' CZ3' ' CD1' ' A' ' 160' ' ' ILE . 76.4 t-105 -76.66 -40.49 48.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.915 -1.116 . . . . 0.0 109.333 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.48 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 43.3 mt-10 -73.87 -48.38 31.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -48.27 -40.62 25.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 11.2 mm100 -61.14 -48.14 82.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.507 HG23 HD11 ' A' ' 199' ' ' ILE . 22.8 mt -73.21 -49.99 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.656 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 179' ' ' SER . 1.5 m-20 -52.57 -42.9 64.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.2 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -52.18 -46.26 65.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.698 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 65.6 mm-40 -56.19 -51.7 67.07 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -68.69 -24.13 64.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 175' ' ' ASP . 32.1 p -52.58 -38.2 59.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.754 -1.217 . . . . 0.0 107.802 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 28.8 mt-30 -102.21 31.76 3.83 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.471 ' HA ' HD21 ' A' ' 7' ' ' LEU . 17.6 m-80 48.2 51.22 15.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 109.148 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 27.2 mt-30 -124.08 116.09 27.41 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.561 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.9 Cg_endo -64.76 166.59 17.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.07 1.847 . . . . 0.0 112.497 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 77.0 t -125.55 140.73 47.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.102 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.616 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -86.02 120.17 27.12 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 4.2 t80 -123.63 161.41 25.09 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.061 -1.024 . . . . 0.0 109.5 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.7 pt20 -167.63 130.29 1.62 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 117.591 -1.644 . . . . 0.0 112.007 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.431 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -94.11 114.06 4.68 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 21.5 t -71.89 167.69 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.902 -1.351 . . . . 0.0 110.647 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -174.87 -141.18 3.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -37.53 16.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.026 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.1 m -80.75 1.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.94 -1.1 . . . . 0.0 111.153 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 118.86 -162.21 13.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -89.84 106.01 3.28 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.721 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.75 125.4 27.05 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -114.1 160.46 18.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.612 -1.235 . . . . 0.0 112.923 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 29.9 p90 -156.66 168.76 26.42 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 55' ' ' ILE . 71.5 t -114.18 136.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.755 -1.216 . . . . 0.0 112.158 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 39.5 mt -100.05 114.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.4 p30 -130.44 37.59 3.84 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.304 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -177.13 169.73 42.13 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.09 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.594 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -153.25 136.59 15.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.1 0.14 48.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.465 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 88.67 -26.94 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -100.18 51.08 0.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -1.136 . . . . 0.0 109.854 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.48 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 7.5 m120 60.9 20.79 11.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 3.2 m-85 -111.73 137.94 48.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.083 -1.011 . . . . 0.0 109.406 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.6 m-85 -122.87 164.3 18.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 110.097 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.9 t-80 -92.45 120.28 32.79 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.584 HG13 ' CD1' ' A' ' 197' ' ' PHE . 26.7 t -114.73 145.08 20.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.112 -0.992 . . . . 0.0 111.802 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.485 ' N ' HG11 ' A' ' 210' ' ' VAL . 16.4 t-20 -112.34 79.18 1.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.581 ' CD2' HG12 ' A' ' 210' ' ' VAL . 32.9 m95 -46.74 164.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.903 -1.123 . . . . 0.0 109.572 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.493 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -86.1 23.19 9.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.516 ' NE1' ' O ' ' A' ' 230' ' ' SER . 47.8 m95 -112.7 -168.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.236 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.18 -100.15 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.55 50.59 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 218' ' ' SER . 1.5 p -79.55 -98.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -1.136 . . . . 0.0 109.614 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.554 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 23.6 m -89.8 17.76 6.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.498 ' HA ' ' CD1' ' A' ' 212' ' ' TRP . 0.1 OUTLIER -53.23 125.6 18.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.364 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 162.32 -106.92 0.29 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -85.69 -173.74 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.167 . . . . 0.0 109.718 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.534 ' CB ' HG21 ' A' ' 210' ' ' VAL . 0.1 OUTLIER -105.82 165.96 10.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.625 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -87.85 156.06 19.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -120.78 12.77 11.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 109.921 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.9 OUTLIER -116.47 -81.04 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.993 -1.067 . . . . 0.0 110.028 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.97 -93.89 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.965 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.515 ' O ' ' CD ' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -114.06 -160.21 0.72 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 -179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.58 ' HB3' ' CH2' ' A' ' 212' ' ' TRP . 0.8 OUTLIER -111.17 160.65 28.29 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.063 -1.023 . . . . 0.0 109.986 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 228' ' ' ASN . 36.3 Cg_endo -78.47 -28.05 4.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.784 2.323 . . . . 0.0 110.648 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.516 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 54.1 p -48.85 -21.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.01 -58.06 4.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.486 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -156.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.66 9.83 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 9.45 14.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.324 -1.104 . . . . 0.0 109.705 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.74 32.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -99.16 88.44 0.83 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -133.48 169.39 22.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -134.49 16.86 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.204 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -123.52 133.27 8.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -154.83 32.29 0.67 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 171.13 8.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -1.13 . . . . 0.0 109.438 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.536 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 0.9 OUTLIER -109.53 79.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 244' ' ' TYR . . . -77.9 -48.72 7.55 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' A' ' 243' ' ' GLY . 13.1 m-85 -135.51 159.86 40.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.997 . . . . 0.0 109.126 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.536 ' HG3' ' ND2' ' A' ' 242' ' ' ASN . 80.4 mt-30 -155.48 144.39 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.886 . . . . 0.0 108.726 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 79.8 p -161.71 161.67 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.64 144.79 35.93 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.47 0.652 . . . . 0.0 109.57 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 16.8 t -105.2 116.46 49.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.698 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 4.1 m -117.05 139.12 45.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.318 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 90.7 47.17 3.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.619 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 mt -94.5 98.25 7.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.16 149.34 10.05 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.603 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.283 1.989 . . . . 0.0 110.358 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.416 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 32.5 tt0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.57 155.72 31.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.357 2.038 . . . . 0.0 110.091 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 204' ' ' GLY . 40.7 t -87.23 142.41 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' ' 178' ' ' LEU . 86.8 t -134.17 132.06 55.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.542 -0.724 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 20.3 mmtp -76.4 -179.77 5.36 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 108.545 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 9' ' ' ASP . 27.6 t -77.82 105.65 9.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.652 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.684 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 34.3 mt -58.53 -50.44 73.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -0.86 . . . . 0.0 108.824 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.46 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 14.1 mt -54.6 -39.2 67.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 0.0 108.516 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 6.0 t0 -67.85 -42.21 81.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 109.801 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 44.0 p -58.04 -14.91 7.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.156 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -117.74 19.67 13.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.69 35.72 4.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 42.8 mt -85.52 110.45 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.328 -1.101 . . . . 0.0 110.287 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.6 m-70 -134.01 81.9 1.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CE2' HD13 ' A' ' 116' ' ' ILE . 11.4 m-30 -92.18 170.54 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.229 1.014 . . . . 0.0 111.475 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -147.98 -167.65 2.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 213' ' ' GLY . 16.6 mt-30 -125.45 -2.81 7.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.798 -1.189 . . . . 0.0 110.471 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.665 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.37 -54.81 0.33 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.465 -1.35 . . . . 0.0 112.31 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.703 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -129.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.579 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.938 -176.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -77.38 6.25 4.53 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 123.435 2.263 . . . . 0.0 109.062 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.736 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 85.8 m-85 -77.19 -35.92 55.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.85 -0.531 . . . . 0.0 110.077 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 47.2 p30 -98.85 20.33 13.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.773 -1.205 . . . . 0.0 109.043 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 23' ' ' LEU . 6.9 mt -71.43 -6.11 37.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 111.079 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 118' ' ' GLU . 7.6 mt -131.91 0.59 3.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.687 -1.258 . . . . 0.0 109.789 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -67.31 167.04 16.54 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -70.58 142.85 45.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.747 1.632 . . . . 0.0 111.509 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.24 150.08 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.592 0.711 . . . . 0.0 110.37 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.796 HG21 ' HB3' ' A' ' 79' ' ' TYR . 34.1 mt -77.64 147.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.552 0.692 . . . . 0.0 110.165 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 28' ' ' ILE . 1.9 mm-40 -124.49 -22.7 4.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.212 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 79' ' ' TYR . 3.8 mtpt -122.68 168.76 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.371 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 37' ' ' SER . 42.5 t -114.33 151.16 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.78 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 18.7 tttt -86.45 127.75 59.7 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.76 122.11 8.55 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.338 1.359 . . . . 0.0 109.765 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.22 26.27 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.47 177.34 9.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.948 . . . . 0.0 108.807 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -76.58 176.24 8.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.07 . . . . 0.0 109.788 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -84.06 128.94 34.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 109.741 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.594 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.4 m-85 -123.72 27.34 7.36 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.036 -1.04 . . . . 0.0 109.344 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 31' ' ' VAL . 49.2 t -73.58 142.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.484 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HG11 ' A' ' 39' ' ' VAL . . . 79.46 -2.38 72.45 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.2 mt-30 -82.58 133.98 35.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.317 -1.108 . . . . 0.0 109.827 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -73.23 109.07 6.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.49 159.08 1.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.215 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -79.12 165.55 23.21 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.726 0.775 . . . . 0.0 109.857 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 120' ' ' MET . 5.8 p -81.06 -34.14 32.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 108.588 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.96 137.11 8.16 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.0 p -55.29 -48.98 73.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 37.7 t -47.02 -53.72 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.557 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.28 -50.87 72.33 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.64 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 86.6 m -64.19 -31.48 72.7 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.852 -0.53 . . . . 0.0 109.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.13 -43.09 83.27 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.055 -1.458 . . . . 0.0 107.292 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' HG23 ' A' ' 143' ' ' VAL . 21.7 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.595 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.65 -39.19 57.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 109.785 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.601 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.9 mt-30 -60.05 -51.15 70.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.695 -1.253 . . . . 0.0 107.647 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 198' ' ' VAL . 35.0 mt -63.41 -24.21 35.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.618 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 21.9 mtp -73.0 -38.46 66.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 44.7 tptt -69.17 -40.58 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.684 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 50.2 t80 -53.53 -30.5 41.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.058 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.0 m-70 -107.86 -23.08 12.2 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.214 -0.929 . . . . 0.0 110.763 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.602 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 54.4 m-20 44.44 54.8 6.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.606 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -76.79 -75.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 119.443 -0.903 . . . . 0.0 113.406 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' CD ' ' CB ' ' A' ' 61' ' ' TYR . 34.0 Cg_endo -67.09 104.19 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 120.3 0.667 . . . . 0.0 112.107 -176.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.4 -20.32 62.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.4 OUTLIER -133.96 143.68 48.32 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.8 34.96 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.226 -1.464 . . . . 0.0 109.847 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.534 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -90.14 -64.88 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.379 -1.071 . . . . 0.0 109.645 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 5.9 tttt -131.9 148.82 52.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 m-20 -73.9 179.58 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 70' ' ' THR . 14.2 t80 -153.9 151.32 29.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.307 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 t -155.03 152.42 29.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.096 -1.002 . . . . 0.0 109.656 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 21.3 p90 -161.66 155.01 21.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 109.61 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 97.0 m -93.33 139.37 30.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' CG ' ' A' ' 77' ' ' ASN . 9.9 tp -56.55 147.78 21.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 111.221 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -61.95 143.79 55.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.35 0.595 . . . . 0.0 109.749 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -70.13 -2.14 12.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.0 m120 -97.47 -8.94 28.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 29.8 t-20 -70.44 109.51 5.11 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.747 -0.596 . . . . 0.0 109.88 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -89.16 15.82 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.959 2.439 . . . . 0.0 110.193 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.796 ' HB3' HG21 ' A' ' 28' ' ' ILE . 78.7 m-85 -105.92 -25.86 11.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.718 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' C ' ' A' ' 81' ' ' ASN . 8.7 m-85 -119.21 163.0 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.5 m-80 -46.58 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.06 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 111.041 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.17 56.63 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 N-CA-C 107.24 -1.869 . . . . 0.0 107.24 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.92 106.73 17.37 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.408 -178.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 134.29 43.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.641 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.91 125.03 51.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.51 124.93 46.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.147 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.451 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.21 108.47 19.91 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.9 54.19 0.36 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.799 -1.188 . . . . 0.0 108.428 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.644 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 46.6 mt -52.43 -45.75 46.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 O-C-N 121.405 -0.809 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 p -45.42 -26.46 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.799 -1.188 . . . . 0.0 109.286 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 26.75 10.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.45 154.13 22.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.111 -0.993 . . . . 0.0 110.375 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.27 95.03 4.79 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 7.0 m-85 -81.82 88.96 6.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 110.857 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.479 ' O ' HG13 ' A' ' 100' ' ' ILE . 11.7 t30 -79.94 91.13 5.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.603 ' CE3' HD12 ' A' ' 100' ' ' ILE . 61.7 m95 -61.29 -6.25 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.423 -0.798 . . . . 0.0 110.805 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -90.33 -18.86 24.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.779 -1.201 . . . . 0.0 107.876 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.3 m-20 -99.59 -29.11 12.88 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.603 HD12 ' CE3' ' A' ' 97' ' ' TRP . 31.0 mt -73.83 63.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.522 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 61.0 mt -46.27 148.64 1.51 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.544 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.5 Cg_endo -77.75 -29.07 4.73 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.598 2.199 . . . . 0.0 110.455 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 14' ' ' HIS . 7.6 t -134.68 124.5 25.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.122 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.0 m-85 -109.42 138.92 45.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.6 p -100.09 1.65 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.79 89.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -120.13 9.66 11.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.196 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -74.73 -178.95 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -76.38 174.98 9.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 1.2 m120 -78.48 -36.76 44.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.658 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.9 t -53.47 -59.42 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.801 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -33.15 73.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 108.94 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.539 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 32.1 mttt -67.81 -44.22 77.8 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -33.18 70.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.437 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.09 -67.84 0.28 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.71 -0.619 . . . . 0.0 109.579 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.632 HD13 ' CE2' ' A' ' 15' ' ' TYR . 2.9 tp -61.96 -41.34 90.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.193 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.552 ' N ' HG23 ' A' ' 116' ' ' ILE . 4.5 p -57.15 -40.02 76.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 109.164 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 31.3 tt0 -69.99 -43.26 71.8 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.473 HD22 ' CD1' ' A' ' 116' ' ' ILE . 6.8 tp -57.41 -48.41 79.16 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.736 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -56.61 -47.6 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.476 178.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.71 -39.22 93.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 126' ' ' SER . 13.0 m-20 -65.3 -53.87 37.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 49' ' ' ALA . 89.1 t -65.31 -54.99 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.296 -0.878 . . . . 0.0 109.454 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -47.22 -53.07 11.9 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.1 mt -65.99 -53.16 40.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -1.093 . . . . 0.0 108.516 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.49 ' OG ' ' HA ' ' A' ' 123' ' ' VAL . 60.3 p -45.53 -33.53 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.067 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.7 m -100.86 38.69 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.713 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' VAL . 22.4 m-20 37.15 52.04 1.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.517 -0.74 . . . . 0.0 109.624 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 45' ' ' THR . 44.2 tpp -66.63 130.55 43.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.57 -0.707 . . . . 0.0 111.774 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 135' ' ' SER . 8.0 t70 -76.92 122.01 24.26 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.629 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.59 120.31 40.63 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.479 1.133 . . . . 0.0 113.029 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -152.09 -163.21 11.37 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 104.485 -3.446 . . . . 0.0 104.485 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -62.26 -31.54 82.16 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 N-CA-C 105.551 -2.519 . . . . 0.0 105.551 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.2 m -109.36 142.21 40.62 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 30.7 m -124.64 109.8 13.61 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 119.961 -1.712 . . . . 0.0 110.104 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.3 137.41 14.08 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 3.5 t -117.35 -162.22 0.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.69 -50.65 5.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.524 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 121.37 -126.24 6.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.488 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 10.4 m -47.08 -60.55 2.39 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.712 -0.875 . . . . 0.0 112.279 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.4 p -47.18 -41.45 18.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 0.0 109.253 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 3.5 mmp_? -79.9 -41.14 26.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.432 1.111 . . . . 0.0 109.142 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.593 HG21 ' CZ ' ' A' ' 185' ' ' TYR . 55.1 t -67.71 -60.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.16 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.46 ' HB3' HG23 ' A' ' 248' ' ' VAL . 1.9 pp0? -56.2 -34.78 66.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.755 -1.216 . . . . 0.0 108.651 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -70.66 -44.8 66.31 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.315 -0.866 . . . . 0.0 109.329 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -67.76 -36.91 81.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.182 -0.949 . . . . 0.0 110.662 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.575 HD13 HG12 ' A' ' 251' ' ' ILE . 76.6 mt -55.67 -54.73 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 109.921 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.546 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 11.1 mtmt -81.07 -33.87 33.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 111.597 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 84.9 mt-10 -74.09 -66.97 0.65 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.48 -1.388 . . . . 0.0 112.628 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -81.63 -31.78 32.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.923 -1.111 . . . . 0.0 111.727 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.618 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 22.4 m-85 -102.57 -8.17 21.22 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.64 -1.287 . . . . 0.0 110.382 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.534 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 53.74 38.45 59.29 Favored Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.137 -0.977 . . . . 0.0 112.212 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.24 162.8 9.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.3 -1.706 . . . . 0.0 107.677 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 35.8 t-20 -47.11 143.87 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 109.586 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 155' ' ' GLN . 11.3 mm-40 -53.58 -19.97 4.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.492 -0.755 . . . . 0.0 109.009 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 154' ' ' ASN . 3.7 p -53.99 -16.63 2.01 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.812 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.546 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 41.0 t -61.34 127.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.911 -1.118 . . . . 0.0 109.552 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.585 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 18.7 p-80 -149.08 158.76 44.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.375 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 3.8 tt0 -102.78 149.22 24.69 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.583 HD11 ' CH2' ' A' ' 170' ' ' TRP . 14.8 pt -127.87 146.79 32.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.8 m-80 -112.36 102.98 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.131 . . . . 0.0 111.125 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.21 -28.41 3.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.83 . . . . 0.0 109.049 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.523 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.54 -27.69 73.31 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -103.85 4.72 35.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.1 -1.235 . . . . 0.0 111.6 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.08 171.04 8.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.404 -1.435 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 167' ' ' LYS . 84.1 p -103.94 134.56 47.02 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 166' ' ' SER . 54.7 tttt -30.57 -45.08 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.923 -0.485 . . . . 0.0 111.077 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -63.3 -66.04 0.6 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.185 . . . . 0.0 109.851 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -16.01 58.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 109.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.657 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 45.8 t-105 -72.18 -49.34 36.39 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.153 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 175' ' ' ASP . 18.8 mt-10 -67.6 -33.7 75.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.7 -48.01 20.32 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -61.01 -38.47 86.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.555 HG23 ' CD1' ' A' ' 199' ' ' ILE . 53.3 mt -75.92 -63.86 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 110.425 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -49.28 -53.89 19.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -51.92 -40.2 60.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 108.112 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.552 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.0 mm-40 -61.11 -50.26 73.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.535 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.2 mt -68.61 -25.78 65.03 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.484 -0.76 . . . . 0.0 109.7 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 37.0 p -51.85 -38.0 54.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 108.26 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 23.4 mt-30 -101.09 33.87 2.71 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.526 ' CB ' HD21 ' A' ' 7' ' ' LEU . 2.0 m-80 45.97 50.66 11.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 15.0 mt-30 -124.07 107.14 30.7 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.49 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -64.19 170.06 9.79 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.145 1.897 . . . . 0.0 112.667 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 51.6 t -123.67 135.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.614 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.593 ' CZ ' HG21 ' A' ' 143' ' ' VAL . 1.2 t80 -83.42 117.95 23.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 4.1 t80 -123.19 153.41 40.12 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 120.845 -1.16 . . . . 0.0 109.705 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.609 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.9 pt20 -164.81 135.5 4.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.328 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.92 114.98 4.66 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 107.239 -2.345 . . . . 0.0 107.239 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 41.5 t -80.96 145.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.255 . . . . 0.0 111.349 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.553 ' HA3' ' CD1' ' A' ' 241' ' ' PHE . . . -145.9 -145.75 4.3 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -87.95 -29.77 20.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -1.162 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.2 m -82.9 -13.07 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.8 -166.13 25.18 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -97.91 110.89 4.12 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 119.038 -1.553 . . . . 0.0 110.735 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.33 117.37 12.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.551 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.99 160.92 15.41 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.373 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 46.7 p90 -159.09 166.5 31.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 55' ' ' ILE . 94.8 t -114.11 136.11 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.696 -1.253 . . . . 0.0 112.036 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 7.4 mt -98.71 125.79 52.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.596 ' OD2' ' CD2' ' A' ' 209' ' ' HIS . 1.5 p30 -139.92 32.33 1.99 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.716 -1.594 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 208' ' ' TYR . . . -167.03 173.45 42.29 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 117.862 -2.113 . . . . 0.0 111.719 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.497 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -160.92 149.28 16.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -122.46 31.66 6.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.711 -1.243 . . . . 0.0 110.45 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.47 ' N ' HG21 ' A' ' 3' ' ' VAL . . . 44.33 25.38 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 2.2 mtt180 -142.26 21.79 2.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.227 -1.16 . . . . 0.0 108.95 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.9 OUTLIER 77.88 23.51 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.221 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 29.7 m-85 -122.72 128.45 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.928 . . . . 0.0 109.356 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.3 m-85 -122.94 171.6 9.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.299 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.596 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.4 t60 -93.64 136.39 33.96 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 212' ' ' TRP . 51.2 t -128.62 137.32 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.052 -1.03 . . . . 0.0 110.414 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.5 t-20 -111.85 73.13 0.8 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.578 ' CE2' HG12 ' A' ' 210' ' ' VAL . 82.3 m95 -46.93 173.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.459 -0.776 . . . . 0.0 110.179 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -88.16 21.22 25.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.47 -165.46 1.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -1.128 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -73.92 -98.74 0.09 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.27 45.68 1.12 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 218' ' ' SER . 2.3 p -76.09 -103.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -1.168 . . . . 0.0 109.917 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.513 ' O ' ' NE1' ' A' ' 212' ' ' TRP . 1.0 OUTLIER -85.39 34.18 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.924 -1.11 . . . . 0.0 110.236 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.75 92.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.955 -1.091 . . . . 0.0 109.327 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 208' ' ' TYR . . . 161.16 -97.24 0.15 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.468 ' HB3' ' NH2' ' A' ' 223' ' ' ARG . 30.5 m-85 -60.01 126.01 25.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.35 -1.088 . . . . 0.0 109.992 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.581 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -85.7 171.53 11.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.468 ' NH2' ' HB3' ' A' ' 221' ' ' PHE . 3.1 mmp_? -110.58 155.22 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.068 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -109.63 -48.79 3.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 110.001 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.68 1.34 17.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.124 -0.985 . . . . 0.0 109.455 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.23 86.13 2.53 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.326 1.06 . . . . 0.0 108.735 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.84 45.82 1.24 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.757 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.59 157.53 34.87 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.65 149.57 26.91 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.537 2.158 . . . . 0.0 110.298 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 217' ' ' VAL . 23.7 m -64.68 -59.0 4.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.64 135.04 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.462 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.445 HD22 ' HA2' ' A' ' 239' ' ' GLY . 10.9 mt -93.75 24.74 3.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.422 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.33 154.8 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -34.63 10.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.497 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -90.83 -56.64 1.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.65 12.1 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 144.75 94.98 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.05 -62.54 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.445 ' HA2' HD22 ' A' ' 232' ' ' LEU . . . 164.0 -126.67 1.55 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -95.87 94.27 1.66 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.553 ' CD1' ' HA3' ' A' ' 190' ' ' GLY . 0.2 OUTLIER -117.38 70.21 0.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.446 ' ND2' ' C ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -73.06 72.81 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.0 109.695 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.43 -38.48 21.21 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.502 ' CB ' ' HB ' ' A' ' 189' ' ' VAL . 1.9 m-85 -135.84 156.55 48.62 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 1.4 pt20 -156.5 142.94 18.39 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.8 -1.187 . . . . 0.0 109.321 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.511 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 15.1 p -166.1 163.21 18.11 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -142.08 167.15 22.81 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.942 0.877 . . . . 0.0 109.925 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.588 HG21 HG12 ' A' ' 143' ' ' VAL . 15.5 t -118.0 120.77 65.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.585 ' CG2' ' NE2' ' A' ' 158' ' ' HIS . 33.4 m -120.69 149.75 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.95 -1.094 . . . . 0.0 111.282 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 86.03 46.92 5.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.616 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.1 mt -93.57 93.98 4.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.406 -1.055 . . . . 0.0 109.761 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.07 148.67 9.71 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.44 -0.788 . . . . 0.0 108.946 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.606 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.389 2.06 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.473 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 38.4 tt0 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 36.1 Cg_endo -78.54 164.66 25.88 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.339 2.026 . . . . 0.0 109.712 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.477 HG11 ' N ' ' A' ' 4' ' ' VAL . 18.8 t -101.69 141.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.011 -1.055 . . . . 0.0 109.597 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.8 t -137.71 131.42 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.399 -0.813 . . . . 0.0 109.123 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -76.14 -166.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 108.908 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.572 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 2.7 t -87.89 106.11 17.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.873 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.672 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 46.6 mt -58.49 -50.11 74.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 108.906 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.93 -38.02 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.66 -1.275 . . . . 0.0 108.858 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 43.9 m-20 -67.25 -43.48 81.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.796 . . . . 0.0 109.774 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 3.7 p -58.24 -14.44 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.048 . . . . 0.0 109.317 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.5 mtpm? -117.15 17.9 14.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.793 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.26 41.44 6.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.509 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 48.2 mt -91.11 108.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 122.247 1.022 . . . . 0.0 110.526 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 8.5 m-70 -134.83 81.25 1.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 116' ' ' ILE . 9.6 m-30 -87.11 179.99 6.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 111.152 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.74 -162.61 1.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 17.5 mt-30 -125.36 -21.93 4.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.721 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.06 -33.87 1.59 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.604 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.6 -139.68 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.512 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.064 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -74.24 2.99 5.58 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 CA-C-N 122.554 1.948 . . . . 0.0 109.269 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.7 m-85 -77.91 -31.59 51.25 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.404 -0.81 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 23.8 p-10 -93.88 14.35 19.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.632 -1.293 . . . . 0.0 109.746 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.4 -7.83 46.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.738 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 118' ' ' GLU . 11.3 mt -123.74 -9.35 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.092 -1.005 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.0 p -60.85 165.31 6.1 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.2 Cg_endo -70.48 143.02 46.2 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.357 2.038 . . . . 0.0 112.184 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.23 148.12 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.559 0.695 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.668 HD13 ' HD3' ' A' ' 133' ' ' PRO . 23.9 mt -78.51 148.05 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 111.173 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 39' ' ' VAL . 3.9 mt-10 -126.4 -21.5 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.732 -0.605 . . . . 0.0 110.659 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' PRO . 9.0 mtpm? -118.82 168.39 10.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.859 -1.15 . . . . 0.0 110.284 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 37' ' ' SER . 74.9 t -114.84 145.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.557 -0.715 . . . . 0.0 110.69 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.575 ' HG2' ' CG ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -77.58 158.34 78.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.1 Cg_endo -82.3 113.16 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.369 2.046 . . . . 0.0 110.494 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.48 62.83 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.38 159.61 23.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 109.544 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.09 165.6 4.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 109.361 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.442 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.0 t -74.91 138.84 42.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.189 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 82.5 m-85 -123.61 14.71 9.47 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.899 -1.126 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 28' ' ' ILE . 61.0 t -62.99 141.89 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.189 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 1.38 87.39 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -91.97 132.14 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -1.096 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -73.2 111.89 8.74 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.21 160.61 0.75 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 109.003 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.76 166.93 22.34 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.616 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.547 HG22 ' SD ' ' A' ' 120' ' ' MET . 29.5 p -79.67 -35.56 39.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.6 139.02 9.53 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 51' ' ' ALA . 5.6 p -55.17 -49.75 71.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 127' ' ' VAL . 3.9 t -47.02 -52.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -64.77 -47.38 78.39 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.847 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 96.1 m -62.6 -30.2 71.17 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.97 -47.22 69.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.968 -1.083 . . . . 0.0 108.822 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.577 ' OG1' HG23 ' A' ' 143' ' ' VAL . 30.8 m -75.6 -49.82 17.39 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.409 0.623 . . . . 0.0 110.277 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.6 -34.55 37.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 109.078 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.593 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -67.71 -48.93 65.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 198' ' ' VAL . 36.0 mt -66.79 -28.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.601 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 19.3 mtp -67.13 -39.58 86.62 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.563 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -71.89 -39.48 69.56 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.672 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 56.9 t80 -53.44 -34.43 57.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.493 -0.754 . . . . 0.0 109.346 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 83.8 m-70 -107.75 -20.45 13.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.36 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.55 54.63 1.89 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -74.64 -70.7 0.23 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.0 Cg_endo -69.67 103.81 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 122.269 0.615 . . . . 0.0 111.806 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' TYR . 7.6 m120 -70.09 -21.57 63.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -134.78 140.13 45.65 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.84 34.9 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.664 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.447 HD13 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -89.01 -44.3 10.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.62 -0.929 . . . . 0.0 110.387 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.4 tttt -151.61 137.86 18.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 164.94 7.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.0 110.219 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 26.1 t80 -148.94 141.35 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.264 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t -146.99 161.12 41.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.932 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.673 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 28.6 p90 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.656 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 85' ' ' ASN . 27.4 m -93.19 129.82 39.08 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' CB ' ' A' ' 77' ' ' ASN . 10.2 tp -47.67 150.58 0.99 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 111.28 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 t -62.15 140.67 58.42 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -3.82 11.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 0.0 109.868 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 52.6 t30 -99.28 -7.75 25.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.513 ' CB ' HD21 ' A' ' 73' ' ' LEU . 39.6 t-20 -70.37 111.58 9.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 109.971 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.623 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.3 Cg_endo -88.54 13.11 2.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.982 2.454 . . . . 0.0 110.094 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.4 m-85 -104.94 -5.0 21.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 111.139 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 5.5 m-85 -142.22 162.0 36.58 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.564 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 4.8 m120 -46.67 -79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.79 -46.8 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 111.047 175.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.88 57.34 5.67 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 N-CA-C 107.012 -1.957 . . . . 0.0 107.012 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.51 101.59 11.11 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.294 -178.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' OG1' ' A' ' 72' ' ' THR . 37.3 m-80 -100.11 128.87 46.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.756 . . . . 0.0 109.466 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -100.75 134.5 43.63 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.77 129.63 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.81 111.37 23.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 51.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 108.304 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.4 mt -52.77 -54.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.384 -0.822 . . . . 0.0 110.027 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.1 p -44.59 -27.61 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.242 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -111.97 34.36 4.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -0.83 . . . . 0.0 109.177 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.643 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.05 90.31 3.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.4 m-85 -81.31 88.08 6.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 47.3 t-20 -79.4 87.79 5.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.641 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.0 m95 -60.98 -7.04 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -89.43 -18.76 26.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -100.08 -26.48 13.94 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.641 HD12 ' CE3' ' A' ' 97' ' ' TRP . 51.9 mt -76.53 67.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 108.903 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 18.9 mt -46.84 149.42 1.53 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.775 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.522 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.7 Cg_endo -78.99 -18.11 11.63 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.903 2.402 . . . . 0.0 110.725 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 133.3 25.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.995 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.565 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 62.1 m-85 -121.49 136.75 54.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.258 -0.901 . . . . 0.0 109.845 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -99.94 0.91 42.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA2' ' NZ ' ' A' ' 113' ' ' LYS . . . 81.15 -1.76 83.81 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.533 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -110.46 -6.88 14.83 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.423 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.86 164.66 9.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 109.755 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -62.1 172.74 1.31 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 17.3 m-20 -77.03 -31.26 56.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.623 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.2 -60.17 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.467 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 5.2 mp0 -62.76 -35.04 78.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.785 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 33.6 mttt -65.27 -42.34 93.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.469 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 12.2 ttm -59.15 -37.81 78.2 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.33 -68.1 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.672 -0.643 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.617 HD13 ' CE2' ' A' ' 15' ' ' TYR . 3.1 tp -62.37 -37.48 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.633 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.527 ' N ' HG23 ' A' ' 116' ' ' ILE . 14.2 p -57.18 -40.44 77.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.921 -1.112 . . . . 0.0 109.95 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 35.3 tt0 -69.4 -41.57 76.26 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.479 HD22 ' CD1' ' A' ' 116' ' ' ILE . 9.3 tp -54.65 -52.69 61.52 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.553 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.3 mmt -58.68 -43.93 90.1 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.5 -0.75 . . . . 0.0 109.292 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.48 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.09 -36.69 84.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 93' ' ' ARG . 27.8 m-20 -69.6 -54.61 13.2 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 49' ' ' ALA . 48.4 t -63.38 -57.78 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.19 -49.84 13.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.0 mt -63.9 -58.8 5.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 108.276 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.25 -29.23 1.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.517 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.8 HG13 HG22 ' A' ' 143' ' ' VAL . 20.9 m -101.42 36.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.895 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 127' ' ' VAL . 3.3 m-20 37.81 51.93 1.39 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.466 -0.771 . . . . 0.0 109.407 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.7 tpp -66.04 126.92 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.53 -0.731 . . . . 0.0 111.741 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -75.77 120.66 21.44 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 57.3 m-85 -102.83 115.67 31.05 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.279 1.038 . . . . 0.0 112.719 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.513 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.92 -162.88 10.95 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 104.869 -3.292 . . . . 0.0 104.869 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.668 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.39 -30.56 80.72 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 N-CA-C 105.802 -2.422 . . . . 0.0 105.802 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.99 140.76 43.65 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.527 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 32.7 m -124.26 109.66 13.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.843 -1.786 . . . . 0.0 110.286 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -108.88 144.72 16.42 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.648 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.54 -163.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -1.219 . . . . 0.0 107.765 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.566 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.75 -53.97 4.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.533 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 134.18 -139.02 10.51 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 119.145 -1.502 . . . . 0.0 111.981 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.463 ' HB2' ' CD ' ' A' ' 159' ' ' GLN . 0.7 OUTLIER -48.06 -54.37 13.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.139 -0.624 . . . . 0.0 112.237 -177.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 p -46.53 -41.25 13.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.926 -1.109 . . . . 0.0 109.7 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.587 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.3 mmt180 -81.15 -42.63 20.58 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 109.585 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.8 HG22 HG13 ' A' ' 127' ' ' VAL . 44.3 t -68.14 -52.79 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 110.463 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.452 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.8 pp0? -56.9 -34.36 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.554 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 2.4 ttm180 -77.35 -51.8 10.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 109.197 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -61.2 -34.75 75.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 143' ' ' VAL . 46.0 mt -56.92 -50.57 72.17 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.099 -1.0 . . . . 0.0 109.652 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.557 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 4.5 mtmp? -87.65 -41.12 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.017 -1.052 . . . . 0.0 110.589 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 85.1 mt-10 -68.08 -49.1 63.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.919 -1.113 . . . . 0.0 111.727 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -93.94 -43.19 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.907 -1.121 . . . . 0.0 111.652 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.5 m-85 -102.27 15.49 28.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.658 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 35.08 40.22 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.626 -0.671 . . . . 0.0 112.581 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.2 m-85 -62.53 164.06 8.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.062 -1.846 . . . . 0.0 107.853 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.5 t-20 -47.37 145.1 2.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.174 . . . . 0.0 109.617 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -53.43 -19.96 4.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.909 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.537 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 7.8 p -55.72 -14.5 2.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.331 -0.856 . . . . 0.0 109.739 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 4.1 t -66.4 119.85 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.938 -1.101 . . . . 0.0 109.65 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' HG22 ' A' ' 249' ' ' VAL . 3.6 p-80 -148.55 163.17 38.02 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.463 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 2.0 tt0 -104.07 146.36 28.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.617 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.58 ' CG1' ' HB1' ' A' ' 247' ' ' ALA . 4.3 pt -121.93 155.17 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.2 m-80 -123.29 105.73 10.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.814 -1.179 . . . . 0.0 111.041 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 44.4 tpt85 -48.14 -38.9 19.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 109.012 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.54 -25.83 63.69 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.03 -1.03 28.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.064 -1.256 . . . . 0.0 111.273 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.04 173.92 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.785 -1.197 . . . . 0.0 110.027 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 167' ' ' LYS . 83.8 p -98.53 138.71 35.34 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 166' ' ' SER . 35.5 tttt -35.22 -48.43 0.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.766 -0.584 . . . . 0.0 110.361 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.404 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 7.5 mp0 -65.4 -59.23 4.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.049 -1.032 . . . . 0.0 109.854 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.52 -15.59 58.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.988 . . . . 0.0 109.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CH2' ' N ' ' A' ' 162' ' ' ARG . 61.0 t-105 -73.66 -47.78 37.26 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.492 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 29.2 mt-10 -70.76 -30.98 67.63 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.24 65.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 15.8 mm100 -61.26 -41.19 96.49 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.538 ' CG2' HG23 ' A' ' 184' ' ' VAL . 22.3 mt -74.03 -51.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.553 -0.717 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -55.97 -41.98 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 108.626 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -51.97 -43.29 63.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.583 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 51.9 mm-40 -59.72 -51.94 67.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.548 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.94 -25.61 64.65 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.828 . . . . 0.0 110.044 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.5 p -52.05 -38.12 55.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.468 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 25.0 mt-30 -101.55 29.52 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.45 ' C ' HD11 ' A' ' 7' ' ' LEU . 8.1 m-20 51.15 49.18 21.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.72 0.771 . . . . 0.0 109.165 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 27.8 mt-30 -124.34 117.08 26.77 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.554 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.8 Cg_endo -65.67 171.4 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.21 1.94 . . . . 0.0 112.328 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.538 HG23 ' CG2' ' A' ' 174' ' ' ILE . 23.4 t -125.98 115.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.367 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.558 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -66.27 113.27 4.46 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.9 t80 -123.77 157.39 34.13 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 120.891 -1.13 . . . . 0.0 109.658 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.1 pt20 -158.93 129.84 6.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 117.927 -1.509 . . . . 0.0 111.804 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.466 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.17 109.71 3.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 3.6 t -66.8 166.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -1.179 . . . . 0.0 111.099 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.594 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -175.21 -136.78 2.35 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 10.5 mtpt -87.81 -55.85 3.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.24 . . . . 0.0 111.357 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.434 HG23 ' CA ' ' A' ' 238' ' ' ALA . 4.1 m -61.15 -8.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.057 -1.027 . . . . 0.0 111.47 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.45 21.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -91.25 107.57 3.5 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.0 t-80 -71.66 126.19 29.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.539 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -118.92 159.07 24.47 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.533 1.159 . . . . 0.0 112.723 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 43.2 p90 -153.58 -161.05 1.19 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 55' ' ' ILE . 85.9 t -139.34 133.27 38.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 120.362 -1.461 . . . . 0.0 111.377 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 224' ' ' LEU . 82.8 mt -99.14 120.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 3.1 p30 -133.24 33.47 3.61 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.439 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.23 163.92 35.62 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 117.706 -2.188 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.527 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.28 140.9 29.47 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -111.31 11.18 21.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.103 . . . . 0.0 110.567 -178.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.64 4.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -80.57 53.54 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 109.884 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.476 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 2.0 m120 53.09 38.54 27.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.783 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.503 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 1.2 m-85 -121.92 133.92 54.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 12.9 m-85 -122.91 159.77 27.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.07 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.572 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 39.4 t-80 -93.22 117.78 30.48 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.489 HG11 ' N ' ' A' ' 211' ' ' ASN . 29.1 t -114.55 138.64 43.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 111.447 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.51 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 19.4 t-20 -104.62 80.56 1.68 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.5 ' CH2' HD13 ' A' ' 227' ' ' LEU . 23.0 m95 -46.19 166.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -85.83 36.96 3.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.579 ' CD1' HG13 ' A' ' 217' ' ' VAL . 32.7 m95 -116.09 -170.41 1.79 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -1.169 . . . . 0.0 109.227 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.98 -55.36 0.65 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.75 30.32 3.26 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.579 HG13 ' CD1' ' A' ' 214' ' ' TRP . 2.6 p -83.04 -155.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -1.149 . . . . 0.0 109.163 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.559 ' N ' HG11 ' A' ' 217' ' ' VAL . 9.8 m -68.41 52.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.848 -1.158 . . . . 0.0 111.063 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.415 ' OD1' HG12 ' A' ' 217' ' ' VAL . 3.7 m-20 -85.14 121.1 27.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.817 -1.177 . . . . 0.0 109.195 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 172.46 -113.55 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.12 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 221' ' ' PHE . 10.6 p90 -114.95 122.3 45.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -1.128 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -135.35 177.28 7.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.425 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.52 177.78 6.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.124 -0.985 . . . . 0.0 109.589 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.507 ' CD1' HD13 ' A' ' 199' ' ' ILE . 3.7 mm? -121.17 22.64 10.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -36.05 7.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.85 96.94 5.14 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 197' ' ' PHE . 4.3 mm? -89.96 82.92 6.1 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.538 0.685 . . . . 0.0 109.835 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -116.89 142.64 30.12 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.483 -0.761 . . . . 0.0 109.085 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.08 174.97 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.469 2.112 . . . . 0.0 110.378 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.93 -59.34 1.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' HB1' HG22 ' A' ' 217' ' ' VAL . . . -74.86 117.26 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.55 -91.67 0.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.28 52.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -39.89 65.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.143 . . . . 0.0 109.633 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.19 65.0 2.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 237' ' ' GLY . . . -85.73 116.37 4.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 236' ' ' GLY . . . -61.48 -129.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 195' ' ' HIS . . . -110.24 45.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.162 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.34 53.75 4.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -136.78 8.11 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -77.04 166.7 22.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.484 ' CG ' ' NE2' ' A' ' 245' ' ' GLN . 1.3 t-20 -111.26 100.75 9.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 108.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 244' ' ' TYR . . . -108.32 -40.7 1.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 22.1 m-85 -135.54 84.65 2.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.326 -1.103 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.484 ' NE2' ' CG ' ' A' ' 242' ' ' ASN . 1.5 mt-30 -91.26 119.22 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 72.6 p -136.05 164.82 27.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.712 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.91 161.7 37.2 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.552 ' CG2' ' CD1' ' A' ' 185' ' ' TYR . 39.1 t -116.15 113.67 43.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 158' ' ' HIS . 13.9 m -112.55 142.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.941 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.42 ' N ' ' OE1' ' A' ' 177' ' ' GLU . . . 90.65 54.77 2.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.616 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 38.5 mt -102.75 89.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 110.225 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 2.2 pptp? -162.89 151.76 12.41 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 0.0 109.03 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.593 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.335 2.023 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.423 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 36.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 163.95 27.65 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.456 2.104 . . . . 0.0 109.89 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 4' ' ' VAL . 35.1 t -100.46 143.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.433 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.7 t -135.88 131.55 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -76.19 -178.6 4.56 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.496 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 17.5 t -78.13 106.2 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.896 -1.128 . . . . 0.0 109.312 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.677 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.8 mt -56.69 -48.44 77.64 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 13.7 mt -55.01 -42.25 72.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 108.386 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 2.1 t0 -67.19 -40.87 86.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.133 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 p -58.11 -15.7 10.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.998 -1.064 . . . . 0.0 108.772 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 2.0 mtpp -116.9 16.96 15.15 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 46.85 39.22 10.9 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.505 HG13 ' HB2' ' A' ' 11' ' ' LYS . 27.8 mt -91.34 110.67 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -1.037 . . . . 0.0 110.519 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.0 m80 -134.7 83.05 2.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.608 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.2 m-30 -89.49 179.28 6.09 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.141 0.972 . . . . 0.0 110.991 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -147.89 -163.24 1.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 213' ' ' GLY . 37.3 mt-30 -124.95 -21.21 4.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.978 -1.076 . . . . 0.0 110.572 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.31 -35.09 1.36 Allowed Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.522 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -138.06 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.527 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.202 -178.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.1 Cg_endo -75.08 4.46 4.75 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 CA-C-N 122.688 1.996 . . . . 0.0 109.589 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 8.9 m-85 -80.42 -34.1 36.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 29.9 p-10 -88.79 15.65 8.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.536 -1.352 . . . . 0.0 109.177 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 20' ' ' PRO . 6.1 mt -70.17 -5.96 30.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.104 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.523 HD13 ' CA ' ' A' ' 118' ' ' GLU . 14.1 mt -128.57 -5.81 5.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 109.934 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -61.24 164.57 8.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.614 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.1 Cg_endo -69.59 136.36 33.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.231 1.954 . . . . 0.0 112.251 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 ' CG1' ' HA2' ' A' ' 40' ' ' GLY . 38.8 t -76.01 148.19 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.538 0.685 . . . . 0.0 109.924 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.656 HD13 ' HD3' ' A' ' 133' ' ' PRO . 13.7 mt -78.19 150.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.836 0.827 . . . . 0.0 111.122 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 39' ' ' VAL . 3.3 mt-10 -125.06 -23.15 4.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.704 -0.623 . . . . 0.0 110.152 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.0 mtpt -120.75 165.91 14.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 37' ' ' SER . 86.0 t -114.62 143.71 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 110.588 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -73.6 158.99 85.61 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.1 Cg_endo -81.83 113.64 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.565 2.176 . . . . 0.0 110.795 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.33 4.3 58.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.5 tp10 -121.41 161.52 22.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.255 . . . . 0.0 109.575 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -60.6 175.59 0.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.047 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.497 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -81.82 134.36 35.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.687 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 74.4 m-85 -118.52 12.93 13.36 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.995 -1.066 . . . . 0.0 109.156 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 28' ' ' ILE . 78.0 t -62.86 138.94 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.445 ' HA2' ' CG1' ' A' ' 27' ' ' VAL . . . 79.89 1.62 87.53 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 11.8 mt-30 -89.39 134.06 34.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.33 111.18 8.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.29 161.08 0.69 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.974 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.68 167.23 21.91 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.661 -0.649 . . . . 0.0 109.515 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.556 HG22 ' SD ' ' A' ' 120' ' ' MET . 30.5 p -80.48 -33.77 36.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.112 -0.993 . . . . 0.0 108.495 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 102.86 138.22 9.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.0 p -55.21 -48.66 73.55 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 127' ' ' VAL . 3.7 t -47.11 -52.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -64.41 -47.86 77.56 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.088 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.498 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 54.8 m -62.86 -29.47 70.78 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.569 -0.707 . . . . 0.0 109.157 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.91 -47.09 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.751 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.54 ' OG1' HG23 ' A' ' 143' ' ' VAL . 35.4 m -75.72 -48.88 20.05 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.441 0.639 . . . . 0.0 110.255 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.65 -33.96 35.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.513 -0.742 . . . . 0.0 109.085 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.608 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 28.7 mt-30 -68.31 -50.38 53.91 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 HG13 HG22 ' A' ' 198' ' ' VAL . 33.7 mt -65.0 -23.99 34.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.526 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 18.1 mtp -72.56 -36.23 68.17 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.551 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 42.4 tptt -71.5 -44.42 64.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.677 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.9 t80 -53.38 -30.58 40.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.24 0.543 . . . . 0.0 109.739 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 61.0 m-70 -107.81 -23.62 12.0 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.625 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.23 58.92 1.81 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -77.96 -76.82 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.375 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.3 Cg_endo -71.19 108.59 2.37 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 CA-C-N 119.41 0.825 . . . . 0.0 113.225 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.76 -26.99 67.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 103.819 -2.659 . . . . 0.0 103.819 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 18.9 tttt -129.58 130.35 45.58 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.93 167.46 4.35 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.396 -1.859 . . . . 0.0 110.904 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.541 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.11 -38.64 10.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.537 -0.978 . . . . 0.0 111.301 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 73.4 tttt -152.67 132.49 13.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.677 -1.265 . . . . 0.0 110.7 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 3.0 m-20 -60.42 168.29 2.17 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.368 -0.832 . . . . 0.0 109.495 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 35.8 t80 -151.97 141.81 21.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 109.724 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.0 t -144.39 153.51 42.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 109.271 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.683 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 28.1 p90 -152.88 156.7 39.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.44 HG23 ' CG ' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -92.9 127.19 38.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 77' ' ' ASN . 10.5 tp -44.81 150.36 0.37 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 111.205 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -61.99 142.89 57.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.862 -0.524 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 p -70.06 -2.1 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.013 -1.054 . . . . 0.0 109.816 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 16.0 t-20 -99.83 -8.18 24.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.146 -0.971 . . . . 0.0 109.666 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.501 ' CB ' HD21 ' A' ' 73' ' ' LEU . 37.8 t-20 -70.23 112.09 11.51 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.592 -0.693 . . . . 0.0 110.021 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.0 Cg_endo -86.94 9.03 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.042 2.494 . . . . 0.0 110.589 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 58.2 m-85 -104.83 -14.04 15.65 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.106 -0.997 . . . . 0.0 111.5 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 53.2 m-85 -128.18 159.57 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.7 m-80 -46.9 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.47 -48.31 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.966 175.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.58 57.72 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.91 104.98 14.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.487 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.44 ' CG ' HG23 ' A' ' 72' ' ' THR . 2.4 m-80 -100.42 132.23 45.92 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.337 -0.852 . . . . 0.0 109.882 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.683 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -105.86 143.26 34.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -130.91 128.84 41.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.923 -1.11 . . . . 0.0 110.537 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -111.12 112.16 23.76 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.89 53.84 0.48 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.673 -1.267 . . . . 0.0 108.102 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.637 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.3 mt -52.98 -56.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.726 -0.609 . . . . 0.0 111.332 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -43.83 -29.73 0.58 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.703 -1.248 . . . . 0.0 109.456 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -112.93 33.04 5.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.391 179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.637 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 32.7 mmt-85 -82.29 158.12 23.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.736 -1.228 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -116.1 81.73 1.66 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.3 m-85 -81.49 89.9 6.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.581 -0.699 . . . . 0.0 110.198 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.5 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.5 t30 -78.76 90.83 4.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.662 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 63.8 m95 -60.09 -8.16 2.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.75 -18.12 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 46.1 m-20 -99.72 -31.27 11.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' CE3' ' A' ' 97' ' ' TRP . 24.0 mt -73.83 66.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.538 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 24.9 mt -45.79 149.16 1.18 Allowed Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.546 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -78.24 -23.04 9.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.635 2.223 . . . . 0.0 110.441 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -137.57 130.3 30.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.02 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 86.3 m-85 -116.82 144.29 44.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.042 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.2 p -100.53 -16.62 17.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.49 -2.72 57.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -120.19 7.22 10.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -1.227 . . . . 0.0 109.523 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.23 177.31 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.905 . . . . 0.0 109.486 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.452 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 1.3 p -69.33 170.85 9.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.77 -38.53 53.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.9 t -51.44 -56.75 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.452 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -62.46 -40.48 96.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.082 -1.012 . . . . 0.0 109.214 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.506 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.6 mttt -62.53 -39.03 92.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.455 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.0 ttm -59.91 -43.37 94.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -58.58 -52.05 67.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.619 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.6 tp -69.45 -39.2 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.391 -1.443 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.7 p -57.55 -41.74 81.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.079 -1.013 . . . . 0.0 110.454 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.523 ' CA ' HD13 ' A' ' 24' ' ' LEU . 20.6 tt0 -68.76 -38.9 80.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.991 -1.068 . . . . 0.0 108.18 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 53' ' ' ALA . 6.0 tp -56.41 -51.04 69.85 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.556 ' SD ' HG22 ' A' ' 45' ' ' THR . 1.6 mmt -59.69 -44.95 93.44 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 108.999 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.48 -36.28 83.66 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.537 ' OD2' ' CD ' ' A' ' 93' ' ' ARG . 18.5 m-20 -69.41 -52.43 27.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 49' ' ' ALA . 58.6 t -65.89 -57.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.146 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.16 -49.09 14.7 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.01 -58.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.287 -1.125 . . . . 0.0 108.264 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -47.1 -30.2 2.64 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.571 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.831 HG13 HG22 ' A' ' 143' ' ' VAL . 19.2 m -101.08 37.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 0.0 109.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.1 m-20 37.48 51.44 1.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.476 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 57.8 tpp -65.64 125.61 25.79 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 111.545 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.9 t0 -75.86 121.27 22.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.614 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.0 117.68 35.14 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.519 1.152 . . . . 0.0 113.206 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.512 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.64 -164.2 12.01 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 104.659 -3.377 . . . . 0.0 104.659 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.656 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.24 -29.09 79.8 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.44 141.81 43.02 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.519 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 43.4 m -125.33 110.94 14.6 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 119.882 -1.761 . . . . 0.0 110.533 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.92 144.42 16.4 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.7 t -118.17 -163.99 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.111 -1.229 . . . . 0.0 107.719 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.58 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.09 -55.99 3.33 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 135.0 -137.68 9.43 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 119.313 -1.422 . . . . 0.0 111.623 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 2.8 m -48.7 -50.22 34.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.812 -0.816 . . . . 0.0 112.408 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' SER . 57.2 p -45.36 -47.28 13.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 0.0 109.842 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.604 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 17.3 mmt180 -81.41 -38.27 26.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 110.195 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 127' ' ' VAL . 54.1 t -67.67 -53.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.017 . . . . 0.0 110.503 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.477 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.7 pp0? -56.95 -34.82 68.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.896 -1.127 . . . . 0.0 108.389 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -77.38 -52.73 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.581 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -58.52 -34.29 70.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.44 ' HB2' HG13 ' A' ' 157' ' ' VAL . 57.2 mt -59.85 -49.45 77.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.274 -0.891 . . . . 0.0 109.742 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 6.0 mtmt -87.34 -42.74 12.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.891 -1.13 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 32.8 mt-10 -69.31 -51.98 31.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.898 -1.126 . . . . 0.0 112.436 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 21.9 m120 -88.17 -50.47 6.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.725 -1.234 . . . . 0.0 111.986 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 49.9 m-85 -90.04 -16.47 29.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.748 -1.22 . . . . 0.0 110.489 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 68.1 37.8 87.57 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.916 -1.115 . . . . 0.0 111.791 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.9 m-85 -63.04 165.92 6.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.335 -1.686 . . . . 0.0 107.757 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 37.6 t-20 -47.15 143.82 2.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.803 -1.186 . . . . 0.0 109.104 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 11.4 mm100 -53.15 -20.05 3.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 108.983 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.506 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.6 p -55.04 -15.04 1.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 4.1 t -63.57 120.23 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.864 -1.147 . . . . 0.0 109.45 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.644 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 12.0 p-80 -148.12 160.22 43.12 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.1 tt0 -102.48 152.33 21.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.643 ' CD1' ' CH2' ' A' ' 170' ' ' TRP . 3.3 pt -131.48 138.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m-80 -106.18 103.32 12.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.591 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 1.8 tpt180 -47.66 -29.77 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 108.978 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.92 -22.8 65.01 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.68 -2.87 25.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.241 . . . . 0.0 111.402 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -117.84 177.67 4.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.558 -1.339 . . . . 0.0 110.27 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 170' ' ' TRP . 42.3 p -109.06 147.38 32.47 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' SER . 5.1 ttmm -40.44 -44.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 110.136 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.844 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.37 -15.92 63.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.643 ' CH2' ' CD1' ' A' ' 160' ' ' ILE . 40.5 t-105 -75.11 -38.71 61.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.457 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 42.3 mt-10 -71.24 -34.69 71.0 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.24 -0.912 . . . . 0.0 108.769 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 176' ' ' LYS . . . -55.22 -47.3 75.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.86 . . . . 0.0 109.061 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 25.8 mm100 -61.25 -43.5 98.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.045 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.488 HG21 HG23 ' A' ' 184' ' ' VAL . 12.0 mt -75.39 -60.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 111.435 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -49.5 -43.4 45.4 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.496 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 172' ' ' ALA . 9.6 tttt -52.21 -44.67 64.88 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.578 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 42.6 mm-40 -58.93 -54.55 45.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.544 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.9 mt -66.25 -26.37 67.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' ASP . 45.0 p -51.9 -43.83 63.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.476 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 25.2 mt-30 -94.89 32.05 1.73 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.446 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 19.6 m-20 49.65 50.59 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 12.6 mt-30 -124.16 114.5 27.73 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.545 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.1 Cg_endo -66.25 171.13 10.79 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.136 1.89 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 21.2 t -126.91 115.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.775 -0.578 . . . . 0.0 111.007 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.551 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -65.11 112.11 3.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 176.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 5.2 t80 -123.46 155.77 36.83 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.013 -1.054 . . . . 0.0 109.449 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.36 128.66 3.56 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.21 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 245' ' ' GLN . . . -92.19 101.01 2.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 50.8 t -67.13 164.13 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 110.988 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.539 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -167.44 -130.54 1.18 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -87.72 -51.64 5.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -1.214 . . . . 0.0 111.103 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 193' ' ' GLY . 3.8 m -65.35 -18.19 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 111.776 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 192' ' ' VAL . . . 138.09 -158.9 24.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -87.6 106.82 3.23 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.916 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 9.3 t-80 -71.83 119.37 15.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -112.94 160.14 18.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.492 -1.283 . . . . 0.0 112.837 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.642 ' CD1' ' CZ3' ' A' ' 212' ' ' TRP . 54.3 p90 -161.54 173.46 14.77 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 55' ' ' ILE . 94.8 t -116.59 134.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.558 -1.339 . . . . 0.0 111.582 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 96.7 mt -102.7 109.1 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -124.0 33.28 5.33 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.306 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.22 164.92 37.97 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 117.512 -2.28 . . . . 0.0 112.675 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.514 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.91 147.63 34.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -112.45 7.46 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.833 -1.167 . . . . 0.0 110.146 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.87 -46.23 3.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -85.55 44.88 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -1.179 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 222' ' ' PHE . 0.6 OUTLIER 65.34 31.06 10.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.128 -0.982 . . . . 0.0 109.982 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.592 ' HA ' ' CE1' ' A' ' 222' ' ' PHE . 3.6 m-85 -117.93 135.26 54.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.087 -1.008 . . . . 0.0 109.126 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 38.8 m-85 -123.41 162.96 21.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.8 t60 -91.97 137.54 32.28 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.598 HG13 ' CD2' ' A' ' 197' ' ' PHE . 23.9 t -129.46 138.18 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.626 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -109.25 72.59 0.81 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.642 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 81.4 m95 -47.0 167.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 110.26 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -91.06 25.74 13.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -107.11 -168.24 1.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -1.188 . . . . 0.0 109.34 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.25 -101.06 0.09 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.71 63.98 0.62 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 218' ' ' SER . 1.5 p -100.02 -98.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.094 -1.239 . . . . 0.0 109.861 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 10.9 m -90.37 20.96 4.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 212' ' ' TRP . 1.1 m-20 -60.61 109.3 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.46 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 140.01 -92.77 0.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -59.98 131.65 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -1.195 . . . . 0.0 109.376 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -86.93 165.83 15.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.245 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.428 ' HD3' ' CG ' ' A' ' 228' ' ' ASN . 0.0 OUTLIER -84.31 -179.49 7.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.451 -0.781 . . . . 0.0 109.631 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 17.5 mt -117.74 -4.36 11.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.75 -80.43 0.6 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.64 -96.88 0.46 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.069 -1.02 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 1.1 pt? -115.44 177.96 4.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.428 ' CG ' ' HD3' ' A' ' 223' ' ' ARG . 26.0 t-20 -116.43 82.09 11.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.393 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 227' ' ' LEU . 36.0 Cg_endo -78.26 86.8 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.657 2.238 . . . . 0.0 110.534 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.469 ' OG ' HG23 ' A' ' 217' ' ' VAL . 0.0 OUTLIER -88.68 -35.85 16.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.05 98.09 6.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.529 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 237' ' ' GLY . 14.3 mt -53.68 -44.16 69.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 82.9 121.38 0.71 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 24.0 m -100.67 13.52 34.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -87.63 -85.58 1.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -121.93 -29.52 1.37 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 232' ' ' LEU . . . -91.37 113.77 4.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -110.36 32.19 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -1.105 . . . . 0.0 109.562 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 91.75 -161.44 27.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 166.17 117.14 0.39 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -58.3 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -108.02 117.99 35.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.291 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.36 -49.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.524 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 68.6 m-85 -125.6 61.5 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -1.039 . . . . 0.0 108.985 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.497 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 13.3 pt20 -91.51 132.14 36.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 109.789 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 60.1 p -145.72 170.92 15.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.25 161.92 34.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.672 0.749 . . . . 0.0 109.102 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.545 ' CG2' ' CD1' ' A' ' 185' ' ' TYR . 22.8 t -116.3 112.36 39.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 13.6 m -110.64 143.63 20.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.036 -175.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 88.06 46.35 4.79 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 29.3 mt -92.7 94.01 4.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.392 -1.064 . . . . 0.0 109.812 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 9.0 ptmt -160.87 149.08 12.86 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.594 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.6 Cg_endo . . . . . 0 C--N 1.308 -1.553 0 C-N-CA 122.257 1.971 . . . . 0.0 110.452 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.493 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 37.6 tt0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.67 165.31 24.98 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.473 2.115 . . . . 0.0 109.956 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 4' ' ' VAL . 25.6 t -98.16 139.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.091 -1.006 . . . . 0.0 109.483 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.517 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 44.7 t -136.79 127.92 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -76.39 -176.64 3.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.147 -0.971 . . . . 0.0 108.568 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.52 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 3.0 t -77.45 104.82 8.19 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.467 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.653 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 39.4 mt -57.76 -48.16 80.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 108.894 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 11.9 mt -55.63 -42.04 74.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 108.496 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 5.2 m-20 -67.65 -41.41 83.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.068 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -58.32 -14.66 7.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.9 mtpp -118.86 23.43 11.43 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 43.69 38.55 4.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 30.5 mt -90.07 109.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.412 1.101 . . . . 0.0 110.436 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 102' ' ' PRO . 8.7 m-70 -133.59 97.73 4.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CE2' HD13 ' A' ' 116' ' ' ILE . 3.8 m-30 -102.83 174.49 5.85 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.245 1.022 . . . . 0.0 111.614 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -147.01 -172.92 4.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 10.1 mt-30 -124.12 -8.94 7.66 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.828 -1.17 . . . . 0.0 110.036 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.713 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.16 -42.9 0.68 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.788 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.1 -139.98 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.563 0 CA-C-O 118.387 -0.816 . . . . 0.0 111.381 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.788 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.6 Cg_endo -73.75 2.31 6.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 122.545 1.945 . . . . 0.0 109.249 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 48.4 m-85 -73.28 -35.87 66.22 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 34.6 p-10 -98.88 20.53 13.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.617 -1.302 . . . . 0.0 109.797 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -73.52 -2.1 21.31 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.924 . . . . 0.0 109.367 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -128.68 -5.78 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.925 . . . . 0.0 109.726 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 24.6 p -65.25 165.09 18.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.616 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.4 Cg_endo -70.61 139.24 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.108 1.872 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG11 ' N ' ' A' ' 28' ' ' ILE . 10.6 t -84.24 149.55 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.73 . . . . 0.0 110.039 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 79' ' ' TYR . 42.9 mt -78.02 144.2 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 110.351 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 28' ' ' ILE . 80.6 mt-10 -123.56 -23.2 4.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 110.115 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.2 mtpm? -118.83 164.01 16.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 37' ' ' SER . 42.2 t -114.27 152.29 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.216 -0.928 . . . . 0.0 111.27 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.24 128.42 64.83 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.98 126.48 11.91 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.575 1.517 . . . . 0.0 110.247 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.8 6.61 40.19 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.25 -175.52 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.121 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.47 179.76 7.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.27 132.42 33.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.113 -179.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.578 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 70.8 m-85 -120.47 18.68 12.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.92 . . . . 0.0 108.92 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 31' ' ' VAL . 45.3 t -68.77 150.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.14 81.39 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mm-40 -91.43 129.24 37.44 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.339 -1.095 . . . . 0.0 109.738 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.29 112.7 9.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.27 157.4 1.42 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.176 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -76.6 171.63 14.33 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.398 0.618 . . . . 0.0 109.829 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HE2' ' A' ' 129' ' ' MET . 24.5 p -80.34 -36.14 34.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.112 -0.993 . . . . 0.0 108.353 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 107.11 135.63 7.92 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -54.1 -52.77 59.95 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -1.149 . . . . 0.0 108.002 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 64.4 t -45.96 -53.84 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -60.52 -51.88 67.56 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -63.3 -32.24 73.6 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.154 -178.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.3 -41.31 85.6 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.277 -1.369 . . . . 0.0 108.228 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' HG13 ' A' ' 143' ' ' VAL . 44.1 m -73.8 -54.26 8.43 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.004 0.907 . . . . 0.0 109.887 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -51.68 -39.27 57.95 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-30 -60.42 -48.75 80.39 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.501 HG13 HG22 ' A' ' 198' ' ' VAL . 39.1 mt -65.47 -24.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.604 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 36.6 mtp -73.42 -39.51 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 26.7 tptt -68.24 -41.82 80.63 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.69 -34.21 58.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.812 -0.555 . . . . 0.0 109.966 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.8 m-70 -106.92 -20.6 13.28 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.634 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.21 52.59 1.64 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -72.29 -69.01 0.37 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.546 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -70.25 105.79 1.63 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 120.328 0.686 . . . . 0.0 112.17 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -70.35 -22.05 62.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 13.1 tttp -134.19 144.07 48.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.84 141.62 44.73 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.43 -41.95 19.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 0.0 109.967 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 2.6 tttt -152.74 134.55 14.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.916 -1.115 . . . . 0.0 110.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.465 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.18 166.29 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.46 -0.775 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.504 ' CG ' ' HA ' ' A' ' 126' ' ' SER . 43.1 t80 -143.93 146.44 32.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 t -146.41 152.15 38.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.638 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 25.1 p90 -160.24 155.42 24.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.843 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 94.9 m -93.15 137.16 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 77' ' ' ASN . 10.1 tp -53.8 151.12 6.68 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 111.306 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -65.6 -6.51 11.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.038 -1.039 . . . . 0.0 109.727 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.516 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -95.56 -8.24 35.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.506 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 36.9 t-20 -69.74 109.82 5.37 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -88.52 15.51 2.06 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.929 2.419 . . . . 0.0 110.227 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.806 ' HB3' HG21 ' A' ' 28' ' ' ILE . 78.9 m-85 -108.14 -18.29 13.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.696 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.475 ' HB2' HD22 ' A' ' 73' ' ' LEU . 63.5 m-85 -123.69 161.28 25.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 16.7 m-80 -47.51 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 175.07 -47.13 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.337 -0.852 . . . . 0.0 110.947 174.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -77.15 56.25 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.74 104.73 14.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.506 -177.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.95 134.3 44.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 109.405 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.638 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.25 129.71 55.19 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.78 125.71 47.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.04 112.68 25.74 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 68' ' ' ASP . . . -73.67 51.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.053 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 37.0 mt -52.88 -49.86 46.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -44.97 -28.07 0.62 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.765 -1.209 . . . . 0.0 108.957 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 35.9 3.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 109.374 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.646 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -93.81 154.87 17.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.013 -1.054 . . . . 0.0 110.602 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.11 93.39 4.16 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-85 -81.56 91.37 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.692 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -79.8 87.31 5.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 61.2 m95 -61.67 -6.76 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.63 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.83 -21.22 22.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.751 -1.218 . . . . 0.0 108.032 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 21.8 m-20 -100.12 -26.85 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.619 HD12 ' CE3' ' A' ' 97' ' ' TRP . 64.1 mt -73.17 67.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 15.1 mt -46.85 149.2 1.58 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.8 -0.563 . . . . 0.0 110.19 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.3 Cg_endo -78.49 -17.9 12.55 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.965 2.443 . . . . 0.0 110.581 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 1.6 t -146.42 122.45 10.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 108.81 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.452 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 66.3 m-85 -109.48 140.37 43.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.135 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 p -102.81 -1.28 30.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.465 -0.772 . . . . 0.0 108.951 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.59 9.01 86.25 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.67 -10.35 9.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.336 -1.096 . . . . 0.0 109.428 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -64.03 161.0 16.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 171.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.418 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.442 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -74.41 -29.58 61.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.44 -61.38 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -62.5 -33.55 75.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 108.975 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 79.4 mttt -65.1 -44.18 89.66 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.468 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 34.9 ttm -59.41 -36.6 76.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -69.36 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.716 -0.615 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.592 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.4 tp -59.11 -40.37 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.867 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.534 ' N ' HG23 ' A' ' 116' ' ' ILE . 23.0 p -56.83 -41.76 78.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 0.0 110.423 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.525 ' N ' HD11 ' A' ' 24' ' ' LEU . 28.0 tt0 -69.37 -38.51 78.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.279 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tp -59.38 -55.46 34.45 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.604 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.4 mmt -57.45 -40.51 78.62 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.89 -41.52 91.42 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -65.25 -49.68 68.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' ALA . 76.3 t -65.95 -58.12 7.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.518 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.82 -50.5 14.83 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.9 mt -65.36 -54.47 28.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.219 -1.165 . . . . 0.0 108.256 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.504 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 65.0 p -46.48 -31.08 2.5 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.065 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.48 40.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.989 -1.069 . . . . 0.0 110.089 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 127' ' ' VAL . 0.7 OUTLIER 37.26 49.23 0.88 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.597 0.713 . . . . 0.0 109.745 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.547 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 46.7 tpp -66.02 129.02 38.35 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.532 -0.73 . . . . 0.0 111.564 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.2 t0 -76.9 123.14 25.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.616 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.8 m-85 -104.29 118.17 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.405 1.098 . . . . 0.0 113.113 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.524 ' CA ' HD13 ' A' ' 28' ' ' ILE . . . -150.94 -162.87 10.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 104.498 -3.441 . . . . 0.0 104.498 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.661 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.7 Cg_endo -62.31 -29.88 80.38 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 N-CA-C 105.755 -2.44 . . . . 0.0 105.755 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -110.14 137.78 47.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 59.8 m -116.79 107.62 14.86 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.015 -1.678 . . . . 0.0 109.702 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.73 137.08 13.84 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.562 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.8 t -117.33 -161.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.41 -55.46 3.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.564 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 131.83 -127.57 5.03 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.603 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.466 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 3.8 m -51.13 -56.74 11.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.681 -0.894 . . . . 0.0 111.692 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 24.5 p -47.64 -39.89 18.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.045 -1.035 . . . . 0.0 109.865 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.569 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 33.7 mmt-85 -79.05 -43.54 24.01 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.653 HG21 ' CE2' ' A' ' 185' ' ' TYR . 78.4 t -68.82 -55.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.415 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 140' ' ' SER . 2.6 pp0? -56.12 -31.75 63.59 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.084 -1.047 . . . . 0.0 108.577 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp85 -77.14 -49.64 14.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 126' ' ' SER . . . -63.51 -34.8 78.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.146 -0.971 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD12 HG11 ' A' ' 157' ' ' VAL . 51.5 mt -61.06 -48.19 82.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 110.46 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.495 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 47.7 mtmt -86.77 -43.67 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 111.222 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.8 mt-10 -76.21 -41.51 49.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 112.224 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 32.0 m120 -93.91 -44.27 8.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.584 -1.323 . . . . 0.0 111.66 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.604 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 39.4 m-85 -100.33 -2.45 33.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.79 -1.194 . . . . 0.0 110.476 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 52.94 37.72 53.8 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.286 -0.884 . . . . 0.0 112.449 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.426 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.4 m-85 -62.6 167.48 4.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.182 -1.775 . . . . 0.0 107.188 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.8 t-20 -47.82 140.14 6.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.628 -1.295 . . . . 0.0 109.089 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -53.2 -19.68 3.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.313 -0.867 . . . . 0.0 108.906 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.533 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 73.2 p -53.42 -17.2 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.302 -0.874 . . . . 0.0 109.829 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 42.7 t -62.92 122.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.705 -1.247 . . . . 0.0 108.947 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CD2' HG22 ' A' ' 249' ' ' VAL . 2.0 p-80 -146.75 153.38 40.16 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.119 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.466 ' OE1' ' HB2' ' A' ' 140' ' ' SER . 2.8 tt0 -101.32 148.29 25.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.57 HD11 ' CH2' ' A' ' 170' ' ' TRP . 6.5 pt -130.96 159.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -112.37 95.81 5.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.865 -1.147 . . . . 0.0 110.688 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.622 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 39.3 tpt85 -42.81 -27.97 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.395 -0.815 . . . . 0.0 109.083 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -62.39 -36.88 93.73 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.27 38.5 1.85 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.051 -1.264 . . . . 0.0 111.691 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.53 169.14 18.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.542 -1.349 . . . . 0.0 110.05 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -100.63 140.63 34.63 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 166' ' ' SER . 6.4 tttt -40.3 -46.25 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -63.54 -53.26 54.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 110.055 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.0 -26.25 68.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.622 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 69.4 t-105 -74.47 -35.72 63.3 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.132 -0.98 . . . . 0.0 109.911 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.455 ' OE2' ' OD1' ' A' ' 206' ' ' ASN . 45.8 mt-10 -72.22 -32.16 66.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.104 -0.998 . . . . 0.0 109.232 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.59 88.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.31 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.438 ' NE2' HG23 ' A' ' 249' ' ' VAL . 16.1 mm100 -64.78 -50.01 68.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.37 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.528 ' HA ' HG23 ' A' ' 184' ' ' VAL . 64.3 mt -71.84 -52.51 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 111.174 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -53.38 -43.06 67.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.108 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.422 ' HE2' ' NE2' ' A' ' 180' ' ' GLN . 7.4 tttt -51.97 -47.21 64.94 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.603 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 38.9 mm-40 -59.24 -52.67 64.67 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.505 ' HB3' HG11 ' A' ' 4' ' ' VAL . 20.7 mt -65.59 -28.3 69.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.445 -0.784 . . . . 0.0 110.149 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -52.51 -43.23 64.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 108.757 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.519 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 26.7 mt-30 -99.34 42.95 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.481 ' HB3' HD21 ' A' ' 7' ' ' LEU . 14.5 m-20 42.33 51.09 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.77 0.795 . . . . 0.0 108.913 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.519 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 5.1 mt-30 -124.15 109.52 29.37 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.527 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.1 Cg_endo -64.89 169.6 11.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.886 1.724 . . . . 0.0 111.944 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 62.1 t -127.03 131.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.804 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.653 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -80.97 121.34 25.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 177.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.595 ' CD2' HD13 ' A' ' 199' ' ' ILE . 4.7 t80 -123.29 164.68 18.31 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.962 -1.086 . . . . 0.0 109.673 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -165.63 124.5 1.65 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.19 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.16 108.06 3.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 244' ' ' TYR . 40.0 t -71.1 164.38 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.313 . . . . 0.0 111.457 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -161.42 -142.67 3.45 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.411 -1.875 . . . . 0.0 108.411 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -87.64 -29.66 21.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -1.199 . . . . 0.0 110.638 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.453 HG13 ' CB ' ' A' ' 238' ' ' ALA . 21.9 m -83.43 -11.74 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.042 -1.036 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 -168.36 23.21 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -78.76 109.98 2.95 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.362 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.653 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -72.06 130.87 41.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.69 160.32 24.73 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.363 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.608 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 29.1 p90 -163.04 168.53 20.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 55' ' ' ILE . 71.6 t -113.88 137.91 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.753 -1.217 . . . . 0.0 111.888 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.728 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 77.6 mt -104.07 110.42 30.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 209' ' ' HIS . 1.6 p30 -124.8 34.32 5.02 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.372 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.58 161.56 33.85 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 117.073 -2.489 . . . . 0.0 113.202 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.517 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.52 141.27 29.41 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -112.6 11.53 19.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.777 -1.202 . . . . 0.0 110.442 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.45 -50.23 3.99 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -79.46 53.83 1.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 0.0 109.64 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.455 ' OD1' ' OE2' ' A' ' 171' ' ' GLU . 0.7 OUTLIER 50.73 38.16 18.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 0.3 OUTLIER -121.02 132.73 55.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.095 -1.003 . . . . 0.0 109.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 26.2 m-85 -123.6 160.71 26.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.974 . . . . 0.0 110.039 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.8 t60 -92.73 146.56 23.56 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.58 HG13 ' CD1' ' A' ' 197' ' ' PHE . 23.8 t -139.25 139.03 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 25.9 t-20 -108.95 70.38 0.74 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.608 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 89.7 m95 -48.86 169.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.456 -0.777 . . . . 0.0 110.193 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.87 -2.4 57.34 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -107.21 165.71 11.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.133 -1.216 . . . . 0.0 108.998 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -128.99 13.88 6.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.85 -1.4 5.89 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 218' ' ' SER . 2.7 p -105.69 -146.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.547 ' N ' ' CG1' ' A' ' 217' ' ' VAL . 19.6 m -63.35 61.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.123 . . . . 0.0 110.771 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.7 OUTLIER -77.45 88.08 3.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.95 -1.094 . . . . 0.0 109.41 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 147.33 -89.15 0.15 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.23 144.82 49.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -1.181 . . . . 0.0 110.117 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -99.26 165.43 11.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.36 -0.837 . . . . 0.0 109.152 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.513 ' NE ' ' OD1' ' A' ' 225' ' ' ASP . 0.9 OUTLIER -84.47 -178.65 6.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.314 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.8 mt -120.9 15.1 11.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.997 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.513 ' OD1' ' NE ' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -123.81 -81.91 0.64 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.905 -1.122 . . . . 0.0 109.695 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.41 -95.57 0.47 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 109.89 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.467 ' O ' ' NE ' ' A' ' 223' ' ' ARG . 1.1 pt? -116.08 -153.08 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.995 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.567 ' HB2' ' CE3' ' A' ' 212' ' ' TRP . 1.9 t30 -95.78 153.46 39.33 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 109.057 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 228' ' ' ASN . 36.0 Cg_endo -78.04 -23.59 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.543 2.162 . . . . 0.0 110.747 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.476 ' CB ' HG21 ' A' ' 217' ' ' VAL . 24.1 t -92.91 30.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 195' ' ' HIS . . . -82.63 -5.06 58.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 233' ' ' GLY . 22.8 tp -82.86 -80.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.368 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 232' ' ' LEU . . . 107.55 -96.42 1.06 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 171.76 13.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -1.12 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -90.73 58.37 3.33 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.4 -120.18 0.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -125.95 -29.77 0.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' A' ' 191' ' ' LYS . . . -58.8 -172.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -177.12 -113.69 0.36 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -123.5 37.7 2.66 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -84.72 136.26 33.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.701 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -116.2 87.79 2.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.124 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -84.27 -48.37 5.11 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.548 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 41.8 m-85 -135.56 129.28 32.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.519 -0.989 . . . . 0.0 109.086 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 2.4 pt20 -128.66 136.3 50.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.816 -1.178 . . . . 0.0 108.469 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 4.9 p -149.43 167.04 27.29 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.74 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -140.99 145.58 36.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.575 0.703 . . . . 0.0 109.536 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 22.0 t -107.94 114.42 46.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 158' ' ' HIS . 12.3 m -119.52 138.95 48.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.252 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 97.95 53.84 1.25 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.608 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.4 mt -103.65 96.36 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -1.152 . . . . 0.0 110.102 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.48 147.42 8.54 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.646 0 C-N-CA 122.227 1.951 . . . . 0.0 110.288 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.47 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 38.6 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 1' ' ' GLN . 35.0 Cg_endo -77.41 -176.57 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.332 2.021 . . . . 0.0 109.548 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.91 143.36 26.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 178' ' ' LEU . 94.7 t -137.68 133.91 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -0.775 . . . . 0.0 109.006 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -76.36 178.44 6.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.469 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 1.8 t -77.9 106.35 9.69 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.024 -1.048 . . . . 0.0 109.241 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.679 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 38.3 mt -57.4 -50.72 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.879 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 12.1 mt -55.49 -41.84 73.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.784 -1.198 . . . . 0.0 109.224 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 29.8 t0 -67.75 -40.47 84.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.581 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.6 p -58.53 -14.16 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.1 -1.0 . . . . 0.0 109.293 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 13' ' ' ILE . 17.7 mtpt -117.75 22.12 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 0.0 108.802 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.0 37.85 4.42 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 48.1 mt -88.63 109.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 122.427 1.108 . . . . 0.0 110.219 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 102' ' ' PRO . 28.0 m80 -133.78 98.0 4.06 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.574 ' CE2' HD13 ' A' ' 116' ' ' ILE . 4.6 m-30 -103.61 171.66 7.24 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.216 1.008 . . . . 0.0 112.064 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.3 t30 -147.19 -173.21 4.19 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 30.3 mt-30 -124.11 -3.7 8.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.64 -56.17 0.35 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.158 -1.496 . . . . 0.0 112.152 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.752 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.65 -125.14 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-O 117.531 -1.224 . . . . 0.0 112.257 -176.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.752 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -80.54 9.21 3.8 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 123.381 2.243 . . . . 0.0 110.212 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 15' ' ' TYR . 71.0 m-85 -83.94 -33.92 24.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 109.818 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.515 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.2 p30 -102.51 21.87 14.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.748 -1.22 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 6.4 mt -69.37 -4.4 18.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.94 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 118' ' ' GLU . 63.6 mt -131.67 -5.67 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.878 -1.139 . . . . 0.0 110.275 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 21.2 p -61.38 165.83 6.32 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 0.0 108.392 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.2 Cg_endo -69.57 131.31 21.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.069 1.846 . . . . 0.0 111.675 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG22 ' ND1' ' A' ' 42' ' ' HIS . 76.6 t -77.34 151.31 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.605 -0.684 . . . . 0.0 109.601 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.667 HD13 ' HD3' ' A' ' 133' ' ' PRO . 12.7 mt -77.54 150.28 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -125.13 -23.37 4.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.434 -0.791 . . . . 0.0 111.15 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' TYR . 16.1 mtpt -121.54 176.35 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.845 -1.159 . . . . 0.0 109.927 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.03 145.11 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.241 -0.912 . . . . 0.0 110.772 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -88.72 130.66 44.26 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.13 123.81 10.33 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.552 1.501 . . . . 0.0 110.315 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.92 27.3 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.6 tp10 -149.01 176.91 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.946 . . . . 0.0 109.139 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -80.27 -175.66 5.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.201 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -83.04 135.87 34.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.6 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 15.74 11.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.918 -1.114 . . . . 0.0 109.571 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.1 143.49 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.91 67.16 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.9 mt-30 -83.92 127.08 33.6 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.192 -1.181 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.482 ' ND1' HG22 ' A' ' 27' ' ' VAL . 3.4 m-70 -72.86 110.28 7.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.23 158.44 1.15 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.599 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -75.75 169.2 18.59 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 109.363 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.476 ' O ' ' HE2' ' A' ' 129' ' ' MET . 8.7 p -80.7 -34.5 34.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.113 . . . . 0.0 108.051 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.06 135.29 7.83 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.422 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.1 p -54.49 -49.19 70.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -1.215 . . . . 0.0 107.93 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.618 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 20.3 t -46.38 -56.41 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -58.7 -50.13 75.03 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.667 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.77 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -66.66 -38.3 86.57 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.071 -1.452 . . . . 0.0 107.632 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.611 ' OG1' HG22 ' A' ' 143' ' ' VAL . 61.8 m -74.55 -53.98 8.38 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.26 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -55.13 -41.37 71.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 110.323 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.4 mt-30 -57.61 -47.5 82.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.491 -1.38 . . . . 0.0 107.331 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.512 HG13 HG22 ' A' ' 198' ' ' VAL . 59.3 mt -65.74 -24.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.6 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 27.7 mtp -73.75 -37.68 64.97 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 22.3 tptt -71.2 -39.04 72.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.679 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.2 t80 -53.53 -34.49 58.38 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 109.528 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 75.5 m-70 -107.62 -20.08 13.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.02 54.33 1.64 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 1.4 t80 -72.38 -73.84 0.16 Allowed Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 34.4 Cg_endo -68.58 103.4 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.342 0.654 . . . . 0.0 112.057 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.442 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t-20 -70.84 -18.83 62.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 8.0 tttp -134.11 141.73 47.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.25 148.6 36.72 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.42 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -87.89 -59.04 2.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -1.02 . . . . 0.0 109.316 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 68' ' ' ASP . 15.6 tttt -139.03 150.42 45.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-20 -74.58 179.99 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 70' ' ' THR . 61.9 t80 -147.73 167.5 24.5 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.374 -0.829 . . . . 0.0 109.605 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 6.8 t -166.22 147.87 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.617 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 19.1 p90 -163.35 152.67 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 21.1 m -93.09 138.14 31.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 77' ' ' ASN . 9.5 tp -52.54 150.03 5.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 111.331 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -61.95 144.07 55.58 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.54 . . . . 0.0 109.715 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -1.91 11.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.82 -8.95 23.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 109.732 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.557 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 31.2 t-20 -70.24 109.4 4.81 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.765 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.594 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.0 Cg_endo -89.3 16.07 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.0 2.467 . . . . 0.0 110.279 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 91.2 m-85 -104.45 -23.53 13.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.746 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 2.4 m-85 -122.56 161.38 23.79 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.573 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 21.7 m-80 -46.1 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.18 -47.1 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 175.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.64 57.55 4.99 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 N-CA-C 107.39 -1.812 . . . . 0.0 107.39 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -105.67 107.25 18.15 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.247 -178.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -100.49 139.12 36.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.617 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.3 mp -115.97 123.14 47.29 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.27 125.25 47.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.079 -1.013 . . . . 0.0 110.059 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.04 113.79 27.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.61 53.0 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.874 -1.141 . . . . 0.0 108.557 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.625 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 48.7 mt -52.37 -46.66 46.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 121.264 -0.897 . . . . 0.0 109.76 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.4 p -45.22 -26.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.162 . . . . 0.0 108.936 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.0 p -111.51 33.19 4.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 0.0 109.203 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -89.37 153.75 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.12 91.24 3.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.23 87.07 6.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.469 -0.769 . . . . 0.0 110.84 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.489 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.3 t30 -79.23 88.58 4.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.645 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 72.3 m95 -61.6 -5.69 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 110.737 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.87 -19.46 24.57 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.15 -27.47 13.51 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD12 ' CE3' ' A' ' 97' ' ' TRP . 48.0 mt -74.14 70.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 38.1 mt -48.8 148.84 3.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.728 -0.607 . . . . 0.0 109.961 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.532 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.1 Cg_endo -79.08 -22.81 8.27 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.758 2.305 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 14' ' ' HIS . 7.6 t -139.51 121.88 16.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 108.878 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 58.2 m-85 -109.43 140.41 43.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -0.947 . . . . 0.0 109.911 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.9 p -99.9 -0.69 39.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.046 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 82.07 -0.74 88.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.3 mtm105 -118.07 1.94 12.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -1.194 . . . . 0.0 109.561 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.68 164.88 15.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.545 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.429 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -60.16 171.55 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.202 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 63.2 m-20 -75.51 -31.48 60.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.89 . . . . 0.0 109.764 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.31 -63.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.87 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 1.1 mp0 -62.46 -31.52 72.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.494 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.2 mttt -66.21 -44.29 84.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.48 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 11.0 ttm -59.11 -34.53 72.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.69 -68.99 0.19 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.697 -0.627 . . . . 0.0 110.539 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.574 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.8 tp -59.85 -40.9 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 110.209 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.542 ' N ' HG23 ' A' ' 116' ' ' ILE . 14.7 p -56.9 -40.22 75.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.767 -1.208 . . . . 0.0 109.764 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 37.2 tt0 -69.84 -39.19 76.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 108.682 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.44 -60.39 3.89 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.591 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -51.24 -39.22 56.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.628 -0.67 . . . . 0.0 109.679 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.62 -41.26 92.92 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 126' ' ' SER . 8.7 m-20 -65.39 -54.59 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 49' ' ' ALA . 87.0 t -63.08 -52.06 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.314 -0.867 . . . . 0.0 108.799 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -51.42 -51.55 36.71 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.3 mt -66.5 -54.39 26.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.076 -1.249 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.478 ' HB2' ' HB1' ' A' ' 146' ' ' ALA . 33.1 p -46.22 -28.13 1.18 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.644 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.8 m -101.28 30.95 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.864 -1.148 . . . . 0.0 109.674 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 4.1 m-20 42.51 38.88 1.37 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.247 -0.908 . . . . 0.0 108.944 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.512 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 37.6 tpp -53.33 132.21 38.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.574 -0.704 . . . . 0.0 111.583 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 15.5 t0 -76.69 120.73 22.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.62 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.65 120.17 40.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.3 1.048 . . . . 0.0 112.96 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -151.11 -164.25 11.93 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.667 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.4 Cg_endo -62.0 -30.94 83.88 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 105.687 -2.466 . . . . 0.0 105.687 175.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 m -109.97 142.46 41.31 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 44.3 m -119.54 110.42 16.86 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 119.849 -1.782 . . . . 0.0 109.972 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.17 133.28 11.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -118.44 -169.0 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -1.115 . . . . 0.0 108.602 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.29 -57.33 2.88 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.572 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 129.94 -122.5 3.73 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.551 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 3.1 m -47.99 -60.58 2.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 24.7 p -46.88 -41.18 15.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.78 -1.2 . . . . 0.0 109.238 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.4 mmp_? -80.33 -42.62 22.64 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.611 HG22 ' OG1' ' A' ' 52' ' ' THR . 84.7 t -68.65 -59.38 3.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.722 -0.612 . . . . 0.0 111.149 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.44 -32.88 65.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.16 -0.963 . . . . 0.0 109.175 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 14.2 ttm180 -75.89 -44.15 41.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.099 -1.0 . . . . 0.0 109.375 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -70.49 -32.11 69.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 109.908 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 151' ' ' PHE . 51.8 mt -60.31 -47.89 84.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.369 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.513 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 24.6 mtmt -87.73 -29.47 21.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.729 -1.232 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 88.4 mt-10 -74.3 -67.46 0.62 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 112.333 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 68' ' ' ASP . 36.1 m120 -82.1 -31.04 30.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.851 -1.156 . . . . 0.0 111.652 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.6 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 19.6 m-85 -102.53 -6.15 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.662 -1.274 . . . . 0.0 110.36 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 48.95 40.45 27.38 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.224 -0.923 . . . . 0.0 112.244 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.6 m-85 -62.76 160.24 14.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.408 -1.643 . . . . 0.0 107.999 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 49.6 t30 -47.64 155.42 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 109.486 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -55.85 -17.57 6.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.895 . . . . 0.0 108.837 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.544 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 21.4 p -53.69 -15.72 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 12.8 t -72.25 119.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.68 -1.262 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.583 ' CD2' HG22 ' A' ' 249' ' ' VAL . 3.1 p-80 -146.77 155.29 42.26 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 2.1 tt0 -102.15 143.78 31.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.672 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' CA ' ' A' ' 246' ' ' SER . 4.1 pt -128.33 154.16 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -109.62 94.93 5.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.991 -1.068 . . . . 0.0 110.542 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.574 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 1.2 tpt85 -46.39 -27.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 108.99 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.82 -23.56 72.57 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -103.64 4.29 35.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.072 -1.252 . . . . 0.0 111.17 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -118.11 167.98 10.98 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.554 -1.341 . . . . 0.0 109.836 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 167' ' ' LYS . 32.0 p -98.94 136.86 38.32 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.495 ' HG3' ' NH2' ' A' ' 223' ' ' ARG . 29.3 tttm -34.42 -45.66 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.76 -0.587 . . . . 0.0 110.721 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -63.55 -62.22 1.81 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.958 -1.089 . . . . 0.0 109.733 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.45 -19.88 65.09 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 109.069 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.574 ' CE3' ' HA ' ' A' ' 162' ' ' ARG . 67.3 t-105 -75.44 -44.25 45.38 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.981 -1.074 . . . . 0.0 108.842 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 208' ' ' TYR . 12.3 mt-10 -61.68 -31.51 71.65 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.97 80.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.826 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -61.32 -45.38 94.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 109.249 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.509 ' HA ' HG23 ' A' ' 184' ' ' VAL . 9.8 mt -76.01 -48.21 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 111.091 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.47 ' OD2' ' HG3' ' A' ' 1' ' ' GLN . 0.3 OUTLIER -58.33 -53.76 54.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.014 -1.054 . . . . 0.0 109.67 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -51.28 -38.0 50.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.558 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.2 mm-40 -61.0 -51.32 69.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.554 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.8 mt -69.09 -24.95 64.2 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.489 -0.757 . . . . 0.0 109.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.425 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.7 p -52.21 -38.16 57.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.95 -1.094 . . . . 0.0 108.096 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 24.2 mt-30 -101.32 33.5 2.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.487 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.7 m-20 47.11 51.15 13.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.1 mt-30 -123.75 106.0 32.27 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.4 Cg_endo -63.59 168.77 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.908 1.738 . . . . 0.0 112.497 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 42.3 t -121.86 135.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.454 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.572 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 3.3 t80 -85.07 118.31 24.55 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.649 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 8.8 t80 -122.29 150.93 41.67 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.808 -1.183 . . . . 0.0 109.774 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.572 ' OE1' ' HA3' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -152.54 121.92 6.77 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.705 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -90.98 112.38 4.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.6 t -66.37 164.82 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -1.178 . . . . 0.0 110.794 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -175.65 -143.22 4.51 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -35.68 18.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.235 . . . . 0.0 110.213 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.59 -9.31 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.12 -162.03 18.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.52 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.93 111.53 3.27 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.584 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.565 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.6 t-80 -71.57 101.23 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.618 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -86.24 153.1 22.25 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.822 1.296 . . . . 0.0 114.216 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.676 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 21.5 p90 -163.58 164.77 24.06 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 55' ' ' ILE . 70.6 t -113.74 139.06 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.705 -1.247 . . . . 0.0 112.011 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 51.9 mt -103.38 111.68 34.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.577 ' OD1' ' CD2' ' A' ' 209' ' ' HIS . 1.6 p30 -125.22 31.33 5.62 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.395 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.08 41.59 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.271 -2.395 . . . . 0.0 112.883 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.456 ' HB3' ' NE2' ' A' ' 1' ' ' GLN . . . -156.48 149.7 24.27 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 207' ' ' PHE . 18.2 p-10 -128.56 29.81 5.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.578 -1.326 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 48.0 22.24 2.04 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 22.7 mtm180 -135.04 25.25 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -1.211 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 1.9 m-80 72.58 18.66 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.465 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 9.7 m-85 -120.15 113.73 20.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.901 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.552 ' CZ ' ' HG2' ' A' ' 171' ' ' GLU . 3.5 m-85 -102.67 167.35 9.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 108.919 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.4 t60 -92.18 139.48 30.58 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.565 HG13 ' CD1' ' A' ' 197' ' ' PHE . 42.4 t -130.89 136.18 58.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.533 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.45 ' N ' HG11 ' A' ' 210' ' ' VAL . 23.3 t-20 -108.62 73.67 0.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.676 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 73.5 m95 -46.13 171.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 110.269 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.15 -2.4 53.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.47 ' HB2' HG12 ' A' ' 217' ' ' VAL . 77.8 m95 -106.96 169.98 8.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -1.1 . . . . 0.0 109.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -123.57 4.84 9.32 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.48 13.59 5.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 218' ' ' SER . 1.8 p -107.96 -153.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -1.081 . . . . 0.0 109.489 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.575 ' HB3' ' CD2' ' A' ' 222' ' ' PHE . 50.4 m -67.52 58.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.906 -1.121 . . . . 0.0 110.213 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 217' ' ' VAL . 13.8 m-20 -83.68 99.55 10.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 156.12 -149.11 19.97 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.371 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 48.0 m-85 -63.06 89.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.979 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 218' ' ' SER . 4.3 m-85 -136.53 129.56 31.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.002 -1.061 . . . . 0.0 110.07 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.495 ' NH2' ' HG3' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -89.31 18.62 5.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.344 -0.847 . . . . 0.0 109.777 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 3.9 mm? -73.98 37.28 0.1 Allowed 'General case' 0 C--N 1.285 -2.198 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.543 ' OD2' ' CE1' ' A' ' 197' ' ' PHE . 4.1 m-20 -86.33 -9.54 56.19 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.229 -0.919 . . . . 0.0 108.883 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.53 -65.38 1.02 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -157.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -92.68 155.06 42.22 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.941 -1.099 . . . . 0.0 109.671 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.556 ' HB3' ' CE2' ' A' ' 212' ' ' TRP . 35.4 Cg_endo -78.21 -161.39 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.82 2.346 . . . . 0.0 110.536 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.72 11.04 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.16 68.13 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.404 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 -26.27 26.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.74 142.61 0.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 85.8 m -97.88 -44.31 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -1.139 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -93.98 -57.47 1.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.14 90.08 1.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 134.49 110.74 1.15 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -91.57 35.38 0.95 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -1.109 . . . . 0.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 45.58 83.93 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.33 -173.7 22.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -122.78 171.39 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.172 -1.193 . . . . 0.0 109.491 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 1.8 t-20 -95.31 75.92 3.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.32 -45.85 8.52 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.473 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 21.1 m-85 -135.43 158.19 45.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.543 -0.975 . . . . 0.0 108.792 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 4.4 pt20 -152.31 143.6 23.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.066 -1.021 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.503 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 14.2 p -155.96 152.4 28.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 109.89 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.479 ' HB1' ' CH2' ' A' ' 170' ' ' TRP . . . -132.12 167.76 19.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.119 0.961 . . . . 0.0 109.854 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 8.7 t -117.42 116.25 51.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 158' ' ' HIS . 29.4 m -117.64 145.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.734 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.89 49.12 3.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.611 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.3 mt -98.98 89.05 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.774 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -160.34 150.71 15.08 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.451 -0.781 . . . . 0.0 109.117 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 33.9 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.447 2.098 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 204' ' ' GLY . 38.6 tt0 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.66 145.17 20.27 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.448 2.099 . . . . 0.0 110.257 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' C ' HG21 ' A' ' 4' ' ' VAL . 46.0 t -81.24 142.94 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.114 -0.991 . . . . 0.0 109.611 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 178' ' ' LEU . 70.1 t -139.47 131.53 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 109.261 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 200' ' ' ASP . 7.4 mmtp -76.23 -177.46 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -0.947 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 32.8 t -78.06 104.35 8.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 109.911 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.4 mt -57.84 -52.87 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.528 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' HB2' ' OD2' ' A' ' 200' ' ' ASP . 16.3 mt -54.44 -40.08 68.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.768 -1.207 . . . . 0.0 108.748 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -68.06 -42.57 80.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.912 . . . . 0.0 109.286 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 p -58.49 -14.78 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.086 -1.009 . . . . 0.0 109.218 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -116.37 22.54 12.76 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.07 33.5 2.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 11' ' ' LYS . 31.5 mt -85.85 109.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.498 -1.001 . . . . 0.0 110.261 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' PRO . 40.1 m80 -134.8 77.46 1.69 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.0 m-30 -85.13 177.08 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.148 0.975 . . . . 0.0 111.197 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -147.68 -164.26 1.96 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 213' ' ' GLY . 25.8 mt-30 -124.85 -20.57 4.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.856 -1.153 . . . . 0.0 110.583 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.43 -34.56 1.42 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.469 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.755 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 -140.22 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.466 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.846 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.8 Cg_endo -74.2 3.44 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 CA-C-N 122.511 1.933 . . . . 0.0 109.559 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.558 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 9.1 m-85 -78.87 -31.37 45.53 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.478 -0.764 . . . . 0.0 108.962 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 28.1 p-10 -93.9 19.84 8.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.556 -1.34 . . . . 0.0 109.617 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD1' ' HD3' ' A' ' 113' ' ' LYS . 11.3 mt -74.49 -3.05 28.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD13 ' HG3' ' A' ' 114' ' ' MET . 6.3 mt -129.24 -0.98 5.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 0.0 109.485 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -66.12 166.01 18.91 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.7 Cg_endo -71.32 141.36 38.87 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.368 2.045 . . . . 0.0 112.223 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 35.8 t -80.01 147.05 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.658 HD13 ' HD3' ' A' ' 133' ' ' PRO . 21.6 mt -77.88 148.47 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.704 0.764 . . . . 0.0 110.853 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.6 mm-40 -125.73 -21.54 4.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.621 -0.675 . . . . 0.0 110.432 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 80' ' ' PHE . 13.8 mtpp -122.76 166.97 14.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 37' ' ' SER . 91.8 t -114.63 150.45 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.558 -0.714 . . . . 0.0 110.577 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HG2' ' CG ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -75.81 163.18 68.67 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.2 Cg_endo -81.61 122.38 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.411 2.074 . . . . 0.0 110.606 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.48 86.23 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.58 169.37 9.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.089 -1.242 . . . . 0.0 109.778 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.83 172.07 4.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.632 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -86.93 133.27 33.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 109.435 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.608 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 76.0 m-85 -123.62 15.89 9.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.931 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' HG22 ' A' ' 28' ' ' ILE . 94.1 t -63.3 136.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.51 -3.12 83.58 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.441 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.5 mt-30 -83.76 132.92 34.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.293 -1.122 . . . . 0.0 109.605 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -73.64 110.31 7.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.48 159.39 1.03 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.8 171.78 14.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.455 0.645 . . . . 0.0 109.701 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.558 HG22 ' SD ' ' A' ' 120' ' ' MET . 24.6 p -80.81 -34.62 33.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 108.708 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.34 137.29 8.92 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -48.03 74.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.326 -1.103 . . . . 0.0 108.313 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 127' ' ' VAL . 3.3 t -46.93 -53.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -63.47 -47.94 79.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.888 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 70.9 m -62.91 -30.47 71.57 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.642 -0.661 . . . . 0.0 109.499 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.7 72.14 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.808 -1.157 . . . . 0.0 108.439 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.561 ' OG1' HG23 ' A' ' 143' ' ' VAL . 40.3 m -76.2 -49.5 17.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.293 0.568 . . . . 0.0 110.752 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.02 -34.28 28.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.177 -0.952 . . . . 0.0 108.742 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.609 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-30 -68.26 -48.95 63.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 198' ' ' VAL . 55.2 mt -65.58 -23.1 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' THR . 22.8 mtp -73.92 -34.23 64.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 100' ' ' ILE . 42.8 tptt -72.34 -45.46 59.82 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.67 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.4 t80 -52.42 -30.83 31.36 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.265 0.555 . . . . 0.0 109.815 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.638 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 59.3 m-70 -108.35 -24.09 11.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 111.151 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.23 57.15 2.5 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -79.33 -71.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.0 Cg_endo -68.34 103.43 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 122.26 0.611 . . . . 0.0 111.838 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -21.88 63.48 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 4.9 ttpt -134.8 141.25 46.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.08 146.6 39.29 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.351 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -82.91 -45.15 14.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -1.027 . . . . 0.0 110.206 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.2 ttpp -152.16 135.29 15.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.035 -1.041 . . . . 0.0 110.069 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.5 OUTLIER -60.65 164.39 4.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.043 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.459 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 45.2 t80 -143.37 154.37 43.66 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t -154.52 150.43 27.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 14.7 p90 -155.3 152.3 29.04 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.466 ' OG1' ' OD1' ' A' ' 85' ' ' ASN . 46.5 m -92.75 140.25 29.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.495 HD21 ' CG ' ' A' ' 77' ' ' ASN . 8.7 tp -55.5 148.57 15.26 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 111.467 -178.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.444 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 3.5 p -61.69 141.87 57.57 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.301 0.572 . . . . 0.0 110.122 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.7 m -67.32 -5.41 14.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.9 m120 -99.45 -3.64 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 28.1 t-20 -70.68 111.78 10.82 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.552 -0.717 . . . . 0.0 109.878 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.644 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.1 Cg_endo -88.5 13.64 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.975 2.45 . . . . 0.0 109.792 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.644 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 59.2 m-85 -112.73 -4.07 14.12 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.283 -0.885 . . . . 0.0 111.641 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.488 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 69.1 m-85 -140.62 161.0 38.79 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 44.5 m-80 -47.77 -81.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 1.1 m-70 174.95 -46.84 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.506 -0.746 . . . . 0.0 110.929 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.2 Cg_endo -76.95 54.6 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 N-CA-C 107.419 -1.8 . . . . 0.0 107.419 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 4.8 tptt -105.67 105.71 15.87 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.068 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' OG1' ' A' ' 72' ' ' THR . 11.6 m-80 -100.3 140.06 35.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.661 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -113.93 128.38 56.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -120.31 129.68 54.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.094 -1.003 . . . . 0.0 110.235 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.64 111.13 23.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.56 52.44 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.733 -1.23 . . . . 0.0 108.372 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.644 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.7 mt -52.43 -52.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.565 -0.709 . . . . 0.0 109.417 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -45.51 -26.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.096 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -112.26 19.85 17.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.5 mmt-85 -76.59 152.84 35.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 89.11 3.04 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.0 89.9 5.95 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 110.508 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 15.9 t-20 -80.05 92.32 5.6 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.4 m95 -61.14 -8.82 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 110.026 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -90.79 -15.94 29.22 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 27.2 m-20 -99.26 -33.59 10.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.602 HD12 ' CE3' ' A' ' 97' ' ' TRP . 30.6 mt -73.46 93.71 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 30.1 mt -71.05 151.33 94.9 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -78.87 -28.15 4.23 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.132 . . . . 0.0 110.223 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.93 127.65 27.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.902 . . . . 0.0 109.31 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.588 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 82.6 m-85 -112.0 145.33 39.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 109.874 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 p -100.11 -12.79 19.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.98 -3.4 62.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -118.68 15.32 13.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.153 . . . . 0.0 109.287 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.02 -172.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.2 p -87.32 179.82 6.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.433 -0.792 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -78.01 -38.61 44.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.54 -58.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.71 -35.27 79.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.289 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.527 ' HD3' ' CD1' ' A' ' 23' ' ' LEU . 14.6 mttm -64.02 -43.06 96.75 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.469 ' HG3' HD13 ' A' ' 24' ' ' LEU . 23.1 ttm -60.0 -38.29 82.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.55 -68.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.704 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.588 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.3 tp -66.0 -48.64 81.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.386 -0.821 . . . . 0.0 109.68 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 51.3 p -47.48 -44.84 25.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.938 -1.101 . . . . 0.0 108.378 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.585 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 4.2 tt0 -70.26 -47.47 61.13 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 53' ' ' ALA . 7.2 tp -48.62 -51.66 26.97 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 45' ' ' THR . 1.3 mmt -60.26 -46.55 89.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.688 -0.632 . . . . 0.0 109.755 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.58 -35.64 81.17 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 126' ' ' SER . 4.9 m-20 -68.09 -55.47 12.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 49' ' ' ALA . 44.8 t -62.93 -58.32 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.0 109.185 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -45.55 -50.13 11.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.2 mt -63.68 -58.98 5.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.185 -1.186 . . . . 0.0 108.216 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.9 OUTLIER -46.4 -28.59 1.4 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.39 -177.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.783 HG13 HG22 ' A' ' 143' ' ' VAL . 24.2 m -101.24 34.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.592 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.2 m-20 38.74 53.05 1.93 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.321 -0.862 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.549 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.4 tpp -65.69 127.01 30.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 111.726 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -75.92 121.64 22.98 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 52.5 m-85 -103.31 117.69 35.08 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.545 1.164 . . . . 0.0 113.316 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.52 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.02 -162.55 10.75 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 104.617 -3.393 . . . . 0.0 104.617 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.658 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.45 -30.89 80.66 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 105.812 -2.418 . . . . 0.0 105.812 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.86 140.75 43.45 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 173.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.521 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.4 m -121.09 109.69 15.33 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 119.913 -1.742 . . . . 0.0 110.076 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.9 136.76 13.66 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.444 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 11.2 t -111.66 -161.69 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.569 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.89 -57.1 2.93 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.581 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.55 -134.57 7.2 Favored Glycine 0 N--CA 1.479 1.54 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.504 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.542 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -52.85 -53.26 51.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.804 -0.821 . . . . 0.0 111.89 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 140' ' ' SER . 5.2 p -45.89 -41.85 11.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.003 . . . . 0.0 109.07 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 26.3 mmt180 -81.35 -43.15 19.45 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.783 HG22 HG13 ' A' ' 127' ' ' VAL . 41.5 t -68.38 -53.88 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.634 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.1 pp0? -56.71 -34.21 67.24 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.256 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -77.82 -51.19 10.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.973 178.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -60.44 -37.1 79.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.113 -0.992 . . . . 0.0 110.049 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.4 mt -58.04 -51.55 69.21 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.482 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 29.3 mtmt -80.27 -45.78 17.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 110.182 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 86.2 mt-10 -68.32 -52.03 38.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.048 -1.033 . . . . 0.0 111.905 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -90.43 -46.55 8.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.798 -1.189 . . . . 0.0 111.935 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.476 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 29.9 m-85 -99.38 13.68 32.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.648 -1.282 . . . . 0.0 110.938 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 34.34 41.46 0.22 Allowed Glycine 0 N--CA 1.496 2.679 0 O-C-N 121.512 -0.742 . . . . 0.0 112.815 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.5 m-85 -63.14 169.94 3.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.126 -1.808 . . . . 0.0 107.883 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 30.3 t30 -47.6 136.57 10.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.72 -1.238 . . . . 0.0 109.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.16 -21.01 4.4 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.201 -0.937 . . . . 0.0 108.79 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.502 ' HB3' ' ND2' ' A' ' 154' ' ' ASN . 84.4 p -53.6 -17.44 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 109.787 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.5 t -58.42 125.17 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.969 -1.082 . . . . 0.0 109.121 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.594 ' NE2' ' CG2' ' A' ' 249' ' ' VAL . 9.3 p-80 -146.42 156.7 43.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.6 tt0 -101.74 150.35 23.22 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.872 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 246' ' ' SER . 20.3 pt -130.77 154.22 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.6 m-80 -119.2 106.16 12.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.163 . . . . 0.0 110.906 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 tpt85 -48.03 -45.03 31.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.461 -0.775 . . . . 0.0 109.765 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.92 -22.75 58.13 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 6.7 m-20 -104.75 2.03 29.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.198 -1.177 . . . . 0.0 111.7 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -117.67 175.03 5.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.498 -1.376 . . . . 0.0 110.665 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.474 ' O ' ' C ' ' A' ' 167' ' ' LYS . 1.1 p -100.46 138.19 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.3 ttmm -35.39 -49.61 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.688 -0.632 . . . . 0.0 110.629 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.418 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 38.3 mm-40 -64.15 -58.3 7.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.004 -1.06 . . . . 0.0 109.777 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.86 -20.77 65.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.455 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 68.6 t-105 -76.15 -44.69 37.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.469 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 83.1 mt-10 -73.52 -36.91 65.78 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.172 -0.955 . . . . 0.0 108.497 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.8 -44.3 49.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -61.58 -42.08 98.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 109.028 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.55 HG23 ' CD1' ' A' ' 199' ' ' ILE . 11.5 mt -75.83 -58.08 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 111.051 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.78 -54.05 21.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 0.0 109.665 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -51.03 -41.27 59.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 6.0 mm-40 -59.13 -50.53 73.7 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' A' ' 4' ' ' VAL . 15.2 mt -68.32 -25.92 65.36 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 110.099 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 10.5 p -52.43 -40.19 61.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.95 -1.094 . . . . 0.0 108.427 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 31.1 mt-30 -97.7 31.61 2.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.478 ' HB3' HD21 ' A' ' 7' ' ' LEU . 86.9 m-20 48.61 49.2 18.89 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 26.6 mt-30 -123.7 107.38 31.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.516 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.2 Cg_endo -64.05 168.9 11.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.125 1.883 . . . . 0.0 112.791 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 50.6 t -120.9 134.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.551 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.581 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.5 OUTLIER -82.56 116.02 21.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 5.7 t80 -122.25 158.16 30.09 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 120.954 -1.091 . . . . 0.0 109.355 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -167.2 128.45 1.58 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 117.881 -1.528 . . . . 0.0 111.549 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.441 ' CA ' ' ND2' ' A' ' 228' ' ' ASN . . . -92.01 115.79 4.87 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 5.3 t -80.6 169.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -173.99 -142.91 4.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.6 -28.86 21.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.157 -1.202 . . . . 0.0 110.739 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.0 -14.1 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.931 -1.106 . . . . 0.0 110.973 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.02 -171.06 21.11 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -82.8 105.82 2.69 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.878 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 15.2 t-80 -70.93 127.58 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.44 161.62 20.93 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.426 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 33.0 p90 -157.56 -171.35 3.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 55' ' ' ILE . 75.3 t -134.0 134.94 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.617 -1.302 . . . . 0.0 111.218 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.55 ' CD1' HG23 ' A' ' 174' ' ' ILE . 56.1 mt -97.66 119.25 45.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 33.9 p30 -130.62 31.9 4.48 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.564 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.65 161.72 32.39 Favored Glycine 0 N--CA 1.484 1.839 0 C-N-CA 117.254 -2.403 . . . . 0.0 112.457 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.502 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.46 145.3 32.49 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -116.57 17.69 15.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.863 -1.148 . . . . 0.0 110.328 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 1' ' ' GLN . . . 77.33 -51.26 3.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -79.7 50.69 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.067 -1.255 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 51.04 35.25 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' ASP . 0.2 OUTLIER -115.37 130.08 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.063 -1.023 . . . . 0.0 108.96 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 6.8 m-85 -122.97 156.72 34.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.476 ' HB3' ' OD1' ' A' ' 200' ' ' ASP . 61.0 t-80 -93.29 114.78 27.32 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.592 HG13 ' CD1' ' A' ' 197' ' ' PHE . 14.3 t -113.89 142.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.077 . . . . 0.0 111.797 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 30.1 t-20 -101.32 77.7 1.81 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.462 ' CD2' HG12 ' A' ' 210' ' ' VAL . 45.1 m95 -44.99 168.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.683 0.754 . . . . 0.0 110.991 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -80.58 8.69 53.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.45 ' HB2' HG12 ' A' ' 217' ' ' VAL . 96.0 m95 -107.03 -169.54 1.56 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -1.223 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.47 -90.99 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.08 66.93 0.57 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.579 ' CG2' ' N ' ' A' ' 218' ' ' SER . 1.2 p -97.79 -97.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 109.66 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.579 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 50.8 m -90.45 24.23 2.68 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.117 -0.99 . . . . 0.0 109.521 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.57 125.08 16.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 139.2 -115.28 1.1 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.044 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.482 ' HB2' ' CE1' ' A' ' 207' ' ' PHE . 7.1 p90 -60.44 137.89 58.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.309 -1.112 . . . . 0.0 109.926 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -85.88 164.58 17.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.577 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -129.24 124.24 33.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.529 -0.732 . . . . 0.0 109.077 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 170' ' ' TRP . 1.4 mm? -121.35 25.78 9.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.96 . . . . 0.0 110.486 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -60.89 2.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.871 -1.143 . . . . 0.0 109.29 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.32 -95.35 0.48 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 229' ' ' PRO . 0.7 OUTLIER -91.83 174.25 7.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 108.756 179.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 3.1 m-20 -95.24 -45.51 0.27 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 113.038 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 228' ' ' ASN . 33.1 Cg_endo -75.53 142.19 26.03 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.388 2.059 . . . . 0.0 110.7 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.56 -8.13 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.478 ' HB3' HG13 ' A' ' 217' ' ' VAL . . . -81.32 93.0 6.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.0 mt -135.77 179.3 6.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 96.33 -5.52 65.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 25.0 m -95.57 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.031 -1.276 . . . . 0.0 109.689 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.41 167.26 29.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.15 96.12 0.64 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -155.83 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.14 -56.45 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -1.171 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.74 46.83 10.59 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 68.43 75.83 0.48 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -122.43 130.91 53.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.406 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 1.3 t-20 -115.82 70.27 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -81.68 -40.81 10.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.472 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -135.04 152.9 52.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 6.4 tt0 -153.8 141.8 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.128 . . . . 0.0 109.309 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -166.75 163.29 16.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.763 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.39 165.35 27.66 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.293 1.044 . . . . 0.0 109.749 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 6.6 t -118.32 114.9 46.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.594 ' CG2' ' NE2' ' A' ' 158' ' ' HIS . 27.1 m -115.25 144.95 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 120.942 -1.099 . . . . 0.0 111.092 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 88.69 51.73 2.99 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.638 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.54 95.36 3.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -1.049 . . . . 0.0 109.971 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.65 153.92 13.28 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 108.899 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.8 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.211 1.941 . . . . 0.0 110.509 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.723 ' NE2' ' CE1' ' A' ' 208' ' ' TYR . 39.4 tt0 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.7 Cg_endo -77.71 179.04 6.89 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.283 1.988 . . . . 0.0 109.931 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 4' ' ' VAL . 53.7 t -107.06 142.93 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.391 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 63.8 t -136.34 131.1 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -76.64 172.94 12.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 108.571 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 47.2 t -77.52 103.32 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.119 -0.988 . . . . 0.0 109.158 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.663 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 30.5 mt -58.62 -50.61 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.552 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 200' ' ' ASP . 11.5 mt -55.41 -37.08 67.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.599 -1.313 . . . . 0.0 108.861 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.5 OUTLIER -67.49 -41.44 84.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 p -58.14 -14.65 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 109.278 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' CB ' HG13 ' A' ' 13' ' ' ILE . 1.1 mtpt -121.51 16.4 11.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.82 42.48 6.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 43.1 mt -87.99 110.83 21.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.196 0.998 . . . . 0.0 110.504 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 102' ' ' PRO . 55.3 m80 -134.7 97.71 3.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.5 m-30 -104.0 178.46 4.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.984 -1.073 . . . . 0.0 110.938 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 -165.43 2.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 13.9 mt-30 -124.57 -16.61 6.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.004 -1.06 . . . . 0.0 110.221 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.723 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.77 -37.25 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.305 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.771 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.53 -139.57 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.124 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.771 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.39 3.35 5.35 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 CA-C-N 122.625 1.973 . . . . 0.0 109.161 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.3 m-85 -77.79 -32.29 52.36 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.533 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 37.9 p-10 -94.46 17.8 12.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 12.2 mt -74.18 4.88 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 110.401 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD13 ' HG3' ' A' ' 114' ' ' MET . 9.2 mt -139.45 2.5 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.68 -1.262 . . . . 0.0 110.389 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.6 p -63.4 164.33 15.39 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.5 Cg_endo -70.07 137.16 33.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.731 1.621 . . . . 0.0 110.73 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 145.58 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.649 0.738 . . . . 0.0 110.085 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.759 HD13 ' HD3' ' A' ' 133' ' ' PRO . 6.5 mt -77.43 151.36 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.476 0.655 . . . . 0.0 110.354 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 39' ' ' VAL . 25.5 mt-10 -124.77 -25.44 3.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.468 -0.77 . . . . 0.0 110.779 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.6 mtpm? -117.38 177.22 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.918 -1.114 . . . . 0.0 109.917 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG23 ' CB ' ' A' ' 37' ' ' SER . 97.3 t -114.31 146.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.893 . . . . 0.0 111.536 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 22.2 tttt -86.43 129.67 52.37 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -69.1 124.32 11.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.343 1.362 . . . . 0.0 110.277 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.99 11.87 29.0 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.0 tt0 -152.32 166.51 31.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.292 -1.122 . . . . 0.0 109.606 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -175.33 0.26 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 108.748 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.486 ' CB ' HG23 ' A' ' 31' ' ' VAL . 32.4 t -87.57 138.88 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.01 -1.057 . . . . 0.0 110.332 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.719 ' CD2' ' CG ' ' A' ' 133' ' ' PRO . 18.7 m-30 -111.77 10.97 20.91 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.046 -1.034 . . . . 0.0 109.33 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' GLU . 17.6 t -61.22 119.26 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.749 -1.219 . . . . 0.0 108.726 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.9 -11.23 57.47 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 20.8 mt-30 -76.5 134.41 39.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.569 -0.959 . . . . 0.0 109.305 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.19 112.71 9.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 25' ' ' THR . . . -52.83 163.76 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -87.57 170.18 11.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.863 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.518 HG22 ' SD ' ' A' ' 120' ' ' MET . 30.3 p -82.73 -36.58 25.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 102.82 136.36 9.1 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.504 ' N ' ' NE2' ' A' ' 17' ' ' GLN . 2.1 p -54.58 -50.44 68.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.138 -1.213 . . . . 0.0 108.02 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.637 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 40.6 t -46.44 -54.86 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.15 -51.31 70.57 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.034 0.921 . . . . 0.0 109.625 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.51 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 48.0 m -62.92 -34.5 77.58 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.813 -0.554 . . . . 0.0 110.232 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.24 -39.95 86.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.575 -1.328 . . . . 0.0 108.331 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.492 ' OG1' HG23 ' A' ' 143' ' ' VAL . 61.8 m -74.41 -52.04 13.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.608 0.718 . . . . 0.0 109.993 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.06 -39.35 59.52 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.624 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.7 mt-30 -59.57 -53.1 61.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.726 -1.233 . . . . 0.0 107.86 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 198' ' ' VAL . 26.1 mt -63.24 -29.63 47.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.514 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 26.2 mtp -66.23 -42.61 88.41 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.558 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.5 tptt -67.51 -39.43 85.13 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.3 t80 -53.7 -32.5 52.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.644 -0.66 . . . . 0.0 110.245 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 80.6 m-70 -107.03 -21.26 13.06 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.261 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.599 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 81.4 m-20 44.37 53.39 6.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.2 t80 -74.11 -76.62 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.7 -0.8 . . . . 0.0 113.082 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.93 105.1 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 CA-C-N 119.071 0.704 . . . . 0.0 112.084 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.2 m-80 -69.9 -21.51 63.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.04 141.73 49.32 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.37 147.99 34.51 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.601 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.61 -48.77 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.585 -0.95 . . . . 0.0 109.94 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 28.3 tttp -151.59 140.07 20.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 109.626 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 39.1 m-20 -59.35 172.7 0.6 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.471 -0.768 . . . . 0.0 109.767 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CD1' ' OD1' ' A' ' 150' ' ' ASN . 40.7 t80 -148.0 161.03 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.446 -0.784 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 14.8 t -159.7 149.69 18.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.624 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 24.5 p90 -160.03 155.63 25.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.097 -1.002 . . . . 0.0 109.829 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 82.7 m -92.77 132.71 36.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.572 HD23 ' CD1' ' A' ' 80' ' ' PHE . 10.0 tp -44.45 147.76 0.54 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.264 -0.898 . . . . 0.0 110.77 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t -61.27 143.63 55.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.434 0.635 . . . . 0.0 110.263 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 p -68.58 -3.93 13.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.56 -2.55 35.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.538 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 19.5 t-20 -71.27 110.89 8.3 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.763 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.8 Cg_endo -91.09 20.26 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.089 2.526 . . . . 0.0 108.886 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 38' ' ' PHE . 53.7 m-85 -114.93 -22.97 9.33 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.306 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -123.54 165.47 17.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.8 m-80 -47.94 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.8 -47.16 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 111.202 175.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.72 57.63 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.394 -1.81 . . . . 0.0 107.394 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.4 tptt -110.86 108.2 17.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.536 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.553 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.81 145.16 28.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.624 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 6.0 mp -116.98 156.99 26.52 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 32.8 t80 -143.26 128.37 18.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.978 -1.076 . . . . 0.0 110.424 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.83 115.38 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.04 53.3 0.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.653 -1.279 . . . . 0.0 108.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.8 mt -52.9 -55.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.451 -0.781 . . . . 0.0 110.339 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -45.7 -26.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.475 -1.39 . . . . 0.0 109.207 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -111.25 22.4 15.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.65 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 42.8 mmt-85 -82.45 152.7 26.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.983 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.471 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.02 91.27 3.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.09 90.22 6.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 110.425 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 35.3 t-20 -80.03 90.27 5.39 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.642 ' CE3' HD12 ' A' ' 100' ' ' ILE . 51.9 m95 -61.16 -7.53 2.78 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.585 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -90.14 -18.52 25.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.6 m-20 -98.88 -30.06 12.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.642 HD12 ' CE3' ' A' ' 97' ' ' TRP . 44.1 mt -73.84 69.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 24.6 mt -47.45 150.26 1.71 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.805 -0.559 . . . . 0.0 110.108 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -80.16 -28.13 3.26 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.824 2.349 . . . . 0.0 110.735 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -135.29 121.89 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 63.0 m-85 -109.53 139.9 43.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 109.899 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 p -100.19 -7.97 24.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 -0.01 73.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -118.37 7.31 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -1.123 . . . . 0.0 109.384 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.485 ' O ' ' NZ ' ' A' ' 113' ' ' LYS . 0.5 OUTLIER -72.41 168.76 17.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.1 p -64.18 165.27 9.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.7 m-20 -71.72 -32.03 67.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -52.41 -61.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -62.31 -33.65 75.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.495 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 17.0 mttt -65.88 -44.06 86.46 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.473 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -58.74 -36.53 74.47 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.465 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.19 -67.86 0.28 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.647 -0.658 . . . . 0.0 109.584 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.624 HD13 ' CE2' ' A' ' 15' ' ' TYR . 2.2 tp -63.74 -40.7 90.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.557 ' N ' HG23 ' A' ' 116' ' ' ILE . 10.5 p -58.13 -43.38 87.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.92 -1.112 . . . . 0.0 108.841 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' OE2' ' CD ' ' A' ' 93' ' ' ARG . 50.3 tt0 -69.29 -38.0 78.1 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.556 HD22 ' CD1' ' A' ' 116' ' ' ILE . 24.6 tp -56.83 -52.37 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.581 ' HE2' ' CD2' ' A' ' 21' ' ' TYR . 1.1 mmt -57.78 -43.06 85.3 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.87 -38.61 91.56 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 6.1 m-20 -69.41 -54.85 12.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 49' ' ' ALA . 49.0 t -58.84 -62.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.37 -46.74 16.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.484 HD13 ' HB2' ' A' ' 88' ' ' ALA . 3.0 mt -63.63 -57.45 11.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 107.979 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.43 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 1.7 p -46.55 -27.33 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.81 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.521 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -104.5 31.53 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 45.7 m-20 41.75 43.52 2.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.158 -0.964 . . . . 0.0 109.747 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.517 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 35.2 tpp -60.37 134.2 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -0.778 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -76.96 123.16 25.91 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' C ' ' HB3' ' A' ' 43' ' ' ALA . 34.3 m-85 -103.47 103.92 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -142.04 -170.03 12.36 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.759 ' HD3' HD13 ' A' ' 28' ' ' ILE . 13.6 Cg_endo -62.55 -20.91 72.08 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.633 -2.103 . . . . 0.0 106.633 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.64 130.31 55.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 72.6 m -113.87 113.83 25.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 119.753 -1.842 . . . . 0.0 110.339 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.67 126.48 8.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -118.06 -170.7 1.93 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.149 -1.207 . . . . 0.0 107.8 178.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.585 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.45 -49.95 6.23 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.545 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 116.76 -111.19 2.26 Favored Glycine 0 N--CA 1.481 1.657 0 C-N-CA 119.955 -1.117 . . . . 0.0 111.751 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.502 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 6.1 m -48.46 -72.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.862 . . . . 0.0 112.317 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 11.4 p -46.61 -32.86 3.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 110.276 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.523 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 24.4 mmt180 -80.41 -49.92 10.8 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.972 -1.08 . . . . 0.0 109.787 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.676 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.9 t -68.37 -58.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.7 -0.625 . . . . 0.0 111.049 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 3.1 pp0? -56.55 -31.88 64.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.016 -1.052 . . . . 0.0 108.608 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.48 ' CB ' ' O ' ' A' ' 141' ' ' SER . 1.9 ttm-85 -77.31 -52.84 8.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.002 -1.061 . . . . 0.0 109.61 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -63.95 -37.81 88.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.0 110.053 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.51 HD13 HG11 ' A' ' 143' ' ' VAL . 34.3 mt -55.21 -47.31 75.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.549 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 50.5 mtmt -87.38 -45.17 10.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.063 -1.023 . . . . 0.0 110.887 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.96 -48.99 69.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.999 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.56 ' OD1' ' CD1' ' A' ' 69' ' ' TYR . 10.5 m120 -94.36 -45.43 7.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.676 -1.265 . . . . 0.0 111.645 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.514 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 27.4 m-85 -99.97 18.67 17.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.763 -1.21 . . . . 0.0 110.716 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 30.16 43.55 0.07 OUTLIER Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.777 -0.577 . . . . 0.0 112.857 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 7.0 m-85 -64.17 164.16 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.267 -1.725 . . . . 0.0 108.013 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 27.3 t-20 -47.99 151.4 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.843 -1.161 . . . . 0.0 109.626 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 9.0 mm100 -56.16 -17.14 6.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.066 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.593 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 22.3 p -55.17 -14.84 1.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.84 . . . . 0.0 109.852 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.549 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 39.8 t -72.66 119.61 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 156' ' ' SER . 1.0 OUTLIER -149.56 -177.7 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.596 178.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.502 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.7 tt0 -123.42 139.1 54.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.902 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 246' ' ' SER . 7.7 pt -123.91 176.2 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 1.2 m-80 -128.55 97.54 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.793 -1.192 . . . . 0.0 110.558 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.636 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.2 tpt180 -46.91 -41.15 15.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.047 -1.033 . . . . 0.0 109.327 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.72 -21.04 54.29 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 64.3 m-20 -104.04 0.25 29.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -1.228 . . . . 0.0 111.677 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.18 173.49 6.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.444 -1.41 . . . . 0.0 110.491 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 167' ' ' LYS . 18.6 p -101.33 136.51 41.05 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.522 ' HD2' ' CD1' ' A' ' 224' ' ' LEU . 15.0 ttpp -31.48 -51.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.912 -0.492 . . . . 0.0 111.228 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.65 -58.77 5.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.449 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 15.2 m-20 -62.6 -19.67 63.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.0 108.513 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.636 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 71.4 t-105 -74.95 -47.55 28.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 19.8 mt-10 -64.15 -23.98 67.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 169' ' ' ASP . . . -61.28 -43.44 98.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -60.5 -44.07 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 108.687 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.539 HG21 ' CG2' ' A' ' 184' ' ' VAL . 4.9 mt -74.24 -41.52 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 108.644 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -50.74 -51.87 45.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 109.08 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 179' ' ' SER . 13.1 tttt -51.96 -50.73 60.64 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 53.7 mm-40 -56.64 -61.25 2.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' A' ' 208' ' ' TYR . 13.1 mt -55.72 -32.36 63.27 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.183 0.516 . . . . 0.0 110.263 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.5 p -52.32 -53.23 47.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 25.5 mt-30 -88.75 44.13 1.19 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.468 ' HB3' HD21 ' A' ' 7' ' ' LEU . 2.0 m120 41.97 52.45 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 4.7 mt-30 -124.49 113.56 27.45 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.574 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.2 Cg_endo -66.34 169.14 14.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 121.743 1.629 . . . . 0.0 111.591 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 55.4 t -125.1 134.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.811 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.676 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.48 122.5 30.51 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 175.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.8 t80 -123.3 163.35 20.89 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.799 -1.188 . . . . 0.0 109.826 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -166.17 123.6 1.41 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.281 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 245' ' ' GLN . . . -93.2 124.26 7.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 177.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 244' ' ' TYR . 60.5 t -82.03 158.4 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.81 -1.406 . . . . 0.0 111.212 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.56 -137.8 2.28 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -36.33 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.65 -6.78 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.943 -1.098 . . . . 0.0 111.077 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.71 -159.78 19.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.48 114.29 4.04 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.849 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 32.3 t-80 -70.3 145.48 51.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.56 154.72 38.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 117.852 -1.539 . . . . 0.0 113.908 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.596 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 10.4 p90 -163.4 163.56 24.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.5 HG22 HG13 ' A' ' 55' ' ' ILE . 81.7 t -112.51 137.51 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.869 -1.145 . . . . 0.0 112.171 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.645 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 50.5 mt -103.74 121.03 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 19.1 p30 -126.3 16.17 7.75 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.493 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 178' ' ' LEU . . . -160.98 172.31 37.23 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 116.613 -2.708 . . . . 0.0 114.721 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.745 ' CB ' ' CE1' ' A' ' 208' ' ' TYR . . . -159.06 152.07 22.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.405 ' C ' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -126.97 28.82 5.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.416 -1.428 . . . . 0.0 109.494 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 1' ' ' GLN . . . 59.0 14.76 25.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -142.4 47.28 1.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -1.157 . . . . 0.0 108.972 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.99 19.87 2.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 108.967 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.682 ' CD1' ' CZ ' ' A' ' 222' ' ' PHE . 9.1 m-30 -102.06 92.38 4.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.745 ' CE1' ' CB ' ' A' ' 202' ' ' ALA . 3.3 m-30 -102.86 155.97 17.97 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.068 -1.02 . . . . 0.0 111.232 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.574 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.0 t60 -90.96 139.21 30.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.008 -1.682 . . . . 0.0 107.331 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 197' ' ' PHE . 19.4 t -131.09 139.62 50.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.516 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 39.3 t-20 -114.04 84.17 1.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.596 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 94.8 m95 -52.14 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -7.79 52.18 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.483 ' HB2' HG12 ' A' ' 217' ' ' VAL . 77.3 m95 -108.26 168.93 8.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -1.168 . . . . 0.0 108.908 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -127.6 4.92 7.09 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.024 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -130.42 5.72 5.93 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' A' ' 218' ' ' SER . 1.4 p -107.19 -150.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -1.204 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 15.0 m -64.91 54.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 217' ' ' VAL . 7.9 m-20 -91.29 95.12 9.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 109.814 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' VAL . . . 157.77 -53.94 0.39 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.87 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.648 ' CE2' ' CG ' ' A' ' 223' ' ' ARG . 2.1 p90 -60.05 109.21 0.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.04 -1.271 . . . . 0.0 111.297 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.682 ' CZ ' ' CD1' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -51.24 125.9 15.33 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.443 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.648 ' CG ' ' CE2' ' A' ' 221' ' ' PHE . 5.0 mmm180 -128.6 118.85 23.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 109.356 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.522 ' CD1' ' HD2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -121.33 -6.21 9.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.02 -23.53 9.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.186 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.99 89.07 3.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.259 1.028 . . . . 0.0 108.768 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.26 54.19 2.51 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.628 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -114.2 156.82 43.71 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.259 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.22 144.36 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.585 2.19 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -44.81 10.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.26 109.55 21.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mp -92.07 -65.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 109.378 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.6 -150.85 24.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -71.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -1.181 . . . . 0.0 109.394 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -95.51 25.66 23.57 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -94.92 -67.34 1.01 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.8 26.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -120.2 -35.42 3.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.45 -143.3 7.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' PHE . . . 139.26 76.92 0.06 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -54.96 -172.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -1.163 . . . . 0.0 109.27 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 1.8 t-20 -104.55 70.05 0.93 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -73.12 -46.15 28.87 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.497 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 90.1 m-85 -136.14 166.19 23.98 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.577 ' NE2' ' CG ' ' A' ' 162' ' ' ARG . 7.3 tt0 -156.96 132.43 9.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.0 109.123 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -148.83 166.76 27.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 170' ' ' TRP . . . -140.64 151.99 45.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.116 0.96 . . . . 0.0 110.057 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 84.7 t -109.15 118.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.591 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 33.5 m -127.1 144.03 38.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.164 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 91.87 55.71 1.72 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.615 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 36.4 mt -102.44 81.62 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.35 -1.088 . . . . 0.0 110.148 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -156.89 148.91 17.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.185 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.586 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.975 . . . . 0.0 110.573 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.464 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 38.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.44 163.39 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.449 2.099 . . . . 0.0 110.028 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 4' ' ' VAL . 41.3 t -95.71 142.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.101 -0.999 . . . . 0.0 109.599 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.8 t -135.48 130.54 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 200' ' ' ASP . 4.9 mmtp -75.91 -178.11 4.17 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.518 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 1.9 t -77.72 105.68 9.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.011 -1.056 . . . . 0.0 109.408 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.654 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 45.7 mt -57.4 -49.37 76.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 108.986 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 198' ' ' VAL . 10.4 mt -55.66 -41.57 73.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.807 -1.183 . . . . 0.0 108.781 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 24.5 t70 -67.4 -39.09 85.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.159 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -58.58 -14.38 8.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' CB ' HG13 ' A' ' 13' ' ' ILE . 4.1 mtpp -121.01 21.74 11.24 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.28 -0.888 . . . . 0.0 108.707 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.78 38.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 48.8 mt -86.61 109.62 19.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 122.283 1.039 . . . . 0.0 110.355 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 102' ' ' PRO . 20.1 m-70 -134.5 88.37 2.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.1 m-30 -95.0 -179.65 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.885 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.449 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 1.4 t-20 -148.54 -163.93 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.512 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 43.9 mt-30 -124.6 -23.37 4.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.076 -1.015 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.716 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -114.92 -34.67 1.47 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.308 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.771 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.21 -140.36 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.242 -178.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.771 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -74.37 3.77 4.98 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 CA-C-N 122.545 1.945 . . . . 0.0 109.694 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.543 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 8.8 m-85 -80.41 -31.46 37.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.435 -0.791 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 17.4 p-10 -92.13 15.26 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.604 -1.31 . . . . 0.0 109.103 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -69.55 -6.97 34.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.852 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.517 HD11 ' N ' ' A' ' 118' ' ' GLU . 15.9 mt -125.92 -9.24 6.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.007 . . . . 0.0 109.761 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -60.88 166.64 4.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.4 Cg_endo -70.06 145.88 56.72 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.014 1.81 . . . . 0.0 112.367 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -85.74 148.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.554 0.692 . . . . 0.0 109.808 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.65 HD13 ' HD3' ' A' ' 133' ' ' PRO . 25.4 mt -78.21 149.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.448 -0.782 . . . . 0.0 111.295 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' VAL . 92.9 mt-10 -126.17 -22.16 4.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.596 . . . . 0.0 110.468 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 30.3 mtpt -120.26 169.47 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.858 -1.151 . . . . 0.0 110.258 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 37' ' ' SER . 88.0 t -114.44 154.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' NZ ' ' CD ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -86.73 158.88 53.26 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' CD ' ' NZ ' ' A' ' 32' ' ' LYS . 32.3 Cg_endo -82.56 107.01 1.56 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.607 2.204 . . . . 0.0 110.173 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.84 51.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 7.0 tt0 -122.0 159.33 27.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -1.172 . . . . 0.0 109.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -62.35 175.53 0.74 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.169 -0.957 . . . . 0.0 109.033 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 31' ' ' VAL . 1.3 t -80.61 134.97 35.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.146 -0.972 . . . . 0.0 109.075 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 13.92 11.49 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.903 -1.123 . . . . 0.0 109.763 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 28' ' ' ILE . 58.7 t -62.99 141.07 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 109.436 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 39' ' ' VAL . . . 80.79 -2.27 80.36 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.6 mt-30 -86.92 132.84 33.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -1.188 . . . . 0.0 109.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -73.34 111.14 8.19 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.22 161.21 0.66 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.106 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.38 169.51 18.13 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.405 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.565 ' O ' ' CE ' ' A' ' 129' ' ' MET . 24.0 p -80.66 -33.84 35.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 108.469 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.05 135.87 8.01 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 14.1 p -53.69 -47.89 70.05 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 29.9 t -47.8 -57.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.372 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.78 -45.16 93.14 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 110.555 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 76.2 m -62.5 -39.24 92.86 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.64 -0.662 . . . . 0.0 110.244 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.62 80.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.489 -1.382 . . . . 0.0 108.778 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.569 ' OG1' HG22 ' A' ' 143' ' ' VAL . 60.7 m -74.71 -55.19 6.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.3 -34.91 48.88 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.643 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.4 mt-30 -63.5 -53.83 45.82 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 HG13 HG23 ' A' ' 198' ' ' VAL . 63.2 mt -63.1 -22.29 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.597 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 24.7 mtp -73.36 -37.36 66.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.568 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.4 tptt -71.19 -40.07 71.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 40.9 t80 -53.65 -31.46 47.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.653 -0.654 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.1 m-70 -107.93 -22.4 12.45 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.287 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.639 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.13 57.3 2.0 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -178.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -77.54 -71.59 0.18 Allowed Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -69.17 105.65 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 120.272 0.648 . . . . 0.0 112.171 -176.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.04 -20.35 61.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 34.0 tttt -134.28 139.8 45.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 148.4 37.4 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.411 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.79 -46.79 8.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.989 . . . . 0.0 109.822 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 38.3 tttt -151.92 140.51 20.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' SER . 10.7 m-20 -67.62 174.71 3.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.453 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 36.9 t80 -152.16 150.16 29.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.13 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.451 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.61 164.47 35.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 30.0 p90 -169.3 155.79 6.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 91.3 m -93.04 130.29 38.69 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.503 HD13 HD11 ' A' ' 86' ' ' LEU . 9.9 tp -45.37 149.97 0.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 111.057 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.421 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -61.42 137.37 58.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.694 -0.629 . . . . 0.0 109.568 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -64.44 -7.24 9.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 109.875 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 m120 -96.73 -6.03 37.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 35.2 t-20 -71.04 111.8 11.19 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 53.3 Cg_endo -88.48 12.3 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.887 2.391 . . . . 0.0 109.8 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 70.9 m-85 -107.04 -1.99 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 111.461 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 34.0 m-85 -142.35 161.91 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.572 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.3 m-80 -47.54 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 174.62 -46.47 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 111.008 174.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.94 55.98 5.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.83 103.46 12.97 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.649 -178.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -100.85 132.75 46.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.621 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -105.25 137.92 42.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 20.9 t80 -125.13 125.34 43.58 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.151 -0.968 . . . . 0.0 110.395 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.87 105.7 15.63 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.01 54.79 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 108.67 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 70.5 mt -52.71 -52.87 23.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.543 -0.723 . . . . 0.0 110.433 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 p -44.4 -25.47 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -110.56 35.75 3.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 108.565 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 23.5 mmt-85 -95.75 155.65 16.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.843 . . . . 0.0 110.735 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -118.69 91.41 3.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -81.66 88.18 6.25 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 110.951 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.501 ' O ' HG13 ' A' ' 100' ' ' ILE . 42.8 t-20 -79.66 89.63 5.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.639 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 79.1 m95 -61.27 -6.62 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.85 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 -16.14 31.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -99.9 -30.84 11.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' CE3' ' A' ' 97' ' ' TRP . 27.7 mt -73.42 67.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.492 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 12.9 mt -46.32 150.71 1.08 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.542 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.9 Cg_endo -77.45 -26.67 7.05 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.607 2.205 . . . . 0.0 110.946 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.426 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 2.1 t -138.2 125.23 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.616 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 87.2 m-85 -109.62 139.45 44.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.91 4.51 45.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 108.991 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.72 -6.86 63.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -113.52 15.94 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -1.148 . . . . 0.0 109.395 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -75.8 167.53 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.8 OUTLIER -63.18 -179.69 0.33 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -82.68 -43.94 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.54 -51.88 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.787 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.433 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -62.56 -44.43 96.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.032 -1.043 . . . . 0.0 109.084 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.8 mttt -61.93 -36.56 81.75 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.257 -0.902 . . . . 0.0 108.835 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.446 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 14.8 ttm -60.35 -45.32 93.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -58.13 -51.6 69.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 111.098 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.616 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 tp -69.35 -39.11 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.601 -1.312 . . . . 0.0 110.04 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.466 ' OG ' HD11 ' A' ' 24' ' ' LEU . 5.7 p -58.04 -41.49 83.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.098 -1.001 . . . . 0.0 110.44 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 93' ' ' ARG . 22.6 tt0 -68.86 -37.39 79.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.954 -1.091 . . . . 0.0 108.218 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 53' ' ' ALA . 6.0 tp -57.95 -51.8 68.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.554 ' SD ' HG22 ' A' ' 45' ' ' THR . 1.4 mmt -59.37 -40.62 87.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.524 -0.735 . . . . 0.0 109.465 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.23 -37.93 88.81 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -69.07 -57.43 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' ALA . 22.6 t -61.73 -48.48 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.048 -1.033 . . . . 0.0 108.835 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -54.64 -54.03 35.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.4 mt -65.91 -53.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.009 -1.289 . . . . 0.0 108.321 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 59.8 p -45.99 -32.11 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.577 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.637 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.5 m -101.39 39.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.3 m-20 37.41 50.97 1.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.565 ' CE ' ' O ' ' A' ' 45' ' ' THR . 51.2 tpp -65.98 127.45 32.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.427 -0.795 . . . . 0.0 111.602 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.6 OUTLIER -76.26 123.05 25.29 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.632 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.4 m-85 -103.94 118.77 37.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.326 1.06 . . . . 0.0 113.578 -175.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.525 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.07 -163.8 11.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 104.598 -3.401 . . . . 0.0 104.598 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.65 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.29 -30.86 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.573 -2.51 . . . . 0.0 105.573 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.88 142.03 41.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 46.4 m -122.25 113.22 19.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 119.855 -1.778 . . . . 0.0 110.157 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.47 132.49 11.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -117.84 -164.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -1.112 . . . . 0.0 108.12 178.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.86 -64.37 1.12 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.807 -1.183 . . . . 0.0 108.125 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.568 ' HA2' HG13 ' A' ' 48' ' ' VAL . . . 132.31 -130.56 5.92 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.837 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 144' ' ' GLN . 1.4 m -47.36 -55.59 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.745 -0.856 . . . . 0.0 111.531 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -45.69 21.22 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.867 -1.146 . . . . 0.0 109.269 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.637 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.6 mmp_? -80.63 -38.79 28.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.61 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.569 HG22 ' OG1' ' A' ' 52' ' ' THR . 76.2 t -67.77 -57.29 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 140' ' ' SER . 0.8 OUTLIER -56.7 -33.09 66.12 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.103 -1.039 . . . . 0.0 108.674 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 141' ' ' SER . 2.6 ttp85 -77.8 -46.45 21.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -67.14 -33.8 76.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.699 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 143' ' ' VAL . 59.1 mt -60.58 -46.5 90.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.697 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.568 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 43.5 mtmt -88.08 -38.87 15.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.784 -1.197 . . . . 0.0 110.722 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 48.3 mt-10 -72.87 -51.66 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.85 -1.156 . . . . 0.0 111.753 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.3 m120 -89.56 -41.38 12.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.884 -1.135 . . . . 0.0 111.587 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.597 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 33.4 m-85 -102.83 8.25 39.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.756 -1.215 . . . . 0.0 110.834 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.526 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 39.38 40.92 1.44 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 121.172 -0.955 . . . . 0.0 112.122 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.13 168.9 3.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.385 -1.656 . . . . 0.0 108.318 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.4 t30 -47.82 142.39 4.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.097 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.43 -20.91 5.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.923 . . . . 0.0 108.956 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.494 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 79.0 p -56.49 -14.46 3.09 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 109.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 7.0 t -61.82 122.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 0.0 109.586 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 12.1 p-80 -148.55 159.19 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.709 -0.797 . . . . 0.0 109.202 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 144' ' ' GLN . 2.3 tt0 -102.79 145.38 29.84 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.635 ' CD1' ' CH2' ' A' ' 170' ' ' TRP . 3.4 pt -121.77 154.4 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -121.53 99.51 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.874 -1.141 . . . . 0.0 110.646 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.629 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 1.1 tpt180 -46.29 -38.86 9.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.35 -24.26 61.16 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -104.52 1.54 29.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.243 . . . . 0.0 111.857 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -117.77 179.7 4.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.4 -1.437 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 167' ' ' LYS . 60.6 p -104.85 136.64 43.97 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.487 ' HD2' ' NE2' ' A' ' 168' ' ' GLN . 21.7 ttmt -34.35 -47.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.74 -0.6 . . . . 0.0 110.825 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.487 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 49.1 mm-40 -64.97 -59.5 4.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.117 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.51 -16.25 60.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.28 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 160' ' ' ILE . 50.8 t-105 -71.01 -47.97 55.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.486 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 33.8 mt-10 -67.1 -38.01 84.92 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -44.67 -49.59 10.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 23.4 mm100 -61.1 -42.02 97.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 108.725 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 199' ' ' ILE . 96.6 mt -71.71 -63.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 0.0 111.381 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.5 OUTLIER -48.11 -43.3 30.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 -177.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.426 ' O ' ' OG ' ' A' ' 179' ' ' SER . 12.4 tmtt? -51.84 -43.46 63.19 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.553 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 48.8 mm-40 -59.8 -53.51 57.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.53 ' HB3' HG11 ' A' ' 4' ' ' VAL . 11.4 mt -68.38 -25.06 64.88 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.911 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 175' ' ' ASP . 28.4 p -52.24 -40.12 61.23 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.481 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 25.7 mt-30 -99.94 33.54 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 7' ' ' LEU . 12.9 m120 49.22 48.99 20.38 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 10.6 mt-30 -124.15 114.78 27.67 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.566 ' HD3' HD12 ' A' ' 7' ' ' LEU . 19.7 Cg_endo -66.67 172.14 9.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.03 1.82 . . . . 0.0 112.187 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 18.9 t -125.87 118.04 50.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 26.4 t80 -67.78 111.95 4.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.629 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 6.5 t80 -123.21 156.64 34.72 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.17 -0.956 . . . . 0.0 109.465 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -164.65 128.73 2.52 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.813 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' HA2' ' CG ' ' A' ' 245' ' ' GLN . . . -91.63 109.08 3.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.556 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.0 t -71.7 160.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.459 -1.024 . . . . 0.0 111.382 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.57 -137.8 2.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -43.32 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.05 -1.265 . . . . 0.0 111.13 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.96 -13.56 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.96 -1.087 . . . . 0.0 111.457 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.99 -165.35 24.9 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.5 108.42 3.21 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.798 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -71.48 118.34 14.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.4 160.52 15.58 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.773 1.273 . . . . 0.0 113.072 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.629 ' CE1' ' HB3' ' A' ' 186' ' ' TYR . 20.5 p90 -162.36 170.2 19.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.579 ' HB ' HD11 ' A' ' 8' ' ' LEU . 47.4 t -114.37 136.07 52.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 120.673 -1.267 . . . . 0.0 112.234 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 174' ' ' ILE . 65.7 mt -100.56 108.73 23.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.0 p30 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.68 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -172.5 161.86 33.52 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 117.142 -2.456 . . . . 0.0 112.878 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.519 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -142.73 144.54 32.71 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 207' ' ' PHE . 1.8 t0 -114.11 11.45 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.751 -1.218 . . . . 0.0 110.61 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.77 -47.28 3.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -79.33 50.42 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 109.751 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 53.01 31.67 11.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 110.096 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.1 m-85 -121.06 135.89 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 109.769 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 5.7 m-85 -123.39 164.71 18.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.599 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 0.7 OUTLIER -92.73 148.46 22.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.638 ' CG2' ' CG ' ' A' ' 222' ' ' PHE . 22.4 t -139.59 137.82 39.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.547 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 32.7 t-20 -102.02 80.58 2.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.499 ' CZ2' ' CZ ' ' A' ' 222' ' ' PHE . 1.6 m95 -45.95 170.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 109.773 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -85.76 14.69 51.12 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.479 ' CE2' ' HB3' ' A' ' 231' ' ' ALA . 99.5 m95 -107.2 -171.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.256 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.35 -95.64 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.42 69.25 0.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.52 ' CG2' ' N ' ' A' ' 218' ' ' SER . 2.1 p -105.62 -103.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.003 -1.292 . . . . 0.0 109.962 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.52 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 3.8 m -89.03 13.98 11.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.861 -1.15 . . . . 0.0 109.971 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 217' ' ' VAL . 0.5 OUTLIER -64.47 138.45 58.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.6 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 132.0 -112.21 1.15 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -59.96 139.79 57.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.183 . . . . 0.0 109.187 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.638 ' CG ' ' CG2' ' A' ' 210' ' ' VAL . 0.1 OUTLIER -123.89 -179.14 4.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.933 . . . . 0.0 110.259 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -124.67 172.6 9.14 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.461 ' HG ' ' OE2' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -120.87 -1.27 9.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.912 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.83 -26.86 3.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.025 -1.047 . . . . 0.0 109.966 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.17 88.16 2.88 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.112 0.958 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.498 HD12 ' CE2' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -91.31 77.59 5.85 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.42 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 228' ' ' ASN . 1.5 m-20 -116.77 151.25 47.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.481 -0.762 . . . . 0.0 109.587 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.83 169.63 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.771 2.314 . . . . 0.0 110.512 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.438 ' CB ' HG23 ' A' ' 217' ' ' VAL . 6.3 m -85.61 -60.26 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.479 ' HB3' ' CE2' ' A' ' 214' ' ' TRP . . . -92.44 119.15 31.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.449 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 4.8 mp -112.37 -55.26 2.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 109.835 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 64.5 173.88 3.56 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 235' ' ' GLY . 46.2 p -109.06 -73.2 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.465 ' N ' ' OG1' ' A' ' 234' ' ' THR . . . -96.42 44.33 2.0 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.28 -40.52 1.5 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 238' ' ' ALA . . . 160.89 -108.86 0.37 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 237' ' ' GLY . . . -55.95 -169.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -1.177 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 232' ' ' LEU . . . 96.59 102.48 2.05 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -161.24 -146.79 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.01 -172.4 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.451 ' ND2' ' C ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -104.81 77.52 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.445 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.0 4.86 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.516 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 65.3 m-85 -136.18 113.82 11.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.48 -1.012 . . . . 0.0 109.368 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 4.7 mt-30 -95.3 120.93 36.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.401 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 34.5 p -131.1 155.53 46.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.381 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -141.11 162.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.831 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 16.3 t -116.16 110.32 31.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 15.4 m -107.75 146.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 121.379 -0.826 . . . . 0.0 110.943 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 84.42 42.42 7.42 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 54.0 mt -89.58 86.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.536 -0.979 . . . . 0.0 110.362 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.51 156.37 17.89 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.604 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.378 2.052 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.463 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 34.0 tt0 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 34.9 Cg_endo -76.81 153.8 33.68 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.332 2.021 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 4' ' ' VAL . 38.9 t -93.03 140.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 178' ' ' LEU . 78.0 t -140.66 129.67 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.848 . . . . 0.0 109.002 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 200' ' ' ASP . 11.4 mmtp -75.8 -177.18 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 108.947 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 209' ' ' HIS . 66.3 m -77.72 103.08 7.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.647 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.696 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 36.3 mt -57.97 -51.62 68.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 109.483 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 200' ' ' ASP . 9.0 mt -55.55 -39.32 70.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.746 -1.221 . . . . 0.0 109.021 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -67.33 -37.63 83.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -58.43 -14.49 7.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mtpt -121.08 18.93 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 108.846 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.95 39.74 5.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' CG ' ' A' ' 57' ' ' LYS . 18.7 mt -86.14 111.42 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.423 -1.045 . . . . 0.0 110.36 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 42.4 m80 -135.23 87.48 2.33 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.619 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.2 m-30 -88.29 178.23 6.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.977 0.894 . . . . 0.0 110.781 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.73 -163.77 1.85 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.474 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 53.5 mt-30 -125.01 -20.97 4.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.963 -1.086 . . . . 0.0 111.061 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.14 -36.28 1.24 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.22 -1.467 . . . . 0.0 111.666 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.777 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.35 -140.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.492 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.016 -177.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.777 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.2 Cg_endo -73.85 2.84 5.52 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 CA-C-N 122.538 1.942 . . . . 0.0 109.753 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.566 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 9.1 m-85 -78.26 -31.52 49.13 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.024 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 24.6 p-10 -92.36 15.71 13.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.584 -1.323 . . . . 0.0 109.463 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 113' ' ' LYS . 11.4 mt -70.38 -3.72 18.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 HD13 ' CA ' ' A' ' 118' ' ' GLU . 14.7 mt -129.27 -6.36 4.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 109.988 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.9 p -61.58 165.47 7.28 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.617 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.1 Cg_endo -69.16 145.65 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.058 1.839 . . . . 0.0 112.041 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.25 147.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.73 0.776 . . . . 0.0 110.396 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.653 HD13 ' HD3' ' A' ' 133' ' ' PRO . 22.6 mt -78.02 149.68 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.683 0.754 . . . . 0.0 111.396 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 39' ' ' VAL . 2.2 mt-10 -126.06 -20.83 4.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 110.573 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -121.25 168.13 11.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 110.15 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 37' ' ' SER . 84.9 t -114.27 146.42 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 111.119 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -75.55 160.47 79.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.573 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.6 Cg_endo -81.77 123.2 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.427 2.085 . . . . 0.0 110.703 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.47 88.57 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -117.08 168.58 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.497 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -69.69 -177.84 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.159 -0.963 . . . . 0.0 108.987 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.469 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -87.02 133.21 33.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.561 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 74.7 m-85 -118.54 13.07 13.37 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.451 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 28' ' ' ILE . 77.2 t -63.35 142.52 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 109.367 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 39' ' ' VAL . . . 79.43 -1.26 77.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.455 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 3.0 mt-30 -87.92 131.72 34.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 25' ' ' THR . 4.5 m-70 -73.55 111.69 8.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -51.93 161.42 0.57 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.08 -1.013 . . . . 0.0 109.329 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.53 170.88 15.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.564 0.697 . . . . 0.0 109.866 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.555 HG22 ' SD ' ' A' ' 120' ' ' MET . 28.2 p -81.2 -34.31 32.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 108.646 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 103.75 137.82 9.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 51' ' ' ALA . 4.3 p -55.14 -52.56 62.89 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -1.086 . . . . 0.0 108.172 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.55 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 55.3 t -46.8 -51.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -61.43 -51.53 68.35 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.501 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 m -63.19 -30.96 72.01 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.705 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.53 -42.23 83.07 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.733 -1.23 . . . . 0.0 107.836 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 56' ' ' MET . 55.8 m -74.76 -53.03 9.94 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.494 0.664 . . . . 0.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.29 -35.4 37.42 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.501 -0.749 . . . . 0.0 109.646 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.587 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.5 mt-30 -64.32 -53.99 40.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.514 HG13 HG22 ' A' ' 198' ' ' VAL . 36.7 mt -60.88 -24.45 32.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.581 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 29.7 mtp -72.72 -31.68 65.15 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CG ' HG12 ' A' ' 13' ' ' ILE . 41.3 tptt -73.69 -47.07 42.39 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 41.8 t80 -52.95 -29.98 32.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.727 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 50.4 m-70 -107.32 -24.44 11.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.755 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.609 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 86.1 m-20 44.83 56.17 5.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.8 t80 -79.77 -76.08 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.8 Cg_endo -70.24 105.16 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 119.258 0.771 . . . . 0.0 111.837 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.6 OUTLIER -72.0 -20.75 61.67 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.0 tttt -133.95 138.6 45.57 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.82 152.71 26.89 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.164 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.643 HD12 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mt -94.95 -59.84 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.431 -1.041 . . . . 0.0 110.492 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 14.1 tttm -134.11 151.36 51.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 21.6 m-20 -74.45 172.56 11.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.829 . . . . 0.0 109.499 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 70' ' ' THR . 28.9 t80 -147.48 153.82 40.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.582 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -157.37 149.68 22.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.095 -1.003 . . . . 0.0 110.097 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.656 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 26.9 p90 -156.44 157.05 34.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.583 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.3 m -93.35 134.95 35.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.516 HD21 ' CG ' ' A' ' 77' ' ' ASN . 9.9 tp -52.78 149.99 5.71 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 111.136 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.78 138.26 58.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.729 -0.607 . . . . 0.0 109.596 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -6.08 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 6.8 m-20 -96.2 -7.26 36.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.164 -0.96 . . . . 0.0 109.575 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 32.3 t-20 -70.25 111.54 9.67 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 109.82 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.641 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 50.3 Cg_endo -88.19 12.68 2.77 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.973 2.449 . . . . 0.0 109.996 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.641 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.0 m-85 -105.18 -11.86 16.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.69 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 4.3 m-85 -134.76 163.19 30.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.3 m120 -47.48 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.25 -46.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 111.039 175.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.5 Cg_endo -76.69 56.72 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.99 102.51 11.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.63 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.86 128.85 46.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.656 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -102.06 129.1 48.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 11.2 t80 -121.78 126.91 49.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.92 . . . . 0.0 110.047 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -107.55 116.05 31.24 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.86 51.26 0.62 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.854 -1.154 . . . . 0.0 108.314 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 25.8 mt -52.09 -44.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 O-C-N 121.259 -0.901 . . . . 0.0 109.579 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 4.7 p -45.62 -26.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.649 -1.282 . . . . 0.0 108.76 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -112.51 34.51 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.411 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.646 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 2.2 mmt-85 -93.0 151.5 19.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 110.336 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.462 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.2 94.51 4.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.7 m-85 -81.55 93.04 6.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.472 -0.768 . . . . 0.0 110.408 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 30.7 t-20 -79.81 90.15 5.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.609 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 65.0 m95 -61.22 -9.29 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -90.53 -15.59 30.41 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 22.9 m-20 -98.69 -34.27 10.61 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.599 HD12 ' CE3' ' A' ' 97' ' ' TRP . 34.2 mt -73.1 91.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 14.8 mt -71.06 151.62 94.85 Favored Pre-proline 0 C--N 1.29 -1.99 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.2 Cg_endo -76.58 -20.7 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.462 2.108 . . . . 0.0 110.783 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 140.4 32.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.281 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.578 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 82.8 m-85 -126.61 135.45 51.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.409 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.6 p -99.52 1.87 44.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 108.962 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.44 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -118.29 11.41 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.331 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -73.11 172.59 10.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.669 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.44 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 0.9 OUTLIER -66.83 177.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.331 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -80.85 -42.1 22.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.97 -51.76 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.44 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.458 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 20' ' ' PRO . 15.8 mttt -61.18 -37.46 83.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.12 -0.987 . . . . 0.0 109.118 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.437 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.2 ttm -59.62 -45.24 92.56 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.373 -0.829 . . . . 0.0 110.028 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.31 70.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.857 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 3.6 tp -69.78 -43.5 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.549 -1.344 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.467 ' OG ' HD11 ' A' ' 24' ' ' LEU . 4.7 p -54.33 -40.36 67.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CA ' HD13 ' A' ' 24' ' ' LEU . 19.6 tt0 -70.46 -43.28 70.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 53' ' ' ALA . 7.1 tp -54.04 -51.48 63.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.566 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.7 mmt -60.16 -44.22 95.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.598 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.57 -41.82 96.03 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -65.37 -52.54 52.93 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' ALA . 78.6 t -61.18 -61.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.74 -50.99 13.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.8 mt -63.65 -55.45 22.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.319 . . . . 0.0 108.418 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 3.4 p -46.19 -31.3 2.36 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.515 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.592 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.2 m -102.28 40.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.156 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER 39.38 38.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.339 -0.851 . . . . 0.0 110.253 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.54 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 48.2 tpp -52.56 128.34 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 111.314 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 25.4 t0 -78.33 123.2 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.617 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 68.7 m-85 -104.5 115.81 31.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 113.579 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.509 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -150.73 -163.82 11.55 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 104.482 -3.447 . . . . 0.0 104.482 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.653 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.34 -29.47 79.71 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 105.589 -2.504 . . . . 0.0 105.589 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -110.47 137.7 47.82 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 50.5 m -116.64 108.7 16.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 119.872 -1.768 . . . . 0.0 109.977 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.1 136.22 13.24 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.54 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 14.6 t -118.56 -163.41 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 108.8 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.29 -55.55 3.38 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.543 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 126.99 -123.78 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.758 -1.21 . . . . 0.0 111.934 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 10.7 m -48.38 -65.39 0.57 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.817 -0.814 . . . . 0.0 112.458 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -46.52 -34.27 4.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.931 -1.106 . . . . 0.0 109.402 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 29.6 mmt180 -80.12 -49.74 11.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.876 0.846 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 185' ' ' TYR . 92.9 t -68.31 -54.82 19.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.867 -0.521 . . . . 0.0 111.19 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.466 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.3 pp0? -56.68 -34.11 67.06 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.958 -1.089 . . . . 0.0 108.741 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -77.24 -47.85 19.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -66.29 -34.48 78.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 109.927 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 143' ' ' VAL . 66.0 mt -57.13 -49.0 77.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 109.607 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.557 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 58.3 mtmt -87.39 -33.69 19.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 111.116 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 69.6 mt-10 -72.23 -63.94 1.04 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.432 -1.417 . . . . 0.0 112.182 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 10.6 m120 -82.89 -37.22 24.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.581 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 22.4 m-85 -100.76 1.53 40.42 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.752 -1.217 . . . . 0.0 110.471 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.643 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 42.94 41.41 4.57 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.344 -0.848 . . . . 0.0 112.445 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.4 m-85 -61.99 164.75 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.162 -1.787 . . . . 0.0 107.598 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.0 t-20 -47.23 144.7 2.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.683 -1.261 . . . . 0.0 109.014 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 148' ' ' LYS . 7.8 tp-100 -53.02 -19.75 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.004 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.1 p -54.85 -15.17 1.75 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.301 -0.874 . . . . 0.0 110.08 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 5.5 t -65.02 121.36 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.46 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.638 ' CE1' ' CG2' ' A' ' 249' ' ' VAL . 8.9 p-80 -147.86 159.9 43.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.748 . . . . 0.0 109.164 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.3 tt0 -101.81 155.73 17.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 109.925 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.542 ' CG1' ' HB1' ' A' ' 247' ' ' ALA . 7.1 pt -135.43 143.23 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.2 m-80 -107.91 104.63 14.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.886 -1.134 . . . . 0.0 111.027 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 10.0 tpt180 -47.52 -37.15 11.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 108.857 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -64.44 -20.48 65.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 161' ' ' ASN . 6.4 m-20 -103.63 -4.09 24.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -1.231 . . . . 0.0 110.89 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -118.03 168.18 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.239 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 167' ' ' LYS . 43.4 p -97.19 136.49 37.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 166' ' ' SER . 2.1 tttt -32.69 -45.63 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.152 0.501 . . . . 0.0 110.642 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -64.47 -63.89 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.087 -1.008 . . . . 0.0 109.832 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -63.4 -14.37 49.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.29 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.2 t-105 -75.95 -47.67 24.19 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 76.9 mt-10 -70.93 -30.73 67.13 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.53 -44.27 76.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.853 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -61.25 -40.2 93.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.296 -0.877 . . . . 0.0 108.731 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.603 HG23 ' CD1' ' A' ' 199' ' ' ILE . 21.2 mt -73.35 -57.9 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.441 -0.787 . . . . 0.0 110.447 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.43 -43.5 44.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.004 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -51.65 -44.19 62.91 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.577 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.3 mm-40 -60.98 -49.0 79.22 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.555 ' HB3' HG11 ' A' ' 4' ' ' VAL . 30.1 mt -67.4 -28.48 67.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.677 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 175' ' ' ASP . 9.9 p -51.33 -42.59 61.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 108.573 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.8 mt-30 -97.37 32.67 2.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.467 ' HA ' HD21 ' A' ' 7' ' ' LEU . 81.5 m-20 48.71 49.96 18.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.3 mt-30 -123.88 116.29 27.63 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.567 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.5 Cg_endo -66.35 169.76 13.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.143 1.896 . . . . 0.0 112.461 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 57.5 t -126.53 130.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.479 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -79.39 120.18 23.46 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 176.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 7.1 t80 -123.1 159.33 28.74 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.995 -1.066 . . . . 0.0 109.766 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -166.78 125.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.776 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 245' ' ' GLN . . . -93.85 104.43 3.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 46.6 t -68.32 164.07 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 110.925 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.559 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -165.12 -141.46 3.14 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.526 -1.829 . . . . 0.0 108.526 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -30.9 20.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.076 -1.249 . . . . 0.0 110.237 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 232' ' ' LEU . 4.3 m -78.47 -22.49 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.022 -1.049 . . . . 0.0 110.495 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.11 -169.48 24.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.561 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.91 102.34 1.9 Allowed Glycine 0 N--CA 1.482 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 111.138 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.604 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.0 t-80 -71.29 128.14 34.9 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.55 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -118.82 161.79 19.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.295 -1.362 . . . . 0.0 113.195 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.703 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 13.6 p90 -159.29 167.8 28.03 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.514 HG22 HG13 ' A' ' 55' ' ' ILE . 83.5 t -114.69 136.92 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.756 -1.215 . . . . 0.0 112.236 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.603 ' CD1' HG23 ' A' ' 174' ' ' ILE . 70.7 mt -99.63 125.04 53.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 20.1 p-10 -135.05 30.0 3.36 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.458 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -176.52 165.82 36.36 Favored Glycine 0 N--CA 1.483 1.79 0 C-N-CA 117.369 -2.348 . . . . 0.0 112.226 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 207' ' ' PHE . . . -148.86 146.6 28.02 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.98 2.61 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 110.071 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 86.07 -35.84 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.098 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER -88.46 32.04 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -1.23 . . . . 0.0 110.192 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.1 OUTLIER 76.28 27.44 0.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 7.2 m-85 -118.88 133.27 55.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.186 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 221' ' ' PHE . 48.0 m-85 -122.96 165.24 17.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.375 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 6' ' ' SER . 29.1 t-80 -92.89 145.53 24.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.541 HG12 ' CE2' ' A' ' 212' ' ' TRP . 97.6 t -135.05 137.83 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.917 -1.114 . . . . 0.0 111.558 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 30.4 t-20 -111.22 68.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 98.2 m95 -46.93 164.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.808 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.38 -2.52 49.36 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.497 ' HB2' HG12 ' A' ' 217' ' ' VAL . 66.7 m95 -107.38 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -1.129 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -118.92 3.48 14.53 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.24 1.91 4.99 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 218' ' ' SER . 1.7 p -91.6 -152.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 212' ' ' TRP . 57.7 m -66.93 55.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.97 -1.082 . . . . 0.0 110.711 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 214' ' ' TRP . 0.5 OUTLIER -80.07 116.64 20.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.89 -1.131 . . . . 0.0 108.987 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 209' ' ' HIS . . . 162.5 -80.36 0.14 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.608 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 29.9 m-85 -135.11 175.42 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.261 . . . . 0.0 110.821 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.478 ' HA ' HG21 ' A' ' 210' ' ' VAL . 0.2 OUTLIER -63.92 160.62 17.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.698 . . . . 0.0 110.539 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 167.02 11.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.664 -0.648 . . . . 0.0 109.345 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.55 20.31 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 225' ' ' ASP . 0.4 OUTLIER -107.02 -80.52 0.56 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.996 -1.065 . . . . 0.0 110.157 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.498 ' HB1' HD12 ' A' ' 227' ' ' LEU . . . -123.2 -110.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 0.0 109.501 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.617 ' CD1' ' N ' ' A' ' 227' ' ' LEU . 0.0 OUTLIER -96.85 -91.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.716 -1.24 . . . . 0.0 108.786 178.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 212' ' ' TRP . 0.8 OUTLIER -100.13 158.53 31.85 Favored Pre-proline 0 C--N 1.288 -2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.48 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.567 ' HD3' ' CZ2' ' A' ' 212' ' ' TRP . 35.8 Cg_endo -77.52 -81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.648 2.232 . . . . 0.0 110.481 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.4 m -118.88 60.25 0.81 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.361 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.508 ' HB3' ' CG ' ' A' ' 195' ' ' HIS . . . -70.22 -36.41 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.431 HD23 HG23 ' A' ' 192' ' ' VAL . 1.1 mp -104.28 -9.42 18.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.44 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 66.29 -168.21 34.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.49 33.3 3.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -1.148 . . . . 0.0 109.454 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -97.3 -174.67 34.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -64.37 127.49 34.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 140.24 -173.03 23.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -63.8 173.42 1.78 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -152.87 74.58 0.25 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 96.17 14.85 43.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -67.93 128.91 38.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -1.158 . . . . 0.0 109.433 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 245' ' ' GLN . 3.6 t-20 -130.84 93.64 3.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.548 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -108.7 -40.84 1.53 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.542 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 58.6 m-85 -135.45 77.35 1.67 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -1.143 . . . . 0.0 109.717 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.511 ' HB2' ' ND2' ' A' ' 242' ' ' ASN . 25.1 tt0 -92.14 140.05 30.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.996 -1.065 . . . . 0.0 109.327 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.506 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 2.5 p -155.41 169.38 24.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.427 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.542 ' HB1' ' CG1' ' A' ' 160' ' ' ILE . . . -141.19 162.55 35.22 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.774 0.797 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 18.3 t -116.51 124.06 72.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 158' ' ' HIS . 9.2 m -123.2 139.96 48.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.85 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.45 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 92.98 51.39 2.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 37.2 mt -98.41 91.09 2.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.319 -1.107 . . . . 0.0 109.567 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.4 148.31 9.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 109.095 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.566 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.264 1.976 . . . . 0.0 110.465 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.472 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 39.5 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.7 Cg_endo -78.65 148.98 23.33 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.465 2.11 . . . . 0.0 110.144 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 4' ' ' VAL . 23.6 t -90.08 143.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.671 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.0 t -137.72 132.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 108.963 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 200' ' ' ASP . 59.8 mmtt -75.51 -177.14 3.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.071 -1.018 . . . . 0.0 108.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.592 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 4.5 t -77.53 104.25 7.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.679 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.8 mt -56.99 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.028 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 8' ' ' LEU . 14.2 mt -54.47 -43.79 72.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 108.595 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -67.55 -37.03 82.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -15.67 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 108.856 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 13' ' ' ILE . 11.8 mtpp -121.12 22.17 11.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.2 38.59 6.5 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 32.3 mt -90.86 109.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.332 -1.099 . . . . 0.0 110.138 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 102' ' ' PRO . 79.6 m80 -134.08 85.85 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.635 ' CZ ' HD13 ' A' ' 116' ' ' ILE . 9.0 m-30 -93.59 174.21 7.3 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.252 1.025 . . . . 0.0 111.614 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 25.5 t30 -148.38 -172.42 4.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.475 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 1.3 mt-30 -125.4 -0.98 7.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.867 -1.146 . . . . 0.0 110.238 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.51 -56.31 0.35 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.252 -1.452 . . . . 0.0 112.145 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.725 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.07 -126.07 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.966 -176.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.725 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 41.0 Cg_endo -79.11 6.69 4.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 CA-C-N 123.56 2.307 . . . . 0.0 109.713 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 16' ' ' ASN . 57.8 m-85 -78.18 -35.3 48.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.641 -0.662 . . . . 0.0 109.535 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 47.8 p30 -96.78 20.29 11.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.831 -1.168 . . . . 0.0 109.098 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 20' ' ' PRO . 4.9 mt -74.39 1.74 11.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 110.106 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD13 ' CA ' ' A' ' 118' ' ' GLU . 16.6 mt -134.68 0.9 3.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.829 -1.17 . . . . 0.0 110.265 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 43' ' ' ALA . 29.6 p -66.72 164.4 33.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.57 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 18.6 Cg_endo -71.8 131.08 17.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.701 1.601 . . . . 0.0 110.297 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.44 145.63 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.77 0.795 . . . . 0.0 110.429 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.754 HD13 ' HD3' ' A' ' 133' ' ' PRO . 10.3 mt -77.65 148.92 6.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.624 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.24 -22.28 4.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.104 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' TYR . 17.4 mtpp -119.39 172.85 7.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 37' ' ' SER . 88.2 t -114.17 148.91 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.376 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.6 tttt -89.29 130.81 42.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -69.89 128.79 16.41 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.29 1.327 . . . . 0.0 109.982 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.52 5.8 39.11 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.4 tt0 -148.18 171.83 15.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -1.105 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -68.22 -173.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.488 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.3 t -87.46 139.88 30.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 13.2 m-85 -116.3 9.81 14.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.796 -1.19 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' GLU . 34.1 t -60.72 117.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.728 -1.232 . . . . 0.0 108.521 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.38 -11.23 50.93 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 22.9 mt-30 -76.18 133.25 40.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.447 -1.031 . . . . 0.0 109.168 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.83 114.7 11.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -53.24 145.81 13.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -69.97 167.35 17.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.871 -1.143 . . . . 0.0 109.697 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 120' ' ' MET . 23.4 p -82.14 -33.03 29.79 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 108.511 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.71 138.62 9.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 p -55.17 -51.45 66.48 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.236 -1.155 . . . . 0.0 107.94 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 127' ' ' VAL . 23.4 t -45.11 -53.99 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.786 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.13 -55.76 30.87 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.44 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 59.3 m -63.47 -28.43 69.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.572 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -66.5 -47.99 71.25 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.219 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.554 ' OG1' HG23 ' A' ' 143' ' ' VAL . 85.8 m -75.38 -48.97 20.51 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.842 0.83 . . . . 0.0 109.864 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.83 -33.76 37.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.426 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.614 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.9 mt-30 -68.34 -50.1 55.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 251' ' ' ILE . 40.2 mt -62.95 -23.37 33.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.494 ' HG3' HG22 ' A' ' 52' ' ' THR . 20.0 mtp -73.55 -40.89 63.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 43.6 tptt -65.91 -44.48 85.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.679 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 34.8 t80 -53.39 -28.4 29.22 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 41.0 m-70 -107.65 -25.26 11.4 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.094 -1.004 . . . . 0.0 110.866 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.615 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 94.9 m-20 43.76 59.69 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.7 t80 -83.09 -78.76 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.572 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.37 108.68 2.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 CA-C-N 119.6 0.893 . . . . 0.0 112.996 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.9 -26.22 66.77 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 2.7 ttpt -130.52 130.76 44.55 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.96 164.97 5.68 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 118.487 -1.816 . . . . 0.0 110.682 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.13 -35.84 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.986 . . . . 0.0 111.188 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 8.6 tttm -152.42 131.71 12.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.73 -1.231 . . . . 0.0 110.489 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.567 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 36.5 m-20 -60.23 170.68 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.368 -0.832 . . . . 0.0 108.962 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.506 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 43.4 t80 -145.8 142.1 28.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 152.34 41.97 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.208 -0.932 . . . . 0.0 109.419 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 28.7 p90 -160.05 158.09 29.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -92.6 126.3 37.63 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 86' ' ' LEU . 12.1 tp -43.99 147.53 0.49 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.664 0.745 . . . . 0.0 110.509 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 142.79 54.93 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.527 0.68 . . . . 0.0 110.632 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.7 t -69.49 -2.97 12.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.732 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.8 m-80 -97.57 -2.17 42.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.222 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 18.9 t-20 -70.04 109.6 5.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.9 Cg_endo -90.57 19.63 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.95 2.433 . . . . 0.0 108.827 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 44.7 m-85 -117.66 -25.83 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.835 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' ASN . 88.4 m-85 -117.35 170.76 8.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.676 -1.265 . . . . 0.0 108.102 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.5 m-80 -53.96 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.47 -49.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.289 -0.882 . . . . 0.0 111.426 174.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 32.0 Cg_endo -75.92 58.51 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.328 -1.836 . . . . 0.0 107.328 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.575 ' HG3' HD12 ' A' ' 86' ' ' LEU . 18.7 tptt -105.52 121.88 44.87 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.663 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.45 116.65 33.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 0.0 110.225 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.4 mp -96.17 134.01 39.77 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 26.0 t80 -132.36 131.38 41.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.776 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -111.77 118.21 34.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.7 53.01 0.42 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.724 -1.235 . . . . 0.0 108.273 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.655 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 mt -52.88 -58.1 3.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 0.0 111.23 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.3 p -44.52 -27.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.874 -1.141 . . . . 0.0 108.84 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -112.56 30.48 7.08 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.655 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 31.0 mmt-85 -81.17 157.36 25.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.514 -1.366 . . . . 0.0 109.542 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -116.32 81.47 1.62 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 12.1 m-85 -80.96 88.3 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.485 -0.759 . . . . 0.0 110.082 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.2 t-20 -79.17 91.84 5.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.622 ' CE3' HD12 ' A' ' 100' ' ' ILE . 60.0 m95 -60.59 -7.75 2.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.823 . . . . 0.0 110.381 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 9.1 m-20 -89.37 -18.83 26.08 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 24.3 m-20 -100.35 -31.2 11.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.622 HD12 ' CE3' ' A' ' 97' ' ' TRP . 24.1 mt -74.03 65.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.532 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 47.9 mt -45.65 149.16 1.13 Allowed Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.6 Cg_endo -77.23 -20.27 12.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.013 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.7 t -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.945 -1.097 . . . . 0.0 109.414 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.54 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 96.8 m-85 -109.26 144.01 37.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.971 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -99.16 -3.4 34.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' HA3' ' ND2' ' A' ' 19' ' ' ASN . . . 81.84 3.65 90.53 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -119.22 6.69 11.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.44 -1.035 . . . . 0.0 108.836 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -174.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.451 ' OG ' ' OE1' ' A' ' 112' ' ' GLN . 3.0 p -72.27 173.57 8.47 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.229 -0.92 . . . . 0.0 108.778 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.0 m120 -78.74 -34.57 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.136 -0.977 . . . . 0.0 109.446 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.24 -61.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.818 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.451 ' OE1' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -62.2 -34.21 76.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.996 -1.065 . . . . 0.0 109.038 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 73.6 mttt -66.1 -44.27 84.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.421 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 40.2 ttm -59.53 -34.93 73.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.491 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.73 -67.89 0.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.83 -0.544 . . . . 0.0 110.752 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.635 HD13 ' CZ ' ' A' ' 15' ' ' TYR . 4.0 tp -59.43 -42.35 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.52 ' N ' HG23 ' A' ' 116' ' ' ILE . 5.7 p -53.47 -41.71 66.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.92 -1.112 . . . . 0.0 109.908 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.529 ' CA ' HD13 ' A' ' 24' ' ' LEU . 8.5 tt0 -69.31 -45.36 69.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 53' ' ' ALA . 4.6 tp -55.42 -50.03 70.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.597 ' HE1' ' CD2' ' A' ' 15' ' ' TYR . 22.7 mmt -58.26 -46.12 86.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.42 -38.46 89.97 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.529 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 20.8 m-20 -64.77 -55.68 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 49' ' ' ALA . 51.4 t -61.8 -51.36 73.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' A' ' 49' ' ' ALA . . . -50.86 -49.15 42.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 88' ' ' ALA . 2.2 mt -64.95 -60.42 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -1.103 . . . . 0.0 108.489 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.485 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -45.98 -30.5 1.83 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.494 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.731 HG13 HG22 ' A' ' 143' ' ' VAL . 32.9 m -101.26 38.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.152 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.6 m-20 35.82 54.06 0.89 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.577 0.703 . . . . 0.0 109.619 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.547 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 40.1 tpp -66.3 130.56 43.62 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 112.144 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' SER . 7.4 t0 -75.87 119.8 20.34 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.539 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 29.5 m-85 -102.34 108.82 20.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -174.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 28' ' ' ILE . . . -149.76 -169.35 15.97 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 103.956 -3.658 . . . . 0.0 103.956 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.754 ' HD3' HD13 ' A' ' 28' ' ' ILE . 14.2 Cg_endo -62.5 -21.28 72.6 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 N-CA-C 106.887 -2.005 . . . . 0.0 106.887 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.42 131.04 55.4 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.519 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 68.0 m -117.3 105.48 12.23 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 119.96 -1.713 . . . . 0.0 110.127 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -109.01 134.41 12.23 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.89 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.603 ' OG ' ' NE ' ' A' ' 142' ' ' ARG . 24.9 t -117.42 -160.86 0.79 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -1.214 . . . . 0.0 108.221 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.514 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.7 -49.82 6.26 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.695 ' O ' ' NH2' ' A' ' 142' ' ' ARG . . . 122.87 -111.72 1.79 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.448 ' HB3' ' CD ' ' A' ' 159' ' ' GLN . 0.4 OUTLIER -59.1 -54.14 50.35 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 119.22 -2.341 . . . . 0.0 114.759 -175.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 p -47.12 -32.24 4.08 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.674 -1.266 . . . . 0.0 114.091 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.78 ' CZ ' ' HB2' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -92.93 -36.28 12.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.977 -1.702 . . . . 0.0 110.58 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.731 HG22 HG13 ' A' ' 127' ' ' VAL . 84.0 t -65.32 -42.69 94.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 109.534 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.439 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 3.6 pp0? -69.27 -37.18 77.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp180 -75.31 -51.6 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 109.689 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -62.7 -38.69 91.39 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 110.322 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' HB2' HG13 ' A' ' 157' ' ' VAL . 27.6 mt -56.68 -45.05 81.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.941 -1.1 . . . . 0.0 109.203 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.563 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 32.5 mtmt -87.97 -39.0 15.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.993 -1.067 . . . . 0.0 110.791 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 71.5 mt-10 -71.61 -60.69 2.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.723 -1.235 . . . . 0.0 112.535 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.7 m120 -82.28 -44.92 15.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.73 -1.231 . . . . 0.0 111.937 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 36.4 m-85 -90.84 -14.13 32.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.656 -1.278 . . . . 0.0 110.553 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 66.63 33.25 83.88 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.208 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 10.1 m-85 -63.61 156.71 25.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.22 -1.753 . . . . 0.0 108.014 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.21 153.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.948 -1.095 . . . . 0.0 109.718 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -55.41 -16.77 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.607 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 0.7 OUTLIER -52.99 -17.56 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.185 -0.947 . . . . 0.0 109.617 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.563 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 21.8 t -70.66 121.42 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.911 -1.118 . . . . 0.0 109.405 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 156' ' ' SER . 1.5 p-80 -148.11 170.42 17.85 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.069 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.448 ' CD ' ' HB3' ' A' ' 140' ' ' SER . 3.9 tt0 -111.24 147.29 35.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.694 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 246' ' ' SER . 10.2 pt -141.51 141.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.5 m-80 -104.81 107.86 19.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.059 -1.025 . . . . 0.0 110.377 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.4 -28.94 3.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.057 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.04 -13.53 79.26 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 161' ' ' ASN . 0.7 OUTLIER -103.65 -4.63 23.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -1.134 . . . . 0.0 110.192 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -118.66 179.76 4.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.915 -1.116 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.47 ' OG ' ' OD2' ' A' ' 169' ' ' ASP . 1.8 p -107.18 141.88 37.76 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 41.2 tttp -35.39 -49.3 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.702 -0.623 . . . . 0.0 110.818 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -64.18 -57.76 8.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.946 -1.097 . . . . 0.0 110.18 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.47 ' OD2' ' OG ' ' A' ' 166' ' ' SER . 59.1 m-20 -64.03 -19.69 65.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.02 . . . . 0.0 109.463 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 63.9 t-105 -73.18 -43.11 61.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 208' ' ' TYR . 30.1 mt-10 -64.33 -33.68 76.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 108.706 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.76 81.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.426 -0.796 . . . . 0.0 109.392 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -61.03 -47.13 87.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.166 -0.959 . . . . 0.0 109.162 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.529 HG21 ' CG2' ' A' ' 184' ' ' VAL . 16.8 mt -76.06 -50.67 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.099 -1.0 . . . . 0.0 110.706 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -55.28 -53.36 57.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.129 -0.982 . . . . 0.0 108.984 -178.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -51.45 -40.29 59.14 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.597 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.9 mm-40 -61.15 -52.7 63.76 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.75 -24.31 64.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 175' ' ' ASP . 33.5 p -52.74 -38.82 61.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 181' ' ' ASN . 28.5 mt-30 -101.33 38.09 1.65 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.488 ' HB3' HD21 ' A' ' 7' ' ' LEU . 16.3 m-20 42.61 50.73 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.745 0.784 . . . . 0.0 108.938 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 7.5 mt-30 -123.51 106.43 32.59 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.505 ' HD3' HD12 ' A' ' 7' ' ' LEU . 14.9 Cg_endo -63.22 169.36 9.46 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.237 1.958 . . . . 0.0 113.086 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 40.8 t -122.8 135.15 63.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.273 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.65 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.2 OUTLIER -86.73 114.35 23.34 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.619 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 4.2 t80 -121.36 162.52 20.2 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.2 pt20 -167.35 132.95 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.952 -1.499 . . . . 0.0 111.624 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.42 110.75 4.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.612 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 94.2 t -78.2 162.59 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.334 . . . . 0.0 111.496 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.492 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -164.68 -139.77 2.72 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 2.6 mtmp? -87.86 -38.4 15.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -1.23 . . . . 0.0 110.985 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 m -76.66 -12.18 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.988 -1.07 . . . . 0.0 111.076 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.59 -172.57 21.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.14 107.95 3.22 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.516 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 8.7 t-80 -72.76 125.12 26.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -119.58 164.38 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.123 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 37.7 p90 -156.59 -158.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 55' ' ' ILE . 70.5 t -139.39 136.53 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.496 -1.377 . . . . 0.0 111.204 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 51.3 mt -102.94 112.51 36.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 23.4 p-10 -124.5 35.06 4.88 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.335 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.1 167.04 39.36 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 117.837 -2.125 . . . . 0.0 112.272 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.52 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -148.43 148.22 30.06 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.417 ' C ' HG21 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.38 22.53 12.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 109.686 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.466 ' N ' HG21 ' A' ' 3' ' ' VAL . . . 49.61 21.89 3.62 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.5 mtp180 -138.66 29.74 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -1.188 . . . . 0.0 109.108 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 11.7 m120 74.36 11.62 4.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 109.503 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.73 138.06 51.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.519 ' OH ' ' CG ' ' A' ' 171' ' ' GLU . 5.8 m-85 -123.07 168.13 12.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.054 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.592 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 51.2 t-80 -93.33 115.76 28.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.9 t -113.67 138.15 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.98 -1.075 . . . . 0.0 111.457 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 14.9 t-20 -100.28 80.92 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.557 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 3.4 m95 -46.68 167.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.442 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -87.22 30.89 4.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.411 ' CZ2' ' O ' ' A' ' 231' ' ' ALA . 70.3 m95 -119.39 -170.8 2.0 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -1.199 . . . . 0.0 109.483 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.55 -99.12 0.22 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 219' ' ' ASP . . . -126.59 52.6 0.81 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 218' ' ' SER . 7.1 p -91.78 -119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -1.159 . . . . 0.0 109.317 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 217' ' ' VAL . 3.5 m -75.46 2.06 12.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.482 -1.386 . . . . 0.0 110.16 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 28.9 p-10 -54.24 150.29 8.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 130.82 -143.83 15.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 8.5 p90 -68.84 124.17 22.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 -164.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 109.659 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.75 176.98 4.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 227' ' ' LEU . 0.5 OUTLIER -121.17 18.2 11.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.12 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -107.71 -43.52 4.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 109.747 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.38 93.38 3.93 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.143 0.973 . . . . 0.0 108.664 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 224' ' ' LEU . 3.9 mm? -91.0 85.54 5.98 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.673 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.431 ' OD1' ' HA2' ' A' ' 240' ' ' GLY . 6.9 m-20 -116.26 154.91 48.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.243 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.2 152.58 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.609 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.26 -45.57 2.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.321 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.411 ' O ' ' CZ2' ' A' ' 214' ' ' TRP . . . -81.89 104.55 12.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.382 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.94 -52.89 4.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.497 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 47.49 -102.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.09 168.59 19.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -1.165 . . . . 0.0 109.506 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -93.19 59.75 2.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -105.72 -75.99 1.02 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.38 58.59 4.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -87.43 -172.53 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -1.178 . . . . 0.0 109.574 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.71 104.94 1.76 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.431 ' HA2' ' OD1' ' A' ' 228' ' ' ASN . . . -104.77 42.78 1.81 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -122.92 -177.77 3.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 109.442 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 245' ' ' GLN . 0.8 OUTLIER -135.67 80.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.67 -58.52 4.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.556 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 29.4 m-85 -129.55 96.23 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.529 ' HB3' ' ND2' ' A' ' 242' ' ' ASN . 3.2 pt20 -91.79 138.34 31.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.981 -1.075 . . . . 0.0 108.981 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 96.9 p -167.45 161.93 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -138.92 169.07 18.46 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.694 1.235 . . . . 0.0 110.4 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 40.6 t -117.12 119.2 61.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 158' ' ' HIS . 19.7 m -125.24 145.16 33.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 156' ' ' SER . . . 101.11 52.42 1.08 Allowed Glycine 0 N--CA 1.486 1.997 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.051 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.4 mt -103.94 93.63 2.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.273 . . . . 0.0 110.421 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.2 OUTLIER -162.41 141.99 7.25 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 178.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.579 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.354 2.036 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 206' ' ' ASN . 43.7 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 36.1 Cg_endo -78.59 163.4 26.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.443 2.095 . . . . 0.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.477 HG11 ' N ' ' A' ' 4' ' ' VAL . 29.3 t -94.63 141.91 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.587 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 201' ' ' GLY . 58.7 t -132.84 131.67 59.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.436 -0.79 . . . . 0.0 109.905 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 200' ' ' ASP . 18.4 mmtt -75.37 177.84 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 108.945 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.604 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.1 OUTLIER -77.49 103.04 7.19 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.607 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.669 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 23.8 mt -58.27 -52.97 63.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 108.89 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 ' HB ' ' A' ' 198' ' ' VAL . 11.3 mt -54.96 -41.3 70.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.698 -1.251 . . . . 0.0 108.893 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.5 t70 -68.92 -41.8 77.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.063 . . . . 0.0 108.903 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 p -58.48 -15.03 9.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 108.992 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 58' ' ' TYR . 9.4 mtpp -117.08 22.0 12.84 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.39 34.01 3.3 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 25.4 mt -87.35 108.3 18.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.379 -1.071 . . . . 0.0 110.06 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' CD2' ' HB ' ' A' ' 103' ' ' THR . 23.0 m-70 -134.82 83.62 2.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.625 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -90.4 176.17 6.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.84 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.415 ' O ' HG21 ' A' ' 50' ' ' THR . 6.1 t-20 -147.22 -164.66 2.05 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.6 mt-30 -124.52 -17.7 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.337 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.734 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.31 -36.98 1.05 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.632 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.755 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.02 -142.02 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.55 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.341 -177.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -74.13 3.72 4.9 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 CA-C-N 122.394 1.891 . . . . 0.0 109.417 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 11.1 m-85 -78.86 -32.26 45.95 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.1 p-10 -92.79 23.63 4.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.595 -1.316 . . . . 0.0 109.635 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mt -77.05 -1.33 28.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.169 -0.957 . . . . 0.0 110.362 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD13 ' HG3' ' A' ' 114' ' ' MET . 10.8 mt -134.14 14.09 3.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.717 -1.239 . . . . 0.0 109.359 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 22.3 p -82.68 163.88 49.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.65 134.63 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.002 1.801 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' CE2' ' A' ' 80' ' ' PHE . 20.7 t -78.89 149.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.502 0.668 . . . . 0.0 109.738 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.67 HD13 ' HD3' ' A' ' 133' ' ' PRO . 22.1 mt -78.3 148.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.804 0.811 . . . . 0.0 111.169 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' VAL . 9.0 mm-40 -126.04 -21.2 4.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.782 -0.574 . . . . 0.0 110.235 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.428 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 10.0 mtpt -121.28 164.51 16.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.148 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 37' ' ' SER . 80.9 t -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.576 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -78.94 160.29 71.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.2 Cg_endo -82.13 114.3 2.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.583 2.189 . . . . 0.0 110.253 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.81 7.54 66.24 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -119.73 160.75 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -1.163 . . . . 0.0 109.425 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -60.98 173.09 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.496 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -83.16 132.18 35.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.457 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 64.7 m-85 -119.94 15.52 12.52 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.922 -1.111 . . . . 0.0 109.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 28' ' ' ILE . 62.3 t -63.83 137.44 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.599 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.19 -7.36 67.72 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.442 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.7 mt-30 -77.72 130.84 37.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -1.113 . . . . 0.0 109.651 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -73.15 110.0 7.1 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.15 159.9 0.85 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.141 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.61 168.3 19.97 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.599 0.714 . . . . 0.0 110.043 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.526 HG22 ' SD ' ' A' ' 120' ' ' MET . 18.0 p -78.85 -35.19 44.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 109.69 134.51 6.94 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 p -54.02 -50.49 66.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.55 HG13 ' HA2' ' A' ' 139' ' ' GLY . 47.0 t -47.05 -55.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -59.68 -48.15 82.81 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.911 0.862 . . . . 0.0 110.351 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.1 m -61.28 -38.92 88.51 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.49 -37.36 80.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.642 -1.286 . . . . 0.0 108.334 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 56' ' ' MET . 97.6 m -70.44 -56.68 6.04 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.36 -34.98 50.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.52 -0.737 . . . . 0.0 109.199 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.625 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 24.9 mt-30 -63.49 -61.95 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.493 HG13 HG23 ' A' ' 198' ' ' VAL . 46.4 mt -57.23 -30.19 34.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.515 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 25.8 mtp -63.36 -32.41 73.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.558 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 49.2 tptt -74.65 -43.38 55.62 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.669 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 39.2 t80 -51.8 -33.12 34.2 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.69 -0.631 . . . . 0.0 109.789 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 93.4 m-70 -108.71 -22.18 12.35 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 111.05 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.619 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 41.08 55.25 3.22 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -177.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -76.39 -68.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.7 Cg_endo -68.2 96.82 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.31 0.673 . . . . 0.0 111.962 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.06 -20.23 64.94 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -135.44 138.05 42.82 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 177.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.71 149.16 33.74 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.365 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.452 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -88.96 -54.35 4.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.951 . . . . 0.0 110.326 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.9 tttt -140.71 134.52 30.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.088 -1.008 . . . . 0.0 110.245 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -62.2 166.25 5.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.518 -0.738 . . . . 0.0 109.942 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 36.2 t80 -150.04 143.81 25.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.202 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.14 171.63 16.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.16 -0.963 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.617 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 27.3 p90 -173.06 158.57 3.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 109.92 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 89.0 m -93.66 137.89 32.46 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 HD11 ' A' ' 86' ' ' LEU . 9.3 tp -53.26 149.74 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.035 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 141.32 57.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.767 -0.583 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -69.08 -3.01 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t30 -99.53 -6.01 28.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.467 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 22.0 t-20 -70.12 110.87 7.54 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.867 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.4 Cg_endo -87.46 10.86 3.37 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.973 2.449 . . . . 0.0 110.216 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.642 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 56.6 m-85 -108.8 -1.71 19.06 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 111.415 -176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASN . 74.7 m-85 -141.57 160.93 39.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 9.2 m-80 -48.37 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER 174.42 -46.32 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.385 -0.822 . . . . 0.0 111.284 174.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.41 55.81 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 107.549 -1.75 . . . . 0.0 107.549 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 3.3 tptt -105.8 103.69 13.25 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.77 133.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 109.558 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.617 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -106.31 154.19 21.12 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 7.0 t80 -144.41 139.43 28.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.101 -178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.53 111.02 18.07 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.62 50.68 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.694 -1.254 . . . . 0.0 108.19 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.602 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 4.3 mt -52.81 -51.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.401 -0.812 . . . . 0.0 109.516 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.6 p -44.21 -29.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.674 -1.266 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -112.88 33.73 4.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 108.774 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.594 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.48 153.3 23.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.993 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -122.49 85.58 2.44 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-85 -80.9 95.47 6.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.272 -0.892 . . . . 0.0 109.896 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.1 m120 -78.69 92.11 4.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.619 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 50.2 m95 -60.95 -8.81 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.354 -0.841 . . . . 0.0 109.932 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -90.48 -23.51 20.95 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 8.3 m-20 -97.99 -26.62 14.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.558 ' O ' ' CE ' ' A' ' 57' ' ' LYS . 51.7 mt -74.05 64.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 59.4 mt -46.28 150.7 1.07 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.639 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -79.01 -27.12 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.496 2.131 . . . . 0.0 110.364 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.519 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -139.31 133.05 30.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.98 . . . . 0.0 109.132 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.648 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 76.9 m-85 -115.97 142.82 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.155 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.82 -4.39 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.96 10.11 84.43 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.93 -6.14 10.05 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.465 -1.02 . . . . 0.0 109.424 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HA ' ' NE ' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -63.97 169.54 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -71.07 -176.82 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.693 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 2.8 m120 -80.55 -33.84 35.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.78 -61.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -35.03 78.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.151 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.493 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.0 mttt -64.45 -43.25 94.85 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.058 -1.026 . . . . 0.0 108.308 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -59.91 -37.95 80.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 108.709 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.99 -68.26 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.501 -0.749 . . . . 0.0 109.762 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 2.2 tp -64.17 -43.72 97.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.559 -0.713 . . . . 0.0 109.679 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 24.1 p -56.63 -40.31 75.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 108.588 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.493 ' OE2' ' CZ ' ' A' ' 93' ' ' ARG . 6.3 tt0 -70.65 -40.79 72.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.553 HD22 ' CD1' ' A' ' 116' ' ' ILE . 24.2 tp -55.48 -50.54 69.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.546 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 1.2 mmt -60.01 -52.11 66.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.898 -0.501 . . . . 0.0 111.531 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.65 95.33 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 118' ' ' GLU . 6.8 m-20 -65.62 -49.43 68.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 49' ' ' ALA . 48.5 t -61.1 -60.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 108.953 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 127' ' ' VAL . . . -46.6 -44.37 16.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.44 -53.39 32.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.023 -1.281 . . . . 0.0 107.676 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 p -47.43 -32.44 5.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.39 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.6 m -101.49 36.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.005 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 127' ' ' VAL . 11.1 m-20 40.1 53.27 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.398 -0.814 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.539 ' HE3' ' CB ' ' A' ' 137' ' ' SER . 48.6 tpp -67.59 137.68 55.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 111.899 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 5.9 t0 -87.32 123.82 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.612 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 83.8 m-85 -104.7 120.57 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.482 1.134 . . . . 0.0 113.824 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.95 -162.44 10.82 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 104.69 -3.364 . . . . 0.0 104.69 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.67 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.16 -31.59 82.87 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 N-CA-C 105.648 -2.482 . . . . 0.0 105.648 175.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.9 m -110.23 143.04 40.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 173.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.509 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.8 m -121.33 110.92 16.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 119.87 -1.769 . . . . 0.0 110.087 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.86 137.94 14.32 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.455 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -117.26 -163.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 107.954 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.631 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.92 -56.22 3.26 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.567 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 125.88 -123.53 4.89 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.499 -1.334 . . . . 0.0 112.009 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.2 m -48.55 -65.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.797 -0.825 . . . . 0.0 112.602 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.48 -32.03 3.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.789 -1.194 . . . . 0.0 109.293 -178.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 53.2 mmt-85 -80.86 -51.25 8.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.973 0.892 . . . . 0.0 109.212 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' A' ' 185' ' ' TYR . 82.7 t -66.9 -54.84 21.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.809 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 2.4 pp0? -57.34 -34.35 68.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.955 -1.091 . . . . 0.0 108.749 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.523 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 6.0 ttm180 -78.4 -53.56 7.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.012 -1.055 . . . . 0.0 109.433 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -61.1 -37.27 82.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.21 -0.931 . . . . 0.0 110.223 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 143' ' ' VAL . 38.1 mt -58.47 -46.09 87.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.952 -1.092 . . . . 0.0 109.377 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.552 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 59.5 mtmt -87.72 -49.24 7.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.104 . . . . 0.0 110.981 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.523 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 34.2 mt-10 -67.07 -43.01 83.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.679 -1.263 . . . . 0.0 111.566 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 31.9 m120 -94.4 -49.7 5.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.681 -1.262 . . . . 0.0 111.485 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.515 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 29.6 m-85 -99.42 20.33 13.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.874 -1.141 . . . . 0.0 110.598 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 30.66 40.64 0.05 OUTLIER Glycine 0 N--CA 1.497 2.767 0 O-C-N 121.862 -0.524 . . . . 0.0 112.62 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.9 m-85 -62.88 158.84 18.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.142 -1.799 . . . . 0.0 107.564 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 61.7 t30 -47.17 154.35 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.741 -1.224 . . . . 0.0 109.533 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -56.05 -16.52 5.1 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.6 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 3.6 p -53.02 -17.35 1.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 40.5 t -72.67 119.61 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.866 -1.146 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.605 ' CD2' HG22 ' A' ' 249' ' ' VAL . 0.6 OUTLIER -148.19 166.81 26.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.191 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.533 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -112.68 137.03 51.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.953 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.578 HG13 ' CH2' ' A' ' 170' ' ' TRP . 14.7 pt -122.62 170.34 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 1.3 m-80 -127.53 103.46 7.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.683 -1.261 . . . . 0.0 110.509 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.6 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.44 -39.45 15.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.86 . . . . 0.0 109.226 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.08 -26.91 64.1 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -104.8 4.57 32.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.057 -1.26 . . . . 0.0 112.274 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.47 163.81 15.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.2 -1.562 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.7 ttpt -29.36 -51.49 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.21 -60.67 2.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.895 -1.128 . . . . 0.0 110.775 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.47 -18.24 58.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 109.571 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.6 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 71.3 t-105 -74.73 -50.89 15.8 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 46.1 mt-10 -69.99 -36.1 74.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -45.75 -41.65 10.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -60.62 -43.65 97.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 199' ' ' ILE . 14.7 mt -68.6 -53.91 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.27 -49.17 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.138 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' A' ' 179' ' ' SER . 6.3 tttt -51.52 -45.26 62.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.912 -1.118 . . . . 0.0 108.611 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.559 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 19.9 mm-40 -60.53 -52.32 65.68 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.902 . . . . 0.0 108.946 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 199' ' ' ILE . 93.5 mt -65.15 -26.76 68.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.779 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.475 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 22.3 p -51.89 -39.99 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.505 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.499 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 19.6 mt-30 -102.32 35.08 2.52 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 7' ' ' LEU . 16.2 m120 47.82 50.43 15.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 16.7 mt-30 -123.04 105.04 34.92 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 199' ' ' ILE . 18.7 Cg_endo -62.62 168.85 9.32 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 121.602 1.535 . . . . 0.0 111.869 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.553 HG12 HD12 ' A' ' 199' ' ' ILE . 2.4 t -129.84 138.18 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.097 0.951 . . . . 0.0 110.79 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.687 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.1 OUTLIER -86.83 123.34 31.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -123.73 161.45 25.14 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -166.45 129.54 1.95 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 117.666 -1.614 . . . . 0.0 111.115 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.19 122.37 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.527 HG22 ' NE2' ' A' ' 187' ' ' GLN . 5.1 t -85.73 168.84 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.152 -1.205 . . . . 0.0 111.117 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -176.41 -142.82 4.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 4.8 mtmm -87.73 -36.49 17.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.07 -1.253 . . . . 0.0 110.624 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.4 m -75.03 -17.76 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.153 -0.967 . . . . 0.0 110.928 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.17 -170.17 22.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.55 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -89.85 107.38 3.42 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.753 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.2 t-80 -72.46 134.92 45.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.64 162.71 20.22 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.609 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 18.3 p90 -157.13 172.3 18.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.603 ' HB ' HD11 ' A' ' 8' ' ' LEU . 87.5 t -113.29 140.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.736 -1.228 . . . . 0.0 112.752 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 209' ' ' HIS . 36.2 mt -98.16 130.44 46.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 7.5 p-10 -150.81 37.45 0.65 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.926 -1.51 . . . . 0.0 111.494 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 4' ' ' VAL . . . 174.92 -179.46 46.2 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 120.267 -1.52 . . . . 0.0 110.464 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.638 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.4 150.9 7.72 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -1.209 . . . . 0.0 109.661 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.456 ' C ' HG21 ' A' ' 3' ' ' VAL . 13.8 m-20 -111.28 27.52 9.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.07 . . . . 0.0 109.897 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 1' ' ' GLN . . . 49.94 22.34 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.68 44.6 2.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -1.193 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.483 ' N ' ' OE1' ' A' ' 1' ' ' GLN . 0.5 OUTLIER 63.67 22.36 13.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.598 ' HA ' ' CE1' ' A' ' 222' ' ' PHE . 5.2 m-85 -121.59 136.69 54.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.509 ' HB3' HG21 ' A' ' 199' ' ' ILE . 28.2 m-85 -121.29 167.64 12.51 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 2.1 t60 -91.55 135.52 33.8 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.089 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 197' ' ' PHE . 49.9 t -123.62 136.18 60.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.204 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.515 ' ND2' HD13 ' A' ' 8' ' ' LEU . 19.6 t-20 -112.91 78.87 1.17 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 229' ' ' PRO . 84.5 m95 -46.33 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -86.08 25.49 6.86 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 230' ' ' SER . 18.0 m95 -108.42 -165.32 1.02 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -1.162 . . . . 0.0 109.779 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -85.32 -81.38 1.1 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.17 45.66 1.12 Allowed Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.091 -1.241 . . . . 0.0 110.027 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 218' ' ' SER . 13.8 p -81.2 -128.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.073 -1.251 . . . . 0.0 109.01 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.529 ' O ' ' NE1' ' A' ' 212' ' ' TRP . 36.7 m -70.99 56.56 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.27 -1.518 . . . . 0.0 109.977 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.95 109.35 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.61 ' HA2' ' CE1' ' A' ' 209' ' ' HIS . . . 151.14 -65.81 0.36 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -94.54 149.08 21.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.865 -1.373 . . . . 0.0 110.057 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -99.47 164.68 11.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.183 -0.948 . . . . 0.0 109.678 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.68 151.52 46.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 224' ' ' LEU . 0.2 OUTLIER -110.01 -38.54 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.136 -0.978 . . . . 0.0 109.807 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -94.41 -3.1 50.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.34 86.34 2.56 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.035 0.922 . . . . 0.0 109.368 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.465 HD21 ' OE1' ' A' ' 245' ' ' GLN . 0.6 OUTLIER -89.72 -6.44 56.06 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.351 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -107.55 105.15 55.3 Favored Pre-proline 0 C--N 1.294 -1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 109.15 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.581 ' HG3' ' CE3' ' A' ' 212' ' ' TRP . 36.2 Cg_endo -77.1 -165.46 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.428 2.085 . . . . 0.0 110.442 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.532 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 0.4 OUTLIER -88.42 57.87 4.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.425 ' HB3' ' CD2' ' A' ' 195' ' ' HIS . . . -69.42 -44.72 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 109.696 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 231' ' ' ALA . 6.1 mt -45.46 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.24 -146.73 16.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 t -79.75 1.22 27.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.356 -1.085 . . . . 0.0 109.748 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.96 -155.44 32.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.405 ' O ' HD22 ' A' ' 232' ' ' LEU . . . -119.37 -158.04 10.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 152.02 143.55 3.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.44 -18.96 65.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.19 . . . . 0.0 109.282 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 126.96 -161.58 21.2 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -172.0 57.03 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -57.43 -169.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.169 . . . . 0.0 109.364 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 245' ' ' GLN . 1.5 t-20 -101.06 68.35 1.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.9 . . . . 0.0 109.175 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -71.8 -49.63 22.51 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.49 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 16.4 m-85 -136.01 162.79 31.89 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -1.018 . . . . 0.0 108.986 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.523 ' OE1' ' ND2' ' A' ' 242' ' ' ASN . 38.6 mt-30 -155.07 136.21 13.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.985 . . . . 0.0 108.681 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 77.2 p -148.72 158.72 44.34 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.207 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.442 ' HB3' ' CH2' ' A' ' 170' ' ' TRP . . . -131.11 151.11 51.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.886 0.851 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 75.8 t -116.54 116.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.605 HG22 ' CD2' ' A' ' 158' ' ' HIS . 18.7 m -124.15 143.05 38.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.741 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.81 56.89 1.57 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.627 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.68 79.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 110.565 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 13.8 pttm -159.58 155.96 24.05 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.9 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.274 1.982 . . . . 0.0 110.439 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.21 148.65 21.53 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.453 2.102 . . . . 0.0 110.416 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 4' ' ' VAL . 45.1 t -80.36 140.06 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.97 . . . . 0.0 108.999 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.758 HG13 ' HA2' ' A' ' 201' ' ' GLY . 29.0 t -133.87 130.84 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 110.757 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -77.03 175.72 9.33 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.581 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 11.2 t -77.12 111.28 12.56 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.971 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 52.5 mt -58.41 -50.77 72.48 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 13' ' ' ILE . 10.0 mt -56.3 -34.32 66.38 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.964 -1.085 . . . . 0.0 108.339 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 26.5 t0 -66.87 -41.16 87.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 0.0 109.274 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 82.8 p -58.1 -16.06 11.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.095 . . . . 0.0 108.593 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 13' ' ' ILE . 16.7 mtpt -122.41 19.75 10.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 41.84 42.5 3.88 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 11.6 mt -86.8 100.69 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.293 -1.122 . . . . 0.0 110.677 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.5 m-70 -128.05 75.32 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 13.5 m-30 -81.18 170.01 16.66 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.283 1.04 . . . . 0.0 111.851 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.77 -174.91 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 47' ' ' SER . 6.3 mt-30 -125.08 18.36 8.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.816 -1.178 . . . . 0.0 110.056 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 22' ' ' ASN . . . -116.74 -87.14 1.28 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.319 -1.419 . . . . 0.0 113.474 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.848 ' ND2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -46.38 -103.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 116.658 -1.639 . . . . 0.0 113.945 -175.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.848 ' HD2' ' ND2' ' A' ' 19' ' ' ASN . 51.9 Cg_endo -83.95 5.58 6.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 123.332 2.226 . . . . 0.0 112.486 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.447 ' CD1' HG12 ' A' ' 116' ' ' ILE . 83.1 m-85 -87.05 -31.97 20.24 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 120.94 -1.1 . . . . 0.0 110.118 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 38.2 p-10 -101.66 27.95 5.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 109.725 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 9.0 mt -76.03 -4.49 41.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD21 ' HA ' ' A' ' 24' ' ' LEU . 12.2 mt -131.19 21.7 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.8 -1.188 . . . . 0.0 109.264 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.538 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.3 p -89.68 164.31 29.62 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.97 136.46 35.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.248 1.965 . . . . 0.0 112.048 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.08 148.7 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.663 0.744 . . . . 0.0 110.123 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD13 ' HD3' ' A' ' 133' ' ' PRO . 23.8 mt -78.78 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.646 0.736 . . . . 0.0 111.392 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' VAL . 2.6 mt-10 -126.54 -20.38 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.776 -0.578 . . . . 0.0 110.458 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HB2' ' CA ' ' A' ' 79' ' ' TYR . 12.4 mtpp -117.65 168.07 10.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.93 -1.106 . . . . 0.0 110.663 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.5 t -114.43 147.09 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.595 -0.691 . . . . 0.0 110.335 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.567 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -79.97 157.96 73.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.567 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 32.7 Cg_endo -82.38 113.58 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.537 2.158 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 4.67 58.66 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 2.2 tt0 -125.2 160.45 29.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.137 -1.214 . . . . 0.0 109.591 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -61.08 -179.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.1 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -86.79 139.65 30.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.9 m-85 -122.4 16.0 10.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.012 -1.055 . . . . 0.0 109.45 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 28' ' ' ILE . 60.5 t -64.03 139.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.932 . . . . 0.0 109.554 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 2.18 89.3 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 21.8 mt-30 -89.02 130.29 35.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -1.165 . . . . 0.0 109.511 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.01 110.14 7.07 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.17 159.01 1.0 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.031 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' OG ' ' A' ' 135' ' ' SER . . . -77.52 166.27 23.28 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.498 0.666 . . . . 0.0 110.085 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.542 ' O ' ' CE ' ' A' ' 129' ' ' MET . 13.2 p -78.89 -30.15 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 100.96 137.19 9.67 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.522 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 7.8 p -55.58 -48.53 74.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.317 -1.107 . . . . 0.0 108.188 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 127' ' ' VAL . 3.3 t -46.43 -52.84 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . . . -61.52 -50.73 71.54 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.685 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 16.9 m -64.83 -28.43 69.55 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.487 -0.758 . . . . 0.0 109.811 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -66.41 -45.15 80.91 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.127 -1.429 . . . . 0.0 107.791 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.569 ' OG1' HG23 ' A' ' 143' ' ' VAL . 33.3 m -76.13 -49.74 16.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.683 0.754 . . . . 0.0 110.281 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -51.13 -34.49 31.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.391 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.5 mt-30 -67.18 -52.54 40.13 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' CG2' HD13 ' A' ' 251' ' ' ILE . 29.9 mt -61.24 -25.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.577 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 15.1 mtp -70.5 -36.02 73.57 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.575 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.1 tptt -76.11 -40.87 51.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.63 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 52.7 t80 -53.93 -25.56 21.05 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.015 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.1 m-70 -108.09 -28.0 9.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 110.529 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.616 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.5 m-20 47.88 61.75 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -84.67 -78.9 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.0 Cg_endo -71.49 107.47 2.17 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.815 0.97 . . . . 0.0 113.25 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 -24.85 65.65 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 3.5 ttpt -130.12 128.34 41.62 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.56 164.05 5.71 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.463 -1.827 . . . . 0.0 110.397 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.564 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -96.59 -35.36 11.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -1.063 . . . . 0.0 111.285 -179.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.1 tttt -152.67 134.14 14.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.607 -1.308 . . . . 0.0 110.402 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 7.7 m-20 -64.08 172.98 2.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.434 -0.791 . . . . 0.0 109.424 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 27.6 t80 -153.94 147.2 24.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -150.32 169.75 20.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.778 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 28.0 p90 -169.59 157.13 6.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 m -93.01 133.88 35.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 HD21 ' CG ' ' A' ' 77' ' ' ASN . 8.9 tp -50.57 149.56 3.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 111.21 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.43 140.65 58.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.932 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.84 -4.15 11.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.954 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 t30 -99.13 -5.88 29.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.021 -1.049 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 23.5 t-20 -70.17 110.33 6.55 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.733 -0.605 . . . . 0.0 110.208 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.648 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 48.7 Cg_endo -88.61 13.59 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.81 2.34 . . . . 0.0 109.619 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.648 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.1 m-85 -107.89 -4.8 17.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 111.363 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 81' ' ' ASN . 35.3 m-85 -142.24 164.15 30.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.6 m120 -49.23 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 173.74 -47.18 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.976 175.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.62 56.31 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 6.4 tptt -106.06 105.8 16.01 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.342 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.05 139.35 35.84 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -112.07 137.53 49.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 61.5 t80 -125.13 132.24 53.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.593 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -112.75 114.13 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 92' ' ' THR . . . -73.62 50.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.85 -1.156 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.638 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.9 mt -53.47 -57.33 5.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.551 -0.718 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.2 p -43.81 -29.5 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.763 -1.211 . . . . 0.0 109.103 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.58 34.11 4.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.604 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.638 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 8.6 mmt180 -84.31 157.85 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.446 -1.409 . . . . 0.0 109.365 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.14 85.74 2.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.8 m-85 -81.13 93.8 6.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.463 -0.773 . . . . 0.0 110.154 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -77.94 93.27 4.4 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.616 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 56.8 m95 -60.81 -8.35 2.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.518 -0.739 . . . . 0.0 110.458 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -91.02 -21.45 21.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.85 -1.157 . . . . 0.0 108.298 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 26.2 m-20 -99.74 -25.63 14.32 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.608 HD12 ' CE3' ' A' ' 97' ' ' TRP . 68.9 mt -73.69 70.97 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 36.7 mt -52.84 150.43 9.9 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.564 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.8 Cg_endo -79.23 -23.09 7.86 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.964 2.442 . . . . 0.0 110.192 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -144.24 123.93 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.859 -1.151 . . . . 0.0 109.975 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 35.2 m-85 -110.62 138.47 46.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.15 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -99.74 -4.56 30.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.27 7.5 60.7 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -120.28 -1.32 10.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -1.118 . . . . 0.0 109.427 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.33 167.11 7.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.35 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -69.55 170.63 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.339 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.58 -35.19 70.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.01 -61.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.763 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.39 -32.15 72.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.356 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 10.4 mttt -66.5 -44.03 83.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.18 -0.95 . . . . 0.0 108.488 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.434 ' CG ' HD13 ' A' ' 24' ' ' LEU . 4.7 ttm -59.13 -34.49 72.1 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 100' ' ' ILE . . . -56.9 -68.05 0.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.529 -0.732 . . . . 0.0 109.437 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.619 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.5 tp -63.28 -52.13 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.123 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 23' ' ' LEU . 4.2 p -45.6 -41.0 9.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 34.7 tt0 -70.61 -54.4 12.16 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.549 HD22 ' HB3' ' A' ' 53' ' ' ALA . 8.8 tp -46.9 -48.14 21.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.578 ' HE1' ' CD2' ' A' ' 15' ' ' TYR . 24.1 mmt -59.44 -53.99 51.75 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.842 -0.536 . . . . 0.0 111.047 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.22 75.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.939 -1.101 . . . . 0.0 108.564 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.485 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 9.5 m-20 -64.2 -47.3 80.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 49' ' ' ALA . 63.0 t -71.54 -51.65 31.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.126 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.86 -51.7 12.82 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 88' ' ' ALA . 2.9 mt -62.57 -57.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.177 -1.19 . . . . 0.0 108.258 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.512 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.67 -29.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.396 -178.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.764 HG13 HG22 ' A' ' 143' ' ' VAL . 28.5 m -101.08 34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.428 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 127' ' ' VAL . 95.4 m-20 40.83 51.19 3.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 109.246 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.5 tpp -66.04 126.16 27.72 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 111.698 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 135' ' ' SER . 4.5 t0 -76.53 122.57 24.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.593 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.0 m-85 -103.42 116.79 33.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.248 1.023 . . . . 0.0 113.141 -175.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.514 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -151.28 -162.48 10.74 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.686 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -62.64 -29.47 77.86 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 105.818 -2.416 . . . . 0.0 105.818 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 139.54 45.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 44' ' ' ALA . 50.4 m -121.11 107.88 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.067 -1.646 . . . . 0.0 110.008 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.76 143.73 16.28 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.002 -1.095 . . . . 0.0 110.606 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.5 -163.47 0.93 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.61 -60.1 2.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.602 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 139.43 -134.5 6.71 Favored Glycine 0 N--CA 1.48 1.573 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.627 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.507 ' OG ' HG23 ' A' ' 248' ' ' VAL . 71.7 m -51.42 -49.41 61.68 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.677 -0.896 . . . . 0.0 112.298 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -45.84 -47.47 15.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 110.005 -177.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.6 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.1 mmt180 -81.25 -37.01 29.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.98 -1.075 . . . . 0.0 110.322 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.764 HG22 HG13 ' A' ' 127' ' ' VAL . 48.2 t -66.24 -61.27 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.739 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.38 -31.52 63.91 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.925 -1.109 . . . . 0.0 108.217 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' NH1' ' OE2' ' A' ' 149' ' ' GLU . 1.6 ttm-85 -76.12 -48.95 18.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 109.28 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -66.56 -36.16 81.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.159 -0.963 . . . . 0.0 110.097 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.494 HD13 HG11 ' A' ' 143' ' ' VAL . 35.8 mt -56.47 -46.4 80.43 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.545 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 56.1 mtmt -87.47 -40.75 14.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.903 -1.123 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.495 ' OE2' ' NH1' ' A' ' 145' ' ' ARG . 29.8 mt-10 -68.65 -58.56 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.836 -1.165 . . . . 0.0 112.316 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 90' ' ' ILE . 23.4 m120 -85.07 -46.59 11.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.832 -1.168 . . . . 0.0 112.387 -177.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 44.3 m-85 -89.9 -12.53 38.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.619 -1.3 . . . . 0.0 110.343 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.564 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 66.16 32.15 81.4 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.482 177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 15.2 m-85 -63.35 153.7 34.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.264 -1.727 . . . . 0.0 107.663 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.5 t-20 -46.71 155.71 0.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.786 -1.196 . . . . 0.0 109.971 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 76.7 mm-40 -55.98 -15.99 4.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.379 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.606 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 70.8 p -53.1 -17.61 1.67 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.169 -0.957 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 19.7 t -71.47 122.2 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.926 -1.108 . . . . 0.0 109.495 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.606 ' CE1' ' O ' ' A' ' 156' ' ' SER . 1.5 p-80 -146.99 -178.26 6.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.119 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 4.2 tt0 -124.91 152.51 43.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 110.472 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.515 ' O ' ' CA ' ' A' ' 246' ' ' SER . 11.0 pt -133.07 145.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -110.56 103.68 12.3 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.034 -1.041 . . . . 0.0 110.895 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.616 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.54 -40.21 18.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.21 -0.931 . . . . 0.0 109.353 179.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.02 -23.57 59.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.23 -0.83 27.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.093 -1.239 . . . . 0.0 111.56 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -117.48 169.04 9.84 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.467 -1.396 . . . . 0.0 109.94 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 167' ' ' LYS . 6.9 p -94.7 132.5 39.38 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 166' ' ' SER . 37.2 tttp -32.73 -44.02 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -64.3 -65.35 0.69 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.55 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 4.0 m-20 -62.36 -14.33 38.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.134 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.616 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 62.2 t-105 -72.76 -52.5 14.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.043 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.477 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 30.8 mt-10 -67.77 -21.99 65.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 169' ' ' ASP . . . -56.54 -45.33 81.25 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.05 -35.93 78.24 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 199' ' ' ILE . 15.5 mt -74.57 -61.81 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.231 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.85 -51.59 39.02 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.373 -0.829 . . . . 0.0 109.767 -178.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -51.15 -44.14 61.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.572 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 4.0 mm-40 -61.1 -46.73 89.44 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.571 HD12 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -67.84 -28.15 67.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.536 -0.728 . . . . 0.0 109.916 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 175' ' ' ASP . 22.5 p -52.45 -40.3 62.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.958 -1.089 . . . . 0.0 108.638 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.442 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 11.4 mt-30 -99.57 33.61 2.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.558 ' HA ' HD21 ' A' ' 7' ' ' LEU . 75.5 m-20 43.73 53.46 6.02 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.892 0.853 . . . . 0.0 108.985 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.53 ' CB ' ' OE1' ' A' ' 177' ' ' GLU . 6.5 mt-30 -124.36 110.68 28.47 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.502 ' HD3' HD12 ' A' ' 7' ' ' LEU . 17.7 Cg_endo -64.84 165.48 21.02 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.765 1.643 . . . . 0.0 112.658 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 25.0 t -121.03 132.97 69.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.043 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.2 OUTLIER -83.93 116.57 22.86 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 176.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.686 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 7.3 t80 -122.08 157.44 31.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.957 -1.09 . . . . 0.0 110.153 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.59 131.74 4.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.998 -1.481 . . . . 0.0 111.682 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.83 132.79 11.44 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 244' ' ' TYR . 2.9 t -88.99 172.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.916 -1.343 . . . . 0.0 110.964 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -176.28 -148.96 7.27 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -30.04 20.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.1 -1.235 . . . . 0.0 110.716 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -83.39 -16.17 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.91 -1.118 . . . . 0.0 111.034 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.19 -164.18 25.32 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.526 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -95.15 112.34 4.37 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.964 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.4 t-80 -71.94 134.05 45.75 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -120.35 162.92 18.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.058 -1.457 . . . . 0.0 112.777 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.686 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 44.0 p90 -162.44 166.67 24.71 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 55' ' ' ILE . 81.7 t -114.24 137.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.89 -1.131 . . . . 0.0 112.699 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.619 HD13 ' CE1' ' A' ' 222' ' ' PHE . 54.0 mt -98.09 131.32 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.9 p30 -143.43 30.09 1.39 Allowed 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.232 -1.387 . . . . 0.0 110.386 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.758 ' HA2' HG13 ' A' ' 4' ' ' VAL . . . 177.36 -174.25 46.83 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 117.794 -2.145 . . . . 0.0 111.93 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.655 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.2 154.94 11.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.662 -0.905 . . . . 0.0 108.794 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.57 5.96 12.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.757 -1.214 . . . . 0.0 110.314 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.51 -32.79 5.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -84.9 45.67 1.18 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.259 -1.142 . . . . 0.0 109.884 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.29 16.76 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 8.9 m-85 -104.11 145.11 30.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.014 -1.054 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.558 ' HB3' HG21 ' A' ' 199' ' ' ILE . 54.4 m-85 -123.44 161.76 24.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.581 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 30.1 t-80 -91.75 123.02 34.82 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.581 HG12 ' CE2' ' A' ' 212' ' ' TRP . 33.1 t -115.3 150.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.49 -177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.2 t-20 -120.38 70.22 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.595 ' CZ3' ' HB3' ' A' ' 228' ' ' ASN . 18.4 m95 -52.31 174.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 111.316 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -93.11 39.61 2.94 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.473 ' HB2' HG23 ' A' ' 217' ' ' VAL . 24.5 m95 -118.58 -163.37 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -107.65 -38.35 2.07 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.132 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -116.47 -29.07 2.38 Favored Glycine 0 N--CA 1.493 2.488 0 O-C-N 120.653 -1.498 . . . . 0.0 109.661 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 218' ' ' SER . 1.3 m -73.91 -30.06 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -1.004 . . . . 0.0 108.942 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.509 ' N ' HG23 ' A' ' 217' ' ' VAL . 2.6 t -43.05 -46.25 5.54 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.238 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 0.0 OUTLIER -94.24 96.82 9.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.569 -1.332 . . . . 0.0 110.25 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -155.63 -153.95 6.75 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 28.1 m-85 -114.94 179.34 3.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -1.122 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -71.99 144.8 48.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.257 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.25 149.62 24.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.8 mt -120.41 36.48 4.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.093 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -83.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.044 -1.035 . . . . 0.0 109.816 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.409 ' HB1' HD23 ' A' ' 227' ' ' LEU . . . -124.24 -94.81 0.48 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.409 HD23 ' HB1' ' A' ' 226' ' ' ALA . 0.3 OUTLIER -99.83 -122.84 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 110.005 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.595 ' HB3' ' CZ3' ' A' ' 212' ' ' TRP . 0.0 OUTLIER -91.69 177.23 2.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.879 -1.138 . . . . 0.0 109.477 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 228' ' ' ASN . 35.3 Cg_endo -77.86 -92.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.599 2.199 . . . . 0.0 110.374 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.417 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 19.3 m -98.58 98.64 9.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.995 . . . . 0.0 109.313 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.417 ' C ' ' HG ' ' A' ' 232' ' ' LEU . . . -97.73 12.58 33.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -131.89 -40.44 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.56 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 54.59 -103.27 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.28 -13.85 14.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -1.116 . . . . 0.0 109.365 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -85.09 134.11 12.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -88.08 94.51 1.99 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.16 172.78 43.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 239' ' ' GLY . . . -97.64 81.88 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 238' ' ' ALA . . . 62.9 140.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -147.38 89.23 0.15 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 -172.36 2.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -1.121 . . . . 0.0 109.322 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.0 OUTLIER -109.43 73.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.37 -54.04 8.19 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.505 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 71.4 m-85 -135.93 162.21 33.49 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.555 -0.967 . . . . 0.0 108.664 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 22.2 mt-30 -152.83 140.37 19.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 109.319 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.515 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 19.6 p -159.17 159.73 34.69 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.145 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.6 163.86 29.15 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.146 0.974 . . . . 0.0 109.714 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 95.3 t -117.25 126.73 74.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.6 ' CG2' ' CD2' ' A' ' 158' ' ' HIS . 22.8 m -132.49 149.08 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 157' ' ' VAL . . . 98.05 55.06 1.15 Allowed Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.942 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.606 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.2 mt -104.0 94.9 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.165 -1.197 . . . . 0.0 110.447 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 18.0 pttt -163.67 144.9 7.19 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.13 -0.981 . . . . 0.0 109.136 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.594 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.233 1.955 . . . . 0.0 110.387 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.45 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 58.6 tt0 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.45 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.5 Cg_endo -78.14 -176.24 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.455 2.103 . . . . 0.0 110.039 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.549 HG21 ' N ' ' A' ' 204' ' ' GLY . 11.2 t -139.73 131.87 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 110.006 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 178' ' ' LEU . 98.2 t -126.93 133.44 68.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -74.17 -178.34 3.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.984 -1.072 . . . . 0.0 108.359 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -77.53 104.0 7.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.054 -1.029 . . . . 0.0 110.36 -178.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.655 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 33.4 mt -58.06 -45.54 86.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HG ' ' OD2' ' A' ' 200' ' ' ASP . 7.7 mt -61.2 -41.16 96.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.842 -1.161 . . . . 0.0 109.035 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.1 t70 -66.14 -37.52 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -57.64 -16.36 10.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 13' ' ' ILE . 1.7 mtpt -122.39 17.45 10.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.41 45.73 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.9 mt -90.55 107.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -1.021 . . . . 0.0 111.084 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 102' ' ' PRO . 31.5 m80 -131.43 95.58 3.79 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 9.7 m-30 -97.35 179.93 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.93 0.872 . . . . 0.0 111.274 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.42 -164.81 2.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 33.9 mt-30 -124.49 -23.56 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.064 -1.022 . . . . 0.0 110.053 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.68 -33.17 1.61 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.231 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.768 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.63 -142.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.518 0 CA-C-N 117.693 0.746 . . . . 0.0 111.093 -178.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.768 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -73.68 3.24 5.05 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 CA-C-N 122.229 1.832 . . . . 0.0 109.606 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.567 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 7.3 m-85 -80.37 -27.89 38.11 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.002 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.8 p-10 -97.83 16.48 20.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.461 -1.399 . . . . 0.0 109.743 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 5.8 mt -70.84 -3.44 19.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 110.003 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD13 ' CA ' ' A' ' 118' ' ' GLU . 15.7 mt -129.61 -6.37 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.064 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -60.82 164.47 7.52 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.9 Cg_endo -70.22 136.36 31.57 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.017 1.811 . . . . 0.0 111.625 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 42' ' ' HIS . 35.6 t -82.39 149.86 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.557 0.694 . . . . 0.0 109.953 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 ' HD3' ' A' ' 133' ' ' PRO . 9.8 mt -77.75 151.03 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.62 0.724 . . . . 0.0 110.75 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -125.54 -21.96 4.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.683 -0.636 . . . . 0.0 110.417 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' TYR . 48.5 mtpt -124.0 171.1 10.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 110.068 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 37' ' ' SER . 77.1 t -114.4 149.58 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.341 -0.849 . . . . 0.0 110.812 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 7.5 tttt -85.13 128.3 60.6 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.96 118.24 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.465 1.443 . . . . 0.0 110.072 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.47 18.55 12.82 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.93 -178.34 6.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.621 -0.929 . . . . 0.0 109.17 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.92 176.92 9.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -84.29 132.71 34.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.596 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 73.9 m-85 -124.0 21.79 8.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.898 -1.126 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 28' ' ' ILE . 70.7 t -68.24 139.13 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.776 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.35 1.37 85.92 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 29.0 mt-30 -86.1 129.82 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.542 ' CE1' HG21 ' A' ' 27' ' ' VAL . 1.3 m-70 -73.36 111.38 8.43 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.56 158.08 1.37 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.861 -177.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -74.51 169.36 17.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.429 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 HG22 ' SD ' ' A' ' 120' ' ' MET . 31.7 p -80.76 -34.66 34.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 108.675 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.515 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 103.34 134.47 8.3 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.8 p -54.49 -50.86 66.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.135 -1.214 . . . . 0.0 108.362 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 55.6 t -46.6 -53.87 2.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.599 -0.84 . . . . 0.0 108.754 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HA ' HG12 ' A' ' 123' ' ' VAL . . . -58.49 -52.03 67.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.46 -0.775 . . . . 0.0 110.206 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.496 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 17.4 m -63.48 -34.33 77.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.15 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -63.42 -41.42 98.7 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.299 -1.361 . . . . 0.0 107.865 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.488 ' OG1' HG13 ' A' ' 143' ' ' VAL . 34.0 m -74.68 -49.0 22.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.42 0.629 . . . . 0.0 109.623 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HB3' HD22 ' A' ' 119' ' ' LEU . . . -52.65 -41.83 64.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.822 . . . . 0.0 109.883 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.631 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 31.0 mt-30 -60.16 -51.64 68.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.759 -1.213 . . . . 0.0 107.941 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.508 HG13 HG22 ' A' ' 198' ' ' VAL . 34.1 mt -63.79 -28.1 44.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.535 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 18.5 mtp -67.93 -36.18 79.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -76.38 -42.55 44.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.3 t80 -53.34 -29.66 35.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 109.312 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 36.7 m-70 -105.5 -25.93 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 110.163 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.612 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.4 m-20 45.0 59.14 3.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -84.34 -70.16 0.13 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.024 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.4 Cg_endo -67.37 96.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.398 0.732 . . . . 0.0 111.623 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.15 -20.39 64.88 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 91' ' ' SER . 4.1 tttp -135.68 140.08 44.18 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.93 144.51 41.62 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.124 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -83.11 -53.85 5.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.951 . . . . 0.0 110.176 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 9.9 ttpp -145.25 142.5 29.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.29 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 9.7 m-20 -66.69 171.51 5.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -0.852 . . . . 0.0 109.884 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 70' ' ' THR . 51.1 t80 -148.62 164.39 34.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.58 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 14.5 t -166.11 162.53 17.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.65 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 24.9 p90 -166.62 154.65 9.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -92.97 136.97 32.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.531 HD21 ' CG ' ' A' ' 77' ' ' ASN . 10.2 tp -54.18 150.77 7.92 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.193 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.74 141.53 57.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.349 0.595 . . . . 0.0 110.076 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -3.26 13.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.082 -1.011 . . . . 0.0 109.71 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.4 m-20 -99.74 -7.27 25.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 33.8 t-20 -69.92 109.84 5.49 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.709 -0.62 . . . . 0.0 109.785 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.635 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.89 16.19 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.867 2.378 . . . . 0.0 110.126 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.635 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.9 m-85 -106.57 -26.25 11.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 111.033 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 3.7 m-85 -118.64 162.74 17.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.1 m-80 -46.36 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.15 -47.88 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.164 -0.96 . . . . 0.0 111.178 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.1 Cg_endo -76.75 57.21 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 106.877 -2.009 . . . . 0.0 106.877 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.66 104.46 14.18 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.394 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -100.53 134.11 43.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.339 -0.85 . . . . 0.0 109.679 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.65 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -106.3 137.32 44.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 27.1 t80 -128.54 131.55 48.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.06 -1.025 . . . . 0.0 110.261 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -108.01 114.75 28.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.48 51.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.728 -1.232 . . . . 0.0 108.312 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.61 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 6.7 mt -52.55 -54.32 16.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.492 -0.755 . . . . 0.0 109.593 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 90' ' ' ILE . 3.6 p -45.41 -26.62 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.497 -1.377 . . . . 0.0 109.154 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -111.38 28.48 8.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.606 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.52 150.72 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.872 0.844 . . . . 0.0 110.822 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 86.9 2.6 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.5 m-85 -80.8 91.41 5.93 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.339 -0.851 . . . . 0.0 110.19 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 24.2 t-20 -79.58 90.6 5.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 58.0 m95 -61.07 -9.06 3.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.229 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.39 -14.7 32.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 53.3 m-20 -100.13 -32.92 10.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.595 HD12 ' CE3' ' A' ' 97' ' ' TRP . 23.4 mt -73.35 95.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.35 1.071 . . . . 0.0 108.566 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 11.8 mt -72.46 153.13 91.97 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.314 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.1 Cg_endo -79.14 -31.84 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.831 2.354 . . . . 0.0 110.344 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -136.8 136.03 38.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.581 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 74.9 m-85 -120.12 140.63 50.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 p -102.18 -1.06 32.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.15 88.62 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.513 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -118.74 -2.46 10.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.476 -1.014 . . . . 0.0 109.264 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.416 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 14.0 mp0 -64.03 167.79 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.3 p -65.05 179.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -82.97 -40.48 19.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.8 t -52.05 -52.36 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.15 98.75 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 108.988 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.473 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 24.1 mttt -61.21 -36.83 80.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.422 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 50.4 ttm -59.26 -46.03 89.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.5 -0.75 . . . . 0.0 109.666 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.403 ' HB2' HG12 ' A' ' 100' ' ' ILE . . . -58.1 -51.88 67.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.581 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 4.9 tp -68.86 -44.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.49 -1.381 . . . . 0.0 109.468 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.8 p -52.9 -41.45 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.024 -1.047 . . . . 0.0 108.649 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.538 ' CA ' HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -70.01 -45.59 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 53' ' ' ALA . 13.2 tp -50.86 -54.41 24.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.567 ' HG3' ' HB3' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -59.84 -43.92 94.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.685 . . . . 0.0 109.521 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.85 -39.86 94.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 126' ' ' SER . 24.8 m-20 -68.69 -43.37 76.24 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 49' ' ' ALA . 79.8 t -70.75 -62.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.726 -0.609 . . . . 0.0 109.849 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.532 ' HA2' ' HB3' ' A' ' 49' ' ' ALA . . . -46.65 -45.32 17.8 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.81 -57.49 11.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.07 -1.253 . . . . 0.0 108.106 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 9.4 p -46.06 -29.62 1.56 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.61 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.04 37.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.019 -1.051 . . . . 0.0 110.093 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HB2' ' NE ' ' A' ' 142' ' ' ARG . 2.9 m-20 40.31 38.5 0.55 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.369 -0.832 . . . . 0.0 109.656 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.521 ' HE3' ' HB2' ' A' ' 137' ' ' SER . 45.9 tpp -52.97 129.11 29.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.822 . . . . 0.0 111.192 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.9 t0 -78.72 122.78 26.43 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.609 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 66.3 m-85 -105.2 119.39 38.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.995 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.506 ' C ' HD13 ' A' ' 28' ' ' ILE . . . -149.99 -163.29 11.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 103.753 -3.739 . . . . 0.0 103.753 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -61.58 -31.0 86.85 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 105.438 -2.562 . . . . 0.0 105.438 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.75 138.26 47.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -114.44 110.5 19.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.853 -1.779 . . . . 0.0 109.577 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -106.81 135.45 12.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 14.9 t -118.18 -163.79 0.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.127 -1.22 . . . . 0.0 108.672 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.533 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -92.07 -56.05 3.22 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.54 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 128.16 -119.89 3.24 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.796 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.549 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.6 m -51.32 -66.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.85 -0.794 . . . . 0.0 112.871 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -46.89 -35.1 6.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.89 -1.131 . . . . 0.0 109.871 -177.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.567 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 48.0 mmt-85 -79.54 -47.86 14.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.299 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.677 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.7 t -67.29 -60.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.483 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -55.9 -30.18 61.17 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.362 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 3.5 ttt180 -77.35 -41.53 40.06 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.252 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -70.23 -37.44 75.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 110.31 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 251' ' ' ILE . 58.8 mt -58.11 -53.5 57.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.651 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.579 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 53.6 mtmt -77.46 -52.57 8.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.715 . . . . 0.0 112.097 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 9.2 mt-10 -66.23 -45.56 80.26 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.49 -1.381 . . . . 0.0 112.383 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.02 -45.26 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.559 -1.338 . . . . 0.0 111.506 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.535 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 34.2 m-85 -100.02 19.99 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 30.66 39.6 0.04 OUTLIER Glycine 0 N--CA 1.496 2.668 0 O-C-N 121.905 -0.497 . . . . 0.0 112.992 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 9.8 m-85 -63.36 161.08 14.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.212 -1.758 . . . . 0.0 107.478 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.0 t-20 -47.44 147.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.765 -1.209 . . . . 0.0 109.612 -178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -54.81 -17.11 3.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.254 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.585 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 4.4 p -53.54 -15.87 1.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.579 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 67.0 t -68.81 129.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.638 -1.289 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.613 ' CD2' HG22 ' A' ' 249' ' ' VAL . 1.1 p-80 -149.46 172.67 14.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.24 -0.912 . . . . 0.0 109.796 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.549 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -117.49 136.36 53.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 246' ' ' SER . 8.8 pt -123.19 170.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.3 m-80 -123.87 102.66 7.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 110.485 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 2.6 tpt180 -47.22 -39.2 13.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 109.084 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.51 69.74 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -104.91 34.35 3.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.995 -1.297 . . . . 0.0 112.258 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.59 170.94 14.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.306 -1.496 . . . . 0.0 110.217 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.0 p -96.43 135.8 37.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 6.7 ttpt -34.78 -51.49 0.5 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.813 -0.554 . . . . 0.0 110.978 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -56.09 17.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.403 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.404 ' HB2' ' OG ' ' A' ' 166' ' ' SER . 1.5 m-20 -63.09 -22.32 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.124 -0.985 . . . . 0.0 109.612 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 70.0 t-105 -71.87 -45.73 60.32 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.133 -0.979 . . . . 0.0 109.169 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.451 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 69.3 mt-10 -70.87 -26.37 63.22 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.078 -1.014 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.05 83.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.14 -40.45 93.87 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.588 HG23 ' CD1' ' A' ' 199' ' ' ILE . 12.5 mt -75.72 -56.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.422 -0.799 . . . . 0.0 110.486 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -49.87 -46.09 51.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.979 -1.076 . . . . 0.0 109.022 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.439 ' O ' ' OG ' ' A' ' 179' ' ' SER . 6.6 tttt -52.15 -45.26 64.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 108.215 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 31.0 mm-40 -59.71 -48.36 81.98 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.511 ' HB3' HG11 ' A' ' 4' ' ' VAL . 22.6 mt -67.63 -27.63 67.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 176' ' ' LYS . 20.7 p -51.36 -42.78 61.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 108.716 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 181' ' ' ASN . 19.3 mt-30 -98.67 38.58 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.49 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 90.5 m-20 43.3 49.97 5.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 5.3 mt-30 -123.64 114.49 28.52 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.543 ' HD3' HD12 ' A' ' 7' ' ' LEU . 16.3 Cg_endo -65.72 169.6 12.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.421 2.08 . . . . 0.0 112.807 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.7 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 58.5 t -125.61 131.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.81 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.677 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -82.93 120.14 25.31 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.98 161.93 23.3 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.894 -1.129 . . . . 0.0 109.546 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -166.74 129.01 1.78 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.466 -1.693 . . . . 0.0 112.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -93.19 124.8 7.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 244' ' ' TYR . 5.6 t -83.19 170.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.305 . . . . 0.0 111.12 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -175.33 -145.24 5.34 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -87.66 -29.48 21.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.021 -1.282 . . . . 0.0 110.678 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 m -81.82 -14.82 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.959 -1.088 . . . . 0.0 110.893 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.66 -164.41 24.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.539 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -87.93 106.45 3.21 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 121.089 -1.242 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 11.4 t-80 -71.43 132.75 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.71 165.05 15.62 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.102 -1.439 . . . . 0.0 113.006 -177.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.604 ' HB3' ' CE3' ' A' ' 212' ' ' TRP . 17.5 p90 -162.64 168.91 20.97 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.508 HG22 HG13 ' A' ' 55' ' ' ILE . 75.7 t -114.22 136.75 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.638 -1.289 . . . . 0.0 112.376 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.7 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 81.7 mt -101.71 125.64 55.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.61 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 3.9 p30 -134.86 30.23 3.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.842 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 177.42 163.49 29.44 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 117.614 -2.232 . . . . 0.0 112.671 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -144.24 157.06 44.5 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.483 ' C ' ' CG2' ' A' ' 3' ' ' VAL . 9.5 p-10 -120.86 -0.5 10.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.698 -1.251 . . . . 0.0 110.576 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.549 ' N ' HG21 ' A' ' 3' ' ' VAL . . . 91.0 -27.67 8.81 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 36.4 mtt180 -89.22 30.08 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -1.187 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.6 OUTLIER 71.46 20.48 4.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.691 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.435 ' HB2' ' CG ' ' A' ' 203' ' ' ASP . 16.3 m-85 -116.73 135.12 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.103 -0.998 . . . . 0.0 109.468 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 16.3 m-85 -121.11 168.4 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.367 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.61 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.1 t60 -91.51 147.02 23.32 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.4 t -138.79 137.51 42.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -105.88 78.81 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -46.57 164.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.716 . . . . 0.0 110.238 -178.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -92.97 26.16 16.16 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.451 ' HB2' HG12 ' A' ' 217' ' ' VAL . 22.2 m95 -107.06 -168.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.638 -0.919 . . . . 0.0 109.748 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -80.36 -87.32 0.58 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.13 53.08 0.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.521 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 8.6 p -100.14 -134.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.181 -1.188 . . . . 0.0 109.138 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.514 ' N ' HG11 ' A' ' 217' ' ' VAL . 6.4 m -67.31 57.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.498 -1.376 . . . . 0.0 110.366 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' VAL . 5.3 m-20 -95.83 96.14 8.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.973 . . . . 0.0 109.271 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 160.13 -114.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -58.76 145.34 40.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.463 -1.022 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -118.06 -166.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.769 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.464 ' HB2' ' HB3' ' A' ' 226' ' ' ALA . 41.0 mtt180 -128.97 -165.99 1.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.401 HD22 ' OD1' ' A' ' 206' ' ' ASN . 3.4 mt -115.03 -47.99 2.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -98.61 8.31 45.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 223' ' ' ARG . . . -122.33 84.01 2.19 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.147 0.975 . . . . 0.0 108.605 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.425 ' HB2' ' OE1' ' A' ' 245' ' ' GLN . 0.2 OUTLIER -93.86 -3.6 51.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.9 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 241' ' ' PHE . 1.7 m-80 -92.15 159.22 37.95 Favored Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.369 -0.832 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 212' ' ' TRP . 35.9 Cg_endo -78.21 159.64 29.83 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.786 2.324 . . . . 0.0 110.851 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.6 p -102.72 -39.86 6.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.389 -0.819 . . . . 0.0 109.113 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.7 106.92 5.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 109.216 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.1 mt -69.69 -63.48 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.27 -172.41 16.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 3.8 m -109.12 -48.62 3.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 109.749 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -89.71 18.47 46.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.77 -66.19 0.64 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.35 58.3 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.537 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -46.51 -69.3 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.156 . . . . 0.0 109.358 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 116.45 -97.71 0.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.33 65.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -123.65 168.83 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -1.116 . . . . 0.0 109.508 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.1 t-20 -132.4 74.82 1.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.815 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -76.26 -53.12 5.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.502 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 23.8 m-85 -133.47 159.34 40.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -1.048 . . . . 0.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.545 ' HG3' ' ND2' ' A' ' 242' ' ' ASN . 28.7 mt-30 -153.45 143.52 22.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 40.5 p -155.21 162.03 41.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.642 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.465 ' HB3' ' CH2' ' A' ' 170' ' ' TRP . . . -136.93 148.16 46.82 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.204 1.002 . . . . 0.0 110.085 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.9 t -110.49 121.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.613 HG22 ' CD2' ' A' ' 158' ' ' HIS . 24.7 m -132.96 146.45 32.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.675 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 157' ' ' VAL . . . 94.53 54.54 1.55 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.595 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 mt -101.14 97.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.308 -1.113 . . . . 0.0 110.004 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 7.9 pttm -162.85 144.38 7.82 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.17 1.913 . . . . 0.0 110.4 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.525 ' NE2' ' OD1' ' A' ' 175' ' ' ASP . 41.6 tt0 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.471 ' HD2' ' OD2' ' A' ' 175' ' ' ASP . 35.6 Cg_endo -77.65 136.44 15.37 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.347 2.031 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.495 HG11 ' N ' ' A' ' 4' ' ' VAL . 16.8 t -79.34 142.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 109.702 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.541 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 22.6 t -136.73 130.67 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.505 -0.747 . . . . 0.0 109.218 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 200' ' ' ASP . 63.7 mmtt -76.43 -172.95 2.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.086 -1.009 . . . . 0.0 108.517 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 4.2 t -79.27 101.8 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.4 mt -56.89 -50.23 73.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 108.818 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 200' ' ' ASP . 12.8 mt -55.04 -44.08 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.857 -1.152 . . . . 0.0 108.702 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 97.9 m-20 -67.83 -38.71 83.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.183 -0.948 . . . . 0.0 108.548 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.6 p -58.32 -14.87 8.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 9.4 mtpp -119.13 23.33 11.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.47 35.69 5.54 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 58' ' ' TYR . 17.5 mt -88.91 109.39 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.409 1.1 . . . . 0.0 110.432 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PRO . 63.1 m80 -133.4 98.82 4.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' HD13 ' A' ' 116' ' ' ILE . 4.1 m-30 -103.76 176.81 5.03 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.273 1.035 . . . . 0.0 112.299 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.582 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 t-20 -147.2 -172.74 4.08 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.545 ' CG ' ' OG1' ' A' ' 50' ' ' THR . 4.6 mt-30 -124.23 -14.94 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.917 -1.115 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.711 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.18 -39.11 0.97 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.799 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.781 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.2 -138.96 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.489 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.108 -178.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.2 Cg_endo -74.62 4.02 4.9 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 122.667 1.988 . . . . 0.0 109.185 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 64.1 m-85 -75.79 -35.21 60.15 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.632 -0.667 . . . . 0.0 109.903 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.7 p30 -97.95 21.78 10.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.494 -1.379 . . . . 0.0 109.998 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.7 -2.39 20.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.48 HD11 ' OG ' ' A' ' 117' ' ' SER . 12.3 mt -129.03 -6.3 4.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.988 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 43' ' ' ALA . 23.2 p -62.07 162.62 16.93 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.628 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -70.69 130.37 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.14 1.893 . . . . 0.0 111.841 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG22 ' ND1' ' A' ' 42' ' ' HIS . 71.3 t -76.44 149.15 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.551 0.691 . . . . 0.0 110.168 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.828 HG21 ' HB3' ' A' ' 79' ' ' TYR . 33.7 mt -77.8 144.66 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.558 0.694 . . . . 0.0 110.689 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' N ' HG22 ' A' ' 28' ' ' ILE . 20.5 mt-10 -123.6 -23.51 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.512 -0.742 . . . . 0.0 110.052 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.9 mtpp -118.94 162.5 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.264 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 37' ' ' SER . 42.4 t -114.48 149.14 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -79.31 127.13 79.85 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -70.71 123.11 9.49 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.371 1.381 . . . . 0.0 110.484 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.67 11.21 31.29 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.47 -177.95 5.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.309 -1.112 . . . . 0.0 109.39 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.48 169.25 18.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -82.38 131.44 35.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.461 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.568 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 87.0 m-85 -123.29 25.03 8.54 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.055 -1.028 . . . . 0.0 109.634 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 HG21 ' A' ' 31' ' ' VAL . 77.1 t -73.74 148.3 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.192 -0.942 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.21 -1.87 73.47 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 5.1 mm-40 -88.27 131.02 34.95 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.423 -1.045 . . . . 0.0 109.668 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.416 ' ND1' HG22 ' A' ' 27' ' ' VAL . 6.6 m-70 -73.13 112.66 9.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.59 157.12 1.64 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.913 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.81 169.43 18.3 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.332 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.532 ' O ' ' HE2' ' A' ' 129' ' ' MET . 31.4 p -77.81 -34.11 52.18 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.979 -1.076 . . . . 0.0 108.385 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA3' ' HE1' ' A' ' 129' ' ' MET . . . 101.64 136.88 9.46 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -54.3 -51.33 64.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.235 -1.156 . . . . 0.0 108.891 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.8 t -46.7 -53.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . . . -60.19 -50.6 73.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.25 -0.907 . . . . 0.0 110.329 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -63.62 -31.72 72.98 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.654 -0.653 . . . . 0.0 110.714 -178.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 55' ' ' ILE . . . -67.08 -41.94 85.49 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.261 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 143' ' ' VAL . 53.8 m -73.51 -54.2 8.78 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.874 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.88 -39.59 62.79 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.809 -0.557 . . . . 0.0 110.316 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.1 mt-30 -61.09 -44.48 97.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.742 -1.224 . . . . 0.0 107.733 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 198' ' ' VAL . 44.1 mt -68.35 -24.53 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.587 ' HE2' ' CD1' ' A' ' 151' ' ' PHE . 29.2 mtp -73.36 -38.63 65.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 33.6 tptt -68.46 -43.54 76.8 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.03 -32.66 48.0 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.679 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 53.6 m-70 -107.52 -22.21 12.62 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.521 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.596 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.64 55.54 1.91 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.2 t80 -77.0 -70.52 0.21 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.8 Cg_endo -70.51 104.2 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 120.399 0.733 . . . . 0.0 111.942 -176.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.4 m-80 -69.55 -22.61 63.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 3.6 ttpm? -134.55 141.72 46.76 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.94 153.06 26.65 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.507 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -94.35 -38.65 10.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -1.019 . . . . 0.0 109.984 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 46.3 tttt -152.16 139.45 19.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 91' ' ' SER . 77.7 m-20 -63.87 170.3 3.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 22.8 t80 -153.03 135.66 15.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.069 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.8 t -142.57 152.83 42.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 109.759 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 19.9 p90 -156.44 152.98 28.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.844 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.469 HG23 ' ND2' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -92.74 126.58 37.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.479 HD21 ' CG ' ' A' ' 77' ' ' ASN . 11.5 tp -44.03 147.29 0.52 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.77 0.795 . . . . 0.0 110.947 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 146.55 48.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.716 -0.615 . . . . 0.0 110.187 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.41 1.63 9.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.856 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 10.0 m-20 -98.65 -9.4 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.333 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 28.7 t-20 -69.73 109.35 4.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.782 -0.574 . . . . 0.0 110.35 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.3 Cg_endo -88.72 14.54 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.79 2.327 . . . . 0.0 110.386 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.828 ' HB3' HG21 ' A' ' 28' ' ' ILE . 80.1 m-85 -107.92 -22.6 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 110.66 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' ASN . 87.7 m-85 -118.48 163.35 16.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 7.7 m-80 -49.14 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 175.39 -48.38 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.508 175.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -75.85 58.88 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 N-CA-C 107.01 -1.958 . . . . 0.0 107.01 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.538 ' HG3' HD12 ' A' ' 86' ' ' LEU . 12.1 tptt -105.49 121.86 44.81 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.784 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' HG23 ' A' ' 72' ' ' THR . 2.5 m-80 -105.83 115.98 31.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.0 mp -95.49 128.85 42.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -129.81 141.06 50.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -117.28 113.26 21.91 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -73.24 52.81 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 108.118 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 mt -52.77 -53.63 20.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.555 -0.716 . . . . 0.0 110.205 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 p -45.65 -25.6 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.637 -1.289 . . . . 0.0 109.147 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -111.28 19.78 17.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.352 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.634 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.9 mmt-85 -79.43 151.49 30.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.443 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -117.36 90.99 3.45 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.21 94.66 6.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 110.828 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.7 t30 -82.64 89.39 6.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.621 ' CE3' HD12 ' A' ' 100' ' ' ILE . 68.1 m95 -61.39 -7.13 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 -178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -89.87 -19.8 24.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 6.0 m-20 -99.71 -28.0 13.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.621 HD12 ' CE3' ' A' ' 97' ' ' TRP . 44.9 mt -73.77 65.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 21.2 mt -45.89 148.62 1.35 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.723 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.549 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.0 Cg_endo -78.0 -17.96 13.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.641 2.228 . . . . 0.0 110.446 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 14' ' ' HIS . 9.0 t -144.92 122.5 11.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.2 -0.938 . . . . 0.0 109.082 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.571 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 81.7 m-85 -109.5 141.75 41.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -99.93 -5.95 27.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.452 -0.78 . . . . 0.0 109.086 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -3.78 83.28 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -116.48 0.66 12.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -1.179 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.48 160.82 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 167.47 0.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.176 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 6.1 m-80 -72.79 -29.41 63.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.1 t -51.9 -63.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.519 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.464 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 3.2 mp0 -62.46 -32.42 73.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.271 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 24.6 mttt -66.54 -43.7 84.4 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.486 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.8 ttm -59.6 -35.52 74.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -68.71 0.21 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.676 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.576 HD13 ' CE2' ' A' ' 15' ' ' TYR . 1.3 tp -59.84 -37.6 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.295 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.527 ' N ' HG23 ' A' ' 116' ' ' ILE . 13.8 p -57.39 -43.39 83.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.895 -1.128 . . . . 0.0 110.755 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.535 ' HG2' ' NE ' ' A' ' 93' ' ' ARG . 0.7 OUTLIER -69.23 -37.18 77.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 108.95 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 53' ' ' ALA . 3.6 tp -59.48 -59.52 5.31 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.612 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.0 mmt -49.87 -40.59 43.11 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.211 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -70.38 -41.04 73.59 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 36.7 m-20 -64.63 -47.14 79.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 49' ' ' ALA . 54.5 t -70.08 -49.7 53.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -60.18 -33.05 78.31 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 88' ' ' ALA . 1.2 mt -75.22 -57.0 7.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.494 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . 1.4 p -47.79 -26.92 1.78 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 143' ' ' VAL . 32.9 m -100.44 28.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.358 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 4.4 m-20 39.46 48.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 53.5 tpp -59.66 131.79 52.0 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.1 t0 -76.89 120.66 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.628 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.7 m-85 -103.05 115.69 31.07 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.572 1.177 . . . . 0.0 113.245 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -151.1 -163.7 11.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 104.747 -3.341 . . . . 0.0 104.747 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.657 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.31 -31.44 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 N-CA-C 105.87 -2.396 . . . . 0.0 105.87 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.3 m -109.22 144.35 37.45 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 46.2 m -123.7 110.66 15.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 119.859 -1.776 . . . . 0.0 110.451 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.99 141.55 15.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.529 ' HB2' ' HE3' ' A' ' 129' ' ' MET . 29.4 t -118.22 -162.48 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -1.182 . . . . 0.0 108.998 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.78 -61.45 1.63 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 138.57 -137.31 8.63 Favored Glycine 0 N--CA 1.481 1.649 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.996 176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.3 m -48.34 -50.06 31.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.882 -0.775 . . . . 0.0 112.422 -178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 p -45.95 -48.45 16.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 110.407 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.638 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 7.0 mmt180 -80.7 -36.17 32.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.821 -1.174 . . . . 0.0 110.069 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 127' ' ' VAL . 87.8 t -67.2 -58.45 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.359 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 248' ' ' VAL . 1.3 pp0? -56.03 -31.61 63.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.308 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.4 ttt180 -77.72 -47.67 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.419 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 142' ' ' ARG . . . -66.41 -35.06 79.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.544 ' CD1' HG12 ' A' ' 143' ' ' VAL . 39.4 mt -60.13 -46.25 90.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 110.016 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.522 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 28.1 mtmt -87.38 -45.25 10.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 60.2 mt-10 -70.73 -43.54 68.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.875 -1.14 . . . . 0.0 111.792 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.46 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 24.2 m120 -94.42 -44.66 7.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 111.608 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CD1' ' HE2' ' A' ' 56' ' ' MET . 32.3 m-85 -102.26 15.86 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 110.673 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.535 ' HA3' ' CD1' ' A' ' 66' ' ' LEU . . . 33.74 38.93 0.1 OUTLIER Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.639 -0.663 . . . . 0.0 112.75 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.6 m-85 -61.97 164.67 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.189 -1.771 . . . . 0.0 107.666 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 45.5 t30 -47.76 143.12 4.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.893 -1.129 . . . . 0.0 109.084 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -53.51 -18.69 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 109.079 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.519 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 78.0 p -53.36 -16.34 1.33 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -0.856 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.5 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 56.0 t -66.29 118.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.83 -1.168 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 249' ' ' VAL . 9.1 p-80 -142.2 155.57 45.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.378 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -101.15 163.24 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.539 HG13 ' CH2' ' A' ' 170' ' ' TRP . 17.4 pt -145.56 165.77 10.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 162' ' ' ARG . 3.5 m-80 -125.13 100.08 6.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 110.086 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.615 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 45.1 tpt85 -45.34 -35.22 3.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.142 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.34 -28.04 70.31 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -103.89 6.26 36.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.899 -1.353 . . . . 0.0 111.876 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -118.1 177.27 4.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.388 -1.445 . . . . 0.0 110.407 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 88.4 p -103.95 132.65 49.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 20.5 ttmt -33.21 -46.27 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.848 -0.533 . . . . 0.0 110.885 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -64.21 -62.39 1.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.861 -1.15 . . . . 0.0 109.878 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -17.19 61.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.615 ' CH2' ' N ' ' A' ' 162' ' ' ARG . 75.7 t-105 -75.81 -47.01 27.48 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.197 -0.94 . . . . 0.0 109.162 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.469 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 55.5 mt-10 -69.84 -38.19 76.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.168 -0.957 . . . . 0.0 108.549 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.19 50.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.446 ' NE2' HG23 ' A' ' 249' ' ' VAL . 10.9 mm100 -61.07 -41.47 96.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.592 HG23 ' CD1' ' A' ' 199' ' ' ILE . 13.2 mt -75.66 -58.24 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.39 -0.819 . . . . 0.0 110.575 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 1' ' ' GLN . 0.3 OUTLIER -49.46 -45.32 46.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.725 -1.235 . . . . 0.0 108.888 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -51.61 -43.03 62.41 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.617 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 44.6 mm-40 -60.18 -50.99 71.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.8 mt -68.27 -26.48 65.69 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.8 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.7 p -52.17 -39.29 59.85 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.4 mt-30 -100.93 35.41 2.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.452 ' HA ' HD21 ' A' ' 7' ' ' LEU . 15.0 m-80 47.18 51.06 13.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 12.6 mt-30 -123.31 113.0 29.56 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.546 ' HD3' HD12 ' A' ' 7' ' ' LEU . 15.1 Cg_endo -64.95 169.85 11.2 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.742 1.628 . . . . 0.0 111.792 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.633 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 96.5 t -126.61 130.78 71.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.722 -176.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.576 ' OH ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -82.86 116.91 22.38 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 176.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -122.48 159.19 28.17 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.92 -1.113 . . . . 0.0 109.35 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.3 pt20 -167.06 130.87 1.88 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.511 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.466 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.43 125.93 8.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.597 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 53.9 t -91.33 162.73 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.147 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.53 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -170.6 -133.27 1.58 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -87.76 -47.83 8.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.72 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.97 -11.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.175 -0.953 . . . . 0.0 111.205 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.33 -160.18 20.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -95.09 110.59 4.04 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.258 -1.448 . . . . 0.0 111.125 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.617 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.7 t-80 -72.4 132.23 43.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.74 163.92 16.71 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.059 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 186' ' ' TYR . 15.9 p90 -161.8 168.05 23.82 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.534 HG22 HG13 ' A' ' 55' ' ' ILE . 84.5 t -114.71 135.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.59 -1.319 . . . . 0.0 112.185 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.633 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 76.1 mt -97.62 124.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 8.3 p-10 -137.1 33.05 2.61 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.992 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 178' ' ' LEU . . . -173.73 167.9 40.62 Favored Glycine 0 N--CA 1.484 1.887 0 C-N-CA 117.757 -2.163 . . . . 0.0 112.356 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.541 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.34 149.37 28.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.99 29.07 8.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 110.258 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 3' ' ' VAL . . . 49.5 22.63 3.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -140.74 25.95 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -1.068 . . . . 0.0 108.91 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 222' ' ' PHE . 0.8 OUTLIER 75.23 7.77 4.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.401 -0.812 . . . . 0.0 109.719 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 25.9 m-85 -103.33 136.54 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 221' ' ' PHE . 49.8 m-85 -123.65 163.07 21.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 111.119 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 40.4 t-80 -93.68 123.01 36.73 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 197' ' ' PHE . 54.1 t -117.42 141.67 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 111.619 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 18.2 t-20 -110.1 76.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.516 ' CD2' HG12 ' A' ' 210' ' ' VAL . 65.1 m95 -47.08 173.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.479 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -89.51 30.77 5.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -118.85 -167.37 1.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -1.157 . . . . 0.0 108.985 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.12 -104.62 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.47 52.38 0.83 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 218' ' ' SER . 0.8 OUTLIER -95.05 -93.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -1.142 . . . . 0.0 109.806 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.567 ' N ' ' CG2' ' A' ' 217' ' ' VAL . 0.5 OUTLIER -69.32 -3.86 15.76 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.403 -0.81 . . . . 0.0 110.101 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.75 128.42 26.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.218 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.97 -113.34 0.56 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 88.1 m-85 -87.02 159.02 19.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -1.141 . . . . 0.0 109.716 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.564 ' CE1' ' O ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -90.93 172.92 8.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 109.495 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.24 -165.97 1.48 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 34.8 mt -118.05 -51.55 2.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.42 -8.94 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.674 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.3 92.71 3.75 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.061 0.934 . . . . 0.0 109.051 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 227' ' ' LEU . 2.6 mm? -90.81 76.45 6.36 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-O 121.484 0.659 . . . . 0.0 109.292 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -116.52 166.03 13.66 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 195' ' ' HIS . 36.5 Cg_endo -80.18 179.92 5.78 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.789 2.326 . . . . 0.0 110.412 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.5 p -84.58 -36.41 22.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.085 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.68 115.88 27.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.08 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 59.66 4.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.882 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 100.15 126.86 5.85 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.93 -53.43 4.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.289 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -86.85 -160.37 34.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -75.03 96.81 0.99 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.13 178.12 21.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -88.67 164.99 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -1.136 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.01 -123.89 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 175.72 75.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -64.29 -174.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 109.535 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.43 ' CG ' ' OE1' ' A' ' 245' ' ' GLN . 1.5 t-20 -104.3 110.36 22.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -119.43 -46.5 0.4 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.539 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 72.5 m-85 -135.22 87.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.384 -1.068 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 162' ' ' ARG . 7.1 mt-30 -91.38 120.04 31.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.0 108.624 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 30.6 p -133.41 165.34 25.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.473 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 159' ' ' GLN . . . -141.23 152.68 44.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.725 0.774 . . . . 0.0 110.247 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.57 ' CG2' ' CD1' ' A' ' 185' ' ' TYR . 16.5 t -112.84 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.617 ' HB ' ' CG ' ' A' ' 177' ' ' GLU . 4.6 m -109.97 139.72 32.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.318 0.58 . . . . 0.0 110.174 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.434 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 100.5 48.58 1.52 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.211 -1.471 . . . . 0.0 109.659 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 9.0 mt -104.61 94.67 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.245 -1.15 . . . . 0.0 111.131 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 252' ' ' LYS . 0.0 OUTLIER -163.43 146.03 7.94 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.153 1.902 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.673 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 36.7 t . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.181 0.515 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -75.23 172.89 11.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.9 t -76.9 108.13 9.73 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.488 -0.757 . . . . 0.0 110.807 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.684 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 41.0 mt -58.54 -50.4 73.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 198' ' ' VAL . 13.5 mt -55.54 -40.81 72.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.879 -1.138 . . . . 0.0 108.503 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 14.6 m-20 -67.84 -42.8 80.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.292 -0.88 . . . . 0.0 109.149 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -57.98 -15.09 7.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 108.932 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 5.8 mtpp -116.54 20.39 14.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.34 37.01 4.5 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 58' ' ' TYR . 59.2 mt -88.54 110.1 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 122.351 1.072 . . . . 0.0 110.385 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 77.4 m80 -133.53 97.96 4.08 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.563 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.2 m-30 -103.16 174.31 5.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.157 0.98 . . . . 0.0 111.823 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 m-20 -146.83 -171.26 3.72 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 4.3 mt-30 -124.2 -11.19 7.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.919 -1.113 . . . . 0.0 109.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.73 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.17 -39.75 0.86 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.982 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.2 t-20 -45.13 -140.75 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.511 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.253 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.4 Cg_endo -73.85 2.3 6.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 122.523 1.937 . . . . 0.0 109.0 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 46.9 m-85 -72.76 -37.48 67.66 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.704 -0.622 . . . . 0.0 109.59 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 38.3 p-10 -96.15 21.24 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.564 -1.335 . . . . 0.0 110.087 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -74.75 4.44 6.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.315 -0.865 . . . . 0.0 109.622 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.0 mt -136.29 -1.81 2.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.936 -1.103 . . . . 0.0 110.467 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.3 p -61.56 161.77 18.44 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HG3' HD21 ' A' ' 86' ' ' LEU . 20.0 Cg_endo -69.85 137.51 35.38 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.697 1.598 . . . . 0.0 110.597 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.92 142.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.792 0.806 . . . . 0.0 110.82 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.5 mt -76.9 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.415 0.626 . . . . 0.0 109.833 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.745 ' HA ' HG13 ' A' ' 39' ' ' VAL . 64.0 mt-10 -126.22 -19.31 4.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.804 . . . . 0.0 111.398 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' TYR . 34.0 mtpt -123.11 171.77 9.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.729 -1.232 . . . . 0.0 110.58 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 37' ' ' SER . 94.4 t . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.742 0.782 . . . . 0.0 110.963 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.481 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.5 t . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.2 m-85 -124.07 18.97 9.2 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.853 -1.154 . . . . 0.0 110.23 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 29' ' ' GLU . 45.1 t -67.88 140.36 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.556 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.39 -2.26 72.61 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 13.2 mt-30 -83.4 136.52 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.33 -1.1 . . . . 0.0 109.824 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -73.2 108.58 6.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.2 168.79 0.09 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.721 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -90.24 173.36 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.005 . . . . 0.0 110.066 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.553 ' O ' ' HE3' ' A' ' 129' ' ' MET . 31.3 p -83.15 -37.68 23.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.229 -0.919 . . . . 0.0 108.603 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' A' ' 135' ' ' SER . . . 105.05 136.44 8.69 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' VAL . 2.8 p -54.57 -54.04 46.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -1.231 . . . . 0.0 108.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 38.2 t -46.38 -52.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.26 -52.28 66.35 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.865 0.84 . . . . 0.0 109.791 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.529 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.27 -32.61 74.07 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.186 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.86 86.69 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.222 -1.391 . . . . 0.0 108.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.43 HG23 HD21 ' A' ' 147' ' ' LEU . 83.9 m -73.52 -53.05 11.49 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.754 0.788 . . . . 0.0 109.651 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.39 -42.64 64.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.805 -0.56 . . . . 0.0 110.193 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.563 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.1 mt-30 -56.66 -48.75 76.9 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 198' ' ' VAL . 32.5 mt -66.27 -26.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.612 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -70.31 -35.88 73.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 23.7 tptt -72.58 -42.05 65.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.684 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.1 t80 -53.9 -31.61 50.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 71.9 m-70 -107.86 -22.35 12.48 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.649 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.68 51.43 3.03 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.5 t80 -70.02 -74.34 0.16 Allowed Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 33.9 Cg_endo -68.97 107.59 1.74 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 CA-C-N 119.044 0.694 . . . . 0.0 112.158 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -70.32 -21.95 62.87 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.2 tttm -134.27 148.06 50.75 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 144.9 42.42 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.238 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.963 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.435 -1.038 . . . . 0.0 111.579 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' ' OD1' ' A' ' 150' ' ' ASN . 51.7 tttt -151.51 137.24 17.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.093 -1.629 . . . . 0.0 111.229 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' N ' ' HB3' ' A' ' 91' ' ' SER . 75.6 m-20 -59.42 152.76 20.71 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.862 ' CZ ' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -126.85 172.81 10.08 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.62 -1.3 . . . . 0.0 107.986 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.7 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 10.9 t -167.87 134.74 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.01 173.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.615 ' HD2' ' CE2' ' A' ' 69' ' ' TYR . 3.3 p90 -148.67 146.47 28.18 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.258 -0.901 . . . . 0.0 109.112 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.8 m -93.43 135.15 34.95 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.724 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -52.14 144.58 12.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.86 0.838 . . . . 0.0 111.428 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.93 145.08 53.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.364 0.602 . . . . 0.0 110.453 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -72.46 -0.15 11.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.92 . . . . 0.0 109.756 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -96.28 -10.36 28.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.204 -0.935 . . . . 0.0 108.874 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.724 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.0 t-20 -69.79 111.0 7.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.713 -0.617 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.1 Cg_endo -88.95 17.5 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.82 2.346 . . . . 0.0 109.193 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 89.6 m-85 -107.1 -15.27 14.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.575 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -135.52 167.21 21.51 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.584 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.0 m120 -48.7 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 175.12 -48.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 111.302 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -75.66 60.54 5.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 N-CA-C 106.955 -1.979 . . . . 0.0 106.955 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HG3' HD12 ' A' ' 86' ' ' LEU . 2.0 tptt -104.5 119.78 39.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.424 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.88 119.28 38.46 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.406 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 26' ' ' PRO . 2.7 mp -94.88 143.57 26.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.526 ' HA ' ' CE1' ' A' ' 69' ' ' TYR . 18.2 t80 -139.03 130.75 27.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 110.726 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -110.22 119.4 39.13 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.7 45.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.696 -1.252 . . . . 0.0 107.834 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.832 HD12 ' CG ' ' A' ' 150' ' ' ASN . 15.4 mt -52.32 -56.56 6.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 O-C-N 121.578 -0.701 . . . . 0.0 109.999 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.545 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -44.56 -26.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 108.987 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -111.47 34.72 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 108.916 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.707 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 38.1 mmt-85 -93.35 155.81 17.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 110.868 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.73 88.77 2.98 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -80.76 86.38 5.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.208 -0.932 . . . . 0.0 110.416 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.6 t-20 -79.38 90.96 5.03 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.649 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 77.5 m95 -61.36 -6.23 2.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.438 -0.789 . . . . 0.0 110.46 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.4 t-20 -89.88 -19.26 24.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 12.9 m-20 -99.67 -28.72 13.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 115' ' ' ALA . 41.8 mt -74.34 66.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 101' ' ' LEU . 9.4 mt -46.32 148.66 1.53 Allowed Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 121.662 -0.649 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.548 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.5 Cg_endo -78.79 -19.5 11.09 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.92 2.414 . . . . 0.0 110.432 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 2.5 t -142.78 121.58 12.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.113 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 116' ' ' ILE . 64.4 m-85 -109.28 138.54 45.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.932 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -101.11 -3.84 28.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.0 108.973 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.28 87.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -115.06 -1.03 13.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -1.231 . . . . 0.0 109.606 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -67.08 170.83 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.717 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.9 174.27 2.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -77.26 -34.34 55.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.56 -59.72 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 109.576 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.8 -34.15 76.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.132 -0.98 . . . . 0.0 109.158 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.503 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 85.4 mttt -66.01 -42.72 89.34 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 35.8 ttm -59.34 -35.63 74.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.21 -68.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.726 -0.609 . . . . 0.0 110.592 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.599 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.7 tp -60.14 -41.69 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 11.5 p -53.73 -43.24 68.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.853 -1.154 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.796 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.2 tt0 -69.36 -42.14 75.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.999 -1.063 . . . . 0.0 108.78 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.599 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.2 tp -54.05 -53.69 49.57 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.608 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -57.07 -43.06 81.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -66.18 -39.66 89.88 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 15.6 m-20 -68.47 -46.48 69.63 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 127' ' ' VAL . 43.6 t -67.01 -63.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.22 -38.82 9.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.862 HG23 ' CZ ' ' A' ' 69' ' ' TYR . 2.9 mt -69.84 -60.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.306 -1.114 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.607 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.2 p -46.47 -25.74 0.73 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.851 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 123' ' ' VAL . 27.1 m -104.26 33.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 109.792 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.2 m-20 41.75 40.96 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 109.8 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.603 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 35.4 tpp -56.42 134.05 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 111.589 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 34.4 m-20 -78.09 122.41 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 40.3 m-85 -103.9 106.24 16.68 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -141.2 -162.09 8.98 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 104.332 -3.507 . . . . 0.0 104.332 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.64 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.74 -30.96 78.73 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 106.007 -2.343 . . . . 0.0 106.007 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.93 139.15 45.34 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.56 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 73.8 m -114.14 112.72 23.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 119.934 -1.729 . . . . 0.0 110.721 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.67 130.52 10.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.624 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -117.23 -168.16 1.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.056 -1.261 . . . . 0.0 108.3 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.926 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.15 -50.85 5.76 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 124.01 -129.08 7.09 Favored Glycine 0 N--CA 1.481 1.684 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.257 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.534 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 4.2 m -48.23 -59.71 3.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.962 -0.728 . . . . 0.0 112.019 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 140' ' ' SER . 40.1 p -46.97 -35.35 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.789 -1.194 . . . . 0.0 108.622 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.926 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 74.9 mmt-85 -80.62 -48.51 12.56 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.91 0.862 . . . . 0.0 109.192 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.77 HG21 ' CE2' ' A' ' 185' ' ' TYR . 89.0 t -66.66 -59.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.477 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 1.4 pp0? -56.5 -33.21 65.79 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 108.58 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.8 ttm180 -76.79 -53.91 7.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.007 -1.058 . . . . 0.0 109.48 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -64.33 -38.21 90.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.105 -0.997 . . . . 0.0 109.575 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.561 ' HB2' HG11 ' A' ' 157' ' ' VAL . 17.1 mt -51.05 -48.6 61.52 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.665 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 55.2 mtmt -88.17 -31.2 19.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 111.285 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 19.8 mt-10 -74.29 -65.51 0.84 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.718 -1.239 . . . . 0.0 112.732 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.832 ' CG ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.98 -32.17 30.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.633 -1.292 . . . . 0.0 111.966 -177.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 32.8 m-85 -103.55 -10.26 18.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.512 -1.367 . . . . 0.0 110.768 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.963 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 58.6 39.15 92.93 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.097 -1.002 . . . . 0.0 112.531 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.2 m-85 -63.3 162.01 12.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.202 -1.764 . . . . 0.0 107.641 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 50.4 t-20 -47.1 147.9 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.826 -1.171 . . . . 0.0 109.923 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -53.86 -17.97 2.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.529 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 26.4 p -57.37 -11.95 2.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 110.051 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.561 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.0 t -70.92 121.44 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.798 -1.189 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 1.026 ' CE1' HG23 ' A' ' 249' ' ' VAL . 7.6 p-80 -148.65 179.79 7.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 38.5 tt0 -123.8 138.41 54.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.764 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -122.96 152.37 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 8.5 m-80 -109.89 103.23 11.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.109 . . . . 0.0 111.027 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.604 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 13.2 tpt180 -47.83 -36.48 11.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.043 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.6 67.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 4.74 35.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.922 -1.34 . . . . 0.0 111.668 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -118.17 161.19 20.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.569 -1.332 . . . . 0.0 110.143 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 5.2 p -87.06 131.71 34.03 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.3 ttpt -32.78 -44.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.83 -0.543 . . . . 0.0 110.906 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -63.59 -63.73 1.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.953 -1.092 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -62.42 -17.34 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.741 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.764 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.31 -47.86 22.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.087 -1.008 . . . . 0.0 109.172 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 174' ' ' ILE . 59.5 mt-10 -67.71 -22.73 65.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.98 97.14 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -60.94 -36.2 78.71 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.586 ' CG2' HG21 ' A' ' 199' ' ' ILE . 18.5 mt -73.78 -66.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.385 -0.822 . . . . 0.0 110.575 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -48.27 -41.72 28.61 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 109.446 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -52.29 -47.47 65.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.0 mm-40 -61.06 -45.21 95.69 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.559 HD11 ' CG2' ' A' ' 199' ' ' ILE . 27.8 mt -68.29 -30.34 69.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.665 -0.647 . . . . 0.0 110.425 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' ASP . 62.7 p -52.55 -35.94 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.069 -1.019 . . . . 0.0 108.799 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 17.7 mt-30 -101.17 28.78 5.1 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.481 ' HB3' HD22 ' A' ' 7' ' ' LEU . 96.3 m-20 49.26 50.72 17.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 21.4 mt-30 -123.67 110.95 29.7 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.8 Cg_endo -64.21 166.16 17.64 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.567 1.511 . . . . 0.0 112.087 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.602 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 35.8 t -123.7 136.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.266 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.77 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -85.38 118.34 24.85 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 175.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 6.5 t80 -122.45 158.18 30.31 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.793 -1.192 . . . . 0.0 109.399 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 187' ' ' GLN . 3.5 pt20 -167.38 136.73 2.74 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.538 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.68 108.91 2.97 Favored Glycine 0 C--N 1.288 -2.108 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.598 HG22 ' CA ' ' A' ' 194' ' ' GLY . 19.3 t -78.56 160.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.241 -1.152 . . . . 0.0 112.159 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.12 -56.12 3.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -1.212 . . . . 0.0 110.507 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.04 -23.86 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.271 -0.893 . . . . 0.0 111.416 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.53 -167.54 24.98 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.598 ' CA ' HG22 ' A' ' 189' ' ' VAL . . . -85.62 106.25 3.01 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 121.062 -1.257 . . . . 0.0 111.496 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 6.5 t-80 -72.09 125.33 26.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -117.34 163.93 15.6 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.081 -1.448 . . . . 0.0 113.199 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 186' ' ' TYR . 32.2 p90 -159.48 170.16 22.31 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 55' ' ' ILE . 85.5 t -114.67 135.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.515 -1.365 . . . . 0.0 112.45 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 208' ' ' TYR . 11.8 mt -97.72 127.56 49.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.565 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.1 p30 -140.28 33.64 1.89 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.611 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.603 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 172.71 -175.51 45.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.442 -1.837 . . . . 0.0 111.003 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.673 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -161.3 152.2 18.31 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.424 -1.045 . . . . 0.0 109.092 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -113.81 14.62 18.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.775 -1.203 . . . . 0.0 111.338 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.87 -4.99 85.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.706 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 207' ' ' PHE . 4.5 mtp180 -128.2 70.83 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.802 -1.41 . . . . 0.0 110.59 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 205' ' ' ARG . 64.2 m-20 39.33 28.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 109.919 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -121.08 128.43 52.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.299 -0.876 . . . . 0.0 109.046 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 199' ' ' ILE . 73.9 m-85 -109.05 170.33 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.614 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 53.3 t-80 -91.55 115.34 27.96 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.558 HG13 ' CD2' ' A' ' 197' ' ' PHE . 11.5 t -112.85 142.84 23.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 122.256 1.027 . . . . 0.0 112.277 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.455 ' HB2' HD12 ' A' ' 8' ' ' LEU . 21.8 t-20 -110.6 78.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.506 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 68.9 m95 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.149 -0.969 . . . . 0.0 110.109 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 162' ' ' ARG . 12.0 tt0 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.3 p -151.62 169.95 20.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.059 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.92 146.34 37.28 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.186 0.993 . . . . 0.0 110.934 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.8 t -105.13 118.81 53.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 1.026 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.3 m -125.88 145.71 32.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.86 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.09 52.21 2.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.632 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 50.6 mt -97.44 88.94 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -1.083 . . . . 0.0 109.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.21 152.32 12.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.342 2.028 . . . . 0.0 110.402 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.678 HG11 ' HB3' ' A' ' 178' ' ' LEU . 85.4 t . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.508 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -74.43 -173.63 1.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.069 -1.02 . . . . 0.0 109.012 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.591 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 69.8 m -77.44 100.35 5.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.808 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.659 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 18.2 mt -58.83 -48.25 81.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.185 -0.947 . . . . 0.0 108.485 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.709 HD11 HG11 ' A' ' 198' ' ' VAL . 9.5 mt -55.91 -41.45 74.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 33.8 t0 -67.0 -38.73 86.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -15.9 11.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 108.558 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 16.0 mtpp -120.07 14.8 12.34 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.95 43.67 8.52 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.8 mt -93.1 110.28 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.493 -1.004 . . . . 0.0 110.574 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 51.6 m80 -135.13 100.02 4.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . 14.6 m-30 -102.4 175.9 5.36 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.891 -1.131 . . . . 0.0 110.843 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 5.1 t-20 -146.54 -171.27 3.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.585 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . 58.4 mt-30 -124.97 -3.56 7.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.829 -1.17 . . . . 0.0 110.676 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.03 -60.61 0.34 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.147 -1.501 . . . . 0.0 112.737 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.781 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -44.78 -123.72 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.424 0 CA-C-O 117.369 -1.3 . . . . 0.0 112.371 -176.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.781 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 42.7 Cg_endo -81.41 10.54 3.4 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 123.452 2.269 . . . . 0.0 109.596 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.824 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 92.6 m-85 -83.03 -38.64 22.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 110.663 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 44.4 p30 -103.55 35.39 2.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.622 -1.299 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.7 mt -78.11 -3.96 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.873 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 118' ' ' GLU . 21.3 mt -129.4 10.82 5.77 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.923 -1.11 . . . . 0.0 109.391 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.3 p -81.39 163.21 55.7 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.4 Cg_endo -69.82 128.59 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.131 1.887 . . . . 0.0 111.82 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 42' ' ' HIS . 10.8 t -74.43 150.67 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.737 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.2 mt -77.67 148.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.467 -0.771 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.55 -21.75 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.721 -0.612 . . . . 0.0 110.404 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.3 mtpp -122.29 171.96 8.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 110.071 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.0 t . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.394 -0.816 . . . . 0.0 111.113 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.9 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.069 0.462 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.4 m-85 -123.78 19.05 9.43 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' ILE . 66.9 t -66.8 144.5 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.73 -4.01 66.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 28.5 mt-30 -86.65 128.77 35.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -1.174 . . . . 0.0 109.564 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 25' ' ' THR . 1.1 m-70 -73.23 113.79 10.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.81 158.07 1.47 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.77 -1.172 . . . . 0.0 108.933 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 17' ' ' GLN . . . -78.47 170.09 17.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.391 0.615 . . . . 0.0 109.973 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 129' ' ' MET . 10.3 p -77.63 -31.58 52.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 103.6 138.08 9.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 p -54.51 -53.65 51.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -1.068 . . . . 0.0 108.408 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 4.9 t -47.01 -52.27 4.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.29 -50.12 74.89 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.947 0.879 . . . . 0.0 110.068 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.36 -33.88 76.5 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -178.248 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.56 87.66 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.217 -1.393 . . . . 0.0 107.43 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.722 HG23 HD21 ' A' ' 147' ' ' LEU . 59.7 m -74.42 -53.54 9.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 108.852 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -53.32 -37.94 62.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.813 -0.554 . . . . 0.0 110.77 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.505 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 27.1 mt-30 -67.34 -52.85 35.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.581 -1.324 . . . . 0.0 108.108 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 198' ' ' VAL . 31.9 mt -65.0 -18.8 24.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 34.4 mtp -73.84 -45.25 52.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 18.4 tptt -67.12 -36.02 81.0 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.659 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 65.9 t80 -54.06 -31.93 53.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.431 -0.793 . . . . 0.0 109.297 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 60' ' ' ASN . 26.3 m80 -106.92 -22.04 12.82 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 98.4 m-20 45.61 56.12 6.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 4.3 t80 -79.82 -74.54 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -68.11 103.15 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-N 119.104 0.716 . . . . 0.0 111.888 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.429 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 65.3 m-80 -70.56 -22.79 62.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.41 140.8 45.22 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.59 151.13 33.37 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.752 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.753 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.84 -44.29 10.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.506 -0.997 . . . . 0.0 109.97 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 13.9 tttp -152.57 142.35 21.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.103 -0.998 . . . . 0.0 109.855 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 89' ' ' ALA . 1.5 m-20 -65.24 164.49 13.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.673 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 70' ' ' THR . 7.6 t80 -143.78 147.19 33.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.431 -0.793 . . . . 0.0 109.272 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.629 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t -150.2 166.11 30.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.1 p90 -171.68 157.03 4.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 86.9 m -93.13 131.37 38.25 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.776 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -44.94 150.13 0.4 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 111.403 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 p -61.56 139.46 58.25 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -4.83 11.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -97.59 -7.41 31.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.588 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.776 ' ND2' HD21 ' A' ' 73' ' ' LEU . 25.9 t-20 -70.01 108.59 3.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 109.73 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.1 Cg_endo -89.36 15.73 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.997 2.465 . . . . 0.0 110.533 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.59 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 85.0 m-85 -106.42 -24.43 12.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.0 110.866 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' A' ' 81' ' ' ASN . 72.8 m-85 -117.71 163.85 15.86 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 10.3 m120 -48.19 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.546 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER 175.04 -47.56 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 111.307 175.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.47 55.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.0 tptt -106.0 104.94 14.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.253 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.14 140.99 33.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.124 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -115.23 145.88 41.99 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 5.8 t80 -136.83 128.42 28.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.303 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.32 111.84 23.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 87' ' ' PHE . . . -72.81 53.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.577 -1.327 . . . . 0.0 107.909 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 10.5 mt -52.62 -54.17 16.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.033 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -45.36 -26.14 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.751 -1.218 . . . . 0.0 109.073 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -110.86 32.34 5.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 108.892 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 35.0 mmt-85 -92.48 154.22 18.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -117.32 90.98 3.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.61 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.5 m-85 -80.84 85.04 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 110.664 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 4.9 t30 -78.88 89.33 4.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 100' ' ' ILE . 77.7 m95 -61.36 -5.1 1.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.525 -0.734 . . . . 0.0 110.939 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.25 -15.58 33.24 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.728 -1.233 . . . . 0.0 107.684 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 36.3 m-20 -99.65 -30.75 11.93 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.821 HG12 ' HB1' ' A' ' 115' ' ' ALA . 22.3 mt -73.64 67.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.653 0.74 . . . . 0.0 109.307 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 16.0 mt -47.47 148.78 2.23 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.597 -0.689 . . . . 0.0 109.528 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.567 ' HB3' HG12 ' A' ' 13' ' ' ILE . 31.4 Cg_endo -79.39 -17.38 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.648 2.232 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.27 123.08 9.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.044 . . . . 0.0 109.478 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 90.8 m-85 -110.79 144.03 40.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -100.53 2.68 42.18 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.325 -0.86 . . . . 0.0 108.816 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 81.67 0.73 89.67 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 2.84 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 104' ' ' TYR . 1.3 mp0 -67.11 169.02 9.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -64.9 177.46 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.278 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 1.2 m-20 -82.11 -36.49 27.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.854 . . . . 0.0 109.632 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.06 -57.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -38.08 89.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.14 -0.975 . . . . 0.0 108.84 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.532 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 81.0 mttt -63.78 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.45 -0.781 . . . . 0.0 109.011 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.496 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.0 ttm -58.78 -40.83 85.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 0.0 109.182 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.821 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.79 -54.58 45.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.626 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -68.36 -38.51 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.538 -1.352 . . . . 0.0 109.743 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -56.71 -43.65 80.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.102 -0.999 . . . . 0.0 109.887 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.596 ' N ' HD12 ' A' ' 24' ' ' LEU . 35.2 tt0 -69.99 -37.02 75.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.4 tp -62.97 -52.01 64.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.824 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -60.68 -48.05 83.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.559 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.72 90.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 0.0 108.821 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.592 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 88.3 m-20 -63.95 -41.44 97.6 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 119' ' ' LEU . 72.3 t -71.44 -59.16 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.391 0.615 . . . . 0.0 109.46 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.99 -47.43 14.68 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 126' ' ' SER . 2.3 mt -63.7 -56.15 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.316 -1.108 . . . . 0.0 108.217 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 2.2 p -45.96 -29.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.298 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 17.6 m -105.95 38.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.486 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 9.1 p-10 36.94 50.76 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.515 0.674 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.564 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 49.8 tpp -59.76 128.14 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.55 -0.718 . . . . 0.0 110.74 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 135' ' ' SER . 33.8 t70 -75.36 123.8 26.0 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.631 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 64.9 m-85 -103.33 114.09 28.1 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.539 1.161 . . . . 0.0 113.144 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.737 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.3 -164.24 11.74 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 0.0 104.426 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.618 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 17.8 Cg_endo -62.35 -29.38 79.49 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 N-CA-C 105.952 -2.365 . . . . 0.0 105.952 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.75 139.5 44.73 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.543 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 54.8 m -119.42 109.19 15.47 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.898 -1.751 . . . . 0.0 109.948 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.08 142.91 16.02 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.826 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 4.7 t -116.43 -162.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.829 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.96 -47.55 7.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 132.41 -139.55 11.04 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.029 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.627 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 9.0 m -50.32 -53.01 31.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.795 -0.826 . . . . 0.0 112.329 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 145' ' ' ARG . 1.5 p -47.42 -33.84 6.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.708 -1.245 . . . . 0.0 108.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.1 mmp_? -80.51 -48.22 13.1 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.949 0.88 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 185' ' ' TYR . 70.4 t -67.24 -56.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.914 -0.491 . . . . 0.0 110.966 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.9 pp0? -56.12 -33.54 65.24 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -77.37 -48.1 18.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.35 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.94 -36.15 77.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.157 -0.964 . . . . 0.0 110.274 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 52' ' ' THR . 41.7 mt -57.13 -46.26 82.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.825 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 51.8 mtmt -87.18 -44.02 11.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.995 -1.066 . . . . 0.0 111.18 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.0 mt-10 -69.34 -50.5 45.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.399 -1.438 . . . . 0.0 111.446 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 18.1 m120 -88.63 -45.52 9.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 0.0 111.636 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.61 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 33.5 m-85 -102.2 18.28 21.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.753 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 31.63 41.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.648 -0.658 . . . . 0.0 112.985 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.1 m-85 -63.41 164.32 9.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.268 -1.725 . . . . 0.0 108.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.51 145.86 2.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.928 -1.108 . . . . 0.0 109.529 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -53.8 -18.96 3.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.056 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.576 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 84.6 p -55.3 -15.0 2.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.626 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.5 t -67.61 121.57 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.781 -1.199 . . . . 0.0 109.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.2 p-80 -147.84 175.61 10.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 109.449 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.627 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 25.1 tt0 -120.86 138.45 54.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.721 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.846 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 12.7 pt -125.75 158.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.6 m-80 -114.56 101.22 8.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.871 -1.143 . . . . 0.0 110.71 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HD3' ' CD1' ' A' ' 170' ' ' TRP . 1.2 tpt180 -45.71 -36.82 5.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 109.072 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.59 -27.77 66.67 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.88 6.92 36.77 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.984 -1.303 . . . . 0.0 111.917 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -118.12 171.24 8.24 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.392 -1.443 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 95.0 p -95.23 134.34 38.1 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 9.4 ttpp -35.36 -48.98 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.717 -0.615 . . . . 0.0 110.781 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.37 -57.74 8.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.996 -1.065 . . . . 0.0 110.294 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.2 -20.56 65.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.846 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.7 t-105 -75.26 -43.96 48.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.397 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 174' ' ' ILE . 90.3 mt-10 -68.97 -31.28 70.03 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.948 -1.095 . . . . 0.0 108.311 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.25 73.95 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 36.6 mm-40 -61.14 -41.63 97.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 108.975 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 199' ' ' ILE . 10.4 mt -75.38 -57.35 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 110.56 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -42.61 43.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.069 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -54.17 -46.03 72.23 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 45.7 mm-40 -58.55 -50.46 73.72 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.678 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.0 mt -65.8 -29.27 69.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.371 -0.83 . . . . 0.0 109.626 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 5.8 p -50.03 -42.98 50.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 108.729 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 14.7 mt-30 -95.83 30.76 2.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.599 ' C ' HD13 ' A' ' 7' ' ' LEU . 66.7 m-80 49.36 51.37 16.46 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 22.1 mt-30 -123.14 111.96 30.29 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 55' ' ' ILE . 13.8 Cg_endo -62.88 173.64 3.65 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.223 1.949 . . . . 0.0 112.539 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.661 HG21 HG23 ' A' ' 174' ' ' ILE . 93.7 t -133.45 142.16 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.36 1.076 . . . . 0.0 112.803 -176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.801 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -90.85 117.7 29.67 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 175.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 10.0 t80 -122.51 161.57 23.37 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.129 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.2 pt20 -167.29 138.73 3.15 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 118.171 -1.412 . . . . 0.0 110.791 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -111.48 108.33 2.31 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 190' ' ' GLY . 21.9 t -66.85 163.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 111.174 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.521 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.87 -136.59 2.07 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -32.49 18.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 111.253 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.78 -18.7 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.874 -1.141 . . . . 0.0 111.504 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.88 -170.43 23.47 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -78.11 100.15 1.61 Allowed Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.83 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.635 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.1 t-80 -72.26 126.69 30.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.13 165.86 13.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.053 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 40.7 p90 -156.89 -159.91 0.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.043 HG22 HD11 ' A' ' 55' ' ' ILE . 11.5 t -139.74 138.77 38.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.693 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.758 HD13 HG21 ' A' ' 174' ' ' ILE . 90.7 mt -107.08 111.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 15.1 p-10 -123.7 34.21 5.14 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.285 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 174.62 160.1 22.09 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.354 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -138.42 168.38 19.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -126.76 -11.17 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.958 -1.089 . . . . 0.0 110.209 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.59 -35.85 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 4.8 mtt180 -88.73 35.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.253 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 70.43 31.67 2.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 109.648 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 48.5 m-85 -122.26 133.78 54.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.17 -0.956 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 33.9 m-85 -124.07 160.47 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.311 -0.868 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.591 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 40.3 t-80 -92.13 134.6 34.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 198' ' ' VAL . 21.4 t -131.58 146.19 33.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.337 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.564 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 42.6 t-20 -114.45 81.92 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 91.4 m95 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.721 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.558 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -149.58 166.16 30.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.045 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.26 152.23 44.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.278 1.037 . . . . 0.0 110.925 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 68.9 t -111.02 117.56 55.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.719 HG23 ' NE2' ' A' ' 158' ' ' HIS . 25.0 m -123.12 145.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.066 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 87.74 56.44 2.1 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 HG21 ' A' ' 55' ' ' ILE . 63.2 mt -100.32 74.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.565 -0.962 . . . . 0.0 110.674 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -152.4 156.76 33.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.086 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.613 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.295 1.997 . . . . 0.0 110.476 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 202' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 200' ' ' ASP . 35.4 mmtt -76.77 179.57 6.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . 4.2 m -77.67 104.93 8.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.014 -1.054 . . . . 0.0 109.363 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.666 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.6 mt -57.95 -56.17 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD11 ' CG1' ' A' ' 198' ' ' VAL . 18.2 mt -55.14 -36.88 66.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.41 -1.431 . . . . 0.0 108.294 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 22.4 t0 -68.52 -42.1 79.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.126 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -58.55 -14.98 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.05 -1.031 . . . . 0.0 109.045 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 15.5 mtpt -120.56 20.27 11.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.42 37.6 4.86 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.6 mt -85.31 106.92 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.386 1.089 . . . . 0.0 110.551 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 102' ' ' PRO . 17.7 m-70 -134.81 95.43 3.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 9.3 m-30 -98.95 179.13 4.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 111.064 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 26.1 t-20 -145.96 -177.44 5.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 39.0 mt-30 -116.64 -18.0 10.42 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.923 -1.111 . . . . 0.0 110.164 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.72 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.95 -38.22 0.9 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.337 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.3 t-20 -45.01 -142.5 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.458 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -73.78 2.99 5.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 122.411 1.897 . . . . 0.0 109.441 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 116' ' ' ILE . 11.2 m-85 -79.29 -28.01 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.122 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 14.7 p-10 -96.51 23.38 6.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.593 -1.317 . . . . 0.0 109.783 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 8.7 mt -76.79 -5.64 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.566 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.8 mt -125.57 9.46 7.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.602 -1.311 . . . . 0.0 109.428 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 40.9 p -82.06 160.87 62.14 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.606 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -68.82 126.18 13.61 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.14 1.894 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.493 HG22 ' CG ' ' A' ' 42' ' ' HIS . 44.4 t -74.65 151.45 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.423 0.63 . . . . 0.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.2 mt -77.69 147.23 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 110.899 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.7 mt-10 -126.31 -20.74 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.745 -0.597 . . . . 0.0 110.535 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 48.0 mtpt -120.12 172.9 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.005 -1.059 . . . . 0.0 110.158 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 79.7 t . . . . . 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 111.05 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.5 t . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.157 0.503 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 75.5 m-85 -124.18 23.92 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.107 -0.996 . . . . 0.0 109.367 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 29' ' ' GLU . 70.2 t -69.99 146.49 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.809 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.05 1.84 86.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 13.3 mt-30 -93.06 126.8 38.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -1.131 . . . . 0.0 109.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 27' ' ' VAL . 1.7 m-70 -72.83 111.55 8.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.32 157.69 1.37 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.997 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.07 166.04 23.81 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.628 0.727 . . . . 0.0 109.946 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.771 HG21 ' SD ' ' A' ' 120' ' ' MET . 19.1 p -77.11 -33.66 56.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 106.18 136.57 8.44 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.487 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 5.3 p -54.85 -50.12 69.45 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.292 -1.122 . . . . 0.0 108.275 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 9.5 t -47.52 -53.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.53 -48.65 80.85 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.046 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.737 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -62.79 -33.6 75.53 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.966 -177.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.93 91.62 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.882 -1.527 . . . . 0.0 108.036 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 56' ' ' MET . 31.3 m -75.46 -50.68 15.03 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.426 0.631 . . . . 0.0 110.003 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.32 -35.57 38.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 mt-30 -68.47 -44.88 73.85 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 198' ' ' VAL . 53.0 mt -69.92 -22.9 25.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.616 ' HG3' HG22 ' A' ' 52' ' ' THR . 16.8 mtp -73.76 -34.58 64.77 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.599 ' HD3' HG22 ' A' ' 100' ' ' ILE . 33.7 tptt -74.9 -43.39 54.59 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.8 t80 -54.06 -25.46 21.71 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.351 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 32.1 m-70 -108.31 -27.81 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 110.674 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 67.6 m-20 45.11 61.36 2.57 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.3 t80 -84.98 -77.56 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.6 Cg_endo -70.66 106.47 1.83 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 119.467 0.845 . . . . 0.0 113.83 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -67.51 -24.79 65.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -131.83 127.04 35.76 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 176.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.73 166.08 4.84 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 118.566 -1.778 . . . . 0.0 110.877 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.046 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -95.95 -35.29 11.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.469 -1.018 . . . . 0.0 111.44 -178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 27.0 tttp -152.76 130.54 11.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.534 -1.354 . . . . 0.0 110.887 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 3.4 m-20 -62.25 171.35 1.88 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.08 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.405 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 47.4 t80 -149.11 141.8 24.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.578 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t -144.65 148.37 34.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.67 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.5 p90 -160.47 155.2 24.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 29.1 m -93.01 131.71 37.76 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.783 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.13 147.72 0.68 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.845 . . . . 0.0 110.727 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 1.5 t -61.79 146.75 48.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.941 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 0.99 9.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.109 -0.994 . . . . 0.0 109.745 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -99.47 -7.99 25.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.783 ' ND2' HD21 ' A' ' 73' ' ' LEU . 17.6 t-20 -70.32 109.41 4.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.751 -0.593 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.2 Cg_endo -89.26 15.68 1.95 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 73.9 m-85 -110.78 -23.65 10.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 111.167 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 80.4 m-85 -118.14 160.69 21.11 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.7 m120 -48.22 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 174.76 -45.75 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.387 -0.821 . . . . 0.0 111.311 175.322 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.0 Cg_endo -75.76 55.32 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 N-CA-C 107.86 -1.631 . . . . 0.0 107.86 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 5.4 tptt -106.75 106.81 17.51 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.237 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -100.1 141.54 32.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.64 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.67 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 mp -118.26 125.41 50.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 12.1 t80 -120.16 127.71 52.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.956 . . . . 0.0 110.133 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -108.34 111.9 24.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -72.94 53.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.739 -1.226 . . . . 0.0 108.352 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.658 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.7 mt -53.24 -58.3 3.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.746 -0.596 . . . . 0.0 111.195 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.0 p -43.56 -29.44 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.815 -1.178 . . . . 0.0 109.257 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.884 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.29 30.14 7.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.46 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.814 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 27.7 mmt-85 -79.22 156.06 28.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.537 -1.352 . . . . 0.0 109.4 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -116.46 83.78 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 122' ' ' ASP . 9.1 m-85 -80.71 97.83 7.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.611 -0.681 . . . . 0.0 110.132 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 100' ' ' ILE . 29.5 t-20 -79.02 89.88 4.79 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 45.5 m95 -60.54 -8.89 3.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.68 -21.68 21.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.2 m-20 -100.07 -24.76 14.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 57' ' ' LYS . 36.3 mt -73.49 64.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.575 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 37.7 mt -46.4 149.23 1.4 Allowed Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 13' ' ' ILE . 29.6 Cg_endo -77.58 -25.17 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.579 2.186 . . . . 0.0 110.522 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 125.37 16.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 109.516 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.575 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 76.5 m-85 -112.78 145.14 41.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -99.56 -4.36 31.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 82.49 7.64 87.26 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -118.5 9.12 12.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -1.068 . . . . 0.0 108.724 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -72.76 -177.84 2.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.437 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -73.92 172.94 10.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -74.81 -36.18 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.634 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.3 t -51.81 -60.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.437 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 5.2 mp0 -62.54 -36.24 82.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.974 -1.079 . . . . 0.0 108.989 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.5 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 72.9 mttt -64.5 -42.67 95.7 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.484 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.5 ttm -60.03 -38.73 83.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.11 -69.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.485 -0.76 . . . . 0.0 110.476 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.722 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.0 tp -57.92 -43.6 84.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 110.227 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 5.3 p -50.51 -40.52 51.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.493 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.62 -48.96 58.23 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.4 tp -49.19 -48.76 45.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.771 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -58.82 -55.28 37.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.577 -0.702 . . . . 0.0 110.583 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.42 -33.43 75.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.814 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 21.6 m-20 -64.37 -47.12 80.48 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 119' ' ' LEU . 62.1 t -71.35 -55.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.499 -0.75 . . . . 0.0 109.264 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.26 -50.53 12.94 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.0 mt -63.69 -55.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.255 -1.144 . . . . 0.0 108.046 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 6.9 p -46.93 -32.05 3.57 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.296 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.598 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 14.1 m -100.66 34.32 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.9 m-20 38.6 53.69 1.88 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.611 0.719 . . . . 0.0 109.509 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.601 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 57.3 tpp -65.87 129.56 40.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 111.629 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -76.61 121.83 23.78 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 75.6 m-85 -103.38 117.46 34.53 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.705 1.24 . . . . 0.0 113.432 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.54 -162.46 10.6 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 104.12 -3.592 . . . . 0.0 104.12 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.656 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.53 -30.48 79.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 106.049 -2.327 . . . . 0.0 106.049 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.94 143.06 40.42 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.0 m -124.59 112.55 16.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.975 -1.703 . . . . 0.0 110.092 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 146.28 16.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.578 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 33.5 t -120.0 -164.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -91.89 -52.31 4.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.15 -143.33 14.75 Favored Glycine 0 N--CA 1.48 1.592 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.978 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.65 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 74.6 m -48.37 -51.18 27.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.755 -0.85 . . . . 0.0 111.846 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.49 -39.17 10.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.789 -1.195 . . . . 0.0 108.761 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.799 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 10.5 mmt180 -81.77 -44.3 17.18 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.203 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.2 t -69.07 -51.28 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 110.584 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.4 pp0? -56.95 -35.73 69.44 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.001 -1.062 . . . . 0.0 108.691 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 30.6 ttm180 -77.27 -47.0 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.965 . . . . 0.0 110.147 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.55 84.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.125 -0.984 . . . . 0.0 110.353 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 251' ' ' ILE . 67.7 mt -59.7 -46.35 89.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.751 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 33.2 mtmt -85.0 -47.72 9.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 110.758 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 18.8 mt-10 -70.63 -47.07 61.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.911 -1.118 . . . . 0.0 112.273 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 18.6 m120 -89.57 -53.27 4.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.575 -1.328 . . . . 0.0 112.126 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.407 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 46.6 m-85 -90.06 -13.75 35.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 110.448 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.046 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 65.52 36.55 92.65 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.054 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 251' ' ' ILE . 7.9 m-85 -63.43 172.63 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.374 -1.662 . . . . 0.0 107.808 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 33.5 t-20 -47.86 134.74 12.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.725 -1.234 . . . . 0.0 109.235 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 8.8 mm100 -53.31 -21.67 5.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.958 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 154' ' ' ASN . 52.6 p -54.49 -16.72 2.51 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.369 -0.832 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.4 t -57.19 123.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.032 -1.043 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.969 ' CE1' HG23 ' A' ' 249' ' ' VAL . 15.2 p-80 -143.46 161.35 38.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.65 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 41.4 tt0 -102.27 154.65 18.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 0.0 110.274 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.556 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.7 pt -137.64 134.92 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.5 m-80 -102.73 107.36 18.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.838 -1.163 . . . . 0.0 111.069 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.667 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -47.38 -44.46 24.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.85 -21.58 55.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 18.1 m-20 -104.9 2.24 29.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.953 -1.322 . . . . 0.0 112.162 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -117.65 175.05 5.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.302 -1.498 . . . . 0.0 110.314 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.509 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.1 p -100.41 131.63 46.22 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.509 ' C ' ' O ' ' A' ' 166' ' ' SER . 28.3 ttmt -30.09 -49.35 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.204 0.526 . . . . 0.0 111.002 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -62.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.96 -1.087 . . . . 0.0 110.188 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.39 -16.12 52.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.004 -1.06 . . . . 0.0 109.28 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 57.6 t-105 -72.71 -51.14 20.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.522 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.0 mt-10 -68.88 -37.12 78.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.08 -1.012 . . . . 0.0 108.319 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.61 -42.16 15.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.01 -42.81 99.17 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 199' ' ' ILE . 6.9 mt -70.34 -53.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.729 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.471 ' OD1' ' CE2' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -49.84 -55.92 12.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.634 -178.283 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -50.91 -41.32 58.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.837 -1.165 . . . . 0.0 108.517 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.59 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.7 mm-40 -61.26 -49.79 75.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 199' ' ' ILE . 46.9 mt -68.53 -24.67 64.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.247 -0.908 . . . . 0.0 110.257 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 53.3 p -52.05 -37.12 52.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.479 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 mt-30 -102.71 34.11 2.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.618 ' HB3' HD22 ' A' ' 7' ' ' LEU . 30.5 m-20 44.21 51.71 7.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.15 -0.969 . . . . 0.0 108.893 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 9.5 mt-30 -123.79 107.44 31.25 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.614 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.7 Cg_endo -62.63 165.74 15.13 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.708 1.605 . . . . 0.0 112.681 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.661 HG22 HG12 ' A' ' 249' ' ' VAL . 18.7 t -120.04 134.88 62.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.207 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.865 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.9 OUTLIER -82.81 115.3 21.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.12 158.59 28.96 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.914 -1.117 . . . . 0.0 108.798 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 196' ' ' ALA . 2.0 pt20 -167.77 128.37 1.41 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.006 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' HIS . . . -91.1 124.44 7.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 106.154 -2.778 . . . . 0.0 106.154 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 194' ' ' GLY . 1.9 t -101.86 164.51 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.727 -1.455 . . . . 0.0 112.957 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -160.07 -136.61 2.06 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -25.28 22.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.817 -1.402 . . . . 0.0 110.777 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.46 -22.43 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.003 -1.061 . . . . 0.0 111.659 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.467 ' C ' HG13 ' A' ' 189' ' ' VAL . . . 138.31 176.8 14.76 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.562 ' N ' HG13 ' A' ' 189' ' ' VAL . . . -76.87 113.19 3.72 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.57 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 33.5 t-80 -71.27 95.32 1.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -86.12 155.67 20.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.719 1.247 . . . . 0.0 113.793 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 35.0 p90 -154.04 177.06 11.48 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.723 HG22 HD11 ' A' ' 55' ' ' ILE . 97.9 t -123.26 136.66 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.496 -1.377 . . . . 0.0 112.418 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 178' ' ' LEU . 64.9 mt -97.11 124.13 49.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 7.4 p-10 -137.15 29.65 2.76 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.989 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -168.87 174.36 43.44 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.506 -2.283 . . . . 0.0 112.169 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -166.87 147.79 5.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -120.33 34.41 5.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.654 -1.279 . . . . 0.0 109.686 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 53.88 18.62 8.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 3.2 mtt85 -136.63 32.58 2.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -1.178 . . . . 0.0 109.225 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 1.3 m120 64.75 22.79 12.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 10.0 m-85 -110.73 100.26 9.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.534 ' HB3' HG23 ' A' ' 199' ' ' ILE . 11.1 m-85 -96.56 156.28 16.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.444 -0.785 . . . . 0.0 110.292 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.2 t-80 -93.17 123.32 36.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 9.1 t -112.76 135.31 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.821 1.296 . . . . 0.0 111.825 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 8' ' ' LEU . 3.8 t30 -112.95 99.55 7.95 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.89 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 197' ' ' PHE . 43.9 m95 . . . . . 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.749 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 5.4 tt0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 25.6 p -150.57 164.56 35.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 110.617 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.41 163.47 32.72 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.846 0.832 . . . . 0.0 109.703 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.865 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.4 t -117.28 128.42 74.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.969 HG23 ' CE1' ' A' ' 158' ' ' HIS . 32.7 m -127.05 144.96 35.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.796 -1.19 . . . . 0.0 111.072 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.18 51.45 2.97 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 147' ' ' LEU . 8.2 mt -102.43 97.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.575 -0.956 . . . . 0.0 109.824 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.6 150.78 10.58 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.095 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.633 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.6 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.178 1.918 . . . . 0.0 110.359 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 178' ' ' LEU . 13.7 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.0 mmtt -74.82 -169.28 0.86 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.061 -1.024 . . . . 0.0 108.291 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.587 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 72.7 m -80.86 101.58 9.5 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.155 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 200' ' ' ASP . 45.0 mt -58.15 -49.18 77.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.999 -1.063 . . . . 0.0 108.737 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.632 HD11 HG11 ' A' ' 198' ' ' VAL . 9.4 mt -59.74 -38.82 82.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.073 -1.017 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 8.0 t0 -67.26 -37.75 84.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 109.152 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 p -57.88 -15.73 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.005 . . . . 0.0 108.575 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 13' ' ' ILE . 3.1 mtpt -120.84 18.16 11.82 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 47.1 41.25 14.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.3 mt -89.63 102.0 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -1.039 . . . . 0.0 110.29 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 27.1 m80 -128.1 77.7 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.625 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 11.4 m-30 -81.61 -179.79 7.52 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.102 0.953 . . . . 0.0 111.182 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.98 -164.04 1.93 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 20.7 mt-30 -125.16 -19.64 5.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.061 -1.025 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.83 -35.44 1.26 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.617 -1.277 . . . . 0.0 111.424 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.6 t-20 -45.77 -140.17 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 118.469 -0.776 . . . . 0.0 110.981 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.3 Cg_endo -74.16 3.54 5.06 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 122.46 1.914 . . . . 0.0 109.616 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 7.5 m-85 -79.93 -31.13 40.07 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.231 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.0 p-10 -93.46 17.88 10.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.484 -1.385 . . . . 0.0 109.944 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.5 4.92 5.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.862 . . . . 0.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 118' ' ' GLU . 13.3 mt -133.39 -4.45 2.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.721 -1.237 . . . . 0.0 110.368 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.6 p -61.99 164.62 10.02 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.9 Cg_endo -71.7 132.96 21.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.648 1.565 . . . . 0.0 110.573 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.93 145.38 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 110.229 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HA2' ' A' ' 132' ' ' GLY . 8.9 mt -77.01 149.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.592 -0.692 . . . . 0.0 110.565 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.629 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.2 mt-10 -125.39 -23.84 4.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.703 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 79' ' ' TYR . 25.8 mtpp -114.74 174.48 5.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.958 -1.089 . . . . 0.0 109.98 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 37' ' ' SER . 98.3 t . . . . . 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.887 . . . . 0.0 111.008 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.0 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.014 0.435 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.768 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 17.3 m-30 -111.78 11.69 20.93 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 109.275 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 29' ' ' GLU . 20.3 t -61.54 119.15 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.841 -1.162 . . . . 0.0 108.617 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.04 52.34 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CD ' ' HA ' ' A' ' 38' ' ' PHE . 67.1 mt-30 -74.53 135.81 42.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.947 . . . . 0.0 109.255 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.48 116.14 13.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.92 156.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.326 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.825 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -80.57 167.12 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.0 p -81.96 -37.61 26.44 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.567 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 105.14 139.3 9.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' VAL . 1.2 p -55.11 -50.26 69.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -1.161 . . . . 0.0 108.158 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 127' ' ' VAL . 2.7 t -46.32 -53.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.57 -48.04 79.04 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.468 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 53.2 m -62.51 -31.87 72.7 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.734 -0.604 . . . . 0.0 109.439 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.37 76.24 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.69 -1.256 . . . . 0.0 108.756 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.592 HG22 ' HG3' ' A' ' 56' ' ' MET . 28.2 m -74.75 -51.71 13.47 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.567 0.698 . . . . 0.0 109.729 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -50.94 -36.69 40.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.684 -0.635 . . . . 0.0 109.567 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.625 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 23.1 mt-30 -69.69 -58.91 3.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.665 -1.272 . . . . 0.0 107.969 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.058 HD11 HG22 ' A' ' 198' ' ' VAL . 78.0 mt -57.68 -20.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.592 ' HG3' HG22 ' A' ' 52' ' ' THR . 24.7 mtp -73.91 -35.82 64.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 28.9 tptt -77.49 -41.04 40.85 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.188 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 46.3 t80 -53.19 -26.76 18.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 108.813 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 65.2 m-70 -107.85 -26.66 10.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 110.426 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.604 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 85.7 m-20 47.97 58.39 5.12 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.5 t80 -83.91 -73.88 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 113.087 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.8 Cg_endo -68.23 101.61 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.026 0.688 . . . . 0.0 111.6 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.42 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 4.2 m120 -70.32 -20.51 63.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 51.5 tttt -134.74 142.25 46.7 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.89 147.47 37.3 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.928 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -86.81 -50.57 6.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.989 . . . . 0.0 109.992 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 44.9 tttt -148.49 152.73 37.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.943 . . . . 0.0 109.594 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 89' ' ' ALA . 12.9 m-20 -73.01 178.01 4.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 70' ' ' THR . 24.5 t80 -154.26 153.82 32.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.373 -0.83 . . . . 0.0 109.581 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.616 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -158.0 154.12 27.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.8 p90 -161.66 162.73 30.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 56.6 m -93.83 131.67 38.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.76 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -47.13 148.43 1.19 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 111.11 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.67 143.43 56.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.689 -0.632 . . . . 0.0 110.041 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 t -69.61 -2.76 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 110.087 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 m-20 -99.39 -3.72 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.026 -1.046 . . . . 0.0 109.39 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.76 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.6 t-20 -70.65 110.67 7.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.536 -0.728 . . . . 0.0 110.11 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.633 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -90.91 20.19 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 123.101 2.534 . . . . 0.0 108.559 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.633 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 45.2 m-85 -114.11 -28.34 7.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 111.879 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' ASN . 49.3 m-85 -118.06 164.83 14.52 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.0 m120 -46.99 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 174.95 -47.48 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 111.044 175.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -77.38 54.31 4.65 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 N-CA-C 107.216 -1.879 . . . . 0.0 107.216 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HE3' ' HG ' ' A' ' 86' ' ' LEU . 13.3 tptt -106.68 107.08 17.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.812 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -100.93 140.17 35.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 108.983 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.7 mp -111.32 149.41 31.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -137.17 123.19 20.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.994 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.12 112.85 25.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -74.72 50.98 0.46 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.795 -1.191 . . . . 0.0 108.4 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 92.9 mt -52.6 -45.4 47.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.9 p -45.23 -26.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.738 -1.226 . . . . 0.0 109.047 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -111.38 37.76 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 108.929 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.65 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 11.9 mmt-85 -95.48 154.93 16.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.493 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.48 91.95 3.71 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.7 m-85 -81.19 90.26 6.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 110.573 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -78.92 92.18 4.88 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.604 ' CE3' ' HA ' ' A' ' 60' ' ' ASN . 67.0 m95 -60.72 -9.17 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.408 -0.808 . . . . 0.0 110.164 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -90.75 -20.39 22.46 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 30.9 m-20 -92.08 -34.62 14.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.527 HG12 ' HB1' ' A' ' 115' ' ' ALA . 25.9 mt -73.83 94.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.0 mt -71.47 153.03 93.94 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.496 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.4 Cg_endo -80.05 -30.31 2.25 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.808 2.339 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 t -136.7 128.15 28.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 68.1 m-85 -112.52 138.01 49.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.7 p -99.95 2.02 43.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 108.707 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.72 0.12 89.87 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -120.1 13.23 12.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 0.0 109.461 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 3.7 mp0 -72.5 170.25 14.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.9 173.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.125 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -79.72 -44.12 21.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.98 -47.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.21 -43.54 97.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.094 -1.004 . . . . 0.0 109.207 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 52.1 mttt -60.52 -36.22 77.86 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.429 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 6.2 ttm -60.07 -46.74 88.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.49 -50.4 73.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.187 -0.945 . . . . 0.0 110.727 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.748 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.3 tp -69.55 -46.96 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.612 -1.305 . . . . 0.0 109.734 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . 5.2 p -53.71 -40.26 65.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.003 . . . . 0.0 109.156 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.833 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.1 tp10 -69.81 -45.42 67.94 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.748 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.0 tp -51.42 -50.25 60.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.663 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -60.87 -46.8 89.19 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.768 -0.582 . . . . 0.0 109.816 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.67 -39.66 94.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.467 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -64.53 -46.12 84.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 119' ' ' LEU . 89.1 t -71.4 -58.92 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.53 0.681 . . . . 0.0 109.822 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.79 -48.25 13.36 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.9 mt -63.5 -58.05 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.3 p -47.58 -29.22 2.72 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.986 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.664 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.8 m -100.68 37.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 127' ' ' VAL . 91.1 m-20 37.1 50.19 0.91 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.679 0.752 . . . . 0.0 109.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 54.9 tpp -65.75 130.55 43.68 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.539 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 38.6 t0 -76.57 118.69 19.48 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 104.014 -2.588 . . . . 0.0 104.014 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.567 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 39.8 m-85 -101.19 110.6 22.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.673 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -150.14 -170.34 17.32 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 103.722 -3.751 . . . . 0.0 103.722 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.768 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.9 Cg_endo -62.54 -20.61 71.19 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 106.923 -1.991 . . . . 0.0 106.923 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -110.86 135.21 51.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.825 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 69.1 m -123.6 111.05 15.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 119.817 -1.802 . . . . 0.0 110.97 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.57 130.91 10.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 5.5 t -110.1 -163.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.879 -1.365 . . . . 0.0 107.433 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.576 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -89.8 -55.92 3.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.621 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 142.92 -136.2 6.95 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.051 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.658 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 13.8 m -56.62 -45.16 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.858 -0.789 . . . . 0.0 112.108 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 140' ' ' SER . 14.7 p -46.11 -43.35 14.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.946 -1.096 . . . . 0.0 109.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.8 mmt180 -82.34 -40.25 21.67 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 1.008 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.3 t -68.33 -54.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.7 pp0? -56.73 -33.95 67.02 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.268 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.1 ttp180 -77.15 -48.52 17.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.95 78.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.959 . . . . 0.0 110.043 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 157' ' ' VAL . 50.7 mt -58.77 -47.93 83.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.088 -1.008 . . . . 0.0 109.475 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 14.0 mtmt -87.17 -35.65 18.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.859 -1.15 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 43.2 mt-10 -77.68 -55.28 5.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.406 -1.434 . . . . 0.0 111.823 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 34.2 m120 -84.35 -40.39 17.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.966 -1.084 . . . . 0.0 111.578 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.442 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 33.6 m-85 -102.51 -2.25 28.97 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.767 -1.208 . . . . 0.0 110.665 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.928 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.0 36.65 43.49 Favored Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.163 -0.961 . . . . 0.0 112.011 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.3 m-85 -62.01 163.85 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.242 -1.74 . . . . 0.0 107.993 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.9 t30 -47.3 147.01 1.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.452 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.37 4.71 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.23 -0.918 . . . . 0.0 108.698 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.536 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 16.7 p -54.08 -16.21 1.86 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.417 -0.802 . . . . 0.0 109.955 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.7 t -65.3 120.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.787 -1.195 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.799 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.9 p-80 -147.21 157.57 43.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.027 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 6.7 tt0 -101.93 155.81 17.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 246' ' ' SER . 2.6 pt -138.57 154.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.88 97.59 7.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 110.569 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 5.3 tpt180 -47.77 -31.58 5.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.25 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.541 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -63.7 -23.64 67.32 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -103.64 2.03 32.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.124 -1.221 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -117.92 140.57 49.54 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.63 -1.294 . . . . 0.0 109.81 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -67.98 139.97 56.37 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 59.2 tttt -38.04 -46.78 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -56.83 12.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 169' ' ' ASP . 1.7 m-20 -63.43 -23.38 67.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 109.268 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.798 ' NE1' HD11 ' A' ' 174' ' ' ILE . 66.8 t-105 -72.53 -43.63 63.28 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 175' ' ' ASP . 34.3 mt-10 -62.71 -26.62 68.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.34 81.94 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.22 -42.4 98.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -0.851 . . . . 0.0 108.881 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.981 HD13 ' CD1' ' A' ' 199' ' ' ILE . 28.7 mt -75.99 -61.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.713 . . . . 0.0 110.889 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.4 OUTLIER -49.29 -51.58 33.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.967 -1.083 . . . . 0.0 109.601 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -52.1 -40.69 61.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.882 -1.136 . . . . 0.0 107.988 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.58 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 5.0 mm-40 -60.88 -53.96 50.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.603 -0.686 . . . . 0.0 109.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.97 ' HB2' HG21 ' A' ' 4' ' ' VAL . 5.8 mt -65.69 -24.68 67.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.43 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 24.8 p -52.31 -45.17 65.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.974 -1.079 . . . . 0.0 108.193 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.5 mt-30 -94.29 39.09 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.477 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.3 m-20 42.52 51.2 4.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 10.2 mt-30 -123.94 105.14 32.32 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.447 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.1 Cg_endo -63.93 173.58 4.69 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.103 1.869 . . . . 0.0 112.653 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 63.9 t -129.84 142.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.242 1.02 . . . . 0.0 112.236 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 1.008 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -93.29 121.17 34.39 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.675 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 14.0 t80 -122.69 159.42 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.549 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -152.52 119.86 5.94 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.594 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 195' ' ' HIS . . . -91.97 106.03 3.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 10.1 t -67.11 160.76 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.25 -1.147 . . . . 0.0 110.644 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -172.34 -145.65 5.04 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -30.45 20.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.292 . . . . 0.0 110.229 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.51 -22.2 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.3 -169.61 23.94 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -77.38 112.55 3.53 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.176 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.5 t-80 -77.44 113.73 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -105.98 164.34 12.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.782 1.277 . . . . 0.0 114.036 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' ' 186' ' ' TYR . 43.5 p90 -162.64 -160.68 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.058 HG22 HD11 ' A' ' 55' ' ' ILE . 5.7 t -139.61 139.35 38.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.206 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.981 ' CD1' HD13 ' A' ' 174' ' ' ILE . 40.0 mt -105.66 108.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 10.2 p-10 -120.87 32.43 5.97 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.428 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 4' ' ' VAL . . . 178.17 166.16 34.11 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.267 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -145.77 164.26 32.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.65 2.15 3.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.369 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.8 -31.06 4.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 10.0 mtt-85 -87.49 39.19 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.033 -1.275 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 17.0 m120 61.71 16.18 7.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 110.094 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -114.43 138.2 50.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 9.2 m-85 -123.17 162.48 22.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.337 -0.852 . . . . 0.0 110.285 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 59.2 t-80 -92.11 139.63 30.44 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 212' ' ' TRP . 2.7 t -140.23 157.96 25.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.867 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.544 ' HB2' HD12 ' A' ' 8' ' ' LEU . 43.9 t-20 -117.95 85.23 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.71 ' CE2' HG11 ' A' ' 210' ' ' VAL . 19.7 m95 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.146 -0.972 . . . . 0.0 112.019 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 13.5 p -167.53 149.88 5.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 110.085 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.409 ' H ' HG13 ' A' ' 160' ' ' ILE . . . -129.98 169.15 15.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.249 1.024 . . . . 0.0 109.751 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 185' ' ' TYR . 11.4 t -117.95 119.9 62.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.799 HG23 ' NE2' ' A' ' 158' ' ' HIS . 30.1 m -119.17 150.23 21.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.286 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 84.82 33.2 19.33 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.626 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 46.8 mt -79.18 90.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.341 -1.093 . . . . 0.0 109.974 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.76 152.04 12.87 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.599 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.316 2.011 . . . . 0.0 110.447 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.772 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.9 t . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 200' ' ' ASP . 49.2 mmtt -75.07 178.52 5.61 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.032 -1.043 . . . . 0.0 108.441 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 1.6 t -77.6 103.82 7.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.099 -1.001 . . . . 0.0 109.208 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.726 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.7 mt -57.15 -49.0 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.871 . . . . 0.0 108.923 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.6 mt -56.5 -42.18 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.739 -1.226 . . . . 0.0 108.826 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 54.8 t0 -67.48 -36.31 80.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.151 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -16.79 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.034 -1.042 . . . . 0.0 108.266 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.8 mtpt -122.32 18.32 10.63 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.25 43.12 7.24 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 58' ' ' TYR . 57.6 mt -87.72 107.37 17.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.255 1.026 . . . . 0.0 110.23 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.8 m80 -135.02 86.97 2.29 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.7 m-30 -92.95 -179.9 5.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 110.768 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -147.17 -163.81 1.85 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.0 mt-30 -124.88 -20.8 4.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.929 -1.107 . . . . 0.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.38 -35.62 1.29 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.43 -1.367 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.835 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.7 t-20 -45.13 -142.74 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.529 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.132 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.835 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.6 Cg_endo -72.98 1.83 6.11 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 CA-C-N 122.363 1.88 . . . . 0.0 109.559 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 10.4 m-85 -76.46 -31.12 57.63 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.953 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 10.8 p-10 -94.09 17.33 12.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.596 -1.315 . . . . 0.0 109.566 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 26.7 mt -72.28 -3.03 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.978 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.0 mt -127.13 -7.56 5.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.5 p -61.9 164.93 8.91 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.674 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.6 Cg_endo -71.43 138.89 33.58 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.435 2.09 . . . . 0.0 112.11 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.8 t -81.11 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.646 -0.659 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.738 HD11 ' C ' ' A' ' 132' ' ' GLY . 17.1 mt -78.11 148.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.499 -0.751 . . . . 0.0 110.523 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.8 mt-10 -125.73 -22.12 4.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.759 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.3 mtpp -121.19 173.34 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.992 -1.068 . . . . 0.0 109.893 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 37' ' ' SER . 98.7 t . . . . . 0 N--CA 1.487 1.417 0 O-C-N 121.401 -0.812 . . . . 0.0 110.676 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.471 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.022 0.439 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.3 m-85 -124.45 16.93 8.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.084 -1.01 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 29' ' ' GLU . 47.2 t -63.26 143.59 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.041 -1.037 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.07 -4.23 67.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.0 mt-30 -85.46 129.43 34.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -1.201 . . . . 0.0 109.595 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 25' ' ' THR . 1.8 m-70 -73.11 113.39 10.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.76 160.0 1.0 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.097 -1.041 . . . . 0.0 109.538 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.48 170.19 17.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.697 0.761 . . . . 0.0 109.793 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.701 ' O ' ' HE3' ' A' ' 129' ' ' MET . 29.8 p -81.62 -34.98 30.57 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.533 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 104.28 136.65 8.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.9 p -55.18 -51.01 67.89 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.393 -1.063 . . . . 0.0 108.501 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.619 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 51.1 t -47.48 -52.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.38 -50.67 72.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.11 0.957 . . . . 0.0 109.437 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 99.1 m -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.931 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.21 -41.91 84.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.734 -1.229 . . . . 0.0 108.119 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 ' HG3' ' A' ' 56' ' ' MET . 43.8 m -74.64 -53.25 9.69 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.447 0.641 . . . . 0.0 110.405 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.0 -37.71 46.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.572 -0.705 . . . . 0.0 109.585 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 32.0 mt-30 -63.05 -45.67 91.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 198' ' ' VAL . 53.1 mt -70.12 -28.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.581 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.3 mtp -66.97 -40.78 87.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HD3' HG22 ' A' ' 100' ' ' ILE . 29.9 tptt -70.33 -41.35 73.34 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 49.0 t80 -54.05 -30.4 47.76 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 43.4 m-70 -107.39 -24.03 11.99 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.05 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.63 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 79.2 m-20 44.3 54.17 6.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.9 t80 -78.75 -70.65 0.19 Allowed Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.308 -175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.9 Cg_endo -70.23 100.81 0.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 CA-C-N 118.929 0.653 . . . . 0.0 111.609 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.97 -20.58 64.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -134.33 141.87 47.06 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.19 151.84 26.22 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.098 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -89.14 -60.97 1.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -1.043 . . . . 0.0 110.186 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 49.0 tttt -135.95 134.46 38.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 109.598 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 4.5 m-20 -58.2 159.79 5.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.454 -0.779 . . . . 0.0 109.605 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 31.9 t80 -144.43 139.65 28.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -143.19 153.82 43.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.084 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.6 p90 -154.46 155.41 34.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.886 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 98.4 m -92.83 130.07 38.55 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.787 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -45.18 148.91 0.54 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.935 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 t -61.6 142.31 57.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.818 -0.551 . . . . 0.0 109.835 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -68.65 -3.38 11.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.038 -1.039 . . . . 0.0 109.75 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -98.7 -7.69 27.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.787 ' ND2' HD21 ' A' ' 73' ' ' LEU . 30.2 t-20 -70.49 110.1 6.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -89.26 16.28 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.968 2.445 . . . . 0.0 110.483 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 90.9 m-85 -106.01 -22.65 12.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.132 -0.98 . . . . 0.0 111.315 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.8 m-85 -122.34 162.56 21.32 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.561 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.4 m-80 -46.02 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 174.45 -46.04 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.451 175.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.3 56.48 5.01 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 N-CA-C 107.51 -1.765 . . . . 0.0 107.51 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.98 102.97 12.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.116 -178.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.14 134.9 43.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.656 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.71 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -108.15 144.56 35.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 17.7 t80 -134.0 130.23 37.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.007 -1.058 . . . . 0.0 110.365 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.68 113.82 27.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.84 53.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.642 -1.286 . . . . 0.0 108.458 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 9.8 mt -52.89 -52.73 25.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 4.1 p -45.55 -26.6 0.61 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.342 -1.473 . . . . 0.0 109.219 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -111.78 19.78 17.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 109.534 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 13.5 mmt-85 -76.83 147.55 37.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 110.378 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 90.34 3.31 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-85 -81.02 96.95 7.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.548 -0.72 . . . . 0.0 110.617 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.6 t-20 -80.53 88.69 5.65 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.63 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 39.1 m95 -61.03 -8.98 3.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.446 -0.784 . . . . 0.0 110.411 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -19.17 23.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.6 m-20 -100.24 -26.29 13.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.623 HG22 ' HD3' ' A' ' 57' ' ' LYS . 66.6 mt -73.88 67.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.7 mt -46.83 150.12 1.37 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.56 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.4 Cg_endo -78.84 -21.2 9.86 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.759 2.306 . . . . 0.0 110.587 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 134.47 26.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.007 -1.058 . . . . 0.0 109.684 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 89.3 m-85 -124.49 137.9 54.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.923 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.9 p -99.04 -0.09 42.65 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 81.45 10.02 85.07 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.17 5.9 10.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.395 -1.062 . . . . 0.0 108.956 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.14 167.72 19.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.694 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -57.79 171.71 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.195 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -76.9 -33.97 57.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -51.99 -60.42 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 2.1 mp0 -62.45 -35.16 78.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 0.0 109.376 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' SER . 26.7 mttt -63.8 -43.47 96.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 108.291 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.469 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 28.7 ttm -59.93 -38.24 81.8 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -57.16 -68.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.535 -0.728 . . . . 0.0 110.403 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.73 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -59.9 -39.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.471 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 25.2 p -53.61 -43.74 68.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.956 -1.09 . . . . 0.0 109.635 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 24' ' ' LEU . 4.4 tt0 -69.88 -42.49 73.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 108.518 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.7 tp -52.15 -51.6 56.98 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.693 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.5 mmt -59.7 -45.7 91.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.635 -0.666 . . . . 0.0 109.489 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.515 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.75 -38.35 90.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.6 m-20 -68.67 -48.43 63.97 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 56' ' ' MET . 55.9 t -67.12 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.41 -42.39 13.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.9 mt -69.72 -57.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.346 -1.091 . . . . 0.0 108.325 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.53 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.1 p -45.47 -27.64 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.429 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.6 m -105.0 32.76 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.139 -0.976 . . . . 0.0 109.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.565 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 43.1 m-20 40.71 44.99 1.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.343 -0.848 . . . . 0.0 109.651 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.701 ' HE3' ' O ' ' A' ' 45' ' ' THR . 41.1 tpp -56.86 133.09 54.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 111.145 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 18.6 t0 -79.56 122.66 26.76 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.82 117.79 35.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.312 1.053 . . . . 0.0 113.064 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.738 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.6 -164.56 12.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 104.261 -3.536 . . . . 0.0 104.261 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.617 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -61.96 -31.5 84.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 105.582 -2.507 . . . . 0.0 105.582 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.0 m -109.7 141.54 42.14 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.5 m -119.2 109.84 16.33 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 119.966 -1.709 . . . . 0.0 109.919 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.83 136.12 13.24 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 13.1 t -117.87 -162.59 0.89 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.234 -1.156 . . . . 0.0 108.335 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.76 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.02 -57.21 2.8 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.553 ' HA3' ' NE2' ' A' ' 187' ' ' GLN . . . 131.46 -131.05 6.21 Favored Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.393 -1.384 . . . . 0.0 112.042 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 36.8 m -47.83 -58.62 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.891 -0.77 . . . . 0.0 111.786 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' SER . 11.1 p -46.75 -36.81 7.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 0.0 108.95 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.76 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.9 mmt-85 -80.37 -47.88 13.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.01 0.909 . . . . 0.0 108.92 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 185' ' ' TYR . 93.9 t -67.85 -56.57 12.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.7 pp0? -56.48 -33.73 66.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.171 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.512 ' NE ' ' OE2' ' A' ' 149' ' ' GLU . 12.1 ttt85 -77.1 -52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.53 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.56 -35.95 82.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.086 -1.009 . . . . 0.0 110.047 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.596 HD13 HG12 ' A' ' 251' ' ' ILE . 40.5 mt -56.41 -48.44 76.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.6 mtmt -86.45 -39.13 16.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.133 -0.979 . . . . 0.0 110.407 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.512 ' OE2' ' NE ' ' A' ' 145' ' ' ARG . 54.1 mt-10 -67.97 -54.46 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 112.007 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 20.7 m120 -92.75 -40.87 10.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.703 -1.248 . . . . 0.0 111.746 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.2 m-85 -99.56 10.59 41.08 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.715 -1.241 . . . . 0.0 110.514 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 36.04 39.12 0.27 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.55 -0.719 . . . . 0.0 112.875 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.5 m-85 -61.92 162.88 8.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.142 -1.799 . . . . 0.0 107.364 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.1 t-20 -47.48 139.02 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.87 -1.144 . . . . 0.0 109.414 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.407 ' NE2' ' HD2' ' A' ' 148' ' ' LYS . 9.2 tp-100 -53.72 -18.97 3.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 58.7 p -53.07 -18.23 1.99 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.8 t -58.33 123.7 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 109.158 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.931 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.7 p-80 -143.87 154.82 43.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.086 -1.009 . . . . 0.0 109.404 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 41.9 tt0 -100.73 154.2 18.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.36 -0.838 . . . . 0.0 110.509 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.595 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 10.5 pt -135.96 142.37 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.6 m120 -107.25 100.49 9.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.873 -1.142 . . . . 0.0 111.065 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.639 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.9 tpt180 -44.01 -41.22 5.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.154 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.09 -23.17 59.21 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ASN . 0.8 OUTLIER -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.063 -1.257 . . . . 0.0 111.576 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.92 174.94 5.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.516 -1.365 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -103.91 134.28 47.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 166' ' ' SER . 18.3 ttmt -31.91 -45.62 0.1 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.101 0.477 . . . . 0.0 110.869 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -64.17 -63.69 1.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.927 -1.108 . . . . 0.0 109.823 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.22 -15.67 57.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.359 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.9 t-105 -74.85 -46.95 33.0 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.177 -0.952 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 174' ' ' ILE . 43.4 mt-10 -69.53 -30.48 68.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.091 -1.006 . . . . 0.0 108.606 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.66 -45.43 73.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 108.751 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -61.13 -40.28 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 108.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.886 HG23 HG21 ' A' ' 184' ' ' VAL . 13.7 mt -76.13 -60.94 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.557 -0.714 . . . . 0.0 111.119 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.03 -46.67 44.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 109.24 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.756 ' HZ3' ' HB3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -51.35 -48.67 62.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.4 mm-40 -54.87 -51.07 67.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.772 ' HB3' HG11 ' A' ' 4' ' ' VAL . 17.6 mt -68.2 -33.51 74.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.205 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 53.4 p -51.99 -30.78 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -102.41 33.65 3.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.534 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.6 m120 40.67 46.68 2.27 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.816 0.817 . . . . 0.0 108.918 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 14.7 mt-30 -123.69 111.8 29.35 Favored Pre-proline 0 C--N 1.294 -1.815 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.7 Cg_endo -65.09 169.66 11.7 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.803 1.668 . . . . 0.0 112.653 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.886 HG21 HG23 ' A' ' 174' ' ' ILE . 45.9 t -121.12 132.79 69.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.58 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.713 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -81.57 116.39 21.31 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 175.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 6.5 t80 -121.97 157.27 31.65 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.809 -1.182 . . . . 0.0 110.192 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 4.8 pt20 -167.06 136.05 2.76 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.6 1.66 Allowed Glycine 0 C--N 1.289 -2.031 0 N-CA-C 107.675 -2.17 . . . . 0.0 107.675 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 190' ' ' GLY . 6.8 t -69.93 166.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -1.117 . . . . 0.0 111.419 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.547 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.53 -129.11 1.08 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -88.11 -36.96 16.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.251 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.0 m -79.92 -15.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.974 -1.079 . . . . 0.0 111.284 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.88 -167.63 22.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -83.47 101.51 2.36 Favored Glycine 0 N--CA 1.485 1.929 0 O-C-N 121.049 -1.265 . . . . 0.0 110.781 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 17.3 t-80 -71.27 121.11 17.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -113.08 160.67 17.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.517 -1.273 . . . . 0.0 113.361 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.809 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -156.91 175.19 14.41 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 55' ' ' ILE . 92.8 t -121.14 135.69 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.575 -1.328 . . . . 0.0 112.094 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.712 HD13 HG21 ' A' ' 174' ' ' ILE . 73.6 mt -99.9 123.13 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -134.17 32.76 3.41 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.131 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.618 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -171.69 167.68 40.75 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 117.709 -2.186 . . . . 0.0 112.345 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.538 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.17 148.0 27.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ARG . 0.5 OUTLIER -121.61 24.26 9.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.755 -1.216 . . . . 0.0 110.357 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 43.05 26.45 0.49 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 14.3 mtt-85 -142.43 21.44 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -1.118 . . . . 0.0 109.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 9.4 t30 80.6 20.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.563 -0.711 . . . . 0.0 109.65 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.27 128.26 49.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 178' ' ' LEU . 25.7 m-85 -120.7 163.51 17.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.0 . . . . 0.0 109.557 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 37.1 t-80 -93.39 116.11 28.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.809 HG13 ' CD1' ' A' ' 197' ' ' PHE . 20.7 t -114.51 140.02 37.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.105 -0.997 . . . . 0.0 111.165 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 8' ' ' LEU . 28.2 t-20 -108.64 92.32 4.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.476 ' O ' ' O ' ' A' ' 211' ' ' ASN . 3.1 m95 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 0.0 110.404 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.552 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 3.9 mt-30 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 56.4 p -159.15 157.39 30.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.029 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.14 166.47 24.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.4 -0.812 . . . . 0.0 110.021 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 46.9 t -119.29 114.59 45.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.931 HG23 ' CE1' ' A' ' 158' ' ' HIS . 16.6 m -114.69 147.85 17.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 O-C-N 121.282 -0.886 . . . . 0.0 110.402 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 96.12 47.14 2.48 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.042 -1.551 . . . . 0.0 109.881 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.602 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.9 mt -103.22 96.11 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -1.185 . . . . 0.0 110.173 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.39 146.77 8.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.632 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.1 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.206 1.937 . . . . 0.0 110.452 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 202' ' ' ALA . 12.0 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.212 0.53 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 200' ' ' ASP . 58.3 mmtt -77.01 -179.51 5.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.526 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 34.7 t -77.79 102.42 7.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.687 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 35.7 mt -57.63 -49.65 75.75 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.8 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 211' ' ' ASN . 11.9 mt -56.02 -42.46 76.52 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.776 -1.202 . . . . 0.0 108.641 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -68.34 -36.19 78.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.058 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -58.08 -15.36 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.102 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' CB ' HG13 ' A' ' 13' ' ' ILE . 9.1 mtpt -121.95 23.54 9.97 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.97 39.89 5.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 58' ' ' TYR . 40.2 mt -86.03 110.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.355 1.074 . . . . 0.0 110.408 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 102' ' ' PRO . 6.7 m-70 -133.45 99.44 4.51 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 6.4 m-30 -103.66 176.0 5.29 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.012 . . . . 0.0 111.513 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -146.98 -175.17 4.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mt-30 -118.37 -20.96 8.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.943 -1.098 . . . . 0.0 109.977 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.42 -34.13 1.49 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.94 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.838 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.5 t-20 -46.0 -140.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.021 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.872 ' HA ' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -74.32 3.22 5.42 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 CA-C-N 122.55 1.947 . . . . 0.0 109.325 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.1 m-85 -78.63 -30.66 46.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.478 -0.764 . . . . 0.0 109.068 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 20.6 p-10 -96.12 12.86 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.545 -1.347 . . . . 0.0 109.341 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.872 HD12 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -67.79 -8.61 37.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.918 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD12 ' OG ' ' A' ' 117' ' ' SER . 8.7 mt -126.68 -6.23 6.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 0.0 109.703 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.606 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.8 p -61.14 165.95 5.7 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -71.1 136.81 30.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.013 1.809 . . . . 0.0 111.609 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.16 149.97 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.614 0.721 . . . . 0.0 110.136 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 132' ' ' GLY . 16.8 mt -77.77 148.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.565 -0.709 . . . . 0.0 110.544 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -125.67 -20.82 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.705 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 79' ' ' TYR . 44.7 mtpt -123.72 172.01 9.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.89 -1.131 . . . . 0.0 109.949 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 37' ' ' SER . 75.0 t . . . . . 0 C--N 1.304 -1.392 0 O-C-N 121.397 -0.814 . . . . 0.0 110.94 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 31' ' ' VAL . 5.0 t . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -123.81 19.52 9.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.084 -1.01 . . . . 0.0 109.798 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.6 t -67.74 145.08 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.557 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.15 -1.9 73.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.7 mt-30 -88.03 130.3 35.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 109.813 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -73.06 112.34 9.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.77 158.28 1.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.847 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 135' ' ' SER . . . -71.59 166.38 21.97 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.67 HG21 ' SD ' ' A' ' 120' ' ' MET . 41.1 p -80.45 -29.15 37.54 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 99.08 136.85 9.53 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.6 p -54.67 -52.94 60.79 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.217 -1.167 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.636 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 54.7 t -46.91 -52.53 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.46 -51.29 70.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.969 0.89 . . . . 0.0 109.861 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.771 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -64.21 -32.31 73.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.664 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.44 88.48 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.648 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.3 m -74.59 -53.63 9.01 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.701 0.762 . . . . 0.0 110.05 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.22 -38.43 52.41 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.702 -0.624 . . . . 0.0 109.837 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -63.91 -46.88 82.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.13 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 37.7 mt -67.87 -24.49 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.5 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.6 mtp -73.57 -32.26 64.06 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.588 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 26.0 tptt -75.82 -44.34 41.6 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.687 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 33.8 t80 -53.61 -27.78 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.75 -0.594 . . . . 0.0 110.023 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 35.0 m-70 -107.5 -26.09 11.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.288 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.635 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 90.2 m-20 44.54 59.2 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.0 t80 -84.88 -72.22 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 37.2 Cg_endo -69.77 105.76 1.54 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 CA-C-N 118.955 0.663 . . . . 0.0 111.952 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 8.0 m120 -72.14 -23.59 61.32 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -135.89 137.33 41.32 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.67 152.06 31.8 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.421 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 66' ' ' LEU . 2.6 mt -92.31 -42.01 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.406 -1.055 . . . . 0.0 109.961 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 11.7 ttpp -152.29 136.41 16.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.934 -1.104 . . . . 0.0 110.334 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -59.41 164.66 3.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.629 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 70' ' ' THR . 20.6 t80 -141.78 152.05 43.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 3.4 t -151.22 166.06 32.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.927 -1.108 . . . . 0.0 110.192 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.745 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.6 p90 -169.12 154.03 5.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.443 -0.786 . . . . 0.0 109.32 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.9 m -92.81 136.06 33.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.794 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -52.34 153.17 3.03 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.335 -0.853 . . . . 0.0 111.335 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -61.33 137.0 58.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.33 0.586 . . . . 0.0 110.016 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 p -64.58 -7.74 11.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.7 t-20 -99.66 -4.21 31.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.029 -1.045 . . . . 0.0 109.717 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.794 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.4 t-20 -69.9 109.97 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.774 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.6 15.55 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.83 2.353 . . . . 0.0 109.991 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 75.0 m-85 -105.71 -27.26 11.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' ASN . 19.2 m-85 -118.91 164.43 15.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.636 -1.29 . . . . 0.0 107.774 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.4 m120 -47.39 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 175.64 -48.2 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 175.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.9 56.71 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 N-CA-C 106.958 -1.978 . . . . 0.0 106.958 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.46 104.1 13.76 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.13 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.96 130.65 46.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.824 . . . . 0.0 109.441 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -102.47 137.73 40.33 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -124.96 129.08 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.375 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.18 114.12 27.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 50.03 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.665 -1.272 . . . . 0.0 108.569 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.8 mt -52.48 -51.49 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.325 -0.859 . . . . 0.0 109.085 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.92 -29.24 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.065 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.15 30.21 7.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 6.4 mmt-85 -85.5 150.44 24.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -116.9 91.09 3.48 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.6 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.3 m-85 -81.08 91.31 6.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.472 -0.767 . . . . 0.0 111.134 -176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 100' ' ' ILE . 38.2 t-20 -79.76 87.14 5.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.635 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 63.2 m95 -61.23 -8.32 3.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.36 -17.73 26.79 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 8.5 m-20 -99.6 -27.72 13.55 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.612 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 58.0 mt -74.41 66.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 101' ' ' LEU . 24.3 mt -46.71 149.25 1.52 Allowed Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.854 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.7 Cg_endo -78.67 -23.97 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.74 2.293 . . . . 0.0 110.409 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.19 126.69 23.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 108.994 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 116' ' ' ILE . 54.8 m-85 -113.51 148.82 35.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' OE1' ' A' ' 108' ' ' GLU . 36.1 p -103.5 -9.83 19.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.56 -0.11 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -120.11 1.06 10.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -1.171 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' OE1' ' OG ' ' A' ' 105' ' ' SER . 0.1 OUTLIER -64.86 165.29 10.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.808 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.38 166.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -72.37 -34.45 67.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.36 -58.97 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.435 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.63 -36.28 80.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 0.0 108.897 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 21.4 mttt -65.71 -44.19 86.85 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.446 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.8 ttm -59.28 -35.72 74.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.09 -66.63 0.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.61 -0.681 . . . . 0.0 109.619 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.699 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.4 tp -65.74 -40.15 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.815 . . . . 0.0 109.552 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 11.2 p -57.21 -41.89 80.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.222 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.621 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 22.9 tt0 -69.72 -40.59 76.13 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.3 tp -54.84 -52.32 63.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.771 ' CE ' HG23 ' A' ' 50' ' ' THR . 1.6 mmt -58.51 -44.84 89.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.46 -38.84 92.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.649 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 5.9 m-20 -69.22 -43.02 74.91 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 127' ' ' VAL . 55.3 t -71.21 -62.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.609 -0.682 . . . . 0.0 109.774 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.31 -45.77 16.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.8 mt -65.03 -57.62 10.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 108.664 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 5.2 p -46.32 -31.08 2.36 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.771 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.0 m -101.46 37.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 109.626 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.8 m-20 39.36 42.14 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.482 -0.761 . . . . 0.0 109.782 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.648 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -55.59 128.23 33.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.405 -0.809 . . . . 0.0 111.446 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 21.6 t0 -77.71 126.07 30.31 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.658 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.0 m-85 -108.18 120.72 43.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.759 -1.177 . . . . 0.0 113.51 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.729 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.9 -164.0 11.71 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 103.834 -3.706 . . . . 0.0 103.834 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -61.38 -30.26 86.99 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 N-CA-C 105.445 -2.56 . . . . 0.0 105.445 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.54 46.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -115.71 112.83 22.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.853 -1.779 . . . . 0.0 109.851 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.29 133.72 11.81 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.549 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 16.0 t -118.27 -162.11 0.87 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -1.182 . . . . 0.0 108.761 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.836 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.21 -60.51 1.83 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.544 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 136.29 -133.71 6.74 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.888 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.565 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -48.11 -57.83 5.31 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.797 -0.825 . . . . 0.0 111.911 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 1.7 p -47.31 -36.72 9.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.752 -1.217 . . . . 0.0 109.015 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.836 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 25.8 mmt180 -79.84 -46.69 16.41 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.064 0.935 . . . . 0.0 108.797 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 185' ' ' TYR . 79.5 t -68.09 -56.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.275 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.53 -34.53 67.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 109.357 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' CG ' ' OE2' ' A' ' 149' ' ' GLU . 34.1 ttm-85 -77.36 -42.89 34.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.944 -1.098 . . . . 0.0 109.836 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.68 71.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.601 HD13 HG12 ' A' ' 251' ' ' ILE . 53.7 mt -60.85 -48.44 81.78 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.521 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.8 mtmt -86.55 -44.25 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.07 -1.019 . . . . 0.0 110.583 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.504 ' OE2' ' CG ' ' A' ' 145' ' ' ARG . 82.1 mt-10 -67.4 -47.93 68.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.879 -1.138 . . . . 0.0 111.498 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -94.37 -44.19 8.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 111.671 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.6 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 31.1 m-85 -101.6 16.6 25.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 110.618 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 33.32 39.86 0.1 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 121.594 -0.691 . . . . 0.0 113.16 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.4 m-85 -62.04 159.81 13.72 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 120.529 2.165 . . . . 0.0 107.154 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 51.4 t-20 -47.06 143.8 2.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.737 -1.227 . . . . 0.0 109.372 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.64 -17.86 2.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.398 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.495 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 18.9 p -53.29 -17.08 1.55 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 109.876 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 251' ' ' ILE . 38.8 t -64.59 127.88 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.75 -1.219 . . . . 0.0 109.438 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.843 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.2 p-80 -147.37 149.58 33.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -100.69 139.92 35.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.921 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 16.4 pt -122.5 158.04 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m-80 -116.88 103.65 10.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.183 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 8.2 tpt180 -47.46 -28.65 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.602 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.3 75.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -103.96 16.17 26.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.013 -1.287 . . . . 0.0 111.675 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -121.45 155.86 33.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.57 -1.331 . . . . 0.0 109.89 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -84.86 139.62 31.76 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.8 ttmm -36.79 -47.98 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.559 -0.713 . . . . 0.0 110.704 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.93 -56.74 13.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 110.356 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.54 -21.5 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 110.123 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.921 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.66 -40.49 48.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.915 -1.116 . . . . 0.0 109.333 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.48 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 43.3 mt-10 -73.87 -48.38 31.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -48.27 -40.62 25.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 48.4 mm-40 -61.14 -48.14 82.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.713 HG23 HG21 ' A' ' 184' ' ' VAL . 22.8 mt -73.21 -49.99 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.656 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 179' ' ' SER . 1.5 m-20 -52.57 -42.9 64.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.2 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -52.18 -46.26 65.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.722 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 65.6 mm-40 -56.19 -51.7 67.07 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.701 ' HB3' HG11 ' A' ' 4' ' ' VAL . 40.9 mt -68.69 -24.13 64.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 175' ' ' ASP . 32.1 p -52.58 -38.2 59.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.754 -1.217 . . . . 0.0 107.802 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 28.8 mt-30 -102.21 31.76 3.83 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.539 ' C ' HD13 ' A' ' 7' ' ' LEU . 17.6 m-80 48.2 51.22 15.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 109.148 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 27.2 mt-30 -124.08 116.09 27.41 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.9 Cg_endo -64.76 166.59 17.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.07 1.847 . . . . 0.0 112.497 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.713 HG21 HG23 ' A' ' 174' ' ' ILE . 77.0 t -125.55 140.73 47.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.102 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -86.02 120.17 27.12 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 4.2 t80 -123.63 161.41 25.09 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.061 -1.024 . . . . 0.0 109.5 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.7 pt20 -167.63 130.29 1.62 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 117.591 -1.644 . . . . 0.0 112.007 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -94.11 114.06 4.68 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 190' ' ' GLY . 21.5 t -71.89 167.69 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.902 -1.351 . . . . 0.0 110.647 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -174.87 -141.18 3.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -37.53 16.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.026 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.1 m -80.75 1.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.94 -1.1 . . . . 0.0 111.153 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 118.86 -162.21 13.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -89.84 106.01 3.28 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.721 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.75 125.4 27.05 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.636 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -114.1 160.46 18.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.612 -1.235 . . . . 0.0 112.923 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.803 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.9 p90 -156.66 168.76 26.42 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 71.5 t -114.18 136.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.755 -1.216 . . . . 0.0 112.158 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 208' ' ' TYR . 39.5 mt -100.05 114.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.4 p30 -130.44 37.59 3.84 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.304 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -177.13 169.73 42.13 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.09 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -153.25 136.59 15.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -97.1 0.14 48.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.465 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 88.67 -26.94 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -100.18 51.08 0.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -1.136 . . . . 0.0 109.854 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.48 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 7.5 m120 60.9 20.79 11.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 3.2 m-85 -111.73 137.94 48.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.083 -1.011 . . . . 0.0 109.406 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.6 ' HB3' HG23 ' A' ' 199' ' ' ILE . 4.6 m-85 -122.87 164.3 18.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 110.097 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.9 t-80 -92.45 120.28 32.79 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.898 HG11 ' CZ3' ' A' ' 212' ' ' TRP . 26.7 t -114.73 145.08 20.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.112 -0.992 . . . . 0.0 111.802 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.509 ' HB2' HD12 ' A' ' 8' ' ' LEU . 16.4 t-20 -112.34 79.18 1.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.898 ' CZ3' HG11 ' A' ' 210' ' ' VAL . 32.9 m95 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 120.903 -1.123 . . . . 0.0 109.572 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 80.4 mt-30 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 79.8 p -161.71 161.67 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.513 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.64 144.79 35.93 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.47 0.652 . . . . 0.0 109.57 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.8 t -105.2 116.46 49.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.843 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.1 m -117.05 139.12 45.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.318 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 90.7 47.17 3.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.619 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 mt -94.5 98.25 7.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.16 149.34 10.05 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.625 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.283 1.989 . . . . 0.0 110.358 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.79 HG11 ' HB3' ' A' ' 178' ' ' LEU . 86.8 t . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 20.3 mmtp -76.4 -179.77 5.36 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 108.545 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.483 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 27.6 t -77.82 105.65 9.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.652 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.707 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 34.3 mt -58.53 -50.44 73.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -0.86 . . . . 0.0 108.824 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.1 mt -54.6 -39.2 67.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 0.0 108.516 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 6.0 t0 -67.85 -42.21 81.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 109.801 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 44.0 p -58.04 -14.91 7.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.156 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -117.74 19.67 13.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.69 35.72 4.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 58' ' ' TYR . 42.8 mt -85.52 110.45 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.328 -1.101 . . . . 0.0 110.287 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.6 m-70 -134.01 81.9 1.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.621 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -92.18 170.54 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.229 1.014 . . . . 0.0 111.475 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -147.98 -167.65 2.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.515 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 16.6 mt-30 -125.45 -2.81 7.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.798 -1.189 . . . . 0.0 110.471 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.665 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.37 -54.81 0.33 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.465 -1.35 . . . . 0.0 112.31 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 10.6 t-20 -45.64 -129.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.579 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.938 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -77.38 6.25 4.53 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 123.435 2.263 . . . . 0.0 109.062 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.762 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 85.8 m-85 -77.19 -35.92 55.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.85 -0.531 . . . . 0.0 110.077 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 47.2 p30 -98.85 20.33 13.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.773 -1.205 . . . . 0.0 109.043 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.9 mt -71.43 -6.11 37.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 111.079 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.56 HD12 ' OG ' ' A' ' 117' ' ' SER . 7.6 mt -131.91 0.59 3.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.687 -1.258 . . . . 0.0 109.789 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -67.31 167.04 16.54 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -70.58 142.85 45.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.747 1.632 . . . . 0.0 111.509 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.24 150.08 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.592 0.711 . . . . 0.0 110.37 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.754 HD11 ' C ' ' A' ' 132' ' ' GLY . 34.1 mt -77.64 147.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.552 0.692 . . . . 0.0 110.165 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.9 mm-40 -124.49 -22.7 4.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.212 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 79' ' ' TYR . 3.8 mtpt -122.68 168.76 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.371 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 39' ' ' VAL . 42.5 t . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.78 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.082 0.468 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.4 m-85 -123.72 27.34 7.36 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.036 -1.04 . . . . 0.0 109.344 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 31' ' ' VAL . 49.2 t -73.58 142.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.484 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.46 -2.38 72.45 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -82.58 133.98 35.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.317 -1.108 . . . . 0.0 109.827 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -73.23 109.07 6.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.49 159.08 1.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.215 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -79.12 165.55 23.21 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.726 0.775 . . . . 0.0 109.857 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.978 HG21 ' SD ' ' A' ' 120' ' ' MET . 5.8 p -81.06 -34.14 32.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 108.588 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.96 137.11 8.16 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.512 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.0 p -55.29 -48.98 73.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 37.7 t -47.02 -53.72 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.28 -50.87 72.33 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.64 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.515 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 86.6 m -64.19 -31.48 72.7 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.852 -0.53 . . . . 0.0 109.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.13 -43.09 83.27 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.055 -1.458 . . . . 0.0 107.292 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.65 -39.19 57.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 109.785 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.9 mt-30 -60.05 -51.15 70.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.695 -1.253 . . . . 0.0 107.647 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.695 HD11 HG22 ' A' ' 198' ' ' VAL . 35.0 mt -63.41 -24.21 35.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 21.9 mtp -73.0 -38.46 66.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 44.7 tptt -69.17 -40.58 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.707 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 50.2 t80 -53.53 -30.5 41.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.058 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.0 m-70 -107.86 -23.08 12.2 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.214 -0.929 . . . . 0.0 110.763 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 54.4 m-20 44.44 54.8 6.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -76.79 -75.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 119.443 -0.903 . . . . 0.0 113.406 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 34.0 Cg_endo -67.09 104.19 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 120.3 0.667 . . . . 0.0 112.107 -176.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.4 -20.32 62.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.4 OUTLIER -133.96 143.68 48.32 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.8 34.96 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.226 -1.464 . . . . 0.0 109.847 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.943 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -90.14 -64.88 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.379 -1.071 . . . . 0.0 109.645 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 5.9 tttt -131.9 148.82 52.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 m-20 -73.9 179.58 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 70' ' ' THR . 14.2 t80 -153.9 151.32 29.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.307 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 t -155.03 152.42 29.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.096 -1.002 . . . . 0.0 109.656 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.701 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 21.3 p90 -161.66 155.01 21.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 109.61 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 97.0 m -93.33 139.37 30.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.789 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -56.55 147.78 21.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 111.221 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -61.95 143.79 55.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.35 0.595 . . . . 0.0 109.749 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -70.13 -2.14 12.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.526 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 18.9 m-20 -97.47 -8.94 28.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.789 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.8 t-20 -70.44 109.51 5.11 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.747 -0.596 . . . . 0.0 109.88 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -89.16 15.82 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.959 2.439 . . . . 0.0 110.193 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.676 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.7 m-85 -105.92 -25.86 11.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.718 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' C ' ' A' ' 81' ' ' ASN . 8.7 m-85 -119.21 163.0 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.5 m120 -46.58 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 175.06 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 111.041 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.17 56.63 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 N-CA-C 107.24 -1.869 . . . . 0.0 107.24 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.92 106.73 17.37 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.408 -178.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 134.29 43.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.91 125.03 51.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.51 124.93 46.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.147 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.21 108.47 19.91 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.9 54.19 0.36 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.799 -1.188 . . . . 0.0 108.428 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 46.6 mt -52.43 -45.75 46.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 O-C-N 121.405 -0.809 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 p -45.42 -26.46 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.799 -1.188 . . . . 0.0 109.286 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 26.75 10.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.811 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -84.45 154.13 22.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.111 -0.993 . . . . 0.0 110.375 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.27 95.03 4.79 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 7.0 m-85 -81.82 88.96 6.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 110.857 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 11.7 t30 -79.94 91.13 5.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CE2' ' HA ' ' A' ' 60' ' ' ASN . 61.7 m95 -61.29 -6.25 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.423 -0.798 . . . . 0.0 110.805 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -90.33 -18.86 24.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.779 -1.201 . . . . 0.0 107.876 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.3 m-20 -99.59 -29.11 12.88 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.694 HG12 ' HB1' ' A' ' 115' ' ' ALA . 31.0 mt -73.83 63.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.522 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 61.0 mt -46.27 148.64 1.51 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.555 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.5 Cg_endo -77.75 -29.07 4.73 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.598 2.199 . . . . 0.0 110.455 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -134.68 124.5 25.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.122 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.0 m-85 -109.42 138.92 45.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.6 p -100.09 1.65 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.472 ' HA3' HD22 ' A' ' 19' ' ' ASN . . . 81.93 0.79 89.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -120.13 9.66 11.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.196 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -74.73 -178.95 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -76.38 174.98 9.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 1.2 m120 -78.48 -36.76 44.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.658 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.9 t -53.47 -59.42 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.801 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.85 -33.15 73.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 108.94 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.533 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 32.1 mttt -67.81 -44.22 77.8 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -33.18 70.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.694 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.09 -67.84 0.28 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.71 -0.619 . . . . 0.0 109.579 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.9 tp -61.96 -41.34 90.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.193 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.56 ' OG ' HD12 ' A' ' 24' ' ' LEU . 4.5 p -57.15 -40.02 76.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 109.164 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.811 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 31.3 tt0 -69.99 -43.26 71.8 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.8 tp -57.41 -48.41 79.16 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.978 ' SD ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -56.61 -47.6 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.476 178.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.71 -39.22 93.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 126' ' ' SER . 13.0 m-20 -65.3 -53.87 37.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 127' ' ' VAL . 89.1 t -65.31 -54.99 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.296 -0.878 . . . . 0.0 109.454 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -47.22 -53.07 11.9 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.1 mt -65.99 -53.16 40.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -1.093 . . . . 0.0 108.516 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 123' ' ' VAL . 60.3 p -45.53 -33.53 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.067 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 123' ' ' VAL . 35.7 m -100.86 38.69 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.713 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' VAL . 22.4 m-20 37.15 52.04 1.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.517 -0.74 . . . . 0.0 109.624 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.66 ' HE3' ' O ' ' A' ' 45' ' ' THR . 44.2 tpp -66.63 130.55 43.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.57 -0.707 . . . . 0.0 111.774 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' SER . 8.0 t70 -76.92 122.01 24.26 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.652 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.59 120.31 40.63 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.479 1.133 . . . . 0.0 113.029 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.754 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -152.09 -163.21 11.37 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 104.485 -3.446 . . . . 0.0 104.485 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.623 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -62.26 -31.54 82.16 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 N-CA-C 105.551 -2.519 . . . . 0.0 105.551 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.2 m -109.36 142.21 40.62 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.509 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 30.7 m -124.64 109.8 13.61 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 119.961 -1.712 . . . . 0.0 110.104 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.3 137.41 14.08 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 3.5 t -117.35 -162.22 0.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.879 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.69 -50.65 5.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 143' ' ' VAL . . . 121.37 -126.24 6.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.488 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 10.4 m -47.08 -60.55 2.39 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.712 -0.875 . . . . 0.0 112.279 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 79.4 p -47.18 -41.45 18.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 0.0 109.253 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.879 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.5 mmp_? -79.9 -41.14 26.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.432 1.111 . . . . 0.0 109.142 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.792 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.1 t -67.71 -60.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.16 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.9 pp0? -56.2 -34.78 66.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.755 -1.216 . . . . 0.0 108.651 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.569 ' HE ' ' NH2' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -70.66 -44.8 66.31 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.315 -0.866 . . . . 0.0 109.329 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.76 -36.91 81.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.182 -0.949 . . . . 0.0 110.662 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.831 HD13 HG12 ' A' ' 251' ' ' ILE . 76.6 mt -55.67 -54.73 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 109.921 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 11.1 mtmt -81.07 -33.87 33.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 111.597 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 84.9 mt-10 -74.09 -66.97 0.65 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.48 -1.388 . . . . 0.0 112.628 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.556 ' HB3' HD13 ' A' ' 90' ' ' ILE . 26.3 m120 -81.63 -31.78 32.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.923 -1.111 . . . . 0.0 111.727 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 22.4 m-85 -102.57 -8.17 21.22 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.64 -1.287 . . . . 0.0 110.382 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.943 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 53.74 38.45 59.29 Favored Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.137 -0.977 . . . . 0.0 112.212 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.24 162.8 9.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.3 -1.706 . . . . 0.0 107.677 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 35.8 t-20 -47.11 143.87 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 109.586 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -53.58 -19.97 4.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.492 -0.755 . . . . 0.0 109.009 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 154' ' ' ASN . 3.7 p -53.99 -16.63 2.01 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.812 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.559 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 41.0 t -61.34 127.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.911 -1.118 . . . . 0.0 109.552 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.898 ' CE1' HG23 ' A' ' 249' ' ' VAL . 18.7 p-80 -149.08 158.76 44.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.375 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 33.0 tt0 -102.78 149.22 24.69 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.894 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -127.87 146.79 32.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.8 m120 -112.36 102.98 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.131 . . . . 0.0 111.125 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.669 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.21 -28.41 3.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.83 . . . . 0.0 109.049 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.542 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.54 -27.69 73.31 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -103.85 4.72 35.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.1 -1.235 . . . . 0.0 111.6 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.08 171.04 8.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.404 -1.435 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 167' ' ' LYS . 84.1 p -103.94 134.56 47.02 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 166' ' ' SER . 54.7 tttt -30.57 -45.08 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.923 -0.485 . . . . 0.0 111.077 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -63.3 -66.04 0.6 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.185 . . . . 0.0 109.851 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -16.01 58.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 109.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.894 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 45.8 t-105 -72.18 -49.34 36.39 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.153 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 174' ' ' ILE . 18.8 mt-10 -67.6 -33.7 75.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.7 -48.01 20.32 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -61.01 -38.47 86.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.765 HG21 HD13 ' A' ' 199' ' ' ILE . 53.3 mt -75.92 -63.86 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 110.425 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -49.28 -53.89 19.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -51.92 -40.2 60.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 108.112 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.557 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.0 mm-40 -61.11 -50.26 73.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.874 HD21 HG22 ' A' ' 199' ' ' ILE . 13.2 mt -68.61 -25.78 65.03 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.484 -0.76 . . . . 0.0 109.7 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 37.0 p -51.85 -38.0 54.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 108.26 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 10.7 mt-30 -101.09 33.87 2.71 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.489 ' C ' HD13 ' A' ' 7' ' ' LEU . 5.4 m120 45.97 50.66 11.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 15.0 mt-30 -124.07 107.14 30.7 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.451 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -64.19 170.06 9.79 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.145 1.897 . . . . 0.0 112.667 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 51.6 t -123.67 135.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.614 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.792 ' CE2' HG21 ' A' ' 143' ' ' VAL . 1.2 t80 -83.42 117.95 23.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.624 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 4.1 t80 -123.19 153.41 40.12 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 120.845 -1.16 . . . . 0.0 109.705 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.9 pt20 -164.81 135.5 4.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.328 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.92 114.98 4.66 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 107.239 -2.345 . . . . 0.0 107.239 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 41.5 t -80.96 145.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.255 . . . . 0.0 111.349 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -145.9 -145.75 4.3 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -87.95 -29.77 20.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -1.162 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.2 m -82.9 -13.07 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.8 -166.13 25.18 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -97.91 110.89 4.12 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 119.038 -1.553 . . . . 0.0 110.735 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.33 117.37 12.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -107.99 160.92 15.41 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.373 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.721 ' CD1' HG13 ' A' ' 210' ' ' VAL . 46.7 p90 -159.09 166.5 31.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.695 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -114.11 136.11 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.696 -1.253 . . . . 0.0 112.036 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.874 HG22 HD21 ' A' ' 178' ' ' LEU . 7.4 mt -98.71 125.79 52.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.5 p30 -139.92 32.33 1.99 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.716 -1.594 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -167.03 173.45 42.29 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 117.862 -2.113 . . . . 0.0 111.719 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.498 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -160.92 149.28 16.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -122.46 31.66 6.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.711 -1.243 . . . . 0.0 110.45 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 44.33 25.38 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 2.2 mtt180 -142.26 21.79 2.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.227 -1.16 . . . . 0.0 108.95 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.9 OUTLIER 77.88 23.51 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.221 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 29.7 m-85 -122.72 128.45 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.928 . . . . 0.0 109.356 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.3 m-85 -122.94 171.6 9.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.299 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 1.0 OUTLIER -93.64 136.39 33.96 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.721 HG13 ' CD1' ' A' ' 197' ' ' PHE . 51.2 t -128.62 137.32 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.052 -1.03 . . . . 0.0 110.414 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.5 t-20 -111.85 73.13 0.8 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.523 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 82.3 m95 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.459 -0.776 . . . . 0.0 110.179 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 6.6 pt20 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 15.1 p -166.1 163.21 18.11 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -142.08 167.15 22.81 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.942 0.877 . . . . 0.0 109.925 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 147' ' ' LEU . 15.5 t -118.0 120.77 65.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.898 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.4 m -120.69 149.75 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.95 -1.094 . . . . 0.0 111.282 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 86.03 46.92 5.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.831 HG12 HD13 ' A' ' 147' ' ' LEU . 4.1 mt -93.57 93.98 4.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.406 -1.055 . . . . 0.0 109.761 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.07 148.67 9.71 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.44 -0.788 . . . . 0.0 108.946 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.626 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.389 2.06 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.8 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 201' ' ' GLY . 10.1 mmtt -76.14 -166.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 108.908 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.566 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 2.7 t -87.89 106.11 17.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.873 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.694 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 46.6 mt -58.49 -50.11 74.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 108.906 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.4 mt -55.93 -38.02 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.66 -1.275 . . . . 0.0 108.858 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.507 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 43.9 m-20 -67.25 -43.48 81.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.796 . . . . 0.0 109.774 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 3.7 p -58.24 -14.44 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.048 . . . . 0.0 109.317 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.5 mtpm? -117.15 17.9 14.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.793 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.26 41.44 6.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.2 mt -91.11 108.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 122.247 1.022 . . . . 0.0 110.526 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 8.5 m-70 -134.83 81.25 1.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.6 m-30 -87.11 179.99 6.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 111.152 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.74 -162.61 1.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 45' ' ' THR . 29.8 mt-30 -125.36 -21.93 4.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.721 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.06 -33.87 1.59 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.604 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.828 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.7 t-20 -45.6 -139.68 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.512 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.064 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -74.24 2.99 5.58 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 CA-C-N 122.554 1.948 . . . . 0.0 109.269 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.7 m-85 -77.91 -31.59 51.25 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.404 -0.81 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.478 ' HA ' HG23 ' A' ' 25' ' ' THR . 23.8 p-10 -93.88 14.35 19.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.632 -1.293 . . . . 0.0 109.746 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.2 mt -70.4 -7.83 46.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.738 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 118' ' ' GLU . 11.3 mt -123.74 -9.35 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.092 -1.005 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.0 p -60.85 165.31 6.1 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.2 Cg_endo -70.48 143.02 46.2 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.357 2.038 . . . . 0.0 112.184 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.23 148.12 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.559 0.695 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.9 mt -78.51 148.05 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 111.173 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.9 mt-10 -126.4 -21.5 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.732 -0.605 . . . . 0.0 110.659 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 9.0 mtpm? -118.82 168.39 10.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.859 -1.15 . . . . 0.0 110.284 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 37' ' ' SER . 74.9 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.557 -0.715 . . . . 0.0 110.69 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 31' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.616 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 82.5 m-85 -123.61 14.71 9.47 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.899 -1.126 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 29' ' ' GLU . 61.0 t -62.99 141.89 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.189 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 1.38 87.39 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -91.97 132.14 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -1.096 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -73.2 111.89 8.74 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.21 160.61 0.75 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 109.003 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.76 166.93 22.34 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.616 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.697 HG21 ' SD ' ' A' ' 120' ' ' MET . 29.5 p -79.67 -35.56 39.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.6 139.02 9.53 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 51' ' ' ALA . 5.6 p -55.17 -49.75 71.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 3.9 t -47.02 -52.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.77 -47.38 78.39 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.847 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 96.1 m -62.6 -30.2 71.17 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.97 -47.22 69.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.968 -1.083 . . . . 0.0 108.822 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 56' ' ' MET . 30.8 m -75.6 -49.82 17.39 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.409 0.623 . . . . 0.0 110.277 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.6 -34.55 37.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 109.078 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.609 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -67.71 -48.93 65.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.74 HD11 HG22 ' A' ' 198' ' ' VAL . 36.0 mt -66.79 -28.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 52' ' ' THR . 19.3 mtp -67.13 -39.58 86.62 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -71.89 -39.48 69.56 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.694 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 56.9 t80 -53.44 -34.43 57.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.493 -0.754 . . . . 0.0 109.346 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.615 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 36.8 m80 -107.75 -20.45 13.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.36 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.641 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.0 OUTLIER 38.55 54.63 1.89 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -74.64 -70.7 0.23 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.0 Cg_endo -69.67 103.81 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 122.269 0.615 . . . . 0.0 111.806 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' TYR . 7.6 m120 -70.09 -21.57 63.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -134.78 140.13 45.65 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.84 34.9 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.664 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.883 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -89.01 -44.3 10.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.62 -0.929 . . . . 0.0 110.387 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.4 tttt -151.61 137.86 18.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 164.94 7.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.0 110.219 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 26.1 t80 -148.94 141.35 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.264 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t -146.99 161.12 41.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.932 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.6 p90 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.656 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.494 HG23 ' OD1' ' A' ' 85' ' ' ASN . 27.4 m -93.19 129.82 39.08 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.826 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -47.67 150.58 0.99 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 111.28 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 t -62.15 140.67 58.42 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -68.09 -3.82 11.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 0.0 109.868 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 52.6 t30 -99.28 -7.75 25.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.826 ' ND2' HD21 ' A' ' 73' ' ' LEU . 39.6 t-20 -70.37 111.58 9.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 109.971 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.621 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.3 Cg_endo -88.54 13.11 2.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.982 2.454 . . . . 0.0 110.094 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.4 m-85 -104.94 -5.0 21.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 111.139 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 5.5 m-85 -142.22 162.0 36.58 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.564 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 23.5 m-20 -46.67 -79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 174.79 -46.8 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 111.047 175.307 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.88 57.34 5.67 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 N-CA-C 107.012 -1.957 . . . . 0.0 107.012 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.51 101.59 11.11 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.294 -178.028 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.494 ' OD1' HG23 ' A' ' 72' ' ' THR . 37.3 m-80 -100.11 128.87 46.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.756 . . . . 0.0 109.466 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -100.75 134.5 43.63 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.77 129.63 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.81 111.37 23.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 51.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 108.304 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.4 mt -52.77 -54.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.384 -0.822 . . . . 0.0 110.027 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.1 p -44.59 -27.61 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.242 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -111.97 34.36 4.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -0.83 . . . . 0.0 109.177 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.748 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.05 90.31 3.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.4 m-85 -81.31 88.08 6.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 47.3 t-20 -79.4 87.79 5.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.641 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.0 m95 -60.98 -7.04 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -89.43 -18.76 26.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 7.9 m-20 -100.08 -26.48 13.94 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.609 HG12 ' HB1' ' A' ' 115' ' ' ALA . 51.9 mt -76.53 67.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 108.903 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 18.9 mt -46.84 149.42 1.53 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.775 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.534 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.7 Cg_endo -78.99 -18.11 11.63 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.903 2.402 . . . . 0.0 110.725 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 133.3 25.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.995 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.625 ' CE2' HG21 ' A' ' 116' ' ' ILE . 62.1 m-85 -121.49 136.75 54.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.258 -0.901 . . . . 0.0 109.845 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -99.94 0.91 42.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 113' ' ' LYS . . . 81.15 -1.76 83.81 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.631 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -110.46 -6.88 14.83 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.423 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.631 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 3.0 mp0 -63.86 164.66 9.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 109.755 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -62.1 172.74 1.31 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 17.3 m-20 -77.03 -31.26 56.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.623 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.2 -60.17 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 5.2 mp0 -62.76 -35.04 78.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.785 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.546 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 33.6 mttt -65.27 -42.34 93.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.463 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 12.2 ttm -59.15 -37.81 78.2 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.609 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.33 -68.1 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.672 -0.643 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.733 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.1 tp -62.37 -37.48 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.633 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.2 p -57.18 -40.44 77.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.921 -1.112 . . . . 0.0 109.95 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.748 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 35.3 tt0 -69.4 -41.57 76.26 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.733 HD23 ' CD1' ' A' ' 116' ' ' ILE . 9.3 tp -54.65 -52.69 61.52 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.697 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -58.68 -43.93 90.1 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.5 -0.75 . . . . 0.0 109.292 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.09 -36.69 84.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 93' ' ' ARG . 27.8 m-20 -69.6 -54.61 13.2 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 127' ' ' VAL . 48.4 t -63.38 -57.78 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.19 -49.84 13.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.0 mt -63.9 -58.8 5.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 108.276 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.25 -29.23 1.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.517 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 20.9 m -101.42 36.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.895 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 127' ' ' VAL . 3.3 m-20 37.81 51.93 1.39 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.466 -0.771 . . . . 0.0 109.407 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.7 tpp -66.04 126.92 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.53 -0.731 . . . . 0.0 111.741 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -75.77 120.66 21.44 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 57.3 m-85 -102.83 115.67 31.05 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.279 1.038 . . . . 0.0 112.719 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.744 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.92 -162.88 10.95 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 104.869 -3.292 . . . . 0.0 104.869 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 18.0 Cg_endo -62.39 -30.56 80.72 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 N-CA-C 105.802 -2.422 . . . . 0.0 105.802 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.99 140.76 43.65 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 32.7 m -124.26 109.66 13.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.843 -1.786 . . . . 0.0 110.286 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -108.88 144.72 16.42 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.648 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.54 -163.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -1.219 . . . . 0.0 107.765 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.75 -53.97 4.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 134.18 -139.02 10.51 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 119.145 -1.502 . . . . 0.0 111.981 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB2' ' CD ' ' A' ' 159' ' ' GLN . 0.7 OUTLIER -48.06 -54.37 13.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.139 -0.624 . . . . 0.0 112.237 -177.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 4.1 p -46.53 -41.25 13.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.926 -1.109 . . . . 0.0 109.7 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.708 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 2.3 mmt180 -81.15 -42.63 20.58 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 109.585 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.855 HG21 ' CE2' ' A' ' 185' ' ' TYR . 44.3 t -68.14 -52.79 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 110.463 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.44 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 1.8 pp0? -56.9 -34.36 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.554 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 2.4 ttm180 -77.35 -51.8 10.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 109.197 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.75 75.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.587 ' HB2' HG11 ' A' ' 157' ' ' VAL . 46.0 mt -56.92 -50.57 72.17 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.099 -1.0 . . . . 0.0 109.652 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 4.5 mtmp? -87.65 -41.12 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.017 -1.052 . . . . 0.0 110.589 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 85.1 mt-10 -68.08 -49.1 63.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.919 -1.113 . . . . 0.0 111.727 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -93.94 -43.19 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.907 -1.121 . . . . 0.0 111.652 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 152' ' ' GLY . 33.5 m-85 -102.27 15.49 28.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.658 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.883 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 35.08 40.22 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.626 -0.671 . . . . 0.0 112.581 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.2 m-85 -62.53 164.06 8.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.062 -1.846 . . . . 0.0 107.853 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.5 t-20 -47.37 145.1 2.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.174 . . . . 0.0 109.617 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -53.43 -19.96 4.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.909 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.537 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 7.8 p -55.72 -14.5 2.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.331 -0.856 . . . . 0.0 109.739 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -66.4 119.85 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.938 -1.101 . . . . 0.0 109.65 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.6 p-80 -148.55 163.17 38.02 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.495 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 18.4 tt0 -104.07 146.36 28.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.617 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 4.3 pt -121.93 155.17 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m120 -123.29 105.73 10.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.814 -1.179 . . . . 0.0 111.041 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 44.4 tpt85 -48.14 -38.9 19.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 109.012 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.54 -25.83 63.69 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.03 -1.03 28.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.064 -1.256 . . . . 0.0 111.273 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.04 173.92 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.785 -1.197 . . . . 0.0 110.027 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 167' ' ' LYS . 83.8 p -98.53 138.71 35.34 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 166' ' ' SER . 35.5 tttt -35.22 -48.43 0.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.766 -0.584 . . . . 0.0 110.361 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.404 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 7.5 mp0 -65.4 -59.23 4.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.049 -1.032 . . . . 0.0 109.854 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.52 -15.59 58.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.988 . . . . 0.0 109.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 61.0 t-105 -73.66 -47.78 37.26 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.664 ' HA ' HD12 ' A' ' 174' ' ' ILE . 29.2 mt-10 -70.76 -30.98 67.63 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.24 65.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 63.8 mm-40 -61.26 -41.19 96.49 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.001 HG23 HG21 ' A' ' 184' ' ' VAL . 22.3 mt -74.03 -51.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.553 -0.717 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -55.97 -41.98 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 108.626 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -51.97 -43.29 63.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.582 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 51.9 mm-40 -59.72 -51.94 67.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.94 -25.61 64.65 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.828 . . . . 0.0 110.044 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.484 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.5 p -52.05 -38.12 55.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 25.0 mt-30 -101.55 29.52 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.528 ' C ' HD13 ' A' ' 7' ' ' LEU . 8.1 m-20 51.15 49.18 21.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.72 0.771 . . . . 0.0 109.165 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 77.8 mt-30 -124.34 117.08 26.77 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.8 Cg_endo -65.67 171.4 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.21 1.94 . . . . 0.0 112.328 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 174' ' ' ILE . 23.4 t -125.98 115.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.367 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.855 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -66.27 113.27 4.46 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 10.9 t80 -123.77 157.39 34.13 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 120.891 -1.13 . . . . 0.0 109.658 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.1 pt20 -158.93 129.84 6.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 117.927 -1.509 . . . . 0.0 111.804 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.17 109.71 3.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 3.6 t -66.8 166.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -1.179 . . . . 0.0 111.099 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.594 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -175.21 -136.78 2.35 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -87.81 -55.85 3.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.24 . . . . 0.0 111.357 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.15 -8.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.057 -1.027 . . . . 0.0 111.47 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.45 21.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -91.25 107.57 3.5 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.0 t-80 -71.66 126.19 29.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.92 159.07 24.47 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.533 1.159 . . . . 0.0 112.723 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.693 ' CD1' HG13 ' A' ' 210' ' ' VAL . 43.2 p90 -153.58 -161.05 1.19 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' ILE . 85.9 t -139.34 133.27 38.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 120.362 -1.461 . . . . 0.0 111.377 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.633 HD13 HG21 ' A' ' 174' ' ' ILE . 82.8 mt -99.14 120.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 3.1 p30 -133.24 33.47 3.61 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.439 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.23 163.92 35.62 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 117.706 -2.188 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.533 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.28 140.9 29.47 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -111.31 11.18 21.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.103 . . . . 0.0 110.567 -178.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.64 4.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -80.57 53.54 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 109.884 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 53.09 38.54 27.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.783 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.528 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 1.2 m-85 -121.92 133.92 54.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 12.9 m-85 -122.91 159.77 27.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.07 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 39.4 t-80 -93.22 117.78 30.48 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 197' ' ' PHE . 29.1 t -114.55 138.64 43.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 111.447 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 8' ' ' LEU . 19.4 t-20 -104.62 80.56 1.68 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 23.0 m95 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -178.876 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 1.5 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 72.6 p -136.05 164.82 27.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.712 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.695 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.91 161.7 37.2 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.75 HG23 ' CD1' ' A' ' 185' ' ' TYR . 39.1 t -116.15 113.67 43.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 184' ' ' VAL . 13.9 m -112.55 142.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.941 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.42 ' N ' ' OE1' ' A' ' 177' ' ' GLU . . . 90.65 54.77 2.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.59 ' O ' ' CE1' ' A' ' 59' ' ' HIS . 38.5 mt -102.75 89.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 110.225 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 2.2 pptp? -162.89 151.76 12.41 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 0.0 109.03 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.335 2.023 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.7 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -76.19 -178.6 4.56 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.687 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 17.5 t -78.13 106.2 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.896 -1.128 . . . . 0.0 109.312 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.8 mt -56.69 -48.44 77.64 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD11 ' CG1' ' A' ' 198' ' ' VAL . 13.7 mt -55.01 -42.25 72.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 108.386 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 2.1 t0 -67.19 -40.87 86.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.133 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 p -58.11 -15.7 10.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.998 -1.064 . . . . 0.0 108.772 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.584 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 2.0 mtpp -116.9 16.96 15.15 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 46.85 39.22 10.9 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 11' ' ' LYS . 27.8 mt -91.34 110.67 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -1.037 . . . . 0.0 110.519 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.0 m80 -134.7 83.05 2.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.2 m-30 -89.49 179.28 6.09 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.141 0.972 . . . . 0.0 110.991 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -147.89 -163.24 1.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 45' ' ' THR . 37.3 mt-30 -124.95 -21.21 4.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.978 -1.076 . . . . 0.0 110.572 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.31 -35.09 1.36 Allowed Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.522 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.844 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.6 t-20 -45.64 -138.06 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.527 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.202 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.844 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.1 Cg_endo -75.08 4.46 4.75 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 CA-C-N 122.688 1.996 . . . . 0.0 109.589 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.9 m-85 -80.42 -34.1 36.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 29.9 p-10 -88.79 15.65 8.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.536 -1.352 . . . . 0.0 109.177 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.17 -5.96 30.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.104 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.1 mt -128.57 -5.81 5.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 109.934 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -61.24 164.57 8.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.1 Cg_endo -69.59 136.36 33.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.231 1.954 . . . . 0.0 112.251 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG1' ' HA2' ' A' ' 40' ' ' GLY . 38.8 t -76.01 148.19 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.538 0.685 . . . . 0.0 109.924 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 132' ' ' GLY . 13.7 mt -78.19 150.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.836 0.827 . . . . 0.0 111.122 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' C ' HG22 ' A' ' 39' ' ' VAL . 3.3 mt-10 -125.06 -23.15 4.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.704 -0.623 . . . . 0.0 110.152 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.0 mtpt -120.75 165.91 14.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 38' ' ' PHE . 86.0 t . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 110.588 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.419 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 74.4 m-85 -118.52 12.93 13.36 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.995 -1.066 . . . . 0.0 109.156 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HA ' HG22 ' A' ' 28' ' ' ILE . 78.0 t -62.86 138.94 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' CG1' ' A' ' 27' ' ' VAL . . . 79.89 1.62 87.53 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 11.8 mt-30 -89.39 134.06 34.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.33 111.18 8.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.29 161.08 0.69 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.974 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.68 167.23 21.91 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.661 -0.649 . . . . 0.0 109.515 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.706 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.5 p -80.48 -33.77 36.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.112 -0.993 . . . . 0.0 108.495 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 102.86 138.22 9.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.0 p -55.21 -48.66 73.55 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.585 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.7 t -47.11 -52.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.41 -47.86 77.56 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.088 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.505 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 54.8 m -62.86 -29.47 70.78 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.569 -0.707 . . . . 0.0 109.157 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.91 -47.09 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.751 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 56' ' ' MET . 35.4 m -75.72 -48.88 20.05 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.441 0.639 . . . . 0.0 110.255 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.65 -33.96 35.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.513 -0.742 . . . . 0.0 109.085 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.627 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 28.7 mt-30 -68.31 -50.38 53.91 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 198' ' ' VAL . 33.7 mt -65.0 -23.99 34.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.582 ' HG3' HG22 ' A' ' 52' ' ' THR . 18.1 mtp -72.56 -36.23 68.17 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.558 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 42.4 tptt -71.5 -44.42 64.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.9 t80 -53.38 -30.58 40.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.24 0.543 . . . . 0.0 109.739 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 61.0 m-70 -107.81 -23.62 12.0 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.625 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.662 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.23 58.92 1.81 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -77.96 -76.82 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.375 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.3 Cg_endo -71.19 108.59 2.37 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 CA-C-N 119.41 0.825 . . . . 0.0 113.225 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.76 -26.99 67.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 103.819 -2.659 . . . . 0.0 103.819 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 18.9 tttt -129.58 130.35 45.58 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.93 167.46 4.35 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.396 -1.859 . . . . 0.0 110.904 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.11 -38.64 10.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.537 -0.978 . . . . 0.0 111.301 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 73.4 tttt -152.67 132.49 13.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.677 -1.265 . . . . 0.0 110.7 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 3.0 m-20 -60.42 168.29 2.17 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.368 -0.832 . . . . 0.0 109.495 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 35.8 t80 -151.97 141.81 21.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 109.724 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.0 t -144.39 153.51 42.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 109.271 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.793 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.1 p90 -152.88 156.7 39.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.819 HG23 ' OD1' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -92.9 127.19 38.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.819 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -44.81 150.36 0.37 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 111.205 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -61.99 142.89 57.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.862 -0.524 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.401 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 p -70.06 -2.1 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.013 -1.054 . . . . 0.0 109.816 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 16.0 t-20 -99.83 -8.18 24.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.146 -0.971 . . . . 0.0 109.666 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.819 ' ND2' HD21 ' A' ' 73' ' ' LEU . 37.8 t-20 -70.23 112.09 11.51 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.592 -0.693 . . . . 0.0 110.021 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.0 Cg_endo -86.94 9.03 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.042 2.494 . . . . 0.0 110.589 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 58.2 m-85 -104.83 -14.04 15.65 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.106 -0.997 . . . . 0.0 111.5 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 53.2 m-85 -128.18 159.57 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.4 m120 -46.9 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 175.47 -48.31 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.966 175.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.58 57.72 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.91 104.98 14.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.487 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.819 ' OD1' HG23 ' A' ' 72' ' ' THR . 2.4 m-80 -100.42 132.23 45.92 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.337 -0.852 . . . . 0.0 109.882 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.793 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -105.86 143.26 34.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -130.91 128.84 41.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.923 -1.11 . . . . 0.0 110.537 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -111.12 112.16 23.76 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.89 53.84 0.48 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.673 -1.267 . . . . 0.0 108.102 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.3 mt -52.98 -56.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.726 -0.609 . . . . 0.0 111.332 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -43.83 -29.73 0.58 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.703 -1.248 . . . . 0.0 109.456 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.93 33.04 5.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.391 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.873 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 32.7 mmt-85 -82.29 158.12 23.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.736 -1.228 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -116.1 81.73 1.66 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.3 m-85 -81.49 89.9 6.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.581 -0.699 . . . . 0.0 110.198 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.506 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.5 t30 -78.76 90.83 4.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.662 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 63.8 m95 -60.09 -8.16 2.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.75 -18.12 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 46.1 m-20 -99.72 -31.27 11.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.0 mt -73.83 66.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.538 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 24.9 mt -45.79 149.16 1.18 Allowed Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.558 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -78.24 -23.04 9.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.635 2.223 . . . . 0.0 110.441 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -137.57 130.3 30.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.02 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 86.3 m-85 -116.82 144.29 44.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.042 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.2 p -100.53 -16.62 17.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.49 -2.72 57.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -120.19 7.22 10.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -1.227 . . . . 0.0 109.523 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.23 177.31 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.905 . . . . 0.0 109.486 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 p -69.33 170.85 9.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.77 -38.53 53.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.9 t -51.44 -56.75 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -40.48 96.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.082 -1.012 . . . . 0.0 109.214 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.501 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.6 mttt -62.53 -39.03 92.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.0 ttm -59.91 -43.37 94.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.677 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.58 -52.05 67.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.673 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.6 tp -69.45 -39.2 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.391 -1.443 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -57.55 -41.74 81.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.079 -1.013 . . . . 0.0 110.454 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 20.6 tt0 -68.76 -38.9 80.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.991 -1.068 . . . . 0.0 108.18 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -56.41 -51.04 69.85 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.706 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.6 mmt -59.69 -44.95 93.44 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 108.999 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.48 -36.28 83.66 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.873 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 18.5 m-20 -69.41 -52.43 27.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 127' ' ' VAL . 58.6 t -65.89 -57.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.146 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.16 -49.09 14.7 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.01 -58.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.287 -1.125 . . . . 0.0 108.264 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -47.1 -30.2 2.64 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.571 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.2 m -101.08 37.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 0.0 109.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.1 m-20 37.48 51.44 1.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.476 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 57.8 tpp -65.64 125.61 25.79 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 111.545 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.9 t0 -75.86 121.27 22.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.636 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.0 117.68 35.14 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.519 1.152 . . . . 0.0 113.206 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.751 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.64 -164.2 12.01 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 104.659 -3.377 . . . . 0.0 104.659 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.622 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.24 -29.09 79.8 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.44 141.81 43.02 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 43.4 m -125.33 110.94 14.6 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 119.882 -1.761 . . . . 0.0 110.533 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.92 144.42 16.4 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.7 t -118.17 -163.99 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.111 -1.229 . . . . 0.0 107.719 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.58 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.09 -55.99 3.33 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.567 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 135.0 -137.68 9.43 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 119.313 -1.422 . . . . 0.0 111.623 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.56 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 2.8 m -48.7 -50.22 34.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.812 -0.816 . . . . 0.0 112.408 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' SER . 57.2 p -45.36 -47.28 13.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 0.0 109.842 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.65 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 17.3 mmt180 -81.41 -38.27 26.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 110.195 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.83 HG21 ' CE2' ' A' ' 185' ' ' TYR . 54.1 t -67.67 -53.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.017 . . . . 0.0 110.503 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.95 -34.82 68.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.896 -1.127 . . . . 0.0 108.389 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -77.38 -52.73 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.581 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.52 -34.29 70.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.592 ' HB2' HG11 ' A' ' 157' ' ' VAL . 57.2 mt -59.85 -49.45 77.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.274 -0.891 . . . . 0.0 109.742 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 6.0 mtmt -87.34 -42.74 12.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.891 -1.13 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 32.8 mt-10 -69.31 -51.98 31.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.898 -1.126 . . . . 0.0 112.436 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 21.9 m120 -88.17 -50.47 6.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.725 -1.234 . . . . 0.0 111.986 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -90.04 -16.47 29.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.748 -1.22 . . . . 0.0 110.489 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 68.1 37.8 87.57 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.916 -1.115 . . . . 0.0 111.791 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.9 m-85 -63.04 165.92 6.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.335 -1.686 . . . . 0.0 107.757 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 37.6 t-20 -47.15 143.82 2.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.803 -1.186 . . . . 0.0 109.104 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 11.4 mm100 -53.15 -20.05 3.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 108.983 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.506 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.6 p -55.04 -15.04 1.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -63.57 120.23 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.864 -1.147 . . . . 0.0 109.45 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 1.006 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.0 p-80 -148.12 160.22 43.12 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.1 tt0 -102.48 152.33 21.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 1.078 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.3 pt -131.48 138.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m-80 -106.18 103.32 12.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 1.8 tpt180 -47.66 -29.77 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 108.978 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.92 -22.8 65.01 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.68 -2.87 25.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.241 . . . . 0.0 111.402 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -117.84 177.67 4.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.558 -1.339 . . . . 0.0 110.27 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 170' ' ' TRP . 42.3 p -109.06 147.38 32.47 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' SER . 5.1 ttmm -40.44 -44.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 110.136 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.844 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.37 -15.92 63.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 1.078 ' CH2' HD12 ' A' ' 160' ' ' ILE . 40.5 t-105 -75.11 -38.71 61.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.448 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 42.3 mt-10 -71.24 -34.69 71.0 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.24 -0.912 . . . . 0.0 108.769 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 176' ' ' LYS . . . -55.22 -47.3 75.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.86 . . . . 0.0 109.061 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 80.3 mm-40 -61.25 -43.5 98.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.045 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.952 HG23 HG21 ' A' ' 184' ' ' VAL . 12.0 mt -75.39 -60.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 111.435 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -49.5 -43.4 45.4 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.496 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 172' ' ' ALA . 9.6 tttt -52.21 -44.67 64.88 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.576 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 42.6 mm-40 -58.93 -54.55 45.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.9 mt -66.25 -26.37 67.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' ASP . 45.0 p -51.9 -43.83 63.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.2 mt-30 -94.89 32.05 1.73 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.609 ' C ' HD13 ' A' ' 7' ' ' LEU . 19.6 m-20 49.65 50.59 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 12.6 mt-30 -124.16 114.5 27.73 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.1 Cg_endo -66.25 171.13 10.79 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.136 1.89 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.959 HG13 HG12 ' A' ' 249' ' ' VAL . 21.2 t -126.91 115.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.775 -0.578 . . . . 0.0 111.007 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.83 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -65.11 112.11 3.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 176.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.625 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 5.2 t80 -123.46 155.77 36.83 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.013 -1.054 . . . . 0.0 109.449 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.36 128.66 3.56 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.21 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 245' ' ' GLN . . . -92.19 101.01 2.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 190' ' ' GLY . 50.8 t -67.13 164.13 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 110.988 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.583 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.44 -130.54 1.18 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -87.72 -51.64 5.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -1.214 . . . . 0.0 111.103 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.35 -18.19 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 111.776 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.09 -158.9 24.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 189' ' ' VAL . . . -87.6 106.82 3.23 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.916 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 9.3 t-80 -71.83 119.37 15.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -112.94 160.14 18.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.492 -1.283 . . . . 0.0 112.837 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.883 ' CD2' HG13 ' A' ' 210' ' ' VAL . 54.3 p90 -161.54 173.46 14.77 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -116.59 134.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.558 -1.339 . . . . 0.0 111.582 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 96.7 mt -102.7 109.1 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -124.0 33.28 5.33 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.306 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.22 164.92 37.97 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 117.512 -2.28 . . . . 0.0 112.675 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.521 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.91 147.63 34.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -112.45 7.46 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.833 -1.167 . . . . 0.0 110.146 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.87 -46.23 3.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -85.55 44.88 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -1.179 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.34 31.06 10.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.128 -0.982 . . . . 0.0 109.982 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.564 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 3.6 m-85 -117.93 135.26 54.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.087 -1.008 . . . . 0.0 109.126 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 38.8 m-85 -123.41 162.96 21.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.687 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 1.0 OUTLIER -91.97 137.54 32.28 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.883 HG13 ' CD2' ' A' ' 197' ' ' PHE . 23.9 t -129.46 138.18 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.626 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -109.25 72.59 0.81 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.658 ' CE2' HG11 ' A' ' 210' ' ' VAL . 81.4 m95 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 110.26 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 13.3 pt20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.513 0.673 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 60.1 p -145.72 170.92 15.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -135.25 161.92 34.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.672 0.749 . . . . 0.0 109.102 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.802 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.8 t -116.3 112.36 39.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 1.006 HG23 ' CE1' ' A' ' 158' ' ' HIS . 13.6 m -110.64 143.63 20.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.036 -175.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 88.06 46.35 4.79 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 29.3 mt -92.7 94.01 4.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.392 -1.064 . . . . 0.0 109.812 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 9.0 ptmt -160.87 149.08 12.86 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.619 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.6 Cg_endo . . . . . 0 C--N 1.308 -1.553 0 C-N-CA 122.257 1.971 . . . . 0.0 110.452 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 178' ' ' LEU . 44.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -76.39 -176.64 3.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.147 -0.971 . . . . 0.0 108.568 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.716 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.0 t -77.45 104.82 8.19 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.467 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 39.4 mt -57.76 -48.16 80.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 108.894 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD11 HG11 ' A' ' 198' ' ' VAL . 11.9 mt -55.63 -42.04 74.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 108.496 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 5.2 m-20 -67.65 -41.41 83.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.068 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -58.32 -14.66 7.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.9 mtpp -118.86 23.43 11.43 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 43.69 38.55 4.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.566 HD11 ' HA ' ' A' ' 58' ' ' TYR . 30.5 mt -90.07 109.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.412 1.101 . . . . 0.0 110.436 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 102' ' ' PRO . 8.7 m-70 -133.59 97.73 4.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.573 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 3.8 m-30 -102.83 174.49 5.85 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.245 1.022 . . . . 0.0 111.614 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.4 OUTLIER -147.01 -172.92 4.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 10.1 mt-30 -124.12 -8.94 7.66 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.828 -1.17 . . . . 0.0 110.036 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.713 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.16 -42.9 0.68 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.852 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.2 t-20 -45.1 -139.98 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.563 0 CA-C-O 118.387 -0.816 . . . . 0.0 111.381 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.852 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.6 Cg_endo -73.75 2.31 6.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 122.545 1.945 . . . . 0.0 109.249 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 48.4 m-85 -73.28 -35.87 66.22 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 34.6 p-10 -98.88 20.53 13.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.617 -1.302 . . . . 0.0 109.797 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -73.52 -2.1 21.31 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.924 . . . . 0.0 109.367 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -128.68 -5.78 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.925 . . . . 0.0 109.726 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 24.6 p -65.25 165.09 18.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.4 Cg_endo -70.61 139.24 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.108 1.872 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 t -84.24 149.55 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.73 . . . . 0.0 110.039 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.811 HD11 ' C ' ' A' ' 132' ' ' GLY . 42.9 mt -78.02 144.2 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 110.351 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' C ' HG22 ' A' ' 39' ' ' VAL . 80.6 mt-10 -123.56 -23.2 4.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 110.115 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.2 mtpm? -118.83 164.01 16.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' VAL . 42.2 t . . . . . 0 N--CA 1.487 1.415 0 O-C-N 121.216 -0.928 . . . . 0.0 111.27 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.114 0.483 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 70.8 m-85 -120.47 18.68 12.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.92 . . . . 0.0 108.92 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 31' ' ' VAL . 45.3 t -68.77 150.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.14 81.39 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mm-40 -91.43 129.24 37.44 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.339 -1.095 . . . . 0.0 109.738 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.29 112.7 9.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.27 157.4 1.42 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.176 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -76.6 171.63 14.33 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.398 0.618 . . . . 0.0 109.829 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.595 ' O ' ' HE3' ' A' ' 129' ' ' MET . 24.5 p -80.34 -36.14 34.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.112 -0.993 . . . . 0.0 108.353 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 107.11 135.63 7.92 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -54.1 -52.77 59.95 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -1.149 . . . . 0.0 108.002 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 64.4 t -45.96 -53.84 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.52 -51.88 67.56 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.524 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.3 -32.24 73.6 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.154 -178.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.3 -41.31 85.6 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.277 -1.369 . . . . 0.0 108.228 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.444 HG22 ' HG3' ' A' ' 56' ' ' MET . 44.1 m -73.8 -54.26 8.43 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.004 0.907 . . . . 0.0 109.887 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -51.68 -39.27 57.95 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-30 -60.42 -48.75 80.39 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 198' ' ' VAL . 39.1 mt -65.47 -24.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.597 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 36.6 mtp -73.42 -39.51 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 26.7 tptt -68.24 -41.82 80.63 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.674 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.69 -34.21 58.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.812 -0.555 . . . . 0.0 109.966 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.8 m-70 -106.92 -20.6 13.28 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.634 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.21 52.59 1.64 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -72.29 -69.01 0.37 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.4 Cg_endo -70.25 105.79 1.63 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 120.328 0.686 . . . . 0.0 112.17 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -70.35 -22.05 62.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 13.1 tttp -134.19 144.07 48.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.84 141.62 44.73 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.932 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.43 -41.95 19.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 0.0 109.967 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 2.6 tttt -152.74 134.55 14.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.916 -1.115 . . . . 0.0 110.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.18 166.29 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.46 -0.775 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.515 ' CG ' ' HA ' ' A' ' 126' ' ' SER . 43.1 t80 -143.93 146.44 32.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 t -146.41 152.15 38.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.1 p90 -160.24 155.42 24.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.843 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 94.9 m -93.15 137.16 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.8 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.1 tp -53.8 151.12 6.68 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 111.306 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.509 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 7.4 t -65.6 -6.51 11.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.038 -1.039 . . . . 0.0 109.727 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -95.56 -8.24 35.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.506 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.8 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.9 t-20 -69.74 109.82 5.37 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -88.52 15.51 2.06 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.929 2.419 . . . . 0.0 110.227 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.765 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.9 m-85 -108.14 -18.29 13.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.696 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 81' ' ' ASN . 63.5 m-85 -123.69 161.28 25.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 12.8 m120 -47.51 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.07 -47.13 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.337 -0.852 . . . . 0.0 110.947 174.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -77.15 56.25 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.74 104.73 14.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.506 -177.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.95 134.3 44.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 109.405 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.25 129.71 55.19 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.78 125.71 47.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.04 112.68 25.74 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 68' ' ' ASP . . . -73.67 51.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.053 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 37.0 mt -52.88 -49.86 46.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.439 ' H ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.97 -28.07 0.62 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.765 -1.209 . . . . 0.0 108.957 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 35.9 3.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 109.374 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -93.81 154.87 17.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.013 -1.054 . . . . 0.0 110.602 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -117.11 93.39 4.16 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-85 -81.56 91.37 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.692 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -79.8 87.31 5.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 61.2 m95 -61.67 -6.76 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.63 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.83 -21.22 22.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.751 -1.218 . . . . 0.0 108.032 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 21.8 m-20 -100.12 -26.85 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.629 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 64.1 mt -73.17 67.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 15.1 mt -46.85 149.2 1.58 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.8 -0.563 . . . . 0.0 110.19 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.54 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.3 Cg_endo -78.49 -17.9 12.55 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.965 2.443 . . . . 0.0 110.581 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 1.6 t -146.42 122.45 10.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 108.81 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 116' ' ' ILE . 66.3 m-85 -109.48 140.37 43.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.135 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 p -102.81 -1.28 30.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.465 -0.772 . . . . 0.0 108.951 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.59 9.01 86.25 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.67 -10.35 9.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.336 -1.096 . . . . 0.0 109.428 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -64.03 161.0 16.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 171.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.418 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -74.41 -29.58 61.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.44 -61.38 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -62.5 -33.55 75.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 108.975 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 79.4 mttt -65.1 -44.18 89.66 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.468 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 34.9 ttm -59.41 -36.6 76.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.72 -69.36 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.716 -0.615 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.643 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.4 tp -59.11 -40.37 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.867 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 23.0 p -56.83 -41.76 78.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 0.0 110.423 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.791 ' N ' HD12 ' A' ' 24' ' ' LEU . 28.0 tt0 -69.37 -38.51 78.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.279 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.643 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.8 tp -59.38 -55.46 34.45 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.604 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.4 mmt -57.45 -40.51 78.62 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.89 -41.52 91.42 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -65.25 -49.68 68.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 127' ' ' VAL . 76.3 t -65.95 -58.12 7.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.518 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.82 -50.5 14.83 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.9 mt -65.36 -54.47 28.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.219 -1.165 . . . . 0.0 108.256 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 65.0 p -46.48 -31.08 2.5 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.065 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 123' ' ' VAL . 33.6 m -103.48 40.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.989 -1.069 . . . . 0.0 110.089 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 127' ' ' VAL . 0.7 OUTLIER 37.26 49.23 0.88 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.597 0.713 . . . . 0.0 109.745 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.595 ' HE3' ' O ' ' A' ' 45' ' ' THR . 46.7 tpp -66.02 129.02 38.35 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.532 -0.73 . . . . 0.0 111.564 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.2 t0 -76.9 123.14 25.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.64 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.8 m-85 -104.29 118.17 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.405 1.098 . . . . 0.0 113.113 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.811 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.94 -162.87 10.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 104.498 -3.441 . . . . 0.0 104.498 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.652 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.7 Cg_endo -62.31 -29.88 80.38 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 N-CA-C 105.755 -2.44 . . . . 0.0 105.755 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -110.14 137.78 47.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 59.8 m -116.79 107.62 14.86 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.015 -1.678 . . . . 0.0 109.702 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.73 137.08 13.84 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.562 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.8 t -117.33 -161.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.908 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.41 -55.46 3.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.564 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 131.83 -127.57 5.03 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.603 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.628 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 3.8 m -51.13 -56.74 11.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.681 -0.894 . . . . 0.0 111.692 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 24.5 p -47.64 -39.89 18.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.045 -1.035 . . . . 0.0 109.865 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.908 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 33.7 mmt-85 -79.05 -43.54 24.01 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 185' ' ' TYR . 78.4 t -68.82 -55.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.415 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -56.12 -31.75 63.59 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.084 -1.047 . . . . 0.0 108.577 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp85 -77.14 -49.64 14.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.8 78.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.146 -0.971 . . . . 0.0 110.376 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 251' ' ' ILE . 51.5 mt -61.06 -48.19 82.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 110.46 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.7 mtmt -86.77 -43.67 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 111.222 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.8 mt-10 -76.21 -41.51 49.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 112.224 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 32.0 m120 -93.91 -44.27 8.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.584 -1.323 . . . . 0.0 111.66 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.441 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 39.4 m-85 -100.33 -2.45 33.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.79 -1.194 . . . . 0.0 110.476 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.932 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.94 37.72 53.8 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.286 -0.884 . . . . 0.0 112.449 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.426 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.4 m-85 -62.6 167.48 4.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.182 -1.775 . . . . 0.0 107.188 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.8 t-20 -47.82 140.14 6.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.628 -1.295 . . . . 0.0 109.089 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -53.2 -19.68 3.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.313 -0.867 . . . . 0.0 108.906 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.533 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 73.2 p -53.42 -17.2 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.302 -0.874 . . . . 0.0 109.829 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 42.7 t -62.92 122.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.705 -1.247 . . . . 0.0 108.947 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.645 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.0 p-80 -146.75 153.38 40.16 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.119 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.628 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 19.6 tt0 -101.32 148.29 25.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.875 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 6.5 pt -130.96 159.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -112.37 95.81 5.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.865 -1.147 . . . . 0.0 110.688 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.635 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 39.3 tpt85 -42.81 -27.97 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.395 -0.815 . . . . 0.0 109.083 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -62.39 -36.88 93.73 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.27 38.5 1.85 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.051 -1.264 . . . . 0.0 111.691 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.53 169.14 18.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.542 -1.349 . . . . 0.0 110.05 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -100.63 140.63 34.63 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 171' ' ' GLU . 6.4 tttt -40.3 -46.25 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -63.54 -53.26 54.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 110.055 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.0 -26.25 68.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.875 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 69.4 t-105 -74.47 -35.72 63.3 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.132 -0.98 . . . . 0.0 109.911 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 167' ' ' LYS . 45.8 mt-10 -72.22 -32.16 66.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.104 -0.998 . . . . 0.0 109.232 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.59 88.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.31 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.409 ' OE1' HG21 ' A' ' 249' ' ' VAL . 40.0 mm-40 -64.78 -50.01 68.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.37 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 184' ' ' VAL . 64.3 mt -71.84 -52.51 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 111.174 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -53.38 -43.06 67.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.108 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -51.97 -47.21 64.94 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 38.9 mm-40 -59.24 -52.67 64.67 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.763 ' HB3' HG11 ' A' ' 4' ' ' VAL . 20.7 mt -65.59 -28.3 69.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.445 -0.784 . . . . 0.0 110.149 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -52.51 -43.23 64.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 108.757 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.5 mt-30 -99.34 42.95 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 7' ' ' LEU . 14.5 m-20 42.33 51.09 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.77 0.795 . . . . 0.0 108.913 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 5.1 mt-30 -124.15 109.52 29.37 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.89 169.6 11.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.886 1.724 . . . . 0.0 111.944 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 HG23 ' A' ' 174' ' ' ILE . 62.1 t -127.03 131.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.804 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -80.97 121.34 25.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 177.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 4.7 t80 -123.29 164.68 18.31 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.962 -1.086 . . . . 0.0 109.673 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -165.63 124.5 1.65 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.19 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.16 108.06 3.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 190' ' ' GLY . 40.0 t -71.1 164.38 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.313 . . . . 0.0 111.457 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.601 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.42 -142.67 3.45 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.411 -1.875 . . . . 0.0 108.411 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.64 -29.66 21.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -1.199 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 m -83.43 -11.74 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.042 -1.036 . . . . 0.0 111.381 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 -168.36 23.21 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -78.76 109.98 2.95 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.362 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -72.06 130.87 41.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.69 160.32 24.73 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.363 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.874 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.1 p90 -163.04 168.53 20.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 55' ' ' ILE . 71.6 t -113.88 137.91 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.753 -1.217 . . . . 0.0 111.888 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.754 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 77.6 mt -104.07 110.42 30.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -124.8 34.32 5.02 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.372 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -171.58 161.56 33.85 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 117.073 -2.489 . . . . 0.0 113.202 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.522 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.52 141.27 29.41 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -112.6 11.53 19.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.777 -1.202 . . . . 0.0 110.442 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.45 -50.23 3.99 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -79.46 53.83 1.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 0.0 109.64 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.455 ' OD1' ' OE2' ' A' ' 171' ' ' GLU . 0.7 OUTLIER 50.73 38.16 18.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 0.3 OUTLIER -121.02 132.73 55.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.095 -1.003 . . . . 0.0 109.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 26.2 m-85 -123.6 160.71 26.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.974 . . . . 0.0 110.039 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.716 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 1.1 t-80 -92.73 146.56 23.56 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 197' ' ' PHE . 23.8 t -139.25 139.03 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.497 ' HB2' HD12 ' A' ' 8' ' ' LEU . 25.9 t-20 -108.95 70.38 0.74 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.687 ' CE2' HG11 ' A' ' 210' ' ' VAL . 89.7 m95 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.456 -0.777 . . . . 0.0 110.193 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 2.4 pt20 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 4.9 p -149.43 167.04 27.29 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.74 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.99 145.58 36.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.575 0.703 . . . . 0.0 109.536 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.585 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.0 t -107.94 114.42 46.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.645 HG23 ' NE2' ' A' ' 158' ' ' HIS . 12.3 m -119.52 138.95 48.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.252 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 97.95 53.84 1.25 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 147' ' ' LEU . 5.4 mt -103.65 96.36 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -1.152 . . . . 0.0 110.102 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.48 147.42 8.54 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.612 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.646 0 C-N-CA 122.227 1.951 . . . . 0.0 110.288 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 178' ' ' LEU . 94.7 t . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.5 mmtt -76.36 178.44 6.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.665 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 1.8 t -77.9 106.35 9.69 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.024 -1.048 . . . . 0.0 109.241 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.705 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 38.3 mt -57.4 -50.72 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.879 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.1 mt -55.49 -41.84 73.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.784 -1.198 . . . . 0.0 109.224 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 29.8 t0 -67.75 -40.47 84.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.581 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.6 p -58.53 -14.16 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.1 -1.0 . . . . 0.0 109.293 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' HG13 ' A' ' 13' ' ' ILE . 17.7 mtpt -117.75 22.12 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 0.0 108.802 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.0 37.85 4.42 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.1 mt -88.63 109.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 122.427 1.108 . . . . 0.0 110.219 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 28.0 m80 -133.78 98.0 4.06 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.6 m-30 -103.61 171.66 7.24 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.216 1.008 . . . . 0.0 112.064 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.498 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.3 t30 -147.19 -173.21 4.19 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.479 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.3 mt-30 -124.11 -3.7 8.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.64 -56.17 0.35 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.158 -1.496 . . . . 0.0 112.152 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.791 HD22 ' HA3' ' A' ' 106' ' ' GLY . 9.7 t-20 -45.65 -125.14 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-O 117.531 -1.224 . . . . 0.0 112.257 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.788 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -80.54 9.21 3.8 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 123.381 2.243 . . . . 0.0 110.212 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 15' ' ' TYR . 71.0 m-85 -83.94 -33.92 24.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 109.818 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.2 p30 -102.51 21.87 14.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.748 -1.22 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.4 mt -69.37 -4.4 18.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.94 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 118' ' ' GLU . 63.6 mt -131.67 -5.67 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.878 -1.139 . . . . 0.0 110.275 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 21.2 p -61.38 165.83 6.32 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 0.0 108.392 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.2 Cg_endo -69.57 131.31 21.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.069 1.846 . . . . 0.0 111.675 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.6 t -77.34 151.31 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.605 -0.684 . . . . 0.0 109.601 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 132' ' ' GLY . 12.7 mt -77.54 150.28 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -125.13 -23.37 4.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.434 -0.791 . . . . 0.0 111.15 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' TYR . 16.1 mtpt -121.54 176.35 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.845 -1.159 . . . . 0.0 109.927 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 37' ' ' SER . 79.5 t . . . . . 0 N--CA 1.486 1.337 0 O-C-N 121.241 -0.912 . . . . 0.0 110.772 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 15.74 11.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.918 -1.114 . . . . 0.0 109.571 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.1 t -63.1 143.49 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.91 67.16 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.9 mt-30 -83.92 127.08 33.6 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.192 -1.181 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -72.86 110.28 7.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.23 158.44 1.15 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.599 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -75.75 169.2 18.59 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 109.363 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.65 ' O ' ' HE3' ' A' ' 129' ' ' MET . 8.7 p -80.7 -34.5 34.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.113 . . . . 0.0 108.051 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.06 135.29 7.83 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.1 p -54.49 -49.19 70.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -1.215 . . . . 0.0 107.93 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.628 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 20.3 t -46.38 -56.41 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -58.7 -50.13 75.03 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.667 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.77 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.415 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -66.66 -38.3 86.57 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.071 -1.452 . . . . 0.0 107.632 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.507 ' CG2' HG13 ' A' ' 143' ' ' VAL . 61.8 m -74.55 -53.98 8.38 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.26 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -55.13 -41.37 71.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 110.323 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.575 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.4 mt-30 -57.61 -47.5 82.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.491 -1.38 . . . . 0.0 107.331 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 198' ' ' VAL . 59.3 mt -65.74 -24.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 27.7 mtp -73.75 -37.68 64.97 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 22.3 tptt -71.2 -39.04 72.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.2 t80 -53.53 -34.49 58.38 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 109.528 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 60' ' ' ASN . 34.5 m80 -107.62 -20.08 13.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.645 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.02 54.33 1.64 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 1.4 t80 -72.38 -73.84 0.16 Allowed Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 34.4 Cg_endo -68.58 103.4 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.342 0.654 . . . . 0.0 112.057 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.456 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t-20 -70.84 -18.83 62.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 8.0 tttp -134.11 141.73 47.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.25 148.6 36.72 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.42 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.968 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -87.89 -59.04 2.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -1.02 . . . . 0.0 109.316 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' A' ' 68' ' ' ASP . 15.6 tttt -139.03 150.42 45.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-20 -74.58 179.99 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 70' ' ' THR . 61.9 t80 -147.73 167.5 24.5 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.374 -0.829 . . . . 0.0 109.605 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 6.8 t -166.22 147.87 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 19.1 p90 -163.35 152.67 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 21.1 m -93.09 138.14 31.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.803 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.5 tp -52.54 150.03 5.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 111.331 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -61.95 144.07 55.58 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.54 . . . . 0.0 109.715 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -1.91 11.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.82 -8.95 23.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 109.732 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.803 ' ND2' HD21 ' A' ' 73' ' ' LEU . 31.2 t-20 -70.24 109.4 4.81 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.765 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.0 Cg_endo -89.3 16.07 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.0 2.467 . . . . 0.0 110.279 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 91.2 m-85 -104.45 -23.53 13.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.746 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.4 m-85 -122.56 161.38 23.79 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.573 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.4 m120 -46.1 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 175.18 -47.1 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 175.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.64 57.55 4.99 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 N-CA-C 107.39 -1.812 . . . . 0.0 107.39 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -105.67 107.25 18.15 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.247 -178.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.49 139.12 36.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.3 mp -115.97 123.14 47.29 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.27 125.25 47.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.079 -1.013 . . . . 0.0 110.059 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.04 113.79 27.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.61 53.0 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.874 -1.141 . . . . 0.0 108.557 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 48.7 mt -52.37 -46.66 46.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 121.264 -0.897 . . . . 0.0 109.76 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.4 p -45.22 -26.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.162 . . . . 0.0 108.936 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.0 p -111.51 33.19 4.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 0.0 109.203 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.643 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -89.37 153.75 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.12 91.24 3.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.23 87.07 6.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.469 -0.769 . . . . 0.0 110.84 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.3 t30 -79.23 88.58 4.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.645 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 72.3 m95 -61.6 -5.69 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 110.737 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.87 -19.46 24.57 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.15 -27.47 13.51 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.68 HG12 ' HB1' ' A' ' 115' ' ' ALA . 48.0 mt -74.14 70.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 38.1 mt -48.8 148.84 3.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.728 -0.607 . . . . 0.0 109.961 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.544 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.1 Cg_endo -79.08 -22.81 8.27 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.758 2.305 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -139.51 121.88 16.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 108.878 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 58.2 m-85 -109.43 140.41 43.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -0.947 . . . . 0.0 109.911 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.9 p -99.9 -0.69 39.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.046 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.791 ' HA3' HD22 ' A' ' 19' ' ' ASN . . . 82.07 -0.74 88.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 107' ' ' ARG . 16.3 mtm105 -118.07 1.94 12.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -1.194 . . . . 0.0 109.561 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.68 164.88 15.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.545 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.429 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -60.16 171.55 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.202 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 63.2 m-20 -75.51 -31.48 60.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.89 . . . . 0.0 109.764 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.31 -63.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.87 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 1.1 mp0 -62.46 -31.52 72.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.2 mttt -66.21 -44.29 84.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.476 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 11.0 ttm -59.11 -34.53 72.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.68 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.69 -68.99 0.19 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.697 -0.627 . . . . 0.0 110.539 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.618 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -59.85 -40.9 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 110.209 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.7 p -56.9 -40.22 75.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.767 -1.208 . . . . 0.0 109.764 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.752 ' N ' HD12 ' A' ' 24' ' ' LEU . 37.2 tt0 -69.84 -39.19 76.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 108.682 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.618 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.9 tp -60.44 -60.39 3.89 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.591 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -51.24 -39.22 56.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.628 -0.67 . . . . 0.0 109.679 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.62 -41.26 92.92 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 8.7 m-20 -65.39 -54.59 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.763 ' O ' HG22 ' A' ' 127' ' ' VAL . 87.0 t -63.08 -52.06 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.314 -0.867 . . . . 0.0 108.799 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -51.42 -51.55 36.71 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.3 mt -66.5 -54.39 26.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.076 -1.249 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 125' ' ' ILE . 33.1 p -46.22 -28.13 1.18 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.644 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -101.28 30.95 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.864 -1.148 . . . . 0.0 109.674 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 4.1 m-20 42.51 38.88 1.37 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.247 -0.908 . . . . 0.0 108.944 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.65 ' HE3' ' O ' ' A' ' 45' ' ' THR . 37.6 tpp -53.33 132.21 38.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.574 -0.704 . . . . 0.0 111.583 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 15.5 t0 -76.69 120.73 22.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.65 120.17 40.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.3 1.048 . . . . 0.0 112.96 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.756 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.11 -164.25 11.93 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.4 Cg_endo -62.0 -30.94 83.88 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 105.687 -2.466 . . . . 0.0 105.687 175.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 m -109.97 142.46 41.31 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.3 m -119.54 110.42 16.86 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 119.849 -1.782 . . . . 0.0 109.972 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.17 133.28 11.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -118.44 -169.0 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -1.115 . . . . 0.0 108.602 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.29 -57.33 2.88 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.598 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 129.94 -122.5 3.73 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.551 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.629 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 3.1 m -47.99 -60.58 2.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 24.7 p -46.88 -41.18 15.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.78 -1.2 . . . . 0.0 109.238 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.4 mmp_? -80.33 -42.62 22.64 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.7 t -68.65 -59.38 3.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.722 -0.612 . . . . 0.0 111.149 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.44 -32.88 65.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.16 -0.963 . . . . 0.0 109.175 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 14.2 ttm180 -75.89 -44.15 41.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.099 -1.0 . . . . 0.0 109.375 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 151' ' ' PHE . . . -70.49 -32.11 69.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 109.908 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 251' ' ' ILE . 51.8 mt -60.31 -47.89 84.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.369 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.525 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 24.6 mtmt -87.73 -29.47 21.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.729 -1.232 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 88.4 mt-10 -74.3 -67.46 0.62 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 112.333 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.543 ' HB3' HD13 ' A' ' 90' ' ' ILE . 36.1 m120 -82.1 -31.04 30.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.851 -1.156 . . . . 0.0 111.652 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 19.6 m-85 -102.53 -6.15 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.662 -1.274 . . . . 0.0 110.36 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.968 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 48.95 40.45 27.38 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.224 -0.923 . . . . 0.0 112.244 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.443 ' CE2' HG22 ' A' ' 251' ' ' ILE . 8.6 m-85 -62.76 160.24 14.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.408 -1.643 . . . . 0.0 107.999 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 14.9 t-20 -47.64 155.42 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 109.486 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -55.85 -17.57 6.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.895 . . . . 0.0 108.837 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.544 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 21.4 p -53.69 -15.72 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 147' ' ' LEU . 12.8 t -72.25 119.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.68 -1.262 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.817 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.1 p-80 -146.77 155.29 42.26 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.629 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 15.2 tt0 -102.15 143.78 31.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.672 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' CA ' ' A' ' 246' ' ' SER . 4.1 pt -128.33 154.16 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -109.62 94.93 5.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.991 -1.068 . . . . 0.0 110.542 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.579 ' HD2' ' CG ' ' A' ' 170' ' ' TRP . 1.2 tpt85 -46.39 -27.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 108.99 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.82 -23.56 72.57 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -103.64 4.29 35.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.072 -1.252 . . . . 0.0 111.17 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -118.11 167.98 10.98 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.554 -1.341 . . . . 0.0 109.836 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 167' ' ' LYS . 32.0 p -98.94 136.86 38.32 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 166' ' ' SER . 29.3 tttm -34.42 -45.66 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.76 -0.587 . . . . 0.0 110.721 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -63.55 -62.22 1.81 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.958 -1.089 . . . . 0.0 109.733 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.45 -19.88 65.09 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 109.069 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.776 ' NE1' HD11 ' A' ' 174' ' ' ILE . 67.3 t-105 -75.44 -44.25 45.38 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.981 -1.074 . . . . 0.0 108.842 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 208' ' ' TYR . 12.3 mt-10 -61.68 -31.51 71.65 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.97 80.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.826 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -61.32 -45.38 94.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 109.249 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 184' ' ' VAL . 9.8 mt -76.01 -48.21 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 111.091 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -58.33 -53.76 54.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.014 -1.054 . . . . 0.0 109.67 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -51.28 -38.0 50.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.564 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.2 mm-40 -61.0 -51.32 69.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.8 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.8 mt -69.09 -24.95 64.2 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.489 -0.757 . . . . 0.0 109.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.435 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.7 p -52.21 -38.16 57.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.95 -1.094 . . . . 0.0 108.096 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 24.2 mt-30 -101.32 33.5 2.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.7 m-20 47.11 51.15 13.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 18.1 mt-30 -123.75 106.0 32.27 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.444 ' HD3' HD13 ' A' ' 7' ' ' LEU . 15.4 Cg_endo -63.59 168.77 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.908 1.738 . . . . 0.0 112.497 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 174' ' ' ILE . 42.3 t -121.86 135.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.454 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.757 ' CD1' HG23 ' A' ' 248' ' ' VAL . 3.3 t80 -85.07 118.31 24.55 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.649 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 8.8 t80 -122.29 150.93 41.67 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.808 -1.183 . . . . 0.0 109.774 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.593 ' OE1' ' HA3' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -152.54 121.92 6.77 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.705 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -90.98 112.38 4.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 190' ' ' GLY . 24.6 t -66.37 164.82 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -1.178 . . . . 0.0 110.794 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.585 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -175.65 -143.22 4.51 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -35.68 18.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.235 . . . . 0.0 110.213 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.59 -9.31 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.12 -162.03 18.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.542 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.93 111.53 3.27 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.584 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.6 t-80 -71.57 101.23 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.628 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -86.24 153.1 22.25 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.822 1.296 . . . . 0.0 114.216 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CD1' HG13 ' A' ' 210' ' ' VAL . 21.5 p90 -163.58 164.77 24.06 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.677 HG22 HD11 ' A' ' 55' ' ' ILE . 70.6 t -113.74 139.06 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.705 -1.247 . . . . 0.0 112.011 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.896 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.9 mt -103.38 111.68 34.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -125.22 31.33 5.62 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.395 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.08 41.59 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.271 -2.395 . . . . 0.0 112.883 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 4' ' ' VAL . . . -156.48 149.7 24.27 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 207' ' ' PHE . 18.2 p-10 -128.56 29.81 5.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.578 -1.326 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 48.0 22.24 2.04 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.474 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 22.7 mtm180 -135.04 25.25 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -1.211 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 1.6 m120 72.58 18.66 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.487 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 9.7 m-85 -120.15 113.73 20.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.901 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 171' ' ' GLU . 3.5 m-85 -102.67 167.35 9.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 108.919 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.665 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 0.9 OUTLIER -92.18 139.48 30.58 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.82 HG13 ' CD1' ' A' ' 197' ' ' PHE . 42.4 t -130.89 136.18 58.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.533 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.467 ' HB2' HD12 ' A' ' 8' ' ' LEU . 23.3 t-20 -108.62 73.67 0.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.676 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 73.5 m95 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 110.269 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 4.4 pt20 . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.503 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 14.2 p -155.96 152.4 28.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 109.89 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 185' ' ' TYR . . . -132.12 167.76 19.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.119 0.961 . . . . 0.0 109.854 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.757 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.7 t -117.42 116.25 51.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.817 HG23 ' NE2' ' A' ' 158' ' ' HIS . 29.4 m -117.64 145.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.734 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.89 49.12 3.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.686 HG12 HD13 ' A' ' 147' ' ' LEU . 4.3 mt -98.98 89.05 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.774 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -160.34 150.71 15.08 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.451 -0.781 . . . . 0.0 109.117 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.635 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 33.9 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.447 2.098 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 178' ' ' LEU . 70.1 t . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 200' ' ' ASP . 7.4 mmtp -76.23 -177.46 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -0.947 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 32.8 t -78.06 104.35 8.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 109.911 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.4 mt -57.84 -52.87 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.528 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 211' ' ' ASN . 16.3 mt -54.44 -40.08 68.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.768 -1.207 . . . . 0.0 108.748 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -68.06 -42.57 80.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.912 . . . . 0.0 109.286 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 p -58.49 -14.78 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.086 -1.009 . . . . 0.0 109.218 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -116.37 22.54 12.76 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.07 33.5 2.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 11' ' ' LYS . 31.5 mt -85.85 109.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.498 -1.001 . . . . 0.0 110.261 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 102' ' ' PRO . 40.1 m80 -134.8 77.46 1.69 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.626 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.0 m-30 -85.13 177.08 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.148 0.975 . . . . 0.0 111.197 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.544 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -147.68 -164.26 1.96 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 45' ' ' THR . 25.8 mt-30 -124.85 -20.57 4.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.856 -1.153 . . . . 0.0 110.583 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.43 -34.56 1.42 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.469 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.811 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.7 t-20 -45.92 -140.22 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.466 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.846 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.811 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.8 Cg_endo -74.2 3.44 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 CA-C-N 122.511 1.933 . . . . 0.0 109.559 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CD2' HG12 ' A' ' 116' ' ' ILE . 9.1 m-85 -78.87 -31.37 45.53 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.478 -0.764 . . . . 0.0 108.962 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 28.1 p-10 -93.9 19.84 8.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.556 -1.34 . . . . 0.0 109.617 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.3 mt -74.49 -3.05 28.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 24' ' ' LEU . 6.3 mt -129.24 -0.98 5.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 0.0 109.485 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -66.12 166.01 18.91 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.7 Cg_endo -71.32 141.36 38.87 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.368 2.045 . . . . 0.0 112.223 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 35.8 t -80.01 147.05 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.777 HD11 ' C ' ' A' ' 132' ' ' GLY . 21.6 mt -77.88 148.47 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.704 0.764 . . . . 0.0 110.853 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.508 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.6 mm-40 -125.73 -21.54 4.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.621 -0.675 . . . . 0.0 110.432 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 80' ' ' PHE . 13.8 mtpp -122.76 166.97 14.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 38' ' ' PHE . 91.8 t . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.558 -0.714 . . . . 0.0 110.577 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 76.0 m-85 -123.62 15.89 9.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.931 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 28' ' ' ILE . 94.1 t -63.3 136.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.51 -3.12 83.58 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.5 mt-30 -83.76 132.92 34.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.293 -1.122 . . . . 0.0 109.605 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -73.64 110.31 7.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.48 159.39 1.03 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.8 171.78 14.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.455 0.645 . . . . 0.0 109.701 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.696 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.6 p -80.81 -34.62 33.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 108.708 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.34 137.29 8.92 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -48.03 74.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.326 -1.103 . . . . 0.0 108.313 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 137' ' ' SER . 3.3 t -46.93 -53.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.47 -47.94 79.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.888 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 70.9 m -62.91 -30.47 71.57 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.642 -0.661 . . . . 0.0 109.499 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.7 72.14 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.808 -1.157 . . . . 0.0 108.439 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 56' ' ' MET . 40.3 m -76.2 -49.5 17.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.293 0.568 . . . . 0.0 110.752 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.02 -34.28 28.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.177 -0.952 . . . . 0.0 108.742 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-30 -68.26 -48.95 63.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 55.2 mt -65.58 -23.1 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.57 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.8 mtp -73.92 -34.23 64.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 42.8 tptt -72.34 -45.46 59.82 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.4 t80 -52.42 -30.83 31.36 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.265 0.555 . . . . 0.0 109.815 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.638 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 59.3 m-70 -108.35 -24.09 11.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 111.151 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.633 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.23 57.15 2.5 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -79.33 -71.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.0 Cg_endo -68.34 103.43 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 122.26 0.611 . . . . 0.0 111.838 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -21.88 63.48 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 4.9 ttpt -134.8 141.25 46.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.08 146.6 39.29 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.351 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.925 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -82.91 -45.15 14.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -1.027 . . . . 0.0 110.206 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.2 ttpp -152.16 135.29 15.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.035 -1.041 . . . . 0.0 110.069 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' N ' ' H ' ' A' ' 91' ' ' SER . 0.5 OUTLIER -60.65 164.39 4.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.043 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 45.2 t80 -143.37 154.37 43.66 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t -154.52 150.43 27.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 14.7 p90 -155.3 152.3 29.04 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 46.5 m -92.75 140.25 29.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.759 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -55.5 148.57 15.26 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 111.467 -178.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 3.5 p -61.69 141.87 57.57 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.301 0.572 . . . . 0.0 110.122 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.7 m -67.32 -5.41 14.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.9 m120 -99.45 -3.64 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.759 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.1 t-20 -70.68 111.78 10.82 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.552 -0.717 . . . . 0.0 109.878 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.1 Cg_endo -88.5 13.64 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.975 2.45 . . . . 0.0 109.792 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.638 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 59.2 m-85 -112.73 -4.07 14.12 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.283 -0.885 . . . . 0.0 111.641 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.489 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 69.1 m-85 -140.62 161.0 38.79 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 44.5 m-80 -47.77 -81.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 1.1 m170 174.95 -46.84 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.506 -0.746 . . . . 0.0 110.929 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.2 Cg_endo -76.95 54.6 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 N-CA-C 107.419 -1.8 . . . . 0.0 107.419 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 4.8 tptt -105.67 105.71 15.87 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.068 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.6 m-80 -100.3 140.06 35.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.7 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -113.93 128.38 56.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -120.31 129.68 54.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.094 -1.003 . . . . 0.0 110.235 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.64 111.13 23.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.56 52.44 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.733 -1.23 . . . . 0.0 108.372 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.7 mt -52.43 -52.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.565 -0.709 . . . . 0.0 109.417 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -45.51 -26.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.096 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -112.26 19.85 17.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 17.5 mmt-85 -76.59 152.84 35.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 89.11 3.04 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.0 89.9 5.95 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 110.508 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 15.9 t-20 -80.05 92.32 5.6 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.4 m95 -61.14 -8.82 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 110.026 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -90.79 -15.94 29.22 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 27.2 m-20 -99.26 -33.59 10.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 30.6 mt -73.46 93.71 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 30.1 mt -71.05 151.33 94.9 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' HIS . 30.9 Cg_endo -78.87 -28.15 4.23 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.132 . . . . 0.0 110.223 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.93 127.65 27.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.902 . . . . 0.0 109.31 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.6 m-85 -112.0 145.33 39.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 109.874 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 p -100.11 -12.79 19.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.98 -3.4 62.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -118.68 15.32 13.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.153 . . . . 0.0 109.287 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.02 -172.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.2 p -87.32 179.82 6.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.433 -0.792 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -78.01 -38.61 44.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.54 -58.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.71 -35.27 79.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.289 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.521 ' HD3' ' CD1' ' A' ' 23' ' ' LEU . 14.6 mttm -64.02 -43.06 96.75 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.46 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 23.1 ttm -60.0 -38.29 82.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.55 -68.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.704 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 119' ' ' LEU . 5.3 tp -66.0 -48.64 81.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.386 -0.821 . . . . 0.0 109.68 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 116' ' ' ILE . 51.3 p -47.48 -44.84 25.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.938 -1.101 . . . . 0.0 108.378 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.585 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 4.2 tt0 -70.26 -47.47 61.13 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.875 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.2 tp -48.62 -51.66 26.97 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.696 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -60.26 -46.55 89.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.688 -0.632 . . . . 0.0 109.755 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.58 -35.64 81.17 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.759 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 4.9 m-20 -68.09 -55.47 12.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 127' ' ' VAL . 44.8 t -62.93 -58.32 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.0 109.185 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.55 -50.13 11.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.2 mt -63.68 -58.98 5.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.185 -1.186 . . . . 0.0 108.216 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.9 OUTLIER -46.4 -28.59 1.4 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.39 -177.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 24.2 m -101.24 34.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.592 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.2 m-20 38.74 53.05 1.93 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.321 -0.862 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.4 tpp -65.69 127.01 30.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 111.726 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' SER . 0.7 OUTLIER -75.92 121.64 22.98 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 52.5 m-85 -103.31 117.69 35.08 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.545 1.164 . . . . 0.0 113.316 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.777 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.02 -162.55 10.75 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 104.617 -3.393 . . . . 0.0 104.617 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.652 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.45 -30.89 80.66 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 105.812 -2.418 . . . . 0.0 105.812 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.86 140.75 43.45 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 173.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.4 m -121.09 109.69 15.33 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 119.913 -1.742 . . . . 0.0 110.076 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.9 136.76 13.66 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.444 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 11.2 t -111.66 -161.69 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB3' ' HG3' ' A' ' 142' ' ' ARG . . . -90.89 -57.1 2.93 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.55 -134.57 7.2 Favored Glycine 0 N--CA 1.479 1.54 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.504 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.647 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 3.8 m -52.85 -53.26 51.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.804 -0.821 . . . . 0.0 111.89 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 140' ' ' SER . 5.2 p -45.89 -41.85 11.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.003 . . . . 0.0 109.07 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 138' ' ' ALA . 26.3 mmt180 -81.35 -43.15 19.45 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.635 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.5 t -68.38 -53.88 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.634 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 140' ' ' SER . 2.1 pp0? -56.71 -34.21 67.24 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.256 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -77.82 -51.19 10.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.973 178.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.1 79.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.113 -0.992 . . . . 0.0 110.049 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 251' ' ' ILE . 38.4 mt -58.04 -51.55 69.21 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.482 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 29.3 mtmt -80.27 -45.78 17.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 110.182 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.437 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 86.2 mt-10 -68.32 -52.03 38.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.048 -1.033 . . . . 0.0 111.905 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -90.43 -46.55 8.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.798 -1.189 . . . . 0.0 111.935 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.9 m-85 -99.38 13.68 32.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.648 -1.282 . . . . 0.0 110.938 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.925 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 34.34 41.46 0.22 Allowed Glycine 0 N--CA 1.496 2.679 0 O-C-N 121.512 -0.742 . . . . 0.0 112.815 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.5 m-85 -63.14 169.94 3.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.126 -1.808 . . . . 0.0 107.883 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 30.3 t30 -47.6 136.57 10.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.72 -1.238 . . . . 0.0 109.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.16 -21.01 4.4 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.201 -0.937 . . . . 0.0 108.79 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.503 ' HB3' ' ND2' ' A' ' 154' ' ' ASN . 84.4 p -53.6 -17.44 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 109.787 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 251' ' ' ILE . 37.5 t -58.42 125.17 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.969 -1.082 . . . . 0.0 109.121 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 1.004 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.3 p-80 -146.42 156.7 43.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.562 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.6 tt0 -101.74 150.35 23.22 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.872 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.718 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 20.3 pt -130.77 154.22 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.6 m-80 -119.2 106.16 12.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.163 . . . . 0.0 110.906 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 tpt85 -48.03 -45.03 31.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.461 -0.775 . . . . 0.0 109.765 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.92 -22.75 58.13 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 6.7 m-20 -104.75 2.03 29.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.198 -1.177 . . . . 0.0 111.7 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -117.67 175.03 5.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.498 -1.376 . . . . 0.0 110.665 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.474 ' O ' ' C ' ' A' ' 167' ' ' LYS . 1.1 p -100.46 138.19 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.3 ttmm -35.39 -49.61 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.688 -0.632 . . . . 0.0 110.629 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.431 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 38.3 mm-40 -64.15 -58.3 7.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.004 -1.06 . . . . 0.0 109.777 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.86 -20.77 65.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.455 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.718 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 68.6 t-105 -76.15 -44.69 37.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 174' ' ' ILE . 83.1 mt-10 -73.52 -36.91 65.78 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.172 -0.955 . . . . 0.0 108.497 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.8 -44.3 49.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -61.58 -42.08 98.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 109.028 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.798 HG23 HG21 ' A' ' 184' ' ' VAL . 11.5 mt -75.83 -58.08 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 111.051 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.78 -54.05 21.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 0.0 109.665 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -51.03 -41.27 59.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.578 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 6.0 mm-40 -59.13 -50.53 73.7 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.729 ' HB3' HG11 ' A' ' 4' ' ' VAL . 15.2 mt -68.32 -25.92 65.36 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 110.099 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.414 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 10.5 p -52.43 -40.19 61.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.95 -1.094 . . . . 0.0 108.427 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 31.1 mt-30 -97.7 31.61 2.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 7' ' ' LEU . 86.9 m-20 48.61 49.2 18.89 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 79.6 mt-30 -123.7 107.38 31.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.512 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.2 Cg_endo -64.05 168.9 11.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.125 1.883 . . . . 0.0 112.791 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 174' ' ' ILE . 50.6 t -120.9 134.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.551 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.926 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -82.56 116.02 21.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 5.7 t80 -122.25 158.16 30.09 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 120.954 -1.091 . . . . 0.0 109.355 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -167.2 128.45 1.58 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 117.881 -1.528 . . . . 0.0 111.549 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.01 115.79 4.87 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.3 t -80.6 169.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -173.99 -142.91 4.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.6 -28.86 21.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.157 -1.202 . . . . 0.0 110.739 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.0 -14.1 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.931 -1.106 . . . . 0.0 110.973 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.02 -171.06 21.11 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -82.8 105.82 2.69 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.878 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 15.2 t-80 -70.93 127.58 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.44 161.62 20.93 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.426 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -157.56 -171.35 3.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 75.3 t -134.0 134.94 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.617 -1.302 . . . . 0.0 111.218 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 174' ' ' ILE . 56.1 mt -97.66 119.25 45.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 33.9 p30 -130.62 31.9 4.48 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.564 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.65 161.72 32.39 Favored Glycine 0 N--CA 1.484 1.839 0 C-N-CA 117.254 -2.403 . . . . 0.0 112.457 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.507 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.46 145.3 32.49 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -116.57 17.69 15.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.863 -1.148 . . . . 0.0 110.328 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.33 -51.26 3.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -79.7 50.69 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.067 -1.255 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 51.04 35.25 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' ASP . 0.2 OUTLIER -115.37 130.08 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.063 -1.023 . . . . 0.0 108.96 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 6.8 m-85 -122.97 156.72 34.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 200' ' ' ASP . 61.0 t-80 -93.29 114.78 27.32 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 197' ' ' PHE . 14.3 t -113.89 142.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.077 . . . . 0.0 111.797 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.531 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.1 t-20 -101.32 77.7 1.81 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 45.1 m95 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.683 0.754 . . . . 0.0 110.991 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 26.7 tt0 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -166.75 163.29 16.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.763 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.39 165.35 27.66 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.293 1.044 . . . . 0.0 109.749 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.926 HG23 ' CD1' ' A' ' 185' ' ' TYR . 6.6 t -118.32 114.9 46.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 1.004 HG23 ' CE1' ' A' ' 158' ' ' HIS . 27.1 m -115.25 144.95 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 120.942 -1.099 . . . . 0.0 111.092 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 88.69 51.73 2.99 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.638 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.54 95.36 3.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -1.049 . . . . 0.0 109.971 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.65 153.92 13.28 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 108.899 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.64 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.8 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.211 1.941 . . . . 0.0 110.509 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.731 HG11 ' HB3' ' A' ' 178' ' ' LEU . 63.8 t . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -76.64 172.94 12.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 108.571 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 47.2 t -77.52 103.32 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.119 -0.988 . . . . 0.0 109.158 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 30.5 mt -58.62 -50.61 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.552 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 198' ' ' VAL . 11.5 mt -55.41 -37.08 67.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.599 -1.313 . . . . 0.0 108.861 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.5 OUTLIER -67.49 -41.44 84.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 p -58.14 -14.65 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 109.278 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.1 mtpt -121.51 16.4 11.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.82 42.48 6.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 58' ' ' TYR . 43.1 mt -87.99 110.83 21.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.196 0.998 . . . . 0.0 110.504 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 102' ' ' PRO . 55.3 m80 -134.7 97.71 3.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.5 m-30 -104.0 178.46 4.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.984 -1.073 . . . . 0.0 110.938 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 -165.43 2.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.52 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 28.2 mt-30 -124.57 -16.61 6.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.004 -1.06 . . . . 0.0 110.221 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.723 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.77 -37.25 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.305 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.5 t-20 -45.53 -139.57 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.124 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.39 3.35 5.35 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 CA-C-N 122.625 1.973 . . . . 0.0 109.161 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.3 m-85 -77.79 -32.29 52.36 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.533 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 37.9 p-10 -94.46 17.8 12.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 20' ' ' PRO . 12.2 mt -74.18 4.88 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 110.401 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 24' ' ' LEU . 9.2 mt -139.45 2.5 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.68 -1.262 . . . . 0.0 110.389 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.6 p -63.4 164.33 15.39 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.5 Cg_endo -70.07 137.16 33.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.731 1.621 . . . . 0.0 110.73 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 145.58 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.649 0.738 . . . . 0.0 110.085 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.717 HD11 ' HA2' ' A' ' 132' ' ' GLY . 6.5 mt -77.43 151.36 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.476 0.655 . . . . 0.0 110.354 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 39' ' ' VAL . 25.5 mt-10 -124.77 -25.44 3.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.468 -0.77 . . . . 0.0 110.779 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.6 mtpm? -117.38 177.22 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.918 -1.114 . . . . 0.0 109.917 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 37' ' ' SER . 97.3 t . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.893 . . . . 0.0 111.536 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.094 0.473 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.757 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 18.7 m-30 -111.77 10.97 20.91 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.046 -1.034 . . . . 0.0 109.33 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 29' ' ' GLU . 17.6 t -61.22 119.26 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.749 -1.219 . . . . 0.0 108.726 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.9 -11.23 57.47 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' OE1' ' CD1' ' A' ' 38' ' ' PHE . 64.0 mt-30 -76.5 134.41 39.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.569 -0.959 . . . . 0.0 109.305 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.19 112.71 9.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.83 163.76 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -87.57 170.18 11.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.863 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.578 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.3 p -82.73 -36.58 25.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 102.82 136.36 9.1 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.462 ' C ' ' HB3' ' A' ' 196' ' ' ALA . 2.1 p -54.58 -50.44 68.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.138 -1.213 . . . . 0.0 108.02 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 40.6 t -46.44 -54.86 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.15 -51.31 70.57 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.034 0.921 . . . . 0.0 109.625 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 48.0 m -62.92 -34.5 77.58 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.813 -0.554 . . . . 0.0 110.232 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -67.24 -39.95 86.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.575 -1.328 . . . . 0.0 108.331 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 56' ' ' MET . 61.8 m -74.41 -52.04 13.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.608 0.718 . . . . 0.0 109.993 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HB3' ' HE2' ' A' ' 120' ' ' MET . . . -52.06 -39.35 59.52 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.638 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.7 mt-30 -59.57 -53.1 61.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.726 -1.233 . . . . 0.0 107.86 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.765 HD11 HG22 ' A' ' 198' ' ' VAL . 26.1 mt -63.24 -29.63 47.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.537 ' SD ' HG22 ' A' ' 123' ' ' VAL . 26.2 mtp -66.23 -42.61 88.41 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.573 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.5 tptt -67.51 -39.43 85.13 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.3 t80 -53.7 -32.5 52.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.644 -0.66 . . . . 0.0 110.245 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 80.6 m-70 -107.03 -21.26 13.06 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.261 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.623 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 81.4 m-20 44.37 53.39 6.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.2 t80 -74.11 -76.62 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.7 -0.8 . . . . 0.0 113.082 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.93 105.1 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 CA-C-N 119.071 0.704 . . . . 0.0 112.084 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.2 m-80 -69.9 -21.51 63.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.04 141.73 49.32 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.37 147.99 34.51 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.601 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.914 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.61 -48.77 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.585 -0.95 . . . . 0.0 109.94 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 28.3 tttp -151.59 140.07 20.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 109.626 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 39.1 m-20 -59.35 172.7 0.6 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.471 -0.768 . . . . 0.0 109.767 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CD1' ' OD1' ' A' ' 150' ' ' ASN . 40.7 t80 -148.0 161.03 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.446 -0.784 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.418 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 14.8 t -159.7 149.69 18.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.5 p90 -160.03 155.63 25.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.097 -1.002 . . . . 0.0 109.829 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 82.7 m -92.77 132.71 36.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.741 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.0 tp -44.45 147.76 0.54 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.264 -0.898 . . . . 0.0 110.77 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t -61.27 143.63 55.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.434 0.635 . . . . 0.0 110.263 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 p -68.58 -3.93 13.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.56 -2.55 35.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.741 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.5 t-20 -71.27 110.89 8.3 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.763 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.592 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.8 Cg_endo -91.09 20.26 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.089 2.526 . . . . 0.0 108.886 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 38' ' ' PHE . 53.7 m-85 -114.93 -22.97 9.33 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.306 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -123.54 165.47 17.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.3 m120 -47.94 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.8 -47.16 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 111.202 175.174 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.72 57.63 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.394 -1.81 . . . . 0.0 107.394 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.4 tptt -110.86 108.2 17.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.536 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.81 145.16 28.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 6.0 mp -116.98 156.99 26.52 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 32.8 t80 -143.26 128.37 18.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.978 -1.076 . . . . 0.0 110.424 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.83 115.38 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.04 53.3 0.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.653 -1.279 . . . . 0.0 108.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.8 mt -52.9 -55.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.451 -0.781 . . . . 0.0 110.339 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -45.7 -26.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.475 -1.39 . . . . 0.0 109.207 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -111.25 22.4 15.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.66 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 42.8 mmt-85 -82.45 152.7 26.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.983 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -117.02 91.27 3.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.616 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 3.8 m-85 -81.09 90.22 6.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 110.425 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 35.3 t-20 -80.03 90.27 5.39 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 51.9 m95 -61.16 -7.53 2.78 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.585 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -90.14 -18.52 25.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.6 m-20 -98.88 -30.06 12.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.674 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.1 mt -73.84 69.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 24.6 mt -47.45 150.26 1.71 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.805 -0.559 . . . . 0.0 110.108 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.532 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -80.16 -28.13 3.26 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.824 2.349 . . . . 0.0 110.735 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -135.29 121.89 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.653 ' CE2' HG21 ' A' ' 116' ' ' ILE . 63.0 m-85 -109.53 139.9 43.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 109.899 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 p -100.19 -7.97 24.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.508 ' C ' ' HZ1' ' A' ' 113' ' ' LYS . . . 91.69 -0.01 73.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -118.37 7.31 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -1.123 . . . . 0.0 109.384 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 168.76 17.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.1 p -64.18 165.27 9.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.7 m-20 -71.72 -32.03 67.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -52.41 -61.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -33.65 75.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.508 ' HZ1' ' C ' ' A' ' 106' ' ' GLY . 17.0 mttt -65.88 -44.06 86.46 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -58.74 -36.53 74.47 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.674 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.19 -67.86 0.28 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.647 -0.658 . . . . 0.0 109.584 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.653 HG21 ' CE2' ' A' ' 104' ' ' TYR . 2.2 tp -63.74 -40.7 90.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 10.5 p -58.13 -43.38 87.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.92 -1.112 . . . . 0.0 108.841 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' OE2' ' CD ' ' A' ' 93' ' ' ARG . 50.3 tt0 -69.29 -38.0 78.1 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.61 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.6 tp -56.83 -52.37 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -57.78 -43.06 85.3 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.87 -38.61 91.56 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.644 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.1 m-20 -69.41 -54.85 12.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.537 HG22 ' SD ' ' A' ' 56' ' ' MET . 49.0 t -58.84 -62.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.37 -46.74 16.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.0 mt -63.63 -57.45 11.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 107.979 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.508 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 1.7 p -46.55 -27.33 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.81 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -104.5 31.53 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 45.7 m-20 41.75 43.52 2.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.158 -0.964 . . . . 0.0 109.747 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 45' ' ' THR . 35.2 tpp -60.37 134.2 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -0.778 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -76.96 123.16 25.91 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 34.3 m-85 -103.47 103.92 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -142.04 -170.03 12.36 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.757 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.6 Cg_endo -62.55 -20.91 72.08 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.633 -2.103 . . . . 0.0 106.633 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.64 130.31 55.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 72.6 m -113.87 113.83 25.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 119.753 -1.842 . . . . 0.0 110.339 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.67 126.48 8.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -118.06 -170.7 1.93 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.149 -1.207 . . . . 0.0 107.8 178.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.918 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.45 -49.95 6.23 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 116.76 -111.19 2.26 Favored Glycine 0 N--CA 1.481 1.657 0 C-N-CA 119.955 -1.117 . . . . 0.0 111.751 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.523 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 6.1 m -48.46 -72.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.862 . . . . 0.0 112.317 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 11.4 p -46.61 -32.86 3.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 110.276 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.918 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 24.4 mmt180 -80.41 -49.92 10.8 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.972 -1.08 . . . . 0.0 109.787 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.9 t -68.37 -58.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.7 -0.625 . . . . 0.0 111.049 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 3.1 pp0? -56.55 -31.88 64.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.016 -1.052 . . . . 0.0 108.608 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' SER . 1.9 ttm-85 -77.31 -52.84 8.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.002 -1.061 . . . . 0.0 109.61 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.508 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.95 -37.81 88.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.0 110.053 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.631 ' HB2' HG11 ' A' ' 157' ' ' VAL . 34.3 mt -55.21 -47.31 75.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 50.5 mtmt -87.38 -45.17 10.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.063 -1.023 . . . . 0.0 110.887 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.96 -48.99 69.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.999 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.56 ' OD1' ' CD1' ' A' ' 69' ' ' TYR . 10.5 m120 -94.36 -45.43 7.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.676 -1.265 . . . . 0.0 111.645 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.616 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 27.4 m-85 -99.97 18.67 17.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.763 -1.21 . . . . 0.0 110.716 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.914 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.16 43.55 0.07 OUTLIER Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.777 -0.577 . . . . 0.0 112.857 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 7.0 m-85 -64.17 164.16 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.267 -1.725 . . . . 0.0 108.013 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 27.3 t-20 -47.99 151.4 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.843 -1.161 . . . . 0.0 109.626 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 9.0 mm100 -56.16 -17.14 6.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.066 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.593 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 22.3 p -55.17 -14.84 1.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.84 . . . . 0.0 109.852 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 147' ' ' LEU . 39.8 t -72.66 119.61 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.711 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -149.56 -177.7 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.596 178.065 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.523 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.7 tt0 -123.42 139.1 54.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.902 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.7 pt -123.91 176.2 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 1.9 m120 -128.55 97.54 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.793 -1.192 . . . . 0.0 110.558 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.2 tpt180 -46.91 -41.15 15.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.047 -1.033 . . . . 0.0 109.327 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.72 -21.04 54.29 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 64.3 m-20 -104.04 0.25 29.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -1.228 . . . . 0.0 111.677 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.18 173.49 6.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.444 -1.41 . . . . 0.0 110.491 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 167' ' ' LYS . 18.6 p -101.33 136.51 41.05 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 166' ' ' SER . 15.0 ttpp -31.48 -51.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.912 -0.492 . . . . 0.0 111.228 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.65 -58.77 5.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.449 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.6 -19.67 63.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.0 108.513 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.4 t-105 -74.95 -47.55 28.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.502 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 19.8 mt-10 -64.15 -23.98 67.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.28 -43.44 98.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -60.5 -44.07 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 108.687 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 4.9 mt -74.24 -41.52 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 108.644 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -50.74 -51.87 45.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 109.08 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -51.96 -50.73 60.64 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 53.7 mm-40 -56.64 -61.25 2.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.731 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.1 mt -55.72 -32.36 63.27 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.183 0.516 . . . . 0.0 110.263 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.5 p -52.32 -53.23 47.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 19.6 mt-30 -88.75 44.13 1.19 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.0 m120 41.97 52.45 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 4.7 mt-30 -124.49 113.56 27.45 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.561 ' HG2' HG23 ' A' ' 55' ' ' ILE . 15.2 Cg_endo -66.34 169.14 14.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 121.743 1.629 . . . . 0.0 111.591 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 55.4 t -125.1 134.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.811 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.748 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.48 122.5 30.51 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 175.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.8 t80 -123.3 163.35 20.89 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.799 -1.188 . . . . 0.0 109.826 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -166.17 123.6 1.41 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.281 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 245' ' ' GLN . . . -93.2 124.26 7.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 190' ' ' GLY . 60.5 t -82.03 158.4 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.81 -1.406 . . . . 0.0 111.212 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.56 -137.8 2.28 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -36.33 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.65 -6.78 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.943 -1.098 . . . . 0.0 111.077 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.71 -159.78 19.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.48 114.29 4.04 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.849 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 32.3 t-80 -70.3 145.48 51.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.56 154.72 38.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 117.852 -1.539 . . . . 0.0 113.908 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.865 ' CD1' HG13 ' A' ' 210' ' ' VAL . 10.4 p90 -163.4 163.56 24.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.765 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -112.51 137.51 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.869 -1.145 . . . . 0.0 112.171 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.684 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 50.5 mt -103.74 121.03 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 19.1 p30 -126.3 16.17 7.75 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.493 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 178' ' ' LEU . . . -160.98 172.31 37.23 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 116.613 -2.708 . . . . 0.0 114.721 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.745 ' CB ' ' CE1' ' A' ' 208' ' ' TYR . . . -159.06 152.07 22.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.97 28.82 5.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.416 -1.428 . . . . 0.0 109.494 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 59.0 14.76 25.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -142.4 47.28 1.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -1.157 . . . . 0.0 108.972 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.502 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 9.6 m120 53.99 19.87 2.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 108.967 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -102.06 92.38 4.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.745 ' CE1' ' CB ' ' A' ' 202' ' ' ALA . 3.3 m-30 -102.86 155.97 17.97 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.068 -1.02 . . . . 0.0 111.232 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.574 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 1.3 t-80 -90.96 139.21 30.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.008 -1.682 . . . . 0.0 107.331 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.865 HG13 ' CD1' ' A' ' 197' ' ' PHE . 19.4 t -131.09 139.62 50.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.517 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 39.3 t-20 -114.04 84.17 1.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.596 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 94.8 m95 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.505 ' CG ' ' HB3' ' A' ' 162' ' ' ARG . 43.2 tt0 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -148.83 166.76 27.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.64 151.99 45.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.116 0.96 . . . . 0.0 110.057 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 84.7 t -109.15 118.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.711 HG23 ' NE2' ' A' ' 158' ' ' HIS . 33.5 m -127.1 144.03 38.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.164 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 91.87 55.71 1.72 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.615 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 36.4 mt -102.44 81.62 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.35 -1.088 . . . . 0.0 110.148 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -156.89 148.91 17.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.185 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.975 . . . . 0.0 110.573 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.819 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.8 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -75.91 -178.11 4.17 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.715 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 1.9 t -77.72 105.68 9.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.011 -1.056 . . . . 0.0 109.408 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.673 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 45.7 mt -57.4 -49.37 76.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 108.986 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 198' ' ' VAL . 10.4 mt -55.66 -41.57 73.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.807 -1.183 . . . . 0.0 108.781 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 24.5 t70 -67.4 -39.09 85.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.159 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -58.58 -14.38 8.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.1 mtpp -121.01 21.74 11.24 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.28 -0.888 . . . . 0.0 108.707 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.78 38.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.8 mt -86.61 109.62 19.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 122.283 1.039 . . . . 0.0 110.355 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 102' ' ' PRO . 20.1 m-70 -134.5 88.37 2.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.1 m-30 -95.0 -179.65 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.885 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 1.4 t-20 -148.54 -163.93 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.533 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 43.9 mt-30 -124.6 -23.37 4.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.076 -1.015 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.716 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -114.92 -34.67 1.47 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.308 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.2 t-20 -45.21 -140.36 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.242 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -74.37 3.77 4.98 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 CA-C-N 122.545 1.945 . . . . 0.0 109.694 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.8 m-85 -80.41 -31.46 37.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.435 -0.791 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.4 p-10 -92.13 15.26 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.604 -1.31 . . . . 0.0 109.103 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.7 mt -69.55 -6.97 34.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.9 mt -125.92 -9.24 6.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.007 . . . . 0.0 109.761 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -60.88 166.64 4.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.654 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.4 Cg_endo -70.06 145.88 56.72 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.014 1.81 . . . . 0.0 112.367 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -85.74 148.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.554 0.692 . . . . 0.0 109.808 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.794 HD11 ' C ' ' A' ' 132' ' ' GLY . 25.4 mt -78.21 149.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.448 -0.782 . . . . 0.0 111.295 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 92.9 mt-10 -126.17 -22.16 4.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.596 . . . . 0.0 110.468 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 30.3 mtpt -120.26 169.47 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.858 -1.151 . . . . 0.0 110.258 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 37' ' ' SER . 88.0 t . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.3 t . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 13.92 11.49 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.903 -1.123 . . . . 0.0 109.763 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 29' ' ' GLU . 58.7 t -62.99 141.07 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 109.436 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.27 80.36 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.6 mt-30 -86.92 132.84 33.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -1.188 . . . . 0.0 109.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -73.34 111.14 8.19 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.22 161.21 0.66 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.106 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.38 169.51 18.13 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.405 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.707 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.0 p -80.66 -33.84 35.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 108.469 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.05 135.87 8.01 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.431 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 14.1 p -53.69 -47.89 70.05 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.593 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 29.9 t -47.8 -57.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.372 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.78 -45.16 93.14 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 110.555 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 76.2 m -62.5 -39.24 92.86 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.64 -0.662 . . . . 0.0 110.244 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.62 80.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.489 -1.382 . . . . 0.0 108.778 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.505 ' HB ' HG11 ' A' ' 123' ' ' VAL . 60.7 m -74.71 -55.19 6.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.3 -34.91 48.88 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.662 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.4 mt-30 -63.5 -53.83 45.82 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -63.1 -22.29 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.498 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 24.7 mtp -73.36 -37.36 66.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.4 tptt -71.19 -40.07 71.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 40.9 t80 -53.65 -31.46 47.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.653 -0.654 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.1 m-70 -107.93 -22.4 12.45 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.287 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.639 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.13 57.3 2.0 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -178.078 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -77.54 -71.59 0.18 Allowed Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -69.17 105.65 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 120.272 0.648 . . . . 0.0 112.171 -176.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -72.04 -20.35 61.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 34.0 tttt -134.28 139.8 45.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 148.4 37.4 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.411 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.974 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.79 -46.79 8.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.989 . . . . 0.0 109.822 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.504 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 38.3 tttt -151.92 140.51 20.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' SER . 10.7 m-20 -67.62 174.71 3.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 70' ' ' THR . 36.9 t80 -152.16 150.16 29.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.13 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.451 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.61 164.47 35.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.68 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.0 p90 -169.3 155.79 6.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 91.3 m -93.04 130.29 38.69 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.775 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.37 149.97 0.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 111.057 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -61.42 137.37 58.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.694 -0.629 . . . . 0.0 109.568 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -64.44 -7.24 9.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 109.875 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.0 m-80 -96.73 -6.03 37.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.775 ' ND2' HD21 ' A' ' 73' ' ' LEU . 35.2 t-20 -71.04 111.8 11.19 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 53.3 Cg_endo -88.48 12.3 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.887 2.391 . . . . 0.0 109.8 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 70.9 m-85 -107.04 -1.99 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 111.461 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 34.0 m-85 -142.35 161.91 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.572 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.7 m120 -47.54 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 174.62 -46.47 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 111.008 174.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.94 55.98 5.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.83 103.46 12.97 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.649 -178.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -100.85 132.75 46.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -105.25 137.92 42.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 20.9 t80 -125.13 125.34 43.58 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.151 -0.968 . . . . 0.0 110.395 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.87 105.7 15.63 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.01 54.79 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 108.67 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 70.5 mt -52.71 -52.87 23.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.543 -0.723 . . . . 0.0 110.433 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 p -44.4 -25.47 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -110.56 35.75 3.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 108.565 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.708 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 23.5 mmt-85 -95.75 155.65 16.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.843 . . . . 0.0 110.735 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -118.69 91.41 3.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -81.66 88.18 6.25 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 110.951 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.507 ' O ' HG13 ' A' ' 100' ' ' ILE . 42.8 t-20 -79.66 89.63 5.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.639 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 79.1 m95 -61.27 -6.62 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.85 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 -16.14 31.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -99.9 -30.84 11.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.658 HG12 ' HB1' ' A' ' 115' ' ' ALA . 27.7 mt -73.42 67.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.492 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 12.9 mt -46.32 150.71 1.08 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.554 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.9 Cg_endo -77.45 -26.67 7.05 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.607 2.205 . . . . 0.0 110.946 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 2.1 t -138.2 125.23 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 87.2 m-85 -109.62 139.45 44.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.91 4.51 45.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 108.991 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.72 -6.86 63.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -113.52 15.94 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -1.148 . . . . 0.0 109.395 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.452 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.3 mp0 -75.8 167.53 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -179.69 0.33 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.68 -43.94 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.54 -51.88 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.787 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -44.43 96.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.032 -1.043 . . . . 0.0 109.084 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 75.8 mttt -61.93 -36.56 81.75 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.257 -0.902 . . . . 0.0 108.835 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.461 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 14.8 ttm -60.35 -45.32 93.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.13 -51.6 69.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 111.098 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.631 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.5 tp -69.35 -39.11 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.601 -1.312 . . . . 0.0 110.04 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -58.04 -41.49 83.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.098 -1.001 . . . . 0.0 110.44 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.888 ' N ' HD12 ' A' ' 24' ' ' LEU . 22.6 tt0 -68.86 -37.39 79.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.954 -1.091 . . . . 0.0 108.218 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -57.95 -51.8 68.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.4 mmt -59.37 -40.62 87.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.524 -0.735 . . . . 0.0 109.465 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.23 -37.93 88.81 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -69.07 -57.43 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.955 ' O ' HG22 ' A' ' 127' ' ' VAL . 22.6 t -61.73 -48.48 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.048 -1.033 . . . . 0.0 108.835 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -54.64 -54.03 35.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.4 mt -65.91 -53.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.009 -1.289 . . . . 0.0 108.321 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 59.8 p -45.99 -32.11 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.577 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 123' ' ' VAL . 31.5 m -101.39 39.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.3 m-20 37.41 50.97 1.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.665 ' HE3' ' O ' ' A' ' 45' ' ' THR . 51.2 tpp -65.98 127.45 32.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.427 -0.795 . . . . 0.0 111.602 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.6 OUTLIER -76.26 123.05 25.29 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.654 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.4 m-85 -103.94 118.77 37.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.326 1.06 . . . . 0.0 113.578 -175.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.794 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.07 -163.8 11.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 104.598 -3.401 . . . . 0.0 104.598 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.659 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.29 -30.86 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.573 -2.51 . . . . 0.0 105.573 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.88 142.03 41.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.4 m -122.25 113.22 19.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 119.855 -1.778 . . . . 0.0 110.157 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.47 132.49 11.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -117.84 -164.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -1.112 . . . . 0.0 108.12 178.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.613 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.86 -64.37 1.12 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.807 -1.183 . . . . 0.0 108.125 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.575 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 132.31 -130.56 5.92 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.837 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.472 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 1.4 m -47.36 -55.59 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.745 -0.856 . . . . 0.0 111.531 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -45.69 21.22 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.867 -1.146 . . . . 0.0 109.269 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.6 mmp_? -80.63 -38.79 28.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.61 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 185' ' ' TYR . 76.2 t -67.77 -57.29 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.462 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 0.8 OUTLIER -56.7 -33.09 66.12 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.103 -1.039 . . . . 0.0 108.674 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' SER . 2.6 ttp85 -77.8 -46.45 21.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.8 76.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.699 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.647 HD12 HG11 ' A' ' 248' ' ' VAL . 59.1 mt -60.58 -46.5 90.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.697 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.582 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 43.5 mtmt -88.08 -38.87 15.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.784 -1.197 . . . . 0.0 110.722 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 48.3 mt-10 -72.87 -51.66 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.85 -1.156 . . . . 0.0 111.753 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.3 m120 -89.56 -41.38 12.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.884 -1.135 . . . . 0.0 111.587 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.83 8.25 39.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.756 -1.215 . . . . 0.0 110.834 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.974 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 39.38 40.92 1.44 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 121.172 -0.955 . . . . 0.0 112.122 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.13 168.9 3.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.385 -1.656 . . . . 0.0 108.318 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.4 t30 -47.82 142.39 4.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.097 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.43 -20.91 5.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.923 . . . . 0.0 108.956 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.494 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 79.0 p -56.49 -14.46 3.09 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 109.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.582 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 7.0 t -61.82 122.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 0.0 109.586 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.986 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.1 p-80 -148.55 159.19 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.709 -0.797 . . . . 0.0 109.202 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 16.5 tt0 -102.79 145.38 29.84 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 1.048 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.4 pt -121.77 154.4 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m120 -121.53 99.51 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.874 -1.141 . . . . 0.0 110.646 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.629 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 1.1 tpt180 -46.29 -38.86 9.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.35 -24.26 61.16 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -104.52 1.54 29.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.243 . . . . 0.0 111.857 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -117.77 179.7 4.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.4 -1.437 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 167' ' ' LYS . 60.6 p -104.85 136.64 43.97 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.498 ' HD2' ' NE2' ' A' ' 168' ' ' GLN . 21.7 ttmt -34.35 -47.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.74 -0.6 . . . . 0.0 110.825 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.498 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 49.1 mm-40 -64.97 -59.5 4.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.117 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.51 -16.25 60.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.28 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 1.048 ' CH2' HD12 ' A' ' 160' ' ' ILE . 50.8 t-105 -71.01 -47.97 55.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 33.8 mt-10 -67.1 -38.01 84.92 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -44.67 -49.59 10.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.511 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 83.1 mm-40 -61.1 -42.02 97.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 108.725 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.76 HG23 HG21 ' A' ' 184' ' ' VAL . 96.6 mt -71.71 -63.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 0.0 111.381 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.5 OUTLIER -48.11 -43.3 30.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 -177.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -51.84 -43.46 63.19 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.544 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 48.8 mm-40 -59.8 -53.51 57.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.819 ' HB3' HG11 ' A' ' 4' ' ' VAL . 11.4 mt -68.38 -25.06 64.88 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.911 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 175' ' ' ASP . 28.4 p -52.24 -40.12 61.23 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.7 mt-30 -99.94 33.54 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.576 ' C ' HD13 ' A' ' 7' ' ' LEU . 12.9 m120 49.22 48.99 20.38 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 10.6 mt-30 -124.15 114.78 27.67 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 19.7 Cg_endo -66.67 172.14 9.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.03 1.82 . . . . 0.0 112.187 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 249' ' ' VAL . 18.9 t -125.87 118.04 50.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.648 ' HD2' HG23 ' A' ' 248' ' ' VAL . 26.4 t80 -67.78 111.95 4.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.651 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 6.5 t80 -123.21 156.64 34.72 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.17 -0.956 . . . . 0.0 109.465 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -164.65 128.73 2.52 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.813 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 245' ' ' GLN . . . -91.63 109.08 3.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.0 t -71.7 160.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.459 -1.024 . . . . 0.0 111.382 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -162.57 -137.8 2.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -43.32 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.05 -1.265 . . . . 0.0 111.13 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.96 -13.56 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.96 -1.087 . . . . 0.0 111.457 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.99 -165.35 24.9 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.5 108.42 3.21 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.798 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -71.48 118.34 14.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.4 160.52 15.58 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.773 1.273 . . . . 0.0 113.072 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.719 ' CD1' HG13 ' A' ' 210' ' ' VAL . 20.5 p90 -162.36 170.2 19.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 8' ' ' LEU . 47.4 t -114.37 136.07 52.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 120.673 -1.267 . . . . 0.0 112.234 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 65.7 mt -100.56 108.73 23.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.0 p30 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.68 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.426 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -172.5 161.86 33.52 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 117.142 -2.456 . . . . 0.0 112.878 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.525 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -142.73 144.54 32.71 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 207' ' ' PHE . 1.8 t0 -114.11 11.45 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.751 -1.218 . . . . 0.0 110.61 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.77 -47.28 3.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -79.33 50.42 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 109.751 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 53.01 31.67 11.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 110.096 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.1 m-85 -121.06 135.89 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 109.769 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 5.7 m-85 -123.39 164.71 18.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.715 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 0.3 OUTLIER -92.73 148.46 22.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.719 HG13 ' CD1' ' A' ' 197' ' ' PHE . 22.4 t -139.59 137.82 39.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.551 ' HB2' HD12 ' A' ' 8' ' ' LEU . 32.7 t-20 -102.02 80.58 2.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.461 ' CE3' ' HA ' ' A' ' 212' ' ' TRP . 1.6 m95 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 109.773 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.566 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 4.8 mt-30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 34.5 p -131.1 155.53 46.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.381 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.11 162.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.831 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.648 HG23 ' HD2' ' A' ' 185' ' ' TYR . 16.3 t -116.16 110.32 31.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 158' ' ' HIS . 15.4 m -107.75 146.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 121.379 -0.826 . . . . 0.0 110.943 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 84.42 42.42 7.42 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 54.0 mt -89.58 86.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.536 -0.979 . . . . 0.0 110.362 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.51 156.37 17.89 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.624 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.378 2.052 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 178' ' ' LEU . 78.0 t . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 200' ' ' ASP . 11.4 mmtp -75.8 -177.18 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 108.947 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 209' ' ' HIS . 66.3 m -77.72 103.08 7.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.647 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 36.3 mt -57.97 -51.62 68.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 109.483 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.588 HD11 HG11 ' A' ' 198' ' ' VAL . 9.0 mt -55.55 -39.32 70.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.746 -1.221 . . . . 0.0 109.021 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 16.0 t0 -67.33 -37.63 83.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 109.35 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -58.43 -14.49 7.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mtpt -121.08 18.93 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 108.846 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.95 39.74 5.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 18.7 mt -86.14 111.42 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.423 -1.045 . . . . 0.0 110.36 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 102' ' ' PRO . 42.4 m80 -135.23 87.48 2.33 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.619 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.599 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.2 m-30 -88.29 178.23 6.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.977 0.894 . . . . 0.0 110.781 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.73 -163.77 1.85 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.495 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 53.5 mt-30 -125.01 -20.97 4.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.963 -1.086 . . . . 0.0 111.061 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.14 -36.28 1.24 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.22 -1.467 . . . . 0.0 111.666 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.4 t-20 -45.35 -140.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.492 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.016 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.2 Cg_endo -73.85 2.84 5.52 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 CA-C-N 122.538 1.942 . . . . 0.0 109.753 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 9.1 m-85 -78.26 -31.52 49.13 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.024 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 24.6 p-10 -92.36 15.71 13.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.584 -1.323 . . . . 0.0 109.463 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.4 mt -70.38 -3.72 18.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.7 mt -129.27 -6.36 4.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 109.988 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.9 p -61.58 165.47 7.28 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.1 Cg_endo -69.16 145.65 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.058 1.839 . . . . 0.0 112.041 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.25 147.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.73 0.776 . . . . 0.0 110.396 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.76 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.6 mt -78.02 149.68 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.683 0.754 . . . . 0.0 111.396 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.2 mt-10 -126.06 -20.83 4.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 110.573 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -121.25 168.13 11.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 110.15 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.9 t . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 111.119 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.564 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 74.7 m-85 -118.54 13.07 13.37 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.451 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 28' ' ' ILE . 77.2 t -63.35 142.52 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 109.367 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 -1.26 77.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 8.2 mt-30 -87.92 131.72 34.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 25' ' ' THR . 4.5 m-70 -73.55 111.69 8.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -51.93 161.42 0.57 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.08 -1.013 . . . . 0.0 109.329 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.53 170.88 15.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.564 0.697 . . . . 0.0 109.866 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.691 HG21 ' SD ' ' A' ' 120' ' ' MET . 28.2 p -81.2 -34.31 32.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 108.646 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.75 137.82 9.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 51' ' ' ALA . 4.3 p -55.14 -52.56 62.89 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -1.086 . . . . 0.0 108.172 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.3 t -46.8 -51.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.566 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -61.43 -51.53 68.35 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.501 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.495 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 39.8 m -63.19 -30.96 72.01 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.705 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.53 -42.23 83.07 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.733 -1.23 . . . . 0.0 107.836 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.494 HG23 HD21 ' A' ' 147' ' ' LEU . 55.8 m -74.76 -53.03 9.94 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.494 0.664 . . . . 0.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.29 -35.4 37.42 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.501 -0.749 . . . . 0.0 109.646 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.599 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.5 mt-30 -64.32 -53.99 40.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.751 HD11 HG22 ' A' ' 198' ' ' VAL . 36.7 mt -60.88 -24.45 32.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.519 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -72.72 -31.68 65.15 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CG ' HG12 ' A' ' 13' ' ' ILE . 41.3 tptt -73.69 -47.07 42.39 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 41.8 t80 -52.95 -29.98 32.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.727 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 50.4 m-70 -107.32 -24.44 11.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.755 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.612 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 86.1 m-20 44.83 56.17 5.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.8 t80 -79.77 -76.08 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.8 Cg_endo -70.24 105.16 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 119.258 0.771 . . . . 0.0 111.837 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.6 OUTLIER -72.0 -20.75 61.67 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -133.95 138.6 45.57 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.652 ' C ' HD23 ' A' ' 66' ' ' LEU . . . -57.82 152.71 26.89 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.164 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.773 HD12 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mt -94.95 -59.84 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.431 -1.041 . . . . 0.0 110.492 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 14.1 tttm -134.11 151.36 51.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.562 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 21.6 m-20 -74.45 172.56 11.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.829 . . . . 0.0 109.499 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 70' ' ' THR . 28.9 t80 -147.48 153.82 40.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.582 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -157.37 149.68 22.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.095 -1.003 . . . . 0.0 110.097 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.715 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.9 p90 -156.44 157.05 34.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.583 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 87.3 m -93.35 134.95 35.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.786 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -52.78 149.99 5.71 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 111.136 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.78 138.26 58.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.729 -0.607 . . . . 0.0 109.596 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -65.78 -6.08 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 6.8 m-20 -96.2 -7.26 36.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.164 -0.96 . . . . 0.0 109.575 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.786 ' ND2' HD21 ' A' ' 73' ' ' LEU . 32.3 t-20 -70.25 111.54 9.67 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 109.82 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 50.3 Cg_endo -88.19 12.68 2.77 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.973 2.449 . . . . 0.0 109.996 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.0 m-85 -105.18 -11.86 16.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.69 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.3 m-85 -134.76 163.19 30.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 10.2 m-20 -47.48 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.25 -46.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 111.039 175.198 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.5 Cg_endo -76.69 56.72 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.99 102.51 11.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.63 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.86 128.85 46.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -102.06 129.1 48.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 11.2 t80 -121.78 126.91 49.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.92 . . . . 0.0 110.047 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.55 116.05 31.24 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.86 51.26 0.62 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.854 -1.154 . . . . 0.0 108.314 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 25.8 mt -52.09 -44.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 O-C-N 121.259 -0.901 . . . . 0.0 109.579 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 4.7 p -45.62 -26.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.649 -1.282 . . . . 0.0 108.76 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -112.51 34.51 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.411 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.718 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 2.2 mmt-85 -93.0 151.5 19.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 110.336 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -117.2 94.51 4.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.7 m-85 -81.55 93.04 6.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.472 -0.768 . . . . 0.0 110.408 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 30.7 t-20 -79.81 90.15 5.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.612 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 65.0 m95 -61.22 -9.29 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -90.53 -15.59 30.41 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 22.9 m-20 -98.69 -34.27 10.61 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.552 HG12 ' HB1' ' A' ' 115' ' ' ALA . 34.2 mt -73.1 91.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 14.8 mt -71.06 151.62 94.85 Favored Pre-proline 0 C--N 1.29 -1.99 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.2 Cg_endo -76.58 -20.7 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.462 2.108 . . . . 0.0 110.783 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 140.4 32.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.281 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.505 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.8 m-85 -126.61 135.45 51.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.409 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.6 p -99.52 1.87 44.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 108.962 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.44 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -118.29 11.41 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.331 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -73.11 172.59 10.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.669 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.83 177.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.331 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -80.85 -42.1 22.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.97 -51.76 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.458 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 20' ' ' PRO . 15.8 mttt -61.18 -37.46 83.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.12 -0.987 . . . . 0.0 109.118 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.449 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.2 ttm -59.62 -45.24 92.56 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.373 -0.829 . . . . 0.0 110.028 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.07 -51.31 70.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.857 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -69.78 -43.5 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.549 -1.344 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 24' ' ' LEU . 4.7 p -54.33 -40.36 67.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 19.6 tt0 -70.46 -43.28 70.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.1 tp -54.04 -51.48 63.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.691 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -60.16 -44.22 95.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.598 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.537 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.57 -41.82 96.03 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -65.37 -52.54 52.93 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 127' ' ' VAL . 78.6 t -61.18 -61.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.74 -50.99 13.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.8 mt -63.65 -55.45 22.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.319 . . . . 0.0 108.418 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 3.4 p -46.19 -31.3 2.36 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.515 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.2 m -102.28 40.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.156 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER 39.38 38.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.339 -0.851 . . . . 0.0 110.253 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.647 ' HE3' ' O ' ' A' ' 45' ' ' THR . 48.2 tpp -52.56 128.34 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 111.314 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 25.4 t0 -78.33 123.2 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 68.7 m-85 -104.5 115.81 31.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 113.579 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.76 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.73 -163.82 11.55 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 104.482 -3.447 . . . . 0.0 104.482 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.618 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.34 -29.47 79.71 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 105.589 -2.504 . . . . 0.0 105.589 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -110.47 137.7 47.82 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 50.5 m -116.64 108.7 16.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 119.872 -1.768 . . . . 0.0 109.977 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.1 136.22 13.24 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.547 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 14.6 t -118.56 -163.41 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 108.8 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.892 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.29 -55.55 3.38 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.57 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 126.99 -123.78 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.758 -1.21 . . . . 0.0 111.934 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 10.7 m -48.38 -65.39 0.57 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.817 -0.814 . . . . 0.0 112.458 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -46.52 -34.27 4.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.931 -1.106 . . . . 0.0 109.402 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.892 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 29.6 mmt180 -80.12 -49.74 11.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.876 0.846 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.681 HG21 ' CE2' ' A' ' 185' ' ' TYR . 92.9 t -68.31 -54.82 19.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.867 -0.521 . . . . 0.0 111.19 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -56.68 -34.11 67.06 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.958 -1.089 . . . . 0.0 108.741 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -77.24 -47.85 19.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.48 78.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 109.927 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.607 ' CD1' HG12 ' A' ' 143' ' ' VAL . 66.0 mt -57.13 -49.0 77.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 109.607 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.566 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 58.3 mtmt -87.39 -33.69 19.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 111.116 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 69.6 mt-10 -72.23 -63.94 1.04 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.432 -1.417 . . . . 0.0 112.182 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 10.6 m120 -82.89 -37.22 24.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.433 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 22.4 m-85 -100.76 1.53 40.42 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.752 -1.217 . . . . 0.0 110.471 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.773 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 42.94 41.41 4.57 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.344 -0.848 . . . . 0.0 112.445 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.4 m-85 -61.99 164.75 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.162 -1.787 . . . . 0.0 107.598 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.0 t-20 -47.23 144.7 2.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.683 -1.261 . . . . 0.0 109.014 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -53.02 -19.75 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.004 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.1 p -54.85 -15.17 1.75 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.301 -0.874 . . . . 0.0 110.08 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 147' ' ' LEU . 5.5 t -65.02 121.36 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.46 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.949 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.9 p-80 -147.86 159.9 43.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.748 . . . . 0.0 109.164 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.3 tt0 -101.81 155.73 17.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 109.925 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.1 pt -135.43 143.23 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.2 m-80 -107.91 104.63 14.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.886 -1.134 . . . . 0.0 111.027 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 10.0 tpt180 -47.52 -37.15 11.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 108.857 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -64.44 -20.48 65.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 161' ' ' ASN . 6.4 m-20 -103.63 -4.09 24.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -1.231 . . . . 0.0 110.89 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -118.03 168.18 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.239 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 167' ' ' LYS . 43.4 p -97.19 136.49 37.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 166' ' ' SER . 2.1 tttt -32.69 -45.63 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.152 0.501 . . . . 0.0 110.642 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -64.47 -63.89 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.087 -1.008 . . . . 0.0 109.832 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -63.4 -14.37 49.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.29 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 65.2 t-105 -75.95 -47.67 24.19 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.683 ' HA ' HD12 ' A' ' 174' ' ' ILE . 76.9 mt-10 -70.93 -30.73 67.13 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.53 -44.27 76.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.853 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -61.25 -40.2 93.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.296 -0.877 . . . . 0.0 108.731 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 184' ' ' VAL . 21.2 mt -73.35 -57.9 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.441 -0.787 . . . . 0.0 110.447 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.43 -43.5 44.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.004 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -51.65 -44.19 62.91 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.579 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.3 mm-40 -60.98 -49.0 79.22 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.727 ' HB3' HG11 ' A' ' 4' ' ' VAL . 30.1 mt -67.4 -28.48 67.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.677 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 175' ' ' ASP . 9.9 p -51.33 -42.59 61.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 108.573 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.8 mt-30 -97.37 32.67 2.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.536 ' C ' HD13 ' A' ' 7' ' ' LEU . 81.5 m-20 48.71 49.96 18.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.3 mt-30 -123.88 116.29 27.63 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.5 Cg_endo -66.35 169.76 13.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.143 1.896 . . . . 0.0 112.461 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 174' ' ' ILE . 57.5 t -126.53 130.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.479 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.817 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -79.39 120.18 23.46 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 176.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 7.1 t80 -123.1 159.33 28.74 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.995 -1.066 . . . . 0.0 109.766 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -166.78 125.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.776 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.493 ' HA2' ' OE1' ' A' ' 245' ' ' GLN . . . -93.85 104.43 3.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 190' ' ' GLY . 46.6 t -68.32 164.07 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 110.925 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.575 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -165.12 -141.46 3.14 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.526 -1.829 . . . . 0.0 108.526 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -30.9 20.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.076 -1.249 . . . . 0.0 110.237 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.47 -22.49 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.022 -1.049 . . . . 0.0 110.495 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.11 -169.48 24.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.583 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.91 102.34 1.9 Allowed Glycine 0 N--CA 1.482 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 111.138 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.0 t-80 -71.29 128.14 34.9 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.82 161.79 19.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.295 -1.362 . . . . 0.0 113.195 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 13.6 p90 -159.29 167.8 28.03 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.751 HG22 HD11 ' A' ' 55' ' ' ILE . 83.5 t -114.69 136.92 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.756 -1.215 . . . . 0.0 112.236 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.931 HD13 HG21 ' A' ' 174' ' ' ILE . 70.7 mt -99.63 125.04 53.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 20.1 p-10 -135.05 30.0 3.36 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.458 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -176.52 165.82 36.36 Favored Glycine 0 N--CA 1.483 1.79 0 C-N-CA 117.369 -2.348 . . . . 0.0 112.226 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 207' ' ' PHE . . . -148.86 146.6 28.02 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.98 2.61 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 110.071 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 86.07 -35.84 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.098 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER -88.46 32.04 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -1.23 . . . . 0.0 110.192 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.1 OUTLIER 76.28 27.44 0.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 7.2 m-85 -118.88 133.27 55.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.186 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 48.0 m-85 -122.96 165.24 17.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.375 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 6' ' ' SER . 29.1 t-80 -92.89 145.53 24.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 97.6 t -135.05 137.83 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.917 -1.114 . . . . 0.0 111.558 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.4 t-20 -111.22 68.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 98.2 m95 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.808 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.493 ' OE1' ' HA2' ' A' ' 188' ' ' GLY . 25.1 tt0 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.506 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 2.5 p -155.41 169.38 24.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.427 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.19 162.55 35.22 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.774 0.797 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 185' ' ' TYR . 18.3 t -116.51 124.06 72.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.949 HG23 ' CE1' ' A' ' 158' ' ' HIS . 9.2 m -123.2 139.96 48.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.85 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.45 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 92.98 51.39 2.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 37.2 mt -98.41 91.09 2.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.319 -1.107 . . . . 0.0 109.567 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.4 148.31 9.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 109.095 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.58 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.264 1.976 . . . . 0.0 110.465 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.0 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 200' ' ' ASP . 59.8 mmtt -75.51 -177.14 3.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.071 -1.018 . . . . 0.0 108.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 4.5 t -77.53 104.25 7.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.699 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.8 mt -56.99 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.028 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.2 mt -54.47 -43.79 72.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 108.595 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -67.55 -37.03 82.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -15.67 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 108.856 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 13' ' ' ILE . 11.8 mtpp -121.12 22.17 11.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.2 38.59 6.5 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 11' ' ' LYS . 32.3 mt -90.86 109.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.332 -1.099 . . . . 0.0 110.138 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 79.6 m80 -134.08 85.85 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.63 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.0 m-30 -93.59 174.21 7.3 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.252 1.025 . . . . 0.0 111.614 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 25.5 t30 -148.38 -172.42 4.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 3.1 mt-30 -125.4 -0.98 7.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.867 -1.146 . . . . 0.0 110.238 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.51 -56.31 0.35 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.252 -1.452 . . . . 0.0 112.145 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.763 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 10.0 t-20 -46.07 -126.07 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.966 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.763 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 41.0 Cg_endo -79.11 6.69 4.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 CA-C-N 123.56 2.307 . . . . 0.0 109.713 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 16' ' ' ASN . 57.8 m-85 -78.18 -35.3 48.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.641 -0.662 . . . . 0.0 109.535 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 47.8 p30 -96.78 20.29 11.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.831 -1.168 . . . . 0.0 109.098 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.39 1.74 11.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 110.106 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 118' ' ' GLU . 16.6 mt -134.68 0.9 3.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.829 -1.17 . . . . 0.0 110.265 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 29.6 p -66.72 164.4 33.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.711 ' HG3' HD21 ' A' ' 86' ' ' LEU . 18.6 Cg_endo -71.8 131.08 17.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.701 1.601 . . . . 0.0 110.297 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.44 145.63 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.77 0.795 . . . . 0.0 110.429 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 132' ' ' GLY . 10.3 mt -77.65 148.92 6.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.624 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.24 -22.28 4.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.104 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' TYR . 17.4 mtpp -119.39 172.85 7.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 37' ' ' SER . 88.2 t . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.376 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.813 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 13.2 m-85 -116.3 9.81 14.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.796 -1.19 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 29' ' ' GLU . 34.1 t -60.72 117.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.728 -1.232 . . . . 0.0 108.521 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.38 -11.23 50.93 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.42 ' CD ' ' HA ' ' A' ' 38' ' ' PHE . 73.2 mt-30 -76.18 133.25 40.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.447 -1.031 . . . . 0.0 109.168 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.83 114.7 11.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -53.24 145.81 13.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -69.97 167.35 17.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.871 -1.143 . . . . 0.0 109.697 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.476 ' O ' ' HE3' ' A' ' 129' ' ' MET . 23.4 p -82.14 -33.03 29.79 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 108.511 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.71 138.62 9.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 p -55.17 -51.45 66.48 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.236 -1.155 . . . . 0.0 107.94 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 HG21 ' A' ' 127' ' ' VAL . 23.4 t -45.11 -53.99 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.13 -55.76 30.87 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.44 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 59.3 m -63.47 -28.43 69.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.572 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -66.5 -47.99 71.25 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.219 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 123' ' ' VAL . 85.8 m -75.38 -48.97 20.51 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.842 0.83 . . . . 0.0 109.864 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.83 -33.76 37.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.426 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.63 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.9 mt-30 -68.34 -50.1 55.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.004 HG21 HD13 ' A' ' 251' ' ' ILE . 40.2 mt -62.95 -23.37 33.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.502 ' HG3' HG22 ' A' ' 52' ' ' THR . 20.0 mtp -73.55 -40.89 63.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 43.6 tptt -65.91 -44.48 85.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.699 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 34.8 t80 -53.39 -28.4 29.22 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 41.0 m-70 -107.65 -25.26 11.4 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.094 -1.004 . . . . 0.0 110.866 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 94.9 m-20 43.76 59.69 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.7 t80 -83.09 -78.76 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.37 108.68 2.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 CA-C-N 119.6 0.893 . . . . 0.0 112.996 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.9 -26.22 66.77 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 2.7 ttpt -130.52 130.76 44.55 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.96 164.97 5.68 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 118.487 -1.816 . . . . 0.0 110.682 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.13 -35.84 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.986 . . . . 0.0 111.188 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 8.6 tttm -152.42 131.71 12.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.73 -1.231 . . . . 0.0 110.489 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 36.5 m-20 -60.23 170.68 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.368 -0.832 . . . . 0.0 108.962 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.505 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 43.4 t80 -145.8 142.1 28.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.2 t -142.9 152.34 41.97 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.208 -0.932 . . . . 0.0 109.419 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 28.7 p90 -160.05 158.09 29.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -92.6 126.3 37.63 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.707 HD21 ' ND2' ' A' ' 77' ' ' ASN . 12.1 tp -43.99 147.53 0.49 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.664 0.745 . . . . 0.0 110.509 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 142.79 54.93 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.527 0.68 . . . . 0.0 110.632 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.7 t -69.49 -2.97 12.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.732 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 8.2 m120 -97.57 -2.17 42.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.222 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.707 ' ND2' HD21 ' A' ' 73' ' ' LEU . 18.9 t-20 -70.04 109.6 5.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.9 Cg_endo -90.57 19.63 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.95 2.433 . . . . 0.0 108.827 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.655 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 44.7 m-85 -117.66 -25.83 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.835 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' ASN . 88.4 m-85 -117.35 170.76 8.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.676 -1.265 . . . . 0.0 108.102 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 m120 -53.96 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.47 -49.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.289 -0.882 . . . . 0.0 111.426 174.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 32.0 Cg_endo -75.92 58.51 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.328 -1.836 . . . . 0.0 107.328 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 86' ' ' LEU . 18.7 tptt -105.52 121.88 44.87 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.663 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -102.45 116.65 33.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 0.0 110.225 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 26' ' ' PRO . 3.4 mp -96.17 134.01 39.77 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 26.0 t80 -132.36 131.38 41.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.776 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -111.77 118.21 34.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.7 53.01 0.42 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.724 -1.235 . . . . 0.0 108.273 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 mt -52.88 -58.1 3.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 0.0 111.23 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.3 p -44.52 -27.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.874 -1.141 . . . . 0.0 108.84 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -112.56 30.48 7.08 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 31.0 mmt-85 -81.17 157.36 25.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.514 -1.366 . . . . 0.0 109.542 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -116.32 81.47 1.62 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 12.1 m-85 -80.96 88.3 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.485 -0.759 . . . . 0.0 110.082 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.2 t-20 -79.17 91.84 5.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.644 ' CE3' HD12 ' A' ' 100' ' ' ILE . 60.0 m95 -60.59 -7.75 2.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.823 . . . . 0.0 110.381 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 9.1 m-20 -89.37 -18.83 26.08 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 24.3 m-20 -100.35 -31.2 11.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.777 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.1 mt -74.03 65.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.532 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 47.9 mt -45.65 149.16 1.13 Allowed Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.553 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.6 Cg_endo -77.23 -20.27 12.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.013 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 103' ' ' THR . 2.7 t -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.945 -1.097 . . . . 0.0 109.414 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 96.8 m-85 -109.26 144.01 37.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.971 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -99.16 -3.4 34.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.617 ' HA3' ' ND2' ' A' ' 19' ' ' ASN . . . 81.84 3.65 90.53 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -119.22 6.69 11.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.44 -1.035 . . . . 0.0 108.836 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -174.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 p -72.27 173.57 8.47 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.229 -0.92 . . . . 0.0 108.778 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.0 m120 -78.74 -34.57 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.136 -0.977 . . . . 0.0 109.446 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.24 -61.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.818 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -62.2 -34.21 76.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.996 -1.065 . . . . 0.0 109.038 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 73.6 mttt -66.1 -44.27 84.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.416 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 40.2 ttm -59.53 -34.93 73.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.73 -67.89 0.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.83 -0.544 . . . . 0.0 110.752 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.83 HD11 ' HE2' ' A' ' 120' ' ' MET . 4.0 tp -59.43 -42.35 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.7 p -53.47 -41.71 66.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.92 -1.112 . . . . 0.0 109.908 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.761 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.5 tt0 -69.31 -45.36 69.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.712 HD23 ' CD1' ' A' ' 116' ' ' ILE . 4.6 tp -55.42 -50.03 70.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.83 ' HE2' HD11 ' A' ' 116' ' ' ILE . 22.7 mmt -58.26 -46.12 86.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.42 -38.46 89.97 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.692 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 20.8 m-20 -64.77 -55.68 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 127' ' ' VAL . 51.4 t -61.8 -51.36 73.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -50.86 -49.15 42.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 126' ' ' SER . 2.2 mt -64.95 -60.42 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -1.103 . . . . 0.0 108.489 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.556 ' N ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -45.98 -30.5 1.83 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.494 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 123' ' ' VAL . 32.9 m -101.26 38.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.152 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.6 m-20 35.82 54.06 0.89 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.577 0.703 . . . . 0.0 109.619 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.569 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 40.1 tpp -66.3 130.56 43.62 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 112.144 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' SER . 7.4 t0 -75.87 119.8 20.34 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.537 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 29.5 m-85 -102.34 108.82 20.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -174.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -149.76 -169.35 15.97 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 103.956 -3.658 . . . . 0.0 103.956 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.813 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 14.2 Cg_endo -62.5 -21.28 72.6 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 N-CA-C 106.887 -2.005 . . . . 0.0 106.887 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.42 131.04 55.4 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.739 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 68.0 m -117.3 105.48 12.23 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 119.96 -1.713 . . . . 0.0 110.127 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -109.01 134.41 12.23 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.89 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.593 ' OG ' ' NE ' ' A' ' 142' ' ' ARG . 24.9 t -117.42 -160.86 0.79 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -1.214 . . . . 0.0 108.221 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HB3' HH11 ' A' ' 142' ' ' ARG . . . -90.7 -49.82 6.26 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.747 ' H ' ' CZ ' ' A' ' 142' ' ' ARG . . . 122.87 -111.72 1.79 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.466 ' HB3' ' CD ' ' A' ' 159' ' ' GLN . 0.4 OUTLIER -59.1 -54.14 50.35 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 119.22 -2.341 . . . . 0.0 114.759 -175.177 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 p -47.12 -32.24 4.08 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.674 -1.266 . . . . 0.0 114.091 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.847 HH22 HG23 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -92.93 -36.28 12.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.977 -1.702 . . . . 0.0 110.58 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.0 t -65.32 -42.69 94.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 109.534 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.448 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 3.6 pp0? -69.27 -37.18 77.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 13.4 ttp180 -75.31 -51.6 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 109.689 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.69 91.39 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 110.322 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB2' HG11 ' A' ' 157' ' ' VAL . 27.6 mt -56.68 -45.05 81.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.941 -1.1 . . . . 0.0 109.203 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.572 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 32.5 mtmt -87.97 -39.0 15.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.993 -1.067 . . . . 0.0 110.791 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 71.5 mt-10 -71.61 -60.69 2.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.723 -1.235 . . . . 0.0 112.535 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.7 m120 -82.28 -44.92 15.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.73 -1.231 . . . . 0.0 111.937 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.42 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 36.4 m-85 -90.84 -14.13 32.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.656 -1.278 . . . . 0.0 110.553 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.63 33.25 83.88 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.208 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.58 ' CE2' HG22 ' A' ' 251' ' ' ILE . 10.1 m-85 -63.61 156.71 25.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.22 -1.753 . . . . 0.0 108.014 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.21 153.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.948 -1.095 . . . . 0.0 109.718 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -55.41 -16.77 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.607 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 0.7 OUTLIER -52.99 -17.56 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.185 -0.947 . . . . 0.0 109.617 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.629 HG11 ' HB2' ' A' ' 147' ' ' LEU . 21.8 t -70.66 121.42 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.911 -1.118 . . . . 0.0 109.405 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.701 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -148.11 170.42 17.85 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.069 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.466 ' CD ' ' HB3' ' A' ' 140' ' ' SER . 26.7 tt0 -111.24 147.29 35.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.694 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 246' ' ' SER . 10.2 pt -141.51 141.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.5 m-80 -104.81 107.86 19.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.059 -1.025 . . . . 0.0 110.377 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.714 ' HB2' ' HH ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -48.4 -28.94 3.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.057 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.04 -13.53 79.26 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 161' ' ' ASN . 0.7 OUTLIER -103.65 -4.63 23.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -1.134 . . . . 0.0 110.192 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -118.66 179.76 4.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.915 -1.116 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.47 ' OG ' ' OD2' ' A' ' 169' ' ' ASP . 1.8 p -107.18 141.88 37.76 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 41.2 tttp -35.39 -49.3 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.702 -0.623 . . . . 0.0 110.818 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -64.18 -57.76 8.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.946 -1.097 . . . . 0.0 110.18 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.47 ' OD2' ' OG ' ' A' ' 166' ' ' SER . 59.1 m-20 -64.03 -19.69 65.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.02 . . . . 0.0 109.463 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 63.9 t-105 -73.18 -43.11 61.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 208' ' ' TYR . 30.1 mt-10 -64.33 -33.68 76.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 108.706 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.76 81.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.426 -0.796 . . . . 0.0 109.392 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -61.03 -47.13 87.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.166 -0.959 . . . . 0.0 109.162 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 16.8 mt -76.06 -50.67 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.099 -1.0 . . . . 0.0 110.706 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -55.28 -53.36 57.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.129 -0.982 . . . . 0.0 108.984 -178.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -51.45 -40.29 59.14 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.9 mm-40 -61.15 -52.7 63.76 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.808 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.75 -24.31 64.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 175' ' ' ASP . 33.5 p -52.74 -38.82 61.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 181' ' ' ASN . 28.5 mt-30 -101.33 38.09 1.65 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.497 ' C ' HD13 ' A' ' 7' ' ' LEU . 16.3 m-20 42.61 50.73 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.745 0.784 . . . . 0.0 108.938 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 7.5 mt-30 -123.51 106.43 32.59 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.418 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.9 Cg_endo -63.22 169.36 9.46 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.237 1.958 . . . . 0.0 113.086 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 40.8 t -122.8 135.15 63.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.273 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.73 114.35 23.34 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.785 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 4.2 t80 -121.36 162.52 20.2 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.2 pt20 -167.35 132.95 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.952 -1.499 . . . . 0.0 111.624 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.42 110.75 4.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.642 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 94.2 t -78.2 162.59 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.334 . . . . 0.0 111.496 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -164.68 -139.77 2.72 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -87.86 -38.4 15.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -1.23 . . . . 0.0 110.985 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 m -76.66 -12.18 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.988 -1.07 . . . . 0.0 111.076 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.59 -172.57 21.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.14 107.95 3.22 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.516 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 8.7 t-80 -72.76 125.12 26.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.58 164.38 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.123 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.864 ' CD1' HG13 ' A' ' 210' ' ' VAL . 37.7 p90 -156.59 -158.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.692 HG22 HD11 ' A' ' 55' ' ' ILE . 70.5 t -139.39 136.53 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.496 -1.377 . . . . 0.0 111.204 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.723 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.3 mt -102.94 112.51 36.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.615 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 23.4 p-10 -124.5 35.06 4.88 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.335 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.1 167.04 39.36 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 117.837 -2.125 . . . . 0.0 112.272 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -148.43 148.22 30.06 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.38 22.53 12.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 109.686 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.61 21.89 3.62 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.5 mtp180 -138.66 29.74 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -1.188 . . . . 0.0 109.108 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.472 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . 11.7 m120 74.36 11.62 4.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 109.503 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.73 138.06 51.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.519 ' OH ' ' CG ' ' A' ' 171' ' ' GLU . 5.8 m-85 -123.07 168.13 12.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.054 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 51.2 t-80 -93.33 115.76 28.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.864 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.9 t -113.67 138.15 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.98 -1.075 . . . . 0.0 111.457 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.54 ' HB2' HD12 ' A' ' 8' ' ' LEU . 14.9 t-20 -100.28 80.92 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.557 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 3.4 m95 . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 25.6 pt20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 96.9 p -167.45 161.93 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.785 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -138.92 169.07 18.46 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.694 1.235 . . . . 0.0 110.4 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.688 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 40.6 t -117.12 119.2 61.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.701 HG23 ' NE2' ' A' ' 158' ' ' HIS . 19.7 m -125.24 145.16 33.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 156' ' ' SER . . . 101.11 52.42 1.08 Allowed Glycine 0 N--CA 1.486 1.997 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.051 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 55' ' ' ILE . 2.4 mt -103.94 93.63 2.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.273 . . . . 0.0 110.421 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.2 OUTLIER -162.41 141.99 7.25 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 178.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.354 2.036 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.696 HG12 ' HA2' ' A' ' 201' ' ' GLY . 58.7 t . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 121.209 0.528 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 200' ' ' ASP . 18.4 mmtt -75.37 177.84 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 108.945 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -77.49 103.04 7.19 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.607 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.691 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 23.8 mt -58.27 -52.97 63.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 108.89 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.625 HD11 HG11 ' A' ' 198' ' ' VAL . 11.3 mt -54.96 -41.3 70.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.698 -1.251 . . . . 0.0 108.893 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.5 t70 -68.92 -41.8 77.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.063 . . . . 0.0 108.903 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 p -58.48 -15.03 9.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 108.992 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 58' ' ' TYR . 9.4 mtpp -117.08 22.0 12.84 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.39 34.01 3.3 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 25.4 mt -87.35 108.3 18.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.379 -1.071 . . . . 0.0 110.06 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' PRO . 23.0 m-70 -134.82 83.62 2.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.636 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -90.4 176.17 6.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.84 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -147.22 -164.66 2.05 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 13.0 mt-30 -124.52 -17.7 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.337 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.734 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.31 -36.98 1.05 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.632 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.7 t-20 -45.02 -142.02 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.55 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.341 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.82 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -74.13 3.72 4.9 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 CA-C-N 122.394 1.891 . . . . 0.0 109.417 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 11.1 m-85 -78.86 -32.26 45.95 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.1 p-10 -92.79 23.63 4.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.595 -1.316 . . . . 0.0 109.635 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.6 mt -77.05 -1.33 28.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.169 -0.957 . . . . 0.0 110.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 24' ' ' LEU . 10.8 mt -134.14 14.09 3.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.717 -1.239 . . . . 0.0 109.359 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 22.3 p -82.68 163.88 49.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.65 134.63 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.002 1.801 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' CE2' ' A' ' 80' ' ' PHE . 20.7 t -78.89 149.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.502 0.668 . . . . 0.0 109.738 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.829 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.1 mt -78.3 148.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.804 0.811 . . . . 0.0 111.169 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' C ' HG22 ' A' ' 39' ' ' VAL . 9.0 mm-40 -126.04 -21.2 4.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.782 -0.574 . . . . 0.0 110.235 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.0 mtpt -121.28 164.51 16.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.148 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 38' ' ' PHE . 80.9 t . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 110.625 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 64.7 m-85 -119.94 15.52 12.52 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.922 -1.111 . . . . 0.0 109.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 28' ' ' ILE . 62.3 t -63.83 137.44 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.599 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.19 -7.36 67.72 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.7 mt-30 -77.72 130.84 37.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -1.113 . . . . 0.0 109.651 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -73.15 110.0 7.1 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.15 159.9 0.85 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.141 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.61 168.3 19.97 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.599 0.714 . . . . 0.0 110.043 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.63 HG21 ' SD ' ' A' ' 120' ' ' MET . 18.0 p -78.85 -35.19 44.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 109.69 134.51 6.94 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 p -54.02 -50.49 66.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 47.0 t -47.05 -55.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.68 -48.15 82.81 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.911 0.862 . . . . 0.0 110.351 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.1 m -61.28 -38.92 88.51 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.49 -37.36 80.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.642 -1.286 . . . . 0.0 108.334 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 56' ' ' MET . 97.6 m -70.44 -56.68 6.04 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.36 -34.98 50.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.52 -0.737 . . . . 0.0 109.199 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.636 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 24.9 mt-30 -63.49 -61.95 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 251' ' ' ILE . 46.4 mt -57.23 -30.19 34.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 52' ' ' THR . 25.8 mtp -63.36 -32.41 73.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.558 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 49.2 tptt -74.65 -43.38 55.62 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 39.2 t80 -51.8 -33.12 34.2 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.69 -0.631 . . . . 0.0 109.789 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.53 ' O ' ' C ' ' A' ' 60' ' ' ASN . 43.1 m80 -108.71 -22.18 12.35 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 111.05 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.626 ' HB2' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 41.08 55.25 3.22 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -177.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -76.39 -68.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -68.2 96.82 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.31 0.673 . . . . 0.0 111.962 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.06 -20.23 64.94 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -135.44 138.05 42.82 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 177.444 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.71 149.16 33.74 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.365 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.915 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -88.96 -54.35 4.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.951 . . . . 0.0 110.326 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.9 tttt -140.71 134.52 30.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.088 -1.008 . . . . 0.0 110.245 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -62.2 166.25 5.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.518 -0.738 . . . . 0.0 109.942 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 36.2 t80 -150.04 143.81 25.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.202 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.14 171.63 16.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.16 -0.963 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.3 p90 -173.06 158.57 3.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 109.92 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 89.0 m -93.66 137.89 32.46 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.721 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.3 tp -53.26 149.74 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.035 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 141.32 57.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.767 -0.583 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -69.08 -3.01 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t30 -99.53 -6.01 28.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.467 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.721 ' ND2' HD21 ' A' ' 73' ' ' LEU . 22.0 t-20 -70.12 110.87 7.54 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.867 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.636 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.4 Cg_endo -87.46 10.86 3.37 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.973 2.449 . . . . 0.0 110.216 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 56.6 m-85 -108.8 -1.71 19.06 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 111.415 -176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASN . 74.7 m-85 -141.57 160.93 39.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 9.4 m120 -48.37 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 174.42 -46.32 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.385 -0.822 . . . . 0.0 111.284 174.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.41 55.81 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 107.549 -1.75 . . . . 0.0 107.549 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.3 tptt -105.8 103.69 13.25 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 133.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 109.558 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.2 mp -106.31 154.19 21.12 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 7.0 t80 -144.41 139.43 28.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.101 -178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -118.53 111.02 18.07 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.62 50.68 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.694 -1.254 . . . . 0.0 108.19 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 4.3 mt -52.81 -51.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.401 -0.812 . . . . 0.0 109.516 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.6 p -44.21 -29.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.674 -1.266 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -112.88 33.73 4.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 108.774 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.48 153.3 23.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.993 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -122.49 85.58 2.44 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-85 -80.9 95.47 6.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.272 -0.892 . . . . 0.0 109.896 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.1 m120 -78.69 92.11 4.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.626 ' CG ' ' HB2' ' A' ' 60' ' ' ASN . 50.2 m95 -60.95 -8.81 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.354 -0.841 . . . . 0.0 109.932 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -90.48 -23.51 20.95 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 8.3 m-20 -97.99 -26.62 14.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.558 ' O ' ' CE ' ' A' ' 57' ' ' LYS . 51.7 mt -74.05 64.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 59.4 mt -46.28 150.7 1.07 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.639 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -79.01 -27.12 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.496 2.131 . . . . 0.0 110.364 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.525 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -139.31 133.05 30.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.98 . . . . 0.0 109.132 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 76.9 m-85 -115.97 142.82 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.155 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.82 -4.39 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.96 10.11 84.43 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -119.93 -6.14 10.05 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.465 -1.02 . . . . 0.0 109.424 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.79 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -63.97 169.54 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -71.07 -176.82 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.693 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 2.8 m120 -80.55 -33.84 35.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.78 -61.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HG3' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -62.52 -35.03 78.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.151 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.494 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 19.0 mttt -64.45 -43.25 94.85 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.058 -1.026 . . . . 0.0 108.308 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.435 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -59.91 -37.95 80.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 108.709 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -56.99 -68.26 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.501 -0.749 . . . . 0.0 109.762 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.647 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.2 tp -64.17 -43.72 97.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.559 -0.713 . . . . 0.0 109.679 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 116' ' ' ILE . 24.1 p -56.63 -40.31 75.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 108.588 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.493 ' OE2' ' CZ ' ' A' ' 93' ' ' ARG . 6.3 tt0 -70.65 -40.79 72.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.2 tp -55.48 -50.54 69.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.2 mmt -60.01 -52.11 66.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.898 -0.501 . . . . 0.0 111.531 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.65 95.33 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 118' ' ' GLU . 6.8 m-20 -65.62 -49.43 68.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 119' ' ' LEU . 48.5 t -61.1 -60.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 108.953 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.6 -44.37 16.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.44 -53.39 32.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.023 -1.281 . . . . 0.0 107.676 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 p -47.43 -32.44 5.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.39 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.6 m -101.49 36.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.005 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.776 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 11.1 m-20 40.1 53.27 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.398 -0.814 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 48.6 tpp -67.59 137.68 55.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 111.899 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 5.9 t0 -87.32 123.82 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.633 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 83.8 m-85 -104.7 120.57 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.482 1.134 . . . . 0.0 113.824 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.829 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.95 -162.44 10.82 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 104.69 -3.364 . . . . 0.0 104.69 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.718 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.16 -31.59 82.87 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 N-CA-C 105.648 -2.482 . . . . 0.0 105.648 175.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.9 m -110.23 143.04 40.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 173.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.535 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.8 m -121.33 110.92 16.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 119.87 -1.769 . . . . 0.0 110.087 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.86 137.94 14.32 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.455 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -117.26 -163.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 107.954 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.921 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.92 -56.22 3.26 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.567 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 125.88 -123.53 4.89 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.499 -1.334 . . . . 0.0 112.009 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.2 m -48.55 -65.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.797 -0.825 . . . . 0.0 112.602 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.48 -32.03 3.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.789 -1.194 . . . . 0.0 109.293 -178.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.921 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.2 mmt-85 -80.86 -51.25 8.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.973 0.892 . . . . 0.0 109.212 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 185' ' ' TYR . 82.7 t -66.9 -54.84 21.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.809 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 2.4 pp0? -57.34 -34.35 68.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.955 -1.091 . . . . 0.0 108.749 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.523 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 6.0 ttm180 -78.4 -53.56 7.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.012 -1.055 . . . . 0.0 109.433 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.27 82.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.21 -0.931 . . . . 0.0 110.223 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 38.1 mt -58.47 -46.09 87.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.952 -1.092 . . . . 0.0 109.377 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 59.5 mtmt -87.72 -49.24 7.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.104 . . . . 0.0 110.981 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.523 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 34.2 mt-10 -67.07 -43.01 83.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.679 -1.263 . . . . 0.0 111.566 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 31.9 m120 -94.4 -49.7 5.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.681 -1.262 . . . . 0.0 111.485 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 56' ' ' MET . 29.6 m-85 -99.42 20.33 13.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.874 -1.141 . . . . 0.0 110.598 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.915 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 40.64 0.05 OUTLIER Glycine 0 N--CA 1.497 2.767 0 O-C-N 121.862 -0.524 . . . . 0.0 112.62 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.9 m-85 -62.88 158.84 18.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.142 -1.799 . . . . 0.0 107.564 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 61.7 t30 -47.17 154.35 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.741 -1.224 . . . . 0.0 109.533 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -56.05 -16.52 5.1 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.6 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 3.6 p -53.02 -17.35 1.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 40.5 t -72.67 119.61 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.866 -1.146 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.707 ' NE2' HG23 ' A' ' 249' ' ' VAL . 0.6 OUTLIER -148.19 166.81 26.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.191 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.55 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 25.5 tt0 -112.68 137.03 51.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.953 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 247' ' ' ALA . 14.7 pt -122.62 170.34 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 2.0 m120 -127.53 103.46 7.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.683 -1.261 . . . . 0.0 110.509 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.603 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.44 -39.45 15.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.86 . . . . 0.0 109.226 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.08 -26.91 64.1 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -104.8 4.57 32.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.057 -1.26 . . . . 0.0 112.274 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.47 163.81 15.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.2 -1.562 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.7 ttpt -29.36 -51.49 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.21 -60.67 2.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.895 -1.128 . . . . 0.0 110.775 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.47 -18.24 58.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 109.571 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.3 t-105 -74.73 -50.89 15.8 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 174' ' ' ILE . 46.1 mt-10 -69.99 -36.1 74.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -45.75 -41.65 10.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -60.62 -43.65 97.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 199' ' ' ILE . 14.7 mt -68.6 -53.91 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.27 -49.17 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.138 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -51.52 -45.26 62.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.912 -1.118 . . . . 0.0 108.611 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.57 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 19.9 mm-40 -60.53 -52.32 65.68 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.902 . . . . 0.0 108.946 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 199' ' ' ILE . 93.5 mt -65.15 -26.76 68.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.779 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 22.3 p -51.89 -39.99 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.505 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.51 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 19.6 mt-30 -102.32 35.08 2.52 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.513 ' HB3' HD22 ' A' ' 7' ' ' LEU . 83.4 m-20 47.82 50.43 15.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 16.7 mt-30 -123.04 105.04 34.92 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.585 ' HD3' HD13 ' A' ' 7' ' ' LEU . 18.7 Cg_endo -62.62 168.85 9.32 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 121.602 1.535 . . . . 0.0 111.869 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 174' ' ' ILE . 2.4 t -129.84 138.18 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.097 0.951 . . . . 0.0 110.79 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.727 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.1 OUTLIER -86.83 123.34 31.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.316 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -123.73 161.45 25.14 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.631 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -166.45 129.54 1.95 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 117.666 -1.614 . . . . 0.0 111.115 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.477 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.19 122.37 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.1 t -85.73 168.84 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.152 -1.205 . . . . 0.0 111.117 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.41 -142.82 4.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -87.73 -36.49 17.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.07 -1.253 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.4 m -75.03 -17.76 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.153 -0.967 . . . . 0.0 110.928 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.17 -170.17 22.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.564 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -89.85 107.38 3.42 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.753 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.631 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.2 t-80 -72.46 134.92 45.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -121.64 162.71 20.22 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.609 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.899 ' CD1' HG13 ' A' ' 210' ' ' VAL . 18.3 p90 -157.13 172.3 18.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.625 HG11 HD11 ' A' ' 8' ' ' LEU . 87.5 t -113.29 140.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.736 -1.228 . . . . 0.0 112.752 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 178' ' ' LEU . 36.2 mt -98.16 130.44 46.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 7.5 p-10 -150.81 37.45 0.65 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.926 -1.51 . . . . 0.0 111.494 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA2' HG12 ' A' ' 4' ' ' VAL . . . 174.92 -179.46 46.2 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 120.267 -1.52 . . . . 0.0 110.464 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.642 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.4 150.9 7.72 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -1.209 . . . . 0.0 109.661 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -111.28 27.52 9.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.07 . . . . 0.0 109.897 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.94 22.34 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.68 44.6 2.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -1.193 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.67 22.36 13.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 5.2 m-85 -121.59 136.69 54.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 28.2 m-85 -121.29 167.64 12.51 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 12.0 t-160 -91.55 135.52 33.8 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.089 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.899 HG13 ' CD1' ' A' ' 197' ' ' PHE . 49.9 t -123.62 136.18 60.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.204 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.62 ' CB ' HD12 ' A' ' 8' ' ' LEU . 19.6 t-20 -112.91 78.87 1.17 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.574 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 84.5 m95 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 77.2 p -148.72 158.72 44.34 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.207 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -131.11 151.11 51.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.886 0.851 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.727 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 75.8 t -116.54 116.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.707 HG23 ' NE2' ' A' ' 158' ' ' HIS . 18.7 m -124.15 143.05 38.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.741 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.81 56.89 1.57 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.67 HD13 HG21 ' A' ' 55' ' ' ILE . 6.0 mt -102.68 79.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 110.565 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 13.8 pttm -159.58 155.96 24.05 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.9 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.274 1.982 . . . . 0.0 110.439 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.665 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 29.0 t . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.282 0.563 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -77.03 175.72 9.33 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 11.2 t -77.12 111.28 12.56 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.971 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.652 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 52.5 mt -58.41 -50.77 72.48 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.56 HD11 HG11 ' A' ' 198' ' ' VAL . 10.0 mt -56.3 -34.32 66.38 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.964 -1.085 . . . . 0.0 108.339 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 26.5 t0 -66.87 -41.16 87.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 0.0 109.274 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.8 p -58.1 -16.06 11.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.095 . . . . 0.0 108.593 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HB2' HG13 ' A' ' 13' ' ' ILE . 16.7 mtpt -122.41 19.75 10.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 41.84 42.5 3.88 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.581 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 11.6 mt -86.8 100.69 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.293 -1.122 . . . . 0.0 110.677 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.5 m-70 -128.05 75.32 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 13.5 m-30 -81.18 170.01 16.66 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.283 1.04 . . . . 0.0 111.851 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.77 -174.91 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 47' ' ' SER . 6.3 mt-30 -125.08 18.36 8.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.816 -1.178 . . . . 0.0 110.056 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 22' ' ' ASN . . . -116.74 -87.14 1.28 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.319 -1.419 . . . . 0.0 113.474 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.762 ' OD1' ' HD2' ' A' ' 20' ' ' PRO . 3.8 p30 -46.38 -103.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 116.658 -1.639 . . . . 0.0 113.945 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.762 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 51.9 Cg_endo -83.95 5.58 6.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 123.332 2.226 . . . . 0.0 112.486 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD1' HG12 ' A' ' 116' ' ' ILE . 83.1 m-85 -87.05 -31.97 20.24 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 120.94 -1.1 . . . . 0.0 110.118 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 38.2 p-10 -101.66 27.95 5.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 109.725 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.0 mt -76.03 -4.49 41.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.2 mt -131.19 21.7 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.8 -1.188 . . . . 0.0 109.264 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.3 p -89.68 164.31 29.62 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.97 136.46 35.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.248 1.965 . . . . 0.0 112.048 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.08 148.7 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.663 0.744 . . . . 0.0 110.123 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.814 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.8 mt -78.78 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.646 0.736 . . . . 0.0 111.392 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.6 mt-10 -126.54 -20.38 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.776 -0.578 . . . . 0.0 110.458 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HB2' ' CA ' ' A' ' 79' ' ' TYR . 12.4 mtpp -117.65 168.07 10.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.93 -1.106 . . . . 0.0 110.663 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.5 t . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.595 -0.691 . . . . 0.0 110.335 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 31' ' ' VAL . 13.1 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.9 m-85 -122.4 16.0 10.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.012 -1.055 . . . . 0.0 109.45 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 29' ' ' GLU . 60.5 t -64.03 139.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.932 . . . . 0.0 109.554 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 2.18 89.3 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 21.8 mt-30 -89.02 130.29 35.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -1.165 . . . . 0.0 109.511 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.01 110.14 7.07 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.17 159.01 1.0 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.031 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' OG ' ' A' ' 135' ' ' SER . . . -77.52 166.27 23.28 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.498 0.666 . . . . 0.0 110.085 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.542 ' O ' ' CE ' ' A' ' 129' ' ' MET . 13.2 p -78.89 -30.15 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 100.96 137.19 9.67 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.522 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 7.8 p -55.58 -48.53 74.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.317 -1.107 . . . . 0.0 108.188 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.561 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.3 t -46.43 -52.84 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -61.52 -50.73 71.54 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.685 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 16.9 m -64.83 -28.43 69.55 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.487 -0.758 . . . . 0.0 109.811 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -66.41 -45.15 80.91 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.127 -1.429 . . . . 0.0 107.791 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 56' ' ' MET . 33.3 m -76.13 -49.74 16.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.683 0.754 . . . . 0.0 110.281 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.13 -34.49 31.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.391 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.632 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 33.5 mt-30 -67.18 -52.54 40.13 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.022 HG21 HD13 ' A' ' 251' ' ' ILE . 29.9 mt -61.24 -25.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.539 ' HG3' HG22 ' A' ' 52' ' ' THR . 15.1 mtp -70.5 -36.02 73.57 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.589 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.1 tptt -76.11 -40.87 51.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.652 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 52.7 t80 -53.93 -25.56 21.05 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.015 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.1 m-70 -108.09 -28.0 9.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 110.529 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.619 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 62.5 m-20 47.88 61.75 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -84.67 -78.9 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.0 Cg_endo -71.49 107.47 2.17 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.815 0.97 . . . . 0.0 113.25 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 -24.85 65.65 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 3.5 ttpt -130.12 128.34 41.62 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.56 164.05 5.71 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.463 -1.827 . . . . 0.0 110.397 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.026 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -96.59 -35.36 11.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -1.063 . . . . 0.0 111.285 -179.01 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.1 tttt -152.67 134.14 14.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.607 -1.308 . . . . 0.0 110.402 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 7.7 m-20 -64.08 172.98 2.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.434 -0.791 . . . . 0.0 109.424 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 27.6 t80 -153.94 147.2 24.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -150.32 169.75 20.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.778 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.687 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.0 p90 -169.59 157.13 6.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 m -93.01 133.88 35.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.753 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.9 tp -50.57 149.56 3.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 111.21 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.43 140.65 58.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.932 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.84 -4.15 11.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.954 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 19.4 t-20 -99.13 -5.88 29.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.021 -1.049 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.753 ' ND2' HD21 ' A' ' 73' ' ' LEU . 23.5 t-20 -70.17 110.33 6.55 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.733 -0.605 . . . . 0.0 110.208 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 48.7 Cg_endo -88.61 13.59 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.81 2.34 . . . . 0.0 109.619 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.646 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.1 m-85 -107.89 -4.8 17.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 111.363 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 81' ' ' ASN . 35.3 m-85 -142.24 164.15 30.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 4.1 m-20 -49.23 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 173.74 -47.18 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.976 175.035 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.62 56.31 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 6.4 tptt -106.06 105.8 16.01 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.342 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.05 139.35 35.84 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -112.07 137.53 49.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 61.5 t80 -125.13 132.24 53.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.593 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.75 114.13 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.865 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -73.62 50.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.85 -1.156 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.9 mt -53.47 -57.33 5.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.551 -0.718 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.2 p -43.81 -29.5 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.763 -1.211 . . . . 0.0 109.103 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.865 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.58 34.11 4.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.604 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 8.6 mmt180 -84.31 157.85 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.446 -1.409 . . . . 0.0 109.365 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -117.14 85.74 2.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.8 m-85 -81.13 93.8 6.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.463 -0.773 . . . . 0.0 110.154 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -77.94 93.27 4.4 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.619 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 56.8 m95 -60.81 -8.35 2.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.518 -0.739 . . . . 0.0 110.458 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -91.02 -21.45 21.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.85 -1.157 . . . . 0.0 108.298 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 26.2 m-20 -99.74 -25.63 14.32 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 68.9 mt -73.69 70.97 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HG2' ' A' ' 108' ' ' GLU . 36.7 mt -52.84 150.43 9.9 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.581 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.8 Cg_endo -79.23 -23.09 7.86 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.964 2.442 . . . . 0.0 110.192 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.24 123.93 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.859 -1.151 . . . . 0.0 109.975 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.51 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 35.2 m-85 -110.62 138.47 46.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.15 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -99.74 -4.56 30.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.27 7.5 60.7 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -120.28 -1.32 10.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -1.118 . . . . 0.0 109.427 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.4 mp0 -64.33 167.11 7.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.35 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -69.55 170.63 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.339 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.58 -35.19 70.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.01 -61.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.763 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.39 -32.15 72.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.356 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 10.4 mttt -66.5 -44.03 83.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.18 -0.95 . . . . 0.0 108.488 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.7 ttm -59.13 -34.49 72.1 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.9 -68.05 0.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.529 -0.732 . . . . 0.0 109.437 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.038 HD11 ' HE2' ' A' ' 120' ' ' MET . 5.5 tp -63.28 -52.13 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.123 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 116' ' ' ILE . 4.2 p -45.6 -41.0 9.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' MET . 34.7 tt0 -70.61 -54.4 12.16 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.836 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.8 tp -46.9 -48.14 21.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . 1.038 ' HE2' HD11 ' A' ' 116' ' ' ILE . 24.1 mmt -59.44 -53.99 51.75 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.842 -0.536 . . . . 0.0 111.047 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.22 75.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.939 -1.101 . . . . 0.0 108.564 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 9.5 m-20 -64.2 -47.3 80.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 127' ' ' VAL . 63.0 t -71.54 -51.65 31.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.126 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.86 -51.7 12.82 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 126' ' ' SER . 2.9 mt -62.57 -57.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.177 -1.19 . . . . 0.0 108.258 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.67 -29.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.396 -178.019 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.641 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.5 m -101.08 34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.428 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 71' ' ' TYR . 95.4 m-20 40.83 51.19 3.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 109.246 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.5 tpp -66.04 126.16 27.72 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 111.698 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' SER . 4.5 t0 -76.53 122.57 24.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.0 m-85 -103.42 116.79 33.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.248 1.023 . . . . 0.0 113.141 -175.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.814 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.28 -162.48 10.74 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.647 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -62.64 -29.47 77.86 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 105.818 -2.416 . . . . 0.0 105.818 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 139.54 45.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.533 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 50.4 m -121.11 107.88 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.067 -1.646 . . . . 0.0 110.008 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.76 143.73 16.28 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.002 -1.095 . . . . 0.0 110.606 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.5 -163.47 0.93 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.61 -60.1 2.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.624 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 139.43 -134.5 6.71 Favored Glycine 0 N--CA 1.48 1.573 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.627 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.493 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 71.7 m -51.42 -49.41 61.68 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.677 -0.896 . . . . 0.0 112.298 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -45.84 -47.47 15.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 110.005 -177.501 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.1 mmt180 -81.25 -37.01 29.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.98 -1.075 . . . . 0.0 110.322 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.893 HG21 ' CE2' ' A' ' 185' ' ' TYR . 48.2 t -66.24 -61.27 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.739 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.38 -31.52 63.91 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.925 -1.109 . . . . 0.0 108.217 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.495 ' NH1' ' OE2' ' A' ' 149' ' ' GLU . 1.6 ttm-85 -76.12 -48.95 18.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 109.28 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.56 -36.16 81.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.159 -0.963 . . . . 0.0 110.097 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 35.8 mt -56.47 -46.4 80.43 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 56.1 mtmt -87.47 -40.75 14.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.903 -1.123 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.495 ' OE2' ' NH1' ' A' ' 145' ' ' ARG . 29.8 mt-10 -68.65 -58.56 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.836 -1.165 . . . . 0.0 112.316 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.07 -46.59 11.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.832 -1.168 . . . . 0.0 112.387 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 44.3 m-85 -89.9 -12.53 38.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.619 -1.3 . . . . 0.0 110.343 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.16 32.15 81.4 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.482 177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.558 ' CD2' HG22 ' A' ' 251' ' ' ILE . 15.2 m-85 -63.35 153.7 34.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.264 -1.727 . . . . 0.0 107.663 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.5 t-20 -46.71 155.71 0.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.786 -1.196 . . . . 0.0 109.971 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 76.7 mm-40 -55.98 -15.99 4.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.379 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.606 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 70.8 p -53.1 -17.61 1.67 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.169 -0.957 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 19.7 t -71.47 122.2 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.926 -1.108 . . . . 0.0 109.495 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.676 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -146.99 -178.26 6.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.119 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.493 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 36.1 tt0 -124.91 152.51 43.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 110.472 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.515 ' O ' ' CA ' ' A' ' 246' ' ' SER . 11.0 pt -133.07 145.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m120 -110.56 103.68 12.3 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.034 -1.041 . . . . 0.0 110.895 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.54 -40.21 18.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.21 -0.931 . . . . 0.0 109.353 179.146 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.02 -23.57 59.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.23 -0.83 27.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.093 -1.239 . . . . 0.0 111.56 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -117.48 169.04 9.84 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.467 -1.396 . . . . 0.0 109.94 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 167' ' ' LYS . 6.9 p -94.7 132.5 39.38 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 166' ' ' SER . 37.2 tttp -32.73 -44.02 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -64.3 -65.35 0.69 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.55 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -14.33 38.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.134 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 62.2 t-105 -72.76 -52.5 14.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.043 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.562 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.8 mt-10 -67.77 -21.99 65.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.33 81.25 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -61.05 -35.93 78.24 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.657 ' HA ' HG21 ' A' ' 184' ' ' VAL . 15.5 mt -74.57 -61.81 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.231 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.85 -51.59 39.02 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.373 -0.829 . . . . 0.0 109.767 -178.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -51.15 -44.14 61.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 4.0 mm-40 -61.1 -46.73 89.44 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -67.84 -28.15 67.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.536 -0.728 . . . . 0.0 109.916 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 175' ' ' ASP . 22.5 p -52.45 -40.3 62.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.958 -1.089 . . . . 0.0 108.638 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.449 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 11.4 mt-30 -99.57 33.61 2.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.648 ' HB3' HD22 ' A' ' 7' ' ' LEU . 75.5 m-20 43.73 53.46 6.02 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.892 0.853 . . . . 0.0 108.985 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.53 ' CB ' ' OE1' ' A' ' 177' ' ' GLU . 6.5 mt-30 -124.36 110.68 28.47 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.522 ' HD3' HD13 ' A' ' 7' ' ' LEU . 17.7 Cg_endo -64.84 165.48 21.02 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.765 1.643 . . . . 0.0 112.658 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 249' ' ' VAL . 25.0 t -121.03 132.97 69.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.043 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.893 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -83.93 116.57 22.86 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 176.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.686 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 7.3 t80 -122.08 157.44 31.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.957 -1.09 . . . . 0.0 110.153 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.59 131.74 4.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.998 -1.481 . . . . 0.0 111.682 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.83 132.79 11.44 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 190' ' ' GLY . 2.9 t -88.99 172.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.916 -1.343 . . . . 0.0 110.964 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.28 -148.96 7.27 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -30.04 20.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.1 -1.235 . . . . 0.0 110.716 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -83.39 -16.17 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.91 -1.118 . . . . 0.0 111.034 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.19 -164.18 25.32 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -95.15 112.34 4.37 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.964 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.618 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.4 t-80 -71.94 134.05 45.75 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -120.35 162.92 18.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.058 -1.457 . . . . 0.0 112.777 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.686 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 44.0 p90 -162.44 166.67 24.71 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.763 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -114.24 137.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.89 -1.131 . . . . 0.0 112.699 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.652 HG21 ' CG2' ' A' ' 174' ' ' ILE . 54.0 mt -98.09 131.32 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.9 p30 -143.43 30.09 1.39 Allowed 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.232 -1.387 . . . . 0.0 110.386 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.578 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 177.36 -174.25 46.83 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 117.794 -2.145 . . . . 0.0 111.93 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.665 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.2 154.94 11.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.662 -0.905 . . . . 0.0 108.794 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.57 5.96 12.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.757 -1.214 . . . . 0.0 110.314 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.51 -32.79 5.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -84.9 45.67 1.18 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.259 -1.142 . . . . 0.0 109.884 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.29 16.76 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 8.9 m-85 -104.11 145.11 30.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.014 -1.054 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 54.4 m-85 -123.44 161.76 24.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 30.1 t-80 -91.75 123.02 34.82 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.795 HG11 ' CE2' ' A' ' 212' ' ' TRP . 33.1 t -115.3 150.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.49 -177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.2 t-20 -120.38 70.22 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.795 ' CE2' HG11 ' A' ' 210' ' ' VAL . 18.4 m95 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 111.316 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 22.2 mt-30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 19.6 p -159.17 159.73 34.69 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.145 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.6 163.86 29.15 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.146 0.974 . . . . 0.0 109.714 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 95.3 t -117.25 126.73 74.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 184' ' ' VAL . 22.8 m -132.49 149.08 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 157' ' ' VAL . . . 98.05 55.06 1.15 Allowed Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.942 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 1.022 HD13 HG21 ' A' ' 55' ' ' ILE . 2.2 mt -104.0 94.9 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.165 -1.197 . . . . 0.0 110.447 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 18.0 pttt -163.67 144.9 7.19 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.13 -0.981 . . . . 0.0 109.136 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.233 1.955 . . . . 0.0 110.387 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 178' ' ' LEU . 98.2 t . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -74.17 -178.34 3.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.984 -1.072 . . . . 0.0 108.359 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.709 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.0 OUTLIER -77.53 104.0 7.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.054 -1.029 . . . . 0.0 110.36 -178.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.676 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 33.4 mt -58.06 -45.54 86.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 198' ' ' VAL . 7.7 mt -61.2 -41.16 96.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.842 -1.161 . . . . 0.0 109.035 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.1 t70 -66.14 -37.52 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -57.64 -16.36 10.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 13' ' ' ILE . 1.7 mtpt -122.39 17.45 10.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.41 45.73 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.9 mt -90.55 107.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -1.021 . . . . 0.0 111.084 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' PRO . 31.5 m80 -131.43 95.58 3.79 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.66 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 9.7 m-30 -97.35 179.93 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.93 0.872 . . . . 0.0 111.274 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.42 -164.81 2.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 33.9 mt-30 -124.49 -23.56 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.064 -1.022 . . . . 0.0 110.053 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.68 -33.17 1.61 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.231 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.83 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.9 t-20 -45.63 -142.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.518 0 CA-C-N 117.693 0.746 . . . . 0.0 111.093 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -73.68 3.24 5.05 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 CA-C-N 122.229 1.832 . . . . 0.0 109.606 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.57 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 7.3 m-85 -80.37 -27.89 38.11 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.002 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.8 p-10 -97.83 16.48 20.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.461 -1.399 . . . . 0.0 109.743 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.8 mt -70.84 -3.44 19.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 110.003 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.7 mt -129.61 -6.37 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.064 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -60.82 164.47 7.52 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.9 Cg_endo -70.22 136.36 31.57 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.017 1.811 . . . . 0.0 111.625 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.695 HG23 ' CE1' ' A' ' 42' ' ' HIS . 35.6 t -82.39 149.86 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.557 0.694 . . . . 0.0 109.953 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 132' ' ' GLY . 9.8 mt -77.75 151.03 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.62 0.724 . . . . 0.0 110.75 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' C ' HG22 ' A' ' 39' ' ' VAL . 28.5 mt-10 -125.54 -21.96 4.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.683 -0.636 . . . . 0.0 110.417 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' TYR . 48.5 mtpt -124.0 171.1 10.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 110.068 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 37' ' ' SER . 77.1 t . . . . . 0 N--CA 1.487 1.376 0 O-C-N 121.341 -0.849 . . . . 0.0 110.812 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.412 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 73.9 m-85 -124.0 21.79 8.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.898 -1.126 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 28' ' ' ILE . 70.7 t -68.24 139.13 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.776 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 27' ' ' VAL . . . 79.35 1.37 85.92 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 29.0 mt-30 -86.1 129.82 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 27' ' ' VAL . 1.3 m-70 -73.36 111.38 8.43 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.56 158.08 1.37 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.861 -177.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -74.51 169.36 17.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.429 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.7 p -80.76 -34.66 34.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 108.675 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.34 134.47 8.3 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.8 p -54.49 -50.86 66.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.135 -1.214 . . . . 0.0 108.362 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.6 t -46.6 -53.87 2.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.599 -0.84 . . . . 0.0 108.754 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -58.49 -52.03 67.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.46 -0.775 . . . . 0.0 110.206 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.789 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 17.4 m -63.48 -34.33 77.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.15 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.42 98.7 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.299 -1.361 . . . . 0.0 107.865 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 56' ' ' MET . 34.0 m -74.68 -49.0 22.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.42 0.629 . . . . 0.0 109.623 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.65 -41.83 64.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.822 . . . . 0.0 109.883 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.66 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 31.0 mt-30 -60.16 -51.64 68.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.759 -1.213 . . . . 0.0 107.941 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 251' ' ' ILE . 34.1 mt -63.79 -28.1 44.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.527 ' SD ' HG22 ' A' ' 123' ' ' VAL . 18.5 mtp -67.93 -36.18 79.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.564 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -76.38 -42.55 44.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.3 t80 -53.34 -29.66 35.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 109.312 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 36.7 m-70 -105.5 -25.93 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 110.163 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.613 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.4 m-20 45.0 59.14 3.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -84.34 -70.16 0.13 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.024 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.4 Cg_endo -67.37 96.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.398 0.732 . . . . 0.0 111.623 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.15 -20.39 64.88 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 91' ' ' SER . 4.1 tttp -135.68 140.08 44.18 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.93 144.51 41.62 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.124 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.844 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -83.11 -53.85 5.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.951 . . . . 0.0 110.176 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 9.9 ttpp -145.25 142.5 29.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.29 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 9.7 m-20 -66.69 171.51 5.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -0.852 . . . . 0.0 109.884 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 70' ' ' THR . 51.1 t80 -148.62 164.39 34.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.58 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 14.5 t -166.11 162.53 17.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.723 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.9 p90 -166.62 154.65 9.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -92.97 136.97 32.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -54.18 150.77 7.92 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.193 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.74 141.53 57.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.349 0.595 . . . . 0.0 110.076 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -3.26 13.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.082 -1.011 . . . . 0.0 109.71 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.4 m-20 -99.74 -7.27 25.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.793 ' ND2' HD21 ' A' ' 73' ' ' LEU . 33.8 t-20 -69.92 109.84 5.49 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.709 -0.62 . . . . 0.0 109.785 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.634 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.89 16.19 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.867 2.378 . . . . 0.0 110.126 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.9 m-85 -106.57 -26.25 11.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 111.033 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 3.7 m-85 -118.64 162.74 17.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.4 m120 -46.36 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 175.15 -47.88 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.164 -0.96 . . . . 0.0 111.178 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.1 Cg_endo -76.75 57.21 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 106.877 -2.009 . . . . 0.0 106.877 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.66 104.46 14.18 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.394 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -100.53 134.11 43.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.339 -0.85 . . . . 0.0 109.679 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.723 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -106.3 137.32 44.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 27.1 t80 -128.54 131.55 48.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.06 -1.025 . . . . 0.0 110.261 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.01 114.75 28.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.48 51.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.728 -1.232 . . . . 0.0 108.312 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.7 mt -52.55 -54.32 16.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.492 -0.755 . . . . 0.0 109.593 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 90' ' ' ILE . 3.6 p -45.41 -26.62 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.497 -1.377 . . . . 0.0 109.154 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.1 OUTLIER -111.38 28.48 8.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.618 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.52 150.72 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.872 0.844 . . . . 0.0 110.822 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 86.9 2.6 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.5 m-85 -80.8 91.41 5.93 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.339 -0.851 . . . . 0.0 110.19 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 24.2 t-20 -79.58 90.6 5.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 58.0 m95 -61.07 -9.06 3.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.229 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.39 -14.7 32.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 53.3 m-20 -100.13 -32.92 10.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.702 HG12 ' HB1' ' A' ' 115' ' ' ALA . 23.4 mt -73.35 95.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.35 1.071 . . . . 0.0 108.566 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 11.8 mt -72.46 153.13 91.97 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.314 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.1 Cg_endo -79.14 -31.84 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.831 2.354 . . . . 0.0 110.344 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -136.8 136.03 38.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 74.9 m-85 -120.12 140.63 50.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 p -102.18 -1.06 32.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.15 88.62 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -118.74 -2.46 10.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.476 -1.014 . . . . 0.0 109.264 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 14.0 mp0 -64.03 167.79 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.3 p -65.05 179.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -82.97 -40.48 19.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.8 t -52.05 -52.36 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.15 98.75 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 108.988 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 24.1 mttt -61.21 -36.83 80.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 50.4 ttm -59.26 -46.03 89.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.5 -0.75 . . . . 0.0 109.666 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.1 -51.88 67.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.787 ' CD1' HD23 ' A' ' 119' ' ' LEU . 4.9 tp -68.86 -44.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.49 -1.381 . . . . 0.0 109.468 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.8 p -52.9 -41.45 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.024 -1.047 . . . . 0.0 108.649 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.733 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -70.01 -45.59 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 116' ' ' ILE . 13.2 tp -50.86 -54.41 24.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.789 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -59.84 -43.92 94.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.685 . . . . 0.0 109.521 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.85 -39.86 94.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 126' ' ' SER . 24.8 m-20 -68.69 -43.37 76.24 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.527 HG22 ' SD ' ' A' ' 56' ' ' MET . 79.8 t -70.75 -62.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.726 -0.609 . . . . 0.0 109.849 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.65 -45.32 17.8 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.5 mt -64.81 -57.49 11.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.07 -1.253 . . . . 0.0 108.106 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 9.4 p -46.06 -29.62 1.56 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.61 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.04 37.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.019 -1.051 . . . . 0.0 110.093 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.688 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.9 m-20 40.31 38.5 0.55 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.369 -0.832 . . . . 0.0 109.656 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.653 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -52.97 129.11 29.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.822 . . . . 0.0 111.192 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.9 t0 -78.72 122.78 26.43 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 66.3 m-85 -105.2 119.39 38.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.995 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.736 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -149.99 -163.29 11.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 103.753 -3.739 . . . . 0.0 103.753 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -61.58 -31.0 86.85 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 105.438 -2.562 . . . . 0.0 105.438 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.75 138.26 47.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -114.44 110.5 19.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.853 -1.779 . . . . 0.0 109.577 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -106.81 135.45 12.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 14.9 t -118.18 -163.79 0.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.127 -1.22 . . . . 0.0 108.672 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.739 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.07 -56.05 3.22 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.708 ' HA3' ' NE2' ' A' ' 187' ' ' GLN . . . 128.16 -119.89 3.24 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.796 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.6 m -51.32 -66.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.85 -0.794 . . . . 0.0 112.871 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -46.89 -35.1 6.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.89 -1.131 . . . . 0.0 109.871 -177.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.739 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 48.0 mmt-85 -79.54 -47.86 14.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.299 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.7 t -67.29 -60.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.483 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -55.9 -30.18 61.17 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.362 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 3.5 ttt180 -77.35 -41.53 40.06 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.252 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.44 75.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 251' ' ' ILE . 58.8 mt -58.11 -53.5 57.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.651 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.596 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 53.6 mtmt -77.46 -52.57 8.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.715 . . . . 0.0 112.097 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 9.2 mt-10 -66.23 -45.56 80.26 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.49 -1.381 . . . . 0.0 112.383 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.02 -45.26 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.559 -1.338 . . . . 0.0 111.506 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 152' ' ' GLY . 34.2 m-85 -100.02 19.99 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 39.6 0.04 OUTLIER Glycine 0 N--CA 1.496 2.668 0 O-C-N 121.905 -0.497 . . . . 0.0 112.992 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.643 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.8 m-85 -63.36 161.08 14.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.212 -1.758 . . . . 0.0 107.478 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.0 t-20 -47.44 147.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.765 -1.209 . . . . 0.0 109.612 -178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.0 mm-40 -54.81 -17.11 3.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.585 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 4.4 p -53.54 -15.87 1.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.596 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 67.0 t -68.81 129.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.638 -1.289 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.746 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.1 p-80 -149.46 172.67 14.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.24 -0.912 . . . . 0.0 109.796 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.568 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -117.49 136.36 53.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.772 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 8.8 pt -123.19 170.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.3 m-80 -123.87 102.66 7.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 110.485 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.632 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 2.6 tpt180 -47.22 -39.2 13.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 109.084 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.51 69.74 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -104.91 34.35 3.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.995 -1.297 . . . . 0.0 112.258 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.59 170.94 14.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.306 -1.496 . . . . 0.0 110.217 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.0 p -96.43 135.8 37.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 6.7 ttpt -34.78 -51.49 0.5 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.813 -0.554 . . . . 0.0 110.978 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -56.09 17.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.403 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.09 -22.32 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.124 -0.985 . . . . 0.0 109.612 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.772 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 70.0 t-105 -71.87 -45.73 60.32 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.133 -0.979 . . . . 0.0 109.169 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 174' ' ' ILE . 69.3 mt-10 -70.87 -26.37 63.22 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.078 -1.014 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.05 83.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -61.14 -40.45 93.87 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.897 HG23 HG21 ' A' ' 184' ' ' VAL . 12.5 mt -75.72 -56.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.422 -0.799 . . . . 0.0 110.486 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.1 OUTLIER -49.87 -46.09 51.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.979 -1.076 . . . . 0.0 109.022 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -52.15 -45.26 64.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 108.215 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.617 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 31.0 mm-40 -59.71 -48.36 81.98 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.688 ' HB3' HG11 ' A' ' 4' ' ' VAL . 22.6 mt -67.63 -27.63 67.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 20.7 p -51.36 -42.78 61.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 108.716 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 181' ' ' ASN . 19.3 mt-30 -98.67 38.58 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.65 ' C ' HD13 ' A' ' 7' ' ' LEU . 90.5 m-20 43.3 49.97 5.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 5.3 mt-30 -123.64 114.49 28.52 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.3 Cg_endo -65.72 169.6 12.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.421 2.08 . . . . 0.0 112.807 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.897 HG21 HG23 ' A' ' 174' ' ' ILE . 58.5 t -125.61 131.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.81 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -82.93 120.14 25.31 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.98 161.93 23.3 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.894 -1.129 . . . . 0.0 109.546 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.72 HE22 ' HA3' ' A' ' 194' ' ' GLY . 0.0 OUTLIER -166.74 129.01 1.78 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.466 -1.693 . . . . 0.0 112.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -93.19 124.8 7.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.6 t -83.19 170.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.305 . . . . 0.0 111.12 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -175.33 -145.24 5.34 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -87.66 -29.48 21.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.021 -1.282 . . . . 0.0 110.678 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 m -81.82 -14.82 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.959 -1.088 . . . . 0.0 110.893 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.66 -164.41 24.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.72 ' HA3' HE22 ' A' ' 187' ' ' GLN . . . -87.93 106.45 3.21 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 121.089 -1.242 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.598 ' O ' ' CA ' ' A' ' 187' ' ' GLN . 11.4 t-80 -71.43 132.75 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -120.71 165.05 15.62 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.102 -1.439 . . . . 0.0 113.006 -177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.819 ' CD1' HG13 ' A' ' 210' ' ' VAL . 17.5 p90 -162.64 168.91 20.97 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.771 HG22 HD11 ' A' ' 55' ' ' ILE . 75.7 t -114.22 136.75 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.638 -1.289 . . . . 0.0 112.376 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 174' ' ' ILE . 81.7 mt -101.71 125.64 55.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.61 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 3.9 p30 -134.86 30.23 3.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.842 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 177.42 163.49 29.44 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 117.614 -2.232 . . . . 0.0 112.671 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -144.24 157.06 44.5 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.446 ' CG ' ' HB2' ' A' ' 207' ' ' PHE . 9.5 p-10 -120.86 -0.5 10.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.698 -1.251 . . . . 0.0 110.576 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.0 -27.67 8.81 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 36.4 mtt180 -89.22 30.08 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -1.187 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.6 OUTLIER 71.46 20.48 4.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.691 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 203' ' ' ASP . 16.3 m-85 -116.73 135.12 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.103 -0.998 . . . . 0.0 109.468 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 16.3 m-85 -121.11 168.4 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.367 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.709 ' CD2' ' HB3' ' A' ' 6' ' ' SER . 1.4 t-80 -91.51 147.02 23.32 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.819 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.4 t -138.79 137.51 42.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -105.88 78.81 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.623 ' CE3' ' HB3' ' A' ' 197' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.716 . . . . 0.0 110.238 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 28.7 mt-30 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.323 0.582 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 40.5 p -155.21 162.03 41.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.642 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.691 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -136.93 148.16 46.82 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.204 1.002 . . . . 0.0 110.085 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.9 t -110.49 121.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.746 HG23 ' NE2' ' A' ' 158' ' ' HIS . 24.7 m -132.96 146.45 32.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.675 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 94.53 54.54 1.55 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 mt -101.14 97.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.308 -1.113 . . . . 0.0 110.004 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 7.9 pttm -162.85 144.38 7.82 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.17 1.913 . . . . 0.0 110.4 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 178' ' ' LEU . 22.6 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 200' ' ' ASP . 63.7 mmtt -76.43 -172.95 2.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.086 -1.009 . . . . 0.0 108.517 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 4.2 t -79.27 101.8 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.711 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.4 mt -56.89 -50.23 73.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 108.818 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 198' ' ' VAL . 12.8 mt -55.04 -44.08 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.857 -1.152 . . . . 0.0 108.702 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 97.9 m-20 -67.83 -38.71 83.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.183 -0.948 . . . . 0.0 108.548 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.6 p -58.32 -14.87 8.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 9.4 mtpp -119.13 23.33 11.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.47 35.69 5.54 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 58' ' ' TYR . 17.5 mt -88.91 109.39 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.409 1.1 . . . . 0.0 110.432 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PRO . 63.1 m80 -133.4 98.82 4.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.1 m-30 -103.76 176.81 5.03 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.273 1.035 . . . . 0.0 112.299 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.602 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 t-20 -147.2 -172.74 4.08 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.545 ' CG ' ' OG1' ' A' ' 50' ' ' THR . 6.4 mt-30 -124.23 -14.94 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.917 -1.115 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.711 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.18 -39.11 0.97 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.799 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.847 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.7 t-20 -45.2 -138.96 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.489 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.108 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.2 Cg_endo -74.62 4.02 4.9 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 122.667 1.988 . . . . 0.0 109.185 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.602 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 64.1 m-85 -75.79 -35.21 60.15 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.632 -0.667 . . . . 0.0 109.903 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.7 p30 -97.95 21.78 10.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.494 -1.379 . . . . 0.0 109.998 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 23' ' ' LEU . 14.6 mt -72.7 -2.39 20.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -129.03 -6.3 4.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.988 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -62.07 162.62 16.93 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.644 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -70.69 130.37 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.14 1.893 . . . . 0.0 111.841 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.44 149.15 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.551 0.691 . . . . 0.0 110.168 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 79' ' ' TYR . 33.7 mt -77.8 144.66 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.558 0.694 . . . . 0.0 110.689 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HA ' HG13 ' A' ' 39' ' ' VAL . 20.5 mt-10 -123.6 -23.51 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.512 -0.742 . . . . 0.0 110.052 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.9 mtpp -118.94 162.5 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.264 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 39' ' ' VAL . 42.4 t . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 87.0 m-85 -123.29 25.03 8.54 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.055 -1.028 . . . . 0.0 109.634 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 31' ' ' VAL . 77.1 t -73.74 148.3 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.192 -0.942 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.21 -1.87 73.47 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 5.1 mm-40 -88.27 131.02 34.95 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.423 -1.045 . . . . 0.0 109.668 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.13 112.66 9.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.59 157.12 1.64 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.913 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.81 169.43 18.3 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.332 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.5 ' O ' ' HE2' ' A' ' 129' ' ' MET . 31.4 p -77.81 -34.11 52.18 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.979 -1.076 . . . . 0.0 108.385 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 101.64 136.88 9.46 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -54.3 -51.33 64.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.235 -1.156 . . . . 0.0 108.891 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.8 t -46.7 -53.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' HE2' ' A' ' 129' ' ' MET . . . -60.19 -50.6 73.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.25 -0.907 . . . . 0.0 110.329 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -63.62 -31.72 72.98 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.654 -0.653 . . . . 0.0 110.714 -178.11 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.08 -41.94 85.49 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.261 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -73.51 -54.2 8.78 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.874 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.88 -39.59 62.79 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.809 -0.557 . . . . 0.0 110.316 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.1 mt-30 -61.09 -44.48 97.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.742 -1.224 . . . . 0.0 107.733 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD11 HG22 ' A' ' 198' ' ' VAL . 44.1 mt -68.35 -24.53 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.568 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.2 mtp -73.36 -38.63 65.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 33.6 tptt -68.46 -43.54 76.8 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.03 -32.66 48.0 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.679 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 53.6 m-70 -107.52 -22.21 12.62 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.521 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.64 55.54 1.91 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.514 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.621 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.2 t80 -77.0 -70.52 0.21 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.8 Cg_endo -70.51 104.2 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 120.399 0.733 . . . . 0.0 111.942 -176.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -69.55 -22.61 63.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 3.6 ttpm? -134.55 141.72 46.76 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.94 153.06 26.65 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.507 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.05 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -94.35 -38.65 10.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -1.019 . . . . 0.0 109.984 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 46.3 tttt -152.16 139.45 19.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 91' ' ' SER . 77.7 m-20 -63.87 170.3 3.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 22.8 t80 -153.03 135.66 15.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.069 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.8 t -142.57 152.83 42.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 109.759 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 19.9 p90 -156.44 152.98 28.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.844 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.611 HG23 ' ND2' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -92.74 126.58 37.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.733 HD21 ' ND2' ' A' ' 77' ' ' ASN . 11.5 tp -44.03 147.29 0.52 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.77 0.795 . . . . 0.0 110.947 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 146.55 48.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.716 -0.615 . . . . 0.0 110.187 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.41 1.63 9.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.856 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.519 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 10.0 m-20 -98.65 -9.4 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.333 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.733 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.7 t-20 -69.73 109.35 4.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.782 -0.574 . . . . 0.0 110.35 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.3 Cg_endo -88.72 14.54 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.79 2.327 . . . . 0.0 110.386 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.784 ' HB3' HG23 ' A' ' 28' ' ' ILE . 80.1 m-85 -107.92 -22.6 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 110.66 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' ASN . 87.7 m-85 -118.48 163.35 16.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 8.5 m120 -49.14 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 175.39 -48.38 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.508 175.097 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -75.85 58.88 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 N-CA-C 107.01 -1.958 . . . . 0.0 107.01 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 86' ' ' LEU . 12.1 tptt -105.49 121.86 44.81 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.784 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.611 ' ND2' HG23 ' A' ' 72' ' ' THR . 6.1 m120 -105.83 115.98 31.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.0 mp -95.49 128.85 42.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -129.81 141.06 50.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -117.28 113.26 21.91 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -73.24 52.81 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 108.118 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 mt -52.77 -53.63 20.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.555 -0.716 . . . . 0.0 110.205 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 p -45.65 -25.6 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.637 -1.289 . . . . 0.0 109.147 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -111.28 19.78 17.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.352 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.647 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.9 mmt-85 -79.43 151.49 30.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -117.36 90.99 3.45 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.21 94.66 6.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 110.828 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.7 t30 -82.64 89.39 6.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.607 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 68.1 m95 -61.39 -7.13 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 -178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.87 -19.8 24.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 6.0 m-20 -99.71 -28.0 13.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.9 mt -73.77 65.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 21.2 mt -45.89 148.62 1.35 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.723 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.562 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.0 Cg_endo -78.0 -17.96 13.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.641 2.228 . . . . 0.0 110.446 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' THR . 9.0 t -144.92 122.5 11.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.2 -0.938 . . . . 0.0 109.082 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.7 m-85 -109.5 141.75 41.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -99.93 -5.95 27.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.452 -0.78 . . . . 0.0 109.086 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -3.78 83.28 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -116.48 0.66 12.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -1.179 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.48 160.82 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 167.47 0.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.176 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 6.1 m-80 -72.79 -29.41 63.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.1 t -51.9 -63.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.519 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 3.2 mp0 -62.46 -32.42 73.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.271 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 110' ' ' ASN . 24.6 mttt -66.54 -43.7 84.4 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.48 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.8 ttm -59.6 -35.52 74.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -68.71 0.21 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.676 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.536 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.3 tp -59.84 -37.6 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.295 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 13.8 p -57.39 -43.39 83.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.895 -1.128 . . . . 0.0 110.755 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.743 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.23 -37.18 77.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 108.95 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.578 HD21 ' HB1' ' A' ' 53' ' ' ALA . 3.6 tp -59.48 -59.52 5.31 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.612 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.0 mmt -49.87 -40.59 43.11 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.211 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -70.38 -41.04 73.59 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.639 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 36.7 m-20 -64.63 -47.14 79.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 127' ' ' VAL . 54.5 t -70.08 -49.7 53.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . -60.18 -33.05 78.31 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 126' ' ' SER . 1.2 mt -75.22 -57.0 7.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 125' ' ' ILE . 1.4 p -47.79 -26.92 1.78 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 32.9 m -100.44 28.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.358 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 4.4 m-20 39.46 48.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.57 ' HE1' ' HB2' ' A' ' 137' ' ' SER . 53.5 tpp -59.66 131.79 52.0 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.1 t0 -76.89 120.66 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.644 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.7 m-85 -103.05 115.69 31.07 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.572 1.177 . . . . 0.0 113.245 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.764 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.1 -163.7 11.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 104.747 -3.341 . . . . 0.0 104.747 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.31 -31.44 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 N-CA-C 105.87 -2.396 . . . . 0.0 105.87 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.3 m -109.22 144.35 37.45 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.2 m -123.7 110.66 15.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 119.859 -1.776 . . . . 0.0 110.451 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.99 141.55 15.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.57 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 29.4 t -118.22 -162.48 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -1.182 . . . . 0.0 108.998 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.78 -61.45 1.63 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 138.57 -137.31 8.63 Favored Glycine 0 N--CA 1.481 1.649 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.996 176.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.3 m -48.34 -50.06 31.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.882 -0.775 . . . . 0.0 112.422 -178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 p -45.95 -48.45 16.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 110.407 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 7.0 mmt180 -80.7 -36.17 32.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.821 -1.174 . . . . 0.0 110.069 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.8 t -67.2 -58.45 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.359 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -56.03 -31.61 63.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.308 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.4 ttt180 -77.72 -47.67 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.419 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -66.41 -35.06 79.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.497 HD12 HG11 ' A' ' 248' ' ' VAL . 39.4 mt -60.13 -46.25 90.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 110.016 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 28.1 mtmt -87.38 -45.25 10.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 60.2 mt-10 -70.73 -43.54 68.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.875 -1.14 . . . . 0.0 111.792 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 24.2 m120 -94.42 -44.66 7.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 111.608 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 152' ' ' GLY . 32.3 m-85 -102.26 15.86 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 110.673 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.05 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 33.74 38.93 0.1 OUTLIER Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.639 -0.663 . . . . 0.0 112.75 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.6 m-85 -61.97 164.67 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.189 -1.771 . . . . 0.0 107.666 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 45.5 t30 -47.76 143.12 4.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.893 -1.129 . . . . 0.0 109.084 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -53.51 -18.69 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 109.079 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.519 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 78.0 p -53.36 -16.34 1.33 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -0.856 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 251' ' ' ILE . 56.0 t -66.29 118.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.83 -1.168 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.918 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.1 p-80 -142.2 155.57 45.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.378 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -101.15 163.24 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 17.4 pt -145.56 165.77 10.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 162' ' ' ARG . 3.5 m-80 -125.13 100.08 6.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 110.086 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.615 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 45.1 tpt85 -45.34 -35.22 3.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.142 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.34 -28.04 70.31 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -103.89 6.26 36.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.899 -1.353 . . . . 0.0 111.876 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -118.1 177.27 4.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.388 -1.445 . . . . 0.0 110.407 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 88.4 p -103.95 132.65 49.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 20.5 ttmt -33.21 -46.27 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.848 -0.533 . . . . 0.0 110.885 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -64.21 -62.39 1.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.861 -1.15 . . . . 0.0 109.878 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -17.19 61.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 75.7 t-105 -75.81 -47.01 27.48 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.197 -0.94 . . . . 0.0 109.162 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HA ' HD12 ' A' ' 174' ' ' ILE . 55.5 mt-10 -69.84 -38.19 76.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.168 -0.957 . . . . 0.0 108.549 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.19 50.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 35.4 mm-40 -61.07 -41.47 96.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 184' ' ' VAL . 13.2 mt -75.66 -58.24 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.39 -0.819 . . . . 0.0 110.575 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -49.46 -45.32 46.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.725 -1.235 . . . . 0.0 108.888 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -51.61 -43.03 62.41 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.621 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 44.6 mm-40 -60.18 -50.99 71.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.75 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.8 mt -68.27 -26.48 65.69 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.8 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.7 p -52.17 -39.29 59.85 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.4 mt-30 -100.93 35.41 2.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 7' ' ' LEU . 15.0 m-80 47.18 51.06 13.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 12.6 mt-30 -123.31 113.0 29.56 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.95 169.85 11.2 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.742 1.628 . . . . 0.0 111.792 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 174' ' ' ILE . 96.5 t -126.61 130.78 71.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.722 -176.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.832 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -82.86 116.91 22.38 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 176.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -122.48 159.19 28.17 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.92 -1.113 . . . . 0.0 109.35 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.3 pt20 -167.06 130.87 1.88 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.511 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.43 125.93 8.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 53.9 t -91.33 162.73 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.147 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.6 -133.27 1.58 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -87.76 -47.83 8.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.72 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.97 -11.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.175 -0.953 . . . . 0.0 111.205 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.33 -160.18 20.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -95.09 110.59 4.04 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.258 -1.448 . . . . 0.0 111.125 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.625 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.7 t-80 -72.4 132.23 43.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.74 163.92 16.71 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.059 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.872 ' CD1' HG13 ' A' ' 210' ' ' VAL . 15.9 p90 -161.8 168.05 23.82 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.649 HG22 HD11 ' A' ' 55' ' ' ILE . 84.5 t -114.71 135.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.59 -1.319 . . . . 0.0 112.185 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 174' ' ' ILE . 76.1 mt -97.62 124.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 8.3 p-10 -137.1 33.05 2.61 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.992 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -173.73 167.9 40.62 Favored Glycine 0 N--CA 1.484 1.887 0 C-N-CA 117.757 -2.163 . . . . 0.0 112.356 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -152.34 149.37 28.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.99 29.07 8.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 110.258 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.5 22.63 3.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -140.74 25.95 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -1.068 . . . . 0.0 108.91 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 75.23 7.77 4.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.401 -0.812 . . . . 0.0 109.719 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 25.9 m-85 -103.33 136.54 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 49.8 m-85 -123.65 163.07 21.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 111.119 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 40.4 t-80 -93.68 123.01 36.73 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.872 HG13 ' CD1' ' A' ' 197' ' ' PHE . 54.1 t -117.42 141.67 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 111.619 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.506 ' HB2' HD12 ' A' ' 8' ' ' LEU . 18.2 t-20 -110.1 76.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 211' ' ' ASN . 65.1 m95 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 7.1 mt-30 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 30.6 p -133.41 165.34 25.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.473 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.23 152.68 44.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.725 0.774 . . . . 0.0 110.247 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.832 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.5 t -112.84 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.918 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.6 m -109.97 139.72 32.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.318 0.58 . . . . 0.0 110.174 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.434 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 100.5 48.58 1.52 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.211 -1.471 . . . . 0.0 109.659 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 9.0 mt -104.61 94.67 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.245 -1.15 . . . . 0.0 111.131 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 252' ' ' LYS . 0.0 OUTLIER -163.43 146.03 7.94 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.153 1.902 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.499 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 30.5 tt0 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.4 Cg_endo -77.59 151.99 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.192 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG22 ' C ' ' A' ' 203' ' ' ASP . 9.4 t -89.55 145.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.326 -0.858 . . . . 0.0 109.746 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 36.7 t -137.02 132.82 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 110.095 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -75.23 172.89 11.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.9 t -76.9 108.13 9.73 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.488 -0.757 . . . . 0.0 110.807 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.684 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 41.0 mt -58.54 -50.4 73.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 198' ' ' VAL . 13.5 mt -55.54 -40.81 72.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.879 -1.138 . . . . 0.0 108.503 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 14.6 m-20 -67.84 -42.8 80.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.292 -0.88 . . . . 0.0 109.149 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -57.98 -15.09 7.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 108.932 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 5.8 mtpp -116.54 20.39 14.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.34 37.01 4.5 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 58' ' ' TYR . 59.2 mt -88.54 110.1 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 122.351 1.072 . . . . 0.0 110.385 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 77.4 m80 -133.53 97.96 4.08 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.563 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.2 m-30 -103.16 174.31 5.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.157 0.98 . . . . 0.0 111.823 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 m-20 -146.83 -171.26 3.72 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 4.3 mt-30 -124.2 -11.19 7.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.919 -1.113 . . . . 0.0 109.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.73 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.17 -39.75 0.86 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.982 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.2 t-20 -45.13 -140.75 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.511 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.253 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.4 Cg_endo -73.85 2.3 6.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 122.523 1.937 . . . . 0.0 109.0 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 46.9 m-85 -72.76 -37.48 67.66 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.704 -0.622 . . . . 0.0 109.59 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 38.3 p-10 -96.15 21.24 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.564 -1.335 . . . . 0.0 110.087 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -74.75 4.44 6.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.315 -0.865 . . . . 0.0 109.622 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.0 mt -136.29 -1.81 2.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.936 -1.103 . . . . 0.0 110.467 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.3 p -61.56 161.77 18.44 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HG3' HD21 ' A' ' 86' ' ' LEU . 20.0 Cg_endo -69.85 137.51 35.38 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.697 1.598 . . . . 0.0 110.597 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.92 142.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.792 0.806 . . . . 0.0 110.82 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.5 mt -76.9 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.415 0.626 . . . . 0.0 109.833 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.745 ' HA ' HG13 ' A' ' 39' ' ' VAL . 64.0 mt-10 -126.22 -19.31 4.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.804 . . . . 0.0 111.398 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' TYR . 34.0 mtpt -123.11 171.77 9.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.729 -1.232 . . . . 0.0 110.58 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 37' ' ' SER . 94.4 t -114.44 148.61 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.742 0.782 . . . . 0.0 110.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -89.7 129.04 48.21 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.416 1.411 . . . . 0.0 109.951 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.42 18.28 13.52 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.77 -179.98 7.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.597 -0.943 . . . . 0.0 109.232 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -82.07 174.68 11.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 109.633 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.481 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.5 t -81.37 135.81 35.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.2 m-85 -124.07 18.97 9.2 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.853 -1.154 . . . . 0.0 110.23 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 29' ' ' GLU . 45.1 t -67.88 140.36 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.556 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.39 -2.26 72.61 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 13.2 mt-30 -83.4 136.52 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.33 -1.1 . . . . 0.0 109.824 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -73.2 108.58 6.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.2 168.79 0.09 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.721 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -90.24 173.36 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.005 . . . . 0.0 110.066 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.553 ' O ' ' HE3' ' A' ' 129' ' ' MET . 31.3 p -83.15 -37.68 23.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.229 -0.919 . . . . 0.0 108.603 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' A' ' 135' ' ' SER . . . 105.05 136.44 8.69 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' VAL . 2.8 p -54.57 -54.04 46.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -1.231 . . . . 0.0 108.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 38.2 t -46.38 -52.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.26 -52.28 66.35 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.865 0.84 . . . . 0.0 109.791 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.529 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.27 -32.61 74.07 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.186 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.86 86.69 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.222 -1.391 . . . . 0.0 108.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.43 HG23 HD21 ' A' ' 147' ' ' LEU . 83.9 m -73.52 -53.05 11.49 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.754 0.788 . . . . 0.0 109.651 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.39 -42.64 64.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.805 -0.56 . . . . 0.0 110.193 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.563 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.1 mt-30 -56.66 -48.75 76.9 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 198' ' ' VAL . 32.5 mt -66.27 -26.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.612 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -70.31 -35.88 73.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 23.7 tptt -72.58 -42.05 65.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.684 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.1 t80 -53.9 -31.61 50.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 71.9 m-70 -107.86 -22.35 12.48 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.649 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.68 51.43 3.03 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.5 t80 -70.02 -74.34 0.16 Allowed Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 33.9 Cg_endo -68.97 107.59 1.74 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 CA-C-N 119.044 0.694 . . . . 0.0 112.158 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -70.32 -21.95 62.87 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.2 tttm -134.27 148.06 50.75 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 144.9 42.42 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.238 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.435 -1.038 . . . . 0.0 111.579 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' ' OD1' ' A' ' 150' ' ' ASN . 51.7 tttt -151.51 137.24 17.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.093 -1.629 . . . . 0.0 111.229 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' N ' ' HB3' ' A' ' 91' ' ' SER . 75.6 m-20 -59.42 152.76 20.71 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.862 ' CZ ' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -126.85 172.81 10.08 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.62 -1.3 . . . . 0.0 107.986 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.7 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 10.9 t -167.87 134.74 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.01 173.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.615 ' HD2' ' CE2' ' A' ' 69' ' ' TYR . 3.3 p90 -148.67 146.47 28.18 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.258 -0.901 . . . . 0.0 109.112 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.8 m -93.43 135.15 34.95 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.724 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -52.14 144.58 12.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.86 0.838 . . . . 0.0 111.428 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.93 145.08 53.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.364 0.602 . . . . 0.0 110.453 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -72.46 -0.15 11.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.92 . . . . 0.0 109.756 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -96.28 -10.36 28.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.204 -0.935 . . . . 0.0 108.874 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.724 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.0 t-20 -69.79 111.0 7.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.713 -0.617 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.1 Cg_endo -88.95 17.5 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.82 2.346 . . . . 0.0 109.193 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 89.6 m-85 -107.1 -15.27 14.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.575 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -135.52 167.21 21.51 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.584 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.0 m120 -48.7 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 175.12 -48.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 111.302 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -75.66 60.54 5.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 N-CA-C 106.955 -1.979 . . . . 0.0 106.955 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HG3' HD12 ' A' ' 86' ' ' LEU . 2.0 tptt -104.5 119.78 39.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.424 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.88 119.28 38.46 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.406 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 26' ' ' PRO . 2.7 mp -94.88 143.57 26.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.526 ' HA ' ' CE1' ' A' ' 69' ' ' TYR . 18.2 t80 -139.03 130.75 27.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 110.726 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -110.22 119.4 39.13 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.7 45.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.696 -1.252 . . . . 0.0 107.834 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.832 HD12 ' CG ' ' A' ' 150' ' ' ASN . 15.4 mt -52.32 -56.56 6.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 O-C-N 121.578 -0.701 . . . . 0.0 109.999 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.545 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -44.56 -26.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 108.987 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -111.47 34.72 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 108.916 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.707 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 38.1 mmt-85 -93.35 155.81 17.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 110.868 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.73 88.77 2.98 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -80.76 86.38 5.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.208 -0.932 . . . . 0.0 110.416 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.6 t-20 -79.38 90.96 5.03 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.649 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 77.5 m95 -61.36 -6.23 2.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.438 -0.789 . . . . 0.0 110.46 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.4 t-20 -89.88 -19.26 24.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 12.9 m-20 -99.67 -28.72 13.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 115' ' ' ALA . 41.8 mt -74.34 66.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 101' ' ' LEU . 9.4 mt -46.32 148.66 1.53 Allowed Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 121.662 -0.649 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.548 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.5 Cg_endo -78.79 -19.5 11.09 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.92 2.414 . . . . 0.0 110.432 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 2.5 t -142.78 121.58 12.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.113 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 116' ' ' ILE . 64.4 m-85 -109.28 138.54 45.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.932 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -101.11 -3.84 28.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.0 108.973 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.28 87.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -115.06 -1.03 13.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -1.231 . . . . 0.0 109.606 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -67.08 170.83 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.717 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.9 174.27 2.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -77.26 -34.34 55.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.56 -59.72 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 109.576 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.8 -34.15 76.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.132 -0.98 . . . . 0.0 109.158 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.503 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 85.4 mttt -66.01 -42.72 89.34 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 35.8 ttm -59.34 -35.63 74.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.21 -68.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.726 -0.609 . . . . 0.0 110.592 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.599 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.7 tp -60.14 -41.69 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 11.5 p -53.73 -43.24 68.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.853 -1.154 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.796 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.2 tt0 -69.36 -42.14 75.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.999 -1.063 . . . . 0.0 108.78 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.599 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.2 tp -54.05 -53.69 49.57 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.608 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -57.07 -43.06 81.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -66.18 -39.66 89.88 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 15.6 m-20 -68.47 -46.48 69.63 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 127' ' ' VAL . 43.6 t -67.01 -63.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.22 -38.82 9.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.862 HG23 ' CZ ' ' A' ' 69' ' ' TYR . 2.9 mt -69.84 -60.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.306 -1.114 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.607 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.2 p -46.47 -25.74 0.73 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.851 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 123' ' ' VAL . 27.1 m -104.26 33.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 109.792 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.2 m-20 41.75 40.96 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 109.8 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.603 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 35.4 tpp -56.42 134.05 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 111.589 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 34.4 m-20 -78.09 122.41 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 40.3 m-85 -103.9 106.24 16.68 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -141.2 -162.09 8.98 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 104.332 -3.507 . . . . 0.0 104.332 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.64 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.74 -30.96 78.73 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 106.007 -2.343 . . . . 0.0 106.007 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.93 139.15 45.34 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.56 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 73.8 m -114.14 112.72 23.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 119.934 -1.729 . . . . 0.0 110.721 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.67 130.52 10.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.624 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -117.23 -168.16 1.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.056 -1.261 . . . . 0.0 108.3 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.926 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.15 -50.85 5.76 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 124.01 -129.08 7.09 Favored Glycine 0 N--CA 1.481 1.684 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.257 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.534 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 4.2 m -48.23 -59.71 3.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.962 -0.728 . . . . 0.0 112.019 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 140' ' ' SER . 40.1 p -46.97 -35.35 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.789 -1.194 . . . . 0.0 108.622 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.926 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 74.9 mmt-85 -80.62 -48.51 12.56 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.91 0.862 . . . . 0.0 109.192 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.77 HG21 ' CE2' ' A' ' 185' ' ' TYR . 89.0 t -66.66 -59.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.477 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 1.4 pp0? -56.5 -33.21 65.79 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 108.58 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.8 ttm180 -76.79 -53.91 7.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.007 -1.058 . . . . 0.0 109.48 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -64.33 -38.21 90.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.105 -0.997 . . . . 0.0 109.575 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.561 ' HB2' HG11 ' A' ' 157' ' ' VAL . 17.1 mt -51.05 -48.6 61.52 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.665 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 55.2 mtmt -88.17 -31.2 19.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 111.285 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 19.8 mt-10 -74.29 -65.51 0.84 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.718 -1.239 . . . . 0.0 112.732 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.832 ' CG ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.98 -32.17 30.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.633 -1.292 . . . . 0.0 111.966 -177.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 32.8 m-85 -103.55 -10.26 18.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.512 -1.367 . . . . 0.0 110.768 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.963 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 58.6 39.15 92.93 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.097 -1.002 . . . . 0.0 112.531 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.2 m-85 -63.3 162.01 12.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.202 -1.764 . . . . 0.0 107.641 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 50.4 t-20 -47.1 147.9 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.826 -1.171 . . . . 0.0 109.923 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -53.86 -17.97 2.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.529 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 26.4 p -57.37 -11.95 2.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 110.051 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.561 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.0 t -70.92 121.44 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.798 -1.189 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 1.026 ' CE1' HG23 ' A' ' 249' ' ' VAL . 7.6 p-80 -148.65 179.79 7.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 38.5 tt0 -123.8 138.41 54.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.764 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -122.96 152.37 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 5.4 m120 -109.89 103.23 11.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.109 . . . . 0.0 111.027 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.604 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 13.2 tpt180 -47.83 -36.48 11.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.043 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.6 67.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 4.74 35.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.922 -1.34 . . . . 0.0 111.668 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -118.17 161.19 20.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.569 -1.332 . . . . 0.0 110.143 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 5.2 p -87.06 131.71 34.03 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.3 ttpt -32.78 -44.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.83 -0.543 . . . . 0.0 110.906 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -63.59 -63.73 1.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.953 -1.092 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -62.42 -17.34 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.741 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.764 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.31 -47.86 22.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.087 -1.008 . . . . 0.0 109.172 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 174' ' ' ILE . 59.5 mt-10 -67.71 -22.73 65.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.98 97.14 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -60.94 -36.2 78.71 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.586 ' CG2' HG21 ' A' ' 199' ' ' ILE . 18.5 mt -73.78 -66.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.385 -0.822 . . . . 0.0 110.575 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -48.27 -41.72 28.61 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 109.446 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -52.29 -47.47 65.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.0 mm-40 -61.06 -45.21 95.69 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.559 HD11 ' CG2' ' A' ' 199' ' ' ILE . 27.8 mt -68.29 -30.34 69.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.665 -0.647 . . . . 0.0 110.425 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' ASP . 62.7 p -52.55 -35.94 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.069 -1.019 . . . . 0.0 108.799 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 17.7 mt-30 -101.17 28.78 5.1 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.481 ' HB3' HD22 ' A' ' 7' ' ' LEU . 96.3 m-20 49.26 50.72 17.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 21.4 mt-30 -123.67 110.95 29.7 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.8 Cg_endo -64.21 166.16 17.64 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.567 1.511 . . . . 0.0 112.087 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.602 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 35.8 t -123.7 136.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.266 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.77 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -85.38 118.34 24.85 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 175.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 6.5 t80 -122.45 158.18 30.31 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.793 -1.192 . . . . 0.0 109.399 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 187' ' ' GLN . 3.5 pt20 -167.38 136.73 2.74 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.538 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.68 108.91 2.97 Favored Glycine 0 C--N 1.288 -2.108 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.598 HG22 ' CA ' ' A' ' 194' ' ' GLY . 19.3 t -78.56 160.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.241 -1.152 . . . . 0.0 112.159 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB2' ' HA3' ' A' ' 237' ' ' GLY . 0.7 OUTLIER -88.12 -56.12 3.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -1.212 . . . . 0.0 110.507 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 237' ' ' GLY . 2.9 m -59.04 -23.86 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.271 -0.893 . . . . 0.0 111.416 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.53 -167.54 24.98 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.598 ' CA ' HG22 ' A' ' 189' ' ' VAL . . . -85.62 106.25 3.01 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 121.062 -1.257 . . . . 0.0 111.496 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 29.5 t60 -72.09 125.33 26.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -117.34 163.93 15.6 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.081 -1.448 . . . . 0.0 113.199 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 186' ' ' TYR . 32.2 p90 -159.48 170.16 22.31 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 55' ' ' ILE . 85.5 t -114.67 135.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.515 -1.365 . . . . 0.0 112.45 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 208' ' ' TYR . 11.8 mt -97.72 127.56 49.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.565 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.1 p30 -140.28 33.64 1.89 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.611 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.603 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 172.71 -175.51 45.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.442 -1.837 . . . . 0.0 111.003 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.673 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -161.3 152.2 18.31 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.424 -1.045 . . . . 0.0 109.092 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.663 ' C ' HG22 ' A' ' 3' ' ' VAL . 6.7 t0 -113.81 14.62 18.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.775 -1.203 . . . . 0.0 111.338 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.87 -4.99 85.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.706 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 207' ' ' PHE . 4.5 mtp180 -128.2 70.83 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.802 -1.41 . . . . 0.0 110.59 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 4.8 m120 39.33 28.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 109.919 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -121.08 128.43 52.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.299 -0.876 . . . . 0.0 109.046 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 199' ' ' ILE . 73.9 m-85 -109.05 170.33 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.614 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 53.3 t-80 -91.55 115.34 27.96 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 222' ' ' PHE . 11.5 t -112.85 142.84 23.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 122.256 1.027 . . . . 0.0 112.277 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.455 ' HB2' HD12 ' A' ' 8' ' ' LEU . 21.8 t-20 -110.6 78.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.506 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 68.9 m95 -46.75 167.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.149 -0.969 . . . . 0.0 110.109 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.86 27.54 7.23 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -119.18 -169.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -1.141 . . . . 0.0 109.519 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -77.68 -95.6 0.22 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.25 64.34 0.6 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.79 HG22 ' N ' ' A' ' 218' ' ' SER . 1.7 p -95.12 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -1.165 . . . . 0.0 109.516 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.79 ' N ' HG22 ' A' ' 217' ' ' VAL . 21.5 m -90.39 19.07 5.47 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.75 126.96 23.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.18 -91.59 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 25.5 p90 -102.1 163.24 12.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.7 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.649 ' HB2' HG21 ' A' ' 210' ' ' VAL . 0.0 OUTLIER -91.62 176.62 6.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.111 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.55 ' O ' ' CE2' ' A' ' 222' ' ' PHE . 0.0 OUTLIER -114.64 153.39 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.725 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -116.67 -22.39 8.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.299 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.11 -25.64 7.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.08 86.39 2.57 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.111 0.957 . . . . 0.0 109.197 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.547 HD11 ' CE1' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -91.77 48.93 1.5 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-O 121.383 0.611 . . . . 0.0 109.557 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.466 ' HB3' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER -115.94 163.34 21.6 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.251 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 228' ' ' ASN . 35.8 Cg_endo -78.24 128.3 8.87 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.623 2.215 . . . . 0.0 110.468 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.642 ' HB3' HG21 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -57.8 -45.56 85.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.98 88.25 6.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.67 -171.26 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.2 62.11 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.14 -86.99 0.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -1.165 . . . . 0.0 109.685 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -98.36 -123.78 4.88 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.92 15.92 7.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 191' ' ' LYS . . . -112.3 24.95 13.12 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -50.21 169.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 240' ' ' GLY . . . 84.88 140.41 4.99 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 239' ' ' GLY . . . 44.53 91.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -108.38 30.88 6.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -1.176 . . . . 0.0 109.848 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 25.8 t30 -136.2 58.81 1.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.967 -1.083 . . . . 0.0 109.991 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . . . -84.84 -41.99 7.41 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -135.75 94.05 3.03 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.69 -0.888 . . . . 0.0 109.085 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 162' ' ' ARG . 3.9 tt0 -91.6 126.52 36.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.83 -1.169 . . . . 0.0 108.738 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.3 p -151.62 169.95 20.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.059 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.92 146.34 37.28 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.186 0.993 . . . . 0.0 110.934 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.8 t -105.13 118.81 53.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 1.026 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.3 m -125.88 145.71 32.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.86 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.09 52.21 2.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.632 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 50.6 mt -97.44 88.94 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -1.083 . . . . 0.0 109.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.21 152.32 12.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.342 2.028 . . . . 0.0 110.402 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.467 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 51.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.467 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.9 Cg_endo -78.28 174.67 12.08 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.515 2.143 . . . . 0.0 110.169 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.614 HG22 ' C ' ' A' ' 203' ' ' ASP . 54.8 t -123.47 136.58 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.678 HG11 ' HB3' ' A' ' 178' ' ' LEU . 85.4 t -131.85 130.82 61.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.508 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -74.43 -173.63 1.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.069 -1.02 . . . . 0.0 109.012 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.591 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 69.8 m -77.44 100.35 5.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.808 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.659 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 18.2 mt -58.83 -48.25 81.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.185 -0.947 . . . . 0.0 108.485 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.709 HD11 HG11 ' A' ' 198' ' ' VAL . 9.5 mt -55.91 -41.45 74.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 33.8 t0 -67.0 -38.73 86.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -15.9 11.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 108.558 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 16.0 mtpp -120.07 14.8 12.34 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.95 43.67 8.52 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.8 mt -93.1 110.28 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.493 -1.004 . . . . 0.0 110.574 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 51.6 m80 -135.13 100.02 4.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . 14.6 m-30 -102.4 175.9 5.36 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.891 -1.131 . . . . 0.0 110.843 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 5.1 t-20 -146.54 -171.27 3.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.585 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . 58.4 mt-30 -124.97 -3.56 7.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.829 -1.17 . . . . 0.0 110.676 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.03 -60.61 0.34 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.147 -1.501 . . . . 0.0 112.737 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.781 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -44.78 -123.72 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.424 0 CA-C-O 117.369 -1.3 . . . . 0.0 112.371 -176.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.781 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 42.7 Cg_endo -81.41 10.54 3.4 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 123.452 2.269 . . . . 0.0 109.596 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.824 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 92.6 m-85 -83.03 -38.64 22.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 110.663 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 44.4 p30 -103.55 35.39 2.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.622 -1.299 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.7 mt -78.11 -3.96 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.873 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 118' ' ' GLU . 21.3 mt -129.4 10.82 5.77 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.923 -1.11 . . . . 0.0 109.391 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.3 p -81.39 163.21 55.7 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.4 Cg_endo -69.82 128.59 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.131 1.887 . . . . 0.0 111.82 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 42' ' ' HIS . 10.8 t -74.43 150.67 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.737 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.2 mt -77.67 148.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.467 -0.771 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.55 -21.75 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.721 -0.612 . . . . 0.0 110.404 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.3 mtpp -122.29 171.96 8.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 110.071 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.0 t -114.36 148.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.394 -0.816 . . . . 0.0 111.113 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -87.84 130.05 48.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -70.31 125.3 11.71 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.57 1.513 . . . . 0.0 110.42 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.92 9.62 34.25 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -146.84 -177.37 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -1.062 . . . . 0.0 109.157 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -80.68 -176.21 5.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.9 t -86.4 138.36 31.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.4 m-85 -123.78 19.05 9.43 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' ILE . 66.9 t -66.8 144.5 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.73 -4.01 66.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 28.5 mt-30 -86.65 128.77 35.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -1.174 . . . . 0.0 109.564 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 25' ' ' THR . 1.1 m-70 -73.23 113.79 10.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.81 158.07 1.47 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.77 -1.172 . . . . 0.0 108.933 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 17' ' ' GLN . . . -78.47 170.09 17.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.391 0.615 . . . . 0.0 109.973 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 129' ' ' MET . 10.3 p -77.63 -31.58 52.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 103.6 138.08 9.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 p -54.51 -53.65 51.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -1.068 . . . . 0.0 108.408 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 4.9 t -47.01 -52.27 4.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.29 -50.12 74.89 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.947 0.879 . . . . 0.0 110.068 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.36 -33.88 76.5 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -178.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.56 87.66 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.217 -1.393 . . . . 0.0 107.43 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.722 HG23 HD21 ' A' ' 147' ' ' LEU . 59.7 m -74.42 -53.54 9.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 108.852 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -53.32 -37.94 62.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.813 -0.554 . . . . 0.0 110.77 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 27.1 mt-30 -67.34 -52.85 35.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.581 -1.324 . . . . 0.0 108.108 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 198' ' ' VAL . 31.9 mt -65.0 -18.8 24.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 34.4 mtp -73.84 -45.25 52.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 18.4 tptt -67.12 -36.02 81.0 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.659 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 65.9 t80 -54.06 -31.93 53.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.431 -0.793 . . . . 0.0 109.297 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 60' ' ' ASN . 26.3 m80 -106.92 -22.04 12.82 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 98.4 m-20 45.61 56.12 6.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 4.3 t80 -79.82 -74.54 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -68.11 103.15 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-N 119.104 0.716 . . . . 0.0 111.888 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.429 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 65.3 m-80 -70.56 -22.79 62.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.41 140.8 45.22 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.59 151.13 33.37 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.752 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.753 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.84 -44.29 10.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.506 -0.997 . . . . 0.0 109.97 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 13.9 tttp -152.57 142.35 21.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.103 -0.998 . . . . 0.0 109.855 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 89' ' ' ALA . 1.5 m-20 -65.24 164.49 13.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.673 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 70' ' ' THR . 7.6 t80 -143.78 147.19 33.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.431 -0.793 . . . . 0.0 109.272 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.629 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t -150.2 166.11 30.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.1 p90 -171.68 157.03 4.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 86.9 m -93.13 131.37 38.25 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.776 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -44.94 150.13 0.4 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 111.403 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 p -61.56 139.46 58.25 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -4.83 11.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -97.59 -7.41 31.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.588 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.776 ' ND2' HD21 ' A' ' 73' ' ' LEU . 25.9 t-20 -70.01 108.59 3.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 109.73 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.1 Cg_endo -89.36 15.73 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.997 2.465 . . . . 0.0 110.533 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.59 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 85.0 m-85 -106.42 -24.43 12.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.0 110.866 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' A' ' 81' ' ' ASN . 72.8 m-85 -117.71 163.85 15.86 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 10.3 m120 -48.19 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.546 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER 175.04 -47.56 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 111.307 175.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.47 55.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.0 tptt -106.0 104.94 14.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.253 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.14 140.99 33.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.124 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -115.23 145.88 41.99 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 5.8 t80 -136.83 128.42 28.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.303 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.32 111.84 23.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 87' ' ' PHE . . . -72.81 53.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.577 -1.327 . . . . 0.0 107.909 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 10.5 mt -52.62 -54.17 16.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.033 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -45.36 -26.14 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.751 -1.218 . . . . 0.0 109.073 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -110.86 32.34 5.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 108.892 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 35.0 mmt-85 -92.48 154.22 18.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -117.32 90.98 3.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.61 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.5 m-85 -80.84 85.04 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 110.664 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 4.9 t30 -78.88 89.33 4.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 100' ' ' ILE . 77.7 m95 -61.36 -5.1 1.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.525 -0.734 . . . . 0.0 110.939 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.25 -15.58 33.24 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.728 -1.233 . . . . 0.0 107.684 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 36.3 m-20 -99.65 -30.75 11.93 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.821 HG12 ' HB1' ' A' ' 115' ' ' ALA . 22.3 mt -73.64 67.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.653 0.74 . . . . 0.0 109.307 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 16.0 mt -47.47 148.78 2.23 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.597 -0.689 . . . . 0.0 109.528 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.567 ' HB3' HG12 ' A' ' 13' ' ' ILE . 31.4 Cg_endo -79.39 -17.38 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.648 2.232 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.27 123.08 9.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.044 . . . . 0.0 109.478 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 90.8 m-85 -110.79 144.03 40.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -100.53 2.68 42.18 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.325 -0.86 . . . . 0.0 108.816 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 81.67 0.73 89.67 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 2.84 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 104' ' ' TYR . 1.3 mp0 -67.11 169.02 9.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -64.9 177.46 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.278 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 1.2 m-20 -82.11 -36.49 27.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.854 . . . . 0.0 109.632 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.06 -57.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -38.08 89.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.14 -0.975 . . . . 0.0 108.84 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.532 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 81.0 mttt -63.78 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.45 -0.781 . . . . 0.0 109.011 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.496 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.0 ttm -58.78 -40.83 85.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 0.0 109.182 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.821 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.79 -54.58 45.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.626 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -68.36 -38.51 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.538 -1.352 . . . . 0.0 109.743 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -56.71 -43.65 80.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.102 -0.999 . . . . 0.0 109.887 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.596 ' N ' HD12 ' A' ' 24' ' ' LEU . 35.2 tt0 -69.99 -37.02 75.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.4 tp -62.97 -52.01 64.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.824 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -60.68 -48.05 83.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.559 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.72 90.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 0.0 108.821 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.592 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 88.3 m-20 -63.95 -41.44 97.6 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 119' ' ' LEU . 72.3 t -71.44 -59.16 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.391 0.615 . . . . 0.0 109.46 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.99 -47.43 14.68 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 126' ' ' SER . 2.3 mt -63.7 -56.15 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.316 -1.108 . . . . 0.0 108.217 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 2.2 p -45.96 -29.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.298 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 17.6 m -105.95 38.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.486 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 9.1 p-10 36.94 50.76 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.515 0.674 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.564 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 49.8 tpp -59.76 128.14 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.55 -0.718 . . . . 0.0 110.74 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 135' ' ' SER . 33.8 t70 -75.36 123.8 26.0 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.631 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 64.9 m-85 -103.33 114.09 28.1 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.539 1.161 . . . . 0.0 113.144 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.737 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.3 -164.24 11.74 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 0.0 104.426 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.618 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 17.8 Cg_endo -62.35 -29.38 79.49 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 N-CA-C 105.952 -2.365 . . . . 0.0 105.952 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.75 139.5 44.73 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.543 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 54.8 m -119.42 109.19 15.47 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.898 -1.751 . . . . 0.0 109.948 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.08 142.91 16.02 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.826 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 4.7 t -116.43 -162.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.829 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.96 -47.55 7.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 132.41 -139.55 11.04 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.029 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.627 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 9.0 m -50.32 -53.01 31.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.795 -0.826 . . . . 0.0 112.329 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 145' ' ' ARG . 1.5 p -47.42 -33.84 6.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.708 -1.245 . . . . 0.0 108.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.1 mmp_? -80.51 -48.22 13.1 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.949 0.88 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 185' ' ' TYR . 70.4 t -67.24 -56.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.914 -0.491 . . . . 0.0 110.966 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.9 pp0? -56.12 -33.54 65.24 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -77.37 -48.1 18.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.35 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.94 -36.15 77.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.157 -0.964 . . . . 0.0 110.274 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 52' ' ' THR . 41.7 mt -57.13 -46.26 82.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.825 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 51.8 mtmt -87.18 -44.02 11.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.995 -1.066 . . . . 0.0 111.18 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.0 mt-10 -69.34 -50.5 45.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.399 -1.438 . . . . 0.0 111.446 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 18.1 m120 -88.63 -45.52 9.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 0.0 111.636 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.61 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 33.5 m-85 -102.2 18.28 21.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.753 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 31.63 41.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.648 -0.658 . . . . 0.0 112.985 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.1 m-85 -63.41 164.32 9.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.268 -1.725 . . . . 0.0 108.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.51 145.86 2.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.928 -1.108 . . . . 0.0 109.529 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -53.8 -18.96 3.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.056 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.576 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 84.6 p -55.3 -15.0 2.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.626 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.5 t -67.61 121.57 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.781 -1.199 . . . . 0.0 109.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.2 p-80 -147.84 175.61 10.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 109.449 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.627 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 25.1 tt0 -120.86 138.45 54.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.721 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.846 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 12.7 pt -125.75 158.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.6 m-80 -114.56 101.22 8.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.871 -1.143 . . . . 0.0 110.71 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HD3' ' CD1' ' A' ' 170' ' ' TRP . 1.2 tpt180 -45.71 -36.82 5.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 109.072 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.59 -27.77 66.67 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.88 6.92 36.77 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.984 -1.303 . . . . 0.0 111.917 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -118.12 171.24 8.24 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.392 -1.443 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 95.0 p -95.23 134.34 38.1 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 9.4 ttpp -35.36 -48.98 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.717 -0.615 . . . . 0.0 110.781 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.37 -57.74 8.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.996 -1.065 . . . . 0.0 110.294 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.2 -20.56 65.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.846 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.7 t-105 -75.26 -43.96 48.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.397 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 174' ' ' ILE . 90.3 mt-10 -68.97 -31.28 70.03 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.948 -1.095 . . . . 0.0 108.311 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.25 73.95 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 36.6 mm-40 -61.14 -41.63 97.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 108.975 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 199' ' ' ILE . 10.4 mt -75.38 -57.35 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 110.56 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -42.61 43.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.069 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -54.17 -46.03 72.23 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 45.7 mm-40 -58.55 -50.46 73.72 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.678 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.0 mt -65.8 -29.27 69.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.371 -0.83 . . . . 0.0 109.626 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 5.8 p -50.03 -42.98 50.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 108.729 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 14.7 mt-30 -95.83 30.76 2.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.599 ' C ' HD13 ' A' ' 7' ' ' LEU . 66.7 m-80 49.36 51.37 16.46 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 22.1 mt-30 -123.14 111.96 30.29 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 55' ' ' ILE . 13.8 Cg_endo -62.88 173.64 3.65 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.223 1.949 . . . . 0.0 112.539 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.661 HG21 HG23 ' A' ' 174' ' ' ILE . 93.7 t -133.45 142.16 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.36 1.076 . . . . 0.0 112.803 -176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.801 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -90.85 117.7 29.67 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 175.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 10.0 t80 -122.51 161.57 23.37 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.129 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.2 pt20 -167.29 138.73 3.15 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 118.171 -1.412 . . . . 0.0 110.791 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -111.48 108.33 2.31 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 244' ' ' TYR . 21.9 t -66.85 163.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 111.174 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.521 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.87 -136.59 2.07 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -88.17 -32.49 18.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 111.253 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 238' ' ' ALA . 3.8 m -82.78 -18.7 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.874 -1.141 . . . . 0.0 111.504 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.88 -170.43 23.47 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -78.11 100.15 1.61 Allowed Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.83 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.635 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 40.0 t60 -72.26 126.69 30.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.13 165.86 13.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.053 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 40.7 p90 -156.89 -159.91 0.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.043 HG22 HD11 ' A' ' 55' ' ' ILE . 11.5 t -139.74 138.77 38.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.693 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.758 HD13 HG21 ' A' ' 174' ' ' ILE . 90.7 mt -107.08 111.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 15.1 p-10 -123.7 34.21 5.14 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.285 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 174.62 160.1 22.09 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.354 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -138.42 168.38 19.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.614 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -126.76 -11.17 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.958 -1.089 . . . . 0.0 110.209 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.59 -35.85 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 4.8 mtt180 -88.73 35.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.253 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 70.43 31.67 2.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 109.648 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 48.5 m-85 -122.26 133.78 54.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.17 -0.956 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 33.9 m-85 -124.07 160.47 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.311 -0.868 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.591 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 40.3 t-80 -92.13 134.6 34.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 222' ' ' PHE . 21.4 t -131.58 146.19 33.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.337 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.564 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 42.6 t-20 -114.45 81.92 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 91.4 m95 -57.21 163.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.721 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.24 17.4 47.74 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.19 -169.61 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.41 -1.053 . . . . 0.0 108.92 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -76.45 -90.47 0.25 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.65 68.96 0.54 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.83 HG22 ' N ' ' A' ' 218' ' ' SER . 0.7 OUTLIER -101.2 -92.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.875 -1.367 . . . . 0.0 110.166 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.83 ' N ' HG22 ' A' ' 217' ' ' VAL . 19.1 m -88.29 11.38 16.77 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.21 124.22 13.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.073 . . . . 0.0 109.016 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 209' ' ' HIS . . . 145.48 -97.41 0.19 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.352 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 98.9 m-85 -110.19 174.08 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.246 . . . . 0.0 110.473 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.708 ' CZ ' ' ND2' ' A' ' 228' ' ' ASN . 0.1 OUTLIER -78.42 156.49 29.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 109.669 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.692 ' C ' HD22 ' A' ' 224' ' ' LEU . 5.1 mmt180 -111.3 141.85 44.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.83 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.2 mm? -120.79 39.34 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.003 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.6 OUTLIER -95.57 -77.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.88 -92.91 0.52 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.291 -0.88 . . . . 0.0 109.261 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -90.94 -163.09 0.98 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.279 -0.888 . . . . 0.0 108.651 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.708 ' ND2' ' CZ ' ' A' ' 222' ' ' PHE . 2.1 m120 -91.29 -52.19 0.3 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 111.878 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 228' ' ' ASN . 33.4 Cg_endo -74.65 149.0 37.8 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.487 2.125 . . . . 0.0 110.64 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.1 t -122.15 -0.34 9.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.62 122.47 40.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 239' ' ' GLY . 0.1 OUTLIER -90.34 34.15 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.573 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 93.29 120.8 3.03 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 30.1 p -86.49 -26.25 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -1.129 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -96.17 -73.66 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -89.64 -137.54 6.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 166.08 98.31 0.12 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' A' ' 192' ' ' VAL . . . -105.61 -14.7 15.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -1.143 . . . . 0.0 109.516 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' A' ' 232' ' ' LEU . . . 132.13 -98.55 0.37 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 96.03 58.93 1.07 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.469 ' CD1' ' HA2' ' A' ' 190' ' ' GLY . 0.8 OUTLIER -81.67 -178.92 7.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -1.179 . . . . 0.0 109.137 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -99.07 84.27 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -82.27 -66.1 1.59 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.575 ' O ' HG23 ' A' ' 189' ' ' VAL . 9.6 m-85 -135.25 110.68 9.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -1.052 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.558 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 -92.5 140.0 30.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 108.751 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -149.58 166.16 30.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.045 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.26 152.23 44.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.278 1.037 . . . . 0.0 110.925 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 68.9 t -111.02 117.56 55.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.719 HG23 ' NE2' ' A' ' 158' ' ' HIS . 25.0 m -123.12 145.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.066 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 87.74 56.44 2.1 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 HG21 ' A' ' 55' ' ' ILE . 63.2 mt -100.32 74.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.565 -0.962 . . . . 0.0 110.674 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -152.4 156.76 33.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.086 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.613 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.295 1.997 . . . . 0.0 110.476 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.503 ' OE1' ' CA ' ' A' ' 204' ' ' GLY . 12.5 tt0 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' A' ' 1' ' ' GLN . 35.9 Cg_endo -78.95 169.93 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.494 2.13 . . . . 0.0 110.24 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG22 ' C ' ' A' ' 203' ' ' ASP . 41.8 t -98.11 134.38 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.452 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 202' ' ' ALA . 6.7 t -124.49 130.47 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 200' ' ' ASP . 35.4 mmtt -76.77 179.57 6.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . 4.2 m -77.67 104.93 8.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.014 -1.054 . . . . 0.0 109.363 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.666 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.6 mt -57.95 -56.17 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD11 ' CG1' ' A' ' 198' ' ' VAL . 18.2 mt -55.14 -36.88 66.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.41 -1.431 . . . . 0.0 108.294 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 22.4 t0 -68.52 -42.1 79.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.126 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -58.55 -14.98 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.05 -1.031 . . . . 0.0 109.045 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 15.5 mtpt -120.56 20.27 11.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.42 37.6 4.86 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.6 mt -85.31 106.92 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.386 1.089 . . . . 0.0 110.551 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 102' ' ' PRO . 17.7 m-70 -134.81 95.43 3.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 9.3 m-30 -98.95 179.13 4.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 111.064 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 26.1 t-20 -145.96 -177.44 5.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 39.0 mt-30 -116.64 -18.0 10.42 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.923 -1.111 . . . . 0.0 110.164 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.72 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.95 -38.22 0.9 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.337 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.3 t-20 -45.01 -142.5 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.458 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -73.78 2.99 5.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 122.411 1.897 . . . . 0.0 109.441 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 116' ' ' ILE . 11.2 m-85 -79.29 -28.01 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.122 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 14.7 p-10 -96.51 23.38 6.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.593 -1.317 . . . . 0.0 109.783 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 8.7 mt -76.79 -5.64 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.566 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.8 mt -125.57 9.46 7.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.602 -1.311 . . . . 0.0 109.428 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 40.9 p -82.06 160.87 62.14 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.606 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -68.82 126.18 13.61 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.14 1.894 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.493 HG22 ' CG ' ' A' ' 42' ' ' HIS . 44.4 t -74.65 151.45 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.423 0.63 . . . . 0.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.2 mt -77.69 147.23 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 110.899 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.7 mt-10 -126.31 -20.74 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.745 -0.597 . . . . 0.0 110.535 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 48.0 mtpt -120.12 172.9 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.005 -1.059 . . . . 0.0 110.158 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 79.7 t -114.4 143.04 24.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 111.05 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HD3' ' OE1' ' A' ' 35' ' ' GLU . 19.3 tttt -76.83 128.72 80.91 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.54 118.61 5.78 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.319 1.346 . . . . 0.0 110.286 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.03 17.05 14.87 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' OE1' ' HD3' ' A' ' 32' ' ' LYS . 32.3 tt0 -152.79 173.81 14.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.433 -1.039 . . . . 0.0 109.56 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -179.32 2.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 109.996 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.5 t -87.5 139.2 30.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.363 -0.836 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 75.5 m-85 -124.18 23.92 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.107 -0.996 . . . . 0.0 109.367 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 29' ' ' GLU . 70.2 t -69.99 146.49 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.809 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.05 1.84 86.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 13.3 mt-30 -93.06 126.8 38.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -1.131 . . . . 0.0 109.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 27' ' ' VAL . 1.7 m-70 -72.83 111.55 8.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.32 157.69 1.37 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.997 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.07 166.04 23.81 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.628 0.727 . . . . 0.0 109.946 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.771 HG21 ' SD ' ' A' ' 120' ' ' MET . 19.1 p -77.11 -33.66 56.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 106.18 136.57 8.44 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.487 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 5.3 p -54.85 -50.12 69.45 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.292 -1.122 . . . . 0.0 108.275 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 9.5 t -47.52 -53.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.53 -48.65 80.85 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.046 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.737 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -62.79 -33.6 75.53 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.966 -177.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.93 91.62 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.882 -1.527 . . . . 0.0 108.036 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 56' ' ' MET . 31.3 m -75.46 -50.68 15.03 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.426 0.631 . . . . 0.0 110.003 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.32 -35.57 38.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 mt-30 -68.47 -44.88 73.85 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 198' ' ' VAL . 53.0 mt -69.92 -22.9 25.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.616 ' HG3' HG22 ' A' ' 52' ' ' THR . 16.8 mtp -73.76 -34.58 64.77 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.599 ' HD3' HG22 ' A' ' 100' ' ' ILE . 33.7 tptt -74.9 -43.39 54.59 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.8 t80 -54.06 -25.46 21.71 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.351 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 32.1 m-70 -108.31 -27.81 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 110.674 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 67.6 m-20 45.11 61.36 2.57 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.3 t80 -84.98 -77.56 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.6 Cg_endo -70.66 106.47 1.83 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 119.467 0.845 . . . . 0.0 113.83 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -67.51 -24.79 65.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -131.83 127.04 35.76 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 176.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.73 166.08 4.84 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 118.566 -1.778 . . . . 0.0 110.877 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.046 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -95.95 -35.29 11.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.469 -1.018 . . . . 0.0 111.44 -178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 27.0 tttp -152.76 130.54 11.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.534 -1.354 . . . . 0.0 110.887 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 3.4 m-20 -62.25 171.35 1.88 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.08 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.405 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 47.4 t80 -149.11 141.8 24.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.578 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t -144.65 148.37 34.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.67 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.5 p90 -160.47 155.2 24.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 29.1 m -93.01 131.71 37.76 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.783 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.13 147.72 0.68 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.845 . . . . 0.0 110.727 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 1.5 t -61.79 146.75 48.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.941 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 0.99 9.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.109 -0.994 . . . . 0.0 109.745 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -99.47 -7.99 25.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.783 ' ND2' HD21 ' A' ' 73' ' ' LEU . 17.6 t-20 -70.32 109.41 4.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.751 -0.593 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.2 Cg_endo -89.26 15.68 1.95 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 73.9 m-85 -110.78 -23.65 10.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 111.167 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 80.4 m-85 -118.14 160.69 21.11 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.7 m120 -48.22 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 174.76 -45.75 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.387 -0.821 . . . . 0.0 111.311 175.322 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.0 Cg_endo -75.76 55.32 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 N-CA-C 107.86 -1.631 . . . . 0.0 107.86 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 5.4 tptt -106.75 106.81 17.51 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.237 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -100.1 141.54 32.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.64 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.67 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 mp -118.26 125.41 50.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 12.1 t80 -120.16 127.71 52.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.956 . . . . 0.0 110.133 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -108.34 111.9 24.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -72.94 53.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.739 -1.226 . . . . 0.0 108.352 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.658 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.7 mt -53.24 -58.3 3.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.746 -0.596 . . . . 0.0 111.195 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.0 p -43.56 -29.44 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.815 -1.178 . . . . 0.0 109.257 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.884 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.29 30.14 7.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.46 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.814 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 27.7 mmt-85 -79.22 156.06 28.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.537 -1.352 . . . . 0.0 109.4 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -116.46 83.78 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 122' ' ' ASP . 9.1 m-85 -80.71 97.83 7.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.611 -0.681 . . . . 0.0 110.132 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 100' ' ' ILE . 29.5 t-20 -79.02 89.88 4.79 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 45.5 m95 -60.54 -8.89 3.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.68 -21.68 21.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.2 m-20 -100.07 -24.76 14.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 57' ' ' LYS . 36.3 mt -73.49 64.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.575 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 37.7 mt -46.4 149.23 1.4 Allowed Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 13' ' ' ILE . 29.6 Cg_endo -77.58 -25.17 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.579 2.186 . . . . 0.0 110.522 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 125.37 16.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 109.516 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.575 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 76.5 m-85 -112.78 145.14 41.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -99.56 -4.36 31.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 82.49 7.64 87.26 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -118.5 9.12 12.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -1.068 . . . . 0.0 108.724 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -72.76 -177.84 2.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.437 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -73.92 172.94 10.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -74.81 -36.18 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.634 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.3 t -51.81 -60.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.437 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 5.2 mp0 -62.54 -36.24 82.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.974 -1.079 . . . . 0.0 108.989 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.5 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 72.9 mttt -64.5 -42.67 95.7 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.484 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.5 ttm -60.03 -38.73 83.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.11 -69.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.485 -0.76 . . . . 0.0 110.476 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.722 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.0 tp -57.92 -43.6 84.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 110.227 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 5.3 p -50.51 -40.52 51.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.493 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.62 -48.96 58.23 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.4 tp -49.19 -48.76 45.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.771 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -58.82 -55.28 37.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.577 -0.702 . . . . 0.0 110.583 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.42 -33.43 75.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.814 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 21.6 m-20 -64.37 -47.12 80.48 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 119' ' ' LEU . 62.1 t -71.35 -55.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.499 -0.75 . . . . 0.0 109.264 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.26 -50.53 12.94 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.0 mt -63.69 -55.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.255 -1.144 . . . . 0.0 108.046 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 6.9 p -46.93 -32.05 3.57 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.296 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.598 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 14.1 m -100.66 34.32 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.9 m-20 38.6 53.69 1.88 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.611 0.719 . . . . 0.0 109.509 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.601 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 57.3 tpp -65.87 129.56 40.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 111.629 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -76.61 121.83 23.78 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 75.6 m-85 -103.38 117.46 34.53 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.705 1.24 . . . . 0.0 113.432 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.54 -162.46 10.6 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 104.12 -3.592 . . . . 0.0 104.12 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.656 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.53 -30.48 79.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 106.049 -2.327 . . . . 0.0 106.049 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.94 143.06 40.42 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.0 m -124.59 112.55 16.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.975 -1.703 . . . . 0.0 110.092 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 146.28 16.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.578 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 33.5 t -120.0 -164.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -91.89 -52.31 4.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.15 -143.33 14.75 Favored Glycine 0 N--CA 1.48 1.592 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.978 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.65 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 74.6 m -48.37 -51.18 27.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.755 -0.85 . . . . 0.0 111.846 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.49 -39.17 10.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.789 -1.195 . . . . 0.0 108.761 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.799 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 10.5 mmt180 -81.77 -44.3 17.18 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.203 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.2 t -69.07 -51.28 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 110.584 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.4 pp0? -56.95 -35.73 69.44 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.001 -1.062 . . . . 0.0 108.691 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 30.6 ttm180 -77.27 -47.0 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.965 . . . . 0.0 110.147 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.55 84.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.125 -0.984 . . . . 0.0 110.353 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 251' ' ' ILE . 67.7 mt -59.7 -46.35 89.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.751 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 33.2 mtmt -85.0 -47.72 9.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 110.758 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 18.8 mt-10 -70.63 -47.07 61.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.911 -1.118 . . . . 0.0 112.273 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 18.6 m120 -89.57 -53.27 4.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.575 -1.328 . . . . 0.0 112.126 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.407 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 46.6 m-85 -90.06 -13.75 35.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 110.448 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.046 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 65.52 36.55 92.65 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.054 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 251' ' ' ILE . 7.9 m-85 -63.43 172.63 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.374 -1.662 . . . . 0.0 107.808 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 33.5 t-20 -47.86 134.74 12.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.725 -1.234 . . . . 0.0 109.235 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 8.8 mm100 -53.31 -21.67 5.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.958 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 154' ' ' ASN . 52.6 p -54.49 -16.72 2.51 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.369 -0.832 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.4 t -57.19 123.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.032 -1.043 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.969 ' CE1' HG23 ' A' ' 249' ' ' VAL . 15.2 p-80 -143.46 161.35 38.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.65 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 41.4 tt0 -102.27 154.65 18.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 0.0 110.274 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.556 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.7 pt -137.64 134.92 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.5 m-80 -102.73 107.36 18.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.838 -1.163 . . . . 0.0 111.069 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.667 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -47.38 -44.46 24.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.85 -21.58 55.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 18.1 m-20 -104.9 2.24 29.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.953 -1.322 . . . . 0.0 112.162 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -117.65 175.05 5.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.302 -1.498 . . . . 0.0 110.314 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.509 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.1 p -100.41 131.63 46.22 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.509 ' C ' ' O ' ' A' ' 166' ' ' SER . 28.3 ttmt -30.09 -49.35 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.204 0.526 . . . . 0.0 111.002 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -62.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.96 -1.087 . . . . 0.0 110.188 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.39 -16.12 52.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.004 -1.06 . . . . 0.0 109.28 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 57.6 t-105 -72.71 -51.14 20.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.522 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.0 mt-10 -68.88 -37.12 78.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.08 -1.012 . . . . 0.0 108.319 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.61 -42.16 15.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -61.01 -42.81 99.17 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 199' ' ' ILE . 6.9 mt -70.34 -53.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.729 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.471 ' OD1' ' CE2' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -49.84 -55.92 12.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.634 -178.283 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -50.91 -41.32 58.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.837 -1.165 . . . . 0.0 108.517 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.59 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.7 mm-40 -61.26 -49.79 75.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 199' ' ' ILE . 46.9 mt -68.53 -24.67 64.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.247 -0.908 . . . . 0.0 110.257 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 53.3 p -52.05 -37.12 52.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.479 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 mt-30 -102.71 34.11 2.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.618 ' HB3' HD22 ' A' ' 7' ' ' LEU . 30.5 m-20 44.21 51.71 7.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.15 -0.969 . . . . 0.0 108.893 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 9.5 mt-30 -123.79 107.44 31.25 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.614 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.7 Cg_endo -62.63 165.74 15.13 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.708 1.605 . . . . 0.0 112.681 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.661 HG22 HG12 ' A' ' 249' ' ' VAL . 18.7 t -120.04 134.88 62.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.207 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.865 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.9 OUTLIER -82.81 115.3 21.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.12 158.59 28.96 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.914 -1.117 . . . . 0.0 108.798 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 196' ' ' ALA . 2.0 pt20 -167.77 128.37 1.41 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.006 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' HIS . . . -91.1 124.44 7.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 106.154 -2.778 . . . . 0.0 106.154 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 194' ' ' GLY . 1.9 t -101.86 164.51 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.727 -1.455 . . . . 0.0 112.957 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -160.07 -136.61 2.06 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -25.28 22.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.817 -1.402 . . . . 0.0 110.777 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.468 ' CG1' ' HA3' ' A' ' 237' ' ' GLY . 15.8 m -83.46 -22.43 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.003 -1.061 . . . . 0.0 111.659 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.467 ' C ' HG13 ' A' ' 189' ' ' VAL . . . 138.31 176.8 14.76 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.562 ' N ' HG13 ' A' ' 189' ' ' VAL . . . -76.87 113.19 3.72 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.57 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 33.5 t-80 -71.27 95.32 1.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -86.12 155.67 20.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.719 1.247 . . . . 0.0 113.793 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 35.0 p90 -154.04 177.06 11.48 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.723 HG22 HD11 ' A' ' 55' ' ' ILE . 97.9 t -123.26 136.66 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.496 -1.377 . . . . 0.0 112.418 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 178' ' ' LEU . 64.9 mt -97.11 124.13 49.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 7.4 p-10 -137.15 29.65 2.76 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.989 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -168.87 174.36 43.44 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.506 -2.283 . . . . 0.0 112.169 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -166.87 147.79 5.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.47 ' C ' HG22 ' A' ' 3' ' ' VAL . 5.3 t70 -120.33 34.41 5.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.654 -1.279 . . . . 0.0 109.686 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.503 ' CA ' ' OE1' ' A' ' 1' ' ' GLN . . . 53.88 18.62 8.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 3.2 mtt85 -136.63 32.58 2.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -1.178 . . . . 0.0 109.225 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 1.3 m120 64.75 22.79 12.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 10.0 m-85 -110.73 100.26 9.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.605 ' H ' ' CB ' ' A' ' 222' ' ' PHE . 11.1 m-85 -96.56 156.28 16.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.444 -0.785 . . . . 0.0 110.292 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.639 ' CD2' ' HA3' ' A' ' 220' ' ' GLY . 56.2 t-80 -93.17 123.32 36.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 9.1 t -112.76 135.31 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.821 1.296 . . . . 0.0 111.825 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 8' ' ' LEU . 3.8 t30 -112.95 99.55 7.95 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.89 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.668 ' CD1' HG23 ' A' ' 217' ' ' VAL . 43.9 m95 -49.0 178.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.749 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 17' ' ' GLN . . . -86.64 15.45 51.49 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.727 ' HB2' HG22 ' A' ' 217' ' ' VAL . 65.9 m95 -109.52 -167.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.291 . . . . 0.0 109.575 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 15' ' ' TYR . . . -117.87 -28.5 2.24 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.595 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.58 -24.09 9.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 214' ' ' TRP . 0.9 OUTLIER -85.58 -37.93 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.848 -0.795 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 217' ' ' VAL . 0.2 OUTLIER -41.51 93.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 217' ' ' VAL . 1.9 t70 -98.7 -77.0 0.52 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.025 0.917 . . . . 0.0 112.13 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 144.18 59.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.516 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 1.2 m-85 -120.94 120.12 34.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.126 -1.22 . . . . 0.0 110.975 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.605 ' CB ' ' H ' ' A' ' 208' ' ' TYR . 0.3 OUTLIER -77.11 15.8 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.763 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.715 ' C ' HD22 ' A' ' 224' ' ' LEU . 3.3 mtp180 -85.6 119.25 25.73 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.3 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.819 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.4 mm? -120.78 21.36 11.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.313 -0.867 . . . . 0.0 109.957 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -34.26 31.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 109.051 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.66 97.89 5.49 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -89.14 69.49 8.32 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 121.585 0.707 . . . . 0.0 109.657 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -116.56 102.52 53.3 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 232' ' ' LEU . 34.7 Cg_endo -76.34 159.16 36.66 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 110.726 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.6 m -87.41 -35.14 18.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.549 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.26 45.57 1.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 229' ' ' PRO . 27.0 tp -79.17 -34.63 42.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.66 151.38 1.92 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.37 59.54 1.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -84.71 172.2 48.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -70.55 88.03 0.35 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.468 ' HA3' ' CG1' ' A' ' 192' ' ' VAL . . . -173.77 -167.68 33.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -106.74 163.31 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -1.14 . . . . 0.0 109.399 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.78 -43.89 8.07 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.91 72.21 0.42 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -110.07 127.74 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.141 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 9.1 t30 -108.35 70.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.962 . . . . 0.0 109.779 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -77.04 -47.0 9.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' VAL . 3.1 m-85 -135.43 148.14 49.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -1.07 . . . . 0.0 109.079 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 5.4 tt0 -151.63 122.43 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 25.6 p -150.57 164.56 35.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 110.617 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.41 163.47 32.72 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.846 0.832 . . . . 0.0 109.703 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.865 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.4 t -117.28 128.42 74.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.969 HG23 ' CE1' ' A' ' 158' ' ' HIS . 32.7 m -127.05 144.96 35.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.796 -1.19 . . . . 0.0 111.072 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.18 51.45 2.97 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 147' ' ' LEU . 8.2 mt -102.43 97.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.575 -0.956 . . . . 0.0 109.824 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.6 150.78 10.58 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.095 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.633 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.6 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.178 1.918 . . . . 0.0 110.359 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.464 ' NE2' ' CZ ' ' A' ' 208' ' ' TYR . 55.1 tt0 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.33 -170.95 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.403 2.069 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 ' C ' ' A' ' 203' ' ' ASP . 25.1 t -133.45 138.48 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.158 -0.964 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 178' ' ' LEU . 13.7 t -130.92 131.15 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.0 mmtt -74.82 -169.28 0.86 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.061 -1.024 . . . . 0.0 108.291 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.587 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 72.7 m -80.86 101.58 9.5 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.155 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 200' ' ' ASP . 45.0 mt -58.15 -49.18 77.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.999 -1.063 . . . . 0.0 108.737 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.632 HD11 HG11 ' A' ' 198' ' ' VAL . 9.4 mt -59.74 -38.82 82.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.073 -1.017 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 8.0 t0 -67.26 -37.75 84.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 109.152 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 p -57.88 -15.73 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.005 . . . . 0.0 108.575 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 13' ' ' ILE . 3.1 mtpt -120.84 18.16 11.82 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 47.1 41.25 14.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.3 mt -89.63 102.0 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -1.039 . . . . 0.0 110.29 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 27.1 m80 -128.1 77.7 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.625 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 11.4 m-30 -81.61 -179.79 7.52 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.102 0.953 . . . . 0.0 111.182 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.98 -164.04 1.93 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 3.0 mt-30 -125.16 -19.64 5.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.061 -1.025 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.83 -35.44 1.26 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.617 -1.277 . . . . 0.0 111.424 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.6 t-20 -45.77 -140.17 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 118.469 -0.776 . . . . 0.0 110.981 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.3 Cg_endo -74.16 3.54 5.06 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 122.46 1.914 . . . . 0.0 109.616 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 7.5 m-85 -79.93 -31.13 40.07 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.231 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.0 p-10 -93.46 17.88 10.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.484 -1.385 . . . . 0.0 109.944 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.5 4.92 5.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.862 . . . . 0.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 118' ' ' GLU . 13.3 mt -133.39 -4.45 2.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.721 -1.237 . . . . 0.0 110.368 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.6 p -61.99 164.62 10.02 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.9 Cg_endo -71.7 132.96 21.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.648 1.565 . . . . 0.0 110.573 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.93 145.38 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 110.229 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HA2' ' A' ' 132' ' ' GLY . 8.9 mt -77.01 149.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.592 -0.692 . . . . 0.0 110.565 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.629 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.2 mt-10 -125.39 -23.84 4.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.703 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 79' ' ' TYR . 25.8 mtpp -114.74 174.48 5.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.958 -1.089 . . . . 0.0 109.98 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 37' ' ' SER . 98.3 t -114.32 146.48 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.887 . . . . 0.0 111.008 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 58.3 tttt -86.6 130.76 47.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.65 123.91 10.6 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.466 1.444 . . . . 0.0 110.182 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 11.43 29.86 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.7 tt0 -151.25 168.09 25.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -1.082 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.3 -175.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 108.62 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.0 t -87.76 139.1 30.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 110.275 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.768 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 17.3 m-30 -111.78 11.69 20.93 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 109.275 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 29' ' ' GLU . 20.3 t -61.54 119.15 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.841 -1.162 . . . . 0.0 108.617 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.04 52.34 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CD ' ' HA ' ' A' ' 38' ' ' PHE . 67.1 mt-30 -74.53 135.81 42.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.947 . . . . 0.0 109.255 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.48 116.14 13.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.92 156.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.326 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.825 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -80.57 167.12 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.0 p -81.96 -37.61 26.44 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.567 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 105.14 139.3 9.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' VAL . 1.2 p -55.11 -50.26 69.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -1.161 . . . . 0.0 108.158 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 127' ' ' VAL . 2.7 t -46.32 -53.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.57 -48.04 79.04 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.468 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 53.2 m -62.51 -31.87 72.7 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.734 -0.604 . . . . 0.0 109.439 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.37 76.24 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.69 -1.256 . . . . 0.0 108.756 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.592 HG22 ' HG3' ' A' ' 56' ' ' MET . 28.2 m -74.75 -51.71 13.47 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.567 0.698 . . . . 0.0 109.729 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -50.94 -36.69 40.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.684 -0.635 . . . . 0.0 109.567 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.625 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 23.1 mt-30 -69.69 -58.91 3.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.665 -1.272 . . . . 0.0 107.969 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.058 HD11 HG22 ' A' ' 198' ' ' VAL . 78.0 mt -57.68 -20.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.592 ' HG3' HG22 ' A' ' 52' ' ' THR . 24.7 mtp -73.91 -35.82 64.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 28.9 tptt -77.49 -41.04 40.85 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.188 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 46.3 t80 -53.19 -26.76 18.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 108.813 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 65.2 m-70 -107.85 -26.66 10.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 110.426 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 85.7 m-20 47.97 58.39 5.12 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.5 t80 -83.91 -73.88 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 113.087 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.8 Cg_endo -68.23 101.61 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.026 0.688 . . . . 0.0 111.6 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.42 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 4.2 m120 -70.32 -20.51 63.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 51.5 tttt -134.74 142.25 46.7 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.89 147.47 37.3 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.928 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -86.81 -50.57 6.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.989 . . . . 0.0 109.992 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 44.9 tttt -148.49 152.73 37.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.943 . . . . 0.0 109.594 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 89' ' ' ALA . 12.9 m-20 -73.01 178.01 4.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 70' ' ' THR . 24.5 t80 -154.26 153.82 32.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.373 -0.83 . . . . 0.0 109.581 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.616 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -158.0 154.12 27.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.8 p90 -161.66 162.73 30.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 56.6 m -93.83 131.67 38.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.76 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -47.13 148.43 1.19 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 111.11 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.67 143.43 56.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.689 -0.632 . . . . 0.0 110.041 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 t -69.61 -2.76 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 110.087 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 m-20 -99.39 -3.72 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.026 -1.046 . . . . 0.0 109.39 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.76 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.6 t-20 -70.65 110.67 7.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.536 -0.728 . . . . 0.0 110.11 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.633 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -90.91 20.19 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 123.101 2.534 . . . . 0.0 108.559 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.633 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 45.2 m-85 -114.11 -28.34 7.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 111.879 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' ASN . 49.3 m-85 -118.06 164.83 14.52 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.0 m120 -46.99 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 174.95 -47.48 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 111.044 175.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -77.38 54.31 4.65 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 N-CA-C 107.216 -1.879 . . . . 0.0 107.216 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HE3' ' HG ' ' A' ' 86' ' ' LEU . 13.3 tptt -106.68 107.08 17.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.812 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -100.93 140.17 35.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 108.983 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.7 mp -111.32 149.41 31.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -137.17 123.19 20.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.994 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.12 112.85 25.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -74.72 50.98 0.46 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.795 -1.191 . . . . 0.0 108.4 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 92.9 mt -52.6 -45.4 47.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.9 p -45.23 -26.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.738 -1.226 . . . . 0.0 109.047 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -111.38 37.76 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 108.929 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.65 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 11.9 mmt-85 -95.48 154.93 16.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.493 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.48 91.95 3.71 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.7 m-85 -81.19 90.26 6.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 110.573 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -78.92 92.18 4.88 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.604 ' CE3' ' HA ' ' A' ' 60' ' ' ASN . 67.0 m95 -60.72 -9.17 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.408 -0.808 . . . . 0.0 110.164 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -90.75 -20.39 22.46 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 30.9 m-20 -92.08 -34.62 14.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.527 HG12 ' HB1' ' A' ' 115' ' ' ALA . 25.9 mt -73.83 94.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.0 mt -71.47 153.03 93.94 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.496 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.4 Cg_endo -80.05 -30.31 2.25 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.808 2.339 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 t -136.7 128.15 28.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 68.1 m-85 -112.52 138.01 49.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.7 p -99.95 2.02 43.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 108.707 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.72 0.12 89.87 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -120.1 13.23 12.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 0.0 109.461 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 3.7 mp0 -72.5 170.25 14.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.9 173.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.125 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -79.72 -44.12 21.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.98 -47.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.21 -43.54 97.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.094 -1.004 . . . . 0.0 109.207 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 52.1 mttt -60.52 -36.22 77.86 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.429 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 6.2 ttm -60.07 -46.74 88.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.49 -50.4 73.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.187 -0.945 . . . . 0.0 110.727 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.748 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.3 tp -69.55 -46.96 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.612 -1.305 . . . . 0.0 109.734 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . 5.2 p -53.71 -40.26 65.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.003 . . . . 0.0 109.156 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.833 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.1 tp10 -69.81 -45.42 67.94 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.748 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.0 tp -51.42 -50.25 60.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.663 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -60.87 -46.8 89.19 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.768 -0.582 . . . . 0.0 109.816 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.67 -39.66 94.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.467 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -64.53 -46.12 84.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 119' ' ' LEU . 89.1 t -71.4 -58.92 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.53 0.681 . . . . 0.0 109.822 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.79 -48.25 13.36 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.9 mt -63.5 -58.05 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.3 p -47.58 -29.22 2.72 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.986 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.664 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.8 m -100.68 37.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 127' ' ' VAL . 91.1 m-20 37.1 50.19 0.91 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.679 0.752 . . . . 0.0 109.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 54.9 tpp -65.75 130.55 43.68 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.539 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 38.6 t0 -76.57 118.69 19.48 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 104.014 -2.588 . . . . 0.0 104.014 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.567 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 39.8 m-85 -101.19 110.6 22.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.673 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -150.14 -170.34 17.32 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 103.722 -3.751 . . . . 0.0 103.722 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.768 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.9 Cg_endo -62.54 -20.61 71.19 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 106.923 -1.991 . . . . 0.0 106.923 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -110.86 135.21 51.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.825 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 69.1 m -123.6 111.05 15.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 119.817 -1.802 . . . . 0.0 110.97 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.57 130.91 10.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 5.5 t -110.1 -163.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.879 -1.365 . . . . 0.0 107.433 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.576 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -89.8 -55.92 3.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.621 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 142.92 -136.2 6.95 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.051 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.658 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 13.8 m -56.62 -45.16 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.858 -0.789 . . . . 0.0 112.108 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 140' ' ' SER . 14.7 p -46.11 -43.35 14.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.946 -1.096 . . . . 0.0 109.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.8 mmt180 -82.34 -40.25 21.67 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 1.008 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.3 t -68.33 -54.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.7 pp0? -56.73 -33.95 67.02 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.268 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.1 ttp180 -77.15 -48.52 17.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.95 78.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.959 . . . . 0.0 110.043 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 157' ' ' VAL . 50.7 mt -58.77 -47.93 83.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.088 -1.008 . . . . 0.0 109.475 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 14.0 mtmt -87.17 -35.65 18.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.859 -1.15 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 43.2 mt-10 -77.68 -55.28 5.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.406 -1.434 . . . . 0.0 111.823 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 34.2 m120 -84.35 -40.39 17.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.966 -1.084 . . . . 0.0 111.578 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.442 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 33.6 m-85 -102.51 -2.25 28.97 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.767 -1.208 . . . . 0.0 110.665 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.928 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.0 36.65 43.49 Favored Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.163 -0.961 . . . . 0.0 112.011 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.3 m-85 -62.01 163.85 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.242 -1.74 . . . . 0.0 107.993 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.9 t30 -47.3 147.01 1.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.452 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.37 4.71 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.23 -0.918 . . . . 0.0 108.698 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.536 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 16.7 p -54.08 -16.21 1.86 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.417 -0.802 . . . . 0.0 109.955 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.7 t -65.3 120.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.787 -1.195 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.799 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.9 p-80 -147.21 157.57 43.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.027 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 6.7 tt0 -101.93 155.81 17.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 246' ' ' SER . 2.6 pt -138.57 154.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.88 97.59 7.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 110.569 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.765 ' HG3' HE21 ' A' ' 245' ' ' GLN . 5.3 tpt180 -47.77 -31.58 5.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.25 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.541 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -63.7 -23.64 67.32 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -103.64 2.03 32.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.124 -1.221 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -117.92 140.57 49.54 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.63 -1.294 . . . . 0.0 109.81 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -67.98 139.97 56.37 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 59.2 tttt -38.04 -46.78 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -56.83 12.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 169' ' ' ASP . 1.7 m-20 -63.43 -23.38 67.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 109.268 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.798 ' NE1' HD11 ' A' ' 174' ' ' ILE . 66.8 t-105 -72.53 -43.63 63.28 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 175' ' ' ASP . 34.3 mt-10 -62.71 -26.62 68.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.34 81.94 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.22 -42.4 98.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -0.851 . . . . 0.0 108.881 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.981 HD13 ' CD1' ' A' ' 199' ' ' ILE . 28.7 mt -75.99 -61.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.713 . . . . 0.0 110.889 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.4 OUTLIER -49.29 -51.58 33.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.967 -1.083 . . . . 0.0 109.601 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -52.1 -40.69 61.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.882 -1.136 . . . . 0.0 107.988 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.58 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 5.0 mm-40 -60.88 -53.96 50.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.603 -0.686 . . . . 0.0 109.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.97 ' HB2' HG21 ' A' ' 4' ' ' VAL . 5.8 mt -65.69 -24.68 67.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.43 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 24.8 p -52.31 -45.17 65.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.974 -1.079 . . . . 0.0 108.193 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.5 mt-30 -94.29 39.09 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.477 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.3 m-20 42.52 51.2 4.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 10.2 mt-30 -123.94 105.14 32.32 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.447 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.1 Cg_endo -63.93 173.58 4.69 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.103 1.869 . . . . 0.0 112.653 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 63.9 t -129.84 142.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.242 1.02 . . . . 0.0 112.236 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 1.008 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -93.29 121.17 34.39 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.675 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 14.0 t80 -122.69 159.42 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.549 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -152.52 119.86 5.94 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.594 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 195' ' ' HIS . . . -91.97 106.03 3.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 10.1 t -67.11 160.76 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.25 -1.147 . . . . 0.0 110.644 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -172.34 -145.65 5.04 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -30.45 20.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.292 . . . . 0.0 110.229 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.488 HG11 ' O ' ' A' ' 238' ' ' ALA . 5.5 m -83.51 -22.2 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.3 -169.61 23.94 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -77.38 112.55 3.53 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.176 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.5 t-80 -77.44 113.73 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -105.98 164.34 12.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.782 1.277 . . . . 0.0 114.036 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' ' 186' ' ' TYR . 43.5 p90 -162.64 -160.68 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.058 HG22 HD11 ' A' ' 55' ' ' ILE . 5.7 t -139.61 139.35 38.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.206 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.981 ' CD1' HD13 ' A' ' 174' ' ' ILE . 40.0 mt -105.66 108.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 10.2 p-10 -120.87 32.43 5.97 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.428 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 4' ' ' VAL . . . 178.17 166.16 34.11 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.267 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -145.77 164.26 32.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.615 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -133.65 2.15 3.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.369 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.8 -31.06 4.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 10.0 mtt-85 -87.49 39.19 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.033 -1.275 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 17.0 m120 61.71 16.18 7.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 110.094 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -114.43 138.2 50.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 9.2 m-85 -123.17 162.48 22.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.337 -0.852 . . . . 0.0 110.285 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 59.2 t-80 -92.11 139.63 30.44 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 212' ' ' TRP . 2.7 t -140.23 157.96 25.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.867 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.544 ' HB2' HD12 ' A' ' 8' ' ' LEU . 43.9 t-20 -117.95 85.23 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.71 ' CE2' HG11 ' A' ' 210' ' ' VAL . 19.7 m95 -70.52 176.4 4.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.146 -0.972 . . . . 0.0 112.019 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.03 33.85 5.0 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.914 ' HB2' HG22 ' A' ' 217' ' ' VAL . 40.2 m95 -114.85 -162.6 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -1.134 . . . . 0.0 109.716 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -100.97 -53.58 1.02 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.846 -1.168 . . . . 0.0 111.498 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -108.54 -23.09 6.73 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.69 -1.476 . . . . 0.0 110.03 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.93 HG11 ' HB2' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -73.91 -28.32 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.369 -1.077 . . . . 0.0 108.821 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.475 ' HA ' ' HB2' ' A' ' 212' ' ' TRP . 1.2 t -43.54 -48.53 7.48 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.179 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.14 93.38 6.91 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.494 -1.379 . . . . 0.0 110.095 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -156.19 150.99 22.48 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -100.01 85.07 2.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -1.212 . . . . 0.0 109.327 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -138.65 -177.65 4.96 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.491 0.662 . . . . 0.0 110.176 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.69 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -129.72 122.12 28.26 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 223' ' ' ARG . 4.1 mm? -119.66 36.49 4.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.289 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.607 ' O ' ' NE2' ' A' ' 245' ' ' GLN . 14.3 m-20 -80.07 4.38 17.36 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.589 ' O ' ' ND2' ' A' ' 242' ' ' ASN . . . -114.96 -65.46 1.19 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 109.68 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.1 -155.62 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 109.942 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.548 ' CB ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER -100.7 176.97 1.66 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.844 . . . . 0.0 109.394 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 228' ' ' ASN . 35.8 Cg_endo -78.34 -157.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.813 2.342 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.6 t -117.54 22.49 12.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.068 -1.02 . . . . 0.0 109.767 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.93 ' HB2' HG11 ' A' ' 217' ' ' VAL . . . -114.79 126.21 54.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 mt -122.46 18.17 10.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' N ' ' CH2' ' A' ' 214' ' ' TRP . . . 58.55 -176.05 2.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 26.9 m -95.12 -75.79 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -1.191 . . . . 0.0 109.422 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.405 ' O ' ' OE2' ' A' ' 35' ' ' GLU . . . -94.47 31.28 6.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -65.34 -139.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -137.76 -97.25 0.43 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.488 ' O ' HG11 ' A' ' 192' ' ' VAL . . . -132.18 130.9 41.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.429 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -52.01 -74.98 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 241' ' ' PHE . . . 128.95 111.64 1.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -51.72 -177.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -1.133 . . . . 0.0 109.493 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 226' ' ' ALA . 7.0 t30 -104.77 77.7 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.457 ' HA3' ' CZ ' ' A' ' 241' ' ' PHE . . . -73.06 -55.82 6.11 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 74.3 m-85 -135.4 162.36 32.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.558 -0.966 . . . . 0.0 108.587 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.765 HE21 ' HG3' ' A' ' 162' ' ' ARG . 1.4 pt20 -149.52 155.88 41.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.917 . . . . 0.0 108.804 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 13.5 p -167.53 149.88 5.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 110.085 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.409 ' H ' HG13 ' A' ' 160' ' ' ILE . . . -129.98 169.15 15.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.249 1.024 . . . . 0.0 109.751 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 185' ' ' TYR . 11.4 t -117.95 119.9 62.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.799 HG23 ' NE2' ' A' ' 158' ' ' HIS . 30.1 m -119.17 150.23 21.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.286 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 84.82 33.2 19.33 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.626 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 46.8 mt -79.18 90.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.341 -1.093 . . . . 0.0 109.974 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.76 152.04 12.87 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.599 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.316 2.011 . . . . 0.0 110.447 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.543 ' NE2' ' CZ ' ' A' ' 208' ' ' TYR . 31.7 tt0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.1 -174.49 2.26 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.48 2.12 . . . . 0.0 110.038 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG22 ' C ' ' A' ' 203' ' ' ASP . 47.7 t -116.82 141.86 33.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.119 -0.988 . . . . 0.0 109.986 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.772 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.9 t -138.03 132.41 43.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 200' ' ' ASP . 49.2 mmtt -75.07 178.52 5.61 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.032 -1.043 . . . . 0.0 108.441 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 1.6 t -77.6 103.82 7.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.099 -1.001 . . . . 0.0 109.208 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.726 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.7 mt -57.15 -49.0 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.871 . . . . 0.0 108.923 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.6 mt -56.5 -42.18 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.739 -1.226 . . . . 0.0 108.826 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 54.8 t0 -67.48 -36.31 80.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.151 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -16.79 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.034 -1.042 . . . . 0.0 108.266 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.8 mtpt -122.32 18.32 10.63 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.25 43.12 7.24 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 58' ' ' TYR . 57.6 mt -87.72 107.37 17.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.255 1.026 . . . . 0.0 110.23 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.8 m80 -135.02 86.97 2.29 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.7 m-30 -92.95 -179.9 5.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 110.768 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -147.17 -163.81 1.85 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.0 mt-30 -124.88 -20.8 4.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.929 -1.107 . . . . 0.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.38 -35.62 1.29 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.43 -1.367 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.835 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.7 t-20 -45.13 -142.74 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.529 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.132 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.835 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.6 Cg_endo -72.98 1.83 6.11 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 CA-C-N 122.363 1.88 . . . . 0.0 109.559 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 10.4 m-85 -76.46 -31.12 57.63 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.953 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 10.8 p-10 -94.09 17.33 12.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.596 -1.315 . . . . 0.0 109.566 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 26.7 mt -72.28 -3.03 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.978 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.0 mt -127.13 -7.56 5.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.5 p -61.9 164.93 8.91 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.674 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.6 Cg_endo -71.43 138.89 33.58 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.435 2.09 . . . . 0.0 112.11 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.8 t -81.11 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.646 -0.659 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.738 HD11 ' C ' ' A' ' 132' ' ' GLY . 17.1 mt -78.11 148.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.499 -0.751 . . . . 0.0 110.523 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.8 mt-10 -125.73 -22.12 4.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.759 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.3 mtpp -121.19 173.34 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.992 -1.068 . . . . 0.0 109.893 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 37' ' ' SER . 98.7 t -114.04 139.52 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.401 -0.812 . . . . 0.0 110.676 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 11.3 tttt -78.71 130.48 70.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.87 124.51 11.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.396 1.398 . . . . 0.0 110.054 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.99 10.91 31.26 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 6.7 tt0 -148.73 -179.65 7.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -1.038 . . . . 0.0 109.273 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.468 ' O ' HG13 ' A' ' 31' ' ' VAL . 32.9 mt-30 -78.89 -174.99 4.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.195 -0.941 . . . . 0.0 109.865 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.471 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.4 t -87.11 137.93 31.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 109.929 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.3 m-85 -124.45 16.93 8.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.084 -1.01 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 29' ' ' GLU . 47.2 t -63.26 143.59 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.041 -1.037 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.07 -4.23 67.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.0 mt-30 -85.46 129.43 34.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -1.201 . . . . 0.0 109.595 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 25' ' ' THR . 1.8 m-70 -73.11 113.39 10.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.76 160.0 1.0 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.097 -1.041 . . . . 0.0 109.538 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.48 170.19 17.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.697 0.761 . . . . 0.0 109.793 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.701 ' O ' ' HE3' ' A' ' 129' ' ' MET . 29.8 p -81.62 -34.98 30.57 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.533 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 104.28 136.65 8.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.9 p -55.18 -51.01 67.89 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.393 -1.063 . . . . 0.0 108.501 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.619 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 51.1 t -47.48 -52.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.38 -50.67 72.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.11 0.957 . . . . 0.0 109.437 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 99.1 m -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.931 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.21 -41.91 84.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.734 -1.229 . . . . 0.0 108.119 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 ' HG3' ' A' ' 56' ' ' MET . 43.8 m -74.64 -53.25 9.69 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.447 0.641 . . . . 0.0 110.405 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.0 -37.71 46.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.572 -0.705 . . . . 0.0 109.585 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 32.0 mt-30 -63.05 -45.67 91.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 198' ' ' VAL . 53.1 mt -70.12 -28.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.581 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.3 mtp -66.97 -40.78 87.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HD3' HG22 ' A' ' 100' ' ' ILE . 29.9 tptt -70.33 -41.35 73.34 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 49.0 t80 -54.05 -30.4 47.76 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 43.4 m-70 -107.39 -24.03 11.99 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.05 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.63 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 79.2 m-20 44.3 54.17 6.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.9 t80 -78.75 -70.65 0.19 Allowed Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.308 -175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.9 Cg_endo -70.23 100.81 0.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 CA-C-N 118.929 0.653 . . . . 0.0 111.609 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.97 -20.58 64.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -134.33 141.87 47.06 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.19 151.84 26.22 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.098 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -89.14 -60.97 1.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -1.043 . . . . 0.0 110.186 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 49.0 tttt -135.95 134.46 38.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 109.598 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 4.5 m-20 -58.2 159.79 5.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.454 -0.779 . . . . 0.0 109.605 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 31.9 t80 -144.43 139.65 28.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -143.19 153.82 43.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.084 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.6 p90 -154.46 155.41 34.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.886 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 98.4 m -92.83 130.07 38.55 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.787 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -45.18 148.91 0.54 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.935 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 t -61.6 142.31 57.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.818 -0.551 . . . . 0.0 109.835 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -68.65 -3.38 11.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.038 -1.039 . . . . 0.0 109.75 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -98.7 -7.69 27.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.787 ' ND2' HD21 ' A' ' 73' ' ' LEU . 30.2 t-20 -70.49 110.1 6.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -89.26 16.28 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.968 2.445 . . . . 0.0 110.483 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 90.9 m-85 -106.01 -22.65 12.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.132 -0.98 . . . . 0.0 111.315 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.8 m-85 -122.34 162.56 21.32 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.561 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.4 m-80 -46.02 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 174.45 -46.04 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.451 175.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.3 56.48 5.01 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 N-CA-C 107.51 -1.765 . . . . 0.0 107.51 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.98 102.97 12.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.116 -178.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.14 134.9 43.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.656 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.71 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -108.15 144.56 35.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 17.7 t80 -134.0 130.23 37.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.007 -1.058 . . . . 0.0 110.365 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.68 113.82 27.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.84 53.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.642 -1.286 . . . . 0.0 108.458 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 9.8 mt -52.89 -52.73 25.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 4.1 p -45.55 -26.6 0.61 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.342 -1.473 . . . . 0.0 109.219 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -111.78 19.78 17.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 109.534 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 13.5 mmt-85 -76.83 147.55 37.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 110.378 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 90.34 3.31 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-85 -81.02 96.95 7.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.548 -0.72 . . . . 0.0 110.617 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.6 t-20 -80.53 88.69 5.65 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.63 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 39.1 m95 -61.03 -8.98 3.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.446 -0.784 . . . . 0.0 110.411 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -19.17 23.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.6 m-20 -100.24 -26.29 13.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.623 HG22 ' HD3' ' A' ' 57' ' ' LYS . 66.6 mt -73.88 67.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.7 mt -46.83 150.12 1.37 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.56 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.4 Cg_endo -78.84 -21.2 9.86 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.759 2.306 . . . . 0.0 110.587 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 134.47 26.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.007 -1.058 . . . . 0.0 109.684 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 89.3 m-85 -124.49 137.9 54.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.923 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.9 p -99.04 -0.09 42.65 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 81.45 10.02 85.07 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.17 5.9 10.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.395 -1.062 . . . . 0.0 108.956 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.14 167.72 19.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.694 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -57.79 171.71 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.195 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -76.9 -33.97 57.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -51.99 -60.42 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 2.1 mp0 -62.45 -35.16 78.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 0.0 109.376 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' SER . 26.7 mttt -63.8 -43.47 96.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 108.291 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.469 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 28.7 ttm -59.93 -38.24 81.8 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -57.16 -68.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.535 -0.728 . . . . 0.0 110.403 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.73 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -59.9 -39.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.471 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 25.2 p -53.61 -43.74 68.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.956 -1.09 . . . . 0.0 109.635 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 24' ' ' LEU . 4.4 tt0 -69.88 -42.49 73.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 108.518 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.7 tp -52.15 -51.6 56.98 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.693 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.5 mmt -59.7 -45.7 91.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.635 -0.666 . . . . 0.0 109.489 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.515 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.75 -38.35 90.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.6 m-20 -68.67 -48.43 63.97 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 56' ' ' MET . 55.9 t -67.12 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.41 -42.39 13.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.9 mt -69.72 -57.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.346 -1.091 . . . . 0.0 108.325 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.53 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.1 p -45.47 -27.64 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.429 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.6 m -105.0 32.76 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.139 -0.976 . . . . 0.0 109.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.565 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 43.1 m-20 40.71 44.99 1.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.343 -0.848 . . . . 0.0 109.651 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.701 ' HE3' ' O ' ' A' ' 45' ' ' THR . 41.1 tpp -56.86 133.09 54.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 111.145 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 18.6 t0 -79.56 122.66 26.76 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.82 117.79 35.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.312 1.053 . . . . 0.0 113.064 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.738 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.6 -164.56 12.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 104.261 -3.536 . . . . 0.0 104.261 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.617 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -61.96 -31.5 84.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 105.582 -2.507 . . . . 0.0 105.582 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.0 m -109.7 141.54 42.14 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.5 m -119.2 109.84 16.33 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 119.966 -1.709 . . . . 0.0 109.919 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.83 136.12 13.24 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 13.1 t -117.87 -162.59 0.89 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.234 -1.156 . . . . 0.0 108.335 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.76 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.02 -57.21 2.8 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.553 ' HA3' ' NE2' ' A' ' 187' ' ' GLN . . . 131.46 -131.05 6.21 Favored Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.393 -1.384 . . . . 0.0 112.042 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 36.8 m -47.83 -58.62 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.891 -0.77 . . . . 0.0 111.786 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' SER . 11.1 p -46.75 -36.81 7.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 0.0 108.95 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.76 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.9 mmt-85 -80.37 -47.88 13.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.01 0.909 . . . . 0.0 108.92 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 185' ' ' TYR . 93.9 t -67.85 -56.57 12.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.7 pp0? -56.48 -33.73 66.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.171 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' NE ' ' OE2' ' A' ' 149' ' ' GLU . 12.1 ttt85 -77.1 -52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.53 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.56 -35.95 82.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.086 -1.009 . . . . 0.0 110.047 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.596 HD13 HG12 ' A' ' 251' ' ' ILE . 40.5 mt -56.41 -48.44 76.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.6 mtmt -86.45 -39.13 16.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.133 -0.979 . . . . 0.0 110.407 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.512 ' OE2' ' NE ' ' A' ' 145' ' ' ARG . 54.1 mt-10 -67.97 -54.46 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 112.007 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 20.7 m120 -92.75 -40.87 10.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.703 -1.248 . . . . 0.0 111.746 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.2 m-85 -99.56 10.59 41.08 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.715 -1.241 . . . . 0.0 110.514 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 36.04 39.12 0.27 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.55 -0.719 . . . . 0.0 112.875 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.5 m-85 -61.92 162.88 8.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.142 -1.799 . . . . 0.0 107.364 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.1 t-20 -47.48 139.02 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.87 -1.144 . . . . 0.0 109.414 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.407 ' NE2' ' HD2' ' A' ' 148' ' ' LYS . 9.2 tp-100 -53.72 -18.97 3.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 58.7 p -53.07 -18.23 1.99 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.8 t -58.33 123.7 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 109.158 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.931 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.7 p-80 -143.87 154.82 43.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.086 -1.009 . . . . 0.0 109.404 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 41.9 tt0 -100.73 154.2 18.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.36 -0.838 . . . . 0.0 110.509 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.595 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 10.5 pt -135.96 142.37 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.6 m120 -107.25 100.49 9.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.873 -1.142 . . . . 0.0 111.065 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.639 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.9 tpt180 -44.01 -41.22 5.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.154 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.09 -23.17 59.21 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ASN . 0.8 OUTLIER -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.063 -1.257 . . . . 0.0 111.576 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.92 174.94 5.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.516 -1.365 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -103.91 134.28 47.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 166' ' ' SER . 18.3 ttmt -31.91 -45.62 0.1 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.101 0.477 . . . . 0.0 110.869 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -64.17 -63.69 1.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.927 -1.108 . . . . 0.0 109.823 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.22 -15.67 57.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.359 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.9 t-105 -74.85 -46.95 33.0 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.177 -0.952 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 174' ' ' ILE . 43.4 mt-10 -69.53 -30.48 68.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.091 -1.006 . . . . 0.0 108.606 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.66 -45.43 73.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 108.751 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -61.13 -40.28 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 108.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.886 HG23 HG21 ' A' ' 184' ' ' VAL . 13.7 mt -76.13 -60.94 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.557 -0.714 . . . . 0.0 111.119 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -49.03 -46.67 44.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 109.24 -178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.756 ' HZ3' ' HB3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -51.35 -48.67 62.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.4 mm-40 -54.87 -51.07 67.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.772 ' HB3' HG11 ' A' ' 4' ' ' VAL . 17.6 mt -68.2 -33.51 74.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.205 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 53.4 p -51.99 -30.78 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -102.41 33.65 3.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.534 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.6 m120 40.67 46.68 2.27 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.816 0.817 . . . . 0.0 108.918 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 14.7 mt-30 -123.69 111.8 29.35 Favored Pre-proline 0 C--N 1.294 -1.815 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.7 Cg_endo -65.09 169.66 11.7 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.803 1.668 . . . . 0.0 112.653 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.886 HG21 HG23 ' A' ' 174' ' ' ILE . 45.9 t -121.12 132.79 69.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.58 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.713 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -81.57 116.39 21.31 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 175.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 6.5 t80 -121.97 157.27 31.65 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.809 -1.182 . . . . 0.0 110.192 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 4.8 pt20 -167.06 136.05 2.76 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.6 1.66 Allowed Glycine 0 C--N 1.289 -2.031 0 N-CA-C 107.675 -2.17 . . . . 0.0 107.675 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 244' ' ' TYR . 6.8 t -69.93 166.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -1.117 . . . . 0.0 111.419 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.547 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.53 -129.11 1.08 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -88.11 -36.96 16.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.251 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 236' ' ' GLY . 3.0 m -79.92 -15.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.974 -1.079 . . . . 0.0 111.284 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.88 -167.63 22.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -83.47 101.51 2.36 Favored Glycine 0 N--CA 1.485 1.929 0 O-C-N 121.049 -1.265 . . . . 0.0 110.781 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 45.4 t60 -71.27 121.11 17.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -113.08 160.67 17.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.517 -1.273 . . . . 0.0 113.361 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.809 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -156.91 175.19 14.41 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 55' ' ' ILE . 92.8 t -121.14 135.69 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.575 -1.328 . . . . 0.0 112.094 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.712 HD13 HG21 ' A' ' 174' ' ' ILE . 73.6 mt -99.9 123.13 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -134.17 32.76 3.41 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.131 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.618 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -171.69 167.68 40.75 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 117.709 -2.186 . . . . 0.0 112.345 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.538 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.17 148.0 27.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ARG . 0.5 OUTLIER -121.61 24.26 9.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.755 -1.216 . . . . 0.0 110.357 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 1' ' ' GLN . . . 43.05 26.45 0.49 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 14.3 mtt-85 -142.43 21.44 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -1.118 . . . . 0.0 109.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 9.4 t30 80.6 20.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.563 -0.711 . . . . 0.0 109.65 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.27 128.26 49.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.545 ' CD1' HD21 ' A' ' 224' ' ' LEU . 25.7 m-85 -120.7 163.51 17.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.0 . . . . 0.0 109.557 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 37.1 t-80 -93.39 116.11 28.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.809 HG13 ' CD1' ' A' ' 197' ' ' PHE . 20.7 t -114.51 140.02 37.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.105 -0.997 . . . . 0.0 111.165 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 8' ' ' LEU . 28.2 t-20 -108.64 92.32 4.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.476 ' O ' ' O ' ' A' ' 211' ' ' ASN . 3.1 m95 -46.54 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 0.0 110.404 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.16 -10.06 58.62 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.428 ' CE2' ' HB3' ' A' ' 231' ' ' ALA . 49.1 m95 -107.72 168.52 9.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -1.019 . . . . 0.0 109.015 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.01 3.66 12.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.22 5.18 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.759 HG13 ' N ' ' A' ' 218' ' ' SER . 1.9 p -96.11 -153.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.274 -1.133 . . . . 0.0 109.622 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.759 ' N ' HG13 ' A' ' 217' ' ' VAL . 14.4 m -68.68 58.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.99 -1.068 . . . . 0.0 110.399 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.7 OUTLIER -86.84 120.36 28.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.047 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 172.77 -148.78 10.79 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.92 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 94.2 m-85 -75.15 119.86 19.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -1.089 . . . . 0.0 109.785 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.64 -173.16 3.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 109.044 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.549 ' C ' HD13 ' A' ' 224' ' ' LEU . 11.5 mtp180 -109.95 167.35 10.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.855 HD22 ' N ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -108.86 1.9 21.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.155 -0.966 . . . . 0.0 109.935 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.462 ' OD1' ' NH2' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -95.96 -30.77 13.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.205 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.19 88.22 2.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 109.089 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 224' ' ' LEU . 4.2 mm? -91.39 93.12 8.88 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-O 121.485 0.66 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -116.83 117.72 37.22 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.213 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.69 154.7 30.82 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.399 2.066 . . . . 0.0 110.75 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -98.53 -39.23 8.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.428 ' HB3' ' CE2' ' A' ' 214' ' ' TRP . . . -88.25 71.67 9.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.84 -27.04 13.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 68.93 157.55 1.27 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 234' ' ' THR . 57.5 m -101.69 33.65 2.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -1.142 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -105.51 -98.98 2.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 192' ' ' VAL . . . -79.63 4.6 63.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -89.45 129.41 9.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.15 159.54 15.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.405 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -49.84 -87.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -51.93 127.85 32.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 195' ' ' HIS . 1.0 OUTLIER -122.14 42.38 3.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -1.117 . . . . 0.0 109.695 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 245' ' ' GLN . 13.8 t30 -135.29 70.63 1.43 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 110.05 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 189' ' ' VAL . . . -80.17 -62.02 2.15 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.604 ' O ' HG23 ' A' ' 189' ' ' VAL . 57.6 m-85 -136.0 109.25 7.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -1.034 . . . . 0.0 108.863 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.552 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 3.9 mt-30 -91.97 133.83 35.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.828 -1.17 . . . . 0.0 109.359 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 56.4 p -159.15 157.39 30.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.029 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.14 166.47 24.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.4 -0.812 . . . . 0.0 110.021 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 46.9 t -119.29 114.59 45.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.931 HG23 ' CE1' ' A' ' 158' ' ' HIS . 16.6 m -114.69 147.85 17.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 O-C-N 121.282 -0.886 . . . . 0.0 110.402 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 96.12 47.14 2.48 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.042 -1.551 . . . . 0.0 109.881 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.602 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.9 mt -103.22 96.11 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -1.185 . . . . 0.0 110.173 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.39 146.77 8.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.632 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.1 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.206 1.937 . . . . 0.0 110.452 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.442 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 34.5 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.9 156.73 27.12 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.297 1.998 . . . . 0.0 109.759 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 t -90.97 143.6 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.06 -1.025 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 202' ' ' ALA . 12.0 t -131.22 131.88 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 200' ' ' ASP . 58.3 mmtt -77.01 -179.51 5.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.526 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 34.7 t -77.79 102.42 7.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.687 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 35.7 mt -57.63 -49.65 75.75 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.8 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 211' ' ' ASN . 11.9 mt -56.02 -42.46 76.52 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.776 -1.202 . . . . 0.0 108.641 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -68.34 -36.19 78.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.058 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -58.08 -15.36 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.102 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' CB ' HG13 ' A' ' 13' ' ' ILE . 9.1 mtpt -121.95 23.54 9.97 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.97 39.89 5.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 58' ' ' TYR . 40.2 mt -86.03 110.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.355 1.074 . . . . 0.0 110.408 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 102' ' ' PRO . 6.7 m-70 -133.45 99.44 4.51 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 6.4 m-30 -103.66 176.0 5.29 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.012 . . . . 0.0 111.513 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -146.98 -175.17 4.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 3.4 mt-30 -118.37 -20.96 8.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.943 -1.098 . . . . 0.0 109.977 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.42 -34.13 1.49 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.94 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.838 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.5 t-20 -46.0 -140.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.021 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.872 ' HA ' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -74.32 3.22 5.42 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 CA-C-N 122.55 1.947 . . . . 0.0 109.325 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.1 m-85 -78.63 -30.66 46.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.478 -0.764 . . . . 0.0 109.068 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 20.6 p-10 -96.12 12.86 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.545 -1.347 . . . . 0.0 109.341 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.872 HD12 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -67.79 -8.61 37.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.918 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD12 ' OG ' ' A' ' 117' ' ' SER . 8.7 mt -126.68 -6.23 6.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 0.0 109.703 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.606 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.8 p -61.14 165.95 5.7 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -71.1 136.81 30.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.013 1.809 . . . . 0.0 111.609 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.16 149.97 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.614 0.721 . . . . 0.0 110.136 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 132' ' ' GLY . 16.8 mt -77.77 148.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.565 -0.709 . . . . 0.0 110.544 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -125.67 -20.82 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.705 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 79' ' ' TYR . 44.7 mtpt -123.72 172.01 9.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.89 -1.131 . . . . 0.0 109.949 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 37' ' ' SER . 75.0 t -114.44 147.41 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.397 -0.814 . . . . 0.0 110.94 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 9.9 tttt -86.19 129.39 53.93 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.42 124.18 10.57 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.424 1.416 . . . . 0.0 110.369 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.67 11.96 29.48 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 tt0 -147.83 -176.85 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -1.11 . . . . 0.0 109.481 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -80.52 -177.3 6.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 31' ' ' VAL . 5.0 t -87.47 137.64 32.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -123.81 19.52 9.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.084 -1.01 . . . . 0.0 109.798 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.6 t -67.74 145.08 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.557 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.15 -1.9 73.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.7 mt-30 -88.03 130.3 35.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 109.813 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -73.06 112.34 9.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.77 158.28 1.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.847 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 135' ' ' SER . . . -71.59 166.38 21.97 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.67 HG21 ' SD ' ' A' ' 120' ' ' MET . 41.1 p -80.45 -29.15 37.54 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 99.08 136.85 9.53 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.6 p -54.67 -52.94 60.79 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.217 -1.167 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.636 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 54.7 t -46.91 -52.53 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.46 -51.29 70.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.969 0.89 . . . . 0.0 109.861 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.771 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -64.21 -32.31 73.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.664 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.44 88.48 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.648 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.3 m -74.59 -53.63 9.01 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.701 0.762 . . . . 0.0 110.05 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.22 -38.43 52.41 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.702 -0.624 . . . . 0.0 109.837 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -63.91 -46.88 82.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.13 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 37.7 mt -67.87 -24.49 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.5 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.6 mtp -73.57 -32.26 64.06 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.588 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 26.0 tptt -75.82 -44.34 41.6 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.687 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 33.8 t80 -53.61 -27.78 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.75 -0.594 . . . . 0.0 110.023 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 35.0 m-70 -107.5 -26.09 11.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.288 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.635 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 90.2 m-20 44.54 59.2 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.0 t80 -84.88 -72.22 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 37.2 Cg_endo -69.77 105.76 1.54 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 CA-C-N 118.955 0.663 . . . . 0.0 111.952 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 8.0 m120 -72.14 -23.59 61.32 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -135.89 137.33 41.32 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.67 152.06 31.8 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.421 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 66' ' ' LEU . 2.6 mt -92.31 -42.01 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.406 -1.055 . . . . 0.0 109.961 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 11.7 ttpp -152.29 136.41 16.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.934 -1.104 . . . . 0.0 110.334 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -59.41 164.66 3.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.629 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 70' ' ' THR . 20.6 t80 -141.78 152.05 43.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 3.4 t -151.22 166.06 32.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.927 -1.108 . . . . 0.0 110.192 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.745 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.6 p90 -169.12 154.03 5.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.443 -0.786 . . . . 0.0 109.32 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.9 m -92.81 136.06 33.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.794 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -52.34 153.17 3.03 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.335 -0.853 . . . . 0.0 111.335 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -61.33 137.0 58.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.33 0.586 . . . . 0.0 110.016 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 p -64.58 -7.74 11.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.7 t-20 -99.66 -4.21 31.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.029 -1.045 . . . . 0.0 109.717 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.794 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.4 t-20 -69.9 109.97 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.774 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.6 15.55 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.83 2.353 . . . . 0.0 109.991 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 75.0 m-85 -105.71 -27.26 11.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' ASN . 19.2 m-85 -118.91 164.43 15.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.636 -1.29 . . . . 0.0 107.774 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.4 m120 -47.39 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 175.64 -48.2 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 175.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.9 56.71 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 N-CA-C 106.958 -1.978 . . . . 0.0 106.958 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.46 104.1 13.76 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.13 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.96 130.65 46.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.824 . . . . 0.0 109.441 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -102.47 137.73 40.33 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -124.96 129.08 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.375 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.18 114.12 27.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 50.03 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.665 -1.272 . . . . 0.0 108.569 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.8 mt -52.48 -51.49 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.325 -0.859 . . . . 0.0 109.085 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.92 -29.24 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.065 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.15 30.21 7.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 6.4 mmt-85 -85.5 150.44 24.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -116.9 91.09 3.48 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.6 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.3 m-85 -81.08 91.31 6.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.472 -0.767 . . . . 0.0 111.134 -176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 100' ' ' ILE . 38.2 t-20 -79.76 87.14 5.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.635 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 63.2 m95 -61.23 -8.32 3.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.36 -17.73 26.79 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 8.5 m-20 -99.6 -27.72 13.55 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.612 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 58.0 mt -74.41 66.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 101' ' ' LEU . 24.3 mt -46.71 149.25 1.52 Allowed Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.854 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.7 Cg_endo -78.67 -23.97 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.74 2.293 . . . . 0.0 110.409 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.19 126.69 23.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 108.994 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 116' ' ' ILE . 54.8 m-85 -113.51 148.82 35.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' OE1' ' A' ' 108' ' ' GLU . 36.1 p -103.5 -9.83 19.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.56 -0.11 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -120.11 1.06 10.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -1.171 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' OE1' ' OG ' ' A' ' 105' ' ' SER . 0.1 OUTLIER -64.86 165.29 10.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.808 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.38 166.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -72.37 -34.45 67.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.36 -58.97 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.435 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.63 -36.28 80.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 0.0 108.897 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 21.4 mttt -65.71 -44.19 86.85 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.446 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.8 ttm -59.28 -35.72 74.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.09 -66.63 0.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.61 -0.681 . . . . 0.0 109.619 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.699 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.4 tp -65.74 -40.15 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.815 . . . . 0.0 109.552 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 11.2 p -57.21 -41.89 80.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.222 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.621 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 22.9 tt0 -69.72 -40.59 76.13 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.3 tp -54.84 -52.32 63.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.771 ' CE ' HG23 ' A' ' 50' ' ' THR . 1.6 mmt -58.51 -44.84 89.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.46 -38.84 92.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.649 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 5.9 m-20 -69.22 -43.02 74.91 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 127' ' ' VAL . 55.3 t -71.21 -62.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.609 -0.682 . . . . 0.0 109.774 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.31 -45.77 16.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.8 mt -65.03 -57.62 10.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 108.664 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 5.2 p -46.32 -31.08 2.36 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.771 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.0 m -101.46 37.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 109.626 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.8 m-20 39.36 42.14 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.482 -0.761 . . . . 0.0 109.782 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.648 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -55.59 128.23 33.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.405 -0.809 . . . . 0.0 111.446 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 21.6 t0 -77.71 126.07 30.31 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.658 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.0 m-85 -108.18 120.72 43.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.759 -1.177 . . . . 0.0 113.51 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.729 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.9 -164.0 11.71 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 103.834 -3.706 . . . . 0.0 103.834 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -61.38 -30.26 86.99 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 N-CA-C 105.445 -2.56 . . . . 0.0 105.445 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.54 46.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -115.71 112.83 22.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.853 -1.779 . . . . 0.0 109.851 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.29 133.72 11.81 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.549 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 16.0 t -118.27 -162.11 0.87 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -1.182 . . . . 0.0 108.761 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.836 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.21 -60.51 1.83 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.544 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 136.29 -133.71 6.74 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.888 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.565 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -48.11 -57.83 5.31 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.797 -0.825 . . . . 0.0 111.911 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 1.7 p -47.31 -36.72 9.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.752 -1.217 . . . . 0.0 109.015 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.836 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 25.8 mmt180 -79.84 -46.69 16.41 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.064 0.935 . . . . 0.0 108.797 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 185' ' ' TYR . 79.5 t -68.09 -56.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.275 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.53 -34.53 67.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 109.357 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' CG ' ' OE2' ' A' ' 149' ' ' GLU . 34.1 ttm-85 -77.36 -42.89 34.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.944 -1.098 . . . . 0.0 109.836 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.68 71.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.601 HD13 HG12 ' A' ' 251' ' ' ILE . 53.7 mt -60.85 -48.44 81.78 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.521 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.8 mtmt -86.55 -44.25 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.07 -1.019 . . . . 0.0 110.583 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.504 ' OE2' ' CG ' ' A' ' 145' ' ' ARG . 82.1 mt-10 -67.4 -47.93 68.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.879 -1.138 . . . . 0.0 111.498 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -94.37 -44.19 8.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 111.671 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.6 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 31.1 m-85 -101.6 16.6 25.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 110.618 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 33.32 39.86 0.1 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 121.594 -0.691 . . . . 0.0 113.16 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.4 m-85 -62.04 159.81 13.72 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 120.529 2.165 . . . . 0.0 107.154 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 51.4 t-20 -47.06 143.8 2.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.737 -1.227 . . . . 0.0 109.372 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.64 -17.86 2.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.398 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.495 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 18.9 p -53.29 -17.08 1.55 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 109.876 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 251' ' ' ILE . 38.8 t -64.59 127.88 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.75 -1.219 . . . . 0.0 109.438 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.843 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.2 p-80 -147.37 149.58 33.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -100.69 139.92 35.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.921 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 16.4 pt -122.5 158.04 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m-80 -116.88 103.65 10.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.183 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 8.2 tpt180 -47.46 -28.65 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.602 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.3 75.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -103.96 16.17 26.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.013 -1.287 . . . . 0.0 111.675 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -121.45 155.86 33.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.57 -1.331 . . . . 0.0 109.89 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -84.86 139.62 31.76 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.8 ttmm -36.79 -47.98 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.559 -0.713 . . . . 0.0 110.704 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.93 -56.74 13.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 110.356 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.54 -21.5 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 110.123 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.921 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.66 -40.49 48.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.915 -1.116 . . . . 0.0 109.333 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.48 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 43.3 mt-10 -73.87 -48.38 31.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -48.27 -40.62 25.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 48.4 mm-40 -61.14 -48.14 82.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.713 HG23 HG21 ' A' ' 184' ' ' VAL . 22.8 mt -73.21 -49.99 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.656 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 179' ' ' SER . 1.5 m-20 -52.57 -42.9 64.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.2 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -52.18 -46.26 65.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.722 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 65.6 mm-40 -56.19 -51.7 67.07 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.701 ' HB3' HG11 ' A' ' 4' ' ' VAL . 40.9 mt -68.69 -24.13 64.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 175' ' ' ASP . 32.1 p -52.58 -38.2 59.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.754 -1.217 . . . . 0.0 107.802 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 28.8 mt-30 -102.21 31.76 3.83 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.539 ' C ' HD13 ' A' ' 7' ' ' LEU . 17.6 m-80 48.2 51.22 15.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 109.148 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 27.2 mt-30 -124.08 116.09 27.41 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.9 Cg_endo -64.76 166.59 17.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.07 1.847 . . . . 0.0 112.497 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.713 HG21 HG23 ' A' ' 174' ' ' ILE . 77.0 t -125.55 140.73 47.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.102 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -86.02 120.17 27.12 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 4.2 t80 -123.63 161.41 25.09 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.061 -1.024 . . . . 0.0 109.5 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.7 pt20 -167.63 130.29 1.62 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 117.591 -1.644 . . . . 0.0 112.007 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -94.11 114.06 4.68 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' A' ' 244' ' ' TYR . 21.5 t -71.89 167.69 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.902 -1.351 . . . . 0.0 110.647 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -174.87 -141.18 3.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -37.53 16.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.026 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.1 m -80.75 1.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.94 -1.1 . . . . 0.0 111.153 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 118.86 -162.21 13.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -89.84 106.01 3.28 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.721 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.75 125.4 27.05 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.636 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -114.1 160.46 18.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.612 -1.235 . . . . 0.0 112.923 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.803 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.9 p90 -156.66 168.76 26.42 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 71.5 t -114.18 136.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.755 -1.216 . . . . 0.0 112.158 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 208' ' ' TYR . 39.5 mt -100.05 114.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.4 p30 -130.44 37.59 3.84 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.304 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -177.13 169.73 42.13 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.09 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -153.25 136.59 15.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -97.1 0.14 48.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.465 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 88.67 -26.94 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -100.18 51.08 0.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -1.136 . . . . 0.0 109.854 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.48 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 7.5 m120 60.9 20.79 11.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 3.2 m-85 -111.73 137.94 48.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.083 -1.011 . . . . 0.0 109.406 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.6 ' HB3' HG23 ' A' ' 199' ' ' ILE . 4.6 m-85 -122.87 164.3 18.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 110.097 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.9 t-80 -92.45 120.28 32.79 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.898 HG11 ' CZ3' ' A' ' 212' ' ' TRP . 26.7 t -114.73 145.08 20.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.112 -0.992 . . . . 0.0 111.802 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.509 ' HB2' HD12 ' A' ' 8' ' ' LEU . 16.4 t-20 -112.34 79.18 1.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.898 ' CZ3' HG11 ' A' ' 210' ' ' VAL . 32.9 m95 -46.74 164.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.903 -1.123 . . . . 0.0 109.572 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -86.1 23.19 9.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.516 ' NE1' ' O ' ' A' ' 230' ' ' SER . 47.8 m95 -112.7 -168.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.236 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.18 -100.15 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.55 50.59 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.802 HG22 ' N ' ' A' ' 218' ' ' SER . 1.5 p -79.55 -98.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -1.136 . . . . 0.0 109.614 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.802 ' N ' HG22 ' A' ' 217' ' ' VAL . 23.6 m -89.8 17.76 6.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.504 ' HA ' ' CD1' ' A' ' 212' ' ' TRP . 0.1 OUTLIER -53.23 125.6 18.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.364 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 162.32 -106.92 0.29 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -85.69 -173.74 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.167 . . . . 0.0 109.718 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -105.82 165.96 10.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.625 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -87.85 156.06 19.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.576 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -120.78 12.77 11.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 109.921 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.9 OUTLIER -116.47 -81.04 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.993 -1.067 . . . . 0.0 110.028 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.97 -93.89 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.965 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.515 ' O ' ' CD ' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -114.06 -160.21 0.72 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 -179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.599 ' HB3' ' CH2' ' A' ' 212' ' ' TRP . 2.0 p30 -111.17 160.65 28.29 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.063 -1.023 . . . . 0.0 109.986 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 228' ' ' ASN . 36.3 Cg_endo -78.47 -28.05 4.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.784 2.323 . . . . 0.0 110.648 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.516 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 54.1 p -48.85 -21.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.01 -58.06 4.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.486 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -156.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.66 9.83 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 9.45 14.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.324 -1.104 . . . . 0.0 109.705 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.74 32.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -99.16 88.44 0.83 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -133.48 169.39 22.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -134.49 16.86 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.204 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -123.52 133.27 8.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -154.83 32.29 0.67 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 171.13 8.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -1.13 . . . . 0.0 109.438 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -109.53 79.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 244' ' ' TYR . . . -77.9 -48.72 7.55 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.73 ' HB2' HG21 ' A' ' 189' ' ' VAL . 13.1 m-85 -135.51 159.86 40.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.997 . . . . 0.0 109.126 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 244' ' ' TYR . 80.4 mt-30 -155.48 144.39 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.886 . . . . 0.0 108.726 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 79.8 p -161.71 161.67 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.513 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.64 144.79 35.93 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.47 0.652 . . . . 0.0 109.57 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.8 t -105.2 116.46 49.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.843 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.1 m -117.05 139.12 45.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.318 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 90.7 47.17 3.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.619 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 mt -94.5 98.25 7.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.16 149.34 10.05 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.625 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.283 1.989 . . . . 0.0 110.358 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.414 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 32.5 tt0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.57 155.72 31.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.357 2.038 . . . . 0.0 110.091 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.51 HG22 ' C ' ' A' ' 203' ' ' ASP . 40.7 t -87.23 142.41 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.79 HG11 ' HB3' ' A' ' 178' ' ' LEU . 86.8 t -134.17 132.06 55.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.542 -0.724 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 20.3 mmtp -76.4 -179.77 5.36 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 108.545 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.483 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 27.6 t -77.82 105.65 9.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.652 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.707 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 34.3 mt -58.53 -50.44 73.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -0.86 . . . . 0.0 108.824 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.1 mt -54.6 -39.2 67.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 0.0 108.516 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 6.0 t0 -67.85 -42.21 81.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 109.801 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 44.0 p -58.04 -14.91 7.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.156 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -117.74 19.67 13.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.69 35.72 4.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 58' ' ' TYR . 42.8 mt -85.52 110.45 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.328 -1.101 . . . . 0.0 110.287 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.6 m-70 -134.01 81.9 1.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.621 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -92.18 170.54 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.229 1.014 . . . . 0.0 111.475 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -147.98 -167.65 2.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.515 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 3.3 mt-30 -125.45 -2.81 7.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.798 -1.189 . . . . 0.0 110.471 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.665 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.37 -54.81 0.33 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.465 -1.35 . . . . 0.0 112.31 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 10.6 t-20 -45.64 -129.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.579 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.938 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -77.38 6.25 4.53 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 123.435 2.263 . . . . 0.0 109.062 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.762 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 85.8 m-85 -77.19 -35.92 55.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.85 -0.531 . . . . 0.0 110.077 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 47.2 p30 -98.85 20.33 13.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.773 -1.205 . . . . 0.0 109.043 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.9 mt -71.43 -6.11 37.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 111.079 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.56 HD12 ' OG ' ' A' ' 117' ' ' SER . 7.6 mt -131.91 0.59 3.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.687 -1.258 . . . . 0.0 109.789 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -67.31 167.04 16.54 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -70.58 142.85 45.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.747 1.632 . . . . 0.0 111.509 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.24 150.08 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.592 0.711 . . . . 0.0 110.37 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.754 HD11 ' C ' ' A' ' 132' ' ' GLY . 34.1 mt -77.64 147.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.552 0.692 . . . . 0.0 110.165 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.9 mm-40 -124.49 -22.7 4.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.212 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 79' ' ' TYR . 3.8 mtpt -122.68 168.76 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.371 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 39' ' ' VAL . 42.5 t -114.33 151.16 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.78 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 18.7 tttt -86.45 127.75 59.7 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.76 122.11 8.55 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.338 1.359 . . . . 0.0 109.765 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.22 26.27 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.47 177.34 9.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.948 . . . . 0.0 108.807 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -76.58 176.24 8.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.07 . . . . 0.0 109.788 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.06 128.94 34.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 109.741 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.4 m-85 -123.72 27.34 7.36 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.036 -1.04 . . . . 0.0 109.344 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 31' ' ' VAL . 49.2 t -73.58 142.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.484 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.46 -2.38 72.45 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -82.58 133.98 35.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.317 -1.108 . . . . 0.0 109.827 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -73.23 109.07 6.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.49 159.08 1.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.215 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -79.12 165.55 23.21 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.726 0.775 . . . . 0.0 109.857 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.978 HG21 ' SD ' ' A' ' 120' ' ' MET . 5.8 p -81.06 -34.14 32.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 108.588 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.96 137.11 8.16 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -55.29 -48.98 73.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 37.7 t -47.02 -53.72 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.28 -50.87 72.33 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.64 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.515 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 86.6 m -64.19 -31.48 72.7 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.852 -0.53 . . . . 0.0 109.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.13 -43.09 83.27 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.055 -1.458 . . . . 0.0 107.292 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.65 -39.19 57.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 109.785 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.9 mt-30 -60.05 -51.15 70.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.695 -1.253 . . . . 0.0 107.647 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.695 HD11 HG22 ' A' ' 198' ' ' VAL . 35.0 mt -63.41 -24.21 35.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 21.9 mtp -73.0 -38.46 66.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 44.7 tptt -69.17 -40.58 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.707 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 50.2 t80 -53.53 -30.5 41.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.058 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.0 m-70 -107.86 -23.08 12.2 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.214 -0.929 . . . . 0.0 110.763 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 54.4 m-20 44.44 54.8 6.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -76.79 -75.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 119.443 -0.903 . . . . 0.0 113.406 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 34.0 Cg_endo -67.09 104.19 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 120.3 0.667 . . . . 0.0 112.107 -176.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.4 -20.32 62.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.4 OUTLIER -133.96 143.68 48.32 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.8 34.96 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.226 -1.464 . . . . 0.0 109.847 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.943 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -90.14 -64.88 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.379 -1.071 . . . . 0.0 109.645 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 5.9 tttt -131.9 148.82 52.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 m-20 -73.9 179.58 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 70' ' ' THR . 14.2 t80 -153.9 151.32 29.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.307 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 t -155.03 152.42 29.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.096 -1.002 . . . . 0.0 109.656 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.701 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 21.3 p90 -161.66 155.01 21.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 109.61 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 97.0 m -93.33 139.37 30.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.789 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -56.55 147.78 21.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 111.221 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -61.95 143.79 55.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.35 0.595 . . . . 0.0 109.749 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -70.13 -2.14 12.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.526 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 18.9 m-20 -97.47 -8.94 28.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.789 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.8 t-20 -70.44 109.51 5.11 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.747 -0.596 . . . . 0.0 109.88 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -89.16 15.82 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.959 2.439 . . . . 0.0 110.193 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.676 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.7 m-85 -105.92 -25.86 11.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.718 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' C ' ' A' ' 81' ' ' ASN . 8.7 m-85 -119.21 163.0 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.5 m120 -46.58 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 175.06 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 111.041 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.17 56.63 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 N-CA-C 107.24 -1.869 . . . . 0.0 107.24 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.92 106.73 17.37 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.408 -178.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 134.29 43.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.91 125.03 51.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.51 124.93 46.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.147 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.21 108.47 19.91 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.9 54.19 0.36 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.799 -1.188 . . . . 0.0 108.428 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 46.6 mt -52.43 -45.75 46.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 O-C-N 121.405 -0.809 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 p -45.42 -26.46 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.799 -1.188 . . . . 0.0 109.286 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 26.75 10.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.811 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -84.45 154.13 22.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.111 -0.993 . . . . 0.0 110.375 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.27 95.03 4.79 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 7.0 m-85 -81.82 88.96 6.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 110.857 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 11.7 t30 -79.94 91.13 5.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CE2' ' HA ' ' A' ' 60' ' ' ASN . 61.7 m95 -61.29 -6.25 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.423 -0.798 . . . . 0.0 110.805 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -90.33 -18.86 24.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.779 -1.201 . . . . 0.0 107.876 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.3 m-20 -99.59 -29.11 12.88 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.694 HG12 ' HB1' ' A' ' 115' ' ' ALA . 31.0 mt -73.83 63.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.522 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 61.0 mt -46.27 148.64 1.51 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.555 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.5 Cg_endo -77.75 -29.07 4.73 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.598 2.199 . . . . 0.0 110.455 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -134.68 124.5 25.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.122 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.0 m-85 -109.42 138.92 45.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.6 p -100.09 1.65 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.472 ' HA3' HD22 ' A' ' 19' ' ' ASN . . . 81.93 0.79 89.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -120.13 9.66 11.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.196 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -74.73 -178.95 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -76.38 174.98 9.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 1.2 m120 -78.48 -36.76 44.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.658 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.9 t -53.47 -59.42 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.801 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.85 -33.15 73.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 108.94 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.533 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 32.1 mttt -67.81 -44.22 77.8 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -33.18 70.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.694 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.09 -67.84 0.28 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.71 -0.619 . . . . 0.0 109.579 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.9 tp -61.96 -41.34 90.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.193 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.56 ' OG ' HD12 ' A' ' 24' ' ' LEU . 4.5 p -57.15 -40.02 76.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 109.164 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.811 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 31.3 tt0 -69.99 -43.26 71.8 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.8 tp -57.41 -48.41 79.16 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.978 ' SD ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -56.61 -47.6 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.476 178.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.71 -39.22 93.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 126' ' ' SER . 13.0 m-20 -65.3 -53.87 37.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 127' ' ' VAL . 89.1 t -65.31 -54.99 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.296 -0.878 . . . . 0.0 109.454 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -47.22 -53.07 11.9 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.1 mt -65.99 -53.16 40.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -1.093 . . . . 0.0 108.516 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 123' ' ' VAL . 60.3 p -45.53 -33.53 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.067 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 123' ' ' VAL . 35.7 m -100.86 38.69 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.713 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' VAL . 22.4 m-20 37.15 52.04 1.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.517 -0.74 . . . . 0.0 109.624 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.66 ' HE3' ' O ' ' A' ' 45' ' ' THR . 44.2 tpp -66.63 130.55 43.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.57 -0.707 . . . . 0.0 111.774 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' SER . 8.0 t70 -76.92 122.01 24.26 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.652 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.59 120.31 40.63 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.479 1.133 . . . . 0.0 113.029 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.754 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -152.09 -163.21 11.37 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 104.485 -3.446 . . . . 0.0 104.485 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.623 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -62.26 -31.54 82.16 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 N-CA-C 105.551 -2.519 . . . . 0.0 105.551 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.2 m -109.36 142.21 40.62 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.509 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 30.7 m -124.64 109.8 13.61 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 119.961 -1.712 . . . . 0.0 110.104 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.3 137.41 14.08 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 3.5 t -117.35 -162.22 0.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.879 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.69 -50.65 5.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 143' ' ' VAL . . . 121.37 -126.24 6.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.488 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 10.4 m -47.08 -60.55 2.39 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.712 -0.875 . . . . 0.0 112.279 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 79.4 p -47.18 -41.45 18.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 0.0 109.253 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.879 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.5 mmp_? -79.9 -41.14 26.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.432 1.111 . . . . 0.0 109.142 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.792 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.1 t -67.71 -60.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.16 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.9 pp0? -56.2 -34.78 66.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.755 -1.216 . . . . 0.0 108.651 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.569 ' HE ' ' NH2' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -70.66 -44.8 66.31 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.315 -0.866 . . . . 0.0 109.329 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.76 -36.91 81.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.182 -0.949 . . . . 0.0 110.662 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.831 HD13 HG12 ' A' ' 251' ' ' ILE . 76.6 mt -55.67 -54.73 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 109.921 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 11.1 mtmt -81.07 -33.87 33.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 111.597 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 84.9 mt-10 -74.09 -66.97 0.65 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.48 -1.388 . . . . 0.0 112.628 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.556 ' HB3' HD13 ' A' ' 90' ' ' ILE . 26.3 m120 -81.63 -31.78 32.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.923 -1.111 . . . . 0.0 111.727 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 22.4 m-85 -102.57 -8.17 21.22 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.64 -1.287 . . . . 0.0 110.382 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.943 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 53.74 38.45 59.29 Favored Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.137 -0.977 . . . . 0.0 112.212 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.24 162.8 9.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.3 -1.706 . . . . 0.0 107.677 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 35.8 t-20 -47.11 143.87 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 109.586 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -53.58 -19.97 4.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.492 -0.755 . . . . 0.0 109.009 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 154' ' ' ASN . 3.7 p -53.99 -16.63 2.01 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.812 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.559 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 41.0 t -61.34 127.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.911 -1.118 . . . . 0.0 109.552 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.898 ' CE1' HG23 ' A' ' 249' ' ' VAL . 18.7 p-80 -149.08 158.76 44.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.375 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 33.0 tt0 -102.78 149.22 24.69 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.894 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -127.87 146.79 32.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.8 m120 -112.36 102.98 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.131 . . . . 0.0 111.125 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.669 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.21 -28.41 3.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.83 . . . . 0.0 109.049 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.542 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.54 -27.69 73.31 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -103.85 4.72 35.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.1 -1.235 . . . . 0.0 111.6 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.08 171.04 8.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.404 -1.435 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 167' ' ' LYS . 84.1 p -103.94 134.56 47.02 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 166' ' ' SER . 54.7 tttt -30.57 -45.08 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.923 -0.485 . . . . 0.0 111.077 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -63.3 -66.04 0.6 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.185 . . . . 0.0 109.851 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -16.01 58.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 109.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.894 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 45.8 t-105 -72.18 -49.34 36.39 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.153 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 174' ' ' ILE . 18.8 mt-10 -67.6 -33.7 75.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.7 -48.01 20.32 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -61.01 -38.47 86.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.765 HG21 HD13 ' A' ' 199' ' ' ILE . 53.3 mt -75.92 -63.86 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 110.425 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -49.28 -53.89 19.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -51.92 -40.2 60.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 108.112 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.557 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.0 mm-40 -61.11 -50.26 73.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.874 HD21 HG22 ' A' ' 199' ' ' ILE . 13.2 mt -68.61 -25.78 65.03 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.484 -0.76 . . . . 0.0 109.7 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 37.0 p -51.85 -38.0 54.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 108.26 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 10.7 mt-30 -101.09 33.87 2.71 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.489 ' C ' HD13 ' A' ' 7' ' ' LEU . 5.4 m120 45.97 50.66 11.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 15.0 mt-30 -124.07 107.14 30.7 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.451 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -64.19 170.06 9.79 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.145 1.897 . . . . 0.0 112.667 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 51.6 t -123.67 135.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.614 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.792 ' CE2' HG21 ' A' ' 143' ' ' VAL . 1.2 t80 -83.42 117.95 23.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.624 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 4.1 t80 -123.19 153.41 40.12 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 120.845 -1.16 . . . . 0.0 109.705 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.9 pt20 -164.81 135.5 4.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.328 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.92 114.98 4.66 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 107.239 -2.345 . . . . 0.0 107.239 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 41.5 t -80.96 145.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.255 . . . . 0.0 111.349 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.573 ' HA3' ' CD1' ' A' ' 241' ' ' PHE . . . -145.9 -145.75 4.3 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -87.95 -29.77 20.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -1.162 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.2 m -82.9 -13.07 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.8 -166.13 25.18 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -97.91 110.89 4.12 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 119.038 -1.553 . . . . 0.0 110.735 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.33 117.37 12.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -107.99 160.92 15.41 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.373 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.721 ' CD1' HG13 ' A' ' 210' ' ' VAL . 46.7 p90 -159.09 166.5 31.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.695 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -114.11 136.11 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.696 -1.253 . . . . 0.0 112.036 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.874 HG22 HD21 ' A' ' 178' ' ' LEU . 7.4 mt -98.71 125.79 52.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.5 p30 -139.92 32.33 1.99 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.716 -1.594 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -167.03 173.45 42.29 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 117.862 -2.113 . . . . 0.0 111.719 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.498 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -160.92 149.28 16.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.51 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -122.46 31.66 6.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.711 -1.243 . . . . 0.0 110.45 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 44.33 25.38 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 2.2 mtt180 -142.26 21.79 2.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.227 -1.16 . . . . 0.0 108.95 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.9 OUTLIER 77.88 23.51 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.221 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 29.7 m-85 -122.72 128.45 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.928 . . . . 0.0 109.356 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.3 m-85 -122.94 171.6 9.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.299 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.527 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 1.0 OUTLIER -93.64 136.39 33.96 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.721 HG13 ' CD1' ' A' ' 197' ' ' PHE . 51.2 t -128.62 137.32 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.052 -1.03 . . . . 0.0 110.414 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.5 t-20 -111.85 73.13 0.8 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.523 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 82.3 m95 -46.93 173.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.459 -0.776 . . . . 0.0 110.179 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.16 21.22 25.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.47 -165.46 1.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -1.128 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -73.92 -98.74 0.09 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.27 45.68 1.12 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.774 HG22 ' N ' ' A' ' 218' ' ' SER . 2.3 p -76.09 -103.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -1.168 . . . . 0.0 109.917 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.774 ' N ' HG22 ' A' ' 217' ' ' VAL . 1.0 OUTLIER -85.39 34.18 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.924 -1.11 . . . . 0.0 110.236 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.75 92.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.955 -1.091 . . . . 0.0 109.327 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 208' ' ' TYR . . . 161.16 -97.24 0.15 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.493 ' HB3' ' NH2' ' A' ' 223' ' ' ARG . 30.5 m-85 -60.01 126.01 25.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.35 -1.088 . . . . 0.0 109.992 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.581 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -85.7 171.53 11.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.493 ' NH2' ' HB3' ' A' ' 221' ' ' PHE . 3.1 mmp_? -110.58 155.22 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.068 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -109.63 -48.79 3.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 110.001 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.68 1.34 17.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.124 -0.985 . . . . 0.0 109.455 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.23 86.13 2.53 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.326 1.06 . . . . 0.0 108.735 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.84 45.82 1.24 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.757 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.59 157.53 34.87 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.65 149.57 26.91 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.537 2.158 . . . . 0.0 110.298 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.495 ' HB3' HG21 ' A' ' 217' ' ' VAL . 23.7 m -64.68 -59.0 4.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.64 135.04 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.462 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.661 HD13 ' HA2' ' A' ' 239' ' ' GLY . 10.9 mt -93.75 24.74 3.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.422 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.33 154.8 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -34.63 10.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.497 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -90.83 -56.64 1.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.65 12.1 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 144.75 94.98 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 241' ' ' PHE . . . -59.05 -62.54 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.568 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.661 ' HA2' HD13 ' A' ' 232' ' ' LEU . . . 164.0 -126.67 1.55 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -95.87 94.27 1.66 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -117.38 70.21 0.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.431 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 8.3 t30 -73.06 72.81 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.0 109.695 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.43 -38.48 21.21 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.511 ' CB ' ' HB ' ' A' ' 189' ' ' VAL . 1.9 m-85 -135.84 156.55 48.62 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 1.4 pt20 -156.5 142.94 18.39 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.8 -1.187 . . . . 0.0 109.321 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 15.1 p -166.1 163.21 18.11 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -142.08 167.15 22.81 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.942 0.877 . . . . 0.0 109.925 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 147' ' ' LEU . 15.5 t -118.0 120.77 65.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.898 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.4 m -120.69 149.75 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.95 -1.094 . . . . 0.0 111.282 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 86.03 46.92 5.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.831 HG12 HD13 ' A' ' 147' ' ' LEU . 4.1 mt -93.57 93.98 4.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.406 -1.055 . . . . 0.0 109.761 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.07 148.67 9.71 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.44 -0.788 . . . . 0.0 108.946 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.626 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.389 2.06 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.499 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 38.4 tt0 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 36.1 Cg_endo -78.54 164.66 25.88 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.339 2.026 . . . . 0.0 109.712 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.8 t -101.69 141.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.011 -1.055 . . . . 0.0 109.597 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.8 t -137.71 131.42 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.399 -0.813 . . . . 0.0 109.123 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 201' ' ' GLY . 10.1 mmtt -76.14 -166.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 108.908 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.566 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 2.7 t -87.89 106.11 17.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.873 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.694 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 46.6 mt -58.49 -50.11 74.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 108.906 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.4 mt -55.93 -38.02 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.66 -1.275 . . . . 0.0 108.858 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.507 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 43.9 m-20 -67.25 -43.48 81.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.796 . . . . 0.0 109.774 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 3.7 p -58.24 -14.44 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.048 . . . . 0.0 109.317 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.5 mtpm? -117.15 17.9 14.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.793 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.26 41.44 6.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.2 mt -91.11 108.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 122.247 1.022 . . . . 0.0 110.526 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 8.5 m-70 -134.83 81.25 1.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.6 m-30 -87.11 179.99 6.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 111.152 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.74 -162.61 1.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 45' ' ' THR . 17.5 mt-30 -125.36 -21.93 4.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.721 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.06 -33.87 1.59 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.604 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.828 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.7 t-20 -45.6 -139.68 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.512 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.064 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -74.24 2.99 5.58 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 CA-C-N 122.554 1.948 . . . . 0.0 109.269 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.7 m-85 -77.91 -31.59 51.25 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.404 -0.81 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.478 ' HA ' HG23 ' A' ' 25' ' ' THR . 23.8 p-10 -93.88 14.35 19.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.632 -1.293 . . . . 0.0 109.746 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.2 mt -70.4 -7.83 46.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.738 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 118' ' ' GLU . 11.3 mt -123.74 -9.35 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.092 -1.005 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.0 p -60.85 165.31 6.1 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.2 Cg_endo -70.48 143.02 46.2 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.357 2.038 . . . . 0.0 112.184 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.23 148.12 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.559 0.695 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.9 mt -78.51 148.05 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 111.173 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.9 mt-10 -126.4 -21.5 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.732 -0.605 . . . . 0.0 110.659 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 9.0 mtpm? -118.82 168.39 10.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.859 -1.15 . . . . 0.0 110.284 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 37' ' ' SER . 74.9 t -114.84 145.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.557 -0.715 . . . . 0.0 110.69 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.602 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -77.58 158.34 78.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.1 Cg_endo -82.3 113.16 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.369 2.046 . . . . 0.0 110.494 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.48 62.83 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.38 159.61 23.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 109.544 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.09 165.6 4.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 109.361 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 31' ' ' VAL . 3.0 t -74.91 138.84 42.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.189 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.616 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 82.5 m-85 -123.61 14.71 9.47 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.899 -1.126 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 29' ' ' GLU . 61.0 t -62.99 141.89 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.189 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 1.38 87.39 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -91.97 132.14 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -1.096 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -73.2 111.89 8.74 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.21 160.61 0.75 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 109.003 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.76 166.93 22.34 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.616 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.697 HG21 ' SD ' ' A' ' 120' ' ' MET . 29.5 p -79.67 -35.56 39.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.6 139.02 9.53 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 51' ' ' ALA . 5.6 p -55.17 -49.75 71.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 3.9 t -47.02 -52.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.77 -47.38 78.39 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.847 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 96.1 m -62.6 -30.2 71.17 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.97 -47.22 69.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.968 -1.083 . . . . 0.0 108.822 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 56' ' ' MET . 30.8 m -75.6 -49.82 17.39 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.409 0.623 . . . . 0.0 110.277 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.6 -34.55 37.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 109.078 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.609 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -67.71 -48.93 65.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.74 HD11 HG22 ' A' ' 198' ' ' VAL . 36.0 mt -66.79 -28.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 52' ' ' THR . 19.3 mtp -67.13 -39.58 86.62 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -71.89 -39.48 69.56 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.694 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 56.9 t80 -53.44 -34.43 57.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.493 -0.754 . . . . 0.0 109.346 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.615 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 36.8 m80 -107.75 -20.45 13.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.36 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.0 OUTLIER 38.55 54.63 1.89 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -74.64 -70.7 0.23 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.0 Cg_endo -69.67 103.81 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 122.269 0.615 . . . . 0.0 111.806 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' TYR . 7.6 m120 -70.09 -21.57 63.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -134.78 140.13 45.65 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.84 34.9 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.664 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.883 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -89.01 -44.3 10.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.62 -0.929 . . . . 0.0 110.387 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.4 tttt -151.61 137.86 18.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 164.94 7.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.0 110.219 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 26.1 t80 -148.94 141.35 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.264 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t -146.99 161.12 41.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.932 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.6 p90 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.656 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.494 HG23 ' OD1' ' A' ' 85' ' ' ASN . 27.4 m -93.19 129.82 39.08 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.826 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -47.67 150.58 0.99 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 111.28 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 t -62.15 140.67 58.42 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -68.09 -3.82 11.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 0.0 109.868 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 52.6 t30 -99.28 -7.75 25.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.826 ' ND2' HD21 ' A' ' 73' ' ' LEU . 39.6 t-20 -70.37 111.58 9.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 109.971 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.621 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.3 Cg_endo -88.54 13.11 2.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.982 2.454 . . . . 0.0 110.094 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.4 m-85 -104.94 -5.0 21.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 111.139 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 5.5 m-85 -142.22 162.0 36.58 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.564 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 23.5 m-20 -46.67 -79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 174.79 -46.8 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 111.047 175.307 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.88 57.34 5.67 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 N-CA-C 107.012 -1.957 . . . . 0.0 107.012 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.51 101.59 11.11 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.294 -178.028 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.494 ' OD1' HG23 ' A' ' 72' ' ' THR . 37.3 m-80 -100.11 128.87 46.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.756 . . . . 0.0 109.466 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -100.75 134.5 43.63 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.77 129.63 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.81 111.37 23.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 51.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 108.304 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.4 mt -52.77 -54.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.384 -0.822 . . . . 0.0 110.027 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.1 p -44.59 -27.61 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.242 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -111.97 34.36 4.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -0.83 . . . . 0.0 109.177 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.748 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.05 90.31 3.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.4 m-85 -81.31 88.08 6.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 47.3 t-20 -79.4 87.79 5.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.641 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.0 m95 -60.98 -7.04 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -89.43 -18.76 26.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 7.9 m-20 -100.08 -26.48 13.94 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.609 HG12 ' HB1' ' A' ' 115' ' ' ALA . 51.9 mt -76.53 67.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 108.903 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 18.9 mt -46.84 149.42 1.53 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.775 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.7 Cg_endo -78.99 -18.11 11.63 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.903 2.402 . . . . 0.0 110.725 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 133.3 25.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.995 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.625 ' CE2' HG21 ' A' ' 116' ' ' ILE . 62.1 m-85 -121.49 136.75 54.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.258 -0.901 . . . . 0.0 109.845 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -99.94 0.91 42.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 113' ' ' LYS . . . 81.15 -1.76 83.81 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.631 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -110.46 -6.88 14.83 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.423 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.631 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 3.0 mp0 -63.86 164.66 9.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 109.755 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -62.1 172.74 1.31 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 17.3 m-20 -77.03 -31.26 56.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.623 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.2 -60.17 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 5.2 mp0 -62.76 -35.04 78.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.785 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.546 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 33.6 mttt -65.27 -42.34 93.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.463 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 12.2 ttm -59.15 -37.81 78.2 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.609 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.33 -68.1 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.672 -0.643 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.733 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.1 tp -62.37 -37.48 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.633 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.2 p -57.18 -40.44 77.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.921 -1.112 . . . . 0.0 109.95 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.748 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 35.3 tt0 -69.4 -41.57 76.26 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.733 HD23 ' CD1' ' A' ' 116' ' ' ILE . 9.3 tp -54.65 -52.69 61.52 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.697 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -58.68 -43.93 90.1 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.5 -0.75 . . . . 0.0 109.292 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.09 -36.69 84.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 93' ' ' ARG . 27.8 m-20 -69.6 -54.61 13.2 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 127' ' ' VAL . 48.4 t -63.38 -57.78 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.19 -49.84 13.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.0 mt -63.9 -58.8 5.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 108.276 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.25 -29.23 1.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.517 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 20.9 m -101.42 36.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.895 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 127' ' ' VAL . 3.3 m-20 37.81 51.93 1.39 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.466 -0.771 . . . . 0.0 109.407 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.7 tpp -66.04 126.92 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.53 -0.731 . . . . 0.0 111.741 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -75.77 120.66 21.44 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 57.3 m-85 -102.83 115.67 31.05 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.279 1.038 . . . . 0.0 112.719 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.744 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.92 -162.88 10.95 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 104.869 -3.292 . . . . 0.0 104.869 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 18.0 Cg_endo -62.39 -30.56 80.72 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 N-CA-C 105.802 -2.422 . . . . 0.0 105.802 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.99 140.76 43.65 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 32.7 m -124.26 109.66 13.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.843 -1.786 . . . . 0.0 110.286 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -108.88 144.72 16.42 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.648 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.54 -163.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -1.219 . . . . 0.0 107.765 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.75 -53.97 4.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 134.18 -139.02 10.51 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 119.145 -1.502 . . . . 0.0 111.981 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB2' ' CD ' ' A' ' 159' ' ' GLN . 0.7 OUTLIER -48.06 -54.37 13.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.139 -0.624 . . . . 0.0 112.237 -177.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 4.1 p -46.53 -41.25 13.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.926 -1.109 . . . . 0.0 109.7 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.708 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 2.3 mmt180 -81.15 -42.63 20.58 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 109.585 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.855 HG21 ' CE2' ' A' ' 185' ' ' TYR . 44.3 t -68.14 -52.79 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 110.463 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.44 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 1.8 pp0? -56.9 -34.36 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.554 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 2.4 ttm180 -77.35 -51.8 10.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 109.197 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.75 75.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.587 ' HB2' HG11 ' A' ' 157' ' ' VAL . 46.0 mt -56.92 -50.57 72.17 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.099 -1.0 . . . . 0.0 109.652 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 4.5 mtmp? -87.65 -41.12 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.017 -1.052 . . . . 0.0 110.589 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 85.1 mt-10 -68.08 -49.1 63.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.919 -1.113 . . . . 0.0 111.727 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -93.94 -43.19 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.907 -1.121 . . . . 0.0 111.652 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 152' ' ' GLY . 33.5 m-85 -102.27 15.49 28.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.658 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.883 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 35.08 40.22 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.626 -0.671 . . . . 0.0 112.581 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.2 m-85 -62.53 164.06 8.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.062 -1.846 . . . . 0.0 107.853 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.5 t-20 -47.37 145.1 2.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.174 . . . . 0.0 109.617 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -53.43 -19.96 4.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.909 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.537 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 7.8 p -55.72 -14.5 2.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.331 -0.856 . . . . 0.0 109.739 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -66.4 119.85 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.938 -1.101 . . . . 0.0 109.65 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.6 p-80 -148.55 163.17 38.02 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.495 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 18.4 tt0 -104.07 146.36 28.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.617 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 4.3 pt -121.93 155.17 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m120 -123.29 105.73 10.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.814 -1.179 . . . . 0.0 111.041 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 44.4 tpt85 -48.14 -38.9 19.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 109.012 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.54 -25.83 63.69 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.03 -1.03 28.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.064 -1.256 . . . . 0.0 111.273 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.04 173.92 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.785 -1.197 . . . . 0.0 110.027 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 167' ' ' LYS . 83.8 p -98.53 138.71 35.34 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 166' ' ' SER . 35.5 tttt -35.22 -48.43 0.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.766 -0.584 . . . . 0.0 110.361 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.404 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 7.5 mp0 -65.4 -59.23 4.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.049 -1.032 . . . . 0.0 109.854 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.52 -15.59 58.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.988 . . . . 0.0 109.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 61.0 t-105 -73.66 -47.78 37.26 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.664 ' HA ' HD12 ' A' ' 174' ' ' ILE . 29.2 mt-10 -70.76 -30.98 67.63 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.24 65.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 63.8 mm-40 -61.26 -41.19 96.49 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.001 HG23 HG21 ' A' ' 184' ' ' VAL . 22.3 mt -74.03 -51.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.553 -0.717 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -55.97 -41.98 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 108.626 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -51.97 -43.29 63.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.582 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 51.9 mm-40 -59.72 -51.94 67.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.94 -25.61 64.65 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.828 . . . . 0.0 110.044 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.484 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.5 p -52.05 -38.12 55.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 25.0 mt-30 -101.55 29.52 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.528 ' C ' HD13 ' A' ' 7' ' ' LEU . 8.1 m-20 51.15 49.18 21.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.72 0.771 . . . . 0.0 109.165 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 77.8 mt-30 -124.34 117.08 26.77 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.8 Cg_endo -65.67 171.4 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.21 1.94 . . . . 0.0 112.328 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 174' ' ' ILE . 23.4 t -125.98 115.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.367 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.855 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -66.27 113.27 4.46 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 10.9 t80 -123.77 157.39 34.13 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 120.891 -1.13 . . . . 0.0 109.658 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.1 pt20 -158.93 129.84 6.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 117.927 -1.509 . . . . 0.0 111.804 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.17 109.71 3.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 3.6 t -66.8 166.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -1.179 . . . . 0.0 111.099 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.594 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -175.21 -136.78 2.35 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 10.5 mtpt -87.81 -55.85 3.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.24 . . . . 0.0 111.357 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.571 ' CG2' ' HB2' ' A' ' 238' ' ' ALA . 4.1 m -61.15 -8.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.057 -1.027 . . . . 0.0 111.47 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.45 21.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -91.25 107.57 3.5 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.861 ' HB2' ' HB3' ' A' ' 238' ' ' ALA . 25.0 t60 -71.66 126.19 29.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.92 159.07 24.47 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.533 1.159 . . . . 0.0 112.723 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.693 ' CD1' HG13 ' A' ' 210' ' ' VAL . 43.2 p90 -153.58 -161.05 1.19 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' ILE . 85.9 t -139.34 133.27 38.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 120.362 -1.461 . . . . 0.0 111.377 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.785 HD11 HD11 ' A' ' 224' ' ' LEU . 82.8 mt -99.14 120.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 3.1 p30 -133.24 33.47 3.61 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.439 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.23 163.92 35.62 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 117.706 -2.188 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.533 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.28 140.9 29.47 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -111.31 11.18 21.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.103 . . . . 0.0 110.567 -178.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.64 4.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -80.57 53.54 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 109.884 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 53.09 38.54 27.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.783 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.675 ' HE1' ' HE ' ' A' ' 223' ' ' ARG . 1.2 m-85 -121.92 133.92 54.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 12.9 m-85 -122.91 159.77 27.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.07 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 39.4 t-80 -93.22 117.78 30.48 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 197' ' ' PHE . 29.1 t -114.55 138.64 43.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 111.447 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 8' ' ' LEU . 19.4 t-20 -104.62 80.56 1.68 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.412 ' CH2' ' CD1' ' A' ' 227' ' ' LEU . 23.0 m95 -46.19 166.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -85.83 36.96 3.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.574 ' HB2' HG12 ' A' ' 217' ' ' VAL . 32.7 m95 -116.09 -170.41 1.79 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -1.169 . . . . 0.0 109.227 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.98 -55.36 0.65 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.75 30.32 3.26 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 218' ' ' SER . 2.6 p -83.04 -155.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -1.149 . . . . 0.0 109.163 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.719 ' H ' HG22 ' A' ' 217' ' ' VAL . 9.8 m -68.41 52.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.848 -1.158 . . . . 0.0 111.063 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 217' ' ' VAL . 3.7 m-20 -85.14 121.1 27.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.817 -1.177 . . . . 0.0 109.195 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 172.46 -113.55 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.12 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 221' ' ' PHE . 10.6 p90 -114.95 122.3 45.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -1.128 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -135.35 177.28 7.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.675 ' HE ' ' HE1' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -88.52 177.78 6.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.124 -0.985 . . . . 0.0 109.589 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 199' ' ' ILE . 3.7 mm? -121.17 22.64 10.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -36.05 7.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.85 96.94 5.14 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.666 HD12 ' CE2' ' A' ' 197' ' ' PHE . 4.3 mm? -89.96 82.92 6.1 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.538 0.685 . . . . 0.0 109.835 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 1.5 p-10 -116.89 142.64 30.12 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.483 -0.761 . . . . 0.0 109.085 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 228' ' ' ASN . 35.5 Cg_endo -78.08 174.97 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.469 2.112 . . . . 0.0 110.378 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.93 -59.34 1.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.495 ' HB3' ' CE2' ' A' ' 214' ' ' TRP . . . -74.86 117.26 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 231' ' ' ALA . 5.5 mp -124.55 -91.67 0.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.28 52.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -39.89 65.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.143 . . . . 0.0 109.633 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.19 65.0 2.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 237' ' ' GLY . . . -85.73 116.37 4.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 236' ' ' GLY . . . -61.48 -129.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 195' ' ' HIS . . . -110.24 45.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.162 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.34 53.75 4.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -136.78 8.11 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.474 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -77.04 166.7 22.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -111.26 100.75 9.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 108.99 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 244' ' ' TYR . . . -108.32 -40.7 1.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 22.1 m-85 -135.54 84.65 2.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.326 -1.103 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 2.2 mt-30 -91.26 119.22 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 72.6 p -136.05 164.82 27.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.712 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.695 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.91 161.7 37.2 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.75 HG23 ' CD1' ' A' ' 185' ' ' TYR . 39.1 t -116.15 113.67 43.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 184' ' ' VAL . 13.9 m -112.55 142.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.941 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.42 ' N ' ' OE1' ' A' ' 177' ' ' GLU . . . 90.65 54.77 2.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.59 ' O ' ' CE1' ' A' ' 59' ' ' HIS . 38.5 mt -102.75 89.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 110.225 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 2.2 pptp? -162.89 151.76 12.41 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 0.0 109.03 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.335 2.023 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.423 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 36.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 1' ' ' GLN . 36.0 Cg_endo -78.07 163.95 27.65 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.456 2.104 . . . . 0.0 109.89 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 t -100.46 143.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.433 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.7 t -135.88 131.55 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -76.19 -178.6 4.56 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.687 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 17.5 t -78.13 106.2 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.896 -1.128 . . . . 0.0 109.312 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.8 mt -56.69 -48.44 77.64 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD11 ' CG1' ' A' ' 198' ' ' VAL . 13.7 mt -55.01 -42.25 72.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 108.386 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 2.1 t0 -67.19 -40.87 86.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.133 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 p -58.11 -15.7 10.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.998 -1.064 . . . . 0.0 108.772 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.584 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 2.0 mtpp -116.9 16.96 15.15 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 46.85 39.22 10.9 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 11' ' ' LYS . 27.8 mt -91.34 110.67 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -1.037 . . . . 0.0 110.519 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.0 m80 -134.7 83.05 2.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.2 m-30 -89.49 179.28 6.09 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.141 0.972 . . . . 0.0 110.991 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -147.89 -163.24 1.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 45' ' ' THR . 8.0 mt-30 -124.95 -21.21 4.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.978 -1.076 . . . . 0.0 110.572 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.31 -35.09 1.36 Allowed Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.522 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.844 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.6 t-20 -45.64 -138.06 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.527 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.202 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.844 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.1 Cg_endo -75.08 4.46 4.75 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 CA-C-N 122.688 1.996 . . . . 0.0 109.589 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.9 m-85 -80.42 -34.1 36.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 29.9 p-10 -88.79 15.65 8.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.536 -1.352 . . . . 0.0 109.177 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.17 -5.96 30.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.104 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.1 mt -128.57 -5.81 5.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 109.934 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -61.24 164.57 8.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.1 Cg_endo -69.59 136.36 33.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.231 1.954 . . . . 0.0 112.251 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG1' ' HA2' ' A' ' 40' ' ' GLY . 38.8 t -76.01 148.19 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.538 0.685 . . . . 0.0 109.924 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 132' ' ' GLY . 13.7 mt -78.19 150.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.836 0.827 . . . . 0.0 111.122 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' C ' HG22 ' A' ' 39' ' ' VAL . 3.3 mt-10 -125.06 -23.15 4.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.704 -0.623 . . . . 0.0 110.152 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.0 mtpt -120.75 165.91 14.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 38' ' ' PHE . 86.0 t -114.62 143.71 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 110.588 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -73.6 158.99 85.61 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.625 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.1 Cg_endo -81.83 113.64 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.565 2.176 . . . . 0.0 110.795 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.33 4.3 58.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.5 tp10 -121.41 161.52 22.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.255 . . . . 0.0 109.575 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' HG13 ' A' ' 31' ' ' VAL . 20.0 mm-40 -60.6 175.59 0.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.419 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -81.82 134.36 35.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.687 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 74.4 m-85 -118.52 12.93 13.36 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.995 -1.066 . . . . 0.0 109.156 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HA ' HG22 ' A' ' 28' ' ' ILE . 78.0 t -62.86 138.94 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' CG1' ' A' ' 27' ' ' VAL . . . 79.89 1.62 87.53 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 11.8 mt-30 -89.39 134.06 34.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.33 111.18 8.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.29 161.08 0.69 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.974 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.68 167.23 21.91 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.661 -0.649 . . . . 0.0 109.515 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.706 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.5 p -80.48 -33.77 36.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.112 -0.993 . . . . 0.0 108.495 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 102.86 138.22 9.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.0 p -55.21 -48.66 73.55 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.7 t -47.11 -52.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.41 -47.86 77.56 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.088 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.505 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 54.8 m -62.86 -29.47 70.78 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.569 -0.707 . . . . 0.0 109.157 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.91 -47.09 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.751 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 56' ' ' MET . 35.4 m -75.72 -48.88 20.05 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.441 0.639 . . . . 0.0 110.255 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.65 -33.96 35.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.513 -0.742 . . . . 0.0 109.085 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.627 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 28.7 mt-30 -68.31 -50.38 53.91 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 198' ' ' VAL . 33.7 mt -65.0 -23.99 34.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.582 ' HG3' HG22 ' A' ' 52' ' ' THR . 18.1 mtp -72.56 -36.23 68.17 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.558 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 42.4 tptt -71.5 -44.42 64.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.9 t80 -53.38 -30.58 40.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.24 0.543 . . . . 0.0 109.739 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 61.0 m-70 -107.81 -23.62 12.0 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.625 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.23 58.92 1.81 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -77.96 -76.82 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.375 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.3 Cg_endo -71.19 108.59 2.37 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 CA-C-N 119.41 0.825 . . . . 0.0 113.225 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.76 -26.99 67.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 103.819 -2.659 . . . . 0.0 103.819 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 18.9 tttt -129.58 130.35 45.58 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.93 167.46 4.35 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.396 -1.859 . . . . 0.0 110.904 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.11 -38.64 10.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.537 -0.978 . . . . 0.0 111.301 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 73.4 tttt -152.67 132.49 13.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.677 -1.265 . . . . 0.0 110.7 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 3.0 m-20 -60.42 168.29 2.17 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.368 -0.832 . . . . 0.0 109.495 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 35.8 t80 -151.97 141.81 21.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 109.724 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.0 t -144.39 153.51 42.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 109.271 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.793 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.1 p90 -152.88 156.7 39.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.819 HG23 ' OD1' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -92.9 127.19 38.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.819 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -44.81 150.36 0.37 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 111.205 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -61.99 142.89 57.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.862 -0.524 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.401 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 p -70.06 -2.1 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.013 -1.054 . . . . 0.0 109.816 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 16.0 t-20 -99.83 -8.18 24.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.146 -0.971 . . . . 0.0 109.666 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.819 ' ND2' HD21 ' A' ' 73' ' ' LEU . 37.8 t-20 -70.23 112.09 11.51 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.592 -0.693 . . . . 0.0 110.021 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.0 Cg_endo -86.94 9.03 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.042 2.494 . . . . 0.0 110.589 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 58.2 m-85 -104.83 -14.04 15.65 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.106 -0.997 . . . . 0.0 111.5 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 53.2 m-85 -128.18 159.57 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.4 m120 -46.9 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 175.47 -48.31 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.966 175.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.58 57.72 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.91 104.98 14.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.487 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.819 ' OD1' HG23 ' A' ' 72' ' ' THR . 2.4 m-80 -100.42 132.23 45.92 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.337 -0.852 . . . . 0.0 109.882 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.793 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -105.86 143.26 34.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -130.91 128.84 41.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.923 -1.11 . . . . 0.0 110.537 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -111.12 112.16 23.76 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.89 53.84 0.48 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.673 -1.267 . . . . 0.0 108.102 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.3 mt -52.98 -56.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.726 -0.609 . . . . 0.0 111.332 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -43.83 -29.73 0.58 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.703 -1.248 . . . . 0.0 109.456 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.93 33.04 5.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.391 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.873 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 32.7 mmt-85 -82.29 158.12 23.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.736 -1.228 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -116.1 81.73 1.66 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.3 m-85 -81.49 89.9 6.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.581 -0.699 . . . . 0.0 110.198 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.506 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.5 t30 -78.76 90.83 4.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.662 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 63.8 m95 -60.09 -8.16 2.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.75 -18.12 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 46.1 m-20 -99.72 -31.27 11.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.0 mt -73.83 66.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.538 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 24.9 mt -45.79 149.16 1.18 Allowed Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -78.24 -23.04 9.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.635 2.223 . . . . 0.0 110.441 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -137.57 130.3 30.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.02 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 86.3 m-85 -116.82 144.29 44.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.042 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.2 p -100.53 -16.62 17.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.49 -2.72 57.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -120.19 7.22 10.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -1.227 . . . . 0.0 109.523 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.23 177.31 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.905 . . . . 0.0 109.486 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 p -69.33 170.85 9.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.77 -38.53 53.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.9 t -51.44 -56.75 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -40.48 96.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.082 -1.012 . . . . 0.0 109.214 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.501 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.6 mttt -62.53 -39.03 92.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.0 ttm -59.91 -43.37 94.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.677 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.58 -52.05 67.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.673 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.6 tp -69.45 -39.2 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.391 -1.443 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -57.55 -41.74 81.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.079 -1.013 . . . . 0.0 110.454 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 20.6 tt0 -68.76 -38.9 80.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.991 -1.068 . . . . 0.0 108.18 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -56.41 -51.04 69.85 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.706 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.6 mmt -59.69 -44.95 93.44 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 108.999 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.48 -36.28 83.66 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.873 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 18.5 m-20 -69.41 -52.43 27.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 127' ' ' VAL . 58.6 t -65.89 -57.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.146 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.16 -49.09 14.7 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.01 -58.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.287 -1.125 . . . . 0.0 108.264 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -47.1 -30.2 2.64 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.571 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.2 m -101.08 37.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 0.0 109.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.1 m-20 37.48 51.44 1.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.476 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 57.8 tpp -65.64 125.61 25.79 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 111.545 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.9 t0 -75.86 121.27 22.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.636 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.0 117.68 35.14 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.519 1.152 . . . . 0.0 113.206 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.751 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.64 -164.2 12.01 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 104.659 -3.377 . . . . 0.0 104.659 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.622 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.24 -29.09 79.8 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.44 141.81 43.02 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 43.4 m -125.33 110.94 14.6 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 119.882 -1.761 . . . . 0.0 110.533 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.92 144.42 16.4 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.7 t -118.17 -163.99 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.111 -1.229 . . . . 0.0 107.719 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.58 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.09 -55.99 3.33 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.567 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 135.0 -137.68 9.43 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 119.313 -1.422 . . . . 0.0 111.623 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.56 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 2.8 m -48.7 -50.22 34.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.812 -0.816 . . . . 0.0 112.408 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' SER . 57.2 p -45.36 -47.28 13.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 0.0 109.842 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.65 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 17.3 mmt180 -81.41 -38.27 26.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 110.195 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.83 HG21 ' CE2' ' A' ' 185' ' ' TYR . 54.1 t -67.67 -53.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.017 . . . . 0.0 110.503 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.95 -34.82 68.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.896 -1.127 . . . . 0.0 108.389 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -77.38 -52.73 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.581 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.52 -34.29 70.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.592 ' HB2' HG11 ' A' ' 157' ' ' VAL . 57.2 mt -59.85 -49.45 77.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.274 -0.891 . . . . 0.0 109.742 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 6.0 mtmt -87.34 -42.74 12.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.891 -1.13 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 32.8 mt-10 -69.31 -51.98 31.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.898 -1.126 . . . . 0.0 112.436 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 21.9 m120 -88.17 -50.47 6.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.725 -1.234 . . . . 0.0 111.986 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -90.04 -16.47 29.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.748 -1.22 . . . . 0.0 110.489 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 68.1 37.8 87.57 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.916 -1.115 . . . . 0.0 111.791 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.9 m-85 -63.04 165.92 6.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.335 -1.686 . . . . 0.0 107.757 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 37.6 t-20 -47.15 143.82 2.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.803 -1.186 . . . . 0.0 109.104 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 11.4 mm100 -53.15 -20.05 3.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 108.983 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.506 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.6 p -55.04 -15.04 1.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -63.57 120.23 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.864 -1.147 . . . . 0.0 109.45 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 1.006 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.0 p-80 -148.12 160.22 43.12 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.1 tt0 -102.48 152.33 21.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 1.078 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.3 pt -131.48 138.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m-80 -106.18 103.32 12.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 1.8 tpt180 -47.66 -29.77 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 108.978 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.92 -22.8 65.01 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.68 -2.87 25.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.241 . . . . 0.0 111.402 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -117.84 177.67 4.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.558 -1.339 . . . . 0.0 110.27 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 170' ' ' TRP . 42.3 p -109.06 147.38 32.47 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' SER . 5.1 ttmm -40.44 -44.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 110.136 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.844 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.37 -15.92 63.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 1.078 ' CH2' HD12 ' A' ' 160' ' ' ILE . 40.5 t-105 -75.11 -38.71 61.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.448 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 42.3 mt-10 -71.24 -34.69 71.0 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.24 -0.912 . . . . 0.0 108.769 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 176' ' ' LYS . . . -55.22 -47.3 75.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.86 . . . . 0.0 109.061 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 80.3 mm-40 -61.25 -43.5 98.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.045 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.952 HG23 HG21 ' A' ' 184' ' ' VAL . 12.0 mt -75.39 -60.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 111.435 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -49.5 -43.4 45.4 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.496 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 172' ' ' ALA . 9.6 tttt -52.21 -44.67 64.88 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.576 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 42.6 mm-40 -58.93 -54.55 45.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.9 mt -66.25 -26.37 67.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' ASP . 45.0 p -51.9 -43.83 63.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.2 mt-30 -94.89 32.05 1.73 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.609 ' C ' HD13 ' A' ' 7' ' ' LEU . 19.6 m-20 49.65 50.59 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 12.6 mt-30 -124.16 114.5 27.73 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.1 Cg_endo -66.25 171.13 10.79 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.136 1.89 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.959 HG13 HG12 ' A' ' 249' ' ' VAL . 21.2 t -126.91 115.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.775 -0.578 . . . . 0.0 111.007 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.83 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -65.11 112.11 3.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 176.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.625 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 5.2 t80 -123.46 155.77 36.83 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.013 -1.054 . . . . 0.0 109.449 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.36 128.66 3.56 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.21 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 245' ' ' GLN . . . -92.19 101.01 2.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 190' ' ' GLY . 50.8 t -67.13 164.13 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 110.988 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.583 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.44 -130.54 1.18 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -87.72 -51.64 5.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -1.214 . . . . 0.0 111.103 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.439 HG11 ' HA2' ' A' ' 237' ' ' GLY . 3.8 m -65.35 -18.19 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 111.776 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.09 -158.9 24.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 189' ' ' VAL . . . -87.6 106.82 3.23 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.916 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 9.3 t-80 -71.83 119.37 15.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -112.94 160.14 18.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.492 -1.283 . . . . 0.0 112.837 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.883 ' CD2' HG13 ' A' ' 210' ' ' VAL . 54.3 p90 -161.54 173.46 14.77 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -116.59 134.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.558 -1.339 . . . . 0.0 111.582 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 96.7 mt -102.7 109.1 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -124.0 33.28 5.33 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.306 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.22 164.92 37.97 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 117.512 -2.28 . . . . 0.0 112.675 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.521 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.91 147.63 34.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -112.45 7.46 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.833 -1.167 . . . . 0.0 110.146 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.87 -46.23 3.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -85.55 44.88 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -1.179 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 222' ' ' PHE . 0.6 OUTLIER 65.34 31.06 10.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.128 -0.982 . . . . 0.0 109.982 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.599 ' HA ' ' CE1' ' A' ' 222' ' ' PHE . 3.6 m-85 -117.93 135.26 54.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.087 -1.008 . . . . 0.0 109.126 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 38.8 m-85 -123.41 162.96 21.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.687 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 1.0 OUTLIER -91.97 137.54 32.28 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.883 HG13 ' CD2' ' A' ' 197' ' ' PHE . 23.9 t -129.46 138.18 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.626 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -109.25 72.59 0.81 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.658 ' CE2' HG11 ' A' ' 210' ' ' VAL . 81.4 m95 -47.0 167.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 110.26 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -91.06 25.74 13.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -107.11 -168.24 1.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -1.188 . . . . 0.0 109.34 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.25 -101.06 0.09 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.71 63.98 0.62 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.795 HG22 ' N ' ' A' ' 218' ' ' SER . 1.5 p -100.02 -98.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.094 -1.239 . . . . 0.0 109.861 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.795 ' N ' HG22 ' A' ' 217' ' ' VAL . 10.9 m -90.37 20.96 4.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 212' ' ' TRP . 1.1 m-20 -60.61 109.3 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.46 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 140.01 -92.77 0.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -59.98 131.65 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -1.195 . . . . 0.0 109.376 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -86.93 165.83 15.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.245 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.451 ' HD3' ' CG ' ' A' ' 228' ' ' ASN . 0.0 OUTLIER -84.31 -179.49 7.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.451 -0.781 . . . . 0.0 109.631 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 17.5 mt -117.74 -4.36 11.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.75 -80.43 0.6 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.64 -96.88 0.46 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.069 -1.02 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 227' ' ' LEU . 1.1 pt? -115.44 177.96 4.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.451 ' CG ' ' HD3' ' A' ' 223' ' ' ARG . 26.0 t-20 -116.43 82.09 11.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.393 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' LEU . 36.0 Cg_endo -78.26 86.8 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.657 2.238 . . . . 0.0 110.534 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.783 ' HB2' HG21 ' A' ' 217' ' ' VAL . 0.0 OUTLIER -88.68 -35.85 16.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.05 98.09 6.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.529 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 237' ' ' GLY . 14.3 mt -53.68 -44.16 69.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 82.9 121.38 0.71 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 234' ' ' THR . 24.0 m -100.67 13.52 34.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -87.63 -85.58 1.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -121.93 -29.52 1.37 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 232' ' ' LEU . . . -91.37 113.77 4.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -110.36 32.19 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -1.105 . . . . 0.0 109.562 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 91.75 -161.44 27.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 166.17 117.14 0.39 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -58.3 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 245' ' ' GLN . 8.0 t30 -108.02 117.99 35.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.36 -49.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.524 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 68.6 m-85 -125.6 61.5 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -1.039 . . . . 0.0 108.985 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 13.3 pt20 -91.51 132.14 36.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 109.789 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 60.1 p -145.72 170.92 15.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -135.25 161.92 34.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.672 0.749 . . . . 0.0 109.102 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.802 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.8 t -116.3 112.36 39.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 1.006 HG23 ' CE1' ' A' ' 158' ' ' HIS . 13.6 m -110.64 143.63 20.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.036 -175.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 88.06 46.35 4.79 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 29.3 mt -92.7 94.01 4.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.392 -1.064 . . . . 0.0 109.812 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 9.0 ptmt -160.87 149.08 12.86 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.619 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.6 Cg_endo . . . . . 0 C--N 1.308 -1.553 0 C-N-CA 122.257 1.971 . . . . 0.0 110.452 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.493 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 37.6 tt0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.67 165.31 24.98 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.473 2.115 . . . . 0.0 109.956 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.16 139.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.091 -1.006 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 178' ' ' LEU . 44.7 t -136.79 127.92 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -76.39 -176.64 3.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.147 -0.971 . . . . 0.0 108.568 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.716 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.0 t -77.45 104.82 8.19 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.467 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 39.4 mt -57.76 -48.16 80.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 108.894 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD11 HG11 ' A' ' 198' ' ' VAL . 11.9 mt -55.63 -42.04 74.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 108.496 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 5.2 m-20 -67.65 -41.41 83.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.068 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -58.32 -14.66 7.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.9 mtpp -118.86 23.43 11.43 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 43.69 38.55 4.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.566 HD11 ' HA ' ' A' ' 58' ' ' TYR . 30.5 mt -90.07 109.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.412 1.101 . . . . 0.0 110.436 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 102' ' ' PRO . 8.7 m-70 -133.59 97.73 4.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.573 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 3.8 m-30 -102.83 174.49 5.85 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.245 1.022 . . . . 0.0 111.614 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.4 OUTLIER -147.01 -172.92 4.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 10.1 mt-30 -124.12 -8.94 7.66 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.828 -1.17 . . . . 0.0 110.036 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.713 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.16 -42.9 0.68 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.852 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.2 t-20 -45.1 -139.98 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.563 0 CA-C-O 118.387 -0.816 . . . . 0.0 111.381 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.852 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.6 Cg_endo -73.75 2.31 6.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 122.545 1.945 . . . . 0.0 109.249 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 48.4 m-85 -73.28 -35.87 66.22 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 34.6 p-10 -98.88 20.53 13.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.617 -1.302 . . . . 0.0 109.797 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -73.52 -2.1 21.31 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.924 . . . . 0.0 109.367 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -128.68 -5.78 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.925 . . . . 0.0 109.726 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 24.6 p -65.25 165.09 18.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.4 Cg_endo -70.61 139.24 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.108 1.872 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 t -84.24 149.55 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.73 . . . . 0.0 110.039 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.811 HD11 ' C ' ' A' ' 132' ' ' GLY . 42.9 mt -78.02 144.2 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 110.351 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' C ' HG22 ' A' ' 39' ' ' VAL . 80.6 mt-10 -123.56 -23.2 4.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 110.115 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.2 mtpm? -118.83 164.01 16.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' VAL . 42.2 t -114.27 152.29 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.216 -0.928 . . . . 0.0 111.27 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.24 128.42 64.83 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.98 126.48 11.91 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.575 1.517 . . . . 0.0 110.247 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.8 6.61 40.19 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.25 -175.52 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.121 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -79.47 179.76 7.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.27 132.42 33.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.113 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 70.8 m-85 -120.47 18.68 12.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.92 . . . . 0.0 108.92 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 31' ' ' VAL . 45.3 t -68.77 150.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.14 81.39 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mm-40 -91.43 129.24 37.44 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.339 -1.095 . . . . 0.0 109.738 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.29 112.7 9.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.27 157.4 1.42 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.176 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -76.6 171.63 14.33 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.398 0.618 . . . . 0.0 109.829 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.595 ' O ' ' HE3' ' A' ' 129' ' ' MET . 24.5 p -80.34 -36.14 34.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.112 -0.993 . . . . 0.0 108.353 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 107.11 135.63 7.92 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -54.1 -52.77 59.95 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -1.149 . . . . 0.0 108.002 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 64.4 t -45.96 -53.84 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.52 -51.88 67.56 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.524 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.3 -32.24 73.6 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.154 -178.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.3 -41.31 85.6 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.277 -1.369 . . . . 0.0 108.228 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.444 HG22 ' HG3' ' A' ' 56' ' ' MET . 44.1 m -73.8 -54.26 8.43 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.004 0.907 . . . . 0.0 109.887 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -51.68 -39.27 57.95 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-30 -60.42 -48.75 80.39 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 198' ' ' VAL . 39.1 mt -65.47 -24.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.597 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 36.6 mtp -73.42 -39.51 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 26.7 tptt -68.24 -41.82 80.63 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.674 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.69 -34.21 58.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.812 -0.555 . . . . 0.0 109.966 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.8 m-70 -106.92 -20.6 13.28 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.634 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.21 52.59 1.64 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -72.29 -69.01 0.37 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.4 Cg_endo -70.25 105.79 1.63 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 120.328 0.686 . . . . 0.0 112.17 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -70.35 -22.05 62.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 13.1 tttp -134.19 144.07 48.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.84 141.62 44.73 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.932 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.43 -41.95 19.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 0.0 109.967 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 2.6 tttt -152.74 134.55 14.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.916 -1.115 . . . . 0.0 110.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.18 166.29 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.46 -0.775 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.515 ' CG ' ' HA ' ' A' ' 126' ' ' SER . 43.1 t80 -143.93 146.44 32.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 t -146.41 152.15 38.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.1 p90 -160.24 155.42 24.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.843 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 94.9 m -93.15 137.16 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.8 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.1 tp -53.8 151.12 6.68 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 111.306 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.509 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 7.4 t -65.6 -6.51 11.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.038 -1.039 . . . . 0.0 109.727 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -95.56 -8.24 35.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.506 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.8 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.9 t-20 -69.74 109.82 5.37 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -88.52 15.51 2.06 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.929 2.419 . . . . 0.0 110.227 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.765 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.9 m-85 -108.14 -18.29 13.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.696 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 81' ' ' ASN . 63.5 m-85 -123.69 161.28 25.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 12.8 m120 -47.51 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.07 -47.13 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.337 -0.852 . . . . 0.0 110.947 174.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -77.15 56.25 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.74 104.73 14.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.506 -177.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.95 134.3 44.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 109.405 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.25 129.71 55.19 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.78 125.71 47.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.04 112.68 25.74 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 68' ' ' ASP . . . -73.67 51.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.053 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 37.0 mt -52.88 -49.86 46.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.439 ' H ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.97 -28.07 0.62 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.765 -1.209 . . . . 0.0 108.957 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 35.9 3.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 109.374 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -93.81 154.87 17.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.013 -1.054 . . . . 0.0 110.602 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -117.11 93.39 4.16 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-85 -81.56 91.37 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.692 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -79.8 87.31 5.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 61.2 m95 -61.67 -6.76 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.63 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.83 -21.22 22.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.751 -1.218 . . . . 0.0 108.032 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 21.8 m-20 -100.12 -26.85 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.629 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 64.1 mt -73.17 67.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 15.1 mt -46.85 149.2 1.58 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.8 -0.563 . . . . 0.0 110.19 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.3 Cg_endo -78.49 -17.9 12.55 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.965 2.443 . . . . 0.0 110.581 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 1.6 t -146.42 122.45 10.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 108.81 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 116' ' ' ILE . 66.3 m-85 -109.48 140.37 43.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.135 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 p -102.81 -1.28 30.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.465 -0.772 . . . . 0.0 108.951 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.59 9.01 86.25 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.67 -10.35 9.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.336 -1.096 . . . . 0.0 109.428 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -64.03 161.0 16.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 171.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.418 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -74.41 -29.58 61.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.44 -61.38 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -62.5 -33.55 75.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 108.975 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 79.4 mttt -65.1 -44.18 89.66 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.468 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 34.9 ttm -59.41 -36.6 76.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.72 -69.36 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.716 -0.615 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.643 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.4 tp -59.11 -40.37 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.867 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 23.0 p -56.83 -41.76 78.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 0.0 110.423 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.791 ' N ' HD12 ' A' ' 24' ' ' LEU . 28.0 tt0 -69.37 -38.51 78.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.279 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.643 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.8 tp -59.38 -55.46 34.45 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.604 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.4 mmt -57.45 -40.51 78.62 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.89 -41.52 91.42 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -65.25 -49.68 68.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 127' ' ' VAL . 76.3 t -65.95 -58.12 7.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.518 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.82 -50.5 14.83 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.9 mt -65.36 -54.47 28.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.219 -1.165 . . . . 0.0 108.256 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 65.0 p -46.48 -31.08 2.5 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.065 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 123' ' ' VAL . 33.6 m -103.48 40.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.989 -1.069 . . . . 0.0 110.089 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 127' ' ' VAL . 0.7 OUTLIER 37.26 49.23 0.88 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.597 0.713 . . . . 0.0 109.745 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.595 ' HE3' ' O ' ' A' ' 45' ' ' THR . 46.7 tpp -66.02 129.02 38.35 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.532 -0.73 . . . . 0.0 111.564 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.2 t0 -76.9 123.14 25.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.64 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.8 m-85 -104.29 118.17 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.405 1.098 . . . . 0.0 113.113 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.811 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.94 -162.87 10.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 104.498 -3.441 . . . . 0.0 104.498 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.652 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.7 Cg_endo -62.31 -29.88 80.38 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 N-CA-C 105.755 -2.44 . . . . 0.0 105.755 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -110.14 137.78 47.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 59.8 m -116.79 107.62 14.86 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.015 -1.678 . . . . 0.0 109.702 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.73 137.08 13.84 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.562 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.8 t -117.33 -161.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.908 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.41 -55.46 3.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.564 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 131.83 -127.57 5.03 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.603 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.628 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 3.8 m -51.13 -56.74 11.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.681 -0.894 . . . . 0.0 111.692 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 24.5 p -47.64 -39.89 18.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.045 -1.035 . . . . 0.0 109.865 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.908 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 33.7 mmt-85 -79.05 -43.54 24.01 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 185' ' ' TYR . 78.4 t -68.82 -55.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.415 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -56.12 -31.75 63.59 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.084 -1.047 . . . . 0.0 108.577 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp85 -77.14 -49.64 14.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.8 78.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.146 -0.971 . . . . 0.0 110.376 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 251' ' ' ILE . 51.5 mt -61.06 -48.19 82.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 110.46 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.7 mtmt -86.77 -43.67 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 111.222 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.8 mt-10 -76.21 -41.51 49.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 112.224 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 32.0 m120 -93.91 -44.27 8.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.584 -1.323 . . . . 0.0 111.66 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.441 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 39.4 m-85 -100.33 -2.45 33.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.79 -1.194 . . . . 0.0 110.476 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.932 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.94 37.72 53.8 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.286 -0.884 . . . . 0.0 112.449 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.426 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.4 m-85 -62.6 167.48 4.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.182 -1.775 . . . . 0.0 107.188 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.8 t-20 -47.82 140.14 6.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.628 -1.295 . . . . 0.0 109.089 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -53.2 -19.68 3.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.313 -0.867 . . . . 0.0 108.906 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.533 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 73.2 p -53.42 -17.2 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.302 -0.874 . . . . 0.0 109.829 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 42.7 t -62.92 122.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.705 -1.247 . . . . 0.0 108.947 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.645 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.0 p-80 -146.75 153.38 40.16 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.119 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.628 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 19.6 tt0 -101.32 148.29 25.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.875 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 6.5 pt -130.96 159.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -112.37 95.81 5.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.865 -1.147 . . . . 0.0 110.688 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.635 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 39.3 tpt85 -42.81 -27.97 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.395 -0.815 . . . . 0.0 109.083 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -62.39 -36.88 93.73 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.27 38.5 1.85 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.051 -1.264 . . . . 0.0 111.691 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.53 169.14 18.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.542 -1.349 . . . . 0.0 110.05 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -100.63 140.63 34.63 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 171' ' ' GLU . 6.4 tttt -40.3 -46.25 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -63.54 -53.26 54.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 110.055 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.0 -26.25 68.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.875 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 69.4 t-105 -74.47 -35.72 63.3 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.132 -0.98 . . . . 0.0 109.911 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 167' ' ' LYS . 45.8 mt-10 -72.22 -32.16 66.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.104 -0.998 . . . . 0.0 109.232 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.59 88.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.31 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.409 ' OE1' HG21 ' A' ' 249' ' ' VAL . 40.0 mm-40 -64.78 -50.01 68.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.37 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 184' ' ' VAL . 64.3 mt -71.84 -52.51 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 111.174 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.493 ' OD2' ' NE2' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -53.38 -43.06 67.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.108 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -51.97 -47.21 64.94 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 38.9 mm-40 -59.24 -52.67 64.67 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.763 ' HB3' HG11 ' A' ' 4' ' ' VAL . 20.7 mt -65.59 -28.3 69.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.445 -0.784 . . . . 0.0 110.149 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -52.51 -43.23 64.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 108.757 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.5 mt-30 -99.34 42.95 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 7' ' ' LEU . 14.5 m-20 42.33 51.09 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.77 0.795 . . . . 0.0 108.913 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 5.1 mt-30 -124.15 109.52 29.37 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.89 169.6 11.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.886 1.724 . . . . 0.0 111.944 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 HG23 ' A' ' 174' ' ' ILE . 62.1 t -127.03 131.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.804 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -80.97 121.34 25.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 177.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 4.7 t80 -123.29 164.68 18.31 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.962 -1.086 . . . . 0.0 109.673 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -165.63 124.5 1.65 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.19 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.16 108.06 3.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 190' ' ' GLY . 40.0 t -71.1 164.38 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.313 . . . . 0.0 111.457 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.601 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.42 -142.67 3.45 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.411 -1.875 . . . . 0.0 108.411 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.457 ' HG3' ' HA ' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -87.64 -29.66 21.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -1.199 . . . . 0.0 110.638 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.874 HG13 ' HB2' ' A' ' 238' ' ' ALA . 21.9 m -83.43 -11.74 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.042 -1.036 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 -168.36 23.21 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -78.76 109.98 2.95 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.362 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -72.06 130.87 41.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.69 160.32 24.73 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.363 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.874 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.1 p90 -163.04 168.53 20.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 55' ' ' ILE . 71.6 t -113.88 137.91 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.753 -1.217 . . . . 0.0 111.888 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.754 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 77.6 mt -104.07 110.42 30.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -124.8 34.32 5.02 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.372 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -171.58 161.56 33.85 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 117.073 -2.489 . . . . 0.0 113.202 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.522 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.52 141.27 29.41 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -112.6 11.53 19.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.777 -1.202 . . . . 0.0 110.442 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.45 -50.23 3.99 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -79.46 53.83 1.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 0.0 109.64 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.455 ' OD1' ' OE2' ' A' ' 171' ' ' GLU . 0.7 OUTLIER 50.73 38.16 18.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 0.3 OUTLIER -121.02 132.73 55.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.095 -1.003 . . . . 0.0 109.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 26.2 m-85 -123.6 160.71 26.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.974 . . . . 0.0 110.039 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.716 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 1.1 t-80 -92.73 146.56 23.56 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 197' ' ' PHE . 23.8 t -139.25 139.03 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.497 ' HB2' HD12 ' A' ' 8' ' ' LEU . 25.9 t-20 -108.95 70.38 0.74 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.687 ' CE2' HG11 ' A' ' 210' ' ' VAL . 89.7 m95 -48.86 169.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.456 -0.777 . . . . 0.0 110.193 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.87 -2.4 57.34 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -107.21 165.71 11.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.133 -1.216 . . . . 0.0 108.998 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -128.99 13.88 6.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.85 -1.4 5.89 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.798 HG13 ' N ' ' A' ' 218' ' ' SER . 2.7 p -105.69 -146.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.798 ' N ' HG13 ' A' ' 217' ' ' VAL . 19.6 m -63.35 61.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.123 . . . . 0.0 110.771 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.7 OUTLIER -77.45 88.08 3.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.95 -1.094 . . . . 0.0 109.41 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 147.33 -89.15 0.15 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.23 144.82 49.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -1.181 . . . . 0.0 110.117 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -99.26 165.43 11.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.36 -0.837 . . . . 0.0 109.152 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.504 ' NE ' ' OD1' ' A' ' 225' ' ' ASP . 0.9 OUTLIER -84.47 -178.65 6.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.314 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.8 mt -120.9 15.1 11.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.997 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.504 ' OD1' ' NE ' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -123.81 -81.91 0.64 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.905 -1.122 . . . . 0.0 109.695 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.41 -95.57 0.47 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 109.89 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 227' ' ' LEU . 1.1 pt? -116.08 -153.08 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.995 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.581 ' HB2' ' CE3' ' A' ' 212' ' ' TRP . 1.9 t30 -95.78 153.46 39.33 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 109.057 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 228' ' ' ASN . 36.0 Cg_endo -78.04 -23.59 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.543 2.162 . . . . 0.0 110.747 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.749 ' CB ' HG21 ' A' ' 217' ' ' VAL . 24.1 t -92.91 30.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 195' ' ' HIS . . . -82.63 -5.06 58.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 233' ' ' GLY . 22.8 tp -82.86 -80.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.368 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 232' ' ' LEU . . . 107.55 -96.42 1.06 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 171.76 13.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -1.12 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -90.73 58.37 3.33 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.4 -120.18 0.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -125.95 -29.77 0.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.874 ' HB2' HG13 ' A' ' 192' ' ' VAL . . . -58.8 -172.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -177.12 -113.69 0.36 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -123.5 37.7 2.66 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -84.72 136.26 33.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.701 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -116.2 87.79 2.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.124 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -84.27 -48.37 5.11 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.548 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 41.8 m-85 -135.56 129.28 32.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.519 -0.989 . . . . 0.0 109.086 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 2.4 pt20 -128.66 136.3 50.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.816 -1.178 . . . . 0.0 108.469 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 4.9 p -149.43 167.04 27.29 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.74 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.99 145.58 36.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.575 0.703 . . . . 0.0 109.536 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.585 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.0 t -107.94 114.42 46.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.645 HG23 ' NE2' ' A' ' 158' ' ' HIS . 12.3 m -119.52 138.95 48.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.252 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 97.95 53.84 1.25 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 147' ' ' LEU . 5.4 mt -103.65 96.36 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -1.152 . . . . 0.0 110.102 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.48 147.42 8.54 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.612 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.646 0 C-N-CA 122.227 1.951 . . . . 0.0 110.288 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 2' ' ' PRO . 38.6 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 1' ' ' GLN . 35.0 Cg_endo -77.41 -176.57 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.332 2.021 . . . . 0.0 109.548 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 203' ' ' ASP . 54.1 t -115.91 143.36 26.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 178' ' ' LEU . 94.7 t -137.68 133.91 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -0.775 . . . . 0.0 109.006 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.5 mmtt -76.36 178.44 6.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.665 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 1.8 t -77.9 106.35 9.69 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.024 -1.048 . . . . 0.0 109.241 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.705 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 38.3 mt -57.4 -50.72 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.879 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.1 mt -55.49 -41.84 73.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.784 -1.198 . . . . 0.0 109.224 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 29.8 t0 -67.75 -40.47 84.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.581 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.6 p -58.53 -14.16 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.1 -1.0 . . . . 0.0 109.293 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' HG13 ' A' ' 13' ' ' ILE . 17.7 mtpt -117.75 22.12 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 0.0 108.802 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.0 37.85 4.42 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.1 mt -88.63 109.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 122.427 1.108 . . . . 0.0 110.219 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 28.0 m80 -133.78 98.0 4.06 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.6 m-30 -103.61 171.66 7.24 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.216 1.008 . . . . 0.0 112.064 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.3 t30 -147.19 -173.21 4.19 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.479 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.3 mt-30 -124.11 -3.7 8.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.64 -56.17 0.35 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.158 -1.496 . . . . 0.0 112.152 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.791 HD22 ' HA3' ' A' ' 106' ' ' GLY . 9.7 t-20 -45.65 -125.14 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-O 117.531 -1.224 . . . . 0.0 112.257 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.788 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -80.54 9.21 3.8 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 123.381 2.243 . . . . 0.0 110.212 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 15' ' ' TYR . 71.0 m-85 -83.94 -33.92 24.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 109.818 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.2 p30 -102.51 21.87 14.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.748 -1.22 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.4 mt -69.37 -4.4 18.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.94 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 118' ' ' GLU . 63.6 mt -131.67 -5.67 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.878 -1.139 . . . . 0.0 110.275 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 21.2 p -61.38 165.83 6.32 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 0.0 108.392 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.2 Cg_endo -69.57 131.31 21.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.069 1.846 . . . . 0.0 111.675 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.6 t -77.34 151.31 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.605 -0.684 . . . . 0.0 109.601 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 132' ' ' GLY . 12.7 mt -77.54 150.28 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -125.13 -23.37 4.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.434 -0.791 . . . . 0.0 111.15 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' TYR . 16.1 mtpt -121.54 176.35 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.845 -1.159 . . . . 0.0 109.927 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 37' ' ' SER . 79.5 t -114.03 145.11 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.241 -0.912 . . . . 0.0 110.772 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -88.72 130.66 44.26 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.13 123.81 10.33 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.552 1.501 . . . . 0.0 110.315 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.92 27.3 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.6 tp10 -149.01 176.91 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.946 . . . . 0.0 109.139 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -80.27 -175.66 5.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.201 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 9.2 t -83.04 135.87 34.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.6 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 15.74 11.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.918 -1.114 . . . . 0.0 109.571 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.1 t -63.1 143.49 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.91 67.16 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.9 mt-30 -83.92 127.08 33.6 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.192 -1.181 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -72.86 110.28 7.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.23 158.44 1.15 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.599 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -75.75 169.2 18.59 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 109.363 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.65 ' O ' ' HE3' ' A' ' 129' ' ' MET . 8.7 p -80.7 -34.5 34.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.113 . . . . 0.0 108.051 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.06 135.29 7.83 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.1 p -54.49 -49.19 70.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -1.215 . . . . 0.0 107.93 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.628 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 20.3 t -46.38 -56.41 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -58.7 -50.13 75.03 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.667 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.77 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.415 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -66.66 -38.3 86.57 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.071 -1.452 . . . . 0.0 107.632 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.507 ' CG2' HG13 ' A' ' 143' ' ' VAL . 61.8 m -74.55 -53.98 8.38 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.26 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -55.13 -41.37 71.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 110.323 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.575 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.4 mt-30 -57.61 -47.5 82.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.491 -1.38 . . . . 0.0 107.331 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 198' ' ' VAL . 59.3 mt -65.74 -24.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 27.7 mtp -73.75 -37.68 64.97 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 22.3 tptt -71.2 -39.04 72.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.2 t80 -53.53 -34.49 58.38 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 109.528 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 60' ' ' ASN . 34.5 m80 -107.62 -20.08 13.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.02 54.33 1.64 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 1.4 t80 -72.38 -73.84 0.16 Allowed Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 34.4 Cg_endo -68.58 103.4 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.342 0.654 . . . . 0.0 112.057 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.456 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t-20 -70.84 -18.83 62.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 8.0 tttp -134.11 141.73 47.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.25 148.6 36.72 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.42 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.968 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -87.89 -59.04 2.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -1.02 . . . . 0.0 109.316 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' A' ' 68' ' ' ASP . 15.6 tttt -139.03 150.42 45.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-20 -74.58 179.99 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 70' ' ' THR . 61.9 t80 -147.73 167.5 24.5 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.374 -0.829 . . . . 0.0 109.605 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 6.8 t -166.22 147.87 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 19.1 p90 -163.35 152.67 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 21.1 m -93.09 138.14 31.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.803 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.5 tp -52.54 150.03 5.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 111.331 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -61.95 144.07 55.58 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.54 . . . . 0.0 109.715 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -1.91 11.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.82 -8.95 23.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 109.732 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.803 ' ND2' HD21 ' A' ' 73' ' ' LEU . 31.2 t-20 -70.24 109.4 4.81 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.765 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.0 Cg_endo -89.3 16.07 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.0 2.467 . . . . 0.0 110.279 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 91.2 m-85 -104.45 -23.53 13.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.746 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.4 m-85 -122.56 161.38 23.79 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.573 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.4 m120 -46.1 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 175.18 -47.1 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 175.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.64 57.55 4.99 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 N-CA-C 107.39 -1.812 . . . . 0.0 107.39 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -105.67 107.25 18.15 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.247 -178.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.49 139.12 36.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.3 mp -115.97 123.14 47.29 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.27 125.25 47.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.079 -1.013 . . . . 0.0 110.059 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.04 113.79 27.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.61 53.0 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.874 -1.141 . . . . 0.0 108.557 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 48.7 mt -52.37 -46.66 46.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 121.264 -0.897 . . . . 0.0 109.76 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.4 p -45.22 -26.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.162 . . . . 0.0 108.936 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.0 p -111.51 33.19 4.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 0.0 109.203 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.643 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -89.37 153.75 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.12 91.24 3.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.23 87.07 6.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.469 -0.769 . . . . 0.0 110.84 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.3 t30 -79.23 88.58 4.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.645 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 72.3 m95 -61.6 -5.69 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 110.737 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.87 -19.46 24.57 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.15 -27.47 13.51 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.68 HG12 ' HB1' ' A' ' 115' ' ' ALA . 48.0 mt -74.14 70.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 38.1 mt -48.8 148.84 3.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.728 -0.607 . . . . 0.0 109.961 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.544 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.1 Cg_endo -79.08 -22.81 8.27 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.758 2.305 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -139.51 121.88 16.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 108.878 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 58.2 m-85 -109.43 140.41 43.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -0.947 . . . . 0.0 109.911 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.9 p -99.9 -0.69 39.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.046 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.791 ' HA3' HD22 ' A' ' 19' ' ' ASN . . . 82.07 -0.74 88.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 107' ' ' ARG . 16.3 mtm105 -118.07 1.94 12.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -1.194 . . . . 0.0 109.561 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.68 164.88 15.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.545 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.429 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -60.16 171.55 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.202 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 63.2 m-20 -75.51 -31.48 60.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.89 . . . . 0.0 109.764 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.31 -63.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.87 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 1.1 mp0 -62.46 -31.52 72.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.2 mttt -66.21 -44.29 84.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.476 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 11.0 ttm -59.11 -34.53 72.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.68 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.69 -68.99 0.19 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.697 -0.627 . . . . 0.0 110.539 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.618 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -59.85 -40.9 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 110.209 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.7 p -56.9 -40.22 75.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.767 -1.208 . . . . 0.0 109.764 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.752 ' N ' HD12 ' A' ' 24' ' ' LEU . 37.2 tt0 -69.84 -39.19 76.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 108.682 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.618 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.9 tp -60.44 -60.39 3.89 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.591 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -51.24 -39.22 56.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.628 -0.67 . . . . 0.0 109.679 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.62 -41.26 92.92 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 8.7 m-20 -65.39 -54.59 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.763 ' O ' HG22 ' A' ' 127' ' ' VAL . 87.0 t -63.08 -52.06 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.314 -0.867 . . . . 0.0 108.799 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -51.42 -51.55 36.71 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.3 mt -66.5 -54.39 26.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.076 -1.249 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 125' ' ' ILE . 33.1 p -46.22 -28.13 1.18 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.644 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -101.28 30.95 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.864 -1.148 . . . . 0.0 109.674 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 4.1 m-20 42.51 38.88 1.37 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.247 -0.908 . . . . 0.0 108.944 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.65 ' HE3' ' O ' ' A' ' 45' ' ' THR . 37.6 tpp -53.33 132.21 38.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.574 -0.704 . . . . 0.0 111.583 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 15.5 t0 -76.69 120.73 22.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.65 120.17 40.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.3 1.048 . . . . 0.0 112.96 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.756 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.11 -164.25 11.93 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.4 Cg_endo -62.0 -30.94 83.88 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 105.687 -2.466 . . . . 0.0 105.687 175.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 m -109.97 142.46 41.31 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.3 m -119.54 110.42 16.86 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 119.849 -1.782 . . . . 0.0 109.972 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.17 133.28 11.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -118.44 -169.0 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -1.115 . . . . 0.0 108.602 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.29 -57.33 2.88 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.598 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 129.94 -122.5 3.73 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.551 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.629 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 3.1 m -47.99 -60.58 2.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 24.7 p -46.88 -41.18 15.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.78 -1.2 . . . . 0.0 109.238 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.4 mmp_? -80.33 -42.62 22.64 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.7 t -68.65 -59.38 3.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.722 -0.612 . . . . 0.0 111.149 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.44 -32.88 65.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.16 -0.963 . . . . 0.0 109.175 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 14.2 ttm180 -75.89 -44.15 41.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.099 -1.0 . . . . 0.0 109.375 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 151' ' ' PHE . . . -70.49 -32.11 69.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 109.908 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 251' ' ' ILE . 51.8 mt -60.31 -47.89 84.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.369 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.525 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 24.6 mtmt -87.73 -29.47 21.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.729 -1.232 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 88.4 mt-10 -74.3 -67.46 0.62 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 112.333 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.543 ' HB3' HD13 ' A' ' 90' ' ' ILE . 36.1 m120 -82.1 -31.04 30.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.851 -1.156 . . . . 0.0 111.652 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 19.6 m-85 -102.53 -6.15 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.662 -1.274 . . . . 0.0 110.36 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.968 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 48.95 40.45 27.38 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.224 -0.923 . . . . 0.0 112.244 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.443 ' CE2' HG22 ' A' ' 251' ' ' ILE . 8.6 m-85 -62.76 160.24 14.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.408 -1.643 . . . . 0.0 107.999 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 14.9 t-20 -47.64 155.42 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 109.486 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -55.85 -17.57 6.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.895 . . . . 0.0 108.837 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.544 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 21.4 p -53.69 -15.72 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 147' ' ' LEU . 12.8 t -72.25 119.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.68 -1.262 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.817 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.1 p-80 -146.77 155.29 42.26 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.629 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 15.2 tt0 -102.15 143.78 31.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.672 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' CA ' ' A' ' 246' ' ' SER . 4.1 pt -128.33 154.16 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -109.62 94.93 5.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.991 -1.068 . . . . 0.0 110.542 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.579 ' HD2' ' CG ' ' A' ' 170' ' ' TRP . 1.2 tpt85 -46.39 -27.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 108.99 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.82 -23.56 72.57 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -103.64 4.29 35.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.072 -1.252 . . . . 0.0 111.17 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -118.11 167.98 10.98 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.554 -1.341 . . . . 0.0 109.836 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 167' ' ' LYS . 32.0 p -98.94 136.86 38.32 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.507 ' HG3' ' NH2' ' A' ' 223' ' ' ARG . 29.3 tttm -34.42 -45.66 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.76 -0.587 . . . . 0.0 110.721 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -63.55 -62.22 1.81 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.958 -1.089 . . . . 0.0 109.733 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.45 -19.88 65.09 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 109.069 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.776 ' NE1' HD11 ' A' ' 174' ' ' ILE . 67.3 t-105 -75.44 -44.25 45.38 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.981 -1.074 . . . . 0.0 108.842 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 208' ' ' TYR . 12.3 mt-10 -61.68 -31.51 71.65 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.97 80.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.826 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -61.32 -45.38 94.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 109.249 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 184' ' ' VAL . 9.8 mt -76.01 -48.21 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 111.091 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 1' ' ' GLN . 0.3 OUTLIER -58.33 -53.76 54.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.014 -1.054 . . . . 0.0 109.67 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -51.28 -38.0 50.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.564 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.2 mm-40 -61.0 -51.32 69.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.8 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.8 mt -69.09 -24.95 64.2 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.489 -0.757 . . . . 0.0 109.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.435 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.7 p -52.21 -38.16 57.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.95 -1.094 . . . . 0.0 108.096 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 24.2 mt-30 -101.32 33.5 2.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.7 m-20 47.11 51.15 13.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 18.1 mt-30 -123.75 106.0 32.27 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.444 ' HD3' HD13 ' A' ' 7' ' ' LEU . 15.4 Cg_endo -63.59 168.77 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.908 1.738 . . . . 0.0 112.497 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 174' ' ' ILE . 42.3 t -121.86 135.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.454 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.757 ' CD1' HG23 ' A' ' 248' ' ' VAL . 3.3 t80 -85.07 118.31 24.55 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.649 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 8.8 t80 -122.29 150.93 41.67 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.808 -1.183 . . . . 0.0 109.774 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.593 ' OE1' ' HA3' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -152.54 121.92 6.77 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.705 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -90.98 112.38 4.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 190' ' ' GLY . 24.6 t -66.37 164.82 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -1.178 . . . . 0.0 110.794 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.585 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -175.65 -143.22 4.51 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -35.68 18.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.235 . . . . 0.0 110.213 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.59 -9.31 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.12 -162.03 18.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.542 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.93 111.53 3.27 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.584 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.6 t-80 -71.57 101.23 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.628 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -86.24 153.1 22.25 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.822 1.296 . . . . 0.0 114.216 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CD1' HG13 ' A' ' 210' ' ' VAL . 21.5 p90 -163.58 164.77 24.06 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.677 HG22 HD11 ' A' ' 55' ' ' ILE . 70.6 t -113.74 139.06 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.705 -1.247 . . . . 0.0 112.011 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.896 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.9 mt -103.38 111.68 34.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -125.22 31.33 5.62 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.395 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.08 41.59 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.271 -2.395 . . . . 0.0 112.883 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.443 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -156.48 149.7 24.27 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 207' ' ' PHE . 18.2 p-10 -128.56 29.81 5.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.578 -1.326 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 48.0 22.24 2.04 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.474 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 22.7 mtm180 -135.04 25.25 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -1.211 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 1.6 m120 72.58 18.66 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.487 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 9.7 m-85 -120.15 113.73 20.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.901 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 171' ' ' GLU . 3.5 m-85 -102.67 167.35 9.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 108.919 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.665 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 0.9 OUTLIER -92.18 139.48 30.58 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.82 HG13 ' CD1' ' A' ' 197' ' ' PHE . 42.4 t -130.89 136.18 58.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.533 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.467 ' HB2' HD12 ' A' ' 8' ' ' LEU . 23.3 t-20 -108.62 73.67 0.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.676 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 73.5 m95 -46.13 171.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 110.269 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.15 -2.4 53.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.446 ' NE1' ' HB1' ' A' ' 231' ' ' ALA . 77.8 m95 -106.96 169.98 8.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -1.1 . . . . 0.0 109.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -123.57 4.84 9.32 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.48 13.59 5.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 218' ' ' SER . 1.8 p -107.96 -153.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -1.081 . . . . 0.0 109.489 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.753 ' N ' HG13 ' A' ' 217' ' ' VAL . 50.4 m -67.52 58.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.906 -1.121 . . . . 0.0 110.213 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 217' ' ' VAL . 13.8 m-20 -83.68 99.55 10.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 156.12 -149.11 19.97 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.371 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 48.0 m-85 -63.06 89.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.979 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 218' ' ' SER . 4.3 m-85 -136.53 129.56 31.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.002 -1.061 . . . . 0.0 110.07 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.644 HH12 ' HB2' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -89.31 18.62 5.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.344 -0.847 . . . . 0.0 109.777 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 3.9 mm? -73.98 37.28 0.1 Allowed 'General case' 0 C--N 1.285 -2.198 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.543 ' OD2' ' CE1' ' A' ' 197' ' ' PHE . 4.1 m-20 -86.33 -9.54 56.19 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.229 -0.919 . . . . 0.0 108.883 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.644 ' HB2' HH12 ' A' ' 223' ' ' ARG . . . -88.53 -65.38 1.02 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 227' ' ' LEU . 0.5 OUTLIER -91.8 -157.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -92.68 155.06 42.22 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.941 -1.099 . . . . 0.0 109.671 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.565 ' HB3' ' CE2' ' A' ' 212' ' ' TRP . 35.4 Cg_endo -78.21 -161.39 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.82 2.346 . . . . 0.0 110.536 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.72 11.04 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.446 ' HB1' ' NE1' ' A' ' 214' ' ' TRP . . . -103.16 68.13 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.404 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 -26.27 26.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.74 142.61 0.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 85.8 m -97.88 -44.31 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -1.139 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -93.98 -57.47 1.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.14 90.08 1.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 134.49 110.74 1.15 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -91.57 35.38 0.95 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -1.109 . . . . 0.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 45.58 83.93 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.33 -173.7 22.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -122.78 171.39 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.172 -1.193 . . . . 0.0 109.491 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 6.8 t30 -95.31 75.92 3.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.32 -45.85 8.52 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 21.1 m-85 -135.43 158.19 45.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.543 -0.975 . . . . 0.0 108.792 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 1.3 pt20 -152.31 143.6 23.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.066 -1.021 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.503 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 14.2 p -155.96 152.4 28.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 109.89 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 185' ' ' TYR . . . -132.12 167.76 19.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.119 0.961 . . . . 0.0 109.854 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.757 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.7 t -117.42 116.25 51.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.817 HG23 ' NE2' ' A' ' 158' ' ' HIS . 29.4 m -117.64 145.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.734 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.89 49.12 3.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.686 HG12 HD13 ' A' ' 147' ' ' LEU . 4.3 mt -98.98 89.05 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.774 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -160.34 150.71 15.08 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.451 -0.781 . . . . 0.0 109.117 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.635 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 33.9 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.447 2.098 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 204' ' ' GLY . 38.6 tt0 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.66 145.17 20.27 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.448 2.099 . . . . 0.0 110.257 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.24 142.94 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.114 -0.991 . . . . 0.0 109.611 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 178' ' ' LEU . 70.1 t -139.47 131.53 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 109.261 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 200' ' ' ASP . 7.4 mmtp -76.23 -177.46 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -0.947 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 32.8 t -78.06 104.35 8.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 109.911 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.4 mt -57.84 -52.87 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.528 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 211' ' ' ASN . 16.3 mt -54.44 -40.08 68.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.768 -1.207 . . . . 0.0 108.748 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -68.06 -42.57 80.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.912 . . . . 0.0 109.286 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 p -58.49 -14.78 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.086 -1.009 . . . . 0.0 109.218 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -116.37 22.54 12.76 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.07 33.5 2.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 11' ' ' LYS . 31.5 mt -85.85 109.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.498 -1.001 . . . . 0.0 110.261 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 102' ' ' PRO . 40.1 m80 -134.8 77.46 1.69 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.626 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.0 m-30 -85.13 177.08 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.148 0.975 . . . . 0.0 111.197 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -147.68 -164.26 1.96 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 45' ' ' THR . 25.8 mt-30 -124.85 -20.57 4.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.856 -1.153 . . . . 0.0 110.583 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.43 -34.56 1.42 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.469 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.811 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.7 t-20 -45.92 -140.22 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.466 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.846 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.811 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.8 Cg_endo -74.2 3.44 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 CA-C-N 122.511 1.933 . . . . 0.0 109.559 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CD2' HG12 ' A' ' 116' ' ' ILE . 9.1 m-85 -78.87 -31.37 45.53 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.478 -0.764 . . . . 0.0 108.962 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 28.1 p-10 -93.9 19.84 8.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.556 -1.34 . . . . 0.0 109.617 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.3 mt -74.49 -3.05 28.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 24' ' ' LEU . 6.3 mt -129.24 -0.98 5.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 0.0 109.485 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -66.12 166.01 18.91 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.7 Cg_endo -71.32 141.36 38.87 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.368 2.045 . . . . 0.0 112.223 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 35.8 t -80.01 147.05 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.777 HD11 ' C ' ' A' ' 132' ' ' GLY . 21.6 mt -77.88 148.47 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.704 0.764 . . . . 0.0 110.853 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.508 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.6 mm-40 -125.73 -21.54 4.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.621 -0.675 . . . . 0.0 110.432 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 80' ' ' PHE . 13.8 mtpp -122.76 166.97 14.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 36' ' ' GLN . 91.8 t -114.63 150.45 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.558 -0.714 . . . . 0.0 110.577 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -75.81 163.18 68.67 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.2 Cg_endo -81.61 122.38 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.411 2.074 . . . . 0.0 110.606 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.48 86.23 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.58 169.37 9.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.089 -1.242 . . . . 0.0 109.778 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 31' ' ' VAL . 1.9 mp0 -66.83 172.07 4.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.632 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -86.93 133.27 33.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 109.435 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 76.0 m-85 -123.62 15.89 9.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.931 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 28' ' ' ILE . 94.1 t -63.3 136.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.51 -3.12 83.58 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.5 mt-30 -83.76 132.92 34.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.293 -1.122 . . . . 0.0 109.605 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -73.64 110.31 7.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.48 159.39 1.03 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.8 171.78 14.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.455 0.645 . . . . 0.0 109.701 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.696 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.6 p -80.81 -34.62 33.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 108.708 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.34 137.29 8.92 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -48.03 74.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.326 -1.103 . . . . 0.0 108.313 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 137' ' ' SER . 3.3 t -46.93 -53.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.47 -47.94 79.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.888 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 70.9 m -62.91 -30.47 71.57 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.642 -0.661 . . . . 0.0 109.499 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.7 72.14 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.808 -1.157 . . . . 0.0 108.439 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 56' ' ' MET . 40.3 m -76.2 -49.5 17.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.293 0.568 . . . . 0.0 110.752 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.02 -34.28 28.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.177 -0.952 . . . . 0.0 108.742 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-30 -68.26 -48.95 63.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 55.2 mt -65.58 -23.1 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.57 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.8 mtp -73.92 -34.23 64.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 42.8 tptt -72.34 -45.46 59.82 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.4 t80 -52.42 -30.83 31.36 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.265 0.555 . . . . 0.0 109.815 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.638 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 59.3 m-70 -108.35 -24.09 11.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 111.151 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.23 57.15 2.5 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -79.33 -71.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.0 Cg_endo -68.34 103.43 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 122.26 0.611 . . . . 0.0 111.838 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -21.88 63.48 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 4.9 ttpt -134.8 141.25 46.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.08 146.6 39.29 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.351 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.925 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -82.91 -45.15 14.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -1.027 . . . . 0.0 110.206 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.2 ttpp -152.16 135.29 15.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.035 -1.041 . . . . 0.0 110.069 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' N ' ' H ' ' A' ' 91' ' ' SER . 0.5 OUTLIER -60.65 164.39 4.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.043 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 45.2 t80 -143.37 154.37 43.66 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t -154.52 150.43 27.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 14.7 p90 -155.3 152.3 29.04 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 46.5 m -92.75 140.25 29.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.759 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -55.5 148.57 15.26 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 111.467 -178.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 3.5 p -61.69 141.87 57.57 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.301 0.572 . . . . 0.0 110.122 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.7 m -67.32 -5.41 14.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.9 m120 -99.45 -3.64 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.759 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.1 t-20 -70.68 111.78 10.82 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.552 -0.717 . . . . 0.0 109.878 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.1 Cg_endo -88.5 13.64 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.975 2.45 . . . . 0.0 109.792 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.638 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 59.2 m-85 -112.73 -4.07 14.12 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.283 -0.885 . . . . 0.0 111.641 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.489 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 69.1 m-85 -140.62 161.0 38.79 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 44.5 m-80 -47.77 -81.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 1.1 m170 174.95 -46.84 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.506 -0.746 . . . . 0.0 110.929 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.2 Cg_endo -76.95 54.6 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 N-CA-C 107.419 -1.8 . . . . 0.0 107.419 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 4.8 tptt -105.67 105.71 15.87 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.068 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.6 m-80 -100.3 140.06 35.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.7 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -113.93 128.38 56.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -120.31 129.68 54.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.094 -1.003 . . . . 0.0 110.235 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.64 111.13 23.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.56 52.44 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.733 -1.23 . . . . 0.0 108.372 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.7 mt -52.43 -52.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.565 -0.709 . . . . 0.0 109.417 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -45.51 -26.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.096 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -112.26 19.85 17.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 17.5 mmt-85 -76.59 152.84 35.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 89.11 3.04 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.0 89.9 5.95 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 110.508 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 15.9 t-20 -80.05 92.32 5.6 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.4 m95 -61.14 -8.82 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 110.026 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -90.79 -15.94 29.22 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 27.2 m-20 -99.26 -33.59 10.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 30.6 mt -73.46 93.71 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 30.1 mt -71.05 151.33 94.9 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' HIS . 30.9 Cg_endo -78.87 -28.15 4.23 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.132 . . . . 0.0 110.223 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.93 127.65 27.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.902 . . . . 0.0 109.31 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.6 m-85 -112.0 145.33 39.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 109.874 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 p -100.11 -12.79 19.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.98 -3.4 62.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -118.68 15.32 13.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.153 . . . . 0.0 109.287 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.02 -172.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.2 p -87.32 179.82 6.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.433 -0.792 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -78.01 -38.61 44.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.54 -58.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.71 -35.27 79.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.289 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.521 ' HD3' ' CD1' ' A' ' 23' ' ' LEU . 14.6 mttm -64.02 -43.06 96.75 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.46 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 23.1 ttm -60.0 -38.29 82.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.55 -68.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.704 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 119' ' ' LEU . 5.3 tp -66.0 -48.64 81.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.386 -0.821 . . . . 0.0 109.68 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 116' ' ' ILE . 51.3 p -47.48 -44.84 25.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.938 -1.101 . . . . 0.0 108.378 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.585 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 4.2 tt0 -70.26 -47.47 61.13 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.875 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.2 tp -48.62 -51.66 26.97 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.696 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -60.26 -46.55 89.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.688 -0.632 . . . . 0.0 109.755 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.58 -35.64 81.17 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.759 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 4.9 m-20 -68.09 -55.47 12.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 127' ' ' VAL . 44.8 t -62.93 -58.32 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.0 109.185 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.55 -50.13 11.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.2 mt -63.68 -58.98 5.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.185 -1.186 . . . . 0.0 108.216 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.9 OUTLIER -46.4 -28.59 1.4 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.39 -177.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 24.2 m -101.24 34.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.592 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.2 m-20 38.74 53.05 1.93 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.321 -0.862 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.4 tpp -65.69 127.01 30.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 111.726 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' SER . 0.7 OUTLIER -75.92 121.64 22.98 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 52.5 m-85 -103.31 117.69 35.08 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.545 1.164 . . . . 0.0 113.316 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.777 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.02 -162.55 10.75 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 104.617 -3.393 . . . . 0.0 104.617 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.652 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.45 -30.89 80.66 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 105.812 -2.418 . . . . 0.0 105.812 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.86 140.75 43.45 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 173.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.4 m -121.09 109.69 15.33 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 119.913 -1.742 . . . . 0.0 110.076 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.9 136.76 13.66 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.444 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 11.2 t -111.66 -161.69 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB3' ' HG3' ' A' ' 142' ' ' ARG . . . -90.89 -57.1 2.93 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.55 -134.57 7.2 Favored Glycine 0 N--CA 1.479 1.54 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.504 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.647 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 3.8 m -52.85 -53.26 51.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.804 -0.821 . . . . 0.0 111.89 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 140' ' ' SER . 5.2 p -45.89 -41.85 11.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.003 . . . . 0.0 109.07 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 138' ' ' ALA . 26.3 mmt180 -81.35 -43.15 19.45 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.635 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.5 t -68.38 -53.88 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.634 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 140' ' ' SER . 2.1 pp0? -56.71 -34.21 67.24 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.256 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -77.82 -51.19 10.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.973 178.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.1 79.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.113 -0.992 . . . . 0.0 110.049 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 251' ' ' ILE . 38.4 mt -58.04 -51.55 69.21 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.482 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 29.3 mtmt -80.27 -45.78 17.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 110.182 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 86.2 mt-10 -68.32 -52.03 38.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.048 -1.033 . . . . 0.0 111.905 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -90.43 -46.55 8.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.798 -1.189 . . . . 0.0 111.935 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.9 m-85 -99.38 13.68 32.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.648 -1.282 . . . . 0.0 110.938 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.925 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 34.34 41.46 0.22 Allowed Glycine 0 N--CA 1.496 2.679 0 O-C-N 121.512 -0.742 . . . . 0.0 112.815 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.5 m-85 -63.14 169.94 3.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.126 -1.808 . . . . 0.0 107.883 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 30.3 t30 -47.6 136.57 10.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.72 -1.238 . . . . 0.0 109.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.16 -21.01 4.4 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.201 -0.937 . . . . 0.0 108.79 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.503 ' HB3' ' ND2' ' A' ' 154' ' ' ASN . 84.4 p -53.6 -17.44 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 109.787 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 251' ' ' ILE . 37.5 t -58.42 125.17 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.969 -1.082 . . . . 0.0 109.121 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 1.004 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.3 p-80 -146.42 156.7 43.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.562 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.6 tt0 -101.74 150.35 23.22 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.872 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.718 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 20.3 pt -130.77 154.22 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.6 m-80 -119.2 106.16 12.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.163 . . . . 0.0 110.906 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 tpt85 -48.03 -45.03 31.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.461 -0.775 . . . . 0.0 109.765 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.92 -22.75 58.13 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 6.7 m-20 -104.75 2.03 29.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.198 -1.177 . . . . 0.0 111.7 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -117.67 175.03 5.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.498 -1.376 . . . . 0.0 110.665 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.474 ' O ' ' C ' ' A' ' 167' ' ' LYS . 1.1 p -100.46 138.19 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.3 ttmm -35.39 -49.61 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.688 -0.632 . . . . 0.0 110.629 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.431 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 38.3 mm-40 -64.15 -58.3 7.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.004 -1.06 . . . . 0.0 109.777 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.86 -20.77 65.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.455 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.718 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 68.6 t-105 -76.15 -44.69 37.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 174' ' ' ILE . 83.1 mt-10 -73.52 -36.91 65.78 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.172 -0.955 . . . . 0.0 108.497 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.8 -44.3 49.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -61.58 -42.08 98.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 109.028 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.798 HG23 HG21 ' A' ' 184' ' ' VAL . 11.5 mt -75.83 -58.08 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 111.051 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.78 -54.05 21.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 0.0 109.665 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -51.03 -41.27 59.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.578 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 6.0 mm-40 -59.13 -50.53 73.7 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.729 ' HB3' HG11 ' A' ' 4' ' ' VAL . 15.2 mt -68.32 -25.92 65.36 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 110.099 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.414 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 10.5 p -52.43 -40.19 61.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.95 -1.094 . . . . 0.0 108.427 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 31.1 mt-30 -97.7 31.61 2.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 7' ' ' LEU . 86.9 m-20 48.61 49.2 18.89 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 79.6 mt-30 -123.7 107.38 31.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.512 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.2 Cg_endo -64.05 168.9 11.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.125 1.883 . . . . 0.0 112.791 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 174' ' ' ILE . 50.6 t -120.9 134.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.551 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.926 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -82.56 116.02 21.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 5.7 t80 -122.25 158.16 30.09 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 120.954 -1.091 . . . . 0.0 109.355 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -167.2 128.45 1.58 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 117.881 -1.528 . . . . 0.0 111.549 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.01 115.79 4.87 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.3 t -80.6 169.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -173.99 -142.91 4.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.6 -28.86 21.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.157 -1.202 . . . . 0.0 110.739 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 238' ' ' ALA . 4.1 m -83.0 -14.1 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.931 -1.106 . . . . 0.0 110.973 -178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.02 -171.06 21.11 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -82.8 105.82 2.69 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.878 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 15.2 t-80 -70.93 127.58 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.44 161.62 20.93 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.426 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -157.56 -171.35 3.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 75.3 t -134.0 134.94 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.617 -1.302 . . . . 0.0 111.218 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 174' ' ' ILE . 56.1 mt -97.66 119.25 45.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 33.9 p30 -130.62 31.9 4.48 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.564 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.65 161.72 32.39 Favored Glycine 0 N--CA 1.484 1.839 0 C-N-CA 117.254 -2.403 . . . . 0.0 112.457 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.507 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.46 145.3 32.49 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -116.57 17.69 15.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.863 -1.148 . . . . 0.0 110.328 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 1' ' ' GLN . . . 77.33 -51.26 3.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -79.7 50.69 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.067 -1.255 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 51.04 35.25 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' ASP . 0.2 OUTLIER -115.37 130.08 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.063 -1.023 . . . . 0.0 108.96 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 6.8 m-85 -122.97 156.72 34.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 200' ' ' ASP . 61.0 t-80 -93.29 114.78 27.32 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 197' ' ' PHE . 14.3 t -113.89 142.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.077 . . . . 0.0 111.797 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.531 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.1 t-20 -101.32 77.7 1.81 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.462 ' CH2' ' O ' ' A' ' 228' ' ' ASN . 45.1 m95 -44.99 168.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.683 0.754 . . . . 0.0 110.991 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -80.58 8.69 53.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 231' ' ' ALA . 96.0 m95 -107.03 -169.54 1.56 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -1.223 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.47 -90.99 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.08 66.93 0.57 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.839 HG22 ' N ' ' A' ' 218' ' ' SER . 1.2 p -97.79 -97.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 109.66 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.839 ' N ' HG22 ' A' ' 217' ' ' VAL . 50.8 m -90.45 24.23 2.68 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.117 -0.99 . . . . 0.0 109.521 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.57 125.08 16.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 139.2 -115.28 1.1 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.044 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.508 ' HB2' ' CE1' ' A' ' 207' ' ' PHE . 7.1 p90 -60.44 137.89 58.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.309 -1.112 . . . . 0.0 109.926 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.799 ' CD2' HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -85.88 164.58 17.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.577 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.563 ' O ' HD22 ' A' ' 224' ' ' LEU . 25.2 mtm180 -129.24 124.24 33.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.529 -0.732 . . . . 0.0 109.077 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.799 HD23 ' CD2' ' A' ' 222' ' ' PHE . 1.4 mm? -121.35 25.78 9.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.96 . . . . 0.0 110.486 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -60.89 2.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.871 -1.143 . . . . 0.0 109.29 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.32 -95.35 0.48 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -91.83 174.25 7.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 108.756 179.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.609 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 1.5 m120 -95.24 -45.51 0.27 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 113.038 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 228' ' ' ASN . 33.1 Cg_endo -75.53 142.19 26.03 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.388 2.059 . . . . 0.0 110.7 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.56 -8.13 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.734 ' HB2' HG11 ' A' ' 217' ' ' VAL . . . -81.32 93.0 6.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 231' ' ' ALA . 9.0 mt -135.77 179.3 6.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 96.33 -5.52 65.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 25.0 m -95.57 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.031 -1.276 . . . . 0.0 109.689 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.41 167.26 29.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.15 96.12 0.64 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -155.83 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.625 ' HB2' HG13 ' A' ' 192' ' ' VAL . . . -73.14 -56.45 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -1.171 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.74 46.83 10.59 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 227' ' ' LEU . . . 68.43 75.83 0.48 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -122.43 130.91 53.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.406 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 9.3 t30 -115.82 70.27 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -81.68 -40.81 10.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.475 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -135.04 152.9 52.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.543 ' CD ' HD22 ' A' ' 228' ' ' ASN . 6.4 tt0 -153.8 141.8 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.128 . . . . 0.0 109.309 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -166.75 163.29 16.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.763 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.39 165.35 27.66 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.293 1.044 . . . . 0.0 109.749 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.926 HG23 ' CD1' ' A' ' 185' ' ' TYR . 6.6 t -118.32 114.9 46.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 1.004 HG23 ' CE1' ' A' ' 158' ' ' HIS . 27.1 m -115.25 144.95 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 120.942 -1.099 . . . . 0.0 111.092 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 88.69 51.73 2.99 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.638 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.54 95.36 3.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -1.049 . . . . 0.0 109.971 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.65 153.92 13.28 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 108.899 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.64 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.8 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.211 1.941 . . . . 0.0 110.509 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.723 ' NE2' ' CE1' ' A' ' 208' ' ' TYR . 39.4 tt0 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.7 Cg_endo -77.71 179.04 6.89 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.283 1.988 . . . . 0.0 109.931 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 203' ' ' ASP . 53.7 t -107.06 142.93 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.391 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.731 HG11 ' HB3' ' A' ' 178' ' ' LEU . 63.8 t -136.34 131.1 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -76.64 172.94 12.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 108.571 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 47.2 t -77.52 103.32 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.119 -0.988 . . . . 0.0 109.158 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 30.5 mt -58.62 -50.61 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.552 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 198' ' ' VAL . 11.5 mt -55.41 -37.08 67.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.599 -1.313 . . . . 0.0 108.861 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.5 OUTLIER -67.49 -41.44 84.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 p -58.14 -14.65 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 109.278 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.1 mtpt -121.51 16.4 11.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.82 42.48 6.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 58' ' ' TYR . 43.1 mt -87.99 110.83 21.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.196 0.998 . . . . 0.0 110.504 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 102' ' ' PRO . 55.3 m80 -134.7 97.71 3.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.5 m-30 -104.0 178.46 4.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.984 -1.073 . . . . 0.0 110.938 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 -165.43 2.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.52 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 28.2 mt-30 -124.57 -16.61 6.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.004 -1.06 . . . . 0.0 110.221 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.723 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.77 -37.25 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.305 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.5 t-20 -45.53 -139.57 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.124 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.39 3.35 5.35 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 CA-C-N 122.625 1.973 . . . . 0.0 109.161 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.3 m-85 -77.79 -32.29 52.36 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.533 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 37.9 p-10 -94.46 17.8 12.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 20' ' ' PRO . 12.2 mt -74.18 4.88 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 110.401 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 24' ' ' LEU . 9.2 mt -139.45 2.5 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.68 -1.262 . . . . 0.0 110.389 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.6 p -63.4 164.33 15.39 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.5 Cg_endo -70.07 137.16 33.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.731 1.621 . . . . 0.0 110.73 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 145.58 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.649 0.738 . . . . 0.0 110.085 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.717 HD11 ' HA2' ' A' ' 132' ' ' GLY . 6.5 mt -77.43 151.36 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.476 0.655 . . . . 0.0 110.354 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 39' ' ' VAL . 25.5 mt-10 -124.77 -25.44 3.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.468 -0.77 . . . . 0.0 110.779 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.6 mtpm? -117.38 177.22 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.918 -1.114 . . . . 0.0 109.917 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 37' ' ' SER . 97.3 t -114.31 146.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.893 . . . . 0.0 111.536 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 22.2 tttt -86.43 129.67 52.37 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -69.1 124.32 11.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.343 1.362 . . . . 0.0 110.277 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.99 11.87 29.0 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.0 tt0 -152.32 166.51 31.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.292 -1.122 . . . . 0.0 109.606 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -175.33 0.26 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 108.748 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.4 t -87.57 138.88 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.01 -1.057 . . . . 0.0 110.332 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.757 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 18.7 m-30 -111.77 10.97 20.91 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.046 -1.034 . . . . 0.0 109.33 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 29' ' ' GLU . 17.6 t -61.22 119.26 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.749 -1.219 . . . . 0.0 108.726 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.9 -11.23 57.47 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' OE1' ' CD1' ' A' ' 38' ' ' PHE . 64.0 mt-30 -76.5 134.41 39.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.569 -0.959 . . . . 0.0 109.305 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.19 112.71 9.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.83 163.76 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -87.57 170.18 11.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.863 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.578 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.3 p -82.73 -36.58 25.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 102.82 136.36 9.1 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.462 ' C ' ' HB3' ' A' ' 196' ' ' ALA . 2.1 p -54.58 -50.44 68.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.138 -1.213 . . . . 0.0 108.02 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 40.6 t -46.44 -54.86 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.15 -51.31 70.57 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.034 0.921 . . . . 0.0 109.625 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 48.0 m -62.92 -34.5 77.58 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.813 -0.554 . . . . 0.0 110.232 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -67.24 -39.95 86.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.575 -1.328 . . . . 0.0 108.331 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 56' ' ' MET . 61.8 m -74.41 -52.04 13.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.608 0.718 . . . . 0.0 109.993 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HB3' ' HE2' ' A' ' 120' ' ' MET . . . -52.06 -39.35 59.52 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.638 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.7 mt-30 -59.57 -53.1 61.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.726 -1.233 . . . . 0.0 107.86 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.765 HD11 HG22 ' A' ' 198' ' ' VAL . 26.1 mt -63.24 -29.63 47.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.537 ' SD ' HG22 ' A' ' 123' ' ' VAL . 26.2 mtp -66.23 -42.61 88.41 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.573 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.5 tptt -67.51 -39.43 85.13 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.3 t80 -53.7 -32.5 52.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.644 -0.66 . . . . 0.0 110.245 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 80.6 m-70 -107.03 -21.26 13.06 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.261 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.623 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 81.4 m-20 44.37 53.39 6.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.2 t80 -74.11 -76.62 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.7 -0.8 . . . . 0.0 113.082 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.93 105.1 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 CA-C-N 119.071 0.704 . . . . 0.0 112.084 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.2 m-80 -69.9 -21.51 63.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.04 141.73 49.32 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.37 147.99 34.51 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.601 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.914 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.61 -48.77 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.585 -0.95 . . . . 0.0 109.94 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 28.3 tttp -151.59 140.07 20.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 109.626 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 39.1 m-20 -59.35 172.7 0.6 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.471 -0.768 . . . . 0.0 109.767 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CD1' ' OD1' ' A' ' 150' ' ' ASN . 40.7 t80 -148.0 161.03 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.446 -0.784 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.418 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 14.8 t -159.7 149.69 18.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.5 p90 -160.03 155.63 25.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.097 -1.002 . . . . 0.0 109.829 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 82.7 m -92.77 132.71 36.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.741 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.0 tp -44.45 147.76 0.54 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.264 -0.898 . . . . 0.0 110.77 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t -61.27 143.63 55.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.434 0.635 . . . . 0.0 110.263 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 p -68.58 -3.93 13.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.56 -2.55 35.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.741 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.5 t-20 -71.27 110.89 8.3 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.763 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.592 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.8 Cg_endo -91.09 20.26 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.089 2.526 . . . . 0.0 108.886 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 38' ' ' PHE . 53.7 m-85 -114.93 -22.97 9.33 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.306 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -123.54 165.47 17.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.3 m120 -47.94 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.8 -47.16 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 111.202 175.174 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.72 57.63 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.394 -1.81 . . . . 0.0 107.394 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.4 tptt -110.86 108.2 17.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.536 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.81 145.16 28.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 6.0 mp -116.98 156.99 26.52 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 32.8 t80 -143.26 128.37 18.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.978 -1.076 . . . . 0.0 110.424 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.83 115.38 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.04 53.3 0.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.653 -1.279 . . . . 0.0 108.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.8 mt -52.9 -55.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.451 -0.781 . . . . 0.0 110.339 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -45.7 -26.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.475 -1.39 . . . . 0.0 109.207 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -111.25 22.4 15.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.66 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 42.8 mmt-85 -82.45 152.7 26.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.983 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -117.02 91.27 3.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.616 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 3.8 m-85 -81.09 90.22 6.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 110.425 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 35.3 t-20 -80.03 90.27 5.39 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 51.9 m95 -61.16 -7.53 2.78 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.585 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -90.14 -18.52 25.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.6 m-20 -98.88 -30.06 12.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.674 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.1 mt -73.84 69.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 24.6 mt -47.45 150.26 1.71 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.805 -0.559 . . . . 0.0 110.108 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.532 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -80.16 -28.13 3.26 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.824 2.349 . . . . 0.0 110.735 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -135.29 121.89 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.653 ' CE2' HG21 ' A' ' 116' ' ' ILE . 63.0 m-85 -109.53 139.9 43.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 109.899 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 p -100.19 -7.97 24.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.508 ' C ' ' HZ1' ' A' ' 113' ' ' LYS . . . 91.69 -0.01 73.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -118.37 7.31 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -1.123 . . . . 0.0 109.384 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 168.76 17.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.1 p -64.18 165.27 9.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.7 m-20 -71.72 -32.03 67.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -52.41 -61.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -33.65 75.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.508 ' HZ1' ' C ' ' A' ' 106' ' ' GLY . 17.0 mttt -65.88 -44.06 86.46 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -58.74 -36.53 74.47 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.674 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.19 -67.86 0.28 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.647 -0.658 . . . . 0.0 109.584 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.653 HG21 ' CE2' ' A' ' 104' ' ' TYR . 2.2 tp -63.74 -40.7 90.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 10.5 p -58.13 -43.38 87.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.92 -1.112 . . . . 0.0 108.841 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' OE2' ' CD ' ' A' ' 93' ' ' ARG . 50.3 tt0 -69.29 -38.0 78.1 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.61 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.6 tp -56.83 -52.37 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -57.78 -43.06 85.3 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.87 -38.61 91.56 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.644 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.1 m-20 -69.41 -54.85 12.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.537 HG22 ' SD ' ' A' ' 56' ' ' MET . 49.0 t -58.84 -62.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.37 -46.74 16.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.0 mt -63.63 -57.45 11.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 107.979 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.508 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 1.7 p -46.55 -27.33 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.81 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -104.5 31.53 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 45.7 m-20 41.75 43.52 2.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.158 -0.964 . . . . 0.0 109.747 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 45' ' ' THR . 35.2 tpp -60.37 134.2 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -0.778 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -76.96 123.16 25.91 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 34.3 m-85 -103.47 103.92 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -142.04 -170.03 12.36 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.757 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.6 Cg_endo -62.55 -20.91 72.08 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.633 -2.103 . . . . 0.0 106.633 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.64 130.31 55.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 72.6 m -113.87 113.83 25.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 119.753 -1.842 . . . . 0.0 110.339 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.67 126.48 8.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -118.06 -170.7 1.93 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.149 -1.207 . . . . 0.0 107.8 178.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.918 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.45 -49.95 6.23 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 116.76 -111.19 2.26 Favored Glycine 0 N--CA 1.481 1.657 0 C-N-CA 119.955 -1.117 . . . . 0.0 111.751 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.523 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 6.1 m -48.46 -72.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.862 . . . . 0.0 112.317 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 11.4 p -46.61 -32.86 3.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 110.276 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.918 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 24.4 mmt180 -80.41 -49.92 10.8 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.972 -1.08 . . . . 0.0 109.787 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.9 t -68.37 -58.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.7 -0.625 . . . . 0.0 111.049 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 3.1 pp0? -56.55 -31.88 64.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.016 -1.052 . . . . 0.0 108.608 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' SER . 1.9 ttm-85 -77.31 -52.84 8.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.002 -1.061 . . . . 0.0 109.61 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.508 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.95 -37.81 88.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.0 110.053 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.631 ' HB2' HG11 ' A' ' 157' ' ' VAL . 34.3 mt -55.21 -47.31 75.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 50.5 mtmt -87.38 -45.17 10.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.063 -1.023 . . . . 0.0 110.887 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.96 -48.99 69.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.999 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.56 ' OD1' ' CD1' ' A' ' 69' ' ' TYR . 10.5 m120 -94.36 -45.43 7.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.676 -1.265 . . . . 0.0 111.645 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 27.4 m-85 -99.97 18.67 17.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.763 -1.21 . . . . 0.0 110.716 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.914 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.16 43.55 0.07 OUTLIER Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.777 -0.577 . . . . 0.0 112.857 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 7.0 m-85 -64.17 164.16 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.267 -1.725 . . . . 0.0 108.013 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 27.3 t-20 -47.99 151.4 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.843 -1.161 . . . . 0.0 109.626 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 9.0 mm100 -56.16 -17.14 6.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.066 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.593 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 22.3 p -55.17 -14.84 1.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.84 . . . . 0.0 109.852 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 147' ' ' LEU . 39.8 t -72.66 119.61 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.711 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -149.56 -177.7 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.596 178.065 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.523 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.7 tt0 -123.42 139.1 54.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.902 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.7 pt -123.91 176.2 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 1.9 m120 -128.55 97.54 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.793 -1.192 . . . . 0.0 110.558 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.2 tpt180 -46.91 -41.15 15.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.047 -1.033 . . . . 0.0 109.327 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.72 -21.04 54.29 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 64.3 m-20 -104.04 0.25 29.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -1.228 . . . . 0.0 111.677 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.18 173.49 6.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.444 -1.41 . . . . 0.0 110.491 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 167' ' ' LYS . 18.6 p -101.33 136.51 41.05 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' HD2' HD12 ' A' ' 224' ' ' LEU . 15.0 ttpp -31.48 -51.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.912 -0.492 . . . . 0.0 111.228 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.65 -58.77 5.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.449 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.6 -19.67 63.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.0 108.513 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.4 t-105 -74.95 -47.55 28.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 19.8 mt-10 -64.15 -23.98 67.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.28 -43.44 98.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -60.5 -44.07 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 108.687 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 4.9 mt -74.24 -41.52 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 108.644 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -50.74 -51.87 45.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 109.08 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -51.96 -50.73 60.64 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 53.7 mm-40 -56.64 -61.25 2.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.731 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.1 mt -55.72 -32.36 63.27 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.183 0.516 . . . . 0.0 110.263 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.5 p -52.32 -53.23 47.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 19.6 mt-30 -88.75 44.13 1.19 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.0 m120 41.97 52.45 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 4.7 mt-30 -124.49 113.56 27.45 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.561 ' HG2' HG23 ' A' ' 55' ' ' ILE . 15.2 Cg_endo -66.34 169.14 14.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 121.743 1.629 . . . . 0.0 111.591 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 55.4 t -125.1 134.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.811 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.748 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.48 122.5 30.51 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 175.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.8 t80 -123.3 163.35 20.89 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.799 -1.188 . . . . 0.0 109.826 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -166.17 123.6 1.41 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.281 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 245' ' ' GLN . . . -93.2 124.26 7.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 190' ' ' GLY . 60.5 t -82.03 158.4 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.81 -1.406 . . . . 0.0 111.212 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.56 -137.8 2.28 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -36.33 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.65 -6.78 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.943 -1.098 . . . . 0.0 111.077 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.71 -159.78 19.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.48 114.29 4.04 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.849 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 32.3 t-80 -70.3 145.48 51.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.56 154.72 38.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 117.852 -1.539 . . . . 0.0 113.908 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.865 ' CD1' HG13 ' A' ' 210' ' ' VAL . 10.4 p90 -163.4 163.56 24.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.765 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -112.51 137.51 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.869 -1.145 . . . . 0.0 112.171 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.684 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 50.5 mt -103.74 121.03 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 19.1 p30 -126.3 16.17 7.75 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.493 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 178' ' ' LEU . . . -160.98 172.31 37.23 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 116.613 -2.708 . . . . 0.0 114.721 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.745 ' CB ' ' CE1' ' A' ' 208' ' ' TYR . . . -159.06 152.07 22.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.42 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -126.97 28.82 5.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.416 -1.428 . . . . 0.0 109.494 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 1' ' ' GLN . . . 59.0 14.76 25.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -142.4 47.28 1.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -1.157 . . . . 0.0 108.972 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.99 19.87 2.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 108.967 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.682 ' CD1' ' CZ ' ' A' ' 222' ' ' PHE . 9.1 m-30 -102.06 92.38 4.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.745 ' CE1' ' CB ' ' A' ' 202' ' ' ALA . 3.3 m-30 -102.86 155.97 17.97 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.068 -1.02 . . . . 0.0 111.232 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.574 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 1.3 t-80 -90.96 139.21 30.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.008 -1.682 . . . . 0.0 107.331 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.865 HG13 ' CD1' ' A' ' 197' ' ' PHE . 19.4 t -131.09 139.62 50.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.517 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 39.3 t-20 -114.04 84.17 1.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.596 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 94.8 m95 -52.14 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -7.79 52.18 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.412 ' HB2' HG12 ' A' ' 217' ' ' VAL . 77.3 m95 -108.26 168.93 8.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -1.168 . . . . 0.0 108.908 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -127.6 4.92 7.09 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.024 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -130.42 5.72 5.93 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.847 HG13 ' N ' ' A' ' 218' ' ' SER . 1.4 p -107.19 -150.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -1.204 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.847 ' N ' HG13 ' A' ' 217' ' ' VAL . 15.0 m -64.91 54.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 217' ' ' VAL . 7.9 m-20 -91.29 95.12 9.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 109.814 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' VAL . . . 157.77 -53.94 0.39 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.87 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.648 ' CE2' ' CG ' ' A' ' 223' ' ' ARG . 2.1 p90 -60.05 109.21 0.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.04 -1.271 . . . . 0.0 111.297 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.682 ' CZ ' ' CD1' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -51.24 125.9 15.33 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.443 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.648 ' CG ' ' CE2' ' A' ' 221' ' ' PHE . 5.0 mmm180 -128.6 118.85 23.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 109.356 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -121.33 -6.21 9.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.02 -23.53 9.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.186 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.429 ' HB3' ' NE ' ' A' ' 223' ' ' ARG . . . -122.99 89.07 3.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.259 1.028 . . . . 0.0 108.768 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.597 HD21 ' HE2' ' A' ' 197' ' ' PHE . 0.1 OUTLIER -91.26 54.19 2.51 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.628 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -114.2 156.82 43.71 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.259 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.22 144.36 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.585 2.19 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -44.81 10.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.26 109.55 21.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mp -92.07 -65.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 109.378 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.6 -150.85 24.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -71.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -1.181 . . . . 0.0 109.394 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -95.51 25.66 23.57 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -94.92 -67.34 1.01 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.8 26.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -120.2 -35.42 3.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.45 -143.3 7.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' PHE . . . 139.26 76.92 0.06 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -54.96 -172.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -1.163 . . . . 0.0 109.27 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 10.1 t30 -104.55 70.05 0.93 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -73.12 -46.15 28.87 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.505 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 90.1 m-85 -136.14 166.19 23.98 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.505 ' CG ' ' HB3' ' A' ' 162' ' ' ARG . 43.2 tt0 -156.96 132.43 9.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.0 109.123 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -148.83 166.76 27.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.64 151.99 45.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.116 0.96 . . . . 0.0 110.057 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 84.7 t -109.15 118.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.711 HG23 ' NE2' ' A' ' 158' ' ' HIS . 33.5 m -127.1 144.03 38.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.164 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 91.87 55.71 1.72 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.615 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 36.4 mt -102.44 81.62 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.35 -1.088 . . . . 0.0 110.148 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -156.89 148.91 17.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.185 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.975 . . . . 0.0 110.573 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.456 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 38.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.44 163.39 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.449 2.099 . . . . 0.0 110.028 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.71 142.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.101 -0.999 . . . . 0.0 109.599 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.819 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.8 t -135.48 130.54 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -75.91 -178.11 4.17 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.715 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 1.9 t -77.72 105.68 9.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.011 -1.056 . . . . 0.0 109.408 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.673 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 45.7 mt -57.4 -49.37 76.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 108.986 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 198' ' ' VAL . 10.4 mt -55.66 -41.57 73.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.807 -1.183 . . . . 0.0 108.781 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 24.5 t70 -67.4 -39.09 85.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.159 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -58.58 -14.38 8.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.1 mtpp -121.01 21.74 11.24 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.28 -0.888 . . . . 0.0 108.707 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.78 38.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.8 mt -86.61 109.62 19.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 122.283 1.039 . . . . 0.0 110.355 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 102' ' ' PRO . 20.1 m-70 -134.5 88.37 2.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.1 m-30 -95.0 -179.65 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.885 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 1.4 t-20 -148.54 -163.93 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.533 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 43.9 mt-30 -124.6 -23.37 4.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.076 -1.015 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.716 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -114.92 -34.67 1.47 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.308 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.2 t-20 -45.21 -140.36 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.242 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -74.37 3.77 4.98 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 CA-C-N 122.545 1.945 . . . . 0.0 109.694 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.8 m-85 -80.41 -31.46 37.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.435 -0.791 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.4 p-10 -92.13 15.26 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.604 -1.31 . . . . 0.0 109.103 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.7 mt -69.55 -6.97 34.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.9 mt -125.92 -9.24 6.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.007 . . . . 0.0 109.761 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -60.88 166.64 4.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.4 Cg_endo -70.06 145.88 56.72 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.014 1.81 . . . . 0.0 112.367 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -85.74 148.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.554 0.692 . . . . 0.0 109.808 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.794 HD11 ' C ' ' A' ' 132' ' ' GLY . 25.4 mt -78.21 149.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.448 -0.782 . . . . 0.0 111.295 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 92.9 mt-10 -126.17 -22.16 4.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.596 . . . . 0.0 110.468 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 30.3 mtpt -120.26 169.47 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.858 -1.151 . . . . 0.0 110.258 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 32' ' ' LYS . 88.0 t -114.44 154.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.6 ' HZ3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -86.73 158.88 53.26 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' HD3' ' HZ3' ' A' ' 32' ' ' LYS . 32.3 Cg_endo -82.56 107.01 1.56 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.607 2.204 . . . . 0.0 110.173 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.84 51.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 7.0 tt0 -122.0 159.33 27.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -1.172 . . . . 0.0 109.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -62.35 175.53 0.74 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.169 -0.957 . . . . 0.0 109.033 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.3 t -80.61 134.97 35.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.146 -0.972 . . . . 0.0 109.075 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 13.92 11.49 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.903 -1.123 . . . . 0.0 109.763 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 29' ' ' GLU . 58.7 t -62.99 141.07 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 109.436 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.27 80.36 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.6 mt-30 -86.92 132.84 33.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -1.188 . . . . 0.0 109.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -73.34 111.14 8.19 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.22 161.21 0.66 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.106 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.38 169.51 18.13 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.405 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.707 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.0 p -80.66 -33.84 35.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 108.469 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.05 135.87 8.01 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.431 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 14.1 p -53.69 -47.89 70.05 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.593 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 29.9 t -47.8 -57.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.372 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.78 -45.16 93.14 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 110.555 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 76.2 m -62.5 -39.24 92.86 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.64 -0.662 . . . . 0.0 110.244 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.62 80.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.489 -1.382 . . . . 0.0 108.778 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.505 ' HB ' HG11 ' A' ' 123' ' ' VAL . 60.7 m -74.71 -55.19 6.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.3 -34.91 48.88 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.662 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.4 mt-30 -63.5 -53.83 45.82 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -63.1 -22.29 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.498 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 24.7 mtp -73.36 -37.36 66.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.4 tptt -71.19 -40.07 71.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 40.9 t80 -53.65 -31.46 47.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.653 -0.654 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.1 m-70 -107.93 -22.4 12.45 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.287 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.639 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.13 57.3 2.0 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -178.078 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -77.54 -71.59 0.18 Allowed Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -69.17 105.65 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 120.272 0.648 . . . . 0.0 112.171 -176.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -72.04 -20.35 61.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 34.0 tttt -134.28 139.8 45.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 148.4 37.4 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.411 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.974 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.79 -46.79 8.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.989 . . . . 0.0 109.822 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.504 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 38.3 tttt -151.92 140.51 20.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' SER . 10.7 m-20 -67.62 174.71 3.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 70' ' ' THR . 36.9 t80 -152.16 150.16 29.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.13 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.451 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.61 164.47 35.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.68 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.0 p90 -169.3 155.79 6.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 91.3 m -93.04 130.29 38.69 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.775 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.37 149.97 0.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 111.057 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -61.42 137.37 58.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.694 -0.629 . . . . 0.0 109.568 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -64.44 -7.24 9.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 109.875 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.0 m-80 -96.73 -6.03 37.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.775 ' ND2' HD21 ' A' ' 73' ' ' LEU . 35.2 t-20 -71.04 111.8 11.19 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 53.3 Cg_endo -88.48 12.3 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.887 2.391 . . . . 0.0 109.8 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 70.9 m-85 -107.04 -1.99 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 111.461 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 34.0 m-85 -142.35 161.91 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.572 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.7 m120 -47.54 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 174.62 -46.47 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 111.008 174.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.94 55.98 5.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.83 103.46 12.97 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.649 -178.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -100.85 132.75 46.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -105.25 137.92 42.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 20.9 t80 -125.13 125.34 43.58 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.151 -0.968 . . . . 0.0 110.395 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.87 105.7 15.63 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.01 54.79 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 108.67 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 70.5 mt -52.71 -52.87 23.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.543 -0.723 . . . . 0.0 110.433 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 p -44.4 -25.47 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -110.56 35.75 3.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 108.565 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.708 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 23.5 mmt-85 -95.75 155.65 16.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.843 . . . . 0.0 110.735 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -118.69 91.41 3.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -81.66 88.18 6.25 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 110.951 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.507 ' O ' HG13 ' A' ' 100' ' ' ILE . 42.8 t-20 -79.66 89.63 5.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.639 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 79.1 m95 -61.27 -6.62 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.85 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 -16.14 31.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -99.9 -30.84 11.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.658 HG12 ' HB1' ' A' ' 115' ' ' ALA . 27.7 mt -73.42 67.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.492 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 12.9 mt -46.32 150.71 1.08 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.554 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.9 Cg_endo -77.45 -26.67 7.05 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.607 2.205 . . . . 0.0 110.946 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 2.1 t -138.2 125.23 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 87.2 m-85 -109.62 139.45 44.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.91 4.51 45.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 108.991 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.72 -6.86 63.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -113.52 15.94 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -1.148 . . . . 0.0 109.395 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.452 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.3 mp0 -75.8 167.53 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -179.69 0.33 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.68 -43.94 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.54 -51.88 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.787 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -44.43 96.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.032 -1.043 . . . . 0.0 109.084 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 75.8 mttt -61.93 -36.56 81.75 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.257 -0.902 . . . . 0.0 108.835 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.461 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 14.8 ttm -60.35 -45.32 93.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.13 -51.6 69.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 111.098 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.631 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.5 tp -69.35 -39.11 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.601 -1.312 . . . . 0.0 110.04 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -58.04 -41.49 83.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.098 -1.001 . . . . 0.0 110.44 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.888 ' N ' HD12 ' A' ' 24' ' ' LEU . 22.6 tt0 -68.86 -37.39 79.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.954 -1.091 . . . . 0.0 108.218 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -57.95 -51.8 68.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.4 mmt -59.37 -40.62 87.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.524 -0.735 . . . . 0.0 109.465 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.23 -37.93 88.81 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -69.07 -57.43 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.955 ' O ' HG22 ' A' ' 127' ' ' VAL . 22.6 t -61.73 -48.48 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.048 -1.033 . . . . 0.0 108.835 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -54.64 -54.03 35.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.4 mt -65.91 -53.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.009 -1.289 . . . . 0.0 108.321 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 59.8 p -45.99 -32.11 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.577 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 123' ' ' VAL . 31.5 m -101.39 39.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.3 m-20 37.41 50.97 1.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.665 ' HE3' ' O ' ' A' ' 45' ' ' THR . 51.2 tpp -65.98 127.45 32.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.427 -0.795 . . . . 0.0 111.602 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.6 OUTLIER -76.26 123.05 25.29 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.654 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.4 m-85 -103.94 118.77 37.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.326 1.06 . . . . 0.0 113.578 -175.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.794 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.07 -163.8 11.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 104.598 -3.401 . . . . 0.0 104.598 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.659 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.29 -30.86 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.573 -2.51 . . . . 0.0 105.573 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.88 142.03 41.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.4 m -122.25 113.22 19.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 119.855 -1.778 . . . . 0.0 110.157 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.47 132.49 11.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -117.84 -164.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -1.112 . . . . 0.0 108.12 178.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.86 -64.37 1.12 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.807 -1.183 . . . . 0.0 108.125 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.575 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 132.31 -130.56 5.92 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.837 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.472 ' HB2' ' NE2' ' A' ' 159' ' ' GLN . 1.4 m -47.36 -55.59 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.745 -0.856 . . . . 0.0 111.531 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -45.69 21.22 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.867 -1.146 . . . . 0.0 109.269 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.6 mmp_? -80.63 -38.79 28.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.61 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 185' ' ' TYR . 76.2 t -67.77 -57.29 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.462 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 0.8 OUTLIER -56.7 -33.09 66.12 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.103 -1.039 . . . . 0.0 108.674 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' SER . 2.6 ttp85 -77.8 -46.45 21.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.8 76.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.699 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.647 HD12 HG11 ' A' ' 248' ' ' VAL . 59.1 mt -60.58 -46.5 90.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.697 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.582 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 43.5 mtmt -88.08 -38.87 15.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.784 -1.197 . . . . 0.0 110.722 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 48.3 mt-10 -72.87 -51.66 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.85 -1.156 . . . . 0.0 111.753 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.3 m120 -89.56 -41.38 12.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.884 -1.135 . . . . 0.0 111.587 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.83 8.25 39.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.756 -1.215 . . . . 0.0 110.834 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.974 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 39.38 40.92 1.44 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 121.172 -0.955 . . . . 0.0 112.122 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.13 168.9 3.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.385 -1.656 . . . . 0.0 108.318 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.4 t30 -47.82 142.39 4.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.097 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.43 -20.91 5.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.923 . . . . 0.0 108.956 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.494 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 79.0 p -56.49 -14.46 3.09 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 109.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.582 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 7.0 t -61.82 122.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 0.0 109.586 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.986 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.1 p-80 -148.55 159.19 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.709 -0.797 . . . . 0.0 109.202 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 140' ' ' SER . 16.5 tt0 -102.79 145.38 29.84 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 1.048 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.4 pt -121.77 154.4 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m120 -121.53 99.51 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.874 -1.141 . . . . 0.0 110.646 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.629 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 1.1 tpt180 -46.29 -38.86 9.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.35 -24.26 61.16 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -104.52 1.54 29.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.243 . . . . 0.0 111.857 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -117.77 179.7 4.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.4 -1.437 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 167' ' ' LYS . 60.6 p -104.85 136.64 43.97 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.663 ' HG3' HD12 ' A' ' 224' ' ' LEU . 21.7 ttmt -34.35 -47.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.74 -0.6 . . . . 0.0 110.825 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.498 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 49.1 mm-40 -64.97 -59.5 4.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.117 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.51 -16.25 60.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.28 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 1.048 ' CH2' HD12 ' A' ' 160' ' ' ILE . 50.8 t-105 -71.01 -47.97 55.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 33.8 mt-10 -67.1 -38.01 84.92 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -44.67 -49.59 10.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.511 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 83.1 mm-40 -61.1 -42.02 97.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 108.725 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.76 HG23 HG21 ' A' ' 184' ' ' VAL . 96.6 mt -71.71 -63.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 0.0 111.381 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.5 OUTLIER -48.11 -43.3 30.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 -177.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -51.84 -43.46 63.19 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.544 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 48.8 mm-40 -59.8 -53.51 57.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.819 ' HB3' HG11 ' A' ' 4' ' ' VAL . 11.4 mt -68.38 -25.06 64.88 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.911 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 175' ' ' ASP . 28.4 p -52.24 -40.12 61.23 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.7 mt-30 -99.94 33.54 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.576 ' C ' HD13 ' A' ' 7' ' ' LEU . 12.9 m120 49.22 48.99 20.38 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 10.6 mt-30 -124.15 114.78 27.67 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 19.7 Cg_endo -66.67 172.14 9.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.03 1.82 . . . . 0.0 112.187 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 249' ' ' VAL . 18.9 t -125.87 118.04 50.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.648 ' HD2' HG23 ' A' ' 248' ' ' VAL . 26.4 t80 -67.78 111.95 4.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.651 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 6.5 t80 -123.21 156.64 34.72 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.17 -0.956 . . . . 0.0 109.465 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -164.65 128.73 2.52 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.813 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 245' ' ' GLN . . . -91.63 109.08 3.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.0 t -71.7 160.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.459 -1.024 . . . . 0.0 111.382 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -162.57 -137.8 2.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -43.32 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.05 -1.265 . . . . 0.0 111.13 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 238' ' ' ALA . 3.5 m -71.96 -13.56 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.96 -1.087 . . . . 0.0 111.457 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.99 -165.35 24.9 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.5 108.42 3.21 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.798 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -71.48 118.34 14.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.4 160.52 15.58 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.773 1.273 . . . . 0.0 113.072 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.719 ' CD1' HG13 ' A' ' 210' ' ' VAL . 20.5 p90 -162.36 170.2 19.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 8' ' ' LEU . 47.4 t -114.37 136.07 52.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 120.673 -1.267 . . . . 0.0 112.234 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 65.7 mt -100.56 108.73 23.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.0 p30 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.68 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.426 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -172.5 161.86 33.52 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 117.142 -2.456 . . . . 0.0 112.878 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.525 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -142.73 144.54 32.71 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 207' ' ' PHE . 1.8 t0 -114.11 11.45 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.751 -1.218 . . . . 0.0 110.61 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.77 -47.28 3.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -79.33 50.42 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 109.751 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 53.01 31.67 11.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 110.096 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.1 m-85 -121.06 135.89 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 109.769 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 5.7 m-85 -123.39 164.71 18.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.715 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 0.3 OUTLIER -92.73 148.46 22.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.985 HG11 ' CE1' ' A' ' 222' ' ' PHE . 22.4 t -139.59 137.82 39.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.551 ' HB2' HD12 ' A' ' 8' ' ' LEU . 32.7 t-20 -102.02 80.58 2.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.499 ' CZ2' ' CZ ' ' A' ' 222' ' ' PHE . 1.6 m95 -45.95 170.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 109.773 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -85.76 14.69 51.12 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 231' ' ' ALA . 99.5 m95 -107.2 -171.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.256 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.35 -95.64 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.42 69.25 0.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.79 HG22 ' N ' ' A' ' 218' ' ' SER . 2.1 p -105.62 -103.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.003 -1.292 . . . . 0.0 109.962 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.79 ' N ' HG22 ' A' ' 217' ' ' VAL . 3.8 m -89.03 13.98 11.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.861 -1.15 . . . . 0.0 109.971 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 217' ' ' VAL . 0.5 OUTLIER -64.47 138.45 58.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.6 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 132.0 -112.21 1.15 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -59.96 139.79 57.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.183 . . . . 0.0 109.187 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.985 ' CE1' HG11 ' A' ' 210' ' ' VAL . 0.1 OUTLIER -123.89 -179.14 4.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.933 . . . . 0.0 110.259 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -124.67 172.6 9.14 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.663 HD12 ' HG3' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -120.87 -1.27 9.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.912 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.83 -26.86 3.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.025 -1.047 . . . . 0.0 109.966 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.17 88.16 2.88 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.112 0.958 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.868 HD11 ' CE2' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -91.31 77.59 5.85 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.42 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 228' ' ' ASN . 1.5 m-20 -116.77 151.25 47.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.481 -0.762 . . . . 0.0 109.587 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.413 ' HG2' ' HG ' ' A' ' 232' ' ' LEU . 36.3 Cg_endo -78.83 169.63 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.771 2.314 . . . . 0.0 110.512 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.3 m -85.61 -60.26 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 214' ' ' TRP . . . -92.44 119.15 31.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.476 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 4.8 mp -112.37 -55.26 2.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 109.835 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 64.5 173.88 3.56 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 235' ' ' GLY . 46.2 p -109.06 -73.2 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.465 ' N ' ' OG1' ' A' ' 234' ' ' THR . . . -96.42 44.33 2.0 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.28 -40.52 1.5 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.601 ' O ' HG11 ' A' ' 192' ' ' VAL . . . 160.89 -108.86 0.37 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.829 ' HA ' HG21 ' A' ' 192' ' ' VAL . . . -55.95 -169.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -1.177 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.476 ' HA2' ' HG ' ' A' ' 232' ' ' LEU . . . 96.59 102.48 2.05 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -161.24 -146.79 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.01 -172.4 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 6.4 t30 -104.81 77.52 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.0 4.86 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.516 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 65.3 m-85 -136.18 113.82 11.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.48 -1.012 . . . . 0.0 109.368 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.566 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 4.7 mt-30 -95.3 120.93 36.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.401 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 34.5 p -131.1 155.53 46.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.381 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.11 162.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.831 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.648 HG23 ' HD2' ' A' ' 185' ' ' TYR . 16.3 t -116.16 110.32 31.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 158' ' ' HIS . 15.4 m -107.75 146.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 121.379 -0.826 . . . . 0.0 110.943 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 84.42 42.42 7.42 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 54.0 mt -89.58 86.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.536 -0.979 . . . . 0.0 110.362 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.51 156.37 17.89 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.624 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.378 2.052 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.485 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 34.0 tt0 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.485 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 34.9 Cg_endo -76.81 153.8 33.68 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.332 2.021 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.9 t -93.03 140.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 178' ' ' LEU . 78.0 t -140.66 129.67 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.848 . . . . 0.0 109.002 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 200' ' ' ASP . 11.4 mmtp -75.8 -177.18 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 108.947 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 209' ' ' HIS . 66.3 m -77.72 103.08 7.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.647 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 36.3 mt -57.97 -51.62 68.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 109.483 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.588 HD11 HG11 ' A' ' 198' ' ' VAL . 9.0 mt -55.55 -39.32 70.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.746 -1.221 . . . . 0.0 109.021 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 16.0 t0 -67.33 -37.63 83.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 109.35 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -58.43 -14.49 7.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mtpt -121.08 18.93 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 108.846 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.95 39.74 5.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 18.7 mt -86.14 111.42 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.423 -1.045 . . . . 0.0 110.36 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 102' ' ' PRO . 42.4 m80 -135.23 87.48 2.33 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.619 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.599 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.2 m-30 -88.29 178.23 6.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.977 0.894 . . . . 0.0 110.781 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.73 -163.77 1.85 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.495 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 53.5 mt-30 -125.01 -20.97 4.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.963 -1.086 . . . . 0.0 111.061 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.14 -36.28 1.24 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.22 -1.467 . . . . 0.0 111.666 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.4 t-20 -45.35 -140.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.492 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.016 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.2 Cg_endo -73.85 2.84 5.52 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 CA-C-N 122.538 1.942 . . . . 0.0 109.753 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 9.1 m-85 -78.26 -31.52 49.13 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.024 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 24.6 p-10 -92.36 15.71 13.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.584 -1.323 . . . . 0.0 109.463 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.4 mt -70.38 -3.72 18.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.7 mt -129.27 -6.36 4.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 109.988 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.9 p -61.58 165.47 7.28 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.1 Cg_endo -69.16 145.65 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.058 1.839 . . . . 0.0 112.041 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.25 147.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.73 0.776 . . . . 0.0 110.396 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.76 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.6 mt -78.02 149.68 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.683 0.754 . . . . 0.0 111.396 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.2 mt-10 -126.06 -20.83 4.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 110.573 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -121.25 168.13 11.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 110.15 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 36' ' ' GLN . 84.9 t -114.27 146.42 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 111.119 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -75.55 160.47 79.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.62 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.6 Cg_endo -81.77 123.2 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.427 2.085 . . . . 0.0 110.703 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.47 88.57 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -117.08 168.58 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.497 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.618 ' O ' HG13 ' A' ' 31' ' ' VAL . 3.9 mt-30 -69.69 -177.84 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.159 -0.963 . . . . 0.0 108.987 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -87.02 133.21 33.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.564 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 74.7 m-85 -118.54 13.07 13.37 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.451 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 28' ' ' ILE . 77.2 t -63.35 142.52 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 109.367 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 -1.26 77.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 8.2 mt-30 -87.92 131.72 34.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 25' ' ' THR . 4.5 m-70 -73.55 111.69 8.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -51.93 161.42 0.57 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.08 -1.013 . . . . 0.0 109.329 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.53 170.88 15.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.564 0.697 . . . . 0.0 109.866 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.691 HG21 ' SD ' ' A' ' 120' ' ' MET . 28.2 p -81.2 -34.31 32.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 108.646 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.75 137.82 9.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 51' ' ' ALA . 4.3 p -55.14 -52.56 62.89 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -1.086 . . . . 0.0 108.172 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.3 t -46.8 -51.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.566 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -61.43 -51.53 68.35 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.501 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.495 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 39.8 m -63.19 -30.96 72.01 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.705 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.53 -42.23 83.07 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.733 -1.23 . . . . 0.0 107.836 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.494 HG23 HD21 ' A' ' 147' ' ' LEU . 55.8 m -74.76 -53.03 9.94 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.494 0.664 . . . . 0.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.29 -35.4 37.42 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.501 -0.749 . . . . 0.0 109.646 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.599 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.5 mt-30 -64.32 -53.99 40.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.751 HD11 HG22 ' A' ' 198' ' ' VAL . 36.7 mt -60.88 -24.45 32.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.519 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -72.72 -31.68 65.15 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CG ' HG12 ' A' ' 13' ' ' ILE . 41.3 tptt -73.69 -47.07 42.39 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 41.8 t80 -52.95 -29.98 32.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.727 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 50.4 m-70 -107.32 -24.44 11.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.755 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.612 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 86.1 m-20 44.83 56.17 5.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.8 t80 -79.77 -76.08 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.8 Cg_endo -70.24 105.16 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 119.258 0.771 . . . . 0.0 111.837 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.6 OUTLIER -72.0 -20.75 61.67 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -133.95 138.6 45.57 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.652 ' C ' HD23 ' A' ' 66' ' ' LEU . . . -57.82 152.71 26.89 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.164 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.773 HD12 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mt -94.95 -59.84 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.431 -1.041 . . . . 0.0 110.492 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 14.1 tttm -134.11 151.36 51.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.562 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 21.6 m-20 -74.45 172.56 11.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.829 . . . . 0.0 109.499 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 70' ' ' THR . 28.9 t80 -147.48 153.82 40.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.582 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -157.37 149.68 22.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.095 -1.003 . . . . 0.0 110.097 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.715 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.9 p90 -156.44 157.05 34.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.583 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 87.3 m -93.35 134.95 35.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.786 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -52.78 149.99 5.71 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 111.136 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.78 138.26 58.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.729 -0.607 . . . . 0.0 109.596 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -65.78 -6.08 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 6.8 m-20 -96.2 -7.26 36.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.164 -0.96 . . . . 0.0 109.575 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.786 ' ND2' HD21 ' A' ' 73' ' ' LEU . 32.3 t-20 -70.25 111.54 9.67 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 109.82 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 50.3 Cg_endo -88.19 12.68 2.77 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.973 2.449 . . . . 0.0 109.996 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.0 m-85 -105.18 -11.86 16.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.69 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.3 m-85 -134.76 163.19 30.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 10.2 m-20 -47.48 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.25 -46.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 111.039 175.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.5 Cg_endo -76.69 56.72 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.99 102.51 11.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.63 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.86 128.85 46.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -102.06 129.1 48.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 11.2 t80 -121.78 126.91 49.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.92 . . . . 0.0 110.047 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.55 116.05 31.24 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.86 51.26 0.62 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.854 -1.154 . . . . 0.0 108.314 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 25.8 mt -52.09 -44.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 O-C-N 121.259 -0.901 . . . . 0.0 109.579 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 4.7 p -45.62 -26.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.649 -1.282 . . . . 0.0 108.76 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -112.51 34.51 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.411 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.718 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 2.2 mmt-85 -93.0 151.5 19.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 110.336 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -117.2 94.51 4.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.7 m-85 -81.55 93.04 6.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.472 -0.768 . . . . 0.0 110.408 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 30.7 t-20 -79.81 90.15 5.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.612 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 65.0 m95 -61.22 -9.29 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -90.53 -15.59 30.41 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 22.9 m-20 -98.69 -34.27 10.61 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.552 HG12 ' HB1' ' A' ' 115' ' ' ALA . 34.2 mt -73.1 91.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 14.8 mt -71.06 151.62 94.85 Favored Pre-proline 0 C--N 1.29 -1.99 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.2 Cg_endo -76.58 -20.7 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.462 2.108 . . . . 0.0 110.783 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 140.4 32.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.281 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.505 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.8 m-85 -126.61 135.45 51.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.409 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.6 p -99.52 1.87 44.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 108.962 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.44 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -118.29 11.41 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.331 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -73.11 172.59 10.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.669 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.83 177.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.331 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -80.85 -42.1 22.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.97 -51.76 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.458 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 20' ' ' PRO . 15.8 mttt -61.18 -37.46 83.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.12 -0.987 . . . . 0.0 109.118 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.449 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.2 ttm -59.62 -45.24 92.56 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.373 -0.829 . . . . 0.0 110.028 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.07 -51.31 70.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.857 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -69.78 -43.5 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.549 -1.344 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 24' ' ' LEU . 4.7 p -54.33 -40.36 67.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 19.6 tt0 -70.46 -43.28 70.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.1 tp -54.04 -51.48 63.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.691 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -60.16 -44.22 95.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.598 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.537 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.57 -41.82 96.03 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -65.37 -52.54 52.93 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 127' ' ' VAL . 78.6 t -61.18 -61.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.74 -50.99 13.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.8 mt -63.65 -55.45 22.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.319 . . . . 0.0 108.418 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 3.4 p -46.19 -31.3 2.36 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.515 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.2 m -102.28 40.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.156 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER 39.38 38.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.339 -0.851 . . . . 0.0 110.253 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.647 ' HE3' ' O ' ' A' ' 45' ' ' THR . 48.2 tpp -52.56 128.34 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 111.314 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 25.4 t0 -78.33 123.2 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 68.7 m-85 -104.5 115.81 31.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 113.579 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.76 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.73 -163.82 11.55 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 104.482 -3.447 . . . . 0.0 104.482 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.618 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.34 -29.47 79.71 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 105.589 -2.504 . . . . 0.0 105.589 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -110.47 137.7 47.82 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 50.5 m -116.64 108.7 16.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 119.872 -1.768 . . . . 0.0 109.977 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.1 136.22 13.24 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.547 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 14.6 t -118.56 -163.41 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 108.8 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.892 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.29 -55.55 3.38 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.57 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 126.99 -123.78 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.758 -1.21 . . . . 0.0 111.934 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 10.7 m -48.38 -65.39 0.57 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.817 -0.814 . . . . 0.0 112.458 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -46.52 -34.27 4.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.931 -1.106 . . . . 0.0 109.402 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.892 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 29.6 mmt180 -80.12 -49.74 11.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.876 0.846 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.681 HG21 ' CE2' ' A' ' 185' ' ' TYR . 92.9 t -68.31 -54.82 19.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.867 -0.521 . . . . 0.0 111.19 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -56.68 -34.11 67.06 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.958 -1.089 . . . . 0.0 108.741 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -77.24 -47.85 19.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.48 78.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 109.927 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.607 ' CD1' HG12 ' A' ' 143' ' ' VAL . 66.0 mt -57.13 -49.0 77.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 109.607 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.566 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 58.3 mtmt -87.39 -33.69 19.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 111.116 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 69.6 mt-10 -72.23 -63.94 1.04 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.432 -1.417 . . . . 0.0 112.182 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 10.6 m120 -82.89 -37.22 24.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.433 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 22.4 m-85 -100.76 1.53 40.42 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.752 -1.217 . . . . 0.0 110.471 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.773 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 42.94 41.41 4.57 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.344 -0.848 . . . . 0.0 112.445 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.4 m-85 -61.99 164.75 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.162 -1.787 . . . . 0.0 107.598 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.0 t-20 -47.23 144.7 2.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.683 -1.261 . . . . 0.0 109.014 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -53.02 -19.75 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.004 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.1 p -54.85 -15.17 1.75 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.301 -0.874 . . . . 0.0 110.08 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 147' ' ' LEU . 5.5 t -65.02 121.36 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.46 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.949 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.9 p-80 -147.86 159.9 43.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.748 . . . . 0.0 109.164 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.3 tt0 -101.81 155.73 17.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 109.925 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.1 pt -135.43 143.23 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.2 m-80 -107.91 104.63 14.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.886 -1.134 . . . . 0.0 111.027 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 10.0 tpt180 -47.52 -37.15 11.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 108.857 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -64.44 -20.48 65.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 161' ' ' ASN . 6.4 m-20 -103.63 -4.09 24.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -1.231 . . . . 0.0 110.89 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -118.03 168.18 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.239 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 167' ' ' LYS . 43.4 p -97.19 136.49 37.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 166' ' ' SER . 2.1 tttt -32.69 -45.63 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.152 0.501 . . . . 0.0 110.642 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -64.47 -63.89 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.087 -1.008 . . . . 0.0 109.832 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -63.4 -14.37 49.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.29 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 65.2 t-105 -75.95 -47.67 24.19 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.683 ' HA ' HD12 ' A' ' 174' ' ' ILE . 76.9 mt-10 -70.93 -30.73 67.13 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.53 -44.27 76.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.853 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -61.25 -40.2 93.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.296 -0.877 . . . . 0.0 108.731 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 184' ' ' VAL . 21.2 mt -73.35 -57.9 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.441 -0.787 . . . . 0.0 110.447 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.43 -43.5 44.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.004 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -51.65 -44.19 62.91 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.579 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.3 mm-40 -60.98 -49.0 79.22 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.727 ' HB3' HG11 ' A' ' 4' ' ' VAL . 30.1 mt -67.4 -28.48 67.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.677 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 175' ' ' ASP . 9.9 p -51.33 -42.59 61.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 108.573 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.8 mt-30 -97.37 32.67 2.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.536 ' C ' HD13 ' A' ' 7' ' ' LEU . 81.5 m-20 48.71 49.96 18.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.3 mt-30 -123.88 116.29 27.63 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.5 Cg_endo -66.35 169.76 13.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.143 1.896 . . . . 0.0 112.461 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 174' ' ' ILE . 57.5 t -126.53 130.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.479 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.817 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -79.39 120.18 23.46 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 176.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 7.1 t80 -123.1 159.33 28.74 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.995 -1.066 . . . . 0.0 109.766 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -166.78 125.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.776 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' HA2' ' OE1' ' A' ' 245' ' ' GLN . . . -93.85 104.43 3.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 190' ' ' GLY . 46.6 t -68.32 164.07 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 110.925 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.575 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -165.12 -141.46 3.14 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.526 -1.829 . . . . 0.0 108.526 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -87.59 -30.9 20.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.076 -1.249 . . . . 0.0 110.237 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.47 -22.49 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.022 -1.049 . . . . 0.0 110.495 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.11 -169.48 24.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.583 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.91 102.34 1.9 Allowed Glycine 0 N--CA 1.482 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 111.138 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.0 t-80 -71.29 128.14 34.9 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.82 161.79 19.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.295 -1.362 . . . . 0.0 113.195 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 13.6 p90 -159.29 167.8 28.03 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.751 HG22 HD11 ' A' ' 55' ' ' ILE . 83.5 t -114.69 136.92 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.756 -1.215 . . . . 0.0 112.236 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.931 HD13 HG21 ' A' ' 174' ' ' ILE . 70.7 mt -99.63 125.04 53.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 20.1 p-10 -135.05 30.0 3.36 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.458 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -176.52 165.82 36.36 Favored Glycine 0 N--CA 1.483 1.79 0 C-N-CA 117.369 -2.348 . . . . 0.0 112.226 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 207' ' ' PHE . . . -148.86 146.6 28.02 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.98 2.61 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 110.071 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 86.07 -35.84 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.098 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER -88.46 32.04 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -1.23 . . . . 0.0 110.192 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.1 OUTLIER 76.28 27.44 0.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 7.2 m-85 -118.88 133.27 55.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.186 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 221' ' ' PHE . 48.0 m-85 -122.96 165.24 17.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.375 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 6' ' ' SER . 29.1 t-80 -92.89 145.53 24.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 97.6 t -135.05 137.83 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.917 -1.114 . . . . 0.0 111.558 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.4 t-20 -111.22 68.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 98.2 m95 -46.93 164.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.808 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.38 -2.52 49.36 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.446 ' O ' ' OD2' ' A' ' 219' ' ' ASP . 66.7 m95 -107.38 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -1.129 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -118.92 3.48 14.53 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.24 1.91 4.99 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.785 HG13 ' N ' ' A' ' 218' ' ' SER . 1.7 p -91.6 -152.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.785 ' N ' HG13 ' A' ' 217' ' ' VAL . 57.7 m -66.93 55.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.97 -1.082 . . . . 0.0 110.711 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.5 OUTLIER -80.07 116.64 20.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.89 -1.131 . . . . 0.0 108.987 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 209' ' ' HIS . . . 162.5 -80.36 0.14 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.608 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 29.9 m-85 -135.11 175.42 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.261 . . . . 0.0 110.821 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.92 160.62 17.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.698 . . . . 0.0 110.539 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 167.02 11.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.664 -0.648 . . . . 0.0 109.345 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 224' ' ' LEU . 0.5 OUTLIER -121.55 20.31 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.4 OUTLIER -107.02 -80.52 0.56 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.996 -1.065 . . . . 0.0 110.157 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.492 ' HB1' HD13 ' A' ' 227' ' ' LEU . . . -123.2 -110.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 0.0 109.501 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.918 ' N ' HD13 ' A' ' 227' ' ' LEU . 0.0 OUTLIER -96.85 -91.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.716 -1.24 . . . . 0.0 108.786 178.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 212' ' ' TRP . 1.4 m-20 -100.13 158.53 31.85 Favored Pre-proline 0 C--N 1.288 -2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.603 ' HD3' ' CZ2' ' A' ' 212' ' ' TRP . 35.8 Cg_endo -77.52 -81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.648 2.232 . . . . 0.0 110.481 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.4 m -118.88 60.25 0.81 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.361 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.586 ' HB1' ' ND1' ' A' ' 195' ' ' HIS . . . -70.22 -36.41 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 238' ' ' ALA . 1.1 mp -104.28 -9.42 18.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.44 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 66.29 -168.21 34.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.49 33.3 3.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -1.148 . . . . 0.0 109.454 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -97.3 -174.67 34.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -64.37 127.49 34.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 140.24 -173.03 23.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 232' ' ' LEU . . . -63.8 173.42 1.78 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -152.87 74.58 0.25 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 96.17 14.85 43.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -67.93 128.91 38.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -1.158 . . . . 0.0 109.433 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -130.84 93.64 3.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.548 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -108.7 -40.84 1.53 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.542 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 58.6 m-85 -135.45 77.35 1.67 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -1.143 . . . . 0.0 109.717 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.493 ' OE1' ' HA2' ' A' ' 188' ' ' GLY . 25.1 tt0 -92.14 140.05 30.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.996 -1.065 . . . . 0.0 109.327 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.506 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 2.5 p -155.41 169.38 24.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.427 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.19 162.55 35.22 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.774 0.797 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 185' ' ' TYR . 18.3 t -116.51 124.06 72.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.949 HG23 ' CE1' ' A' ' 158' ' ' HIS . 9.2 m -123.2 139.96 48.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.85 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.45 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 92.98 51.39 2.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 37.2 mt -98.41 91.09 2.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.319 -1.107 . . . . 0.0 109.567 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.4 148.31 9.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 109.095 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.58 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.264 1.976 . . . . 0.0 110.465 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.505 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 39.5 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.7 Cg_endo -78.65 148.98 23.33 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.465 2.11 . . . . 0.0 110.144 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 ' C ' ' A' ' 203' ' ' ASP . 23.6 t -90.08 143.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.671 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.0 t -137.72 132.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 108.963 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 200' ' ' ASP . 59.8 mmtt -75.51 -177.14 3.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.071 -1.018 . . . . 0.0 108.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 4.5 t -77.53 104.25 7.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.699 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.8 mt -56.99 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.028 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.2 mt -54.47 -43.79 72.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 108.595 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -67.55 -37.03 82.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -15.67 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 108.856 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 13' ' ' ILE . 11.8 mtpp -121.12 22.17 11.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.2 38.59 6.5 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 11' ' ' LYS . 32.3 mt -90.86 109.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.332 -1.099 . . . . 0.0 110.138 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 79.6 m80 -134.08 85.85 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.63 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.0 m-30 -93.59 174.21 7.3 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.252 1.025 . . . . 0.0 111.614 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 25.5 t30 -148.38 -172.42 4.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.592 ' NE2' ' O ' ' A' ' 213' ' ' GLY . 3.1 mt-30 -125.4 -0.98 7.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.867 -1.146 . . . . 0.0 110.238 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.51 -56.31 0.35 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.252 -1.452 . . . . 0.0 112.145 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.763 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 10.0 t-20 -46.07 -126.07 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.966 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.763 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 41.0 Cg_endo -79.11 6.69 4.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 CA-C-N 123.56 2.307 . . . . 0.0 109.713 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 16' ' ' ASN . 57.8 m-85 -78.18 -35.3 48.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.641 -0.662 . . . . 0.0 109.535 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 47.8 p30 -96.78 20.29 11.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.831 -1.168 . . . . 0.0 109.098 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.39 1.74 11.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 110.106 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 118' ' ' GLU . 16.6 mt -134.68 0.9 3.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.829 -1.17 . . . . 0.0 110.265 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 29.6 p -66.72 164.4 33.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.711 ' HG3' HD21 ' A' ' 86' ' ' LEU . 18.6 Cg_endo -71.8 131.08 17.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.701 1.601 . . . . 0.0 110.297 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.44 145.63 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.77 0.795 . . . . 0.0 110.429 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 132' ' ' GLY . 10.3 mt -77.65 148.92 6.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.624 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.24 -22.28 4.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.104 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' TYR . 17.4 mtpp -119.39 172.85 7.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 37' ' ' SER . 88.2 t -114.17 148.91 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.376 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.6 tttt -89.29 130.81 42.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -69.89 128.79 16.41 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.29 1.327 . . . . 0.0 109.982 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.52 5.8 39.11 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.4 tt0 -148.18 171.83 15.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -1.105 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -68.22 -173.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.3 t -87.46 139.88 30.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.813 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 13.2 m-85 -116.3 9.81 14.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.796 -1.19 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 29' ' ' GLU . 34.1 t -60.72 117.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.728 -1.232 . . . . 0.0 108.521 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.38 -11.23 50.93 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.42 ' CD ' ' HA ' ' A' ' 38' ' ' PHE . 73.2 mt-30 -76.18 133.25 40.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.447 -1.031 . . . . 0.0 109.168 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.83 114.7 11.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -53.24 145.81 13.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -69.97 167.35 17.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.871 -1.143 . . . . 0.0 109.697 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.476 ' O ' ' HE3' ' A' ' 129' ' ' MET . 23.4 p -82.14 -33.03 29.79 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 108.511 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.71 138.62 9.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 p -55.17 -51.45 66.48 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.236 -1.155 . . . . 0.0 107.94 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 HG21 ' A' ' 127' ' ' VAL . 23.4 t -45.11 -53.99 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.13 -55.76 30.87 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.44 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 59.3 m -63.47 -28.43 69.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.572 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -66.5 -47.99 71.25 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.219 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 123' ' ' VAL . 85.8 m -75.38 -48.97 20.51 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.842 0.83 . . . . 0.0 109.864 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.83 -33.76 37.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.426 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.63 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.9 mt-30 -68.34 -50.1 55.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.004 HG21 HD13 ' A' ' 251' ' ' ILE . 40.2 mt -62.95 -23.37 33.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.502 ' HG3' HG22 ' A' ' 52' ' ' THR . 20.0 mtp -73.55 -40.89 63.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 43.6 tptt -65.91 -44.48 85.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.699 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 34.8 t80 -53.39 -28.4 29.22 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 41.0 m-70 -107.65 -25.26 11.4 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.094 -1.004 . . . . 0.0 110.866 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 94.9 m-20 43.76 59.69 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.7 t80 -83.09 -78.76 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.37 108.68 2.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 CA-C-N 119.6 0.893 . . . . 0.0 112.996 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.9 -26.22 66.77 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 2.7 ttpt -130.52 130.76 44.55 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.96 164.97 5.68 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 118.487 -1.816 . . . . 0.0 110.682 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.13 -35.84 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.986 . . . . 0.0 111.188 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 8.6 tttm -152.42 131.71 12.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.73 -1.231 . . . . 0.0 110.489 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 36.5 m-20 -60.23 170.68 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.368 -0.832 . . . . 0.0 108.962 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.505 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 43.4 t80 -145.8 142.1 28.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.2 t -142.9 152.34 41.97 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.208 -0.932 . . . . 0.0 109.419 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 28.7 p90 -160.05 158.09 29.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -92.6 126.3 37.63 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.707 HD21 ' ND2' ' A' ' 77' ' ' ASN . 12.1 tp -43.99 147.53 0.49 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.664 0.745 . . . . 0.0 110.509 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 142.79 54.93 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.527 0.68 . . . . 0.0 110.632 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.7 t -69.49 -2.97 12.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.732 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 8.2 m120 -97.57 -2.17 42.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.222 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.707 ' ND2' HD21 ' A' ' 73' ' ' LEU . 18.9 t-20 -70.04 109.6 5.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.9 Cg_endo -90.57 19.63 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.95 2.433 . . . . 0.0 108.827 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.655 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 44.7 m-85 -117.66 -25.83 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.835 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' ASN . 88.4 m-85 -117.35 170.76 8.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.676 -1.265 . . . . 0.0 108.102 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 m120 -53.96 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.47 -49.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.289 -0.882 . . . . 0.0 111.426 174.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 32.0 Cg_endo -75.92 58.51 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.328 -1.836 . . . . 0.0 107.328 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 86' ' ' LEU . 18.7 tptt -105.52 121.88 44.87 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.663 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -102.45 116.65 33.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 0.0 110.225 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 26' ' ' PRO . 3.4 mp -96.17 134.01 39.77 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 26.0 t80 -132.36 131.38 41.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.776 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -111.77 118.21 34.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.7 53.01 0.42 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.724 -1.235 . . . . 0.0 108.273 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 mt -52.88 -58.1 3.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 0.0 111.23 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.3 p -44.52 -27.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.874 -1.141 . . . . 0.0 108.84 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -112.56 30.48 7.08 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 31.0 mmt-85 -81.17 157.36 25.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.514 -1.366 . . . . 0.0 109.542 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -116.32 81.47 1.62 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 12.1 m-85 -80.96 88.3 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.485 -0.759 . . . . 0.0 110.082 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.2 t-20 -79.17 91.84 5.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.644 ' CE3' HD12 ' A' ' 100' ' ' ILE . 60.0 m95 -60.59 -7.75 2.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.823 . . . . 0.0 110.381 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 9.1 m-20 -89.37 -18.83 26.08 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 24.3 m-20 -100.35 -31.2 11.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.777 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.1 mt -74.03 65.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.532 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 47.9 mt -45.65 149.16 1.13 Allowed Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.553 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.6 Cg_endo -77.23 -20.27 12.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.013 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 103' ' ' THR . 2.7 t -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.945 -1.097 . . . . 0.0 109.414 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 96.8 m-85 -109.26 144.01 37.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.971 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -99.16 -3.4 34.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.617 ' HA3' ' ND2' ' A' ' 19' ' ' ASN . . . 81.84 3.65 90.53 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -119.22 6.69 11.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.44 -1.035 . . . . 0.0 108.836 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -174.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 p -72.27 173.57 8.47 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.229 -0.92 . . . . 0.0 108.778 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.0 m120 -78.74 -34.57 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.136 -0.977 . . . . 0.0 109.446 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.24 -61.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.818 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -62.2 -34.21 76.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.996 -1.065 . . . . 0.0 109.038 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 73.6 mttt -66.1 -44.27 84.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.416 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 40.2 ttm -59.53 -34.93 73.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.73 -67.89 0.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.83 -0.544 . . . . 0.0 110.752 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.83 HD11 ' HE2' ' A' ' 120' ' ' MET . 4.0 tp -59.43 -42.35 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.7 p -53.47 -41.71 66.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.92 -1.112 . . . . 0.0 109.908 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.761 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.5 tt0 -69.31 -45.36 69.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.712 HD23 ' CD1' ' A' ' 116' ' ' ILE . 4.6 tp -55.42 -50.03 70.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.83 ' HE2' HD11 ' A' ' 116' ' ' ILE . 22.7 mmt -58.26 -46.12 86.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.42 -38.46 89.97 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.692 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 20.8 m-20 -64.77 -55.68 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 127' ' ' VAL . 51.4 t -61.8 -51.36 73.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -50.86 -49.15 42.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 126' ' ' SER . 2.2 mt -64.95 -60.42 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -1.103 . . . . 0.0 108.489 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.556 ' N ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -45.98 -30.5 1.83 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.494 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 123' ' ' VAL . 32.9 m -101.26 38.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.152 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.6 m-20 35.82 54.06 0.89 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.577 0.703 . . . . 0.0 109.619 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.569 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 40.1 tpp -66.3 130.56 43.62 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 112.144 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' SER . 7.4 t0 -75.87 119.8 20.34 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.537 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 29.5 m-85 -102.34 108.82 20.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -174.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -149.76 -169.35 15.97 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 103.956 -3.658 . . . . 0.0 103.956 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.813 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 14.2 Cg_endo -62.5 -21.28 72.6 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 N-CA-C 106.887 -2.005 . . . . 0.0 106.887 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.42 131.04 55.4 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.739 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 68.0 m -117.3 105.48 12.23 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 119.96 -1.713 . . . . 0.0 110.127 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -109.01 134.41 12.23 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.89 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.593 ' OG ' ' NE ' ' A' ' 142' ' ' ARG . 24.9 t -117.42 -160.86 0.79 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -1.214 . . . . 0.0 108.221 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HB3' HH11 ' A' ' 142' ' ' ARG . . . -90.7 -49.82 6.26 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.747 ' H ' ' CZ ' ' A' ' 142' ' ' ARG . . . 122.87 -111.72 1.79 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.466 ' HB3' ' CD ' ' A' ' 159' ' ' GLN . 0.4 OUTLIER -59.1 -54.14 50.35 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 119.22 -2.341 . . . . 0.0 114.759 -175.177 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 p -47.12 -32.24 4.08 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.674 -1.266 . . . . 0.0 114.091 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.847 HH22 HG23 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -92.93 -36.28 12.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.977 -1.702 . . . . 0.0 110.58 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.0 t -65.32 -42.69 94.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 109.534 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.448 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 3.6 pp0? -69.27 -37.18 77.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 13.4 ttp180 -75.31 -51.6 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 109.689 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.69 91.39 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 110.322 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB2' HG11 ' A' ' 157' ' ' VAL . 27.6 mt -56.68 -45.05 81.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.941 -1.1 . . . . 0.0 109.203 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.572 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 32.5 mtmt -87.97 -39.0 15.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.993 -1.067 . . . . 0.0 110.791 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 71.5 mt-10 -71.61 -60.69 2.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.723 -1.235 . . . . 0.0 112.535 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.7 m120 -82.28 -44.92 15.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.73 -1.231 . . . . 0.0 111.937 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.42 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 36.4 m-85 -90.84 -14.13 32.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.656 -1.278 . . . . 0.0 110.553 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.63 33.25 83.88 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.208 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.58 ' CE2' HG22 ' A' ' 251' ' ' ILE . 10.1 m-85 -63.61 156.71 25.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.22 -1.753 . . . . 0.0 108.014 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.21 153.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.948 -1.095 . . . . 0.0 109.718 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -55.41 -16.77 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.607 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 0.7 OUTLIER -52.99 -17.56 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.185 -0.947 . . . . 0.0 109.617 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.629 HG11 ' HB2' ' A' ' 147' ' ' LEU . 21.8 t -70.66 121.42 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.911 -1.118 . . . . 0.0 109.405 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.701 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -148.11 170.42 17.85 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.069 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.466 ' CD ' ' HB3' ' A' ' 140' ' ' SER . 26.7 tt0 -111.24 147.29 35.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.694 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 246' ' ' SER . 10.2 pt -141.51 141.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.5 m-80 -104.81 107.86 19.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.059 -1.025 . . . . 0.0 110.377 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.714 ' HB2' ' HH ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -48.4 -28.94 3.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.057 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.04 -13.53 79.26 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 161' ' ' ASN . 0.7 OUTLIER -103.65 -4.63 23.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -1.134 . . . . 0.0 110.192 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -118.66 179.76 4.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.915 -1.116 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.47 ' OG ' ' OD2' ' A' ' 169' ' ' ASP . 1.8 p -107.18 141.88 37.76 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 41.2 tttp -35.39 -49.3 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.702 -0.623 . . . . 0.0 110.818 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -64.18 -57.76 8.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.946 -1.097 . . . . 0.0 110.18 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.47 ' OD2' ' OG ' ' A' ' 166' ' ' SER . 59.1 m-20 -64.03 -19.69 65.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.02 . . . . 0.0 109.463 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 63.9 t-105 -73.18 -43.11 61.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 208' ' ' TYR . 30.1 mt-10 -64.33 -33.68 76.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 108.706 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.76 81.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.426 -0.796 . . . . 0.0 109.392 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -61.03 -47.13 87.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.166 -0.959 . . . . 0.0 109.162 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 16.8 mt -76.06 -50.67 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.099 -1.0 . . . . 0.0 110.706 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -55.28 -53.36 57.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.129 -0.982 . . . . 0.0 108.984 -178.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -51.45 -40.29 59.14 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.9 mm-40 -61.15 -52.7 63.76 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.808 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.75 -24.31 64.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 175' ' ' ASP . 33.5 p -52.74 -38.82 61.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 181' ' ' ASN . 28.5 mt-30 -101.33 38.09 1.65 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.497 ' C ' HD13 ' A' ' 7' ' ' LEU . 16.3 m-20 42.61 50.73 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.745 0.784 . . . . 0.0 108.938 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 7.5 mt-30 -123.51 106.43 32.59 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.418 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.9 Cg_endo -63.22 169.36 9.46 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.237 1.958 . . . . 0.0 113.086 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 40.8 t -122.8 135.15 63.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.273 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.73 114.35 23.34 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.785 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 4.2 t80 -121.36 162.52 20.2 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.2 pt20 -167.35 132.95 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.952 -1.499 . . . . 0.0 111.624 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.42 110.75 4.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.642 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 94.2 t -78.2 162.59 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.334 . . . . 0.0 111.496 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -164.68 -139.77 2.72 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 2.6 mtmp? -87.86 -38.4 15.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -1.23 . . . . 0.0 110.985 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 m -76.66 -12.18 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.988 -1.07 . . . . 0.0 111.076 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.59 -172.57 21.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.14 107.95 3.22 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.516 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 8.7 t-80 -72.76 125.12 26.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.58 164.38 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.123 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.864 ' CD1' HG13 ' A' ' 210' ' ' VAL . 37.7 p90 -156.59 -158.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.692 HG22 HD11 ' A' ' 55' ' ' ILE . 70.5 t -139.39 136.53 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.496 -1.377 . . . . 0.0 111.204 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.723 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.3 mt -102.94 112.51 36.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.615 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 23.4 p-10 -124.5 35.06 4.88 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.335 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.1 167.04 39.36 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 117.837 -2.125 . . . . 0.0 112.272 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -148.43 148.22 30.06 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.566 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.38 22.53 12.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 109.686 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.61 21.89 3.62 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.5 mtp180 -138.66 29.74 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -1.188 . . . . 0.0 109.108 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.472 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . 11.7 m120 74.36 11.62 4.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 109.503 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.73 138.06 51.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.581 ' CD1' HD23 ' A' ' 224' ' ' LEU . 5.8 m-85 -123.07 168.13 12.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.054 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 51.2 t-80 -93.33 115.76 28.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.864 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.9 t -113.67 138.15 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.98 -1.075 . . . . 0.0 111.457 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.54 ' HB2' HD12 ' A' ' 8' ' ' LEU . 14.9 t-20 -100.28 80.92 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.557 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 3.4 m95 -46.68 167.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.592 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -87.22 30.89 4.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.411 ' CZ2' ' O ' ' A' ' 231' ' ' ALA . 70.3 m95 -119.39 -170.8 2.0 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -1.199 . . . . 0.0 109.483 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.55 -99.12 0.22 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 219' ' ' ASP . . . -126.59 52.6 0.81 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 218' ' ' SER . 7.1 p -91.78 -119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -1.159 . . . . 0.0 109.317 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.655 ' H ' HG22 ' A' ' 217' ' ' VAL . 3.5 m -75.46 2.06 12.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.482 -1.386 . . . . 0.0 110.16 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 216' ' ' GLY . 28.9 p-10 -54.24 150.29 8.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 130.82 -143.83 15.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 8.5 p90 -68.84 124.17 22.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 -164.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 109.659 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.75 176.98 4.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.581 HD23 ' CD1' ' A' ' 208' ' ' TYR . 0.5 OUTLIER -121.17 18.2 11.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.12 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -107.71 -43.52 4.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 109.747 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.38 93.38 3.93 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.143 0.973 . . . . 0.0 108.664 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 227' ' ' LEU . 3.9 mm? -91.0 85.54 5.98 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.673 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.437 ' OD1' ' HA2' ' A' ' 240' ' ' GLY . 6.9 m-20 -116.26 154.91 48.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.243 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.2 152.58 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.609 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.26 -45.57 2.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.321 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' HB2' HG11 ' A' ' 217' ' ' VAL . . . -81.89 104.55 12.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.382 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.94 -52.89 4.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.497 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 47.49 -102.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.09 168.59 19.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -1.165 . . . . 0.0 109.506 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -93.19 59.75 2.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -105.72 -75.99 1.02 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.38 58.59 4.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -87.43 -172.53 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -1.178 . . . . 0.0 109.574 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.71 104.94 1.76 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.437 ' HA2' ' OD1' ' A' ' 228' ' ' ASN . . . -104.77 42.78 1.81 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.556 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -122.92 -177.77 3.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 109.442 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 4.5 t30 -135.67 80.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.67 -58.52 4.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.556 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 29.4 m-85 -129.55 96.23 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.495 ' NE2' ' CG ' ' A' ' 162' ' ' ARG . 3.2 pt20 -91.79 138.34 31.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.981 -1.075 . . . . 0.0 108.981 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 96.9 p -167.45 161.93 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.785 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -138.92 169.07 18.46 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.694 1.235 . . . . 0.0 110.4 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.688 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 40.6 t -117.12 119.2 61.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.701 HG23 ' NE2' ' A' ' 158' ' ' HIS . 19.7 m -125.24 145.16 33.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 156' ' ' SER . . . 101.11 52.42 1.08 Allowed Glycine 0 N--CA 1.486 1.997 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.051 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 55' ' ' ILE . 2.4 mt -103.94 93.63 2.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.273 . . . . 0.0 110.421 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.2 OUTLIER -162.41 141.99 7.25 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 178.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.354 2.036 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.502 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 43.7 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.502 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 36.1 Cg_endo -78.59 163.4 26.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.443 2.095 . . . . 0.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG22 ' C ' ' A' ' 203' ' ' ASP . 29.3 t -94.63 141.91 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.587 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.696 HG12 ' HA2' ' A' ' 201' ' ' GLY . 58.7 t -132.84 131.67 59.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.436 -0.79 . . . . 0.0 109.905 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 200' ' ' ASP . 18.4 mmtt -75.37 177.84 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 108.945 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.1 OUTLIER -77.49 103.04 7.19 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.607 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.691 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 23.8 mt -58.27 -52.97 63.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 108.89 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.625 HD11 HG11 ' A' ' 198' ' ' VAL . 11.3 mt -54.96 -41.3 70.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.698 -1.251 . . . . 0.0 108.893 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.5 t70 -68.92 -41.8 77.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.063 . . . . 0.0 108.903 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 p -58.48 -15.03 9.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 108.992 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 58' ' ' TYR . 9.4 mtpp -117.08 22.0 12.84 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.39 34.01 3.3 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 25.4 mt -87.35 108.3 18.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.379 -1.071 . . . . 0.0 110.06 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' PRO . 23.0 m-70 -134.82 83.62 2.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.636 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -90.4 176.17 6.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.84 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -147.22 -164.66 2.05 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.637 ' NE2' ' O ' ' A' ' 213' ' ' GLY . 13.0 mt-30 -124.52 -17.7 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.337 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.734 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.31 -36.98 1.05 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.632 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.7 t-20 -45.02 -142.02 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.55 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.341 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.82 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -74.13 3.72 4.9 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 CA-C-N 122.394 1.891 . . . . 0.0 109.417 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 11.1 m-85 -78.86 -32.26 45.95 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.1 p-10 -92.79 23.63 4.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.595 -1.316 . . . . 0.0 109.635 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.6 mt -77.05 -1.33 28.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.169 -0.957 . . . . 0.0 110.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 24' ' ' LEU . 10.8 mt -134.14 14.09 3.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.717 -1.239 . . . . 0.0 109.359 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 22.3 p -82.68 163.88 49.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.65 134.63 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.002 1.801 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' CE2' ' A' ' 80' ' ' PHE . 20.7 t -78.89 149.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.502 0.668 . . . . 0.0 109.738 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.829 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.1 mt -78.3 148.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.804 0.811 . . . . 0.0 111.169 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' C ' HG22 ' A' ' 39' ' ' VAL . 9.0 mm-40 -126.04 -21.2 4.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.782 -0.574 . . . . 0.0 110.235 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.0 mtpt -121.28 164.51 16.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.148 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 32' ' ' LYS . 80.9 t -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.627 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -78.94 160.29 71.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.2 Cg_endo -82.13 114.3 2.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.583 2.189 . . . . 0.0 110.253 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.81 7.54 66.24 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -119.73 160.75 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -1.163 . . . . 0.0 109.425 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.41 ' O ' HG13 ' A' ' 31' ' ' VAL . 3.1 mt-30 -60.98 173.09 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -83.16 132.18 35.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.457 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 64.7 m-85 -119.94 15.52 12.52 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.922 -1.111 . . . . 0.0 109.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 28' ' ' ILE . 62.3 t -63.83 137.44 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.599 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.19 -7.36 67.72 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.7 mt-30 -77.72 130.84 37.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -1.113 . . . . 0.0 109.651 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -73.15 110.0 7.1 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.15 159.9 0.85 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.141 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.61 168.3 19.97 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.599 0.714 . . . . 0.0 110.043 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.63 HG21 ' SD ' ' A' ' 120' ' ' MET . 18.0 p -78.85 -35.19 44.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 109.69 134.51 6.94 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 p -54.02 -50.49 66.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 47.0 t -47.05 -55.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.68 -48.15 82.81 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.911 0.862 . . . . 0.0 110.351 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.1 m -61.28 -38.92 88.51 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.49 -37.36 80.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.642 -1.286 . . . . 0.0 108.334 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 56' ' ' MET . 97.6 m -70.44 -56.68 6.04 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.36 -34.98 50.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.52 -0.737 . . . . 0.0 109.199 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.636 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 24.9 mt-30 -63.49 -61.95 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 251' ' ' ILE . 46.4 mt -57.23 -30.19 34.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 52' ' ' THR . 25.8 mtp -63.36 -32.41 73.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.558 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 49.2 tptt -74.65 -43.38 55.62 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 39.2 t80 -51.8 -33.12 34.2 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.69 -0.631 . . . . 0.0 109.789 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.53 ' O ' ' C ' ' A' ' 60' ' ' ASN . 43.1 m80 -108.71 -22.18 12.35 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 111.05 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.626 ' HB2' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 41.08 55.25 3.22 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -177.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -76.39 -68.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -68.2 96.82 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.31 0.673 . . . . 0.0 111.962 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.06 -20.23 64.94 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -135.44 138.05 42.82 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 177.444 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.71 149.16 33.74 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.365 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.915 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -88.96 -54.35 4.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.951 . . . . 0.0 110.326 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.9 tttt -140.71 134.52 30.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.088 -1.008 . . . . 0.0 110.245 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -62.2 166.25 5.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.518 -0.738 . . . . 0.0 109.942 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 36.2 t80 -150.04 143.81 25.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.202 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.14 171.63 16.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.16 -0.963 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.3 p90 -173.06 158.57 3.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 109.92 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 89.0 m -93.66 137.89 32.46 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.721 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.3 tp -53.26 149.74 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.035 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 141.32 57.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.767 -0.583 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -69.08 -3.01 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t30 -99.53 -6.01 28.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.467 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.721 ' ND2' HD21 ' A' ' 73' ' ' LEU . 22.0 t-20 -70.12 110.87 7.54 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.867 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.636 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.4 Cg_endo -87.46 10.86 3.37 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.973 2.449 . . . . 0.0 110.216 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 56.6 m-85 -108.8 -1.71 19.06 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 111.415 -176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASN . 74.7 m-85 -141.57 160.93 39.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 9.4 m120 -48.37 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 174.42 -46.32 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.385 -0.822 . . . . 0.0 111.284 174.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.41 55.81 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 107.549 -1.75 . . . . 0.0 107.549 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.3 tptt -105.8 103.69 13.25 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 133.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 109.558 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.2 mp -106.31 154.19 21.12 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 7.0 t80 -144.41 139.43 28.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.101 -178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -118.53 111.02 18.07 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.62 50.68 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.694 -1.254 . . . . 0.0 108.19 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 4.3 mt -52.81 -51.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.401 -0.812 . . . . 0.0 109.516 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.6 p -44.21 -29.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.674 -1.266 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -112.88 33.73 4.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 108.774 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.48 153.3 23.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.993 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -122.49 85.58 2.44 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-85 -80.9 95.47 6.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.272 -0.892 . . . . 0.0 109.896 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.1 m120 -78.69 92.11 4.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.626 ' CG ' ' HB2' ' A' ' 60' ' ' ASN . 50.2 m95 -60.95 -8.81 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.354 -0.841 . . . . 0.0 109.932 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -90.48 -23.51 20.95 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 8.3 m-20 -97.99 -26.62 14.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.558 ' O ' ' CE ' ' A' ' 57' ' ' LYS . 51.7 mt -74.05 64.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 59.4 mt -46.28 150.7 1.07 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.639 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -79.01 -27.12 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.496 2.131 . . . . 0.0 110.364 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.525 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -139.31 133.05 30.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.98 . . . . 0.0 109.132 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 76.9 m-85 -115.97 142.82 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.155 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.82 -4.39 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.96 10.11 84.43 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -119.93 -6.14 10.05 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.465 -1.02 . . . . 0.0 109.424 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.79 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -63.97 169.54 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -71.07 -176.82 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.693 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 2.8 m120 -80.55 -33.84 35.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.78 -61.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HG3' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -62.52 -35.03 78.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.151 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.494 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 19.0 mttt -64.45 -43.25 94.85 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.058 -1.026 . . . . 0.0 108.308 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.435 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -59.91 -37.95 80.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 108.709 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -56.99 -68.26 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.501 -0.749 . . . . 0.0 109.762 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.647 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.2 tp -64.17 -43.72 97.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.559 -0.713 . . . . 0.0 109.679 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 116' ' ' ILE . 24.1 p -56.63 -40.31 75.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 108.588 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.493 ' OE2' ' CZ ' ' A' ' 93' ' ' ARG . 6.3 tt0 -70.65 -40.79 72.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.2 tp -55.48 -50.54 69.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.2 mmt -60.01 -52.11 66.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.898 -0.501 . . . . 0.0 111.531 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.65 95.33 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 118' ' ' GLU . 6.8 m-20 -65.62 -49.43 68.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 119' ' ' LEU . 48.5 t -61.1 -60.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 108.953 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.6 -44.37 16.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.44 -53.39 32.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.023 -1.281 . . . . 0.0 107.676 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 p -47.43 -32.44 5.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.39 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.6 m -101.49 36.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.005 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.776 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 11.1 m-20 40.1 53.27 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.398 -0.814 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 48.6 tpp -67.59 137.68 55.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 111.899 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 5.9 t0 -87.32 123.82 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.633 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 83.8 m-85 -104.7 120.57 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.482 1.134 . . . . 0.0 113.824 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.829 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.95 -162.44 10.82 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 104.69 -3.364 . . . . 0.0 104.69 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.718 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.16 -31.59 82.87 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 N-CA-C 105.648 -2.482 . . . . 0.0 105.648 175.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.9 m -110.23 143.04 40.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 173.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.535 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.8 m -121.33 110.92 16.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 119.87 -1.769 . . . . 0.0 110.087 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.86 137.94 14.32 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.455 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -117.26 -163.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 107.954 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.921 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.92 -56.22 3.26 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.567 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 125.88 -123.53 4.89 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.499 -1.334 . . . . 0.0 112.009 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.2 m -48.55 -65.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.797 -0.825 . . . . 0.0 112.602 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.48 -32.03 3.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.789 -1.194 . . . . 0.0 109.293 -178.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.921 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.2 mmt-85 -80.86 -51.25 8.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.973 0.892 . . . . 0.0 109.212 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 185' ' ' TYR . 82.7 t -66.9 -54.84 21.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.809 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 2.4 pp0? -57.34 -34.35 68.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.955 -1.091 . . . . 0.0 108.749 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.523 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 6.0 ttm180 -78.4 -53.56 7.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.012 -1.055 . . . . 0.0 109.433 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.27 82.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.21 -0.931 . . . . 0.0 110.223 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 38.1 mt -58.47 -46.09 87.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.952 -1.092 . . . . 0.0 109.377 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 59.5 mtmt -87.72 -49.24 7.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.104 . . . . 0.0 110.981 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.523 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 34.2 mt-10 -67.07 -43.01 83.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.679 -1.263 . . . . 0.0 111.566 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 31.9 m120 -94.4 -49.7 5.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.681 -1.262 . . . . 0.0 111.485 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 56' ' ' MET . 29.6 m-85 -99.42 20.33 13.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.874 -1.141 . . . . 0.0 110.598 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.915 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 40.64 0.05 OUTLIER Glycine 0 N--CA 1.497 2.767 0 O-C-N 121.862 -0.524 . . . . 0.0 112.62 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.9 m-85 -62.88 158.84 18.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.142 -1.799 . . . . 0.0 107.564 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 61.7 t30 -47.17 154.35 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.741 -1.224 . . . . 0.0 109.533 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -56.05 -16.52 5.1 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.6 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 3.6 p -53.02 -17.35 1.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 40.5 t -72.67 119.61 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.866 -1.146 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.707 ' NE2' HG23 ' A' ' 249' ' ' VAL . 0.6 OUTLIER -148.19 166.81 26.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.191 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.55 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 25.5 tt0 -112.68 137.03 51.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.953 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 247' ' ' ALA . 14.7 pt -122.62 170.34 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 2.0 m120 -127.53 103.46 7.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.683 -1.261 . . . . 0.0 110.509 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.603 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.44 -39.45 15.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.86 . . . . 0.0 109.226 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.08 -26.91 64.1 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -104.8 4.57 32.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.057 -1.26 . . . . 0.0 112.274 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.47 163.81 15.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.2 -1.562 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.7 ttpt -29.36 -51.49 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.21 -60.67 2.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.895 -1.128 . . . . 0.0 110.775 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.47 -18.24 58.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 109.571 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.3 t-105 -74.73 -50.89 15.8 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 174' ' ' ILE . 46.1 mt-10 -69.99 -36.1 74.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -45.75 -41.65 10.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -60.62 -43.65 97.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 199' ' ' ILE . 14.7 mt -68.6 -53.91 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.27 -49.17 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.138 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -51.52 -45.26 62.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.912 -1.118 . . . . 0.0 108.611 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 19.9 mm-40 -60.53 -52.32 65.68 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.902 . . . . 0.0 108.946 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 199' ' ' ILE . 93.5 mt -65.15 -26.76 68.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.779 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 22.3 p -51.89 -39.99 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.505 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.51 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 19.6 mt-30 -102.32 35.08 2.52 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.513 ' HB3' HD22 ' A' ' 7' ' ' LEU . 83.4 m-20 47.82 50.43 15.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 16.7 mt-30 -123.04 105.04 34.92 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.585 ' HD3' HD13 ' A' ' 7' ' ' LEU . 18.7 Cg_endo -62.62 168.85 9.32 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 121.602 1.535 . . . . 0.0 111.869 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 174' ' ' ILE . 2.4 t -129.84 138.18 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.097 0.951 . . . . 0.0 110.79 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.727 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.1 OUTLIER -86.83 123.34 31.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -123.73 161.45 25.14 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.631 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -166.45 129.54 1.95 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 117.666 -1.614 . . . . 0.0 111.115 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.477 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.19 122.37 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.1 t -85.73 168.84 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.152 -1.205 . . . . 0.0 111.117 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.41 -142.82 4.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 4.8 mtmm -87.73 -36.49 17.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.07 -1.253 . . . . 0.0 110.624 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.4 m -75.03 -17.76 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.153 -0.967 . . . . 0.0 110.928 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.17 -170.17 22.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.564 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -89.85 107.38 3.42 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.753 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.631 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.2 t-80 -72.46 134.92 45.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -121.64 162.71 20.22 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.609 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.899 ' CD1' HG13 ' A' ' 210' ' ' VAL . 18.3 p90 -157.13 172.3 18.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.625 HG11 HD11 ' A' ' 8' ' ' LEU . 87.5 t -113.29 140.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.736 -1.228 . . . . 0.0 112.752 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 178' ' ' LEU . 36.2 mt -98.16 130.44 46.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 7.5 p-10 -150.81 37.45 0.65 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.926 -1.51 . . . . 0.0 111.494 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA2' HG12 ' A' ' 4' ' ' VAL . . . 174.92 -179.46 46.2 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 120.267 -1.52 . . . . 0.0 110.464 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.642 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.4 150.9 7.72 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -1.209 . . . . 0.0 109.661 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.497 ' C ' HG22 ' A' ' 3' ' ' VAL . 13.8 m-20 -111.28 27.52 9.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.07 . . . . 0.0 109.897 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 1' ' ' GLN . . . 49.94 22.34 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.68 44.6 2.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -1.193 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.481 ' O ' ' CE1' ' A' ' 222' ' ' PHE . 0.5 OUTLIER 63.67 22.36 13.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.61 ' HA ' ' CE1' ' A' ' 222' ' ' PHE . 5.2 m-85 -121.59 136.69 54.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 28.2 m-85 -121.29 167.64 12.51 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 2.1 t60 -91.55 135.52 33.8 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.089 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.899 HG13 ' CD1' ' A' ' 197' ' ' PHE . 49.9 t -123.62 136.18 60.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.204 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.62 ' CB ' HD12 ' A' ' 8' ' ' LEU . 19.6 t-20 -112.91 78.87 1.17 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 229' ' ' PRO . 84.5 m95 -46.33 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.637 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -86.08 25.49 6.86 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 230' ' ' SER . 18.0 m95 -108.42 -165.32 1.02 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -1.162 . . . . 0.0 109.779 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -85.32 -81.38 1.1 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.17 45.66 1.12 Allowed Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.091 -1.241 . . . . 0.0 110.027 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.7 HG22 ' H ' ' A' ' 218' ' ' SER . 13.8 p -81.2 -128.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.073 -1.251 . . . . 0.0 109.01 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.7 ' H ' HG22 ' A' ' 217' ' ' VAL . 36.7 m -70.99 56.56 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.27 -1.518 . . . . 0.0 109.977 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 217' ' ' VAL . 6.6 m-20 -94.95 109.35 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 209' ' ' HIS . . . 151.14 -65.81 0.36 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -94.54 149.08 21.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.865 -1.373 . . . . 0.0 110.057 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -99.47 164.68 11.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.183 -0.948 . . . . 0.0 109.678 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.669 ' HD3' ' HB3' ' A' ' 226' ' ' ALA . 0.2 OUTLIER -125.68 151.52 46.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -110.01 -38.54 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.136 -0.978 . . . . 0.0 109.807 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -94.41 -3.1 50.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.669 ' HB3' ' HD3' ' A' ' 223' ' ' ARG . . . -123.34 86.34 2.56 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.035 0.922 . . . . 0.0 109.368 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -89.72 -6.44 56.06 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.351 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -107.55 105.15 55.3 Favored Pre-proline 0 C--N 1.294 -1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 109.15 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.604 ' HG2' ' CE1' ' A' ' 195' ' ' HIS . 36.2 Cg_endo -77.1 -165.46 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.428 2.085 . . . . 0.0 110.442 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.532 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 0.4 OUTLIER -88.42 57.87 4.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' A' ' 195' ' ' HIS . . . -69.42 -44.72 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 109.696 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 231' ' ' ALA . 6.1 mt -45.46 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.24 -146.73 16.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 t -79.75 1.22 27.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.356 -1.085 . . . . 0.0 109.748 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.96 -155.44 32.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.37 -158.04 10.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 152.02 143.55 3.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.44 -18.96 65.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.19 . . . . 0.0 109.282 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 126.96 -161.58 21.2 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -172.0 57.03 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -57.43 -169.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.169 . . . . 0.0 109.364 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.597 ' HB2' HD21 ' A' ' 227' ' ' LEU . 9.5 t30 -101.06 68.35 1.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.9 . . . . 0.0 109.175 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -71.8 -49.63 22.51 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.491 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 16.4 m-85 -136.01 162.79 31.89 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -1.018 . . . . 0.0 108.986 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 -155.07 136.21 13.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.985 . . . . 0.0 108.681 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 77.2 p -148.72 158.72 44.34 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.207 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -131.11 151.11 51.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.886 0.851 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.727 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 75.8 t -116.54 116.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.707 HG23 ' NE2' ' A' ' 158' ' ' HIS . 18.7 m -124.15 143.05 38.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.741 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.81 56.89 1.57 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.67 HD13 HG21 ' A' ' 55' ' ' ILE . 6.0 mt -102.68 79.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 110.565 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 13.8 pttm -159.58 155.96 24.05 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.9 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.274 1.982 . . . . 0.0 110.439 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 206' ' ' ASN . 45.3 tt0 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.21 148.65 21.53 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.453 2.102 . . . . 0.0 110.416 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.529 HG22 ' C ' ' A' ' 203' ' ' ASP . 45.1 t -80.36 140.06 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.97 . . . . 0.0 108.999 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.665 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 29.0 t -133.87 130.84 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 110.757 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -77.03 175.72 9.33 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 11.2 t -77.12 111.28 12.56 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.971 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.652 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 52.5 mt -58.41 -50.77 72.48 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.56 HD11 HG11 ' A' ' 198' ' ' VAL . 10.0 mt -56.3 -34.32 66.38 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.964 -1.085 . . . . 0.0 108.339 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 26.5 t0 -66.87 -41.16 87.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 0.0 109.274 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.8 p -58.1 -16.06 11.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.095 . . . . 0.0 108.593 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HB2' HG13 ' A' ' 13' ' ' ILE . 16.7 mtpt -122.41 19.75 10.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 41.84 42.5 3.88 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.581 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 11.6 mt -86.8 100.69 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.293 -1.122 . . . . 0.0 110.677 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.5 m-70 -128.05 75.32 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 13.5 m-30 -81.18 170.01 16.66 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.283 1.04 . . . . 0.0 111.851 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.77 -174.91 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 47' ' ' SER . 6.3 mt-30 -125.08 18.36 8.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.816 -1.178 . . . . 0.0 110.056 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 22' ' ' ASN . . . -116.74 -87.14 1.28 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.319 -1.419 . . . . 0.0 113.474 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.762 ' OD1' ' HD2' ' A' ' 20' ' ' PRO . 3.8 p30 -46.38 -103.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 116.658 -1.639 . . . . 0.0 113.945 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.762 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 51.9 Cg_endo -83.95 5.58 6.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 123.332 2.226 . . . . 0.0 112.486 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD1' HG12 ' A' ' 116' ' ' ILE . 83.1 m-85 -87.05 -31.97 20.24 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 120.94 -1.1 . . . . 0.0 110.118 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 38.2 p-10 -101.66 27.95 5.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 109.725 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.0 mt -76.03 -4.49 41.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.2 mt -131.19 21.7 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.8 -1.188 . . . . 0.0 109.264 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.3 p -89.68 164.31 29.62 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.97 136.46 35.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.248 1.965 . . . . 0.0 112.048 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.08 148.7 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.663 0.744 . . . . 0.0 110.123 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.814 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.8 mt -78.78 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.646 0.736 . . . . 0.0 111.392 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.6 mt-10 -126.54 -20.38 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.776 -0.578 . . . . 0.0 110.458 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HB2' ' CA ' ' A' ' 79' ' ' TYR . 12.4 mtpp -117.65 168.07 10.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.93 -1.106 . . . . 0.0 110.663 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.5 t -114.43 147.09 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.595 -0.691 . . . . 0.0 110.335 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -79.97 157.96 73.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.614 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 32.7 Cg_endo -82.38 113.58 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.537 2.158 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 4.67 58.66 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 2.2 tt0 -125.2 160.45 29.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.137 -1.214 . . . . 0.0 109.591 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' HG13 ' A' ' 31' ' ' VAL . 3.7 mt-30 -61.08 -179.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.1 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 31' ' ' VAL . 13.1 t -86.79 139.65 30.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.9 m-85 -122.4 16.0 10.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.012 -1.055 . . . . 0.0 109.45 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 29' ' ' GLU . 60.5 t -64.03 139.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.932 . . . . 0.0 109.554 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 2.18 89.3 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 21.8 mt-30 -89.02 130.29 35.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -1.165 . . . . 0.0 109.511 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.01 110.14 7.07 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.17 159.01 1.0 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.031 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' OG ' ' A' ' 135' ' ' SER . . . -77.52 166.27 23.28 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.498 0.666 . . . . 0.0 110.085 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.542 ' O ' ' CE ' ' A' ' 129' ' ' MET . 13.2 p -78.89 -30.15 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 100.96 137.19 9.67 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.522 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 7.8 p -55.58 -48.53 74.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.317 -1.107 . . . . 0.0 108.188 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.561 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.3 t -46.43 -52.84 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -61.52 -50.73 71.54 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.685 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 16.9 m -64.83 -28.43 69.55 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.487 -0.758 . . . . 0.0 109.811 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -66.41 -45.15 80.91 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.127 -1.429 . . . . 0.0 107.791 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 56' ' ' MET . 33.3 m -76.13 -49.74 16.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.683 0.754 . . . . 0.0 110.281 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.13 -34.49 31.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.391 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.632 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 33.5 mt-30 -67.18 -52.54 40.13 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.022 HG21 HD13 ' A' ' 251' ' ' ILE . 29.9 mt -61.24 -25.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.539 ' HG3' HG22 ' A' ' 52' ' ' THR . 15.1 mtp -70.5 -36.02 73.57 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.589 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.1 tptt -76.11 -40.87 51.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.652 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 52.7 t80 -53.93 -25.56 21.05 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.015 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.1 m-70 -108.09 -28.0 9.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 110.529 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.619 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 62.5 m-20 47.88 61.75 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -84.67 -78.9 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.0 Cg_endo -71.49 107.47 2.17 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.815 0.97 . . . . 0.0 113.25 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 -24.85 65.65 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 3.5 ttpt -130.12 128.34 41.62 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.56 164.05 5.71 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.463 -1.827 . . . . 0.0 110.397 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.026 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -96.59 -35.36 11.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -1.063 . . . . 0.0 111.285 -179.01 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.1 tttt -152.67 134.14 14.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.607 -1.308 . . . . 0.0 110.402 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 7.7 m-20 -64.08 172.98 2.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.434 -0.791 . . . . 0.0 109.424 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 27.6 t80 -153.94 147.2 24.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -150.32 169.75 20.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.778 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.687 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.0 p90 -169.59 157.13 6.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 m -93.01 133.88 35.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.753 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.9 tp -50.57 149.56 3.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 111.21 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.43 140.65 58.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.932 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.84 -4.15 11.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.954 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 19.4 t-20 -99.13 -5.88 29.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.021 -1.049 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.753 ' ND2' HD21 ' A' ' 73' ' ' LEU . 23.5 t-20 -70.17 110.33 6.55 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.733 -0.605 . . . . 0.0 110.208 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 48.7 Cg_endo -88.61 13.59 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.81 2.34 . . . . 0.0 109.619 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.646 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.1 m-85 -107.89 -4.8 17.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 111.363 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 81' ' ' ASN . 35.3 m-85 -142.24 164.15 30.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 4.1 m-20 -49.23 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 173.74 -47.18 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.976 175.035 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.62 56.31 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 6.4 tptt -106.06 105.8 16.01 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.342 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.05 139.35 35.84 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -112.07 137.53 49.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 61.5 t80 -125.13 132.24 53.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.593 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.75 114.13 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.865 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -73.62 50.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.85 -1.156 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.9 mt -53.47 -57.33 5.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.551 -0.718 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.2 p -43.81 -29.5 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.763 -1.211 . . . . 0.0 109.103 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.865 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.58 34.11 4.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.604 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 8.6 mmt180 -84.31 157.85 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.446 -1.409 . . . . 0.0 109.365 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -117.14 85.74 2.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.8 m-85 -81.13 93.8 6.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.463 -0.773 . . . . 0.0 110.154 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -77.94 93.27 4.4 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.619 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 56.8 m95 -60.81 -8.35 2.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.518 -0.739 . . . . 0.0 110.458 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -91.02 -21.45 21.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.85 -1.157 . . . . 0.0 108.298 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 26.2 m-20 -99.74 -25.63 14.32 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 68.9 mt -73.69 70.97 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HG2' ' A' ' 108' ' ' GLU . 36.7 mt -52.84 150.43 9.9 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.581 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.8 Cg_endo -79.23 -23.09 7.86 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.964 2.442 . . . . 0.0 110.192 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.24 123.93 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.859 -1.151 . . . . 0.0 109.975 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.51 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 35.2 m-85 -110.62 138.47 46.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.15 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -99.74 -4.56 30.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.27 7.5 60.7 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -120.28 -1.32 10.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -1.118 . . . . 0.0 109.427 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.4 mp0 -64.33 167.11 7.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.35 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -69.55 170.63 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.339 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.58 -35.19 70.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.01 -61.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.763 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.39 -32.15 72.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.356 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 10.4 mttt -66.5 -44.03 83.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.18 -0.95 . . . . 0.0 108.488 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.7 ttm -59.13 -34.49 72.1 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.9 -68.05 0.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.529 -0.732 . . . . 0.0 109.437 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.038 HD11 ' HE2' ' A' ' 120' ' ' MET . 5.5 tp -63.28 -52.13 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.123 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 116' ' ' ILE . 4.2 p -45.6 -41.0 9.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' MET . 34.7 tt0 -70.61 -54.4 12.16 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.836 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.8 tp -46.9 -48.14 21.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . 1.038 ' HE2' HD11 ' A' ' 116' ' ' ILE . 24.1 mmt -59.44 -53.99 51.75 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.842 -0.536 . . . . 0.0 111.047 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.22 75.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.939 -1.101 . . . . 0.0 108.564 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 9.5 m-20 -64.2 -47.3 80.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 127' ' ' VAL . 63.0 t -71.54 -51.65 31.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.126 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.86 -51.7 12.82 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 126' ' ' SER . 2.9 mt -62.57 -57.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.177 -1.19 . . . . 0.0 108.258 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.67 -29.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.396 -178.019 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.641 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.5 m -101.08 34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.428 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 71' ' ' TYR . 95.4 m-20 40.83 51.19 3.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 109.246 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.5 tpp -66.04 126.16 27.72 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 111.698 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' SER . 4.5 t0 -76.53 122.57 24.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.0 m-85 -103.42 116.79 33.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.248 1.023 . . . . 0.0 113.141 -175.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.814 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.28 -162.48 10.74 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.647 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -62.64 -29.47 77.86 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 105.818 -2.416 . . . . 0.0 105.818 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 139.54 45.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.533 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 50.4 m -121.11 107.88 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.067 -1.646 . . . . 0.0 110.008 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.76 143.73 16.28 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.002 -1.095 . . . . 0.0 110.606 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.5 -163.47 0.93 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.61 -60.1 2.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.624 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 139.43 -134.5 6.71 Favored Glycine 0 N--CA 1.48 1.573 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.627 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.493 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 71.7 m -51.42 -49.41 61.68 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.677 -0.896 . . . . 0.0 112.298 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -45.84 -47.47 15.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 110.005 -177.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.1 mmt180 -81.25 -37.01 29.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.98 -1.075 . . . . 0.0 110.322 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.893 HG21 ' CE2' ' A' ' 185' ' ' TYR . 48.2 t -66.24 -61.27 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.739 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.38 -31.52 63.91 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.925 -1.109 . . . . 0.0 108.217 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' NH1' ' OE2' ' A' ' 149' ' ' GLU . 1.6 ttm-85 -76.12 -48.95 18.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 109.28 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.56 -36.16 81.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.159 -0.963 . . . . 0.0 110.097 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 35.8 mt -56.47 -46.4 80.43 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 56.1 mtmt -87.47 -40.75 14.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.903 -1.123 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.495 ' OE2' ' NH1' ' A' ' 145' ' ' ARG . 29.8 mt-10 -68.65 -58.56 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.836 -1.165 . . . . 0.0 112.316 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.07 -46.59 11.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.832 -1.168 . . . . 0.0 112.387 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 44.3 m-85 -89.9 -12.53 38.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.619 -1.3 . . . . 0.0 110.343 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.16 32.15 81.4 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.482 177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.558 ' CD2' HG22 ' A' ' 251' ' ' ILE . 15.2 m-85 -63.35 153.7 34.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.264 -1.727 . . . . 0.0 107.663 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.5 t-20 -46.71 155.71 0.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.786 -1.196 . . . . 0.0 109.971 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 76.7 mm-40 -55.98 -15.99 4.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.379 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.606 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 70.8 p -53.1 -17.61 1.67 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.169 -0.957 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 19.7 t -71.47 122.2 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.926 -1.108 . . . . 0.0 109.495 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.676 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -146.99 -178.26 6.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.119 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.493 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 36.1 tt0 -124.91 152.51 43.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 110.472 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.515 ' O ' ' CA ' ' A' ' 246' ' ' SER . 11.0 pt -133.07 145.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m120 -110.56 103.68 12.3 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.034 -1.041 . . . . 0.0 110.895 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.54 -40.21 18.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.21 -0.931 . . . . 0.0 109.353 179.146 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.02 -23.57 59.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.23 -0.83 27.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.093 -1.239 . . . . 0.0 111.56 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -117.48 169.04 9.84 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.467 -1.396 . . . . 0.0 109.94 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 167' ' ' LYS . 6.9 p -94.7 132.5 39.38 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 166' ' ' SER . 37.2 tttp -32.73 -44.02 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -64.3 -65.35 0.69 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.55 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -14.33 38.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.134 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 62.2 t-105 -72.76 -52.5 14.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.043 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.562 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.8 mt-10 -67.77 -21.99 65.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.33 81.25 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -61.05 -35.93 78.24 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.657 ' HA ' HG21 ' A' ' 184' ' ' VAL . 15.5 mt -74.57 -61.81 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.231 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.85 -51.59 39.02 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.373 -0.829 . . . . 0.0 109.767 -178.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -51.15 -44.14 61.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 4.0 mm-40 -61.1 -46.73 89.44 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -67.84 -28.15 67.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.536 -0.728 . . . . 0.0 109.916 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 175' ' ' ASP . 22.5 p -52.45 -40.3 62.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.958 -1.089 . . . . 0.0 108.638 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.449 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 11.4 mt-30 -99.57 33.61 2.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.648 ' HB3' HD22 ' A' ' 7' ' ' LEU . 75.5 m-20 43.73 53.46 6.02 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.892 0.853 . . . . 0.0 108.985 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.53 ' CB ' ' OE1' ' A' ' 177' ' ' GLU . 6.5 mt-30 -124.36 110.68 28.47 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.522 ' HD3' HD13 ' A' ' 7' ' ' LEU . 17.7 Cg_endo -64.84 165.48 21.02 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.765 1.643 . . . . 0.0 112.658 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 249' ' ' VAL . 25.0 t -121.03 132.97 69.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.043 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.893 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -83.93 116.57 22.86 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 176.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.686 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 7.3 t80 -122.08 157.44 31.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.957 -1.09 . . . . 0.0 110.153 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.59 131.74 4.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.998 -1.481 . . . . 0.0 111.682 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.83 132.79 11.44 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 190' ' ' GLY . 2.9 t -88.99 172.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.916 -1.343 . . . . 0.0 110.964 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.28 -148.96 7.27 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -30.04 20.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.1 -1.235 . . . . 0.0 110.716 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -83.39 -16.17 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.91 -1.118 . . . . 0.0 111.034 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.19 -164.18 25.32 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -95.15 112.34 4.37 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.964 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.618 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.4 t-80 -71.94 134.05 45.75 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -120.35 162.92 18.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.058 -1.457 . . . . 0.0 112.777 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.686 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 44.0 p90 -162.44 166.67 24.71 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.763 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -114.24 137.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.89 -1.131 . . . . 0.0 112.699 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.652 HG21 ' CG2' ' A' ' 174' ' ' ILE . 54.0 mt -98.09 131.32 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.9 p30 -143.43 30.09 1.39 Allowed 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.232 -1.387 . . . . 0.0 110.386 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.578 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 177.36 -174.25 46.83 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 117.794 -2.145 . . . . 0.0 111.93 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.665 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.2 154.94 11.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.662 -0.905 . . . . 0.0 108.794 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.529 ' C ' HG22 ' A' ' 3' ' ' VAL . 1.6 m-20 -117.57 5.96 12.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.757 -1.214 . . . . 0.0 110.314 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.51 -32.79 5.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -84.9 45.67 1.18 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.259 -1.142 . . . . 0.0 109.884 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 1.2 t-20 58.29 16.76 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 224' ' ' LEU . 8.9 m-85 -104.11 145.11 30.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.014 -1.054 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 54.4 m-85 -123.44 161.76 24.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 30.1 t-80 -91.75 123.02 34.82 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.795 HG11 ' CE2' ' A' ' 212' ' ' TRP . 33.1 t -115.3 150.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.49 -177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.2 t-20 -120.38 70.22 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.795 ' CE2' HG11 ' A' ' 210' ' ' VAL . 18.4 m95 -52.31 174.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 111.316 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -93.11 39.61 2.94 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.864 ' HB2' HG22 ' A' ' 217' ' ' VAL . 24.5 m95 -118.58 -163.37 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -107.65 -38.35 2.07 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.132 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -116.47 -29.07 2.38 Favored Glycine 0 N--CA 1.493 2.488 0 O-C-N 120.653 -1.498 . . . . 0.0 109.661 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.864 HG22 ' HB2' ' A' ' 214' ' ' TRP . 1.3 m -73.91 -30.06 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -1.004 . . . . 0.0 108.942 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 210' ' ' VAL . 2.6 t -43.05 -46.25 5.54 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.238 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 219' ' ' ASP . 0.0 OUTLIER -94.24 96.82 9.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.569 -1.332 . . . . 0.0 110.25 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -155.63 -153.95 6.75 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 28.1 m-85 -114.94 179.34 3.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -1.122 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -71.99 144.8 48.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.257 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.25 149.62 24.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.632 HD11 ' CZ ' ' A' ' 207' ' ' PHE . 1.8 mt -120.41 36.48 4.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.093 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -83.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.044 -1.035 . . . . 0.0 109.816 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.24 -94.81 0.48 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 110.344 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 228' ' ' ASN . 0.3 OUTLIER -99.83 -122.84 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 110.005 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.592 ' HB3' ' CZ3' ' A' ' 212' ' ' TRP . 0.0 OUTLIER -91.69 177.23 2.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.879 -1.138 . . . . 0.0 109.477 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 228' ' ' ASN . 35.3 Cg_endo -77.86 -92.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.599 2.199 . . . . 0.0 110.374 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.417 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 19.3 m -98.58 98.64 9.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.995 . . . . 0.0 109.313 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.427 ' C ' ' HG ' ' A' ' 232' ' ' LEU . . . -97.73 12.58 33.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.427 ' HG ' ' C ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -131.89 -40.44 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.56 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 54.59 -103.27 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.28 -13.85 14.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -1.116 . . . . 0.0 109.365 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -85.09 134.11 12.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -88.08 94.51 1.99 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.16 172.78 43.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 239' ' ' GLY . . . -97.64 81.88 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 238' ' ' ALA . . . 62.9 140.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -147.38 89.23 0.15 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 -172.36 2.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -1.121 . . . . 0.0 109.322 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 8.7 t30 -109.43 73.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.37 -54.04 8.19 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 189' ' ' VAL . 71.4 m-85 -135.93 162.21 33.49 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.555 -0.967 . . . . 0.0 108.664 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 81.1 mt-30 -152.83 140.37 19.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 109.319 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 19.6 p -159.17 159.73 34.69 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.145 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.6 163.86 29.15 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.146 0.974 . . . . 0.0 109.714 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 95.3 t -117.25 126.73 74.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 184' ' ' VAL . 22.8 m -132.49 149.08 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 157' ' ' VAL . . . 98.05 55.06 1.15 Allowed Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.942 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 1.022 HD13 HG21 ' A' ' 55' ' ' ILE . 2.2 mt -104.0 94.9 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.165 -1.197 . . . . 0.0 110.447 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 18.0 pttt -163.67 144.9 7.19 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.13 -0.981 . . . . 0.0 109.136 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.233 1.955 . . . . 0.0 110.387 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.48 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 58.6 tt0 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.5 Cg_endo -78.14 -176.24 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.455 2.103 . . . . 0.0 110.039 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG22 ' C ' ' A' ' 203' ' ' ASP . 11.2 t -139.73 131.87 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 110.006 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 178' ' ' LEU . 98.2 t -126.93 133.44 68.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -74.17 -178.34 3.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.984 -1.072 . . . . 0.0 108.359 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.709 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.0 OUTLIER -77.53 104.0 7.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.054 -1.029 . . . . 0.0 110.36 -178.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.676 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 33.4 mt -58.06 -45.54 86.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 198' ' ' VAL . 7.7 mt -61.2 -41.16 96.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.842 -1.161 . . . . 0.0 109.035 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.1 t70 -66.14 -37.52 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -57.64 -16.36 10.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 13' ' ' ILE . 1.7 mtpt -122.39 17.45 10.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.41 45.73 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.9 mt -90.55 107.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -1.021 . . . . 0.0 111.084 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' PRO . 31.5 m80 -131.43 95.58 3.79 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.66 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 9.7 m-30 -97.35 179.93 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.93 0.872 . . . . 0.0 111.274 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.42 -164.81 2.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 33.9 mt-30 -124.49 -23.56 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.064 -1.022 . . . . 0.0 110.053 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.68 -33.17 1.61 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.231 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.83 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 6.9 t-20 -45.63 -142.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.518 0 CA-C-N 117.693 0.746 . . . . 0.0 111.093 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -73.68 3.24 5.05 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 CA-C-N 122.229 1.832 . . . . 0.0 109.606 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.57 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 7.3 m-85 -80.37 -27.89 38.11 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.002 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.8 p-10 -97.83 16.48 20.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.461 -1.399 . . . . 0.0 109.743 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.8 mt -70.84 -3.44 19.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 110.003 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.7 mt -129.61 -6.37 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.064 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -60.82 164.47 7.52 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.9 Cg_endo -70.22 136.36 31.57 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.017 1.811 . . . . 0.0 111.625 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.695 HG23 ' CE1' ' A' ' 42' ' ' HIS . 35.6 t -82.39 149.86 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.557 0.694 . . . . 0.0 109.953 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 132' ' ' GLY . 9.8 mt -77.75 151.03 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.62 0.724 . . . . 0.0 110.75 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' C ' HG22 ' A' ' 39' ' ' VAL . 28.5 mt-10 -125.54 -21.96 4.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.683 -0.636 . . . . 0.0 110.417 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' TYR . 48.5 mtpt -124.0 171.1 10.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 110.068 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 37' ' ' SER . 77.1 t -114.4 149.58 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.341 -0.849 . . . . 0.0 110.812 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 7.5 tttt -85.13 128.3 60.6 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.96 118.24 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.465 1.443 . . . . 0.0 110.072 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.47 18.55 12.82 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.93 -178.34 6.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.621 -0.929 . . . . 0.0 109.17 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.92 176.92 9.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.412 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -84.29 132.71 34.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 73.9 m-85 -124.0 21.79 8.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.898 -1.126 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 28' ' ' ILE . 70.7 t -68.24 139.13 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.776 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 27' ' ' VAL . . . 79.35 1.37 85.92 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 29.0 mt-30 -86.1 129.82 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 27' ' ' VAL . 1.3 m-70 -73.36 111.38 8.43 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.56 158.08 1.37 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.861 -177.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -74.51 169.36 17.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.429 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.7 p -80.76 -34.66 34.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 108.675 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.34 134.47 8.3 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.8 p -54.49 -50.86 66.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.135 -1.214 . . . . 0.0 108.362 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.6 t -46.6 -53.87 2.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.599 -0.84 . . . . 0.0 108.754 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -58.49 -52.03 67.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.46 -0.775 . . . . 0.0 110.206 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.789 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 17.4 m -63.48 -34.33 77.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.15 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.42 98.7 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.299 -1.361 . . . . 0.0 107.865 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 56' ' ' MET . 34.0 m -74.68 -49.0 22.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.42 0.629 . . . . 0.0 109.623 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.65 -41.83 64.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.822 . . . . 0.0 109.883 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.66 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 31.0 mt-30 -60.16 -51.64 68.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.759 -1.213 . . . . 0.0 107.941 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 251' ' ' ILE . 34.1 mt -63.79 -28.1 44.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.527 ' SD ' HG22 ' A' ' 123' ' ' VAL . 18.5 mtp -67.93 -36.18 79.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.564 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -76.38 -42.55 44.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.3 t80 -53.34 -29.66 35.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 109.312 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 36.7 m-70 -105.5 -25.93 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 110.163 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.613 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.4 m-20 45.0 59.14 3.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -84.34 -70.16 0.13 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.024 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.4 Cg_endo -67.37 96.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.398 0.732 . . . . 0.0 111.623 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.15 -20.39 64.88 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 91' ' ' SER . 4.1 tttp -135.68 140.08 44.18 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.93 144.51 41.62 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.124 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.844 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -83.11 -53.85 5.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.951 . . . . 0.0 110.176 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 9.9 ttpp -145.25 142.5 29.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.29 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 9.7 m-20 -66.69 171.51 5.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -0.852 . . . . 0.0 109.884 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 70' ' ' THR . 51.1 t80 -148.62 164.39 34.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.58 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 14.5 t -166.11 162.53 17.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.723 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.9 p90 -166.62 154.65 9.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -92.97 136.97 32.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -54.18 150.77 7.92 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.193 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.74 141.53 57.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.349 0.595 . . . . 0.0 110.076 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -3.26 13.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.082 -1.011 . . . . 0.0 109.71 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.4 m-20 -99.74 -7.27 25.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.793 ' ND2' HD21 ' A' ' 73' ' ' LEU . 33.8 t-20 -69.92 109.84 5.49 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.709 -0.62 . . . . 0.0 109.785 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.634 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.89 16.19 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.867 2.378 . . . . 0.0 110.126 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.9 m-85 -106.57 -26.25 11.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 111.033 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 3.7 m-85 -118.64 162.74 17.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 13.4 m120 -46.36 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 175.15 -47.88 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.164 -0.96 . . . . 0.0 111.178 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.1 Cg_endo -76.75 57.21 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 106.877 -2.009 . . . . 0.0 106.877 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.66 104.46 14.18 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.394 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -100.53 134.11 43.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.339 -0.85 . . . . 0.0 109.679 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.723 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -106.3 137.32 44.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 27.1 t80 -128.54 131.55 48.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.06 -1.025 . . . . 0.0 110.261 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.01 114.75 28.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.48 51.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.728 -1.232 . . . . 0.0 108.312 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.7 mt -52.55 -54.32 16.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.492 -0.755 . . . . 0.0 109.593 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 90' ' ' ILE . 3.6 p -45.41 -26.62 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.497 -1.377 . . . . 0.0 109.154 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.1 OUTLIER -111.38 28.48 8.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.618 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.52 150.72 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.872 0.844 . . . . 0.0 110.822 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 86.9 2.6 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.5 m-85 -80.8 91.41 5.93 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.339 -0.851 . . . . 0.0 110.19 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 24.2 t-20 -79.58 90.6 5.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 58.0 m95 -61.07 -9.06 3.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.229 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.39 -14.7 32.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 53.3 m-20 -100.13 -32.92 10.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.702 HG12 ' HB1' ' A' ' 115' ' ' ALA . 23.4 mt -73.35 95.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.35 1.071 . . . . 0.0 108.566 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 11.8 mt -72.46 153.13 91.97 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.314 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.1 Cg_endo -79.14 -31.84 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.831 2.354 . . . . 0.0 110.344 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -136.8 136.03 38.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 74.9 m-85 -120.12 140.63 50.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 p -102.18 -1.06 32.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.15 88.62 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -118.74 -2.46 10.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.476 -1.014 . . . . 0.0 109.264 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 14.0 mp0 -64.03 167.79 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.3 p -65.05 179.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -82.97 -40.48 19.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.8 t -52.05 -52.36 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.15 98.75 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 108.988 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 24.1 mttt -61.21 -36.83 80.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 50.4 ttm -59.26 -46.03 89.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.5 -0.75 . . . . 0.0 109.666 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.1 -51.88 67.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.787 ' CD1' HD23 ' A' ' 119' ' ' LEU . 4.9 tp -68.86 -44.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.49 -1.381 . . . . 0.0 109.468 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.8 p -52.9 -41.45 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.024 -1.047 . . . . 0.0 108.649 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.733 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -70.01 -45.59 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 116' ' ' ILE . 13.2 tp -50.86 -54.41 24.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.789 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -59.84 -43.92 94.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.685 . . . . 0.0 109.521 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.85 -39.86 94.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 126' ' ' SER . 24.8 m-20 -68.69 -43.37 76.24 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.527 HG22 ' SD ' ' A' ' 56' ' ' MET . 79.8 t -70.75 -62.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.726 -0.609 . . . . 0.0 109.849 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.65 -45.32 17.8 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.5 mt -64.81 -57.49 11.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.07 -1.253 . . . . 0.0 108.106 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 9.4 p -46.06 -29.62 1.56 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.61 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.04 37.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.019 -1.051 . . . . 0.0 110.093 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.688 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.9 m-20 40.31 38.5 0.55 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.369 -0.832 . . . . 0.0 109.656 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.653 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -52.97 129.11 29.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.822 . . . . 0.0 111.192 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.9 t0 -78.72 122.78 26.43 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 66.3 m-85 -105.2 119.39 38.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.995 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.736 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -149.99 -163.29 11.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 103.753 -3.739 . . . . 0.0 103.753 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -61.58 -31.0 86.85 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 105.438 -2.562 . . . . 0.0 105.438 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.75 138.26 47.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -114.44 110.5 19.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.853 -1.779 . . . . 0.0 109.577 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -106.81 135.45 12.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 14.9 t -118.18 -163.79 0.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.127 -1.22 . . . . 0.0 108.672 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.739 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.07 -56.05 3.22 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.708 ' HA3' ' NE2' ' A' ' 187' ' ' GLN . . . 128.16 -119.89 3.24 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.796 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.6 m -51.32 -66.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.85 -0.794 . . . . 0.0 112.871 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -46.89 -35.1 6.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.89 -1.131 . . . . 0.0 109.871 -177.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.739 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 48.0 mmt-85 -79.54 -47.86 14.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.299 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.7 t -67.29 -60.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.483 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -55.9 -30.18 61.17 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.362 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 3.5 ttt180 -77.35 -41.53 40.06 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.252 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.44 75.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 251' ' ' ILE . 58.8 mt -58.11 -53.5 57.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.651 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.596 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 53.6 mtmt -77.46 -52.57 8.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.715 . . . . 0.0 112.097 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 9.2 mt-10 -66.23 -45.56 80.26 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.49 -1.381 . . . . 0.0 112.383 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.02 -45.26 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.559 -1.338 . . . . 0.0 111.506 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 152' ' ' GLY . 34.2 m-85 -100.02 19.99 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 39.6 0.04 OUTLIER Glycine 0 N--CA 1.496 2.668 0 O-C-N 121.905 -0.497 . . . . 0.0 112.992 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.643 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.8 m-85 -63.36 161.08 14.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.212 -1.758 . . . . 0.0 107.478 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.0 t-20 -47.44 147.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.765 -1.209 . . . . 0.0 109.612 -178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.0 mm-40 -54.81 -17.11 3.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.585 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 4.4 p -53.54 -15.87 1.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.596 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 67.0 t -68.81 129.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.638 -1.289 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.746 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.1 p-80 -149.46 172.67 14.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.24 -0.912 . . . . 0.0 109.796 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.568 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -117.49 136.36 53.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.772 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 8.8 pt -123.19 170.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.3 m-80 -123.87 102.66 7.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 110.485 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.632 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 2.6 tpt180 -47.22 -39.2 13.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 109.084 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.51 69.74 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -104.91 34.35 3.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.995 -1.297 . . . . 0.0 112.258 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.59 170.94 14.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.306 -1.496 . . . . 0.0 110.217 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.0 p -96.43 135.8 37.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.687 ' NZ ' HD13 ' A' ' 224' ' ' LEU . 6.7 ttpt -34.78 -51.49 0.5 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.813 -0.554 . . . . 0.0 110.978 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -56.09 17.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.403 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.09 -22.32 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.124 -0.985 . . . . 0.0 109.612 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.772 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 70.0 t-105 -71.87 -45.73 60.32 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.133 -0.979 . . . . 0.0 109.169 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 174' ' ' ILE . 69.3 mt-10 -70.87 -26.37 63.22 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.078 -1.014 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.05 83.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -61.14 -40.45 93.87 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.897 HG23 HG21 ' A' ' 184' ' ' VAL . 12.5 mt -75.72 -56.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.422 -0.799 . . . . 0.0 110.486 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.1 OUTLIER -49.87 -46.09 51.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.979 -1.076 . . . . 0.0 109.022 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -52.15 -45.26 64.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 108.215 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.617 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 31.0 mm-40 -59.71 -48.36 81.98 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.688 ' HB3' HG11 ' A' ' 4' ' ' VAL . 22.6 mt -67.63 -27.63 67.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 20.7 p -51.36 -42.78 61.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 108.716 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 181' ' ' ASN . 19.3 mt-30 -98.67 38.58 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.65 ' C ' HD13 ' A' ' 7' ' ' LEU . 90.5 m-20 43.3 49.97 5.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 5.3 mt-30 -123.64 114.49 28.52 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.3 Cg_endo -65.72 169.6 12.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.421 2.08 . . . . 0.0 112.807 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.897 HG21 HG23 ' A' ' 174' ' ' ILE . 58.5 t -125.61 131.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.81 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -82.93 120.14 25.31 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.98 161.93 23.3 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.894 -1.129 . . . . 0.0 109.546 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.72 HE22 ' HA3' ' A' ' 194' ' ' GLY . 0.0 OUTLIER -166.74 129.01 1.78 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.466 -1.693 . . . . 0.0 112.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -93.19 124.8 7.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.6 t -83.19 170.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.305 . . . . 0.0 111.12 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -175.33 -145.24 5.34 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -87.66 -29.48 21.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.021 -1.282 . . . . 0.0 110.678 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 m -81.82 -14.82 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.959 -1.088 . . . . 0.0 110.893 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.66 -164.41 24.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.72 ' HA3' HE22 ' A' ' 187' ' ' GLN . . . -87.93 106.45 3.21 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 121.089 -1.242 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.598 ' O ' ' CA ' ' A' ' 187' ' ' GLN . 11.4 t-80 -71.43 132.75 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -120.71 165.05 15.62 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.102 -1.439 . . . . 0.0 113.006 -177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.819 ' CD1' HG13 ' A' ' 210' ' ' VAL . 17.5 p90 -162.64 168.91 20.97 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.771 HG22 HD11 ' A' ' 55' ' ' ILE . 75.7 t -114.22 136.75 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.638 -1.289 . . . . 0.0 112.376 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 174' ' ' ILE . 81.7 mt -101.71 125.64 55.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.61 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 3.9 p30 -134.86 30.23 3.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.842 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 177.42 163.49 29.44 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 117.614 -2.232 . . . . 0.0 112.671 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -144.24 157.06 44.5 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.858 ' C ' HG22 ' A' ' 3' ' ' VAL . 9.5 p-10 -120.86 -0.5 10.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.698 -1.251 . . . . 0.0 110.576 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.583 ' N ' HG22 ' A' ' 3' ' ' VAL . . . 91.0 -27.67 8.81 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 36.4 mtt180 -89.22 30.08 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -1.187 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.6 OUTLIER 71.46 20.48 4.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.691 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 203' ' ' ASP . 16.3 m-85 -116.73 135.12 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.103 -0.998 . . . . 0.0 109.468 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 16.3 m-85 -121.11 168.4 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.367 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.709 ' CD2' ' HB3' ' A' ' 6' ' ' SER . 1.4 t-80 -91.51 147.02 23.32 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.941 HG21 ' CG ' ' A' ' 222' ' ' PHE . 37.4 t -138.79 137.51 42.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -105.88 78.81 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.623 ' CE3' ' HB3' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -46.57 164.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.716 . . . . 0.0 110.238 -178.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -92.97 26.16 16.16 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 231' ' ' ALA . 22.2 m95 -107.06 -168.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.638 -0.919 . . . . 0.0 109.748 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -80.36 -87.32 0.58 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.13 53.08 0.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG13 ' N ' ' A' ' 218' ' ' SER . 8.6 p -100.14 -134.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.181 -1.188 . . . . 0.0 109.138 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.718 ' N ' HG13 ' A' ' 217' ' ' VAL . 6.4 m -67.31 57.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.498 -1.376 . . . . 0.0 110.366 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' VAL . 5.3 m-20 -95.83 96.14 8.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.973 . . . . 0.0 109.271 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 160.13 -114.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -58.76 145.34 40.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.463 -1.022 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.941 ' CG ' HG21 ' A' ' 210' ' ' VAL . 0.0 OUTLIER -118.06 -166.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.769 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 226' ' ' ALA . 41.0 mtt180 -128.97 -165.99 1.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.687 HD13 ' NZ ' ' A' ' 167' ' ' LYS . 3.4 mt -115.03 -47.99 2.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -98.61 8.31 45.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 223' ' ' ARG . . . -122.33 84.01 2.19 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.147 0.975 . . . . 0.0 108.605 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.813 HD13 ' OE1' ' A' ' 245' ' ' GLN . 0.2 OUTLIER -93.86 -3.6 51.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.9 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 241' ' ' PHE . 1.7 m-80 -92.15 159.22 37.95 Favored Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.369 -0.832 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 212' ' ' TRP . 35.9 Cg_endo -78.21 159.64 29.83 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.786 2.324 . . . . 0.0 110.851 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.6 p -102.72 -39.86 6.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.389 -0.819 . . . . 0.0 109.113 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 217' ' ' VAL . . . -73.7 106.92 5.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 109.216 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.1 mt -69.69 -63.48 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.27 -172.41 16.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 3.8 m -109.12 -48.62 3.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 109.749 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -89.71 18.47 46.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.77 -66.19 0.64 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.35 58.3 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.537 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -46.51 -69.3 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.156 . . . . 0.0 109.358 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 116.45 -97.71 0.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.33 65.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -123.65 168.83 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -1.116 . . . . 0.0 109.508 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -132.4 74.82 1.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -76.26 -53.12 5.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.504 ' O ' ' HG3' ' A' ' 245' ' ' GLN . 23.8 m-85 -133.47 159.34 40.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -1.048 . . . . 0.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.813 ' OE1' HD13 ' A' ' 227' ' ' LEU . 28.7 mt-30 -153.45 143.52 22.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 40.5 p -155.21 162.03 41.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.642 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.691 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -136.93 148.16 46.82 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.204 1.002 . . . . 0.0 110.085 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.9 t -110.49 121.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.746 HG23 ' NE2' ' A' ' 158' ' ' HIS . 24.7 m -132.96 146.45 32.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.675 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 94.53 54.54 1.55 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 mt -101.14 97.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.308 -1.113 . . . . 0.0 110.004 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 7.9 pttm -162.85 144.38 7.82 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.17 1.913 . . . . 0.0 110.4 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.525 ' NE2' ' OD1' ' A' ' 175' ' ' ASP . 41.6 tt0 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HD2' ' OD2' ' A' ' 175' ' ' ASP . 35.6 Cg_endo -77.65 136.44 15.37 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.347 2.031 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' C ' ' A' ' 203' ' ' ASP . 16.8 t -79.34 142.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 109.702 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 178' ' ' LEU . 22.6 t -136.73 130.67 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.505 -0.747 . . . . 0.0 109.218 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 200' ' ' ASP . 63.7 mmtt -76.43 -172.95 2.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.086 -1.009 . . . . 0.0 108.517 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 4.2 t -79.27 101.8 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.711 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.4 mt -56.89 -50.23 73.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 108.818 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 198' ' ' VAL . 12.8 mt -55.04 -44.08 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.857 -1.152 . . . . 0.0 108.702 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 97.9 m-20 -67.83 -38.71 83.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.183 -0.948 . . . . 0.0 108.548 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.6 p -58.32 -14.87 8.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 9.4 mtpp -119.13 23.33 11.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.47 35.69 5.54 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 58' ' ' TYR . 17.5 mt -88.91 109.39 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.409 1.1 . . . . 0.0 110.432 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PRO . 63.1 m80 -133.4 98.82 4.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.1 m-30 -103.76 176.81 5.03 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.273 1.035 . . . . 0.0 112.299 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.602 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 t-20 -147.2 -172.74 4.08 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.611 ' NE2' ' O ' ' A' ' 213' ' ' GLY . 6.4 mt-30 -124.23 -14.94 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.917 -1.115 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.711 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.18 -39.11 0.97 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.799 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.847 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 7.7 t-20 -45.2 -138.96 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.489 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.108 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.2 Cg_endo -74.62 4.02 4.9 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 122.667 1.988 . . . . 0.0 109.185 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.602 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 64.1 m-85 -75.79 -35.21 60.15 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.632 -0.667 . . . . 0.0 109.903 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.7 p30 -97.95 21.78 10.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.494 -1.379 . . . . 0.0 109.998 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 23' ' ' LEU . 14.6 mt -72.7 -2.39 20.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -129.03 -6.3 4.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.988 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -62.07 162.62 16.93 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.644 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -70.69 130.37 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.14 1.893 . . . . 0.0 111.841 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.44 149.15 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.551 0.691 . . . . 0.0 110.168 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 79' ' ' TYR . 33.7 mt -77.8 144.66 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.558 0.694 . . . . 0.0 110.689 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HA ' HG13 ' A' ' 39' ' ' VAL . 20.5 mt-10 -123.6 -23.51 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.512 -0.742 . . . . 0.0 110.052 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.9 mtpp -118.94 162.5 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.264 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 39' ' ' VAL . 42.4 t -114.48 149.14 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -79.31 127.13 79.85 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -70.71 123.11 9.49 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.371 1.381 . . . . 0.0 110.484 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.67 11.21 31.29 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.47 -177.95 5.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.309 -1.112 . . . . 0.0 109.39 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.48 169.25 18.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.38 131.44 35.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 87.0 m-85 -123.29 25.03 8.54 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.055 -1.028 . . . . 0.0 109.634 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 31' ' ' VAL . 77.1 t -73.74 148.3 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.192 -0.942 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.21 -1.87 73.47 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 5.1 mm-40 -88.27 131.02 34.95 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.423 -1.045 . . . . 0.0 109.668 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.13 112.66 9.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.59 157.12 1.64 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.913 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.81 169.43 18.3 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.332 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.5 ' O ' ' HE2' ' A' ' 129' ' ' MET . 31.4 p -77.81 -34.11 52.18 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.979 -1.076 . . . . 0.0 108.385 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 101.64 136.88 9.46 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -54.3 -51.33 64.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.235 -1.156 . . . . 0.0 108.891 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.8 t -46.7 -53.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' HE2' ' A' ' 129' ' ' MET . . . -60.19 -50.6 73.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.25 -0.907 . . . . 0.0 110.329 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -63.62 -31.72 72.98 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.654 -0.653 . . . . 0.0 110.714 -178.11 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.08 -41.94 85.49 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.261 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -73.51 -54.2 8.78 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.874 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.88 -39.59 62.79 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.809 -0.557 . . . . 0.0 110.316 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.1 mt-30 -61.09 -44.48 97.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.742 -1.224 . . . . 0.0 107.733 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD11 HG22 ' A' ' 198' ' ' VAL . 44.1 mt -68.35 -24.53 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.568 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.2 mtp -73.36 -38.63 65.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 33.6 tptt -68.46 -43.54 76.8 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.03 -32.66 48.0 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.679 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 53.6 m-70 -107.52 -22.21 12.62 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.521 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.64 55.54 1.91 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.621 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.2 t80 -77.0 -70.52 0.21 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.8 Cg_endo -70.51 104.2 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 120.399 0.733 . . . . 0.0 111.942 -176.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -69.55 -22.61 63.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 3.6 ttpm? -134.55 141.72 46.76 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.94 153.06 26.65 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.507 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.05 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -94.35 -38.65 10.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -1.019 . . . . 0.0 109.984 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 46.3 tttt -152.16 139.45 19.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 91' ' ' SER . 77.7 m-20 -63.87 170.3 3.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 22.8 t80 -153.03 135.66 15.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.069 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.8 t -142.57 152.83 42.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 109.759 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 19.9 p90 -156.44 152.98 28.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.844 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.611 HG23 ' ND2' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -92.74 126.58 37.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.733 HD21 ' ND2' ' A' ' 77' ' ' ASN . 11.5 tp -44.03 147.29 0.52 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.77 0.795 . . . . 0.0 110.947 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 146.55 48.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.716 -0.615 . . . . 0.0 110.187 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.41 1.63 9.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.856 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.519 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 10.0 m-20 -98.65 -9.4 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.333 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.733 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.7 t-20 -69.73 109.35 4.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.782 -0.574 . . . . 0.0 110.35 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.3 Cg_endo -88.72 14.54 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.79 2.327 . . . . 0.0 110.386 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.784 ' HB3' HG23 ' A' ' 28' ' ' ILE . 80.1 m-85 -107.92 -22.6 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 110.66 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' ASN . 87.7 m-85 -118.48 163.35 16.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 8.5 m120 -49.14 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER 175.39 -48.38 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.508 175.097 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -75.85 58.88 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 N-CA-C 107.01 -1.958 . . . . 0.0 107.01 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 86' ' ' LEU . 12.1 tptt -105.49 121.86 44.81 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.784 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.611 ' ND2' HG23 ' A' ' 72' ' ' THR . 6.1 m120 -105.83 115.98 31.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.0 mp -95.49 128.85 42.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -129.81 141.06 50.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -117.28 113.26 21.91 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -73.24 52.81 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 108.118 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 mt -52.77 -53.63 20.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.555 -0.716 . . . . 0.0 110.205 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 p -45.65 -25.6 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.637 -1.289 . . . . 0.0 109.147 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -111.28 19.78 17.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.352 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.647 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.9 mmt-85 -79.43 151.49 30.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -117.36 90.99 3.45 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.21 94.66 6.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 110.828 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.7 t30 -82.64 89.39 6.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.607 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 68.1 m95 -61.39 -7.13 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 -178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.87 -19.8 24.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 6.0 m-20 -99.71 -28.0 13.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.9 mt -73.77 65.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 21.2 mt -45.89 148.62 1.35 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.723 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.562 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.0 Cg_endo -78.0 -17.96 13.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.641 2.228 . . . . 0.0 110.446 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' THR . 9.0 t -144.92 122.5 11.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.2 -0.938 . . . . 0.0 109.082 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.7 m-85 -109.5 141.75 41.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -99.93 -5.95 27.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.452 -0.78 . . . . 0.0 109.086 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -3.78 83.28 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -116.48 0.66 12.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -1.179 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.48 160.82 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 167.47 0.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.176 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 6.1 m-80 -72.79 -29.41 63.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.1 t -51.9 -63.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.519 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 3.2 mp0 -62.46 -32.42 73.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.271 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 110' ' ' ASN . 24.6 mttt -66.54 -43.7 84.4 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.48 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.8 ttm -59.6 -35.52 74.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -68.71 0.21 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.676 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.536 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.3 tp -59.84 -37.6 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.295 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 13.8 p -57.39 -43.39 83.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.895 -1.128 . . . . 0.0 110.755 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.743 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.23 -37.18 77.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 108.95 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.578 HD21 ' HB1' ' A' ' 53' ' ' ALA . 3.6 tp -59.48 -59.52 5.31 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.612 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.0 mmt -49.87 -40.59 43.11 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.211 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -70.38 -41.04 73.59 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.639 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 36.7 m-20 -64.63 -47.14 79.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 127' ' ' VAL . 54.5 t -70.08 -49.7 53.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . -60.18 -33.05 78.31 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 126' ' ' SER . 1.2 mt -75.22 -57.0 7.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 125' ' ' ILE . 1.4 p -47.79 -26.92 1.78 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 32.9 m -100.44 28.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.358 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 4.4 m-20 39.46 48.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.57 ' HE1' ' HB2' ' A' ' 137' ' ' SER . 53.5 tpp -59.66 131.79 52.0 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.1 t0 -76.89 120.66 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.644 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.7 m-85 -103.05 115.69 31.07 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.572 1.177 . . . . 0.0 113.245 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.764 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.1 -163.7 11.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 104.747 -3.341 . . . . 0.0 104.747 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.31 -31.44 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 N-CA-C 105.87 -2.396 . . . . 0.0 105.87 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.3 m -109.22 144.35 37.45 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.2 m -123.7 110.66 15.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 119.859 -1.776 . . . . 0.0 110.451 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.99 141.55 15.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.57 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 29.4 t -118.22 -162.48 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -1.182 . . . . 0.0 108.998 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.78 -61.45 1.63 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 138.57 -137.31 8.63 Favored Glycine 0 N--CA 1.481 1.649 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.996 176.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.3 m -48.34 -50.06 31.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.882 -0.775 . . . . 0.0 112.422 -178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 p -45.95 -48.45 16.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 110.407 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 7.0 mmt180 -80.7 -36.17 32.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.821 -1.174 . . . . 0.0 110.069 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.8 t -67.2 -58.45 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.359 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -56.03 -31.61 63.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.308 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.4 ttt180 -77.72 -47.67 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.419 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -66.41 -35.06 79.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.497 HD12 HG11 ' A' ' 248' ' ' VAL . 39.4 mt -60.13 -46.25 90.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 110.016 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 28.1 mtmt -87.38 -45.25 10.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 60.2 mt-10 -70.73 -43.54 68.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.875 -1.14 . . . . 0.0 111.792 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 24.2 m120 -94.42 -44.66 7.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 111.608 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 152' ' ' GLY . 32.3 m-85 -102.26 15.86 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 110.673 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.05 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 33.74 38.93 0.1 OUTLIER Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.639 -0.663 . . . . 0.0 112.75 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.6 m-85 -61.97 164.67 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.189 -1.771 . . . . 0.0 107.666 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 45.5 t30 -47.76 143.12 4.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.893 -1.129 . . . . 0.0 109.084 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -53.51 -18.69 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 109.079 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.519 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 78.0 p -53.36 -16.34 1.33 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -0.856 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 251' ' ' ILE . 56.0 t -66.29 118.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.83 -1.168 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.918 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.1 p-80 -142.2 155.57 45.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.378 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -101.15 163.24 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 17.4 pt -145.56 165.77 10.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 162' ' ' ARG . 3.5 m-80 -125.13 100.08 6.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 110.086 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.615 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 45.1 tpt85 -45.34 -35.22 3.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.142 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.34 -28.04 70.31 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -103.89 6.26 36.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.899 -1.353 . . . . 0.0 111.876 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -118.1 177.27 4.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.388 -1.445 . . . . 0.0 110.407 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 88.4 p -103.95 132.65 49.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 20.5 ttmt -33.21 -46.27 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.848 -0.533 . . . . 0.0 110.885 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -64.21 -62.39 1.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.861 -1.15 . . . . 0.0 109.878 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -17.19 61.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 75.7 t-105 -75.81 -47.01 27.48 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.197 -0.94 . . . . 0.0 109.162 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HA ' HD12 ' A' ' 174' ' ' ILE . 55.5 mt-10 -69.84 -38.19 76.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.168 -0.957 . . . . 0.0 108.549 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.19 50.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 35.4 mm-40 -61.07 -41.47 96.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 184' ' ' VAL . 13.2 mt -75.66 -58.24 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.39 -0.819 . . . . 0.0 110.575 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 1' ' ' GLN . 0.3 OUTLIER -49.46 -45.32 46.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.725 -1.235 . . . . 0.0 108.888 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -51.61 -43.03 62.41 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.621 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 44.6 mm-40 -60.18 -50.99 71.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.75 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.8 mt -68.27 -26.48 65.69 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.8 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.7 p -52.17 -39.29 59.85 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.4 mt-30 -100.93 35.41 2.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 7' ' ' LEU . 15.0 m-80 47.18 51.06 13.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 12.6 mt-30 -123.31 113.0 29.56 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.95 169.85 11.2 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.742 1.628 . . . . 0.0 111.792 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 174' ' ' ILE . 96.5 t -126.61 130.78 71.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.722 -176.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.832 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -82.86 116.91 22.38 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 176.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -122.48 159.19 28.17 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.92 -1.113 . . . . 0.0 109.35 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.3 pt20 -167.06 130.87 1.88 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.511 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.43 125.93 8.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 53.9 t -91.33 162.73 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.147 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.6 -133.27 1.58 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.538 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -87.76 -47.83 8.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.72 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.97 -11.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.175 -0.953 . . . . 0.0 111.205 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.33 -160.18 20.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -95.09 110.59 4.04 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.258 -1.448 . . . . 0.0 111.125 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.625 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 40.1 t60 -72.4 132.23 43.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.74 163.92 16.71 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.059 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.872 ' CD1' HG13 ' A' ' 210' ' ' VAL . 15.9 p90 -161.8 168.05 23.82 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.649 HG22 HD11 ' A' ' 55' ' ' ILE . 84.5 t -114.71 135.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.59 -1.319 . . . . 0.0 112.185 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 174' ' ' ILE . 76.1 mt -97.62 124.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 8.3 p-10 -137.1 33.05 2.61 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.992 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -173.73 167.9 40.62 Favored Glycine 0 N--CA 1.484 1.887 0 C-N-CA 117.757 -2.163 . . . . 0.0 112.356 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -152.34 149.37 28.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.641 ' C ' HG22 ' A' ' 3' ' ' VAL . 1.3 m-20 -117.99 29.07 8.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 110.258 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 3' ' ' VAL . . . 49.5 22.63 3.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -140.74 25.95 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -1.068 . . . . 0.0 108.91 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 222' ' ' PHE . 0.8 OUTLIER 75.23 7.77 4.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.401 -0.812 . . . . 0.0 109.719 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 25.9 m-85 -103.33 136.54 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 49.8 m-85 -123.65 163.07 21.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 111.119 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 40.4 t-80 -93.68 123.01 36.73 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.872 HG13 ' CD1' ' A' ' 197' ' ' PHE . 54.1 t -117.42 141.67 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 111.619 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.506 ' HB2' HD12 ' A' ' 8' ' ' LEU . 18.2 t-20 -110.1 76.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 211' ' ' ASN . 65.1 m95 -47.08 173.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.611 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -89.51 30.77 5.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -118.85 -167.37 1.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -1.157 . . . . 0.0 108.985 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.12 -104.62 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.47 52.38 0.83 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.809 HG22 ' N ' ' A' ' 218' ' ' SER . 0.8 OUTLIER -95.05 -93.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -1.142 . . . . 0.0 109.806 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.809 ' N ' HG22 ' A' ' 217' ' ' VAL . 0.5 OUTLIER -69.32 -3.86 15.76 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.403 -0.81 . . . . 0.0 110.101 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.75 128.42 26.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.218 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.97 -113.34 0.56 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 88.1 m-85 -87.02 159.02 19.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -1.141 . . . . 0.0 109.716 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.564 ' CE1' ' O ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -90.93 172.92 8.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 109.495 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.24 -165.97 1.48 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 34.8 mt -118.05 -51.55 2.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.42 -8.94 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.674 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.3 92.71 3.75 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.061 0.934 . . . . 0.0 109.051 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 227' ' ' LEU . 2.6 mm? -90.81 76.45 6.36 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-O 121.484 0.659 . . . . 0.0 109.292 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -116.52 166.03 13.66 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.18 179.92 5.78 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.789 2.326 . . . . 0.0 110.412 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.5 p -84.58 -36.41 22.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.085 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.68 115.88 27.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.08 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 59.66 4.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.882 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 100.15 126.86 5.85 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.93 -53.43 4.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.289 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -86.85 -160.37 34.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -75.03 96.81 0.99 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.13 178.12 21.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -88.67 164.99 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -1.136 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.01 -123.89 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 175.72 75.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.538 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -64.29 -174.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 109.535 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.43 ' CG ' ' OE1' ' A' ' 245' ' ' GLN . 8.5 t30 -104.3 110.36 22.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -119.43 -46.5 0.4 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.539 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 72.5 m-85 -135.22 87.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.384 -1.068 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 7.1 mt-30 -91.38 120.04 31.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.0 108.624 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 30.6 p -133.41 165.34 25.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.473 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.23 152.68 44.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.725 0.774 . . . . 0.0 110.247 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.832 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.5 t -112.84 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.918 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.6 m -109.97 139.72 32.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.318 0.58 . . . . 0.0 110.174 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.434 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 100.5 48.58 1.52 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.211 -1.471 . . . . 0.0 109.659 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 9.0 mt -104.61 94.67 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.245 -1.15 . . . . 0.0 111.131 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 252' ' ' LYS . 0.0 OUTLIER -163.43 146.03 7.94 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.153 1.902 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.673 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 36.7 t . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.181 0.515 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -75.23 172.89 11.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.9 t -76.9 108.13 9.73 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.488 -0.757 . . . . 0.0 110.807 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.684 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 41.0 mt -58.54 -50.4 73.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 198' ' ' VAL . 13.5 mt -55.54 -40.81 72.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.879 -1.138 . . . . 0.0 108.503 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 14.6 m-20 -67.84 -42.8 80.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.292 -0.88 . . . . 0.0 109.149 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -57.98 -15.09 7.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 108.932 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 5.8 mtpp -116.54 20.39 14.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.34 37.01 4.5 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 58' ' ' TYR . 59.2 mt -88.54 110.1 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 122.351 1.072 . . . . 0.0 110.385 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 77.4 m80 -133.53 97.96 4.08 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.563 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.2 m-30 -103.16 174.31 5.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.157 0.98 . . . . 0.0 111.823 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -146.83 -171.26 3.72 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.9 mt-30 -124.2 -11.19 7.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.919 -1.113 . . . . 0.0 109.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.73 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.17 -39.75 0.86 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.982 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -140.75 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.511 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.253 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.4 Cg_endo -73.85 2.3 6.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 122.523 1.937 . . . . 0.0 109.0 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 46.9 m-85 -72.76 -37.48 67.66 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.704 -0.622 . . . . 0.0 109.59 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 38.3 p-10 -96.15 21.24 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.564 -1.335 . . . . 0.0 110.087 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -74.75 4.44 6.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.315 -0.865 . . . . 0.0 109.622 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.0 mt -136.29 -1.81 2.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.936 -1.103 . . . . 0.0 110.467 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.3 p -61.56 161.77 18.44 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HG3' HD21 ' A' ' 86' ' ' LEU . 20.0 Cg_endo -69.85 137.51 35.38 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.697 1.598 . . . . 0.0 110.597 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.92 142.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.792 0.806 . . . . 0.0 110.82 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.5 mt -76.9 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.415 0.626 . . . . 0.0 109.833 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.745 ' HA ' HG13 ' A' ' 39' ' ' VAL . 64.0 mt-10 -126.22 -19.31 4.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.804 . . . . 0.0 111.398 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' TYR . 34.0 mtpt -123.11 171.77 9.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.729 -1.232 . . . . 0.0 110.58 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 37' ' ' SER . 94.4 t . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.742 0.782 . . . . 0.0 110.963 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.481 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.5 t . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.2 m-85 -124.07 18.97 9.2 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.853 -1.154 . . . . 0.0 110.23 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 29' ' ' GLU . 45.1 t -67.88 140.36 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.556 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.39 -2.26 72.61 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 13.2 mt-30 -83.4 136.52 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.33 -1.1 . . . . 0.0 109.824 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -73.2 108.58 6.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.2 168.79 0.09 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.721 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -90.24 173.36 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.005 . . . . 0.0 110.066 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.553 ' O ' ' HE3' ' A' ' 129' ' ' MET . 31.3 p -83.15 -37.68 23.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.229 -0.919 . . . . 0.0 108.603 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' A' ' 135' ' ' SER . . . 105.05 136.44 8.69 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' VAL . 2.8 p -54.57 -54.04 46.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -1.231 . . . . 0.0 108.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 38.2 t -46.38 -52.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.26 -52.28 66.35 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.865 0.84 . . . . 0.0 109.791 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.529 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.27 -32.61 74.07 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.186 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.86 86.69 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.222 -1.391 . . . . 0.0 108.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.43 HG23 HD21 ' A' ' 147' ' ' LEU . 83.9 m -73.52 -53.05 11.49 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.754 0.788 . . . . 0.0 109.651 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.39 -42.64 64.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.805 -0.56 . . . . 0.0 110.193 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.563 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.1 mt-30 -56.66 -48.75 76.9 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 198' ' ' VAL . 32.5 mt -66.27 -26.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.612 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -70.31 -35.88 73.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 23.7 tptt -72.58 -42.05 65.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.684 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.1 t80 -53.9 -31.61 50.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 71.9 m-70 -107.86 -22.35 12.48 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.649 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.68 51.43 3.03 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.5 t80 -70.02 -74.34 0.16 Allowed Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 33.9 Cg_endo -68.97 107.59 1.74 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 CA-C-N 119.044 0.694 . . . . 0.0 112.158 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -70.32 -21.95 62.87 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.2 tttm -134.27 148.06 50.75 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 144.9 42.42 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.238 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.963 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.435 -1.038 . . . . 0.0 111.579 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' ' OD1' ' A' ' 150' ' ' ASN . 51.7 tttt -151.51 137.24 17.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.093 -1.629 . . . . 0.0 111.229 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' N ' ' HB3' ' A' ' 91' ' ' SER . 75.6 m-20 -59.42 152.76 20.71 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.862 ' CZ ' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -126.85 172.81 10.08 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.62 -1.3 . . . . 0.0 107.986 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.7 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 10.9 t -167.87 134.74 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.01 173.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.615 ' HD2' ' CE2' ' A' ' 69' ' ' TYR . 3.3 p90 -148.67 146.47 28.18 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.258 -0.901 . . . . 0.0 109.112 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.8 m -93.43 135.15 34.95 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.724 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -52.14 144.58 12.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.86 0.838 . . . . 0.0 111.428 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.93 145.08 53.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.364 0.602 . . . . 0.0 110.453 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -0.15 11.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.92 . . . . 0.0 109.756 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -96.28 -10.36 28.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.204 -0.935 . . . . 0.0 108.874 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.724 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.0 t-20 -69.79 111.0 7.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.713 -0.617 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.1 Cg_endo -88.95 17.5 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.82 2.346 . . . . 0.0 109.193 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 89.6 m-85 -107.1 -15.27 14.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.575 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -135.52 167.21 21.51 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.584 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 19.3 m-80 -48.7 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.12 -48.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 111.302 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -75.66 60.54 5.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 N-CA-C 106.955 -1.979 . . . . 0.0 106.955 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HG3' HD12 ' A' ' 86' ' ' LEU . 2.0 tptt -104.5 119.78 39.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.424 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -100.88 119.28 38.46 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.406 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 26' ' ' PRO . 2.7 mp -94.88 143.57 26.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.526 ' HA ' ' CE1' ' A' ' 69' ' ' TYR . 18.2 t80 -139.03 130.75 27.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 110.726 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -110.22 119.4 39.13 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.7 45.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.696 -1.252 . . . . 0.0 107.834 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.832 HD12 ' CG ' ' A' ' 150' ' ' ASN . 15.4 mt -52.32 -56.56 6.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 O-C-N 121.578 -0.701 . . . . 0.0 109.999 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.545 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -44.56 -26.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 108.987 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -111.47 34.72 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 108.916 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.707 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 38.1 mmt-85 -93.35 155.81 17.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 110.868 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.73 88.77 2.98 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -80.76 86.38 5.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.208 -0.932 . . . . 0.0 110.416 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 30.3 t30 -79.38 90.96 5.03 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.649 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 77.5 m95 -61.36 -6.23 2.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.438 -0.789 . . . . 0.0 110.46 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.4 t-20 -89.88 -19.26 24.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 12.9 m-20 -99.67 -28.72 13.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 115' ' ' ALA . 41.8 mt -74.34 66.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 101' ' ' LEU . 9.4 mt -46.32 148.66 1.53 Allowed Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 121.662 -0.649 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.548 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.5 Cg_endo -78.79 -19.5 11.09 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.92 2.414 . . . . 0.0 110.432 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 2.5 t -142.78 121.58 12.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.113 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 116' ' ' ILE . 64.4 m-85 -109.28 138.54 45.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.932 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -101.11 -3.84 28.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.0 108.973 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.28 87.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -115.06 -1.03 13.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -1.231 . . . . 0.0 109.606 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -67.08 170.83 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.717 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.9 174.27 2.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -77.26 -34.34 55.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.56 -59.72 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 109.576 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.8 -34.15 76.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.132 -0.98 . . . . 0.0 109.158 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.503 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 85.4 mttt -66.01 -42.72 89.34 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 35.8 ttm -59.34 -35.63 74.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.21 -68.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.726 -0.609 . . . . 0.0 110.592 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.599 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.7 tp -60.14 -41.69 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 11.5 p -53.73 -43.24 68.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.853 -1.154 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.796 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.2 tt0 -69.36 -42.14 75.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.999 -1.063 . . . . 0.0 108.78 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.599 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.2 tp -54.05 -53.69 49.57 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.608 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -57.07 -43.06 81.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -66.18 -39.66 89.88 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 15.6 m-20 -68.47 -46.48 69.63 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 127' ' ' VAL . 43.6 t -67.01 -63.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.22 -38.82 9.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.862 HG23 ' CZ ' ' A' ' 69' ' ' TYR . 2.9 mt -69.84 -60.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.306 -1.114 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.607 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.2 p -46.47 -25.74 0.73 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.851 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 123' ' ' VAL . 27.1 m -104.26 33.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 109.792 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.2 m-20 41.75 40.96 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 109.8 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.603 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 35.4 tpp -56.42 134.05 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 111.589 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 34.4 m-20 -78.09 122.41 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 40.3 m-85 -103.9 106.24 16.68 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -141.2 -162.09 8.98 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 104.332 -3.507 . . . . 0.0 104.332 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.64 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.74 -30.96 78.73 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 106.007 -2.343 . . . . 0.0 106.007 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.93 139.15 45.34 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.56 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 73.8 m -114.14 112.72 23.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 119.934 -1.729 . . . . 0.0 110.721 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.67 130.52 10.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.624 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -117.23 -168.16 1.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.056 -1.261 . . . . 0.0 108.3 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.926 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.15 -50.85 5.76 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 124.01 -129.08 7.09 Favored Glycine 0 N--CA 1.481 1.684 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.257 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.534 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 4.2 m -48.23 -59.71 3.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.962 -0.728 . . . . 0.0 112.019 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 140' ' ' SER . 40.1 p -46.97 -35.35 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.789 -1.194 . . . . 0.0 108.622 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.926 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 74.9 mmt-85 -80.62 -48.51 12.56 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.91 0.862 . . . . 0.0 109.192 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.77 HG21 ' CE2' ' A' ' 185' ' ' TYR . 89.0 t -66.66 -59.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.477 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 1.4 pp0? -56.5 -33.21 65.79 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 108.58 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.8 ttm180 -76.79 -53.91 7.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.007 -1.058 . . . . 0.0 109.48 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -64.33 -38.21 90.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.105 -0.997 . . . . 0.0 109.575 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.561 ' HB2' HG11 ' A' ' 157' ' ' VAL . 17.1 mt -51.05 -48.6 61.52 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.665 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 55.2 mtmt -88.17 -31.2 19.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 111.285 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 19.8 mt-10 -74.29 -65.51 0.84 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.718 -1.239 . . . . 0.0 112.732 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.832 ' CG ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.98 -32.17 30.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.633 -1.292 . . . . 0.0 111.966 -177.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 32.8 m-85 -103.55 -10.26 18.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.512 -1.367 . . . . 0.0 110.768 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.963 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 58.6 39.15 92.93 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.097 -1.002 . . . . 0.0 112.531 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.2 m-85 -63.3 162.01 12.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.202 -1.764 . . . . 0.0 107.641 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 50.4 t-20 -47.1 147.9 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.826 -1.171 . . . . 0.0 109.923 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -53.86 -17.97 2.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.529 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 26.4 p -57.37 -11.95 2.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 110.051 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.561 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.0 t -70.92 121.44 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.798 -1.189 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 1.026 ' CE1' HG23 ' A' ' 249' ' ' VAL . 7.6 p-80 -148.65 179.79 7.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 4.5 tt0 -123.8 138.41 54.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.764 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -122.96 152.37 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 8.5 m-80 -109.89 103.23 11.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.109 . . . . 0.0 111.027 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.604 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 13.2 tpt180 -47.83 -36.48 11.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.043 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.6 67.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 4.74 35.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.922 -1.34 . . . . 0.0 111.668 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -118.17 161.19 20.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.569 -1.332 . . . . 0.0 110.143 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 5.2 p -87.06 131.71 34.03 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.3 ttpt -32.78 -44.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.83 -0.543 . . . . 0.0 110.906 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -63.59 -63.73 1.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.953 -1.092 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -62.42 -17.34 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.741 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.764 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.31 -47.86 22.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.087 -1.008 . . . . 0.0 109.172 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 174' ' ' ILE . 59.5 mt-10 -67.71 -22.73 65.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.98 97.14 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.56 HE21 HG21 ' A' ' 249' ' ' VAL . 15.2 mm100 -60.94 -36.2 78.71 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.586 ' CG2' HG21 ' A' ' 199' ' ' ILE . 18.5 mt -73.78 -66.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.385 -0.822 . . . . 0.0 110.575 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -48.27 -41.72 28.61 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 109.446 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -52.29 -47.47 65.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.0 mm-40 -61.06 -45.21 95.69 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.559 HD11 ' CG2' ' A' ' 199' ' ' ILE . 27.8 mt -68.29 -30.34 69.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.665 -0.647 . . . . 0.0 110.425 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' ASP . 62.7 p -52.55 -35.94 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.069 -1.019 . . . . 0.0 108.799 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 17.7 mt-30 -101.17 28.78 5.1 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.481 ' HB3' HD22 ' A' ' 7' ' ' LEU . 96.3 m-20 49.26 50.72 17.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 21.4 mt-30 -123.67 110.95 29.7 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.8 Cg_endo -64.21 166.16 17.64 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.567 1.511 . . . . 0.0 112.087 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.602 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 35.8 t -123.7 136.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.266 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.77 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -85.38 118.34 24.85 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 175.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 6.5 t80 -122.45 158.18 30.31 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.793 -1.192 . . . . 0.0 109.399 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 187' ' ' GLN . 3.5 pt20 -167.38 136.73 2.74 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.538 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.68 108.91 2.97 Favored Glycine 0 C--N 1.288 -2.108 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.598 HG22 ' CA ' ' A' ' 194' ' ' GLY . 19.3 t -78.56 160.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.241 -1.152 . . . . 0.0 112.159 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.12 -56.12 3.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -1.212 . . . . 0.0 110.507 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.04 -23.86 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.271 -0.893 . . . . 0.0 111.416 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.53 -167.54 24.98 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.598 ' CA ' HG22 ' A' ' 189' ' ' VAL . . . -85.62 106.25 3.01 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 121.062 -1.257 . . . . 0.0 111.496 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 6.5 t-80 -72.09 125.33 26.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -117.34 163.93 15.6 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.081 -1.448 . . . . 0.0 113.199 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 186' ' ' TYR . 32.2 p90 -159.48 170.16 22.31 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 55' ' ' ILE . 85.5 t -114.67 135.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.515 -1.365 . . . . 0.0 112.45 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 208' ' ' TYR . 11.8 mt -97.72 127.56 49.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.565 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.1 p30 -140.28 33.64 1.89 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.611 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.603 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 172.71 -175.51 45.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.442 -1.837 . . . . 0.0 111.003 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.673 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -161.3 152.2 18.31 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.424 -1.045 . . . . 0.0 109.092 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -113.81 14.62 18.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.775 -1.203 . . . . 0.0 111.338 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.87 -4.99 85.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.706 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 207' ' ' PHE . 4.5 mtp180 -128.2 70.83 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.802 -1.41 . . . . 0.0 110.59 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 205' ' ' ARG . 64.2 m-20 39.33 28.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 109.919 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -121.08 128.43 52.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.299 -0.876 . . . . 0.0 109.046 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 199' ' ' ILE . 73.9 m-85 -109.05 170.33 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.614 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 53.3 t-80 -91.55 115.34 27.96 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.558 HG13 ' CD2' ' A' ' 197' ' ' PHE . 11.5 t -112.85 142.84 23.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 122.256 1.027 . . . . 0.0 112.277 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.455 ' HB2' HD12 ' A' ' 8' ' ' LEU . 21.8 t-20 -110.6 78.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.506 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 68.9 m95 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.149 -0.969 . . . . 0.0 110.109 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 162' ' ' ARG . 12.0 tt0 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.3 p -151.62 169.95 20.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.059 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.92 146.34 37.28 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.186 0.993 . . . . 0.0 110.934 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.8 t -105.13 118.81 53.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 1.026 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.3 m -125.88 145.71 32.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.86 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.09 52.21 2.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.632 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 50.6 mt -97.44 88.94 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -1.083 . . . . 0.0 109.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.21 152.32 12.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.342 2.028 . . . . 0.0 110.402 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.678 HG11 ' HB3' ' A' ' 178' ' ' LEU . 85.4 t . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.508 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -74.43 -173.63 1.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.069 -1.02 . . . . 0.0 109.012 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.591 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 69.8 m -77.44 100.35 5.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.808 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.659 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 18.2 mt -58.83 -48.25 81.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.185 -0.947 . . . . 0.0 108.485 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.709 HD11 HG11 ' A' ' 198' ' ' VAL . 9.5 mt -55.91 -41.45 74.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 33.8 t0 -67.0 -38.73 86.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -15.9 11.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 108.558 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 16.0 mtpp -120.07 14.8 12.34 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.95 43.67 8.52 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.8 mt -93.1 110.28 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.493 -1.004 . . . . 0.0 110.574 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 51.6 m80 -135.13 100.02 4.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . 14.6 m-30 -102.4 175.9 5.36 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.891 -1.131 . . . . 0.0 110.843 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 5.1 t-20 -146.54 -171.27 3.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.585 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . 58.4 mt-30 -124.97 -3.56 7.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.829 -1.17 . . . . 0.0 110.676 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.03 -60.61 0.34 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.147 -1.501 . . . . 0.0 112.737 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.781 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -44.78 -123.72 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.424 0 CA-C-O 117.369 -1.3 . . . . 0.0 112.371 -176.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.781 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 42.7 Cg_endo -81.41 10.54 3.4 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 123.452 2.269 . . . . 0.0 109.596 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.824 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 92.6 m-85 -83.03 -38.64 22.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 110.663 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 44.4 p30 -103.55 35.39 2.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.622 -1.299 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.7 mt -78.11 -3.96 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.873 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 118' ' ' GLU . 21.3 mt -129.4 10.82 5.77 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.923 -1.11 . . . . 0.0 109.391 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.3 p -81.39 163.21 55.7 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.4 Cg_endo -69.82 128.59 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.131 1.887 . . . . 0.0 111.82 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 42' ' ' HIS . 10.8 t -74.43 150.67 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.737 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.2 mt -77.67 148.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.467 -0.771 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.55 -21.75 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.721 -0.612 . . . . 0.0 110.404 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.3 mtpp -122.29 171.96 8.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 110.071 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.0 t . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.394 -0.816 . . . . 0.0 111.113 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.9 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.069 0.462 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.4 m-85 -123.78 19.05 9.43 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' ILE . 66.9 t -66.8 144.5 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.73 -4.01 66.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 28.5 mt-30 -86.65 128.77 35.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -1.174 . . . . 0.0 109.564 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 25' ' ' THR . 1.1 m-70 -73.23 113.79 10.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.81 158.07 1.47 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.77 -1.172 . . . . 0.0 108.933 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 17' ' ' GLN . . . -78.47 170.09 17.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.391 0.615 . . . . 0.0 109.973 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 129' ' ' MET . 10.3 p -77.63 -31.58 52.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 103.6 138.08 9.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 p -54.51 -53.65 51.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -1.068 . . . . 0.0 108.408 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 4.9 t -47.01 -52.27 4.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.29 -50.12 74.89 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.947 0.879 . . . . 0.0 110.068 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.36 -33.88 76.5 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -178.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.56 87.66 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.217 -1.393 . . . . 0.0 107.43 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.722 HG23 HD21 ' A' ' 147' ' ' LEU . 59.7 m -74.42 -53.54 9.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 108.852 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -53.32 -37.94 62.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.813 -0.554 . . . . 0.0 110.77 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.505 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 27.1 mt-30 -67.34 -52.85 35.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.581 -1.324 . . . . 0.0 108.108 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 198' ' ' VAL . 31.9 mt -65.0 -18.8 24.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 34.4 mtp -73.84 -45.25 52.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 18.4 tptt -67.12 -36.02 81.0 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.659 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 65.9 t80 -54.06 -31.93 53.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.431 -0.793 . . . . 0.0 109.297 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 70.9 m-70 -106.92 -22.04 12.82 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 98.4 m-20 45.61 56.12 6.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 4.3 t80 -79.82 -74.54 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -68.11 103.15 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-N 119.104 0.716 . . . . 0.0 111.888 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.429 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 28.7 m120 -70.56 -22.79 62.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.41 140.8 45.22 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.59 151.13 33.37 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.752 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.753 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.84 -44.29 10.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.506 -0.997 . . . . 0.0 109.97 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 13.9 tttp -152.57 142.35 21.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.103 -0.998 . . . . 0.0 109.855 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 89' ' ' ALA . 1.5 m-20 -65.24 164.49 13.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.673 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 70' ' ' THR . 7.6 t80 -143.78 147.19 33.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.431 -0.793 . . . . 0.0 109.272 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.629 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t -150.2 166.11 30.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.1 p90 -171.68 157.03 4.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.529 HG23 HD22 ' A' ' 85' ' ' ASN . 86.9 m -93.13 131.37 38.25 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.776 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -44.94 150.13 0.4 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 111.403 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 p -61.56 139.46 58.25 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -4.83 11.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -97.59 -7.41 31.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.588 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.776 ' ND2' HD21 ' A' ' 73' ' ' LEU . 25.9 t-20 -70.01 108.59 3.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 109.73 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.1 Cg_endo -89.36 15.73 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.997 2.465 . . . . 0.0 110.533 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.59 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 85.0 m-85 -106.42 -24.43 12.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.0 110.866 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' A' ' 81' ' ' ASN . 72.8 m-85 -117.71 163.85 15.86 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.7 m-80 -48.19 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.4 OUTLIER 175.04 -47.56 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 111.307 175.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.47 55.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.0 tptt -106.0 104.94 14.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.253 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.529 HD22 HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.14 140.99 33.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.124 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -115.23 145.88 41.99 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 5.8 t80 -136.83 128.42 28.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.303 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.32 111.84 23.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 87' ' ' PHE . . . -72.81 53.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.577 -1.327 . . . . 0.0 107.909 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 10.5 mt -52.62 -54.17 16.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.033 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -45.36 -26.14 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.751 -1.218 . . . . 0.0 109.073 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -110.86 32.34 5.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 108.892 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 35.0 mmt-85 -92.48 154.22 18.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.432 ' CA ' ' NE2' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -117.32 90.98 3.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.61 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.5 m-85 -80.84 85.04 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 110.664 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 4.9 t30 -78.88 89.33 4.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 100' ' ' ILE . 77.7 m95 -61.36 -5.1 1.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.525 -0.734 . . . . 0.0 110.939 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.25 -15.58 33.24 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.728 -1.233 . . . . 0.0 107.684 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 36.3 m-20 -99.65 -30.75 11.93 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.821 HG12 ' HB1' ' A' ' 115' ' ' ALA . 22.3 mt -73.64 67.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.653 0.74 . . . . 0.0 109.307 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 16.0 mt -47.47 148.78 2.23 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.597 -0.689 . . . . 0.0 109.528 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.567 ' HB3' HG12 ' A' ' 13' ' ' ILE . 31.4 Cg_endo -79.39 -17.38 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.648 2.232 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.27 123.08 9.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.044 . . . . 0.0 109.478 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 90.8 m-85 -110.79 144.03 40.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -100.53 2.68 42.18 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.325 -0.86 . . . . 0.0 108.816 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 81.67 0.73 89.67 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 2.84 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 104' ' ' TYR . 1.3 mp0 -67.11 169.02 9.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -64.9 177.46 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.278 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 1.2 m-20 -82.11 -36.49 27.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.854 . . . . 0.0 109.632 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.06 -57.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -38.08 89.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.14 -0.975 . . . . 0.0 108.84 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.532 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 81.0 mttt -63.78 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.45 -0.781 . . . . 0.0 109.011 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.496 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.0 ttm -58.78 -40.83 85.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 0.0 109.182 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.821 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.79 -54.58 45.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.626 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -68.36 -38.51 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.538 -1.352 . . . . 0.0 109.743 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -56.71 -43.65 80.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.102 -0.999 . . . . 0.0 109.887 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.596 ' N ' HD12 ' A' ' 24' ' ' LEU . 35.2 tt0 -69.99 -37.02 75.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.4 tp -62.97 -52.01 64.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.824 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -60.68 -48.05 83.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.559 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.72 90.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 0.0 108.821 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.592 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 88.3 m-20 -63.95 -41.44 97.6 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 119' ' ' LEU . 72.3 t -71.44 -59.16 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.391 0.615 . . . . 0.0 109.46 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.99 -47.43 14.68 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 126' ' ' SER . 2.3 mt -63.7 -56.15 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.316 -1.108 . . . . 0.0 108.217 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 2.2 p -45.96 -29.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.298 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 17.6 m -105.95 38.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.486 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 9.1 p-10 36.94 50.76 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.515 0.674 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.564 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 49.8 tpp -59.76 128.14 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.55 -0.718 . . . . 0.0 110.74 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 135' ' ' SER . 33.8 t70 -75.36 123.8 26.0 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.631 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 64.9 m-85 -103.33 114.09 28.1 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.539 1.161 . . . . 0.0 113.144 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.737 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.3 -164.24 11.74 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 0.0 104.426 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.618 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 17.8 Cg_endo -62.35 -29.38 79.49 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 N-CA-C 105.952 -2.365 . . . . 0.0 105.952 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.75 139.5 44.73 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.543 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 54.8 m -119.42 109.19 15.47 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.898 -1.751 . . . . 0.0 109.948 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.08 142.91 16.02 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.826 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 4.7 t -116.43 -162.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.829 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.96 -47.55 7.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 132.41 -139.55 11.04 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.029 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.477 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 9.0 m -50.32 -53.01 31.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.795 -0.826 . . . . 0.0 112.329 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 145' ' ' ARG . 1.5 p -47.42 -33.84 6.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.708 -1.245 . . . . 0.0 108.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.1 mmp_? -80.51 -48.22 13.1 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.949 0.88 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 185' ' ' TYR . 70.4 t -67.24 -56.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.914 -0.491 . . . . 0.0 110.966 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.9 pp0? -56.12 -33.54 65.24 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -77.37 -48.1 18.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.35 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.94 -36.15 77.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.157 -0.964 . . . . 0.0 110.274 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 52' ' ' THR . 41.7 mt -57.13 -46.26 82.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.825 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 51.8 mtmt -87.18 -44.02 11.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.995 -1.066 . . . . 0.0 111.18 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.0 mt-10 -69.34 -50.5 45.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.399 -1.438 . . . . 0.0 111.446 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 18.1 m120 -88.63 -45.52 9.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 0.0 111.636 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.61 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 33.5 m-85 -102.2 18.28 21.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.753 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 31.63 41.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.648 -0.658 . . . . 0.0 112.985 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.1 m-85 -63.41 164.32 9.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.268 -1.725 . . . . 0.0 108.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.51 145.86 2.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.928 -1.108 . . . . 0.0 109.529 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -53.8 -18.96 3.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.056 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.576 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 84.6 p -55.3 -15.0 2.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.626 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.5 t -67.61 121.57 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.781 -1.199 . . . . 0.0 109.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.2 p-80 -147.84 175.61 10.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 109.449 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.517 ' HB2' ' HG2' ' A' ' 144' ' ' GLN . 3.7 tt0 -120.86 138.45 54.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.721 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.846 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 12.7 pt -125.75 158.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.6 m-80 -114.56 101.22 8.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.871 -1.143 . . . . 0.0 110.71 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HD3' ' CD1' ' A' ' 170' ' ' TRP . 1.2 tpt180 -45.71 -36.82 5.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 109.072 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.59 -27.77 66.67 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.88 6.92 36.77 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.984 -1.303 . . . . 0.0 111.917 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -118.12 171.24 8.24 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.392 -1.443 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 95.0 p -95.23 134.34 38.1 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 9.4 ttpp -35.36 -48.98 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.717 -0.615 . . . . 0.0 110.781 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -57.74 8.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.996 -1.065 . . . . 0.0 110.294 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.2 -20.56 65.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.846 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.7 t-105 -75.26 -43.96 48.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.397 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 174' ' ' ILE . 90.3 mt-10 -68.97 -31.28 70.03 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.948 -1.095 . . . . 0.0 108.311 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.25 73.95 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.524 ' NE2' HG21 ' A' ' 249' ' ' VAL . 12.0 mm100 -61.14 -41.63 97.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 108.975 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 199' ' ' ILE . 10.4 mt -75.38 -57.35 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 110.56 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -42.61 43.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.069 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -54.17 -46.03 72.23 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 45.7 mm-40 -58.55 -50.46 73.72 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.678 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.0 mt -65.8 -29.27 69.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.371 -0.83 . . . . 0.0 109.626 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 5.8 p -50.03 -42.98 50.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 108.729 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 14.7 mt-30 -95.83 30.76 2.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.599 ' C ' HD13 ' A' ' 7' ' ' LEU . 66.7 m-80 49.36 51.37 16.46 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 22.1 mt-30 -123.14 111.96 30.29 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 55' ' ' ILE . 13.8 Cg_endo -62.88 173.64 3.65 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.223 1.949 . . . . 0.0 112.539 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.661 HG21 HG23 ' A' ' 174' ' ' ILE . 93.7 t -133.45 142.16 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.36 1.076 . . . . 0.0 112.803 -176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.801 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -90.85 117.7 29.67 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 175.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 10.0 t80 -122.51 161.57 23.37 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.129 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.2 pt20 -167.29 138.73 3.15 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 118.171 -1.412 . . . . 0.0 110.791 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -111.48 108.33 2.31 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 190' ' ' GLY . 21.9 t -66.85 163.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 111.174 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.521 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.87 -136.59 2.07 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -32.49 18.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 111.253 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.78 -18.7 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.874 -1.141 . . . . 0.0 111.504 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.88 -170.43 23.47 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -78.11 100.15 1.61 Allowed Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.83 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.635 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.1 t-80 -72.26 126.69 30.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.13 165.86 13.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.053 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 40.7 p90 -156.89 -159.91 0.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.043 HG22 HD11 ' A' ' 55' ' ' ILE . 11.5 t -139.74 138.77 38.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.693 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.758 HD13 HG21 ' A' ' 174' ' ' ILE . 90.7 mt -107.08 111.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 15.1 p-10 -123.7 34.21 5.14 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.285 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 174.62 160.1 22.09 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.354 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -138.42 168.38 19.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -126.76 -11.17 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.958 -1.089 . . . . 0.0 110.209 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.59 -35.85 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 4.8 mtt180 -88.73 35.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.253 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 70.43 31.67 2.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 109.648 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 48.5 m-85 -122.26 133.78 54.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.17 -0.956 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 33.9 m-85 -124.07 160.47 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.311 -0.868 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.591 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 40.3 t-80 -92.13 134.6 34.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 198' ' ' VAL . 21.4 t -131.58 146.19 33.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.337 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.564 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 42.6 t-20 -114.45 81.92 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 91.4 m95 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.721 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.558 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -149.58 166.16 30.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.045 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.26 152.23 44.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.278 1.037 . . . . 0.0 110.925 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 68.9 t -111.02 117.56 55.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.719 HG23 ' NE2' ' A' ' 158' ' ' HIS . 25.0 m -123.12 145.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.066 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 87.74 56.44 2.1 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 63.2 mt -100.32 74.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.565 -0.962 . . . . 0.0 110.674 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -152.4 156.76 33.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.086 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.613 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.295 1.997 . . . . 0.0 110.476 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 202' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 200' ' ' ASP . 35.4 mmtt -76.77 179.57 6.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . 4.2 m -77.67 104.93 8.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.014 -1.054 . . . . 0.0 109.363 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.666 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.6 mt -57.95 -56.17 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD11 ' CG1' ' A' ' 198' ' ' VAL . 18.2 mt -55.14 -36.88 66.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.41 -1.431 . . . . 0.0 108.294 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 22.4 t0 -68.52 -42.1 79.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.126 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -58.55 -14.98 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.05 -1.031 . . . . 0.0 109.045 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 15.5 mtpt -120.56 20.27 11.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.42 37.6 4.86 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.6 mt -85.31 106.92 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.386 1.089 . . . . 0.0 110.551 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 102' ' ' PRO . 17.7 m-70 -134.81 95.43 3.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 9.3 m-30 -98.95 179.13 4.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 111.064 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 26.1 t-20 -145.96 -177.44 5.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 39.0 mt-30 -116.64 -18.0 10.42 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.923 -1.111 . . . . 0.0 110.164 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.72 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.95 -38.22 0.9 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.337 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.01 -142.5 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.458 -177.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -73.78 2.99 5.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 122.411 1.897 . . . . 0.0 109.441 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 116' ' ' ILE . 11.2 m-85 -79.29 -28.01 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.122 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 14.7 p-10 -96.51 23.38 6.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.593 -1.317 . . . . 0.0 109.783 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 8.7 mt -76.79 -5.64 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.566 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.8 mt -125.57 9.46 7.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.602 -1.311 . . . . 0.0 109.428 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 40.9 p -82.06 160.87 62.14 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.606 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -68.82 126.18 13.61 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.14 1.894 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.493 HG22 ' CG ' ' A' ' 42' ' ' HIS . 44.4 t -74.65 151.45 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.423 0.63 . . . . 0.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.2 mt -77.69 147.23 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 110.899 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.7 mt-10 -126.31 -20.74 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.745 -0.597 . . . . 0.0 110.535 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 48.0 mtpt -120.12 172.9 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.005 -1.059 . . . . 0.0 110.158 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 79.7 t . . . . . 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 111.05 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.5 t . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.157 0.503 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 75.5 m-85 -124.18 23.92 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.107 -0.996 . . . . 0.0 109.367 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 29' ' ' GLU . 70.2 t -69.99 146.49 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.809 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.05 1.84 86.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mt-30 -93.06 126.8 38.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -1.131 . . . . 0.0 109.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 27' ' ' VAL . 1.7 m-70 -72.83 111.55 8.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.32 157.69 1.37 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.997 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.07 166.04 23.81 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.628 0.727 . . . . 0.0 109.946 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.771 HG21 ' SD ' ' A' ' 120' ' ' MET . 19.1 p -77.11 -33.66 56.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 106.18 136.57 8.44 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.487 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 5.3 p -54.85 -50.12 69.45 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.292 -1.122 . . . . 0.0 108.275 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 9.5 t -47.52 -53.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.53 -48.65 80.85 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.046 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.737 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -62.79 -33.6 75.53 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.966 -177.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.93 91.62 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.882 -1.527 . . . . 0.0 108.036 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 56' ' ' MET . 31.3 m -75.46 -50.68 15.03 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.426 0.631 . . . . 0.0 110.003 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.32 -35.57 38.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 mt-30 -68.47 -44.88 73.85 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 198' ' ' VAL . 53.0 mt -69.92 -22.9 25.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.616 ' HG3' HG22 ' A' ' 52' ' ' THR . 16.8 mtp -73.76 -34.58 64.77 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.599 ' HD3' HG22 ' A' ' 100' ' ' ILE . 33.7 tptt -74.9 -43.39 54.59 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.8 t80 -54.06 -25.46 21.71 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.351 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 32.1 m-70 -108.31 -27.81 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 110.674 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 67.6 m-20 45.11 61.36 2.57 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.3 t80 -84.98 -77.56 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.6 Cg_endo -70.66 106.47 1.83 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 119.467 0.845 . . . . 0.0 113.83 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -67.51 -24.79 65.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -131.83 127.04 35.76 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 176.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.73 166.08 4.84 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 118.566 -1.778 . . . . 0.0 110.877 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.046 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -95.95 -35.29 11.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.469 -1.018 . . . . 0.0 111.44 -178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 27.0 tttp -152.76 130.54 11.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.534 -1.354 . . . . 0.0 110.887 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 3.4 m-20 -62.25 171.35 1.88 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.08 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.405 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 47.4 t80 -149.11 141.8 24.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.578 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t -144.65 148.37 34.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.67 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.5 p90 -160.47 155.2 24.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 29.1 m -93.01 131.71 37.76 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.783 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.13 147.72 0.68 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.845 . . . . 0.0 110.727 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 1.5 t -61.79 146.75 48.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.941 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 0.99 9.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.109 -0.994 . . . . 0.0 109.745 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -99.47 -7.99 25.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.783 ' ND2' HD21 ' A' ' 73' ' ' LEU . 17.6 t-20 -70.32 109.41 4.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.751 -0.593 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.2 Cg_endo -89.26 15.68 1.95 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 73.9 m-85 -110.78 -23.65 10.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 111.167 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 80.4 m-85 -118.14 160.69 21.11 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 15.4 m-80 -48.22 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 174.76 -45.75 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.387 -0.821 . . . . 0.0 111.311 175.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.0 Cg_endo -75.76 55.32 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 N-CA-C 107.86 -1.631 . . . . 0.0 107.86 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 5.4 tptt -106.75 106.81 17.51 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.237 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -100.1 141.54 32.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.64 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.67 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 mp -118.26 125.41 50.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 12.1 t80 -120.16 127.71 52.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.956 . . . . 0.0 110.133 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -108.34 111.9 24.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -72.94 53.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.739 -1.226 . . . . 0.0 108.352 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.658 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.7 mt -53.24 -58.3 3.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.746 -0.596 . . . . 0.0 111.195 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.0 p -43.56 -29.44 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.815 -1.178 . . . . 0.0 109.257 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.884 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.29 30.14 7.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.46 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.814 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 27.7 mmt-85 -79.22 156.06 28.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.537 -1.352 . . . . 0.0 109.4 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 94' ' ' GLN . 5.6 mm-40 -116.46 83.78 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 122' ' ' ASP . 9.1 m-85 -80.71 97.83 7.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.611 -0.681 . . . . 0.0 110.132 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 100' ' ' ILE . 29.5 t-20 -79.02 89.88 4.79 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 45.5 m95 -60.54 -8.89 3.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.68 -21.68 21.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.2 m-20 -100.07 -24.76 14.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 57' ' ' LYS . 36.3 mt -73.49 64.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.575 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 37.7 mt -46.4 149.23 1.4 Allowed Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 13' ' ' ILE . 29.6 Cg_endo -77.58 -25.17 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.579 2.186 . . . . 0.0 110.522 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 125.37 16.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 109.516 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.575 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 76.5 m-85 -112.78 145.14 41.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -99.56 -4.36 31.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 82.49 7.64 87.26 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -118.5 9.12 12.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -1.068 . . . . 0.0 108.724 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -72.76 -177.84 2.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.437 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -73.92 172.94 10.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -74.81 -36.18 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.634 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.3 t -51.81 -60.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.437 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 5.2 mp0 -62.54 -36.24 82.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.974 -1.079 . . . . 0.0 108.989 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.5 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 72.9 mttt -64.5 -42.67 95.7 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.484 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.5 ttm -60.03 -38.73 83.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.11 -69.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.485 -0.76 . . . . 0.0 110.476 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.722 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.0 tp -57.92 -43.6 84.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 110.227 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 5.3 p -50.51 -40.52 51.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.493 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.62 -48.96 58.23 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.4 tp -49.19 -48.76 45.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.771 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -58.82 -55.28 37.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.577 -0.702 . . . . 0.0 110.583 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.42 -33.43 75.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.814 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 21.6 m-20 -64.37 -47.12 80.48 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 119' ' ' LEU . 62.1 t -71.35 -55.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.499 -0.75 . . . . 0.0 109.264 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.26 -50.53 12.94 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.0 mt -63.69 -55.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.255 -1.144 . . . . 0.0 108.046 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 6.9 p -46.93 -32.05 3.57 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.296 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.598 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 14.1 m -100.66 34.32 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.9 m-20 38.6 53.69 1.88 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.611 0.719 . . . . 0.0 109.509 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.601 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 57.3 tpp -65.87 129.56 40.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 111.629 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -76.61 121.83 23.78 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 75.6 m-85 -103.38 117.46 34.53 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.705 1.24 . . . . 0.0 113.432 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.54 -162.46 10.6 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 104.12 -3.592 . . . . 0.0 104.12 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.656 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.53 -30.48 79.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 106.049 -2.327 . . . . 0.0 106.049 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.94 143.06 40.42 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.0 m -124.59 112.55 16.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.975 -1.703 . . . . 0.0 110.092 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 146.28 16.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.578 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 33.5 t -120.0 -164.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -91.89 -52.31 4.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.15 -143.33 14.75 Favored Glycine 0 N--CA 1.48 1.592 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.978 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 74.6 m -48.37 -51.18 27.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.755 -0.85 . . . . 0.0 111.846 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.49 -39.17 10.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.789 -1.195 . . . . 0.0 108.761 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.799 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 10.5 mmt180 -81.77 -44.3 17.18 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.203 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.2 t -69.07 -51.28 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 110.584 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.4 pp0? -56.95 -35.73 69.44 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.001 -1.062 . . . . 0.0 108.691 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 30.6 ttm180 -77.27 -47.0 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.965 . . . . 0.0 110.147 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.55 84.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.125 -0.984 . . . . 0.0 110.353 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 251' ' ' ILE . 67.7 mt -59.7 -46.35 89.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.751 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 33.2 mtmt -85.0 -47.72 9.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 110.758 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 18.8 mt-10 -70.63 -47.07 61.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.911 -1.118 . . . . 0.0 112.273 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 18.6 m120 -89.57 -53.27 4.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.575 -1.328 . . . . 0.0 112.126 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.407 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 46.6 m-85 -90.06 -13.75 35.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 110.448 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.046 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 65.52 36.55 92.65 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.054 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 251' ' ' ILE . 7.9 m-85 -63.43 172.63 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.374 -1.662 . . . . 0.0 107.808 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 33.5 t-20 -47.86 134.74 12.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.725 -1.234 . . . . 0.0 109.235 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 30.1 mm-40 -53.31 -21.67 5.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.958 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 154' ' ' ASN . 52.6 p -54.49 -16.72 2.51 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.369 -0.832 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.4 t -57.19 123.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.032 -1.043 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.969 ' CE1' HG23 ' A' ' 249' ' ' VAL . 15.2 p-80 -143.46 161.35 38.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 6.4 tt0 -102.27 154.65 18.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 0.0 110.274 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.566 HG21 HE21 ' A' ' 173' ' ' GLN . 14.7 pt -137.64 134.92 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.5 m-80 -102.73 107.36 18.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.838 -1.163 . . . . 0.0 111.069 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.667 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -47.38 -44.46 24.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.85 -21.58 55.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 18.1 m-20 -104.9 2.24 29.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.953 -1.322 . . . . 0.0 112.162 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -117.65 175.05 5.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.302 -1.498 . . . . 0.0 110.314 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.509 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.1 p -100.41 131.63 46.22 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.509 ' C ' ' O ' ' A' ' 166' ' ' SER . 28.3 ttmt -30.09 -49.35 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.204 0.526 . . . . 0.0 111.002 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -62.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.96 -1.087 . . . . 0.0 110.188 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.39 -16.12 52.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.004 -1.06 . . . . 0.0 109.28 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 57.6 t-105 -72.71 -51.14 20.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.522 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.0 mt-10 -68.88 -37.12 78.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.08 -1.012 . . . . 0.0 108.319 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.61 -42.16 15.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.566 HE21 HG21 ' A' ' 160' ' ' ILE . 11.4 mm100 -61.01 -42.81 99.17 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 199' ' ' ILE . 6.9 mt -70.34 -53.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.729 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.471 ' OD1' ' CE2' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -49.84 -55.92 12.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.634 -178.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -50.91 -41.32 58.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.837 -1.165 . . . . 0.0 108.517 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.59 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.7 mm-40 -61.26 -49.79 75.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 199' ' ' ILE . 46.9 mt -68.53 -24.67 64.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.247 -0.908 . . . . 0.0 110.257 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 53.3 p -52.05 -37.12 52.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.479 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 mt-30 -102.71 34.11 2.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.618 ' HB3' HD22 ' A' ' 7' ' ' LEU . 30.5 m-20 44.21 51.71 7.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.15 -0.969 . . . . 0.0 108.893 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 9.5 mt-30 -123.79 107.44 31.25 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.614 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.7 Cg_endo -62.63 165.74 15.13 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.708 1.605 . . . . 0.0 112.681 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.661 HG22 HG12 ' A' ' 249' ' ' VAL . 18.7 t -120.04 134.88 62.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.207 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.865 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.9 OUTLIER -82.81 115.3 21.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.12 158.59 28.96 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.914 -1.117 . . . . 0.0 108.798 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 196' ' ' ALA . 2.0 pt20 -167.77 128.37 1.41 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.006 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' HIS . . . -91.1 124.44 7.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 106.154 -2.778 . . . . 0.0 106.154 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 194' ' ' GLY . 1.9 t -101.86 164.51 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.727 -1.455 . . . . 0.0 112.957 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -160.07 -136.61 2.06 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -25.28 22.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.817 -1.402 . . . . 0.0 110.777 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.46 -22.43 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.003 -1.061 . . . . 0.0 111.659 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.467 ' C ' HG13 ' A' ' 189' ' ' VAL . . . 138.31 176.8 14.76 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.562 ' N ' HG13 ' A' ' 189' ' ' VAL . . . -76.87 113.19 3.72 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.57 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 33.5 t-80 -71.27 95.32 1.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -86.12 155.67 20.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.719 1.247 . . . . 0.0 113.793 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 35.0 p90 -154.04 177.06 11.48 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.723 HG22 HD11 ' A' ' 55' ' ' ILE . 97.9 t -123.26 136.66 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.496 -1.377 . . . . 0.0 112.418 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 178' ' ' LEU . 64.9 mt -97.11 124.13 49.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 7.4 p-10 -137.15 29.65 2.76 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.989 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -168.87 174.36 43.44 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.506 -2.283 . . . . 0.0 112.169 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -166.87 147.79 5.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -120.33 34.41 5.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.654 -1.279 . . . . 0.0 109.686 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 53.88 18.62 8.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 3.2 mtt85 -136.63 32.58 2.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -1.178 . . . . 0.0 109.225 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 1.3 m120 64.75 22.79 12.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 10.0 m-85 -110.73 100.26 9.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.534 ' HB3' HG23 ' A' ' 199' ' ' ILE . 11.1 m-85 -96.56 156.28 16.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.444 -0.785 . . . . 0.0 110.292 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.2 t-80 -93.17 123.32 36.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 9.1 t -112.76 135.31 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.821 1.296 . . . . 0.0 111.825 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 8' ' ' LEU . 3.8 t30 -112.95 99.55 7.95 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.89 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 197' ' ' PHE . 43.9 m95 . . . . . 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.749 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 5.4 tt0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 25.6 p -150.57 164.56 35.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 110.617 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.41 163.47 32.72 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.846 0.832 . . . . 0.0 109.703 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.865 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.4 t -117.28 128.42 74.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.969 HG23 ' CE1' ' A' ' 158' ' ' HIS . 32.7 m -127.05 144.96 35.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.796 -1.19 . . . . 0.0 111.072 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.18 51.45 2.97 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 147' ' ' LEU . 8.2 mt -102.43 97.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.575 -0.956 . . . . 0.0 109.824 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.6 150.78 10.58 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.095 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.633 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.6 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.178 1.918 . . . . 0.0 110.359 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 178' ' ' LEU . 13.7 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.0 mmtt -74.82 -169.28 0.86 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.061 -1.024 . . . . 0.0 108.291 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.587 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 72.7 m -80.86 101.58 9.5 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.155 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 200' ' ' ASP . 45.0 mt -58.15 -49.18 77.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.999 -1.063 . . . . 0.0 108.737 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.632 HD11 HG11 ' A' ' 198' ' ' VAL . 9.4 mt -59.74 -38.82 82.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.073 -1.017 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 8.0 t0 -67.26 -37.75 84.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 109.152 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 p -57.88 -15.73 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.005 . . . . 0.0 108.575 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 13' ' ' ILE . 3.1 mtpt -120.84 18.16 11.82 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 47.1 41.25 14.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.3 mt -89.63 102.0 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -1.039 . . . . 0.0 110.29 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 27.1 m80 -128.1 77.7 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.625 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 11.4 m-30 -81.61 -179.79 7.52 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.102 0.953 . . . . 0.0 111.182 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.98 -164.04 1.93 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 20.7 mt-30 -125.16 -19.64 5.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.061 -1.025 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.83 -35.44 1.26 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.617 -1.277 . . . . 0.0 111.424 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.77 -140.17 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 118.469 -0.776 . . . . 0.0 110.981 -178.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.3 Cg_endo -74.16 3.54 5.06 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 122.46 1.914 . . . . 0.0 109.616 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 7.5 m-85 -79.93 -31.13 40.07 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.231 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.0 p-10 -93.46 17.88 10.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.484 -1.385 . . . . 0.0 109.944 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.5 4.92 5.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.862 . . . . 0.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 118' ' ' GLU . 13.3 mt -133.39 -4.45 2.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.721 -1.237 . . . . 0.0 110.368 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.6 p -61.99 164.62 10.02 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.9 Cg_endo -71.7 132.96 21.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.648 1.565 . . . . 0.0 110.573 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.93 145.38 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 110.229 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HA2' ' A' ' 132' ' ' GLY . 8.9 mt -77.01 149.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.592 -0.692 . . . . 0.0 110.565 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.629 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.2 mt-10 -125.39 -23.84 4.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.703 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 79' ' ' TYR . 25.8 mtpp -114.74 174.48 5.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.958 -1.089 . . . . 0.0 109.98 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 37' ' ' SER . 98.3 t . . . . . 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.887 . . . . 0.0 111.008 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.0 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.014 0.435 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.768 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 17.3 m-30 -111.78 11.69 20.93 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 109.275 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 29' ' ' GLU . 20.3 t -61.54 119.15 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.841 -1.162 . . . . 0.0 108.617 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.04 52.34 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 21.8 mt-30 -74.53 135.81 42.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.947 . . . . 0.0 109.255 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.48 116.14 13.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.92 156.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.326 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.825 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -80.57 167.12 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.0 p -81.96 -37.61 26.44 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.567 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 105.14 139.3 9.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' VAL . 1.2 p -55.11 -50.26 69.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -1.161 . . . . 0.0 108.158 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 127' ' ' VAL . 2.7 t -46.32 -53.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.57 -48.04 79.04 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.468 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 53.2 m -62.51 -31.87 72.7 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.734 -0.604 . . . . 0.0 109.439 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.37 76.24 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.69 -1.256 . . . . 0.0 108.756 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.592 HG22 ' HG3' ' A' ' 56' ' ' MET . 28.2 m -74.75 -51.71 13.47 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.567 0.698 . . . . 0.0 109.729 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -50.94 -36.69 40.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.684 -0.635 . . . . 0.0 109.567 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.625 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 23.1 mt-30 -69.69 -58.91 3.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.665 -1.272 . . . . 0.0 107.969 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.058 HD11 HG22 ' A' ' 198' ' ' VAL . 78.0 mt -57.68 -20.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.592 ' HG3' HG22 ' A' ' 52' ' ' THR . 24.7 mtp -73.91 -35.82 64.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 28.9 tptt -77.49 -41.04 40.85 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.188 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 46.3 t80 -53.19 -26.76 18.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 108.813 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 65.2 m-70 -107.85 -26.66 10.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 110.426 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.604 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 85.7 m-20 47.97 58.39 5.12 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.5 t80 -83.91 -73.88 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 113.087 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.8 Cg_endo -68.23 101.61 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.026 0.688 . . . . 0.0 111.6 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.42 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 4.2 m120 -70.32 -20.51 63.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 51.5 tttt -134.74 142.25 46.7 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.89 147.47 37.3 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.928 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -86.81 -50.57 6.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.989 . . . . 0.0 109.992 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 44.9 tttt -148.49 152.73 37.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.943 . . . . 0.0 109.594 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 89' ' ' ALA . 12.9 m-20 -73.01 178.01 4.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 70' ' ' THR . 24.5 t80 -154.26 153.82 32.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.373 -0.83 . . . . 0.0 109.581 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.616 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -158.0 154.12 27.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.8 p90 -161.66 162.73 30.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 56.6 m -93.83 131.67 38.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.76 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -47.13 148.43 1.19 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 111.11 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.67 143.43 56.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.689 -0.632 . . . . 0.0 110.041 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 t -69.61 -2.76 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 110.087 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 m-20 -99.39 -3.72 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.026 -1.046 . . . . 0.0 109.39 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.76 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.6 t-20 -70.65 110.67 7.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.536 -0.728 . . . . 0.0 110.11 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.633 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -90.91 20.19 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 123.101 2.534 . . . . 0.0 108.559 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.633 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 45.2 m-85 -114.11 -28.34 7.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 111.879 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' ASN . 49.3 m-85 -118.06 164.83 14.52 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.3 m-80 -46.99 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.95 -47.48 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 111.044 175.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -77.38 54.31 4.65 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 N-CA-C 107.216 -1.879 . . . . 0.0 107.216 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HE3' ' HG ' ' A' ' 86' ' ' LEU . 13.3 tptt -106.68 107.08 17.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.812 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -100.93 140.17 35.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 108.983 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.7 mp -111.32 149.41 31.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -137.17 123.19 20.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.994 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.12 112.85 25.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -74.72 50.98 0.46 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.795 -1.191 . . . . 0.0 108.4 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 92.9 mt -52.6 -45.4 47.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.9 p -45.23 -26.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.738 -1.226 . . . . 0.0 109.047 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -111.38 37.76 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 108.929 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.65 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 11.9 mmt-85 -95.48 154.93 16.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.493 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.48 91.95 3.71 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.7 m-85 -81.19 90.26 6.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 110.573 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -78.92 92.18 4.88 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.604 ' CE3' ' HA ' ' A' ' 60' ' ' ASN . 67.0 m95 -60.72 -9.17 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.408 -0.808 . . . . 0.0 110.164 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -90.75 -20.39 22.46 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 30.9 m-20 -92.08 -34.62 14.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.527 HG12 ' HB1' ' A' ' 115' ' ' ALA . 25.9 mt -73.83 94.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.0 mt -71.47 153.03 93.94 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.496 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.4 Cg_endo -80.05 -30.31 2.25 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.808 2.339 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 t -136.7 128.15 28.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 68.1 m-85 -112.52 138.01 49.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.7 p -99.95 2.02 43.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 108.707 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.72 0.12 89.87 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -120.1 13.23 12.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 0.0 109.461 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 3.7 mp0 -72.5 170.25 14.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.9 173.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.125 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -79.72 -44.12 21.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.98 -47.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.21 -43.54 97.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.094 -1.004 . . . . 0.0 109.207 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 52.1 mttt -60.52 -36.22 77.86 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.429 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 6.2 ttm -60.07 -46.74 88.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.49 -50.4 73.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.187 -0.945 . . . . 0.0 110.727 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.748 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.3 tp -69.55 -46.96 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.612 -1.305 . . . . 0.0 109.734 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . 5.2 p -53.71 -40.26 65.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.003 . . . . 0.0 109.156 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.833 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.1 tp10 -69.81 -45.42 67.94 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.748 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.0 tp -51.42 -50.25 60.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.663 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -60.87 -46.8 89.19 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.768 -0.582 . . . . 0.0 109.816 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.67 -39.66 94.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.467 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -64.53 -46.12 84.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 119' ' ' LEU . 89.1 t -71.4 -58.92 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.53 0.681 . . . . 0.0 109.822 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.79 -48.25 13.36 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.9 mt -63.5 -58.05 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.3 p -47.58 -29.22 2.72 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.986 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.664 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.8 m -100.68 37.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 127' ' ' VAL . 91.1 m-20 37.1 50.19 0.91 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.679 0.752 . . . . 0.0 109.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 54.9 tpp -65.75 130.55 43.68 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.539 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 38.6 t0 -76.57 118.69 19.48 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 104.014 -2.588 . . . . 0.0 104.014 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.567 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 39.8 m-85 -101.19 110.6 22.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.673 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -150.14 -170.34 17.32 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 103.722 -3.751 . . . . 0.0 103.722 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.768 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.9 Cg_endo -62.54 -20.61 71.19 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 106.923 -1.991 . . . . 0.0 106.923 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -110.86 135.21 51.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.825 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 69.1 m -123.6 111.05 15.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 119.817 -1.802 . . . . 0.0 110.97 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.57 130.91 10.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 5.5 t -110.1 -163.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.879 -1.365 . . . . 0.0 107.433 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.576 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -89.8 -55.92 3.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.621 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 142.92 -136.2 6.95 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.051 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.658 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 13.8 m -56.62 -45.16 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.858 -0.789 . . . . 0.0 112.108 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 140' ' ' SER . 14.7 p -46.11 -43.35 14.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.946 -1.096 . . . . 0.0 109.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.8 mmt180 -82.34 -40.25 21.67 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 1.008 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.3 t -68.33 -54.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.7 pp0? -56.73 -33.95 67.02 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.268 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.1 ttp180 -77.15 -48.52 17.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.95 78.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.959 . . . . 0.0 110.043 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 157' ' ' VAL . 50.7 mt -58.77 -47.93 83.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.088 -1.008 . . . . 0.0 109.475 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 14.0 mtmt -87.17 -35.65 18.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.859 -1.15 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 43.2 mt-10 -77.68 -55.28 5.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.406 -1.434 . . . . 0.0 111.823 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 34.2 m120 -84.35 -40.39 17.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.966 -1.084 . . . . 0.0 111.578 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.442 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 33.6 m-85 -102.51 -2.25 28.97 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.767 -1.208 . . . . 0.0 110.665 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.928 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.0 36.65 43.49 Favored Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.163 -0.961 . . . . 0.0 112.011 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.3 m-85 -62.01 163.85 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.242 -1.74 . . . . 0.0 107.993 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.9 t30 -47.3 147.01 1.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.452 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.37 4.71 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.23 -0.918 . . . . 0.0 108.698 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.536 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 16.7 p -54.08 -16.21 1.86 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.417 -0.802 . . . . 0.0 109.955 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.7 t -65.3 120.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.787 -1.195 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.799 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.9 p-80 -147.21 157.57 43.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.027 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 6.7 tt0 -101.93 155.81 17.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 246' ' ' SER . 2.6 pt -138.57 154.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.88 97.59 7.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 110.569 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 5.3 tpt180 -47.77 -31.58 5.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.25 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.541 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -63.7 -23.64 67.32 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -103.64 2.03 32.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.124 -1.221 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -117.92 140.57 49.54 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.63 -1.294 . . . . 0.0 109.81 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -67.98 139.97 56.37 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 59.2 tttt -38.04 -46.78 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -56.83 12.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 169' ' ' ASP . 1.7 m-20 -63.43 -23.38 67.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 109.268 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.798 ' NE1' HD11 ' A' ' 174' ' ' ILE . 66.8 t-105 -72.53 -43.63 63.28 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 175' ' ' ASP . 34.3 mt-10 -62.71 -26.62 68.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.34 81.94 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -61.22 -42.4 98.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -0.851 . . . . 0.0 108.881 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.981 HD13 ' CD1' ' A' ' 199' ' ' ILE . 28.7 mt -75.99 -61.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.713 . . . . 0.0 110.889 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.4 OUTLIER -49.29 -51.58 33.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.967 -1.083 . . . . 0.0 109.601 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -52.1 -40.69 61.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.882 -1.136 . . . . 0.0 107.988 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.58 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 5.0 mm-40 -60.88 -53.96 50.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.603 -0.686 . . . . 0.0 109.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.97 ' HB2' HG21 ' A' ' 4' ' ' VAL . 5.8 mt -65.69 -24.68 67.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.43 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 24.8 p -52.31 -45.17 65.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.974 -1.079 . . . . 0.0 108.193 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 19.9 mt-30 -94.29 39.09 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.477 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.3 m-20 42.52 51.2 4.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 10.2 mt-30 -123.94 105.14 32.32 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.447 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.1 Cg_endo -63.93 173.58 4.69 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.103 1.869 . . . . 0.0 112.653 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 63.9 t -129.84 142.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.242 1.02 . . . . 0.0 112.236 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 1.008 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -93.29 121.17 34.39 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.675 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 14.0 t80 -122.69 159.42 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.549 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -152.52 119.86 5.94 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.594 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 195' ' ' HIS . . . -91.97 106.03 3.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 10.1 t -67.11 160.76 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.25 -1.147 . . . . 0.0 110.644 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -172.34 -145.65 5.04 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -30.45 20.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.292 . . . . 0.0 110.229 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.51 -22.2 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.3 -169.61 23.94 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -77.38 112.55 3.53 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.176 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.5 t-80 -77.44 113.73 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -105.98 164.34 12.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.782 1.277 . . . . 0.0 114.036 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' ' 186' ' ' TYR . 43.5 p90 -162.64 -160.68 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.058 HG22 HD11 ' A' ' 55' ' ' ILE . 5.7 t -139.61 139.35 38.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.206 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.981 ' CD1' HD13 ' A' ' 174' ' ' ILE . 40.0 mt -105.66 108.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 10.2 p-10 -120.87 32.43 5.97 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.428 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 4' ' ' VAL . . . 178.17 166.16 34.11 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.267 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -145.77 164.26 32.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.65 2.15 3.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.369 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.8 -31.06 4.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 10.0 mtt-85 -87.49 39.19 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.033 -1.275 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 17.0 m120 61.71 16.18 7.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 110.094 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -114.43 138.2 50.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 9.2 m-85 -123.17 162.48 22.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.337 -0.852 . . . . 0.0 110.285 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 59.2 t-80 -92.11 139.63 30.44 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 212' ' ' TRP . 2.7 t -140.23 157.96 25.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.867 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.544 ' HB2' HD12 ' A' ' 8' ' ' LEU . 43.9 t-20 -117.95 85.23 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.71 ' CE2' HG11 ' A' ' 210' ' ' VAL . 19.7 m95 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.146 -0.972 . . . . 0.0 112.019 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 13.5 p -167.53 149.88 5.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 110.085 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.409 ' H ' HG13 ' A' ' 160' ' ' ILE . . . -129.98 169.15 15.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.249 1.024 . . . . 0.0 109.751 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 185' ' ' TYR . 11.4 t -117.95 119.9 62.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.799 HG23 ' NE2' ' A' ' 158' ' ' HIS . 30.1 m -119.17 150.23 21.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.286 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 84.82 33.2 19.33 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.626 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 46.8 mt -79.18 90.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.341 -1.093 . . . . 0.0 109.974 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.76 152.04 12.87 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.599 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.316 2.011 . . . . 0.0 110.447 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.772 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.9 t . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 200' ' ' ASP . 49.2 mmtt -75.07 178.52 5.61 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.032 -1.043 . . . . 0.0 108.441 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 1.6 t -77.6 103.82 7.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.099 -1.001 . . . . 0.0 109.208 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.726 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.7 mt -57.15 -49.0 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.871 . . . . 0.0 108.923 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.6 mt -56.5 -42.18 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.739 -1.226 . . . . 0.0 108.826 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 54.8 t0 -67.48 -36.31 80.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.151 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -16.79 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.034 -1.042 . . . . 0.0 108.266 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.8 mtpt -122.32 18.32 10.63 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.25 43.12 7.24 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 58' ' ' TYR . 57.6 mt -87.72 107.37 17.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.255 1.026 . . . . 0.0 110.23 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.8 m80 -135.02 86.97 2.29 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.7 m-30 -92.95 -179.9 5.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 110.768 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -147.17 -163.81 1.85 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.0 mt-30 -124.88 -20.8 4.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.929 -1.107 . . . . 0.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.38 -35.62 1.29 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.43 -1.367 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.835 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -142.74 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.529 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.132 -177.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.835 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.6 Cg_endo -72.98 1.83 6.11 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 CA-C-N 122.363 1.88 . . . . 0.0 109.559 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 10.4 m-85 -76.46 -31.12 57.63 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.953 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 10.8 p-10 -94.09 17.33 12.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.596 -1.315 . . . . 0.0 109.566 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 26.7 mt -72.28 -3.03 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.978 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.0 mt -127.13 -7.56 5.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.5 p -61.9 164.93 8.91 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.674 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.6 Cg_endo -71.43 138.89 33.58 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.435 2.09 . . . . 0.0 112.11 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.8 t -81.11 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.646 -0.659 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.738 HD11 ' C ' ' A' ' 132' ' ' GLY . 17.1 mt -78.11 148.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.499 -0.751 . . . . 0.0 110.523 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.8 mt-10 -125.73 -22.12 4.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.759 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.3 mtpp -121.19 173.34 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.992 -1.068 . . . . 0.0 109.893 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 37' ' ' SER . 98.7 t . . . . . 0 N--CA 1.487 1.417 0 O-C-N 121.401 -0.812 . . . . 0.0 110.676 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.471 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.022 0.439 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.3 m-85 -124.45 16.93 8.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.084 -1.01 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 29' ' ' GLU . 47.2 t -63.26 143.59 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.041 -1.037 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.07 -4.23 67.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.0 mt-30 -85.46 129.43 34.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -1.201 . . . . 0.0 109.595 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 25' ' ' THR . 1.8 m-70 -73.11 113.39 10.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.76 160.0 1.0 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.097 -1.041 . . . . 0.0 109.538 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.48 170.19 17.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.697 0.761 . . . . 0.0 109.793 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.701 ' O ' ' HE3' ' A' ' 129' ' ' MET . 29.8 p -81.62 -34.98 30.57 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.533 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 104.28 136.65 8.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.9 p -55.18 -51.01 67.89 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.393 -1.063 . . . . 0.0 108.501 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.619 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 51.1 t -47.48 -52.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.38 -50.67 72.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.11 0.957 . . . . 0.0 109.437 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 99.1 m -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.931 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.21 -41.91 84.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.734 -1.229 . . . . 0.0 108.119 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 ' HG3' ' A' ' 56' ' ' MET . 43.8 m -74.64 -53.25 9.69 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.447 0.641 . . . . 0.0 110.405 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.0 -37.71 46.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.572 -0.705 . . . . 0.0 109.585 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 32.0 mt-30 -63.05 -45.67 91.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 198' ' ' VAL . 53.1 mt -70.12 -28.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.581 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.3 mtp -66.97 -40.78 87.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HD3' HG22 ' A' ' 100' ' ' ILE . 29.9 tptt -70.33 -41.35 73.34 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 49.0 t80 -54.05 -30.4 47.76 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 43.4 m-70 -107.39 -24.03 11.99 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.05 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.63 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 79.2 m-20 44.3 54.17 6.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.9 t80 -78.75 -70.65 0.19 Allowed Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.308 -175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.9 Cg_endo -70.23 100.81 0.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 CA-C-N 118.929 0.653 . . . . 0.0 111.609 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -68.97 -20.58 64.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -134.33 141.87 47.06 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.19 151.84 26.22 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.098 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -89.14 -60.97 1.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -1.043 . . . . 0.0 110.186 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 49.0 tttt -135.95 134.46 38.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 109.598 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 4.5 m-20 -58.2 159.79 5.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.454 -0.779 . . . . 0.0 109.605 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 31.9 t80 -144.43 139.65 28.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -143.19 153.82 43.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.084 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.6 p90 -154.46 155.41 34.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.886 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 98.4 m -92.83 130.07 38.55 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.787 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -45.18 148.91 0.54 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.935 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 t -61.6 142.31 57.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.818 -0.551 . . . . 0.0 109.835 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -68.65 -3.38 11.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.038 -1.039 . . . . 0.0 109.75 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -98.7 -7.69 27.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.787 ' ND2' HD21 ' A' ' 73' ' ' LEU . 30.2 t-20 -70.49 110.1 6.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -89.26 16.28 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.968 2.445 . . . . 0.0 110.483 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 90.9 m-85 -106.01 -22.65 12.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.132 -0.98 . . . . 0.0 111.315 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.8 m-85 -122.34 162.56 21.32 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.561 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.4 m-80 -46.02 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.45 -46.04 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.451 175.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.3 56.48 5.01 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 N-CA-C 107.51 -1.765 . . . . 0.0 107.51 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.98 102.97 12.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.116 -178.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.14 134.9 43.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.656 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.71 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -108.15 144.56 35.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 17.7 t80 -134.0 130.23 37.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.007 -1.058 . . . . 0.0 110.365 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.68 113.82 27.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.84 53.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.642 -1.286 . . . . 0.0 108.458 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 9.8 mt -52.89 -52.73 25.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 4.1 p -45.55 -26.6 0.61 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.342 -1.473 . . . . 0.0 109.219 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -111.78 19.78 17.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 109.534 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 13.5 mmt-85 -76.83 147.55 37.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 110.378 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 90.34 3.31 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-85 -81.02 96.95 7.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.548 -0.72 . . . . 0.0 110.617 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.6 t-20 -80.53 88.69 5.65 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.63 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 39.1 m95 -61.03 -8.98 3.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.446 -0.784 . . . . 0.0 110.411 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -19.17 23.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.6 m-20 -100.24 -26.29 13.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.623 HG22 ' HD3' ' A' ' 57' ' ' LYS . 66.6 mt -73.88 67.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.7 mt -46.83 150.12 1.37 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.56 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.4 Cg_endo -78.84 -21.2 9.86 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.759 2.306 . . . . 0.0 110.587 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 134.47 26.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.007 -1.058 . . . . 0.0 109.684 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 89.3 m-85 -124.49 137.9 54.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.923 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.9 p -99.04 -0.09 42.65 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 81.45 10.02 85.07 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.17 5.9 10.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.395 -1.062 . . . . 0.0 108.956 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.14 167.72 19.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.694 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -57.79 171.71 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.195 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -76.9 -33.97 57.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -51.99 -60.42 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 2.1 mp0 -62.45 -35.16 78.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 0.0 109.376 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' SER . 26.7 mttt -63.8 -43.47 96.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 108.291 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.469 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 28.7 ttm -59.93 -38.24 81.8 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -57.16 -68.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.535 -0.728 . . . . 0.0 110.403 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.73 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -59.9 -39.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.471 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 25.2 p -53.61 -43.74 68.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.956 -1.09 . . . . 0.0 109.635 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 24' ' ' LEU . 4.4 tt0 -69.88 -42.49 73.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 108.518 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.7 tp -52.15 -51.6 56.98 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.693 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.5 mmt -59.7 -45.7 91.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.635 -0.666 . . . . 0.0 109.489 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.515 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.75 -38.35 90.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.6 m-20 -68.67 -48.43 63.97 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 56' ' ' MET . 55.9 t -67.12 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.41 -42.39 13.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.9 mt -69.72 -57.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.346 -1.091 . . . . 0.0 108.325 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.53 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.1 p -45.47 -27.64 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.429 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.6 m -105.0 32.76 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.139 -0.976 . . . . 0.0 109.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.565 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 43.1 m-20 40.71 44.99 1.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.343 -0.848 . . . . 0.0 109.651 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.701 ' HE3' ' O ' ' A' ' 45' ' ' THR . 41.1 tpp -56.86 133.09 54.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 111.145 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 18.6 t0 -79.56 122.66 26.76 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.82 117.79 35.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.312 1.053 . . . . 0.0 113.064 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.738 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.6 -164.56 12.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 104.261 -3.536 . . . . 0.0 104.261 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.617 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -61.96 -31.5 84.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 105.582 -2.507 . . . . 0.0 105.582 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.0 m -109.7 141.54 42.14 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.5 m -119.2 109.84 16.33 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 119.966 -1.709 . . . . 0.0 109.919 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.83 136.12 13.24 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 13.1 t -117.87 -162.59 0.89 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.234 -1.156 . . . . 0.0 108.335 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.76 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.02 -57.21 2.8 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.553 ' HA3' ' NE2' ' A' ' 187' ' ' GLN . . . 131.46 -131.05 6.21 Favored Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.393 -1.384 . . . . 0.0 112.042 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 36.8 m -47.83 -58.62 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.891 -0.77 . . . . 0.0 111.786 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' SER . 11.1 p -46.75 -36.81 7.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 0.0 108.95 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.76 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.9 mmt-85 -80.37 -47.88 13.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.01 0.909 . . . . 0.0 108.92 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 185' ' ' TYR . 93.9 t -67.85 -56.57 12.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.7 pp0? -56.48 -33.73 66.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.171 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.512 ' NE ' ' OE2' ' A' ' 149' ' ' GLU . 12.1 ttt85 -77.1 -52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.53 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.56 -35.95 82.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.086 -1.009 . . . . 0.0 110.047 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.596 HD13 HG12 ' A' ' 251' ' ' ILE . 40.5 mt -56.41 -48.44 76.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.6 mtmt -86.45 -39.13 16.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.133 -0.979 . . . . 0.0 110.407 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.512 ' OE2' ' NE ' ' A' ' 145' ' ' ARG . 54.1 mt-10 -67.97 -54.46 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 112.007 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 20.7 m120 -92.75 -40.87 10.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.703 -1.248 . . . . 0.0 111.746 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.2 m-85 -99.56 10.59 41.08 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.715 -1.241 . . . . 0.0 110.514 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 36.04 39.12 0.27 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.55 -0.719 . . . . 0.0 112.875 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.5 m-85 -61.92 162.88 8.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.142 -1.799 . . . . 0.0 107.364 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.1 t-20 -47.48 139.02 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.87 -1.144 . . . . 0.0 109.414 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.407 ' NE2' ' HD2' ' A' ' 148' ' ' LYS . 9.2 tp-100 -53.72 -18.97 3.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 58.7 p -53.07 -18.23 1.99 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.8 t -58.33 123.7 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 109.158 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.931 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.7 p-80 -143.87 154.82 43.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.086 -1.009 . . . . 0.0 109.404 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.0 tt0 -100.73 154.2 18.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.36 -0.838 . . . . 0.0 110.509 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.595 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 10.5 pt -135.96 142.37 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.9 m-80 -107.25 100.49 9.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.873 -1.142 . . . . 0.0 111.065 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.639 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.9 tpt180 -44.01 -41.22 5.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.154 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.09 -23.17 59.21 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ASN . 0.8 OUTLIER -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.063 -1.257 . . . . 0.0 111.576 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.92 174.94 5.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.516 -1.365 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -103.91 134.28 47.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 166' ' ' SER . 18.3 ttmt -31.91 -45.62 0.1 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.101 0.477 . . . . 0.0 110.869 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -64.17 -63.69 1.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.927 -1.108 . . . . 0.0 109.823 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.22 -15.67 57.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.359 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.9 t-105 -74.85 -46.95 33.0 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.177 -0.952 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 174' ' ' ILE . 43.4 mt-10 -69.53 -30.48 68.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.091 -1.006 . . . . 0.0 108.606 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.66 -45.43 73.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 108.751 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -61.13 -40.28 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 108.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.886 HG23 HG21 ' A' ' 184' ' ' VAL . 13.7 mt -76.13 -60.94 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.557 -0.714 . . . . 0.0 111.119 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.03 -46.67 44.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 109.24 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.756 ' HZ3' ' HB3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -51.35 -48.67 62.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.4 mm-40 -54.87 -51.07 67.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.772 ' HB3' HG11 ' A' ' 4' ' ' VAL . 17.6 mt -68.2 -33.51 74.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.205 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 53.4 p -51.99 -30.78 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.518 HE21 ' HD2' ' A' ' 176' ' ' LYS . 1.2 mt-30 -102.41 33.65 3.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.534 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.6 m120 40.67 46.68 2.27 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.816 0.817 . . . . 0.0 108.918 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 14.7 mt-30 -123.69 111.8 29.35 Favored Pre-proline 0 C--N 1.294 -1.815 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.7 Cg_endo -65.09 169.66 11.7 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.803 1.668 . . . . 0.0 112.653 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.886 HG21 HG23 ' A' ' 174' ' ' ILE . 45.9 t -121.12 132.79 69.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.58 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.713 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -81.57 116.39 21.31 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 175.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 6.5 t80 -121.97 157.27 31.65 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.809 -1.182 . . . . 0.0 110.192 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 4.8 pt20 -167.06 136.05 2.76 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.6 1.66 Allowed Glycine 0 C--N 1.289 -2.031 0 N-CA-C 107.675 -2.17 . . . . 0.0 107.675 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 190' ' ' GLY . 6.8 t -69.93 166.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -1.117 . . . . 0.0 111.419 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.547 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.53 -129.11 1.08 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -88.11 -36.96 16.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.251 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.0 m -79.92 -15.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.974 -1.079 . . . . 0.0 111.284 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.88 -167.63 22.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -83.47 101.51 2.36 Favored Glycine 0 N--CA 1.485 1.929 0 O-C-N 121.049 -1.265 . . . . 0.0 110.781 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 17.3 t-80 -71.27 121.11 17.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -113.08 160.67 17.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.517 -1.273 . . . . 0.0 113.361 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.809 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -156.91 175.19 14.41 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 55' ' ' ILE . 92.8 t -121.14 135.69 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.575 -1.328 . . . . 0.0 112.094 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.712 HD13 HG21 ' A' ' 174' ' ' ILE . 73.6 mt -99.9 123.13 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -134.17 32.76 3.41 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.131 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.618 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -171.69 167.68 40.75 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 117.709 -2.186 . . . . 0.0 112.345 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.538 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.17 148.0 27.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ARG . 0.5 OUTLIER -121.61 24.26 9.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.755 -1.216 . . . . 0.0 110.357 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 43.05 26.45 0.49 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 14.3 mtt-85 -142.43 21.44 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -1.118 . . . . 0.0 109.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 9.4 t30 80.6 20.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.563 -0.711 . . . . 0.0 109.65 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.27 128.26 49.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.435 ' HD2' ' CD1' ' A' ' 178' ' ' LEU . 25.7 m-85 -120.7 163.51 17.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.0 . . . . 0.0 109.557 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 37.1 t-80 -93.39 116.11 28.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.809 HG13 ' CD1' ' A' ' 197' ' ' PHE . 20.7 t -114.51 140.02 37.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.105 -0.997 . . . . 0.0 111.165 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 8' ' ' LEU . 28.2 t-20 -108.64 92.32 4.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.476 ' O ' ' O ' ' A' ' 211' ' ' ASN . 3.1 m95 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 0.0 110.404 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.552 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 3.9 mt-30 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 56.4 p -159.15 157.39 30.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.029 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.14 166.47 24.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.4 -0.812 . . . . 0.0 110.021 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 46.9 t -119.29 114.59 45.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.931 HG23 ' CE1' ' A' ' 158' ' ' HIS . 16.6 m -114.69 147.85 17.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 O-C-N 121.282 -0.886 . . . . 0.0 110.402 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 96.12 47.14 2.48 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.042 -1.551 . . . . 0.0 109.881 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.602 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.9 mt -103.22 96.11 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -1.185 . . . . 0.0 110.173 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.39 146.77 8.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.632 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.1 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.206 1.937 . . . . 0.0 110.452 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 202' ' ' ALA . 12.0 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.212 0.53 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 200' ' ' ASP . 58.3 mmtt -77.01 -179.51 5.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.526 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 34.7 t -77.79 102.42 7.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.687 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 35.7 mt -57.63 -49.65 75.75 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.8 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 211' ' ' ASN . 11.9 mt -56.02 -42.46 76.52 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.776 -1.202 . . . . 0.0 108.641 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -68.34 -36.19 78.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.058 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -58.08 -15.36 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.102 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' CB ' HG13 ' A' ' 13' ' ' ILE . 9.1 mtpt -121.95 23.54 9.97 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.97 39.89 5.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 58' ' ' TYR . 40.2 mt -86.03 110.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.355 1.074 . . . . 0.0 110.408 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 102' ' ' PRO . 6.7 m-70 -133.45 99.44 4.51 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 6.4 m-30 -103.66 176.0 5.29 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.012 . . . . 0.0 111.513 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -146.98 -175.17 4.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mt-30 -118.37 -20.96 8.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.943 -1.098 . . . . 0.0 109.977 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.42 -34.13 1.49 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.94 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.838 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.0 -140.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.021 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.872 ' HA ' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -74.32 3.22 5.42 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 CA-C-N 122.55 1.947 . . . . 0.0 109.325 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.1 m-85 -78.63 -30.66 46.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.478 -0.764 . . . . 0.0 109.068 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 20.6 p-10 -96.12 12.86 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.545 -1.347 . . . . 0.0 109.341 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.872 HD12 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -67.79 -8.61 37.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.918 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD12 ' OG ' ' A' ' 117' ' ' SER . 8.7 mt -126.68 -6.23 6.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 0.0 109.703 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.606 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.8 p -61.14 165.95 5.7 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -71.1 136.81 30.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.013 1.809 . . . . 0.0 111.609 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.16 149.97 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.614 0.721 . . . . 0.0 110.136 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 132' ' ' GLY . 16.8 mt -77.77 148.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.565 -0.709 . . . . 0.0 110.544 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -125.67 -20.82 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.705 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 79' ' ' TYR . 44.7 mtpt -123.72 172.01 9.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.89 -1.131 . . . . 0.0 109.949 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 37' ' ' SER . 75.0 t . . . . . 0 C--N 1.304 -1.392 0 O-C-N 121.397 -0.814 . . . . 0.0 110.94 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 31' ' ' VAL . 5.0 t . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -123.81 19.52 9.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.084 -1.01 . . . . 0.0 109.798 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.6 t -67.74 145.08 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.557 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.15 -1.9 73.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.1 mt-30 -88.03 130.3 35.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 109.813 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -73.06 112.34 9.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.77 158.28 1.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.847 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 135' ' ' SER . . . -71.59 166.38 21.97 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.67 HG21 ' SD ' ' A' ' 120' ' ' MET . 41.1 p -80.45 -29.15 37.54 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 99.08 136.85 9.53 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.6 p -54.67 -52.94 60.79 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.217 -1.167 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.636 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 54.7 t -46.91 -52.53 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.46 -51.29 70.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.969 0.89 . . . . 0.0 109.861 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.771 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -64.21 -32.31 73.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.664 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.44 88.48 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.648 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.3 m -74.59 -53.63 9.01 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.701 0.762 . . . . 0.0 110.05 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.22 -38.43 52.41 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.702 -0.624 . . . . 0.0 109.837 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -63.91 -46.88 82.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.13 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 37.7 mt -67.87 -24.49 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.5 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.6 mtp -73.57 -32.26 64.06 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.588 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 26.0 tptt -75.82 -44.34 41.6 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.687 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 33.8 t80 -53.61 -27.78 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.75 -0.594 . . . . 0.0 110.023 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 35.0 m-70 -107.5 -26.09 11.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.288 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.635 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 90.2 m-20 44.54 59.2 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.0 t80 -84.88 -72.22 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 37.2 Cg_endo -69.77 105.76 1.54 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 CA-C-N 118.955 0.663 . . . . 0.0 111.952 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 8.0 m120 -72.14 -23.59 61.32 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -135.89 137.33 41.32 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.67 152.06 31.8 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.421 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 66' ' ' LEU . 2.6 mt -92.31 -42.01 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.406 -1.055 . . . . 0.0 109.961 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 11.7 ttpp -152.29 136.41 16.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.934 -1.104 . . . . 0.0 110.334 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -59.41 164.66 3.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.629 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 70' ' ' THR . 20.6 t80 -141.78 152.05 43.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 3.4 t -151.22 166.06 32.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.927 -1.108 . . . . 0.0 110.192 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.745 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.6 p90 -169.12 154.03 5.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.443 -0.786 . . . . 0.0 109.32 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.9 m -92.81 136.06 33.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.794 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -52.34 153.17 3.03 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.335 -0.853 . . . . 0.0 111.335 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -61.33 137.0 58.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.33 0.586 . . . . 0.0 110.016 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 p -64.58 -7.74 11.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.7 t-20 -99.66 -4.21 31.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.029 -1.045 . . . . 0.0 109.717 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.794 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.4 t-20 -69.9 109.97 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.774 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.6 15.55 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.83 2.353 . . . . 0.0 109.991 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 75.0 m-85 -105.71 -27.26 11.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' ASN . 19.2 m-85 -118.91 164.43 15.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.636 -1.29 . . . . 0.0 107.774 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.9 m-80 -47.39 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.64 -48.2 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 175.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.9 56.71 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 N-CA-C 106.958 -1.978 . . . . 0.0 106.958 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.46 104.1 13.76 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.13 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.96 130.65 46.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.824 . . . . 0.0 109.441 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -102.47 137.73 40.33 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -124.96 129.08 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.375 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.18 114.12 27.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 50.03 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.665 -1.272 . . . . 0.0 108.569 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.8 mt -52.48 -51.49 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.325 -0.859 . . . . 0.0 109.085 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.92 -29.24 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.065 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.15 30.21 7.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 6.4 mmt-85 -85.5 150.44 24.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.505 ' HA ' ' NE2' ' A' ' 94' ' ' GLN . 1.9 mm100 -116.9 91.09 3.48 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.6 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.3 m-85 -81.08 91.31 6.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.472 -0.767 . . . . 0.0 111.134 -176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 100' ' ' ILE . 38.2 t-20 -79.76 87.14 5.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.635 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 63.2 m95 -61.23 -8.32 3.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.36 -17.73 26.79 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 8.5 m-20 -99.6 -27.72 13.55 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.612 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 58.0 mt -74.41 66.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 101' ' ' LEU . 24.3 mt -46.71 149.25 1.52 Allowed Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.854 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.7 Cg_endo -78.67 -23.97 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.74 2.293 . . . . 0.0 110.409 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.19 126.69 23.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 108.994 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 116' ' ' ILE . 54.8 m-85 -113.51 148.82 35.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' OE1' ' A' ' 108' ' ' GLU . 36.1 p -103.5 -9.83 19.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.56 -0.11 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -120.11 1.06 10.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -1.171 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' OE1' ' OG ' ' A' ' 105' ' ' SER . 0.1 OUTLIER -64.86 165.29 10.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.808 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.38 166.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -72.37 -34.45 67.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.36 -58.97 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.435 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.63 -36.28 80.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 0.0 108.897 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 21.4 mttt -65.71 -44.19 86.85 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.446 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.8 ttm -59.28 -35.72 74.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.09 -66.63 0.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.61 -0.681 . . . . 0.0 109.619 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.699 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.4 tp -65.74 -40.15 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.815 . . . . 0.0 109.552 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 11.2 p -57.21 -41.89 80.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.222 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.621 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 22.9 tt0 -69.72 -40.59 76.13 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.3 tp -54.84 -52.32 63.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.771 ' CE ' HG23 ' A' ' 50' ' ' THR . 1.6 mmt -58.51 -44.84 89.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.46 -38.84 92.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.649 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 5.9 m-20 -69.22 -43.02 74.91 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 127' ' ' VAL . 55.3 t -71.21 -62.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.609 -0.682 . . . . 0.0 109.774 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.31 -45.77 16.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.8 mt -65.03 -57.62 10.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 108.664 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 5.2 p -46.32 -31.08 2.36 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.771 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.0 m -101.46 37.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 109.626 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.8 m-20 39.36 42.14 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.482 -0.761 . . . . 0.0 109.782 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.648 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -55.59 128.23 33.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.405 -0.809 . . . . 0.0 111.446 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 21.6 t0 -77.71 126.07 30.31 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.658 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.0 m-85 -108.18 120.72 43.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.759 -1.177 . . . . 0.0 113.51 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.729 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.9 -164.0 11.71 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 103.834 -3.706 . . . . 0.0 103.834 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -61.38 -30.26 86.99 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 N-CA-C 105.445 -2.56 . . . . 0.0 105.445 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.54 46.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -115.71 112.83 22.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.853 -1.779 . . . . 0.0 109.851 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.29 133.72 11.81 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.549 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 16.0 t -118.27 -162.11 0.87 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -1.182 . . . . 0.0 108.761 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.836 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.21 -60.51 1.83 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.544 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 136.29 -133.71 6.74 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.888 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.565 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -48.11 -57.83 5.31 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.797 -0.825 . . . . 0.0 111.911 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 1.7 p -47.31 -36.72 9.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.752 -1.217 . . . . 0.0 109.015 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.836 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 25.8 mmt180 -79.84 -46.69 16.41 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.064 0.935 . . . . 0.0 108.797 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 185' ' ' TYR . 79.5 t -68.09 -56.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.275 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.53 -34.53 67.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 109.357 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' CG ' ' OE2' ' A' ' 149' ' ' GLU . 34.1 ttm-85 -77.36 -42.89 34.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.944 -1.098 . . . . 0.0 109.836 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.68 71.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.601 HD13 HG12 ' A' ' 251' ' ' ILE . 53.7 mt -60.85 -48.44 81.78 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.521 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.8 mtmt -86.55 -44.25 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.07 -1.019 . . . . 0.0 110.583 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.504 ' OE2' ' CG ' ' A' ' 145' ' ' ARG . 82.1 mt-10 -67.4 -47.93 68.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.879 -1.138 . . . . 0.0 111.498 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -94.37 -44.19 8.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 111.671 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.6 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 31.1 m-85 -101.6 16.6 25.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 110.618 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 33.32 39.86 0.1 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 121.594 -0.691 . . . . 0.0 113.16 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.4 m-85 -62.04 159.81 13.72 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 120.529 2.165 . . . . 0.0 107.154 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 51.4 t-20 -47.06 143.8 2.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.737 -1.227 . . . . 0.0 109.372 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.64 -17.86 2.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.398 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.495 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 18.9 p -53.29 -17.08 1.55 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 109.876 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 251' ' ' ILE . 38.8 t -64.59 127.88 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.75 -1.219 . . . . 0.0 109.438 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.843 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.2 p-80 -147.37 149.58 33.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -100.69 139.92 35.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.921 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 16.4 pt -122.5 158.04 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m-80 -116.88 103.65 10.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.183 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 8.2 tpt180 -47.46 -28.65 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.602 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.3 75.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -103.96 16.17 26.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.013 -1.287 . . . . 0.0 111.675 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -121.45 155.86 33.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.57 -1.331 . . . . 0.0 109.89 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -84.86 139.62 31.76 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.8 ttmm -36.79 -47.98 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.559 -0.713 . . . . 0.0 110.704 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.93 -56.74 13.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 110.356 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.54 -21.5 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 110.123 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.921 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.66 -40.49 48.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.915 -1.116 . . . . 0.0 109.333 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.48 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 43.3 mt-10 -73.87 -48.38 31.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -48.27 -40.62 25.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 11.2 mm100 -61.14 -48.14 82.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.713 HG23 HG21 ' A' ' 184' ' ' VAL . 22.8 mt -73.21 -49.99 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.656 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 179' ' ' SER . 1.5 m-20 -52.57 -42.9 64.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.2 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -52.18 -46.26 65.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.722 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 65.6 mm-40 -56.19 -51.7 67.07 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.701 ' HB3' HG11 ' A' ' 4' ' ' VAL . 40.9 mt -68.69 -24.13 64.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 175' ' ' ASP . 32.1 p -52.58 -38.2 59.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.754 -1.217 . . . . 0.0 107.802 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 28.8 mt-30 -102.21 31.76 3.83 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.539 ' C ' HD13 ' A' ' 7' ' ' LEU . 17.6 m-80 48.2 51.22 15.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 109.148 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 27.2 mt-30 -124.08 116.09 27.41 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.9 Cg_endo -64.76 166.59 17.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.07 1.847 . . . . 0.0 112.497 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.713 HG21 HG23 ' A' ' 174' ' ' ILE . 77.0 t -125.55 140.73 47.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.102 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -86.02 120.17 27.12 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 4.2 t80 -123.63 161.41 25.09 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.061 -1.024 . . . . 0.0 109.5 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.7 pt20 -167.63 130.29 1.62 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 117.591 -1.644 . . . . 0.0 112.007 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -94.11 114.06 4.68 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 190' ' ' GLY . 21.5 t -71.89 167.69 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.902 -1.351 . . . . 0.0 110.647 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -174.87 -141.18 3.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -37.53 16.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.026 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.1 m -80.75 1.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.94 -1.1 . . . . 0.0 111.153 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 118.86 -162.21 13.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -89.84 106.01 3.28 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.721 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.75 125.4 27.05 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.636 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -114.1 160.46 18.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.612 -1.235 . . . . 0.0 112.923 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.803 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.9 p90 -156.66 168.76 26.42 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 71.5 t -114.18 136.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.755 -1.216 . . . . 0.0 112.158 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 208' ' ' TYR . 39.5 mt -100.05 114.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.4 p30 -130.44 37.59 3.84 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.304 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -177.13 169.73 42.13 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.09 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -153.25 136.59 15.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -97.1 0.14 48.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.465 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 88.67 -26.94 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -100.18 51.08 0.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -1.136 . . . . 0.0 109.854 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.48 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 7.5 m120 60.9 20.79 11.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 3.2 m-85 -111.73 137.94 48.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.083 -1.011 . . . . 0.0 109.406 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.6 ' HB3' HG23 ' A' ' 199' ' ' ILE . 4.6 m-85 -122.87 164.3 18.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 110.097 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.9 t-80 -92.45 120.28 32.79 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.898 HG11 ' CZ3' ' A' ' 212' ' ' TRP . 26.7 t -114.73 145.08 20.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.112 -0.992 . . . . 0.0 111.802 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.509 ' HB2' HD12 ' A' ' 8' ' ' LEU . 16.4 t-20 -112.34 79.18 1.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.898 ' CZ3' HG11 ' A' ' 210' ' ' VAL . 32.9 m95 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 120.903 -1.123 . . . . 0.0 109.572 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 80.4 mt-30 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 79.8 p -161.71 161.67 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.513 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.64 144.79 35.93 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.47 0.652 . . . . 0.0 109.57 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.8 t -105.2 116.46 49.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.843 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.1 m -117.05 139.12 45.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.318 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 90.7 47.17 3.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.619 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 mt -94.5 98.25 7.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.16 149.34 10.05 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.625 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.283 1.989 . . . . 0.0 110.358 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.79 HG11 ' HB3' ' A' ' 178' ' ' LEU . 86.8 t . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 20.3 mmtp -76.4 -179.77 5.36 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 108.545 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 9' ' ' ASP . 27.6 t -77.82 105.65 9.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.652 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.707 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 34.3 mt -58.53 -50.44 73.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -0.86 . . . . 0.0 108.824 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.1 mt -54.6 -39.2 67.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 0.0 108.516 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 6.0 t0 -67.85 -42.21 81.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 109.801 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 44.0 p -58.04 -14.91 7.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.156 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -117.74 19.67 13.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.69 35.72 4.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 58' ' ' TYR . 42.8 mt -85.52 110.45 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.328 -1.101 . . . . 0.0 110.287 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.6 m-70 -134.01 81.9 1.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.621 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -92.18 170.54 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.229 1.014 . . . . 0.0 111.475 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -147.98 -167.65 2.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.515 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 16.6 mt-30 -125.45 -2.81 7.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.798 -1.189 . . . . 0.0 110.471 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.665 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.37 -54.81 0.33 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.465 -1.35 . . . . 0.0 112.31 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -129.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.579 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.938 -176.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -77.38 6.25 4.53 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 123.435 2.263 . . . . 0.0 109.062 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.762 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 85.8 m-85 -77.19 -35.92 55.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.85 -0.531 . . . . 0.0 110.077 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 47.2 p30 -98.85 20.33 13.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.773 -1.205 . . . . 0.0 109.043 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.9 mt -71.43 -6.11 37.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 111.079 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.56 HD12 ' OG ' ' A' ' 117' ' ' SER . 7.6 mt -131.91 0.59 3.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.687 -1.258 . . . . 0.0 109.789 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -67.31 167.04 16.54 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -70.58 142.85 45.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.747 1.632 . . . . 0.0 111.509 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.24 150.08 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.592 0.711 . . . . 0.0 110.37 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.754 HD11 ' C ' ' A' ' 132' ' ' GLY . 34.1 mt -77.64 147.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.552 0.692 . . . . 0.0 110.165 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.9 mm-40 -124.49 -22.7 4.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.212 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 79' ' ' TYR . 3.8 mtpt -122.68 168.76 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.371 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 39' ' ' VAL . 42.5 t . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.78 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.082 0.468 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.4 m-85 -123.72 27.34 7.36 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.036 -1.04 . . . . 0.0 109.344 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 31' ' ' VAL . 49.2 t -73.58 142.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.484 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.46 -2.38 72.45 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.2 mt-30 -82.58 133.98 35.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.317 -1.108 . . . . 0.0 109.827 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -73.23 109.07 6.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.49 159.08 1.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.215 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -79.12 165.55 23.21 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.726 0.775 . . . . 0.0 109.857 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.978 HG21 ' SD ' ' A' ' 120' ' ' MET . 5.8 p -81.06 -34.14 32.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 108.588 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.96 137.11 8.16 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.512 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.0 p -55.29 -48.98 73.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 37.7 t -47.02 -53.72 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.28 -50.87 72.33 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.64 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.515 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 86.6 m -64.19 -31.48 72.7 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.852 -0.53 . . . . 0.0 109.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.13 -43.09 83.27 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.055 -1.458 . . . . 0.0 107.292 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.65 -39.19 57.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 109.785 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.9 mt-30 -60.05 -51.15 70.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.695 -1.253 . . . . 0.0 107.647 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.695 HD11 HG22 ' A' ' 198' ' ' VAL . 35.0 mt -63.41 -24.21 35.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 21.9 mtp -73.0 -38.46 66.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 44.7 tptt -69.17 -40.58 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.707 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 50.2 t80 -53.53 -30.5 41.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.058 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.0 m-70 -107.86 -23.08 12.2 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.214 -0.929 . . . . 0.0 110.763 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 54.4 m-20 44.44 54.8 6.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -76.79 -75.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 119.443 -0.903 . . . . 0.0 113.406 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 34.0 Cg_endo -67.09 104.19 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 120.3 0.667 . . . . 0.0 112.107 -176.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.4 -20.32 62.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.4 OUTLIER -133.96 143.68 48.32 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.8 34.96 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.226 -1.464 . . . . 0.0 109.847 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.943 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -90.14 -64.88 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.379 -1.071 . . . . 0.0 109.645 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 5.9 tttt -131.9 148.82 52.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 m-20 -73.9 179.58 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 70' ' ' THR . 14.2 t80 -153.9 151.32 29.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.307 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 t -155.03 152.42 29.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.096 -1.002 . . . . 0.0 109.656 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.701 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 21.3 p90 -161.66 155.01 21.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 109.61 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 97.0 m -93.33 139.37 30.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.789 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -56.55 147.78 21.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 111.221 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -61.95 143.79 55.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.35 0.595 . . . . 0.0 109.749 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -70.13 -2.14 12.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.526 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.0 m120 -97.47 -8.94 28.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.789 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.8 t-20 -70.44 109.51 5.11 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.747 -0.596 . . . . 0.0 109.88 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -89.16 15.82 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.959 2.439 . . . . 0.0 110.193 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.676 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.7 m-85 -105.92 -25.86 11.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.718 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' C ' ' A' ' 81' ' ' ASN . 8.7 m-85 -119.21 163.0 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.5 m-80 -46.58 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.06 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 111.041 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.17 56.63 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 N-CA-C 107.24 -1.869 . . . . 0.0 107.24 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.92 106.73 17.37 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.408 -178.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 134.29 43.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.91 125.03 51.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.51 124.93 46.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.147 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.21 108.47 19.91 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.9 54.19 0.36 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.799 -1.188 . . . . 0.0 108.428 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 46.6 mt -52.43 -45.75 46.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 O-C-N 121.405 -0.809 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 p -45.42 -26.46 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.799 -1.188 . . . . 0.0 109.286 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 26.75 10.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.811 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -84.45 154.13 22.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.111 -0.993 . . . . 0.0 110.375 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.27 95.03 4.79 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 7.0 m-85 -81.82 88.96 6.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 110.857 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 11.7 t30 -79.94 91.13 5.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CE2' ' HA ' ' A' ' 60' ' ' ASN . 61.7 m95 -61.29 -6.25 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.423 -0.798 . . . . 0.0 110.805 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -90.33 -18.86 24.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.779 -1.201 . . . . 0.0 107.876 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.3 m-20 -99.59 -29.11 12.88 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.694 HG12 ' HB1' ' A' ' 115' ' ' ALA . 31.0 mt -73.83 63.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.522 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 61.0 mt -46.27 148.64 1.51 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.555 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.5 Cg_endo -77.75 -29.07 4.73 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.598 2.199 . . . . 0.0 110.455 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -134.68 124.5 25.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.122 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.0 m-85 -109.42 138.92 45.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.6 p -100.09 1.65 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.79 89.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -120.13 9.66 11.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.196 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -74.73 -178.95 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -76.38 174.98 9.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 1.2 m120 -78.48 -36.76 44.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.658 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.9 t -53.47 -59.42 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.801 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.85 -33.15 73.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 108.94 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.533 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 32.1 mttt -67.81 -44.22 77.8 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -33.18 70.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.694 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.09 -67.84 0.28 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.71 -0.619 . . . . 0.0 109.579 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.9 tp -61.96 -41.34 90.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.193 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.56 ' OG ' HD12 ' A' ' 24' ' ' LEU . 4.5 p -57.15 -40.02 76.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 109.164 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.811 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 31.3 tt0 -69.99 -43.26 71.8 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.8 tp -57.41 -48.41 79.16 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.978 ' SD ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -56.61 -47.6 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.476 178.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.71 -39.22 93.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 126' ' ' SER . 13.0 m-20 -65.3 -53.87 37.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 127' ' ' VAL . 89.1 t -65.31 -54.99 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.296 -0.878 . . . . 0.0 109.454 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -47.22 -53.07 11.9 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.1 mt -65.99 -53.16 40.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -1.093 . . . . 0.0 108.516 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 123' ' ' VAL . 60.3 p -45.53 -33.53 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.067 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 123' ' ' VAL . 35.7 m -100.86 38.69 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.713 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' VAL . 22.4 m-20 37.15 52.04 1.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.517 -0.74 . . . . 0.0 109.624 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.66 ' HE3' ' O ' ' A' ' 45' ' ' THR . 44.2 tpp -66.63 130.55 43.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.57 -0.707 . . . . 0.0 111.774 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' SER . 8.0 t70 -76.92 122.01 24.26 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.652 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.59 120.31 40.63 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.479 1.133 . . . . 0.0 113.029 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.754 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -152.09 -163.21 11.37 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 104.485 -3.446 . . . . 0.0 104.485 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.623 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -62.26 -31.54 82.16 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 N-CA-C 105.551 -2.519 . . . . 0.0 105.551 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.2 m -109.36 142.21 40.62 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.509 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 30.7 m -124.64 109.8 13.61 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 119.961 -1.712 . . . . 0.0 110.104 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.3 137.41 14.08 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 3.5 t -117.35 -162.22 0.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.879 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.69 -50.65 5.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 143' ' ' VAL . . . 121.37 -126.24 6.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.488 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 10.4 m -47.08 -60.55 2.39 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.712 -0.875 . . . . 0.0 112.279 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 79.4 p -47.18 -41.45 18.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 0.0 109.253 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.879 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.5 mmp_? -79.9 -41.14 26.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.432 1.111 . . . . 0.0 109.142 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.792 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.1 t -67.71 -60.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.16 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.9 pp0? -56.2 -34.78 66.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.755 -1.216 . . . . 0.0 108.651 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.569 ' HE ' ' NH2' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -70.66 -44.8 66.31 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.315 -0.866 . . . . 0.0 109.329 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.76 -36.91 81.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.182 -0.949 . . . . 0.0 110.662 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.831 HD13 HG12 ' A' ' 251' ' ' ILE . 76.6 mt -55.67 -54.73 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 109.921 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 11.1 mtmt -81.07 -33.87 33.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 111.597 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 84.9 mt-10 -74.09 -66.97 0.65 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.48 -1.388 . . . . 0.0 112.628 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.556 ' HB3' HD13 ' A' ' 90' ' ' ILE . 26.3 m120 -81.63 -31.78 32.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.923 -1.111 . . . . 0.0 111.727 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 22.4 m-85 -102.57 -8.17 21.22 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.64 -1.287 . . . . 0.0 110.382 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.943 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 53.74 38.45 59.29 Favored Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.137 -0.977 . . . . 0.0 112.212 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.24 162.8 9.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.3 -1.706 . . . . 0.0 107.677 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 35.8 t-20 -47.11 143.87 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 109.586 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 155' ' ' GLN . 11.3 mm-40 -53.58 -19.97 4.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.492 -0.755 . . . . 0.0 109.009 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 154' ' ' ASN . 3.7 p -53.99 -16.63 2.01 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.812 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.559 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 41.0 t -61.34 127.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.911 -1.118 . . . . 0.0 109.552 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.898 ' CE1' HG23 ' A' ' 249' ' ' VAL . 18.7 p-80 -149.08 158.76 44.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.375 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 3.8 tt0 -102.78 149.22 24.69 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.894 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -127.87 146.79 32.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.8 m-80 -112.36 102.98 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.131 . . . . 0.0 111.125 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.669 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.21 -28.41 3.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.83 . . . . 0.0 109.049 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.542 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.54 -27.69 73.31 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -103.85 4.72 35.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.1 -1.235 . . . . 0.0 111.6 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.08 171.04 8.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.404 -1.435 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 167' ' ' LYS . 84.1 p -103.94 134.56 47.02 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 166' ' ' SER . 54.7 tttt -30.57 -45.08 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.923 -0.485 . . . . 0.0 111.077 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -63.3 -66.04 0.6 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.185 . . . . 0.0 109.851 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -16.01 58.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 109.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.894 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 45.8 t-105 -72.18 -49.34 36.39 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.153 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 174' ' ' ILE . 18.8 mt-10 -67.6 -33.7 75.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.7 -48.01 20.32 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.629 HE21 HG21 ' A' ' 249' ' ' VAL . 22.0 mm100 -61.01 -38.47 86.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.765 HG21 HD13 ' A' ' 199' ' ' ILE . 53.3 mt -75.92 -63.86 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 110.425 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -49.28 -53.89 19.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -51.92 -40.2 60.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 108.112 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.557 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.0 mm-40 -61.11 -50.26 73.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.874 HD21 HG22 ' A' ' 199' ' ' ILE . 13.2 mt -68.61 -25.78 65.03 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.484 -0.76 . . . . 0.0 109.7 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 37.0 p -51.85 -38.0 54.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 108.26 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 23.4 mt-30 -101.09 33.87 2.71 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.489 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.0 m-80 45.97 50.66 11.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 15.0 mt-30 -124.07 107.14 30.7 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.451 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -64.19 170.06 9.79 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.145 1.897 . . . . 0.0 112.667 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 51.6 t -123.67 135.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.614 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.792 ' CE2' HG21 ' A' ' 143' ' ' VAL . 1.2 t80 -83.42 117.95 23.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.624 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 4.1 t80 -123.19 153.41 40.12 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 120.845 -1.16 . . . . 0.0 109.705 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.9 pt20 -164.81 135.5 4.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.328 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.92 114.98 4.66 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 107.239 -2.345 . . . . 0.0 107.239 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 41.5 t -80.96 145.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.255 . . . . 0.0 111.349 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -145.9 -145.75 4.3 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -87.95 -29.77 20.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -1.162 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.2 m -82.9 -13.07 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.8 -166.13 25.18 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -97.91 110.89 4.12 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 119.038 -1.553 . . . . 0.0 110.735 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.33 117.37 12.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -107.99 160.92 15.41 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.373 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.721 ' CD1' HG13 ' A' ' 210' ' ' VAL . 46.7 p90 -159.09 166.5 31.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.695 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -114.11 136.11 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.696 -1.253 . . . . 0.0 112.036 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.874 HG22 HD21 ' A' ' 178' ' ' LEU . 7.4 mt -98.71 125.79 52.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.596 ' OD2' ' CD2' ' A' ' 209' ' ' HIS . 1.5 p30 -139.92 32.33 1.99 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.716 -1.594 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -167.03 173.45 42.29 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 117.862 -2.113 . . . . 0.0 111.719 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.498 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -160.92 149.28 16.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -122.46 31.66 6.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.711 -1.243 . . . . 0.0 110.45 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 44.33 25.38 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 2.2 mtt180 -142.26 21.79 2.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.227 -1.16 . . . . 0.0 108.95 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.9 OUTLIER 77.88 23.51 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.221 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 29.7 m-85 -122.72 128.45 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.928 . . . . 0.0 109.356 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.3 m-85 -122.94 171.6 9.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.299 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.596 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.4 t60 -93.64 136.39 33.96 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.721 HG13 ' CD1' ' A' ' 197' ' ' PHE . 51.2 t -128.62 137.32 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.052 -1.03 . . . . 0.0 110.414 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.5 t-20 -111.85 73.13 0.8 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.523 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 82.3 m95 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.459 -0.776 . . . . 0.0 110.179 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 1.4 pt20 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 15.1 p -166.1 163.21 18.11 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -142.08 167.15 22.81 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.942 0.877 . . . . 0.0 109.925 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 147' ' ' LEU . 15.5 t -118.0 120.77 65.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.898 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.4 m -120.69 149.75 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.95 -1.094 . . . . 0.0 111.282 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 86.03 46.92 5.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.831 HG12 HD13 ' A' ' 147' ' ' LEU . 4.1 mt -93.57 93.98 4.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.406 -1.055 . . . . 0.0 109.761 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.07 148.67 9.71 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.44 -0.788 . . . . 0.0 108.946 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.626 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.389 2.06 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.8 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 201' ' ' GLY . 10.1 mmtt -76.14 -166.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 108.908 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.566 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 2.7 t -87.89 106.11 17.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.873 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.694 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 46.6 mt -58.49 -50.11 74.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 108.906 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.4 mt -55.93 -38.02 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.66 -1.275 . . . . 0.0 108.858 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.507 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 43.9 m-20 -67.25 -43.48 81.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.796 . . . . 0.0 109.774 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 3.7 p -58.24 -14.44 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.048 . . . . 0.0 109.317 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.5 mtpm? -117.15 17.9 14.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.793 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.26 41.44 6.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.2 mt -91.11 108.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 122.247 1.022 . . . . 0.0 110.526 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 8.5 m-70 -134.83 81.25 1.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.6 m-30 -87.11 179.99 6.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 111.152 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.74 -162.61 1.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 45' ' ' THR . 17.5 mt-30 -125.36 -21.93 4.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.721 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.06 -33.87 1.59 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.604 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.828 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.6 -139.68 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.512 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.064 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -74.24 2.99 5.58 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 CA-C-N 122.554 1.948 . . . . 0.0 109.269 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.7 m-85 -77.91 -31.59 51.25 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.404 -0.81 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.478 ' HA ' HG23 ' A' ' 25' ' ' THR . 23.8 p-10 -93.88 14.35 19.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.632 -1.293 . . . . 0.0 109.746 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.2 mt -70.4 -7.83 46.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.738 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 118' ' ' GLU . 11.3 mt -123.74 -9.35 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.092 -1.005 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.0 p -60.85 165.31 6.1 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.2 Cg_endo -70.48 143.02 46.2 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.357 2.038 . . . . 0.0 112.184 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.23 148.12 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.559 0.695 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.9 mt -78.51 148.05 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 111.173 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.9 mt-10 -126.4 -21.5 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.732 -0.605 . . . . 0.0 110.659 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 9.0 mtpm? -118.82 168.39 10.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.859 -1.15 . . . . 0.0 110.284 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 37' ' ' SER . 74.9 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.557 -0.715 . . . . 0.0 110.69 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 31' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.616 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 82.5 m-85 -123.61 14.71 9.47 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.899 -1.126 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 29' ' ' GLU . 61.0 t -62.99 141.89 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.189 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 1.38 87.39 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -91.97 132.14 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -1.096 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -73.2 111.89 8.74 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.21 160.61 0.75 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 109.003 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.76 166.93 22.34 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.616 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.697 HG21 ' SD ' ' A' ' 120' ' ' MET . 29.5 p -79.67 -35.56 39.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.6 139.02 9.53 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 51' ' ' ALA . 5.6 p -55.17 -49.75 71.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 3.9 t -47.02 -52.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.77 -47.38 78.39 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.847 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 96.1 m -62.6 -30.2 71.17 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.97 -47.22 69.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.968 -1.083 . . . . 0.0 108.822 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 56' ' ' MET . 30.8 m -75.6 -49.82 17.39 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.409 0.623 . . . . 0.0 110.277 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.6 -34.55 37.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 109.078 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.609 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -67.71 -48.93 65.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.74 HD11 HG22 ' A' ' 198' ' ' VAL . 36.0 mt -66.79 -28.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 52' ' ' THR . 19.3 mtp -67.13 -39.58 86.62 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -71.89 -39.48 69.56 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.694 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 56.9 t80 -53.44 -34.43 57.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.493 -0.754 . . . . 0.0 109.346 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 83.8 m-70 -107.75 -20.45 13.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.36 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.641 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.55 54.63 1.89 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -74.64 -70.7 0.23 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.0 Cg_endo -69.67 103.81 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 122.269 0.615 . . . . 0.0 111.806 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' TYR . 7.6 m120 -70.09 -21.57 63.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -134.78 140.13 45.65 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.84 34.9 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.664 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.883 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -89.01 -44.3 10.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.62 -0.929 . . . . 0.0 110.387 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.4 tttt -151.61 137.86 18.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 164.94 7.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.0 110.219 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 26.1 t80 -148.94 141.35 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.264 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t -146.99 161.12 41.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.932 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.6 p90 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.656 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.494 HG23 ' OD1' ' A' ' 85' ' ' ASN . 27.4 m -93.19 129.82 39.08 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.826 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -47.67 150.58 0.99 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 111.28 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 t -62.15 140.67 58.42 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -3.82 11.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 0.0 109.868 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 52.6 t30 -99.28 -7.75 25.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.826 ' ND2' HD21 ' A' ' 73' ' ' LEU . 39.6 t-20 -70.37 111.58 9.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 109.971 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.621 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.3 Cg_endo -88.54 13.11 2.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.982 2.454 . . . . 0.0 110.094 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.4 m-85 -104.94 -5.0 21.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 111.139 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 5.5 m-85 -142.22 162.0 36.58 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.564 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 4.8 m120 -46.67 -79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.79 -46.8 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 111.047 175.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.88 57.34 5.67 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 N-CA-C 107.012 -1.957 . . . . 0.0 107.012 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.51 101.59 11.11 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.294 -178.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.494 ' OD1' HG23 ' A' ' 72' ' ' THR . 37.3 m-80 -100.11 128.87 46.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.756 . . . . 0.0 109.466 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -100.75 134.5 43.63 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.77 129.63 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.81 111.37 23.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 51.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 108.304 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.4 mt -52.77 -54.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.384 -0.822 . . . . 0.0 110.027 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.1 p -44.59 -27.61 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.242 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -111.97 34.36 4.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -0.83 . . . . 0.0 109.177 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.748 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.05 90.31 3.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.4 m-85 -81.31 88.08 6.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 47.3 t-20 -79.4 87.79 5.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.641 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.0 m95 -60.98 -7.04 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -89.43 -18.76 26.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 7.9 m-20 -100.08 -26.48 13.94 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.609 HG12 ' HB1' ' A' ' 115' ' ' ALA . 51.9 mt -76.53 67.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 108.903 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 18.9 mt -46.84 149.42 1.53 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.775 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.534 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.7 Cg_endo -78.99 -18.11 11.63 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.903 2.402 . . . . 0.0 110.725 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 133.3 25.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.995 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.625 ' CE2' HG21 ' A' ' 116' ' ' ILE . 62.1 m-85 -121.49 136.75 54.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.258 -0.901 . . . . 0.0 109.845 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -99.94 0.91 42.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 113' ' ' LYS . . . 81.15 -1.76 83.81 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.631 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -110.46 -6.88 14.83 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.423 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.631 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 3.0 mp0 -63.86 164.66 9.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 109.755 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -62.1 172.74 1.31 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 17.3 m-20 -77.03 -31.26 56.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.623 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.2 -60.17 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 5.2 mp0 -62.76 -35.04 78.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.785 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.546 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 33.6 mttt -65.27 -42.34 93.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.463 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 12.2 ttm -59.15 -37.81 78.2 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.609 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.33 -68.1 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.672 -0.643 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.733 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.1 tp -62.37 -37.48 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.633 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.2 p -57.18 -40.44 77.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.921 -1.112 . . . . 0.0 109.95 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.748 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 35.3 tt0 -69.4 -41.57 76.26 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.733 HD23 ' CD1' ' A' ' 116' ' ' ILE . 9.3 tp -54.65 -52.69 61.52 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.697 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -58.68 -43.93 90.1 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.5 -0.75 . . . . 0.0 109.292 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.09 -36.69 84.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 93' ' ' ARG . 27.8 m-20 -69.6 -54.61 13.2 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 127' ' ' VAL . 48.4 t -63.38 -57.78 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.19 -49.84 13.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.0 mt -63.9 -58.8 5.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 108.276 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.25 -29.23 1.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.517 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 20.9 m -101.42 36.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.895 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 127' ' ' VAL . 3.3 m-20 37.81 51.93 1.39 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.466 -0.771 . . . . 0.0 109.407 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.7 tpp -66.04 126.92 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.53 -0.731 . . . . 0.0 111.741 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -75.77 120.66 21.44 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 57.3 m-85 -102.83 115.67 31.05 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.279 1.038 . . . . 0.0 112.719 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.744 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.92 -162.88 10.95 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 104.869 -3.292 . . . . 0.0 104.869 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 18.0 Cg_endo -62.39 -30.56 80.72 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 N-CA-C 105.802 -2.422 . . . . 0.0 105.802 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.99 140.76 43.65 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 32.7 m -124.26 109.66 13.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.843 -1.786 . . . . 0.0 110.286 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -108.88 144.72 16.42 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.648 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.54 -163.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -1.219 . . . . 0.0 107.765 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.75 -53.97 4.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 134.18 -139.02 10.51 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 119.145 -1.502 . . . . 0.0 111.981 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB2' ' CD ' ' A' ' 159' ' ' GLN . 0.7 OUTLIER -48.06 -54.37 13.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.139 -0.624 . . . . 0.0 112.237 -177.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 4.1 p -46.53 -41.25 13.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.926 -1.109 . . . . 0.0 109.7 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.708 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 2.3 mmt180 -81.15 -42.63 20.58 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 109.585 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.855 HG21 ' CE2' ' A' ' 185' ' ' TYR . 44.3 t -68.14 -52.79 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 110.463 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.44 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 1.8 pp0? -56.9 -34.36 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.554 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 2.4 ttm180 -77.35 -51.8 10.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 109.197 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.75 75.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.587 ' HB2' HG11 ' A' ' 157' ' ' VAL . 46.0 mt -56.92 -50.57 72.17 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.099 -1.0 . . . . 0.0 109.652 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 4.5 mtmp? -87.65 -41.12 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.017 -1.052 . . . . 0.0 110.589 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 85.1 mt-10 -68.08 -49.1 63.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.919 -1.113 . . . . 0.0 111.727 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -93.94 -43.19 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.907 -1.121 . . . . 0.0 111.652 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 152' ' ' GLY . 33.5 m-85 -102.27 15.49 28.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.658 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.883 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 35.08 40.22 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.626 -0.671 . . . . 0.0 112.581 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.2 m-85 -62.53 164.06 8.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.062 -1.846 . . . . 0.0 107.853 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.5 t-20 -47.37 145.1 2.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.174 . . . . 0.0 109.617 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -53.43 -19.96 4.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.909 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.537 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 7.8 p -55.72 -14.5 2.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.331 -0.856 . . . . 0.0 109.739 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -66.4 119.85 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.938 -1.101 . . . . 0.0 109.65 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.6 p-80 -148.55 163.17 38.02 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.495 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 2.0 tt0 -104.07 146.36 28.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.617 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 4.3 pt -121.93 155.17 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.2 m-80 -123.29 105.73 10.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.814 -1.179 . . . . 0.0 111.041 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 44.4 tpt85 -48.14 -38.9 19.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 109.012 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.54 -25.83 63.69 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.03 -1.03 28.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.064 -1.256 . . . . 0.0 111.273 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.04 173.92 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.785 -1.197 . . . . 0.0 110.027 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 167' ' ' LYS . 83.8 p -98.53 138.71 35.34 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 166' ' ' SER . 35.5 tttt -35.22 -48.43 0.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.766 -0.584 . . . . 0.0 110.361 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.404 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 7.5 mp0 -65.4 -59.23 4.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.049 -1.032 . . . . 0.0 109.854 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.52 -15.59 58.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.988 . . . . 0.0 109.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 61.0 t-105 -73.66 -47.78 37.26 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.664 ' HA ' HD12 ' A' ' 174' ' ' ILE . 29.2 mt-10 -70.76 -30.98 67.63 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.24 65.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.633 HE21 HG21 ' A' ' 160' ' ' ILE . 15.8 mm100 -61.26 -41.19 96.49 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.001 HG23 HG21 ' A' ' 184' ' ' VAL . 22.3 mt -74.03 -51.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.553 -0.717 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -55.97 -41.98 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 108.626 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -51.97 -43.29 63.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.582 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 51.9 mm-40 -59.72 -51.94 67.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.94 -25.61 64.65 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.828 . . . . 0.0 110.044 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.484 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.5 p -52.05 -38.12 55.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 25.0 mt-30 -101.55 29.52 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.528 ' C ' HD13 ' A' ' 7' ' ' LEU . 8.1 m-20 51.15 49.18 21.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.72 0.771 . . . . 0.0 109.165 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 27.8 mt-30 -124.34 117.08 26.77 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.8 Cg_endo -65.67 171.4 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.21 1.94 . . . . 0.0 112.328 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 174' ' ' ILE . 23.4 t -125.98 115.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.367 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.855 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -66.27 113.27 4.46 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 10.9 t80 -123.77 157.39 34.13 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 120.891 -1.13 . . . . 0.0 109.658 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.1 pt20 -158.93 129.84 6.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 117.927 -1.509 . . . . 0.0 111.804 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.17 109.71 3.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 3.6 t -66.8 166.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -1.179 . . . . 0.0 111.099 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.594 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -175.21 -136.78 2.35 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -87.81 -55.85 3.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.24 . . . . 0.0 111.357 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -61.15 -8.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.057 -1.027 . . . . 0.0 111.47 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.45 21.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -91.25 107.57 3.5 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.0 t-80 -71.66 126.19 29.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.92 159.07 24.47 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.533 1.159 . . . . 0.0 112.723 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.693 ' CD1' HG13 ' A' ' 210' ' ' VAL . 43.2 p90 -153.58 -161.05 1.19 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' ILE . 85.9 t -139.34 133.27 38.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 120.362 -1.461 . . . . 0.0 111.377 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.633 HD13 HG21 ' A' ' 174' ' ' ILE . 82.8 mt -99.14 120.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 3.1 p30 -133.24 33.47 3.61 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.439 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.23 163.92 35.62 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 117.706 -2.188 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.533 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.28 140.9 29.47 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -111.31 11.18 21.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.103 . . . . 0.0 110.567 -178.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.64 4.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -80.57 53.54 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 109.884 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.476 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 2.0 m120 53.09 38.54 27.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.783 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.528 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 1.2 m-85 -121.92 133.92 54.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 12.9 m-85 -122.91 159.77 27.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.07 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 39.4 t-80 -93.22 117.78 30.48 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 197' ' ' PHE . 29.1 t -114.55 138.64 43.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 111.447 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 8' ' ' LEU . 19.4 t-20 -104.62 80.56 1.68 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 23.0 m95 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -178.876 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 1.5 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 72.6 p -136.05 164.82 27.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.712 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.695 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.91 161.7 37.2 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.75 HG23 ' CD1' ' A' ' 185' ' ' TYR . 39.1 t -116.15 113.67 43.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 184' ' ' VAL . 13.9 m -112.55 142.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.941 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.42 ' N ' ' OE1' ' A' ' 177' ' ' GLU . . . 90.65 54.77 2.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.616 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 38.5 mt -102.75 89.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 110.225 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 2.2 pptp? -162.89 151.76 12.41 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 0.0 109.03 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.335 2.023 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.7 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -76.19 -178.6 4.56 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.495 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 17.5 t -78.13 106.2 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.896 -1.128 . . . . 0.0 109.312 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.8 mt -56.69 -48.44 77.64 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD11 ' CG1' ' A' ' 198' ' ' VAL . 13.7 mt -55.01 -42.25 72.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 108.386 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 2.1 t0 -67.19 -40.87 86.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.133 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 p -58.11 -15.7 10.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.998 -1.064 . . . . 0.0 108.772 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.584 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 2.0 mtpp -116.9 16.96 15.15 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 46.85 39.22 10.9 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 11' ' ' LYS . 27.8 mt -91.34 110.67 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -1.037 . . . . 0.0 110.519 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.0 m80 -134.7 83.05 2.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.2 m-30 -89.49 179.28 6.09 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.141 0.972 . . . . 0.0 110.991 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -147.89 -163.24 1.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 45' ' ' THR . 37.3 mt-30 -124.95 -21.21 4.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.978 -1.076 . . . . 0.0 110.572 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.31 -35.09 1.36 Allowed Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.522 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.844 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -138.06 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.527 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.202 -178.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.844 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.1 Cg_endo -75.08 4.46 4.75 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 CA-C-N 122.688 1.996 . . . . 0.0 109.589 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.9 m-85 -80.42 -34.1 36.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 29.9 p-10 -88.79 15.65 8.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.536 -1.352 . . . . 0.0 109.177 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.17 -5.96 30.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.104 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.1 mt -128.57 -5.81 5.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 109.934 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -61.24 164.57 8.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.1 Cg_endo -69.59 136.36 33.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.231 1.954 . . . . 0.0 112.251 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG1' ' HA2' ' A' ' 40' ' ' GLY . 38.8 t -76.01 148.19 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.538 0.685 . . . . 0.0 109.924 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 132' ' ' GLY . 13.7 mt -78.19 150.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.836 0.827 . . . . 0.0 111.122 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' C ' HG22 ' A' ' 39' ' ' VAL . 3.3 mt-10 -125.06 -23.15 4.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.704 -0.623 . . . . 0.0 110.152 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.0 mtpt -120.75 165.91 14.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 38' ' ' PHE . 86.0 t . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 110.588 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.419 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 74.4 m-85 -118.52 12.93 13.36 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.995 -1.066 . . . . 0.0 109.156 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HA ' HG22 ' A' ' 28' ' ' ILE . 78.0 t -62.86 138.94 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' CG1' ' A' ' 27' ' ' VAL . . . 79.89 1.62 87.53 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 11.8 mt-30 -89.39 134.06 34.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.33 111.18 8.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.29 161.08 0.69 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.974 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.68 167.23 21.91 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.661 -0.649 . . . . 0.0 109.515 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.706 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.5 p -80.48 -33.77 36.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.112 -0.993 . . . . 0.0 108.495 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 102.86 138.22 9.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.0 p -55.21 -48.66 73.55 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.585 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.7 t -47.11 -52.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.41 -47.86 77.56 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.088 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.505 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 54.8 m -62.86 -29.47 70.78 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.569 -0.707 . . . . 0.0 109.157 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.91 -47.09 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.751 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 56' ' ' MET . 35.4 m -75.72 -48.88 20.05 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.441 0.639 . . . . 0.0 110.255 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.65 -33.96 35.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.513 -0.742 . . . . 0.0 109.085 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.627 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 28.7 mt-30 -68.31 -50.38 53.91 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 198' ' ' VAL . 33.7 mt -65.0 -23.99 34.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.582 ' HG3' HG22 ' A' ' 52' ' ' THR . 18.1 mtp -72.56 -36.23 68.17 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.558 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 42.4 tptt -71.5 -44.42 64.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.9 t80 -53.38 -30.58 40.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.24 0.543 . . . . 0.0 109.739 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 61.0 m-70 -107.81 -23.62 12.0 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.625 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.662 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.23 58.92 1.81 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -77.96 -76.82 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.375 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.3 Cg_endo -71.19 108.59 2.37 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 CA-C-N 119.41 0.825 . . . . 0.0 113.225 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.76 -26.99 67.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 103.819 -2.659 . . . . 0.0 103.819 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 18.9 tttt -129.58 130.35 45.58 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.93 167.46 4.35 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.396 -1.859 . . . . 0.0 110.904 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.11 -38.64 10.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.537 -0.978 . . . . 0.0 111.301 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 73.4 tttt -152.67 132.49 13.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.677 -1.265 . . . . 0.0 110.7 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 3.0 m-20 -60.42 168.29 2.17 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.368 -0.832 . . . . 0.0 109.495 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 35.8 t80 -151.97 141.81 21.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 109.724 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.0 t -144.39 153.51 42.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 109.271 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.793 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.1 p90 -152.88 156.7 39.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.819 HG23 ' OD1' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -92.9 127.19 38.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.819 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -44.81 150.36 0.37 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 111.205 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -61.99 142.89 57.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.862 -0.524 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 p -70.06 -2.1 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.013 -1.054 . . . . 0.0 109.816 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 16.0 t-20 -99.83 -8.18 24.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.146 -0.971 . . . . 0.0 109.666 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.819 ' ND2' HD21 ' A' ' 73' ' ' LEU . 37.8 t-20 -70.23 112.09 11.51 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.592 -0.693 . . . . 0.0 110.021 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.0 Cg_endo -86.94 9.03 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.042 2.494 . . . . 0.0 110.589 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 58.2 m-85 -104.83 -14.04 15.65 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.106 -0.997 . . . . 0.0 111.5 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 53.2 m-85 -128.18 159.57 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.7 m-80 -46.9 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.47 -48.31 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.966 175.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.58 57.72 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.91 104.98 14.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.487 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.819 ' OD1' HG23 ' A' ' 72' ' ' THR . 2.4 m-80 -100.42 132.23 45.92 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.337 -0.852 . . . . 0.0 109.882 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.793 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -105.86 143.26 34.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -130.91 128.84 41.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.923 -1.11 . . . . 0.0 110.537 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -111.12 112.16 23.76 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.89 53.84 0.48 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.673 -1.267 . . . . 0.0 108.102 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.3 mt -52.98 -56.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.726 -0.609 . . . . 0.0 111.332 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -43.83 -29.73 0.58 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.703 -1.248 . . . . 0.0 109.456 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.93 33.04 5.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.391 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.873 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 32.7 mmt-85 -82.29 158.12 23.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.736 -1.228 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 94' ' ' GLN . 2.1 mm-40 -116.1 81.73 1.66 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.3 m-85 -81.49 89.9 6.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.581 -0.699 . . . . 0.0 110.198 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.506 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.5 t30 -78.76 90.83 4.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.662 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 63.8 m95 -60.09 -8.16 2.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.75 -18.12 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 46.1 m-20 -99.72 -31.27 11.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.0 mt -73.83 66.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.538 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 24.9 mt -45.79 149.16 1.18 Allowed Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.558 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -78.24 -23.04 9.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.635 2.223 . . . . 0.0 110.441 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -137.57 130.3 30.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.02 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 86.3 m-85 -116.82 144.29 44.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.042 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.2 p -100.53 -16.62 17.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.49 -2.72 57.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -120.19 7.22 10.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -1.227 . . . . 0.0 109.523 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.23 177.31 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.905 . . . . 0.0 109.486 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 p -69.33 170.85 9.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.77 -38.53 53.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.9 t -51.44 -56.75 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -40.48 96.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.082 -1.012 . . . . 0.0 109.214 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.501 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.6 mttt -62.53 -39.03 92.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.0 ttm -59.91 -43.37 94.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.677 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.58 -52.05 67.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.673 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.6 tp -69.45 -39.2 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.391 -1.443 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -57.55 -41.74 81.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.079 -1.013 . . . . 0.0 110.454 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 20.6 tt0 -68.76 -38.9 80.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.991 -1.068 . . . . 0.0 108.18 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -56.41 -51.04 69.85 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.706 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.6 mmt -59.69 -44.95 93.44 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 108.999 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.48 -36.28 83.66 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.873 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 18.5 m-20 -69.41 -52.43 27.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 127' ' ' VAL . 58.6 t -65.89 -57.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.146 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.16 -49.09 14.7 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.01 -58.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.287 -1.125 . . . . 0.0 108.264 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -47.1 -30.2 2.64 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.571 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.2 m -101.08 37.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 0.0 109.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.1 m-20 37.48 51.44 1.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.476 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 57.8 tpp -65.64 125.61 25.79 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 111.545 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.9 t0 -75.86 121.27 22.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.636 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.0 117.68 35.14 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.519 1.152 . . . . 0.0 113.206 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.751 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.64 -164.2 12.01 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 104.659 -3.377 . . . . 0.0 104.659 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.622 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.24 -29.09 79.8 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.44 141.81 43.02 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 43.4 m -125.33 110.94 14.6 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 119.882 -1.761 . . . . 0.0 110.533 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.92 144.42 16.4 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.7 t -118.17 -163.99 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.111 -1.229 . . . . 0.0 107.719 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.58 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.09 -55.99 3.33 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.567 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 135.0 -137.68 9.43 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 119.313 -1.422 . . . . 0.0 111.623 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.56 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 2.8 m -48.7 -50.22 34.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.812 -0.816 . . . . 0.0 112.408 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' SER . 57.2 p -45.36 -47.28 13.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 0.0 109.842 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.65 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 17.3 mmt180 -81.41 -38.27 26.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 110.195 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.83 HG21 ' CE2' ' A' ' 185' ' ' TYR . 54.1 t -67.67 -53.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.017 . . . . 0.0 110.503 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.95 -34.82 68.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.896 -1.127 . . . . 0.0 108.389 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -77.38 -52.73 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.581 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.52 -34.29 70.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.592 ' HB2' HG11 ' A' ' 157' ' ' VAL . 57.2 mt -59.85 -49.45 77.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.274 -0.891 . . . . 0.0 109.742 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 6.0 mtmt -87.34 -42.74 12.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.891 -1.13 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 32.8 mt-10 -69.31 -51.98 31.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.898 -1.126 . . . . 0.0 112.436 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 21.9 m120 -88.17 -50.47 6.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.725 -1.234 . . . . 0.0 111.986 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -90.04 -16.47 29.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.748 -1.22 . . . . 0.0 110.489 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 68.1 37.8 87.57 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.916 -1.115 . . . . 0.0 111.791 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.9 m-85 -63.04 165.92 6.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.335 -1.686 . . . . 0.0 107.757 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 37.6 t-20 -47.15 143.82 2.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.803 -1.186 . . . . 0.0 109.104 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 11.4 mm100 -53.15 -20.05 3.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 108.983 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.506 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.6 p -55.04 -15.04 1.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -63.57 120.23 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.864 -1.147 . . . . 0.0 109.45 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 1.006 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.0 p-80 -148.12 160.22 43.12 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.1 tt0 -102.48 152.33 21.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 1.078 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.3 pt -131.48 138.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m-80 -106.18 103.32 12.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 1.8 tpt180 -47.66 -29.77 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 108.978 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.92 -22.8 65.01 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.68 -2.87 25.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.241 . . . . 0.0 111.402 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -117.84 177.67 4.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.558 -1.339 . . . . 0.0 110.27 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 170' ' ' TRP . 42.3 p -109.06 147.38 32.47 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' SER . 5.1 ttmm -40.44 -44.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 110.136 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.844 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.37 -15.92 63.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 1.078 ' CH2' HD12 ' A' ' 160' ' ' ILE . 40.5 t-105 -75.11 -38.71 61.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.448 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 42.3 mt-10 -71.24 -34.69 71.0 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.24 -0.912 . . . . 0.0 108.769 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 176' ' ' LYS . . . -55.22 -47.3 75.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.86 . . . . 0.0 109.061 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 25.8 mm100 -61.25 -43.5 98.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.045 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.952 HG23 HG21 ' A' ' 184' ' ' VAL . 12.0 mt -75.39 -60.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 111.435 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -49.5 -43.4 45.4 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.496 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 172' ' ' ALA . 9.6 tttt -52.21 -44.67 64.88 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.576 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 42.6 mm-40 -58.93 -54.55 45.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.9 mt -66.25 -26.37 67.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' ASP . 45.0 p -51.9 -43.83 63.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.2 mt-30 -94.89 32.05 1.73 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.609 ' C ' HD13 ' A' ' 7' ' ' LEU . 19.6 m-20 49.65 50.59 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 12.6 mt-30 -124.16 114.5 27.73 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.1 Cg_endo -66.25 171.13 10.79 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.136 1.89 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.959 HG13 HG12 ' A' ' 249' ' ' VAL . 21.2 t -126.91 115.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.775 -0.578 . . . . 0.0 111.007 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.83 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -65.11 112.11 3.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 176.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.625 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 5.2 t80 -123.46 155.77 36.83 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.013 -1.054 . . . . 0.0 109.449 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.36 128.66 3.56 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.21 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 245' ' ' GLN . . . -92.19 101.01 2.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 190' ' ' GLY . 50.8 t -67.13 164.13 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 110.988 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.583 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.44 -130.54 1.18 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -87.72 -51.64 5.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -1.214 . . . . 0.0 111.103 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.35 -18.19 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 111.776 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.09 -158.9 24.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 189' ' ' VAL . . . -87.6 106.82 3.23 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.916 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 9.3 t-80 -71.83 119.37 15.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -112.94 160.14 18.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.492 -1.283 . . . . 0.0 112.837 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.883 ' CD2' HG13 ' A' ' 210' ' ' VAL . 54.3 p90 -161.54 173.46 14.77 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -116.59 134.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.558 -1.339 . . . . 0.0 111.582 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 96.7 mt -102.7 109.1 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -124.0 33.28 5.33 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.306 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.22 164.92 37.97 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 117.512 -2.28 . . . . 0.0 112.675 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.521 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.91 147.63 34.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -112.45 7.46 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.833 -1.167 . . . . 0.0 110.146 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.87 -46.23 3.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -85.55 44.88 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -1.179 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER 65.34 31.06 10.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.128 -0.982 . . . . 0.0 109.982 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.564 ' CB ' ' HB2' ' A' ' 203' ' ' ASP . 3.6 m-85 -117.93 135.26 54.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.087 -1.008 . . . . 0.0 109.126 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 38.8 m-85 -123.41 162.96 21.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.8 t60 -91.97 137.54 32.28 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.883 HG13 ' CD2' ' A' ' 197' ' ' PHE . 23.9 t -129.46 138.18 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.626 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -109.25 72.59 0.81 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.658 ' CE2' HG11 ' A' ' 210' ' ' VAL . 81.4 m95 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 110.26 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 13.3 pt20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.513 0.673 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 60.1 p -145.72 170.92 15.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -135.25 161.92 34.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.672 0.749 . . . . 0.0 109.102 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.802 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.8 t -116.3 112.36 39.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 1.006 HG23 ' CE1' ' A' ' 158' ' ' HIS . 13.6 m -110.64 143.63 20.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.036 -175.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 88.06 46.35 4.79 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 29.3 mt -92.7 94.01 4.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.392 -1.064 . . . . 0.0 109.812 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 9.0 ptmt -160.87 149.08 12.86 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.619 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.6 Cg_endo . . . . . 0 C--N 1.308 -1.553 0 C-N-CA 122.257 1.971 . . . . 0.0 110.452 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 178' ' ' LEU . 44.7 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -76.39 -176.64 3.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.147 -0.971 . . . . 0.0 108.568 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.516 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 3.0 t -77.45 104.82 8.19 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.467 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 39.4 mt -57.76 -48.16 80.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 108.894 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD11 HG11 ' A' ' 198' ' ' VAL . 11.9 mt -55.63 -42.04 74.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 108.496 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 5.2 m-20 -67.65 -41.41 83.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.068 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -58.32 -14.66 7.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.9 mtpp -118.86 23.43 11.43 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 43.69 38.55 4.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.566 HD11 ' HA ' ' A' ' 58' ' ' TYR . 30.5 mt -90.07 109.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.412 1.101 . . . . 0.0 110.436 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 102' ' ' PRO . 8.7 m-70 -133.59 97.73 4.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.573 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 3.8 m-30 -102.83 174.49 5.85 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.245 1.022 . . . . 0.0 111.614 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -147.01 -172.92 4.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 10.1 mt-30 -124.12 -8.94 7.66 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.828 -1.17 . . . . 0.0 110.036 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.713 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.16 -42.9 0.68 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.852 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.1 -139.98 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.563 0 CA-C-O 118.387 -0.816 . . . . 0.0 111.381 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.852 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.6 Cg_endo -73.75 2.31 6.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 122.545 1.945 . . . . 0.0 109.249 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 48.4 m-85 -73.28 -35.87 66.22 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 34.6 p-10 -98.88 20.53 13.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.617 -1.302 . . . . 0.0 109.797 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -73.52 -2.1 21.31 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.924 . . . . 0.0 109.367 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -128.68 -5.78 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.925 . . . . 0.0 109.726 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 24.6 p -65.25 165.09 18.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.4 Cg_endo -70.61 139.24 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.108 1.872 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 t -84.24 149.55 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.73 . . . . 0.0 110.039 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.811 HD11 ' C ' ' A' ' 132' ' ' GLY . 42.9 mt -78.02 144.2 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 110.351 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' C ' HG22 ' A' ' 39' ' ' VAL . 80.6 mt-10 -123.56 -23.2 4.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 110.115 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.2 mtpm? -118.83 164.01 16.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' VAL . 42.2 t . . . . . 0 N--CA 1.487 1.415 0 O-C-N 121.216 -0.928 . . . . 0.0 111.27 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.114 0.483 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 70.8 m-85 -120.47 18.68 12.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.92 . . . . 0.0 108.92 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 31' ' ' VAL . 45.3 t -68.77 150.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.14 81.39 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mm-40 -91.43 129.24 37.44 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.339 -1.095 . . . . 0.0 109.738 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.29 112.7 9.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.27 157.4 1.42 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.176 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -76.6 171.63 14.33 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.398 0.618 . . . . 0.0 109.829 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.595 ' O ' ' HE3' ' A' ' 129' ' ' MET . 24.5 p -80.34 -36.14 34.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.112 -0.993 . . . . 0.0 108.353 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 107.11 135.63 7.92 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -54.1 -52.77 59.95 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -1.149 . . . . 0.0 108.002 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 64.4 t -45.96 -53.84 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.52 -51.88 67.56 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.524 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.3 -32.24 73.6 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.154 -178.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.3 -41.31 85.6 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.277 -1.369 . . . . 0.0 108.228 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.444 HG22 ' HG3' ' A' ' 56' ' ' MET . 44.1 m -73.8 -54.26 8.43 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.004 0.907 . . . . 0.0 109.887 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -51.68 -39.27 57.95 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-30 -60.42 -48.75 80.39 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 198' ' ' VAL . 39.1 mt -65.47 -24.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.597 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 36.6 mtp -73.42 -39.51 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 26.7 tptt -68.24 -41.82 80.63 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.674 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.69 -34.21 58.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.812 -0.555 . . . . 0.0 109.966 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.8 m-70 -106.92 -20.6 13.28 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.634 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.21 52.59 1.64 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -72.29 -69.01 0.37 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.4 Cg_endo -70.25 105.79 1.63 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 120.328 0.686 . . . . 0.0 112.17 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -70.35 -22.05 62.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 13.1 tttp -134.19 144.07 48.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.84 141.62 44.73 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.932 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.43 -41.95 19.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 0.0 109.967 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 2.6 tttt -152.74 134.55 14.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.916 -1.115 . . . . 0.0 110.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.18 166.29 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.46 -0.775 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.515 ' CG ' ' HA ' ' A' ' 126' ' ' SER . 43.1 t80 -143.93 146.44 32.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 t -146.41 152.15 38.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.1 p90 -160.24 155.42 24.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.843 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 94.9 m -93.15 137.16 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.8 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.1 tp -53.8 151.12 6.68 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 111.306 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -65.6 -6.51 11.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.038 -1.039 . . . . 0.0 109.727 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -95.56 -8.24 35.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.506 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.8 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.9 t-20 -69.74 109.82 5.37 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -88.52 15.51 2.06 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.929 2.419 . . . . 0.0 110.227 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.765 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.9 m-85 -108.14 -18.29 13.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.696 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 81' ' ' ASN . 63.5 m-85 -123.69 161.28 25.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 16.7 m-80 -47.51 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 175.07 -47.13 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.337 -0.852 . . . . 0.0 110.947 174.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -77.15 56.25 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.74 104.73 14.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.506 -177.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.95 134.3 44.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 109.405 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.25 129.71 55.19 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.78 125.71 47.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.04 112.68 25.74 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 68' ' ' ASP . . . -73.67 51.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.053 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 37.0 mt -52.88 -49.86 46.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.439 ' H ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.97 -28.07 0.62 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.765 -1.209 . . . . 0.0 108.957 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 35.9 3.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 109.374 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -93.81 154.87 17.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.013 -1.054 . . . . 0.0 110.602 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.11 93.39 4.16 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-85 -81.56 91.37 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.692 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -79.8 87.31 5.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 61.2 m95 -61.67 -6.76 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.63 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.83 -21.22 22.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.751 -1.218 . . . . 0.0 108.032 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 21.8 m-20 -100.12 -26.85 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.629 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 64.1 mt -73.17 67.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 15.1 mt -46.85 149.2 1.58 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.8 -0.563 . . . . 0.0 110.19 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.54 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.3 Cg_endo -78.49 -17.9 12.55 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.965 2.443 . . . . 0.0 110.581 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 1.6 t -146.42 122.45 10.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 108.81 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 116' ' ' ILE . 66.3 m-85 -109.48 140.37 43.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.135 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 p -102.81 -1.28 30.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.465 -0.772 . . . . 0.0 108.951 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' A' ' 19' ' ' ASN . . . 81.59 9.01 86.25 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.67 -10.35 9.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.336 -1.096 . . . . 0.0 109.428 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -64.03 161.0 16.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 171.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.418 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -74.41 -29.58 61.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.44 -61.38 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -62.5 -33.55 75.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 108.975 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 79.4 mttt -65.1 -44.18 89.66 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.468 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 34.9 ttm -59.41 -36.6 76.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.72 -69.36 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.716 -0.615 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.643 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.4 tp -59.11 -40.37 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.867 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 23.0 p -56.83 -41.76 78.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 0.0 110.423 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.791 ' N ' HD12 ' A' ' 24' ' ' LEU . 28.0 tt0 -69.37 -38.51 78.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.279 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.643 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.8 tp -59.38 -55.46 34.45 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.604 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.4 mmt -57.45 -40.51 78.62 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.89 -41.52 91.42 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -65.25 -49.68 68.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 127' ' ' VAL . 76.3 t -65.95 -58.12 7.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.518 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.82 -50.5 14.83 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.9 mt -65.36 -54.47 28.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.219 -1.165 . . . . 0.0 108.256 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 65.0 p -46.48 -31.08 2.5 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.065 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 123' ' ' VAL . 33.6 m -103.48 40.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.989 -1.069 . . . . 0.0 110.089 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 127' ' ' VAL . 0.7 OUTLIER 37.26 49.23 0.88 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.597 0.713 . . . . 0.0 109.745 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.595 ' HE3' ' O ' ' A' ' 45' ' ' THR . 46.7 tpp -66.02 129.02 38.35 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.532 -0.73 . . . . 0.0 111.564 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.2 t0 -76.9 123.14 25.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.64 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.8 m-85 -104.29 118.17 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.405 1.098 . . . . 0.0 113.113 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.811 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.94 -162.87 10.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 104.498 -3.441 . . . . 0.0 104.498 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.652 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.7 Cg_endo -62.31 -29.88 80.38 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 N-CA-C 105.755 -2.44 . . . . 0.0 105.755 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -110.14 137.78 47.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 59.8 m -116.79 107.62 14.86 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.015 -1.678 . . . . 0.0 109.702 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.73 137.08 13.84 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.562 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.8 t -117.33 -161.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.908 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.41 -55.46 3.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.564 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 131.83 -127.57 5.03 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.603 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.489 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 3.8 m -51.13 -56.74 11.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.681 -0.894 . . . . 0.0 111.692 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 24.5 p -47.64 -39.89 18.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.045 -1.035 . . . . 0.0 109.865 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.908 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 33.7 mmt-85 -79.05 -43.54 24.01 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 185' ' ' TYR . 78.4 t -68.82 -55.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.415 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -56.12 -31.75 63.59 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.084 -1.047 . . . . 0.0 108.577 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp85 -77.14 -49.64 14.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.8 78.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.146 -0.971 . . . . 0.0 110.376 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 251' ' ' ILE . 51.5 mt -61.06 -48.19 82.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 110.46 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.7 mtmt -86.77 -43.67 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 111.222 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.8 mt-10 -76.21 -41.51 49.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 112.224 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 32.0 m120 -93.91 -44.27 8.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.584 -1.323 . . . . 0.0 111.66 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.441 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 39.4 m-85 -100.33 -2.45 33.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.79 -1.194 . . . . 0.0 110.476 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.932 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.94 37.72 53.8 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.286 -0.884 . . . . 0.0 112.449 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.426 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.4 m-85 -62.6 167.48 4.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.182 -1.775 . . . . 0.0 107.188 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.8 t-20 -47.82 140.14 6.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.628 -1.295 . . . . 0.0 109.089 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -53.2 -19.68 3.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.313 -0.867 . . . . 0.0 108.906 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.533 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 73.2 p -53.42 -17.2 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.302 -0.874 . . . . 0.0 109.829 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 42.7 t -62.92 122.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.705 -1.247 . . . . 0.0 108.947 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.645 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.0 p-80 -146.75 153.38 40.16 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.119 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.489 ' OE1' ' HB2' ' A' ' 140' ' ' SER . 2.8 tt0 -101.32 148.29 25.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.875 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 6.5 pt -130.96 159.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -112.37 95.81 5.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.865 -1.147 . . . . 0.0 110.688 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.635 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 39.3 tpt85 -42.81 -27.97 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.395 -0.815 . . . . 0.0 109.083 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -62.39 -36.88 93.73 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.27 38.5 1.85 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.051 -1.264 . . . . 0.0 111.691 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.53 169.14 18.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.542 -1.349 . . . . 0.0 110.05 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -100.63 140.63 34.63 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 171' ' ' GLU . 6.4 tttt -40.3 -46.25 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -63.54 -53.26 54.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 110.055 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.0 -26.25 68.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.875 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 69.4 t-105 -74.47 -35.72 63.3 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.132 -0.98 . . . . 0.0 109.911 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 167' ' ' LYS . 45.8 mt-10 -72.22 -32.16 66.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.104 -0.998 . . . . 0.0 109.232 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.59 88.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.31 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.557 ' NE2' HG21 ' A' ' 249' ' ' VAL . 16.1 mm100 -64.78 -50.01 68.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.37 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 184' ' ' VAL . 64.3 mt -71.84 -52.51 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 111.174 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -53.38 -43.06 67.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.108 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.418 ' HE2' ' NE2' ' A' ' 180' ' ' GLN . 7.4 tttt -51.97 -47.21 64.94 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 38.9 mm-40 -59.24 -52.67 64.67 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.763 ' HB3' HG11 ' A' ' 4' ' ' VAL . 20.7 mt -65.59 -28.3 69.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.445 -0.784 . . . . 0.0 110.149 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -52.51 -43.23 64.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 108.757 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 26.7 mt-30 -99.34 42.95 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 7' ' ' LEU . 14.5 m-20 42.33 51.09 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.77 0.795 . . . . 0.0 108.913 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 5.1 mt-30 -124.15 109.52 29.37 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.89 169.6 11.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.886 1.724 . . . . 0.0 111.944 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 HG23 ' A' ' 174' ' ' ILE . 62.1 t -127.03 131.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.804 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -80.97 121.34 25.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 177.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 4.7 t80 -123.29 164.68 18.31 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.962 -1.086 . . . . 0.0 109.673 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -165.63 124.5 1.65 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.19 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.16 108.06 3.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 190' ' ' GLY . 40.0 t -71.1 164.38 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.313 . . . . 0.0 111.457 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.601 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.42 -142.67 3.45 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.411 -1.875 . . . . 0.0 108.411 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.64 -29.66 21.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -1.199 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 m -83.43 -11.74 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.042 -1.036 . . . . 0.0 111.381 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 -168.36 23.21 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -78.76 109.98 2.95 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.362 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -72.06 130.87 41.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.69 160.32 24.73 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.363 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.874 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.1 p90 -163.04 168.53 20.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 55' ' ' ILE . 71.6 t -113.88 137.91 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.753 -1.217 . . . . 0.0 111.888 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.754 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 77.6 mt -104.07 110.42 30.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -124.8 34.32 5.02 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.372 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -171.58 161.56 33.85 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 117.073 -2.489 . . . . 0.0 113.202 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.522 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.52 141.27 29.41 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -112.6 11.53 19.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.777 -1.202 . . . . 0.0 110.442 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.45 -50.23 3.99 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -79.46 53.83 1.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 0.0 109.64 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.455 ' OD1' ' OE2' ' A' ' 171' ' ' GLU . 0.7 OUTLIER 50.73 38.16 18.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 0.3 OUTLIER -121.02 132.73 55.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.095 -1.003 . . . . 0.0 109.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 26.2 m-85 -123.6 160.71 26.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.974 . . . . 0.0 110.039 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.8 t60 -92.73 146.56 23.56 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 197' ' ' PHE . 23.8 t -139.25 139.03 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.497 ' HB2' HD12 ' A' ' 8' ' ' LEU . 25.9 t-20 -108.95 70.38 0.74 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.687 ' CE2' HG11 ' A' ' 210' ' ' VAL . 89.7 m95 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.456 -0.777 . . . . 0.0 110.193 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 2.4 pt20 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 4.9 p -149.43 167.04 27.29 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.74 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.99 145.58 36.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.575 0.703 . . . . 0.0 109.536 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.585 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.0 t -107.94 114.42 46.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.645 HG23 ' NE2' ' A' ' 158' ' ' HIS . 12.3 m -119.52 138.95 48.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.252 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 97.95 53.84 1.25 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 147' ' ' LEU . 5.4 mt -103.65 96.36 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -1.152 . . . . 0.0 110.102 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.48 147.42 8.54 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.612 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.646 0 C-N-CA 122.227 1.951 . . . . 0.0 110.288 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 178' ' ' LEU . 94.7 t . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.5 mmtt -76.36 178.44 6.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 9' ' ' ASP . 1.8 t -77.9 106.35 9.69 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.024 -1.048 . . . . 0.0 109.241 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.705 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 38.3 mt -57.4 -50.72 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.879 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.1 mt -55.49 -41.84 73.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.784 -1.198 . . . . 0.0 109.224 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 29.8 t0 -67.75 -40.47 84.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.581 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.6 p -58.53 -14.16 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.1 -1.0 . . . . 0.0 109.293 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' HG13 ' A' ' 13' ' ' ILE . 17.7 mtpt -117.75 22.12 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 0.0 108.802 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.0 37.85 4.42 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.1 mt -88.63 109.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 122.427 1.108 . . . . 0.0 110.219 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 28.0 m80 -133.78 98.0 4.06 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.6 m-30 -103.61 171.66 7.24 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.216 1.008 . . . . 0.0 112.064 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.498 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.3 t30 -147.19 -173.21 4.19 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.479 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.3 mt-30 -124.11 -3.7 8.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.64 -56.17 0.35 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.158 -1.496 . . . . 0.0 112.152 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.788 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.65 -125.14 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-O 117.531 -1.224 . . . . 0.0 112.257 -176.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.788 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -80.54 9.21 3.8 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 123.381 2.243 . . . . 0.0 110.212 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 15' ' ' TYR . 71.0 m-85 -83.94 -33.92 24.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 109.818 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.2 p30 -102.51 21.87 14.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.748 -1.22 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.4 mt -69.37 -4.4 18.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.94 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 118' ' ' GLU . 63.6 mt -131.67 -5.67 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.878 -1.139 . . . . 0.0 110.275 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 21.2 p -61.38 165.83 6.32 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 0.0 108.392 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.2 Cg_endo -69.57 131.31 21.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.069 1.846 . . . . 0.0 111.675 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.6 t -77.34 151.31 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.605 -0.684 . . . . 0.0 109.601 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 132' ' ' GLY . 12.7 mt -77.54 150.28 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -125.13 -23.37 4.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.434 -0.791 . . . . 0.0 111.15 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' TYR . 16.1 mtpt -121.54 176.35 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.845 -1.159 . . . . 0.0 109.927 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 37' ' ' SER . 79.5 t . . . . . 0 N--CA 1.486 1.337 0 O-C-N 121.241 -0.912 . . . . 0.0 110.772 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 15.74 11.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.918 -1.114 . . . . 0.0 109.571 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.1 t -63.1 143.49 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.91 67.16 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.9 mt-30 -83.92 127.08 33.6 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.192 -1.181 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -72.86 110.28 7.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.23 158.44 1.15 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.599 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -75.75 169.2 18.59 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 109.363 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.65 ' O ' ' HE3' ' A' ' 129' ' ' MET . 8.7 p -80.7 -34.5 34.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.113 . . . . 0.0 108.051 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.06 135.29 7.83 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.1 p -54.49 -49.19 70.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -1.215 . . . . 0.0 107.93 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.628 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 20.3 t -46.38 -56.41 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -58.7 -50.13 75.03 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.667 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.77 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.415 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -66.66 -38.3 86.57 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.071 -1.452 . . . . 0.0 107.632 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.507 ' CG2' HG13 ' A' ' 143' ' ' VAL . 61.8 m -74.55 -53.98 8.38 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.26 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -55.13 -41.37 71.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 110.323 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.575 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.4 mt-30 -57.61 -47.5 82.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.491 -1.38 . . . . 0.0 107.331 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 198' ' ' VAL . 59.3 mt -65.74 -24.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 27.7 mtp -73.75 -37.68 64.97 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 22.3 tptt -71.2 -39.04 72.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.2 t80 -53.53 -34.49 58.38 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 109.528 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 75.5 m-70 -107.62 -20.08 13.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.645 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.02 54.33 1.64 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 1.4 t80 -72.38 -73.84 0.16 Allowed Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 34.4 Cg_endo -68.58 103.4 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.342 0.654 . . . . 0.0 112.057 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.456 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t-20 -70.84 -18.83 62.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 8.0 tttp -134.11 141.73 47.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.25 148.6 36.72 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.42 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.968 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -87.89 -59.04 2.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -1.02 . . . . 0.0 109.316 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' A' ' 68' ' ' ASP . 15.6 tttt -139.03 150.42 45.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-20 -74.58 179.99 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 70' ' ' THR . 61.9 t80 -147.73 167.5 24.5 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.374 -0.829 . . . . 0.0 109.605 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 6.8 t -166.22 147.87 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 19.1 p90 -163.35 152.67 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.482 HG23 HD22 ' A' ' 85' ' ' ASN . 21.1 m -93.09 138.14 31.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.803 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.5 tp -52.54 150.03 5.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 111.331 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -61.95 144.07 55.58 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.54 . . . . 0.0 109.715 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -1.91 11.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.82 -8.95 23.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 109.732 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.803 ' ND2' HD21 ' A' ' 73' ' ' LEU . 31.2 t-20 -70.24 109.4 4.81 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.765 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.0 Cg_endo -89.3 16.07 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.0 2.467 . . . . 0.0 110.279 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 91.2 m-85 -104.45 -23.53 13.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.746 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.4 m-85 -122.56 161.38 23.79 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.573 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 21.7 m-80 -46.1 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.18 -47.1 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 175.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.64 57.55 4.99 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 N-CA-C 107.39 -1.812 . . . . 0.0 107.39 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -105.67 107.25 18.15 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.247 -178.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -100.49 139.12 36.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.3 mp -115.97 123.14 47.29 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.27 125.25 47.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.079 -1.013 . . . . 0.0 110.059 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.04 113.79 27.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.61 53.0 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.874 -1.141 . . . . 0.0 108.557 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 48.7 mt -52.37 -46.66 46.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 121.264 -0.897 . . . . 0.0 109.76 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.4 p -45.22 -26.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.162 . . . . 0.0 108.936 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.0 p -111.51 33.19 4.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 0.0 109.203 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.643 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -89.37 153.75 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.12 91.24 3.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.23 87.07 6.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.469 -0.769 . . . . 0.0 110.84 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.3 t30 -79.23 88.58 4.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.645 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 72.3 m95 -61.6 -5.69 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 110.737 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.87 -19.46 24.57 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.15 -27.47 13.51 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.68 HG12 ' HB1' ' A' ' 115' ' ' ALA . 48.0 mt -74.14 70.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 38.1 mt -48.8 148.84 3.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.728 -0.607 . . . . 0.0 109.961 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.544 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.1 Cg_endo -79.08 -22.81 8.27 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.758 2.305 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -139.51 121.88 16.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 108.878 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 58.2 m-85 -109.43 140.41 43.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -0.947 . . . . 0.0 109.911 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.9 p -99.9 -0.69 39.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.046 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.483 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 82.07 -0.74 88.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 107' ' ' ARG . 16.3 mtm105 -118.07 1.94 12.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -1.194 . . . . 0.0 109.561 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.68 164.88 15.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.545 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.429 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -60.16 171.55 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.202 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 63.2 m-20 -75.51 -31.48 60.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.89 . . . . 0.0 109.764 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.31 -63.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.87 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 1.1 mp0 -62.46 -31.52 72.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.2 mttt -66.21 -44.29 84.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.476 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 11.0 ttm -59.11 -34.53 72.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.68 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.69 -68.99 0.19 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.697 -0.627 . . . . 0.0 110.539 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.618 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -59.85 -40.9 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 110.209 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.7 p -56.9 -40.22 75.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.767 -1.208 . . . . 0.0 109.764 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.752 ' N ' HD12 ' A' ' 24' ' ' LEU . 37.2 tt0 -69.84 -39.19 76.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 108.682 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.618 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.9 tp -60.44 -60.39 3.89 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.591 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -51.24 -39.22 56.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.628 -0.67 . . . . 0.0 109.679 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.62 -41.26 92.92 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 8.7 m-20 -65.39 -54.59 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.763 ' O ' HG22 ' A' ' 127' ' ' VAL . 87.0 t -63.08 -52.06 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.314 -0.867 . . . . 0.0 108.799 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -51.42 -51.55 36.71 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.3 mt -66.5 -54.39 26.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.076 -1.249 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 125' ' ' ILE . 33.1 p -46.22 -28.13 1.18 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.644 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -101.28 30.95 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.864 -1.148 . . . . 0.0 109.674 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 4.1 m-20 42.51 38.88 1.37 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.247 -0.908 . . . . 0.0 108.944 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.65 ' HE3' ' O ' ' A' ' 45' ' ' THR . 37.6 tpp -53.33 132.21 38.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.574 -0.704 . . . . 0.0 111.583 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 15.5 t0 -76.69 120.73 22.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.65 120.17 40.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.3 1.048 . . . . 0.0 112.96 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.756 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.11 -164.25 11.93 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.4 Cg_endo -62.0 -30.94 83.88 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 105.687 -2.466 . . . . 0.0 105.687 175.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 m -109.97 142.46 41.31 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.3 m -119.54 110.42 16.86 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 119.849 -1.782 . . . . 0.0 109.972 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.17 133.28 11.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -118.44 -169.0 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -1.115 . . . . 0.0 108.602 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.29 -57.33 2.88 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.598 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 129.94 -122.5 3.73 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.551 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.484 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 3.1 m -47.99 -60.58 2.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 24.7 p -46.88 -41.18 15.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.78 -1.2 . . . . 0.0 109.238 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.4 mmp_? -80.33 -42.62 22.64 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.7 t -68.65 -59.38 3.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.722 -0.612 . . . . 0.0 111.149 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.44 -32.88 65.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.16 -0.963 . . . . 0.0 109.175 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 14.2 ttm180 -75.89 -44.15 41.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.099 -1.0 . . . . 0.0 109.375 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 151' ' ' PHE . . . -70.49 -32.11 69.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 109.908 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 251' ' ' ILE . 51.8 mt -60.31 -47.89 84.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.369 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.525 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 24.6 mtmt -87.73 -29.47 21.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.729 -1.232 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 88.4 mt-10 -74.3 -67.46 0.62 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 112.333 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.543 ' HB3' HD13 ' A' ' 90' ' ' ILE . 36.1 m120 -82.1 -31.04 30.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.851 -1.156 . . . . 0.0 111.652 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 19.6 m-85 -102.53 -6.15 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.662 -1.274 . . . . 0.0 110.36 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.968 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 48.95 40.45 27.38 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.224 -0.923 . . . . 0.0 112.244 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.443 ' CE2' HG22 ' A' ' 251' ' ' ILE . 8.6 m-85 -62.76 160.24 14.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.408 -1.643 . . . . 0.0 107.999 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 49.6 t30 -47.64 155.42 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 109.486 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -55.85 -17.57 6.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.895 . . . . 0.0 108.837 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.544 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 21.4 p -53.69 -15.72 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 147' ' ' LEU . 12.8 t -72.25 119.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.68 -1.262 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.817 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.1 p-80 -146.77 155.29 42.26 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.484 ' OE1' ' HB2' ' A' ' 140' ' ' SER . 2.1 tt0 -102.15 143.78 31.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.672 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' CA ' ' A' ' 246' ' ' SER . 4.1 pt -128.33 154.16 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -109.62 94.93 5.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.991 -1.068 . . . . 0.0 110.542 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.579 ' HD2' ' CG ' ' A' ' 170' ' ' TRP . 1.2 tpt85 -46.39 -27.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 108.99 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.82 -23.56 72.57 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -103.64 4.29 35.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.072 -1.252 . . . . 0.0 111.17 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -118.11 167.98 10.98 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.554 -1.341 . . . . 0.0 109.836 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 167' ' ' LYS . 32.0 p -98.94 136.86 38.32 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 166' ' ' SER . 29.3 tttm -34.42 -45.66 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.76 -0.587 . . . . 0.0 110.721 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -63.55 -62.22 1.81 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.958 -1.089 . . . . 0.0 109.733 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.45 -19.88 65.09 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 109.069 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.776 ' NE1' HD11 ' A' ' 174' ' ' ILE . 67.3 t-105 -75.44 -44.25 45.38 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.981 -1.074 . . . . 0.0 108.842 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 208' ' ' TYR . 12.3 mt-10 -61.68 -31.51 71.65 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.97 80.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.826 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.462 ' NE2' HG21 ' A' ' 249' ' ' VAL . 21.3 mm100 -61.32 -45.38 94.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 109.249 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 184' ' ' VAL . 9.8 mt -76.01 -48.21 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 111.091 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -58.33 -53.76 54.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.014 -1.054 . . . . 0.0 109.67 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -51.28 -38.0 50.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.564 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.2 mm-40 -61.0 -51.32 69.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.8 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.8 mt -69.09 -24.95 64.2 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.489 -0.757 . . . . 0.0 109.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.435 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.7 p -52.21 -38.16 57.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.95 -1.094 . . . . 0.0 108.096 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 24.2 mt-30 -101.32 33.5 2.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.7 m-20 47.11 51.15 13.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 18.1 mt-30 -123.75 106.0 32.27 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.444 ' HD3' HD13 ' A' ' 7' ' ' LEU . 15.4 Cg_endo -63.59 168.77 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.908 1.738 . . . . 0.0 112.497 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 174' ' ' ILE . 42.3 t -121.86 135.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.454 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.757 ' CD1' HG23 ' A' ' 248' ' ' VAL . 3.3 t80 -85.07 118.31 24.55 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.649 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 8.8 t80 -122.29 150.93 41.67 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.808 -1.183 . . . . 0.0 109.774 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.593 ' OE1' ' HA3' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -152.54 121.92 6.77 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.705 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -90.98 112.38 4.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 190' ' ' GLY . 24.6 t -66.37 164.82 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -1.178 . . . . 0.0 110.794 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.585 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -175.65 -143.22 4.51 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -35.68 18.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.235 . . . . 0.0 110.213 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.59 -9.31 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.12 -162.03 18.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.542 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.93 111.53 3.27 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.584 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.6 t-80 -71.57 101.23 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.628 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -86.24 153.1 22.25 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.822 1.296 . . . . 0.0 114.216 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CD1' HG13 ' A' ' 210' ' ' VAL . 21.5 p90 -163.58 164.77 24.06 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.677 HG22 HD11 ' A' ' 55' ' ' ILE . 70.6 t -113.74 139.06 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.705 -1.247 . . . . 0.0 112.011 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.896 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.9 mt -103.38 111.68 34.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -125.22 31.33 5.62 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.395 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.08 41.59 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.271 -2.395 . . . . 0.0 112.883 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 4' ' ' VAL . . . -156.48 149.7 24.27 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 207' ' ' PHE . 18.2 p-10 -128.56 29.81 5.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.578 -1.326 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 48.0 22.24 2.04 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.474 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 22.7 mtm180 -135.04 25.25 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -1.211 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 1.9 m-80 72.58 18.66 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.487 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 9.7 m-85 -120.15 113.73 20.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.901 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 171' ' ' GLU . 3.5 m-85 -102.67 167.35 9.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 108.919 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.4 t60 -92.18 139.48 30.58 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.82 HG13 ' CD1' ' A' ' 197' ' ' PHE . 42.4 t -130.89 136.18 58.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.533 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.467 ' HB2' HD12 ' A' ' 8' ' ' LEU . 23.3 t-20 -108.62 73.67 0.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.676 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 73.5 m95 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 110.269 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 4.4 pt20 . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.503 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 14.2 p -155.96 152.4 28.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 109.89 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 185' ' ' TYR . . . -132.12 167.76 19.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.119 0.961 . . . . 0.0 109.854 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.757 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.7 t -117.42 116.25 51.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.817 HG23 ' NE2' ' A' ' 158' ' ' HIS . 29.4 m -117.64 145.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.734 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.89 49.12 3.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.686 HG12 HD13 ' A' ' 147' ' ' LEU . 4.3 mt -98.98 89.05 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.774 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -160.34 150.71 15.08 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.451 -0.781 . . . . 0.0 109.117 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.635 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 33.9 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.447 2.098 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 178' ' ' LEU . 70.1 t . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 200' ' ' ASP . 7.4 mmtp -76.23 -177.46 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -0.947 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 32.8 t -78.06 104.35 8.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 109.911 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.4 mt -57.84 -52.87 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.528 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 211' ' ' ASN . 16.3 mt -54.44 -40.08 68.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.768 -1.207 . . . . 0.0 108.748 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -68.06 -42.57 80.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.912 . . . . 0.0 109.286 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 p -58.49 -14.78 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.086 -1.009 . . . . 0.0 109.218 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -116.37 22.54 12.76 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.07 33.5 2.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 11' ' ' LYS . 31.5 mt -85.85 109.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.498 -1.001 . . . . 0.0 110.261 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 102' ' ' PRO . 40.1 m80 -134.8 77.46 1.69 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.626 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.0 m-30 -85.13 177.08 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.148 0.975 . . . . 0.0 111.197 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.544 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -147.68 -164.26 1.96 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 45' ' ' THR . 25.8 mt-30 -124.85 -20.57 4.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.856 -1.153 . . . . 0.0 110.583 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.43 -34.56 1.42 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.469 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.811 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 -140.22 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.466 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.846 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.811 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.8 Cg_endo -74.2 3.44 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 CA-C-N 122.511 1.933 . . . . 0.0 109.559 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CD2' HG12 ' A' ' 116' ' ' ILE . 9.1 m-85 -78.87 -31.37 45.53 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.478 -0.764 . . . . 0.0 108.962 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 28.1 p-10 -93.9 19.84 8.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.556 -1.34 . . . . 0.0 109.617 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.3 mt -74.49 -3.05 28.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 24' ' ' LEU . 6.3 mt -129.24 -0.98 5.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 0.0 109.485 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -66.12 166.01 18.91 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.7 Cg_endo -71.32 141.36 38.87 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.368 2.045 . . . . 0.0 112.223 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 35.8 t -80.01 147.05 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.777 HD11 ' C ' ' A' ' 132' ' ' GLY . 21.6 mt -77.88 148.47 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.704 0.764 . . . . 0.0 110.853 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.508 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.6 mm-40 -125.73 -21.54 4.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.621 -0.675 . . . . 0.0 110.432 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 80' ' ' PHE . 13.8 mtpp -122.76 166.97 14.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 38' ' ' PHE . 91.8 t . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.558 -0.714 . . . . 0.0 110.577 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 76.0 m-85 -123.62 15.89 9.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.931 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 28' ' ' ILE . 94.1 t -63.3 136.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.51 -3.12 83.58 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.5 mt-30 -83.76 132.92 34.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.293 -1.122 . . . . 0.0 109.605 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -73.64 110.31 7.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.48 159.39 1.03 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.8 171.78 14.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.455 0.645 . . . . 0.0 109.701 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.696 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.6 p -80.81 -34.62 33.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 108.708 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.34 137.29 8.92 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -48.03 74.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.326 -1.103 . . . . 0.0 108.313 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 137' ' ' SER . 3.3 t -46.93 -53.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.47 -47.94 79.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.888 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 70.9 m -62.91 -30.47 71.57 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.642 -0.661 . . . . 0.0 109.499 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.7 72.14 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.808 -1.157 . . . . 0.0 108.439 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 56' ' ' MET . 40.3 m -76.2 -49.5 17.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.293 0.568 . . . . 0.0 110.752 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.02 -34.28 28.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.177 -0.952 . . . . 0.0 108.742 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-30 -68.26 -48.95 63.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 55.2 mt -65.58 -23.1 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.57 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.8 mtp -73.92 -34.23 64.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 42.8 tptt -72.34 -45.46 59.82 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.4 t80 -52.42 -30.83 31.36 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.265 0.555 . . . . 0.0 109.815 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.638 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 59.3 m-70 -108.35 -24.09 11.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 111.151 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.633 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.23 57.15 2.5 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -79.33 -71.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.0 Cg_endo -68.34 103.43 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 122.26 0.611 . . . . 0.0 111.838 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -21.88 63.48 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 4.9 ttpt -134.8 141.25 46.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.08 146.6 39.29 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.351 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.925 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -82.91 -45.15 14.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -1.027 . . . . 0.0 110.206 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.2 ttpp -152.16 135.29 15.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.035 -1.041 . . . . 0.0 110.069 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' N ' ' H ' ' A' ' 91' ' ' SER . 0.5 OUTLIER -60.65 164.39 4.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.043 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 45.2 t80 -143.37 154.37 43.66 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t -154.52 150.43 27.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 14.7 p90 -155.3 152.3 29.04 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 46.5 m -92.75 140.25 29.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.759 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -55.5 148.57 15.26 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 111.467 -178.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 3.5 p -61.69 141.87 57.57 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.301 0.572 . . . . 0.0 110.122 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.7 m -67.32 -5.41 14.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.9 m120 -99.45 -3.64 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.759 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.1 t-20 -70.68 111.78 10.82 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.552 -0.717 . . . . 0.0 109.878 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.1 Cg_endo -88.5 13.64 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.975 2.45 . . . . 0.0 109.792 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.638 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 59.2 m-85 -112.73 -4.07 14.12 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.283 -0.885 . . . . 0.0 111.641 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.489 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 69.1 m-85 -140.62 161.0 38.79 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 44.5 m-80 -47.77 -81.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 1.1 m-70 174.95 -46.84 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.506 -0.746 . . . . 0.0 110.929 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.2 Cg_endo -76.95 54.6 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 N-CA-C 107.419 -1.8 . . . . 0.0 107.419 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 4.8 tptt -105.67 105.71 15.87 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.068 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.6 m-80 -100.3 140.06 35.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.7 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -113.93 128.38 56.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -120.31 129.68 54.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.094 -1.003 . . . . 0.0 110.235 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.64 111.13 23.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.56 52.44 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.733 -1.23 . . . . 0.0 108.372 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.7 mt -52.43 -52.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.565 -0.709 . . . . 0.0 109.417 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -45.51 -26.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.096 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -112.26 19.85 17.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 17.5 mmt-85 -76.59 152.84 35.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 89.11 3.04 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.0 89.9 5.95 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 110.508 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 15.9 t-20 -80.05 92.32 5.6 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.4 m95 -61.14 -8.82 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 110.026 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -90.79 -15.94 29.22 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 27.2 m-20 -99.26 -33.59 10.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 30.6 mt -73.46 93.71 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 30.1 mt -71.05 151.33 94.9 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' HIS . 30.9 Cg_endo -78.87 -28.15 4.23 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.132 . . . . 0.0 110.223 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.93 127.65 27.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.902 . . . . 0.0 109.31 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.6 m-85 -112.0 145.33 39.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 109.874 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 p -100.11 -12.79 19.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.98 -3.4 62.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -118.68 15.32 13.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.153 . . . . 0.0 109.287 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.02 -172.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.2 p -87.32 179.82 6.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.433 -0.792 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -78.01 -38.61 44.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.54 -58.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.71 -35.27 79.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.289 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.521 ' HD3' ' CD1' ' A' ' 23' ' ' LEU . 14.6 mttm -64.02 -43.06 96.75 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.46 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 23.1 ttm -60.0 -38.29 82.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.55 -68.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.704 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 119' ' ' LEU . 5.3 tp -66.0 -48.64 81.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.386 -0.821 . . . . 0.0 109.68 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 116' ' ' ILE . 51.3 p -47.48 -44.84 25.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.938 -1.101 . . . . 0.0 108.378 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.585 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 4.2 tt0 -70.26 -47.47 61.13 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.875 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.2 tp -48.62 -51.66 26.97 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.696 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -60.26 -46.55 89.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.688 -0.632 . . . . 0.0 109.755 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.58 -35.64 81.17 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.759 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 4.9 m-20 -68.09 -55.47 12.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 127' ' ' VAL . 44.8 t -62.93 -58.32 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.0 109.185 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.55 -50.13 11.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.2 mt -63.68 -58.98 5.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.185 -1.186 . . . . 0.0 108.216 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.9 OUTLIER -46.4 -28.59 1.4 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.39 -177.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 24.2 m -101.24 34.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.592 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.2 m-20 38.74 53.05 1.93 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.321 -0.862 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.4 tpp -65.69 127.01 30.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 111.726 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' SER . 0.7 OUTLIER -75.92 121.64 22.98 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 52.5 m-85 -103.31 117.69 35.08 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.545 1.164 . . . . 0.0 113.316 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.777 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.02 -162.55 10.75 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 104.617 -3.393 . . . . 0.0 104.617 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.652 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.45 -30.89 80.66 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 105.812 -2.418 . . . . 0.0 105.812 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.86 140.75 43.45 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 173.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.4 m -121.09 109.69 15.33 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 119.913 -1.742 . . . . 0.0 110.076 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.9 136.76 13.66 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.444 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 11.2 t -111.66 -161.69 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB3' ' HG3' ' A' ' 142' ' ' ARG . . . -90.89 -57.1 2.93 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.55 -134.57 7.2 Favored Glycine 0 N--CA 1.479 1.54 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.504 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.647 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 3.8 m -52.85 -53.26 51.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.804 -0.821 . . . . 0.0 111.89 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 140' ' ' SER . 5.2 p -45.89 -41.85 11.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.003 . . . . 0.0 109.07 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 138' ' ' ALA . 26.3 mmt180 -81.35 -43.15 19.45 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.635 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.5 t -68.38 -53.88 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.634 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 140' ' ' SER . 2.1 pp0? -56.71 -34.21 67.24 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.256 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -77.82 -51.19 10.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.973 178.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.1 79.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.113 -0.992 . . . . 0.0 110.049 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 251' ' ' ILE . 38.4 mt -58.04 -51.55 69.21 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.482 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 29.3 mtmt -80.27 -45.78 17.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 110.182 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.437 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 86.2 mt-10 -68.32 -52.03 38.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.048 -1.033 . . . . 0.0 111.905 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -90.43 -46.55 8.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.798 -1.189 . . . . 0.0 111.935 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.9 m-85 -99.38 13.68 32.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.648 -1.282 . . . . 0.0 110.938 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.925 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 34.34 41.46 0.22 Allowed Glycine 0 N--CA 1.496 2.679 0 O-C-N 121.512 -0.742 . . . . 0.0 112.815 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.5 m-85 -63.14 169.94 3.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.126 -1.808 . . . . 0.0 107.883 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 30.3 t30 -47.6 136.57 10.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.72 -1.238 . . . . 0.0 109.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.16 -21.01 4.4 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.201 -0.937 . . . . 0.0 108.79 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.503 ' HB3' ' ND2' ' A' ' 154' ' ' ASN . 84.4 p -53.6 -17.44 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 109.787 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 251' ' ' ILE . 37.5 t -58.42 125.17 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.969 -1.082 . . . . 0.0 109.121 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 1.004 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.3 p-80 -146.42 156.7 43.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.562 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.6 tt0 -101.74 150.35 23.22 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.872 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.718 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 20.3 pt -130.77 154.22 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.6 m-80 -119.2 106.16 12.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.163 . . . . 0.0 110.906 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 tpt85 -48.03 -45.03 31.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.461 -0.775 . . . . 0.0 109.765 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.92 -22.75 58.13 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 6.7 m-20 -104.75 2.03 29.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.198 -1.177 . . . . 0.0 111.7 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -117.67 175.03 5.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.498 -1.376 . . . . 0.0 110.665 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.474 ' O ' ' C ' ' A' ' 167' ' ' LYS . 1.1 p -100.46 138.19 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.3 ttmm -35.39 -49.61 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.688 -0.632 . . . . 0.0 110.629 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.431 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 38.3 mm-40 -64.15 -58.3 7.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.004 -1.06 . . . . 0.0 109.777 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.86 -20.77 65.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.455 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.718 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 68.6 t-105 -76.15 -44.69 37.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 174' ' ' ILE . 83.1 mt-10 -73.52 -36.91 65.78 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.172 -0.955 . . . . 0.0 108.497 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.8 -44.3 49.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.443 ' NE2' HG21 ' A' ' 249' ' ' VAL . 22.1 mm100 -61.58 -42.08 98.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 109.028 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.798 HG23 HG21 ' A' ' 184' ' ' VAL . 11.5 mt -75.83 -58.08 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 111.051 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.78 -54.05 21.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 0.0 109.665 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -51.03 -41.27 59.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.578 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 6.0 mm-40 -59.13 -50.53 73.7 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.729 ' HB3' HG11 ' A' ' 4' ' ' VAL . 15.2 mt -68.32 -25.92 65.36 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 110.099 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.414 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 10.5 p -52.43 -40.19 61.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.95 -1.094 . . . . 0.0 108.427 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 31.1 mt-30 -97.7 31.61 2.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 7' ' ' LEU . 86.9 m-20 48.61 49.2 18.89 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 26.6 mt-30 -123.7 107.38 31.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.512 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.2 Cg_endo -64.05 168.9 11.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.125 1.883 . . . . 0.0 112.791 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 174' ' ' ILE . 50.6 t -120.9 134.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.551 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.926 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -82.56 116.02 21.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 5.7 t80 -122.25 158.16 30.09 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 120.954 -1.091 . . . . 0.0 109.355 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -167.2 128.45 1.58 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 117.881 -1.528 . . . . 0.0 111.549 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.01 115.79 4.87 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.3 t -80.6 169.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -173.99 -142.91 4.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.6 -28.86 21.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.157 -1.202 . . . . 0.0 110.739 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.1 m -83.0 -14.1 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.931 -1.106 . . . . 0.0 110.973 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.02 -171.06 21.11 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -82.8 105.82 2.69 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.878 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 15.2 t-80 -70.93 127.58 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.44 161.62 20.93 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.426 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -157.56 -171.35 3.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 75.3 t -134.0 134.94 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.617 -1.302 . . . . 0.0 111.218 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 174' ' ' ILE . 56.1 mt -97.66 119.25 45.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 33.9 p30 -130.62 31.9 4.48 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.564 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.65 161.72 32.39 Favored Glycine 0 N--CA 1.484 1.839 0 C-N-CA 117.254 -2.403 . . . . 0.0 112.457 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.507 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.46 145.3 32.49 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -116.57 17.69 15.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.863 -1.148 . . . . 0.0 110.328 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.33 -51.26 3.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -79.7 50.69 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.067 -1.255 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 51.04 35.25 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' ASP . 0.2 OUTLIER -115.37 130.08 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.063 -1.023 . . . . 0.0 108.96 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 6.8 m-85 -122.97 156.72 34.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 200' ' ' ASP . 61.0 t-80 -93.29 114.78 27.32 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 197' ' ' PHE . 14.3 t -113.89 142.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.077 . . . . 0.0 111.797 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.531 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.1 t-20 -101.32 77.7 1.81 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 45.1 m95 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.683 0.754 . . . . 0.0 110.991 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 6.4 tt0 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -166.75 163.29 16.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.763 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.39 165.35 27.66 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.293 1.044 . . . . 0.0 109.749 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.926 HG23 ' CD1' ' A' ' 185' ' ' TYR . 6.6 t -118.32 114.9 46.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 1.004 HG23 ' CE1' ' A' ' 158' ' ' HIS . 27.1 m -115.25 144.95 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 120.942 -1.099 . . . . 0.0 111.092 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 88.69 51.73 2.99 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.638 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.54 95.36 3.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -1.049 . . . . 0.0 109.971 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.65 153.92 13.28 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 108.899 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.64 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.8 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.211 1.941 . . . . 0.0 110.509 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.731 HG11 ' HB3' ' A' ' 178' ' ' LEU . 63.8 t . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -76.64 172.94 12.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 108.571 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.493 ' HG ' ' CE1' ' A' ' 209' ' ' HIS . 47.2 t -77.52 103.32 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.119 -0.988 . . . . 0.0 109.158 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 30.5 mt -58.62 -50.61 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.552 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 198' ' ' VAL . 11.5 mt -55.41 -37.08 67.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.599 -1.313 . . . . 0.0 108.861 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.5 OUTLIER -67.49 -41.44 84.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 p -58.14 -14.65 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 109.278 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.1 mtpt -121.51 16.4 11.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.82 42.48 6.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 58' ' ' TYR . 43.1 mt -87.99 110.83 21.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.196 0.998 . . . . 0.0 110.504 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 102' ' ' PRO . 55.3 m80 -134.7 97.71 3.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.5 m-30 -104.0 178.46 4.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.984 -1.073 . . . . 0.0 110.938 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 -165.43 2.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.52 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 13.9 mt-30 -124.57 -16.61 6.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.004 -1.06 . . . . 0.0 110.221 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.723 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.77 -37.25 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.305 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.53 -139.57 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.124 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.39 3.35 5.35 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 CA-C-N 122.625 1.973 . . . . 0.0 109.161 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.3 m-85 -77.79 -32.29 52.36 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.533 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 37.9 p-10 -94.46 17.8 12.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 20' ' ' PRO . 12.2 mt -74.18 4.88 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 110.401 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 24' ' ' LEU . 9.2 mt -139.45 2.5 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.68 -1.262 . . . . 0.0 110.389 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.6 p -63.4 164.33 15.39 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.5 Cg_endo -70.07 137.16 33.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.731 1.621 . . . . 0.0 110.73 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 145.58 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.649 0.738 . . . . 0.0 110.085 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.717 HD11 ' HA2' ' A' ' 132' ' ' GLY . 6.5 mt -77.43 151.36 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.476 0.655 . . . . 0.0 110.354 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 39' ' ' VAL . 25.5 mt-10 -124.77 -25.44 3.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.468 -0.77 . . . . 0.0 110.779 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.6 mtpm? -117.38 177.22 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.918 -1.114 . . . . 0.0 109.917 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 37' ' ' SER . 97.3 t . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.893 . . . . 0.0 111.536 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.094 0.473 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.757 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 18.7 m-30 -111.77 10.97 20.91 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.046 -1.034 . . . . 0.0 109.33 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 29' ' ' GLU . 17.6 t -61.22 119.26 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.749 -1.219 . . . . 0.0 108.726 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.9 -11.23 57.47 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 20.8 mt-30 -76.5 134.41 39.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.569 -0.959 . . . . 0.0 109.305 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.19 112.71 9.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.83 163.76 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -87.57 170.18 11.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.863 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.578 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.3 p -82.73 -36.58 25.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 102.82 136.36 9.1 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.504 ' N ' ' NE2' ' A' ' 17' ' ' GLN . 2.1 p -54.58 -50.44 68.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.138 -1.213 . . . . 0.0 108.02 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 40.6 t -46.44 -54.86 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.15 -51.31 70.57 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.034 0.921 . . . . 0.0 109.625 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 48.0 m -62.92 -34.5 77.58 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.813 -0.554 . . . . 0.0 110.232 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -67.24 -39.95 86.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.575 -1.328 . . . . 0.0 108.331 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 56' ' ' MET . 61.8 m -74.41 -52.04 13.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.608 0.718 . . . . 0.0 109.993 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HB3' ' HE2' ' A' ' 120' ' ' MET . . . -52.06 -39.35 59.52 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.638 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.7 mt-30 -59.57 -53.1 61.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.726 -1.233 . . . . 0.0 107.86 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.765 HD11 HG22 ' A' ' 198' ' ' VAL . 26.1 mt -63.24 -29.63 47.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.537 ' SD ' HG22 ' A' ' 123' ' ' VAL . 26.2 mtp -66.23 -42.61 88.41 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.573 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.5 tptt -67.51 -39.43 85.13 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.3 t80 -53.7 -32.5 52.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.644 -0.66 . . . . 0.0 110.245 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 80.6 m-70 -107.03 -21.26 13.06 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.261 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.623 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 81.4 m-20 44.37 53.39 6.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.2 t80 -74.11 -76.62 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.7 -0.8 . . . . 0.0 113.082 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.93 105.1 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 CA-C-N 119.071 0.704 . . . . 0.0 112.084 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.2 m-80 -69.9 -21.51 63.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.04 141.73 49.32 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.37 147.99 34.51 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.601 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.914 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.61 -48.77 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.585 -0.95 . . . . 0.0 109.94 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 28.3 tttp -151.59 140.07 20.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 109.626 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 39.1 m-20 -59.35 172.7 0.6 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.471 -0.768 . . . . 0.0 109.767 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CD1' ' OD1' ' A' ' 150' ' ' ASN . 40.7 t80 -148.0 161.03 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.446 -0.784 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.418 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 14.8 t -159.7 149.69 18.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.5 p90 -160.03 155.63 25.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.097 -1.002 . . . . 0.0 109.829 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 82.7 m -92.77 132.71 36.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.741 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.0 tp -44.45 147.76 0.54 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.264 -0.898 . . . . 0.0 110.77 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t -61.27 143.63 55.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.434 0.635 . . . . 0.0 110.263 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 p -68.58 -3.93 13.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.56 -2.55 35.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.741 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.5 t-20 -71.27 110.89 8.3 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.763 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.592 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.8 Cg_endo -91.09 20.26 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.089 2.526 . . . . 0.0 108.886 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 38' ' ' PHE . 53.7 m-85 -114.93 -22.97 9.33 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.306 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -123.54 165.47 17.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.8 m-80 -47.94 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.8 -47.16 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 111.202 175.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.72 57.63 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.394 -1.81 . . . . 0.0 107.394 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.4 tptt -110.86 108.2 17.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.536 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.553 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.81 145.16 28.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 6.0 mp -116.98 156.99 26.52 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 32.8 t80 -143.26 128.37 18.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.978 -1.076 . . . . 0.0 110.424 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.83 115.38 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.04 53.3 0.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.653 -1.279 . . . . 0.0 108.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.8 mt -52.9 -55.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.451 -0.781 . . . . 0.0 110.339 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -45.7 -26.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.475 -1.39 . . . . 0.0 109.207 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -111.25 22.4 15.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.66 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 42.8 mmt-85 -82.45 152.7 26.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.983 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.471 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.02 91.27 3.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.616 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 3.8 m-85 -81.09 90.22 6.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 110.425 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 35.3 t-20 -80.03 90.27 5.39 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 51.9 m95 -61.16 -7.53 2.78 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.585 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -90.14 -18.52 25.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.6 m-20 -98.88 -30.06 12.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.674 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.1 mt -73.84 69.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 24.6 mt -47.45 150.26 1.71 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.805 -0.559 . . . . 0.0 110.108 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.532 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -80.16 -28.13 3.26 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.824 2.349 . . . . 0.0 110.735 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -135.29 121.89 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.653 ' CE2' HG21 ' A' ' 116' ' ' ILE . 63.0 m-85 -109.53 139.9 43.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 109.899 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 p -100.19 -7.97 24.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.508 ' C ' ' HZ1' ' A' ' 113' ' ' LYS . . . 91.69 -0.01 73.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -118.37 7.31 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -1.123 . . . . 0.0 109.384 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 168.76 17.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.1 p -64.18 165.27 9.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.7 m-20 -71.72 -32.03 67.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -52.41 -61.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -33.65 75.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.508 ' HZ1' ' C ' ' A' ' 106' ' ' GLY . 17.0 mttt -65.88 -44.06 86.46 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -58.74 -36.53 74.47 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.674 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.19 -67.86 0.28 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.647 -0.658 . . . . 0.0 109.584 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.653 HG21 ' CE2' ' A' ' 104' ' ' TYR . 2.2 tp -63.74 -40.7 90.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 10.5 p -58.13 -43.38 87.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.92 -1.112 . . . . 0.0 108.841 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' OE2' ' CD ' ' A' ' 93' ' ' ARG . 50.3 tt0 -69.29 -38.0 78.1 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.61 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.6 tp -56.83 -52.37 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -57.78 -43.06 85.3 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.87 -38.61 91.56 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.644 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.1 m-20 -69.41 -54.85 12.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.537 HG22 ' SD ' ' A' ' 56' ' ' MET . 49.0 t -58.84 -62.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.37 -46.74 16.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.0 mt -63.63 -57.45 11.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 107.979 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.508 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 1.7 p -46.55 -27.33 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.81 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -104.5 31.53 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 45.7 m-20 41.75 43.52 2.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.158 -0.964 . . . . 0.0 109.747 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 45' ' ' THR . 35.2 tpp -60.37 134.2 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -0.778 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -76.96 123.16 25.91 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 34.3 m-85 -103.47 103.92 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -142.04 -170.03 12.36 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.757 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.6 Cg_endo -62.55 -20.91 72.08 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.633 -2.103 . . . . 0.0 106.633 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.64 130.31 55.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 72.6 m -113.87 113.83 25.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 119.753 -1.842 . . . . 0.0 110.339 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.67 126.48 8.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -118.06 -170.7 1.93 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.149 -1.207 . . . . 0.0 107.8 178.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.918 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.45 -49.95 6.23 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 116.76 -111.19 2.26 Favored Glycine 0 N--CA 1.481 1.657 0 C-N-CA 119.955 -1.117 . . . . 0.0 111.751 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.523 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 6.1 m -48.46 -72.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.862 . . . . 0.0 112.317 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 11.4 p -46.61 -32.86 3.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 110.276 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.918 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 24.4 mmt180 -80.41 -49.92 10.8 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.972 -1.08 . . . . 0.0 109.787 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.9 t -68.37 -58.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.7 -0.625 . . . . 0.0 111.049 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 3.1 pp0? -56.55 -31.88 64.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.016 -1.052 . . . . 0.0 108.608 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' SER . 1.9 ttm-85 -77.31 -52.84 8.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.002 -1.061 . . . . 0.0 109.61 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.508 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.95 -37.81 88.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.0 110.053 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.631 ' HB2' HG11 ' A' ' 157' ' ' VAL . 34.3 mt -55.21 -47.31 75.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 50.5 mtmt -87.38 -45.17 10.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.063 -1.023 . . . . 0.0 110.887 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.96 -48.99 69.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.999 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.56 ' OD1' ' CD1' ' A' ' 69' ' ' TYR . 10.5 m120 -94.36 -45.43 7.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.676 -1.265 . . . . 0.0 111.645 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.616 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 27.4 m-85 -99.97 18.67 17.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.763 -1.21 . . . . 0.0 110.716 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.914 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.16 43.55 0.07 OUTLIER Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.777 -0.577 . . . . 0.0 112.857 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 7.0 m-85 -64.17 164.16 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.267 -1.725 . . . . 0.0 108.013 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 27.3 t-20 -47.99 151.4 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.843 -1.161 . . . . 0.0 109.626 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 9.0 mm100 -56.16 -17.14 6.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.066 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.593 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 22.3 p -55.17 -14.84 1.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.84 . . . . 0.0 109.852 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 147' ' ' LEU . 39.8 t -72.66 119.61 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.711 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -149.56 -177.7 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.596 178.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.523 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.7 tt0 -123.42 139.1 54.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.902 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.7 pt -123.91 176.2 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 1.2 m-80 -128.55 97.54 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.793 -1.192 . . . . 0.0 110.558 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.2 tpt180 -46.91 -41.15 15.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.047 -1.033 . . . . 0.0 109.327 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.72 -21.04 54.29 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 64.3 m-20 -104.04 0.25 29.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -1.228 . . . . 0.0 111.677 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.18 173.49 6.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.444 -1.41 . . . . 0.0 110.491 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 167' ' ' LYS . 18.6 p -101.33 136.51 41.05 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 166' ' ' SER . 15.0 ttpp -31.48 -51.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.912 -0.492 . . . . 0.0 111.228 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.65 -58.77 5.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.449 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.6 -19.67 63.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.0 108.513 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.4 t-105 -74.95 -47.55 28.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 19.8 mt-10 -64.15 -23.98 67.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.28 -43.44 98.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -60.5 -44.07 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 108.687 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 4.9 mt -74.24 -41.52 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 108.644 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -50.74 -51.87 45.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 109.08 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -51.96 -50.73 60.64 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 53.7 mm-40 -56.64 -61.25 2.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.731 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.1 mt -55.72 -32.36 63.27 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.183 0.516 . . . . 0.0 110.263 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.5 p -52.32 -53.23 47.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 25.5 mt-30 -88.75 44.13 1.19 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.0 m120 41.97 52.45 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 4.7 mt-30 -124.49 113.56 27.45 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.561 ' HG2' HG23 ' A' ' 55' ' ' ILE . 15.2 Cg_endo -66.34 169.14 14.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 121.743 1.629 . . . . 0.0 111.591 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 55.4 t -125.1 134.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.811 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.748 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.48 122.5 30.51 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 175.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.8 t80 -123.3 163.35 20.89 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.799 -1.188 . . . . 0.0 109.826 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -166.17 123.6 1.41 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.281 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 245' ' ' GLN . . . -93.2 124.26 7.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 190' ' ' GLY . 60.5 t -82.03 158.4 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.81 -1.406 . . . . 0.0 111.212 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.56 -137.8 2.28 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -36.33 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.65 -6.78 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.943 -1.098 . . . . 0.0 111.077 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.71 -159.78 19.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.48 114.29 4.04 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.849 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 32.3 t-80 -70.3 145.48 51.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.56 154.72 38.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 117.852 -1.539 . . . . 0.0 113.908 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.865 ' CD1' HG13 ' A' ' 210' ' ' VAL . 10.4 p90 -163.4 163.56 24.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.765 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -112.51 137.51 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.869 -1.145 . . . . 0.0 112.171 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.684 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 50.5 mt -103.74 121.03 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 19.1 p30 -126.3 16.17 7.75 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.493 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 178' ' ' LEU . . . -160.98 172.31 37.23 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 116.613 -2.708 . . . . 0.0 114.721 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.745 ' CB ' ' CE1' ' A' ' 208' ' ' TYR . . . -159.06 152.07 22.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.97 28.82 5.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.416 -1.428 . . . . 0.0 109.494 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 59.0 14.76 25.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -142.4 47.28 1.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -1.157 . . . . 0.0 108.972 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.99 19.87 2.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 108.967 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -102.06 92.38 4.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.745 ' CE1' ' CB ' ' A' ' 202' ' ' ALA . 3.3 m-30 -102.86 155.97 17.97 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.068 -1.02 . . . . 0.0 111.232 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.574 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.0 t60 -90.96 139.21 30.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.008 -1.682 . . . . 0.0 107.331 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.865 HG13 ' CD1' ' A' ' 197' ' ' PHE . 19.4 t -131.09 139.62 50.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.517 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 39.3 t-20 -114.04 84.17 1.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.596 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 94.8 m95 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.577 ' NE2' ' CG ' ' A' ' 162' ' ' ARG . 7.3 tt0 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -148.83 166.76 27.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.64 151.99 45.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.116 0.96 . . . . 0.0 110.057 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 84.7 t -109.15 118.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.711 HG23 ' NE2' ' A' ' 158' ' ' HIS . 33.5 m -127.1 144.03 38.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.164 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 91.87 55.71 1.72 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.615 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 36.4 mt -102.44 81.62 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.35 -1.088 . . . . 0.0 110.148 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -156.89 148.91 17.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.185 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.975 . . . . 0.0 110.573 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.819 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.8 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -75.91 -178.11 4.17 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.519 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 1.9 t -77.72 105.68 9.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.011 -1.056 . . . . 0.0 109.408 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.673 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 45.7 mt -57.4 -49.37 76.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 108.986 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 198' ' ' VAL . 10.4 mt -55.66 -41.57 73.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.807 -1.183 . . . . 0.0 108.781 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 24.5 t70 -67.4 -39.09 85.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.159 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -58.58 -14.38 8.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.1 mtpp -121.01 21.74 11.24 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.28 -0.888 . . . . 0.0 108.707 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.78 38.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.8 mt -86.61 109.62 19.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 122.283 1.039 . . . . 0.0 110.355 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 102' ' ' PRO . 20.1 m-70 -134.5 88.37 2.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.1 m-30 -95.0 -179.65 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.885 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 1.4 t-20 -148.54 -163.93 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.533 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 43.9 mt-30 -124.6 -23.37 4.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.076 -1.015 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.716 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -114.92 -34.67 1.47 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.308 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.21 -140.36 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.242 -178.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -74.37 3.77 4.98 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 CA-C-N 122.545 1.945 . . . . 0.0 109.694 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.8 m-85 -80.41 -31.46 37.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.435 -0.791 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.4 p-10 -92.13 15.26 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.604 -1.31 . . . . 0.0 109.103 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.7 mt -69.55 -6.97 34.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.9 mt -125.92 -9.24 6.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.007 . . . . 0.0 109.761 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -60.88 166.64 4.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.654 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.4 Cg_endo -70.06 145.88 56.72 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.014 1.81 . . . . 0.0 112.367 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -85.74 148.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.554 0.692 . . . . 0.0 109.808 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.794 HD11 ' C ' ' A' ' 132' ' ' GLY . 25.4 mt -78.21 149.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.448 -0.782 . . . . 0.0 111.295 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 92.9 mt-10 -126.17 -22.16 4.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.596 . . . . 0.0 110.468 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 30.3 mtpt -120.26 169.47 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.858 -1.151 . . . . 0.0 110.258 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 37' ' ' SER . 88.0 t . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.3 t . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 13.92 11.49 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.903 -1.123 . . . . 0.0 109.763 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 29' ' ' GLU . 58.7 t -62.99 141.07 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 109.436 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.27 80.36 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.6 mt-30 -86.92 132.84 33.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -1.188 . . . . 0.0 109.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -73.34 111.14 8.19 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.22 161.21 0.66 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.106 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.38 169.51 18.13 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.405 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.707 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.0 p -80.66 -33.84 35.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 108.469 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.05 135.87 8.01 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.431 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 14.1 p -53.69 -47.89 70.05 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.593 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 29.9 t -47.8 -57.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.372 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.78 -45.16 93.14 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 110.555 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 76.2 m -62.5 -39.24 92.86 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.64 -0.662 . . . . 0.0 110.244 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.62 80.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.489 -1.382 . . . . 0.0 108.778 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.505 ' HB ' HG11 ' A' ' 123' ' ' VAL . 60.7 m -74.71 -55.19 6.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.3 -34.91 48.88 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.662 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.4 mt-30 -63.5 -53.83 45.82 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -63.1 -22.29 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.498 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 24.7 mtp -73.36 -37.36 66.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.4 tptt -71.19 -40.07 71.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 40.9 t80 -53.65 -31.46 47.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.653 -0.654 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.1 m-70 -107.93 -22.4 12.45 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.287 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.639 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.13 57.3 2.0 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -178.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -77.54 -71.59 0.18 Allowed Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -69.17 105.65 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 120.272 0.648 . . . . 0.0 112.171 -176.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.04 -20.35 61.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 34.0 tttt -134.28 139.8 45.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 148.4 37.4 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.411 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.974 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.79 -46.79 8.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.989 . . . . 0.0 109.822 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.504 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 38.3 tttt -151.92 140.51 20.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' SER . 10.7 m-20 -67.62 174.71 3.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 70' ' ' THR . 36.9 t80 -152.16 150.16 29.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.13 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.451 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.61 164.47 35.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.68 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.0 p90 -169.3 155.79 6.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 91.3 m -93.04 130.29 38.69 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.775 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.37 149.97 0.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 111.057 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -61.42 137.37 58.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.694 -0.629 . . . . 0.0 109.568 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -64.44 -7.24 9.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 109.875 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 m120 -96.73 -6.03 37.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.775 ' ND2' HD21 ' A' ' 73' ' ' LEU . 35.2 t-20 -71.04 111.8 11.19 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 53.3 Cg_endo -88.48 12.3 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.887 2.391 . . . . 0.0 109.8 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 70.9 m-85 -107.04 -1.99 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 111.461 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 34.0 m-85 -142.35 161.91 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.572 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.3 m-80 -47.54 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 174.62 -46.47 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 111.008 174.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.94 55.98 5.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.83 103.46 12.97 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.649 -178.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -100.85 132.75 46.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -105.25 137.92 42.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 20.9 t80 -125.13 125.34 43.58 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.151 -0.968 . . . . 0.0 110.395 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.87 105.7 15.63 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.01 54.79 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 108.67 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 70.5 mt -52.71 -52.87 23.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.543 -0.723 . . . . 0.0 110.433 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 p -44.4 -25.47 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -110.56 35.75 3.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 108.565 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.708 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 23.5 mmt-85 -95.75 155.65 16.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.843 . . . . 0.0 110.735 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -118.69 91.41 3.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -81.66 88.18 6.25 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 110.951 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.507 ' O ' HG13 ' A' ' 100' ' ' ILE . 42.8 t-20 -79.66 89.63 5.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.639 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 79.1 m95 -61.27 -6.62 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.85 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 -16.14 31.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -99.9 -30.84 11.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.658 HG12 ' HB1' ' A' ' 115' ' ' ALA . 27.7 mt -73.42 67.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.492 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 12.9 mt -46.32 150.71 1.08 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.554 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.9 Cg_endo -77.45 -26.67 7.05 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.607 2.205 . . . . 0.0 110.946 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 2.1 t -138.2 125.23 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 87.2 m-85 -109.62 139.45 44.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.91 4.51 45.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 108.991 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.72 -6.86 63.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -113.52 15.94 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -1.148 . . . . 0.0 109.395 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.452 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.3 mp0 -75.8 167.53 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -179.69 0.33 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -82.68 -43.94 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.54 -51.88 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.787 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -44.43 96.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.032 -1.043 . . . . 0.0 109.084 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 75.8 mttt -61.93 -36.56 81.75 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.257 -0.902 . . . . 0.0 108.835 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.461 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 14.8 ttm -60.35 -45.32 93.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.13 -51.6 69.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 111.098 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.631 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.5 tp -69.35 -39.11 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.601 -1.312 . . . . 0.0 110.04 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -58.04 -41.49 83.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.098 -1.001 . . . . 0.0 110.44 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.888 ' N ' HD12 ' A' ' 24' ' ' LEU . 22.6 tt0 -68.86 -37.39 79.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.954 -1.091 . . . . 0.0 108.218 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -57.95 -51.8 68.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.4 mmt -59.37 -40.62 87.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.524 -0.735 . . . . 0.0 109.465 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.23 -37.93 88.81 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -69.07 -57.43 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.955 ' O ' HG22 ' A' ' 127' ' ' VAL . 22.6 t -61.73 -48.48 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.048 -1.033 . . . . 0.0 108.835 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -54.64 -54.03 35.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.4 mt -65.91 -53.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.009 -1.289 . . . . 0.0 108.321 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 59.8 p -45.99 -32.11 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.577 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 123' ' ' VAL . 31.5 m -101.39 39.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.3 m-20 37.41 50.97 1.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.665 ' HE3' ' O ' ' A' ' 45' ' ' THR . 51.2 tpp -65.98 127.45 32.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.427 -0.795 . . . . 0.0 111.602 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.6 OUTLIER -76.26 123.05 25.29 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.654 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.4 m-85 -103.94 118.77 37.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.326 1.06 . . . . 0.0 113.578 -175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.794 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.07 -163.8 11.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 104.598 -3.401 . . . . 0.0 104.598 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.659 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.29 -30.86 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.573 -2.51 . . . . 0.0 105.573 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.88 142.03 41.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.4 m -122.25 113.22 19.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 119.855 -1.778 . . . . 0.0 110.157 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.47 132.49 11.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -117.84 -164.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -1.112 . . . . 0.0 108.12 178.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.613 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.86 -64.37 1.12 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.807 -1.183 . . . . 0.0 108.125 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.575 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 132.31 -130.56 5.92 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.837 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 144' ' ' GLN . 1.4 m -47.36 -55.59 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.745 -0.856 . . . . 0.0 111.531 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -45.69 21.22 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.867 -1.146 . . . . 0.0 109.269 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.6 mmp_? -80.63 -38.79 28.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.61 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 185' ' ' TYR . 76.2 t -67.77 -57.29 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.462 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 0.8 OUTLIER -56.7 -33.09 66.12 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.103 -1.039 . . . . 0.0 108.674 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' SER . 2.6 ttp85 -77.8 -46.45 21.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.8 76.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.699 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.647 HD12 HG11 ' A' ' 248' ' ' VAL . 59.1 mt -60.58 -46.5 90.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.697 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.582 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 43.5 mtmt -88.08 -38.87 15.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.784 -1.197 . . . . 0.0 110.722 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 48.3 mt-10 -72.87 -51.66 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.85 -1.156 . . . . 0.0 111.753 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.3 m120 -89.56 -41.38 12.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.884 -1.135 . . . . 0.0 111.587 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.83 8.25 39.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.756 -1.215 . . . . 0.0 110.834 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.974 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 39.38 40.92 1.44 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 121.172 -0.955 . . . . 0.0 112.122 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.13 168.9 3.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.385 -1.656 . . . . 0.0 108.318 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.4 t30 -47.82 142.39 4.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.097 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.43 -20.91 5.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.923 . . . . 0.0 108.956 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.494 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 79.0 p -56.49 -14.46 3.09 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 109.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.582 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 7.0 t -61.82 122.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 0.0 109.586 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.986 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.1 p-80 -148.55 159.19 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.709 -0.797 . . . . 0.0 109.202 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.459 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 2.3 tt0 -102.79 145.38 29.84 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 1.048 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.4 pt -121.77 154.4 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -121.53 99.51 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.874 -1.141 . . . . 0.0 110.646 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.629 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 1.1 tpt180 -46.29 -38.86 9.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.35 -24.26 61.16 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -104.52 1.54 29.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.243 . . . . 0.0 111.857 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -117.77 179.7 4.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.4 -1.437 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 167' ' ' LYS . 60.6 p -104.85 136.64 43.97 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.498 ' HD2' ' NE2' ' A' ' 168' ' ' GLN . 21.7 ttmt -34.35 -47.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.74 -0.6 . . . . 0.0 110.825 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.498 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 49.1 mm-40 -64.97 -59.5 4.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.117 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.51 -16.25 60.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.28 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 1.048 ' CH2' HD12 ' A' ' 160' ' ' ILE . 50.8 t-105 -71.01 -47.97 55.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 33.8 mt-10 -67.1 -38.01 84.92 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -44.67 -49.59 10.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.511 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 23.4 mm100 -61.1 -42.02 97.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 108.725 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.76 HG23 HG21 ' A' ' 184' ' ' VAL . 96.6 mt -71.71 -63.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 0.0 111.381 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.5 OUTLIER -48.11 -43.3 30.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 -177.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -51.84 -43.46 63.19 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.544 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 48.8 mm-40 -59.8 -53.51 57.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.819 ' HB3' HG11 ' A' ' 4' ' ' VAL . 11.4 mt -68.38 -25.06 64.88 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.911 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 175' ' ' ASP . 28.4 p -52.24 -40.12 61.23 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.7 mt-30 -99.94 33.54 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.576 ' C ' HD13 ' A' ' 7' ' ' LEU . 12.9 m120 49.22 48.99 20.38 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 10.6 mt-30 -124.15 114.78 27.67 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 19.7 Cg_endo -66.67 172.14 9.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.03 1.82 . . . . 0.0 112.187 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 249' ' ' VAL . 18.9 t -125.87 118.04 50.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.648 ' HD2' HG23 ' A' ' 248' ' ' VAL . 26.4 t80 -67.78 111.95 4.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.651 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 6.5 t80 -123.21 156.64 34.72 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.17 -0.956 . . . . 0.0 109.465 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -164.65 128.73 2.52 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.813 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 245' ' ' GLN . . . -91.63 109.08 3.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.0 t -71.7 160.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.459 -1.024 . . . . 0.0 111.382 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -162.57 -137.8 2.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -43.32 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.05 -1.265 . . . . 0.0 111.13 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.96 -13.56 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.96 -1.087 . . . . 0.0 111.457 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.99 -165.35 24.9 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.5 108.42 3.21 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.798 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -71.48 118.34 14.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.4 160.52 15.58 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.773 1.273 . . . . 0.0 113.072 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.719 ' CD1' HG13 ' A' ' 210' ' ' VAL . 20.5 p90 -162.36 170.2 19.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 8' ' ' LEU . 47.4 t -114.37 136.07 52.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 120.673 -1.267 . . . . 0.0 112.234 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 65.7 mt -100.56 108.73 23.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.0 p30 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.68 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.426 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -172.5 161.86 33.52 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 117.142 -2.456 . . . . 0.0 112.878 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.525 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -142.73 144.54 32.71 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 207' ' ' PHE . 1.8 t0 -114.11 11.45 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.751 -1.218 . . . . 0.0 110.61 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.77 -47.28 3.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -79.33 50.42 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 109.751 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 53.01 31.67 11.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 110.096 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.1 m-85 -121.06 135.89 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 109.769 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 5.7 m-85 -123.39 164.71 18.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.599 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 0.7 OUTLIER -92.73 148.46 22.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.719 HG13 ' CD1' ' A' ' 197' ' ' PHE . 22.4 t -139.59 137.82 39.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.551 ' HB2' HD12 ' A' ' 8' ' ' LEU . 32.7 t-20 -102.02 80.58 2.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.461 ' CE3' ' HA ' ' A' ' 212' ' ' TRP . 1.6 m95 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 109.773 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.566 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 4.7 mt-30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 34.5 p -131.1 155.53 46.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.381 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.11 162.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.831 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.648 HG23 ' HD2' ' A' ' 185' ' ' TYR . 16.3 t -116.16 110.32 31.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 158' ' ' HIS . 15.4 m -107.75 146.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 121.379 -0.826 . . . . 0.0 110.943 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 84.42 42.42 7.42 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 54.0 mt -89.58 86.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.536 -0.979 . . . . 0.0 110.362 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.51 156.37 17.89 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.624 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.378 2.052 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 178' ' ' LEU . 78.0 t . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 200' ' ' ASP . 11.4 mmtp -75.8 -177.18 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 108.947 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 209' ' ' HIS . 66.3 m -77.72 103.08 7.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.647 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 36.3 mt -57.97 -51.62 68.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 109.483 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.588 HD11 HG11 ' A' ' 198' ' ' VAL . 9.0 mt -55.55 -39.32 70.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.746 -1.221 . . . . 0.0 109.021 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 16.0 t0 -67.33 -37.63 83.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 109.35 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -58.43 -14.49 7.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mtpt -121.08 18.93 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 108.846 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.95 39.74 5.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 18.7 mt -86.14 111.42 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.423 -1.045 . . . . 0.0 110.36 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 102' ' ' PRO . 42.4 m80 -135.23 87.48 2.33 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.619 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.599 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.2 m-30 -88.29 178.23 6.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.977 0.894 . . . . 0.0 110.781 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.73 -163.77 1.85 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.495 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 53.5 mt-30 -125.01 -20.97 4.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.963 -1.086 . . . . 0.0 111.061 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.14 -36.28 1.24 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.22 -1.467 . . . . 0.0 111.666 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.35 -140.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.492 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.016 -177.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.2 Cg_endo -73.85 2.84 5.52 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 CA-C-N 122.538 1.942 . . . . 0.0 109.753 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 9.1 m-85 -78.26 -31.52 49.13 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.024 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 24.6 p-10 -92.36 15.71 13.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.584 -1.323 . . . . 0.0 109.463 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.4 mt -70.38 -3.72 18.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.7 mt -129.27 -6.36 4.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 109.988 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.9 p -61.58 165.47 7.28 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.1 Cg_endo -69.16 145.65 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.058 1.839 . . . . 0.0 112.041 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.25 147.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.73 0.776 . . . . 0.0 110.396 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.76 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.6 mt -78.02 149.68 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.683 0.754 . . . . 0.0 111.396 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.2 mt-10 -126.06 -20.83 4.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 110.573 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -121.25 168.13 11.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 110.15 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.9 t . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 111.119 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.564 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 74.7 m-85 -118.54 13.07 13.37 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.451 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 28' ' ' ILE . 77.2 t -63.35 142.52 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 109.367 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 -1.26 77.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 3.0 mt-30 -87.92 131.72 34.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 25' ' ' THR . 4.5 m-70 -73.55 111.69 8.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -51.93 161.42 0.57 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.08 -1.013 . . . . 0.0 109.329 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.53 170.88 15.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.564 0.697 . . . . 0.0 109.866 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.691 HG21 ' SD ' ' A' ' 120' ' ' MET . 28.2 p -81.2 -34.31 32.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 108.646 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.75 137.82 9.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 51' ' ' ALA . 4.3 p -55.14 -52.56 62.89 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -1.086 . . . . 0.0 108.172 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.3 t -46.8 -51.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.566 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -61.43 -51.53 68.35 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.501 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.495 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 39.8 m -63.19 -30.96 72.01 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.705 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.53 -42.23 83.07 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.733 -1.23 . . . . 0.0 107.836 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.494 HG23 HD21 ' A' ' 147' ' ' LEU . 55.8 m -74.76 -53.03 9.94 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.494 0.664 . . . . 0.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.29 -35.4 37.42 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.501 -0.749 . . . . 0.0 109.646 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.599 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.5 mt-30 -64.32 -53.99 40.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.751 HD11 HG22 ' A' ' 198' ' ' VAL . 36.7 mt -60.88 -24.45 32.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.519 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -72.72 -31.68 65.15 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CG ' HG12 ' A' ' 13' ' ' ILE . 41.3 tptt -73.69 -47.07 42.39 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 41.8 t80 -52.95 -29.98 32.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.727 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 50.4 m-70 -107.32 -24.44 11.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.755 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.612 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 86.1 m-20 44.83 56.17 5.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.8 t80 -79.77 -76.08 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.8 Cg_endo -70.24 105.16 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 119.258 0.771 . . . . 0.0 111.837 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.6 OUTLIER -72.0 -20.75 61.67 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -133.95 138.6 45.57 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.652 ' C ' HD23 ' A' ' 66' ' ' LEU . . . -57.82 152.71 26.89 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.164 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.773 HD12 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mt -94.95 -59.84 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.431 -1.041 . . . . 0.0 110.492 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 14.1 tttm -134.11 151.36 51.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.562 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 21.6 m-20 -74.45 172.56 11.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.829 . . . . 0.0 109.499 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 70' ' ' THR . 28.9 t80 -147.48 153.82 40.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.582 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -157.37 149.68 22.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.095 -1.003 . . . . 0.0 110.097 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.715 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.9 p90 -156.44 157.05 34.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.583 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 87.3 m -93.35 134.95 35.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.786 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -52.78 149.99 5.71 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 111.136 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.78 138.26 58.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.729 -0.607 . . . . 0.0 109.596 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -6.08 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 6.8 m-20 -96.2 -7.26 36.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.164 -0.96 . . . . 0.0 109.575 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.786 ' ND2' HD21 ' A' ' 73' ' ' LEU . 32.3 t-20 -70.25 111.54 9.67 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 109.82 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 50.3 Cg_endo -88.19 12.68 2.77 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.973 2.449 . . . . 0.0 109.996 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.0 m-85 -105.18 -11.86 16.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.69 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.3 m-85 -134.76 163.19 30.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.3 m120 -47.48 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.25 -46.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 111.039 175.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.5 Cg_endo -76.69 56.72 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.99 102.51 11.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.63 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.86 128.85 46.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -102.06 129.1 48.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 11.2 t80 -121.78 126.91 49.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.92 . . . . 0.0 110.047 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.55 116.05 31.24 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.86 51.26 0.62 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.854 -1.154 . . . . 0.0 108.314 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 25.8 mt -52.09 -44.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 O-C-N 121.259 -0.901 . . . . 0.0 109.579 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 4.7 p -45.62 -26.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.649 -1.282 . . . . 0.0 108.76 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -112.51 34.51 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.411 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.718 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 2.2 mmt-85 -93.0 151.5 19.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 110.336 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.462 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.2 94.51 4.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.7 m-85 -81.55 93.04 6.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.472 -0.768 . . . . 0.0 110.408 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 30.7 t-20 -79.81 90.15 5.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.612 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 65.0 m95 -61.22 -9.29 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -90.53 -15.59 30.41 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 22.9 m-20 -98.69 -34.27 10.61 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.552 HG12 ' HB1' ' A' ' 115' ' ' ALA . 34.2 mt -73.1 91.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 14.8 mt -71.06 151.62 94.85 Favored Pre-proline 0 C--N 1.29 -1.99 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.2 Cg_endo -76.58 -20.7 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.462 2.108 . . . . 0.0 110.783 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 140.4 32.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.281 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.505 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.8 m-85 -126.61 135.45 51.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.409 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.6 p -99.52 1.87 44.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 108.962 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.44 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -118.29 11.41 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.331 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -73.11 172.59 10.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.669 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.83 177.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.331 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -80.85 -42.1 22.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.97 -51.76 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.458 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 20' ' ' PRO . 15.8 mttt -61.18 -37.46 83.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.12 -0.987 . . . . 0.0 109.118 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.449 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.2 ttm -59.62 -45.24 92.56 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.373 -0.829 . . . . 0.0 110.028 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.07 -51.31 70.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.857 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -69.78 -43.5 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.549 -1.344 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 24' ' ' LEU . 4.7 p -54.33 -40.36 67.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 19.6 tt0 -70.46 -43.28 70.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.1 tp -54.04 -51.48 63.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.691 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -60.16 -44.22 95.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.598 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.537 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.57 -41.82 96.03 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -65.37 -52.54 52.93 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 127' ' ' VAL . 78.6 t -61.18 -61.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.74 -50.99 13.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.8 mt -63.65 -55.45 22.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.319 . . . . 0.0 108.418 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 3.4 p -46.19 -31.3 2.36 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.515 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.2 m -102.28 40.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.156 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER 39.38 38.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.339 -0.851 . . . . 0.0 110.253 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.647 ' HE3' ' O ' ' A' ' 45' ' ' THR . 48.2 tpp -52.56 128.34 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 111.314 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 25.4 t0 -78.33 123.2 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 68.7 m-85 -104.5 115.81 31.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 113.579 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.76 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.73 -163.82 11.55 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 104.482 -3.447 . . . . 0.0 104.482 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.618 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.34 -29.47 79.71 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 105.589 -2.504 . . . . 0.0 105.589 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -110.47 137.7 47.82 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 50.5 m -116.64 108.7 16.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 119.872 -1.768 . . . . 0.0 109.977 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.1 136.22 13.24 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.547 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 14.6 t -118.56 -163.41 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 108.8 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.892 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.29 -55.55 3.38 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.57 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 126.99 -123.78 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.758 -1.21 . . . . 0.0 111.934 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 10.7 m -48.38 -65.39 0.57 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.817 -0.814 . . . . 0.0 112.458 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -46.52 -34.27 4.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.931 -1.106 . . . . 0.0 109.402 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.892 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 29.6 mmt180 -80.12 -49.74 11.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.876 0.846 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.681 HG21 ' CE2' ' A' ' 185' ' ' TYR . 92.9 t -68.31 -54.82 19.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.867 -0.521 . . . . 0.0 111.19 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 1.3 pp0? -56.68 -34.11 67.06 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.958 -1.089 . . . . 0.0 108.741 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -77.24 -47.85 19.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.48 78.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 109.927 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.607 ' CD1' HG12 ' A' ' 143' ' ' VAL . 66.0 mt -57.13 -49.0 77.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 109.607 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.566 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 58.3 mtmt -87.39 -33.69 19.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 111.116 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 69.6 mt-10 -72.23 -63.94 1.04 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.432 -1.417 . . . . 0.0 112.182 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 10.6 m120 -82.89 -37.22 24.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.433 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 22.4 m-85 -100.76 1.53 40.42 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.752 -1.217 . . . . 0.0 110.471 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.773 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 42.94 41.41 4.57 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.344 -0.848 . . . . 0.0 112.445 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.4 m-85 -61.99 164.75 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.162 -1.787 . . . . 0.0 107.598 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.0 t-20 -47.23 144.7 2.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.683 -1.261 . . . . 0.0 109.014 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -53.02 -19.75 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.004 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.1 p -54.85 -15.17 1.75 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.301 -0.874 . . . . 0.0 110.08 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 147' ' ' LEU . 5.5 t -65.02 121.36 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.46 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.949 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.9 p-80 -147.86 159.9 43.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.748 . . . . 0.0 109.164 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.3 tt0 -101.81 155.73 17.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 109.925 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.1 pt -135.43 143.23 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.2 m-80 -107.91 104.63 14.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.886 -1.134 . . . . 0.0 111.027 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 10.0 tpt180 -47.52 -37.15 11.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 108.857 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -64.44 -20.48 65.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 161' ' ' ASN . 6.4 m-20 -103.63 -4.09 24.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -1.231 . . . . 0.0 110.89 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -118.03 168.18 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.239 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 167' ' ' LYS . 43.4 p -97.19 136.49 37.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 166' ' ' SER . 2.1 tttt -32.69 -45.63 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.152 0.501 . . . . 0.0 110.642 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -64.47 -63.89 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.087 -1.008 . . . . 0.0 109.832 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -63.4 -14.37 49.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.29 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 65.2 t-105 -75.95 -47.67 24.19 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.683 ' HA ' HD12 ' A' ' 174' ' ' ILE . 76.9 mt-10 -70.93 -30.73 67.13 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.53 -44.27 76.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.853 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.515 HE21 HG21 ' A' ' 249' ' ' VAL . 18.5 mm100 -61.25 -40.2 93.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.296 -0.877 . . . . 0.0 108.731 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 184' ' ' VAL . 21.2 mt -73.35 -57.9 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.441 -0.787 . . . . 0.0 110.447 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.43 -43.5 44.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.004 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -51.65 -44.19 62.91 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.579 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.3 mm-40 -60.98 -49.0 79.22 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.727 ' HB3' HG11 ' A' ' 4' ' ' VAL . 30.1 mt -67.4 -28.48 67.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.677 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 175' ' ' ASP . 9.9 p -51.33 -42.59 61.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 108.573 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.8 mt-30 -97.37 32.67 2.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.536 ' C ' HD13 ' A' ' 7' ' ' LEU . 81.5 m-20 48.71 49.96 18.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.3 mt-30 -123.88 116.29 27.63 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.5 Cg_endo -66.35 169.76 13.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.143 1.896 . . . . 0.0 112.461 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 174' ' ' ILE . 57.5 t -126.53 130.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.479 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.817 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -79.39 120.18 23.46 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 176.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 7.1 t80 -123.1 159.33 28.74 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.995 -1.066 . . . . 0.0 109.766 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -166.78 125.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.776 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.493 ' HA2' ' OE1' ' A' ' 245' ' ' GLN . . . -93.85 104.43 3.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 190' ' ' GLY . 46.6 t -68.32 164.07 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 110.925 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.575 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -165.12 -141.46 3.14 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.526 -1.829 . . . . 0.0 108.526 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -30.9 20.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.076 -1.249 . . . . 0.0 110.237 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.47 -22.49 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.022 -1.049 . . . . 0.0 110.495 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.11 -169.48 24.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.583 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.91 102.34 1.9 Allowed Glycine 0 N--CA 1.482 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 111.138 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.0 t-80 -71.29 128.14 34.9 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.82 161.79 19.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.295 -1.362 . . . . 0.0 113.195 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 13.6 p90 -159.29 167.8 28.03 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.751 HG22 HD11 ' A' ' 55' ' ' ILE . 83.5 t -114.69 136.92 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.756 -1.215 . . . . 0.0 112.236 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.931 HD13 HG21 ' A' ' 174' ' ' ILE . 70.7 mt -99.63 125.04 53.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 20.1 p-10 -135.05 30.0 3.36 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.458 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -176.52 165.82 36.36 Favored Glycine 0 N--CA 1.483 1.79 0 C-N-CA 117.369 -2.348 . . . . 0.0 112.226 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 207' ' ' PHE . . . -148.86 146.6 28.02 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.98 2.61 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 110.071 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 86.07 -35.84 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.098 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER -88.46 32.04 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -1.23 . . . . 0.0 110.192 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.1 OUTLIER 76.28 27.44 0.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 7.2 m-85 -118.88 133.27 55.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.186 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 48.0 m-85 -122.96 165.24 17.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.375 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 6' ' ' SER . 29.1 t-80 -92.89 145.53 24.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 97.6 t -135.05 137.83 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.917 -1.114 . . . . 0.0 111.558 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.4 t-20 -111.22 68.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 98.2 m95 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.808 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.493 ' OE1' ' HA2' ' A' ' 188' ' ' GLY . 25.1 tt0 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.506 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 2.5 p -155.41 169.38 24.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.427 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.19 162.55 35.22 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.774 0.797 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 185' ' ' TYR . 18.3 t -116.51 124.06 72.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.949 HG23 ' CE1' ' A' ' 158' ' ' HIS . 9.2 m -123.2 139.96 48.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.85 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.45 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 92.98 51.39 2.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 37.2 mt -98.41 91.09 2.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.319 -1.107 . . . . 0.0 109.567 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.4 148.31 9.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 109.095 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.58 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.264 1.976 . . . . 0.0 110.465 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.0 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 200' ' ' ASP . 59.8 mmtt -75.51 -177.14 3.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.071 -1.018 . . . . 0.0 108.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 4.5 t -77.53 104.25 7.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.699 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.8 mt -56.99 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.028 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.2 mt -54.47 -43.79 72.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 108.595 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -67.55 -37.03 82.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -15.67 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 108.856 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 13' ' ' ILE . 11.8 mtpp -121.12 22.17 11.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.2 38.59 6.5 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 11' ' ' LYS . 32.3 mt -90.86 109.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.332 -1.099 . . . . 0.0 110.138 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 79.6 m80 -134.08 85.85 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.63 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.0 m-30 -93.59 174.21 7.3 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.252 1.025 . . . . 0.0 111.614 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 25.5 t30 -148.38 -172.42 4.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 1.3 mt-30 -125.4 -0.98 7.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.867 -1.146 . . . . 0.0 110.238 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.51 -56.31 0.35 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.252 -1.452 . . . . 0.0 112.145 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.763 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.07 -126.07 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.966 -176.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.763 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 41.0 Cg_endo -79.11 6.69 4.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 CA-C-N 123.56 2.307 . . . . 0.0 109.713 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 16' ' ' ASN . 57.8 m-85 -78.18 -35.3 48.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.641 -0.662 . . . . 0.0 109.535 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 47.8 p30 -96.78 20.29 11.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.831 -1.168 . . . . 0.0 109.098 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.39 1.74 11.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 110.106 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 118' ' ' GLU . 16.6 mt -134.68 0.9 3.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.829 -1.17 . . . . 0.0 110.265 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 29.6 p -66.72 164.4 33.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.711 ' HG3' HD21 ' A' ' 86' ' ' LEU . 18.6 Cg_endo -71.8 131.08 17.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.701 1.601 . . . . 0.0 110.297 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.44 145.63 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.77 0.795 . . . . 0.0 110.429 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 132' ' ' GLY . 10.3 mt -77.65 148.92 6.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.624 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.24 -22.28 4.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.104 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' TYR . 17.4 mtpp -119.39 172.85 7.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 37' ' ' SER . 88.2 t . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.376 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.813 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 13.2 m-85 -116.3 9.81 14.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.796 -1.19 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 29' ' ' GLU . 34.1 t -60.72 117.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.728 -1.232 . . . . 0.0 108.521 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.38 -11.23 50.93 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.475 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 22.9 mt-30 -76.18 133.25 40.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.447 -1.031 . . . . 0.0 109.168 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.83 114.7 11.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -53.24 145.81 13.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -69.97 167.35 17.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.871 -1.143 . . . . 0.0 109.697 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.476 ' O ' ' HE3' ' A' ' 129' ' ' MET . 23.4 p -82.14 -33.03 29.79 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 108.511 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.71 138.62 9.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 p -55.17 -51.45 66.48 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.236 -1.155 . . . . 0.0 107.94 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 HG21 ' A' ' 127' ' ' VAL . 23.4 t -45.11 -53.99 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.13 -55.76 30.87 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.44 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 59.3 m -63.47 -28.43 69.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.572 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -66.5 -47.99 71.25 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.219 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 123' ' ' VAL . 85.8 m -75.38 -48.97 20.51 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.842 0.83 . . . . 0.0 109.864 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.83 -33.76 37.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.426 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.63 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.9 mt-30 -68.34 -50.1 55.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.004 HG21 HD13 ' A' ' 251' ' ' ILE . 40.2 mt -62.95 -23.37 33.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.502 ' HG3' HG22 ' A' ' 52' ' ' THR . 20.0 mtp -73.55 -40.89 63.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 43.6 tptt -65.91 -44.48 85.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.699 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 34.8 t80 -53.39 -28.4 29.22 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 41.0 m-70 -107.65 -25.26 11.4 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.094 -1.004 . . . . 0.0 110.866 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 94.9 m-20 43.76 59.69 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.7 t80 -83.09 -78.76 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.37 108.68 2.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 CA-C-N 119.6 0.893 . . . . 0.0 112.996 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.9 -26.22 66.77 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 2.7 ttpt -130.52 130.76 44.55 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.96 164.97 5.68 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 118.487 -1.816 . . . . 0.0 110.682 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.13 -35.84 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.986 . . . . 0.0 111.188 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 8.6 tttm -152.42 131.71 12.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.73 -1.231 . . . . 0.0 110.489 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 36.5 m-20 -60.23 170.68 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.368 -0.832 . . . . 0.0 108.962 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.505 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 43.4 t80 -145.8 142.1 28.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.2 t -142.9 152.34 41.97 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.208 -0.932 . . . . 0.0 109.419 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 28.7 p90 -160.05 158.09 29.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -92.6 126.3 37.63 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.707 HD21 ' ND2' ' A' ' 77' ' ' ASN . 12.1 tp -43.99 147.53 0.49 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.664 0.745 . . . . 0.0 110.509 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 142.79 54.93 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.527 0.68 . . . . 0.0 110.632 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.7 t -69.49 -2.97 12.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.732 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.8 m-80 -97.57 -2.17 42.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.222 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.707 ' ND2' HD21 ' A' ' 73' ' ' LEU . 18.9 t-20 -70.04 109.6 5.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.9 Cg_endo -90.57 19.63 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.95 2.433 . . . . 0.0 108.827 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.655 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 44.7 m-85 -117.66 -25.83 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.835 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' ASN . 88.4 m-85 -117.35 170.76 8.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.676 -1.265 . . . . 0.0 108.102 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.5 m-80 -53.96 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.47 -49.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.289 -0.882 . . . . 0.0 111.426 174.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 32.0 Cg_endo -75.92 58.51 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.328 -1.836 . . . . 0.0 107.328 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 86' ' ' LEU . 18.7 tptt -105.52 121.88 44.87 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.663 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.45 116.65 33.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 0.0 110.225 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 26' ' ' PRO . 3.4 mp -96.17 134.01 39.77 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 26.0 t80 -132.36 131.38 41.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.776 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -111.77 118.21 34.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.7 53.01 0.42 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.724 -1.235 . . . . 0.0 108.273 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 mt -52.88 -58.1 3.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 0.0 111.23 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.3 p -44.52 -27.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.874 -1.141 . . . . 0.0 108.84 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -112.56 30.48 7.08 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 31.0 mmt-85 -81.17 157.36 25.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.514 -1.366 . . . . 0.0 109.542 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -116.32 81.47 1.62 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 12.1 m-85 -80.96 88.3 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.485 -0.759 . . . . 0.0 110.082 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.2 t-20 -79.17 91.84 5.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.644 ' CE3' HD12 ' A' ' 100' ' ' ILE . 60.0 m95 -60.59 -7.75 2.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.823 . . . . 0.0 110.381 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 9.1 m-20 -89.37 -18.83 26.08 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 24.3 m-20 -100.35 -31.2 11.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.777 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.1 mt -74.03 65.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.532 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 47.9 mt -45.65 149.16 1.13 Allowed Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.553 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.6 Cg_endo -77.23 -20.27 12.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.013 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 103' ' ' THR . 2.7 t -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.945 -1.097 . . . . 0.0 109.414 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 96.8 m-85 -109.26 144.01 37.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.971 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -99.16 -3.4 34.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' HA3' ' ND2' ' A' ' 19' ' ' ASN . . . 81.84 3.65 90.53 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -119.22 6.69 11.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.44 -1.035 . . . . 0.0 108.836 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -174.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 p -72.27 173.57 8.47 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.229 -0.92 . . . . 0.0 108.778 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.0 m120 -78.74 -34.57 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.136 -0.977 . . . . 0.0 109.446 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.24 -61.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.818 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -62.2 -34.21 76.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.996 -1.065 . . . . 0.0 109.038 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 73.6 mttt -66.1 -44.27 84.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.416 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 40.2 ttm -59.53 -34.93 73.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.73 -67.89 0.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.83 -0.544 . . . . 0.0 110.752 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.83 HD11 ' HE2' ' A' ' 120' ' ' MET . 4.0 tp -59.43 -42.35 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.7 p -53.47 -41.71 66.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.92 -1.112 . . . . 0.0 109.908 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.761 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.5 tt0 -69.31 -45.36 69.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.712 HD23 ' CD1' ' A' ' 116' ' ' ILE . 4.6 tp -55.42 -50.03 70.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.83 ' HE2' HD11 ' A' ' 116' ' ' ILE . 22.7 mmt -58.26 -46.12 86.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.42 -38.46 89.97 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.692 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 20.8 m-20 -64.77 -55.68 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 127' ' ' VAL . 51.4 t -61.8 -51.36 73.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -50.86 -49.15 42.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 126' ' ' SER . 2.2 mt -64.95 -60.42 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -1.103 . . . . 0.0 108.489 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.556 ' N ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -45.98 -30.5 1.83 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.494 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 123' ' ' VAL . 32.9 m -101.26 38.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.152 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.6 m-20 35.82 54.06 0.89 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.577 0.703 . . . . 0.0 109.619 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.569 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 40.1 tpp -66.3 130.56 43.62 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 112.144 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' SER . 7.4 t0 -75.87 119.8 20.34 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.537 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 29.5 m-85 -102.34 108.82 20.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -174.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -149.76 -169.35 15.97 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 103.956 -3.658 . . . . 0.0 103.956 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.813 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 14.2 Cg_endo -62.5 -21.28 72.6 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 N-CA-C 106.887 -2.005 . . . . 0.0 106.887 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.42 131.04 55.4 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.739 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 68.0 m -117.3 105.48 12.23 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 119.96 -1.713 . . . . 0.0 110.127 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -109.01 134.41 12.23 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.89 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.593 ' OG ' ' NE ' ' A' ' 142' ' ' ARG . 24.9 t -117.42 -160.86 0.79 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -1.214 . . . . 0.0 108.221 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HB3' HH11 ' A' ' 142' ' ' ARG . . . -90.7 -49.82 6.26 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.747 ' H ' ' CZ ' ' A' ' 142' ' ' ARG . . . 122.87 -111.72 1.79 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.466 ' HB3' ' CD ' ' A' ' 159' ' ' GLN . 0.4 OUTLIER -59.1 -54.14 50.35 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 119.22 -2.341 . . . . 0.0 114.759 -175.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 p -47.12 -32.24 4.08 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.674 -1.266 . . . . 0.0 114.091 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.847 HH22 HG23 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -92.93 -36.28 12.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.977 -1.702 . . . . 0.0 110.58 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.0 t -65.32 -42.69 94.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 109.534 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.448 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 3.6 pp0? -69.27 -37.18 77.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 13.4 ttp180 -75.31 -51.6 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 109.689 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.69 91.39 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 110.322 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB2' HG11 ' A' ' 157' ' ' VAL . 27.6 mt -56.68 -45.05 81.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.941 -1.1 . . . . 0.0 109.203 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.572 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 32.5 mtmt -87.97 -39.0 15.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.993 -1.067 . . . . 0.0 110.791 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 71.5 mt-10 -71.61 -60.69 2.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.723 -1.235 . . . . 0.0 112.535 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.7 m120 -82.28 -44.92 15.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.73 -1.231 . . . . 0.0 111.937 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.42 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 36.4 m-85 -90.84 -14.13 32.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.656 -1.278 . . . . 0.0 110.553 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.63 33.25 83.88 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.208 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.58 ' CE2' HG22 ' A' ' 251' ' ' ILE . 10.1 m-85 -63.61 156.71 25.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.22 -1.753 . . . . 0.0 108.014 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.21 153.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.948 -1.095 . . . . 0.0 109.718 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -55.41 -16.77 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.607 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 0.7 OUTLIER -52.99 -17.56 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.185 -0.947 . . . . 0.0 109.617 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.629 HG11 ' HB2' ' A' ' 147' ' ' LEU . 21.8 t -70.66 121.42 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.911 -1.118 . . . . 0.0 109.405 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.701 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -148.11 170.42 17.85 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.069 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.466 ' CD ' ' HB3' ' A' ' 140' ' ' SER . 3.9 tt0 -111.24 147.29 35.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.694 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 246' ' ' SER . 10.2 pt -141.51 141.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.5 m-80 -104.81 107.86 19.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.059 -1.025 . . . . 0.0 110.377 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.714 ' HB2' ' HH ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -48.4 -28.94 3.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.057 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.04 -13.53 79.26 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 161' ' ' ASN . 0.7 OUTLIER -103.65 -4.63 23.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -1.134 . . . . 0.0 110.192 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -118.66 179.76 4.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.915 -1.116 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.47 ' OG ' ' OD2' ' A' ' 169' ' ' ASP . 1.8 p -107.18 141.88 37.76 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 41.2 tttp -35.39 -49.3 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.702 -0.623 . . . . 0.0 110.818 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -64.18 -57.76 8.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.946 -1.097 . . . . 0.0 110.18 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.47 ' OD2' ' OG ' ' A' ' 166' ' ' SER . 59.1 m-20 -64.03 -19.69 65.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.02 . . . . 0.0 109.463 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 63.9 t-105 -73.18 -43.11 61.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 208' ' ' TYR . 30.1 mt-10 -64.33 -33.68 76.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 108.706 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.76 81.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.426 -0.796 . . . . 0.0 109.392 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.505 ' NE2' HG21 ' A' ' 249' ' ' VAL . 18.2 mm100 -61.03 -47.13 87.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.166 -0.959 . . . . 0.0 109.162 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 16.8 mt -76.06 -50.67 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.099 -1.0 . . . . 0.0 110.706 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -55.28 -53.36 57.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.129 -0.982 . . . . 0.0 108.984 -178.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -51.45 -40.29 59.14 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.9 mm-40 -61.15 -52.7 63.76 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.808 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.75 -24.31 64.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 175' ' ' ASP . 33.5 p -52.74 -38.82 61.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 181' ' ' ASN . 28.5 mt-30 -101.33 38.09 1.65 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.497 ' C ' HD13 ' A' ' 7' ' ' LEU . 16.3 m-20 42.61 50.73 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.745 0.784 . . . . 0.0 108.938 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 7.5 mt-30 -123.51 106.43 32.59 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.418 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.9 Cg_endo -63.22 169.36 9.46 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.237 1.958 . . . . 0.0 113.086 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 40.8 t -122.8 135.15 63.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.273 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.73 114.35 23.34 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.785 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 4.2 t80 -121.36 162.52 20.2 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.2 pt20 -167.35 132.95 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.952 -1.499 . . . . 0.0 111.624 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.42 110.75 4.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.642 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 94.2 t -78.2 162.59 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.334 . . . . 0.0 111.496 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -164.68 -139.77 2.72 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -87.86 -38.4 15.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -1.23 . . . . 0.0 110.985 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 m -76.66 -12.18 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.988 -1.07 . . . . 0.0 111.076 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.59 -172.57 21.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.14 107.95 3.22 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.516 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 8.7 t-80 -72.76 125.12 26.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.58 164.38 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.123 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.864 ' CD1' HG13 ' A' ' 210' ' ' VAL . 37.7 p90 -156.59 -158.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.692 HG22 HD11 ' A' ' 55' ' ' ILE . 70.5 t -139.39 136.53 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.496 -1.377 . . . . 0.0 111.204 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.723 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.3 mt -102.94 112.51 36.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.615 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 23.4 p-10 -124.5 35.06 4.88 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.335 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.1 167.04 39.36 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 117.837 -2.125 . . . . 0.0 112.272 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -148.43 148.22 30.06 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.38 22.53 12.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 109.686 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.61 21.89 3.62 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.5 mtp180 -138.66 29.74 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -1.188 . . . . 0.0 109.108 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.472 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . 11.7 m120 74.36 11.62 4.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 109.503 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.73 138.06 51.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.519 ' OH ' ' CG ' ' A' ' 171' ' ' GLU . 5.8 m-85 -123.07 168.13 12.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.054 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 51.2 t-80 -93.33 115.76 28.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.864 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.9 t -113.67 138.15 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.98 -1.075 . . . . 0.0 111.457 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.54 ' HB2' HD12 ' A' ' 8' ' ' LEU . 14.9 t-20 -100.28 80.92 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.557 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 3.4 m95 . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.495 ' NE2' ' CG ' ' A' ' 162' ' ' ARG . 3.2 pt20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 96.9 p -167.45 161.93 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.785 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -138.92 169.07 18.46 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.694 1.235 . . . . 0.0 110.4 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.688 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 40.6 t -117.12 119.2 61.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.701 HG23 ' NE2' ' A' ' 158' ' ' HIS . 19.7 m -125.24 145.16 33.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 156' ' ' SER . . . 101.11 52.42 1.08 Allowed Glycine 0 N--CA 1.486 1.997 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.051 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 55' ' ' ILE . 2.4 mt -103.94 93.63 2.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.273 . . . . 0.0 110.421 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.2 OUTLIER -162.41 141.99 7.25 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 178.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.354 2.036 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.696 HG12 ' HA2' ' A' ' 201' ' ' GLY . 58.7 t . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 121.209 0.528 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 200' ' ' ASP . 18.4 mmtt -75.37 177.84 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 108.945 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.1 OUTLIER -77.49 103.04 7.19 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.607 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.691 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 23.8 mt -58.27 -52.97 63.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 108.89 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.625 HD11 HG11 ' A' ' 198' ' ' VAL . 11.3 mt -54.96 -41.3 70.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.698 -1.251 . . . . 0.0 108.893 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.5 t70 -68.92 -41.8 77.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.063 . . . . 0.0 108.903 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 p -58.48 -15.03 9.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 108.992 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 58' ' ' TYR . 9.4 mtpp -117.08 22.0 12.84 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.39 34.01 3.3 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 25.4 mt -87.35 108.3 18.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.379 -1.071 . . . . 0.0 110.06 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' PRO . 23.0 m-70 -134.82 83.62 2.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.636 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -90.4 176.17 6.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.84 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -147.22 -164.66 2.05 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.6 mt-30 -124.52 -17.7 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.337 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.734 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.31 -36.98 1.05 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.632 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.02 -142.02 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.55 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.341 -177.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.82 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -74.13 3.72 4.9 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 CA-C-N 122.394 1.891 . . . . 0.0 109.417 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 11.1 m-85 -78.86 -32.26 45.95 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.1 p-10 -92.79 23.63 4.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.595 -1.316 . . . . 0.0 109.635 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.6 mt -77.05 -1.33 28.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.169 -0.957 . . . . 0.0 110.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 24' ' ' LEU . 10.8 mt -134.14 14.09 3.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.717 -1.239 . . . . 0.0 109.359 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 22.3 p -82.68 163.88 49.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.65 134.63 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.002 1.801 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' CE2' ' A' ' 80' ' ' PHE . 20.7 t -78.89 149.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.502 0.668 . . . . 0.0 109.738 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.829 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.1 mt -78.3 148.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.804 0.811 . . . . 0.0 111.169 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' C ' HG22 ' A' ' 39' ' ' VAL . 9.0 mm-40 -126.04 -21.2 4.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.782 -0.574 . . . . 0.0 110.235 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.0 mtpt -121.28 164.51 16.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.148 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 38' ' ' PHE . 80.9 t . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 110.625 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 64.7 m-85 -119.94 15.52 12.52 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.922 -1.111 . . . . 0.0 109.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 28' ' ' ILE . 62.3 t -63.83 137.44 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.599 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.19 -7.36 67.72 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.7 mt-30 -77.72 130.84 37.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -1.113 . . . . 0.0 109.651 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -73.15 110.0 7.1 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.15 159.9 0.85 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.141 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.61 168.3 19.97 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.599 0.714 . . . . 0.0 110.043 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.63 HG21 ' SD ' ' A' ' 120' ' ' MET . 18.0 p -78.85 -35.19 44.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 109.69 134.51 6.94 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 p -54.02 -50.49 66.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 47.0 t -47.05 -55.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.68 -48.15 82.81 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.911 0.862 . . . . 0.0 110.351 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.1 m -61.28 -38.92 88.51 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.49 -37.36 80.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.642 -1.286 . . . . 0.0 108.334 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 56' ' ' MET . 97.6 m -70.44 -56.68 6.04 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.36 -34.98 50.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.52 -0.737 . . . . 0.0 109.199 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.636 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 24.9 mt-30 -63.49 -61.95 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 251' ' ' ILE . 46.4 mt -57.23 -30.19 34.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 52' ' ' THR . 25.8 mtp -63.36 -32.41 73.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.558 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 49.2 tptt -74.65 -43.38 55.62 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 39.2 t80 -51.8 -33.12 34.2 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.69 -0.631 . . . . 0.0 109.789 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 93.4 m-70 -108.71 -22.18 12.35 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 111.05 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.626 ' HB2' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 41.08 55.25 3.22 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -177.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -76.39 -68.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -68.2 96.82 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.31 0.673 . . . . 0.0 111.962 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.06 -20.23 64.94 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -135.44 138.05 42.82 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 177.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.71 149.16 33.74 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.365 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.915 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -88.96 -54.35 4.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.951 . . . . 0.0 110.326 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.9 tttt -140.71 134.52 30.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.088 -1.008 . . . . 0.0 110.245 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -62.2 166.25 5.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.518 -0.738 . . . . 0.0 109.942 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 36.2 t80 -150.04 143.81 25.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.202 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.14 171.63 16.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.16 -0.963 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.3 p90 -173.06 158.57 3.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 109.92 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 89.0 m -93.66 137.89 32.46 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.721 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.3 tp -53.26 149.74 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.035 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 141.32 57.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.767 -0.583 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -69.08 -3.01 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t30 -99.53 -6.01 28.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.467 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.721 ' ND2' HD21 ' A' ' 73' ' ' LEU . 22.0 t-20 -70.12 110.87 7.54 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.867 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.636 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.4 Cg_endo -87.46 10.86 3.37 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.973 2.449 . . . . 0.0 110.216 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 56.6 m-85 -108.8 -1.71 19.06 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 111.415 -176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASN . 74.7 m-85 -141.57 160.93 39.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 9.2 m-80 -48.37 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER 174.42 -46.32 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.385 -0.822 . . . . 0.0 111.284 174.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.41 55.81 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 107.549 -1.75 . . . . 0.0 107.549 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.3 tptt -105.8 103.69 13.25 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.77 133.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 109.558 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.2 mp -106.31 154.19 21.12 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 7.0 t80 -144.41 139.43 28.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.101 -178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -118.53 111.02 18.07 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.62 50.68 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.694 -1.254 . . . . 0.0 108.19 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 4.3 mt -52.81 -51.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.401 -0.812 . . . . 0.0 109.516 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.6 p -44.21 -29.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.674 -1.266 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -112.88 33.73 4.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 108.774 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.48 153.3 23.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.993 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.417 ' HA ' ' NE2' ' A' ' 94' ' ' GLN . 1.5 mm-40 -122.49 85.58 2.44 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-85 -80.9 95.47 6.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.272 -0.892 . . . . 0.0 109.896 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.1 m120 -78.69 92.11 4.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.626 ' CG ' ' HB2' ' A' ' 60' ' ' ASN . 50.2 m95 -60.95 -8.81 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.354 -0.841 . . . . 0.0 109.932 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -90.48 -23.51 20.95 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 8.3 m-20 -97.99 -26.62 14.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.558 ' O ' ' CE ' ' A' ' 57' ' ' LYS . 51.7 mt -74.05 64.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 59.4 mt -46.28 150.7 1.07 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.639 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -79.01 -27.12 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.496 2.131 . . . . 0.0 110.364 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.525 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -139.31 133.05 30.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.98 . . . . 0.0 109.132 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 76.9 m-85 -115.97 142.82 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.155 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.82 -4.39 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.96 10.11 84.43 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -119.93 -6.14 10.05 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.465 -1.02 . . . . 0.0 109.424 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.79 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -63.97 169.54 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -71.07 -176.82 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.693 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 2.8 m120 -80.55 -33.84 35.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.78 -61.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HG3' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -62.52 -35.03 78.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.151 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.494 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 19.0 mttt -64.45 -43.25 94.85 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.058 -1.026 . . . . 0.0 108.308 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.435 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -59.91 -37.95 80.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 108.709 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -56.99 -68.26 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.501 -0.749 . . . . 0.0 109.762 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.647 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.2 tp -64.17 -43.72 97.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.559 -0.713 . . . . 0.0 109.679 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 116' ' ' ILE . 24.1 p -56.63 -40.31 75.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 108.588 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.493 ' OE2' ' CZ ' ' A' ' 93' ' ' ARG . 6.3 tt0 -70.65 -40.79 72.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.2 tp -55.48 -50.54 69.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.2 mmt -60.01 -52.11 66.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.898 -0.501 . . . . 0.0 111.531 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.65 95.33 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 118' ' ' GLU . 6.8 m-20 -65.62 -49.43 68.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 119' ' ' LEU . 48.5 t -61.1 -60.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 108.953 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.6 -44.37 16.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.44 -53.39 32.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.023 -1.281 . . . . 0.0 107.676 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 p -47.43 -32.44 5.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.39 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.6 m -101.49 36.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.005 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.776 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 11.1 m-20 40.1 53.27 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.398 -0.814 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 48.6 tpp -67.59 137.68 55.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 111.899 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 5.9 t0 -87.32 123.82 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.633 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 83.8 m-85 -104.7 120.57 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.482 1.134 . . . . 0.0 113.824 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.829 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.95 -162.44 10.82 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 104.69 -3.364 . . . . 0.0 104.69 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.718 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.16 -31.59 82.87 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 N-CA-C 105.648 -2.482 . . . . 0.0 105.648 175.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.9 m -110.23 143.04 40.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 173.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.535 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.8 m -121.33 110.92 16.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 119.87 -1.769 . . . . 0.0 110.087 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.86 137.94 14.32 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.455 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -117.26 -163.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 107.954 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.921 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.92 -56.22 3.26 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.567 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 125.88 -123.53 4.89 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.499 -1.334 . . . . 0.0 112.009 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.2 m -48.55 -65.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.797 -0.825 . . . . 0.0 112.602 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.48 -32.03 3.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.789 -1.194 . . . . 0.0 109.293 -178.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.921 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.2 mmt-85 -80.86 -51.25 8.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.973 0.892 . . . . 0.0 109.212 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 185' ' ' TYR . 82.7 t -66.9 -54.84 21.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.809 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 2.4 pp0? -57.34 -34.35 68.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.955 -1.091 . . . . 0.0 108.749 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.523 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 6.0 ttm180 -78.4 -53.56 7.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.012 -1.055 . . . . 0.0 109.433 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.27 82.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.21 -0.931 . . . . 0.0 110.223 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 38.1 mt -58.47 -46.09 87.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.952 -1.092 . . . . 0.0 109.377 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 59.5 mtmt -87.72 -49.24 7.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.104 . . . . 0.0 110.981 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.523 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 34.2 mt-10 -67.07 -43.01 83.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.679 -1.263 . . . . 0.0 111.566 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 31.9 m120 -94.4 -49.7 5.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.681 -1.262 . . . . 0.0 111.485 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 56' ' ' MET . 29.6 m-85 -99.42 20.33 13.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.874 -1.141 . . . . 0.0 110.598 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.915 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 40.64 0.05 OUTLIER Glycine 0 N--CA 1.497 2.767 0 O-C-N 121.862 -0.524 . . . . 0.0 112.62 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.9 m-85 -62.88 158.84 18.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.142 -1.799 . . . . 0.0 107.564 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 61.7 t30 -47.17 154.35 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.741 -1.224 . . . . 0.0 109.533 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -56.05 -16.52 5.1 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.6 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 3.6 p -53.02 -17.35 1.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 40.5 t -72.67 119.61 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.866 -1.146 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.707 ' NE2' HG23 ' A' ' 249' ' ' VAL . 0.6 OUTLIER -148.19 166.81 26.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.191 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.55 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -112.68 137.03 51.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.953 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 247' ' ' ALA . 14.7 pt -122.62 170.34 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 1.3 m-80 -127.53 103.46 7.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.683 -1.261 . . . . 0.0 110.509 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.603 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.44 -39.45 15.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.86 . . . . 0.0 109.226 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.08 -26.91 64.1 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -104.8 4.57 32.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.057 -1.26 . . . . 0.0 112.274 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.47 163.81 15.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.2 -1.562 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.7 ttpt -29.36 -51.49 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.21 -60.67 2.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.895 -1.128 . . . . 0.0 110.775 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.47 -18.24 58.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 109.571 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.3 t-105 -74.73 -50.89 15.8 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 174' ' ' ILE . 46.1 mt-10 -69.99 -36.1 74.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -45.75 -41.65 10.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.453 ' NE2' HG21 ' A' ' 249' ' ' VAL . 13.3 mm100 -60.62 -43.65 97.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 199' ' ' ILE . 14.7 mt -68.6 -53.91 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.27 -49.17 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.138 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -51.52 -45.26 62.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.912 -1.118 . . . . 0.0 108.611 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.57 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 19.9 mm-40 -60.53 -52.32 65.68 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.902 . . . . 0.0 108.946 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 199' ' ' ILE . 93.5 mt -65.15 -26.76 68.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.779 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 22.3 p -51.89 -39.99 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.505 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.51 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 19.6 mt-30 -102.32 35.08 2.52 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.513 ' HB3' HD22 ' A' ' 7' ' ' LEU . 16.2 m120 47.82 50.43 15.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 16.7 mt-30 -123.04 105.04 34.92 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.585 ' HD3' HD13 ' A' ' 7' ' ' LEU . 18.7 Cg_endo -62.62 168.85 9.32 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 121.602 1.535 . . . . 0.0 111.869 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 174' ' ' ILE . 2.4 t -129.84 138.18 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.097 0.951 . . . . 0.0 110.79 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.727 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.1 OUTLIER -86.83 123.34 31.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -123.73 161.45 25.14 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.631 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -166.45 129.54 1.95 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 117.666 -1.614 . . . . 0.0 111.115 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.477 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.19 122.37 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.1 t -85.73 168.84 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.152 -1.205 . . . . 0.0 111.117 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.41 -142.82 4.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -87.73 -36.49 17.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.07 -1.253 . . . . 0.0 110.624 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.4 m -75.03 -17.76 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.153 -0.967 . . . . 0.0 110.928 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.17 -170.17 22.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.564 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -89.85 107.38 3.42 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.753 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.631 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.2 t-80 -72.46 134.92 45.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -121.64 162.71 20.22 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.609 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.899 ' CD1' HG13 ' A' ' 210' ' ' VAL . 18.3 p90 -157.13 172.3 18.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.625 HG11 HD11 ' A' ' 8' ' ' LEU . 87.5 t -113.29 140.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.736 -1.228 . . . . 0.0 112.752 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 178' ' ' LEU . 36.2 mt -98.16 130.44 46.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 7.5 p-10 -150.81 37.45 0.65 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.926 -1.51 . . . . 0.0 111.494 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA2' HG12 ' A' ' 4' ' ' VAL . . . 174.92 -179.46 46.2 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 120.267 -1.52 . . . . 0.0 110.464 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.642 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.4 150.9 7.72 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -1.209 . . . . 0.0 109.661 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -111.28 27.52 9.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.07 . . . . 0.0 109.897 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.94 22.34 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.68 44.6 2.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -1.193 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.67 22.36 13.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 5.2 m-85 -121.59 136.69 54.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 28.2 m-85 -121.29 167.64 12.51 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 2.1 t60 -91.55 135.52 33.8 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.089 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.899 HG13 ' CD1' ' A' ' 197' ' ' PHE . 49.9 t -123.62 136.18 60.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.204 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.62 ' CB ' HD12 ' A' ' 8' ' ' LEU . 19.6 t-20 -112.91 78.87 1.17 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.574 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 84.5 m95 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 77.2 p -148.72 158.72 44.34 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.207 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -131.11 151.11 51.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.886 0.851 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.727 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 75.8 t -116.54 116.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.707 HG23 ' NE2' ' A' ' 158' ' ' HIS . 18.7 m -124.15 143.05 38.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.741 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.81 56.89 1.57 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.67 HD13 HG21 ' A' ' 55' ' ' ILE . 6.0 mt -102.68 79.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 110.565 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 13.8 pttm -159.58 155.96 24.05 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.9 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.274 1.982 . . . . 0.0 110.439 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.665 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 29.0 t . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.282 0.563 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -77.03 175.72 9.33 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 11.2 t -77.12 111.28 12.56 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.971 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.652 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 52.5 mt -58.41 -50.77 72.48 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.56 HD11 HG11 ' A' ' 198' ' ' VAL . 10.0 mt -56.3 -34.32 66.38 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.964 -1.085 . . . . 0.0 108.339 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 26.5 t0 -66.87 -41.16 87.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 0.0 109.274 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.8 p -58.1 -16.06 11.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.095 . . . . 0.0 108.593 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HB2' HG13 ' A' ' 13' ' ' ILE . 16.7 mtpt -122.41 19.75 10.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 41.84 42.5 3.88 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.581 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 11.6 mt -86.8 100.69 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.293 -1.122 . . . . 0.0 110.677 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.5 m-70 -128.05 75.32 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 13.5 m-30 -81.18 170.01 16.66 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.283 1.04 . . . . 0.0 111.851 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.77 -174.91 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 47' ' ' SER . 6.3 mt-30 -125.08 18.36 8.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.816 -1.178 . . . . 0.0 110.056 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 22' ' ' ASN . . . -116.74 -87.14 1.28 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.319 -1.419 . . . . 0.0 113.474 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.912 ' ND2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -46.38 -103.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 116.658 -1.639 . . . . 0.0 113.945 -175.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.912 ' HD2' ' ND2' ' A' ' 19' ' ' ASN . 51.9 Cg_endo -83.95 5.58 6.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 123.332 2.226 . . . . 0.0 112.486 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD1' HG12 ' A' ' 116' ' ' ILE . 83.1 m-85 -87.05 -31.97 20.24 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 120.94 -1.1 . . . . 0.0 110.118 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 38.2 p-10 -101.66 27.95 5.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 109.725 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.0 mt -76.03 -4.49 41.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.2 mt -131.19 21.7 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.8 -1.188 . . . . 0.0 109.264 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.3 p -89.68 164.31 29.62 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.97 136.46 35.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.248 1.965 . . . . 0.0 112.048 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.08 148.7 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.663 0.744 . . . . 0.0 110.123 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.814 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.8 mt -78.78 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.646 0.736 . . . . 0.0 111.392 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.6 mt-10 -126.54 -20.38 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.776 -0.578 . . . . 0.0 110.458 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HB2' ' CA ' ' A' ' 79' ' ' TYR . 12.4 mtpp -117.65 168.07 10.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.93 -1.106 . . . . 0.0 110.663 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.5 t . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.595 -0.691 . . . . 0.0 110.335 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 31' ' ' VAL . 13.1 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.9 m-85 -122.4 16.0 10.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.012 -1.055 . . . . 0.0 109.45 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 29' ' ' GLU . 60.5 t -64.03 139.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.932 . . . . 0.0 109.554 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 2.18 89.3 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 21.8 mt-30 -89.02 130.29 35.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -1.165 . . . . 0.0 109.511 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.01 110.14 7.07 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.17 159.01 1.0 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.031 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' OG ' ' A' ' 135' ' ' SER . . . -77.52 166.27 23.28 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.498 0.666 . . . . 0.0 110.085 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.542 ' O ' ' CE ' ' A' ' 129' ' ' MET . 13.2 p -78.89 -30.15 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 100.96 137.19 9.67 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.522 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 7.8 p -55.58 -48.53 74.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.317 -1.107 . . . . 0.0 108.188 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.561 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.3 t -46.43 -52.84 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -61.52 -50.73 71.54 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.685 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 16.9 m -64.83 -28.43 69.55 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.487 -0.758 . . . . 0.0 109.811 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -66.41 -45.15 80.91 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.127 -1.429 . . . . 0.0 107.791 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 56' ' ' MET . 33.3 m -76.13 -49.74 16.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.683 0.754 . . . . 0.0 110.281 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.13 -34.49 31.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.391 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.632 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 33.5 mt-30 -67.18 -52.54 40.13 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.022 HG21 HD13 ' A' ' 251' ' ' ILE . 29.9 mt -61.24 -25.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.539 ' HG3' HG22 ' A' ' 52' ' ' THR . 15.1 mtp -70.5 -36.02 73.57 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.589 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.1 tptt -76.11 -40.87 51.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.652 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 52.7 t80 -53.93 -25.56 21.05 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.015 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.1 m-70 -108.09 -28.0 9.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 110.529 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.619 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 62.5 m-20 47.88 61.75 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -84.67 -78.9 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.0 Cg_endo -71.49 107.47 2.17 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.815 0.97 . . . . 0.0 113.25 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 -24.85 65.65 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 3.5 ttpt -130.12 128.34 41.62 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.56 164.05 5.71 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.463 -1.827 . . . . 0.0 110.397 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.026 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -96.59 -35.36 11.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -1.063 . . . . 0.0 111.285 -179.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.1 tttt -152.67 134.14 14.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.607 -1.308 . . . . 0.0 110.402 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 7.7 m-20 -64.08 172.98 2.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.434 -0.791 . . . . 0.0 109.424 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 27.6 t80 -153.94 147.2 24.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -150.32 169.75 20.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.778 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.687 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.0 p90 -169.59 157.13 6.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 m -93.01 133.88 35.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.753 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.9 tp -50.57 149.56 3.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 111.21 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.43 140.65 58.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.932 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.84 -4.15 11.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.954 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 t30 -99.13 -5.88 29.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.021 -1.049 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.753 ' ND2' HD21 ' A' ' 73' ' ' LEU . 23.5 t-20 -70.17 110.33 6.55 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.733 -0.605 . . . . 0.0 110.208 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 48.7 Cg_endo -88.61 13.59 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.81 2.34 . . . . 0.0 109.619 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.646 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.1 m-85 -107.89 -4.8 17.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 111.363 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 81' ' ' ASN . 35.3 m-85 -142.24 164.15 30.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.6 m120 -49.23 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 173.74 -47.18 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.976 175.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.62 56.31 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 6.4 tptt -106.06 105.8 16.01 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.342 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.05 139.35 35.84 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -112.07 137.53 49.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 61.5 t80 -125.13 132.24 53.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.593 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.75 114.13 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.865 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -73.62 50.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.85 -1.156 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.9 mt -53.47 -57.33 5.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.551 -0.718 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.2 p -43.81 -29.5 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.763 -1.211 . . . . 0.0 109.103 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.865 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.58 34.11 4.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.604 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 8.6 mmt180 -84.31 157.85 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.446 -1.409 . . . . 0.0 109.365 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.14 85.74 2.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.8 m-85 -81.13 93.8 6.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.463 -0.773 . . . . 0.0 110.154 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -77.94 93.27 4.4 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.619 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 56.8 m95 -60.81 -8.35 2.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.518 -0.739 . . . . 0.0 110.458 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -91.02 -21.45 21.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.85 -1.157 . . . . 0.0 108.298 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 26.2 m-20 -99.74 -25.63 14.32 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 68.9 mt -73.69 70.97 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HG2' ' A' ' 108' ' ' GLU . 36.7 mt -52.84 150.43 9.9 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.581 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.8 Cg_endo -79.23 -23.09 7.86 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.964 2.442 . . . . 0.0 110.192 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.24 123.93 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.859 -1.151 . . . . 0.0 109.975 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.51 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 35.2 m-85 -110.62 138.47 46.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.15 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -99.74 -4.56 30.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.27 7.5 60.7 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -120.28 -1.32 10.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -1.118 . . . . 0.0 109.427 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.4 mp0 -64.33 167.11 7.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.35 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -69.55 170.63 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.339 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.58 -35.19 70.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.01 -61.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.763 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.39 -32.15 72.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.356 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 10.4 mttt -66.5 -44.03 83.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.18 -0.95 . . . . 0.0 108.488 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.7 ttm -59.13 -34.49 72.1 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.9 -68.05 0.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.529 -0.732 . . . . 0.0 109.437 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.038 HD11 ' HE2' ' A' ' 120' ' ' MET . 5.5 tp -63.28 -52.13 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.123 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 116' ' ' ILE . 4.2 p -45.6 -41.0 9.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' MET . 34.7 tt0 -70.61 -54.4 12.16 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.836 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.8 tp -46.9 -48.14 21.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 1.038 ' HE2' HD11 ' A' ' 116' ' ' ILE . 24.1 mmt -59.44 -53.99 51.75 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.842 -0.536 . . . . 0.0 111.047 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.22 75.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.939 -1.101 . . . . 0.0 108.564 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 9.5 m-20 -64.2 -47.3 80.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 127' ' ' VAL . 63.0 t -71.54 -51.65 31.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.126 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.86 -51.7 12.82 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 126' ' ' SER . 2.9 mt -62.57 -57.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.177 -1.19 . . . . 0.0 108.258 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.67 -29.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.396 -178.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.641 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.5 m -101.08 34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.428 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 71' ' ' TYR . 95.4 m-20 40.83 51.19 3.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 109.246 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.5 tpp -66.04 126.16 27.72 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 111.698 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' SER . 4.5 t0 -76.53 122.57 24.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.0 m-85 -103.42 116.79 33.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.248 1.023 . . . . 0.0 113.141 -175.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.814 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.28 -162.48 10.74 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.647 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -62.64 -29.47 77.86 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 105.818 -2.416 . . . . 0.0 105.818 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 139.54 45.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.533 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 50.4 m -121.11 107.88 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.067 -1.646 . . . . 0.0 110.008 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.76 143.73 16.28 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.002 -1.095 . . . . 0.0 110.606 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.5 -163.47 0.93 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.61 -60.1 2.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.624 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 139.43 -134.5 6.71 Favored Glycine 0 N--CA 1.48 1.573 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.627 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.493 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 71.7 m -51.42 -49.41 61.68 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.677 -0.896 . . . . 0.0 112.298 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -45.84 -47.47 15.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 110.005 -177.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.1 mmt180 -81.25 -37.01 29.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.98 -1.075 . . . . 0.0 110.322 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.893 HG21 ' CE2' ' A' ' 185' ' ' TYR . 48.2 t -66.24 -61.27 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.739 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.38 -31.52 63.91 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.925 -1.109 . . . . 0.0 108.217 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.495 ' NH1' ' OE2' ' A' ' 149' ' ' GLU . 1.6 ttm-85 -76.12 -48.95 18.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 109.28 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.56 -36.16 81.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.159 -0.963 . . . . 0.0 110.097 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 35.8 mt -56.47 -46.4 80.43 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 56.1 mtmt -87.47 -40.75 14.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.903 -1.123 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.495 ' OE2' ' NH1' ' A' ' 145' ' ' ARG . 29.8 mt-10 -68.65 -58.56 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.836 -1.165 . . . . 0.0 112.316 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.07 -46.59 11.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.832 -1.168 . . . . 0.0 112.387 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 44.3 m-85 -89.9 -12.53 38.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.619 -1.3 . . . . 0.0 110.343 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.16 32.15 81.4 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.482 177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.558 ' CD2' HG22 ' A' ' 251' ' ' ILE . 15.2 m-85 -63.35 153.7 34.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.264 -1.727 . . . . 0.0 107.663 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.5 t-20 -46.71 155.71 0.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.786 -1.196 . . . . 0.0 109.971 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 76.7 mm-40 -55.98 -15.99 4.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.379 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.606 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 70.8 p -53.1 -17.61 1.67 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.169 -0.957 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 19.7 t -71.47 122.2 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.926 -1.108 . . . . 0.0 109.495 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.676 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -146.99 -178.26 6.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.119 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.493 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.2 tt0 -124.91 152.51 43.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 110.472 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.515 ' O ' ' CA ' ' A' ' 246' ' ' SER . 11.0 pt -133.07 145.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -110.56 103.68 12.3 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.034 -1.041 . . . . 0.0 110.895 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.54 -40.21 18.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.21 -0.931 . . . . 0.0 109.353 179.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.02 -23.57 59.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.23 -0.83 27.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.093 -1.239 . . . . 0.0 111.56 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -117.48 169.04 9.84 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.467 -1.396 . . . . 0.0 109.94 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 167' ' ' LYS . 6.9 p -94.7 132.5 39.38 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 166' ' ' SER . 37.2 tttp -32.73 -44.02 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -64.3 -65.35 0.69 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.55 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -14.33 38.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.134 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 62.2 t-105 -72.76 -52.5 14.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.043 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.562 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.8 mt-10 -67.77 -21.99 65.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.33 81.25 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.05 -35.93 78.24 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.657 ' HA ' HG21 ' A' ' 184' ' ' VAL . 15.5 mt -74.57 -61.81 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.231 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.85 -51.59 39.02 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.373 -0.829 . . . . 0.0 109.767 -178.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -51.15 -44.14 61.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 4.0 mm-40 -61.1 -46.73 89.44 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -67.84 -28.15 67.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.536 -0.728 . . . . 0.0 109.916 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 175' ' ' ASP . 22.5 p -52.45 -40.3 62.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.958 -1.089 . . . . 0.0 108.638 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.449 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 11.4 mt-30 -99.57 33.61 2.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.648 ' HB3' HD22 ' A' ' 7' ' ' LEU . 75.5 m-20 43.73 53.46 6.02 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.892 0.853 . . . . 0.0 108.985 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.53 ' CB ' ' OE1' ' A' ' 177' ' ' GLU . 6.5 mt-30 -124.36 110.68 28.47 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.522 ' HD3' HD13 ' A' ' 7' ' ' LEU . 17.7 Cg_endo -64.84 165.48 21.02 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.765 1.643 . . . . 0.0 112.658 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 249' ' ' VAL . 25.0 t -121.03 132.97 69.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.043 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.893 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -83.93 116.57 22.86 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 176.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.686 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 7.3 t80 -122.08 157.44 31.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.957 -1.09 . . . . 0.0 110.153 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.59 131.74 4.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.998 -1.481 . . . . 0.0 111.682 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.83 132.79 11.44 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 190' ' ' GLY . 2.9 t -88.99 172.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.916 -1.343 . . . . 0.0 110.964 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.28 -148.96 7.27 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -30.04 20.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.1 -1.235 . . . . 0.0 110.716 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -83.39 -16.17 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.91 -1.118 . . . . 0.0 111.034 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.19 -164.18 25.32 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -95.15 112.34 4.37 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.964 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.618 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.4 t-80 -71.94 134.05 45.75 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -120.35 162.92 18.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.058 -1.457 . . . . 0.0 112.777 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.686 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 44.0 p90 -162.44 166.67 24.71 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.763 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -114.24 137.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.89 -1.131 . . . . 0.0 112.699 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.652 HG21 ' CG2' ' A' ' 174' ' ' ILE . 54.0 mt -98.09 131.32 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.9 p30 -143.43 30.09 1.39 Allowed 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.232 -1.387 . . . . 0.0 110.386 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.578 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 177.36 -174.25 46.83 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 117.794 -2.145 . . . . 0.0 111.93 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.665 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.2 154.94 11.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.662 -0.905 . . . . 0.0 108.794 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.57 5.96 12.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.757 -1.214 . . . . 0.0 110.314 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.51 -32.79 5.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -84.9 45.67 1.18 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.259 -1.142 . . . . 0.0 109.884 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.29 16.76 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 8.9 m-85 -104.11 145.11 30.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.014 -1.054 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 54.4 m-85 -123.44 161.76 24.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 30.1 t-80 -91.75 123.02 34.82 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.795 HG11 ' CE2' ' A' ' 212' ' ' TRP . 33.1 t -115.3 150.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.49 -177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.2 t-20 -120.38 70.22 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.795 ' CE2' HG11 ' A' ' 210' ' ' VAL . 18.4 m95 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 111.316 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 22.2 mt-30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 19.6 p -159.17 159.73 34.69 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.145 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.6 163.86 29.15 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.146 0.974 . . . . 0.0 109.714 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 95.3 t -117.25 126.73 74.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 184' ' ' VAL . 22.8 m -132.49 149.08 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 157' ' ' VAL . . . 98.05 55.06 1.15 Allowed Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.942 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 1.022 HD13 HG21 ' A' ' 55' ' ' ILE . 2.2 mt -104.0 94.9 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.165 -1.197 . . . . 0.0 110.447 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 18.0 pttt -163.67 144.9 7.19 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.13 -0.981 . . . . 0.0 109.136 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.233 1.955 . . . . 0.0 110.387 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 178' ' ' LEU . 98.2 t . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -74.17 -178.34 3.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.984 -1.072 . . . . 0.0 108.359 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.517 ' HB3' ' ND1' ' A' ' 209' ' ' HIS . 0.0 OUTLIER -77.53 104.0 7.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.054 -1.029 . . . . 0.0 110.36 -178.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.676 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 33.4 mt -58.06 -45.54 86.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 198' ' ' VAL . 7.7 mt -61.2 -41.16 96.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.842 -1.161 . . . . 0.0 109.035 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.1 t70 -66.14 -37.52 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -57.64 -16.36 10.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 13' ' ' ILE . 1.7 mtpt -122.39 17.45 10.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.41 45.73 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.9 mt -90.55 107.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -1.021 . . . . 0.0 111.084 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' PRO . 31.5 m80 -131.43 95.58 3.79 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.66 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 9.7 m-30 -97.35 179.93 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.93 0.872 . . . . 0.0 111.274 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.42 -164.81 2.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 33.9 mt-30 -124.49 -23.56 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.064 -1.022 . . . . 0.0 110.053 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.68 -33.17 1.61 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.231 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.83 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.63 -142.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.518 0 CA-C-N 117.693 0.746 . . . . 0.0 111.093 -178.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -73.68 3.24 5.05 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 CA-C-N 122.229 1.832 . . . . 0.0 109.606 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.57 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 7.3 m-85 -80.37 -27.89 38.11 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.002 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.8 p-10 -97.83 16.48 20.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.461 -1.399 . . . . 0.0 109.743 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.8 mt -70.84 -3.44 19.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 110.003 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.7 mt -129.61 -6.37 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.064 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -60.82 164.47 7.52 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.9 Cg_endo -70.22 136.36 31.57 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.017 1.811 . . . . 0.0 111.625 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.695 HG23 ' CE1' ' A' ' 42' ' ' HIS . 35.6 t -82.39 149.86 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.557 0.694 . . . . 0.0 109.953 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 132' ' ' GLY . 9.8 mt -77.75 151.03 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.62 0.724 . . . . 0.0 110.75 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' C ' HG22 ' A' ' 39' ' ' VAL . 28.5 mt-10 -125.54 -21.96 4.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.683 -0.636 . . . . 0.0 110.417 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' TYR . 48.5 mtpt -124.0 171.1 10.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 110.068 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 37' ' ' SER . 77.1 t . . . . . 0 N--CA 1.487 1.376 0 O-C-N 121.341 -0.849 . . . . 0.0 110.812 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.412 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 73.9 m-85 -124.0 21.79 8.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.898 -1.126 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 28' ' ' ILE . 70.7 t -68.24 139.13 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.776 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 27' ' ' VAL . . . 79.35 1.37 85.92 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 29.0 mt-30 -86.1 129.82 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 27' ' ' VAL . 1.3 m-70 -73.36 111.38 8.43 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.56 158.08 1.37 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.861 -177.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -74.51 169.36 17.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.429 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.7 p -80.76 -34.66 34.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 108.675 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.34 134.47 8.3 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.8 p -54.49 -50.86 66.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.135 -1.214 . . . . 0.0 108.362 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.6 t -46.6 -53.87 2.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.599 -0.84 . . . . 0.0 108.754 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -58.49 -52.03 67.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.46 -0.775 . . . . 0.0 110.206 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.789 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 17.4 m -63.48 -34.33 77.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.15 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.42 98.7 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.299 -1.361 . . . . 0.0 107.865 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 56' ' ' MET . 34.0 m -74.68 -49.0 22.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.42 0.629 . . . . 0.0 109.623 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.65 -41.83 64.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.822 . . . . 0.0 109.883 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.66 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 31.0 mt-30 -60.16 -51.64 68.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.759 -1.213 . . . . 0.0 107.941 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 251' ' ' ILE . 34.1 mt -63.79 -28.1 44.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.527 ' SD ' HG22 ' A' ' 123' ' ' VAL . 18.5 mtp -67.93 -36.18 79.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.564 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -76.38 -42.55 44.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.3 t80 -53.34 -29.66 35.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 109.312 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 36.7 m-70 -105.5 -25.93 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 110.163 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.613 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.4 m-20 45.0 59.14 3.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -84.34 -70.16 0.13 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.024 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.4 Cg_endo -67.37 96.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.398 0.732 . . . . 0.0 111.623 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.15 -20.39 64.88 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 91' ' ' SER . 4.1 tttp -135.68 140.08 44.18 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.93 144.51 41.62 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.124 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.844 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -83.11 -53.85 5.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.951 . . . . 0.0 110.176 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 9.9 ttpp -145.25 142.5 29.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.29 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 9.7 m-20 -66.69 171.51 5.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -0.852 . . . . 0.0 109.884 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 70' ' ' THR . 51.1 t80 -148.62 164.39 34.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.58 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 14.5 t -166.11 162.53 17.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.723 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.9 p90 -166.62 154.65 9.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -92.97 136.97 32.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -54.18 150.77 7.92 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.193 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.74 141.53 57.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.349 0.595 . . . . 0.0 110.076 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -3.26 13.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.082 -1.011 . . . . 0.0 109.71 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.4 m-20 -99.74 -7.27 25.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.793 ' ND2' HD21 ' A' ' 73' ' ' LEU . 33.8 t-20 -69.92 109.84 5.49 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.709 -0.62 . . . . 0.0 109.785 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.634 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.89 16.19 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.867 2.378 . . . . 0.0 110.126 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.9 m-85 -106.57 -26.25 11.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 111.033 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 3.7 m-85 -118.64 162.74 17.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.1 m-80 -46.36 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.15 -47.88 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.164 -0.96 . . . . 0.0 111.178 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.1 Cg_endo -76.75 57.21 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 106.877 -2.009 . . . . 0.0 106.877 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.66 104.46 14.18 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.394 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -100.53 134.11 43.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.339 -0.85 . . . . 0.0 109.679 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.723 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -106.3 137.32 44.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 27.1 t80 -128.54 131.55 48.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.06 -1.025 . . . . 0.0 110.261 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.01 114.75 28.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.48 51.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.728 -1.232 . . . . 0.0 108.312 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.7 mt -52.55 -54.32 16.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.492 -0.755 . . . . 0.0 109.593 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 90' ' ' ILE . 3.6 p -45.41 -26.62 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.497 -1.377 . . . . 0.0 109.154 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.1 OUTLIER -111.38 28.48 8.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.618 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.52 150.72 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.872 0.844 . . . . 0.0 110.822 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 86.9 2.6 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.5 m-85 -80.8 91.41 5.93 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.339 -0.851 . . . . 0.0 110.19 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 24.2 t-20 -79.58 90.6 5.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 58.0 m95 -61.07 -9.06 3.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.229 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.39 -14.7 32.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 53.3 m-20 -100.13 -32.92 10.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.702 HG12 ' HB1' ' A' ' 115' ' ' ALA . 23.4 mt -73.35 95.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.35 1.071 . . . . 0.0 108.566 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 11.8 mt -72.46 153.13 91.97 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.314 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.1 Cg_endo -79.14 -31.84 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.831 2.354 . . . . 0.0 110.344 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -136.8 136.03 38.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 74.9 m-85 -120.12 140.63 50.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 p -102.18 -1.06 32.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.15 88.62 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -118.74 -2.46 10.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.476 -1.014 . . . . 0.0 109.264 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 14.0 mp0 -64.03 167.79 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.3 p -65.05 179.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -82.97 -40.48 19.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.8 t -52.05 -52.36 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.15 98.75 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 108.988 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 24.1 mttt -61.21 -36.83 80.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 50.4 ttm -59.26 -46.03 89.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.5 -0.75 . . . . 0.0 109.666 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.1 -51.88 67.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.787 ' CD1' HD23 ' A' ' 119' ' ' LEU . 4.9 tp -68.86 -44.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.49 -1.381 . . . . 0.0 109.468 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.8 p -52.9 -41.45 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.024 -1.047 . . . . 0.0 108.649 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.733 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -70.01 -45.59 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 116' ' ' ILE . 13.2 tp -50.86 -54.41 24.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.789 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -59.84 -43.92 94.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.685 . . . . 0.0 109.521 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.85 -39.86 94.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 126' ' ' SER . 24.8 m-20 -68.69 -43.37 76.24 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.527 HG22 ' SD ' ' A' ' 56' ' ' MET . 79.8 t -70.75 -62.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.726 -0.609 . . . . 0.0 109.849 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.65 -45.32 17.8 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.5 mt -64.81 -57.49 11.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.07 -1.253 . . . . 0.0 108.106 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 9.4 p -46.06 -29.62 1.56 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.61 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.04 37.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.019 -1.051 . . . . 0.0 110.093 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.688 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.9 m-20 40.31 38.5 0.55 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.369 -0.832 . . . . 0.0 109.656 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.653 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -52.97 129.11 29.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.822 . . . . 0.0 111.192 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.9 t0 -78.72 122.78 26.43 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 66.3 m-85 -105.2 119.39 38.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.995 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.736 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -149.99 -163.29 11.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 103.753 -3.739 . . . . 0.0 103.753 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -61.58 -31.0 86.85 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 105.438 -2.562 . . . . 0.0 105.438 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.75 138.26 47.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -114.44 110.5 19.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.853 -1.779 . . . . 0.0 109.577 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -106.81 135.45 12.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 14.9 t -118.18 -163.79 0.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.127 -1.22 . . . . 0.0 108.672 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.739 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.07 -56.05 3.22 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.558 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 128.16 -119.89 3.24 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.796 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.6 m -51.32 -66.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.85 -0.794 . . . . 0.0 112.871 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -46.89 -35.1 6.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.89 -1.131 . . . . 0.0 109.871 -177.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.739 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 48.0 mmt-85 -79.54 -47.86 14.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.299 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.7 t -67.29 -60.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.483 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -55.9 -30.18 61.17 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.362 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 3.5 ttt180 -77.35 -41.53 40.06 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.252 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.44 75.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 251' ' ' ILE . 58.8 mt -58.11 -53.5 57.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.651 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.596 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 53.6 mtmt -77.46 -52.57 8.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.715 . . . . 0.0 112.097 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 9.2 mt-10 -66.23 -45.56 80.26 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.49 -1.381 . . . . 0.0 112.383 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.02 -45.26 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.559 -1.338 . . . . 0.0 111.506 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 152' ' ' GLY . 34.2 m-85 -100.02 19.99 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 39.6 0.04 OUTLIER Glycine 0 N--CA 1.496 2.668 0 O-C-N 121.905 -0.497 . . . . 0.0 112.992 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.643 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.8 m-85 -63.36 161.08 14.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.212 -1.758 . . . . 0.0 107.478 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.0 t-20 -47.44 147.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.765 -1.209 . . . . 0.0 109.612 -178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.0 mm-40 -54.81 -17.11 3.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.585 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 4.4 p -53.54 -15.87 1.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.596 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 67.0 t -68.81 129.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.638 -1.289 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.746 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.1 p-80 -149.46 172.67 14.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.24 -0.912 . . . . 0.0 109.796 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.568 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -117.49 136.36 53.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.772 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 8.8 pt -123.19 170.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.3 m-80 -123.87 102.66 7.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 110.485 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.632 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 2.6 tpt180 -47.22 -39.2 13.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 109.084 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.51 69.74 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -104.91 34.35 3.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.995 -1.297 . . . . 0.0 112.258 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.59 170.94 14.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.306 -1.496 . . . . 0.0 110.217 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.0 p -96.43 135.8 37.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 6.7 ttpt -34.78 -51.49 0.5 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.813 -0.554 . . . . 0.0 110.978 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -56.09 17.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.403 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.09 -22.32 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.124 -0.985 . . . . 0.0 109.612 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.772 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 70.0 t-105 -71.87 -45.73 60.32 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.133 -0.979 . . . . 0.0 109.169 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 174' ' ' ILE . 69.3 mt-10 -70.87 -26.37 63.22 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.078 -1.014 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.05 83.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.14 -40.45 93.87 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.897 HG23 HG21 ' A' ' 184' ' ' VAL . 12.5 mt -75.72 -56.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.422 -0.799 . . . . 0.0 110.486 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.1 OUTLIER -49.87 -46.09 51.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.979 -1.076 . . . . 0.0 109.022 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -52.15 -45.26 64.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 108.215 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.617 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 31.0 mm-40 -59.71 -48.36 81.98 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.688 ' HB3' HG11 ' A' ' 4' ' ' VAL . 22.6 mt -67.63 -27.63 67.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 20.7 p -51.36 -42.78 61.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 108.716 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 181' ' ' ASN . 19.3 mt-30 -98.67 38.58 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.65 ' C ' HD13 ' A' ' 7' ' ' LEU . 90.5 m-20 43.3 49.97 5.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 5.3 mt-30 -123.64 114.49 28.52 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.3 Cg_endo -65.72 169.6 12.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.421 2.08 . . . . 0.0 112.807 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.897 HG21 HG23 ' A' ' 174' ' ' ILE . 58.5 t -125.61 131.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.81 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -82.93 120.14 25.31 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.98 161.93 23.3 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.894 -1.129 . . . . 0.0 109.546 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.598 ' CA ' ' O ' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -166.74 129.01 1.78 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.466 -1.693 . . . . 0.0 112.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -93.19 124.8 7.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.6 t -83.19 170.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.305 . . . . 0.0 111.12 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -175.33 -145.24 5.34 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -87.66 -29.48 21.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.021 -1.282 . . . . 0.0 110.678 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 m -81.82 -14.82 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.959 -1.088 . . . . 0.0 110.893 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.66 -164.41 24.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.56 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -87.93 106.45 3.21 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 121.089 -1.242 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.598 ' O ' ' CA ' ' A' ' 187' ' ' GLN . 11.4 t-80 -71.43 132.75 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -120.71 165.05 15.62 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.102 -1.439 . . . . 0.0 113.006 -177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.819 ' CD1' HG13 ' A' ' 210' ' ' VAL . 17.5 p90 -162.64 168.91 20.97 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.771 HG22 HD11 ' A' ' 55' ' ' ILE . 75.7 t -114.22 136.75 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.638 -1.289 . . . . 0.0 112.376 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 174' ' ' ILE . 81.7 mt -101.71 125.64 55.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.61 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 3.9 p30 -134.86 30.23 3.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.842 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 177.42 163.49 29.44 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 117.614 -2.232 . . . . 0.0 112.671 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -144.24 157.06 44.5 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.446 ' CG ' ' HB2' ' A' ' 207' ' ' PHE . 9.5 p-10 -120.86 -0.5 10.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.698 -1.251 . . . . 0.0 110.576 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.0 -27.67 8.81 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 36.4 mtt180 -89.22 30.08 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -1.187 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.6 OUTLIER 71.46 20.48 4.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.691 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 203' ' ' ASP . 16.3 m-85 -116.73 135.12 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.103 -0.998 . . . . 0.0 109.468 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 16.3 m-85 -121.11 168.4 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.367 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.61 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.1 t60 -91.51 147.02 23.32 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.819 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.4 t -138.79 137.51 42.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -105.88 78.81 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.623 ' CE3' ' HB3' ' A' ' 197' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.716 . . . . 0.0 110.238 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 28.7 mt-30 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.323 0.582 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 40.5 p -155.21 162.03 41.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.642 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.691 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -136.93 148.16 46.82 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.204 1.002 . . . . 0.0 110.085 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.9 t -110.49 121.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.746 HG23 ' NE2' ' A' ' 158' ' ' HIS . 24.7 m -132.96 146.45 32.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.675 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 94.53 54.54 1.55 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 mt -101.14 97.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.308 -1.113 . . . . 0.0 110.004 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 7.9 pttm -162.85 144.38 7.82 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.17 1.913 . . . . 0.0 110.4 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 178' ' ' LEU . 22.6 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 200' ' ' ASP . 63.7 mmtt -76.43 -172.95 2.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.086 -1.009 . . . . 0.0 108.517 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 4.2 t -79.27 101.8 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.711 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.4 mt -56.89 -50.23 73.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 108.818 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 198' ' ' VAL . 12.8 mt -55.04 -44.08 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.857 -1.152 . . . . 0.0 108.702 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 97.9 m-20 -67.83 -38.71 83.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.183 -0.948 . . . . 0.0 108.548 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.6 p -58.32 -14.87 8.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 9.4 mtpp -119.13 23.33 11.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.47 35.69 5.54 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 58' ' ' TYR . 17.5 mt -88.91 109.39 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.409 1.1 . . . . 0.0 110.432 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PRO . 63.1 m80 -133.4 98.82 4.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.1 m-30 -103.76 176.81 5.03 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.273 1.035 . . . . 0.0 112.299 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.602 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 t-20 -147.2 -172.74 4.08 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.545 ' CG ' ' OG1' ' A' ' 50' ' ' THR . 4.6 mt-30 -124.23 -14.94 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.917 -1.115 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.711 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.18 -39.11 0.97 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.799 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.847 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.2 -138.96 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.489 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.108 -178.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.2 Cg_endo -74.62 4.02 4.9 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 122.667 1.988 . . . . 0.0 109.185 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.602 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 64.1 m-85 -75.79 -35.21 60.15 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.632 -0.667 . . . . 0.0 109.903 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.7 p30 -97.95 21.78 10.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.494 -1.379 . . . . 0.0 109.998 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 23' ' ' LEU . 14.6 mt -72.7 -2.39 20.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -129.03 -6.3 4.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.988 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -62.07 162.62 16.93 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.644 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -70.69 130.37 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.14 1.893 . . . . 0.0 111.841 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.44 149.15 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.551 0.691 . . . . 0.0 110.168 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 79' ' ' TYR . 33.7 mt -77.8 144.66 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.558 0.694 . . . . 0.0 110.689 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HA ' HG13 ' A' ' 39' ' ' VAL . 20.5 mt-10 -123.6 -23.51 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.512 -0.742 . . . . 0.0 110.052 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.9 mtpp -118.94 162.5 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.264 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 39' ' ' VAL . 42.4 t . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 87.0 m-85 -123.29 25.03 8.54 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.055 -1.028 . . . . 0.0 109.634 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 31' ' ' VAL . 77.1 t -73.74 148.3 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.192 -0.942 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.21 -1.87 73.47 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 5.1 mm-40 -88.27 131.02 34.95 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.423 -1.045 . . . . 0.0 109.668 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.13 112.66 9.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.59 157.12 1.64 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.913 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.81 169.43 18.3 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.332 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.5 ' O ' ' HE2' ' A' ' 129' ' ' MET . 31.4 p -77.81 -34.11 52.18 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.979 -1.076 . . . . 0.0 108.385 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 101.64 136.88 9.46 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -54.3 -51.33 64.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.235 -1.156 . . . . 0.0 108.891 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.8 t -46.7 -53.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' HE2' ' A' ' 129' ' ' MET . . . -60.19 -50.6 73.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.25 -0.907 . . . . 0.0 110.329 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -63.62 -31.72 72.98 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.654 -0.653 . . . . 0.0 110.714 -178.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.08 -41.94 85.49 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.261 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -73.51 -54.2 8.78 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.874 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.88 -39.59 62.79 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.809 -0.557 . . . . 0.0 110.316 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.1 mt-30 -61.09 -44.48 97.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.742 -1.224 . . . . 0.0 107.733 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD11 HG22 ' A' ' 198' ' ' VAL . 44.1 mt -68.35 -24.53 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.568 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.2 mtp -73.36 -38.63 65.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 33.6 tptt -68.46 -43.54 76.8 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.03 -32.66 48.0 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.679 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 53.6 m-70 -107.52 -22.21 12.62 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.521 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.64 55.54 1.91 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.621 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.2 t80 -77.0 -70.52 0.21 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.8 Cg_endo -70.51 104.2 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 120.399 0.733 . . . . 0.0 111.942 -176.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.4 m-80 -69.55 -22.61 63.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 3.6 ttpm? -134.55 141.72 46.76 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.94 153.06 26.65 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.507 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.05 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -94.35 -38.65 10.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -1.019 . . . . 0.0 109.984 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 46.3 tttt -152.16 139.45 19.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 91' ' ' SER . 77.7 m-20 -63.87 170.3 3.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 22.8 t80 -153.03 135.66 15.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.069 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.8 t -142.57 152.83 42.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 109.759 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 19.9 p90 -156.44 152.98 28.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.844 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.574 HG23 ' CG ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -92.74 126.58 37.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.733 HD21 ' ND2' ' A' ' 77' ' ' ASN . 11.5 tp -44.03 147.29 0.52 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.77 0.795 . . . . 0.0 110.947 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 146.55 48.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.716 -0.615 . . . . 0.0 110.187 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.41 1.63 9.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.856 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.519 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 10.0 m-20 -98.65 -9.4 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.333 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.733 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.7 t-20 -69.73 109.35 4.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.782 -0.574 . . . . 0.0 110.35 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.3 Cg_endo -88.72 14.54 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.79 2.327 . . . . 0.0 110.386 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.784 ' HB3' HG23 ' A' ' 28' ' ' ILE . 80.1 m-85 -107.92 -22.6 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 110.66 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' ASN . 87.7 m-85 -118.48 163.35 16.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 7.7 m-80 -49.14 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 175.39 -48.38 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.508 175.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -75.85 58.88 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 N-CA-C 107.01 -1.958 . . . . 0.0 107.01 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 86' ' ' LEU . 12.1 tptt -105.49 121.86 44.81 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.784 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.574 ' CG ' HG23 ' A' ' 72' ' ' THR . 2.5 m-80 -105.83 115.98 31.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.0 mp -95.49 128.85 42.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -129.81 141.06 50.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -117.28 113.26 21.91 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -73.24 52.81 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 108.118 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 mt -52.77 -53.63 20.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.555 -0.716 . . . . 0.0 110.205 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 p -45.65 -25.6 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.637 -1.289 . . . . 0.0 109.147 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -111.28 19.78 17.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.352 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.647 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.9 mmt-85 -79.43 151.49 30.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -117.36 90.99 3.45 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.21 94.66 6.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 110.828 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.7 t30 -82.64 89.39 6.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.607 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 68.1 m95 -61.39 -7.13 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 -178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -89.87 -19.8 24.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 6.0 m-20 -99.71 -28.0 13.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.9 mt -73.77 65.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 21.2 mt -45.89 148.62 1.35 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.723 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.562 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.0 Cg_endo -78.0 -17.96 13.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.641 2.228 . . . . 0.0 110.446 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' THR . 9.0 t -144.92 122.5 11.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.2 -0.938 . . . . 0.0 109.082 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.7 m-85 -109.5 141.75 41.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -99.93 -5.95 27.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.452 -0.78 . . . . 0.0 109.086 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -3.78 83.28 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -116.48 0.66 12.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -1.179 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.48 160.82 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 167.47 0.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.176 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 6.1 m-80 -72.79 -29.41 63.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.1 t -51.9 -63.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.519 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 3.2 mp0 -62.46 -32.42 73.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.271 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 110' ' ' ASN . 24.6 mttt -66.54 -43.7 84.4 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.48 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.8 ttm -59.6 -35.52 74.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -68.71 0.21 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.676 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.536 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.3 tp -59.84 -37.6 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.295 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 13.8 p -57.39 -43.39 83.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.895 -1.128 . . . . 0.0 110.755 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.743 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.23 -37.18 77.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 108.95 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.578 HD21 ' HB1' ' A' ' 53' ' ' ALA . 3.6 tp -59.48 -59.52 5.31 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.612 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.0 mmt -49.87 -40.59 43.11 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.211 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -70.38 -41.04 73.59 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.639 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 36.7 m-20 -64.63 -47.14 79.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 127' ' ' VAL . 54.5 t -70.08 -49.7 53.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . -60.18 -33.05 78.31 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 126' ' ' SER . 1.2 mt -75.22 -57.0 7.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 125' ' ' ILE . 1.4 p -47.79 -26.92 1.78 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 32.9 m -100.44 28.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.358 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 4.4 m-20 39.46 48.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.57 ' HE1' ' HB2' ' A' ' 137' ' ' SER . 53.5 tpp -59.66 131.79 52.0 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.1 t0 -76.89 120.66 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.644 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.7 m-85 -103.05 115.69 31.07 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.572 1.177 . . . . 0.0 113.245 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.764 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.1 -163.7 11.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 104.747 -3.341 . . . . 0.0 104.747 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.31 -31.44 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 N-CA-C 105.87 -2.396 . . . . 0.0 105.87 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.3 m -109.22 144.35 37.45 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.2 m -123.7 110.66 15.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 119.859 -1.776 . . . . 0.0 110.451 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.99 141.55 15.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.57 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 29.4 t -118.22 -162.48 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -1.182 . . . . 0.0 108.998 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.78 -61.45 1.63 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 138.57 -137.31 8.63 Favored Glycine 0 N--CA 1.481 1.649 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.996 176.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.3 m -48.34 -50.06 31.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.882 -0.775 . . . . 0.0 112.422 -178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 p -45.95 -48.45 16.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 110.407 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 7.0 mmt180 -80.7 -36.17 32.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.821 -1.174 . . . . 0.0 110.069 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.8 t -67.2 -58.45 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.359 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 1.3 pp0? -56.03 -31.61 63.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.308 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.4 ttt180 -77.72 -47.67 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.419 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -66.41 -35.06 79.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.497 HD12 HG11 ' A' ' 248' ' ' VAL . 39.4 mt -60.13 -46.25 90.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 110.016 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 28.1 mtmt -87.38 -45.25 10.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 60.2 mt-10 -70.73 -43.54 68.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.875 -1.14 . . . . 0.0 111.792 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 24.2 m120 -94.42 -44.66 7.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 111.608 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 152' ' ' GLY . 32.3 m-85 -102.26 15.86 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 110.673 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.05 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 33.74 38.93 0.1 OUTLIER Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.639 -0.663 . . . . 0.0 112.75 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.6 m-85 -61.97 164.67 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.189 -1.771 . . . . 0.0 107.666 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 45.5 t30 -47.76 143.12 4.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.893 -1.129 . . . . 0.0 109.084 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -53.51 -18.69 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 109.079 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.519 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 78.0 p -53.36 -16.34 1.33 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -0.856 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 251' ' ' ILE . 56.0 t -66.29 118.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.83 -1.168 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.918 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.1 p-80 -142.2 155.57 45.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.378 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -101.15 163.24 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 17.4 pt -145.56 165.77 10.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 162' ' ' ARG . 3.5 m-80 -125.13 100.08 6.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 110.086 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.615 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 45.1 tpt85 -45.34 -35.22 3.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.142 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.34 -28.04 70.31 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -103.89 6.26 36.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.899 -1.353 . . . . 0.0 111.876 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -118.1 177.27 4.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.388 -1.445 . . . . 0.0 110.407 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 88.4 p -103.95 132.65 49.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 20.5 ttmt -33.21 -46.27 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.848 -0.533 . . . . 0.0 110.885 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -64.21 -62.39 1.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.861 -1.15 . . . . 0.0 109.878 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -17.19 61.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 75.7 t-105 -75.81 -47.01 27.48 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.197 -0.94 . . . . 0.0 109.162 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HA ' HD12 ' A' ' 174' ' ' ILE . 55.5 mt-10 -69.84 -38.19 76.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.168 -0.957 . . . . 0.0 108.549 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.19 50.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.554 ' NE2' HG21 ' A' ' 249' ' ' VAL . 10.9 mm100 -61.07 -41.47 96.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 184' ' ' VAL . 13.2 mt -75.66 -58.24 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.39 -0.819 . . . . 0.0 110.575 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -49.46 -45.32 46.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.725 -1.235 . . . . 0.0 108.888 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -51.61 -43.03 62.41 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.621 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 44.6 mm-40 -60.18 -50.99 71.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.75 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.8 mt -68.27 -26.48 65.69 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.8 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.7 p -52.17 -39.29 59.85 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.4 mt-30 -100.93 35.41 2.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 7' ' ' LEU . 15.0 m-80 47.18 51.06 13.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 12.6 mt-30 -123.31 113.0 29.56 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.95 169.85 11.2 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.742 1.628 . . . . 0.0 111.792 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 174' ' ' ILE . 96.5 t -126.61 130.78 71.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.722 -176.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.832 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -82.86 116.91 22.38 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 176.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -122.48 159.19 28.17 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.92 -1.113 . . . . 0.0 109.35 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.3 pt20 -167.06 130.87 1.88 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.511 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.43 125.93 8.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 53.9 t -91.33 162.73 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.147 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.6 -133.27 1.58 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -87.76 -47.83 8.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.72 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.97 -11.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.175 -0.953 . . . . 0.0 111.205 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.33 -160.18 20.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -95.09 110.59 4.04 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.258 -1.448 . . . . 0.0 111.125 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.625 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.7 t-80 -72.4 132.23 43.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.74 163.92 16.71 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.059 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.872 ' CD1' HG13 ' A' ' 210' ' ' VAL . 15.9 p90 -161.8 168.05 23.82 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.649 HG22 HD11 ' A' ' 55' ' ' ILE . 84.5 t -114.71 135.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.59 -1.319 . . . . 0.0 112.185 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 174' ' ' ILE . 76.1 mt -97.62 124.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 8.3 p-10 -137.1 33.05 2.61 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.992 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -173.73 167.9 40.62 Favored Glycine 0 N--CA 1.484 1.887 0 C-N-CA 117.757 -2.163 . . . . 0.0 112.356 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -152.34 149.37 28.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.99 29.07 8.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 110.258 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.5 22.63 3.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -140.74 25.95 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -1.068 . . . . 0.0 108.91 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 75.23 7.77 4.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.401 -0.812 . . . . 0.0 109.719 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 25.9 m-85 -103.33 136.54 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 49.8 m-85 -123.65 163.07 21.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 111.119 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 40.4 t-80 -93.68 123.01 36.73 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.872 HG13 ' CD1' ' A' ' 197' ' ' PHE . 54.1 t -117.42 141.67 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 111.619 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.506 ' HB2' HD12 ' A' ' 8' ' ' LEU . 18.2 t-20 -110.1 76.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 211' ' ' ASN . 65.1 m95 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 7.1 mt-30 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 30.6 p -133.41 165.34 25.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.473 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.23 152.68 44.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.725 0.774 . . . . 0.0 110.247 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.832 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.5 t -112.84 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.918 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.6 m -109.97 139.72 32.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.318 0.58 . . . . 0.0 110.174 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.434 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 100.5 48.58 1.52 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.211 -1.471 . . . . 0.0 109.659 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 9.0 mt -104.61 94.67 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.245 -1.15 . . . . 0.0 111.131 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 252' ' ' LYS . 0.0 OUTLIER -163.43 146.03 7.94 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.153 1.902 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.499 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 30.5 tt0 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.4 Cg_endo -77.59 151.99 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.192 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG22 ' C ' ' A' ' 203' ' ' ASP . 9.4 t -89.55 145.13 7.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.326 -0.858 . . . . 0.0 109.746 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 36.7 t -137.02 132.82 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 110.095 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -75.23 172.89 11.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB2' ' CD2' ' A' ' 209' ' ' HIS . 3.9 t -76.9 108.13 9.73 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.488 -0.757 . . . . 0.0 110.807 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.684 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 41.0 mt -58.54 -50.4 73.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 198' ' ' VAL . 13.5 mt -55.54 -40.81 72.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.879 -1.138 . . . . 0.0 108.503 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 14.6 m-20 -67.84 -42.8 80.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.292 -0.88 . . . . 0.0 109.149 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -57.98 -15.09 7.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 108.932 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 5.8 mtpp -116.54 20.39 14.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.34 37.01 4.5 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 58' ' ' TYR . 59.2 mt -88.54 110.1 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 122.351 1.072 . . . . 0.0 110.385 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 77.4 m80 -133.53 97.96 4.08 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.563 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.2 m-30 -103.16 174.31 5.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 122.157 0.98 . . . . 0.0 111.823 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -146.83 -171.26 3.72 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.9 mt-30 -124.2 -11.19 7.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.919 -1.113 . . . . 0.0 109.889 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.73 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.17 -39.75 0.86 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.982 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -140.75 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.511 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.253 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.4 Cg_endo -73.85 2.3 6.11 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 122.523 1.937 . . . . 0.0 109.0 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 46.9 m-85 -72.76 -37.48 67.66 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.704 -0.622 . . . . 0.0 109.59 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 38.3 p-10 -96.15 21.24 9.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.564 -1.335 . . . . 0.0 110.087 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -74.75 4.44 6.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.315 -0.865 . . . . 0.0 109.622 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.0 mt -136.29 -1.81 2.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.936 -1.103 . . . . 0.0 110.467 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.3 p -61.56 161.77 18.44 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.649 ' HG3' HD21 ' A' ' 86' ' ' LEU . 20.0 Cg_endo -69.85 137.51 35.38 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.697 1.598 . . . . 0.0 110.597 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.92 142.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.792 0.806 . . . . 0.0 110.82 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.5 mt -76.9 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.415 0.626 . . . . 0.0 109.833 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.745 ' HA ' HG13 ' A' ' 39' ' ' VAL . 64.0 mt-10 -126.22 -19.31 4.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.804 . . . . 0.0 111.398 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' TYR . 34.0 mtpt -123.11 171.77 9.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.729 -1.232 . . . . 0.0 110.58 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 37' ' ' SER . 94.4 t -114.44 148.61 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.742 0.782 . . . . 0.0 110.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -89.7 129.04 48.21 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.416 1.411 . . . . 0.0 109.951 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.42 18.28 13.52 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.77 -179.98 7.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.597 -0.943 . . . . 0.0 109.232 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -82.07 174.68 11.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 109.633 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.481 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.5 t -81.37 135.81 35.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.2 m-85 -124.07 18.97 9.2 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.853 -1.154 . . . . 0.0 110.23 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 29' ' ' GLU . 45.1 t -67.88 140.36 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.556 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.39 -2.26 72.61 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 13.2 mt-30 -83.4 136.52 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.33 -1.1 . . . . 0.0 109.824 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -73.2 108.58 6.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.2 168.79 0.09 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.721 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -90.24 173.36 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.005 . . . . 0.0 110.066 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.553 ' O ' ' HE3' ' A' ' 129' ' ' MET . 31.3 p -83.15 -37.68 23.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.229 -0.919 . . . . 0.0 108.603 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' A' ' 135' ' ' SER . . . 105.05 136.44 8.69 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' VAL . 2.8 p -54.57 -54.04 46.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -1.231 . . . . 0.0 108.487 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 38.2 t -46.38 -52.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.26 -52.28 66.35 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.865 0.84 . . . . 0.0 109.791 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.529 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.27 -32.61 74.07 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.186 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.86 86.69 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.222 -1.391 . . . . 0.0 108.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.43 HG23 HD21 ' A' ' 147' ' ' LEU . 83.9 m -73.52 -53.05 11.49 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.754 0.788 . . . . 0.0 109.651 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.39 -42.64 64.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.805 -0.56 . . . . 0.0 110.193 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.563 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.1 mt-30 -56.66 -48.75 76.9 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 198' ' ' VAL . 32.5 mt -66.27 -26.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.612 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -70.31 -35.88 73.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 23.7 tptt -72.58 -42.05 65.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.684 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.1 t80 -53.9 -31.61 50.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 71.9 m-70 -107.86 -22.35 12.48 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.649 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.68 51.43 3.03 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.5 t80 -70.02 -74.34 0.16 Allowed Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 33.9 Cg_endo -68.97 107.59 1.74 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 CA-C-N 119.044 0.694 . . . . 0.0 112.158 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -70.32 -21.95 62.87 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.2 tttm -134.27 148.06 50.75 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 144.9 42.42 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.238 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.435 -1.038 . . . . 0.0 111.579 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' O ' ' OD1' ' A' ' 150' ' ' ASN . 51.7 tttt -151.51 137.24 17.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.093 -1.629 . . . . 0.0 111.229 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' N ' ' HB3' ' A' ' 91' ' ' SER . 75.6 m-20 -59.42 152.76 20.71 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.862 ' CZ ' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -126.85 172.81 10.08 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.62 -1.3 . . . . 0.0 107.986 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.7 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 10.9 t -167.87 134.74 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 111.01 173.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.615 ' HD2' ' CE2' ' A' ' 69' ' ' TYR . 3.3 p90 -148.67 146.47 28.18 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.258 -0.901 . . . . 0.0 109.112 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.8 m -93.43 135.15 34.95 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.724 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -52.14 144.58 12.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.86 0.838 . . . . 0.0 111.428 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.93 145.08 53.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.364 0.602 . . . . 0.0 110.453 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -0.15 11.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.92 . . . . 0.0 109.756 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -96.28 -10.36 28.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.204 -0.935 . . . . 0.0 108.874 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.724 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.0 t-20 -69.79 111.0 7.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.713 -0.617 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.1 Cg_endo -88.95 17.5 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.82 2.346 . . . . 0.0 109.193 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 89.6 m-85 -107.1 -15.27 14.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.575 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -135.52 167.21 21.51 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.584 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 19.3 m-80 -48.7 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.12 -48.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 111.302 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -75.66 60.54 5.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 N-CA-C 106.955 -1.979 . . . . 0.0 106.955 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HG3' HD12 ' A' ' 86' ' ' LEU . 2.0 tptt -104.5 119.78 39.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.424 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -100.88 119.28 38.46 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.406 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 26' ' ' PRO . 2.7 mp -94.88 143.57 26.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.526 ' HA ' ' CE1' ' A' ' 69' ' ' TYR . 18.2 t80 -139.03 130.75 27.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 110.726 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -110.22 119.4 39.13 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.7 45.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.696 -1.252 . . . . 0.0 107.834 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.832 HD12 ' CG ' ' A' ' 150' ' ' ASN . 15.4 mt -52.32 -56.56 6.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 O-C-N 121.578 -0.701 . . . . 0.0 109.999 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.545 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -44.56 -26.75 0.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.866 -1.146 . . . . 0.0 108.987 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -111.47 34.72 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 108.916 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.707 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 38.1 mmt-85 -93.35 155.81 17.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.037 . . . . 0.0 110.868 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.73 88.77 2.98 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -80.76 86.38 5.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.208 -0.932 . . . . 0.0 110.416 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' HG13 ' A' ' 100' ' ' ILE . 30.3 t30 -79.38 90.96 5.03 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.649 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 77.5 m95 -61.36 -6.23 2.13 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.438 -0.789 . . . . 0.0 110.46 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.4 t-20 -89.88 -19.26 24.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 12.9 m-20 -99.67 -28.72 13.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.647 HG12 ' HB1' ' A' ' 115' ' ' ALA . 41.8 mt -74.34 66.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 101' ' ' LEU . 9.4 mt -46.32 148.66 1.53 Allowed Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 121.662 -0.649 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.548 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.5 Cg_endo -78.79 -19.5 11.09 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.92 2.414 . . . . 0.0 110.432 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 103' ' ' THR . 2.5 t -142.78 121.58 12.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.3 -0.875 . . . . 0.0 109.113 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 116' ' ' ILE . 64.4 m-85 -109.28 138.54 45.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.932 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -101.11 -3.84 28.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.0 108.973 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.28 87.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -115.06 -1.03 13.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -1.231 . . . . 0.0 109.606 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -67.08 170.83 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.717 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.9 174.27 2.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -77.26 -34.34 55.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.643 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.56 -59.72 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.146 -0.971 . . . . 0.0 109.576 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.8 -34.15 76.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.132 -0.98 . . . . 0.0 109.158 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.503 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 85.4 mttt -66.01 -42.72 89.34 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 35.8 ttm -59.34 -35.63 74.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.21 -68.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.726 -0.609 . . . . 0.0 110.592 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.599 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.7 tp -60.14 -41.69 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 11.5 p -53.73 -43.24 68.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.853 -1.154 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.796 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.2 tt0 -69.36 -42.14 75.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.999 -1.063 . . . . 0.0 108.78 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.599 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.2 tp -54.05 -53.69 49.57 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.608 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -57.07 -43.06 81.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -66.18 -39.66 89.88 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 15.6 m-20 -68.47 -46.48 69.63 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 127' ' ' VAL . 43.6 t -67.01 -63.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.22 -38.82 9.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.862 HG23 ' CZ ' ' A' ' 69' ' ' TYR . 2.9 mt -69.84 -60.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.306 -1.114 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.607 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.2 p -46.47 -25.74 0.73 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.851 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 123' ' ' VAL . 27.1 m -104.26 33.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.039 -1.038 . . . . 0.0 109.792 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.2 m-20 41.75 40.96 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 109.8 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.603 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 35.4 tpp -56.42 134.05 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 111.589 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 34.4 m-20 -78.09 122.41 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 26' ' ' PRO . 40.3 m-85 -103.9 106.24 16.68 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -141.2 -162.09 8.98 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 104.332 -3.507 . . . . 0.0 104.332 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.64 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.74 -30.96 78.73 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 106.007 -2.343 . . . . 0.0 106.007 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.93 139.15 45.34 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.56 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 73.8 m -114.14 112.72 23.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 119.934 -1.729 . . . . 0.0 110.721 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.67 130.52 10.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.624 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -117.23 -168.16 1.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.056 -1.261 . . . . 0.0 108.3 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.926 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.15 -50.85 5.76 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 124.01 -129.08 7.09 Favored Glycine 0 N--CA 1.481 1.684 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.257 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.534 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 4.2 m -48.23 -59.71 3.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.962 -0.728 . . . . 0.0 112.019 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 140' ' ' SER . 40.1 p -46.97 -35.35 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.789 -1.194 . . . . 0.0 108.622 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.926 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 74.9 mmt-85 -80.62 -48.51 12.56 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.91 0.862 . . . . 0.0 109.192 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.77 HG21 ' CE2' ' A' ' 185' ' ' TYR . 89.0 t -66.66 -59.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.242 0.544 . . . . 0.0 111.145 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.477 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 1.4 pp0? -56.5 -33.21 65.79 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 108.58 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.8 ttm180 -76.79 -53.91 7.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.007 -1.058 . . . . 0.0 109.48 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -64.33 -38.21 90.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.105 -0.997 . . . . 0.0 109.575 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.561 ' HB2' HG11 ' A' ' 157' ' ' VAL . 17.1 mt -51.05 -48.6 61.52 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.665 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 55.2 mtmt -88.17 -31.2 19.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 111.285 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 19.8 mt-10 -74.29 -65.51 0.84 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.718 -1.239 . . . . 0.0 112.732 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.832 ' CG ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -81.98 -32.17 30.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.633 -1.292 . . . . 0.0 111.966 -177.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 32.8 m-85 -103.55 -10.26 18.61 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.512 -1.367 . . . . 0.0 110.768 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.963 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 58.6 39.15 92.93 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.097 -1.002 . . . . 0.0 112.531 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.2 m-85 -63.3 162.01 12.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.202 -1.764 . . . . 0.0 107.641 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 50.4 t-20 -47.1 147.9 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.826 -1.171 . . . . 0.0 109.923 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -53.86 -17.97 2.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.529 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 26.4 p -57.37 -11.95 2.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 110.051 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.561 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.0 t -70.92 121.44 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.798 -1.189 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 1.026 ' CE1' HG23 ' A' ' 249' ' ' VAL . 7.6 p-80 -148.65 179.79 7.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 4.5 tt0 -123.8 138.41 54.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.764 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -122.96 152.37 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 8.5 m-80 -109.89 103.23 11.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.109 . . . . 0.0 111.027 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.604 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 13.2 tpt180 -47.83 -36.48 11.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.043 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.6 67.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 4.74 35.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.922 -1.34 . . . . 0.0 111.668 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -118.17 161.19 20.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.569 -1.332 . . . . 0.0 110.143 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 5.2 p -87.06 131.71 34.03 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.3 ttpt -32.78 -44.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.83 -0.543 . . . . 0.0 110.906 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -63.59 -63.73 1.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.953 -1.092 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -62.42 -17.34 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.741 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.764 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.31 -47.86 22.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.087 -1.008 . . . . 0.0 109.172 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 174' ' ' ILE . 59.5 mt-10 -67.71 -22.73 65.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.98 97.14 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.56 HE21 HG21 ' A' ' 249' ' ' VAL . 15.2 mm100 -60.94 -36.2 78.71 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.586 ' CG2' HG21 ' A' ' 199' ' ' ILE . 18.5 mt -73.78 -66.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.385 -0.822 . . . . 0.0 110.575 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -48.27 -41.72 28.61 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 109.446 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -52.29 -47.47 65.89 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.0 mm-40 -61.06 -45.21 95.69 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.559 HD11 ' CG2' ' A' ' 199' ' ' ILE . 27.8 mt -68.29 -30.34 69.32 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.665 -0.647 . . . . 0.0 110.425 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' ASP . 62.7 p -52.55 -35.94 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.069 -1.019 . . . . 0.0 108.799 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 17.7 mt-30 -101.17 28.78 5.1 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.481 ' HB3' HD22 ' A' ' 7' ' ' LEU . 96.3 m-20 49.26 50.72 17.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 21.4 mt-30 -123.67 110.95 29.7 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.8 Cg_endo -64.21 166.16 17.64 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.567 1.511 . . . . 0.0 112.087 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.602 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 35.8 t -123.7 136.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.266 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.77 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -85.38 118.34 24.85 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 175.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 197' ' ' PHE . 6.5 t80 -122.45 158.18 30.31 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.793 -1.192 . . . . 0.0 109.399 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 187' ' ' GLN . 3.5 pt20 -167.38 136.73 2.74 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.538 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.68 108.91 2.97 Favored Glycine 0 C--N 1.288 -2.108 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.598 HG22 ' CA ' ' A' ' 194' ' ' GLY . 19.3 t -78.56 160.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.241 -1.152 . . . . 0.0 112.159 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -159.16 -127.45 0.91 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB2' ' HA3' ' A' ' 237' ' ' GLY . 0.7 OUTLIER -88.12 -56.12 3.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -1.212 . . . . 0.0 110.507 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 237' ' ' GLY . 2.9 m -59.04 -23.86 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.271 -0.893 . . . . 0.0 111.416 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.53 -167.54 24.98 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.598 ' CA ' HG22 ' A' ' 189' ' ' VAL . . . -85.62 106.25 3.01 Favored Glycine 0 N--CA 1.488 2.107 0 O-C-N 121.062 -1.257 . . . . 0.0 111.496 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 6.5 t-80 -72.09 125.33 26.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -117.34 163.93 15.6 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.081 -1.448 . . . . 0.0 113.199 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 186' ' ' TYR . 32.2 p90 -159.48 170.16 22.31 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 55' ' ' ILE . 85.5 t -114.67 135.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.515 -1.365 . . . . 0.0 112.45 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 208' ' ' TYR . 11.8 mt -97.72 127.56 49.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.565 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.1 p30 -140.28 33.64 1.89 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.611 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.603 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 172.71 -175.51 45.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.442 -1.837 . . . . 0.0 111.003 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.673 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -161.3 152.2 18.31 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.424 -1.045 . . . . 0.0 109.092 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.663 ' C ' HG22 ' A' ' 3' ' ' VAL . 6.7 t0 -113.81 14.62 18.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.775 -1.203 . . . . 0.0 111.338 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.87 -4.99 85.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.706 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 207' ' ' PHE . 4.5 mtp180 -128.2 70.83 1.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.802 -1.41 . . . . 0.0 110.59 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 64.2 m-20 39.33 28.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 109.919 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -121.08 128.43 52.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.299 -0.876 . . . . 0.0 109.046 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 199' ' ' ILE . 73.9 m-85 -109.05 170.33 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.614 ' CD2' ' HB2' ' A' ' 6' ' ' SER . 53.3 t-80 -91.55 115.34 27.96 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 222' ' ' PHE . 11.5 t -112.85 142.84 23.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 122.256 1.027 . . . . 0.0 112.277 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.455 ' HB2' HD12 ' A' ' 8' ' ' LEU . 21.8 t-20 -110.6 78.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.506 ' CZ3' ' CD1' ' A' ' 197' ' ' PHE . 68.9 m95 -46.75 167.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.149 -0.969 . . . . 0.0 110.109 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.86 27.54 7.23 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -119.18 -169.81 1.81 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -1.141 . . . . 0.0 109.519 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -77.68 -95.6 0.22 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.25 64.34 0.6 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.79 HG22 ' N ' ' A' ' 218' ' ' SER . 1.7 p -95.12 -101.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -1.165 . . . . 0.0 109.516 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.79 ' N ' HG22 ' A' ' 217' ' ' VAL . 21.5 m -90.39 19.07 5.47 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.75 126.96 23.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.391 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.18 -91.59 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 25.5 p90 -102.1 163.24 12.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.7 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.649 ' HB2' HG21 ' A' ' 210' ' ' VAL . 0.0 OUTLIER -91.62 176.62 6.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.111 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.55 ' O ' ' CE2' ' A' ' 222' ' ' PHE . 0.0 OUTLIER -114.64 153.39 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.725 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -116.67 -22.39 8.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.299 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.11 -25.64 7.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.08 86.39 2.57 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.111 0.957 . . . . 0.0 109.197 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.547 HD11 ' CE1' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -91.77 48.93 1.5 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-O 121.383 0.611 . . . . 0.0 109.557 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.466 ' HB3' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER -115.94 163.34 21.6 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.251 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.565 ' HB3' ' CE1' ' A' ' 195' ' ' HIS . 35.8 Cg_endo -78.24 128.3 8.87 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.623 2.215 . . . . 0.0 110.468 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.642 ' HB3' HG21 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -57.8 -45.56 85.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.98 88.25 6.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.67 -171.26 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.2 62.11 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.14 -86.99 0.43 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -1.165 . . . . 0.0 109.685 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -98.36 -123.78 4.88 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.92 15.92 7.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 191' ' ' LYS . . . -112.3 24.95 13.12 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -50.21 169.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 240' ' ' GLY . . . 84.88 140.41 4.99 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 239' ' ' GLY . . . 44.53 91.99 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -108.38 30.88 6.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -1.176 . . . . 0.0 109.848 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 245' ' ' GLN . 1.4 t-20 -136.2 58.81 1.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.967 -1.083 . . . . 0.0 109.991 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' VAL . . . -84.84 -41.99 7.41 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -135.75 94.05 3.03 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.69 -0.888 . . . . 0.0 109.085 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB2' ' ND2' ' A' ' 242' ' ' ASN . 12.0 tt0 -91.6 126.52 36.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.83 -1.169 . . . . 0.0 108.738 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.3 p -151.62 169.95 20.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.059 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.92 146.34 37.28 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.186 0.993 . . . . 0.0 110.934 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.8 t -105.13 118.81 53.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 1.026 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.3 m -125.88 145.71 32.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.86 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.09 52.21 2.44 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.632 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 50.6 mt -97.44 88.94 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -1.083 . . . . 0.0 109.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.21 152.32 12.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.342 2.028 . . . . 0.0 110.402 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.467 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 51.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.467 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.9 Cg_endo -78.28 174.67 12.08 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.515 2.143 . . . . 0.0 110.169 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.614 HG22 ' C ' ' A' ' 203' ' ' ASP . 54.8 t -123.47 136.58 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.678 HG11 ' HB3' ' A' ' 178' ' ' LEU . 85.4 t -131.85 130.82 61.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.508 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -74.43 -173.63 1.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.069 -1.02 . . . . 0.0 109.012 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.591 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 69.8 m -77.44 100.35 5.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.808 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.659 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 18.2 mt -58.83 -48.25 81.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.185 -0.947 . . . . 0.0 108.485 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.709 HD11 HG11 ' A' ' 198' ' ' VAL . 9.5 mt -55.91 -41.45 74.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 33.8 t0 -67.0 -38.73 86.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -15.9 11.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 108.558 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 16.0 mtpp -120.07 14.8 12.34 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.95 43.67 8.52 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.8 mt -93.1 110.28 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.493 -1.004 . . . . 0.0 110.574 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 102' ' ' PRO . 51.6 m80 -135.13 100.02 4.43 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . 14.6 m-30 -102.4 175.9 5.36 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.891 -1.131 . . . . 0.0 110.843 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 5.1 t-20 -146.54 -171.27 3.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.585 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . 58.4 mt-30 -124.97 -3.56 7.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.829 -1.17 . . . . 0.0 110.676 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.03 -60.61 0.34 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.147 -1.501 . . . . 0.0 112.737 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.781 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -44.78 -123.72 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.424 0 CA-C-O 117.369 -1.3 . . . . 0.0 112.371 -176.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.781 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 42.7 Cg_endo -81.41 10.54 3.4 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 123.452 2.269 . . . . 0.0 109.596 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.824 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 92.6 m-85 -83.03 -38.64 22.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 110.663 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 44.4 p30 -103.55 35.39 2.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.622 -1.299 . . . . 0.0 109.828 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.7 mt -78.11 -3.96 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.873 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 118' ' ' GLU . 21.3 mt -129.4 10.82 5.77 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.923 -1.11 . . . . 0.0 109.391 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.3 p -81.39 163.21 55.7 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.4 Cg_endo -69.82 128.59 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.131 1.887 . . . . 0.0 111.82 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 42' ' ' HIS . 10.8 t -74.43 150.67 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.737 HD11 ' C ' ' A' ' 132' ' ' GLY . 18.2 mt -77.67 148.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.467 -0.771 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.55 -21.75 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.721 -0.612 . . . . 0.0 110.404 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.3 mtpp -122.29 171.96 8.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 110.071 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.0 t -114.36 148.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.394 -0.816 . . . . 0.0 111.113 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -87.84 130.05 48.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -70.31 125.3 11.71 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.57 1.513 . . . . 0.0 110.42 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.92 9.62 34.25 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -146.84 -177.37 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -1.062 . . . . 0.0 109.157 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -80.68 -176.21 5.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.082 -1.011 . . . . 0.0 109.69 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.9 t -86.4 138.36 31.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 85.4 m-85 -123.78 19.05 9.43 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' ILE . 66.9 t -66.8 144.5 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.73 -4.01 66.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 28.5 mt-30 -86.65 128.77 35.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -1.174 . . . . 0.0 109.564 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 25' ' ' THR . 1.1 m-70 -73.23 113.79 10.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.81 158.07 1.47 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.77 -1.172 . . . . 0.0 108.933 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 17' ' ' GLN . . . -78.47 170.09 17.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.391 0.615 . . . . 0.0 109.973 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 129' ' ' MET . 10.3 p -77.63 -31.58 52.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 103.6 138.08 9.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 p -54.51 -53.65 51.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -1.068 . . . . 0.0 108.408 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 4.9 t -47.01 -52.27 4.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.29 -50.12 74.89 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.947 0.879 . . . . 0.0 110.068 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.36 -33.88 76.5 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -178.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.56 87.66 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.217 -1.393 . . . . 0.0 107.43 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.722 HG23 HD21 ' A' ' 147' ' ' LEU . 59.7 m -74.42 -53.54 9.38 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 108.852 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -53.32 -37.94 62.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.813 -0.554 . . . . 0.0 110.77 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 27.1 mt-30 -67.34 -52.85 35.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.581 -1.324 . . . . 0.0 108.108 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 198' ' ' VAL . 31.9 mt -65.0 -18.8 24.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 34.4 mtp -73.84 -45.25 52.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 18.4 tptt -67.12 -36.02 81.0 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.659 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 65.9 t80 -54.06 -31.93 53.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.431 -0.793 . . . . 0.0 109.297 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 70.9 m-70 -106.92 -22.04 12.82 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 98.4 m-20 45.61 56.12 6.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 4.3 t80 -79.82 -74.54 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.4 Cg_endo -68.11 103.15 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-N 119.104 0.716 . . . . 0.0 111.888 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.429 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 28.7 m120 -70.56 -22.79 62.55 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.41 140.8 45.22 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.59 151.13 33.37 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.752 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.753 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.84 -44.29 10.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.506 -0.997 . . . . 0.0 109.97 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 13.9 tttp -152.57 142.35 21.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.103 -0.998 . . . . 0.0 109.855 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 89' ' ' ALA . 1.5 m-20 -65.24 164.49 13.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.673 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 70' ' ' THR . 7.6 t80 -143.78 147.19 33.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.431 -0.793 . . . . 0.0 109.272 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.629 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t -150.2 166.11 30.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.653 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.1 p90 -171.68 157.03 4.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.529 HG23 HD22 ' A' ' 85' ' ' ASN . 86.9 m -93.13 131.37 38.25 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.776 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -44.94 150.13 0.4 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 111.403 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 p -61.56 139.46 58.25 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -4.83 11.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.075 -1.015 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -97.59 -7.41 31.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.588 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.776 ' ND2' HD21 ' A' ' 73' ' ' LEU . 25.9 t-20 -70.01 108.59 3.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 109.73 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.1 Cg_endo -89.36 15.73 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.997 2.465 . . . . 0.0 110.533 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.59 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 85.0 m-85 -106.42 -24.43 12.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.0 110.866 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' A' ' 81' ' ' ASN . 72.8 m-85 -117.71 163.85 15.86 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 11.7 m-80 -48.19 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.4 OUTLIER 175.04 -47.56 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 111.307 175.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.47 55.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.0 tptt -106.0 104.94 14.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.253 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.529 HD22 HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.14 140.99 33.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.124 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -115.23 145.88 41.99 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 89' ' ' ALA . 5.8 t80 -136.83 128.42 28.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.303 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.32 111.84 23.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 87' ' ' PHE . . . -72.81 53.43 0.33 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.577 -1.327 . . . . 0.0 107.909 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 10.5 mt -52.62 -54.17 16.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.033 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -45.36 -26.14 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.751 -1.218 . . . . 0.0 109.073 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -110.86 32.34 5.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 108.892 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 35.0 mmt-85 -92.48 154.22 18.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.107 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' CA ' ' NE2' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -117.32 90.98 3.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.61 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.5 m-85 -80.84 85.04 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.449 -0.782 . . . . 0.0 110.664 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 4.9 t30 -78.88 89.33 4.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 100' ' ' ILE . 77.7 m95 -61.36 -5.1 1.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.525 -0.734 . . . . 0.0 110.939 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.25 -15.58 33.24 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.728 -1.233 . . . . 0.0 107.684 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 36.3 m-20 -99.65 -30.75 11.93 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.821 HG12 ' HB1' ' A' ' 115' ' ' ALA . 22.3 mt -73.64 67.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.653 0.74 . . . . 0.0 109.307 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 16.0 mt -47.47 148.78 2.23 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.597 -0.689 . . . . 0.0 109.528 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.567 ' HB3' HG12 ' A' ' 13' ' ' ILE . 31.4 Cg_endo -79.39 -17.38 11.53 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.648 2.232 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.27 123.08 9.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.044 . . . . 0.0 109.478 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 90.8 m-85 -110.79 144.03 40.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -100.53 2.68 42.18 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.325 -0.86 . . . . 0.0 108.816 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 81.67 0.73 89.67 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 2.84 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 104' ' ' TYR . 1.3 mp0 -67.11 169.02 9.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -64.9 177.46 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.278 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 1.2 m-20 -82.11 -36.49 27.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.854 . . . . 0.0 109.632 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -52.06 -57.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -38.08 89.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.14 -0.975 . . . . 0.0 108.84 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.532 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 81.0 mttt -63.78 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.45 -0.781 . . . . 0.0 109.011 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.496 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.0 ttm -58.78 -40.83 85.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.481 -0.762 . . . . 0.0 109.182 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.821 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.79 -54.58 45.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.626 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -68.36 -38.51 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.538 -1.352 . . . . 0.0 109.743 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -56.71 -43.65 80.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.102 -0.999 . . . . 0.0 109.887 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.596 ' N ' HD12 ' A' ' 24' ' ' LEU . 35.2 tt0 -69.99 -37.02 75.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.4 tp -62.97 -52.01 64.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.824 ' SD ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -60.68 -48.05 83.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.559 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.37 -38.72 90.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 0.0 108.821 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.592 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 88.3 m-20 -63.95 -41.44 97.6 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 119' ' ' LEU . 72.3 t -71.44 -59.16 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.391 0.615 . . . . 0.0 109.46 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.99 -47.43 14.68 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 126' ' ' SER . 2.3 mt -63.7 -56.15 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.316 -1.108 . . . . 0.0 108.217 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 2.2 p -45.96 -29.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.298 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 17.6 m -105.95 38.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.486 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 9.1 p-10 36.94 50.76 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.515 0.674 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.564 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 49.8 tpp -59.76 128.14 35.47 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.55 -0.718 . . . . 0.0 110.74 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 135' ' ' SER . 33.8 t70 -75.36 123.8 26.0 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.631 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 64.9 m-85 -103.33 114.09 28.1 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.539 1.161 . . . . 0.0 113.144 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.737 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.3 -164.24 11.74 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 104.426 -3.47 . . . . 0.0 104.426 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.618 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 17.8 Cg_endo -62.35 -29.38 79.49 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 N-CA-C 105.952 -2.365 . . . . 0.0 105.952 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.75 139.5 44.73 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.543 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 54.8 m -119.42 109.19 15.47 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.898 -1.751 . . . . 0.0 109.948 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.08 142.91 16.02 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.826 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 4.7 t -116.43 -162.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.829 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.96 -47.55 7.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.54 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 132.41 -139.55 11.04 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.029 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.477 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 9.0 m -50.32 -53.01 31.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.795 -0.826 . . . . 0.0 112.329 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 145' ' ' ARG . 1.5 p -47.42 -33.84 6.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.708 -1.245 . . . . 0.0 108.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.1 mmp_? -80.51 -48.22 13.1 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.949 0.88 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 185' ' ' TYR . 70.4 t -67.24 -56.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.914 -0.491 . . . . 0.0 110.966 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.9 pp0? -56.12 -33.54 65.24 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.7 OUTLIER -77.37 -48.1 18.18 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.35 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.94 -36.15 77.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.157 -0.964 . . . . 0.0 110.274 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 52' ' ' THR . 41.7 mt -57.13 -46.26 82.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.825 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.562 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 51.8 mtmt -87.18 -44.02 11.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.995 -1.066 . . . . 0.0 111.18 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.0 mt-10 -69.34 -50.5 45.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.399 -1.438 . . . . 0.0 111.446 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 18.1 m120 -88.63 -45.52 9.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 0.0 111.636 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.61 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 33.5 m-85 -102.2 18.28 21.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.753 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 31.63 41.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.648 -0.658 . . . . 0.0 112.985 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 9.1 m-85 -63.41 164.32 9.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.268 -1.725 . . . . 0.0 108.005 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.51 145.86 2.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.928 -1.108 . . . . 0.0 109.529 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -53.8 -18.96 3.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.056 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.576 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 84.6 p -55.3 -15.0 2.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.626 HG11 ' HB2' ' A' ' 147' ' ' LEU . 16.5 t -67.61 121.57 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.781 -1.199 . . . . 0.0 109.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.2 p-80 -147.84 175.61 10.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 109.449 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.517 ' HB2' ' HG2' ' A' ' 144' ' ' GLN . 3.7 tt0 -120.86 138.45 54.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.721 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.846 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 12.7 pt -125.75 158.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.6 m-80 -114.56 101.22 8.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.871 -1.143 . . . . 0.0 110.71 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HD3' ' CD1' ' A' ' 170' ' ' TRP . 1.2 tpt180 -45.71 -36.82 5.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 109.072 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.59 -27.77 66.67 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.88 6.92 36.77 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.984 -1.303 . . . . 0.0 111.917 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -118.12 171.24 8.24 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.392 -1.443 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 95.0 p -95.23 134.34 38.1 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 166' ' ' SER . 9.4 ttpp -35.36 -48.98 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.717 -0.615 . . . . 0.0 110.781 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -57.74 8.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.996 -1.065 . . . . 0.0 110.294 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.2 -20.56 65.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.846 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.7 t-105 -75.26 -43.96 48.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.397 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 174' ' ' ILE . 90.3 mt-10 -68.97 -31.28 70.03 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.948 -1.095 . . . . 0.0 108.311 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.25 73.95 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.524 ' NE2' HG21 ' A' ' 249' ' ' VAL . 12.0 mm100 -61.14 -41.63 97.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 108.975 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 199' ' ' ILE . 10.4 mt -75.38 -57.35 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 110.56 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.42 -42.61 43.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.069 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -54.17 -46.03 72.23 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 45.7 mm-40 -58.55 -50.46 73.72 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.678 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.0 mt -65.8 -29.27 69.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.371 -0.83 . . . . 0.0 109.626 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 5.8 p -50.03 -42.98 50.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 108.729 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 14.7 mt-30 -95.83 30.76 2.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.599 ' C ' HD13 ' A' ' 7' ' ' LEU . 66.7 m-80 49.36 51.37 16.46 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 22.1 mt-30 -123.14 111.96 30.29 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 55' ' ' ILE . 13.8 Cg_endo -62.88 173.64 3.65 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.223 1.949 . . . . 0.0 112.539 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.661 HG21 HG23 ' A' ' 174' ' ' ILE . 93.7 t -133.45 142.16 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.36 1.076 . . . . 0.0 112.803 -176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.801 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -90.85 117.7 29.67 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 175.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 10.0 t80 -122.51 161.57 23.37 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.129 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.2 pt20 -167.29 138.73 3.15 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 118.171 -1.412 . . . . 0.0 110.791 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -111.48 108.33 2.31 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 244' ' ' TYR . 21.9 t -66.85 163.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 111.174 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.521 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.87 -136.59 2.07 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -88.17 -32.49 18.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 111.253 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 238' ' ' ALA . 3.8 m -82.78 -18.7 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.874 -1.141 . . . . 0.0 111.504 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.88 -170.43 23.47 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -78.11 100.15 1.61 Allowed Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.83 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.635 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.1 t-80 -72.26 126.69 30.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.13 165.86 13.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.053 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 212' ' ' TRP . 40.7 p90 -156.89 -159.91 0.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.043 HG22 HD11 ' A' ' 55' ' ' ILE . 11.5 t -139.74 138.77 38.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.693 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.758 HD13 HG21 ' A' ' 174' ' ' ILE . 90.7 mt -107.08 111.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 15.1 p-10 -123.7 34.21 5.14 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.285 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 174.62 160.1 22.09 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.354 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -138.42 168.38 19.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.614 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -126.76 -11.17 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.958 -1.089 . . . . 0.0 110.209 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.59 -35.85 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 4.8 mtt180 -88.73 35.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.253 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.8 OUTLIER 70.43 31.67 2.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 109.648 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 48.5 m-85 -122.26 133.78 54.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.17 -0.956 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 33.9 m-85 -124.07 160.47 27.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.311 -0.868 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.591 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 40.3 t-80 -92.13 134.6 34.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 222' ' ' PHE . 21.4 t -131.58 146.19 33.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.713 -1.195 . . . . 0.0 112.337 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.564 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 42.6 t-20 -114.45 81.92 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 91.4 m95 -57.21 163.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.721 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.24 17.4 47.74 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.551 ' NE1' ' CE1' ' A' ' 195' ' ' HIS . 75.1 m95 -107.19 -169.61 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.41 -1.053 . . . . 0.0 108.92 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -76.45 -90.47 0.25 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.65 68.96 0.54 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.83 HG22 ' N ' ' A' ' 218' ' ' SER . 0.7 OUTLIER -101.2 -92.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.875 -1.367 . . . . 0.0 110.166 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.83 ' N ' HG22 ' A' ' 217' ' ' VAL . 19.1 m -88.29 11.38 16.77 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.21 124.22 13.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.984 -1.073 . . . . 0.0 109.016 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 209' ' ' HIS . . . 145.48 -97.41 0.19 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.352 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 98.9 m-85 -110.19 174.08 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.246 . . . . 0.0 110.473 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 210' ' ' VAL . 0.1 OUTLIER -78.42 156.49 29.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.415 -0.803 . . . . 0.0 109.669 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.692 ' C ' HD22 ' A' ' 224' ' ' LEU . 5.1 mmt180 -111.3 141.85 44.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.83 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.2 mm? -120.79 39.34 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.003 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.6 OUTLIER -95.57 -77.68 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.88 -92.91 0.52 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.291 -0.88 . . . . 0.0 109.261 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -90.94 -163.09 0.98 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.279 -0.888 . . . . 0.0 108.651 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.584 ' O ' ' CH2' ' A' ' 212' ' ' TRP . 2.5 m-80 -91.29 -52.19 0.3 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 111.878 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 228' ' ' ASN . 33.4 Cg_endo -74.65 149.0 37.8 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.487 2.125 . . . . 0.0 110.64 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.1 t -122.15 -0.34 9.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.62 122.47 40.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 239' ' ' GLY . 0.1 OUTLIER -90.34 34.15 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.573 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 93.29 120.8 3.03 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 30.1 p -86.49 -26.25 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -1.129 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -96.17 -73.66 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -89.64 -137.54 6.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 166.08 98.31 0.12 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' A' ' 192' ' ' VAL . . . -105.61 -14.7 15.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -1.143 . . . . 0.0 109.516 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' A' ' 232' ' ' LEU . . . 132.13 -98.55 0.37 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 96.03 58.93 1.07 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.469 ' CD1' ' HA2' ' A' ' 190' ' ' GLY . 0.8 OUTLIER -81.67 -178.92 7.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -1.179 . . . . 0.0 109.137 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.509 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.6 t-20 -99.07 84.27 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -82.27 -66.1 1.59 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.575 ' O ' HG23 ' A' ' 189' ' ' VAL . 9.6 m-85 -135.25 110.68 9.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.411 -1.052 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.558 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 38.6 mt-30 -92.5 140.0 30.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 108.751 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -149.58 166.16 30.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.045 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.26 152.23 44.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.278 1.037 . . . . 0.0 110.925 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 68.9 t -111.02 117.56 55.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.719 HG23 ' NE2' ' A' ' 158' ' ' HIS . 25.0 m -123.12 145.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.066 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 87.74 56.44 2.1 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 63.2 mt -100.32 74.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.565 -0.962 . . . . 0.0 110.674 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -152.4 156.76 33.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.086 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.613 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.295 1.997 . . . . 0.0 110.476 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.503 ' OE1' ' CA ' ' A' ' 204' ' ' GLY . 12.5 tt0 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' A' ' 1' ' ' GLN . 35.9 Cg_endo -78.95 169.93 18.66 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.494 2.13 . . . . 0.0 110.24 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG22 ' C ' ' A' ' 203' ' ' ASP . 41.8 t -98.11 134.38 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.452 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 202' ' ' ALA . 6.7 t -124.49 130.47 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 200' ' ' ASP . 35.4 mmtt -76.77 179.57 6.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . 4.2 m -77.67 104.93 8.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.014 -1.054 . . . . 0.0 109.363 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.666 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.6 mt -57.95 -56.17 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD11 ' CG1' ' A' ' 198' ' ' VAL . 18.2 mt -55.14 -36.88 66.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.41 -1.431 . . . . 0.0 108.294 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 22.4 t0 -68.52 -42.1 79.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.126 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -58.55 -14.98 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.05 -1.031 . . . . 0.0 109.045 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 15.5 mtpt -120.56 20.27 11.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.42 37.6 4.86 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 102' ' ' PRO . 60.6 mt -85.31 106.92 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.386 1.089 . . . . 0.0 110.551 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 102' ' ' PRO . 17.7 m-70 -134.81 95.43 3.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 9.3 m-30 -98.95 179.13 4.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 111.064 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 26.1 t-20 -145.96 -177.44 5.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 39.0 mt-30 -116.64 -18.0 10.42 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.923 -1.111 . . . . 0.0 110.164 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.72 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.95 -38.22 0.9 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.337 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.01 -142.5 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.458 -177.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -73.78 2.99 5.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 122.411 1.897 . . . . 0.0 109.441 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 116' ' ' ILE . 11.2 m-85 -79.29 -28.01 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.122 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 14.7 p-10 -96.51 23.38 6.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.593 -1.317 . . . . 0.0 109.783 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 117' ' ' SER . 8.7 mt -76.79 -5.64 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.566 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.8 mt -125.57 9.46 7.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.602 -1.311 . . . . 0.0 109.428 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 40.9 p -82.06 160.87 62.14 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.606 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -68.82 126.18 13.61 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.14 1.894 . . . . 0.0 112.121 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.493 HG22 ' CG ' ' A' ' 42' ' ' HIS . 44.4 t -74.65 151.45 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.423 0.63 . . . . 0.0 109.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.2 mt -77.69 147.23 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 110.899 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.7 mt-10 -126.31 -20.74 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.745 -0.597 . . . . 0.0 110.535 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 48.0 mtpt -120.12 172.9 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.005 -1.059 . . . . 0.0 110.158 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 37' ' ' SER . 79.7 t -114.4 143.04 24.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 111.05 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HD3' ' OE1' ' A' ' 35' ' ' GLU . 19.3 tttt -76.83 128.72 80.91 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.54 118.61 5.78 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.319 1.346 . . . . 0.0 110.286 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.03 17.05 14.87 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' OE1' ' HD3' ' A' ' 32' ' ' LYS . 32.3 tt0 -152.79 173.81 14.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.433 -1.039 . . . . 0.0 109.56 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -179.32 2.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 109.996 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.5 t -87.5 139.2 30.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.363 -0.836 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 75.5 m-85 -124.18 23.92 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.107 -0.996 . . . . 0.0 109.367 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 29' ' ' GLU . 70.2 t -69.99 146.49 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.809 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.05 1.84 86.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mt-30 -93.06 126.8 38.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -1.131 . . . . 0.0 109.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.493 ' CG ' HG22 ' A' ' 27' ' ' VAL . 1.7 m-70 -72.83 111.55 8.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.32 157.69 1.37 Allowed 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.997 -178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.07 166.04 23.81 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.628 0.727 . . . . 0.0 109.946 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.771 HG21 ' SD ' ' A' ' 120' ' ' MET . 19.1 p -77.11 -33.66 56.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 106.18 136.57 8.44 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.487 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 5.3 p -54.85 -50.12 69.45 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.292 -1.122 . . . . 0.0 108.275 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 9.5 t -47.52 -53.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.53 -48.65 80.85 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.046 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.737 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -62.79 -33.6 75.53 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.966 -177.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.93 91.62 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.882 -1.527 . . . . 0.0 108.036 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 56' ' ' MET . 31.3 m -75.46 -50.68 15.03 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.426 0.631 . . . . 0.0 110.003 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.32 -35.57 38.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 mt-30 -68.47 -44.88 73.85 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.723 HD11 HG22 ' A' ' 198' ' ' VAL . 53.0 mt -69.92 -22.9 25.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.616 ' HG3' HG22 ' A' ' 52' ' ' THR . 16.8 mtp -73.76 -34.58 64.77 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.599 ' HD3' HG22 ' A' ' 100' ' ' ILE . 33.7 tptt -74.9 -43.39 54.59 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.8 t80 -54.06 -25.46 21.71 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.351 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 32.1 m-70 -108.31 -27.81 9.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 110.674 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 67.6 m-20 45.11 61.36 2.57 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.3 t80 -84.98 -77.56 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.6 Cg_endo -70.66 106.47 1.83 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 119.467 0.845 . . . . 0.0 113.83 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -67.51 -24.79 65.61 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -131.83 127.04 35.76 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 176.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.73 166.08 4.84 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 118.566 -1.778 . . . . 0.0 110.877 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.046 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -95.95 -35.29 11.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.469 -1.018 . . . . 0.0 111.44 -178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 27.0 tttp -152.76 130.54 11.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.534 -1.354 . . . . 0.0 110.887 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 3.4 m-20 -62.25 171.35 1.88 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.08 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.405 ' OH ' ' OD1' ' A' ' 128' ' ' ASP . 47.4 t80 -149.11 141.8 24.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.578 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t -144.65 148.37 34.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.67 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.5 p90 -160.47 155.2 24.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 29.1 m -93.01 131.71 37.76 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.783 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.13 147.72 0.68 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.845 . . . . 0.0 110.727 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 1.5 t -61.79 146.75 48.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.941 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 0.99 9.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.109 -0.994 . . . . 0.0 109.745 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -99.47 -7.99 25.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.368 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.783 ' ND2' HD21 ' A' ' 73' ' ' LEU . 17.6 t-20 -70.32 109.41 4.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.751 -0.593 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.2 Cg_endo -89.26 15.68 1.95 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.944 2.429 . . . . 0.0 110.18 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 73.9 m-85 -110.78 -23.65 10.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 111.167 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 80.4 m-85 -118.14 160.69 21.11 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 15.4 m-80 -48.22 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 174.76 -45.75 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.387 -0.821 . . . . 0.0 111.311 175.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.0 Cg_endo -75.76 55.32 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 N-CA-C 107.86 -1.631 . . . . 0.0 107.86 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 5.4 tptt -106.75 106.81 17.51 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.237 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -100.1 141.54 32.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.64 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.67 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 mp -118.26 125.41 50.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 12.1 t80 -120.16 127.71 52.74 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.956 . . . . 0.0 110.133 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -108.34 111.9 24.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -72.94 53.33 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.739 -1.226 . . . . 0.0 108.352 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.658 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.7 mt -53.24 -58.3 3.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.746 -0.596 . . . . 0.0 111.195 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.0 p -43.56 -29.44 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.815 -1.178 . . . . 0.0 109.257 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.884 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.29 30.14 7.44 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.46 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.814 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 27.7 mmt-85 -79.22 156.06 28.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.537 -1.352 . . . . 0.0 109.4 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 94' ' ' GLN . 5.6 mm-40 -116.46 83.78 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 122' ' ' ASP . 9.1 m-85 -80.71 97.83 7.46 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.611 -0.681 . . . . 0.0 110.132 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 100' ' ' ILE . 29.5 t-20 -79.02 89.88 4.79 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 45.5 m95 -60.54 -8.89 3.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.68 -21.68 21.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.2 m-20 -100.07 -24.76 14.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 57' ' ' LYS . 36.3 mt -73.49 64.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.575 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 37.7 mt -46.4 149.23 1.4 Allowed Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 13' ' ' ILE . 29.6 Cg_endo -77.58 -25.17 8.29 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.579 2.186 . . . . 0.0 110.522 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 125.37 16.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 109.516 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.575 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 76.5 m-85 -112.78 145.14 41.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -99.56 -4.36 31.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 82.49 7.64 87.26 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -118.5 9.12 12.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -1.068 . . . . 0.0 108.724 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -72.76 -177.84 2.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.437 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -73.92 172.94 10.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -74.81 -36.18 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.634 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.3 t -51.81 -60.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.437 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 5.2 mp0 -62.54 -36.24 82.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.974 -1.079 . . . . 0.0 108.989 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.5 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 72.9 mttt -64.5 -42.67 95.7 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.484 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.5 ttm -60.03 -38.73 83.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.11 -69.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.485 -0.76 . . . . 0.0 110.476 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.722 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.0 tp -57.92 -43.6 84.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 110.227 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 5.3 p -50.51 -40.52 51.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.493 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.62 -48.96 58.23 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.4 tp -49.19 -48.76 45.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.771 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -58.82 -55.28 37.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.577 -0.702 . . . . 0.0 110.583 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.42 -33.43 75.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.814 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 21.6 m-20 -64.37 -47.12 80.48 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 119' ' ' LEU . 62.1 t -71.35 -55.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.499 -0.75 . . . . 0.0 109.264 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.26 -50.53 12.94 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.0 mt -63.69 -55.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.255 -1.144 . . . . 0.0 108.046 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 6.9 p -46.93 -32.05 3.57 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.296 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.598 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 14.1 m -100.66 34.32 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.9 m-20 38.6 53.69 1.88 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.611 0.719 . . . . 0.0 109.509 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.601 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 57.3 tpp -65.87 129.56 40.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 111.629 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 74' ' ' SER . 0.7 OUTLIER -76.61 121.83 23.78 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 75.6 m-85 -103.38 117.46 34.53 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.705 1.24 . . . . 0.0 113.432 -175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.54 -162.46 10.6 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 104.12 -3.592 . . . . 0.0 104.12 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.656 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.53 -30.48 79.64 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 106.049 -2.327 . . . . 0.0 106.049 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.94 143.06 40.42 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.0 m -124.59 112.55 16.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.975 -1.703 . . . . 0.0 110.092 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 146.28 16.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.578 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 33.5 t -120.0 -164.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -91.89 -52.31 4.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.15 -143.33 14.75 Favored Glycine 0 N--CA 1.48 1.592 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.978 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 159' ' ' GLN . 74.6 m -48.37 -51.18 27.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.755 -0.85 . . . . 0.0 111.846 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.49 -39.17 10.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.789 -1.195 . . . . 0.0 108.761 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.799 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 10.5 mmt180 -81.77 -44.3 17.18 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.203 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.2 t -69.07 -51.28 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 110.584 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.4 pp0? -56.95 -35.73 69.44 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.001 -1.062 . . . . 0.0 108.691 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 30.6 ttm180 -77.27 -47.0 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.965 . . . . 0.0 110.147 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.55 84.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.125 -0.984 . . . . 0.0 110.353 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 251' ' ' ILE . 67.7 mt -59.7 -46.35 89.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.751 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 33.2 mtmt -85.0 -47.72 9.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 110.758 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 18.8 mt-10 -70.63 -47.07 61.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.911 -1.118 . . . . 0.0 112.273 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 18.6 m120 -89.57 -53.27 4.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.575 -1.328 . . . . 0.0 112.126 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.407 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 46.6 m-85 -90.06 -13.75 35.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 110.448 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.046 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 65.52 36.55 92.65 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.054 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 251' ' ' ILE . 7.9 m-85 -63.43 172.63 1.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.374 -1.662 . . . . 0.0 107.808 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 33.5 t-20 -47.86 134.74 12.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.725 -1.234 . . . . 0.0 109.235 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 30.1 mm-40 -53.31 -21.67 5.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.958 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 154' ' ' ASN . 52.6 p -54.49 -16.72 2.51 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.369 -0.832 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.4 t -57.19 123.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.032 -1.043 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.969 ' CE1' HG23 ' A' ' 249' ' ' VAL . 15.2 p-80 -143.46 161.35 38.65 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 140' ' ' SER . 6.4 tt0 -102.27 154.65 18.84 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 0.0 110.274 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.566 HG21 HE21 ' A' ' 173' ' ' GLN . 14.7 pt -137.64 134.92 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.5 m-80 -102.73 107.36 18.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.838 -1.163 . . . . 0.0 111.069 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.667 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -47.38 -44.46 24.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.85 -21.58 55.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 18.1 m-20 -104.9 2.24 29.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.953 -1.322 . . . . 0.0 112.162 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -117.65 175.05 5.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.302 -1.498 . . . . 0.0 110.314 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.509 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.1 p -100.41 131.63 46.22 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.509 ' C ' ' O ' ' A' ' 166' ' ' SER . 28.3 ttmt -30.09 -49.35 0.1 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.204 0.526 . . . . 0.0 111.002 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -62.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.96 -1.087 . . . . 0.0 110.188 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.39 -16.12 52.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.004 -1.06 . . . . 0.0 109.28 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 57.6 t-105 -72.71 -51.14 20.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.522 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.0 mt-10 -68.88 -37.12 78.83 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.08 -1.012 . . . . 0.0 108.319 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.61 -42.16 15.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.566 HE21 HG21 ' A' ' 160' ' ' ILE . 11.4 mm100 -61.01 -42.81 99.17 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 199' ' ' ILE . 6.9 mt -70.34 -53.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.729 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.471 ' OD1' ' CE2' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -49.84 -55.92 12.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.634 -178.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -50.91 -41.32 58.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.837 -1.165 . . . . 0.0 108.517 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.59 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.7 mm-40 -61.26 -49.79 75.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 199' ' ' ILE . 46.9 mt -68.53 -24.67 64.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.247 -0.908 . . . . 0.0 110.257 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 53.3 p -52.05 -37.12 52.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.479 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 mt-30 -102.71 34.11 2.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.618 ' HB3' HD22 ' A' ' 7' ' ' LEU . 30.5 m-20 44.21 51.71 7.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.15 -0.969 . . . . 0.0 108.893 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 9.5 mt-30 -123.79 107.44 31.25 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.614 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.7 Cg_endo -62.63 165.74 15.13 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.708 1.605 . . . . 0.0 112.681 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.661 HG22 HG12 ' A' ' 249' ' ' VAL . 18.7 t -120.04 134.88 62.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.207 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.865 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.9 OUTLIER -82.81 115.3 21.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.12 158.59 28.96 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.914 -1.117 . . . . 0.0 108.798 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 196' ' ' ALA . 2.0 pt20 -167.77 128.37 1.41 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.006 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' HIS . . . -91.1 124.44 7.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 106.154 -2.778 . . . . 0.0 106.154 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.562 HG13 ' N ' ' A' ' 194' ' ' GLY . 1.9 t -101.86 164.51 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.727 -1.455 . . . . 0.0 112.957 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.475 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -160.07 -136.61 2.06 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -25.28 22.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.817 -1.402 . . . . 0.0 110.777 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.468 ' CG1' ' HA3' ' A' ' 237' ' ' GLY . 15.8 m -83.46 -22.43 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.003 -1.061 . . . . 0.0 111.659 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.467 ' C ' HG13 ' A' ' 189' ' ' VAL . . . 138.31 176.8 14.76 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.562 ' N ' HG13 ' A' ' 189' ' ' VAL . . . -76.87 113.19 3.72 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.57 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 33.5 t-80 -71.27 95.32 1.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -86.12 155.67 20.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.719 1.247 . . . . 0.0 113.793 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 35.0 p90 -154.04 177.06 11.48 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.723 HG22 HD11 ' A' ' 55' ' ' ILE . 97.9 t -123.26 136.66 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.496 -1.377 . . . . 0.0 112.418 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 178' ' ' LEU . 64.9 mt -97.11 124.13 49.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 7.4 p-10 -137.15 29.65 2.76 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.989 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -168.87 174.36 43.44 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.506 -2.283 . . . . 0.0 112.169 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -166.87 147.79 5.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.47 ' C ' HG22 ' A' ' 3' ' ' VAL . 5.3 t70 -120.33 34.41 5.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.654 -1.279 . . . . 0.0 109.686 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.503 ' CA ' ' OE1' ' A' ' 1' ' ' GLN . . . 53.88 18.62 8.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 3.2 mtt85 -136.63 32.58 2.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -1.178 . . . . 0.0 109.225 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 1.3 m120 64.75 22.79 12.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 10.0 m-85 -110.73 100.26 9.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.605 ' H ' ' CB ' ' A' ' 222' ' ' PHE . 11.1 m-85 -96.56 156.28 16.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.444 -0.785 . . . . 0.0 110.292 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.639 ' CD2' ' HA3' ' A' ' 220' ' ' GLY . 56.2 t-80 -93.17 123.32 36.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 9.1 t -112.76 135.31 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.821 1.296 . . . . 0.0 111.825 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 8' ' ' LEU . 3.8 t30 -112.95 99.55 7.95 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.89 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.668 ' CD1' HG23 ' A' ' 217' ' ' VAL . 43.9 m95 -49.0 178.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.749 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 17' ' ' GLN . . . -86.64 15.45 51.49 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.727 ' HB2' HG22 ' A' ' 217' ' ' VAL . 65.9 m95 -109.52 -167.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.291 . . . . 0.0 109.575 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 15' ' ' TYR . . . -117.87 -28.5 2.24 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.595 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.58 -24.09 9.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 214' ' ' TRP . 0.9 OUTLIER -85.58 -37.93 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.848 -0.795 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 217' ' ' VAL . 0.2 OUTLIER -41.51 93.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 217' ' ' VAL . 1.9 t70 -98.7 -77.0 0.52 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.025 0.917 . . . . 0.0 112.13 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 144.18 59.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.516 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 1.2 m-85 -120.94 120.12 34.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.126 -1.22 . . . . 0.0 110.975 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.605 ' CB ' ' H ' ' A' ' 208' ' ' TYR . 0.3 OUTLIER -77.11 15.8 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.763 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.715 ' C ' HD22 ' A' ' 224' ' ' LEU . 3.3 mtp180 -85.6 119.25 25.73 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.3 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.819 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.4 mm? -120.78 21.36 11.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.313 -0.867 . . . . 0.0 109.957 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -34.26 31.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.998 -1.064 . . . . 0.0 109.051 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.66 97.89 5.49 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -89.14 69.49 8.32 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 121.585 0.707 . . . . 0.0 109.657 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -116.56 102.52 53.3 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 232' ' ' LEU . 34.7 Cg_endo -76.34 159.16 36.66 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 110.726 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.6 m -87.41 -35.14 18.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.549 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.26 45.57 1.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 229' ' ' PRO . 27.0 tp -79.17 -34.63 42.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.66 151.38 1.92 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.37 59.54 1.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -84.71 172.2 48.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -70.55 88.03 0.35 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.468 ' HA3' ' CG1' ' A' ' 192' ' ' VAL . . . -173.77 -167.68 33.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -106.74 163.31 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -1.14 . . . . 0.0 109.399 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.78 -43.89 8.07 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.91 72.21 0.42 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -110.07 127.74 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.141 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 4.3 t-20 -108.35 70.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.962 . . . . 0.0 109.779 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -77.04 -47.0 9.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' VAL . 3.1 m-85 -135.43 148.14 49.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -1.07 . . . . 0.0 109.079 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 5.4 tt0 -151.63 122.43 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 25.6 p -150.57 164.56 35.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.039 -1.038 . . . . 0.0 110.617 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.41 163.47 32.72 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.846 0.832 . . . . 0.0 109.703 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.865 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.4 t -117.28 128.42 74.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.969 HG23 ' CE1' ' A' ' 158' ' ' HIS . 32.7 m -127.05 144.96 35.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.796 -1.19 . . . . 0.0 111.072 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.18 51.45 2.97 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 147' ' ' LEU . 8.2 mt -102.43 97.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.575 -0.956 . . . . 0.0 109.824 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.6 150.78 10.58 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.095 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.633 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.6 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 C-N-CA 122.178 1.918 . . . . 0.0 110.359 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.464 ' NE2' ' CZ ' ' A' ' 208' ' ' TYR . 55.1 tt0 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.33 -170.95 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.403 2.069 . . . . 0.0 109.949 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 ' C ' ' A' ' 203' ' ' ASP . 25.1 t -133.45 138.48 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.158 -0.964 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 178' ' ' LEU . 13.7 t -130.92 131.15 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.0 mmtt -74.82 -169.28 0.86 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.061 -1.024 . . . . 0.0 108.291 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.587 ' OG ' ' CG ' ' A' ' 209' ' ' HIS . 72.7 m -80.86 101.58 9.5 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.155 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 200' ' ' ASP . 45.0 mt -58.15 -49.18 77.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.999 -1.063 . . . . 0.0 108.737 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.632 HD11 HG11 ' A' ' 198' ' ' VAL . 9.4 mt -59.74 -38.82 82.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.073 -1.017 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 8.0 t0 -67.26 -37.75 84.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 109.152 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 p -57.88 -15.73 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.005 . . . . 0.0 108.575 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 13' ' ' ILE . 3.1 mtpt -120.84 18.16 11.82 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 47.1 41.25 14.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.3 mt -89.63 102.0 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -1.039 . . . . 0.0 110.29 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 27.1 m80 -128.1 77.7 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.625 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 11.4 m-30 -81.61 -179.79 7.52 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.102 0.953 . . . . 0.0 111.182 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.98 -164.04 1.93 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 20.7 mt-30 -125.16 -19.64 5.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.061 -1.025 . . . . 0.0 110.446 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.83 -35.44 1.26 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.617 -1.277 . . . . 0.0 111.424 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.824 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.77 -140.17 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 118.469 -0.776 . . . . 0.0 110.981 -178.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.3 Cg_endo -74.16 3.54 5.06 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 122.46 1.914 . . . . 0.0 109.616 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 7.5 m-85 -79.93 -31.13 40.07 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.231 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.0 p-10 -93.46 17.88 10.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.484 -1.385 . . . . 0.0 109.944 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mt -74.5 4.92 5.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.862 . . . . 0.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 118' ' ' GLU . 13.3 mt -133.39 -4.45 2.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.721 -1.237 . . . . 0.0 110.368 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 32.6 p -61.99 164.62 10.02 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.9 Cg_endo -71.7 132.96 21.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.648 1.565 . . . . 0.0 110.573 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.93 145.38 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 110.229 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HA2' ' A' ' 132' ' ' GLY . 8.9 mt -77.01 149.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.592 -0.692 . . . . 0.0 110.565 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.629 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.2 mt-10 -125.39 -23.84 4.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.703 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 79' ' ' TYR . 25.8 mtpp -114.74 174.48 5.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.958 -1.089 . . . . 0.0 109.98 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 37' ' ' SER . 98.3 t -114.32 146.48 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.887 . . . . 0.0 111.008 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 58.3 tttt -86.6 130.76 47.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.65 123.91 10.6 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.466 1.444 . . . . 0.0 110.182 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.08 11.43 29.86 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.7 tt0 -151.25 168.09 25.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -1.082 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.3 -175.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 108.62 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.0 t -87.76 139.1 30.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 110.275 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.768 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 17.3 m-30 -111.78 11.69 20.93 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.914 -1.116 . . . . 0.0 109.275 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 29' ' ' GLU . 20.3 t -61.54 119.15 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.841 -1.162 . . . . 0.0 108.617 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.04 52.34 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 21.8 mt-30 -74.53 135.81 42.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.59 -0.947 . . . . 0.0 109.255 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.48 116.14 13.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.92 156.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.326 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.825 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -80.57 167.12 20.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.0 p -81.96 -37.61 26.44 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.567 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 105.14 139.3 9.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' VAL . 1.2 p -55.11 -50.26 69.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -1.161 . . . . 0.0 108.158 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 127' ' ' VAL . 2.7 t -46.32 -53.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.57 -48.04 79.04 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.468 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 53.2 m -62.51 -31.87 72.7 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.734 -0.604 . . . . 0.0 109.439 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.37 76.24 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.69 -1.256 . . . . 0.0 108.756 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.592 HG22 ' HG3' ' A' ' 56' ' ' MET . 28.2 m -74.75 -51.71 13.47 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.567 0.698 . . . . 0.0 109.729 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -50.94 -36.69 40.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.684 -0.635 . . . . 0.0 109.567 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.625 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 23.1 mt-30 -69.69 -58.91 3.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.665 -1.272 . . . . 0.0 107.969 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.058 HD11 HG22 ' A' ' 198' ' ' VAL . 78.0 mt -57.68 -20.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.592 ' HG3' HG22 ' A' ' 52' ' ' THR . 24.7 mtp -73.91 -35.82 64.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 28.9 tptt -77.49 -41.04 40.85 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.188 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 46.3 t80 -53.19 -26.76 18.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 108.813 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 65.2 m-70 -107.85 -26.66 10.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.29 -0.881 . . . . 0.0 110.426 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 85.7 m-20 47.97 58.39 5.12 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.5 t80 -83.91 -73.88 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 113.087 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 35.8 Cg_endo -68.23 101.61 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 CA-C-N 119.026 0.688 . . . . 0.0 111.6 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.42 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 4.2 m120 -70.32 -20.51 63.0 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 51.5 tttt -134.74 142.25 46.7 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.89 147.47 37.3 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.279 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.928 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -86.81 -50.57 6.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.519 -0.989 . . . . 0.0 109.992 -179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 44.9 tttt -148.49 152.73 37.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.943 . . . . 0.0 109.594 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 89' ' ' ALA . 12.9 m-20 -73.01 178.01 4.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 70' ' ' THR . 24.5 t80 -154.26 153.82 32.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.373 -0.83 . . . . 0.0 109.581 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.616 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -158.0 154.12 27.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.628 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.8 p90 -161.66 162.73 30.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 56.6 m -93.83 131.67 38.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.76 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -47.13 148.43 1.19 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 111.11 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.67 143.43 56.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.689 -0.632 . . . . 0.0 110.041 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 t -69.61 -2.76 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 110.087 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 m-20 -99.39 -3.72 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.026 -1.046 . . . . 0.0 109.39 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.76 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.6 t-20 -70.65 110.67 7.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.536 -0.728 . . . . 0.0 110.11 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.633 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -90.91 20.19 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 123.101 2.534 . . . . 0.0 108.559 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.633 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 45.2 m-85 -114.11 -28.34 7.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.533 -0.729 . . . . 0.0 111.879 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' ASN . 49.3 m-85 -118.06 164.83 14.52 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.3 m-80 -46.99 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.95 -47.48 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 111.044 175.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -77.38 54.31 4.65 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 N-CA-C 107.216 -1.879 . . . . 0.0 107.216 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HE3' ' HG ' ' A' ' 86' ' ' LEU . 13.3 tptt -106.68 107.08 17.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.812 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -100.93 140.17 35.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.245 -0.909 . . . . 0.0 108.983 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.7 mp -111.32 149.41 31.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -137.17 123.19 20.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.994 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.12 112.85 25.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -74.72 50.98 0.46 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.795 -1.191 . . . . 0.0 108.4 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 92.9 mt -52.6 -45.4 47.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 1.9 p -45.23 -26.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.738 -1.226 . . . . 0.0 109.047 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -111.38 37.76 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 108.929 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.65 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 11.9 mmt-85 -95.48 154.93 16.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 110.493 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.48 91.95 3.71 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.7 m-85 -81.19 90.26 6.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 110.573 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -78.92 92.18 4.88 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.604 ' CE3' ' HA ' ' A' ' 60' ' ' ASN . 67.0 m95 -60.72 -9.17 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.408 -0.808 . . . . 0.0 110.164 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -90.75 -20.39 22.46 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 30.9 m-20 -92.08 -34.62 14.31 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.527 HG12 ' HB1' ' A' ' 115' ' ' ALA . 25.9 mt -73.83 94.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.0 mt -71.47 153.03 93.94 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.496 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.4 Cg_endo -80.05 -30.31 2.25 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.808 2.339 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 t -136.7 128.15 28.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 68.1 m-85 -112.52 138.01 49.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.7 p -99.95 2.02 43.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 108.707 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.72 0.12 89.87 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -120.1 13.23 12.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 0.0 109.461 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 3.7 mp0 -72.5 170.25 14.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.9 173.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.125 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -79.72 -44.12 21.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.98 -47.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.21 -43.54 97.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.094 -1.004 . . . . 0.0 109.207 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 52.1 mttt -60.52 -36.22 77.86 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.429 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 6.2 ttm -60.07 -46.74 88.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.49 -50.4 73.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.187 -0.945 . . . . 0.0 110.727 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.748 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.3 tp -69.55 -46.96 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.612 -1.305 . . . . 0.0 109.734 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 116' ' ' ILE . 5.2 p -53.71 -40.26 65.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.003 . . . . 0.0 109.156 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.833 ' N ' HD12 ' A' ' 24' ' ' LEU . 1.1 tp10 -69.81 -45.42 67.94 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.748 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.0 tp -51.42 -50.25 60.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.663 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -60.87 -46.8 89.19 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.768 -0.582 . . . . 0.0 109.816 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.67 -39.66 94.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.467 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -64.53 -46.12 84.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 119' ' ' LEU . 89.1 t -71.4 -58.92 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 121.53 0.681 . . . . 0.0 109.822 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.79 -48.25 13.36 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.9 mt -63.5 -58.05 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.3 p -47.58 -29.22 2.72 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.986 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.664 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.8 m -100.68 37.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 127' ' ' VAL . 91.1 m-20 37.1 50.19 0.91 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.679 0.752 . . . . 0.0 109.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE3' ' HA3' ' A' ' 46' ' ' GLY . 54.9 tpp -65.75 130.55 43.68 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.539 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 38.6 t0 -76.57 118.69 19.48 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 104.014 -2.588 . . . . 0.0 104.014 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.567 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 39.8 m-85 -101.19 110.6 22.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.673 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -150.14 -170.34 17.32 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 103.722 -3.751 . . . . 0.0 103.722 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.768 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.9 Cg_endo -62.54 -20.61 71.19 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 106.923 -1.991 . . . . 0.0 106.923 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -110.86 135.21 51.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.825 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 69.1 m -123.6 111.05 15.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 119.817 -1.802 . . . . 0.0 110.97 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -109.57 130.91 10.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 5.5 t -110.1 -163.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.879 -1.365 . . . . 0.0 107.433 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.576 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -89.8 -55.92 3.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.621 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 142.92 -136.2 6.95 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.051 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.658 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 13.8 m -56.62 -45.16 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.858 -0.789 . . . . 0.0 112.108 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 140' ' ' SER . 14.7 p -46.11 -43.35 14.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.946 -1.096 . . . . 0.0 109.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.8 mmt180 -82.34 -40.25 21.67 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 1.008 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.3 t -68.33 -54.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.917 . . . . 0.0 110.396 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 140' ' ' SER . 2.7 pp0? -56.73 -33.95 67.02 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.268 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.1 ttp180 -77.15 -48.52 17.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.95 78.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.959 . . . . 0.0 110.043 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 157' ' ' VAL . 50.7 mt -58.77 -47.93 83.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.088 -1.008 . . . . 0.0 109.475 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 14.0 mtmt -87.17 -35.65 18.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.859 -1.15 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 43.2 mt-10 -77.68 -55.28 5.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.406 -1.434 . . . . 0.0 111.823 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 34.2 m120 -84.35 -40.39 17.94 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.966 -1.084 . . . . 0.0 111.578 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.442 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 33.6 m-85 -102.51 -2.25 28.97 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.767 -1.208 . . . . 0.0 110.665 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.928 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.0 36.65 43.49 Favored Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.163 -0.961 . . . . 0.0 112.011 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.3 m-85 -62.01 163.85 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.242 -1.74 . . . . 0.0 107.993 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.9 t30 -47.3 147.01 1.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.452 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.37 4.71 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.23 -0.918 . . . . 0.0 108.698 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.536 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 16.7 p -54.08 -16.21 1.86 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.417 -0.802 . . . . 0.0 109.955 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.7 t -65.3 120.55 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.787 -1.195 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.799 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.9 p-80 -147.21 157.57 43.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.027 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 6.7 tt0 -101.93 155.81 17.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 246' ' ' SER . 2.6 pt -138.57 154.19 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.88 97.59 7.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 110.569 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HA ' ' CE3' ' A' ' 170' ' ' TRP . 5.3 tpt180 -47.77 -31.58 5.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.25 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.541 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -63.7 -23.64 67.32 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -103.64 2.03 32.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.124 -1.221 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -117.92 140.57 49.54 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.63 -1.294 . . . . 0.0 109.81 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -67.98 139.97 56.37 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 59.2 tttt -38.04 -46.78 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -56.83 12.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 169' ' ' ASP . 1.7 m-20 -63.43 -23.38 67.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 109.268 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.798 ' NE1' HD11 ' A' ' 174' ' ' ILE . 66.8 t-105 -72.53 -43.63 63.28 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 175' ' ' ASP . 34.3 mt-10 -62.71 -26.62 68.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.34 81.94 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -61.22 -42.4 98.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.338 -0.851 . . . . 0.0 108.881 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.981 HD13 ' CD1' ' A' ' 199' ' ' ILE . 28.7 mt -75.99 -61.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.558 -0.713 . . . . 0.0 110.889 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.4 OUTLIER -49.29 -51.58 33.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.967 -1.083 . . . . 0.0 109.601 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -52.1 -40.69 61.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.882 -1.136 . . . . 0.0 107.988 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.58 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 5.0 mm-40 -60.88 -53.96 50.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.603 -0.686 . . . . 0.0 109.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.97 ' HB2' HG21 ' A' ' 4' ' ' VAL . 5.8 mt -65.69 -24.68 67.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.43 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 24.8 p -52.31 -45.17 65.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.974 -1.079 . . . . 0.0 108.193 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 19.9 mt-30 -94.29 39.09 1.08 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.477 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.3 m-20 42.52 51.2 4.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 10.2 mt-30 -123.94 105.14 32.32 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.447 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.1 Cg_endo -63.93 173.58 4.69 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.103 1.869 . . . . 0.0 112.653 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 63.9 t -129.84 142.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.242 1.02 . . . . 0.0 112.236 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 1.008 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -93.29 121.17 34.39 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.675 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 14.0 t80 -122.69 159.42 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.549 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -152.52 119.86 5.94 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.594 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 195' ' ' HIS . . . -91.97 106.03 3.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 10.1 t -67.11 160.76 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.25 -1.147 . . . . 0.0 110.644 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -172.34 -145.65 5.04 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -30.45 20.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.292 . . . . 0.0 110.229 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.488 HG11 ' O ' ' A' ' 238' ' ' ALA . 5.5 m -83.51 -22.2 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.3 -169.61 23.94 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -77.38 112.55 3.53 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.176 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.5 t-80 -77.44 113.73 15.53 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -105.98 164.34 12.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.782 1.277 . . . . 0.0 114.036 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' ' 186' ' ' TYR . 43.5 p90 -162.64 -160.68 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.058 HG22 HD11 ' A' ' 55' ' ' ILE . 5.7 t -139.61 139.35 38.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.206 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.981 ' CD1' HD13 ' A' ' 174' ' ' ILE . 40.0 mt -105.66 108.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 10.2 p-10 -120.87 32.43 5.97 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.428 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 4' ' ' VAL . . . 178.17 166.16 34.11 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 117.79 -2.147 . . . . 0.0 112.267 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -145.77 164.26 32.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.615 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -133.65 2.15 3.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.369 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.8 -31.06 4.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 10.0 mtt-85 -87.49 39.19 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.033 -1.275 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 205' ' ' ARG . 17.0 m120 61.71 16.18 7.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 110.094 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -114.43 138.2 50.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.009 -1.057 . . . . 0.0 109.682 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 9.2 m-85 -123.17 162.48 22.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.337 -0.852 . . . . 0.0 110.285 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CG ' ' OG ' ' A' ' 6' ' ' SER . 59.2 t-80 -92.11 139.63 30.44 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 212' ' ' TRP . 2.7 t -140.23 157.96 25.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.867 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.544 ' HB2' HD12 ' A' ' 8' ' ' LEU . 43.9 t-20 -117.95 85.23 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.71 ' CE2' HG11 ' A' ' 210' ' ' VAL . 19.7 m95 -70.52 176.4 4.11 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.146 -0.972 . . . . 0.0 112.019 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.541 ' HA3' ' NE2' ' A' ' 17' ' ' GLN . . . -94.03 33.85 5.0 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.914 ' HB2' HG22 ' A' ' 217' ' ' VAL . 40.2 m95 -114.85 -162.6 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -1.134 . . . . 0.0 109.716 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -100.97 -53.58 1.02 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.846 -1.168 . . . . 0.0 111.498 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -108.54 -23.09 6.73 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 120.69 -1.476 . . . . 0.0 110.03 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.93 HG11 ' HB2' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -73.91 -28.32 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.369 -1.077 . . . . 0.0 108.821 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.475 ' HA ' ' HB2' ' A' ' 212' ' ' TRP . 1.2 t -43.54 -48.53 7.48 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.179 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.14 93.38 6.91 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.494 -1.379 . . . . 0.0 110.095 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -156.19 150.99 22.48 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -100.01 85.07 2.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -1.212 . . . . 0.0 109.327 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -138.65 -177.65 4.96 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.491 0.662 . . . . 0.0 110.176 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.69 ' O ' HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -129.72 122.12 28.26 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 223' ' ' ARG . 4.1 mm? -119.66 36.49 4.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.289 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.487 ' OD2' ' NE1' ' A' ' 170' ' ' TRP . 14.3 m-20 -80.07 4.38 17.36 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 109.393 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 242' ' ' ASN . . . -114.96 -65.46 1.19 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 109.68 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.1 -155.62 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 109.942 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.548 ' CB ' ' HD2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -100.7 176.97 1.66 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.844 . . . . 0.0 109.394 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 228' ' ' ASN . 35.8 Cg_endo -78.34 -157.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.813 2.342 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.6 t -117.54 22.49 12.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.068 -1.02 . . . . 0.0 109.767 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.93 ' HB2' HG11 ' A' ' 217' ' ' VAL . . . -114.79 126.21 54.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.6 mt -122.46 18.17 10.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' N ' ' CH2' ' A' ' 214' ' ' TRP . . . 58.55 -176.05 2.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 26.9 m -95.12 -75.79 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -1.191 . . . . 0.0 109.422 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.405 ' O ' ' OE2' ' A' ' 35' ' ' GLU . . . -94.47 31.28 6.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -65.34 -139.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -137.76 -97.25 0.43 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.488 ' O ' HG11 ' A' ' 192' ' ' VAL . . . -132.18 130.9 41.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.429 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -52.01 -74.98 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 241' ' ' PHE . . . 128.95 111.64 1.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -51.72 -177.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -1.133 . . . . 0.0 109.493 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.532 ' ND2' ' NE2' ' A' ' 245' ' ' GLN . 1.2 t-20 -104.77 77.7 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.457 ' HA3' ' CZ ' ' A' ' 241' ' ' PHE . . . -73.06 -55.82 6.11 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 74.3 m-85 -135.4 162.36 32.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.558 -0.966 . . . . 0.0 108.587 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -149.52 155.88 41.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.917 . . . . 0.0 108.804 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 13.5 p -167.53 149.88 5.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 110.085 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.409 ' H ' HG13 ' A' ' 160' ' ' ILE . . . -129.98 169.15 15.62 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.249 1.024 . . . . 0.0 109.751 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 185' ' ' TYR . 11.4 t -117.95 119.9 62.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.799 HG23 ' NE2' ' A' ' 158' ' ' HIS . 30.1 m -119.17 150.23 21.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.286 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 84.82 33.2 19.33 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.626 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 46.8 mt -79.18 90.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.341 -1.093 . . . . 0.0 109.974 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.76 152.04 12.87 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.599 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.316 2.011 . . . . 0.0 110.447 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.543 ' NE2' ' CZ ' ' A' ' 208' ' ' TYR . 31.7 tt0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.1 -174.49 2.26 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.48 2.12 . . . . 0.0 110.038 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG22 ' C ' ' A' ' 203' ' ' ASP . 47.7 t -116.82 141.86 33.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.119 -0.988 . . . . 0.0 109.986 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.772 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.9 t -138.03 132.41 43.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 200' ' ' ASP . 49.2 mmtt -75.07 178.52 5.61 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.032 -1.043 . . . . 0.0 108.441 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 1.6 t -77.6 103.82 7.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.099 -1.001 . . . . 0.0 109.208 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.726 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 40.7 mt -57.15 -49.0 77.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.871 . . . . 0.0 108.923 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.6 mt -56.5 -42.18 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.739 -1.226 . . . . 0.0 108.826 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 54.8 t0 -67.48 -36.31 80.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.151 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -16.79 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.034 -1.042 . . . . 0.0 108.266 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.8 mtpt -122.32 18.32 10.63 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.25 43.12 7.24 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 58' ' ' TYR . 57.6 mt -87.72 107.37 17.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 122.255 1.026 . . . . 0.0 110.23 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.8 m80 -135.02 86.97 2.29 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.7 m-30 -92.95 -179.9 5.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 110.768 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -147.17 -163.81 1.85 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.0 mt-30 -124.88 -20.8 4.89 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.929 -1.107 . . . . 0.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.38 -35.62 1.29 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.43 -1.367 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.835 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.13 -142.74 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.529 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.132 -177.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.835 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.6 Cg_endo -72.98 1.83 6.11 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 CA-C-N 122.363 1.88 . . . . 0.0 109.559 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 10.4 m-85 -76.46 -31.12 57.63 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 108.953 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 10.8 p-10 -94.09 17.33 12.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.596 -1.315 . . . . 0.0 109.566 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 26.7 mt -72.28 -3.03 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.978 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 118' ' ' GLU . 6.0 mt -127.13 -7.56 5.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.5 p -61.9 164.93 8.91 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.674 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.6 Cg_endo -71.43 138.89 33.58 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.435 2.09 . . . . 0.0 112.11 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.8 t -81.11 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.646 -0.659 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.738 HD11 ' C ' ' A' ' 132' ' ' GLY . 17.1 mt -78.11 148.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.499 -0.751 . . . . 0.0 110.523 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.8 mt-10 -125.73 -22.12 4.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.759 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.3 mtpp -121.19 173.34 7.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.992 -1.068 . . . . 0.0 109.893 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 37' ' ' SER . 98.7 t -114.04 139.52 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.401 -0.812 . . . . 0.0 110.676 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 11.3 tttt -78.71 130.48 70.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.87 124.51 11.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.396 1.398 . . . . 0.0 110.054 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.99 10.91 31.26 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 6.7 tt0 -148.73 -179.65 7.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -1.038 . . . . 0.0 109.273 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.468 ' O ' HG13 ' A' ' 31' ' ' VAL . 32.9 mt-30 -78.89 -174.99 4.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.195 -0.941 . . . . 0.0 109.865 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.471 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.4 t -87.11 137.93 31.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 109.929 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.3 m-85 -124.45 16.93 8.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.084 -1.01 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 29' ' ' GLU . 47.2 t -63.26 143.59 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.041 -1.037 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.07 -4.23 67.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.0 mt-30 -85.46 129.43 34.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -1.201 . . . . 0.0 109.595 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 25' ' ' THR . 1.8 m-70 -73.11 113.39 10.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.76 160.0 1.0 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.097 -1.041 . . . . 0.0 109.538 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.48 170.19 17.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.697 0.761 . . . . 0.0 109.793 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.701 ' O ' ' HE3' ' A' ' 129' ' ' MET . 29.8 p -81.62 -34.98 30.57 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.533 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 104.28 136.65 8.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 51' ' ' ALA . 3.9 p -55.18 -51.01 67.89 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.393 -1.063 . . . . 0.0 108.501 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.619 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 51.1 t -47.48 -52.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.38 -50.67 72.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.11 0.957 . . . . 0.0 109.437 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 99.1 m -62.65 -33.22 74.6 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.931 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.21 -41.91 84.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.734 -1.229 . . . . 0.0 108.119 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 ' HG3' ' A' ' 56' ' ' MET . 43.8 m -74.64 -53.25 9.69 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.447 0.641 . . . . 0.0 110.405 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.0 -37.71 46.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.572 -0.705 . . . . 0.0 109.585 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 32.0 mt-30 -63.05 -45.67 91.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 198' ' ' VAL . 53.1 mt -70.12 -28.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.581 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.3 mtp -66.97 -40.78 87.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HD3' HG22 ' A' ' 100' ' ' ILE . 29.9 tptt -70.33 -41.35 73.34 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 49.0 t80 -54.05 -30.4 47.76 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 43.4 m-70 -107.39 -24.03 11.99 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.05 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.63 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 79.2 m-20 44.3 54.17 6.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.9 t80 -78.75 -70.65 0.19 Allowed Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.36 -0.936 . . . . 0.0 113.308 -175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.9 Cg_endo -70.23 100.81 0.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 CA-C-N 118.929 0.653 . . . . 0.0 111.609 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -68.97 -20.58 64.18 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -134.33 141.87 47.06 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.19 151.84 26.22 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.098 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.904 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -89.14 -60.97 1.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -1.043 . . . . 0.0 110.186 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 49.0 tttt -135.95 134.46 38.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 109.598 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 4.5 m-20 -58.2 159.79 5.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.454 -0.779 . . . . 0.0 109.605 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 31.9 t80 -144.43 139.65 28.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.252 -0.905 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -143.19 153.82 43.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.084 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.6 p90 -154.46 155.41 34.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.886 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 98.4 m -92.83 130.07 38.55 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.787 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.7 tp -45.18 148.91 0.54 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.935 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 t -61.6 142.31 57.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.818 -0.551 . . . . 0.0 109.835 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -68.65 -3.38 11.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.038 -1.039 . . . . 0.0 109.75 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -98.7 -7.69 27.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.787 ' ND2' HD21 ' A' ' 73' ' ' LEU . 30.2 t-20 -70.49 110.1 6.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -89.26 16.28 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.968 2.445 . . . . 0.0 110.483 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 90.9 m-85 -106.01 -22.65 12.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.132 -0.98 . . . . 0.0 111.315 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.8 m-85 -122.34 162.56 21.32 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.561 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.4 m-80 -46.02 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 174.45 -46.04 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.451 175.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.3 56.48 5.01 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 N-CA-C 107.51 -1.765 . . . . 0.0 107.51 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.98 102.97 12.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.116 -178.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -101.14 134.9 43.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.656 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.71 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -108.15 144.56 35.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 17.7 t80 -134.0 130.23 37.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.007 -1.058 . . . . 0.0 110.365 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.68 113.82 27.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.84 53.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.642 -1.286 . . . . 0.0 108.458 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 9.8 mt -52.89 -52.73 25.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 4.1 p -45.55 -26.6 0.61 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.342 -1.473 . . . . 0.0 109.219 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -111.78 19.78 17.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 109.534 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 13.5 mmt-85 -76.83 147.55 37.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 110.378 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 90.34 3.31 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-85 -81.02 96.95 7.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.548 -0.72 . . . . 0.0 110.617 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.6 t-20 -80.53 88.69 5.65 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.63 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 39.1 m95 -61.03 -8.98 3.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.446 -0.784 . . . . 0.0 110.411 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.78 -19.17 23.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.6 m-20 -100.24 -26.29 13.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.623 HG22 ' HD3' ' A' ' 57' ' ' LYS . 66.6 mt -73.88 67.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 29.7 mt -46.83 150.12 1.37 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.56 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.4 Cg_endo -78.84 -21.2 9.86 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.759 2.306 . . . . 0.0 110.587 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 134.47 26.61 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.007 -1.058 . . . . 0.0 109.684 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 89.3 m-85 -124.49 137.9 54.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.923 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.9 p -99.04 -0.09 42.65 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 20' ' ' PRO . . . 81.45 10.02 85.07 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.17 5.9 10.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.395 -1.062 . . . . 0.0 108.956 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.14 167.72 19.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.694 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -57.79 171.71 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.195 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -76.9 -33.97 57.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -51.99 -60.42 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 2.1 mp0 -62.45 -35.16 78.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 0.0 109.376 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' SER . 26.7 mttt -63.8 -43.47 96.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 108.291 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.469 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 28.7 ttm -59.93 -38.24 81.8 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -57.16 -68.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.535 -0.728 . . . . 0.0 110.403 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.73 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -59.9 -39.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.471 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 25.2 p -53.61 -43.74 68.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.956 -1.09 . . . . 0.0 109.635 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 24' ' ' LEU . 4.4 tt0 -69.88 -42.49 73.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 108.518 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.7 tp -52.15 -51.6 56.98 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.693 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.5 mmt -59.7 -45.7 91.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.635 -0.666 . . . . 0.0 109.489 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.515 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.75 -38.35 90.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.6 m-20 -68.67 -48.43 63.97 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 56' ' ' MET . 55.9 t -67.12 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.41 -42.39 13.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.9 mt -69.72 -57.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.346 -1.091 . . . . 0.0 108.325 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.53 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 2.1 p -45.47 -27.64 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.429 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 27.6 m -105.0 32.76 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.139 -0.976 . . . . 0.0 109.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.565 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 43.1 m-20 40.71 44.99 1.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.343 -0.848 . . . . 0.0 109.651 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.701 ' HE3' ' O ' ' A' ' 45' ' ' THR . 41.1 tpp -56.86 133.09 54.19 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 111.145 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 18.6 t0 -79.56 122.66 26.76 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.82 117.79 35.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.312 1.053 . . . . 0.0 113.064 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.738 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.6 -164.56 12.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 104.261 -3.536 . . . . 0.0 104.261 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.617 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -61.96 -31.5 84.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 N-CA-C 105.582 -2.507 . . . . 0.0 105.582 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.0 m -109.7 141.54 42.14 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.528 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.5 m -119.2 109.84 16.33 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 119.966 -1.709 . . . . 0.0 109.919 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.83 136.12 13.24 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 13.1 t -117.87 -162.59 0.89 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.234 -1.156 . . . . 0.0 108.335 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.76 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.02 -57.21 2.8 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.553 ' HA3' ' NE2' ' A' ' 187' ' ' GLN . . . 131.46 -131.05 6.21 Favored Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.393 -1.384 . . . . 0.0 112.042 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 36.8 m -47.83 -58.62 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.891 -0.77 . . . . 0.0 111.786 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' SER . 11.1 p -46.75 -36.81 7.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 0.0 108.95 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.76 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.9 mmt-85 -80.37 -47.88 13.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.01 0.909 . . . . 0.0 108.92 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 185' ' ' TYR . 93.9 t -67.85 -56.57 12.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 140' ' ' SER . 3.7 pp0? -56.48 -33.73 66.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.171 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.512 ' NE ' ' OE2' ' A' ' 149' ' ' GLU . 12.1 ttt85 -77.1 -52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.53 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.56 -35.95 82.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.086 -1.009 . . . . 0.0 110.047 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.596 HD13 HG12 ' A' ' 251' ' ' ILE . 40.5 mt -56.41 -48.44 76.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.6 mtmt -86.45 -39.13 16.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.133 -0.979 . . . . 0.0 110.407 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.512 ' OE2' ' NE ' ' A' ' 145' ' ' ARG . 54.1 mt-10 -67.97 -54.46 18.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 0.0 112.007 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 20.7 m120 -92.75 -40.87 10.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.703 -1.248 . . . . 0.0 111.746 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.2 m-85 -99.56 10.59 41.08 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.715 -1.241 . . . . 0.0 110.514 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.904 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 36.04 39.12 0.27 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.55 -0.719 . . . . 0.0 112.875 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.5 m-85 -61.92 162.88 8.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.142 -1.799 . . . . 0.0 107.364 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.1 t-20 -47.48 139.02 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.87 -1.144 . . . . 0.0 109.414 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.407 ' NE2' ' HD2' ' A' ' 148' ' ' LYS . 9.2 tp-100 -53.72 -18.97 3.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 58.7 p -53.07 -18.23 1.99 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 251' ' ' ILE . 39.8 t -58.33 123.7 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 109.158 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.931 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.7 p-80 -143.87 154.82 43.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.086 -1.009 . . . . 0.0 109.404 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.0 tt0 -100.73 154.2 18.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.36 -0.838 . . . . 0.0 110.509 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.595 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 10.5 pt -135.96 142.37 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.9 m-80 -107.25 100.49 9.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.873 -1.142 . . . . 0.0 111.065 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.639 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 1.9 tpt180 -44.01 -41.22 5.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.154 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.09 -23.17 59.21 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ASN . 0.8 OUTLIER -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.063 -1.257 . . . . 0.0 111.576 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -117.92 174.94 5.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.516 -1.365 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -103.91 134.28 47.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 166' ' ' SER . 18.3 ttmt -31.91 -45.62 0.1 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.101 0.477 . . . . 0.0 110.869 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -64.17 -63.69 1.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.927 -1.108 . . . . 0.0 109.823 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.22 -15.67 57.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.359 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 65.9 t-105 -74.85 -46.95 33.0 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.177 -0.952 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 174' ' ' ILE . 43.4 mt-10 -69.53 -30.48 68.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.091 -1.006 . . . . 0.0 108.606 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.66 -45.43 73.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 108.751 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -61.13 -40.28 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 108.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.886 HG23 HG21 ' A' ' 184' ' ' VAL . 13.7 mt -76.13 -60.94 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.557 -0.714 . . . . 0.0 111.119 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -49.03 -46.67 44.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 109.24 -178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.756 ' HZ3' ' HB3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -51.35 -48.67 62.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 3.4 mm-40 -54.87 -51.07 67.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.772 ' HB3' HG11 ' A' ' 4' ' ' VAL . 17.6 mt -68.2 -33.51 74.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.205 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 53.4 p -51.99 -30.78 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.518 HE21 ' HD2' ' A' ' 176' ' ' LYS . 1.2 mt-30 -102.41 33.65 3.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.534 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.6 m120 40.67 46.68 2.27 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.816 0.817 . . . . 0.0 108.918 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 14.7 mt-30 -123.69 111.8 29.35 Favored Pre-proline 0 C--N 1.294 -1.815 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.7 Cg_endo -65.09 169.66 11.7 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.803 1.668 . . . . 0.0 112.653 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.886 HG21 HG23 ' A' ' 174' ' ' ILE . 45.9 t -121.12 132.79 69.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.58 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.713 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -81.57 116.39 21.31 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 175.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 6.5 t80 -121.97 157.27 31.65 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.809 -1.182 . . . . 0.0 110.192 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 4.8 pt20 -167.06 136.05 2.76 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.3 100.6 1.66 Allowed Glycine 0 C--N 1.289 -2.031 0 N-CA-C 107.675 -2.17 . . . . 0.0 107.675 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 244' ' ' TYR . 6.8 t -69.93 166.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -1.117 . . . . 0.0 111.419 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.547 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.53 -129.11 1.08 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -88.11 -36.96 16.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.251 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 236' ' ' GLY . 3.0 m -79.92 -15.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.974 -1.079 . . . . 0.0 111.284 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.88 -167.63 22.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -83.47 101.51 2.36 Favored Glycine 0 N--CA 1.485 1.929 0 O-C-N 121.049 -1.265 . . . . 0.0 110.781 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 17.3 t-80 -71.27 121.11 17.85 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -113.08 160.67 17.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.517 -1.273 . . . . 0.0 113.361 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.809 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -156.91 175.19 14.41 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 55' ' ' ILE . 92.8 t -121.14 135.69 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.575 -1.328 . . . . 0.0 112.094 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.712 HD13 HG21 ' A' ' 174' ' ' ILE . 73.6 mt -99.9 123.13 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -134.17 32.76 3.41 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.131 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.618 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -171.69 167.68 40.75 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 117.709 -2.186 . . . . 0.0 112.345 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.538 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -152.17 148.0 27.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 205' ' ' ARG . 0.5 OUTLIER -121.61 24.26 9.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.755 -1.216 . . . . 0.0 110.357 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 1' ' ' GLN . . . 43.05 26.45 0.49 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 14.3 mtt-85 -142.43 21.44 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -1.118 . . . . 0.0 109.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 9.4 t30 80.6 20.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.563 -0.711 . . . . 0.0 109.65 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.27 128.26 49.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.545 ' CD1' HD21 ' A' ' 224' ' ' LEU . 25.7 m-85 -120.7 163.51 17.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.0 . . . . 0.0 109.557 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 37.1 t-80 -93.39 116.11 28.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.809 HG13 ' CD1' ' A' ' 197' ' ' PHE . 20.7 t -114.51 140.02 37.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.105 -0.997 . . . . 0.0 111.165 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 8' ' ' LEU . 28.2 t-20 -108.64 92.32 4.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.476 ' O ' ' O ' ' A' ' 211' ' ' ASN . 3.1 m95 -46.54 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 0.0 110.404 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.16 -10.06 58.62 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.428 ' CE2' ' HB3' ' A' ' 231' ' ' ALA . 49.1 m95 -107.72 168.52 9.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.467 -1.019 . . . . 0.0 109.015 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.01 3.66 12.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.22 5.18 5.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.759 HG13 ' N ' ' A' ' 218' ' ' SER . 1.9 p -96.11 -153.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.274 -1.133 . . . . 0.0 109.622 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.759 ' N ' HG13 ' A' ' 217' ' ' VAL . 14.4 m -68.68 58.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.99 -1.068 . . . . 0.0 110.399 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.7 OUTLIER -86.84 120.36 28.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.126 -0.984 . . . . 0.0 109.047 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 172.77 -148.78 10.79 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.92 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 94.2 m-85 -75.15 119.86 19.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -1.089 . . . . 0.0 109.785 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.64 -173.16 3.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 109.044 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.549 ' C ' HD13 ' A' ' 224' ' ' LEU . 11.5 mtp180 -109.95 167.35 10.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.855 HD22 ' N ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -108.86 1.9 21.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.155 -0.966 . . . . 0.0 109.935 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.462 ' OD1' ' NH2' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -95.96 -30.77 13.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.205 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.19 88.22 2.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 109.089 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 224' ' ' LEU . 4.2 mm? -91.39 93.12 8.88 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-O 121.485 0.66 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -116.83 117.72 37.22 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.213 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.69 154.7 30.82 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.399 2.066 . . . . 0.0 110.75 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -98.53 -39.23 8.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.302 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.428 ' HB3' ' CE2' ' A' ' 214' ' ' TRP . . . -88.25 71.67 9.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.84 -27.04 13.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 68.93 157.55 1.27 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 234' ' ' THR . 57.5 m -101.69 33.65 2.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -1.142 . . . . 0.0 109.507 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -105.51 -98.98 2.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 192' ' ' VAL . . . -79.63 4.6 63.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -89.45 129.41 9.67 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.15 159.54 15.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.405 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -49.84 -87.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -51.93 127.85 32.5 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 195' ' ' HIS . 1.0 OUTLIER -122.14 42.38 3.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -1.117 . . . . 0.0 109.695 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.559 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.2 t-20 -135.29 70.63 1.43 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.061 -1.024 . . . . 0.0 110.05 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 189' ' ' VAL . . . -80.17 -62.02 2.15 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.604 ' O ' HG23 ' A' ' 189' ' ' VAL . 57.6 m-85 -136.0 109.25 7.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -1.034 . . . . 0.0 108.863 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.559 ' HG3' ' ND2' ' A' ' 242' ' ' ASN . 3.9 mt-30 -91.97 133.83 35.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.828 -1.17 . . . . 0.0 109.359 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 56.4 p -159.15 157.39 30.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.029 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.14 166.47 24.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.4 -0.812 . . . . 0.0 110.021 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 46.9 t -119.29 114.59 45.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.931 HG23 ' CE1' ' A' ' 158' ' ' HIS . 16.6 m -114.69 147.85 17.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 O-C-N 121.282 -0.886 . . . . 0.0 110.402 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 96.12 47.14 2.48 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.042 -1.551 . . . . 0.0 109.881 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.602 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 5.9 mt -103.22 96.11 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -1.185 . . . . 0.0 110.173 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.39 146.77 8.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.632 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.1 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.206 1.937 . . . . 0.0 110.452 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.442 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 34.5 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.9 156.73 27.12 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.297 1.998 . . . . 0.0 109.759 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 t -90.97 143.6 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.06 -1.025 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 202' ' ' ALA . 12.0 t -131.22 131.88 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 200' ' ' ASP . 58.3 mmtt -77.01 -179.51 5.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.526 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 34.7 t -77.79 102.42 7.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.687 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 35.7 mt -57.63 -49.65 75.75 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.8 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 211' ' ' ASN . 11.9 mt -56.02 -42.46 76.52 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.776 -1.202 . . . . 0.0 108.641 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -68.34 -36.19 78.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.058 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -58.08 -15.36 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.102 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' CB ' HG13 ' A' ' 13' ' ' ILE . 9.1 mtpt -121.95 23.54 9.97 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.97 39.89 5.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 58' ' ' TYR . 40.2 mt -86.03 110.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.355 1.074 . . . . 0.0 110.408 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 102' ' ' PRO . 6.7 m-70 -133.45 99.44 4.51 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' OH ' ' HB2' ' A' ' 57' ' ' LYS . 6.4 m-30 -103.66 176.0 5.29 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.012 . . . . 0.0 111.513 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -146.98 -175.17 4.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mt-30 -118.37 -20.96 8.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.943 -1.098 . . . . 0.0 109.977 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.42 -34.13 1.49 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.94 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.838 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.0 -140.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.021 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.872 ' HA ' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -74.32 3.22 5.42 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 CA-C-N 122.55 1.947 . . . . 0.0 109.325 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.1 m-85 -78.63 -30.66 46.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.478 -0.764 . . . . 0.0 109.068 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 20.6 p-10 -96.12 12.86 29.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.545 -1.347 . . . . 0.0 109.341 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.872 HD12 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -67.79 -8.61 37.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.918 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD12 ' OG ' ' A' ' 117' ' ' SER . 8.7 mt -126.68 -6.23 6.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.019 -1.051 . . . . 0.0 109.703 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.606 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.8 p -61.14 165.95 5.7 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.658 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -71.1 136.81 30.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.013 1.809 . . . . 0.0 111.609 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.16 149.97 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.614 0.721 . . . . 0.0 110.136 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 132' ' ' GLY . 16.8 mt -77.77 148.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.565 -0.709 . . . . 0.0 110.544 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -125.67 -20.82 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.705 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 79' ' ' TYR . 44.7 mtpt -123.72 172.01 9.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.89 -1.131 . . . . 0.0 109.949 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 37' ' ' SER . 75.0 t -114.44 147.41 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.397 -0.814 . . . . 0.0 110.94 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 9.9 tttt -86.19 129.39 53.93 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.42 124.18 10.57 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.424 1.416 . . . . 0.0 110.369 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.67 11.96 29.48 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 tt0 -147.83 -176.85 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -1.11 . . . . 0.0 109.481 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -80.52 -177.3 6.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 31' ' ' VAL . 5.0 t -87.47 137.64 32.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -123.81 19.52 9.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.084 -1.01 . . . . 0.0 109.798 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.6 t -67.74 145.08 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.557 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.15 -1.9 73.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.1 mt-30 -88.03 130.3 35.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -1.11 . . . . 0.0 109.813 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -73.06 112.34 9.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.77 158.28 1.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.847 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 135' ' ' SER . . . -71.59 166.38 21.97 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.67 HG21 ' SD ' ' A' ' 120' ' ' MET . 41.1 p -80.45 -29.15 37.54 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 99.08 136.85 9.53 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.6 p -54.67 -52.94 60.79 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.217 -1.167 . . . . 0.0 108.641 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.636 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 54.7 t -46.91 -52.53 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.46 -51.29 70.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.969 0.89 . . . . 0.0 109.861 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.771 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -64.21 -32.31 73.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.664 -178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.44 88.48 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.648 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 56' ' ' MET . 59.3 m -74.59 -53.63 9.01 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.701 0.762 . . . . 0.0 110.05 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.22 -38.43 52.41 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.702 -0.624 . . . . 0.0 109.837 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -63.91 -46.88 82.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.13 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 37.7 mt -67.87 -24.49 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.5 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 31.6 mtp -73.57 -32.26 64.06 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.588 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 26.0 tptt -75.82 -44.34 41.6 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.687 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 33.8 t80 -53.61 -27.78 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.75 -0.594 . . . . 0.0 110.023 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 35.0 m-70 -107.5 -26.09 11.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.288 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.635 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 90.2 m-20 44.54 59.2 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 3.0 t80 -84.88 -72.22 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 37.2 Cg_endo -69.77 105.76 1.54 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 CA-C-N 118.955 0.663 . . . . 0.0 111.952 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 8.0 m120 -72.14 -23.59 61.32 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -135.89 137.33 41.32 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.67 152.06 31.8 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.421 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 66' ' ' LEU . 2.6 mt -92.31 -42.01 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.406 -1.055 . . . . 0.0 109.961 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 11.7 ttpp -152.29 136.41 16.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.934 -1.104 . . . . 0.0 110.334 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OG ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -59.41 164.66 3.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.629 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 70' ' ' THR . 20.6 t80 -141.78 152.05 43.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 3.4 t -151.22 166.06 32.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.927 -1.108 . . . . 0.0 110.192 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.745 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.6 p90 -169.12 154.03 5.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.443 -0.786 . . . . 0.0 109.32 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.9 m -92.81 136.06 33.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.794 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -52.34 153.17 3.03 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.335 -0.853 . . . . 0.0 111.335 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -61.33 137.0 58.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.33 0.586 . . . . 0.0 110.016 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 p -64.58 -7.74 11.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.7 t-20 -99.66 -4.21 31.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.029 -1.045 . . . . 0.0 109.717 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.794 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.4 t-20 -69.9 109.97 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.774 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.6 15.55 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.83 2.353 . . . . 0.0 109.991 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 75.0 m-85 -105.71 -27.26 11.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' ASN . 19.2 m-85 -118.91 164.43 15.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.636 -1.29 . . . . 0.0 107.774 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 17.9 m-80 -47.39 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.64 -48.2 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 110.668 175.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.9 56.71 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 N-CA-C 106.958 -1.978 . . . . 0.0 106.958 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.46 104.1 13.76 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.13 -177.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.96 130.65 46.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.824 . . . . 0.0 109.441 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -102.47 137.73 40.33 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -124.96 129.08 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.375 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.18 114.12 27.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 50.03 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.665 -1.272 . . . . 0.0 108.569 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.8 mt -52.48 -51.49 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.325 -0.859 . . . . 0.0 109.085 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.92 -29.24 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.065 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.15 30.21 7.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 6.4 mmt-85 -85.5 150.44 24.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.505 ' HA ' ' NE2' ' A' ' 94' ' ' GLN . 1.9 mm100 -116.9 91.09 3.48 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.6 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 2.3 m-85 -81.08 91.31 6.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.472 -0.767 . . . . 0.0 111.134 -176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 100' ' ' ILE . 38.2 t-20 -79.76 87.14 5.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.635 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 63.2 m95 -61.23 -8.32 3.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.36 -17.73 26.79 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 8.5 m-20 -99.6 -27.72 13.55 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.612 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 58.0 mt -74.41 66.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 101' ' ' LEU . 24.3 mt -46.71 149.25 1.52 Allowed Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.854 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.7 Cg_endo -78.67 -23.97 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.74 2.293 . . . . 0.0 110.409 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.19 126.69 23.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 108.994 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 116' ' ' ILE . 54.8 m-85 -113.51 148.82 35.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.037 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' OE1' ' A' ' 108' ' ' GLU . 36.1 p -103.5 -9.83 19.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.56 -0.11 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -120.11 1.06 10.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -1.171 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' OE1' ' OG ' ' A' ' 105' ' ' SER . 0.1 OUTLIER -64.86 165.29 10.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.808 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.38 166.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -72.37 -34.45 67.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.36 -58.97 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.435 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -61.63 -36.28 80.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.171 -0.956 . . . . 0.0 108.897 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 21.4 mttt -65.71 -44.19 86.85 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.446 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.8 ttm -59.28 -35.72 74.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.09 -66.63 0.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.61 -0.681 . . . . 0.0 109.619 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.699 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.4 tp -65.74 -40.15 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.815 . . . . 0.0 109.552 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 11.2 p -57.21 -41.89 80.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.222 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.621 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 22.9 tt0 -69.72 -40.59 76.13 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 116' ' ' ILE . 10.3 tp -54.84 -52.32 63.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.771 ' CE ' HG23 ' A' ' 50' ' ' THR . 1.6 mmt -58.51 -44.84 89.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.46 -38.84 92.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.649 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 5.9 m-20 -69.22 -43.02 74.91 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 127' ' ' VAL . 55.3 t -71.21 -62.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.609 -0.682 . . . . 0.0 109.774 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 129' ' ' MET . . . -46.31 -45.77 16.15 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.8 mt -65.03 -57.62 10.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 108.664 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 5.2 p -46.32 -31.08 2.36 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.771 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.0 m -101.46 37.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 109.626 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 127' ' ' VAL . 4.8 m-20 39.36 42.14 0.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.482 -0.761 . . . . 0.0 109.782 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.648 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -55.59 128.23 33.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.405 -0.809 . . . . 0.0 111.446 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 21.6 t0 -77.71 126.07 30.31 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.658 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.0 m-85 -108.18 120.72 43.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.759 -1.177 . . . . 0.0 113.51 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.729 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.9 -164.0 11.71 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 103.834 -3.706 . . . . 0.0 103.834 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -61.38 -30.26 86.99 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 N-CA-C 105.445 -2.56 . . . . 0.0 105.445 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.54 46.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -115.71 112.83 22.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 119.853 -1.779 . . . . 0.0 109.851 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.29 133.72 11.81 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.549 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 16.0 t -118.27 -162.11 0.87 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -1.182 . . . . 0.0 108.761 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.836 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.21 -60.51 1.83 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.544 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 136.29 -133.71 6.74 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.888 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.565 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.8 m -48.11 -57.83 5.31 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.797 -0.825 . . . . 0.0 111.911 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 1.7 p -47.31 -36.72 9.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.752 -1.217 . . . . 0.0 109.015 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.836 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 25.8 mmt180 -79.84 -46.69 16.41 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.064 0.935 . . . . 0.0 108.797 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 185' ' ' TYR . 79.5 t -68.09 -56.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.275 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.53 -34.53 67.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 109.357 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' CG ' ' OE2' ' A' ' 149' ' ' GLU . 34.1 ttm-85 -77.36 -42.89 34.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.944 -1.098 . . . . 0.0 109.836 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.68 71.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.601 HD13 HG12 ' A' ' 251' ' ' ILE . 53.7 mt -60.85 -48.44 81.78 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.521 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.8 mtmt -86.55 -44.25 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.07 -1.019 . . . . 0.0 110.583 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.504 ' OE2' ' CG ' ' A' ' 145' ' ' ARG . 82.1 mt-10 -67.4 -47.93 68.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.879 -1.138 . . . . 0.0 111.498 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -94.37 -44.19 8.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 111.671 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.6 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 31.1 m-85 -101.6 16.6 25.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 110.618 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 148' ' ' LYS . . . 33.32 39.86 0.1 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 121.594 -0.691 . . . . 0.0 113.16 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.4 m-85 -62.04 159.81 13.72 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 120.529 2.165 . . . . 0.0 107.154 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 51.4 t-20 -47.06 143.8 2.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.737 -1.227 . . . . 0.0 109.372 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.64 -17.86 2.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.398 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.495 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 18.9 p -53.29 -17.08 1.55 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 109.876 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 251' ' ' ILE . 38.8 t -64.59 127.88 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.75 -1.219 . . . . 0.0 109.438 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.843 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.2 p-80 -147.37 149.58 33.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -100.69 139.92 35.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.921 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 16.4 pt -122.5 158.04 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.3 m-80 -116.88 103.65 10.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.183 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 8.2 tpt180 -47.46 -28.65 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.602 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.3 75.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -103.96 16.17 26.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.013 -1.287 . . . . 0.0 111.675 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -121.45 155.86 33.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.57 -1.331 . . . . 0.0 109.89 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -84.86 139.62 31.76 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 166' ' ' SER . 1.8 ttmm -36.79 -47.98 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.559 -0.713 . . . . 0.0 110.704 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.93 -56.74 13.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 110.356 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.54 -21.5 66.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 110.123 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.921 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 76.4 t-105 -76.66 -40.49 48.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.915 -1.116 . . . . 0.0 109.333 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.48 ' OE1' ' ND2' ' A' ' 206' ' ' ASN . 43.3 mt-10 -73.87 -48.38 31.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -48.27 -40.62 25.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 11.2 mm100 -61.14 -48.14 82.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.713 HG23 HG21 ' A' ' 184' ' ' VAL . 22.8 mt -73.21 -49.99 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.656 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 179' ' ' SER . 1.5 m-20 -52.57 -42.9 64.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.2 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -52.18 -46.26 65.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.722 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 65.6 mm-40 -56.19 -51.7 67.07 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.701 ' HB3' HG11 ' A' ' 4' ' ' VAL . 40.9 mt -68.69 -24.13 64.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 175' ' ' ASP . 32.1 p -52.58 -38.2 59.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.754 -1.217 . . . . 0.0 107.802 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 28.8 mt-30 -102.21 31.76 3.83 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.539 ' C ' HD13 ' A' ' 7' ' ' LEU . 17.6 m-80 48.2 51.22 15.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.375 -0.828 . . . . 0.0 109.148 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 27.2 mt-30 -124.08 116.09 27.41 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.9 Cg_endo -64.76 166.59 17.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.07 1.847 . . . . 0.0 112.497 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.713 HG21 HG23 ' A' ' 174' ' ' ILE . 77.0 t -125.55 140.73 47.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.102 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -86.02 120.17 27.12 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 4.2 t80 -123.63 161.41 25.09 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.061 -1.024 . . . . 0.0 109.5 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.7 pt20 -167.63 130.29 1.62 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 117.591 -1.644 . . . . 0.0 112.007 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -94.11 114.06 4.68 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' A' ' 244' ' ' TYR . 21.5 t -71.89 167.69 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.902 -1.351 . . . . 0.0 110.647 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -174.87 -141.18 3.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -37.53 16.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.171 -1.194 . . . . 0.0 111.026 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.1 m -80.75 1.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.94 -1.1 . . . . 0.0 111.153 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 118.86 -162.21 13.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -89.84 106.01 3.28 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.721 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.75 125.4 27.05 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.636 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -114.1 160.46 18.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.612 -1.235 . . . . 0.0 112.923 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.803 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.9 p90 -156.66 168.76 26.42 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 71.5 t -114.18 136.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.755 -1.216 . . . . 0.0 112.158 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 208' ' ' TYR . 39.5 mt -100.05 114.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.4 p30 -130.44 37.59 3.84 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.304 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -177.13 169.73 42.13 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.191 -1.957 . . . . 0.0 111.09 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -153.25 136.59 15.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -97.1 0.14 48.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 0.0 110.465 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 88.67 -26.94 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -100.18 51.08 0.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -1.136 . . . . 0.0 109.854 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.48 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 7.5 m120 60.9 20.79 11.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 3.2 m-85 -111.73 137.94 48.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.083 -1.011 . . . . 0.0 109.406 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.6 ' HB3' HG23 ' A' ' 199' ' ' ILE . 4.6 m-85 -122.87 164.3 18.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 110.097 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 56.9 t-80 -92.45 120.28 32.79 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.898 HG11 ' CZ3' ' A' ' 212' ' ' TRP . 26.7 t -114.73 145.08 20.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.112 -0.992 . . . . 0.0 111.802 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.509 ' HB2' HD12 ' A' ' 8' ' ' LEU . 16.4 t-20 -112.34 79.18 1.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.898 ' CZ3' HG11 ' A' ' 210' ' ' VAL . 32.9 m95 -46.74 164.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.903 -1.123 . . . . 0.0 109.572 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.493 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -86.1 23.19 9.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.516 ' NE1' ' O ' ' A' ' 230' ' ' SER . 47.8 m95 -112.7 -168.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.236 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.18 -100.15 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.55 50.59 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.802 HG22 ' N ' ' A' ' 218' ' ' SER . 1.5 p -79.55 -98.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -1.136 . . . . 0.0 109.614 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.802 ' N ' HG22 ' A' ' 217' ' ' VAL . 23.6 m -89.8 17.76 6.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.504 ' HA ' ' CD1' ' A' ' 212' ' ' TRP . 0.1 OUTLIER -53.23 125.6 18.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.364 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 162.32 -106.92 0.29 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -85.69 -173.74 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.167 . . . . 0.0 109.718 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -105.82 165.96 10.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.625 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 227' ' ' LEU . 0.2 OUTLIER -87.85 156.06 19.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.174 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.576 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -120.78 12.77 11.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 109.921 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.9 OUTLIER -116.47 -81.04 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.993 -1.067 . . . . 0.0 110.028 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.97 -93.89 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.965 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.515 ' O ' ' CD ' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -114.06 -160.21 0.72 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 -179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.599 ' HB3' ' CH2' ' A' ' 212' ' ' TRP . 0.8 OUTLIER -111.17 160.65 28.29 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.063 -1.023 . . . . 0.0 109.986 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 228' ' ' ASN . 36.3 Cg_endo -78.47 -28.05 4.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.784 2.323 . . . . 0.0 110.648 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.516 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 54.1 p -48.85 -21.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.01 -58.06 4.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -1.0 . . . . 0.0 109.486 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -156.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.66 9.83 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 9.45 14.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.324 -1.104 . . . . 0.0 109.705 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.74 32.85 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -99.16 88.44 0.83 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -133.48 169.39 22.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -134.49 16.86 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.204 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -123.52 133.27 8.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -154.83 32.29 0.67 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 171.13 8.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -1.13 . . . . 0.0 109.438 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 0.9 OUTLIER -109.53 79.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 244' ' ' TYR . . . -77.9 -48.72 7.55 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.73 ' HB2' HG21 ' A' ' 189' ' ' VAL . 13.1 m-85 -135.51 159.86 40.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.505 -0.997 . . . . 0.0 109.126 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.53 ' HG3' ' ND2' ' A' ' 242' ' ' ASN . 80.4 mt-30 -155.48 144.39 20.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.886 . . . . 0.0 108.726 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 79.8 p -161.71 161.67 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.513 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.64 144.79 35.93 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.47 0.652 . . . . 0.0 109.57 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.8 t -105.2 116.46 49.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.843 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.1 m -117.05 139.12 45.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.318 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 90.7 47.17 3.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.619 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 mt -94.5 98.25 7.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.16 149.34 10.05 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.625 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.283 1.989 . . . . 0.0 110.358 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.414 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 32.5 tt0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.57 155.72 31.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.357 2.038 . . . . 0.0 110.091 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.51 HG22 ' C ' ' A' ' 203' ' ' ASP . 40.7 t -87.23 142.41 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.79 HG11 ' HB3' ' A' ' 178' ' ' LEU . 86.8 t -134.17 132.06 55.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.542 -0.724 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 20.3 mmtp -76.4 -179.77 5.36 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 108.545 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 9' ' ' ASP . 27.6 t -77.82 105.65 9.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.988 -1.07 . . . . 0.0 109.652 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.707 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 34.3 mt -58.53 -50.44 73.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -0.86 . . . . 0.0 108.824 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.1 mt -54.6 -39.2 67.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 0.0 108.516 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 6.0 t0 -67.85 -42.21 81.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 109.801 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 44.0 p -58.04 -14.91 7.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.927 -1.108 . . . . 0.0 109.156 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -117.74 19.67 13.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.69 35.72 4.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 58' ' ' TYR . 42.8 mt -85.52 110.45 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.328 -1.101 . . . . 0.0 110.287 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.6 m-70 -134.01 81.9 1.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.621 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -92.18 170.54 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.229 1.014 . . . . 0.0 111.475 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -147.98 -167.65 2.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.515 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 16.6 mt-30 -125.45 -2.81 7.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.798 -1.189 . . . . 0.0 110.471 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.665 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.37 -54.81 0.33 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.465 -1.35 . . . . 0.0 112.31 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.775 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -129.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.579 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.938 -176.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -77.38 6.25 4.53 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 123.435 2.263 . . . . 0.0 109.062 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.762 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 85.8 m-85 -77.19 -35.92 55.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.85 -0.531 . . . . 0.0 110.077 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 47.2 p30 -98.85 20.33 13.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.773 -1.205 . . . . 0.0 109.043 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.9 mt -71.43 -6.11 37.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 111.079 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.56 HD12 ' OG ' ' A' ' 117' ' ' SER . 7.6 mt -131.91 0.59 3.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.687 -1.258 . . . . 0.0 109.789 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -67.31 167.04 16.54 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 21.0 Cg_endo -70.58 142.85 45.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.747 1.632 . . . . 0.0 111.509 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.24 150.08 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.592 0.711 . . . . 0.0 110.37 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.754 HD11 ' C ' ' A' ' 132' ' ' GLY . 34.1 mt -77.64 147.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.552 0.692 . . . . 0.0 110.165 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.9 mm-40 -124.49 -22.7 4.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.212 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 79' ' ' TYR . 3.8 mtpt -122.68 168.76 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.371 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 39' ' ' VAL . 42.5 t -114.33 151.16 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.78 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 18.7 tttt -86.45 127.75 59.7 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.76 122.11 8.55 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.338 1.359 . . . . 0.0 109.765 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.22 26.27 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.47 177.34 9.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.588 -0.948 . . . . 0.0 108.807 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -76.58 176.24 8.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.07 . . . . 0.0 109.788 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.06 128.94 34.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 109.741 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 78.4 m-85 -123.72 27.34 7.36 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.036 -1.04 . . . . 0.0 109.344 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 HG23 ' A' ' 31' ' ' VAL . 49.2 t -73.58 142.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.484 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.46 -2.38 72.45 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 2.2 mt-30 -82.58 133.98 35.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.317 -1.108 . . . . 0.0 109.827 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -73.23 109.07 6.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.49 159.08 1.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.215 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -79.12 165.55 23.21 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.726 0.775 . . . . 0.0 109.857 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.978 HG21 ' SD ' ' A' ' 120' ' ' MET . 5.8 p -81.06 -34.14 32.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 108.588 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.96 137.11 8.16 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.512 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.0 p -55.29 -48.98 73.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 37.7 t -47.02 -53.72 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.28 -50.87 72.33 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.64 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.515 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 86.6 m -64.19 -31.48 72.7 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.852 -0.53 . . . . 0.0 109.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.13 -43.09 83.27 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.055 -1.458 . . . . 0.0 107.292 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.65 -39.19 57.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 109.785 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.9 mt-30 -60.05 -51.15 70.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.695 -1.253 . . . . 0.0 107.647 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.695 HD11 HG22 ' A' ' 198' ' ' VAL . 35.0 mt -63.41 -24.21 35.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 21.9 mtp -73.0 -38.46 66.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 44.7 tptt -69.17 -40.58 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.707 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 50.2 t80 -53.53 -30.5 41.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.058 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.0 m-70 -107.86 -23.08 12.2 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.214 -0.929 . . . . 0.0 110.763 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 97' ' ' TRP . 54.4 m-20 44.44 54.8 6.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -76.79 -75.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 119.443 -0.903 . . . . 0.0 113.406 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 34.0 Cg_endo -67.09 104.19 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 120.3 0.667 . . . . 0.0 112.107 -176.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.4 -20.32 62.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 0.4 OUTLIER -133.96 143.68 48.32 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.8 34.96 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.226 -1.464 . . . . 0.0 109.847 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.943 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -90.14 -64.88 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.379 -1.071 . . . . 0.0 109.645 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 5.9 tttt -131.9 148.82 52.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 m-20 -73.9 179.58 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 70' ' ' THR . 14.2 t80 -153.9 151.32 29.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -0.78 . . . . 0.0 109.307 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 t -155.03 152.42 29.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.096 -1.002 . . . . 0.0 109.656 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.701 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 21.3 p90 -161.66 155.01 21.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 109.61 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 97.0 m -93.33 139.37 30.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.789 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -56.55 147.78 21.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 111.221 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -61.95 143.79 55.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.35 0.595 . . . . 0.0 109.749 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -70.13 -2.14 12.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.98 -1.075 . . . . 0.0 109.834 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.526 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.0 m120 -97.47 -8.94 28.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.789 ' ND2' HD21 ' A' ' 73' ' ' LEU . 29.8 t-20 -70.44 109.51 5.11 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.747 -0.596 . . . . 0.0 109.88 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -89.16 15.82 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.959 2.439 . . . . 0.0 110.193 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.676 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.7 m-85 -105.92 -25.86 11.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.718 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' C ' ' A' ' 81' ' ' ASN . 8.7 m-85 -119.21 163.0 17.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.5 m-80 -46.58 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.06 -47.81 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 111.041 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.17 56.63 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 N-CA-C 107.24 -1.869 . . . . 0.0 107.24 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.92 106.73 17.37 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.408 -178.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.77 134.29 43.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.91 125.03 51.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.51 124.93 46.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.147 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.21 108.47 19.91 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.9 54.19 0.36 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.799 -1.188 . . . . 0.0 108.428 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 46.6 mt -52.43 -45.75 46.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 O-C-N 121.405 -0.809 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 p -45.42 -26.46 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.799 -1.188 . . . . 0.0 109.286 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.2 26.75 10.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.811 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -84.45 154.13 22.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.111 -0.993 . . . . 0.0 110.375 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.27 95.03 4.79 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 7.0 m-85 -81.82 88.96 6.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 110.857 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 11.7 t30 -79.94 91.13 5.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CE2' ' HA ' ' A' ' 60' ' ' ASN . 61.7 m95 -61.29 -6.25 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.423 -0.798 . . . . 0.0 110.805 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -90.33 -18.86 24.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.779 -1.201 . . . . 0.0 107.876 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 10.3 m-20 -99.59 -29.11 12.88 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.694 HG12 ' HB1' ' A' ' 115' ' ' ALA . 31.0 mt -73.83 63.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.522 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 61.0 mt -46.27 148.64 1.51 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.555 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.5 Cg_endo -77.75 -29.07 4.73 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.598 2.199 . . . . 0.0 110.455 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -134.68 124.5 25.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.122 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.0 m-85 -109.42 138.92 45.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.6 p -100.09 1.65 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.361 -0.837 . . . . 0.0 109.274 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.79 89.89 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -120.13 9.66 11.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.196 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -74.73 -178.95 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -76.38 174.98 9.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 1.2 m120 -78.48 -36.76 44.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.658 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.9 t -53.47 -59.42 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.903 . . . . 0.0 109.801 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.85 -33.15 73.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 108.94 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.533 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 32.1 mttt -67.81 -44.22 77.8 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -33.18 70.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.694 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.09 -67.84 0.28 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.71 -0.619 . . . . 0.0 109.579 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.9 tp -61.96 -41.34 90.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.193 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.56 ' OG ' HD12 ' A' ' 24' ' ' LEU . 4.5 p -57.15 -40.02 76.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.207 -0.933 . . . . 0.0 109.164 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.811 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 31.3 tt0 -69.99 -43.26 71.8 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.8 tp -57.41 -48.41 79.16 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.978 ' SD ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -56.61 -47.6 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.476 178.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.71 -39.22 93.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 126' ' ' SER . 13.0 m-20 -65.3 -53.87 37.55 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 127' ' ' VAL . 89.1 t -65.31 -54.99 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.296 -0.878 . . . . 0.0 109.454 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -47.22 -53.07 11.9 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.1 mt -65.99 -53.16 40.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -1.093 . . . . 0.0 108.516 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 123' ' ' VAL . 60.3 p -45.53 -33.53 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.067 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 123' ' ' VAL . 35.7 m -100.86 38.69 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.713 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' VAL . 22.4 m-20 37.15 52.04 1.1 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.517 -0.74 . . . . 0.0 109.624 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.66 ' HE3' ' O ' ' A' ' 45' ' ' THR . 44.2 tpp -66.63 130.55 43.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.57 -0.707 . . . . 0.0 111.774 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' SER . 8.0 t70 -76.92 122.01 24.26 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.652 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.59 120.31 40.63 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.479 1.133 . . . . 0.0 113.029 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.754 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -152.09 -163.21 11.37 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 104.485 -3.446 . . . . 0.0 104.485 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.623 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.6 Cg_endo -62.26 -31.54 82.16 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 N-CA-C 105.551 -2.519 . . . . 0.0 105.551 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.2 m -109.36 142.21 40.62 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.509 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 30.7 m -124.64 109.8 13.61 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 119.961 -1.712 . . . . 0.0 110.104 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.3 137.41 14.08 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 3.5 t -117.35 -162.22 0.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.879 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.69 -50.65 5.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 143' ' ' VAL . . . 121.37 -126.24 6.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.488 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 159' ' ' GLN . 10.4 m -47.08 -60.55 2.39 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.712 -0.875 . . . . 0.0 112.279 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 79.4 p -47.18 -41.45 18.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 0.0 109.253 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.879 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.5 mmp_? -79.9 -41.14 26.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.432 1.111 . . . . 0.0 109.142 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.792 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.1 t -67.71 -60.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.16 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.9 pp0? -56.2 -34.78 66.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.755 -1.216 . . . . 0.0 108.651 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.569 ' HE ' ' NH2' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -70.66 -44.8 66.31 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.315 -0.866 . . . . 0.0 109.329 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.76 -36.91 81.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.182 -0.949 . . . . 0.0 110.662 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.831 HD13 HG12 ' A' ' 251' ' ' ILE . 76.6 mt -55.67 -54.73 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 109.921 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 11.1 mtmt -81.07 -33.87 33.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 111.597 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 84.9 mt-10 -74.09 -66.97 0.65 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.48 -1.388 . . . . 0.0 112.628 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.556 ' HB3' HD13 ' A' ' 90' ' ' ILE . 26.3 m120 -81.63 -31.78 32.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.923 -1.111 . . . . 0.0 111.727 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 22.4 m-85 -102.57 -8.17 21.22 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.64 -1.287 . . . . 0.0 110.382 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.943 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 53.74 38.45 59.29 Favored Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.137 -0.977 . . . . 0.0 112.212 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.24 162.8 9.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.3 -1.706 . . . . 0.0 107.677 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 35.8 t-20 -47.11 143.87 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.753 -1.217 . . . . 0.0 109.586 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 155' ' ' GLN . 11.3 mm-40 -53.58 -19.97 4.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.492 -0.755 . . . . 0.0 109.009 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 154' ' ' ASN . 3.7 p -53.99 -16.63 2.01 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 0.0 109.812 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.559 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 41.0 t -61.34 127.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.911 -1.118 . . . . 0.0 109.552 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.898 ' CE1' HG23 ' A' ' 249' ' ' VAL . 18.7 p-80 -149.08 158.76 44.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.375 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 140' ' ' SER . 3.8 tt0 -102.78 149.22 24.69 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.894 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 14.8 pt -127.87 146.79 32.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.8 m-80 -112.36 102.98 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.131 . . . . 0.0 111.125 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.669 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -48.21 -28.41 3.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.371 -0.83 . . . . 0.0 109.049 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.542 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.54 -27.69 73.31 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -103.85 4.72 35.24 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.1 -1.235 . . . . 0.0 111.6 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.08 171.04 8.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.404 -1.435 . . . . 0.0 110.429 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 167' ' ' LYS . 84.1 p -103.94 134.56 47.02 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 166' ' ' SER . 54.7 tttt -30.57 -45.08 0.06 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.923 -0.485 . . . . 0.0 111.077 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -63.3 -66.04 0.6 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.805 -1.185 . . . . 0.0 109.851 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -16.01 58.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 109.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.894 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 45.8 t-105 -72.18 -49.34 36.39 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.153 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 174' ' ' ILE . 18.8 mt-10 -67.6 -33.7 75.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -46.7 -48.01 20.32 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.629 HE21 HG21 ' A' ' 249' ' ' VAL . 22.0 mm100 -61.01 -38.47 86.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.765 HG21 HD13 ' A' ' 199' ' ' ILE . 53.3 mt -75.92 -63.86 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 110.425 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -49.28 -53.89 19.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -51.92 -40.2 60.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 108.112 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.557 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.0 mm-40 -61.11 -50.26 73.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.874 HD21 HG22 ' A' ' 199' ' ' ILE . 13.2 mt -68.61 -25.78 65.03 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.484 -0.76 . . . . 0.0 109.7 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 37.0 p -51.85 -38.0 54.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 108.26 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 23.4 mt-30 -101.09 33.87 2.71 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.489 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.0 m-80 45.97 50.66 11.31 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 15.0 mt-30 -124.07 107.14 30.7 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.451 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.7 Cg_endo -64.19 170.06 9.79 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.145 1.897 . . . . 0.0 112.667 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 51.6 t -123.67 135.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.614 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.792 ' CE2' HG21 ' A' ' 143' ' ' VAL . 1.2 t80 -83.42 117.95 23.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.624 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 4.1 t80 -123.19 153.41 40.12 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 120.845 -1.16 . . . . 0.0 109.705 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.9 pt20 -164.81 135.5 4.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.328 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.92 114.98 4.66 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 107.239 -2.345 . . . . 0.0 107.239 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 41.5 t -80.96 145.16 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.255 . . . . 0.0 111.349 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.573 ' HA3' ' CD1' ' A' ' 241' ' ' PHE . . . -145.9 -145.75 4.3 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -87.95 -29.77 20.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -1.162 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.2 m -82.9 -13.07 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.8 -166.13 25.18 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -97.91 110.89 4.12 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 119.038 -1.553 . . . . 0.0 110.735 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 16.6 t-80 -71.33 117.37 12.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -107.99 160.92 15.41 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.373 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.721 ' CD1' HG13 ' A' ' 210' ' ' VAL . 46.7 p90 -159.09 166.5 31.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.695 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -114.11 136.11 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.696 -1.253 . . . . 0.0 112.036 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.874 HG22 HD21 ' A' ' 178' ' ' LEU . 7.4 mt -98.71 125.79 52.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.596 ' OD2' ' CD2' ' A' ' 209' ' ' HIS . 1.5 p30 -139.92 32.33 1.99 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.716 -1.594 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -167.03 173.45 42.29 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 117.862 -2.113 . . . . 0.0 111.719 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.498 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -160.92 149.28 16.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.51 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -122.46 31.66 6.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.711 -1.243 . . . . 0.0 110.45 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 203' ' ' ASP . . . 44.33 25.38 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 2.2 mtt180 -142.26 21.79 2.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.227 -1.16 . . . . 0.0 108.95 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.9 OUTLIER 77.88 23.51 0.77 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.221 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 203' ' ' ASP . 29.7 m-85 -122.72 128.45 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.928 . . . . 0.0 109.356 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 4.3 m-85 -122.94 171.6 9.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.299 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.596 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.4 t60 -93.64 136.39 33.96 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.721 HG13 ' CD1' ' A' ' 197' ' ' PHE . 51.2 t -128.62 137.32 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.052 -1.03 . . . . 0.0 110.414 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.5 t-20 -111.85 73.13 0.8 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.523 ' HA ' ' CB ' ' A' ' 197' ' ' PHE . 82.3 m95 -46.93 173.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.459 -0.776 . . . . 0.0 110.179 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -88.16 21.22 25.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.47 -165.46 1.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -1.128 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -73.92 -98.74 0.09 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.27 45.68 1.12 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.774 HG22 ' N ' ' A' ' 218' ' ' SER . 2.3 p -76.09 -103.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -1.168 . . . . 0.0 109.917 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.774 ' N ' HG22 ' A' ' 217' ' ' VAL . 1.0 OUTLIER -85.39 34.18 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.924 -1.11 . . . . 0.0 110.236 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.75 92.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.955 -1.091 . . . . 0.0 109.327 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 208' ' ' TYR . . . 161.16 -97.24 0.15 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.493 ' HB3' ' NH2' ' A' ' 223' ' ' ARG . 30.5 m-85 -60.01 126.01 25.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.35 -1.088 . . . . 0.0 109.992 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.581 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -85.7 171.53 11.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.493 ' NH2' ' HB3' ' A' ' 221' ' ' PHE . 3.1 mmp_? -110.58 155.22 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.068 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -109.63 -48.79 3.18 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.128 -0.982 . . . . 0.0 110.001 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.68 1.34 17.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.124 -0.985 . . . . 0.0 109.455 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.23 86.13 2.53 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.326 1.06 . . . . 0.0 108.735 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.84 45.82 1.24 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.757 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.59 157.53 34.87 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.65 149.57 26.91 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.537 2.158 . . . . 0.0 110.298 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.495 ' HB3' HG21 ' A' ' 217' ' ' VAL . 23.7 m -64.68 -59.0 4.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.64 135.04 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.462 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.661 HD13 ' HA2' ' A' ' 239' ' ' GLY . 10.9 mt -93.75 24.74 3.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.422 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 62.33 154.8 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -34.63 10.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.497 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -90.83 -56.64 1.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.65 12.1 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 144.75 94.98 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 241' ' ' PHE . . . -59.05 -62.54 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.568 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.661 ' HA2' HD13 ' A' ' 232' ' ' LEU . . . 164.0 -126.67 1.55 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -95.87 94.27 1.66 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -117.38 70.21 0.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.446 ' ND2' ' C ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -73.06 72.81 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.0 109.695 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.43 -38.48 21.21 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.511 ' CB ' ' HB ' ' A' ' 189' ' ' VAL . 1.9 m-85 -135.84 156.55 48.62 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.542 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 1.4 pt20 -156.5 142.94 18.39 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.8 -1.187 . . . . 0.0 109.321 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 15.1 p -166.1 163.21 18.11 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -142.08 167.15 22.81 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.942 0.877 . . . . 0.0 109.925 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 147' ' ' LEU . 15.5 t -118.0 120.77 65.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.898 HG23 ' CE1' ' A' ' 158' ' ' HIS . 33.4 m -120.69 149.75 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.95 -1.094 . . . . 0.0 111.282 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 86.03 46.92 5.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.831 HG12 HD13 ' A' ' 147' ' ' LEU . 4.1 mt -93.57 93.98 4.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.406 -1.055 . . . . 0.0 109.761 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.1 OUTLIER -163.07 148.67 9.71 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.44 -0.788 . . . . 0.0 108.946 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.626 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.389 2.06 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.499 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 38.4 tt0 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 36.1 Cg_endo -78.54 164.66 25.88 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.339 2.026 . . . . 0.0 109.712 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.8 t -101.69 141.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.011 -1.055 . . . . 0.0 109.597 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.8 t -137.71 131.42 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.399 -0.813 . . . . 0.0 109.123 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 201' ' ' GLY . 10.1 mmtt -76.14 -166.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 108.908 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.566 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 2.7 t -87.89 106.11 17.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.873 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.694 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 46.6 mt -58.49 -50.11 74.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 108.906 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.4 mt -55.93 -38.02 69.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.66 -1.275 . . . . 0.0 108.858 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.507 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 43.9 m-20 -67.25 -43.48 81.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.427 -0.796 . . . . 0.0 109.774 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 7' ' ' LEU . 3.7 p -58.24 -14.44 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.048 . . . . 0.0 109.317 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.5 mtpm? -117.15 17.9 14.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.793 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.26 41.44 6.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.2 mt -91.11 108.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-O 122.247 1.022 . . . . 0.0 110.526 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 13' ' ' ILE . 8.5 m-70 -134.83 81.25 1.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.6 m-30 -87.11 179.99 6.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 111.152 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.74 -162.61 1.58 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 45' ' ' THR . 17.5 mt-30 -125.36 -21.93 4.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.721 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.06 -33.87 1.59 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.604 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.828 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.6 -139.68 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.512 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.064 -178.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -74.24 2.99 5.58 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 CA-C-N 122.554 1.948 . . . . 0.0 109.269 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.7 m-85 -77.91 -31.59 51.25 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.404 -0.81 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.478 ' HA ' HG23 ' A' ' 25' ' ' THR . 23.8 p-10 -93.88 14.35 19.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.632 -1.293 . . . . 0.0 109.746 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.2 mt -70.4 -7.83 46.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.738 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 118' ' ' GLU . 11.3 mt -123.74 -9.35 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.092 -1.005 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.0 p -60.85 165.31 6.1 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.2 Cg_endo -70.48 143.02 46.2 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.357 2.038 . . . . 0.0 112.184 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.23 148.12 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.559 0.695 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.9 mt -78.51 148.05 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 111.173 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.9 mt-10 -126.4 -21.5 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.732 -0.605 . . . . 0.0 110.659 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 9.0 mtpm? -118.82 168.39 10.8 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.859 -1.15 . . . . 0.0 110.284 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 37' ' ' SER . 74.9 t -114.84 145.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.557 -0.715 . . . . 0.0 110.69 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.602 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -77.58 158.34 78.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.1 Cg_endo -82.3 113.16 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.369 2.046 . . . . 0.0 110.494 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.48 62.83 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.38 159.61 23.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -1.185 . . . . 0.0 109.544 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.09 165.6 4.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 109.361 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 31' ' ' VAL . 3.0 t -74.91 138.84 42.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.189 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.616 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 82.5 m-85 -123.61 14.71 9.47 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.899 -1.126 . . . . 0.0 109.791 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG13 ' HA ' ' A' ' 29' ' ' GLU . 61.0 t -62.99 141.89 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.189 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.95 1.38 87.39 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.8 mt-30 -91.97 132.14 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -1.096 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -73.2 111.89 8.74 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.21 160.61 0.75 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 109.003 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.76 166.93 22.34 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.616 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.697 HG21 ' SD ' ' A' ' 120' ' ' MET . 29.5 p -79.67 -35.56 39.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.6 139.02 9.53 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 51' ' ' ALA . 5.6 p -55.17 -49.75 71.08 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 3.9 t -47.02 -52.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.77 -47.38 78.39 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.847 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 96.1 m -62.6 -30.2 71.17 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.97 -47.22 69.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.968 -1.083 . . . . 0.0 108.822 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 56' ' ' MET . 30.8 m -75.6 -49.82 17.39 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.409 0.623 . . . . 0.0 110.277 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.6 -34.55 37.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 109.078 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.609 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 31.3 mt-30 -67.71 -48.93 65.11 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.74 HD11 HG22 ' A' ' 198' ' ' VAL . 36.0 mt -66.79 -28.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 52' ' ' THR . 19.3 mtp -67.13 -39.58 86.62 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -71.89 -39.48 69.56 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.694 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 56.9 t80 -53.44 -34.43 57.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.493 -0.754 . . . . 0.0 109.346 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 83.8 m-70 -107.75 -20.45 13.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.36 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.641 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.55 54.63 1.89 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -74.64 -70.7 0.23 Allowed Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.0 Cg_endo -69.67 103.81 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 122.269 0.615 . . . . 0.0 111.806 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' TYR . 7.6 m120 -70.09 -21.57 63.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -134.78 140.13 45.65 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.86 148.84 34.9 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.664 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.883 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -89.01 -44.3 10.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.62 -0.929 . . . . 0.0 110.387 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.4 tttt -151.61 137.86 18.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 164.94 7.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.0 110.219 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 26.1 t80 -148.94 141.35 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.264 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t -146.99 161.12 41.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.932 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.6 p90 -158.73 155.99 29.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.656 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.494 HG23 ' OD1' ' A' ' 85' ' ' ASN . 27.4 m -93.19 129.82 39.08 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.826 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -47.67 150.58 0.99 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 111.28 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 t -62.15 140.67 58.42 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -3.82 11.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 0.0 109.868 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 52.6 t30 -99.28 -7.75 25.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.826 ' ND2' HD21 ' A' ' 73' ' ' LEU . 39.6 t-20 -70.37 111.58 9.9 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 109.971 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.621 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.3 Cg_endo -88.54 13.11 2.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.982 2.454 . . . . 0.0 110.094 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.4 m-85 -104.94 -5.0 21.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 111.139 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 5.5 m-85 -142.22 162.0 36.58 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.564 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 4.8 m120 -46.67 -79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 174.79 -46.8 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 111.047 175.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.8 Cg_endo -76.88 57.34 5.67 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 N-CA-C 107.012 -1.957 . . . . 0.0 107.012 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.51 101.59 11.11 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.294 -178.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.494 ' OD1' HG23 ' A' ' 72' ' ' THR . 37.3 m-80 -100.11 128.87 46.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.491 -0.756 . . . . 0.0 109.466 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.2 mp -100.75 134.5 43.63 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.77 129.63 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.81 111.37 23.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 51.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 108.304 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.4 mt -52.77 -54.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 121.384 -0.822 . . . . 0.0 110.027 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.1 p -44.59 -27.61 0.49 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.242 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -111.97 34.36 4.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -0.83 . . . . 0.0 109.177 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.748 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.05 90.31 3.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 2.4 m-85 -81.31 88.08 6.1 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 47.3 t-20 -79.4 87.79 5.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.641 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.0 m95 -60.98 -7.04 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -89.43 -18.76 26.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 7.9 m-20 -100.08 -26.48 13.94 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.609 HG12 ' HB1' ' A' ' 115' ' ' ALA . 51.9 mt -76.53 67.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 108.903 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 112' ' ' GLN . 18.9 mt -46.84 149.42 1.53 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.775 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.7 Cg_endo -78.99 -18.11 11.63 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.903 2.402 . . . . 0.0 110.725 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 133.3 25.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.995 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.625 ' CE2' HG21 ' A' ' 116' ' ' ILE . 62.1 m-85 -121.49 136.75 54.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.258 -0.901 . . . . 0.0 109.845 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -99.94 0.91 42.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 113' ' ' LYS . . . 81.15 -1.76 83.81 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.631 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -110.46 -6.88 14.83 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.423 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.631 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 3.0 mp0 -63.86 164.66 9.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.898 . . . . 0.0 109.755 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -62.1 172.74 1.31 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 17.3 m-20 -77.03 -31.26 56.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.623 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.2 -60.17 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 5.2 mp0 -62.76 -35.04 78.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.785 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.546 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 33.6 mttt -65.27 -42.34 93.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.463 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 12.2 ttm -59.15 -37.81 78.2 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.609 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.33 -68.1 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.672 -0.643 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.733 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.1 tp -62.37 -37.48 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.633 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.2 p -57.18 -40.44 77.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.921 -1.112 . . . . 0.0 109.95 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.748 ' HG2' ' HE ' ' A' ' 93' ' ' ARG . 35.3 tt0 -69.4 -41.57 76.26 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.733 HD23 ' CD1' ' A' ' 116' ' ' ILE . 9.3 tp -54.65 -52.69 61.52 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.697 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -58.68 -43.93 90.1 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.5 -0.75 . . . . 0.0 109.292 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.09 -36.69 84.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 93' ' ' ARG . 27.8 m-20 -69.6 -54.61 13.2 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 127' ' ' VAL . 48.4 t -63.38 -57.78 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.19 -49.84 13.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.0 mt -63.9 -58.8 5.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 108.276 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.25 -29.23 1.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.517 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 20.9 m -101.42 36.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.895 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 127' ' ' VAL . 3.3 m-20 37.81 51.93 1.39 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.466 -0.771 . . . . 0.0 109.407 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.7 tpp -66.04 126.92 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.53 -0.731 . . . . 0.0 111.741 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -75.77 120.66 21.44 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 57.3 m-85 -102.83 115.67 31.05 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.279 1.038 . . . . 0.0 112.719 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.744 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.92 -162.88 10.95 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 104.869 -3.292 . . . . 0.0 104.869 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 18.0 Cg_endo -62.39 -30.56 80.72 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 N-CA-C 105.802 -2.422 . . . . 0.0 105.802 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.99 140.76 43.65 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 32.7 m -124.26 109.66 13.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.843 -1.786 . . . . 0.0 110.286 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -108.88 144.72 16.42 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.648 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.54 -163.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -1.219 . . . . 0.0 107.765 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.75 -53.97 4.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 134.18 -139.02 10.51 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 119.145 -1.502 . . . . 0.0 111.981 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB2' ' CD ' ' A' ' 159' ' ' GLN . 0.7 OUTLIER -48.06 -54.37 13.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 122.139 -0.624 . . . . 0.0 112.237 -177.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 4.1 p -46.53 -41.25 13.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.926 -1.109 . . . . 0.0 109.7 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.708 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 2.3 mmt180 -81.15 -42.63 20.58 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 109.585 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.855 HG21 ' CE2' ' A' ' 185' ' ' TYR . 44.3 t -68.14 -52.79 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 110.463 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.44 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 1.8 pp0? -56.9 -34.36 67.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.554 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 2.4 ttm180 -77.35 -51.8 10.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 109.197 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.75 75.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.799 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.587 ' HB2' HG11 ' A' ' 157' ' ' VAL . 46.0 mt -56.92 -50.57 72.17 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.099 -1.0 . . . . 0.0 109.652 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 4.5 mtmp? -87.65 -41.12 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.017 -1.052 . . . . 0.0 110.589 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 85.1 mt-10 -68.08 -49.1 63.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.919 -1.113 . . . . 0.0 111.727 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 26.3 m120 -93.94 -43.19 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.907 -1.121 . . . . 0.0 111.652 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 152' ' ' GLY . 33.5 m-85 -102.27 15.49 28.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.658 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.883 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 35.08 40.22 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.626 -0.671 . . . . 0.0 112.581 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.2 m-85 -62.53 164.06 8.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.062 -1.846 . . . . 0.0 107.853 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.5 t-20 -47.37 145.1 2.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.822 -1.174 . . . . 0.0 109.617 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -53.43 -19.96 4.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.909 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.537 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 7.8 p -55.72 -14.5 2.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.331 -0.856 . . . . 0.0 109.739 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -66.4 119.85 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.938 -1.101 . . . . 0.0 109.65 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.719 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.6 p-80 -148.55 163.17 38.02 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.495 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 2.0 tt0 -104.07 146.36 28.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.617 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 4.3 pt -121.93 155.17 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.2 m-80 -123.29 105.73 10.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.814 -1.179 . . . . 0.0 111.041 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 44.4 tpt85 -48.14 -38.9 19.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 109.012 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.54 -25.83 63.69 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.03 -1.03 28.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.064 -1.256 . . . . 0.0 111.273 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.04 173.92 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.785 -1.197 . . . . 0.0 110.027 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 167' ' ' LYS . 83.8 p -98.53 138.71 35.34 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 166' ' ' SER . 35.5 tttt -35.22 -48.43 0.45 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.766 -0.584 . . . . 0.0 110.361 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.404 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 7.5 mp0 -65.4 -59.23 4.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.049 -1.032 . . . . 0.0 109.854 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.52 -15.59 58.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.988 . . . . 0.0 109.355 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 61.0 t-105 -73.66 -47.78 37.26 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.664 ' HA ' HD12 ' A' ' 174' ' ' ILE . 29.2 mt-10 -70.76 -30.98 67.63 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.24 65.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.633 HE21 HG21 ' A' ' 160' ' ' ILE . 15.8 mm100 -61.26 -41.19 96.49 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.001 HG23 HG21 ' A' ' 184' ' ' VAL . 22.3 mt -74.03 -51.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.553 -0.717 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -55.97 -41.98 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 108.626 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -51.97 -43.29 63.5 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.582 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 51.9 mm-40 -59.72 -51.94 67.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.94 -25.61 64.65 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.828 . . . . 0.0 110.044 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.484 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.5 p -52.05 -38.12 55.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 25.0 mt-30 -101.55 29.52 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.528 ' C ' HD13 ' A' ' 7' ' ' LEU . 8.1 m-20 51.15 49.18 21.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.72 0.771 . . . . 0.0 109.165 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 27.8 mt-30 -124.34 117.08 26.77 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.8 Cg_endo -65.67 171.4 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.21 1.94 . . . . 0.0 112.328 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 174' ' ' ILE . 23.4 t -125.98 115.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.367 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.855 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.5 OUTLIER -66.27 113.27 4.46 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 10.9 t80 -123.77 157.39 34.13 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 120.891 -1.13 . . . . 0.0 109.658 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 3.1 pt20 -158.93 129.84 6.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 117.927 -1.509 . . . . 0.0 111.804 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.17 109.71 3.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 190' ' ' GLY . 3.6 t -66.8 166.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -1.179 . . . . 0.0 111.099 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.594 ' N ' ' CG1' ' A' ' 189' ' ' VAL . . . -175.21 -136.78 2.35 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 10.5 mtpt -87.81 -55.85 3.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.092 -1.24 . . . . 0.0 111.357 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.571 ' CG2' ' HB2' ' A' ' 238' ' ' ALA . 4.1 m -61.15 -8.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.057 -1.027 . . . . 0.0 111.47 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.45 21.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -91.25 107.57 3.5 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.861 ' HB2' ' HB3' ' A' ' 238' ' ' ALA . 10.0 t-80 -71.66 126.19 29.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.92 159.07 24.47 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.533 1.159 . . . . 0.0 112.723 -177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.693 ' CD1' HG13 ' A' ' 210' ' ' VAL . 43.2 p90 -153.58 -161.05 1.19 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' ILE . 85.9 t -139.34 133.27 38.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 120.362 -1.461 . . . . 0.0 111.377 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.785 HD11 HD11 ' A' ' 224' ' ' LEU . 82.8 mt -99.14 120.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 3.1 p30 -133.24 33.47 3.61 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.439 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.23 163.92 35.62 Favored Glycine 0 N--CA 1.487 2.037 0 C-N-CA 117.706 -2.188 . . . . 0.0 112.317 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.533 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.28 140.9 29.47 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -111.31 11.18 21.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.103 . . . . 0.0 110.567 -178.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.64 4.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -80.57 53.54 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 109.884 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.476 ' ND2' ' OE1' ' A' ' 171' ' ' GLU . 2.0 m120 53.09 38.54 27.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.783 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.675 ' HE1' ' HE ' ' A' ' 223' ' ' ARG . 1.2 m-85 -121.92 133.92 54.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 12.9 m-85 -122.91 159.77 27.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.248 -0.907 . . . . 0.0 110.07 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 39.4 t-80 -93.22 117.78 30.48 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 197' ' ' PHE . 29.1 t -114.55 138.64 43.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 111.447 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 8' ' ' LEU . 19.4 t-20 -104.62 80.56 1.68 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.412 ' CH2' ' CD1' ' A' ' 227' ' ' LEU . 23.0 m95 -46.19 166.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -85.83 36.96 3.1 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.574 ' HB2' HG12 ' A' ' 217' ' ' VAL . 32.7 m95 -116.09 -170.41 1.79 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -1.169 . . . . 0.0 109.227 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.98 -55.36 0.65 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.75 30.32 3.26 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 218' ' ' SER . 2.6 p -83.04 -155.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -1.149 . . . . 0.0 109.163 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.719 ' H ' HG22 ' A' ' 217' ' ' VAL . 9.8 m -68.41 52.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.848 -1.158 . . . . 0.0 111.063 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 217' ' ' VAL . 3.7 m-20 -85.14 121.1 27.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.817 -1.177 . . . . 0.0 109.195 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 172.46 -113.55 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.12 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 221' ' ' PHE . 10.6 p90 -114.95 122.3 45.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -1.128 . . . . 0.0 109.848 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -135.35 177.28 7.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.675 ' HE ' ' HE1' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -88.52 177.78 6.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.124 -0.985 . . . . 0.0 109.589 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 199' ' ' ILE . 3.7 mm? -121.17 22.64 10.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.783 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -36.05 7.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.85 96.94 5.14 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.666 HD12 ' CE2' ' A' ' 197' ' ' PHE . 4.3 mm? -89.96 82.92 6.1 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.538 0.685 . . . . 0.0 109.835 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 1.5 p-10 -116.89 142.64 30.12 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.483 -0.761 . . . . 0.0 109.085 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 228' ' ' ASN . 35.5 Cg_endo -78.08 174.97 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.469 2.112 . . . . 0.0 110.378 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.93 -59.34 1.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.495 ' HB3' ' CE2' ' A' ' 214' ' ' TRP . . . -74.86 117.26 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 231' ' ' ALA . 5.5 mp -124.55 -91.67 0.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.28 52.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -39.89 65.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.143 . . . . 0.0 109.633 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.19 65.0 2.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 237' ' ' GLY . . . -85.73 116.37 4.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 236' ' ' GLY . . . -61.48 -129.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 195' ' ' HIS . . . -110.24 45.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.162 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.34 53.75 4.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -136.78 8.11 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.474 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -77.04 166.7 22.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.484 ' CG ' ' NE2' ' A' ' 245' ' ' GLN . 1.3 t-20 -111.26 100.75 9.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 108.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 244' ' ' TYR . . . -108.32 -40.7 1.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 22.1 m-85 -135.54 84.65 2.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.326 -1.103 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 1.5 mt-30 -91.26 119.22 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 72.6 p -136.05 164.82 27.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.712 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.695 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -140.91 161.7 37.2 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.75 HG23 ' CD1' ' A' ' 185' ' ' TYR . 39.1 t -116.15 113.67 43.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 184' ' ' VAL . 13.9 m -112.55 142.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.941 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.42 ' N ' ' OE1' ' A' ' 177' ' ' GLU . . . 90.65 54.77 2.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.616 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 38.5 mt -102.75 89.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.996 . . . . 0.0 110.225 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 2.2 pptp? -162.89 151.76 12.41 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 0.0 109.03 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.335 2.023 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.423 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 36.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 1' ' ' GLN . 36.0 Cg_endo -78.07 163.95 27.65 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.456 2.104 . . . . 0.0 109.89 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 t -100.46 143.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.433 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.7 t -135.88 131.55 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -76.19 -178.6 4.56 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.495 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 17.5 t -78.13 106.2 9.86 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.896 -1.128 . . . . 0.0 109.312 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.8 mt -56.69 -48.44 77.64 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD11 ' CG1' ' A' ' 198' ' ' VAL . 13.7 mt -55.01 -42.25 72.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 108.386 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 2.1 t0 -67.19 -40.87 86.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -0.85 . . . . 0.0 109.133 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 p -58.11 -15.7 10.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.998 -1.064 . . . . 0.0 108.772 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.584 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 2.0 mtpp -116.9 16.96 15.15 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 46.85 39.22 10.9 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 11' ' ' LYS . 27.8 mt -91.34 110.67 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -1.037 . . . . 0.0 110.519 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' PRO . 64.0 m80 -134.7 83.05 2.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.2 m-30 -89.49 179.28 6.09 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.141 0.972 . . . . 0.0 110.991 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -147.89 -163.24 1.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 45' ' ' THR . 37.3 mt-30 -124.95 -21.21 4.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.978 -1.076 . . . . 0.0 110.572 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.721 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.31 -35.09 1.36 Allowed Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.522 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.844 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.64 -138.06 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.527 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.202 -178.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.844 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.1 Cg_endo -75.08 4.46 4.75 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 CA-C-N 122.688 1.996 . . . . 0.0 109.589 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.9 m-85 -80.42 -34.1 36.44 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 29.9 p-10 -88.79 15.65 8.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.536 -1.352 . . . . 0.0 109.177 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.17 -5.96 30.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.104 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.1 mt -128.57 -5.81 5.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 109.934 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 18.0 p -61.24 164.57 8.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.1 Cg_endo -69.59 136.36 33.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.231 1.954 . . . . 0.0 112.251 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG1' ' HA2' ' A' ' 40' ' ' GLY . 38.8 t -76.01 148.19 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-O 121.538 0.685 . . . . 0.0 109.924 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.751 HD11 ' C ' ' A' ' 132' ' ' GLY . 13.7 mt -78.19 150.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.836 0.827 . . . . 0.0 111.122 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' C ' HG22 ' A' ' 39' ' ' VAL . 3.3 mt-10 -125.06 -23.15 4.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.704 -0.623 . . . . 0.0 110.152 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.0 mtpt -120.75 165.91 14.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 38' ' ' PHE . 86.0 t -114.62 143.71 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 110.588 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -73.6 158.99 85.61 Favored Pre-proline 0 N--CA 1.491 1.625 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.625 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.1 Cg_endo -81.83 113.64 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.565 2.176 . . . . 0.0 110.795 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.33 4.3 58.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.5 tp10 -121.41 161.52 22.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.255 . . . . 0.0 109.575 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' HG13 ' A' ' 31' ' ' VAL . 20.0 mm-40 -60.6 175.59 0.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.419 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -81.82 134.36 35.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.687 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 74.4 m-85 -118.52 12.93 13.36 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.995 -1.066 . . . . 0.0 109.156 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HA ' HG22 ' A' ' 28' ' ' ILE . 78.0 t -62.86 138.94 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' CG1' ' A' ' 27' ' ' VAL . . . 79.89 1.62 87.53 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 11.8 mt-30 -89.39 134.06 34.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -73.33 111.18 8.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.29 161.08 0.69 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.974 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.68 167.23 21.91 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.661 -0.649 . . . . 0.0 109.515 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.706 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.5 p -80.48 -33.77 36.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.112 -0.993 . . . . 0.0 108.495 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 102.86 138.22 9.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' ALA . 7.0 p -55.21 -48.66 73.55 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.7 t -47.11 -52.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -64.41 -47.86 77.56 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.088 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.505 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 54.8 m -62.86 -29.47 70.78 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.569 -0.707 . . . . 0.0 109.157 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.91 -47.09 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.751 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 56' ' ' MET . 35.4 m -75.72 -48.88 20.05 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.441 0.639 . . . . 0.0 110.255 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.65 -33.96 35.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.513 -0.742 . . . . 0.0 109.085 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.627 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 28.7 mt-30 -68.31 -50.38 53.91 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 198' ' ' VAL . 33.7 mt -65.0 -23.99 34.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.582 ' HG3' HG22 ' A' ' 52' ' ' THR . 18.1 mtp -72.56 -36.23 68.17 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.558 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 42.4 tptt -71.5 -44.42 64.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.9 t80 -53.38 -30.58 40.5 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.24 0.543 . . . . 0.0 109.739 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 61.0 m-70 -107.81 -23.62 12.0 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.625 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.23 58.92 1.81 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.1 t80 -77.96 -76.82 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.375 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.3 Cg_endo -71.19 108.59 2.37 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 CA-C-N 119.41 0.825 . . . . 0.0 113.225 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.76 -26.99 67.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 103.819 -2.659 . . . . 0.0 103.819 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 18.9 tttt -129.58 130.35 45.58 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 176.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.93 167.46 4.35 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.396 -1.859 . . . . 0.0 110.904 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.11 -38.64 10.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.537 -0.978 . . . . 0.0 111.301 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 73.4 tttt -152.67 132.49 13.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.677 -1.265 . . . . 0.0 110.7 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 3.0 m-20 -60.42 168.29 2.17 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.368 -0.832 . . . . 0.0 109.495 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 35.8 t80 -151.97 141.81 21.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 109.724 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.0 t -144.39 153.51 42.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 109.271 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.793 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.1 p90 -152.88 156.7 39.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.819 HG23 ' OD1' ' A' ' 85' ' ' ASN . 0.3 OUTLIER -92.9 127.19 38.32 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.819 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.5 tp -44.81 150.36 0.37 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 111.205 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -61.99 142.89 57.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.862 -0.524 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 p -70.06 -2.1 11.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.013 -1.054 . . . . 0.0 109.816 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 16.0 t-20 -99.83 -8.18 24.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.146 -0.971 . . . . 0.0 109.666 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.819 ' ND2' HD21 ' A' ' 73' ' ' LEU . 37.8 t-20 -70.23 112.09 11.51 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.592 -0.693 . . . . 0.0 110.021 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.0 Cg_endo -86.94 9.03 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.042 2.494 . . . . 0.0 110.589 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 58.2 m-85 -104.83 -14.04 15.65 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.106 -0.997 . . . . 0.0 111.5 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 53.2 m-85 -128.18 159.57 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 14.7 m-80 -46.9 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.568 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.47 -48.31 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.966 175.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -76.58 57.72 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.91 104.98 14.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.487 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.819 ' OD1' HG23 ' A' ' 72' ' ' THR . 2.4 m-80 -100.42 132.23 45.92 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.337 -0.852 . . . . 0.0 109.882 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.793 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -105.86 143.26 34.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -130.91 128.84 41.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.923 -1.11 . . . . 0.0 110.537 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -111.12 112.16 23.76 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.89 53.84 0.48 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.673 -1.267 . . . . 0.0 108.102 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.3 mt -52.98 -56.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.726 -0.609 . . . . 0.0 111.332 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -43.83 -29.73 0.58 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.703 -1.248 . . . . 0.0 109.456 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.93 33.04 5.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.391 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.873 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 32.7 mmt-85 -82.29 158.12 23.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.736 -1.228 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 94' ' ' GLN . 2.1 mm-40 -116.1 81.73 1.66 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.3 m-85 -81.49 89.9 6.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.581 -0.699 . . . . 0.0 110.198 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.506 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.5 t30 -78.76 90.83 4.65 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.662 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 63.8 m95 -60.09 -8.16 2.24 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.75 -18.12 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 46.1 m-20 -99.72 -31.27 11.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.0 mt -73.83 66.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.538 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 24.9 mt -45.79 149.16 1.18 Allowed Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -78.24 -23.04 9.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.635 2.223 . . . . 0.0 110.441 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 t -137.57 130.3 30.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.02 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.538 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 86.3 m-85 -116.82 144.29 44.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.042 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.2 p -100.53 -16.62 17.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.49 -2.72 57.56 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -120.19 7.22 10.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -1.227 . . . . 0.0 109.523 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.23 177.31 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.905 . . . . 0.0 109.486 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 p -69.33 170.85 9.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.223 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.77 -38.53 53.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.9 t -51.44 -56.75 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -40.48 96.77 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.082 -1.012 . . . . 0.0 109.214 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.501 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 19.6 mttt -62.53 -39.03 92.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 32.0 ttm -59.91 -43.37 94.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.677 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.58 -52.05 67.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.673 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.6 tp -69.45 -39.2 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.391 -1.443 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -57.55 -41.74 81.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.079 -1.013 . . . . 0.0 110.454 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 20.6 tt0 -68.76 -38.9 80.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.991 -1.068 . . . . 0.0 108.18 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -56.41 -51.04 69.85 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.706 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.6 mmt -59.69 -44.95 93.44 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 108.999 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.48 -36.28 83.66 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.873 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 18.5 m-20 -69.41 -52.43 27.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 127' ' ' VAL . 58.6 t -65.89 -57.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.146 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.16 -49.09 14.7 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 3.5 mt -64.01 -58.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.287 -1.125 . . . . 0.0 108.264 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -47.1 -30.2 2.64 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.571 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 19.2 m -101.08 37.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.013 -1.054 . . . . 0.0 109.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.1 m-20 37.48 51.44 1.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.476 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 57.8 tpp -65.64 125.61 25.79 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 111.545 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.9 t0 -75.86 121.27 22.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.636 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.2 m-85 -103.0 117.68 35.14 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.519 1.152 . . . . 0.0 113.206 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.751 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.64 -164.2 12.01 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 104.659 -3.377 . . . . 0.0 104.659 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.622 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.24 -29.09 79.8 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.44 141.81 43.02 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 43.4 m -125.33 110.94 14.6 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 119.882 -1.761 . . . . 0.0 110.533 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.92 144.42 16.4 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.7 t -118.17 -163.99 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.111 -1.229 . . . . 0.0 107.719 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.58 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.09 -55.99 3.33 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.567 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 135.0 -137.68 9.43 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 119.313 -1.422 . . . . 0.0 111.623 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.56 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 2.8 m -48.7 -50.22 34.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.812 -0.816 . . . . 0.0 112.408 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' SER . 57.2 p -45.36 -47.28 13.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 0.0 109.842 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.65 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 17.3 mmt180 -81.41 -38.27 26.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 110.195 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.83 HG21 ' CE2' ' A' ' 185' ' ' TYR . 54.1 t -67.67 -53.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.017 . . . . 0.0 110.503 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.95 -34.82 68.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.896 -1.127 . . . . 0.0 108.389 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -77.38 -52.73 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.581 179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.52 -34.29 70.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.592 ' HB2' HG11 ' A' ' 157' ' ' VAL . 57.2 mt -59.85 -49.45 77.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.274 -0.891 . . . . 0.0 109.742 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.553 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 6.0 mtmt -87.34 -42.74 12.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.891 -1.13 . . . . 0.0 110.882 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 32.8 mt-10 -69.31 -51.98 31.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.898 -1.126 . . . . 0.0 112.436 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 21.9 m120 -88.17 -50.47 6.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.725 -1.234 . . . . 0.0 111.986 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -90.04 -16.47 29.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.748 -1.22 . . . . 0.0 110.489 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 68.1 37.8 87.57 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.916 -1.115 . . . . 0.0 111.791 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.9 m-85 -63.04 165.92 6.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.335 -1.686 . . . . 0.0 107.757 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 37.6 t-20 -47.15 143.82 2.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.803 -1.186 . . . . 0.0 109.104 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 11.4 mm100 -53.15 -20.05 3.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 108.983 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.506 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.6 p -55.04 -15.04 1.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 147' ' ' LEU . 4.1 t -63.57 120.23 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.864 -1.147 . . . . 0.0 109.45 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 1.006 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.0 p-80 -148.12 160.22 43.12 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.1 tt0 -102.48 152.33 21.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 1.078 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.3 pt -131.48 138.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.1 m-80 -106.18 103.32 12.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 1.8 tpt180 -47.66 -29.77 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.21 -0.931 . . . . 0.0 108.978 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.92 -22.8 65.01 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.68 -2.87 25.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.241 . . . . 0.0 111.402 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -117.84 177.67 4.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.558 -1.339 . . . . 0.0 110.27 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 170' ' ' TRP . 42.3 p -109.06 147.38 32.47 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' SER . 5.1 ttmm -40.44 -44.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 110.136 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.844 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.37 -15.92 63.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 1.078 ' CH2' HD12 ' A' ' 160' ' ' ILE . 40.5 t-105 -75.11 -38.71 61.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.306 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.448 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 42.3 mt-10 -71.24 -34.69 71.0 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.24 -0.912 . . . . 0.0 108.769 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 176' ' ' LYS . . . -55.22 -47.3 75.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.86 . . . . 0.0 109.061 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 25.8 mm100 -61.25 -43.5 98.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.045 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.952 HG23 HG21 ' A' ' 184' ' ' VAL . 12.0 mt -75.39 -60.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 111.435 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -49.5 -43.4 45.4 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.496 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 172' ' ' ALA . 9.6 tttt -52.21 -44.67 64.88 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.576 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 42.6 mm-40 -58.93 -54.55 45.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 4' ' ' VAL . 16.9 mt -66.25 -26.37 67.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' ASP . 45.0 p -51.9 -43.83 63.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.2 mt-30 -94.89 32.05 1.73 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.609 ' C ' HD13 ' A' ' 7' ' ' LEU . 19.6 m-20 49.65 50.59 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 12.6 mt-30 -124.16 114.5 27.73 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.1 Cg_endo -66.25 171.13 10.79 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.136 1.89 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.959 HG13 HG12 ' A' ' 249' ' ' VAL . 21.2 t -126.91 115.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.775 -0.578 . . . . 0.0 111.007 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.83 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -65.11 112.11 3.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 176.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.625 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 5.2 t80 -123.46 155.77 36.83 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.013 -1.054 . . . . 0.0 109.449 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.36 128.66 3.56 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.21 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 245' ' ' GLN . . . -92.19 101.01 2.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 190' ' ' GLY . 50.8 t -67.13 164.13 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 110.988 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.583 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -167.44 -130.54 1.18 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -87.72 -51.64 5.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -1.214 . . . . 0.0 111.103 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.439 HG11 ' HA2' ' A' ' 237' ' ' GLY . 3.8 m -65.35 -18.19 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.189 -0.944 . . . . 0.0 111.776 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.09 -158.9 24.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 189' ' ' VAL . . . -87.6 106.82 3.23 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.916 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 9.3 t-80 -71.83 119.37 15.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -112.94 160.14 18.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.492 -1.283 . . . . 0.0 112.837 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.883 ' CD2' HG13 ' A' ' 210' ' ' VAL . 54.3 p90 -161.54 173.46 14.77 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 55' ' ' ILE . 94.8 t -116.59 134.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.558 -1.339 . . . . 0.0 111.582 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 96.7 mt -102.7 109.1 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.7 p30 -124.0 33.28 5.33 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.306 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -171.22 164.92 37.97 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 117.512 -2.28 . . . . 0.0 112.675 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.521 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.91 147.63 34.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -112.45 7.46 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.833 -1.167 . . . . 0.0 110.146 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.87 -46.23 3.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -85.55 44.88 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -1.179 . . . . 0.0 110.415 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 222' ' ' PHE . 0.6 OUTLIER 65.34 31.06 10.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.128 -0.982 . . . . 0.0 109.982 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.599 ' HA ' ' CE1' ' A' ' 222' ' ' PHE . 3.6 m-85 -117.93 135.26 54.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.087 -1.008 . . . . 0.0 109.126 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 38.8 m-85 -123.41 162.96 21.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.8 t60 -91.97 137.54 32.28 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.883 HG13 ' CD2' ' A' ' 197' ' ' PHE . 23.9 t -129.46 138.18 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.626 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -109.25 72.59 0.81 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.658 ' CE2' HG11 ' A' ' 210' ' ' VAL . 81.4 m95 -47.0 167.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 110.26 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -91.06 25.74 13.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -107.11 -168.24 1.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -1.188 . . . . 0.0 109.34 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.25 -101.06 0.09 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.71 63.98 0.62 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.795 HG22 ' N ' ' A' ' 218' ' ' SER . 1.5 p -100.02 -98.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.094 -1.239 . . . . 0.0 109.861 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.795 ' N ' HG22 ' A' ' 217' ' ' VAL . 10.9 m -90.37 20.96 4.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 212' ' ' TRP . 1.1 m-20 -60.61 109.3 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.46 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 140.01 -92.77 0.19 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -59.98 131.65 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -1.195 . . . . 0.0 109.376 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -86.93 165.83 15.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.245 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.451 ' HD3' ' CG ' ' A' ' 228' ' ' ASN . 0.0 OUTLIER -84.31 -179.49 7.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.451 -0.781 . . . . 0.0 109.631 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 17.5 mt -117.74 -4.36 11.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.75 -80.43 0.6 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 0.0 109.818 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.64 -96.88 0.46 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.069 -1.02 . . . . 0.0 109.649 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 227' ' ' LEU . 1.1 pt? -115.44 177.96 4.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.451 ' CG ' ' HD3' ' A' ' 223' ' ' ARG . 26.0 t-20 -116.43 82.09 11.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.393 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' LEU . 36.0 Cg_endo -78.26 86.8 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.657 2.238 . . . . 0.0 110.534 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.783 ' HB2' HG21 ' A' ' 217' ' ' VAL . 0.0 OUTLIER -88.68 -35.85 16.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.05 98.09 6.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.529 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 237' ' ' GLY . 14.3 mt -53.68 -44.16 69.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 82.9 121.38 0.71 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 234' ' ' THR . 24.0 m -100.67 13.52 34.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -87.63 -85.58 1.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -121.93 -29.52 1.37 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 232' ' ' LEU . . . -91.37 113.77 4.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -110.36 32.19 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -1.105 . . . . 0.0 109.562 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 91.75 -161.44 27.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 166.17 117.14 0.39 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -58.3 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -1.107 . . . . 0.0 109.711 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -108.02 117.99 35.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.291 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.36 -49.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.524 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 68.6 m-85 -125.6 61.5 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -1.039 . . . . 0.0 108.985 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' A' ' 162' ' ' ARG . 13.3 pt20 -91.51 132.14 36.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 109.789 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 60.1 p -145.72 170.92 15.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.374 -0.829 . . . . 0.0 109.658 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -135.25 161.92 34.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.672 0.749 . . . . 0.0 109.102 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.802 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.8 t -116.3 112.36 39.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 1.006 HG23 ' CE1' ' A' ' 158' ' ' HIS . 13.6 m -110.64 143.63 20.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.036 -175.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 88.06 46.35 4.79 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 29.3 mt -92.7 94.01 4.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.392 -1.064 . . . . 0.0 109.812 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 9.0 ptmt -160.87 149.08 12.86 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.619 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.6 Cg_endo . . . . . 0 C--N 1.308 -1.553 0 C-N-CA 122.257 1.971 . . . . 0.0 110.452 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.493 ' NE2' ' OD2' ' A' ' 175' ' ' ASP . 37.6 tt0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.67 165.31 24.98 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.473 2.115 . . . . 0.0 109.956 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.16 139.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.091 -1.006 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 178' ' ' LEU . 44.7 t -136.79 127.92 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 200' ' ' ASP . 12.1 mmtp -76.39 -176.64 3.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.147 -0.971 . . . . 0.0 108.568 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.516 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 3.0 t -77.45 104.82 8.19 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.467 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 39.4 mt -57.76 -48.16 80.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 108.894 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD11 HG11 ' A' ' 198' ' ' VAL . 11.9 mt -55.63 -42.04 74.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 108.496 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 5.2 m-20 -67.65 -41.41 83.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.068 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -58.32 -14.66 7.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 109.225 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.9 mtpp -118.86 23.43 11.43 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 43.69 38.55 4.31 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.566 HD11 ' HA ' ' A' ' 58' ' ' TYR . 30.5 mt -90.07 109.17 20.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.412 1.101 . . . . 0.0 110.436 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 102' ' ' PRO . 8.7 m-70 -133.59 97.73 4.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.573 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 3.8 m-30 -102.83 174.49 5.85 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.245 1.022 . . . . 0.0 111.614 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -147.01 -172.92 4.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 10.1 mt-30 -124.12 -8.94 7.66 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.828 -1.17 . . . . 0.0 110.036 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.713 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.16 -42.9 0.68 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.852 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.1 -139.98 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.563 0 CA-C-O 118.387 -0.816 . . . . 0.0 111.381 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.852 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.6 Cg_endo -73.75 2.31 6.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 122.545 1.945 . . . . 0.0 109.249 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 48.4 m-85 -73.28 -35.87 66.22 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 34.6 p-10 -98.88 20.53 13.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.617 -1.302 . . . . 0.0 109.797 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.9 mt -73.52 -2.1 21.31 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.924 . . . . 0.0 109.367 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -128.68 -5.78 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.925 . . . . 0.0 109.726 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 24.6 p -65.25 165.09 18.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.4 Cg_endo -70.61 139.24 36.85 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.108 1.872 . . . . 0.0 111.765 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 t -84.24 149.55 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.73 . . . . 0.0 110.039 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.811 HD11 ' C ' ' A' ' 132' ' ' GLY . 42.9 mt -78.02 144.2 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 110.351 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' C ' HG22 ' A' ' 39' ' ' VAL . 80.6 mt-10 -123.56 -23.2 4.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 110.115 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 79' ' ' TYR . 1.2 mtpm? -118.83 164.01 16.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' VAL . 42.2 t -114.27 152.29 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.216 -0.928 . . . . 0.0 111.27 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -83.24 128.42 64.83 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.98 126.48 11.91 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.575 1.517 . . . . 0.0 110.247 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.8 6.61 40.19 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.25 -175.52 4.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.121 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -79.47 179.76 7.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.27 132.42 33.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.113 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 70.8 m-85 -120.47 18.68 12.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.92 . . . . 0.0 108.92 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 31' ' ' VAL . 45.3 t -68.77 150.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.14 81.39 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 4.4 mm-40 -91.43 129.24 37.44 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.339 -1.095 . . . . 0.0 109.738 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.29 112.7 9.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.27 157.4 1.42 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.176 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -76.6 171.63 14.33 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.398 0.618 . . . . 0.0 109.829 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.595 ' O ' ' HE3' ' A' ' 129' ' ' MET . 24.5 p -80.34 -36.14 34.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.112 -0.993 . . . . 0.0 108.353 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 107.11 135.63 7.92 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -54.1 -52.77 59.95 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -1.149 . . . . 0.0 108.002 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 64.4 t -45.96 -53.84 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.569 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -60.52 -51.88 67.56 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.524 HG23 ' CE ' ' A' ' 120' ' ' MET . 0.2 OUTLIER -63.3 -32.24 73.6 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.154 -178.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.3 -41.31 85.6 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.277 -1.369 . . . . 0.0 108.228 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.444 HG22 ' HG3' ' A' ' 56' ' ' MET . 44.1 m -73.8 -54.26 8.43 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.004 0.907 . . . . 0.0 109.887 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -51.68 -39.27 57.95 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.924 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.6 mt-30 -60.42 -48.75 80.39 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 198' ' ' VAL . 39.1 mt -65.47 -24.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.597 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 36.6 mtp -73.42 -39.51 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 26.7 tptt -68.24 -41.82 80.63 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.674 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.69 -34.21 58.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.812 -0.555 . . . . 0.0 109.966 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.8 m-70 -106.92 -20.6 13.28 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.634 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.21 52.59 1.64 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -72.29 -69.01 0.37 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.4 Cg_endo -70.25 105.79 1.63 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 120.328 0.686 . . . . 0.0 112.17 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 95' ' ' TYR . 2.1 m120 -70.35 -22.05 62.83 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 13.1 tttp -134.19 144.07 48.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.84 141.62 44.73 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.932 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.43 -41.95 19.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 0.0 109.967 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 2.6 tttt -152.74 134.55 14.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.916 -1.115 . . . . 0.0 110.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.18 166.29 8.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.46 -0.775 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.515 ' CG ' ' HA ' ' A' ' 126' ' ' SER . 43.1 t80 -143.93 146.44 32.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.439 -0.788 . . . . 0.0 109.456 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 t -146.41 152.15 38.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 25.1 p90 -160.24 155.42 24.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.843 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 94.9 m -93.15 137.16 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.8 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.1 tp -53.8 151.12 6.68 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 111.306 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 t -65.6 -6.51 11.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.038 -1.039 . . . . 0.0 109.727 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -95.56 -8.24 35.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.506 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.8 ' ND2' HD21 ' A' ' 73' ' ' LEU . 36.9 t-20 -69.74 109.82 5.37 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.4 Cg_endo -88.52 15.51 2.06 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.929 2.419 . . . . 0.0 110.227 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.765 ' HB3' HG23 ' A' ' 28' ' ' ILE . 78.9 m-85 -108.14 -18.29 13.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.696 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 81' ' ' ASN . 63.5 m-85 -123.69 161.28 25.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 16.7 m-80 -47.51 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 175.07 -47.13 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.337 -0.852 . . . . 0.0 110.947 174.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.0 Cg_endo -77.15 56.25 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.74 104.73 14.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.506 -177.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -100.95 134.3 44.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 109.405 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -108.25 129.71 55.19 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.78 125.71 47.16 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.04 112.68 25.74 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 68' ' ' ASP . . . -73.67 51.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.053 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 37.0 mt -52.88 -49.86 46.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.439 ' H ' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -44.97 -28.07 0.62 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.765 -1.209 . . . . 0.0 108.957 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 35.9 3.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 109.374 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -93.81 154.87 17.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.013 -1.054 . . . . 0.0 110.602 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.11 93.39 4.16 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-85 -81.56 91.37 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.692 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -79.8 87.31 5.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 61.2 m95 -61.67 -6.76 2.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.63 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.83 -21.22 22.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.751 -1.218 . . . . 0.0 108.032 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 21.8 m-20 -100.12 -26.85 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.629 ' CG1' ' HB1' ' A' ' 115' ' ' ALA . 64.1 mt -73.17 67.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 15.1 mt -46.85 149.2 1.58 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.8 -0.563 . . . . 0.0 110.19 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.3 Cg_endo -78.49 -17.9 12.55 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.965 2.443 . . . . 0.0 110.581 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 1.6 t -146.42 122.45 10.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 108.81 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 116' ' ' ILE . 66.3 m-85 -109.48 140.37 43.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.135 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 p -102.81 -1.28 30.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.465 -0.772 . . . . 0.0 108.951 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' A' ' 19' ' ' ASN . . . 81.59 9.01 86.25 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -119.67 -10.35 9.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.336 -1.096 . . . . 0.0 109.428 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -64.03 161.0 16.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 171.87 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.418 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 0.4 OUTLIER -74.41 -29.58 61.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.44 -61.38 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -62.5 -33.55 75.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 108.975 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 79.4 mttt -65.1 -44.18 89.66 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.468 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 34.9 ttm -59.41 -36.6 76.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 100' ' ' ILE . . . -57.72 -69.36 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.716 -0.615 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.643 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.4 tp -59.11 -40.37 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.867 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 23.0 p -56.83 -41.76 78.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 0.0 110.423 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.791 ' N ' HD12 ' A' ' 24' ' ' LEU . 28.0 tt0 -69.37 -38.51 78.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.279 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.643 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.8 tp -59.38 -55.46 34.45 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.604 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.4 mmt -57.45 -40.51 78.62 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.89 -41.52 91.42 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 126' ' ' SER . 19.6 m-20 -65.25 -49.68 68.68 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 127' ' ' VAL . 76.3 t -65.95 -58.12 7.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.518 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.82 -50.5 14.83 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 2.9 mt -65.36 -54.47 28.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.219 -1.165 . . . . 0.0 108.256 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 65.0 p -46.48 -31.08 2.5 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.065 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 123' ' ' VAL . 33.6 m -103.48 40.43 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.989 -1.069 . . . . 0.0 110.089 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 127' ' ' VAL . 0.7 OUTLIER 37.26 49.23 0.88 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.597 0.713 . . . . 0.0 109.745 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.595 ' HE3' ' O ' ' A' ' 45' ' ' THR . 46.7 tpp -66.02 129.02 38.35 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.532 -0.73 . . . . 0.0 111.564 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 135' ' ' SER . 3.2 t0 -76.9 123.14 25.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.64 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 67.8 m-85 -104.29 118.17 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.405 1.098 . . . . 0.0 113.113 -176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.811 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.94 -162.87 10.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 104.498 -3.441 . . . . 0.0 104.498 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.652 ' HD3' HD13 ' A' ' 28' ' ' ILE . 17.7 Cg_endo -62.31 -29.88 80.38 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 N-CA-C 105.755 -2.44 . . . . 0.0 105.755 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -110.14 137.78 47.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 59.8 m -116.79 107.62 14.86 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.015 -1.678 . . . . 0.0 109.702 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.73 137.08 13.84 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.562 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 6.8 t -117.33 -161.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.908 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -91.41 -55.46 3.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.564 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 131.83 -127.57 5.03 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.603 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.489 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 3.8 m -51.13 -56.74 11.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.681 -0.894 . . . . 0.0 111.692 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 24.5 p -47.64 -39.89 18.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.045 -1.035 . . . . 0.0 109.865 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.908 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 33.7 mmt-85 -79.05 -43.54 24.01 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 185' ' ' TYR . 78.4 t -68.82 -55.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.415 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -56.12 -31.75 63.59 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.084 -1.047 . . . . 0.0 108.577 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 13.4 ttp85 -77.14 -49.64 14.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.51 -34.8 78.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.146 -0.971 . . . . 0.0 110.376 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 251' ' ' ILE . 51.5 mt -61.06 -48.19 82.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.097 -1.002 . . . . 0.0 110.46 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 47.7 mtmt -86.77 -43.67 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 111.222 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 5.8 mt-10 -76.21 -41.51 49.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 112.224 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 66' ' ' LEU . 32.0 m120 -93.91 -44.27 8.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.584 -1.323 . . . . 0.0 111.66 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.441 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 39.4 m-85 -100.33 -2.45 33.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.79 -1.194 . . . . 0.0 110.476 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.932 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 52.94 37.72 53.8 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.286 -0.884 . . . . 0.0 112.449 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.426 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.4 m-85 -62.6 167.48 4.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.182 -1.775 . . . . 0.0 107.188 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.8 t-20 -47.82 140.14 6.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.628 -1.295 . . . . 0.0 109.089 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -53.2 -19.68 3.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.313 -0.867 . . . . 0.0 108.906 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.533 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 73.2 p -53.42 -17.2 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.302 -0.874 . . . . 0.0 109.829 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 42.7 t -62.92 122.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.705 -1.247 . . . . 0.0 108.947 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.645 ' NE2' HG23 ' A' ' 249' ' ' VAL . 2.0 p-80 -146.75 153.38 40.16 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.119 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.489 ' OE1' ' HB2' ' A' ' 140' ' ' SER . 2.8 tt0 -101.32 148.29 25.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.875 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 6.5 pt -130.96 159.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -112.37 95.81 5.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.865 -1.147 . . . . 0.0 110.688 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.635 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 39.3 tpt85 -42.81 -27.97 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.395 -0.815 . . . . 0.0 109.083 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -62.39 -36.88 93.73 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.27 38.5 1.85 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.051 -1.264 . . . . 0.0 111.691 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.53 169.14 18.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.542 -1.349 . . . . 0.0 110.05 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -100.63 140.63 34.63 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.457 ' HE2' ' OE2' ' A' ' 171' ' ' GLU . 6.4 tttt -40.3 -46.25 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -63.54 -53.26 54.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 110.055 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.0 -26.25 68.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.875 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 69.4 t-105 -74.47 -35.72 63.3 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.132 -0.98 . . . . 0.0 109.911 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.457 ' OE2' ' HE2' ' A' ' 167' ' ' LYS . 45.8 mt-10 -72.22 -32.16 66.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.104 -0.998 . . . . 0.0 109.232 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.59 88.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.31 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.557 ' NE2' HG21 ' A' ' 249' ' ' VAL . 16.1 mm100 -64.78 -50.01 68.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.37 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 184' ' ' VAL . 64.3 mt -71.84 -52.51 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 111.174 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.493 ' OD2' ' NE2' ' A' ' 1' ' ' GLN . 0.4 OUTLIER -53.38 -43.06 67.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.108 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.418 ' HE2' ' NE2' ' A' ' 180' ' ' GLN . 7.4 tttt -51.97 -47.21 64.94 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 38.9 mm-40 -59.24 -52.67 64.67 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.763 ' HB3' HG11 ' A' ' 4' ' ' VAL . 20.7 mt -65.59 -28.3 69.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.445 -0.784 . . . . 0.0 110.149 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -52.51 -43.23 64.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 108.757 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 26.7 mt-30 -99.34 42.95 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 7' ' ' LEU . 14.5 m-20 42.33 51.09 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.77 0.795 . . . . 0.0 108.913 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 5.1 mt-30 -124.15 109.52 29.37 Favored Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.89 169.6 11.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.886 1.724 . . . . 0.0 111.944 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 HG23 ' A' ' 174' ' ' ILE . 62.1 t -127.03 131.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.804 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.7 OUTLIER -80.97 121.34 25.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 177.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 4.7 t80 -123.29 164.68 18.31 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.962 -1.086 . . . . 0.0 109.673 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -165.63 124.5 1.65 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 117.866 -1.534 . . . . 0.0 112.19 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.16 108.06 3.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 190' ' ' GLY . 40.0 t -71.1 164.38 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.313 . . . . 0.0 111.457 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.601 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.42 -142.67 3.45 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.411 -1.875 . . . . 0.0 108.411 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.457 ' HG3' ' HA ' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -87.64 -29.66 21.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -1.199 . . . . 0.0 110.638 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.874 HG13 ' HB2' ' A' ' 238' ' ' ALA . 21.9 m -83.43 -11.74 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.042 -1.036 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 -168.36 23.21 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -78.76 109.98 2.95 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.362 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -72.06 130.87 41.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -121.69 160.32 24.73 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.363 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.874 ' CD1' HG13 ' A' ' 210' ' ' VAL . 29.1 p90 -163.04 168.53 20.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 55' ' ' ILE . 71.6 t -113.88 137.91 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.753 -1.217 . . . . 0.0 111.888 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.754 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 77.6 mt -104.07 110.42 30.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -124.8 34.32 5.02 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.372 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -171.58 161.56 33.85 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 117.073 -2.489 . . . . 0.0 113.202 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.522 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -144.52 141.27 29.41 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -112.6 11.53 19.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.777 -1.202 . . . . 0.0 110.442 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.45 -50.23 3.99 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -79.46 53.83 1.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -1.161 . . . . 0.0 109.64 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.455 ' OD1' ' OE2' ' A' ' 171' ' ' GLU . 0.7 OUTLIER 50.73 38.16 18.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 0.3 OUTLIER -121.02 132.73 55.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.095 -1.003 . . . . 0.0 109.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 201' ' ' GLY . 26.2 m-85 -123.6 160.71 26.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.974 . . . . 0.0 110.039 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 200' ' ' ASP . 1.8 t60 -92.73 146.56 23.56 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.874 HG13 ' CD1' ' A' ' 197' ' ' PHE . 23.8 t -139.25 139.03 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.497 ' HB2' HD12 ' A' ' 8' ' ' LEU . 25.9 t-20 -108.95 70.38 0.74 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.687 ' CE2' HG11 ' A' ' 210' ' ' VAL . 89.7 m95 -48.86 169.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.456 -0.777 . . . . 0.0 110.193 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.87 -2.4 57.34 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -107.21 165.71 11.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.133 -1.216 . . . . 0.0 108.998 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -128.99 13.88 6.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.85 -1.4 5.89 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.798 HG13 ' N ' ' A' ' 218' ' ' SER . 2.7 p -105.69 -146.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.798 ' N ' HG13 ' A' ' 217' ' ' VAL . 19.6 m -63.35 61.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.123 . . . . 0.0 110.771 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.7 OUTLIER -77.45 88.08 3.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.95 -1.094 . . . . 0.0 109.41 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 147.33 -89.15 0.15 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.249 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.23 144.82 49.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -1.181 . . . . 0.0 110.117 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -99.26 165.43 11.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.36 -0.837 . . . . 0.0 109.152 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.504 ' NE ' ' OD1' ' A' ' 225' ' ' ASP . 0.9 OUTLIER -84.47 -178.65 6.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.76 . . . . 0.0 109.314 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.8 mt -120.9 15.1 11.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.997 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.504 ' OD1' ' NE ' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -123.81 -81.91 0.64 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.905 -1.122 . . . . 0.0 109.695 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.41 -95.57 0.47 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 109.89 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 227' ' ' LEU . 1.1 pt? -116.08 -153.08 0.52 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.995 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.581 ' HB2' ' CE3' ' A' ' 212' ' ' TRP . 1.9 t30 -95.78 153.46 39.33 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 109.057 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 228' ' ' ASN . 36.0 Cg_endo -78.04 -23.59 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.543 2.162 . . . . 0.0 110.747 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.749 ' CB ' HG21 ' A' ' 217' ' ' VAL . 24.1 t -92.91 30.24 1.64 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 195' ' ' HIS . . . -82.63 -5.06 58.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 233' ' ' GLY . 22.8 tp -82.86 -80.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.368 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 232' ' ' LEU . . . 107.55 -96.42 1.06 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 171.76 13.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -1.12 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -90.73 58.37 3.33 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.4 -120.18 0.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -125.95 -29.77 0.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.874 ' HB2' HG13 ' A' ' 192' ' ' VAL . . . -58.8 -172.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -177.12 -113.69 0.36 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -123.5 37.7 2.66 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -84.72 136.26 33.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.701 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -116.2 87.79 2.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.124 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -84.27 -48.37 5.11 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.548 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 41.8 m-85 -135.56 129.28 32.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.519 -0.989 . . . . 0.0 109.086 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 2.4 pt20 -128.66 136.3 50.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.816 -1.178 . . . . 0.0 108.469 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 4.9 p -149.43 167.04 27.29 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.74 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 160' ' ' ILE . . . -140.99 145.58 36.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.575 0.703 . . . . 0.0 109.536 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.585 HG23 ' CD1' ' A' ' 185' ' ' TYR . 22.0 t -107.94 114.42 46.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.645 HG23 ' NE2' ' A' ' 158' ' ' HIS . 12.3 m -119.52 138.95 48.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.252 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 97.95 53.84 1.25 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 147' ' ' LEU . 5.4 mt -103.65 96.36 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -1.152 . . . . 0.0 110.102 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.48 147.42 8.54 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.612 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.646 0 C-N-CA 122.227 1.951 . . . . 0.0 110.288 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 2' ' ' PRO . 38.6 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 1' ' ' GLN . 35.0 Cg_endo -77.41 -176.57 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.332 2.021 . . . . 0.0 109.548 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 203' ' ' ASP . 54.1 t -115.91 143.36 26.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 178' ' ' LEU . 94.7 t -137.68 133.91 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -0.775 . . . . 0.0 109.006 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 4' ' ' VAL . 6.5 mmtt -76.36 178.44 6.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 9' ' ' ASP . 1.8 t -77.9 106.35 9.69 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.024 -1.048 . . . . 0.0 109.241 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.705 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 38.3 mt -57.4 -50.72 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.879 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 211' ' ' ASN . 12.1 mt -55.49 -41.84 73.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.784 -1.198 . . . . 0.0 109.224 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 29.8 t0 -67.75 -40.47 84.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.581 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.6 p -58.53 -14.16 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.1 -1.0 . . . . 0.0 109.293 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' HG13 ' A' ' 13' ' ' ILE . 17.7 mtpt -117.75 22.12 12.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 0.0 108.802 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 44.0 37.85 4.42 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.1 mt -88.63 109.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 122.427 1.108 . . . . 0.0 110.219 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 102' ' ' PRO . 28.0 m80 -133.78 98.0 4.06 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.6 m-30 -103.61 171.66 7.24 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.216 1.008 . . . . 0.0 112.064 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.3 t30 -147.19 -173.21 4.19 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.479 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 30.3 mt-30 -124.11 -3.7 8.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.882 -1.136 . . . . 0.0 110.106 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.64 -56.17 0.35 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.158 -1.496 . . . . 0.0 112.152 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.788 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.65 -125.14 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-O 117.531 -1.224 . . . . 0.0 112.257 -176.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.788 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 39.2 Cg_endo -80.54 9.21 3.8 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 123.381 2.243 . . . . 0.0 110.212 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 15' ' ' TYR . 71.0 m-85 -83.94 -33.92 24.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 109.818 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.2 p30 -102.51 21.87 14.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.748 -1.22 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.4 mt -69.37 -4.4 18.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.94 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 118' ' ' GLU . 63.6 mt -131.67 -5.67 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.878 -1.139 . . . . 0.0 110.275 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 21.2 p -61.38 165.83 6.32 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 0.0 108.392 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 20.2 Cg_endo -69.57 131.31 21.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.069 1.846 . . . . 0.0 111.675 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.6 t -77.34 151.31 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.605 -0.684 . . . . 0.0 109.601 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 132' ' ' GLY . 12.7 mt -77.54 150.28 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -125.13 -23.37 4.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.434 -0.791 . . . . 0.0 111.15 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 79' ' ' TYR . 16.1 mtpt -121.54 176.35 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.845 -1.159 . . . . 0.0 109.927 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 37' ' ' SER . 79.5 t -114.03 145.11 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.241 -0.912 . . . . 0.0 110.772 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -88.72 130.66 44.26 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.13 123.81 10.33 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.552 1.501 . . . . 0.0 110.315 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.92 27.3 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 3.6 tp10 -149.01 176.91 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.946 . . . . 0.0 109.139 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -80.27 -175.66 5.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.201 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 9.2 t -83.04 135.87 34.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.6 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 15.74 11.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.918 -1.114 . . . . 0.0 109.571 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 28' ' ' ILE . 59.1 t -63.1 143.49 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.7 -3.91 67.16 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' PHE . 6.9 mt-30 -83.92 127.08 33.6 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.192 -1.181 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -72.86 110.28 7.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.23 158.44 1.15 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.599 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -75.75 169.2 18.59 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 109.363 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.65 ' O ' ' HE3' ' A' ' 129' ' ' MET . 8.7 p -80.7 -34.5 34.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.113 . . . . 0.0 108.051 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.06 135.29 7.83 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 4.1 p -54.49 -49.19 70.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -1.215 . . . . 0.0 107.93 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.628 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 20.3 t -46.38 -56.41 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -58.7 -50.13 75.03 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.667 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.77 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.415 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -66.66 -38.3 86.57 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.071 -1.452 . . . . 0.0 107.632 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.507 ' CG2' HG13 ' A' ' 143' ' ' VAL . 61.8 m -74.55 -53.98 8.38 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.26 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -55.13 -41.37 71.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 110.323 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.575 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.4 mt-30 -57.61 -47.5 82.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.491 -1.38 . . . . 0.0 107.331 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 198' ' ' VAL . 59.3 mt -65.74 -24.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 27.7 mtp -73.75 -37.68 64.97 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 22.3 tptt -71.2 -39.04 72.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.2 t80 -53.53 -34.49 58.38 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 109.528 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 75.5 m-70 -107.62 -20.08 13.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.02 54.33 1.64 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 1.4 t80 -72.38 -73.84 0.16 Allowed Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 34.4 Cg_endo -68.58 103.4 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.342 0.654 . . . . 0.0 112.057 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.456 ' C ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t-20 -70.84 -18.83 62.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 8.0 tttp -134.11 141.73 47.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.25 148.6 36.72 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.42 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.968 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -87.89 -59.04 2.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -1.02 . . . . 0.0 109.316 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' A' ' 68' ' ' ASP . 15.6 tttt -139.03 150.42 45.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-20 -74.58 179.99 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.589 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 70' ' ' THR . 61.9 t80 -147.73 167.5 24.5 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.374 -0.829 . . . . 0.0 109.605 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 6.8 t -166.22 147.87 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.686 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 19.1 p90 -163.35 152.67 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.482 HG23 HD22 ' A' ' 85' ' ' ASN . 21.1 m -93.09 138.14 31.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.803 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.5 tp -52.54 150.03 5.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 111.331 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -61.95 144.07 55.58 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.54 . . . . 0.0 109.715 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -1.91 11.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.82 -8.95 23.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 109.732 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.803 ' ND2' HD21 ' A' ' 73' ' ' LEU . 31.2 t-20 -70.24 109.4 4.81 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.765 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.0 Cg_endo -89.3 16.07 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.0 2.467 . . . . 0.0 110.279 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 91.2 m-85 -104.45 -23.53 13.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.746 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.4 m-85 -122.56 161.38 23.79 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.573 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 21.7 m-80 -46.1 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 175.18 -47.1 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 175.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.64 57.55 4.99 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 N-CA-C 107.39 -1.812 . . . . 0.0 107.39 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -105.67 107.25 18.15 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.247 -178.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -100.49 139.12 36.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.3 mp -115.97 123.14 47.29 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.27 125.25 47.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.079 -1.013 . . . . 0.0 110.059 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.04 113.79 27.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.61 53.0 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.874 -1.141 . . . . 0.0 108.557 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 48.7 mt -52.37 -46.66 46.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 121.264 -0.897 . . . . 0.0 109.76 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 90' ' ' ILE . 1.4 p -45.22 -26.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.162 . . . . 0.0 108.936 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.0 p -111.51 33.19 4.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.375 -0.828 . . . . 0.0 109.203 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.643 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 1.9 mmt-85 -89.37 153.75 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.12 91.24 3.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.23 87.07 6.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.469 -0.769 . . . . 0.0 110.84 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 100' ' ' ILE . 6.3 t30 -79.23 88.58 4.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.645 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 72.3 m95 -61.6 -5.69 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 110.737 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.87 -19.46 24.57 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 10.6 m-20 -100.15 -27.47 13.51 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.68 HG12 ' HB1' ' A' ' 115' ' ' ALA . 48.0 mt -74.14 70.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 38.1 mt -48.8 148.84 3.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.728 -0.607 . . . . 0.0 109.961 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.544 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 29.1 Cg_endo -79.08 -22.81 8.27 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.758 2.305 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' THR . 7.6 t -139.51 121.88 16.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 108.878 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 58.2 m-85 -109.43 140.41 43.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -0.947 . . . . 0.0 109.911 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.9 p -99.9 -0.69 39.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.046 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.483 ' HA3' ' OD1' ' A' ' 19' ' ' ASN . . . 82.07 -0.74 88.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 107' ' ' ARG . 16.3 mtm105 -118.07 1.94 12.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -1.194 . . . . 0.0 109.561 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.68 164.88 15.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.545 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.429 ' CB ' ' OE1' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -60.16 171.55 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.256 -0.902 . . . . 0.0 109.202 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 63.2 m-20 -75.51 -31.48 60.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.89 . . . . 0.0 109.764 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.31 -63.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.87 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' OE1' ' CB ' ' A' ' 109' ' ' SER . 1.1 mp0 -62.46 -31.52 72.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 75.2 mttt -66.21 -44.29 84.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.476 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 11.0 ttm -59.11 -34.53 72.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.68 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.69 -68.99 0.19 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.697 -0.627 . . . . 0.0 110.539 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.618 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.8 tp -59.85 -40.9 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 110.209 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 14.7 p -56.9 -40.22 75.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.767 -1.208 . . . . 0.0 109.764 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.752 ' N ' HD12 ' A' ' 24' ' ' LEU . 37.2 tt0 -69.84 -39.19 76.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 108.682 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.618 HD23 ' CD1' ' A' ' 116' ' ' ILE . 5.9 tp -60.44 -60.39 3.89 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.591 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.3 mmt -51.24 -39.22 56.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.628 -0.67 . . . . 0.0 109.679 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.62 -41.26 92.92 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' ' NE ' ' A' ' 93' ' ' ARG . 8.7 m-20 -65.39 -54.59 26.45 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.763 ' O ' HG22 ' A' ' 127' ' ' VAL . 87.0 t -63.08 -52.06 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.314 -0.867 . . . . 0.0 108.799 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -51.42 -51.55 36.71 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.3 mt -66.5 -54.39 26.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.076 -1.249 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 125' ' ' ILE . 33.1 p -46.22 -28.13 1.18 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.644 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -101.28 30.95 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.864 -1.148 . . . . 0.0 109.674 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 4.1 m-20 42.51 38.88 1.37 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.247 -0.908 . . . . 0.0 108.944 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.65 ' HE3' ' O ' ' A' ' 45' ' ' THR . 37.6 tpp -53.33 132.21 38.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.574 -0.704 . . . . 0.0 111.583 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 15.5 t0 -76.69 120.73 22.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 71.1 m-85 -103.65 120.17 40.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.3 1.048 . . . . 0.0 112.96 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.756 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.11 -164.25 11.93 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.4 Cg_endo -62.0 -30.94 83.88 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 105.687 -2.466 . . . . 0.0 105.687 175.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.0 m -109.97 142.46 41.31 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.3 m -119.54 110.42 16.86 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 119.849 -1.782 . . . . 0.0 109.972 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.17 133.28 11.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -118.44 -169.0 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -1.115 . . . . 0.0 108.602 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.575 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.29 -57.33 2.88 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.598 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 129.94 -122.5 3.73 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.501 -1.333 . . . . 0.0 112.551 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.484 ' HB2' ' OE1' ' A' ' 159' ' ' GLN . 3.1 m -47.99 -60.58 2.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.0 112.094 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 140' ' ' SER . 24.7 p -46.88 -41.18 15.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.78 -1.2 . . . . 0.0 109.238 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.4 mmp_? -80.33 -42.62 22.64 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.7 t -68.65 -59.38 3.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.722 -0.612 . . . . 0.0 111.149 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 140' ' ' SER . 1.7 pp0? -56.44 -32.88 65.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.16 -0.963 . . . . 0.0 109.175 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 14.2 ttm180 -75.89 -44.15 41.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.099 -1.0 . . . . 0.0 109.375 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 151' ' ' PHE . . . -70.49 -32.11 69.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 109.908 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 251' ' ' ILE . 51.8 mt -60.31 -47.89 84.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.369 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.525 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 24.6 mtmt -87.73 -29.47 21.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.729 -1.232 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 88.4 mt-10 -74.3 -67.46 0.62 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 112.333 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.543 ' HB3' HD13 ' A' ' 90' ' ' ILE . 36.1 m120 -82.1 -31.04 30.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.851 -1.156 . . . . 0.0 111.652 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' HD2' ' HA ' ' A' ' 147' ' ' LEU . 19.6 m-85 -102.53 -6.15 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.662 -1.274 . . . . 0.0 110.36 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.968 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 48.95 40.45 27.38 Favored Glycine 0 N--CA 1.495 2.587 0 O-C-N 121.224 -0.923 . . . . 0.0 112.244 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.443 ' CE2' HG22 ' A' ' 251' ' ' ILE . 8.6 m-85 -62.76 160.24 14.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.408 -1.643 . . . . 0.0 107.999 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 49.6 t30 -47.64 155.42 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 109.486 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -55.85 -17.57 6.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.895 . . . . 0.0 108.837 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.544 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 21.4 p -53.69 -15.72 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 147' ' ' LEU . 12.8 t -72.25 119.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.68 -1.262 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.817 ' NE2' HG23 ' A' ' 249' ' ' VAL . 3.1 p-80 -146.77 155.29 42.26 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' OE1' ' HB2' ' A' ' 140' ' ' SER . 2.1 tt0 -102.15 143.78 31.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.672 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' CA ' ' A' ' 246' ' ' SER . 4.1 pt -128.33 154.16 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.7 m-80 -109.62 94.93 5.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.991 -1.068 . . . . 0.0 110.542 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.579 ' HD2' ' CG ' ' A' ' 170' ' ' TRP . 1.2 tpt85 -46.39 -27.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 108.99 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 245' ' ' GLN . . . -66.82 -23.56 72.57 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -103.64 4.29 35.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.072 -1.252 . . . . 0.0 111.17 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -118.11 167.98 10.98 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.554 -1.341 . . . . 0.0 109.836 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 167' ' ' LYS . 32.0 p -98.94 136.86 38.32 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.507 ' HG3' ' NH2' ' A' ' 223' ' ' ARG . 29.3 tttm -34.42 -45.66 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.76 -0.587 . . . . 0.0 110.721 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -63.55 -62.22 1.81 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.958 -1.089 . . . . 0.0 109.733 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.45 -19.88 65.09 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 109.069 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.776 ' NE1' HD11 ' A' ' 174' ' ' ILE . 67.3 t-105 -75.44 -44.25 45.38 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.981 -1.074 . . . . 0.0 108.842 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 208' ' ' TYR . 12.3 mt-10 -61.68 -31.51 71.65 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.97 80.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.826 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.462 ' NE2' HG21 ' A' ' 249' ' ' VAL . 21.3 mm100 -61.32 -45.38 94.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 109.249 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.057 HG23 HG21 ' A' ' 184' ' ' VAL . 9.8 mt -76.01 -48.21 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 111.091 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 1' ' ' GLN . 0.3 OUTLIER -58.33 -53.76 54.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.014 -1.054 . . . . 0.0 109.67 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -51.28 -38.0 50.45 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.564 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.2 mm-40 -61.0 -51.32 69.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.8 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.8 mt -69.09 -24.95 64.2 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.489 -0.757 . . . . 0.0 109.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.435 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 17.7 p -52.21 -38.16 57.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.95 -1.094 . . . . 0.0 108.096 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 24.2 mt-30 -101.32 33.5 2.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.454 ' C ' HD13 ' A' ' 7' ' ' LEU . 4.7 m-20 47.11 51.15 13.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 18.1 mt-30 -123.75 106.0 32.27 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.444 ' HD3' HD13 ' A' ' 7' ' ' LEU . 15.4 Cg_endo -63.59 168.77 10.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.908 1.738 . . . . 0.0 112.497 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 1.057 HG21 HG23 ' A' ' 174' ' ' ILE . 42.3 t -121.86 135.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.454 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.757 ' CD1' HG23 ' A' ' 248' ' ' VAL . 3.3 t80 -85.07 118.31 24.55 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 176.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.649 ' CG ' ' CZ ' ' A' ' 197' ' ' PHE . 8.8 t80 -122.29 150.93 41.67 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.808 -1.183 . . . . 0.0 109.774 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.593 ' OE1' ' HA3' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -152.54 121.92 6.77 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.705 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -90.98 112.38 4.11 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 190' ' ' GLY . 24.6 t -66.37 164.82 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -1.178 . . . . 0.0 110.794 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.585 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -175.65 -143.22 4.51 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -35.68 18.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.235 . . . . 0.0 110.213 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.59 -9.31 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.525 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.12 -162.03 18.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.542 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.93 111.53 3.27 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.584 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.6 t-80 -71.57 101.23 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.628 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -86.24 153.1 22.25 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.822 1.296 . . . . 0.0 114.216 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.82 ' CD1' HG13 ' A' ' 210' ' ' VAL . 21.5 p90 -163.58 164.77 24.06 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.677 HG22 HD11 ' A' ' 55' ' ' ILE . 70.6 t -113.74 139.06 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.705 -1.247 . . . . 0.0 112.011 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.896 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.9 mt -103.38 111.68 34.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.6 p30 -125.22 31.33 5.62 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.395 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.08 41.59 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 117.271 -2.395 . . . . 0.0 112.883 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.443 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -156.48 149.7 24.27 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 207' ' ' PHE . 18.2 p-10 -128.56 29.81 5.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.578 -1.326 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 48.0 22.24 2.04 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.474 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 22.7 mtm180 -135.04 25.25 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -1.211 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 1.9 m-80 72.58 18.66 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.487 ' HB2' ' OD2' ' A' ' 203' ' ' ASP . 9.7 m-85 -120.15 113.73 20.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.901 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 171' ' ' GLU . 3.5 m-85 -102.67 167.35 9.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 108.919 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.587 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 1.4 t60 -92.18 139.48 30.58 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.82 HG13 ' CD1' ' A' ' 197' ' ' PHE . 42.4 t -130.89 136.18 58.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.533 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.467 ' HB2' HD12 ' A' ' 8' ' ' LEU . 23.3 t-20 -108.62 73.67 0.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.676 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 73.5 m95 -46.13 171.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.425 -0.797 . . . . 0.0 110.269 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.15 -2.4 53.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.446 ' NE1' ' HB1' ' A' ' 231' ' ' ALA . 77.8 m95 -106.96 169.98 8.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -1.1 . . . . 0.0 109.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -123.57 4.84 9.32 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.48 13.59 5.38 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 218' ' ' SER . 1.8 p -107.96 -153.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -1.081 . . . . 0.0 109.489 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.753 ' N ' HG13 ' A' ' 217' ' ' VAL . 50.4 m -67.52 58.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.906 -1.121 . . . . 0.0 110.213 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 217' ' ' VAL . 13.8 m-20 -83.68 99.55 10.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 156.12 -149.11 19.97 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.371 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 48.0 m-85 -63.06 89.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.536 -0.979 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 218' ' ' SER . 4.3 m-85 -136.53 129.56 31.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.002 -1.061 . . . . 0.0 110.07 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.644 HH12 ' HB2' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -89.31 18.62 5.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.344 -0.847 . . . . 0.0 109.777 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 224' ' ' LEU . 3.9 mm? -73.98 37.28 0.1 Allowed 'General case' 0 C--N 1.285 -2.198 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.543 ' OD2' ' CE1' ' A' ' 197' ' ' PHE . 4.1 m-20 -86.33 -9.54 56.19 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.229 -0.919 . . . . 0.0 108.883 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.644 ' HB2' HH12 ' A' ' 223' ' ' ARG . . . -88.53 -65.38 1.02 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 227' ' ' LEU . 0.5 OUTLIER -91.8 -157.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -92.68 155.06 42.22 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.941 -1.099 . . . . 0.0 109.671 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.565 ' HB3' ' CE2' ' A' ' 212' ' ' TRP . 35.4 Cg_endo -78.21 -161.39 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.82 2.346 . . . . 0.0 110.536 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.72 11.04 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.446 ' HB1' ' NE1' ' A' ' 214' ' ' TRP . . . -103.16 68.13 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.404 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 -26.27 26.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.953 . . . . 0.0 109.538 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.74 142.61 0.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 85.8 m -97.88 -44.31 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -1.139 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -93.98 -57.47 1.31 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.14 90.08 1.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 134.49 110.74 1.15 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -91.57 35.38 0.95 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -1.109 . . . . 0.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 45.58 83.93 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.33 -173.7 22.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -122.78 171.39 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.172 -1.193 . . . . 0.0 109.491 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 1.8 t-20 -95.31 75.92 3.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -79.32 -45.85 8.52 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 21.1 m-85 -135.43 158.19 45.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.543 -0.975 . . . . 0.0 108.792 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 163' ' ' GLY . 4.4 pt20 -152.31 143.6 23.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.066 -1.021 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.503 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 14.2 p -155.96 152.4 28.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 109.89 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 185' ' ' TYR . . . -132.12 167.76 19.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.119 0.961 . . . . 0.0 109.854 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.757 HG23 ' CD1' ' A' ' 185' ' ' TYR . 8.7 t -117.42 116.25 51.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.817 HG23 ' NE2' ' A' ' 158' ' ' HIS . 29.4 m -117.64 145.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.734 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 89.89 49.12 3.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.686 HG12 HD13 ' A' ' 147' ' ' LEU . 4.3 mt -98.98 89.05 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.774 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -160.34 150.71 15.08 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.451 -0.781 . . . . 0.0 109.117 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.635 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 33.9 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.447 2.098 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 204' ' ' GLY . 38.6 tt0 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.66 145.17 20.27 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.448 2.099 . . . . 0.0 110.257 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.24 142.94 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.114 -0.991 . . . . 0.0 109.611 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 178' ' ' LEU . 70.1 t -139.47 131.53 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 109.261 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 200' ' ' ASP . 7.4 mmtp -76.23 -177.46 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.184 -0.947 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 32.8 t -78.06 104.35 8.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 109.911 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 48.4 mt -57.84 -52.87 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.528 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 211' ' ' ASN . 16.3 mt -54.44 -40.08 68.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.768 -1.207 . . . . 0.0 108.748 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -68.06 -42.57 80.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.912 . . . . 0.0 109.286 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 p -58.49 -14.78 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.086 -1.009 . . . . 0.0 109.218 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.591 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -116.37 22.54 12.76 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.07 33.5 2.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 11' ' ' LYS . 31.5 mt -85.85 109.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.498 -1.001 . . . . 0.0 110.261 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 102' ' ' PRO . 40.1 m80 -134.8 77.46 1.69 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.626 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.0 m-30 -85.13 177.08 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.148 0.975 . . . . 0.0 111.197 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -147.68 -164.26 1.96 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 45' ' ' THR . 25.8 mt-30 -124.85 -20.57 4.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.856 -1.153 . . . . 0.0 110.583 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.731 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.43 -34.56 1.42 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.469 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.811 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 -140.22 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.466 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.846 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.811 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.8 Cg_endo -74.2 3.44 5.17 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 CA-C-N 122.511 1.933 . . . . 0.0 109.559 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' CD2' HG12 ' A' ' 116' ' ' ILE . 9.1 m-85 -78.87 -31.37 45.53 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.478 -0.764 . . . . 0.0 108.962 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 28.1 p-10 -93.9 19.84 8.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.556 -1.34 . . . . 0.0 109.617 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.3 mt -74.49 -3.05 28.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 24' ' ' LEU . 6.3 mt -129.24 -0.98 5.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 0.0 109.485 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -66.12 166.01 18.91 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.7 Cg_endo -71.32 141.36 38.87 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.368 2.045 . . . . 0.0 112.223 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 35.8 t -80.01 147.05 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.777 HD11 ' C ' ' A' ' 132' ' ' GLY . 21.6 mt -77.88 148.47 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.704 0.764 . . . . 0.0 110.853 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.508 ' C ' HG22 ' A' ' 39' ' ' VAL . 1.6 mm-40 -125.73 -21.54 4.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.621 -0.675 . . . . 0.0 110.432 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 80' ' ' PHE . 13.8 mtpp -122.76 166.97 14.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 36' ' ' GLN . 91.8 t -114.63 150.45 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.558 -0.714 . . . . 0.0 110.577 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -75.81 163.18 68.67 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.2 Cg_endo -81.61 122.38 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.411 2.074 . . . . 0.0 110.606 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.48 86.23 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.58 169.37 9.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.089 -1.242 . . . . 0.0 109.778 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 31' ' ' VAL . 1.9 mp0 -66.83 172.07 4.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.632 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -86.93 133.27 33.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.0 109.435 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 76.0 m-85 -123.62 15.89 9.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.931 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 28' ' ' ILE . 94.1 t -63.3 136.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.51 -3.12 83.58 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.5 mt-30 -83.76 132.92 34.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.293 -1.122 . . . . 0.0 109.605 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -73.64 110.31 7.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.48 159.39 1.03 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.8 171.78 14.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.455 0.645 . . . . 0.0 109.701 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.696 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.6 p -80.81 -34.62 33.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 108.708 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 105.34 137.29 8.92 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -48.03 74.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.326 -1.103 . . . . 0.0 108.313 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 137' ' ' SER . 3.3 t -46.93 -53.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -63.47 -47.94 79.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.888 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 70.9 m -62.91 -30.47 71.57 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.642 -0.661 . . . . 0.0 109.499 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.5 -46.7 72.14 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.808 -1.157 . . . . 0.0 108.439 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 56' ' ' MET . 40.3 m -76.2 -49.5 17.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.293 0.568 . . . . 0.0 110.752 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -51.02 -34.28 28.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.177 -0.952 . . . . 0.0 108.742 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.6 mt-30 -68.26 -48.95 63.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 198' ' ' VAL . 55.2 mt -65.58 -23.1 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.57 ' HG3' HG22 ' A' ' 52' ' ' THR . 22.8 mtp -73.92 -34.23 64.26 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 42.8 tptt -72.34 -45.46 59.82 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 38.4 t80 -52.42 -30.83 31.36 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.265 0.555 . . . . 0.0 109.815 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.638 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 59.3 m-70 -108.35 -24.09 11.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 111.151 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' CB ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 40.23 57.15 2.5 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.0 t80 -79.33 -71.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.0 Cg_endo -68.34 103.43 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 122.26 0.611 . . . . 0.0 111.838 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -21.88 63.48 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 4.9 ttpt -134.8 141.25 46.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.08 146.6 39.29 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.351 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.925 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -82.91 -45.15 14.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -1.027 . . . . 0.0 110.206 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.2 ttpp -152.16 135.29 15.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.035 -1.041 . . . . 0.0 110.069 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' N ' ' H ' ' A' ' 91' ' ' SER . 0.5 OUTLIER -60.65 164.39 4.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.043 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 45.2 t80 -143.37 154.37 43.66 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t -154.52 150.43 27.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 14.7 p90 -155.3 152.3 29.04 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 46.5 m -92.75 140.25 29.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.759 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.7 tp -55.5 148.57 15.26 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 111.467 -178.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 130' ' ' ASP . 3.5 p -61.69 141.87 57.57 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.301 0.572 . . . . 0.0 110.122 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.7 m -67.32 -5.41 14.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 5.9 m120 -99.45 -3.64 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.759 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.1 t-20 -70.68 111.78 10.82 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.552 -0.717 . . . . 0.0 109.878 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 49.1 Cg_endo -88.5 13.64 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.975 2.45 . . . . 0.0 109.792 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.638 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 59.2 m-85 -112.73 -4.07 14.12 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.283 -0.885 . . . . 0.0 111.641 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.489 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 69.1 m-85 -140.62 161.0 38.79 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 44.5 m-80 -47.77 -81.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 1.1 m-70 174.95 -46.84 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.506 -0.746 . . . . 0.0 110.929 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.2 Cg_endo -76.95 54.6 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 N-CA-C 107.419 -1.8 . . . . 0.0 107.419 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 4.8 tptt -105.67 105.71 15.87 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.068 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.6 m-80 -100.3 140.06 35.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.216 -0.927 . . . . 0.0 109.754 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.7 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -113.93 128.38 56.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -120.31 129.68 54.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.094 -1.003 . . . . 0.0 110.235 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.64 111.13 23.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.56 52.44 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.733 -1.23 . . . . 0.0 108.372 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.654 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 7.7 mt -52.43 -52.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.565 -0.709 . . . . 0.0 109.417 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -45.51 -26.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.785 -1.197 . . . . 0.0 109.096 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -112.26 19.85 17.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 17.5 mmt-85 -76.59 152.84 35.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 110.304 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 89.11 3.04 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.0 m-85 -81.0 89.9 5.95 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 110.508 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 15.9 t-20 -80.05 92.32 5.6 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.633 ' CD2' ' CB ' ' A' ' 60' ' ' ASN . 76.4 m95 -61.14 -8.82 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 110.026 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -90.79 -15.94 29.22 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 27.2 m-20 -99.26 -33.59 10.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 30.6 mt -73.46 93.71 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 30.1 mt -71.05 151.33 94.9 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 14' ' ' HIS . 30.9 Cg_endo -78.87 -28.15 4.23 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.132 . . . . 0.0 110.223 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.93 127.65 27.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.902 . . . . 0.0 109.31 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.6 m-85 -112.0 145.33 39.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 109.874 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 p -100.11 -12.79 19.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.98 -3.4 62.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -118.68 15.32 13.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.153 . . . . 0.0 109.287 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.02 -172.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.2 p -87.32 179.82 6.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.433 -0.792 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -78.01 -38.61 44.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.54 -58.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.71 -35.27 79.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.289 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.521 ' HD3' ' CD1' ' A' ' 23' ' ' LEU . 14.6 mttm -64.02 -43.06 96.75 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.46 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 23.1 ttm -60.0 -38.29 82.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.55 -68.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.704 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 119' ' ' LEU . 5.3 tp -66.0 -48.64 81.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.386 -0.821 . . . . 0.0 109.68 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 116' ' ' ILE . 51.3 p -47.48 -44.84 25.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.938 -1.101 . . . . 0.0 108.378 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.585 ' CG ' ' NE ' ' A' ' 93' ' ' ARG . 4.2 tt0 -70.26 -47.47 61.13 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.875 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.2 tp -48.62 -51.66 26.97 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.696 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.3 mmt -60.26 -46.55 89.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.688 -0.632 . . . . 0.0 109.755 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -63.58 -35.64 81.17 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.759 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 4.9 m-20 -68.09 -55.47 12.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 127' ' ' VAL . 44.8 t -62.93 -58.32 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.0 109.185 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -45.55 -50.13 11.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.2 mt -63.68 -58.98 5.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.185 -1.186 . . . . 0.0 108.216 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.9 OUTLIER -46.4 -28.59 1.4 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.39 -177.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 24.2 m -101.24 34.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.592 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 127' ' ' VAL . 5.2 m-20 38.74 53.05 1.93 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.321 -0.862 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 131' ' ' TYR . 58.4 tpp -65.69 127.01 30.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 111.726 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' SER . 0.7 OUTLIER -75.92 121.64 22.98 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 52.5 m-85 -103.31 117.69 35.08 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.545 1.164 . . . . 0.0 113.316 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.777 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.02 -162.55 10.75 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 104.617 -3.393 . . . . 0.0 104.617 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.652 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.8 Cg_endo -62.45 -30.89 80.66 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 105.812 -2.418 . . . . 0.0 105.812 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.86 140.75 43.45 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 173.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 47.4 m -121.09 109.69 15.33 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 119.913 -1.742 . . . . 0.0 110.076 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.9 136.76 13.66 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.444 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 11.2 t -111.66 -161.69 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB3' ' HG3' ' A' ' 142' ' ' ARG . . . -90.89 -57.1 2.93 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.603 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 136.55 -134.57 7.2 Favored Glycine 0 N--CA 1.479 1.54 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.504 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.647 ' HG ' ' HE1' ' A' ' 185' ' ' TYR . 3.8 m -52.85 -53.26 51.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.804 -0.821 . . . . 0.0 111.89 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 140' ' ' SER . 5.2 p -45.89 -41.85 11.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.003 . . . . 0.0 109.07 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 138' ' ' ALA . 26.3 mmt180 -81.35 -43.15 19.45 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.635 HG21 ' CE2' ' A' ' 185' ' ' TYR . 41.5 t -68.38 -53.88 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 110.634 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 140' ' ' SER . 2.1 pp0? -56.71 -34.21 67.24 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.256 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -77.82 -51.19 10.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.973 178.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.1 79.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.113 -0.992 . . . . 0.0 110.049 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 251' ' ' ILE . 38.4 mt -58.04 -51.55 69.21 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.482 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 29.3 mtmt -80.27 -45.78 17.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 110.182 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 86.2 mt-10 -68.32 -52.03 38.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.048 -1.033 . . . . 0.0 111.905 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.5 m120 -90.43 -46.55 8.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.798 -1.189 . . . . 0.0 111.935 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' GLY . 29.9 m-85 -99.38 13.68 32.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.648 -1.282 . . . . 0.0 110.938 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.925 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 34.34 41.46 0.22 Allowed Glycine 0 N--CA 1.496 2.679 0 O-C-N 121.512 -0.742 . . . . 0.0 112.815 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' ASN . 8.5 m-85 -63.14 169.94 3.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.126 -1.808 . . . . 0.0 107.883 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 30.3 t30 -47.6 136.57 10.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.72 -1.238 . . . . 0.0 109.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.16 -21.01 4.4 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.201 -0.937 . . . . 0.0 108.79 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.503 ' HB3' ' ND2' ' A' ' 154' ' ' ASN . 84.4 p -53.6 -17.44 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 109.787 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 251' ' ' ILE . 37.5 t -58.42 125.17 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.969 -1.082 . . . . 0.0 109.121 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 1.004 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.3 p-80 -146.42 156.7 43.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.562 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 5.6 tt0 -101.74 150.35 23.22 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.872 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.718 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 20.3 pt -130.77 154.22 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.6 m-80 -119.2 106.16 12.08 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.163 . . . . 0.0 110.906 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 tpt85 -48.03 -45.03 31.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.461 -0.775 . . . . 0.0 109.765 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.92 -22.75 58.13 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 6.7 m-20 -104.75 2.03 29.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.198 -1.177 . . . . 0.0 111.7 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -117.67 175.03 5.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.498 -1.376 . . . . 0.0 110.665 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.474 ' O ' ' C ' ' A' ' 167' ' ' LYS . 1.1 p -100.46 138.19 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.3 ttmm -35.39 -49.61 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.688 -0.632 . . . . 0.0 110.629 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.431 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 38.3 mm-40 -64.15 -58.3 7.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.004 -1.06 . . . . 0.0 109.777 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.86 -20.77 65.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.455 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.718 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 68.6 t-105 -76.15 -44.69 37.1 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 174' ' ' ILE . 83.1 mt-10 -73.52 -36.91 65.78 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.172 -0.955 . . . . 0.0 108.497 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.8 -44.3 49.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.443 ' NE2' HG21 ' A' ' 249' ' ' VAL . 22.1 mm100 -61.58 -42.08 98.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 109.028 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.798 HG23 HG21 ' A' ' 184' ' ' VAL . 11.5 mt -75.83 -58.08 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 111.051 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.78 -54.05 21.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 0.0 109.665 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -51.03 -41.27 59.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.578 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 6.0 mm-40 -59.13 -50.53 73.7 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.729 ' HB3' HG11 ' A' ' 4' ' ' VAL . 15.2 mt -68.32 -25.92 65.36 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 110.099 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.414 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 10.5 p -52.43 -40.19 61.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.95 -1.094 . . . . 0.0 108.427 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 31.1 mt-30 -97.7 31.61 2.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 7' ' ' LEU . 86.9 m-20 48.61 49.2 18.89 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 26.6 mt-30 -123.7 107.38 31.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.512 ' HD3' HD13 ' A' ' 7' ' ' LEU . 16.2 Cg_endo -64.05 168.9 11.41 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.125 1.883 . . . . 0.0 112.791 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 174' ' ' ILE . 50.6 t -120.9 134.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.551 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.926 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -82.56 116.02 21.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 5.7 t80 -122.25 158.16 30.09 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 120.954 -1.091 . . . . 0.0 109.355 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -167.2 128.45 1.58 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 117.881 -1.528 . . . . 0.0 111.549 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.441 ' CA ' ' ND2' ' A' ' 228' ' ' ASN . . . -92.01 115.79 4.87 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.3 t -80.6 169.55 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.221 -1.164 . . . . 0.0 111.171 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -173.99 -142.91 4.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.6 -28.86 21.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.157 -1.202 . . . . 0.0 110.739 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 238' ' ' ALA . 4.1 m -83.0 -14.1 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.931 -1.106 . . . . 0.0 110.973 -178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.02 -171.06 21.11 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -82.8 105.82 2.69 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.878 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 15.2 t-80 -70.93 127.58 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 187' ' ' GLN . . . -120.44 161.62 20.93 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.426 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 210' ' ' VAL . 33.0 p90 -157.56 -171.35 3.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 55' ' ' ILE . 75.3 t -134.0 134.94 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.617 -1.302 . . . . 0.0 111.218 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 174' ' ' ILE . 56.1 mt -97.66 119.25 45.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 33.9 p30 -130.62 31.9 4.48 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.564 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -173.65 161.72 32.39 Favored Glycine 0 N--CA 1.484 1.839 0 C-N-CA 117.254 -2.403 . . . . 0.0 112.457 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.507 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -143.46 145.3 32.49 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -116.57 17.69 15.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.863 -1.148 . . . . 0.0 110.328 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 1' ' ' GLN . . . 77.33 -51.26 3.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -79.7 50.69 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.067 -1.255 . . . . 0.0 109.525 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 51.04 35.25 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' ASP . 0.2 OUTLIER -115.37 130.08 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.063 -1.023 . . . . 0.0 108.96 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 6.8 m-85 -122.97 156.72 34.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.895 -1.128 . . . . 0.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 200' ' ' ASP . 61.0 t-80 -93.29 114.78 27.32 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 197' ' ' PHE . 14.3 t -113.89 142.76 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.077 . . . . 0.0 111.797 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.531 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.1 t-20 -101.32 77.7 1.81 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.462 ' CH2' ' O ' ' A' ' 228' ' ' ASN . 45.1 m95 -44.99 168.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.683 0.754 . . . . 0.0 110.991 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 17' ' ' GLN . . . -80.58 8.69 53.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 231' ' ' ALA . 96.0 m95 -107.03 -169.54 1.56 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -1.223 . . . . 0.0 109.669 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.47 -90.99 0.35 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.08 66.93 0.57 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.839 HG22 ' N ' ' A' ' 218' ' ' SER . 1.2 p -97.79 -97.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 109.66 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.839 ' N ' HG22 ' A' ' 217' ' ' VAL . 50.8 m -90.45 24.23 2.68 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.117 -0.99 . . . . 0.0 109.521 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.57 125.08 16.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 139.2 -115.28 1.1 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.044 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.508 ' HB2' ' CE1' ' A' ' 207' ' ' PHE . 7.1 p90 -60.44 137.89 58.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.309 -1.112 . . . . 0.0 109.926 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.799 ' CD2' HD23 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -85.88 164.58 17.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.577 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.563 ' O ' HD22 ' A' ' 224' ' ' LEU . 25.2 mtm180 -129.24 124.24 33.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.529 -0.732 . . . . 0.0 109.077 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.799 HD23 ' CD2' ' A' ' 222' ' ' PHE . 1.4 mm? -121.35 25.78 9.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.96 . . . . 0.0 110.486 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -60.89 2.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.871 -1.143 . . . . 0.0 109.29 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -122.32 -95.35 0.48 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -91.83 174.25 7.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 108.756 179.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.609 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 3.1 m-20 -95.24 -45.51 0.27 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 113.038 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 228' ' ' ASN . 33.1 Cg_endo -75.53 142.19 26.03 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.388 2.059 . . . . 0.0 110.7 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.56 -8.13 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.734 ' HB2' HG11 ' A' ' 217' ' ' VAL . . . -81.32 93.0 6.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 231' ' ' ALA . 9.0 mt -135.77 179.3 6.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 96.33 -5.52 65.3 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 25.0 m -95.57 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.031 -1.276 . . . . 0.0 109.689 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.41 167.26 29.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.15 96.12 0.64 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -155.83 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.625 ' HB2' HG13 ' A' ' 192' ' ' VAL . . . -73.14 -56.45 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -1.171 . . . . 0.0 109.364 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.74 46.83 10.59 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 227' ' ' LEU . . . 68.43 75.83 0.48 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -122.43 130.91 53.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.406 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 242' ' ' ASN . 1.3 t-20 -115.82 70.27 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -81.68 -40.81 10.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.475 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -135.04 152.9 52.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 6.4 tt0 -153.8 141.8 20.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.128 . . . . 0.0 109.309 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -166.75 163.29 16.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.763 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' ILE . . . -140.39 165.35 27.66 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.293 1.044 . . . . 0.0 109.749 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.926 HG23 ' CD1' ' A' ' 185' ' ' TYR . 6.6 t -118.32 114.9 46.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 1.004 HG23 ' CE1' ' A' ' 158' ' ' HIS . 27.1 m -115.25 144.95 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 120.942 -1.099 . . . . 0.0 111.092 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 88.69 51.73 2.99 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.638 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 6.0 mt -102.54 95.36 3.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -1.049 . . . . 0.0 109.971 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.65 153.92 13.28 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 108.899 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.64 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.8 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.211 1.941 . . . . 0.0 110.509 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.723 ' NE2' ' CE1' ' A' ' 208' ' ' TYR . 39.4 tt0 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.7 Cg_endo -77.71 179.04 6.89 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.283 1.988 . . . . 0.0 109.931 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 203' ' ' ASP . 53.7 t -107.06 142.93 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 109.391 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.731 HG11 ' HB3' ' A' ' 178' ' ' LEU . 63.8 t -136.34 131.1 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.272 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -76.64 172.94 12.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 108.571 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.493 ' HG ' ' CE1' ' A' ' 209' ' ' HIS . 47.2 t -77.52 103.32 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.119 -0.988 . . . . 0.0 109.158 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 30.5 mt -58.62 -50.61 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.552 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 198' ' ' VAL . 11.5 mt -55.41 -37.08 67.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.599 -1.313 . . . . 0.0 108.861 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.5 OUTLIER -67.49 -41.44 84.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 p -58.14 -14.65 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 109.278 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.1 mtpt -121.51 16.4 11.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.82 42.48 6.3 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 58' ' ' TYR . 43.1 mt -87.99 110.83 21.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.196 0.998 . . . . 0.0 110.504 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 102' ' ' PRO . 55.3 m80 -134.7 97.71 3.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.5 m-30 -104.0 178.46 4.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.984 -1.073 . . . . 0.0 110.938 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 -165.43 2.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.52 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 13.9 mt-30 -124.57 -16.61 6.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.004 -1.06 . . . . 0.0 110.221 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.723 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.77 -37.25 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.305 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.53 -139.57 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.124 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.5 Cg_endo -74.39 3.35 5.35 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 CA-C-N 122.625 1.973 . . . . 0.0 109.161 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' CE1' ' HB3' ' A' ' 19' ' ' ASN . 8.3 m-85 -77.79 -32.29 52.36 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.533 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 37.9 p-10 -94.46 17.8 12.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 20' ' ' PRO . 12.2 mt -74.18 4.88 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 110.401 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 24' ' ' LEU . 9.2 mt -139.45 2.5 2.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.68 -1.262 . . . . 0.0 110.389 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.6 p -63.4 164.33 15.39 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 20.5 Cg_endo -70.07 137.16 33.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.731 1.621 . . . . 0.0 110.73 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 145.58 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.649 0.738 . . . . 0.0 110.085 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.717 HD11 ' HA2' ' A' ' 132' ' ' GLY . 6.5 mt -77.43 151.36 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.476 0.655 . . . . 0.0 110.354 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 39' ' ' VAL . 25.5 mt-10 -124.77 -25.44 3.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.468 -0.77 . . . . 0.0 110.779 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' TYR . 4.6 mtpm? -117.38 177.22 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.918 -1.114 . . . . 0.0 109.917 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 37' ' ' SER . 97.3 t -114.31 146.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.893 . . . . 0.0 111.536 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 22.2 tttt -86.43 129.67 52.37 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -69.1 124.32 11.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.343 1.362 . . . . 0.0 110.277 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.99 11.87 29.0 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.0 tt0 -152.32 166.51 31.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.292 -1.122 . . . . 0.0 109.606 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -175.33 0.26 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 108.748 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 31' ' ' VAL . 32.4 t -87.57 138.88 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.01 -1.057 . . . . 0.0 110.332 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.757 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 18.7 m-30 -111.77 10.97 20.91 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.046 -1.034 . . . . 0.0 109.33 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 29' ' ' GLU . 17.6 t -61.22 119.26 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.749 -1.219 . . . . 0.0 108.726 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.9 -11.23 57.47 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 20.8 mt-30 -76.5 134.41 39.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.569 -0.959 . . . . 0.0 109.305 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -73.19 112.71 9.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ASN . . . -52.83 163.76 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -87.57 170.18 11.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.863 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.578 HG21 ' SD ' ' A' ' 120' ' ' MET . 30.3 p -82.73 -36.58 25.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 102.82 136.36 9.1 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.504 ' N ' ' NE2' ' A' ' 17' ' ' GLN . 2.1 p -54.58 -50.44 68.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.138 -1.213 . . . . 0.0 108.02 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 40.6 t -46.44 -54.86 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -59.15 -51.31 70.57 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.034 0.921 . . . . 0.0 109.625 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 48.0 m -62.92 -34.5 77.58 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.813 -0.554 . . . . 0.0 110.232 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' CB ' ' HB1' ' A' ' 196' ' ' ALA . . . -67.24 -39.95 86.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.575 -1.328 . . . . 0.0 108.331 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 56' ' ' MET . 61.8 m -74.41 -52.04 13.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.608 0.718 . . . . 0.0 109.993 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' HB3' ' HE2' ' A' ' 120' ' ' MET . . . -52.06 -39.35 59.52 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.638 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.7 mt-30 -59.57 -53.1 61.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.726 -1.233 . . . . 0.0 107.86 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.765 HD11 HG22 ' A' ' 198' ' ' VAL . 26.1 mt -63.24 -29.63 47.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.537 ' SD ' HG22 ' A' ' 123' ' ' VAL . 26.2 mtp -66.23 -42.61 88.41 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.573 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.5 tptt -67.51 -39.43 85.13 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 55.3 t80 -53.7 -32.5 52.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.644 -0.66 . . . . 0.0 110.245 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 80.6 m-70 -107.03 -21.26 13.06 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.261 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.623 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 81.4 m-20 44.37 53.39 6.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 2.2 t80 -74.11 -76.62 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.7 -0.8 . . . . 0.0 113.082 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.93 105.1 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 CA-C-N 119.071 0.704 . . . . 0.0 112.084 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.2 m-80 -69.9 -21.51 63.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.04 141.73 49.32 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.37 147.99 34.51 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.601 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.914 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -82.61 -48.77 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.585 -0.95 . . . . 0.0 109.94 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 28.3 tttp -151.59 140.07 20.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 109.626 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 39.1 m-20 -59.35 172.7 0.6 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.471 -0.768 . . . . 0.0 109.767 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CD1' ' OD1' ' A' ' 150' ' ' ASN . 40.7 t80 -148.0 161.03 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.446 -0.784 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.418 ' N ' ' CD2' ' A' ' 69' ' ' TYR . 14.8 t -159.7 149.69 18.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.5 p90 -160.03 155.63 25.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.097 -1.002 . . . . 0.0 109.829 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 82.7 m -92.77 132.71 36.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.741 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.0 tp -44.45 147.76 0.54 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.264 -0.898 . . . . 0.0 110.77 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.1 t -61.27 143.63 55.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.434 0.635 . . . . 0.0 110.263 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 p -68.58 -3.93 13.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -99.56 -2.55 35.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.741 ' ND2' HD21 ' A' ' 73' ' ' LEU . 19.5 t-20 -71.27 110.89 8.3 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.763 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.592 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.8 Cg_endo -91.09 20.26 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.089 2.526 . . . . 0.0 108.886 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 38' ' ' PHE . 53.7 m-85 -114.93 -22.97 9.33 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.306 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -123.54 165.47 17.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 20.8 m-80 -47.94 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.8 -47.16 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 111.202 175.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -75.72 57.63 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.394 -1.81 . . . . 0.0 107.394 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.4 tptt -110.86 108.2 17.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.536 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.553 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.81 145.16 28.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 6.0 mp -116.98 156.99 26.52 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 32.8 t80 -143.26 128.37 18.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.978 -1.076 . . . . 0.0 110.424 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -107.83 115.38 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.04 53.3 0.35 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.653 -1.279 . . . . 0.0 108.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.8 mt -52.9 -55.84 10.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.451 -0.781 . . . . 0.0 110.339 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -45.7 -26.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.475 -1.39 . . . . 0.0 109.207 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -111.25 22.4 15.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.66 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 42.8 mmt-85 -82.45 152.7 26.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.983 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.471 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.02 91.27 3.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.616 ' HH ' ' HE1' ' A' ' 151' ' ' PHE . 3.8 m-85 -81.09 90.22 6.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 110.425 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 35.3 t-20 -80.03 90.27 5.39 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 51.9 m95 -61.16 -7.53 2.78 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.585 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -90.14 -18.52 25.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 16.6 m-20 -98.88 -30.06 12.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.674 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.1 mt -73.84 69.03 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 24.6 mt -47.45 150.26 1.71 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.805 -0.559 . . . . 0.0 110.108 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.532 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.9 Cg_endo -80.16 -28.13 3.26 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.824 2.349 . . . . 0.0 110.735 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -135.29 121.89 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.653 ' CE2' HG21 ' A' ' 116' ' ' ILE . 63.0 m-85 -109.53 139.9 43.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 109.899 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 p -100.19 -7.97 24.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.508 ' C ' ' HZ1' ' A' ' 113' ' ' LYS . . . 91.69 -0.01 73.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -118.37 7.31 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -1.123 . . . . 0.0 109.384 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 168.76 17.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.1 p -64.18 165.27 9.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.7 m-20 -71.72 -32.03 67.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -52.41 -61.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -33.65 75.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.508 ' HZ1' ' C ' ' A' ' 106' ' ' GLY . 17.0 mttt -65.88 -44.06 86.46 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.466 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -58.74 -36.53 74.47 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.674 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.19 -67.86 0.28 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.647 -0.658 . . . . 0.0 109.584 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.653 HG21 ' CE2' ' A' ' 104' ' ' TYR . 2.2 tp -63.74 -40.7 90.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 10.5 p -58.13 -43.38 87.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.92 -1.112 . . . . 0.0 108.841 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' OE2' ' CD ' ' A' ' 93' ' ' ARG . 50.3 tt0 -69.29 -38.0 78.1 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.61 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.6 tp -56.83 -52.37 65.36 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.1 mmt -57.78 -43.06 85.3 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.87 -38.61 91.56 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.644 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 6.1 m-20 -69.41 -54.85 12.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.537 HG22 ' SD ' ' A' ' 56' ' ' MET . 49.0 t -58.84 -62.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -46.37 -46.74 16.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.0 mt -63.63 -57.45 11.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.221 -1.164 . . . . 0.0 107.979 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.508 ' OG ' ' HB1' ' A' ' 146' ' ' ALA . 1.7 p -46.55 -27.33 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.81 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CB ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -104.5 31.53 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 45.7 m-20 41.75 43.52 2.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.158 -0.964 . . . . 0.0 109.747 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 45' ' ' THR . 35.2 tpp -60.37 134.2 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -0.778 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -76.96 123.16 25.91 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 34.3 m-85 -103.47 103.92 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -142.04 -170.03 12.36 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.757 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 13.6 Cg_endo -62.55 -20.91 72.08 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.633 -2.103 . . . . 0.0 106.633 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.64 130.31 55.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 72.6 m -113.87 113.83 25.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 119.753 -1.842 . . . . 0.0 110.339 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -107.67 126.48 8.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -118.06 -170.7 1.93 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.149 -1.207 . . . . 0.0 107.8 178.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.918 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -90.45 -49.95 6.23 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 116.76 -111.19 2.26 Favored Glycine 0 N--CA 1.481 1.657 0 C-N-CA 119.955 -1.117 . . . . 0.0 111.751 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.523 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 6.1 m -48.46 -72.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.735 -0.862 . . . . 0.0 112.317 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 11.4 p -46.61 -32.86 3.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 110.276 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.918 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 24.4 mmt180 -80.41 -49.92 10.8 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.972 -1.08 . . . . 0.0 109.787 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.9 t -68.37 -58.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.7 -0.625 . . . . 0.0 111.049 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 157' ' ' VAL . 3.1 pp0? -56.55 -31.88 64.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.016 -1.052 . . . . 0.0 108.608 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' SER . 1.9 ttm-85 -77.31 -52.84 8.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.002 -1.061 . . . . 0.0 109.61 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.508 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -63.95 -37.81 88.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.0 110.053 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.631 ' HB2' HG11 ' A' ' 157' ' ' VAL . 34.3 mt -55.21 -47.31 75.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.559 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 50.5 mtmt -87.38 -45.17 10.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.063 -1.023 . . . . 0.0 110.887 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.96 -48.99 69.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.999 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.56 ' OD1' ' CD1' ' A' ' 69' ' ' TYR . 10.5 m120 -94.36 -45.43 7.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.676 -1.265 . . . . 0.0 111.645 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' HE1' ' HH ' ' A' ' 95' ' ' TYR . 27.4 m-85 -99.97 18.67 17.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.763 -1.21 . . . . 0.0 110.716 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.914 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.16 43.55 0.07 OUTLIER Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.777 -0.577 . . . . 0.0 112.857 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 7.0 m-85 -64.17 164.16 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.267 -1.725 . . . . 0.0 108.013 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 27.3 t-20 -47.99 151.4 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.843 -1.161 . . . . 0.0 109.626 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 9.0 mm100 -56.16 -17.14 6.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.066 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.593 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 22.3 p -55.17 -14.84 1.85 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.84 . . . . 0.0 109.852 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 147' ' ' LEU . 39.8 t -72.66 119.61 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.711 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -149.56 -177.7 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.596 178.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.523 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.7 tt0 -123.42 139.1 54.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.902 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.7 pt -123.91 176.2 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 1.2 m-80 -128.55 97.54 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.793 -1.192 . . . . 0.0 110.558 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 6.2 tpt180 -46.91 -41.15 15.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.047 -1.033 . . . . 0.0 109.327 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -59.72 -21.04 54.29 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 161' ' ' ASN . 64.3 m-20 -104.04 0.25 29.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.113 -1.228 . . . . 0.0 111.677 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.18 173.49 6.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.444 -1.41 . . . . 0.0 110.491 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 167' ' ' LYS . 18.6 p -101.33 136.51 41.05 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' HD2' HD12 ' A' ' 224' ' ' LEU . 15.0 ttpp -31.48 -51.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.912 -0.492 . . . . 0.0 111.228 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.65 -58.77 5.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.449 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.6 -19.67 63.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 0.0 108.513 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.4 t-105 -74.95 -47.55 28.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 19.8 mt-10 -64.15 -23.98 67.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.28 -43.44 98.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -60.5 -44.07 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 0.0 108.687 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 4.9 mt -74.24 -41.52 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 108.644 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.3 OUTLIER -50.74 -51.87 45.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 109.08 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -51.96 -50.73 60.64 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 53.7 mm-40 -56.64 -61.25 2.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.731 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.1 mt -55.72 -32.36 63.27 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.183 0.516 . . . . 0.0 110.263 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.5 p -52.32 -53.23 47.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.115 -0.991 . . . . 0.0 109.432 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 182' ' ' GLN . 25.5 mt-30 -88.75 44.13 1.19 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.0 m120 41.97 52.45 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 4.7 mt-30 -124.49 113.56 27.45 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.561 ' HG2' HG23 ' A' ' 55' ' ' ILE . 15.2 Cg_endo -66.34 169.14 14.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 121.743 1.629 . . . . 0.0 111.591 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 55.4 t -125.1 134.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.811 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.748 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.48 122.5 30.51 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 175.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 10.8 t80 -123.3 163.35 20.89 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.799 -1.188 . . . . 0.0 109.826 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.0 OUTLIER -166.17 123.6 1.41 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.281 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 245' ' ' GLN . . . -93.2 124.26 7.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 190' ' ' GLY . 60.5 t -82.03 158.4 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.81 -1.406 . . . . 0.0 111.212 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -161.56 -137.8 2.28 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -36.33 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -1.168 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.65 -6.78 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.943 -1.098 . . . . 0.0 111.077 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 124.71 -159.78 19.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.48 114.29 4.04 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.849 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 32.3 t-80 -70.3 145.48 51.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -123.56 154.72 38.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 117.852 -1.539 . . . . 0.0 113.908 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.865 ' CD1' HG13 ' A' ' 210' ' ' VAL . 10.4 p90 -163.4 163.56 24.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.765 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -112.51 137.51 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.869 -1.145 . . . . 0.0 112.171 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.684 ' HB ' ' HB ' ' A' ' 184' ' ' VAL . 50.5 mt -103.74 121.03 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 19.1 p30 -126.3 16.17 7.75 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.97 -1.092 . . . . 0.0 109.493 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 178' ' ' LEU . . . -160.98 172.31 37.23 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 116.613 -2.708 . . . . 0.0 114.721 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.745 ' CB ' ' CE1' ' A' ' 208' ' ' TYR . . . -159.06 152.07 22.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.42 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -126.97 28.82 5.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.416 -1.428 . . . . 0.0 109.494 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 1' ' ' GLN . . . 59.0 14.76 25.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -142.4 47.28 1.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -1.157 . . . . 0.0 108.972 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.99 19.87 2.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 108.967 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.682 ' CD1' ' CZ ' ' A' ' 222' ' ' PHE . 9.1 m-30 -102.06 92.38 4.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.745 ' CE1' ' CB ' ' A' ' 202' ' ' ALA . 3.3 m-30 -102.86 155.97 17.97 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.068 -1.02 . . . . 0.0 111.232 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.574 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.0 t60 -90.96 139.21 30.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.008 -1.682 . . . . 0.0 107.331 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.865 HG13 ' CD1' ' A' ' 197' ' ' PHE . 19.4 t -131.09 139.62 50.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.517 ' HB3' ' HB ' ' A' ' 198' ' ' VAL . 39.3 t-20 -114.04 84.17 1.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.596 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 94.8 m95 -52.14 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -7.79 52.18 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.412 ' HB2' HG12 ' A' ' 217' ' ' VAL . 77.3 m95 -108.26 168.93 8.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -1.168 . . . . 0.0 108.908 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -127.6 4.92 7.09 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.024 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -130.42 5.72 5.93 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.847 HG13 ' N ' ' A' ' 218' ' ' SER . 1.4 p -107.19 -150.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -1.204 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.847 ' N ' HG13 ' A' ' 217' ' ' VAL . 15.0 m -64.91 54.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 217' ' ' VAL . 7.9 m-20 -91.29 95.12 9.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 109.814 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' VAL . . . 157.77 -53.94 0.39 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.87 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.648 ' CE2' ' CG ' ' A' ' 223' ' ' ARG . 2.1 p90 -60.05 109.21 0.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.04 -1.271 . . . . 0.0 111.297 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.682 ' CZ ' ' CD1' ' A' ' 207' ' ' PHE . 0.8 OUTLIER -51.24 125.9 15.33 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.443 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.648 ' CG ' ' CE2' ' A' ' 221' ' ' PHE . 5.0 mmm180 -128.6 118.85 23.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 109.356 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -121.33 -6.21 9.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.02 -23.53 9.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 109.186 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.429 ' HB3' ' NE ' ' A' ' 223' ' ' ARG . . . -122.99 89.07 3.04 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.259 1.028 . . . . 0.0 108.768 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.597 HD21 ' HE2' ' A' ' 197' ' ' PHE . 0.1 OUTLIER -91.26 54.19 2.51 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.628 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -114.2 156.82 43.71 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.259 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.22 144.36 23.28 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.585 2.19 . . . . 0.0 110.693 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -44.81 10.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.26 109.55 21.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mp -92.07 -65.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 109.378 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.6 -150.85 24.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -71.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -1.181 . . . . 0.0 109.394 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -95.51 25.66 23.57 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -94.92 -67.34 1.01 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.8 26.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -120.2 -35.42 3.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.45 -143.3 7.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' PHE . . . 139.26 76.92 0.06 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.413 ' O ' ' O ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -54.96 -172.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -1.163 . . . . 0.0 109.27 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 242' ' ' ASN . 1.8 t-20 -104.55 70.05 0.93 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 109.398 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -73.12 -46.15 28.87 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.505 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 90.1 m-85 -136.14 166.19 23.98 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.577 ' NE2' ' CG ' ' A' ' 162' ' ' ARG . 7.3 tt0 -156.96 132.43 9.26 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.043 -1.036 . . . . 0.0 109.123 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -148.83 166.76 27.54 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.748 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -140.64 151.99 45.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.116 0.96 . . . . 0.0 110.057 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 84.7 t -109.15 118.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.711 HG23 ' NE2' ' A' ' 158' ' ' HIS . 33.5 m -127.1 144.03 38.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.164 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 91.87 55.71 1.72 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.615 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 36.4 mt -102.44 81.62 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.35 -1.088 . . . . 0.0 110.148 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -156.89 148.91 17.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.185 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.262 1.975 . . . . 0.0 110.573 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.456 ' HG3' ' OD2' ' A' ' 175' ' ' ASP . 38.7 tt0 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.44 163.39 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.449 2.099 . . . . 0.0 110.028 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.71 142.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.101 -0.999 . . . . 0.0 109.599 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.819 HG11 ' HB3' ' A' ' 178' ' ' LEU . 58.8 t -135.48 130.54 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -75.91 -178.11 4.17 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.519 ' HB2' ' ND1' ' A' ' 209' ' ' HIS . 1.9 t -77.72 105.68 9.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.011 -1.056 . . . . 0.0 109.408 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.673 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 45.7 mt -57.4 -49.37 76.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 108.986 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 198' ' ' VAL . 10.4 mt -55.66 -41.57 73.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.807 -1.183 . . . . 0.0 108.781 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 24.5 t70 -67.4 -39.09 85.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.159 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -58.58 -14.38 8.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 13' ' ' ILE . 4.1 mtpp -121.01 21.74 11.24 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.28 -0.888 . . . . 0.0 108.707 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.78 38.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 58' ' ' TYR . 48.8 mt -86.61 109.62 19.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 122.283 1.039 . . . . 0.0 110.355 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 102' ' ' PRO . 20.1 m-70 -134.5 88.37 2.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.1 m-30 -95.0 -179.65 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.885 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 1.4 t-20 -148.54 -163.93 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.533 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 43.9 mt-30 -124.6 -23.37 4.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.076 -1.015 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.716 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -114.92 -34.67 1.47 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.308 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.21 -140.36 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.242 -178.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 35.5 Cg_endo -74.37 3.77 4.98 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 CA-C-N 122.545 1.945 . . . . 0.0 109.694 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 8.8 m-85 -80.41 -31.46 37.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.435 -0.791 . . . . 0.0 109.262 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.4 p-10 -92.13 15.26 13.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.604 -1.31 . . . . 0.0 109.103 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 23' ' ' LEU . 6.7 mt -69.55 -6.97 34.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.9 mt -125.92 -9.24 6.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.007 . . . . 0.0 109.761 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -60.88 166.64 4.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.4 Cg_endo -70.06 145.88 56.72 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.014 1.81 . . . . 0.0 112.367 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -85.74 148.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.554 0.692 . . . . 0.0 109.808 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.794 HD11 ' C ' ' A' ' 132' ' ' GLY . 25.4 mt -78.21 149.05 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.448 -0.782 . . . . 0.0 111.295 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 92.9 mt-10 -126.17 -22.16 4.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.596 . . . . 0.0 110.468 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 79' ' ' TYR . 30.3 mtpt -120.26 169.47 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.858 -1.151 . . . . 0.0 110.258 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 32' ' ' LYS . 88.0 t -114.44 154.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.6 ' HZ3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -86.73 158.88 53.26 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' HD3' ' HZ3' ' A' ' 32' ' ' LYS . 32.3 Cg_endo -82.56 107.01 1.56 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.607 2.204 . . . . 0.0 110.173 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.84 51.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 7.0 tt0 -122.0 159.33 27.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -1.172 . . . . 0.0 109.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -62.35 175.53 0.74 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.169 -0.957 . . . . 0.0 109.033 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' VAL . 1.3 t -80.61 134.97 35.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.146 -0.972 . . . . 0.0 109.075 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.8 m-85 -120.91 13.92 11.49 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.903 -1.123 . . . . 0.0 109.763 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 29' ' ' GLU . 58.7 t -62.99 141.07 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 109.436 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.27 80.36 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 6.6 mt-30 -86.92 132.84 33.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -1.188 . . . . 0.0 109.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -73.34 111.14 8.19 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.22 161.21 0.66 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.106 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.38 169.51 18.13 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.405 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.707 HG21 ' SD ' ' A' ' 120' ' ' MET . 24.0 p -80.66 -33.84 35.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 108.469 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 107.05 135.87 8.01 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.431 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 14.1 p -53.69 -47.89 70.05 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.593 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 29.9 t -47.8 -57.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.372 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.78 -45.16 93.14 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 110.555 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 76.2 m -62.5 -39.24 92.86 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.64 -0.662 . . . . 0.0 110.244 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.62 80.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.489 -1.382 . . . . 0.0 108.778 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.505 ' HB ' HG11 ' A' ' 123' ' ' VAL . 60.7 m -74.71 -55.19 6.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.3 -34.91 48.88 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.662 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 34.4 mt-30 -63.5 -53.83 45.82 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.2 mt -63.1 -22.29 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.498 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 24.7 mtp -73.36 -37.36 66.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 22.4 tptt -71.19 -40.07 71.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 40.9 t80 -53.65 -31.46 47.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.653 -0.654 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 81.1 m-70 -107.93 -22.4 12.45 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.287 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.639 ' CB ' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 39.13 57.3 2.0 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -178.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -77.54 -71.59 0.18 Allowed Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -69.17 105.65 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 120.272 0.648 . . . . 0.0 112.171 -176.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.04 -20.35 61.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 34.0 tttt -134.28 139.8 45.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -58.34 148.4 37.4 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.411 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.974 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -88.79 -46.79 8.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.518 -0.989 . . . . 0.0 109.822 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.504 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 38.3 tttt -151.92 140.51 20.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' SER . 10.7 m-20 -67.62 174.71 3.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 70' ' ' THR . 36.9 t80 -152.16 150.16 29.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.13 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.451 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.61 164.47 35.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.68 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 30.0 p90 -169.3 155.79 6.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 91.3 m -93.04 130.29 38.69 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.775 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -45.37 149.97 0.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 111.057 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -61.42 137.37 58.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.694 -0.629 . . . . 0.0 109.568 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -64.44 -7.24 9.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 109.875 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 m120 -96.73 -6.03 37.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.775 ' ND2' HD21 ' A' ' 73' ' ' LEU . 35.2 t-20 -71.04 111.8 11.19 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.628 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 53.3 Cg_endo -88.48 12.3 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.887 2.391 . . . . 0.0 109.8 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 70.9 m-85 -107.04 -1.99 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.205 -0.934 . . . . 0.0 111.461 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' O ' ' C ' ' A' ' 81' ' ' ASN . 34.0 m-85 -142.35 161.91 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.572 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.3 m-80 -47.54 -80.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 174.62 -46.47 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 111.008 174.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.94 55.98 5.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 175.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.83 103.46 12.97 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.649 -178.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -100.85 132.75 46.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 -179.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.4 mp -105.25 137.92 42.28 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 20.9 t80 -125.13 125.34 43.58 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.151 -0.968 . . . . 0.0 110.395 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -107.87 105.7 15.63 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.01 54.79 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 108.67 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 70.5 mt -52.71 -52.87 23.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.543 -0.723 . . . . 0.0 110.433 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.1 p -44.4 -25.47 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -110.56 35.75 3.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 108.565 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.708 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 23.5 mmt-85 -95.75 155.65 16.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.843 . . . . 0.0 110.735 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -118.69 91.41 3.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.2 m-85 -81.66 88.18 6.25 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 110.951 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.507 ' O ' HG13 ' A' ' 100' ' ' ILE . 42.8 t-20 -79.66 89.63 5.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.639 ' CG ' ' CB ' ' A' ' 60' ' ' ASN . 79.1 m95 -61.27 -6.62 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 110.85 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.44 -16.14 31.55 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -99.9 -30.84 11.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.658 HG12 ' HB1' ' A' ' 115' ' ' ALA . 27.7 mt -73.42 67.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.492 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 12.9 mt -46.32 150.71 1.08 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.554 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 28.9 Cg_endo -77.45 -26.67 7.05 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.607 2.205 . . . . 0.0 110.946 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 2.1 t -138.2 125.23 21.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.074 -1.016 . . . . 0.0 109.442 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 87.2 m-85 -109.62 139.45 44.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.91 4.51 45.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 108.991 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.72 -6.86 63.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -113.52 15.94 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -1.148 . . . . 0.0 109.395 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.452 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.3 mp0 -75.8 167.53 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -179.69 0.33 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -82.68 -43.94 16.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -51.54 -51.88 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.787 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -44.43 96.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.032 -1.043 . . . . 0.0 109.084 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 20' ' ' PRO . 75.8 mttt -61.93 -36.56 81.75 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.257 -0.902 . . . . 0.0 108.835 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.461 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 14.8 ttm -60.35 -45.32 93.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.366 -0.834 . . . . 0.0 110.021 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.13 -51.6 69.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 111.098 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.631 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.5 tp -69.35 -39.11 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.601 -1.312 . . . . 0.0 110.04 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 5.7 p -58.04 -41.49 83.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.098 -1.001 . . . . 0.0 110.44 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.888 ' N ' HD12 ' A' ' 24' ' ' LEU . 22.6 tt0 -68.86 -37.39 79.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.954 -1.091 . . . . 0.0 108.218 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.631 HD23 ' CD1' ' A' ' 116' ' ' ILE . 6.0 tp -57.95 -51.8 68.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.4 mmt -59.37 -40.62 87.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.524 -0.735 . . . . 0.0 109.465 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.23 -37.93 88.81 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -69.07 -57.43 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.955 ' O ' HG22 ' A' ' 127' ' ' VAL . 22.6 t -61.73 -48.48 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.048 -1.033 . . . . 0.0 108.835 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' MET . . . -54.64 -54.03 35.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 4.4 mt -65.91 -53.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.009 -1.289 . . . . 0.0 108.321 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 59.8 p -45.99 -32.11 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.577 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 123' ' ' VAL . 31.5 m -101.39 39.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.3 m-20 37.41 50.97 1.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.665 ' HE3' ' O ' ' A' ' 45' ' ' THR . 51.2 tpp -65.98 127.45 32.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.427 -0.795 . . . . 0.0 111.602 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 0.6 OUTLIER -76.26 123.05 25.29 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.654 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.4 m-85 -103.94 118.77 37.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.326 1.06 . . . . 0.0 113.578 -175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.794 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.07 -163.8 11.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 104.598 -3.401 . . . . 0.0 104.598 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.659 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.29 -30.86 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.573 -2.51 . . . . 0.0 105.573 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.88 142.03 41.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.4 m -122.25 113.22 19.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 119.855 -1.778 . . . . 0.0 110.157 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.47 132.49 11.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -117.84 -164.68 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -1.112 . . . . 0.0 108.12 178.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.86 -64.37 1.12 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.807 -1.183 . . . . 0.0 108.125 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.575 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 132.31 -130.56 5.92 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.837 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 144' ' ' GLN . 1.4 m -47.36 -55.59 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.745 -0.856 . . . . 0.0 111.531 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -45.69 21.22 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.867 -1.146 . . . . 0.0 109.269 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 2.6 mmp_? -80.63 -38.79 28.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.61 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 185' ' ' TYR . 76.2 t -67.77 -57.29 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.462 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 0.8 OUTLIER -56.7 -33.09 66.12 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.103 -1.039 . . . . 0.0 108.674 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' SER . 2.6 ttp85 -77.8 -46.45 21.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.8 76.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.699 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.647 HD12 HG11 ' A' ' 248' ' ' VAL . 59.1 mt -60.58 -46.5 90.0 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.697 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.582 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 43.5 mtmt -88.08 -38.87 15.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.784 -1.197 . . . . 0.0 110.722 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 48.3 mt-10 -72.87 -51.66 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.85 -1.156 . . . . 0.0 111.753 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.3 m120 -89.56 -41.38 12.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.884 -1.135 . . . . 0.0 111.587 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.83 8.25 39.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.756 -1.215 . . . . 0.0 110.834 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.974 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 39.38 40.92 1.44 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 121.172 -0.955 . . . . 0.0 112.122 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.13 168.9 3.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.385 -1.656 . . . . 0.0 108.318 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 252' ' ' LYS . 55.4 t30 -47.82 142.39 4.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.951 -1.093 . . . . 0.0 109.097 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.43 -20.91 5.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.923 . . . . 0.0 108.956 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.494 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 79.0 p -56.49 -14.46 3.09 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 109.94 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.582 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 7.0 t -61.82 122.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 0.0 109.586 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.986 ' CE1' HG23 ' A' ' 249' ' ' VAL . 12.1 p-80 -148.55 159.19 44.31 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.709 -0.797 . . . . 0.0 109.202 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.459 ' CD ' ' HB2' ' A' ' 140' ' ' SER . 2.3 tt0 -102.79 145.38 29.84 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 1.048 HD12 ' CH2' ' A' ' 170' ' ' TRP . 3.4 pt -121.77 154.4 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -121.53 99.51 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.874 -1.141 . . . . 0.0 110.646 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.629 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 1.1 tpt180 -46.29 -38.86 9.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.35 -24.26 61.16 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -104.52 1.54 29.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.243 . . . . 0.0 111.857 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -117.77 179.7 4.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.4 -1.437 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 167' ' ' LYS . 60.6 p -104.85 136.64 43.97 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.663 ' HG3' HD12 ' A' ' 224' ' ' LEU . 21.7 ttmt -34.35 -47.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.74 -0.6 . . . . 0.0 110.825 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.498 ' NE2' ' HD2' ' A' ' 167' ' ' LYS . 49.1 mm-40 -64.97 -59.5 4.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.117 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.51 -16.25 60.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.28 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 1.048 ' CH2' HD12 ' A' ' 160' ' ' ILE . 50.8 t-105 -71.01 -47.97 55.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HB3' ' OH ' ' A' ' 208' ' ' TYR . 33.8 mt-10 -67.1 -38.01 84.92 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -44.67 -49.59 10.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.511 ' O ' ' HG2' ' A' ' 177' ' ' GLU . 23.4 mm100 -61.1 -42.02 97.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 108.725 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.76 HG23 HG21 ' A' ' 184' ' ' VAL . 96.6 mt -71.71 -63.87 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 0.0 111.381 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.5 OUTLIER -48.11 -43.3 30.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 -177.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -51.84 -43.46 63.19 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.544 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 48.8 mm-40 -59.8 -53.51 57.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.819 ' HB3' HG11 ' A' ' 4' ' ' VAL . 11.4 mt -68.38 -25.06 64.88 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.911 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 175' ' ' ASP . 28.4 p -52.24 -40.12 61.23 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.7 mt-30 -99.94 33.54 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.576 ' C ' HD13 ' A' ' 7' ' ' LEU . 12.9 m120 49.22 48.99 20.38 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 10.6 mt-30 -124.15 114.78 27.67 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 19.7 Cg_endo -66.67 172.14 9.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.03 1.82 . . . . 0.0 112.187 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 249' ' ' VAL . 18.9 t -125.87 118.04 50.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.648 ' HD2' HG23 ' A' ' 248' ' ' VAL . 26.4 t80 -67.78 111.95 4.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.651 ' HB3' ' CE1' ' A' ' 197' ' ' PHE . 6.5 t80 -123.21 156.64 34.72 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 121.17 -0.956 . . . . 0.0 109.465 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.0 pt20 -164.65 128.73 2.52 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.813 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 245' ' ' GLN . . . -91.63 109.08 3.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 24.0 t -71.7 160.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.459 -1.024 . . . . 0.0 111.382 -177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -162.57 -137.8 2.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -43.32 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.05 -1.265 . . . . 0.0 111.13 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 238' ' ' ALA . 3.5 m -71.96 -13.56 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.96 -1.087 . . . . 0.0 111.457 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.99 -165.35 24.9 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -85.5 108.42 3.21 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.798 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 10.4 t-80 -71.48 118.34 14.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -107.4 160.52 15.58 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.773 1.273 . . . . 0.0 113.072 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.719 ' CD1' HG13 ' A' ' 210' ' ' VAL . 20.5 p90 -162.36 170.2 19.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 8' ' ' LEU . 47.4 t -114.37 136.07 52.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 120.673 -1.267 . . . . 0.0 112.234 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 65.7 mt -100.56 108.73 23.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 2.0 p30 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.68 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.426 ' N ' HD22 ' A' ' 178' ' ' LEU . . . -172.5 161.86 33.52 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 117.142 -2.456 . . . . 0.0 112.878 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.525 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -142.73 144.54 32.71 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 207' ' ' PHE . 1.8 t0 -114.11 11.45 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.751 -1.218 . . . . 0.0 110.61 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.77 -47.28 3.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -79.33 50.42 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 109.751 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 53.01 31.67 11.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 110.096 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.1 m-85 -121.06 135.89 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 109.769 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 5.7 m-85 -123.39 164.71 18.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.599 ' CD2' ' C ' ' A' ' 209' ' ' HIS . 0.7 OUTLIER -92.73 148.46 22.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.985 HG11 ' CE1' ' A' ' 222' ' ' PHE . 22.4 t -139.59 137.82 39.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.551 ' HB2' HD12 ' A' ' 8' ' ' LEU . 32.7 t-20 -102.02 80.58 2.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.499 ' CZ2' ' CZ ' ' A' ' 222' ' ' PHE . 1.6 m95 -45.95 170.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.84 . . . . 0.0 109.773 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -85.76 14.69 51.12 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 231' ' ' ALA . 99.5 m95 -107.2 -171.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.256 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.35 -95.64 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.42 69.25 0.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.79 HG22 ' N ' ' A' ' 218' ' ' SER . 2.1 p -105.62 -103.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.003 -1.292 . . . . 0.0 109.962 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.79 ' N ' HG22 ' A' ' 217' ' ' VAL . 3.8 m -89.03 13.98 11.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.861 -1.15 . . . . 0.0 109.971 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 217' ' ' VAL . 0.5 OUTLIER -64.47 138.45 58.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.6 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 132.0 -112.21 1.15 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -59.96 139.79 57.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.183 . . . . 0.0 109.187 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.985 ' CE1' HG11 ' A' ' 210' ' ' VAL . 0.1 OUTLIER -123.89 -179.14 4.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.933 . . . . 0.0 110.259 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -124.67 172.6 9.14 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.663 HD12 ' HG3' ' A' ' 167' ' ' LYS . 0.3 OUTLIER -120.87 -1.27 9.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.912 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.83 -26.86 3.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.025 -1.047 . . . . 0.0 109.966 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.17 88.16 2.88 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.112 0.958 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.868 HD11 ' CE2' ' A' ' 222' ' ' PHE . 0.1 OUTLIER -91.31 77.59 5.85 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.42 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 228' ' ' ASN . 1.5 m-20 -116.77 151.25 47.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.481 -0.762 . . . . 0.0 109.587 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.413 ' HG2' ' HG ' ' A' ' 232' ' ' LEU . 36.3 Cg_endo -78.83 169.63 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.771 2.314 . . . . 0.0 110.512 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.3 m -85.61 -60.26 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 214' ' ' TRP . . . -92.44 119.15 31.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.476 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 4.8 mp -112.37 -55.26 2.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 109.835 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 64.5 173.88 3.56 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 235' ' ' GLY . 46.2 p -109.06 -73.2 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.465 ' N ' ' OG1' ' A' ' 234' ' ' THR . . . -96.42 44.33 2.0 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.28 -40.52 1.5 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.601 ' O ' HG11 ' A' ' 192' ' ' VAL . . . 160.89 -108.86 0.37 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.829 ' HA ' HG21 ' A' ' 192' ' ' VAL . . . -55.95 -169.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -1.177 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.476 ' HA2' ' HG ' ' A' ' 232' ' ' LEU . . . 96.59 102.48 2.05 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -161.24 -146.79 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.01 -172.4 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -1.117 . . . . 0.0 109.599 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.451 ' ND2' ' C ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -104.81 77.52 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.445 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.0 4.86 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.516 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 65.3 m-85 -136.18 113.82 11.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.48 -1.012 . . . . 0.0 109.368 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.566 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 4.7 mt-30 -95.3 120.93 36.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.401 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 34.5 p -131.1 155.53 46.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.381 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.11 162.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.831 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.648 HG23 ' HD2' ' A' ' 185' ' ' TYR . 16.3 t -116.16 110.32 31.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 158' ' ' HIS . 15.4 m -107.75 146.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 121.379 -0.826 . . . . 0.0 110.943 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 84.42 42.42 7.42 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 54.0 mt -89.58 86.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.536 -0.979 . . . . 0.0 110.362 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -162.51 156.37 17.89 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.624 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.378 2.052 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.485 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 34.0 tt0 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.485 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 34.9 Cg_endo -76.81 153.8 33.68 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.332 2.021 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.9 t -93.03 140.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.764 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 178' ' ' LEU . 78.0 t -140.66 129.67 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.344 -0.848 . . . . 0.0 109.002 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 200' ' ' ASP . 11.4 mmtp -75.8 -177.18 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 108.947 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 209' ' ' HIS . 66.3 m -77.72 103.08 7.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.647 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 36.3 mt -57.97 -51.62 68.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 109.483 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.588 HD11 HG11 ' A' ' 198' ' ' VAL . 9.0 mt -55.55 -39.32 70.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.746 -1.221 . . . . 0.0 109.021 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 16.0 t0 -67.33 -37.63 83.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 109.35 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -58.43 -14.49 7.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mtpt -121.08 18.93 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 108.846 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' LYS . . . 43.95 39.74 5.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 18.7 mt -86.14 111.42 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.423 -1.045 . . . . 0.0 110.36 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 102' ' ' PRO . 42.4 m80 -135.23 87.48 2.33 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.619 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.599 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 10.2 m-30 -88.29 178.23 6.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.977 0.894 . . . . 0.0 110.781 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.73 -163.77 1.85 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.495 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 53.5 mt-30 -125.01 -20.97 4.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.963 -1.086 . . . . 0.0 111.061 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.14 -36.28 1.24 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.22 -1.467 . . . . 0.0 111.666 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.831 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.35 -140.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.492 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.016 -177.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.2 Cg_endo -73.85 2.84 5.52 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 CA-C-N 122.538 1.942 . . . . 0.0 109.753 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.571 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 9.1 m-85 -78.26 -31.52 49.13 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.024 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 24.6 p-10 -92.36 15.71 13.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.584 -1.323 . . . . 0.0 109.463 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 23' ' ' LEU . 11.4 mt -70.38 -3.72 18.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 118' ' ' GLU . 14.7 mt -129.27 -6.36 4.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 109.988 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.9 p -61.58 165.47 7.28 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.643 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 19.1 Cg_endo -69.16 145.65 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.058 1.839 . . . . 0.0 112.041 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.25 147.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.73 0.776 . . . . 0.0 110.396 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.76 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.6 mt -78.02 149.68 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.683 0.754 . . . . 0.0 111.396 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.2 mt-10 -126.06 -20.83 4.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 110.573 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -121.25 168.13 11.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 110.15 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 36' ' ' GLN . 84.9 t -114.27 146.42 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 111.119 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -75.55 160.47 79.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.62 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.6 Cg_endo -81.77 123.2 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.427 2.085 . . . . 0.0 110.703 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.47 88.57 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -117.08 168.58 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.497 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.618 ' O ' HG13 ' A' ' 31' ' ' VAL . 3.9 mt-30 -69.69 -177.84 1.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.159 -0.963 . . . . 0.0 108.987 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -87.02 133.21 33.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.151 -0.968 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.564 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 74.7 m-85 -118.54 13.07 13.37 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.024 -1.047 . . . . 0.0 109.451 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 28' ' ' ILE . 77.2 t -63.35 142.52 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 109.367 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 -1.26 77.53 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 3.0 mt-30 -87.92 131.72 34.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 25' ' ' THR . 4.5 m-70 -73.55 111.69 8.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -51.93 161.42 0.57 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.08 -1.013 . . . . 0.0 109.329 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.53 170.88 15.8 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.564 0.697 . . . . 0.0 109.866 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.691 HG21 ' SD ' ' A' ' 120' ' ' MET . 28.2 p -81.2 -34.31 32.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 108.646 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.75 137.82 9.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 51' ' ' ALA . 4.3 p -55.14 -52.56 62.89 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -1.086 . . . . 0.0 108.172 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.3 t -46.8 -51.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.566 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -61.43 -51.53 68.35 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.501 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.495 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 39.8 m -63.19 -30.96 72.01 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.705 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -67.53 -42.23 83.07 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.733 -1.23 . . . . 0.0 107.836 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.494 HG23 HD21 ' A' ' 147' ' ' LEU . 55.8 m -74.76 -53.03 9.94 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.494 0.664 . . . . 0.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' HB1' HD21 ' A' ' 119' ' ' LEU . . . -51.29 -35.4 37.42 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.501 -0.749 . . . . 0.0 109.646 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.599 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 30.5 mt-30 -64.32 -53.99 40.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.751 HD11 HG22 ' A' ' 198' ' ' VAL . 36.7 mt -60.88 -24.45 32.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.519 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.7 mtp -72.72 -31.68 65.15 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CG ' HG12 ' A' ' 13' ' ' ILE . 41.3 tptt -73.69 -47.07 42.39 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 41.8 t80 -52.95 -29.98 32.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.727 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 50.4 m-70 -107.32 -24.44 11.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.755 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.612 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 86.1 m-20 44.83 56.17 5.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.8 t80 -79.77 -76.08 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 95' ' ' TYR . 36.8 Cg_endo -70.24 105.16 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 119.258 0.771 . . . . 0.0 111.837 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' TYR . 0.6 OUTLIER -72.0 -20.75 61.67 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -133.95 138.6 45.57 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.652 ' C ' HD23 ' A' ' 66' ' ' LEU . . . -57.82 152.71 26.89 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.164 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.773 HD12 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mt -94.95 -59.84 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.431 -1.041 . . . . 0.0 110.492 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 14.1 tttm -134.11 151.36 51.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.562 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 21.6 m-20 -74.45 172.56 11.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.373 -0.829 . . . . 0.0 109.499 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 70' ' ' THR . 28.9 t80 -147.48 153.82 40.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.582 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -157.37 149.68 22.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.095 -1.003 . . . . 0.0 110.097 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.715 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 26.9 p90 -156.44 157.05 34.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.583 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 87.3 m -93.35 134.95 35.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.786 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.9 tp -52.78 149.99 5.71 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 111.136 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.78 138.26 58.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.729 -0.607 . . . . 0.0 109.596 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -6.08 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 109.93 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 6.8 m-20 -96.2 -7.26 36.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.164 -0.96 . . . . 0.0 109.575 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.786 ' ND2' HD21 ' A' ' 73' ' ' LEU . 32.3 t-20 -70.25 111.54 9.67 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 109.82 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 50.3 Cg_endo -88.19 12.68 2.77 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.973 2.449 . . . . 0.0 109.996 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 72.0 m-85 -105.18 -11.86 16.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.69 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.3 m-85 -134.76 163.19 30.34 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.583 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.3 m120 -47.48 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 174.25 -46.58 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 111.039 175.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.5 Cg_endo -76.69 56.72 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -105.99 102.51 11.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.63 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.86 128.85 46.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.1 mp -102.06 129.1 48.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 11.2 t80 -121.78 126.91 49.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.92 . . . . 0.0 110.047 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.55 116.05 31.24 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.86 51.26 0.62 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.854 -1.154 . . . . 0.0 108.314 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 25.8 mt -52.09 -44.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 O-C-N 121.259 -0.901 . . . . 0.0 109.579 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 68' ' ' ASP . 4.7 p -45.62 -26.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.649 -1.282 . . . . 0.0 108.76 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -112.51 34.51 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.774 . . . . 0.0 109.411 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.718 ' HE ' ' HG2' ' A' ' 118' ' ' GLU . 2.2 mmt-85 -93.0 151.5 19.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 110.336 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.462 ' NE2' ' CA ' ' A' ' 94' ' ' GLN . 0.1 OUTLIER -117.2 94.51 4.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 4.7 m-85 -81.55 93.04 6.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.472 -0.768 . . . . 0.0 110.408 -177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 30.7 t-20 -79.81 90.15 5.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.612 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 65.0 m95 -61.22 -9.29 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -90.53 -15.59 30.41 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 22.9 m-20 -98.69 -34.27 10.61 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.552 HG12 ' HB1' ' A' ' 115' ' ' ALA . 34.2 mt -73.1 91.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 14.8 mt -71.06 151.62 94.85 Favored Pre-proline 0 C--N 1.29 -1.99 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 29.2 Cg_endo -76.58 -20.7 13.63 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.462 2.108 . . . . 0.0 110.783 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.22 140.4 32.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.281 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.505 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 82.8 m-85 -126.61 135.45 51.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.409 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.6 p -99.52 1.87 44.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 108.962 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 0.44 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -118.29 11.41 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.331 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -73.11 172.59 10.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.669 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.83 177.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.331 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -80.85 -42.1 22.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.97 -51.76 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.458 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 20' ' ' PRO . 15.8 mttt -61.18 -37.46 83.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.12 -0.987 . . . . 0.0 109.118 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.449 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.2 ttm -59.62 -45.24 92.56 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.373 -0.829 . . . . 0.0 110.028 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.07 -51.31 70.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.857 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.752 ' CD1' HD23 ' A' ' 119' ' ' LEU . 3.6 tp -69.78 -43.5 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.549 -1.344 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 24' ' ' LEU . 4.7 p -54.33 -40.36 67.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.821 ' N ' HD12 ' A' ' 24' ' ' LEU . 19.6 tt0 -70.46 -43.28 70.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.752 HD23 ' CD1' ' A' ' 116' ' ' ILE . 7.1 tp -54.04 -51.48 63.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.691 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.7 mmt -60.16 -44.22 95.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.598 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.537 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.57 -41.82 96.03 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 126' ' ' SER . 5.7 m-20 -65.37 -52.54 52.93 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 127' ' ' VAL . 78.6 t -61.18 -61.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 109.488 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.74 -50.99 13.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 121' ' ' ALA . 1.8 mt -63.65 -55.45 22.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.319 . . . . 0.0 108.418 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 3.4 p -46.19 -31.3 2.36 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.515 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 31.2 m -102.28 40.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.156 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER 39.38 38.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.339 -0.851 . . . . 0.0 110.253 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.647 ' HE3' ' O ' ' A' ' 45' ' ' THR . 48.2 tpp -52.56 128.34 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.198 -0.939 . . . . 0.0 111.314 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 25.4 t0 -78.33 123.2 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.643 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 68.7 m-85 -104.5 115.81 31.0 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 113.579 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.76 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -150.73 -163.82 11.55 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 104.482 -3.447 . . . . 0.0 104.482 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.618 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.0 Cg_endo -62.34 -29.47 79.71 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 105.589 -2.504 . . . . 0.0 105.589 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -110.47 137.7 47.82 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 50.5 m -116.64 108.7 16.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 119.872 -1.768 . . . . 0.0 109.977 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.1 136.22 13.24 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.547 ' HB2' ' HE2' ' A' ' 129' ' ' MET . 14.6 t -118.56 -163.41 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 108.8 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.892 ' HB3' ' HG2' ' A' ' 142' ' ' ARG . . . -92.29 -55.55 3.38 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.57 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 126.99 -123.78 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.758 -1.21 . . . . 0.0 111.934 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.557 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 10.7 m -48.38 -65.39 0.57 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.817 -0.814 . . . . 0.0 112.458 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -46.52 -34.27 4.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.931 -1.106 . . . . 0.0 109.402 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.892 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 29.6 mmt180 -80.12 -49.74 11.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.876 0.846 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.681 HG21 ' CE2' ' A' ' 185' ' ' TYR . 92.9 t -68.31 -54.82 19.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.867 -0.521 . . . . 0.0 111.19 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 1.3 pp0? -56.68 -34.11 67.06 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.958 -1.089 . . . . 0.0 108.741 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -77.24 -47.85 19.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.48 78.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 109.927 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.607 ' CD1' HG12 ' A' ' 143' ' ' VAL . 66.0 mt -57.13 -49.0 77.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 109.607 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.566 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 58.3 mtmt -87.39 -33.69 19.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 111.116 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 69.6 mt-10 -72.23 -63.94 1.04 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.432 -1.417 . . . . 0.0 112.182 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 10.6 m120 -82.89 -37.22 24.56 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.433 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 22.4 m-85 -100.76 1.53 40.42 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.752 -1.217 . . . . 0.0 110.471 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.773 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 42.94 41.41 4.57 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.344 -0.848 . . . . 0.0 112.445 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' ASN . 6.4 m-85 -61.99 164.75 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.162 -1.787 . . . . 0.0 107.598 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 23.0 t-20 -47.23 144.7 2.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.683 -1.261 . . . . 0.0 109.014 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -53.02 -19.75 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.004 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 87.1 p -54.85 -15.17 1.75 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.301 -0.874 . . . . 0.0 110.08 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 147' ' ' LEU . 5.5 t -65.02 121.36 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.46 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.949 ' CE1' HG23 ' A' ' 249' ' ' VAL . 8.9 p-80 -147.86 159.9 43.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.748 . . . . 0.0 109.164 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.557 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.3 tt0 -101.81 155.73 17.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 109.925 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.87 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 7.1 pt -135.43 143.23 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 2.2 m-80 -107.91 104.63 14.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.886 -1.134 . . . . 0.0 111.027 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 10.0 tpt180 -47.52 -37.15 11.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 108.857 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -64.44 -20.48 65.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 161' ' ' ASN . 6.4 m-20 -103.63 -4.09 24.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -1.231 . . . . 0.0 110.89 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -118.03 168.18 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.239 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 167' ' ' LYS . 43.4 p -97.19 136.49 37.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 166' ' ' SER . 2.1 tttt -32.69 -45.63 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.152 0.501 . . . . 0.0 110.642 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -64.47 -63.89 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.087 -1.008 . . . . 0.0 109.832 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -63.4 -14.37 49.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.29 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.87 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 65.2 t-105 -75.95 -47.67 24.19 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.092 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.683 ' HA ' HD12 ' A' ' 174' ' ' ILE . 76.9 mt-10 -70.93 -30.73 67.13 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.53 -44.27 76.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.853 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.515 HE21 HG21 ' A' ' 249' ' ' VAL . 18.5 mm100 -61.25 -40.2 93.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.296 -0.877 . . . . 0.0 108.731 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.011 HG23 HG21 ' A' ' 184' ' ' VAL . 21.2 mt -73.35 -57.9 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.441 -0.787 . . . . 0.0 110.447 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.43 -43.5 44.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.004 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -51.65 -44.19 62.91 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.579 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 50.3 mm-40 -60.98 -49.0 79.22 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.727 ' HB3' HG11 ' A' ' 4' ' ' VAL . 30.1 mt -67.4 -28.48 67.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 0.0 109.677 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 175' ' ' ASP . 9.9 p -51.33 -42.59 61.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.141 -0.974 . . . . 0.0 108.573 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 25.8 mt-30 -97.37 32.67 2.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.536 ' C ' HD13 ' A' ' 7' ' ' LEU . 81.5 m-20 48.71 49.96 18.0 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' GLU . 18.3 mt-30 -123.88 116.29 27.63 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 17.5 Cg_endo -66.35 169.76 13.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.143 1.896 . . . . 0.0 112.461 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 1.011 HG21 HG23 ' A' ' 174' ' ' ILE . 57.5 t -126.53 130.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.479 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.817 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.5 OUTLIER -79.39 120.18 23.46 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 176.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 7.1 t80 -123.1 159.33 28.74 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.995 -1.066 . . . . 0.0 109.766 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -166.78 125.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.776 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' HA2' ' OE1' ' A' ' 245' ' ' GLN . . . -93.85 104.43 3.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 190' ' ' GLY . 46.6 t -68.32 164.07 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 110.925 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.575 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -165.12 -141.46 3.14 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.526 -1.829 . . . . 0.0 108.526 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -87.59 -30.9 20.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.076 -1.249 . . . . 0.0 110.237 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.47 -22.49 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.022 -1.049 . . . . 0.0 110.495 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.11 -169.48 24.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.583 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -78.91 102.34 1.9 Allowed Glycine 0 N--CA 1.482 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 111.138 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.0 t-80 -71.29 128.14 34.9 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -118.82 161.79 19.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.295 -1.362 . . . . 0.0 113.195 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.828 ' CD1' HG13 ' A' ' 210' ' ' VAL . 13.6 p90 -159.29 167.8 28.03 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.751 HG22 HD11 ' A' ' 55' ' ' ILE . 83.5 t -114.69 136.92 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.756 -1.215 . . . . 0.0 112.236 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.931 HD13 HG21 ' A' ' 174' ' ' ILE . 70.7 mt -99.63 125.04 53.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 20.1 p-10 -135.05 30.0 3.36 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.458 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . -176.52 165.82 36.36 Favored Glycine 0 N--CA 1.483 1.79 0 C-N-CA 117.369 -2.348 . . . . 0.0 112.226 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 207' ' ' PHE . . . -148.86 146.6 28.02 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.98 2.61 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 110.071 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 86.07 -35.84 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.098 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.6 OUTLIER -88.46 32.04 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -1.23 . . . . 0.0 110.192 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.1 OUTLIER 76.28 27.44 0.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 109.996 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 7.2 m-85 -118.88 133.27 55.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.186 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 221' ' ' PHE . 48.0 m-85 -122.96 165.24 17.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.375 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 6' ' ' SER . 29.1 t-80 -92.89 145.53 24.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.828 HG13 ' CD1' ' A' ' 197' ' ' PHE . 97.6 t -135.05 137.83 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.917 -1.114 . . . . 0.0 111.558 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.529 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.4 t-20 -111.22 68.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.703 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 98.2 m95 -46.93 164.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.808 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.38 -2.52 49.36 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.446 ' O ' ' OD2' ' A' ' 219' ' ' ASP . 66.7 m95 -107.38 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -1.129 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -118.92 3.48 14.53 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.24 1.91 4.99 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.785 HG13 ' N ' ' A' ' 218' ' ' SER . 1.7 p -91.6 -152.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.221 -1.164 . . . . 0.0 109.544 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.785 ' N ' HG13 ' A' ' 217' ' ' VAL . 57.7 m -66.93 55.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.97 -1.082 . . . . 0.0 110.711 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 217' ' ' VAL . 0.5 OUTLIER -80.07 116.64 20.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.89 -1.131 . . . . 0.0 108.987 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 209' ' ' HIS . . . 162.5 -80.36 0.14 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.608 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 29.9 m-85 -135.11 175.42 9.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.261 . . . . 0.0 110.821 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.92 160.62 17.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.583 -0.698 . . . . 0.0 110.539 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 167.02 11.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.664 -0.648 . . . . 0.0 109.345 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 224' ' ' LEU . 0.5 OUTLIER -121.55 20.31 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 225' ' ' ASP . 0.4 OUTLIER -107.02 -80.52 0.56 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.996 -1.065 . . . . 0.0 110.157 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.492 ' HB1' HD13 ' A' ' 227' ' ' LEU . . . -123.2 -110.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 0.0 109.501 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.918 ' N ' HD13 ' A' ' 227' ' ' LEU . 0.0 OUTLIER -96.85 -91.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.716 -1.24 . . . . 0.0 108.786 178.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 212' ' ' TRP . 0.8 OUTLIER -100.13 158.53 31.85 Favored Pre-proline 0 C--N 1.288 -2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.48 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.603 ' HD3' ' CZ2' ' A' ' 212' ' ' TRP . 35.8 Cg_endo -77.52 -81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.648 2.232 . . . . 0.0 110.481 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.4 m -118.88 60.25 0.81 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.361 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.586 ' HB1' ' ND1' ' A' ' 195' ' ' HIS . . . -70.22 -36.41 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 238' ' ' ALA . 1.1 mp -104.28 -9.42 18.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.44 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 66.29 -168.21 34.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.49 33.3 3.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -1.148 . . . . 0.0 109.454 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -97.3 -174.67 34.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -64.37 127.49 34.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 140.24 -173.03 23.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 232' ' ' LEU . . . -63.8 173.42 1.78 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.238 -1.154 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -152.87 74.58 0.25 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 96.17 14.85 43.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -67.93 128.91 38.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -1.158 . . . . 0.0 109.433 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 245' ' ' GLN . 3.6 t-20 -130.84 93.64 3.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.548 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -108.7 -40.84 1.53 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.542 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 58.6 m-85 -135.45 77.35 1.67 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -1.143 . . . . 0.0 109.717 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.534 ' HB2' ' ND2' ' A' ' 242' ' ' ASN . 25.1 tt0 -92.14 140.05 30.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.996 -1.065 . . . . 0.0 109.327 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.506 ' CA ' ' O ' ' A' ' 160' ' ' ILE . 2.5 p -155.41 169.38 24.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.427 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.19 162.55 35.22 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.774 0.797 . . . . 0.0 109.489 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 185' ' ' TYR . 18.3 t -116.51 124.06 72.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.949 HG23 ' CE1' ' A' ' 158' ' ' HIS . 9.2 m -123.2 139.96 48.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.85 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.45 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 92.98 51.39 2.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.617 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 37.2 mt -98.41 91.09 2.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.319 -1.107 . . . . 0.0 109.567 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -163.4 148.31 9.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 109.095 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.58 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.264 1.976 . . . . 0.0 110.465 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.505 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 39.5 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.7 Cg_endo -78.65 148.98 23.33 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.465 2.11 . . . . 0.0 110.144 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 ' C ' ' A' ' 203' ' ' ASP . 23.6 t -90.08 143.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.671 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 178' ' ' LEU . 59.0 t -137.72 132.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 108.963 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 200' ' ' ASP . 59.8 mmtt -75.51 -177.14 3.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.071 -1.018 . . . . 0.0 108.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 4.5 t -77.53 104.25 7.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.699 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.8 mt -56.99 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.028 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 211' ' ' ASN . 14.2 mt -54.47 -43.79 72.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 108.595 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -67.55 -37.03 82.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -15.67 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 108.856 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 13' ' ' ILE . 11.8 mtpp -121.12 22.17 11.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.2 38.59 6.5 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 11' ' ' LYS . 32.3 mt -90.86 109.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.332 -1.099 . . . . 0.0 110.138 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' PRO . 79.6 m80 -134.08 85.85 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.63 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 9.0 m-30 -93.59 174.21 7.3 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.252 1.025 . . . . 0.0 111.614 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 25.5 t30 -148.38 -172.42 4.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 1.3 mt-30 -125.4 -0.98 7.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.867 -1.146 . . . . 0.0 110.238 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.51 -56.31 0.35 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.252 -1.452 . . . . 0.0 112.145 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.763 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -46.07 -126.07 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.966 -176.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.763 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 41.0 Cg_endo -79.11 6.69 4.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 CA-C-N 123.56 2.307 . . . . 0.0 109.713 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 16' ' ' ASN . 57.8 m-85 -78.18 -35.3 48.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.641 -0.662 . . . . 0.0 109.535 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 47.8 p30 -96.78 20.29 11.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.831 -1.168 . . . . 0.0 109.098 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.39 1.74 11.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 110.106 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 118' ' ' GLU . 16.6 mt -134.68 0.9 3.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.829 -1.17 . . . . 0.0 110.265 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 29.6 p -66.72 164.4 33.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.711 ' HG3' HD21 ' A' ' 86' ' ' LEU . 18.6 Cg_endo -71.8 131.08 17.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.701 1.601 . . . . 0.0 110.297 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.44 145.63 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.77 0.795 . . . . 0.0 110.429 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.725 HD11 ' HA2' ' A' ' 132' ' ' GLY . 10.3 mt -77.65 148.92 6.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.605 0.717 . . . . 0.0 110.624 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 39' ' ' VAL . 1.8 mt-10 -125.24 -22.28 4.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.104 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' TYR . 17.4 mtpp -119.39 172.85 7.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.0 109.779 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 37' ' ' SER . 88.2 t -114.17 148.91 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.376 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.6 tttt -89.29 130.81 42.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -69.89 128.79 16.41 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.29 1.327 . . . . 0.0 109.982 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.52 5.8 39.11 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 38' ' ' PHE . 2.4 tt0 -148.18 171.83 15.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -1.105 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -68.22 -173.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 31' ' ' VAL . 2.3 t -87.46 139.88 30.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.813 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 13.2 m-85 -116.3 9.81 14.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.796 -1.19 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 29' ' ' GLU . 34.1 t -60.72 117.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.728 -1.232 . . . . 0.0 108.521 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.38 -11.23 50.93 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' NE2' ' CD1' ' A' ' 38' ' ' PHE . 22.9 mt-30 -76.18 133.25 40.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.447 -1.031 . . . . 0.0 109.168 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.83 114.7 11.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -53.24 145.81 13.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' OG ' ' A' ' 135' ' ' SER . . . -69.97 167.35 17.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.871 -1.143 . . . . 0.0 109.697 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.476 ' O ' ' HE3' ' A' ' 129' ' ' MET . 23.4 p -82.14 -33.03 29.79 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 108.511 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.71 138.62 9.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 p -55.17 -51.45 66.48 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.236 -1.155 . . . . 0.0 107.94 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 HG21 ' A' ' 127' ' ' VAL . 23.4 t -45.11 -53.99 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.13 -55.76 30.87 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.44 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 59.3 m -63.47 -28.43 69.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.572 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 47' ' ' SER . . . -66.5 -47.99 71.25 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.219 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 123' ' ' VAL . 85.8 m -75.38 -48.97 20.51 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.842 0.83 . . . . 0.0 109.864 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.83 -33.76 37.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.426 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.63 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.9 mt-30 -68.34 -50.1 55.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.004 HG21 HD13 ' A' ' 251' ' ' ILE . 40.2 mt -62.95 -23.37 33.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.502 ' HG3' HG22 ' A' ' 52' ' ' THR . 20.0 mtp -73.55 -40.89 63.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 43.6 tptt -65.91 -44.48 85.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.699 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 34.8 t80 -53.39 -28.4 29.22 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 41.0 m-70 -107.65 -25.26 11.4 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.094 -1.004 . . . . 0.0 110.866 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 94.9 m-20 43.76 59.69 3.0 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.7 t80 -83.09 -78.76 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.7 Cg_endo -71.37 108.68 2.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 CA-C-N 119.6 0.893 . . . . 0.0 112.996 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.9 -26.22 66.77 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 2.7 ttpt -130.52 130.76 44.55 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.96 164.97 5.68 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 118.487 -1.816 . . . . 0.0 110.682 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.102 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -96.13 -35.84 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.986 . . . . 0.0 111.188 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 8.6 tttm -152.42 131.71 12.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.73 -1.231 . . . . 0.0 110.489 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 36.5 m-20 -60.23 170.68 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.368 -0.832 . . . . 0.0 108.962 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.505 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 43.4 t80 -145.8 142.1 28.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 13.2 t -142.9 152.34 41.97 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.208 -0.932 . . . . 0.0 109.419 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 28.7 p90 -160.05 158.09 29.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -92.6 126.3 37.63 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.707 HD21 ' ND2' ' A' ' 77' ' ' ASN . 12.1 tp -43.99 147.53 0.49 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.664 0.745 . . . . 0.0 110.509 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 142.79 54.93 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.527 0.68 . . . . 0.0 110.632 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.7 t -69.49 -2.97 12.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.732 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 2.8 m-80 -97.57 -2.17 42.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.222 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.707 ' ND2' HD21 ' A' ' 73' ' ' LEU . 18.9 t-20 -70.04 109.6 5.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 39.9 Cg_endo -90.57 19.63 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.95 2.433 . . . . 0.0 108.827 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.655 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 44.7 m-85 -117.66 -25.83 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.835 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' ASN . 88.4 m-85 -117.35 170.76 8.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.676 -1.265 . . . . 0.0 108.102 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.5 m-80 -53.96 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 175.47 -49.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.289 -0.882 . . . . 0.0 111.426 174.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 32.0 Cg_endo -75.92 58.51 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.328 -1.836 . . . . 0.0 107.328 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 86' ' ' LEU . 18.7 tptt -105.52 121.88 44.87 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.663 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.45 116.65 33.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 0.0 110.225 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 26' ' ' PRO . 3.4 mp -96.17 134.01 39.77 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 26.0 t80 -132.36 131.38 41.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.776 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -111.77 118.21 34.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.7 53.01 0.42 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.724 -1.235 . . . . 0.0 108.273 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 mt -52.88 -58.1 3.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 0.0 111.23 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 1.3 p -44.52 -27.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.874 -1.141 . . . . 0.0 108.84 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -112.56 30.48 7.08 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 31.0 mmt-85 -81.17 157.36 25.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.514 -1.366 . . . . 0.0 109.542 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -116.32 81.47 1.62 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 12.1 m-85 -80.96 88.3 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.485 -0.759 . . . . 0.0 110.082 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 23.2 t-20 -79.17 91.84 5.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.644 ' CE3' HD12 ' A' ' 100' ' ' ILE . 60.0 m95 -60.59 -7.75 2.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.823 . . . . 0.0 110.381 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 9.1 m-20 -89.37 -18.83 26.08 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 24.3 m-20 -100.35 -31.2 11.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.777 HG12 ' HB1' ' A' ' 115' ' ' ALA . 24.1 mt -74.03 65.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.532 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 47.9 mt -45.65 149.16 1.13 Allowed Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.553 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.6 Cg_endo -77.23 -20.27 12.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.013 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 103' ' ' THR . 2.7 t -144.01 120.34 10.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.945 -1.097 . . . . 0.0 109.414 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE2' ' HB ' ' A' ' 116' ' ' ILE . 96.8 m-85 -109.26 144.01 37.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.971 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -99.16 -3.4 34.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' HA3' ' ND2' ' A' ' 19' ' ' ASN . . . 81.84 3.65 90.53 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -119.22 6.69 11.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.44 -1.035 . . . . 0.0 108.836 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -174.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 p -72.27 173.57 8.47 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.229 -0.92 . . . . 0.0 108.778 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 4.0 m120 -78.74 -34.57 45.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.136 -0.977 . . . . 0.0 109.446 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.24 -61.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.818 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -62.2 -34.21 76.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.996 -1.065 . . . . 0.0 109.038 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 73.6 mttt -66.1 -44.27 84.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.416 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 40.2 ttm -59.53 -34.93 73.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.73 -67.89 0.29 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.83 -0.544 . . . . 0.0 110.752 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.83 HD11 ' HE2' ' A' ' 120' ' ' MET . 4.0 tp -59.43 -42.35 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.7 p -53.47 -41.71 66.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.92 -1.112 . . . . 0.0 109.908 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.761 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.5 tt0 -69.31 -45.36 69.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.712 HD23 ' CD1' ' A' ' 116' ' ' ILE . 4.6 tp -55.42 -50.03 70.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.83 ' HE2' HD11 ' A' ' 116' ' ' ILE . 22.7 mmt -58.26 -46.12 86.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -65.42 -38.46 89.97 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.692 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 20.8 m-20 -64.77 -55.68 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 127' ' ' VAL . 51.4 t -61.8 -51.36 73.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -50.86 -49.15 42.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 126' ' ' SER . 2.2 mt -64.95 -60.42 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -1.103 . . . . 0.0 108.489 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.556 ' N ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -45.98 -30.5 1.83 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.494 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 123' ' ' VAL . 32.9 m -101.26 38.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.152 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 127' ' ' VAL . 1.6 m-20 35.82 54.06 0.89 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.577 0.703 . . . . 0.0 109.619 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.569 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 40.1 tpp -66.3 130.56 43.62 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 112.144 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' SER . 7.4 t0 -75.87 119.8 20.34 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.537 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 29.5 m-85 -102.34 108.82 20.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -174.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.725 ' HA2' HD11 ' A' ' 28' ' ' ILE . . . -149.76 -169.35 15.97 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 103.956 -3.658 . . . . 0.0 103.956 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.813 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 14.2 Cg_endo -62.5 -21.28 72.6 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 N-CA-C 106.887 -2.005 . . . . 0.0 106.887 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.42 131.04 55.4 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.739 ' OG ' ' HB3' ' A' ' 44' ' ' ALA . 68.0 m -117.3 105.48 12.23 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 119.96 -1.713 . . . . 0.0 110.127 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -109.01 134.41 12.23 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.89 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.593 ' OG ' ' NE ' ' A' ' 142' ' ' ARG . 24.9 t -117.42 -160.86 0.79 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -1.214 . . . . 0.0 108.221 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HB3' HH11 ' A' ' 142' ' ' ARG . . . -90.7 -49.82 6.26 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.747 ' H ' ' CZ ' ' A' ' 142' ' ' ARG . . . 122.87 -111.72 1.79 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 175.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.466 ' HB3' ' CD ' ' A' ' 159' ' ' GLN . 0.4 OUTLIER -59.1 -54.14 50.35 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 119.22 -2.341 . . . . 0.0 114.759 -175.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 p -47.12 -32.24 4.08 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.674 -1.266 . . . . 0.0 114.091 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.847 HH22 HG23 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -92.93 -36.28 12.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.977 -1.702 . . . . 0.0 110.58 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 185' ' ' TYR . 84.0 t -65.32 -42.69 94.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 109.534 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.448 ' O ' ' HE2' ' A' ' 148' ' ' LYS . 3.6 pp0? -69.27 -37.18 77.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 149' ' ' GLU . 13.4 ttp180 -75.31 -51.6 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 109.689 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.69 91.39 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 110.322 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB2' HG11 ' A' ' 157' ' ' VAL . 27.6 mt -56.68 -45.05 81.97 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.941 -1.1 . . . . 0.0 109.203 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.572 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 32.5 mtmt -87.97 -39.0 15.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.993 -1.067 . . . . 0.0 110.791 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 145' ' ' ARG . 71.5 mt-10 -71.61 -60.69 2.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.723 -1.235 . . . . 0.0 112.535 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 69' ' ' TYR . 33.7 m120 -82.28 -44.92 15.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.73 -1.231 . . . . 0.0 111.937 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.42 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 36.4 m-85 -90.84 -14.13 32.43 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.656 -1.278 . . . . 0.0 110.553 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.63 33.25 83.88 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.208 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.58 ' CE2' HG22 ' A' ' 251' ' ' ILE . 10.1 m-85 -63.61 156.71 25.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.22 -1.753 . . . . 0.0 108.014 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 20.6 t-20 -47.21 153.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.948 -1.095 . . . . 0.0 109.718 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -55.41 -16.77 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.607 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 0.7 OUTLIER -52.99 -17.56 1.51 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.185 -0.947 . . . . 0.0 109.617 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.629 HG11 ' HB2' ' A' ' 147' ' ' LEU . 21.8 t -70.66 121.42 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.911 -1.118 . . . . 0.0 109.405 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.701 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -148.11 170.42 17.85 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.069 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.466 ' CD ' ' HB3' ' A' ' 140' ' ' SER . 3.9 tt0 -111.24 147.29 35.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.694 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 246' ' ' SER . 10.2 pt -141.51 141.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 4.5 m-80 -104.81 107.86 19.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.059 -1.025 . . . . 0.0 110.377 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.714 ' HB2' ' HH ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -48.4 -28.94 3.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.057 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.04 -13.53 79.26 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 161' ' ' ASN . 0.7 OUTLIER -103.65 -4.63 23.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -1.134 . . . . 0.0 110.192 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -118.66 179.76 4.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.915 -1.116 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.47 ' OG ' ' OD2' ' A' ' 169' ' ' ASP . 1.8 p -107.18 141.88 37.76 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 166' ' ' SER . 41.2 tttp -35.39 -49.3 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.702 -0.623 . . . . 0.0 110.818 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -64.18 -57.76 8.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.946 -1.097 . . . . 0.0 110.18 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.47 ' OD2' ' OG ' ' A' ' 166' ' ' SER . 59.1 m-20 -64.03 -19.69 65.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.02 . . . . 0.0 109.463 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 63.9 t-105 -73.18 -43.11 61.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 208' ' ' TYR . 30.1 mt-10 -64.33 -33.68 76.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 108.706 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.82 -43.76 81.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.426 -0.796 . . . . 0.0 109.392 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.505 ' NE2' HG21 ' A' ' 249' ' ' VAL . 18.2 mm100 -61.03 -47.13 87.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.166 -0.959 . . . . 0.0 109.162 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.878 HG23 HG21 ' A' ' 184' ' ' VAL . 16.8 mt -76.06 -50.67 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.099 -1.0 . . . . 0.0 110.706 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -55.28 -53.36 57.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.129 -0.982 . . . . 0.0 108.984 -178.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -51.45 -40.29 59.14 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.61 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 2.9 mm-40 -61.15 -52.7 63.76 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.808 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.5 mt -68.75 -24.31 64.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 175' ' ' ASP . 33.5 p -52.74 -38.82 61.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 181' ' ' ASN . 28.5 mt-30 -101.33 38.09 1.65 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.497 ' C ' HD13 ' A' ' 7' ' ' LEU . 16.3 m-20 42.61 50.73 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.745 0.784 . . . . 0.0 108.938 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 7.5 mt-30 -123.51 106.43 32.59 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.418 ' HD3' HD13 ' A' ' 7' ' ' LEU . 14.9 Cg_endo -63.22 169.36 9.46 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.237 1.958 . . . . 0.0 113.086 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 174' ' ' ILE . 40.8 t -122.8 135.15 63.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.273 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -86.73 114.35 23.34 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.785 ' CD2' ' HB2' ' A' ' 247' ' ' ALA . 4.2 t80 -121.36 162.52 20.2 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 -175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 2.2 pt20 -167.35 132.95 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.952 -1.499 . . . . 0.0 111.624 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.42 110.75 4.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.642 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 94.2 t -78.2 162.59 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.933 -1.334 . . . . 0.0 111.496 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -164.68 -139.77 2.72 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 2.6 mtmp? -87.86 -38.4 15.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -1.23 . . . . 0.0 110.985 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 m -76.66 -12.18 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.988 -1.07 . . . . 0.0 111.076 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.59 -172.57 21.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -86.14 107.95 3.22 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.516 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.581 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 8.7 t-80 -72.76 125.12 26.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -119.58 164.38 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.363 -1.335 . . . . 0.0 113.123 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.864 ' CD1' HG13 ' A' ' 210' ' ' VAL . 37.7 p90 -156.59 -158.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.692 HG22 HD11 ' A' ' 55' ' ' ILE . 70.5 t -139.39 136.53 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.496 -1.377 . . . . 0.0 111.204 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.723 ' CD1' HD13 ' A' ' 174' ' ' ILE . 51.3 mt -102.94 112.51 36.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.615 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 23.4 p-10 -124.5 35.06 4.88 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.335 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.1 167.04 39.36 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 117.837 -2.125 . . . . 0.0 112.272 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -148.43 148.22 30.06 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.566 ' C ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.38 22.53 12.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 109.686 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 49.61 21.89 3.62 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.5 mtp180 -138.66 29.74 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -1.188 . . . . 0.0 109.108 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.472 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . 11.7 m120 74.36 11.62 4.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 109.503 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.73 138.06 51.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.581 ' CD1' HD23 ' A' ' 224' ' ' LEU . 5.8 m-85 -123.07 168.13 12.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.054 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 51.2 t-80 -93.33 115.76 28.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.864 HG13 ' CD1' ' A' ' 197' ' ' PHE . 37.9 t -113.67 138.15 44.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.98 -1.075 . . . . 0.0 111.457 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.54 ' HB2' HD12 ' A' ' 8' ' ' LEU . 14.9 t-20 -100.28 80.92 2.31 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.557 ' CZ3' ' CD2' ' A' ' 197' ' ' PHE . 3.4 m95 -46.68 167.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.774 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.442 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -87.22 30.89 4.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.411 ' CZ2' ' O ' ' A' ' 231' ' ' ALA . 70.3 m95 -119.39 -170.8 2.0 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -1.199 . . . . 0.0 109.483 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.55 -99.12 0.22 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 219' ' ' ASP . . . -126.59 52.6 0.81 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 218' ' ' SER . 7.1 p -91.78 -119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -1.159 . . . . 0.0 109.317 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.655 ' H ' HG22 ' A' ' 217' ' ' VAL . 3.5 m -75.46 2.06 12.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.482 -1.386 . . . . 0.0 110.16 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.469 ' OD2' ' HA2' ' A' ' 216' ' ' GLY . 28.9 p-10 -54.24 150.29 8.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 130.82 -143.83 15.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 8.5 p90 -68.84 124.17 22.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 -164.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 109.659 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.75 176.98 4.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.581 HD23 ' CD1' ' A' ' 208' ' ' TYR . 0.5 OUTLIER -121.17 18.2 11.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.12 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -107.71 -43.52 4.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 109.747 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.38 93.38 3.93 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.143 0.973 . . . . 0.0 108.664 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 227' ' ' LEU . 3.9 mm? -91.0 85.54 5.98 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.673 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.437 ' OD1' ' HA2' ' A' ' 240' ' ' GLY . 6.9 m-20 -116.26 154.91 48.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.243 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.2 152.58 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.609 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.26 -45.57 2.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.321 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' HB2' HG11 ' A' ' 217' ' ' VAL . . . -81.89 104.55 12.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.382 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.94 -52.89 4.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.497 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 47.49 -102.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.09 168.59 19.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -1.165 . . . . 0.0 109.506 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -93.19 59.75 2.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -105.72 -75.99 1.02 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.38 58.59 4.89 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -87.43 -172.53 3.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -1.178 . . . . 0.0 109.574 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.71 104.94 1.76 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.437 ' HA2' ' OD1' ' A' ' 228' ' ' ASN . . . -104.77 42.78 1.81 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.556 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -122.92 -177.77 3.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 109.442 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 245' ' ' GLN . 0.8 OUTLIER -135.67 80.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.201 -0.937 . . . . 0.0 109.532 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.67 -58.52 4.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.556 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 29.4 m-85 -129.55 96.23 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.523 ' HB3' ' ND2' ' A' ' 242' ' ' ASN . 3.2 pt20 -91.79 138.34 31.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.981 -1.075 . . . . 0.0 108.981 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 160' ' ' ILE . 96.9 p -167.45 161.93 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.785 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -138.92 169.07 18.46 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.694 1.235 . . . . 0.0 110.4 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.688 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 40.6 t -117.12 119.2 61.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.701 HG23 ' NE2' ' A' ' 158' ' ' HIS . 19.7 m -125.24 145.16 33.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 156' ' ' SER . . . 101.11 52.42 1.08 Allowed Glycine 0 N--CA 1.486 1.997 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.051 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 55' ' ' ILE . 2.4 mt -103.94 93.63 2.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.273 . . . . 0.0 110.421 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 0.2 OUTLIER -162.41 141.99 7.25 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 178.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.598 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.354 2.036 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.502 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 43.7 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.502 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 36.1 Cg_endo -78.59 163.4 26.79 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.443 2.095 . . . . 0.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG22 ' C ' ' A' ' 203' ' ' ASP . 29.3 t -94.63 141.91 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.587 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.696 HG12 ' HA2' ' A' ' 201' ' ' GLY . 58.7 t -132.84 131.67 59.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.436 -0.79 . . . . 0.0 109.905 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 200' ' ' ASP . 18.4 mmtt -75.37 177.84 6.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 108.945 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.614 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 0.1 OUTLIER -77.49 103.04 7.19 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.607 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.691 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 23.8 mt -58.27 -52.97 63.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 108.89 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.625 HD11 HG11 ' A' ' 198' ' ' VAL . 11.3 mt -54.96 -41.3 70.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.698 -1.251 . . . . 0.0 108.893 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.5 t70 -68.92 -41.8 77.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.063 . . . . 0.0 108.903 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.2 p -58.48 -15.03 9.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 108.992 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 58' ' ' TYR . 9.4 mtpp -117.08 22.0 12.84 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.39 34.01 3.3 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 25.4 mt -87.35 108.3 18.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.379 -1.071 . . . . 0.0 110.06 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' PRO . 23.0 m-70 -134.82 83.62 2.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.636 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.4 m-30 -90.4 176.17 6.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.072 -1.018 . . . . 0.0 110.84 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -147.22 -164.66 2.05 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 6.6 mt-30 -124.52 -17.7 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.337 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.734 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -116.31 -36.98 1.05 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.632 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.02 -142.02 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.55 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.341 -177.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.82 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -74.13 3.72 4.9 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 CA-C-N 122.394 1.891 . . . . 0.0 109.417 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' HB3' ' SD ' ' A' ' 120' ' ' MET . 11.1 m-85 -78.86 -32.26 45.95 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 26.1 p-10 -92.79 23.63 4.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.595 -1.316 . . . . 0.0 109.635 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' PRO . 4.6 mt -77.05 -1.33 28.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.169 -0.957 . . . . 0.0 110.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 24' ' ' LEU . 10.8 mt -134.14 14.09 3.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.717 -1.239 . . . . 0.0 109.359 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 22.3 p -82.68 163.88 49.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.65 134.63 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.002 1.801 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' CE2' ' A' ' 80' ' ' PHE . 20.7 t -78.89 149.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.502 0.668 . . . . 0.0 109.738 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.829 HD11 ' C ' ' A' ' 132' ' ' GLY . 22.1 mt -78.3 148.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.804 0.811 . . . . 0.0 111.169 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' C ' HG22 ' A' ' 39' ' ' VAL . 9.0 mm-40 -126.04 -21.2 4.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.782 -0.574 . . . . 0.0 110.235 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' C ' ' A' ' 80' ' ' PHE . 10.0 mtpt -121.28 164.51 16.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.148 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 32' ' ' LYS . 80.9 t -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.627 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -78.94 160.29 71.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 33.2 Cg_endo -82.13 114.3 2.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.583 2.189 . . . . 0.0 110.253 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.81 7.54 66.24 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -119.73 160.75 21.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -1.163 . . . . 0.0 109.425 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.41 ' O ' HG13 ' A' ' 31' ' ' VAL . 3.1 mt-30 -60.98 173.09 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.361 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -83.16 132.18 35.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.457 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 64.7 m-85 -119.94 15.52 12.52 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.922 -1.111 . . . . 0.0 109.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 28' ' ' ILE . 62.3 t -63.83 137.44 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.439 -0.788 . . . . 0.0 109.599 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.19 -7.36 67.72 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 22.7 mt-30 -77.72 130.84 37.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -1.113 . . . . 0.0 109.651 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -73.15 110.0 7.1 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.15 159.9 0.85 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.141 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -78.61 168.3 19.97 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.599 0.714 . . . . 0.0 110.043 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.63 HG21 ' SD ' ' A' ' 120' ' ' MET . 18.0 p -78.85 -35.19 44.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 135' ' ' SER . . . 109.69 134.51 6.94 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.4 p -54.02 -50.49 66.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 47.0 t -47.05 -55.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -59.68 -48.15 82.81 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.911 0.862 . . . . 0.0 110.351 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 44.1 m -61.28 -38.92 88.51 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.49 -37.36 80.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.642 -1.286 . . . . 0.0 108.334 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 56' ' ' MET . 97.6 m -70.44 -56.68 6.04 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 56' ' ' MET . . . -52.36 -34.98 50.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.52 -0.737 . . . . 0.0 109.199 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.636 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 24.9 mt-30 -63.49 -61.95 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 251' ' ' ILE . 46.4 mt -57.23 -30.19 34.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 52' ' ' THR . 25.8 mtp -63.36 -32.41 73.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.558 ' CE ' ' O ' ' A' ' 100' ' ' ILE . 49.2 tptt -74.65 -43.38 55.62 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 7' ' ' LEU . 39.2 t80 -51.8 -33.12 34.2 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.69 -0.631 . . . . 0.0 109.789 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 93.4 m-70 -108.71 -22.18 12.35 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 111.05 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.626 ' HB2' ' CG ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 41.08 55.25 3.22 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -177.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -76.39 -68.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.7 Cg_endo -68.2 96.82 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.31 0.673 . . . . 0.0 111.962 -176.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.06 -20.23 64.94 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -135.44 138.05 42.82 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 177.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.71 149.16 33.74 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.365 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.915 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -88.96 -54.35 4.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.951 . . . . 0.0 110.326 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 18.9 tttt -140.71 134.52 30.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.088 -1.008 . . . . 0.0 110.245 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -62.2 166.25 5.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.518 -0.738 . . . . 0.0 109.942 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 36.2 t80 -150.04 143.81 25.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.202 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.14 171.63 16.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.16 -0.963 . . . . 0.0 109.473 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 27.3 p90 -173.06 158.57 3.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 109.92 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' ASN . 89.0 m -93.66 137.89 32.46 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.721 HD21 ' ND2' ' A' ' 77' ' ' ASN . 9.3 tp -53.26 149.74 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.035 -178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 141.32 57.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.767 -0.583 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -69.08 -3.01 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t30 -99.53 -6.01 28.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.467 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.721 ' ND2' HD21 ' A' ' 73' ' ' LEU . 22.0 t-20 -70.12 110.87 7.54 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.867 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.636 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 52.4 Cg_endo -87.46 10.86 3.37 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.973 2.449 . . . . 0.0 110.216 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 56.6 m-85 -108.8 -1.71 19.06 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.11 -0.994 . . . . 0.0 111.415 -176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASN . 74.7 m-85 -141.57 160.93 39.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 9.2 m-80 -48.37 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER 174.42 -46.32 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.385 -0.822 . . . . 0.0 111.284 174.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.6 Cg_endo -76.41 55.81 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 107.549 -1.75 . . . . 0.0 107.549 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 3.3 tptt -105.8 103.69 13.25 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 85' ' ' ASN . 0.0 OUTLIER -100.77 133.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 109.558 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.2 mp -106.31 154.19 21.12 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 7.0 t80 -144.41 139.43 28.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.937 -1.102 . . . . 0.0 110.101 -178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 90' ' ' ILE . . . -118.53 111.02 18.07 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.62 50.68 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.694 -1.254 . . . . 0.0 108.19 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 4.3 mt -52.81 -51.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.401 -0.812 . . . . 0.0 109.516 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.6 p -44.21 -29.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.674 -1.266 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -112.88 33.73 4.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 108.774 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -84.48 153.3 23.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.993 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.417 ' HA ' ' NE2' ' A' ' 94' ' ' GLN . 1.5 mm-40 -122.49 85.58 2.44 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-85 -80.9 95.47 6.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.272 -0.892 . . . . 0.0 109.896 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.1 m120 -78.69 92.11 4.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.626 ' CG ' ' HB2' ' A' ' 60' ' ' ASN . 50.2 m95 -60.95 -8.81 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.354 -0.841 . . . . 0.0 109.932 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -90.48 -23.51 20.95 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 8.3 m-20 -97.99 -26.62 14.57 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.558 ' O ' ' CE ' ' A' ' 57' ' ' LYS . 51.7 mt -74.05 64.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 59.4 mt -46.28 150.7 1.07 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.639 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.8 Cg_endo -79.01 -27.12 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.496 2.131 . . . . 0.0 110.364 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.525 ' HB ' ' CD2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -139.31 133.05 30.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.98 . . . . 0.0 109.132 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 76.9 m-85 -115.97 142.82 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.155 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.82 -4.39 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.96 10.11 84.43 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HE ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -119.93 -6.14 10.05 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.465 -1.02 . . . . 0.0 109.424 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.79 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -63.97 169.54 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -71.07 -176.82 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.693 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 2.8 m120 -80.55 -33.84 35.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.78 -61.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HG3' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -62.52 -35.03 78.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.151 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.494 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 19.0 mttt -64.45 -43.25 94.85 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.058 -1.026 . . . . 0.0 108.308 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.435 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -59.91 -37.95 80.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 108.709 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -56.99 -68.26 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.501 -0.749 . . . . 0.0 109.762 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.647 ' CD1' HD23 ' A' ' 119' ' ' LEU . 2.2 tp -64.17 -43.72 97.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.559 -0.713 . . . . 0.0 109.679 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 116' ' ' ILE . 24.1 p -56.63 -40.31 75.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 108.588 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.493 ' OE2' ' CZ ' ' A' ' 93' ' ' ARG . 6.3 tt0 -70.65 -40.79 72.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' CD1' ' A' ' 116' ' ' ILE . 24.2 tp -55.48 -50.54 69.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 45' ' ' THR . 1.2 mmt -60.01 -52.11 66.8 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.898 -0.501 . . . . 0.0 111.531 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.65 95.33 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 118' ' ' GLU . 6.8 m-20 -65.62 -49.43 68.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 119' ' ' LEU . 48.5 t -61.1 -60.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 108.953 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.6 -44.37 16.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 mt -67.44 -53.39 32.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.023 -1.281 . . . . 0.0 107.676 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.4 p -47.43 -32.44 5.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.39 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 35.6 m -101.49 36.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.005 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.776 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 11.1 m-20 40.1 53.27 2.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.398 -0.814 . . . . 0.0 110.114 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.559 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 48.6 tpp -67.59 137.68 55.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 111.899 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 5.9 t0 -87.32 123.82 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.633 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 83.8 m-85 -104.7 120.57 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.482 1.134 . . . . 0.0 113.824 -175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.829 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.95 -162.44 10.82 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 104.69 -3.364 . . . . 0.0 104.69 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.718 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.2 Cg_endo -62.16 -31.59 82.87 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 N-CA-C 105.648 -2.482 . . . . 0.0 105.648 175.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.9 m -110.23 143.04 40.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 173.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.535 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 44.8 m -121.33 110.92 16.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 119.87 -1.769 . . . . 0.0 110.087 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 130' ' ' ASP . . . -107.86 137.94 14.32 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.455 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 1.1 t -117.26 -163.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.15 . . . . 0.0 107.954 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.921 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -90.92 -56.22 3.26 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.567 ' CA ' ' OH ' ' A' ' 185' ' ' TYR . . . 125.88 -123.53 4.89 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.499 -1.334 . . . . 0.0 112.009 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.2 m -48.55 -65.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.797 -0.825 . . . . 0.0 112.602 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -46.48 -32.03 3.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.789 -1.194 . . . . 0.0 109.293 -178.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.921 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 53.2 mmt-85 -80.86 -51.25 8.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.973 0.892 . . . . 0.0 109.212 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 185' ' ' TYR . 82.7 t -66.9 -54.84 21.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.809 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 2.4 pp0? -57.34 -34.35 68.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.955 -1.091 . . . . 0.0 108.749 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.523 ' CG ' ' OE1' ' A' ' 149' ' ' GLU . 6.0 ttm180 -78.4 -53.56 7.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.012 -1.055 . . . . 0.0 109.433 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.1 -37.27 82.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.21 -0.931 . . . . 0.0 110.223 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 38.1 mt -58.47 -46.09 87.33 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.952 -1.092 . . . . 0.0 109.377 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.564 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 59.5 mtmt -87.72 -49.24 7.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.104 . . . . 0.0 110.981 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.523 ' OE1' ' CG ' ' A' ' 145' ' ' ARG . 34.2 mt-10 -67.07 -43.01 83.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.679 -1.263 . . . . 0.0 111.566 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 31.9 m120 -94.4 -49.7 5.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.681 -1.262 . . . . 0.0 111.485 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 56' ' ' MET . 29.6 m-85 -99.42 20.33 13.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.874 -1.141 . . . . 0.0 110.598 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.915 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 40.64 0.05 OUTLIER Glycine 0 N--CA 1.497 2.767 0 O-C-N 121.862 -0.524 . . . . 0.0 112.62 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.9 m-85 -62.88 158.84 18.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.142 -1.799 . . . . 0.0 107.564 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 61.7 t30 -47.17 154.35 0.39 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.741 -1.224 . . . . 0.0 109.533 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -56.05 -16.52 5.1 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.6 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 3.6 p -53.02 -17.35 1.43 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 40.5 t -72.67 119.61 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.866 -1.146 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.707 ' NE2' HG23 ' A' ' 249' ' ' VAL . 0.6 OUTLIER -148.19 166.81 26.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.191 178.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.55 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.7 tt0 -112.68 137.03 51.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.953 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 247' ' ' ALA . 14.7 pt -122.62 170.34 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 245' ' ' GLN . 1.3 m-80 -127.53 103.46 7.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.683 -1.261 . . . . 0.0 110.509 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.603 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.44 -39.45 15.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.86 . . . . 0.0 109.226 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.08 -26.91 64.1 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -104.8 4.57 32.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.057 -1.26 . . . . 0.0 112.274 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.47 163.81 15.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.2 -1.562 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 166' ' ' SER . 3.7 ttpt -29.36 -51.49 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.21 -60.67 2.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.895 -1.128 . . . . 0.0 110.775 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.47 -18.24 58.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 109.571 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.639 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 71.3 t-105 -74.73 -50.89 15.8 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 174' ' ' ILE . 46.1 mt-10 -69.99 -36.1 74.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 171' ' ' GLU . . . -45.75 -41.65 10.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.453 ' NE2' HG21 ' A' ' 249' ' ' VAL . 13.3 mm100 -60.62 -43.65 97.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 199' ' ' ILE . 14.7 mt -68.6 -53.91 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.5 OUTLIER -49.27 -49.17 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.138 -178.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -51.52 -45.26 62.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.912 -1.118 . . . . 0.0 108.611 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 19.9 mm-40 -60.53 -52.32 65.68 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.256 -0.902 . . . . 0.0 108.946 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 199' ' ' ILE . 93.5 mt -65.15 -26.76 68.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.779 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 22.3 p -51.89 -39.99 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.505 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.51 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 19.6 mt-30 -102.32 35.08 2.52 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.513 ' HB3' HD22 ' A' ' 7' ' ' LEU . 16.2 m120 47.82 50.43 15.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 180' ' ' GLN . 16.7 mt-30 -123.04 105.04 34.92 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.585 ' HD3' HD13 ' A' ' 7' ' ' LEU . 18.7 Cg_endo -62.62 168.85 9.32 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 121.602 1.535 . . . . 0.0 111.869 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 174' ' ' ILE . 2.4 t -129.84 138.18 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.097 0.951 . . . . 0.0 110.79 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.727 ' HB3' ' HB ' ' A' ' 248' ' ' VAL . 0.1 OUTLIER -86.83 123.34 31.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -123.73 161.45 25.14 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.631 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 0.5 OUTLIER -166.45 129.54 1.95 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 117.666 -1.614 . . . . 0.0 111.115 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.477 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.19 122.37 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.1 t -85.73 168.84 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.152 -1.205 . . . . 0.0 111.117 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.41 -142.82 4.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 4.8 mtmm -87.73 -36.49 17.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.07 -1.253 . . . . 0.0 110.624 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.4 m -75.03 -17.76 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.153 -0.967 . . . . 0.0 110.928 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.17 -170.17 22.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.564 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -89.85 107.38 3.42 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.753 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.631 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 21.2 t-80 -72.46 134.92 45.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -121.64 162.71 20.22 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.609 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.899 ' CD1' HG13 ' A' ' 210' ' ' VAL . 18.3 p90 -157.13 172.3 18.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.625 HG11 HD11 ' A' ' 8' ' ' LEU . 87.5 t -113.29 140.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.736 -1.228 . . . . 0.0 112.752 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 178' ' ' LEU . 36.2 mt -98.16 130.44 46.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 7.5 p-10 -150.81 37.45 0.65 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 117.926 -1.51 . . . . 0.0 111.494 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA2' HG12 ' A' ' 4' ' ' VAL . . . 174.92 -179.46 46.2 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 120.267 -1.52 . . . . 0.0 110.464 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.642 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.4 150.9 7.72 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -1.209 . . . . 0.0 109.661 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.497 ' C ' HG22 ' A' ' 3' ' ' VAL . 13.8 m-20 -111.28 27.52 9.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.07 . . . . 0.0 109.897 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 1' ' ' GLN . . . 49.94 22.34 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.68 44.6 2.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -1.193 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.481 ' O ' ' CE1' ' A' ' 222' ' ' PHE . 0.5 OUTLIER 63.67 22.36 13.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.61 ' HA ' ' CE1' ' A' ' 222' ' ' PHE . 5.2 m-85 -121.59 136.69 54.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 28.2 m-85 -121.29 167.64 12.51 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 2.1 t60 -91.55 135.52 33.8 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.089 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.899 HG13 ' CD1' ' A' ' 197' ' ' PHE . 49.9 t -123.62 136.18 60.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.204 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.62 ' CB ' HD12 ' A' ' 8' ' ' LEU . 19.6 t-20 -112.91 78.87 1.17 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 229' ' ' PRO . 84.5 m95 -46.33 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -86.08 25.49 6.86 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 230' ' ' SER . 18.0 m95 -108.42 -165.32 1.02 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -1.162 . . . . 0.0 109.779 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -85.32 -81.38 1.1 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.17 45.66 1.12 Allowed Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.091 -1.241 . . . . 0.0 110.027 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.7 HG22 ' H ' ' A' ' 218' ' ' SER . 13.8 p -81.2 -128.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.073 -1.251 . . . . 0.0 109.01 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.7 ' H ' HG22 ' A' ' 217' ' ' VAL . 36.7 m -70.99 56.56 0.19 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.27 -1.518 . . . . 0.0 109.977 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 217' ' ' VAL . 6.6 m-20 -94.95 109.35 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 209' ' ' HIS . . . 151.14 -65.81 0.36 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -94.54 149.08 21.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.865 -1.373 . . . . 0.0 110.057 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 207' ' ' PHE . 0.1 OUTLIER -99.47 164.68 11.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.183 -0.948 . . . . 0.0 109.678 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.669 ' HD3' ' HB3' ' A' ' 226' ' ' ALA . 0.2 OUTLIER -125.68 151.52 46.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -110.01 -38.54 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.136 -0.978 . . . . 0.0 109.807 -179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -94.41 -3.1 50.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.669 ' HB3' ' HD3' ' A' ' 223' ' ' ARG . . . -123.34 86.34 2.56 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.035 0.922 . . . . 0.0 109.368 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -89.72 -6.44 56.06 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.351 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -107.55 105.15 55.3 Favored Pre-proline 0 C--N 1.294 -1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 109.15 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.604 ' HG2' ' CE1' ' A' ' 195' ' ' HIS . 36.2 Cg_endo -77.1 -165.46 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.428 2.085 . . . . 0.0 110.442 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.532 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 0.4 OUTLIER -88.42 57.87 4.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.335 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' A' ' 195' ' ' HIS . . . -69.42 -44.72 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 109.696 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 231' ' ' ALA . 6.1 mt -45.46 -86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.24 -146.73 16.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 t -79.75 1.22 27.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.356 -1.085 . . . . 0.0 109.748 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -92.96 -155.44 32.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.37 -158.04 10.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 152.02 143.55 3.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -64.44 -18.96 65.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -1.19 . . . . 0.0 109.282 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 126.96 -161.58 21.2 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -172.0 57.03 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -57.43 -169.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.169 . . . . 0.0 109.364 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.597 ' HB2' HD21 ' A' ' 227' ' ' LEU . 1.5 t-20 -101.06 68.35 1.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.9 . . . . 0.0 109.175 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -71.8 -49.63 22.51 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.491 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 16.4 m-85 -136.01 162.79 31.89 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.47 -1.018 . . . . 0.0 108.986 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.523 ' OE1' ' ND2' ' A' ' 242' ' ' ASN . 38.6 mt-30 -155.07 136.21 13.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.985 . . . . 0.0 108.681 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 160' ' ' ILE . 77.2 p -148.72 158.72 44.34 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.207 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -131.11 151.11 51.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.886 0.851 . . . . 0.0 109.361 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.727 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 75.8 t -116.54 116.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.707 HG23 ' NE2' ' A' ' 158' ' ' HIS . 18.7 m -124.15 143.05 38.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.741 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 91.81 56.89 1.57 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.67 HD13 HG21 ' A' ' 55' ' ' ILE . 6.0 mt -102.68 79.38 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 110.565 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 13.8 pttm -159.58 155.96 24.05 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.9 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.608 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.274 1.982 . . . . 0.0 110.439 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 206' ' ' ASN . 45.3 tt0 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.21 148.65 21.53 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.453 2.102 . . . . 0.0 110.416 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.529 HG22 ' C ' ' A' ' 203' ' ' ASP . 45.1 t -80.36 140.06 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.97 . . . . 0.0 108.999 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.665 ' HB ' ' N ' ' A' ' 202' ' ' ALA . 29.0 t -133.87 130.84 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 110.757 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 4.9 mmtp -77.03 175.72 9.33 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 11.2 t -77.12 111.28 12.56 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.971 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.652 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 52.5 mt -58.41 -50.77 72.48 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.56 HD11 HG11 ' A' ' 198' ' ' VAL . 10.0 mt -56.3 -34.32 66.38 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.964 -1.085 . . . . 0.0 108.339 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 26.5 t0 -66.87 -41.16 87.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 0.0 109.274 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.8 p -58.1 -16.06 11.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.949 -1.095 . . . . 0.0 108.593 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HB2' HG13 ' A' ' 13' ' ' ILE . 16.7 mtpt -122.41 19.75 10.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 41.84 42.5 3.88 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.581 ' HA ' ' HB2' ' A' ' 102' ' ' PRO . 11.6 mt -86.8 100.69 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.293 -1.122 . . . . 0.0 110.677 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 102' ' ' PRO . 16.5 m-70 -128.05 75.32 1.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 13.5 m-30 -81.18 170.01 16.66 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.283 1.04 . . . . 0.0 111.851 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.77 -174.91 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 47' ' ' SER . 6.3 mt-30 -125.08 18.36 8.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.816 -1.178 . . . . 0.0 110.056 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 22' ' ' ASN . . . -116.74 -87.14 1.28 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.319 -1.419 . . . . 0.0 113.474 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.912 ' ND2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -46.38 -103.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 116.658 -1.639 . . . . 0.0 113.945 -175.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.912 ' HD2' ' ND2' ' A' ' 19' ' ' ASN . 51.9 Cg_endo -83.95 5.58 6.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 123.332 2.226 . . . . 0.0 112.486 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD1' HG12 ' A' ' 116' ' ' ILE . 83.1 m-85 -87.05 -31.97 20.24 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 120.94 -1.1 . . . . 0.0 110.118 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 18' ' ' GLY . 38.2 p-10 -101.66 27.95 5.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 109.725 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 20' ' ' PRO . 9.0 mt -76.03 -4.49 41.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.2 mt -131.19 21.7 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.8 -1.188 . . . . 0.0 109.264 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.3 p -89.68 164.31 29.62 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.7 Cg_endo -68.97 136.46 35.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.248 1.965 . . . . 0.0 112.048 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.08 148.7 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.663 0.744 . . . . 0.0 110.123 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.814 HD11 ' C ' ' A' ' 132' ' ' GLY . 23.8 mt -78.78 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.646 0.736 . . . . 0.0 111.392 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 39' ' ' VAL . 2.6 mt-10 -126.54 -20.38 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.776 -0.578 . . . . 0.0 110.458 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HB2' ' CA ' ' A' ' 79' ' ' TYR . 12.4 mtpp -117.65 168.07 10.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.93 -1.106 . . . . 0.0 110.663 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' SER . 84.5 t -114.43 147.09 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.595 -0.691 . . . . 0.0 110.335 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' CD ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -79.97 157.96 73.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.614 ' HD2' ' CD ' ' A' ' 32' ' ' LYS . 32.7 Cg_endo -82.38 113.58 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.537 2.158 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 4.67 58.66 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HG2' ' CE2' ' A' ' 38' ' ' PHE . 2.2 tt0 -125.2 160.45 29.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.137 -1.214 . . . . 0.0 109.591 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' HG13 ' A' ' 31' ' ' VAL . 3.7 mt-30 -61.08 -179.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.1 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 31' ' ' VAL . 13.1 t -86.79 139.65 30.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CD2' ' HG3' ' A' ' 133' ' ' PRO . 79.9 m-85 -122.4 16.0 10.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.012 -1.055 . . . . 0.0 109.45 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 29' ' ' GLU . 60.5 t -64.03 139.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.932 . . . . 0.0 109.554 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 2.18 89.3 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 21.8 mt-30 -89.02 130.29 35.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -1.165 . . . . 0.0 109.511 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CE1' ' O ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.01 110.14 7.07 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.17 159.01 1.0 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.031 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' OG ' ' A' ' 135' ' ' SER . . . -77.52 166.27 23.28 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.498 0.666 . . . . 0.0 110.085 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.542 ' O ' ' CE ' ' A' ' 129' ' ' MET . 13.2 p -78.89 -30.15 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 100.96 137.19 9.67 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.522 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 7.8 p -55.58 -48.53 74.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.317 -1.107 . . . . 0.0 108.188 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.561 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 3.3 t -46.43 -52.84 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.582 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . . . -61.52 -50.73 71.54 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.685 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 17' ' ' GLN . 16.9 m -64.83 -28.43 69.55 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.487 -0.758 . . . . 0.0 109.811 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -66.41 -45.15 80.91 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.127 -1.429 . . . . 0.0 107.791 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 56' ' ' MET . 33.3 m -76.13 -49.74 16.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.683 0.754 . . . . 0.0 110.281 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -51.13 -34.49 31.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.391 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.632 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 33.5 mt-30 -67.18 -52.54 40.13 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.022 HG21 HD13 ' A' ' 251' ' ' ILE . 29.9 mt -61.24 -25.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.539 ' HG3' HG22 ' A' ' 52' ' ' THR . 15.1 mtp -70.5 -36.02 73.57 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.589 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.1 tptt -76.11 -40.87 51.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.652 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 52.7 t80 -53.93 -25.56 21.05 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.015 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 60.1 m-70 -108.09 -28.0 9.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 110.529 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.619 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 62.5 m-20 47.88 61.75 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.8 t80 -84.67 -78.9 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' CD2' ' A' ' 61' ' ' TYR . 37.0 Cg_endo -71.49 107.47 2.17 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.815 0.97 . . . . 0.0 113.25 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 -24.85 65.65 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 3.5 ttpt -130.12 128.34 41.62 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -56.56 164.05 5.71 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.463 -1.827 . . . . 0.0 110.397 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.026 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -96.59 -35.36 11.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -1.063 . . . . 0.0 111.285 -179.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 10.1 tttt -152.67 134.14 14.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.607 -1.308 . . . . 0.0 110.402 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 7.7 m-20 -64.08 172.98 2.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.434 -0.791 . . . . 0.0 109.424 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 27.6 t80 -153.94 147.2 24.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -150.32 169.75 20.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.778 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.687 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 28.0 p90 -169.59 157.13 6.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 m -93.01 133.88 35.69 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.753 HD21 ' ND2' ' A' ' 77' ' ' ASN . 8.9 tp -50.57 149.56 3.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 111.21 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.43 140.65 58.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.788 -0.57 . . . . 0.0 109.932 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.84 -4.15 11.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.954 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.3 t30 -99.13 -5.88 29.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.021 -1.049 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.753 ' ND2' HD21 ' A' ' 73' ' ' LEU . 23.5 t-20 -70.17 110.33 6.55 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.733 -0.605 . . . . 0.0 110.208 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 48.7 Cg_endo -88.61 13.59 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.81 2.34 . . . . 0.0 109.619 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.646 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.1 m-85 -107.89 -4.8 17.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 111.363 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 81' ' ' ASN . 35.3 m-85 -142.24 164.15 30.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.592 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.6 m120 -49.23 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER 173.74 -47.18 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.976 175.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.4 Cg_endo -76.62 56.31 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 N-CA-C 107.505 -1.767 . . . . 0.0 107.505 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 6.4 tptt -106.06 105.8 16.01 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.342 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.05 139.35 35.84 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -112.07 137.53 49.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 61.5 t80 -125.13 132.24 53.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.593 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.75 114.13 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.865 ' HB1' HG23 ' A' ' 92' ' ' THR . . . -73.62 50.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.85 -1.156 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 4.9 mt -53.47 -57.33 5.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.551 -0.718 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . 3.2 p -43.81 -29.5 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.763 -1.211 . . . . 0.0 109.103 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.865 HG23 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -113.58 34.11 4.76 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.604 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.738 ' HE ' ' CG ' ' A' ' 122' ' ' ASP . 8.6 mmt180 -84.31 157.85 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.446 -1.409 . . . . 0.0 109.365 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.14 85.74 2.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 9.8 m-85 -81.13 93.8 6.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.463 -0.773 . . . . 0.0 110.154 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -77.94 93.27 4.4 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.619 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 56.8 m95 -60.81 -8.35 2.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.518 -0.739 . . . . 0.0 110.458 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -91.02 -21.45 21.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.85 -1.157 . . . . 0.0 108.298 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 26.2 m-20 -99.74 -25.63 14.32 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.612 HG12 ' HB1' ' A' ' 115' ' ' ALA . 68.9 mt -73.69 70.97 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HG2' ' A' ' 108' ' ' GLU . 36.7 mt -52.84 150.43 9.9 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.581 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 30.8 Cg_endo -79.23 -23.09 7.86 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.964 2.442 . . . . 0.0 110.192 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.24 123.93 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.859 -1.151 . . . . 0.0 109.975 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.51 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 35.2 m-85 -110.62 138.47 46.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.15 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -99.74 -4.56 30.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.27 7.5 60.7 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -120.28 -1.32 10.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -1.118 . . . . 0.0 109.427 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' HD12 ' A' ' 101' ' ' LEU . 7.4 mp0 -64.33 167.11 7.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 0.0 109.35 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 0.3 OUTLIER -69.55 170.63 10.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.339 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.58 -35.19 70.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.01 -61.45 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 109.763 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.39 -32.15 72.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.356 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 10.4 mttt -66.5 -44.03 83.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.18 -0.95 . . . . 0.0 108.488 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.7 ttm -59.13 -34.49 72.1 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -56.9 -68.05 0.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.529 -0.732 . . . . 0.0 109.437 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.038 HD11 ' HE2' ' A' ' 120' ' ' MET . 5.5 tp -63.28 -52.13 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.123 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 116' ' ' ILE . 4.2 p -45.6 -41.0 9.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' MET . 34.7 tt0 -70.61 -54.4 12.16 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.836 HD23 ' CD1' ' A' ' 116' ' ' ILE . 8.8 tp -46.9 -48.14 21.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 1.038 ' HE2' HD11 ' A' ' 116' ' ' ILE . 24.1 mmt -59.44 -53.99 51.75 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.842 -0.536 . . . . 0.0 111.047 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.22 75.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.939 -1.101 . . . . 0.0 108.564 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.738 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 9.5 m-20 -64.2 -47.3 80.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 127' ' ' VAL . 63.0 t -71.54 -51.65 31.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.126 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.86 -51.7 12.82 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 126' ' ' SER . 2.9 mt -62.57 -57.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.177 -1.19 . . . . 0.0 108.258 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -46.67 -29.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.396 -178.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.641 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 28.5 m -101.08 34.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.428 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 71' ' ' TYR . 95.4 m-20 40.83 51.19 3.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 109.246 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 45' ' ' THR . 58.5 tpp -66.04 126.16 27.72 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 111.698 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' SER . 4.5 t0 -76.53 122.57 24.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 69.0 m-85 -103.42 116.79 33.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.248 1.023 . . . . 0.0 113.141 -175.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.814 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.28 -162.48 10.74 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.647 ' N ' HD11 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -62.64 -29.47 77.86 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 N-CA-C 105.818 -2.416 . . . . 0.0 105.818 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 139.54 45.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.533 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 50.4 m -121.11 107.88 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.067 -1.646 . . . . 0.0 110.008 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.76 143.73 16.28 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.002 -1.095 . . . . 0.0 110.606 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 10.8 t -117.5 -163.47 0.93 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -90.61 -60.1 2.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.624 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 139.43 -134.5 6.71 Favored Glycine 0 N--CA 1.48 1.573 0 C-N-CA 119.378 -1.391 . . . . 0.0 111.627 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.493 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 71.7 m -51.42 -49.41 61.68 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.677 -0.896 . . . . 0.0 112.298 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -45.84 -47.47 15.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 110.005 -177.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 15.1 mmt180 -81.25 -37.01 29.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.98 -1.075 . . . . 0.0 110.322 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.893 HG21 ' CE2' ' A' ' 185' ' ' TYR . 48.2 t -66.24 -61.27 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.739 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 159' ' ' GLN . 1.4 pp0? -56.38 -31.52 63.91 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.925 -1.109 . . . . 0.0 108.217 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' NH1' ' OE2' ' A' ' 149' ' ' GLU . 1.6 ttm-85 -76.12 -48.95 18.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.161 -0.962 . . . . 0.0 109.28 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.56 -36.16 81.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.159 -0.963 . . . . 0.0 110.097 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 157' ' ' VAL . 35.8 mt -56.47 -46.4 80.43 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 56.1 mtmt -87.47 -40.75 14.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.903 -1.123 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.495 ' OE2' ' NH1' ' A' ' 145' ' ' ARG . 29.8 mt-10 -68.65 -58.56 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.836 -1.165 . . . . 0.0 112.316 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.07 -46.59 11.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.832 -1.168 . . . . 0.0 112.387 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 44.3 m-85 -89.9 -12.53 38.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.619 -1.3 . . . . 0.0 110.343 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 66.16 32.15 81.4 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.482 177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.558 ' CD2' HG22 ' A' ' 251' ' ' ILE . 15.2 m-85 -63.35 153.7 34.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.264 -1.727 . . . . 0.0 107.663 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 19.5 t-20 -46.71 155.71 0.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.786 -1.196 . . . . 0.0 109.971 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 76.7 mm-40 -55.98 -15.99 4.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.379 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.606 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 70.8 p -53.1 -17.61 1.67 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.169 -0.957 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 147' ' ' LEU . 19.7 t -71.47 122.2 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.926 -1.108 . . . . 0.0 109.495 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.676 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.5 p-80 -146.99 -178.26 6.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.119 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.493 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 4.2 tt0 -124.91 152.51 43.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 110.472 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.515 ' O ' ' CA ' ' A' ' 246' ' ' SER . 11.0 pt -133.07 145.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 1.6 m-80 -110.56 103.68 12.3 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.034 -1.041 . . . . 0.0 110.895 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -47.54 -40.21 18.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.21 -0.931 . . . . 0.0 109.353 179.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.02 -23.57 59.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.23 -0.83 27.94 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.093 -1.239 . . . . 0.0 111.56 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -117.48 169.04 9.84 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.467 -1.396 . . . . 0.0 109.94 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.488 ' O ' ' C ' ' A' ' 167' ' ' LYS . 6.9 p -94.7 132.5 39.38 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 166' ' ' SER . 37.2 tttp -32.73 -44.02 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -64.3 -65.35 0.69 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.55 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -14.33 38.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.134 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 162' ' ' ARG . 62.2 t-105 -72.76 -52.5 14.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.043 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.562 ' HA ' HD12 ' A' ' 174' ' ' ILE . 30.8 mt-10 -67.77 -21.99 65.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.33 81.25 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.05 -35.93 78.24 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.657 ' HA ' HG21 ' A' ' 184' ' ' VAL . 15.5 mt -74.57 -61.81 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.538 -0.726 . . . . 0.0 110.231 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.4 OUTLIER -49.85 -51.59 39.02 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.373 -0.829 . . . . 0.0 109.767 -178.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -51.15 -44.14 61.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 4.0 mm-40 -61.1 -46.73 89.44 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 199' ' ' ILE . 40.9 mt -67.84 -28.15 67.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.536 -0.728 . . . . 0.0 109.916 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 175' ' ' ASP . 22.5 p -52.45 -40.3 62.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.958 -1.089 . . . . 0.0 108.638 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.449 ' HG3' ' OG ' ' A' ' 179' ' ' SER . 11.4 mt-30 -99.57 33.61 2.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.648 ' HB3' HD22 ' A' ' 7' ' ' LEU . 75.5 m-20 43.73 53.46 6.02 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.892 0.853 . . . . 0.0 108.985 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.53 ' CB ' ' OE1' ' A' ' 177' ' ' GLU . 6.5 mt-30 -124.36 110.68 28.47 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.522 ' HD3' HD13 ' A' ' 7' ' ' LEU . 17.7 Cg_endo -64.84 165.48 21.02 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.765 1.643 . . . . 0.0 112.658 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 249' ' ' VAL . 25.0 t -121.03 132.97 69.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.043 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.893 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -83.93 116.57 22.86 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 176.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.686 ' CD1' ' CZ ' ' A' ' 197' ' ' PHE . 7.3 t80 -122.08 157.44 31.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.957 -1.09 . . . . 0.0 110.153 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.6 pt20 -162.59 131.74 4.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 117.998 -1.481 . . . . 0.0 111.682 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.83 132.79 11.44 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 190' ' ' GLY . 2.9 t -88.99 172.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.916 -1.343 . . . . 0.0 110.964 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -176.28 -148.96 7.27 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -30.04 20.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.1 -1.235 . . . . 0.0 110.716 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -83.39 -16.17 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.91 -1.118 . . . . 0.0 111.034 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 137.19 -164.18 25.32 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -95.15 112.34 4.37 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.964 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.618 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 14.4 t-80 -71.94 134.05 45.75 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -120.35 162.92 18.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.058 -1.457 . . . . 0.0 112.777 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.686 ' CZ ' ' CD1' ' A' ' 186' ' ' TYR . 44.0 p90 -162.44 166.67 24.71 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.763 HG22 HD11 ' A' ' 55' ' ' ILE . 81.7 t -114.24 137.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.89 -1.131 . . . . 0.0 112.699 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.652 HG21 ' CG2' ' A' ' 174' ' ' ILE . 54.0 mt -98.09 131.32 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 1.9 p30 -143.43 30.09 1.39 Allowed 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.232 -1.387 . . . . 0.0 110.386 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.578 ' HA2' ' CG1' ' A' ' 4' ' ' VAL . . . 177.36 -174.25 46.83 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 117.794 -2.145 . . . . 0.0 111.93 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.665 ' N ' ' HB ' ' A' ' 4' ' ' VAL . . . -166.2 154.94 11.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.662 -0.905 . . . . 0.0 108.794 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.529 ' C ' HG22 ' A' ' 3' ' ' VAL . 1.6 m-20 -117.57 5.96 12.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.757 -1.214 . . . . 0.0 110.314 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.51 -32.79 5.08 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -84.9 45.67 1.18 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.259 -1.142 . . . . 0.0 109.884 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 1.2 t-20 58.29 16.76 4.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 224' ' ' LEU . 8.9 m-85 -104.11 145.11 30.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.014 -1.054 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 54.4 m-85 -123.44 161.76 24.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 6' ' ' SER . 30.1 t-80 -91.75 123.02 34.82 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.795 HG11 ' CE2' ' A' ' 212' ' ' TRP . 33.1 t -115.3 150.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.49 -177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 31.2 t-20 -120.38 70.22 0.88 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.795 ' CE2' HG11 ' A' ' 210' ' ' VAL . 18.4 m95 -52.31 174.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 111.316 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -93.11 39.61 2.94 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.864 ' HB2' HG22 ' A' ' 217' ' ' VAL . 24.5 m95 -118.58 -163.37 0.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -107.65 -38.35 2.07 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.132 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -116.47 -29.07 2.38 Favored Glycine 0 N--CA 1.493 2.488 0 O-C-N 120.653 -1.498 . . . . 0.0 109.661 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.864 HG22 ' HB2' ' A' ' 214' ' ' TRP . 1.3 m -73.91 -30.06 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -1.004 . . . . 0.0 108.942 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 210' ' ' VAL . 2.6 t -43.05 -46.25 5.54 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.238 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 219' ' ' ASP . 0.0 OUTLIER -94.24 96.82 9.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.569 -1.332 . . . . 0.0 110.25 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -155.63 -153.95 6.75 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 28.1 m-85 -114.94 179.34 3.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -1.122 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -71.99 144.8 48.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.257 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.25 149.62 24.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.632 HD11 ' CZ ' ' A' ' 207' ' ' PHE . 1.8 mt -120.41 36.48 4.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.093 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -83.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.044 -1.035 . . . . 0.0 109.816 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.24 -94.81 0.48 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 110.344 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 228' ' ' ASN . 0.3 OUTLIER -99.83 -122.84 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 110.005 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.592 ' HB3' ' CZ3' ' A' ' 212' ' ' TRP . 0.0 OUTLIER -91.69 177.23 2.28 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.879 -1.138 . . . . 0.0 109.477 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 228' ' ' ASN . 35.3 Cg_endo -77.86 -92.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.599 2.199 . . . . 0.0 110.374 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.417 ' O ' ' NE1' ' A' ' 214' ' ' TRP . 19.3 m -98.58 98.64 9.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.995 . . . . 0.0 109.313 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.427 ' C ' ' HG ' ' A' ' 232' ' ' LEU . . . -97.73 12.58 33.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.427 ' HG ' ' C ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -131.89 -40.44 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.56 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 54.59 -103.27 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.28 -13.85 14.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -1.116 . . . . 0.0 109.365 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -85.09 134.11 12.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -88.08 94.51 1.99 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.16 172.78 43.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 239' ' ' GLY . . . -97.64 81.88 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 238' ' ' ALA . . . 62.9 140.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -147.38 89.23 0.15 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 -172.36 2.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -1.121 . . . . 0.0 109.322 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.507 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.0 OUTLIER -109.43 73.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -72.37 -54.04 8.19 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 189' ' ' VAL . 71.4 m-85 -135.93 162.21 33.49 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.555 -0.967 . . . . 0.0 108.664 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 162' ' ' ARG . 22.2 mt-30 -152.83 140.37 19.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 109.319 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 19.6 p -159.17 159.73 34.69 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.145 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . . . -135.6 163.86 29.15 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.146 0.974 . . . . 0.0 109.714 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 95.3 t -117.25 126.73 74.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 184' ' ' VAL . 22.8 m -132.49 149.08 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 157' ' ' VAL . . . 98.05 55.06 1.15 Allowed Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.942 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 1.022 HD13 HG21 ' A' ' 55' ' ' ILE . 2.2 mt -104.0 94.9 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.165 -1.197 . . . . 0.0 110.447 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 18.0 pttt -163.67 144.9 7.19 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.13 -0.981 . . . . 0.0 109.136 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.605 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.233 1.955 . . . . 0.0 110.387 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.48 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 58.6 tt0 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 1' ' ' GLN . 35.5 Cg_endo -78.14 -176.24 3.14 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.455 2.103 . . . . 0.0 110.039 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG22 ' C ' ' A' ' 203' ' ' ASP . 11.2 t -139.73 131.87 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 110.006 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 178' ' ' LEU . 98.2 t -126.93 133.44 68.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 200' ' ' ASP . 16.3 mmtt -74.17 -178.34 3.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.984 -1.072 . . . . 0.0 108.359 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.517 ' HB3' ' ND1' ' A' ' 209' ' ' HIS . 0.0 OUTLIER -77.53 104.0 7.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.054 -1.029 . . . . 0.0 110.36 -178.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.676 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 33.4 mt -58.06 -45.54 86.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 HG11 ' A' ' 198' ' ' VAL . 7.7 mt -61.2 -41.16 96.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.842 -1.161 . . . . 0.0 109.035 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 10.1 t70 -66.14 -37.52 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -57.64 -16.36 10.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 13' ' ' ILE . 1.7 mtpt -122.39 17.45 10.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 44.41 45.73 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 102' ' ' PRO . 8.9 mt -90.55 107.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -1.021 . . . . 0.0 111.084 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' PRO . 31.5 m80 -131.43 95.58 3.79 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.66 ' CG ' ' HG2' ' A' ' 54' ' ' GLN . 9.7 m-30 -97.35 179.93 4.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.93 0.872 . . . . 0.0 111.274 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.42 -164.81 2.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 22' ' ' ASN . 33.9 mt-30 -124.49 -23.56 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.064 -1.022 . . . . 0.0 110.053 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.718 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.68 -33.17 1.61 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.231 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.83 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.63 -142.06 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.518 0 CA-C-N 117.693 0.746 . . . . 0.0 111.093 -178.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 34.7 Cg_endo -73.68 3.24 5.05 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 CA-C-N 122.229 1.832 . . . . 0.0 109.606 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.57 ' HB3' ' HG3' ' A' ' 120' ' ' MET . 7.3 m-85 -80.37 -27.89 38.11 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.002 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' GLN . 17.8 p-10 -97.83 16.48 20.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.461 -1.399 . . . . 0.0 109.743 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 20' ' ' PRO . 5.8 mt -70.84 -3.44 19.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 110.003 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 118' ' ' GLU . 15.7 mt -129.61 -6.37 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.064 . . . . 0.0 109.983 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 20.2 p -60.82 164.47 7.52 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.63 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 18.9 Cg_endo -70.22 136.36 31.57 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.017 1.811 . . . . 0.0 111.625 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.695 HG23 ' CE1' ' A' ' 42' ' ' HIS . 35.6 t -82.39 149.86 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.557 0.694 . . . . 0.0 109.953 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.736 HD11 ' C ' ' A' ' 132' ' ' GLY . 9.8 mt -77.75 151.03 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.62 0.724 . . . . 0.0 110.75 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' C ' HG22 ' A' ' 39' ' ' VAL . 28.5 mt-10 -125.54 -21.96 4.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.683 -0.636 . . . . 0.0 110.417 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' TYR . 48.5 mtpt -124.0 171.1 10.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 110.068 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 37' ' ' SER . 77.1 t -114.4 149.58 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.341 -0.849 . . . . 0.0 110.812 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 78' ' ' PRO . 7.5 tttt -85.13 128.3 60.6 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.96 118.24 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.465 1.443 . . . . 0.0 110.072 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.47 18.55 12.82 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.93 -178.34 6.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.621 -0.929 . . . . 0.0 109.17 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.92 176.92 9.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.412 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -84.29 132.71 34.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.518 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 73.9 m-85 -124.0 21.79 8.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.898 -1.126 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 28' ' ' ILE . 70.7 t -68.24 139.13 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.776 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 27' ' ' VAL . . . 79.35 1.37 85.92 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 29.0 mt-30 -86.1 129.82 34.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 27' ' ' VAL . 1.3 m-70 -73.36 111.38 8.43 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 131' ' ' TYR . . . -52.56 158.08 1.37 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.861 -177.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -74.51 169.36 17.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.429 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 120' ' ' MET . 31.7 p -80.76 -34.66 34.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 108.675 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' HA3' ' SD ' ' A' ' 129' ' ' MET . . . 103.34 134.47 8.3 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' VAL . 3.8 p -54.49 -50.86 66.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.135 -1.214 . . . . 0.0 108.362 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 196' ' ' ALA . 55.6 t -46.6 -53.87 2.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.599 -0.84 . . . . 0.0 108.754 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB2' ' HE3' ' A' ' 129' ' ' MET . . . -58.49 -52.03 67.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.46 -0.775 . . . . 0.0 110.206 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.789 ' HA ' ' HE1' ' A' ' 120' ' ' MET . 17.4 m -63.48 -34.33 77.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.15 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.42 98.7 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.299 -1.361 . . . . 0.0 107.865 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 56' ' ' MET . 34.0 m -74.68 -49.0 22.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.42 0.629 . . . . 0.0 109.623 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB1' ' CD2' ' A' ' 119' ' ' LEU . . . -52.65 -41.83 64.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.822 . . . . 0.0 109.883 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.66 ' HG2' ' CG ' ' A' ' 15' ' ' TYR . 31.0 mt-30 -60.16 -51.64 68.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.759 -1.213 . . . . 0.0 107.941 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 251' ' ' ILE . 34.1 mt -63.79 -28.1 44.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.527 ' SD ' HG22 ' A' ' 123' ' ' VAL . 18.5 mtp -67.93 -36.18 79.71 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.564 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 27.5 tptt -76.38 -42.55 44.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 45.3 t80 -53.34 -29.66 35.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 109.312 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 36.7 m-70 -105.5 -25.93 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 110.163 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.613 ' HB3' ' CG ' ' A' ' 97' ' ' TRP . 62.4 m-20 45.0 59.14 3.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 253' ' ' PRO . 2.6 t80 -84.34 -70.16 0.13 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.024 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 35.4 Cg_endo -67.37 96.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.398 0.732 . . . . 0.0 111.623 -177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.15 -20.39 64.88 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 91' ' ' SER . 4.1 tttp -135.68 140.08 44.18 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.93 144.51 41.62 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.124 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.844 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -83.11 -53.85 5.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.951 . . . . 0.0 110.176 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 9.9 ttpp -145.25 142.5 29.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.29 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 9.7 m-20 -66.69 171.51 5.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -0.852 . . . . 0.0 109.884 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 70' ' ' THR . 51.1 t80 -148.62 164.39 34.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.454 -0.779 . . . . 0.0 109.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.58 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 14.5 t -166.11 162.53 17.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.723 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 24.9 p90 -166.62 154.65 9.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -92.97 136.97 32.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.793 HD21 ' ND2' ' A' ' 77' ' ' ASN . 10.2 tp -54.18 150.77 7.92 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.193 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.74 141.53 57.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.349 0.595 . . . . 0.0 110.076 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -3.26 13.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.082 -1.011 . . . . 0.0 109.71 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 3.4 m-20 -99.74 -7.27 25.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 109.334 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.793 ' ND2' HD21 ' A' ' 73' ' ' LEU . 33.8 t-20 -69.92 109.84 5.49 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.709 -0.62 . . . . 0.0 109.785 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.634 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 37.9 Cg_endo -88.89 16.19 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.867 2.378 . . . . 0.0 110.126 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CD2' ' HD2' ' A' ' 78' ' ' PRO . 66.9 m-85 -106.57 -26.25 11.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 111.033 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 3.7 m-85 -118.64 162.74 17.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 18.1 m-80 -46.36 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 175.15 -47.88 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.164 -0.96 . . . . 0.0 111.178 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 31.1 Cg_endo -76.75 57.21 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 N-CA-C 106.877 -2.009 . . . . 0.0 106.877 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -105.66 104.46 14.18 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.394 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -100.53 134.11 43.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.339 -0.85 . . . . 0.0 109.679 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.723 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 5.5 mp -106.3 137.32 44.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 68' ' ' ASP . 27.1 t80 -128.54 131.55 48.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.06 -1.025 . . . . 0.0 110.261 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -108.01 114.75 28.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . . . -73.48 51.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.728 -1.232 . . . . 0.0 108.312 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 6.7 mt -52.55 -54.32 16.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.492 -0.755 . . . . 0.0 109.593 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 90' ' ' ILE . 3.6 p -45.41 -26.62 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.497 -1.377 . . . . 0.0 109.154 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.1 OUTLIER -111.38 28.48 8.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.618 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.52 150.72 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.872 0.844 . . . . 0.0 110.822 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 86.9 2.6 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.5 m-85 -80.8 91.41 5.93 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.339 -0.851 . . . . 0.0 110.19 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 99' ' ' ASN . 24.2 t-20 -79.58 90.6 5.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 60' ' ' ASN . 58.0 m95 -61.07 -9.06 3.9 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.229 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.39 -14.7 32.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 53.3 m-20 -100.13 -32.92 10.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.702 HG12 ' HB1' ' A' ' 115' ' ' ALA . 23.4 mt -73.35 95.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.35 1.071 . . . . 0.0 108.566 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 104' ' ' TYR . 11.8 mt -72.46 153.13 91.97 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.314 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.566 ' HB3' HG12 ' A' ' 13' ' ' ILE . 30.1 Cg_endo -79.14 -31.84 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.831 2.354 . . . . 0.0 110.344 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -136.8 136.03 38.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 101' ' ' LEU . 74.9 m-85 -120.12 140.63 50.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 p -102.18 -1.06 32.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.15 88.62 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -118.74 -2.46 10.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.476 -1.014 . . . . 0.0 109.264 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 101' ' ' LEU . 14.0 mp0 -64.03 167.79 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 1.3 p -65.05 179.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -82.97 -40.48 19.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.8 t -52.05 -52.36 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.532 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.15 98.75 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 108.988 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.485 ' CE ' ' HB3' ' A' ' 20' ' ' PRO . 24.1 mttt -61.21 -36.83 80.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 50.4 ttm -59.26 -46.03 89.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.5 -0.75 . . . . 0.0 109.666 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -58.1 -51.88 67.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.787 ' CD1' HD23 ' A' ' 119' ' ' LEU . 4.9 tp -68.86 -44.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.49 -1.381 . . . . 0.0 109.468 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 5.8 p -52.9 -41.45 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.024 -1.047 . . . . 0.0 108.649 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.733 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -70.01 -45.59 66.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 116' ' ' ILE . 13.2 tp -50.86 -54.41 24.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.789 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -59.84 -43.92 94.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.603 -0.685 . . . . 0.0 109.521 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -64.85 -39.86 94.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 126' ' ' SER . 24.8 m-20 -68.69 -43.37 76.24 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.527 HG22 ' SD ' ' A' ' 56' ' ' MET . 79.8 t -70.75 -62.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.726 -0.609 . . . . 0.0 109.849 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 49' ' ' ALA . . . -46.65 -45.32 17.8 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' ALA . 3.5 mt -64.81 -57.49 11.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.07 -1.253 . . . . 0.0 108.106 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 9.4 p -46.06 -29.62 1.56 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.61 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 33.6 m -103.04 37.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.019 -1.051 . . . . 0.0 110.093 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.688 ' HB2' ' HE ' ' A' ' 142' ' ' ARG . 2.9 m-20 40.31 38.5 0.55 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.369 -0.832 . . . . 0.0 109.656 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.653 ' HE3' ' HB2' ' A' ' 49' ' ' ALA . 45.9 tpp -52.97 129.11 29.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.822 . . . . 0.0 111.192 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.9 t0 -78.72 122.78 26.43 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.63 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 66.3 m-85 -105.2 119.39 38.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.995 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.736 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -149.99 -163.29 11.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 103.753 -3.739 . . . . 0.0 103.753 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' N ' HD11 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -61.58 -31.0 86.85 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 105.438 -2.562 . . . . 0.0 105.438 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.75 138.26 47.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.506 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -114.44 110.5 19.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.853 -1.779 . . . . 0.0 109.577 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -106.81 135.45 12.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 138' ' ' ALA . 14.9 t -118.18 -163.79 0.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.127 -1.22 . . . . 0.0 108.672 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.739 ' HB3' ' CG ' ' A' ' 142' ' ' ARG . . . -92.07 -56.05 3.22 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.558 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . 128.16 -119.89 3.24 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.796 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 1.6 m -51.32 -66.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.85 -0.794 . . . . 0.0 112.871 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -46.89 -35.1 6.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.89 -1.131 . . . . 0.0 109.871 -177.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.739 ' CG ' ' HB3' ' A' ' 138' ' ' ALA . 48.0 mmt-85 -79.54 -47.86 14.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.299 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 185' ' ' TYR . 55.7 t -67.29 -60.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.483 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -55.9 -30.18 61.17 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.362 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 3.5 ttt180 -77.35 -41.53 40.06 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.232 -0.917 . . . . 0.0 109.252 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.44 75.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 251' ' ' ILE . 58.8 mt -58.11 -53.5 57.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.651 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.596 ' CG ' ' HB ' ' A' ' 157' ' ' VAL . 53.6 mtmt -77.46 -52.57 8.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.715 . . . . 0.0 112.097 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 9.2 mt-10 -66.23 -45.56 80.26 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.49 -1.381 . . . . 0.0 112.383 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.02 -45.26 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.559 -1.338 . . . . 0.0 111.506 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 152' ' ' GLY . 34.2 m-85 -100.02 19.99 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.844 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 30.66 39.6 0.04 OUTLIER Glycine 0 N--CA 1.496 2.668 0 O-C-N 121.905 -0.497 . . . . 0.0 112.992 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.643 ' CD2' HG22 ' A' ' 251' ' ' ILE . 9.8 m-85 -63.36 161.08 14.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.212 -1.758 . . . . 0.0 107.478 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 21.0 t-20 -47.44 147.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.765 -1.209 . . . . 0.0 109.612 -178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.0 mm-40 -54.81 -17.11 3.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.585 ' O ' ' CE1' ' A' ' 158' ' ' HIS . 4.4 p -53.54 -15.87 1.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.596 ' HB ' ' CG ' ' A' ' 148' ' ' LYS . 67.0 t -68.81 129.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.638 -1.289 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.746 ' NE2' HG23 ' A' ' 249' ' ' VAL . 1.1 p-80 -149.46 172.67 14.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.24 -0.912 . . . . 0.0 109.796 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.568 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -117.49 136.36 53.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.772 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 8.8 pt -123.19 170.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 246' ' ' SER . 3.3 m-80 -123.87 102.66 7.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 110.485 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.632 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . 2.6 tpt180 -47.22 -39.2 13.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 109.084 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.55 -29.51 69.74 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -104.91 34.35 3.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.995 -1.297 . . . . 0.0 112.258 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.59 170.94 14.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.306 -1.496 . . . . 0.0 110.217 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 167' ' ' LYS . 97.0 p -96.43 135.8 37.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.687 ' NZ ' HD13 ' A' ' 224' ' ' LEU . 6.7 ttpt -34.78 -51.49 0.5 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.813 -0.554 . . . . 0.0 110.978 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -56.09 17.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.403 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.09 -22.32 66.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.124 -0.985 . . . . 0.0 109.612 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.772 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 70.0 t-105 -71.87 -45.73 60.32 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.133 -0.979 . . . . 0.0 109.169 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 174' ' ' ILE . 69.3 mt-10 -70.87 -26.37 63.22 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.078 -1.014 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.05 83.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.14 -40.45 93.87 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.897 HG23 HG21 ' A' ' 184' ' ' VAL . 12.5 mt -75.72 -56.33 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.422 -0.799 . . . . 0.0 110.486 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 179' ' ' SER . 0.1 OUTLIER -49.87 -46.09 51.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.979 -1.076 . . . . 0.0 109.022 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -52.15 -45.26 64.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 108.215 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.617 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 31.0 mm-40 -59.71 -48.36 81.98 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.688 ' HB3' HG11 ' A' ' 4' ' ' VAL . 22.6 mt -67.63 -27.63 67.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 180' ' ' GLN . 20.7 p -51.36 -42.78 61.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 108.716 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 181' ' ' ASN . 19.3 mt-30 -98.67 38.58 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.65 ' C ' HD13 ' A' ' 7' ' ' LEU . 90.5 m-20 43.3 49.97 5.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 177' ' ' GLU . 5.3 mt-30 -123.64 114.49 28.52 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 16.3 Cg_endo -65.72 169.6 12.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.421 2.08 . . . . 0.0 112.807 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.897 HG21 HG23 ' A' ' 174' ' ' ILE . 58.5 t -125.61 131.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.81 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -82.93 120.14 25.31 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 8.5 t80 -122.98 161.93 23.3 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.894 -1.129 . . . . 0.0 109.546 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.598 ' CA ' ' O ' ' A' ' 195' ' ' HIS . 0.2 OUTLIER -166.74 129.01 1.78 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.466 -1.693 . . . . 0.0 112.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -93.19 124.8 7.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 190' ' ' GLY . 5.6 t -83.19 170.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.305 . . . . 0.0 111.12 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 189' ' ' VAL . . . -175.33 -145.24 5.34 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -87.66 -29.48 21.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.021 -1.282 . . . . 0.0 110.678 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 m -81.82 -14.82 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.959 -1.088 . . . . 0.0 110.893 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.66 -164.41 24.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.56 ' HA3' ' OE1' ' A' ' 187' ' ' GLN . . . -87.93 106.45 3.21 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 121.089 -1.242 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.598 ' O ' ' CA ' ' A' ' 187' ' ' GLN . 11.4 t-80 -71.43 132.75 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . . . -120.71 165.05 15.62 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.102 -1.439 . . . . 0.0 113.006 -177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.819 ' CD1' HG13 ' A' ' 210' ' ' VAL . 17.5 p90 -162.64 168.91 20.97 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.771 HG22 HD11 ' A' ' 55' ' ' ILE . 75.7 t -114.22 136.75 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.638 -1.289 . . . . 0.0 112.376 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 174' ' ' ILE . 81.7 mt -101.71 125.64 55.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.61 ' OD1' ' CG ' ' A' ' 209' ' ' HIS . 3.9 p30 -134.86 30.23 3.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.842 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 208' ' ' TYR . . . 177.42 163.49 29.44 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 117.614 -2.232 . . . . 0.0 112.671 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 208' ' ' TYR . . . -144.24 157.06 44.5 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.858 ' C ' HG22 ' A' ' 3' ' ' VAL . 9.5 p-10 -120.86 -0.5 10.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.698 -1.251 . . . . 0.0 110.576 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.583 ' N ' HG22 ' A' ' 3' ' ' VAL . . . 91.0 -27.67 8.81 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 36.4 mtt180 -89.22 30.08 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -1.187 . . . . 0.0 109.509 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 205' ' ' ARG . 0.6 OUTLIER 71.46 20.48 4.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.691 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 203' ' ' ASP . 16.3 m-85 -116.73 135.12 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.103 -0.998 . . . . 0.0 109.468 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 202' ' ' ALA . 16.3 m-85 -121.11 168.4 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.367 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.61 ' CG ' ' OD1' ' A' ' 200' ' ' ASP . 2.1 t60 -91.51 147.02 23.32 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.941 HG21 ' CG ' ' A' ' 222' ' ' PHE . 37.4 t -138.79 137.51 42.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 54' ' ' GLN . 25.6 t-20 -105.88 78.81 1.36 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.623 ' CE3' ' HB3' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -46.57 164.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.716 . . . . 0.0 110.238 -178.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -92.97 26.16 16.16 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 231' ' ' ALA . 22.2 m95 -107.06 -168.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.638 -0.919 . . . . 0.0 109.748 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -80.36 -87.32 0.58 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.13 53.08 0.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.718 HG13 ' N ' ' A' ' 218' ' ' SER . 8.6 p -100.14 -134.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.181 -1.188 . . . . 0.0 109.138 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.718 ' N ' HG13 ' A' ' 217' ' ' VAL . 6.4 m -67.31 57.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.498 -1.376 . . . . 0.0 110.366 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' VAL . 5.3 m-20 -95.83 96.14 8.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.973 . . . . 0.0 109.271 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 210' ' ' VAL . . . 160.13 -114.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -58.76 145.34 40.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.463 -1.022 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.941 ' CG ' HG21 ' A' ' 210' ' ' VAL . 0.0 OUTLIER -118.06 -166.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.769 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 226' ' ' ALA . 41.0 mtt180 -128.97 -165.99 1.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.687 HD13 ' NZ ' ' A' ' 167' ' ' LYS . 3.4 mt -115.03 -47.99 2.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -98.61 8.31 45.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 223' ' ' ARG . . . -122.33 84.01 2.19 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.147 0.975 . . . . 0.0 108.605 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.813 HD13 ' OE1' ' A' ' 245' ' ' GLN . 0.2 OUTLIER -93.86 -3.6 51.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.9 -178.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 241' ' ' PHE . 1.7 m-80 -92.15 159.22 37.95 Favored Pre-proline 0 C--N 1.292 -1.927 0 O-C-N 121.369 -0.832 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 212' ' ' TRP . 35.9 Cg_endo -78.21 159.64 29.83 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.786 2.324 . . . . 0.0 110.851 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.6 p -102.72 -39.86 6.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.389 -0.819 . . . . 0.0 109.113 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 217' ' ' VAL . . . -73.7 106.92 5.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 109.216 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.1 mt -69.69 -63.48 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.27 -172.41 16.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 3.8 m -109.12 -48.62 3.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 109.749 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -89.71 18.47 46.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.77 -66.19 0.64 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.35 58.3 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.537 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -46.51 -69.3 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.156 . . . . 0.0 109.358 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 116.45 -97.71 0.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.33 65.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -123.65 168.83 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -1.116 . . . . 0.0 109.508 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.543 ' ND2' ' HG3' ' A' ' 245' ' ' GLN . 1.1 t-20 -132.4 74.82 1.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.815 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -76.26 -53.12 5.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.504 ' O ' ' HG3' ' A' ' 245' ' ' GLN . 23.8 m-85 -133.47 159.34 40.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -1.048 . . . . 0.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.813 ' OE1' HD13 ' A' ' 227' ' ' LEU . 28.7 mt-30 -153.45 143.52 22.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 40.5 p -155.21 162.03 41.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.235 -0.915 . . . . 0.0 109.642 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.691 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -136.93 148.16 46.82 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.204 1.002 . . . . 0.0 110.085 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 185' ' ' TYR . 97.9 t -110.49 121.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.746 HG23 ' NE2' ' A' ' 158' ' ' HIS . 24.7 m -132.96 146.45 32.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.675 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 94.53 54.54 1.55 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 mt -101.14 97.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.308 -1.113 . . . . 0.0 110.004 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 154' ' ' ASN . 7.9 pttm -162.85 144.38 7.82 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 36.3 Cg_endo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.17 1.913 . . . . 0.0 110.4 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.525 ' NE2' ' OD1' ' A' ' 175' ' ' ASP . 41.6 tt0 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HD2' ' OD2' ' A' ' 175' ' ' ASP . 35.6 Cg_endo -77.65 136.44 15.37 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.347 2.031 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' C ' ' A' ' 203' ' ' ASP . 16.8 t -79.34 142.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 109.702 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 178' ' ' LEU . 22.6 t -136.73 130.67 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.505 -0.747 . . . . 0.0 109.218 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 200' ' ' ASP . 63.7 mmtt -76.43 -172.95 2.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.086 -1.009 . . . . 0.0 108.517 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 9' ' ' ASP . 4.2 t -79.27 101.8 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.711 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 49.4 mt -56.89 -50.23 73.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 108.818 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 198' ' ' VAL . 12.8 mt -55.04 -44.08 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.857 -1.152 . . . . 0.0 108.702 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 6' ' ' SER . 97.9 m-20 -67.83 -38.71 83.55 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.183 -0.948 . . . . 0.0 108.548 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.6 p -58.32 -14.87 8.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.307 -0.871 . . . . 0.0 109.066 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 9.4 mtpp -119.13 23.33 11.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' PRO . . . 45.47 35.69 5.54 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 58' ' ' TYR . 17.5 mt -88.91 109.39 20.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.409 1.1 . . . . 0.0 110.432 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 102' ' ' PRO . 63.1 m80 -133.4 98.82 4.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.1 m-30 -103.76 176.81 5.03 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.273 1.035 . . . . 0.0 112.299 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.602 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 1.1 t-20 -147.2 -172.74 4.08 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.545 ' CG ' ' OG1' ' A' ' 50' ' ' THR . 4.6 mt-30 -124.23 -14.94 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.917 -1.115 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.711 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -115.18 -39.11 0.97 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.799 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.847 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.2 -138.96 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.489 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.108 -178.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 19' ' ' ASN . 36.2 Cg_endo -74.62 4.02 4.9 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 122.667 1.988 . . . . 0.0 109.185 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.602 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 64.1 m-85 -75.79 -35.21 60.15 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.632 -0.667 . . . . 0.0 109.903 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' ND2' ' HA2' ' A' ' 18' ' ' GLY . 42.7 p30 -97.95 21.78 10.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.494 -1.379 . . . . 0.0 109.998 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 23' ' ' LEU . 14.6 mt -72.7 -2.39 20.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.754 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 118' ' ' GLU . 12.3 mt -129.03 -6.3 4.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.988 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 23.2 p -62.07 162.62 16.93 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.644 ' HG2' ' CG ' ' A' ' 131' ' ' TYR . 17.9 Cg_endo -70.69 130.37 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.14 1.893 . . . . 0.0 111.841 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.44 149.15 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.551 0.691 . . . . 0.0 110.168 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 79' ' ' TYR . 33.7 mt -77.8 144.66 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.558 0.694 . . . . 0.0 110.689 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HA ' HG13 ' A' ' 39' ' ' VAL . 20.5 mt-10 -123.6 -23.51 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.512 -0.742 . . . . 0.0 110.052 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' TYR . 10.9 mtpp -118.94 162.5 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.264 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 39' ' ' VAL . 42.4 t -114.48 149.14 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -79.31 127.13 79.85 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -70.71 123.11 9.49 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.371 1.381 . . . . 0.0 110.484 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.67 11.21 31.29 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.47 -177.95 5.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.309 -1.112 . . . . 0.0 109.39 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.48 169.25 18.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.794 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.38 131.44 35.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' CG ' ' HG3' ' A' ' 133' ' ' PRO . 87.0 m-85 -123.29 25.03 8.54 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.055 -1.028 . . . . 0.0 109.634 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG23 HG23 ' A' ' 31' ' ' VAL . 77.1 t -73.74 148.3 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.192 -0.942 . . . . 0.0 109.078 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.21 -1.87 73.47 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HG3' ' C ' ' A' ' 38' ' ' PHE . 5.1 mm-40 -88.27 131.02 34.95 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.423 -1.045 . . . . 0.0 109.668 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.13 112.66 9.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 132' ' ' GLY . . . -52.59 157.12 1.64 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.913 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' O ' ' OG ' ' A' ' 135' ' ' SER . . . -77.81 169.43 18.3 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.332 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.5 ' O ' ' HE2' ' A' ' 129' ' ' MET . 31.4 p -77.81 -34.11 52.18 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.979 -1.076 . . . . 0.0 108.385 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 129' ' ' MET . . . 101.64 136.88 9.46 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -54.3 -51.33 64.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.235 -1.156 . . . . 0.0 108.891 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 196' ' ' ALA . 2.8 t -46.7 -53.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' HE2' ' A' ' 129' ' ' MET . . . -60.19 -50.6 73.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.25 -0.907 . . . . 0.0 110.329 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -63.62 -31.72 72.98 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.654 -0.653 . . . . 0.0 110.714 -178.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 198' ' ' VAL . . . -67.08 -41.94 85.49 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.072 -1.451 . . . . 0.0 108.261 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -73.51 -54.2 8.78 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.816 0.817 . . . . 0.0 109.874 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' CB ' ' SD ' ' A' ' 120' ' ' MET . . . -52.88 -39.59 62.79 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.809 -0.557 . . . . 0.0 110.316 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' CG ' ' HB2' ' A' ' 15' ' ' TYR . 29.1 mt-30 -61.09 -44.48 97.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.742 -1.224 . . . . 0.0 107.733 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD11 HG22 ' A' ' 198' ' ' VAL . 44.1 mt -68.35 -24.53 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.568 ' HB2' ' HA ' ' A' ' 53' ' ' ALA . 29.2 mtp -73.36 -38.63 65.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HE2' ' N ' ' A' ' 102' ' ' PRO . 33.6 tptt -68.46 -43.54 76.8 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' LEU . 42.5 t80 -53.03 -32.66 48.0 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.679 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 251' ' ' ILE . 53.6 m-70 -107.52 -22.21 12.62 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.521 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.607 ' HA ' ' CD2' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 38.64 55.54 1.91 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.621 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 3.2 t80 -77.0 -70.52 0.21 Allowed Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 61' ' ' TYR . 36.8 Cg_endo -70.51 104.2 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 120.399 0.733 . . . . 0.0 111.942 -176.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 95' ' ' TYR . 1.4 m-80 -69.55 -22.61 63.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 3.6 ttpm? -134.55 141.72 46.76 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 90' ' ' ILE . . . -57.94 153.06 26.65 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.507 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.05 HD12 ' HA3' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -94.35 -38.65 10.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -1.019 . . . . 0.0 109.984 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 46.3 tttt -152.16 139.45 19.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 91' ' ' SER . 77.7 m-20 -63.87 170.3 3.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 126' ' ' SER . 22.8 t80 -153.03 135.66 15.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.069 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.8 t -142.57 152.83 42.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 109.759 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 19.9 p90 -156.44 152.98 28.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.844 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.574 HG23 ' CG ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -92.74 126.58 37.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.733 HD21 ' ND2' ' A' ' 77' ' ' ASN . 11.5 tp -44.03 147.29 0.52 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.77 0.795 . . . . 0.0 110.947 -178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 146.55 48.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.716 -0.615 . . . . 0.0 110.187 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.41 1.63 9.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.856 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.519 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 10.0 m-20 -98.65 -9.4 24.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.333 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.733 ' ND2' HD21 ' A' ' 73' ' ' LEU . 28.7 t-20 -69.73 109.35 4.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.782 -0.574 . . . . 0.0 110.35 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.588 ' HD2' ' CD2' ' A' ' 79' ' ' TYR . 38.3 Cg_endo -88.72 14.54 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.79 2.327 . . . . 0.0 110.386 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.784 ' HB3' HG23 ' A' ' 28' ' ' ILE . 80.1 m-85 -107.92 -22.6 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 110.66 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' ASN . 87.7 m-85 -118.48 163.35 16.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 7.7 m-80 -49.14 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 175.39 -48.38 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.508 175.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 82' ' ' HIS . 30.9 Cg_endo -75.85 58.88 5.57 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 N-CA-C 107.01 -1.958 . . . . 0.0 107.01 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 86' ' ' LEU . 12.1 tptt -105.49 121.86 44.81 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.784 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.574 ' CG ' HG23 ' A' ' 72' ' ' THR . 2.5 m-80 -105.83 115.98 31.16 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.7 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 3.0 mp -95.49 128.85 42.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -129.81 141.06 50.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -117.28 113.26 21.91 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 87' ' ' PHE . . . -73.24 52.81 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 108.118 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 mt -52.77 -53.63 20.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.555 -0.716 . . . . 0.0 110.205 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 p -45.65 -25.6 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.637 -1.289 . . . . 0.0 109.147 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -111.28 19.78 17.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.352 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.647 ' CG ' ' HA ' ' A' ' 90' ' ' ILE . 17.9 mmt-85 -79.43 151.49 30.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -117.36 90.99 3.45 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-85 -81.21 94.66 6.72 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 0.0 110.828 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . 1.7 t30 -82.64 89.39 6.72 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.607 ' CD2' ' HA ' ' A' ' 60' ' ' ASN . 68.1 m95 -61.39 -7.13 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 -178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -89.87 -19.8 24.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 6.0 m-20 -99.71 -28.0 13.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.635 HG12 ' HB1' ' A' ' 115' ' ' ALA . 44.9 mt -73.77 65.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' N ' ' OH ' ' A' ' 104' ' ' TYR . 21.2 mt -45.89 148.62 1.35 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.723 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.562 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 30.0 Cg_endo -78.0 -17.96 13.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.641 2.228 . . . . 0.0 110.446 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' THR . 9.0 t -144.92 122.5 11.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.2 -0.938 . . . . 0.0 109.082 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 101' ' ' LEU . 81.7 m-85 -109.5 141.75 41.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -99.93 -5.95 27.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.452 -0.78 . . . . 0.0 109.086 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -3.78 83.28 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -116.48 0.66 12.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -1.179 . . . . 0.0 109.471 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.48 160.82 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.31 167.47 0.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.176 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 113' ' ' LYS . 6.1 m-80 -72.79 -29.41 63.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.1 t -51.9 -63.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.519 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 3.2 mp0 -62.46 -32.42 73.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.271 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 110' ' ' ASN . 24.6 mttt -66.54 -43.7 84.4 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.48 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 46.8 ttm -59.6 -35.52 74.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 100' ' ' ILE . . . -57.72 -68.71 0.21 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.676 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.536 ' CD1' HD23 ' A' ' 119' ' ' LEU . 1.3 tp -59.84 -37.6 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.295 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 114' ' ' MET . 13.8 p -57.39 -43.39 83.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.895 -1.128 . . . . 0.0 110.755 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.743 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.23 -37.18 77.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 108.95 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.578 HD21 ' HB1' ' A' ' 53' ' ' ALA . 3.6 tp -59.48 -59.52 5.31 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.612 ' SD ' ' CB ' ' A' ' 53' ' ' ALA . 2.0 mmt -49.87 -40.59 43.11 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.211 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -70.38 -41.04 73.59 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.639 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 36.7 m-20 -64.63 -47.14 79.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 127' ' ' VAL . 54.5 t -70.08 -49.7 53.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . -60.18 -33.05 78.31 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 126' ' ' SER . 1.2 mt -75.22 -57.0 7.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 125' ' ' ILE . 1.4 p -47.79 -26.92 1.78 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 142' ' ' ARG . 32.9 m -100.44 28.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.358 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 4.4 m-20 39.46 48.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.57 ' HE1' ' HB2' ' A' ' 137' ' ' SER . 53.5 tpp -59.66 131.79 52.0 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 24.1 t0 -76.89 120.66 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.644 ' CG ' ' HG2' ' A' ' 26' ' ' PRO . 60.7 m-85 -103.05 115.69 31.07 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.572 1.177 . . . . 0.0 113.245 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.764 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -151.1 -163.7 11.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 104.747 -3.341 . . . . 0.0 104.747 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD3' HD13 ' A' ' 28' ' ' ILE . 18.1 Cg_endo -62.31 -31.44 81.75 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 N-CA-C 105.87 -2.396 . . . . 0.0 105.87 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.3 m -109.22 144.35 37.45 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.526 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.2 m -123.7 110.66 15.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 119.859 -1.776 . . . . 0.0 110.451 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . . . -107.99 141.55 15.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.57 ' HB2' ' HE1' ' A' ' 129' ' ' MET . 29.4 t -118.22 -162.48 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -1.182 . . . . 0.0 108.998 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 137' ' ' SER . . . -91.78 -61.45 1.63 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA2' ' OH ' ' A' ' 185' ' ' TYR . . . 138.57 -137.31 8.63 Favored Glycine 0 N--CA 1.481 1.649 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.996 176.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' CG ' ' A' ' 159' ' ' GLN . 3.3 m -48.34 -50.06 31.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.882 -0.775 . . . . 0.0 112.422 -178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 p -45.95 -48.45 16.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 110.407 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HB3' ' HA ' ' A' ' 127' ' ' VAL . 7.0 mmt180 -80.7 -36.17 32.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.821 -1.174 . . . . 0.0 110.069 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 185' ' ' TYR . 87.8 t -67.2 -58.45 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.359 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 148' ' ' LYS . 1.3 pp0? -56.03 -31.61 63.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.308 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 1.4 ttt180 -77.72 -47.67 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.419 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HB1' ' OG ' ' A' ' 126' ' ' SER . . . -66.41 -35.06 79.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.497 HD12 HG11 ' A' ' 248' ' ' VAL . 39.4 mt -60.13 -46.25 90.27 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 110.016 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 28.1 mtmt -87.38 -45.25 10.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 60.2 mt-10 -70.73 -43.54 68.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.875 -1.14 . . . . 0.0 111.792 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 126' ' ' SER . 24.2 m120 -94.42 -44.66 7.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 111.608 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 152' ' ' GLY . 32.3 m-85 -102.26 15.86 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 110.673 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.05 ' HA3' HD12 ' A' ' 66' ' ' LEU . . . 33.74 38.93 0.1 OUTLIER Glycine 0 N--CA 1.494 2.53 0 O-C-N 121.639 -0.663 . . . . 0.0 112.75 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 56' ' ' MET . 8.6 m-85 -61.97 164.67 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.189 -1.771 . . . . 0.0 107.666 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 252' ' ' LYS . 45.5 t30 -47.76 143.12 4.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.893 -1.129 . . . . 0.0 109.084 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -53.51 -18.69 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 109.079 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.519 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 78.0 p -53.36 -16.34 1.33 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -0.856 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 251' ' ' ILE . 56.0 t -66.29 118.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.83 -1.168 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.918 ' CE1' HG23 ' A' ' 249' ' ' VAL . 9.1 p-80 -142.2 155.57 45.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.378 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.554 ' CG ' ' HB3' ' A' ' 140' ' ' SER . 3.0 tt0 -101.15 163.24 12.38 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.805 HD12 ' CZ3' ' A' ' 170' ' ' TRP . 17.4 pt -145.56 165.77 10.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 162' ' ' ARG . 3.5 m-80 -125.13 100.08 6.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 110.086 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.615 ' N ' ' CH2' ' A' ' 170' ' ' TRP . 45.1 tpt85 -45.34 -35.22 3.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.142 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -62.34 -28.04 70.31 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -103.89 6.26 36.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.899 -1.353 . . . . 0.0 111.876 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -118.1 177.27 4.85 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.388 -1.445 . . . . 0.0 110.407 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 167' ' ' LYS . 88.4 p -103.95 132.65 49.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 166' ' ' SER . 20.5 ttmt -33.21 -46.27 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.848 -0.533 . . . . 0.0 110.885 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -64.21 -62.39 1.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.861 -1.15 . . . . 0.0 109.878 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -17.19 61.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.805 ' CZ3' HD12 ' A' ' 160' ' ' ILE . 75.7 t-105 -75.81 -47.01 27.48 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.197 -0.94 . . . . 0.0 109.162 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HA ' HD12 ' A' ' 174' ' ' ILE . 55.5 mt-10 -69.84 -38.19 76.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.168 -0.957 . . . . 0.0 108.549 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.19 50.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.554 ' NE2' HG21 ' A' ' 249' ' ' VAL . 10.9 mm100 -61.07 -41.47 96.69 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.01 HG23 HG21 ' A' ' 184' ' ' VAL . 13.2 mt -75.66 -58.24 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.39 -0.819 . . . . 0.0 110.575 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 1' ' ' GLN . 0.3 OUTLIER -49.46 -45.32 46.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.725 -1.235 . . . . 0.0 108.888 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -51.61 -43.03 62.41 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.621 ' CG ' ' HB ' ' A' ' 249' ' ' VAL . 44.6 mm-40 -60.18 -50.99 71.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.75 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.8 mt -68.27 -26.48 65.69 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.8 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 175' ' ' ASP . 12.7 p -52.17 -39.29 59.85 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 182' ' ' GLN . 13.4 mt-30 -100.93 35.41 2.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.491 ' C ' HD13 ' A' ' 7' ' ' LEU . 15.0 m-80 47.18 51.06 13.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 180' ' ' GLN . 12.6 mt-30 -123.31 113.0 29.56 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 199' ' ' ILE . 15.1 Cg_endo -64.95 169.85 11.2 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.742 1.628 . . . . 0.0 111.792 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 1.01 HG21 HG23 ' A' ' 174' ' ' ILE . 96.5 t -126.61 130.78 71.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.722 -176.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.832 ' CD1' HG23 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -82.86 116.91 22.38 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 176.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 197' ' ' PHE . 6.4 t80 -122.48 159.19 28.17 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.92 -1.113 . . . . 0.0 109.35 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 195' ' ' HIS . 1.3 pt20 -167.06 130.87 1.88 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.511 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 245' ' ' GLN . . . -92.43 125.93 8.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 194' ' ' GLY . 53.9 t -91.33 162.73 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.147 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 189' ' ' VAL . . . -170.6 -133.27 1.58 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.538 ' HG3' ' CZ ' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -87.76 -47.83 8.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.72 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.97 -11.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.175 -0.953 . . . . 0.0 111.205 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.33 -160.18 20.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 189' ' ' VAL . . . -95.09 110.59 4.04 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.258 -1.448 . . . . 0.0 111.125 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.625 ' O ' ' HA ' ' A' ' 187' ' ' GLN . 20.7 t-80 -72.4 132.23 43.66 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 48' ' ' VAL . . . -119.74 163.92 16.71 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.059 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.872 ' CD1' HG13 ' A' ' 210' ' ' VAL . 15.9 p90 -161.8 168.05 23.82 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.649 HG22 HD11 ' A' ' 55' ' ' ILE . 84.5 t -114.71 135.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.59 -1.319 . . . . 0.0 112.185 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 174' ' ' ILE . 76.1 mt -97.62 124.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . 8.3 p-10 -137.1 33.05 2.61 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.992 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 178' ' ' LEU . . . -173.73 167.9 40.62 Favored Glycine 0 N--CA 1.484 1.887 0 C-N-CA 117.757 -2.163 . . . . 0.0 112.356 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -152.34 149.37 28.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.641 ' C ' HG22 ' A' ' 3' ' ' VAL . 1.3 m-20 -117.99 29.07 8.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 110.258 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 3' ' ' VAL . . . 49.5 22.63 3.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 206' ' ' ASN . 0.0 OUTLIER -140.74 25.95 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -1.068 . . . . 0.0 108.91 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.564 ' O ' ' CE1' ' A' ' 222' ' ' PHE . 0.8 OUTLIER 75.23 7.77 4.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.401 -0.812 . . . . 0.0 109.719 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 202' ' ' ALA . 25.9 m-85 -103.33 136.54 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 171' ' ' GLU . 49.8 m-85 -123.65 163.07 21.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 111.119 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 199' ' ' ILE . 40.4 t-80 -93.68 123.01 36.73 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.872 HG13 ' CD1' ' A' ' 197' ' ' PHE . 54.1 t -117.42 141.67 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 111.619 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.506 ' HB2' HD12 ' A' ' 8' ' ' LEU . 18.2 t-20 -110.1 76.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 211' ' ' ASN . 65.1 m95 -47.08 173.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.479 ' O ' ' OE1' ' A' ' 17' ' ' GLN . . . -89.51 30.77 5.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -118.85 -167.37 1.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -1.157 . . . . 0.0 108.985 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.12 -104.62 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.47 52.38 0.83 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.809 HG22 ' N ' ' A' ' 218' ' ' SER . 0.8 OUTLIER -95.05 -93.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -1.142 . . . . 0.0 109.806 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.809 ' N ' HG22 ' A' ' 217' ' ' VAL . 0.5 OUTLIER -69.32 -3.86 15.76 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.403 -0.81 . . . . 0.0 110.101 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.75 128.42 26.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.218 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.97 -113.34 0.56 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 208' ' ' TYR . 88.1 m-85 -87.02 159.02 19.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.261 -1.141 . . . . 0.0 109.716 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.564 ' CE1' ' O ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -90.93 172.92 8.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 109.495 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.24 -165.97 1.48 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.187 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 34.8 mt -118.05 -51.55 2.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.42 -8.94 6.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.674 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.3 92.71 3.75 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.061 0.934 . . . . 0.0 109.051 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 227' ' ' LEU . 2.6 mm? -90.81 76.45 6.36 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-O 121.484 0.659 . . . . 0.0 109.292 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -116.52 166.03 13.66 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.507 ' HB3' ' CE1' ' A' ' 195' ' ' HIS . 36.5 Cg_endo -80.18 179.92 5.78 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.789 2.326 . . . . 0.0 110.412 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.5 p -84.58 -36.41 22.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.085 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.68 115.88 27.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.08 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 59.66 4.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.882 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 100.15 126.86 5.85 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.93 -53.43 4.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 109.289 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -86.85 -160.37 34.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -75.03 96.81 0.99 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.13 178.12 21.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -88.67 164.99 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -1.136 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.01 -123.89 0.3 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 175.72 75.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.538 ' CZ ' ' HG3' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -64.29 -174.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 109.535 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.43 ' CG ' ' OE1' ' A' ' 245' ' ' GLN . 1.5 t-20 -104.3 110.36 22.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -119.43 -46.5 0.4 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.539 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 72.5 m-85 -135.22 87.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.384 -1.068 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 162' ' ' ARG . 7.1 mt-30 -91.38 120.04 31.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.0 108.624 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 30.6 p -133.41 165.34 25.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.473 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 160' ' ' ILE . . . -141.23 152.68 44.76 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.725 0.774 . . . . 0.0 110.247 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.832 HG23 ' CD1' ' A' ' 185' ' ' TYR . 16.5 t -112.84 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.918 HG23 ' CE1' ' A' ' 158' ' ' HIS . 4.6 m -109.97 139.72 32.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.318 0.58 . . . . 0.0 110.174 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.434 ' N ' ' CD ' ' A' ' 177' ' ' GLU . . . 100.5 48.58 1.52 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.211 -1.471 . . . . 0.0 109.659 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 9.0 mt -104.61 94.67 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.245 -1.15 . . . . 0.0 111.131 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 252' ' ' LYS . 0.0 OUTLIER -163.43 146.03 7.94 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.618 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.153 1.902 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 stop_ save_